<SEC-DOCUMENT>0001585364-23-000058.txt : 20230509
<SEC-HEADER>0001585364-23-000058.hdr.sgml : 20230509
<ACCEPTANCE-DATETIME>20230509130511
ACCESSION NUMBER:		0001585364-23-000058
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		101
CONFORMED PERIOD OF REPORT:	20230401
FILED AS OF DATE:		20230509
DATE AS OF CHANGE:		20230509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PERRIGO Co plc
		CENTRAL INDEX KEY:			0001585364
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36353
		FILM NUMBER:		23901132

	BUSINESS ADDRESS:	
		STREET 1:		THE SHARP BUILDING
		STREET 2:		HOGAN PLACE
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 TY74
		BUSINESS PHONE:		269-673-8451

	MAIL ADDRESS:	
		STREET 1:		515 EASTERN AVENUE
		CITY:			ALLEGAN
		STATE:			MI
		ZIP:			49010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PERRIGO Co Ltd
		DATE OF NAME CHANGE:	20130828
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>prgo-20230401.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:d94275d0-2889-4bee-8a41-eed44cff1b4d,g:5de99725-025a-4d3c-a861-61491132bb43,d:391fab8b65b648d5a5c27f0c2d5892b5--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:prgo="http://www.perrigo.com/20230401" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>prgo-20230401</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80L2ZyYWc6YzA2MjY0ZmYzNDc0NDFiYjgzYThmNzRkZmY3MTc3MzMvdGFibGU6OTYzODNiMzU1NWJjNGE1M2FmY2IwNTIxOTcyZDdjNjgvdGFibGVyYW5nZTo5NjM4M2IzNTU1YmM0YTUzYWZjYjA1MjE5NzJkN2M2OF80LTEtMS0xLTI5NzUwMw_832fe373-2b3a-4861-aa15-908b77731cd4">0001585364</ix:nonNumeric><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80L2ZyYWc6YzA2MjY0ZmYzNDc0NDFiYjgzYThmNzRkZmY3MTc3MzMvdGFibGU6OTYzODNiMzU1NWJjNGE1M2FmY2IwNTIxOTcyZDdjNjgvdGFibGVyYW5nZTo5NjM4M2IzNTU1YmM0YTUzYWZjYjA1MjE5NzJkN2M2OF81LTEtMS0xLTI5NzUwMw_b8e0b064-292c-4489-9f8a-e1e02e8ce0c2">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80L2ZyYWc6YzA2MjY0ZmYzNDc0NDFiYjgzYThmNzRkZmY3MTc3MzMvdGFibGU6OTYzODNiMzU1NWJjNGE1M2FmY2IwNTIxOTcyZDdjNjgvdGFibGVyYW5nZTo5NjM4M2IzNTU1YmM0YTUzYWZjYjA1MjE5NzJkN2M2OF85LTEtMS0xLTI5NzUwMw_399cdc34-8a4d-424d-89e8-7683e1113b28">2023</ix:nonNumeric><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80L2ZyYWc6YzA2MjY0ZmYzNDc0NDFiYjgzYThmNzRkZmY3MTc3MzMvdGFibGU6OTYzODNiMzU1NWJjNGE1M2FmY2IwNTIxOTcyZDdjNjgvdGFibGVyYW5nZTo5NjM4M2IzNTU1YmM0YTUzYWZjYjA1MjE5NzJkN2M2OF8xMC0xLTEtMS0yOTc1MDM_62d11935-99b2-4620-a8eb-d76c84d90bfa">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80L2ZyYWc6YzA2MjY0ZmYzNDc0NDFiYjgzYThmNzRkZmY3MTc3MzMvdGFibGU6OTYzODNiMzU1NWJjNGE1M2FmY2IwNTIxOTcyZDdjNjgvdGFibGVyYW5nZTo5NjM4M2IzNTU1YmM0YTUzYWZjYjA1MjE5NzJkN2M2OF8xMS0xLTEtMS0yOTc1MDM_d869671c-51a1-4b50-8fc3-1b198d7fb8fc">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_8393b283-e363-4504-b231-143478dd2c5f">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_87043135-b949-45d0-9eae-f1b4645419a9">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_05036283-a810-4bae-854e-92b3df99922c">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_b5e2a70c-b3bd-48c1-b7a0-2aff813e9b08">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_1a147768-c056-425b-af34-6db715980677">http://fasb.org/us-gaap/2022#LongTermDebtCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_7a7ad5f3-7e3d-4fd6-b39b-bd13f91b4653">http://fasb.org/us-gaap/2022#LongTermDebtCurrent</ix:nonNumeric><ix:nonNumeric contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_156cee65-de81-4dfd-849e-fc62e3c9dfcf">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_88c5c5e3-521f-44d6-b6d7-0639e3d6ce44">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_3eb3333f-44a6-4a5b-bef2-60d0ef263f0a">http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_f509a7f0-b2aa-4888-9b39-8d9314e7b4c4">http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="prgo-20230401.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8661025121e9419ab6b60b4f10d5e2b8_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:OrdinaryShares0001ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b69715b8beb4265b311eb807fec1768_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A3900SeniorNoteDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32b30e53a37f41a1ac98e8fb9995ca4e_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i765e63eea0a54636a90ce216a325be3a_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib67f1fede03d484bba024eb3d57f031f_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A5300UnsecuredSeniorNotesDueNovember152043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95b2b593633042b4b81a8353b11811f5_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A4900SeniorLoanDue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1979f160e0c4d1697ab4c57477e38d1_I20230505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i09f467292f2f4ec28ff4898282903225_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa30a67b78141b8a9689bcf457bb312_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic8ec02b3dd484b4e8275f17f1949e2de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07bcc81fd19e45bdb8acb5118329924f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04cfa05f5fd341f898c851d834e5a6ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd18f1c6b0bf4007931565e3309d3a59_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i712e3d08fced4870b5dd4e881cd7d98a_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47510622497c47db87a31fe64fc51a88_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a185df6ddcb4f0db8975f91beef3d79_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib43124566cd24715b45ad75e52af2328_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id761e753820a44cea1db50ca513e11e5_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6955bfa807de4779804dcda471f50c60_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie326fc7603fc47d2829c2df0bcf4817d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d376c6445864b46856bd7c9eca96a57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5aed5796cb6f4c748a6fbc6e5733a7b5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7e7884fe5fe439cbb60a14a0bfa25da_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if52e0bee33a840b6b04f0e23c7814541_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b9dd69bc08149889b61d83c2b89ce51_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3cf13b5a219470a985bbaa83714a9e5_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2716fca3625c46c785d6b90d8eb978c4_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47f5c13d45a9489b800b1fdca5125d08_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf374477ec7c4dc8a274c7c5c8b33a4e_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67e110cebac446599cfeea238f5aca8e_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40d57b17ab9441e0830bda17d8d7302a_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib41c767804e04e74b0d0675fae86b3e6_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70d2639683f947f1b1d6e8865ba5ab42_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3deb497865334700bccbc0cb9af79e11_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52ca79a594274f7d986860796f5bf5c4_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe154ddc08314c818219ab4974f9b334_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i423427f446af435a8a099e8e39407244_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f4328ac279d49ba94fa79ccb58cca12_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65f795e573b74139b0597df57a87597e_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedde1896a9a744229692a430d32ed377_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkinCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i023898292ce644d4920385454d5ee04c_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkinCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf8cd73c20df4eb1818e515fc7c9333a_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd70fd42144a4756be4ac24e92e7858a_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05a97c7cd9bf4ae49aef6276d404df59_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89b3d9701d1f4e7aad3538d9f6e954f9_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cbf1a7074ed45a3a1f504b48f430acf_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aed093d915e4cb8a09ef81ab74849f2_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73e4fca1b9404a29b27348e58f4f2456_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a41be8290854dd7b445442e9fce77b4_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f64d6970e5341198837503d0ac5e982_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9230b63081f4a419d17b4423287f16d_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id72e917daad64a05bf29a7fa65162e54_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkinCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aeac51b11cd4427af639bde4e8f879a_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkinCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i935b53becd594afcbffb2058d5cf3b02_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7bbc6f93b654156afae3a426cf64660_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i153d82f41fd34b13bb9cdb1b721635fa_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08ee092ef6164e56bd199362643c5c7f_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8ee1193579b4eae9c065c0476e1af27_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c3401426e894533be11508ed857acc6_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c62f3bb392741fda84f5cd9e3a30ea0_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ec2b2f9ab6446b7aee5b5a487b367d9_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8e25af889154d1bb960e56417630fde_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eb71bb33d314222ab57e0143395957a_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86ac2754d6fd4df6b38298e67a72bf14_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i810f1ba4bfdd4a278d0a9f1e7f9c9a68_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib811602f7ff24efc831c6c1156046949_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia940558c4b3444388c68c903c7078507_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i817dfeec890e44ed95bda23a0c957cff_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc50f621c6924bbf8a473a58178c820b_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e003873c79f4b258525ee8b81660c16_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i687906ed625e459a9c846fd176504670_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe0cdbd5f85948e995c7dc28b6cb4f45_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8ac8cde05224960aeb104a710acfa0d_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia14a583947bd41cda0620726204c97bf_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id685e682ee6d45c885e9bd25d7d82f62_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2df41325723f4515a100896e6f2804d2_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe10084d8d8e4b8ea8a1ba4efd5d12ce_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic077248bde32442796615d79eeb0a55f_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3597c655dd73488a968ca15c3fa79180_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16e4dfbabc1449fdb44f59c5ebd68d88_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i09b56fa39043421e9d4157b4a80c13b3_D20220429-20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-29</xbrli:startDate><xbrli:endDate>2022-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="iad94f9c92d974bc2b0f1da3daa6ff5db_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i297276a0f2644603919916e9535ffb86_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a4e7b481e564ec396c3dee7669dcf4a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49b813746d944e9caa272f8a6edd60db_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d0d200110e4e108b8f68acd92ba5e1_I20220309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:AdventInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f76ed2554e846f0acf432bf5b3cc813_D20220309-20220309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:AdventInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-09</xbrli:startDate><xbrli:endDate>2022-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5495ecbabeb74464bd45155077e348aa_I20220309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8a0f1a3d9cf416fbceebe5198581d19_D20220309-20220309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:LatinAmericaBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-09</xbrli:startDate><xbrli:endDate>2022-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ec5ffca5e044c25af00f0856f31cc69_D20220324-20220324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:ScarAwayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-24</xbrli:startDate><xbrli:endDate>2022-03-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife7f164c6edf47848398641f9ffd17b1_I20210706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c40483c42aa43999f3d00d21dcd2535_D20210706-20210706"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ebf7e0bc9094fd6a3ac5764350b0544_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eb38aa56dcf402bb0bb2637e8d49b4d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if103d7bf645e4b24ac84251cdaf12b33_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fd779f91b674ece84c54eb308733a1d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7ca477c08d84a82a9de72b2c524c103_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0244fe0ff77440b9929d419ff9c9da9b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i620cef7dc50148d7a2222193971d347f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8af8f32782cc4ff0b482a38bac5b723b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c25260d2b6b4edab1b3611171d1ce25_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4e56b5dd90f4224b8c29c7ef31fe2a5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f3eb6af9f444b3e8326226555389980_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib24332748044483db83ca8e301c719ca_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63eb2d1285fa4953907a861c6ea961bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc71f8f540634f1ea99e39a92c86aae5_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebce178fd4714f5f92bb9fbec5a443e3_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10071a3c442e4192b302e7657ea94c8c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07824618f65645f69731a6aa1568cec3_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fc973b59afa4340b4dea988d2ff81c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc8978c331594327a5fb3a589e575a4f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e68ee7033cc4aadb5686e063eb8d555_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id55a788697874c2bacf296adc61ea0b7_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13378a6ed8a844e6ab6a6cf5ba0bee6b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ae35b7343b14c67a3ee371bf5c1469e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i491ee1dd84214e7cb151e35c302d008c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied803c95feec417dbbc3ce5403e02dfc_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bc5f5344063450db6361f3d577c9287_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa4f6696fa504105b9bc1e35d5f422b5_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie898e8edfbf646baa27f1856bdfdd572_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia38fe8e9a9f04f668590d3cd5af1bea2_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i323e00f452604c9e8efdeea764a4c5b9_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie008783b9a804da39b8b478db605bf2e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide9fb602617c4361b1e1413aad64fba1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41c166f0f4ac4071b5451ad221b1c85b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04725fb2248c4ebeabaaa3e07ead859d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42c93a65a4db40e38259118bf87ca950_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4efa57993147ecbf3218e1e2ad5e1d_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54d490f02cff46969dc0d4b06f3a6c1a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1480475fcfcf4911a302de8597350461_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9220abdafe514bd1bc03b527e4e345fe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9993c7a02a6a4c7ea61954c3d40b6757_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcd10964e4444c5aa7f56a883baa41b4_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92e48502376142e5ac4f235d7f18af12_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibede6d5d7f6e435d97c1430b6dee57cf_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i182417c07231420c9b57037a5f01eef3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a834f03a804608931a9b7597442b59_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55e23d064ac94e579d65b01ab85c557a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e1c235573a44397aede9c7af5b6226c_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50a400f80e334fac81f4e0f510dd26d4_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie79b2663ac03492fa74b7ec953837986_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ed8e3a070954dd99dcac4657d4e487f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i850a948962d64a65adff8d59644ca588_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24fce60834ce4f74a2d6fdbbbe84bbf8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc98dc57d99e4819af454bec68b9436c_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e444dcadb33488daa64185519d1ac50_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39273b39b09344b1a7df355b3202f917_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfb63dc591b74a43a816a11b9df7a30b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0391704d774f4479b2bd6287047b946b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="derivative"><xbrli:measure>prgo:derivative</xbrli:measure></xbrli:unit><xbrli:context id="i863dc014fe5a4fd69e51cabe6ed66bef_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i703d29ff729d4c809efa88132b4033f6_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie73d3af15eaf44a38b8cd158e74b7934_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if59013eda0ee4c9783bb2aa14130c446_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69de5a172d6c4557ac718e348bdb6557_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fe60b7eb3e54bf4bec247c65d45ad0d_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d3d3fb12721426a98d72c0b4de560d8_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib95874ed8320453c88600e7dd3a13d14_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideed9f35811341b6987034ed4edf23a9_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="brand"><xbrli:measure>prgo:brand</xbrli:measure></xbrli:unit><xbrli:context id="i579bce87d950488c9440b6afa28de94c_I20220601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i231ffb94f5014c56bb9ab4f128394b92_I20220601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id158617640374c9fa1495cf02188a911_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f681b4b8d84632a9cc71f98e1bb3d6_I20221025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea716b8db0224b21bca000c2d1d526a3_I20221025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughDecember152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8461440591543a29bafbb6383d528eb_I20221025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughMarch252026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55284888fcd34a93ba5adfc643dfd08e_I20221025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughJune152030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c0c512854e04191adfce17ad716634b_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72e0c6387a644ace96085e11f8e677ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d39d66893f44acf940bd4020fe80a61_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cd991dd16c04acca9ac92cc1bede2e8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1d7962673e54ecf9e8c6b4bf23987b5_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28f2b3c78bed464c913866d5104a819f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id143f134d71c4b3eab34c1f0ee8afdab_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7f5b573a7f14d31b174ed365e23e979_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52a46e2bb32541beba33898f230357f7_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6c621b427f04e8796899f12e0d2010e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc816fb252f242b985c969760b37834f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f6d73713f78476b8e8534d2a1895b4c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aa8244a981b494783cc178b23ffb387_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9413936dee484f3c8c6f293e20f8e318_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3d2ba962fcb47f197b0697553afd857_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i141d55293db343b9858355f37d0a46e6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf4d615378ef46f4bcb95c10b96705e6_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HUF</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic48b9d0358ef4fc9b04eadf1f455b1f1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HUF</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4570a0e785e400a97404bd558852b0a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf3ff649eb5e43a89fb4b4cc0dcb1556_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24abf1ca03e84edba4b6d0d18c9fcd6a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02c31ca1b12a4d6081f2a49aba1e6718_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefefab2c0f7c4ccaacc90d873855372d_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7136cb4396ad4a658534b085e82dbfc7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58e9f89e450b4789b74027090e527fd2_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2e286c007514bd88ef38594ee3f765b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a74650587a0467ab9f464dd51bad8b6_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i548d3c81888a421d840889bc4a3e1068_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb6d2a114c44f87b07e610ccad0481a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0255c8396730441fab6e09dbb1afb422_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e0b4d9aeda94165b64f6361c52863a1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i055ddb3eb7864ddbb72cc19e608e8248_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3b19260e3134f8eac6745ebd39cfaba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0e4ace05b3746aab7f10dd86bdf5642_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d974173dfdd4a52a46760690fe23666_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eccd056afc545b39529ed76bdd93865_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc338e7d11bb49c0b3dd26e0b630ceaf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72ca5dc3f5a248a1ad6f808b50351d6a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4006135836b64c4a9a25d99b7b066e0d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i883728cd2fe84026a4db286c1fb80ffe_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56e2de60b8a148eeb14a18745abe9a02_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d46728e14d44678a73c2145851d2fb6_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida370fe5573e4ed7ba48cf6fe97b5c67_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ec0d02e7d8d49f2aa9b45ada2bfaef8_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae577995f42d4580ba2516f347bba679_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19bf4a75be9945638b85dd2447d4ad7f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if48bc899a04941fcaa88ed2870642735_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eee7139231548609a6bed77c36f242c_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i415d640a98a648a49bb88703fc4bf417_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86211ac950df4f52b3bdb376967439bd_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb2d9216b7b04cf0a3ecb3d790f50e69_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id11eac94d9bd4b9b8ae0373021cc6731_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d55a845d92a4d0bbc62c63895976038_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i794270c4878944cab78f1bdba967d567_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaec9a490f09d45b88e90070c6c101e1d_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i170e5f4e14d94ed2bf2f5e30f221c7a3_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8be97fbfb6bc4fdc93582f7325963e07_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieecd1150963c4685ab0218460f0f71ce_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2e5203a533d4aee8b2fdbcf22b56556_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22e1c81f675a48eaa5a572a21687d185_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66107ad7ba8046ec942972e9becaaff6_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f3f8cdce8a5422aa8044ef1e7ea60f3_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd5c9b62aef54b399eed74960e878654_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ef3599264dc4912b8aaad190f86b782_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c74f5dd34524d48896153867df4a030_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dae718ccbd74caa8a4114db6e48afcd_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if02007e835294982ad3505eac48241f5_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76e87de477904785908596a6978421c3_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia295c3555b08448eafa786c04116bed5_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9e9d75fab66455da7ef57faeb376f99_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i860de82b30ab45b2a460cf624e3b5b40_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddc45227f2cb42ecb959883c84daf958_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26700cb91c4c4421814c6b2ef530c802_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic26457665a374ac89c8e5ccd299aada6_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5726a6ff23d34fe88fffbd72991b59b5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7e7bb0d19a14bc691198c0608792022_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa673d76aaf84ba09e2965620bcb0d59_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54459b98d2974030b71e7ddc68bfe196_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3900SeniorNoteDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4867f353b0c243f48a056129a364e474_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3900SeniorNoteDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e440215ed7c4652ba80460d905c0a7e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5bf1b892ebf4c429b94a0def27e3812_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c142977f87a47ad9f46502a682caac2_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea71d3a2fb7f454e9569d20da14316f2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ee3cba978c44e42a435b9406ceec87a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5300UnsecuredSeniorNotesDueNovember152043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i019d5a5f11b445d89d3eb9b704641a19_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5300UnsecuredSeniorNotesDueNovember152043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c0b70f0dc5a4bb0a131daa51980752a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4900SeniorLoanDue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia71904c9e6b7439192afc4e42bd89431_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4900SeniorLoanDue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2fa7281600f4aa4a680f08c54770403_I20220615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if67b3d6fb8804d8b955cf3354d79349c_I20230615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4650SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65add94a2f11440981e032bdf4abf03a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3150SeniorNotesDueJune152030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32ce52e94a304b5e9d295cbb2edf2771_I20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2022RevolverMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcb1e6845c364da39d5d2715c7c11d1a_D20220420-20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2022RevolverMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-20</xbrli:startDate><xbrli:endDate>2022-04-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i276b4c882ad542a0b4bc9186be63d917_I20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i462a5d19445e4f4fb147359b0ef2c71a_D20220420-20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-20</xbrli:startDate><xbrli:endDate>2022-04-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d64608f0d33471e9601e5e3541f2100_I20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe49dcf2409b417bb03e87a4807043ce_D20220420-20220420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-20</xbrli:startDate><xbrli:endDate>2022-04-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3050d0889c1b479ca3df780a8a2f67d3_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ae59f1d38b94108baddcb6c4ce9ccc9_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42813d6336b1446ea9d9766969a5d5d2_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i909f5895c8934a849b1ce13d3e9b387a_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77ce2bbbf7924de9b72b6351123d25b7_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2022RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f539b72037a48c99b8a54e846db395d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2022RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98abb9740a4644f0b0afc822f729d80e_I20181031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a686c929d27456898c40f7a87b08e15_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70a16530a4b74ab1ab2c00eb8e6c9b14_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcf2f305941145e58ac95b094337d8ae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i432ffc96a54241f68ddc93d9513378cb_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9384c786716d42738630dbab4c03be2a_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57859208fac141e195976ff766745648_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i506dcfe48b094a3e931d739dfe711e08_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i339887c74bba45cdaf9c842631f3e11f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04473c0869bb4e9cb57c58ccae61c32f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie13f0da93b3b4722b635937b8c483189_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife352f731243473cb38ff3a7c88ad094_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:HRAPharmaIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd510179d2634daf92fb0a1d857cf068_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d97e990bb9f45da875ed0019a943271_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4ad834796dd4944a10c88db4b09a61a_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:HRAPharmaIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib95c3b6aef5f41e9a52f9f10c2866889_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd1391abd493480fb9acd3c58fcf9675_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6134b75d6d3245a1b012e4facd40a083_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:HRAPharmaIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e874d379f764d87a630226253c6b16f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id44c0aea81d045e49ea119c7382cc4e4_D20220101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:HRAPharmaIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfdccbcb51464df8bf6242647eb20916_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb86d716465f4a43b35ce7084bb1a35f_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:UnallocatedSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27edc1f6184c482f97b3b37c5afe0212_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="year"><xbrli:measure>prgo:year</xbrli:measure></xbrli:unit><xbrli:context id="i75ee84a7035145c0b2c910d5dc516972_D20090101-20091231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2009-01-01</xbrli:startDate><xbrli:endDate>2009-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i309429068baf42d9b32476c47f52aaff_D20100101-20101231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f277cfcb9db4505ad801732fd1320f1_D20110101-20111231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2011-01-01</xbrli:startDate><xbrli:endDate>2011-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i201270c4e836404b9f18b06fd151647e_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08faba57c5a94a03969d96709d4fc35b_D20170815-20170815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-15</xbrli:startDate><xbrli:endDate>2017-08-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0064d9e4042944d58d1198901966263d_D20210113-20210113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-13</xbrli:startDate><xbrli:endDate>2021-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13f377e048824747af8070c20b1f773d_D20210113-20210113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-13</xbrli:startDate><xbrli:endDate>2021-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i799c30578ef443f59a649aaeb56da4a1_D20210113-20210113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-13</xbrli:startDate><xbrli:endDate>2021-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6df9a027c7764dc1882048b53958ed7f_I20210113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9a1e1741f134ef190ca8f40ceb9584d_D20221228-20221228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28ca55466881480391b76ea7d3db52a4_I20200610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:StateAttorneyGeneralComplaintMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="plaintiffgroup"><xbrli:measure>prgo:plaintiffGroup</xbrli:measure></xbrli:unit><xbrli:unit id="manufacturer"><xbrli:measure>prgo:manufacturer</xbrli:measure></xbrli:unit><xbrli:unit id="retailer"><xbrli:measure>prgo:retailer</xbrli:measure></xbrli:unit><xbrli:unit id="pharmaceuticalproduct"><xbrli:measure>prgo:pharmaceuticalProduct</xbrli:measure></xbrli:unit><xbrli:context id="ib8a4bae7a747476e97ac581edbcf809e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CanadianClassActionComplaintMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica2a115cf0034cd88c426dea96ad5c21_I20170621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-06-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="individual"><xbrli:measure>prgo:individual</xbrli:measure></xbrli:unit><xbrli:unit id="genericprescriptionpharmaceutical"><xbrli:measure>prgo:genericPrescriptionPharmaceutical</xbrli:measure></xbrli:unit><xbrli:context id="i97aab9c2264f4b1d8268af34bd05d862_I20191114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-11-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="class"><xbrli:measure>prgo:class</xbrli:measure></xbrli:unit><xbrli:context id="i7b7f1a9b91944bd69726984aec58d65e_I20170628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic803f010b538436e9209e345a0be08e1_D20170628-20170628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-06-28</xbrli:startDate><xbrli:endDate>2017-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="ils"><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerILS"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="case"><xbrli:measure>prgo:case</xbrli:measure></xbrli:unit><xbrli:context id="i1bfe66b50bea4a8aa93aa6ad4d382456_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:TalcumPowderLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>prgo:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i2c793269a6cc46b9b3333aaf587cd1d4_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:TalcumPowderLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tender"><xbrli:measure>prgo:tender</xbrli:measure></xbrli:unit><xbrli:context id="i2649c54ab7c149678c1ae6e627aa140e_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>prgo:complaint</xbrli:measure></xbrli:unit><xbrli:unit id="claim"><xbrli:measure>prgo:claim</xbrli:measure></xbrli:unit><xbrli:context id="id52764380c894cadb9ff29bc67bd9ba8_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b63510c803344a6ba94abfe031e6828_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="policyperiod"><xbrli:measure>prgo:policyPeriod</xbrli:measure></xbrli:unit><xbrli:context id="i0b6ce8147676451896841efd4f59b711_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e0b17ca570e463d8112c9aa7539c783_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if88323e455b54b5aae39a5550bdf99d6_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88afdc4249140efb878dc32ef2e31c3_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76faace4db464da8a217c507ee330b44_D20230101-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c4d7777405b48b5a6f0c5963e7e4b91_D20220101-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24a3f5f031674ea3967941fe5f6e80e7_I20190426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib61b709a6db3426a9ffb8c7d3ab7d06f_D20200507-20200507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-07</xbrli:startDate><xbrli:endDate>2020-05-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6893406b8890440696557335070ce018_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie669ed37287d49f79a13f8942d0d9e94_D20230505-20230505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001585364</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-05</xbrli:startDate><xbrli:endDate>2023-05-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_1"></div><div style="min-height:0.9pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDI0_96c0ea1e-02ae-49c1-b8b6-97039e4d4b20">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6OTI2ZjVmNjFhNGYwNGE4ZDhjOGE4YmQzMzhmYTJkYWEvdGFibGVyYW5nZTo5MjZmNWY2MWE0ZjA0YThkOGM4YThiZDMzOGZhMmRhYV8wLTAtMS0xLTI5NzUwMw_f0256076-1b57-408e-9251-dddc5e5bdd86">&#9746;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended: <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMjA_d8fc34ac-0c4f-491a-8a81-1fd6924450f0">April 1, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6YzU0ZGJiMWIxMTk3NDU5Y2IwNjg4YTcxOTJiOTRkNDcvdGFibGVyYW5nZTpjNTRkYmIxYjExOTc0NTljYjA2ODhhNzE5MmI5NGQ0N18wLTAtMS0xLTI5NzUwMw_431345d0-bc02-45a6-9b26-9ae2cf87f4d4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDI5_d3a312aa-7217-4f2c-857c-1b5987641b26">001-36353</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDMw_59862c19-d7fb-4f47-84f4-e7881e6eb8cc">Perrigo Company plc</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________________</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MjFiMjQ2Zjc0NTIzNDkwYzllZThjMTc1MWE4MjE3NjMvdGFibGVyYW5nZToyMWIyNDZmNzQ1MjM0OTBjOWVlOGMxNzUxYTgyMTc2M18wLTAtMS0xLTI5NzUwMw_142de3f9-e629-4aa0-8c72-3ee36107fd70">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Not Applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF80OTc_99732258-94b0-4322-99a4-6354850d5960">The Sharp Building,</ix:nonNumeric> <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF81MDA_f382ac2d-ce81-41b0-b955-fb4506d49c21">Hogan Place,</ix:nonNumeric> <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF81MDM_e647d153-1061-4c0b-9791-fef680f80006">Dublin 2,</ix:nonNumeric> <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF81MDY_bcf2962b-51cb-4c4a-92d1-4b104fcf001d">Ireland</ix:nonNumeric> <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF81MDk_09240cb4-0cb5-4959-9ec8-3bc408f33616">D02 TY74</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDMx_9c9b3fe3-f139-496f-81a3-b52a9942437b">353</ix:nonNumeric> <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDMy_0e3940d0-af79-44cb-b577-b71062c4f331">1</ix:nonNumeric> <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDI1_a76971f9-98af-4f9c-babf-5da021aefe28">7094000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address, including zip code, and telephone number, including </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">area code, of registrant&#8217;s principal executive offices)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8661025121e9419ab6b60b4f10d5e2b8_D20230101-20230401" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8xLTAtMS0xLTI5NzUwMw_6a768457-0ac5-421f-a8bb-b1969bfed7b8">Ordinary shares, &#8364;0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8661025121e9419ab6b60b4f10d5e2b8_D20230101-20230401" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8xLTEtMS0xLTI5NzUwMw_2a584828-35c3-4a9f-bc49-edc046ecc425">PRGO</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8661025121e9419ab6b60b4f10d5e2b8_D20230101-20230401" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8xLTItMS0xLTI5NzUwMw_812e2645-4cda-41aa-94e8-53bbded0a1bf">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b69715b8beb4265b311eb807fec1768_D20230101-20230401" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8yLTAtMS0xLTI5NzUwMw_8f2cdda8-2cbb-4e09-ab80-2a696fc6e507">3.900% Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b69715b8beb4265b311eb807fec1768_D20230101-20230401" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8yLTEtMS0xLTI5NzUwMw_6e3eb9a9-f9f0-4331-a4eb-8143b4680731">PRGO24</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b69715b8beb4265b311eb807fec1768_D20230101-20230401" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8yLTItMS0xLTI5NzUwMw_7d31bde2-ef36-44d2-857b-ad0d16118962">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i32b30e53a37f41a1ac98e8fb9995ca4e_D20230101-20230401" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8zLTAtMS0xLTI5NzUwMw_15d64780-ef5b-42a3-9766-ee90c68a63ec">4.375% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i32b30e53a37f41a1ac98e8fb9995ca4e_D20230101-20230401" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8zLTEtMS0xLTI5NzUwMw_0c77fcc3-4933-407c-a095-86ad61427672">PRGO26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i32b30e53a37f41a1ac98e8fb9995ca4e_D20230101-20230401" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8zLTItMS0xLTI5NzUwMw_cfe14177-129e-4110-b858-3413bb08aaae">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i765e63eea0a54636a90ce216a325be3a_D20230101-20230401" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl80LTAtMS0xLTI5NzUwMw_eca9af60-16f9-4f76-8173-419e2c15e38c">4.400% Notes due 2030</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i765e63eea0a54636a90ce216a325be3a_D20230101-20230401" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl80LTEtMS0xLTI5NzUwMw_aa9b4045-569b-4057-8b89-76a2280e4cb9">PRGO30</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i765e63eea0a54636a90ce216a325be3a_D20230101-20230401" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl80LTItMS0xLTI5NzUwMw_5bfbdc34-a32f-4088-93eb-5ce0e5fcf0f8">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib67f1fede03d484bba024eb3d57f031f_D20230101-20230401" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl81LTAtMS0xLTI5NzUwMw_7065f2e2-d599-4ccf-8fcc-9448e7432641">5.300% Notes due 2043</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib67f1fede03d484bba024eb3d57f031f_D20230101-20230401" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl81LTEtMS0xLTI5NzUwMw_9ff44c43-1f27-441f-9ac9-6b8c413e058a">PRGO43</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib67f1fede03d484bba024eb3d57f031f_D20230101-20230401" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl81LTItMS0xLTI5NzUwMw_3a66e255-79d0-4dac-b0fa-b0d623e5d5b8">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i95b2b593633042b4b81a8353b11811f5_D20230101-20230401" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl82LTAtMS0xLTI5NzUwMw_890f74d9-9fa8-4d1d-9a51-d485b3c32410">4.900% Notes due 2044</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i95b2b593633042b4b81a8353b11811f5_D20230101-20230401" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl82LTEtMS0xLTI5NzUwMw_a806893e-fc17-4c6e-bcc4-5cfd4217260f">PRGO44</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i95b2b593633042b4b81a8353b11811f5_D20230101-20230401" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl82LTItMS0xLTI5NzUwMw_3a0b4054-98ac-4b92-a916-eefe1c57f548">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDMz_9cb8ea67-76b5-44e4-985c-ab882097dd30">Yes</ix:nonNumeric>&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDI2_e0a7fcfa-0cd3-4bba-ae46-0114fa992185">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6OTBiMGMzZWQ5NTk5NDg2ZmFlNDdmN2QwNmVmZmNhMTUvdGFibGVyYW5nZTo5MGIwYzNlZDk1OTk0ODZmYWU0N2Y3ZDA2ZWZmY2ExNV8wLTAtMS0xLTI5NzUwMw_1939805a-f0a0-4291-a27c-eaf552abc954">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6OTBiMGMzZWQ5NTk5NDg2ZmFlNDdmN2QwNmVmZmNhMTUvdGFibGVyYW5nZTo5MGIwYzNlZDk1OTk0ODZmYWU0N2Y3ZDA2ZWZmY2ExNV8wLTEwLTEtMS0yOTc1MDM_83997201-d48f-4f51-a0c9-33739ffc6e42">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6OTBiMGMzZWQ5NTk5NDg2ZmFlNDdmN2QwNmVmZmNhMTUvdGFibGVyYW5nZTo5MGIwYzNlZDk1OTk0ODZmYWU0N2Y3ZDA2ZWZmY2ExNV8xLTEtMS0xLTI5NzUwMw_857eee77-9429-435f-9b7a-d06d9e1033bb">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDI3_a717a1e0-d0e6-4684-9abb-cb8322aac3a7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;No</span></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of May&#160;5, 2023, there were <ix:nonFraction unitRef="shares" contextRef="id1979f160e0c4d1697ab4c57477e38d1_I20230505" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8xOTkz_2240da14-2ebe-45a3-a009-f3000a300cfe">135,325,847</ix:nonFraction> ordinary shares outstanding.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:14.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_7"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.866%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PAGE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">NUMBER</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_10">Cautionary Note Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_10">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART I. FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_13">Item&#160;1. Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_16">Condensed Consolidated Statements of Operations </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_19">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_22">Condensed Consolidated Balance Sheets </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_28">Condensed Consolidated Statements of Shareholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_28">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_34">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_34">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_37">Notes to the Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_40">Summary of Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_40">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_43">Revenue Recognition</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_43">10</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_46">Acquisitions and Divestitures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_46">11</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_61">Discontinued Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_61">12</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_52">Inventories</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_52">13</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_58">Investments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_58">13</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_70">Leases</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_70">14</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_49">Goodwill and Intangible Assets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_49">15</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_55">Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_55">16</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_67">Derivative Instruments and Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_67">17</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_73">Indebtedness</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_73">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_79">Earnings per Share and Shareholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_79">22</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_85">Accumulated Other Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_85">22</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_94">Restructuring Charges</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_94">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_88">Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_88">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_91">Contingencies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_91">25</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_100">Segment Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_100">31</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subsequent Events</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_100">31</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_106">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_106">33</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_163">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_163">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_166">Item&#160;4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_166">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART II. OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_172">Item&#160;1. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_172">45</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_175">Item&#160;1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_175">45</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_178">Item&#160;6. Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_178">47</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_181">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i391fab8b65b648d5a5c27f0c2d5892b5_181">48</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_10"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain statements in this report are &#8220;forward-looking statements&#8221; within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our, or our industry&#8217;s actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements. In particular, statements about our expectations, beliefs, plans, objectives, assumptions, future events or future performance contained in this report, including certain statements contained in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; are forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; "forecast," &#8220;predict,&#8221; &#8220;potential&#8221; or the negative of those terms or other comparable terminology.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company&#8217;s control, including: supply chain impacts on the Company&#8217;s business, including those caused or exacerbated by armed conflict, trade and other economic sanctions and/or disease; general economic, credit, and market conditions; the impact of the war in Ukraine and any escalation thereof, including the effects of economic and political sanctions imposed by the United States, United Kingdom, European Union, and other countries related thereto; the outbreak or escalation of conflict in other regions where we do business; future impairment charges, if we determine that the carrying amount of specific assets may not be recoverable from the expected future cash flows of such assets; customer acceptance of new products; competition from other industry participants, some of whom have greater marketing resources or larger market shares in certain product categories than the Company does; pricing pressures from customers and consumers; resolution of uncertain tax positions and any litigation relating thereto, ongoing or future government investigations and regulatory initiatives; uncertainty regarding the timing of, and the Company&#8217;s ability to obtain and maintain, certain regulatory approvals, including the sale of daily over-the-counter oral contraceptives; potential costs and reputational impact of product recalls or sales halts; potential adverse changes to U.S. and foreign tax, healthcare and other government policy; the effect of the coronavirus (COVID-19) pandemic and its variants; the timing, amount and cost of any share repurchases (or the absence thereof); fluctuations in currency exchange rates and interest rates; the Company&#8217;s ability to achieve the benefits expected from the sale of its Rx business and the risk that potential costs or liabilities incurred or retained in connection with that transaction may exceed the Company&#8217;s estimates or adversely affect the Company&#8217;s business or operations; the Company&#8217;s ability to achieve the benefits expected from the acquisitions of H&#233;ra SAS ("HRA Pharma") and Nestl&#233;&#8217;s Gateway infant formula plant along with the U.S. and Canadian rights to the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> infant formula brand and other related formula brands ("Gateway") and/or the risks that the Company&#8217;s synergy estimates are inaccurate or that the Company faces higher than anticipated integration or other costs in connection with the acquisitions; risks associated with the integration of HRA Pharma and Gateway, including the risk that growth rates are adversely affected by any delay in the integration of sales and distribution networks; the consummation and success of other announced and unannounced acquisitions or dispositions, and the Company&#8217;s ability to realize the desired benefits thereof; and the Company&#8217;s ability to execute and achieve the desired benefits of announced cost-reduction efforts and other strategic initiatives and investments, including the Company&#8217;s ability to achieve the expected benefits from its Supply Chain Reinvention Program. Adverse results with respect to pending litigation could have a material adverse impact on the Company's operating results, cash flows and liquidity, and could ultimately require the use of corporate assets to pay damages, reducing assets that would otherwise be available for other corporate purposes. There can be no assurance that the FDA will approve the sale of daily oral contraceptives without a prescription in the United States. These and other important factors, including those discussed in our Form 10-K for the year ended December&#160;31, 2022, this report under &#8220;Risk Factors&#8221; and in any subsequent filings with the United States Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this report are made only as of the date hereof, and unless otherwise required by applicable securities laws, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRADEMARKS, TRADE NAMES AND SERVICE MARKS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This report contains trademarks, trade names and service marks that are the property of Perrigo Company plc, as well as, for informational purposes, trademarks, trade names, and service marks that are the property of other organizations.&#160;Solely for convenience,&#160;certain trademarks, trade names, and service marks referred to in this report appear without the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8482; and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">SM </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">symbols, but those references are not intended to indicate that we or the applicable owner, as the case may be, will not assert, to the fullest extent under applicable law, our or their rights to such trademarks, trade names, and service marks.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_13"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. &#160;&#160;&#160;&#160;FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:59.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.116%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMi0xLTEtMS0yOTc1MDM_6b7b8cdd-8904-4c94-9512-4ca254f6626f">1,181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMi0zLTEtMS0yOTc1MDM_35163a52-6869-4071-93b4-b6b19bf8404d">1,074.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMy0xLTEtMS0yOTc1MDM_7a944686-d9e1-474d-ac40-0f1a40719323">767.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMy0zLTEtMS0yOTc1MDM_68bec5e3-0d35-4891-86c1-263f823cb795">736.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNC0xLTEtMS0yOTc1MDM_8c42d56a-0add-4c54-8663-ba39e30c5890">413.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNC0zLTEtMS0yOTc1MDM_7ab02870-600d-4757-8075-64d1104131b0">337.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:ProductionAndDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNy0xLTEtMS0yOTc1MDM_4939e0f2-413d-4db7-9e3f-46b663bd74b1">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:ProductionAndDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNy0zLTEtMS0yOTc1MDM_b433482e-316f-4880-ac27-22dad8bba961">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfOC0xLTEtMS0yOTc1MDM_48f5804c-ed00-4bc3-89dc-9661485422fa">31.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfOC0zLTEtMS0yOTc1MDM_55a0e70a-324e-41c6-871c-a35c76c594e0">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfOS0xLTEtMS0yOTc1MDM_d497b2f3-8a2f-4154-930f-5c81e3cd3385">167.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfOS0zLTEtMS0yOTc1MDM_be03c8e9-8a52-44bd-a4cc-28a234207caa">135.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTAtMS0xLTEtMjk3NTAz_7de8356f-ddfe-4351-b20d-d10e7843a995">135.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTAtMy0xLTEtMjk3NTAz_ae4d1aaa-75fa-4cfc-aef4-00b1d1cfdfd8">122.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTItMS0xLTEtMjk3NTAz_8fbe666e-a267-4008-9755-849ca2580f0f">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTItMy0xLTEtMjk3NTAz_1550290b-3027-4b13-b863-25e865a61636">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="prgo:OtherOperatingIncomeLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTMtMS0xLTEtMjk3NTAz_76d7a983-e5b1-4a47-b7c0-2ef08ab84ee6">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="prgo:OtherOperatingIncomeLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTMtMy0xLTEtMjk3NTAz_fecaf1f2-5a84-4c73-8bd6-d01bd16c3af5">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTQtMS0xLTEtMjk3NTAz_da825609-ef75-46c6-b3f6-84839df4b725">365.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTQtMy0xLTEtMjk3NTAz_bf088ee1-846c-4c3d-8b45-d1582035d4be">316.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTYtMS0xLTEtMjk3NTAz_0ea64157-071e-4b5a-a234-976ae11ebdb1">48.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTYtMy0xLTEtMjk3NTAz_42fff2f2-4b0e-4690-a233-ec52c195f689">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTktMS0xLTEtMjk3NTAz_f5827849-3445-47e0-b347-26aaaa28d40d">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTktMy0xLTEtMjk3NTAz_28c24a8e-6f5f-44f4-bcfd-b23e5a852971">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjAtMS0xLTEtMjk3NTAz_e098e497-b59a-4b6d-948a-b7dea7f2c91c">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjAtMy0xLTEtMjk3NTAz_91bbaa0d-7c74-496d-8e1b-ac212fd5ec34">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjItMS0xLTEtMjk3NTAz_7fa47ce8-9a83-4943-a211-ba18c2eb41bd">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjItMy0xLTEtMjk3NTAz_82daf7ff-f090-42c9-92b5-4d43c09491de">13.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjMtMS0xLTEtMjk3NTAz_c6feabe3-0ebe-4169-8f9f-0a9f6702f12f">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjMtMy0xLTEtMjk3NTAz_cd80b042-4d4d-46d4-a7f4-dab4498b373a">11.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjQtMS0xLTEtMjk3NTAz_43f3cbaa-75af-4b7e-bdd3-52a0e43af07f">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjQtMy0xLTEtMjk3NTAz_7b222471-7584-4e74-b163-9aaa6ea505b1">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjUtMS0xLTEtMjk3NTAz_2fa94107-7666-4aba-a0e8-ddfbf6b95eb1">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjUtMy0xLTEtMjk3NTAz_af94a427-797b-461b-96fa-14c8a3021b2f">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjYtMS0xLTEtMjk3NTAz_82a9b30b-8708-453b-b6c1-4b421a9dbe8b">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjYtMy0xLTEtMjk3NTAz_69cdd12b-12f2-4b6f-88df-79c616dc2ba9">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings (loss) per share</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzAtMS0xLTEtMjk3NTAz_64e0a748-0545-4e3c-b8ef-730dfa8cd81a">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzAtMy0xLTEtMjk3NTAz_4ba5aa60-c9a9-47cd-8917-0e3c8a5db3d0">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzEtMS0xLTEtMjk3NTAz_5bee3080-7c6f-4190-bfa8-2c323c39944c">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzEtMy0xLTEtMjk3NTAz_8d3d7140-7e93-4019-a235-a6c66d3a8d87">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic earnings (loss) per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzItMS0xLTEtMjk3NTAz_fafa55fe-82c5-4c7b-9c9e-03e72e668f46">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzItMy0xLTEtMjk3NTAz_e62f7bf6-8b45-438d-834c-236267001e68">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzQtMS0xLTEtMjk3NTAz_c442e6e5-b717-4f62-94db-5d613b9ba006">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzQtMy0xLTEtMjk3NTAz_bf462af5-8bf5-4027-a55c-f0509cb5d768">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzUtMS0xLTEtMjk3NTAz_fe90e1f0-1b9a-4578-9bfd-05ef5cf80f8c">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzUtMy0xLTEtMjk3NTAz_f8fe49eb-c5b3-493e-a04c-5f290dc90c52">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzYtMS0xLTEtMjk3NTAz_7eb82774-5873-4860-b48b-d87e06f3d9e6">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzYtMy0xLTEtMjk3NTAz_e86884f3-aa12-43c4-bdc8-ae92448931a4">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzktMS0xLTEtMjk3NTAz_c70335d3-c52d-4213-8e66-4d6fb1b5564d">134.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzktMy0xLTEtMjk3NTAz_9a51118c-97f6-491d-84b5-0b2ded9f278a">134.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNDAtMS0xLTEtMjk3NTAz_f37439f1-3c2d-4fe0-bada-4e5e66bfb8f3">134.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNDAtMy0xLTEtMjk3NTAz_f7976b9f-fa83-4970-a008-cb1d9ab37dbc">134.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_19"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"></td><td style="width:59.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.959%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfMi0xLTEtMS0yOTc1MDM_82a9b30b-8708-453b-b6c1-4b421a9dbe8b">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfMi0zLTEtMS0yOTc1MDM_69cdd12b-12f2-4b6f-88df-79c616dc2ba9">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNC0xLTEtMS0yOTc1MDM_d83ee2b3-810a-42bc-b0de-2c0f2f69c28e">52.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNC0zLTEtMS0yOTc1MDM_b3630b11-f61f-44ac-99a3-44f5d72beaa1">24.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivative financial instruments, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNS0xLTEtMS0yOTc1MDM_321b2322-6e04-4ac1-b332-75c50f8bb5a1">31.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNS0zLTEtMS0yOTc1MDM_37647005-197f-4830-8ca6-32198ae6024a">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in post-retirement and pension liability, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNy0xLTEtMS0yOTc1MDM_e38d256c-8149-49f7-b20e-b1cb509b5c31">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNy0zLTEtMS0yOTc1MDM_c4742023-0fd0-4c3a-8b7e-db6637ce3f89">6.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfOC0xLTEtMS0yOTc1MDM_48e14606-46a4-4c4c-a40f-4e7bad4ec75b">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfOC0zLTEtMS0yOTc1MDM_2c388533-a597-456a-b7b1-67a208ef90eb">20.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfOS0xLTEtMS0yOTc1MDM_0c48b992-aea1-4304-b522-cc68b775b2a7">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfOS0zLTEtMS0yOTc1MDM_7d6fa2dd-3a59-4a9d-b1d4-3a47850f039a">22.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_22"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMy0xLTEtMS0yOTc1MDM_2e3f07bb-6e9b-41d5-9f7f-329e567c0943">553.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMy0zLTEtMS0yOTc1MDM_1df5aabe-c9a2-45fc-8dbb-fe0c95cc60f8">600.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNS0wLTEtMS0yOTc1MDMvdGV4dHJlZ2lvbjo4ZTg3YzM3OGU1Njk0NmVlOTIyNDA0NDE5NWRjODhmNV82NA_a8dab228-5163-4f0d-9133-4e6a4dd7050b">7.1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNS0wLTEtMS0yOTc1MDMvdGV4dHJlZ2lvbjo4ZTg3YzM3OGU1Njk0NmVlOTIyNDA0NDE5NWRjODhmNV83Mg_274951ac-674a-4d5d-b98c-4bc5f1f6d9f4">6.8</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNS0xLTEtMS0yOTc1MDM_b5a4a2ec-9e5f-4afa-b136-5794003aced6">738.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNS0zLTEtMS0yOTc1MDM_7658effd-d0c0-4af4-92ad-20bd6437d2e6">697.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNi0xLTEtMS0yOTc1MDM_0c516abd-2f1a-4016-b81a-52f5652da337">1,183.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNi0zLTEtMS0yOTc1MDM_a6f78685-7c0c-42af-b6da-e0a65f702ca6">1,150.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfOC0xLTEtMS0yOTc1MDM_ad12a6ed-e166-422e-a8cc-e4076c03a0a1">266.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfOC0zLTEtMS0yOTc1MDM_63a4dfdd-f3bc-446e-9c0f-d22aebad8744">271.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTAtMS0xLTEtMjk3NTAz_832e3620-bbec-4fcc-8efd-267adaf3fa26">2,740.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTAtMy0xLTEtMjk3NTAz_51cf3125-043d-49cf-995b-44d262272b5f">2,719.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTItMS0xLTEtMjk3NTAz_7c42c0da-0b81-4dd8-b88b-a61924539ebd">919.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTItMy0xLTEtMjk3NTAz_42d7690d-3ef6-4ed6-b53f-4ad1ba9ac50a">926.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTMtMS0xLTEtMjk3NTAz_7b54c93f-6a7d-4797-b706-26ba4a4c737a">211.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTMtMy0xLTEtMjk3NTAz_6744cf6b-8ded-44d0-a7c4-657a0a1fc056">217.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:GoodwillAndIndefiniteLivedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTUtMS0xLTEtMjk3NTAz_09d19fba-3f55-49a2-8972-084377785f74">3,650.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="prgo:GoodwillAndIndefiniteLivedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTUtMy0xLTEtMjk3NTAz_e6b93272-8cec-4233-98ff-ea425b7e8ed6">3,549.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite-lived intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTYtMS0xLTEtMjk3NTAz_5524cd96-3a34-4151-94c0-a621618f2634">3,083.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTYtMy0xLTEtMjk3NTAz_77047f88-4365-4e8d-a654-c6ff7b0cacd3">3,230.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTctMS0xLTEtMjk3NTAz_db8869a5-10b4-4cda-a2cd-b6b69074666e">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTctMy0xLTEtMjk3NTAz_8b851e5f-8aa4-48c1-89ca-04d71887b86c">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTktMS0xLTEtMjk3NTAz_9324f999-5216-48ef-9e92-a5d888dd3434">342.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTktMy0xLTEtMjk3NTAz_fc7f9e98-760d-4776-9bb8-87bd3d4706f6">367.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjAtMS0xLTEtMjk3NTAz_936728cb-0fba-4527-82f6-bbb2ab1fc971">8,214.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjAtMy0xLTEtMjk3NTAz_f0d15060-b438-48e6-8b85-039b74ddc42a">8,297.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjEtMS0xLTEtMjk3NTAz_05071493-3648-4b7c-b8db-4762eff83fb0">10,954.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjEtMy0xLTEtMjk3NTAz_2175375a-6ae3-4c4d-98b0-c857c1e06fee">11,017.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjQtMS0xLTEtMjk3NTAz_f581ce18-7409-4ed6-9601-3f36f4000ede">505.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjQtMy0xLTEtMjk3NTAz_8eb2ef15-0eb9-4d55-b93c-46dc5eff51d6">537.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll and related taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjUtMS0xLTEtMjk3NTAz_4b3874c7-7be0-4fa0-8520-770c4d1072bd">106.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjUtMy0xLTEtMjk3NTAz_6eb92e9d-9b89-4f89-b0fa-1985d8e4bbab">136.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued customer programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:AccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjYtMS0xLTEtMjk3NTAz_261e0168-e08f-4537-aae5-115d89d9aeb2">146.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="prgo:AccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjYtMy0xLTEtMjk3NTAz_2ba911e7-f728-4b22-bb7b-aa615d520bcc">139.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjctMS0xLTEtMjk3NTAz_d89631f8-a3a1-478e-85d8-ee8b5200f7f9">272.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjctMy0xLTEtMjk3NTAz_cec59732-db07-4c8f-a953-fe5255b2f6f4">250.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjgtMS0xLTEtMjk3NTAz_4faa9189-cd37-4c1f-932d-8c306cb7bf2d">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjgtMy0xLTEtMjk3NTAz_b0105d2d-422c-4558-97c7-b49e39e7dbb6">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzAtMS0xLTEtMjk3NTAz_10cb4e73-fab8-4501-8db8-79c6fb64b5e9">38.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzAtMy0xLTEtMjk3NTAz_458dc340-1aef-4f5e-94b4-8c5dc776cadd">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzItMS0xLTEtMjk3NTAz_33fd2f58-028d-4eb3-ad4f-1c5eeb458291">1,086.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzItMy0xLTEtMjk3NTAz_5b8c4e57-98e6-411c-9335-727b67a2a0ed">1,113.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzQtMS0xLTEtMjk3NTAz_88848381-37e5-4669-b79a-786decd29ac8">4,062.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzQtMy0xLTEtMjk3NTAz_76074cbb-a040-4eba-a36a-dca59b4dbafb">4,070.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzUtMS0xLTEtMjk3NTAz_9952e7da-c2db-422d-aad2-d66f492f8da1">333.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzUtMy0xLTEtMjk3NTAz_7982319e-f74e-4490-a7b6-e4064a5d8633">368.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzctMS0xLTEtMjk3NTAz_49eec53e-5382-4095-a359-9e799d1a8b8c">637.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzctMy0xLTEtMjk3NTAz_78aaa8bb-56bb-48da-95d0-1adea5473c38">623.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzgtMS0xLTEtMjk3NTAz_a6412823-d00e-40a2-95c3-badb0fa5ab1f">5,034.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzgtMy0xLTEtMjk3NTAz_a335457e-6c84-4e40-81bf-340d90e463f3">5,061.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzktMS0xLTEtMjk3NTAz_b3ad7ecb-3054-4972-938f-4664a5db4518">6,121.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzktMy0xLTEtMjk3NTAz_a21cb2a6-0be5-4341-936a-435085ebce25">6,175.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Contingencies - Refer to Note 16</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDAtMS0xLTEtMjk3NTAz_0defdd2b-7e65-4463-85ef-603691fcee31"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDAtMy0xLTEtMjk3NTAz_987c635a-8327-48a6-ad36-1f74da193114"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Controlling interests:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares, $<ix:nonFraction unitRef="usdPerShare" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ODFmZDdiMWNiOTg4NGJmZGI0ZTE4OWU1YWY3MDQyOGZfMjI_36887c2a-5aa8-4d53-84b0-5359299db6a3"><ix:nonFraction unitRef="usdPerShare" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ODFmZDdiMWNiOTg4NGJmZGI0ZTE4OWU1YWY3MDQyOGZfMjI_d471cc41-ddaa-46ff-ba23-cbe2b7e85317">0.0001</ix:nonFraction></ix:nonFraction> par value per share, <ix:nonFraction unitRef="shares" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ODFmZDdiMWNiOTg4NGJmZGI0ZTE4OWU1YWY3MDQyOGZfNDY_60d4c15b-bb28-45df-a0d3-709b67608484"><ix:nonFraction unitRef="shares" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ODFmZDdiMWNiOTg4NGJmZGI0ZTE4OWU1YWY3MDQyOGZfNDY_9cd49b0b-92e0-46d1-8ac7-b0ba13e75b43">10</ix:nonFraction></ix:nonFraction> shares authorized</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMS0xLTEtMjk3NTAz_09049043-f359-40e6-82a8-86cd6340c5be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMy0xLTEtMjk3NTAz_08a77bce-3714-4bc8-8613-097af42de15f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares, &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ZTRlZWE2Y2Q2NGUyNGY5OTg1YTYzZjgyNzdmYTE4NWZfMjE_33c1e464-9e50-42d7-9570-bea11b0c8e27"><ix:nonFraction unitRef="eurPerShare" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ZTRlZWE2Y2Q2NGUyNGY5OTg1YTYzZjgyNzdmYTE4NWZfMjE_5e25f42e-767b-41b4-bfee-8230cc168866">0.001</ix:nonFraction></ix:nonFraction> par value per share, <ix:nonFraction unitRef="shares" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ZTRlZWE2Y2Q2NGUyNGY5OTg1YTYzZjgyNzdmYTE4NWZfNDU_068e7db9-17a4-4143-b2ce-9c225827edec"><ix:nonFraction unitRef="shares" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ZTRlZWE2Y2Q2NGUyNGY5OTg1YTYzZjgyNzdmYTE4NWZfNDU_d3d5b2e5-4243-4604-862c-353c5225ff8b">10,000</ix:nonFraction></ix:nonFraction> shares authorized</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMS0xLTEtMjk3NTAz_fcc32172-6ad0-48d5-b8c6-851eac6ff652">6,910.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMy0xLTEtMjk3NTAz_d68499b7-fca8-4699-9079-c0d055a7d940">6,936.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDUtMS0xLTEtMjk3NTAz_fb69ea56-c3bd-477f-a252-db5a1ee150de">6.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDUtMy0xLTEtMjk3NTAz_40d11ade-7ecc-4dff-bff4-393f087e7ef3">27.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings (accumulated deficit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDYtMS0xLTEtMjk3NTAz_a8f779b5-730e-4026-9c8f-eef0a4c4bdb8">2,070.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDYtMy0xLTEtMjk3NTAz_f493b9b3-bf40-4f53-bcb7-943ec39bab3d">2,067.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDktMS0xLTEtMjk3NTAz_235854ce-b6df-4db3-9830-3fe5a394015d">4,833.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDktMy0xLTEtMjk3NTAz_ff31d77a-a7f9-4916-83f5-e8fbbce65ff9">4,842.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and shareholders' equity</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTAtMS0xLTEtMjk3NTAz_e0dbcbd2-f34d-4d32-997a-92f628926015">10,954.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTAtMy0xLTEtMjk3NTAz_6fd7f568-bcb4-4908-921c-2e4d3ee26c59">11,017.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplemental Disclosures of Balance Sheet Information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares, issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTMtMS0xLTEtMjk3NTAz_1d2d6108-823e-4101-aedb-a75ec3b9080e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTMtMy0xLTEtMjk3NTAz_28543fb5-c032-4f62-b850-f9977c20bfde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares, issued and outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTQtMS0xLTEtMjk3NTAz_36268493-9612-4623-aa86-e957cd57f2c0">135.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTQtMy0xLTEtMjk3NTAz_495c87d7-d14c-455e-9340-113b62d27109">134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_28"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.397%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary Shares<br/>Issued</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings<br/>(Accumulated Deficit)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8ec02b3dd484b4e8275f17f1949e2de_I20211231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMi0xLTEtMS0yOTc1MDM_2f01b1ec-62dd-4fc5-88c3-a8ea52f5c817">133.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ec02b3dd484b4e8275f17f1949e2de_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMi0zLTEtMS0yOTc1MDM_9d64b979-6965-421e-943f-3c367a193e13">7,043.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07bcc81fd19e45bdb8acb5118329924f_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMi01LTEtMS0yOTc1MDM_318cf015-3b6c-4ca6-b275-3eba6ac02010">35.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04cfa05f5fd341f898c851d834e5a6ed_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMi03LTEtMS0yOTc1MDM_29e257bf-a239-4ff3-b449-c884ea23e85d">1,927.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd18f1c6b0bf4007931565e3309d3a59_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMi05LTEtMS0yOTc1MDM_ec7da91f-b57e-45dc-9d3c-89236c1b2d30">5,151.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i712e3d08fced4870b5dd4e881cd7d98a_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfNC03LTEtMS0yOTc1MDM_f881e9fc-acbc-40ab-afd7-adad431b8853">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfNC05LTEtMS0yOTc1MDM_3f42887c-e7ef-4fde-887d-ea7879f93aa3">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47510622497c47db87a31fe64fc51a88_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfNS01LTEtMS0yOTc1MDM_03abbac0-da18-412c-9157-69c7a32c5992">20.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfNS05LTEtMS0yOTc1MDM_7ba72850-3dd6-4808-bb0f-9d4572a0e6c8">20.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfNy0xLTEtMS0yOTc1MDM_cc047ba8-452e-4631-9b2b-28728b498a2e">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation for restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfOS0zLTEtMS0yOTc1MDM_1043480b-d949-4760-903c-23de575ce47e">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfOS05LTEtMS0yOTc1MDM_3f72610b-7050-416b-a85b-633db48c9d0b">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends, $<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTAtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246MTNmMTljNTAzOGU0NDJiZmI3YTc4OTdiOWI5YzYxYWNfMjA_834c3dc9-f308-480c-b1f5-48466cf5f0df">0.26</ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTAtMy0xLTEtMjk3NTAz_4aa34ba8-bf09-417b-af8d-049dfe678586">34.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTAtOS0xLTEtMjk3NTAz_a5ec2f55-e8d8-44d7-82f1-0881e2afb06a">34.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld for payment of employees' withholding tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTEtMS0xLTEtMjk3NTAz_a807c29f-95d2-4e54-8693-31b886c98515">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTEtMy0xLTEtMjk3NTAz_de53c016-1a5f-4ff3-8504-3d563d939433">16.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTEtOS0xLTEtMjk3NTAz_7f0551a7-7d66-40e3-a17e-91f5e0255d6b">16.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at April 2, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a185df6ddcb4f0db8975f91beef3d79_I20220402" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTMtMS0xLTEtMjk3NTAz_e04d7a6d-4892-4b92-9620-e9b99b3d29f0">134.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a185df6ddcb4f0db8975f91beef3d79_I20220402" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTMtMy0xLTEtMjk3NTAz_db31a840-b988-47f2-b1e2-0b17c5f10d55">7,018.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43124566cd24715b45ad75e52af2328_I20220402" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTMtNS0xLTEtMjk3NTAz_dee921ca-c1da-4474-996c-3d352a9e921a">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id761e753820a44cea1db50ca513e11e5_I20220402" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTMtNy0xLTEtMjk3NTAz_3e24ebea-b749-440e-b02d-0d781ba95e39">1,929.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6955bfa807de4779804dcda471f50c60_I20220402" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTMtOS0xLTEtMjk3NTAz_c4d91822-e3f2-4336-92c3-1ac180066a49">5,104.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.397%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary Shares<br/>Issued</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings<br/>(Accumulated Deficit)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie326fc7603fc47d2829c2df0bcf4817d_I20221231" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMi0xLTEtMS0yOTc1MDM_0ed123d4-19a3-4b8b-b227-ed1d356666c4">134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie326fc7603fc47d2829c2df0bcf4817d_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMi0zLTEtMS0yOTc1MDM_57c5cdb4-dc15-4817-9149-2476a442c436">6,936.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d376c6445864b46856bd7c9eca96a57_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMi01LTEtMS0yOTc1MDM_ece2f0fc-f5e8-43d9-b52c-264c779cd5b4">27.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5aed5796cb6f4c748a6fbc6e5733a7b5_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMi03LTEtMS0yOTc1MDM_397f8588-d8f3-4527-833f-4c75245761a0">2,067.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMi05LTEtMS0yOTc1MDM_a521aac7-8380-47de-8e36-dafa043852de">4,842.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7e7884fe5fe439cbb60a14a0bfa25da_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfNC03LTEtMS0yOTc1MDM_d17ccbc3-2b1a-4506-bdb6-79fec73ac0c1">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfNC05LTEtMS0yOTc1MDM_9418c733-e21d-4e78-abb2-15c1b36415cf">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52e0bee33a840b6b04f0e23c7814541_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfNS01LTEtMS0yOTc1MDM_c808c6c3-051a-442d-96e0-846fb603bdb8">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfNS05LTEtMS0yOTc1MDM_fd1dc13e-feff-41c6-a129-eabdf4b978ef">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfNy0xLTEtMS0yOTc1MDM_5d7ad7a5-9687-47df-b9d8-bf83aeff94b3">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation for restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfOS0zLTEtMS0yOTc1MDM_14c97373-a19a-4e20-a697-f86465e9978b">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfOS05LTEtMS0yOTc1MDM_eb60c5b7-af07-42c5-8149-669099cb98ab">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends, $<ix:nonFraction unitRef="usdPerShare" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTAtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246MDgzODYyZjFiMjVmNDQ3MGFhODJlZjJiNDJjOGQxYjFfMjA_e9b2fc3c-ad3b-498e-bdd4-a3fd44c928b3">0.27</ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTAtMy0xLTEtMjk3NTAz_ab22e5ea-dcf0-4782-9da1-befe05b1e2b1">36.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTAtOS0xLTEtMjk3NTAz_3ec35108-7726-4649-b2ff-10a0376c8c95">36.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld for payment of employees' withholding tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTEtMS0xLTEtMjk3NTAz_87c6efd3-5c7f-41e2-a127-24b856b2abab">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTEtMy0xLTEtMjk3NTAz_adba50b7-9926-4e06-a6c7-1b811f13601e">14.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTEtOS0xLTEtMjk3NTAz_6117a094-60f4-4aef-b3ed-1ba02276987e">14.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b9dd69bc08149889b61d83c2b89ce51_I20230401" decimals="-5" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTItMS0xLTEtMjk3NTAz_4a862785-035d-4ad1-a7ab-ceed3e6f7fc9">135.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9dd69bc08149889b61d83c2b89ce51_I20230401" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTItMy0xLTEtMjk3NTAz_9279c3ef-5cd0-451c-a662-7782b40b0148">6,910.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3cf13b5a219470a985bbaa83714a9e5_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTItNS0xLTEtMjk3NTAz_9d8ff2f8-79aa-4b4d-a725-36dfd9d31129">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2716fca3625c46c785d6b90d8eb978c4_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTItNy0xLTEtMjk3NTAz_57205b4b-de12-49a9-b870-fa784a9a13c4">2,070.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTItOS0xLTEtMjk3NTAz_2df1865b-16ef-4a07-890a-6efe4f5045e8">4,833.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"></td><td style="width:69.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.252%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Flows From (For) Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMy0xLTEtMS0yOTc1MDM_2b3f26af-c978-4da0-a219-626eb916c953">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="prgo:NetLossIncomeAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMy0zLTEtMS0yOTc1MDM_e2b655b1-722c-458a-9d77-419f8c4fead5">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to derive cash flows:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNS0xLTEtMS0yOTc1MDM_a90fae2a-1ed4-44d5-a7b2-9a0ead35ffe0">88.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNS0zLTEtMS0yOTc1MDM_212db0c6-e8b5-471f-923e-7df293914945">69.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNi0xLTEtMS0yOTc1MDM_4dd4b1fc-fdaf-44e8-b59a-a9a35ed3a16d">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNi0zLTEtMS0yOTc1MDM_1d50adce-a78b-4871-87d8-73d50cadcc2c">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="prgo:RestructuringChargesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfOC0xLTEtMS0yOTc1MDM_49dd3cc6-5aa1-40d1-91b2-492eb1ddf0b0">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="prgo:RestructuringChargesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfOC0zLTEtMS0yOTc1MDM_19427b58-ad39-48e0-afeb-642bd674df11">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfOS0xLTEtMS0yOTc1MDM_9b1c996d-218f-46dd-977e-b14f14c50758">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfOS0zLTEtMS0yOTc1MDM_7f58ee3b-ffc8-4e66-b1de-86c5b82f0f9e">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt discount (premium)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTEtMS0xLTEtMjk3NTAz_58937de6-9086-40df-97d3-6e2b527fa41d">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTEtMy0xLTEtMjk3NTAz_05651c79-67a6-4881-9050-fb412bce1f26">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTItMS0xLTEtMjk3NTAz_65f827e7-24d0-4c97-8948-1054ae5ad805">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTItMy0xLTEtMjk3NTAz_02c0d7fa-3b52-41c1-84cc-3d7d39131451">5.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTMtMS0xLTEtMjk3NTAz_8b8087e2-3354-439d-97b3-4264dafbc434">9.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTMtMy0xLTEtMjk3NTAz_054b2d3c-a223-4bc0-a8da-5913d60f647c">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTQtMS0xLTEtMjk3NTAz_076f89ab-42d0-47b5-9c43-599ac1c776cb">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTQtMy0xLTEtMjk3NTAz_d5596b6b-f1eb-449a-863b-8aebcb18561a">17.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="prgo:NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTUtMS0xLTEtMjk3NTAz_a0729082-f083-4031-9783-27c73c15d365">107.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="prgo:NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTUtMy0xLTEtMjk3NTAz_37f8e4cc-0d56-4e73-a8fe-7119f7151ce5">80.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase (decrease) in cash due to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTctMS0xLTEtMjk3NTAz_415a8013-ab62-42f6-9d45-81da6325624f">39.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTctMy0xLTEtMjk3NTAz_a0c0d245-4ae3-4638-be1d-f85cab3806dd">38.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTgtMS0xLTEtMjk3NTAz_58a7c194-a777-47ef-a6a7-d6a90147c01b">28.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTgtMy0xLTEtMjk3NTAz_21511c06-abb8-4288-93c7-826584d386b4">10.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTktMS0xLTEtMjk3NTAz_60d14b34-eff5-4972-adb2-1467b6df5693">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTktMy0xLTEtMjk3NTAz_05c03cb5-59d3-41e1-a908-bbe5e96edc92">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjAtMS0xLTEtMjk3NTAz_b5bff0ce-ccec-443f-b4c9-7ab9a6fb2939">29.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjAtMy0xLTEtMjk3NTAz_4427ee4b-ab78-403d-81fc-5b8c96ffd8c8">72.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll and related taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjEtMS0xLTEtMjk3NTAz_50d67a71-651a-4ae6-8679-f881f1eb4f76">34.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjEtMy0xLTEtMjk3NTAz_7813b46e-b265-4a7a-84e7-c65e515bcf20">31.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued customer programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="prgo:IncreaseDecreaseInAccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjItMS0xLTEtMjk3NTAz_1f59ac97-d932-4b9b-b31a-91052eaf707c">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="prgo:IncreaseDecreaseInAccruedCustomerPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjItMy0xLTEtMjk3NTAz_9d129325-0908-4bb4-bb43-d1bad45a6e37">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjMtMS0xLTEtMjk3NTAz_1d0263fa-8b7e-4125-9866-968be773a3ab">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjMtMy0xLTEtMjk3NTAz_3d2d6733-5a2d-40ce-b009-92c5cb708407">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjQtMS0xLTEtMjk3NTAz_85c871b5-ac7f-44da-96c6-32a869f4f98d">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjQtMy0xLTEtMjk3NTAz_fd94f521-cd67-448c-bc1e-2be7b952468e">33.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjYtMS0xLTEtMjk3NTAz_7286ae8c-78db-46c7-8ff4-57f3ea136a4a">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjYtMy0xLTEtMjk3NTAz_91d12fc6-7cdc-4e4e-85ca-a55b916b52fb">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjctMS0xLTEtMjk3NTAz_77f00073-2052-4727-b8d0-2b799e2035c1">87.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjctMy0xLTEtMjk3NTAz_c635efb4-3c70-4ced-934a-4793a7db85eb">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from (for) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjgtMS0xLTEtMjk3NTAz_c8341545-b4c0-4e77-9a7f-8e3754f8b333">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjgtMy0xLTEtMjk3NTAz_225ebc43-c4ab-4f62-b0ce-24eaf9528a65">79.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Flows From (For) Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzItMS0xLTEtMjk3NTAz_58034274-672d-45ac-af8c-d16dafd886c1">23.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzItMy0xLTEtMjk3NTAz_adc749b6-ec9e-4611-aded-aa7e748d5f9a">20.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from sale of businesses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzUtMS0xLTEtMjk3NTAz_90d7a4f1-fda7-4c43-9f56-cf537c38e2c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzUtMy0xLTEtMjk3NTAz_874716ee-3873-483a-b075-242f924069cb">58.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzYtMS0xLTEtMjk3NTAz_ada82ac0-24ad-45ab-acfe-3366de06fe13">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzYtMy0xLTEtMjk3NTAz_1e0b8380-b0d2-4a87-883d-30bf9fefa5fe">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="prgo:ProceedsfromRoyaltiesReceivedInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzctMS0xLTEtMjk3NTAz_ab795841-c8f0-4da3-a96e-93996350f09c">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="prgo:ProceedsfromRoyaltiesReceivedInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzctMy0xLTEtMjk3NTAz_12759b60-2887-45eb-9b43-1cff9f53e943">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from (for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzktMS0xLTEtMjk3NTAz_2eef8112-c7fd-4e3c-84d9-907da8affea5">19.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzktMy0xLTEtMjk3NTAz_a07a5722-0aeb-480d-b48a-c25ac4f1a67b">62.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Flows From (For) Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Borrowings (repayments) of revolving credit agreements and other financing, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNDMtMS0xLTEtMjk3NTAz_bd058cc3-d183-4965-a61e-3917aa222031">5.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNDMtMy0xLTEtMjk3NTAz_1730f6e2-0631-48f8-89c4-db23429550a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTAtMS0xLTEtMjk3NTAz_eb8fdc9f-e65e-4f25-8640-084c487572bf">36.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTAtMy0xLTEtMjk3NTAz_56a06cf5-d1c7-4788-ac27-7bd74fa77665">34.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTItMS0xLTEtMjk3NTAz_66f8e562-7699-494a-85d0-b12826979142">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTItMy0xLTEtMjk3NTAz_145efd85-0053-4375-a151-4cccd655cf6a">17.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from (for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTMtMS0xLTEtMjk3NTAz_c351f934-230c-4143-b78c-b51adaf00ef3">50.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTMtMy0xLTEtMjk3NTAz_a9f86839-a5a1-4c3c-8c67-1b5f42b6fcb6">51.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTQtMS0xLTEtMjk3NTAz_0dfdf865-abe2-4502-84ad-edc816ef4e7a">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTQtMy0xLTEtMjk3NTAz_15c681a5-00b7-4090-8bd5-fa9576979f67">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTUtMS0xLTEtMjk3NTAz_202259ec-d10c-48c7-b0f8-05d340ebeade">47.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTUtMy0xLTEtMjk3NTAz_9af07769-6612-4e0c-a886-93b5116a55cf">86.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents of continuing operations, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTYtMS0xLTEtMjk3NTAz_b2627e96-b580-4f0a-a67f-1e431460f5e9">600.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd18f1c6b0bf4007931565e3309d3a59_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTYtMy0xLTEtMjk3NTAz_3f929033-a893-4546-804a-53a3217eaa0b">1,864.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents held for sale, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTctMS0xLTEtMjk3NTAz_72f2b3ff-c8e8-483d-b8d6-ac7f08f3031c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd18f1c6b0bf4007931565e3309d3a59_I20211231" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTctMy0xLTEtMjk3NTAz_d0e3d2dd-d9c0-4ac0-9efa-9c2fc06932ac">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less cash and cash equivalents held for sale, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTgtMS0xLTEtMjk3NTAz_0305f8e1-aded-4c19-9302-20945de6736e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6955bfa807de4779804dcda471f50c60_I20220402" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTgtMy0xLTEtMjk3NTAz_5255fc46-39b7-4199-9b78-3bb04c9035ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents of continuing operations, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTktMS0xLTEtMjk3NTAz_40965803-4d40-40c3-ba71-b9c1d3518954">553.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6955bfa807de4779804dcda471f50c60_I20220402" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTktMy0xLTEtMjk3NTAz_08dc70e1-e87e-43d2-a0dd-61b532b66c01">1,965.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_37"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_40"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDc0Nw_f2064144-ae77-46a6-9e71-2417db155f04" continuedAt="ie5670b2b652c4b52b778cf9fae3fa2f2" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie5670b2b652c4b52b778cf9fae3fa2f2" continuedAt="i25b00348fc884e7bafe090960e5da0a3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Information</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading provider of over-the-counter ("OTC") health and wellness solutions that are designed to enhance individual well-being and empower consumers to proactively prevent or treat conditions that can be self-managed. Our vision is t</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">o make lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We are headquartered in Ireland and sell our products primarily in North America and Europe as well as in other markets around the world.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDc1Nw_aeb3d42f-d867-4fbd-808f-1ffe77c363f2" continuedAt="i0c1d5b2093aa46f49c2eed7086c51364" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0c1d5b2093aa46f49c2eed7086c51364">Our unaudited Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022.</ix:continuation> <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDc0OQ_76bbf253-949b-442d-91bb-c48d5d9311b9" escape="true">In the opinion of management, all adjustments considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Some amounts in this report may not add due to rounding.</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDc0Mw_a386e664-015e-4e29-b916-6fc3cf080bcc" continuedAt="if7f37ead89e646598fc6cbe2e138e17e" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting and operating segments are as follows: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:14.5pt">Consumer Self-Care Americas ("CSCA") </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care International ("CSCI") </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic business in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_61">Note </a></span><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_61">4</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if7f37ead89e646598fc6cbe2e138e17e">Our segments reflect the way in which our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company.</ix:continuation> Financial information related to our business segments and geographic locations can be found in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_43">Note 2 </a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_100">Note 17</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDc2NQ_ab51c34f-ed00-4876-b62d-f93d15878ec7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation and Transactions </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate our non-U.S. dollar-denominated operations&#8217; assets and liabilities into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of Accumulated other comprehensive income (loss) ("AOCI"). Gains or losses from foreign currency transactions are included in Other (income) expense, net.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i25b00348fc884e7bafe090960e5da0a3"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. Historical credit loss experience provides the primary basis for estimation of expected credit losses and is adjusted for current conditions and for reasonable and supportable forecasts. Receivables that do not share risk characteristics are evaluated on an individual basis and are not included in the collective evaluation. <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDczNA_0cdc3f55-85c1-41b7-af79-aab1c494df71" continuedAt="if38adc2fcba24a9cb85bd524443283cf" escape="true">The following table presents the allowance for credit losses activity (in millions):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="if38adc2fcba24a9cb85bd524443283cf"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.222%"><tr><td style="width:1.0%"></td><td style="width:61.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.322%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfMi0xLTEtMS0yOTc1MDM_2133746e-f76e-4571-9774-3fa2a1dd8d6d">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd18f1c6b0bf4007931565e3309d3a59_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfMi0zLTEtMS0yOTc1MDM_db135ad1-d085-4aa2-b4c0-849368167c3c">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for credit losses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfMy0xLTEtMS0yOTc1MDM_51f3fe24-e3b3-442d-90aa-ac9cd51c1a81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfMy0zLTEtMS0yOTc1MDM_2db44edc-a60a-4d65-b773-d66549b1d4b5">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables written-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfNC0xLTEtMS0yOTc1MDM_a3a44b7e-2d8a-4325-b549-ca4a3f206f3b">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfNC0zLTEtMS0yOTc1MDM_639fd1ec-4fe9-42f9-b19b-64c24623d680">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfNy0xLTEtMS0yOTc1MDM_23d3e6ba-9f7b-4c47-82aa-7295fccd624d">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfNy0zLTEtMS0yOTc1MDM_1cf8e0c3-8b1d-4757-9573-bd0fc50a8d4b">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfOC0xLTEtMS0yOTc1MDM_5cff8b20-4d0d-4340-ad06-bb7852dce456">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6955bfa807de4779804dcda471f50c60_I20220402" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfOC0zLTEtMS0yOTc1MDM_03ba0ed2-f59b-46d3-9a69-8341324907c4">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_43"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMzA2Mw_0bbc2dc7-7231-4f26-abd8-caa04a3f8da5" continuedAt="ib48008d70575430a9ce7562edbd95a06" escape="true">REVENUE RECOGNITION </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib48008d70575430a9ce7562edbd95a06" continuedAt="ieb51f61c3fb643dba00e80b8ed2dac57"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMzA5NQ_ad15d210-d94e-4427-a21b-c717f3f406d3" continuedAt="i4d724a5369b6446cbdcc33442fbbefc9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our net sales by category</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.00pt"><tr><td style="width:1.0pt"></td><td style="width:226.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f5c13d45a9489b800b1fdca5125d08_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMy0xLTEtMS0yOTc1MDM_d3d63fe4-6a26-4c56-a391-c36dafeb072a">154.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf374477ec7c4dc8a274c7c5c8b33a4e_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMy0zLTEtMS0yOTc1MDM_ac1f0e1d-cc66-4ec2-839d-ab31655ff42e">152.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e110cebac446599cfeea238f5aca8e_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNC0xLTEtMS0yOTc1MDM_1af93b18-12dd-480c-bcf6-9cdfec4ea1b4">139.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d57b17ab9441e0830bda17d8d7302a_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNC0zLTEtMS0yOTc1MDM_92607010-78d8-4e76-be34-e8fa67bddfcb">127.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41c767804e04e74b0d0675fae86b3e6_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNS0xLTEtMS0yOTc1MDM_e403619b-eb6c-4f1c-a860-83a2582594b6">124.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d2639683f947f1b1d6e8865ba5ab42_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNS0zLTEtMS0yOTc1MDM_c89117bc-f0df-42da-ada5-ab37812dc557">118.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3deb497865334700bccbc0cb9af79e11_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNi0xLTEtMS0yOTc1MDM_5fac3580-1348-41e2-9b13-8e62323a9c56">103.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ca79a594274f7d986860796f5bf5c4_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNi0zLTEtMS0yOTc1MDM_3e6481c5-bdcb-491e-91ec-2168e04601e3">102.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe154ddc08314c818219ab4974f9b334_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNy0xLTEtMS0yOTc1MDM_a98e17fc-8275-4b53-adb9-e4368a51940d">84.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i423427f446af435a8a099e8e39407244_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNy0zLTEtMS0yOTc1MDM_3bd9dc5c-8432-4c34-b57e-c076f60608e2">70.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f4328ac279d49ba94fa79ccb58cca12_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfOC0xLTEtMS0yOTc1MDM_2a8b3077-22a1-40cd-a138-656d8252e184">73.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65f795e573b74139b0597df57a87597e_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfOC0zLTEtMS0yOTc1MDM_1cd688cb-7c87-40f2-870d-e345e855c120">67.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedde1896a9a744229692a430d32ed377_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfOS0xLTEtMS0yOTc1MDM_60bd8f89-588e-47a9-99a0-ce27e6414c67">52.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023898292ce644d4920385454d5ee04c_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfOS0zLTEtMS0yOTc1MDM_da13faa0-e9ae-4c8a-840a-841154cacc1e">40.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8cd73c20df4eb1818e515fc7c9333a_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTAtMS0xLTEtMjk3NTAz_ee910e7f-c8f7-48ad-9ac7-53aeab0e08cb">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd70fd42144a4756be4ac24e92e7858a_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTAtMy0xLTEtMjk3NTAz_2057e6b3-d9a8-4010-9234-a7388f63d1f5">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vitamins, Minerals, and Supplements ("VMS")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05a97c7cd9bf4ae49aef6276d404df59_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTEtMS0xLTEtMjk3NTAz_8f2fc260-25c5-4c61-9dff-531290851da4">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b3d9701d1f4e7aad3538d9f6e954f9_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTEtMy0xLTEtMjk3NTAz_69bcea0f-e074-4db5-a9a1-1d9370afc1d0">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cbf1a7074ed45a3a1f504b48f430acf_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTItMS0xLTEtMjk3NTAz_e79cddee-e12b-4b7c-b1f9-475e70de1760">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aed093d915e4cb8a09ef81ab74849f2_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTItMy0xLTEtMjk3NTAz_dd01069a-e20f-4020-abb5-5973460445b5">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCA</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e4fca1b9404a29b27348e58f4f2456_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTMtMS0xLTEtMjk3NTAz_2cdd7c7a-bb89-4883-b3fb-5170990d5e99">763.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a41be8290854dd7b445442e9fce77b4_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTMtMy0xLTEtMjk3NTAz_e4aa69f2-32f2-46f6-bdec-cbf995a3300a">710.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f64d6970e5341198837503d0ac5e982_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTUtMS0xLTEtMzYxMTUx_0dd64f87-e804-4e12-aef1-c6f8f30084bc">84.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9230b63081f4a419d17b4423287f16d_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTUtMy0xLTEtMzYxMTUx_65c58035-51fd-49d9-b8a6-e9e69e767b8a">66.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id72e917daad64a05bf29a7fa65162e54_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTUtMS0xLTEtMjk3NTAz_71465664-4808-4686-85de-776d866777d6">83.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aeac51b11cd4427af639bde4e8f879a_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTUtMy0xLTEtMjk3NTAz_9b1872ed-09a3-40e1-8457-02b715f2d936">73.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i935b53becd594afcbffb2058d5cf3b02_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTgtMS0xLTEtMzU1MDk3_34960d6c-a08e-4f34-b4bb-acab133f298e">66.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bbc6f93b654156afae3a426cf64660_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTgtMy0xLTEtMzU1MDk3_e327ba1d-bebe-4aeb-bc8e-54b41d70b141">58.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153d82f41fd34b13bb9cdb1b721635fa_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTktMS0xLTEtMzYxMTU4_83144d4f-1647-4f05-a74f-80cf600d49f4">49.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08ee092ef6164e56bd199362643c5c7f_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTktMy0xLTEtMzYxMTU4_28ff5ace-7efd-4c74-b028-0398bcf94ce0">54.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VMS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ee1193579b4eae9c065c0476e1af27_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTgtMS0xLTEtMjk3NTAz_528b64cc-4129-4300-a3cd-033eb4beb24c">47.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3401426e894533be11508ed857acc6_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTgtMy0xLTEtMjk3NTAz_c775b5ce-be6f-4731-b61c-7c719b641ccb">49.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c62f3bb392741fda84f5cd9e3a30ea0_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjAtMS0xLTEtMjk3NTAz_78578f53-4181-42d2-853a-b8e3c48bb8b8">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec2b2f9ab6446b7aee5b5a487b367d9_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjAtMy0xLTEtMjk3NTAz_42951ff3-e9f1-474a-ad43-bcc6f9760817">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e25af889154d1bb960e56417630fde_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjEtMS0xLTEtMjk3NTAz_3ef43417-4938-4694-8f6c-de33c3f3c8ed">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb71bb33d314222ab57e0143395957a_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjEtMy0xLTEtMjk3NTAz_079b1700-dec0-4cd7-b08d-0aed801808d2">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86ac2754d6fd4df6b38298e67a72bf14_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjItMS0xLTEtMjk3NTAz_74796625-fe70-4a27-8de1-4bef2b315419">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i810f1ba4bfdd4a278d0a9f1e7f9c9a68_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjItMy0xLTEtMjk3NTAz_6a23d755-6d32-47d1-9cdc-7fd3b6a36300">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib811602f7ff24efc831c6c1156046949_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjMtMS0xLTEtMjk3NTAz_6646ef3a-a9dd-4d1a-ab6a-21bfbf229d99">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia940558c4b3444388c68c903c7078507_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjMtMy0xLTEtMjk3NTAz_b9f02052-1efc-4925-ab25-2c8f5cd2320b">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCI</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i817dfeec890e44ed95bda23a0c957cff_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjQtMS0xLTEtMjk3NTAz_c52268ba-695f-431d-8906-9e6895385347">418.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc50f621c6924bbf8a473a58178c820b_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjQtMy0xLTEtMjk3NTAz_399fe741-81fc-4f2d-9f35-8f96e2128847">364.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjYtMS0xLTEtMjk3NTAz_266a6fc9-d9ad-4267-8a6e-0a3ccc6c35c9">1,181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjYtMy0xLTEtMjk3NTAz_d8dea0a7-20d4-44eb-8a4e-60e2c4666207">1,074.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(1) We updated our global reporting product categories as a result of our product portfolio reconfiguration. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(2) Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 2</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ieb51f61c3fb643dba00e80b8ed2dac57"><ix:continuation id="i4d724a5369b6446cbdcc33442fbbefc9" continuedAt="ia69582168bd24866a581afd6710045c7"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">than 10% of the segment net sales. </span></div></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized over time. Customer contracts recognized over time exist predominately in contract manufacturing arrangements, which occur in both the CSCA and CSCI segments. Contract manufacturing revenue was $<ix:nonFraction unitRef="usd" contextRef="i4e003873c79f4b258525ee8b81660c16_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMjUyNA_65bc0f84-0db0-49fb-9346-4e6ed896aac5">90.0</ix:nonFraction>&#160;million for the three months ended April&#160;1, 2023, and $<ix:nonFraction unitRef="usd" contextRef="i687906ed625e459a9c846fd176504670_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMjU2MA_508620a5-457e-48ff-949d-a25cadc77fb0">70.8</ix:nonFraction>&#160;million for the three months ended April&#160;2, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also recognize a portion of the store brand OTC product revenues in the CSCA segment on an over time basis; however, the timing difference between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery. </span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMzEwNA_9f265dc6-bc07-49a6-8ea7-f0898874ff8e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract assets from contracts with customers (in millions):</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:24.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term contract assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:ContractWithCustomerAssetGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOjMxMzQzYzc0YTNjZDQxOTVhODQ4YjQ5NmZhODVmMjNiL3RhYmxlcmFuZ2U6MzEzNDNjNzRhM2NkNDE5NWE4NDhiNDk2ZmE4NWYyM2JfMS0zLTEtMS0yOTc1MDM_21f39250-e009-4e91-8dd0-545fba94111b">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerAssetGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOjMxMzQzYzc0YTNjZDQxOTVhODQ4YjQ5NmZhODVmMjNiL3RhYmxlcmFuZ2U6MzEzNDNjNzRhM2NkNDE5NWE4NDhiNDk2ZmE4NWYyM2JfMS01LTEtMS0yOTc1MDM_5fea8be0-3680-4e06-8d81-21e478124abe">41.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:continuation id="ia69582168bd24866a581afd6710045c7"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated net sales in the following geographic locations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:366.00pt"><tr><td style="width:1.0pt"></td><td style="width:220.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe0cdbd5f85948e995c7dc28b6cb4f45_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfMi0xLTEtMS0zNTU0Mzc_5092ce7d-3c79-4d7c-afbb-932407918e8d">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ac8cde05224960aeb104a710acfa0d_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfMi0zLTEtMS0zNTU0Mzc_bdb4c5d3-96ac-4564-9058-26013c6fec7c">683.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia14a583947bd41cda0620726204c97bf_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfMy0xLTEtMS0zNTU0Mzc_4d844778-9a29-411c-8963-ef496404cdb7">407.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id685e682ee6d45c885e9bd25d7d82f62_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfMy0zLTEtMS0zNTU0Mzc_d06f1623-fbe7-4c7b-b973-ade4f4e08c92">351.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other countries</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df41325723f4515a100896e6f2804d2_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfNC0xLTEtMS0zNTU0Mzc_98bbc5d9-d2d9-4629-a59e-82aac12abc47">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe10084d8d8e4b8ea8a1ba4efd5d12ce_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfNC0zLTEtMS0zNTU0Mzc_60dbbe32-966b-4052-b683-d12b65afe740">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfNS0xLTEtMS0zNTU0Mzc_7003984a-b1a3-4af2-8851-79a6daeff2aa">1,181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfNS0zLTEtMS0zNTU0Mzc_fd85289e-c085-47ed-8ee1-6be7f6c71191">1,074.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The net sales by geography are derived from the location of the entity that sells to a third party.  </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Includes Ireland net sales of $<ix:nonFraction unitRef="usd" contextRef="ic077248bde32442796615d79eeb0a55f_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMzI5ODUzNDg5MzI0Ng_a8cfff81-e17c-436c-a6d3-152e4b608206">7.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3597c655dd73488a968ca15c3fa79180_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMzI5ODUzNDg5MzI1NA_7b9a0132-8be5-4dd0-96f3-d45066150af6">6.6</ix:nonFraction>&#160;million for the three months ended April&#160;1, 2023 and April&#160;2, 2022, respectively. </span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Includes net sales generated primarily in Australia and Canada.</span></div></ix:continuation></ix:continuation><div style="padding-left:54pt;text-align:justify;text-indent:-54pt"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTkwNg_75013f17-e66f-40ee-aa05-d248ce5b98b9" continuedAt="i7d9d740dff7c4105a56df913dd808a89" escape="true">ACQUISITIONS AND DIVESTITURES</ix:nonNumeric></span></div><ix:continuation id="i7d9d740dff7c4105a56df913dd808a89" continuedAt="i0d4aecbbfec341ee9c13dc82bd4e92f7"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Acquisitions During the Year Ended December 31, 2022</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">H&#233;ra SAS ("</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">HRA Pharma")</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On April 29, 2022, we completed the previously announced acquisition of <ix:nonFraction unitRef="number" contextRef="i16e4dfbabc1449fdb44f59c5ebd68d88_I20220429" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMTI0_cf79d5b8-8c32-4059-a484-e82038ff7749">100</ix:nonFraction>% of the outstanding equity interest in HRA Pharma for total consideration of &#8364;<ix:nonFraction unitRef="eur" contextRef="i09b56fa39043421e9d4157b4a80c13b3_D20220429-20220429" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjAz_410ad0b3-501a-46e7-b85f-4d6d2d1d8f0d">1.8</ix:nonFraction>&#160;billion, or approximately $<ix:nonFraction unitRef="usd" contextRef="i09b56fa39043421e9d4157b4a80c13b3_D20220429-20220429" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjI0_9aae4da5-ad16-496c-b426-072221cb6de5">1.9</ix:nonFraction>&#160;billion. We funded the transaction with cash on hand and borrowings under our New Senior Secured Credit Facilities (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_73">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">). The acquisition of HRA Pharma was accounted for as a business combination and has been reported in our Condensed Consolidated Statements of Operations as of the acquisition date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">HRA Pharma is a self-care based company with consumer brands such as </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Compeed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">, ellaOne</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"> and Mederma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">, as well as a trusted rare disease portfolio. The acquisition completed our transformation to a consumer self-care company. HRA Pharma&#8217;s operations are reported in both our CSCA and CSCI segments. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We recorded the preliminary purchase price allocation in the second quarter of 2022. During the first quarter of 2023, we recorded measurement period adjustments resulting in an increase to goodwill of $<ix:nonFraction unitRef="usd" contextRef="iad94f9c92d974bc2b0f1da3daa6ff5db_I20230401" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjMzNw_c47c23f8-e86e-4750-bfd9-4dd0b0c95cae">80.6</ix:nonFraction>&#160;million, which consisted of a $<ix:nonFraction unitRef="usd" contextRef="i297276a0f2644603919916e9535ffb86_D20230101-20230401" decimals="-5" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjM2Mg_ddcd1cbb-c949-4e8e-8910-ffd78e15aefa">104.3</ix:nonFraction>&#160;million decrease in definite-lived intangibles, $<ix:nonFraction unitRef="usd" contextRef="i297276a0f2644603919916e9535ffb86_D20230101-20230401" decimals="-5" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjM4OA_c213cc73-153b-4ba9-865c-1c285f32a222">27.2</ix:nonFraction>&#160;million decrease in net Deferred income tax liabilities, a net increase of $<ix:nonFraction unitRef="usd" contextRef="iad94f9c92d974bc2b0f1da3daa6ff5db_I20230401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjQ2Mg_1d0b0abf-0255-4afa-8c7b-f16f7a78d217">2.0</ix:nonFraction>&#160;million to other non-current liabilities, and a $<ix:nonFraction unitRef="usd" contextRef="iad94f9c92d974bc2b0f1da3daa6ff5db_I20230401" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjUwOQ_dd3cdb03-c519-441f-8fe1-2f7a0668b682">1.5</ix:nonFraction>&#160;million decrease in Prepaid expenses and other current assets. Current period earnings adjustments of $<ix:nonFraction unitRef="usd" contextRef="i4a4e7b481e564ec396c3dee7669dcf4a_D20220101-20221231" decimals="-5" name="prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMTE1NDQ4NzIxMjg5OTM_7cd79c21-8736-4c3f-b384-3820d3e7aae0">3.5</ix:nonFraction>&#160;million to Cost of sales were recorded that would have been recognized during the year-ended December 31, 2022, if the measurement period adjustments to the provisional opening balance sheet were reflected as of the acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Nestl&#233;&#8217;s Gateway Infant Formula Plant and GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> infant formula brand Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we purchased Nestl&#233;&#8217;s Gateway infant formula plant in Eau Claire, Wisconsin, along with the U.S. and Canadian rights to the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infant formula brand ("Gateway"), for $<ix:nonFraction unitRef="usd" contextRef="i49b813746d944e9caa272f8a6edd60db_D20221101-20221101" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODIzMjMw_89e9caed-110e-4c6e-9a99-8dc6487bdb6c">110.0</ix:nonFraction>&#160;million in cash, subject to customary post-closing adjustments. The acquisition was accounted for as a business combination and operating results attributable to the products are included in our CSCA segment in the Nutrition product category. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 3</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i0d4aecbbfec341ee9c13dc82bd4e92f7"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are in the process of finalizing the valuation for the assets acquired. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired will be finalized as soon as possible but no later than one year from the acquisition date. The final determination may result in asset fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Pro Forma Impact of Business Combinations</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTkwNQ_fddfb82b-611a-44ca-a85d-938c8ddb0880" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents unaudited pro forma information as if the HRA Pharma and Gateway acquisitions had occurred on January 1, 2021 and had been combined with the results reported in our Condensed Consolidated Statements of Operations for the three months ended April&#160;2, 2022 (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:305.25pt"><tr><td style="width:1.0pt"></td><td style="width:208.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:93.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RhYmxlOmVhMjFkY2IyNDVkZDRmMDFhYzUyMWVmOTIzMjQ0YmMyL3RhYmxlcmFuZ2U6ZWEyMWRjYjI0NWRkNGYwMWFjNTIxZWY5MjMyNDRiYzJfMi0zLTEtMS0yOTc1MDM_440cb485-2add-4fb1-9fd0-762bf5fcee88">1,209.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RhYmxlOmVhMjFkY2IyNDVkZDRmMDFhYzUyMWVmOTIzMjQ0YmMyL3RhYmxlcmFuZ2U6ZWEyMWRjYjI0NWRkNGYwMWFjNTIxZWY5MjMyNDRiYzJfMy0zLTEtMS0yOTc1MDM_1081a9d5-a4d8-45bf-822c-3edc5cc93063">10.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma information is presented for information purposes only and is not indicative of the results that would have been achieved if the acquisition had taken place at such time. The unaudited pro forma information presented above includes adjustments primarily for amortization charges for acquired intangible assets, depreciation of property, plant and equipment that have been revalued, certain acquisition-related charges, and related tax effects.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures During the Year Ended December 31, 2022 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Latin American businesses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2022, we completed the sale of our Mexico and Brazil-based OTC businesses ("Latin American businesses"), both within our CSCA segment, to Advent International for total consideration of $<ix:nonFraction unitRef="usd" contextRef="i71d0d200110e4e108b8f68acd92ba5e1_I20220309" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1NjQx_66f5b307-d04a-4c43-b80e-b9d42ceff73b">23.9</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="i1f76ed2554e846f0acf432bf5b3cc813_D20220309-20220309" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1NjYw_7c2c4783-6074-4e04-87ea-c0782a733490">5.4</ix:nonFraction> million in cash, installment receivables due <ix:nonNumeric contextRef="i5495ecbabeb74464bd45155077e348aa_I20220309" name="prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1NzAx_77e30a8e-6347-4552-8196-d97e5959fb60">12</ix:nonNumeric> and <ix:nonNumeric contextRef="i5495ecbabeb74464bd45155077e348aa_I20220309" name="prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1NzA5_70a9af9e-ad50-47fc-9a22-2c9bf8b599c0">18</ix:nonNumeric> months from completion totaling $<ix:nonFraction unitRef="usd" contextRef="i5495ecbabeb74464bd45155077e348aa_I20220309" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1NzQ1_83935eb7-f825-4caa-977c-3ebd507027a7">11.3</ix:nonFraction> million based on the Mexican peso exchange rate at the time of sale, and contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i5495ecbabeb74464bd45155077e348aa_I20220309" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1ODQy_e4372176-8dd1-4810-9948-6d7f7424ecac">7.2</ix:nonFraction> million based on the Brazilian real exchange rate at the time of sale. The sale resulted in a pre-tax loss of $<ix:nonFraction unitRef="usd" contextRef="ib8a0f1a3d9cf416fbceebe5198581d19_D20220309-20220309" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1OTQ4_05412e55-3dac-4987-a869-f4845a7f3ca0">1.4</ix:nonFraction> million, net of professional fees, recorded in Other operating expense, net on the Condensed Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2022, we completed the sale of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand asset, a leading U.S. OTC scar management brand, to Alliance Pharmaceuticals Ltd. for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i3ec5ffca5e044c25af00f0856f31cc69_D20220324-20220324" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI3MDY3_45891bb7-6d33-41fe-816c-07c13a004d2a">20.7</ix:nonFraction> million. The sale resulted in a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="i3ec5ffca5e044c25af00f0856f31cc69_D20220324-20220324" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI3MTEx_34a57761-5048-4db6-961c-05bb1a5c276e">3.6</ix:nonFraction> million recorded in our CSCA segment in Other operating expense, net on the Condensed Consolidated Statements of Operations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfNDE1NA_4361fac0-9708-485b-951b-12810b8c3755" continuedAt="i4c54b9d6253146d0af17ce065a75140a" escape="true">DISCONTINUED OPERATIONS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i4c54b9d6253146d0af17ce065a75140a" continuedAt="iab806899b2954e2a9dda75abd708f8eb"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discontinued operations consist of our generic prescription pharmaceuticals business in the U.S. and our pharmaceuticals and diagnostic businesses in Israel (collectively, the &#8220;Rx business&#8221;).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July&#160;6, 2021, we completed the sale of the Rx business to Altaris Capital Partners, LLC ("Altaris") for aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="ife7f164c6edf47848398641f9ffd17b1_I20210706" decimals="-7" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfMTA5OTUxMTYzMjk0Ng_362d5b62-7ef6-4f55-8b49-bf98959a34a2">1.55</ix:nonFraction> billion. The consideration included a $<ix:nonFraction unitRef="usd" contextRef="ife7f164c6edf47848398641f9ffd17b1_I20210706" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfMTA5OTUxMTYzMjk1MQ_7a719469-e1d8-4e64-8d03-8a31e43df573">53.3</ix:nonFraction> million reimbursement related to an Abbreviated New Drug Application (&#8220;ANDA") for a generic topical lotion which Altaris delivered in cash to Perrigo pursuant to the terms of the definitive agreement during the three months ended April 2, 2022. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of a transition services agreement ("TSA"), we provided transition services which were substantially completed as of the end of the third quarter of 2022. We also entered into reciprocal supply agreements pursuant to which Perrigo will supply certain products to the Rx business and the Rx business will supply certain products to Perrigo. The supply agreements have a term of <ix:nonNumeric contextRef="i6c40483c42aa43999f3d00d21dcd2535_D20210706-20210706" name="prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfNDE1OA_d6ee3d13-fcb7-4bd3-bee7-9dba1747258b">four years</ix:nonNumeric>, extendable up to <ix:nonNumeric contextRef="i6c40483c42aa43999f3d00d21dcd2535_D20210706-20210706" name="prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfNDE0Nw_35733226-9285-40d9-ab4a-f971da8d5a88">seven years</ix:nonNumeric> by the party who is the purchaser of the products under such agreement. We also extended distribution rights to the Rx business for certain OTC products owned and manufactured by Perrigo that may be fulfilled through pharmacy channels, in return for a share of the net profits.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 4</span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="iab806899b2954e2a9dda75abd708f8eb" continuedAt="ib099485bacbc4dd5a8634caadd5963eb"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale, Perrigo retained certain pre-closing liabilities arising out of antitrust (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_91">Note 16 - Contingencies</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the header "Price-Fixing Lawsuits") and opioid matters and the Company&#8217;s Albuterol recall, subject to, in each case, Altaris' obligation to indemnify the Company for <ix:nonFraction unitRef="number" contextRef="ife7f164c6edf47848398641f9ffd17b1_I20210706" decimals="INF" name="prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfNDE0OQ_8e954d0b-b35e-4887-a44b-082b279fbf71">fifty</ix:nonFraction> percent of these liabilities up to an aggregate cap on Altaris' obligation of $<ix:nonFraction unitRef="usd" contextRef="ife7f164c6edf47848398641f9ffd17b1_I20210706" decimals="-5" name="prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfMjk1MQ_60d7e409-fd36-4bc8-9737-2d923be52742">50.0</ix:nonFraction>&#160;million. We have not requested payments from Altaris related to the indemnity of these liabilities during the three months ended April&#160;1, 2023.</span></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib099485bacbc4dd5a8634caadd5963eb">Current and prior period reported net loss from discontinued operations primarily relates to legal fees, partially offset by an income tax benefit.</ix:continuation> </span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_52"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 5 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RleHRyZWdpb246MDc0ZWI2YjI0NWJmNDhhNTgyYzY3MWZiYjY4YmIwYjVfODU_2916244d-fbf0-41f3-bea7-e13e0da5c73c" continuedAt="if76bcc90e9504605a948c2ebafb8f89b" escape="true">INVENTORIES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if76bcc90e9504605a948c2ebafb8f89b"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RleHRyZWdpb246MDc0ZWI2YjI0NWJmNDhhNTgyYzY3MWZiYjY4YmIwYjVfODk_385eebb2-15dc-4c2f-a6b3-bfc37f66b2a6" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major components of inventory were as follows (in millions):</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.602%"><tr><td style="width:1.0%"></td><td style="width:42.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.343%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMS0xLTEtMS0yOTc1MDM_ef752770-ee09-4f94-aa24-20a437000b74">674.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMS0zLTEtMS0yOTc1MDM_83595890-d537-411f-a0b0-9c7722f76100">620.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMi0xLTEtMS0yOTc1MDM_d10ba943-0719-4f66-9782-a9f1357ced0e">251.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMi0zLTEtMS0yOTc1MDM_6ecb173b-fd80-49e5-9a93-7099dc6e96db">262.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMy0xLTEtMS0yOTc1MDM_1693dce9-e82e-4e1f-96f5-095bfe3b6885">257.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMy0zLTEtMS0yOTc1MDM_94200391-95d5-4a10-88ac-357df6bf610d">267.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfNC0xLTEtMS0yOTc1MDM_d690e09b-0359-454f-acc7-f6d8b913670c">1,183.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfNC0zLTEtMS0yOTc1MDM_0dfeda83-616e-47c9-bc17-ab9bd6896126">1,150.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_58"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RleHRyZWdpb246Y2U0YWZjOGQwMmU1NGQ3MjgzMTU1NjkxZTY4NjE0ODZfMzUz_728438b4-e050-47f3-9540-6d94119fe279" continuedAt="i482cbfa330d64a8f89f26725f857ecad" escape="true">INVESTMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i482cbfa330d64a8f89f26725f857ecad"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RleHRyZWdpb246Y2U0YWZjOGQwMmU1NGQ3MjgzMTU1NjkxZTY4NjE0ODZfMzU3_453d2271-a2df-44b5-9f75-a6fc4dee5010" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:26.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebf7e0bc9094fd6a3ac5764350b0544_I20230401" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMS00LTEtMS0yOTc1MDM_74223cba-c3c8-4996-9a18-4cf3e50582b2">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb38aa56dcf402bb0bb2637e8d49b4d_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMS02LTEtMS0yOTc1MDM_1a0c2805-e949-4468-897e-a09d7596c6a1">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if103d7bf645e4b24ac84251cdaf12b33_I20230401" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMi00LTEtMS0yOTc1MDM_587429ab-0152-4c62-ba2e-354b86ad51aa">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fd779f91b674ece84c54eb308733a1d_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMi02LTEtMS0yOTc1MDM_11b4fc3b-792a-4bb6-a947-2cbd10bb1e76">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if103d7bf645e4b24ac84251cdaf12b33_I20230401" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMy00LTEtMS0yOTc1MDM_e8e9f753-d3c8-4807-a008-f3c3fe661fca">62.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fd779f91b674ece84c54eb308733a1d_I20221231" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMy02LTEtMS0yOTc1MDM_9ecc9824-081a-4897-9400-3070ec905216">63.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Measured at fair value using the Net Asset Value practical expedient.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RleHRyZWdpb246Y2U0YWZjOGQwMmU1NGQ3MjgzMTU1NjkxZTY4NjE0ODZfMzUw_57a01cb7-437d-476e-adf8-0e31f52d798b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expense recognized in earnings of our equity securities (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"></td><td style="width:25.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.364%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOjllNjJkNTA1OTkwNTRkYzY4ZTY0ZTdlYzc4OWQwZTE1L3RhYmxlcmFuZ2U6OWU2MmQ1MDU5OTA1NGRjNjhlNjRlN2VjNzg5ZDBlMTVfMi00LTEtMS0yOTc1MDM_60345042-8a9b-41bb-94cd-077614e0efc9">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOjllNjJkNTA1OTkwNTRkYzY4ZTY0ZTdlYzc4OWQwZTE1L3RhYmxlcmFuZ2U6OWU2MmQ1MDU5OTA1NGRjNjhlNjRlN2VjNzg5ZDBlMTVfMi02LTEtMS0yOTc1MDM_ae1db83a-3780-47ca-a513-1587d1b6e666">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOjllNjJkNTA1OTkwNTRkYzY4ZTY0ZTdlYzc4OWQwZTE1L3RhYmxlcmFuZ2U6OWU2MmQ1MDU5OTA1NGRjNjhlNjRlN2VjNzg5ZDBlMTVfNC00LTEtMS0yOTc1MDM_72f4a323-063a-4b2c-b163-160270b8f2a8">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOjllNjJkNTA1OTkwNTRkYzY4ZTY0ZTdlYzc4OWQwZTE1L3RhYmxlcmFuZ2U6OWU2MmQ1MDU5OTA1NGRjNjhlNjRlN2VjNzg5ZDBlMTVfNC02LTEtMS0yOTc1MDM_976435c0-2de2-46b1-b613-2517cb762947">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_70"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 7</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNDkw_6a3f0aba-51b4-43a4-8bdc-652825a55ff8" continuedAt="i4304b6c1ab0649db9d47797811310804" escape="true"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNTAw_6dc833d9-7d0a-4bb5-bc4f-fa7b5ebf2ae0" continuedAt="ia5cc9d0bad4a46aab24c26964e7c5271" escape="true">LEASES</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i4304b6c1ab0649db9d47797811310804" continuedAt="i5db4aa449c5e4698ae4e1b0df878b478"><ix:continuation id="ia5cc9d0bad4a46aab24c26964e7c5271" continuedAt="i9511b08a3355401e84f20c3fa771b61f"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="prgo:AssetsandLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNDk0_6ec20517-e7ef-42e8-99df-68a1e5050c29" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"><tr><td style="width:1.0pt"></td><td style="width:124.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:178.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMS00LTEtMS0yOTc1MDM_0f31b42b-4541-4a81-8f43-6b47e73acbf4">211.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMS02LTEtMS0yOTc1MDM_ea25b1fd-afcc-43b5-9a09-2de6cafadd6b">217.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_8393b283-e363-4504-b231-143478dd2c5f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_87043135-b949-45d0-9eae-f1b4645419a9">Other non-current assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi00LTEtMS0yOTc1MDM_8dbbcfeb-e1dc-4e28-8bf7-d88efeb6d398">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi02LTEtMS0yOTc1MDM_79ec7a2f-4764-4b9b-a0d8-151c4b230b0a">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:RightofUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMy00LTEtMS0yOTc1MDM_0aa1a718-0dfc-4652-b82d-95c94f972dd7">232.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="prgo:RightofUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMy02LTEtMS0yOTc1MDM_af40e278-78d2-47f9-8cb6-1a028e3f32f1">239.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"><tr><td style="width:1.0pt"></td><td style="width:124.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:178.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_05036283-a810-4bae-854e-92b3df99922c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_b5e2a70c-b3bd-48c1-b7a0-2aff813e9b08">Other accrued liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi00LTEtMS0yOTc1MDM_796d1c1c-5921-49a8-bb6a-47493001a7bc">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi02LTEtMS0yOTc1MDM_0b834893-b4a6-434b-a8d8-8868fcbd5edc">28.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_1a147768-c056-425b-af34-6db715980677"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_7a7ad5f3-7e3d-4fd6-b39b-bd13f91b4653">Current indebtedness</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy00LTEtMS0yOTc1MDM_4f61627c-394f-46ad-b4bc-cafe93f981fa">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy02LTEtMS0yOTc1MDM_92427d4c-50b4-49e5-b376-2f181ea78635">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_156cee65-de81-4dfd-849e-fc62e3c9dfcf"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_88c5c5e3-521f-44d6-b6d7-0639e3d6ce44">Other non-current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS00LTEtMS0yOTc1MDM_5f755899-55c7-4494-9524-e1d201017359">184.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS02LTEtMS0yOTc1MDM_c54bfc93-a043-4c99-8c13-2e46aaacc9e6">189.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_3eb3333f-44a6-4a5b-bef2-60d0ef263f0a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_f509a7f0-b2aa-4888-9b39-8d9314e7b4c4">Long-term debt, less current portion</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi00LTEtMS0yOTc1MDM_b04d9b99-96ae-44c2-bc16-f9b57ca31a91">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi02LTEtMS0yOTc1MDM_707487ea-d52b-4c43-b4f9-e776c09ea421">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNy00LTEtMS0yOTc1MDM_362d368d-3129-4c2f-b009-8bf402dc74d3">232.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="prgo:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNy02LTEtMS0yOTc1MDM_d1784b16-2a18-4396-9d38-c952ce4041db">238.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables show our lease assets and liabilities by reporting segment (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"><tr><td style="width:1.0pt"></td><td style="width:133.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ca477c08d84a82a9de72b2c524c103_I20230401" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfMy0yLTEtMS0yOTc1MDM_e78bfd7e-6e12-48c1-8d22-73d967029cf9">97.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0244fe0ff77440b9929d419ff9c9da9b_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfMy00LTEtMS0yOTc1MDM_a78717ed-6cd8-4e75-8590-691d0ffeab5b">100.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ca477c08d84a82a9de72b2c524c103_I20230401" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfMy02LTEtMS0yOTc1MDM_623deda7-6cec-4477-8077-2f9444c66b01">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0244fe0ff77440b9929d419ff9c9da9b_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfMy04LTEtMS0yOTc1MDM_9fbf94bd-e33a-430d-8eff-f7319e1a9bb7">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i620cef7dc50148d7a2222193971d347f_I20230401" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNC0yLTEtMS0yOTc1MDM_41cf9ccf-f13d-49cb-892b-b61d038b0cd0">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af8f32782cc4ff0b482a38bac5b723b_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNC00LTEtMS0yOTc1MDM_4c527802-c545-4661-af47-c5c9ff21a87e">49.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i620cef7dc50148d7a2222193971d347f_I20230401" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNC02LTEtMS0yOTc1MDM_339415d9-dd42-432a-b212-f19c26a3cf8b">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af8f32782cc4ff0b482a38bac5b723b_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNC04LTEtMS0yOTc1MDM_3ddbd168-5cb0-46d3-bd8d-7d1a53ae6211">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25260d2b6b4edab1b3611171d1ce25_I20230401" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNy0yLTEtMS0yOTc1MDM_d13390b0-5393-4f1b-afbd-8255320f890f">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4e56b5dd90f4224b8c29c7ef31fe2a5_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNy00LTEtMS0yOTc1MDM_4c4e7cb8-313a-4c56-b9f1-0edb16f44390">67.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25260d2b6b4edab1b3611171d1ce25_I20230401" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNy02LTEtMS0yOTc1MDM_8228a539-639c-445b-8d36-2133a677692e">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4e56b5dd90f4224b8c29c7ef31fe2a5_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNy04LTEtMS0yOTc1MDM_9d6b5ae9-530d-43aa-8186-effafb51e117">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfOC0yLTEtMS0yOTc1MDM_02699f4f-1267-4ded-bc64-f3cc0e9c7f03">211.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfOC00LTEtMS0yOTc1MDM_10155d25-f07c-4465-bc82-e84650b18ae5">217.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfOC02LTEtMS0yOTc1MDM_55ddf3e1-2866-41b1-8681-2f85d1eb4a89">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfOC04LTEtMS0yOTc1MDM_4a5ee6fc-8cce-4f7a-9912-ed3cd56f5a14">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"><tr><td style="width:1.0pt"></td><td style="width:133.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ca477c08d84a82a9de72b2c524c103_I20230401" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfMy0yLTEtMS0yOTc1MDM_a12ef98a-a0a7-4257-b653-24602cfabbe5">99.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0244fe0ff77440b9929d419ff9c9da9b_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfMy00LTEtMS0yOTc1MDM_f0c55f70-859f-4549-a57a-988323198417">102.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ca477c08d84a82a9de72b2c524c103_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfMy02LTEtMS0yOTc1MDM_46070f74-13b2-45d1-8c78-6e572abbbb6d">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0244fe0ff77440b9929d419ff9c9da9b_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfMy04LTEtMS0yOTc1MDM_0e0ab830-a44b-4951-a6c5-1e67066313fd">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i620cef7dc50148d7a2222193971d347f_I20230401" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNC0yLTEtMS0yOTc1MDM_457643af-b0cc-45de-b587-132f05eb2ae3">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af8f32782cc4ff0b482a38bac5b723b_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNC00LTEtMS0yOTc1MDM_9e409328-4bf5-4f07-8fd4-4244b81d5cae">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i620cef7dc50148d7a2222193971d347f_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNC02LTEtMS0yOTc1MDM_845e9a16-e738-45eb-871f-096ea76d6cc4">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af8f32782cc4ff0b482a38bac5b723b_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNC04LTEtMS0yOTc1MDM_a1604c56-3069-4f36-9c18-0e5f20f97649">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25260d2b6b4edab1b3611171d1ce25_I20230401" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNy0yLTEtMS0yOTc1MDM_63889f5e-d4d8-4b62-8657-d58db2b9e17c">62.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4e56b5dd90f4224b8c29c7ef31fe2a5_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNy00LTEtMS0yOTc1MDM_bab0452b-ffb4-44cd-8ffa-c5474ab114e5">64.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25260d2b6b4edab1b3611171d1ce25_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNy02LTEtMS0yOTc1MDM_b9e8fe40-7dd2-4449-bf5f-2fbe3fec1570">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4e56b5dd90f4224b8c29c7ef31fe2a5_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNy04LTEtMS0yOTc1MDM_da7283c2-316d-4452-895d-40583e8ea27e">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfOC0yLTEtMS0yOTc1MDM_9ff65a08-862d-4c71-8c36-dd74d3c33173">213.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfOC00LTEtMS0yOTc1MDM_cffa4229-9e33-4a64-a083-a9d639cec262">217.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfOC02LTEtMS0yOTc1MDM_0aada447-24e1-4b3c-81ec-98e0bf8867e3">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfOC04LTEtMS0yOTc1MDM_e88f49e1-e053-4577-96d9-eee4bb8c1d3b">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt"><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNDk1_64de758e-3d87-4da1-94a6-ac7bf44a4c38" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:306.00pt"><tr><td style="width:1.0pt"></td><td style="width:133.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfMi0yLTEtMS0yOTc1MDM_54c404cf-1f7e-4cb1-bedf-867e8f260502">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfMi00LTEtMS0yOTc1MDM_b5f6ea1a-baba-46de-887a-20d62a983304">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNS0yLTEtMS0yOTc1MDM_ef1121f0-2fd7-446e-b372-e6697125c17f">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNS00LTEtMS0yOTc1MDM_4fe6f3c4-7aa1-4abe-b6c4-4aabc705aa1f">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNi0yLTEtMS0yOTc1MDM_6cb374e0-7eea-4509-8d62-c58749fc71f0">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNi00LTEtMS0yOTc1MDM_657fba34-edf6-4551-979d-02f5f8864cb9">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="prgo:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNy0yLTEtMS0yOTc1MDM_15fae78d-194c-4eb4-b6a6-00465cc18394">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="prgo:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNy00LTEtMS0yOTc1MDM_a8248226-dc86-4211-b858-dbc0d220ed8b">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  Includes short-term leases and variable lease costs, which are immaterial.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 7</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i5db4aa449c5e4698ae4e1b0df878b478"><ix:continuation id="i9511b08a3355401e84f20c3fa771b61f"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNTA1_933da41d-0f15-4c61-aae7-d828c60caf9f" escape="true"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNTA3_d3dadce5-a694-4d0a-9881-3491727e9c6d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our leases as of April&#160;1, 2023 are as follows (in millions):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:351.00pt"><tr><td style="width:1.0pt"></td><td style="width:142.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMS0yLTEtMS0yOTc1MDM_0f2b5e82-1f16-4862-b7ac-ba13f1f52ef1">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMS00LTEtMS0yOTc1MDM_6451da4e-3cf0-481f-9871-be1d7a3ce876">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LeaseLiabilityPaymentsRemainderofFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMS02LTEtMS0yOTc1MDM_e8cfed1c-98be-4dd7-ac3a-6df11eecb937">27.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMi0yLTEtMS0yOTc1MDM_85b7d96a-cc3e-4ba0-a781-6653ffc5a376">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMi00LTEtMS0yOTc1MDM_c0c52ac2-aa8f-45d8-958a-e0c0d0f512cb">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueYearOne" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMi02LTEtMS0yOTc1MDM_e6e600df-4752-4196-aa67-b13655017198">31.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMy0yLTEtMS0yOTc1MDM_5e20037d-cd15-48b3-801f-398424dc3bd6">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMy00LTEtMS0yOTc1MDM_9a74a6d0-3bbf-4fac-a040-7133d27c401f">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMy02LTEtMS0yOTc1MDM_d02f29bf-d52f-420b-b7a0-da4101095457">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNC0yLTEtMS0yOTc1MDM_f272f1ef-b472-4a20-b55a-503f5b775268">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNC00LTEtMS0yOTc1MDM_2b595af3-d755-4c2a-9f67-370e6c9f9872">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNC02LTEtMS0yOTc1MDM_61f53eaa-4278-4456-a8fb-39cdd5205260">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNS0yLTEtMS0yOTc1MDM_69028c56-e6b3-47c9-a224-e2fd1b6c3041">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNS00LTEtMS0yOTc1MDM_1d0a8cd6-a72d-4a1d-81f5-fc45019133b1">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNS02LTEtMS0yOTc1MDM_dc6dba96-5f0d-4efd-b6ec-4f54d1855a55">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LesseeOperatingLeaseLiabilitytobePaidafterYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNi0yLTEtMS0yOTc1MDM_017808e6-e651-43c9-9e54-e1e9c0960fb1">117.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:FinanceLeaseLiabilitytobePaidafterYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNi00LTEtMS0yOTc1MDM_fd247dcd-f373-4ecc-bdd6-f70c093f14cf">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LeaseLiabilityPaymentsDueafterYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNi02LTEtMS0yOTc1MDM_3826fa9c-6e8a-4fd4-842f-407be475941d">129.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNy0yLTEtMS0yOTc1MDM_2e7b6b6c-dfb6-4aa8-a5b4-2872f4cce1ca">243.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNy00LTEtMS0yOTc1MDM_3a7aaed7-2fca-49f6-b303-9a06e293dd3a">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNy02LTEtMS0yOTc1MDM_5e3921df-9c97-4f23-89c0-9e0a419c94f3">266.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOC0yLTEtMS0yOTc1MDM_b835fea2-2cd2-4bc6-a366-d06aff2f3589">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOC00LTEtMS0yOTc1MDM_29d856da-3606-44af-98b9-71896df69bc9">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOC02LTEtMS0yOTc1MDM_0684eae4-1f7d-48db-8616-cd48bc4e4f0c">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOS0yLTEtMS0yOTc1MDM_dc300268-f80d-40b6-b825-8d7029e2302e">213.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOS00LTEtMS0yOTc1MDM_0f5f04c1-0ffb-40d0-ae7c-b013944587fe">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:LeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOS02LTEtMS0yOTc1MDM_601385f1-91a4-4ad0-902b-ba01f98f122c">232.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNDk2_55a6a7d6-af7f-4f23-b265-80f715eaebf2" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our weighted average lease terms and discount rates are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:352.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfMi0yLTEtMS0yOTc1MDM_adcd6713-8c04-4b92-bec0-3c15bbd159b5">10.85</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6955bfa807de4779804dcda471f50c60_I20220402" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfMi00LTEtMS0yOTc1MDM_a9b649ea-1ad1-4b23-a525-039bb47aabfa">12.09</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfMy0yLTEtMS0yOTc1MDM_271df5af-4c9d-408f-bee8-dee7a9f567fb">9.49</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6955bfa807de4779804dcda471f50c60_I20220402" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfMy00LTEtMS0yOTc1MDM_89fcfd8e-24af-402a-bc61-21d8cf35a396">9.28</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfNS0yLTEtMS0yOTc1MDM_da77b082-8e65-4d1f-be5b-9332ab38c2e6">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6955bfa807de4779804dcda471f50c60_I20220402" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfNS00LTEtMS0yOTc1MDM_aa01aae9-5f7c-45e9-859f-931219d4cf77">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfNi0yLTEtMS0yOTc1MDM_190c8df4-63b8-41d0-a71b-e9ef17510496">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6955bfa807de4779804dcda471f50c60_I20220402" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfNi00LTEtMS0yOTc1MDM_ae9dab5f-9779-4aed-b462-7a2a5f971875">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="prgo:LesseeCashFlowClassificationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNDk5_1989a6cb-a5e4-452d-9ab3-89e09ffa651f" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease cash flow classifications are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:352.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfMy0yLTEtMS0yOTc1MDM_b2b18eec-cc69-4bec-89d0-5735a8bdbc80">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfMy00LTEtMS0yOTc1MDM_51285e7b-9cef-4944-88dd-d4ec98e14cbc">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfNC0yLTEtMS0yOTc1MDM_d2d117a9-7ea5-443a-bd00-090ddfdbd7da">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfNC00LTEtMS0yOTc1MDM_08ae4fb0-0c3b-4623-ae21-3f9136b701e2">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfNS0yLTEtMS0yOTc1MDM_ba0c065e-5c2f-460c-93f3-8c0d11100d32">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfNS00LTEtMS0yOTc1MDM_d03d816d-a9d4-405e-8505-be8c0ce00510">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfOC0yLTEtMS0yOTc1MDM_6734951c-b880-4885-a56d-949e76676ff4">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfOC00LTEtMS0yOTc1MDM_4796b5cb-d058-47d4-92cc-2f074d2fa984">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_49"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfOTA0_13d254ad-3d02-4249-90bb-b7a0b076b751" continuedAt="i7cbe91e662bc4066b8973f49d5170cd7" escape="true">GOODWILL AND INTANGIBLE ASSETS </ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i7cbe91e662bc4066b8973f49d5170cd7" continuedAt="i577b3277838b47e29f5d9d4dd2531993"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfOTIw_2ed49e23-6b2a-4c53-8281-e1314b4d1918" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:14.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.423%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purchase accounting adjustments </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f3eb6af9f444b3e8326226555389980_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMS0yLTEtMS0yOTc1MDM_0daa66dc-7887-4053-b3aa-920d9f9c107d">2,044.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e4fca1b9404a29b27348e58f4f2456_D20230101-20230401" decimals="-5" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMS00LTEtMS0yOTc1MDM_97d8671d-8263-4332-a5dc-d2cbe1127a48">35.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e4fca1b9404a29b27348e58f4f2456_D20230101-20230401" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMS0xNS0xLTEtMjk3NTAz_af7628e6-ff94-42d1-b5bb-d1d3a8d0618a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib24332748044483db83ca8e301c719ca_I20230401" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMS0xNy0xLTEtMjk3NTAz_8d4add57-e4ea-4c51-aeeb-f612318c9513">2,079.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63eb2d1285fa4953907a861c6ea961bc_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMi0yLTEtMS0yOTc1MDM_e60a01ec-614b-4b55-ad9e-a00884513b26">1,446.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i817dfeec890e44ed95bda23a0c957cff_D20230101-20230401" decimals="-5" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMi00LTEtMS0yOTc1MDM_ff03fd0e-bbab-49e7-bd4b-8c28b7f0bbd1">45.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i817dfeec890e44ed95bda23a0c957cff_D20230101-20230401" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMi0xNS0xLTEtMjk3NTAz_64139d4e-6243-41ed-95de-41a8dc5f3d81">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc71f8f540634f1ea99e39a92c86aae5_I20230401" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMi0xNy0xLTEtMjk3NTAz_8aeacaeb-965b-44b7-8f73-1df94cc871b5">1,511.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfNC0yLTEtMS0yOTc1MDM_e5e99b27-3ce8-4f69-8ba1-716c52f6e5ee">3,490.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfNC00LTEtMS0yOTc1MDM_e1b1486a-b1a6-4547-a350-63c99a36c9d6">80.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfNC0xNS0xLTEtMjk3NTAz_ec7ddc0c-ee00-41d7-b4d4-a6c5278fe969">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfNC0xNy0xLTEtMjk3NTAz_60c10172-ca08-4619-8e97-39c86226451a">3,591.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  We had accumulated goodwill impairments of $<ix:nonFraction unitRef="usd" contextRef="ib24332748044483db83ca8e301c719ca_I20230401" decimals="-5" sign="-" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfMTg1_9200cc09-e2f3-478d-9e06-cef4f81df659"><ix:nonFraction unitRef="usd" contextRef="i4f3eb6af9f444b3e8326226555389980_I20221231" decimals="-5" sign="-" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfMTg1_a2f77c25-5ad5-47ea-b161-ab9287f65cf3">6.1</ix:nonFraction></ix:nonFraction> million as of April&#160;1, 2023 and December 31, 2022.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)  We had accumulated goodwill impairments of $<ix:nonFraction unitRef="usd" contextRef="i63eb2d1285fa4953907a861c6ea961bc_I20221231" decimals="-5" sign="-" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfMjYx_3aa044ad-2ad2-4c50-9bd6-501f8954f3b9"><ix:nonFraction unitRef="usd" contextRef="idc71f8f540634f1ea99e39a92c86aae5_I20230401" decimals="-5" sign="-" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfMjYx_f5b8b36d-8014-47fb-9473-87f038c2b291">878.4</ix:nonFraction></ix:nonFraction> million as of April&#160;1, 2023 and December 31, 2022.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 8</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i577b3277838b47e29f5d9d4dd2531993"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfOTE1_1a0486eb-d6ab-489b-a2cf-d0923547e500" continuedAt="i8220c6c3cb524496b6f8213d7656649d" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and related accumulated amortization consisted of the following (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangibles:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebce178fd4714f5f92bb9fbec5a443e3_I20230401" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMy0xLTEtMS0yOTc1MDM_df6b5958-47f3-405d-aaa6-4051dd5ac564">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10071a3c442e4192b302e7657ea94c8c_I20221231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMy01LTEtMS0yOTc1MDM_04dbc1a6-b276-4f1d-bb09-ab1557157ac7">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07824618f65645f69731a6aa1568cec3_I20230401" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNC0xLTEtMS0yOTc1MDM_666c06c3-4f57-4297-90e6-b71d9237a938">56.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc973b59afa4340b4dea988d2ff81c3_I20221231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNC01LTEtMS0yOTc1MDM_45313e88-9eb0-4b49-b773-622706abd87d">55.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total indefinite-lived intangibles</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNS0xLTEtMS0yOTc1MDM_19aa10a0-a02f-48ac-97cf-ff3b543ca2fd">59.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNS01LTEtMS0yOTc1MDM_835a990b-dcba-4130-bc21-326466dd9170">58.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite-lived intangibles:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc8978c331594327a5fb3a589e575a4f_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNy0xLTEtMS0yOTc1MDM_38c961ec-e84c-4f1f-9da5-dbb3e8cdd0f9">95.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc8978c331594327a5fb3a589e575a4f_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNy0zLTEtMS0yOTc1MDM_0a86b3c7-3c5f-4de8-ad76-6ab902059a41">59.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e68ee7033cc4aadb5686e063eb8d555_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNy01LTEtMS0yOTc1MDM_427ed9d8-e00d-4471-afc1-78d744846141">94.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e68ee7033cc4aadb5686e063eb8d555_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNy03LTEtMS0yOTc1MDM_b79f6549-14af-4852-8d8e-ea79fcde3e2f">58.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id55a788697874c2bacf296adc61ea0b7_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOC0xLTEtMS0yOTc1MDM_e30fa731-0056-48c9-a075-08016c8e58fa">474.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id55a788697874c2bacf296adc61ea0b7_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOC0zLTEtMS0yOTc1MDM_c53be361-6c3c-48a5-9b3e-0c23501ff811">218.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13378a6ed8a844e6ab6a6cf5ba0bee6b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOC01LTEtMS0yOTc1MDM_041307b2-9883-4241-99e7-108abe52744f">484.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13378a6ed8a844e6ab6a6cf5ba0bee6b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOC03LTEtMS0yOTc1MDM_6f248183-74e4-455b-95f8-98844b204c68">211.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ae35b7343b14c67a3ee371bf5c1469e_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOS0xLTEtMS0yOTc1MDM_b0181b4c-ec27-43cf-af50-f8f1046729be">1,844.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ae35b7343b14c67a3ee371bf5c1469e_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOS0zLTEtMS0yOTc1MDM_dcea6535-7aac-4cc0-8c97-7071e89ca4df">1,006.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491ee1dd84214e7cb151e35c302d008c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOS01LTEtMS0yOTc1MDM_9559e0a0-fcee-42f1-8bc8-fec094121f91">1,825.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491ee1dd84214e7cb151e35c302d008c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOS03LTEtMS0yOTc1MDM_99e3fe33-99a5-47dc-8f58-57f7584f8b38">965.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied803c95feec417dbbc3ce5403e02dfc_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTAtMS0xLTEtMjk3NTAz_f26cfe01-6299-4267-a600-f8bff782e725">2,462.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied803c95feec417dbbc3ce5403e02dfc_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTAtMy0xLTEtMjk3NTAz_5b9e9d58-3195-435b-8ac7-bb887a194566">509.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc5f5344063450db6361f3d577c9287_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTAtNS0xLTEtMjk3NTAz_7c601d11-f2d8-47ab-86cc-ff000e803cb3">2,542.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc5f5344063450db6361f3d577c9287_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTAtNy0xLTEtMjk3NTAz_c58171e2-fd4e-4638-8826-828beab275cd">481.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4f6696fa504105b9bc1e35d5f422b5_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTEtMS0xLTEtMjk3NTAz_d209b32a-9bc6-4935-8714-080e5b6b5b4e">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4f6696fa504105b9bc1e35d5f422b5_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTEtMy0xLTEtMjk3NTAz_d376b92f-ea58-4a79-a05f-d29ecd28c952">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie898e8edfbf646baa27f1856bdfdd572_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTEtNS0xLTEtMjk3NTAz_ab53a550-1087-4007-8e84-e7a366c337d3">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie898e8edfbf646baa27f1856bdfdd572_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTEtNy0xLTEtMjk3NTAz_8f069c03-eaaa-408c-8c76-0c3c23c228a8">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total definite-lived intangibles</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTItMS0xLTEtMjk3NTAz_444e5156-213e-4951-91b7-084103ea29fe">4,879.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTItMy0xLTEtMjk3NTAz_9eef5e7b-d2a4-4a82-b4d0-825da65421f4">1,795.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTItNS0xLTEtMjk3NTAz_802fae5a-6ca9-4208-9a39-b1363cae2b5a">4,949.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTItNy0xLTEtMjk3NTAz_cf150320-daad-448f-8346-8ab96b955349">1,718.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTMtMS0xLTEtMjk3NTAz_34a122b5-a441-4091-8f3e-9d1b0a33b32d">4,938.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTMtMy0xLTEtMjk3NTAz_4e465ce1-d578-45b4-9b4f-bbdcdd0d3522">1,795.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTMtNS0xLTEtMjk3NTAz_e1b53691-ad3f-4ec4-841c-f3c50193a5d9">5,007.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTMtNy0xLTEtMjk3NTAz_83fa2dcb-c728-454f-911e-68b9f54a42d8">1,718.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i8220c6c3cb524496b6f8213d7656649d">(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.</ix:continuation> </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfNDU4_edb1fdea-c2fa-4986-8c64-3b4b171ab782">65.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfMzI5ODUzNDg4NTUxNg_94422812-22fa-4276-a4c9-abb12727c9fc">48.5</ix:nonFraction>&#160;million for the three months ended April&#160;1, 2023 and April&#160;2, 2022, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_55"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RleHRyZWdpb246MjYwODdiZDk4OGNmNDRhNGJjM2ZkMzMyN2ZhMzI4MWRfMTMzNw_9726dba7-62b9-435e-8bb7-c3a48b9e11af" continuedAt="i1ed13826125c4d43af8a674111af395f" escape="true">FAIR VALUE MEASUREMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1ed13826125c4d43af8a674111af395f" continuedAt="i6ac224872bfb4005878a6a8a4d5fd338"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RleHRyZWdpb246MjYwODdiZDk4OGNmNDRhNGJjM2ZkMzMyN2ZhMzI4MWRfMTM1Mg_9567486f-a260-4523-b8e7-3a3f76fc7c38" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Measured at fair value on a recurring basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38fe8e9a9f04f668590d3cd5af1bea2_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC0yLTEtMS0yOTc1MDM_e259067d-e2cf-4ec6-9378-132e26541030">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i323e00f452604c9e8efdeea764a4c5b9_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC00LTEtMS0yOTc1MDM_46942d19-63fc-4c53-ad98-a742c68dd01b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie008783b9a804da39b8b478db605bf2e_I20230401" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC02LTEtMS0yOTc1MDM_5144f449-d279-4c69-ae62-12fec9251ef5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide9fb602617c4361b1e1413aad64fba1_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC04LTEtMS0yOTc1MDM_9483075c-b550-4bb4-962c-fabbe6dff69f">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c166f0f4ac4071b5451ad221b1c85b_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC0xMC0xLTEtMjk3NTAz_50e91e51-19fa-4af2-a616-544576e07d0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04725fb2248c4ebeabaaa3e07ead859d_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC0xMi0xLTEtMjk3NTAz_9b4ca5a5-0a23-4ad6-82fe-87cdfcbe79cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42c93a65a4db40e38259118bf87ca950_I20230401" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS0yLTEtMS0yOTc1MDM_cca87c2a-18be-47de-b2fa-f6dd6a1efb76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec4efa57993147ecbf3218e1e2ad5e1d_I20230401" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS00LTEtMS0yOTc1MDM_d7be2090-073e-4433-b88c-50827ea6222b">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d490f02cff46969dc0d4b06f3a6c1a_I20230401" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS02LTEtMS0yOTc1MDM_f8b37f52-deea-4c56-b5c2-ad692e3dc160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1480475fcfcf4911a302de8597350461_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS04LTEtMS0yOTc1MDM_01b8f755-c906-4721-8202-14afb1467408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9220abdafe514bd1bc03b527e4e345fe_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS0xMC0xLTEtMjk3NTAz_7fc41065-9d7b-4bc2-974b-704a4d651039">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9993c7a02a6a4c7ea61954c3d40b6757_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS0xMi0xLTEtMjk3NTAz_e64df5a7-1dac-4ee6-bb41-8e83bbc752f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd10964e4444c5aa7f56a883baa41b4_I20230401" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS0yLTEtMS0yOTc1MDM_468f9c47-d365-4ae5-bfdf-ee86effd2ba8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e48502376142e5ac4f235d7f18af12_I20230401" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS00LTEtMS0yOTc1MDM_363157f4-993e-4e5f-9433-adf51629dd79">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibede6d5d7f6e435d97c1430b6dee57cf_I20230401" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS02LTEtMS0yOTc1MDM_aee3d154-9e16-4934-b2ee-6749b75d985e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i182417c07231420c9b57037a5f01eef3_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS04LTEtMS0yOTc1MDM_2355be5b-64fc-493a-a2b3-3117e90d3d39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a834f03a804608931a9b7597442b59_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS0xMC0xLTEtMjk3NTAz_de96adf2-b393-4b51-8ecf-bdc971fac97d">50.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55e23d064ac94e579d65b01ab85c557a_I20221231" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS0xMi0xLTEtMjk3NTAz_8947889b-6adb-4de0-8582-082288f55b4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38fe8e9a9f04f668590d3cd5af1bea2_I20230401" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtMi0xLTEtMjk3NTAz_e6ad8918-715e-4a75-b9c9-1440a0987e70">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i323e00f452604c9e8efdeea764a4c5b9_I20230401" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtNC0xLTEtMjk3NTAz_94c8aabb-33b5-4a79-8115-12231e05fcd2">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie008783b9a804da39b8b478db605bf2e_I20230401" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtNi0xLTEtMjk3NTAz_08af4153-f317-4c44-84f6-f327748bfac0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide9fb602617c4361b1e1413aad64fba1_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtOC0xLTEtMjk3NTAz_ac451cf5-b597-4f64-9f99-aa5b4b10bacd">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c166f0f4ac4071b5451ad221b1c85b_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtMTAtMS0xLTI5NzUwMw_8fcf3c56-0222-4abc-b585-25fb6a42d8a1">54.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04725fb2248c4ebeabaaa3e07ead859d_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtMTItMS0xLTI5NzUwMw_330d18b2-4fb3-4c48-81cb-34d10f49dfcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e1c235573a44397aede9c7af5b6226c_I20230401" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtMi0xLTEtMjk3NTAz_335f4f7c-6f0f-43db-ad2d-03de8ada4113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50a400f80e334fac81f4e0f510dd26d4_I20230401" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtNC0xLTEtMjk3NTAz_8972fef2-b1f7-46f1-9483-fa06ea465004">111.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie79b2663ac03492fa74b7ec953837986_I20230401" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtNi0xLTEtMjk3NTAz_67697d18-5fac-46e5-b575-cf8d0fe4b6fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed8e3a070954dd99dcac4657d4e487f_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtOC0xLTEtMjk3NTAz_3330eaa2-e821-4f81-9d97-1770eb817d57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850a948962d64a65adff8d59644ca588_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtMTAtMS0xLTI5NzUwMw_13a932aa-f426-431e-8d59-ea41d3cbc879">96.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24fce60834ce4f74a2d6fdbbbe84bbf8_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtMTItMS0xLTI5NzUwMw_91219e45-268e-4436-9db4-b67a065be369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42c93a65a4db40e38259118bf87ca950_I20230401" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtMi0xLTEtMjk3NTAz_73958a39-d96d-447c-a190-ff8652382113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec4efa57993147ecbf3218e1e2ad5e1d_I20230401" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtNC0xLTEtMjk3NTAz_160f6a5b-de23-444e-88a6-530b5210d4a4">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d490f02cff46969dc0d4b06f3a6c1a_I20230401" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtNi0xLTEtMjk3NTAz_d64d4bce-bee0-4dc3-ac37-db9ef180121e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1480475fcfcf4911a302de8597350461_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtOC0xLTEtMjk3NTAz_9f157e90-6127-44dd-8652-065e753ae61f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9220abdafe514bd1bc03b527e4e345fe_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtMTAtMS0xLTI5NzUwMw_8bba9eeb-c12d-41f4-afe6-ccbb7464affe">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9993c7a02a6a4c7ea61954c3d40b6757_I20221231" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtMTItMS0xLTI5NzUwMw_96660001-1eac-4abc-a9d1-05a482597da7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38fe8e9a9f04f668590d3cd5af1bea2_I20230401" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtMi0xLTEtMjk3NTAz_535aaf21-31a7-476e-8eae-99549c3287dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i323e00f452604c9e8efdeea764a4c5b9_I20230401" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtNC0xLTEtMjk3NTAz_1f0d26c4-59ec-44e0-a759-32a76b08dcb0">114.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie008783b9a804da39b8b478db605bf2e_I20230401" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtNi0xLTEtMjk3NTAz_76c815f5-abff-4e54-8e09-52fe42d93232">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide9fb602617c4361b1e1413aad64fba1_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtOC0xLTEtMjk3NTAz_90f8cd5c-af00-438a-b16e-272528816b1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c166f0f4ac4071b5451ad221b1c85b_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtMTAtMS0xLTI5NzUwMw_dbc3c1c4-e7f4-41b2-a510-f5eb7f18432a">101.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04725fb2248c4ebeabaaa3e07ead859d_I20221231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtMTItMS0xLTI5NzUwMw_ec501a30-2597-44b7-b71c-f4c074349eb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers within Level 3 fair value measurements during the three months ended April&#160;1, 2023 or the</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-recurring Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-recurring fair values represent only those assets whose carrying values were adjusted to fair value during the reporting period.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 9</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i6ac224872bfb4005878a6a8a4d5fd338" continuedAt="if251198b84a7494ebe0534c870a8b7a2"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Rate Long-term Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RleHRyZWdpb246MjYwODdiZDk4OGNmNDRhNGJjM2ZkMzMyN2ZhMzI4MWRfMTMzNA_f4d1716a-669c-44f1-a1d1-34eef8b07403" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed rate long-term debt consisted of the following (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.00pt"><tr><td style="width:1.0pt"></td><td style="width:172.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:93.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:93.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public Bonds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value (excluding discount)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc98dc57d99e4819af454bec68b9436c_I20230401" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOmM3MzM0NTIzMWIyZjQyN2FhYmI3NjIyZGM0ZDkzMmRiL3RhYmxlcmFuZ2U6YzczMzQ1MjMxYjJmNDI3YWFiYjc2MjJkYzRkOTMyZGJfMy0xLTEtMS0yOTc1MDM_7792ab6e-ace2-4cdb-bd86-ceddd01ac5ca">2,544.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e444dcadb33488daa64185519d1ac50_I20221231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOmM3MzM0NTIzMWIyZjQyN2FhYmI3NjIyZGM0ZDkzMmRiL3RhYmxlcmFuZ2U6YzczMzQ1MjMxYjJmNDI3YWFiYjc2MjJkYzRkOTMyZGJfMy01LTEtMS0yOTc1MDM_d8b35eb6-225e-416e-9554-5d3521872aca">2,544.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39273b39b09344b1a7df355b3202f917_I20230401" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOmM3MzM0NTIzMWIyZjQyN2FhYmI3NjIyZGM0ZDkzMmRiL3RhYmxlcmFuZ2U6YzczMzQ1MjMxYjJmNDI3YWFiYjc2MjJkYzRkOTMyZGJfNC0xLTEtMS0yOTc1MDM_16228b4e-8e52-4d41-98f1-ffe13fbb177d">2,315.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb63dc591b74a43a816a11b9df7a30b_I20221231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOmM3MzM0NTIzMWIyZjQyN2FhYmI3NjIyZGM0ZDkzMmRiL3RhYmxlcmFuZ2U6YzczMzQ1MjMxYjJmNDI3YWFiYjc2MjJkYzRkOTMyZGJfNC01LTEtMS0yOTc1MDM_28121546-12f0-49cc-baf8-7357e14c9164">2,225.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if251198b84a7494ebe0534c870a8b7a2">The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt, revolving credit agreements, and variable rate long-term debt, approximate their fair value.</ix:continuation> </span></div><div><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_67"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTcxMw_7dbc4241-1686-4ac9-87fc-a551d7c194d2" continuedAt="idb71810326494e6f8d395761a13160bd" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES &#160;&#160;&#160;&#160; </ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="idb71810326494e6f8d395761a13160bd" continuedAt="i426e2ee8431b42658cdbb9815d2d3147"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Option Contracts </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price for HRA Pharma, we entered into <ix:nonFraction unitRef="derivative" contextRef="i0391704d774f4479b2bd6287047b946b_I20210930" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY2Nw_000491ca-73fc-413c-bc52-468a7a8dc8c5">two</ix:nonFraction> non-designated currency option contracts with a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="i863dc014fe5a4fd69e51cabe6ed66bef_I20210930" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMzA1_1e59a164-8cbe-4353-816a-9070bb1b777c">1.1</ix:nonFraction> billion that were scheduled to mature in September 2022. In April 2022, due to market conditions, we unwound the <ix:nonFraction unitRef="derivative" contextRef="i703d29ff729d4c809efa88132b4033f6_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY4OA_e258225e-eaa7-4d85-8526-7bb6f766dd32">two</ix:nonFraction> options and entered into <ix:nonFraction unitRef="derivative" contextRef="i703d29ff729d4c809efa88132b4033f6_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY2MA_57a59663-2c71-4920-9555-f27e341d6511">two</ix:nonFraction> new undesignated options to economically hedge the purchase price for HRA Pharma for a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="i703d29ff729d4c809efa88132b4033f6_I20220430" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTU4_d8827702-4d8d-4aee-bef4-4f2b9b07e3f5">2.0</ix:nonFraction>&#160;billion. All premiums associated with the HRA Pharma related currency options were settled in April 2022 for $<ix:nonFraction unitRef="usd" contextRef="ie73d3af15eaf44a38b8cd158e74b7934_D20220401-20220430" decimals="-5" name="prgo:PaymentsForPremiumsOnDerivativeInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNjYy_d5eff91f-1ebb-44b0-9b17-ac6535259590">37.1</ix:nonFraction>&#160;million. Within Other (income) expense we recorded a $<ix:nonFraction unitRef="usd" contextRef="if59013eda0ee4c9783bb2aa14130c446_D20220101-20220402" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTQ5NzU1ODI1NjI2_ce770e65-dd10-4d67-b6d7-1814a40c2498">3.5</ix:nonFraction> million loss for the three months ended April&#160;2, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, to economically hedge the interest rate risk of the New Senior Secured Credit Facilities (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_73">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), we entered into <ix:nonFraction unitRef="derivative" contextRef="i69de5a172d6c4557ac718e348bdb6557_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTM4OA_aa066b52-1d0f-483a-a64a-08a6bfb3596c">five</ix:nonFraction> variable-to-fixed interest rate swap agreements. <ix:nonFraction unitRef="derivative" contextRef="i4fe60b7eb3e54bf4bec247c65d45ad0d_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTQ0MA_480a58c0-6d5f-4b37-8769-709a27a35206">Three</ix:nonFraction> of the interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan B Facility (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_73">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2029, on notional balances that decline from $<ix:nonFraction unitRef="usd" contextRef="i8d3d3fb12721426a98d72c0b4de560d8_I20220430" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTc1Mg_dc58d25c-27b8-4594-baa4-add8d25c99b9">1.0</ix:nonFraction>&#160;billion to $<ix:nonFraction unitRef="usd" contextRef="ib95874ed8320453c88600e7dd3a13d14_I20220430" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTc1OA_f79f8919-4e7b-4926-9ac7-eb066c6e11f8">812.5</ix:nonFraction>&#160;million over the term. The other <ix:nonFraction unitRef="brand" contextRef="ideed9f35811341b6987034ed4edf23a9_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTc4Ng_daff888a-1fce-423d-a324-66076ff36488">two</ix:nonFraction> interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan A Facility (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_73">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2027, on notional balances that decline from $<ix:nonFraction unitRef="usd" contextRef="i579bce87d950488c9440b6afa28de94c_I20220601" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMjA5MQ_7d34a74a-fde4-499c-aadf-36f00a1b4a0f">487.5</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i231ffb94f5014c56bb9ab4f128394b92_I20220601" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMjA5Nw_dc2287ab-7de5-4631-b6d2-99d61a397256">387.5</ix:nonFraction>&#160;million over the term. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a designated cash flow hedge, gains and losses will be deferred in AOCI and recognized within Interest expense, net when interest is paid on the New Senior Secured Credit Facilities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-currency Swaps </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2022, we entered into <ix:nonFraction unitRef="derivative" contextRef="id158617640374c9fa1495cf02188a911_I20220430" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMjQwMg_4b5dfd26-beeb-4f5d-aa2f-efff3f305dbe">three</ix:nonFraction> fixed-for-fixed cross currency interest rate swaps designated as net investment hedge to hedge the EUR currency exposure of our investment in European operations. In October 2022, we replaced those swaps by entering into <ix:nonFraction unitRef="derivative" contextRef="ib6f681b4b8d84632a9cc71f98e1bb3d6_I20221025" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMzMwOA_f19d3129-5817-40d3-bb8f-aaec01a45bac">three</ix:nonFraction> fixed-for-fixed cross currency interest rate swaps at market rates and designated the instruments as net investment hedges on our investment in European operations. The following are the terms and notional amounts outstanding: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$<ix:nonFraction unitRef="usd" contextRef="iea716b8db0224b21bca000c2d1d526a3_I20221025" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMzU0NA_7a682bfa-37ef-48d2-96a2-0095995e4efe">700</ix:nonFraction>&#160;million notional amount outstanding from October 25, 2022 through December 15, 2024; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$<ix:nonFraction unitRef="usd" contextRef="ie8461440591543a29bafbb6383d528eb_I20221025" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMzYyNQ_37cb4c2b-5b14-4c60-abff-61b230ba1d24">700</ix:nonFraction>&#160;million notional amount outstanding from October 25, 2022 through March 15, 2026; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$<ix:nonFraction unitRef="usd" contextRef="i55284888fcd34a93ba5adfc643dfd08e_I20221025" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMzcwNw_4fd49c7d-a8f0-45a7-882e-799ff18ac8ff">100</ix:nonFraction>&#160;million notional amount outstanding from October 25, 2022 through June 15, 2030.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 10</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i426e2ee8431b42658cdbb9815d2d3147" continuedAt="i0cd15fe5449841fb8ba3cbc8b7488150"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forwards</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notional amounts of f<ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY3NQ_fbd5b480-04cf-4869-afed-031e4ebafc3f" continuedAt="ibd4a225d413a4e6c9708ad86c0974a32" escape="true">oreign currency forward contracts were as follows (in millions):</ix:nonNumeric></span></div><ix:continuation id="ibd4a225d413a4e6c9708ad86c0974a32"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.894%"><tr><td style="width:1.0%"></td><td style="width:38.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.943%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Pound (GBP)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0c512854e04191adfce17ad716634b_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMi0yLTEtMS0yOTc1MDM_30ccb7df-a455-4747-9117-bf86264ae723">213.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e0c6387a644ace96085e11f8e677ed_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMi00LTEtMS0yOTc1MDM_54c0c269-06cb-460d-b068-d315f0359837">224.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European Euro (EUR)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d39d66893f44acf940bd4020fe80a61_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMi0yLTEtMS0zNTUxODI_10b7ef25-22c2-4e91-b7ab-aeed84c092b9">65.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd991dd16c04acca9ac92cc1bede2e8_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMi00LTEtMS0zNTUxODI_bfe3941f-7853-4fd8-a7b2-53e0371c370e">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Swedish Krona (SEK)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1d7962673e54ecf9e8c6b4bf23987b5_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMy0yLTEtMS0yOTc1MDM_7996acf4-f503-4eab-be2d-06fe63ba6b81">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f2b3c78bed464c913866d5104a819f_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMy00LTEtMS0yOTc1MDM_c0d69c17-e833-49c8-9e8d-4d1155703141">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States Dollar (USD)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id143f134d71c4b3eab34c1f0ee8afdab_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNC0yLTEtMS0yOTc1MDM_8821fd4e-2cc1-4329-a8e6-f81e6a54d46c">54.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f5b573a7f14d31b174ed365e23e979_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNC00LTEtMS0yOTc1MDM_311ee8ef-8a03-438d-9b10-74694490d81a">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan (CNH)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a46e2bb32541beba33898f230357f7_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNS0yLTEtMS0zNTUxOTI_a6489f1d-f76b-4981-ad65-231d1661a4bf">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c621b427f04e8796899f12e0d2010e_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNS00LTEtMS0zNTUxOTI_f0bf6d76-7362-4cdc-8e14-9cb90c236339">34.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Danish Krone (DKK)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc816fb252f242b985c969760b37834f_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNS0yLTEtMS0yOTc1MDM_ca6a77e4-7dad-4a12-a5f0-68368c57f85b">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6d73713f78476b8e8534d2a1895b4c_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNS00LTEtMS0yOTc1MDM_c76e1e53-b5b3-4d71-9155-6aea0a19d37a">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canadian Dollar (CAD)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aa8244a981b494783cc178b23ffb387_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNi0yLTEtMS0yOTc1MDM_e63938e7-b2df-41e7-b4ea-ec06e12435c8">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9413936dee484f3c8c6f293e20f8e318_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNi00LTEtMS0yOTc1MDM_35b4ea94-f8a6-4a87-9170-d730ca099ff0">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexican Peso (MXN)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3d2ba962fcb47f197b0697553afd857_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNy0yLTEtMS0yOTc1MDM_f8d0196b-f350-4adb-a5ca-f04eb053aa31">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141d55293db343b9858355f37d0a46e6_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNy00LTEtMS0yOTc1MDM_f4e2c48d-8396-4148-b881-00fd52362278">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungarian Forint (HUF)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf4d615378ef46f4bcb95c10b96705e6_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTAtMi0xLTEtMjk3NTAz_b6c39857-cd3c-4d59-a17b-f2b059848aa7">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic48b9d0358ef4fc9b04eadf1f455b1f1_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTAtNC0xLTEtMjk3NTAz_afbd4823-deeb-4c67-b79e-1bcbcaf34c6b">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Polish Zloty (PLZ)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4570a0e785e400a97404bd558852b0a_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTEtMi0xLTEtMjk3NTAz_855644d8-dcfe-4662-8a3d-d58bd616d4fa">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf3ff649eb5e43a89fb4b4cc0dcb1556_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTEtNC0xLTEtMjk3NTAz_68496fa7-9a9c-4b2a-bd18-fa1c0109173d">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Norwegian Krone (NOK)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24abf1ca03e84edba4b6d0d18c9fcd6a_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTItMi0xLTEtMjk3NTAz_687c8de9-0855-40c6-9cad-532126957d62">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02c31ca1b12a4d6081f2a49aba1e6718_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTItNC0xLTEtMjk3NTAz_a0bf2867-1846-4eb8-a4ac-c5e56c136a5b">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefefab2c0f7c4ccaacc90d873855372d_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTktMi0xLTEtMjk3NTAz_32c0b48c-2eca-42b5-950a-1ab9d856518c">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7136cb4396ad4a658534b085e82dbfc7_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTktNC0xLTEtMjk3NTAz_ad22d30e-dbb4-464d-88ab-19d738498d88">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58e9f89e450b4789b74027090e527fd2_I20230401" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMjItMi0xLTEtMjk3NTAz_97e8958b-1248-448c-a8a3-1e0db457a09d">559.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e286c007514bd88ef38594ee3f765b_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMjItNC0xLTEtMjk3NTAz_37169959-6abf-4529-a079-9c4207e6e06f">593.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Number consists of various currencies notional amounts, none of which individually exceed $<ix:nonFraction unitRef="usd" contextRef="iefefab2c0f7c4ccaacc90d873855372d_I20230401" decimals="-5" name="prgo:DerivativeNotionalAmountMaximumIndividualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTQ5NzU1ODE5OTcx_3d237e89-f83f-4d9b-9200-5c6cb419684d"><ix:nonFraction unitRef="usd" contextRef="i7136cb4396ad4a658534b085e82dbfc7_I20221231" decimals="-5" name="prgo:DerivativeNotionalAmountMaximumIndividualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTQ5NzU1ODE5OTcx_b5faf703-c666-49b8-83ad-aed9a4f54dcb">10</ix:nonFraction></ix:nonFraction> million in either period presented.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum term of our forward currency exchange contracts is <ix:nonNumeric contextRef="i9a74650587a0467ab9f464dd51bad8b6_D20230101-20230401" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNDczNw_dda37a53-78f5-4fcf-9e88-b5b4dbb6edb8">60</ix:nonNumeric> months.</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Derivatives on the Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects. <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY2MQ_65d670d7-a983-4920-a96b-ff6edfba4159" continuedAt="i9c9181b404964fc7992bd88987759062" escape="true">The balance sheet location and gross fair value of our derivative instruments were as follows (in millions): </ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i9c9181b404964fc7992bd88987759062"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.75pt"><tr><td style="width:1.0pt"></td><td style="width:164.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:175.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:84.25pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i548d3c81888a421d840889bc4a3e1068_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNC0zLTEtMS0yOTc1MDM_632d1165-1b13-4fe1-ad90-ac5df8d7df42">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb6d2a114c44f87b07e610ccad0481a_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNC01LTEtMS0yOTc1MDM_bd2445a0-b8da-4710-8a62-79e6a6209f09">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0255c8396730441fab6e09dbb1afb422_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNS0zLTEtMS0yOTc1MDM_2387a974-3b35-4fcd-987e-aa3ffd72d85b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e0b4d9aeda94165b64f6361c52863a1_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNS01LTEtMS0yOTc1MDM_edc73dab-c6e0-4198-aca1-0da3cbc1e7fb">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055ddb3eb7864ddbb72cc19e608e8248_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNi0zLTEtMS0yOTc1MDM_87baf576-eb78-431b-9621-179863533e4d">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3b19260e3134f8eac6745ebd39cfaba_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNi01LTEtMS0yOTc1MDM_2ed30539-2fde-44b6-bd82-5f2b8a1d45ab">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e4ace05b3746aab7f10dd86bdf5642_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfOS0zLTEtMS0yOTc1MDM_2c646e17-9678-4265-b9c3-86f40df4b389">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d974173dfdd4a52a46760690fe23666_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfOS01LTEtMS0yOTc1MDM_10d95d2e-7f60-4afd-a6dd-5dedc0aa3ccc">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivative assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eccd056afc545b39529ed76bdd93865_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTAtMy0xLTEtMjk3NTAz_2797712a-cd91-4918-a956-7e0aad9de0b3">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc338e7d11bb49c0b3dd26e0b630ceaf_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTAtNS0xLTEtMjk3NTAz_37872d32-bc54-4c93-9316-09e22645c467">52.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ca5dc3f5a248a1ad6f808b50351d6a_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTItMy0xLTEtMjk3NTAz_5edae56f-1664-46c7-94d5-cb1a95c5522d">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4006135836b64c4a9a25d99b7b066e0d_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTItNS0xLTEtMjk3NTAz_8dac300f-5114-4085-a7b5-a759c91c1207">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-designated derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883728cd2fe84026a4db286c1fb80ffe_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTQtMy0xLTEtMjk3NTAz_1d5d2a12-d011-4cce-97e9-ef0c20b480c2">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e2de60b8a148eeb14a18745abe9a02_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTQtNS0xLTEtMjk3NTAz_bc360dbb-9a71-4c5d-bf49-13ea22ad584d">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d46728e14d44678a73c2145851d2fb6_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTctMy0xLTEtMzQxMjU4_66c782a6-b77c-4596-ac28-5dc52f75a0b5">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida370fe5573e4ed7ba48cf6fe97b5c67_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTctNS0xLTEtMzExNzA5_a6986248-cb54-499a-9421-8caa7774c72b">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec0d02e7d8d49f2aa9b45ada2bfaef8_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTgtMy0xLTEtMzQxMjU4_dacc3070-a282-4738-9020-494532d01aa8">111.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae577995f42d4580ba2516f347bba679_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTgtNS0xLTEtMzExNzI0_6a559ae7-e55e-49aa-8fab-5df43922b8f9">96.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eccd056afc545b39529ed76bdd93865_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMjAtMy0xLTEtMzQxMjU4_ebcc8766-f04e-498a-aac4-83611385fee3">113.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc338e7d11bb49c0b3dd26e0b630ceaf_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMjAtNS0xLTEtMzExNzM3_0eaa2603-7cba-4c2c-89fe-73717c44d366">100.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19bf4a75be9945638b85dd2447d4ad7f_I20230401" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMjItMy0xLTEtMzQxMjU4_86969b1e-5bb9-4ba7-919b-0af08074fac9">0.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48bc899a04941fcaa88ed2870642735_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMjItNS0xLTEtMzExNzcy_8da19d35-2027-448b-8cc9-1d0f4ebcbeaa">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 10</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i0cd15fe5449841fb8ba3cbc8b7488150" continuedAt="ifeb4ddb3271340409defdaf2ddb95754"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMjE5OTAyMzI2MzQ0MQ_62502fbe-6d9c-451b-a2b5-3afa9baa8d1b" escape="true"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Consolidated Statements of Operations were as follows (in millions): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:34.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.937%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Designated Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eee7139231548609a6bed77c36f242c_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfMi00LTEtMS0zMTIzMTg_371de3ce-51b1-4682-9141-16c840864276">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415d640a98a648a49bb88703fc4bf417_D20220101-20220402" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfMi02LTEtMS0zMTIyNTI_7bfb1c8c-af2a-4cfd-8bb8-c3c2e1e9a414">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86211ac950df4f52b3bdb376967439bd_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfMy00LTEtMS0zMTIzMjg_cc371716-95a0-4bb3-8ebb-af3c91ae1604">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb2d9216b7b04cf0a3ecb3d790f50e69_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfMy02LTEtMS0zMTIyNjk_4c4766fc-2991-402f-9e89-365512174998">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id11eac94d9bd4b9b8ae0373021cc6731_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfNC00LTEtMS0zMTIzNDM_0c229edc-8e1d-470f-99b4-be17a684a843">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d55a845d92a4d0bbc62c63895976038_D20220101-20220402" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfNC02LTEtMS0zMTIyODI_7cabe964-a918-4fec-a90f-1f27e1a029df">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i794270c4878944cab78f1bdba967d567_D20230101-20230401" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfNi00LTEtMS0zMTIzNjY_a2f0a678-46ee-4d12-b3d3-9956a13a8a6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if59013eda0ee4c9783bb2aa14130c446_D20220101-20220402" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfNi02LTEtMS0zMTIzMDA_8b8952a9-2fd5-403e-95e0-aa4feb52251b">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY4OQ_1fbb62f2-4321-4d1d-9c29-997b32ca9759" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effect of derivative instruments designated as hedging instruments in AOCI (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:570.75pt"><tr><td style="width:1.0pt"></td><td style="width:150.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:90.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:117.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain/(Loss)</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reclassified from AOCI into Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Related to Amounts Excluded from Effectiveness Testing</span></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recorded in OCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in Earnings on Derivatives</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec9a490f09d45b88e90070c6c101e1d_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNi0yLTEtMS0yOTc1MDM_a34914df-d39c-43d4-8f1f-b486e1849d96">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec9a490f09d45b88e90070c6c101e1d_D20230101-20230401" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNi02LTEtMS0yOTc1MDM_96286daf-8b8a-4da9-b4a3-008e180390d1">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i170e5f4e14d94ed2bf2f5e30f221c7a3_D20230101-20230401" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNi0xMC0xLTEtMjk3NTAz_808bd76a-8dff-4f06-8ff4-9154db52b5d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a74650587a0467ab9f464dd51bad8b6_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNy0yLTEtMS0yOTc1MDM_f263c606-8e36-4614-9193-a8121390657c">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8be97fbfb6bc4fdc93582f7325963e07_D20230101-20230401" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNy02LTEtMS0yOTc1MDM_f76060c0-106f-409e-be8e-3c58b3c88e9d">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8be97fbfb6bc4fdc93582f7325963e07_D20230101-20230401" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNy0xMC0xLTEtMjk3NTAz_87809c7c-3aa4-47c0-a28b-1862c87806d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieecd1150963c4685ab0218460f0f71ce_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfOC02LTEtMS0yOTc1MDM_eab326f2-9acf-4be6-92d0-e8d8f34e1e10">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieecd1150963c4685ab0218460f0f71ce_D20230101-20230401" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfOC0xMC0xLTEtMjk3NTAz_25dca020-987b-419d-a8fb-2c8594fb4f2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfOS0xMC0xLTEtMjk3NTAz_ed12fb4f-530a-45e3-81d1-6c3199e6840b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTAtMi0xLTEtMjk3NTAz_e20ae864-af91-4a7a-8915-8b12ab47b3a0">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTAtNi0xLTEtMjk3NTAz_f27309a6-d454-48bd-b8ad-597f2c429dbb">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTAtMTAtMS0xLTI5NzUwMw_6718220a-e806-495c-ac4b-d30d314e0ea8">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e5203a533d4aee8b2fdbcf22b56556_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTItMi0xLTEtMjk3NTAz_7f2b095f-86be-4a5d-9164-3147a27d8f74">23.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22e1c81f675a48eaa5a572a21687d185_D20230101-20230401" decimals="-5" sign="-" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTItMTAtMS0xLTI5NzUwMw_af65abab-649e-4850-bd9b-dd693b31d96f">6.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66107ad7ba8046ec942972e9becaaff6_D20220101-20220402" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTktMi0xLTEtMzMyODk2_458c9073-f634-4194-970c-f19ed7bce197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66107ad7ba8046ec942972e9becaaff6_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTktNi0xLTEtMzMyOTY1_7eb10d5d-7025-44d6-a29c-a9f39287eaff">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f3f8cdce8a5422aa8044ef1e7ea60f3_D20220101-20220402" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTktMTAtMS0xLTMzMjk5MA_dd1476b5-11a7-46c1-a28f-aaf4a67ccd43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd5c9b62aef54b399eed74960e878654_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjAtMi0xLTEtMzMyOTAw_4059d61a-3ebc-4ac3-b3da-de2d05bc0582">7.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef3599264dc4912b8aaad190f86b782_D20220101-20220402" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjAtNi0xLTEtMzMyOTcw_aa5364d2-e70f-4f22-9eea-3abc197d0d1c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef3599264dc4912b8aaad190f86b782_D20220101-20220402" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjAtMTAtMS0xLTMzMjk5NA_051fe2b9-62c5-40e3-99a4-001f01193785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c74f5dd34524d48896153867df4a030_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjEtNi0xLTEtMzMyOTc1_1c351e0d-4b59-495f-8548-7a05b4371217">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c74f5dd34524d48896153867df4a030_D20220101-20220402" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjEtMTAtMS0xLTMzMjk5OA_4f67bd1d-4a28-4283-8c2b-9b081e75ad1a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjItMTAtMS0xLTMzMzAwMg_43d8c8ed-1537-4b7c-9894-eb0591162e8e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjMtMi0xLTEtMzMyOTA0_e7a1bcd2-0355-4c6e-9a80-e5ac3cf0089b">7.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjMtNi0xLTEtMzMyOTg2_de670354-eb4d-43f8-92c0-7773ab7c41f8">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjMtMTAtMS0xLTMzMzAwNg_0a90dd58-7e8a-49a0-a4aa-eeced635c495">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dae718ccbd74caa8a4114db6e48afcd_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjUtMi0xLTEtMzMyOTA5_bd58e44f-7546-4ec7-a066-59e7e332545d">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if02007e835294982ad3505eac48241f5_D20220101-20220402" decimals="-5" sign="-" name="prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjUtMTAtMS0xLTMzMzAxMA_5508a720-26b9-463f-91c7-49e788746ab9">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Net loss of $<ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTA5OTUxMTYzOTQxOQ_c62922e3-3309-4a23-bc6a-6383850aed06">1.6</ix:nonFraction> million is expected to be reclassified out of AOCI into earnings during the next 12 months.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 10</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ifeb4ddb3271340409defdaf2ddb95754"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTcxNA_f1463495-3b8e-46eb-9c6c-bebe3430aa34" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:246.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost of Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other (Income) Expense, net</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:39pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMy0yLTEtMS0yOTc1MDM_6b7b8cdd-8904-4c94-9512-4ca254f6626f">1,181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMy00LTEtMS0yOTc1MDM_7a944686-d9e1-474d-ac40-0f1a40719323">767.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMy02LTEtMS0yOTc1MDM_f5827849-3445-47e0-b347-26aaaa28d40d">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMy04LTEtMS0yOTc1MDM_e098e497-b59a-4b6d-948a-b7dea7f2c91c">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8be97fbfb6bc4fdc93582f7325963e07_D20230101-20230401" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOC0yLTEtMS0yOTc1MDM_f76060c0-106f-409e-be8e-3c58b3c88e9d">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieecd1150963c4685ab0218460f0f71ce_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOC00LTEtMS0yOTc1MDM_eab326f2-9acf-4be6-92d0-e8d8f34e1e10">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i170e5f4e14d94ed2bf2f5e30f221c7a3_D20230101-20230401" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOC02LTEtMS0yOTc1MDM_97172a6d-783d-4a17-821a-ce4e13869ff5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOC04LTEtMS0yOTc1MDM_0c0e7eee-7a17-4a5a-918e-161f714e1e3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8be97fbfb6bc4fdc93582f7325963e07_D20230101-20230401" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOS0yLTEtMS0yOTc1MDM_87809c7c-3aa4-47c0-a28b-1862c87806d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieecd1150963c4685ab0218460f0f71ce_D20230101-20230401" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOS00LTEtMS0yOTc1MDM_25dca020-987b-419d-a8fb-2c8594fb4f2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i170e5f4e14d94ed2bf2f5e30f221c7a3_D20230101-20230401" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOS02LTEtMS0yOTc1MDM_ef13196e-ec72-426a-9353-b5f324a02f0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOS04LTEtMS0yOTc1MDM_ed12fb4f-530a-45e3-81d1-6c3199e6840b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e87de477904785908596a6978421c3_D20230101-20230401" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMTYtMi0xLTEtMjk3NTAz_3791ed77-a923-4ab2-a6ae-ae0d2b068405">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia295c3555b08448eafa786c04116bed5_D20230101-20230401" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMTYtNC0xLTEtMjk3NTAz_8919e124-d923-4dbc-b1e1-3b2a2e9cdec8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec9a490f09d45b88e90070c6c101e1d_D20230101-20230401" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMTYtNi0xLTEtMjk3NTAz_96286daf-8b8a-4da9-b4a3-008e180390d1">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e9d75fab66455da7ef57faeb376f99_D20230101-20230401" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMTYtOC0xLTEtMjk3NTAz_6cfa8c8c-9d09-40f5-a2c9-80dcbb1ba74e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:39pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjAtMi0xLTEtMzMzOTky_35163a52-6869-4071-93b4-b6b19bf8404d">1,074.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjAtNC0xLTEtMzMzOTk2_68bec5e3-0d35-4891-86c1-263f823cb795">736.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjAtNi0xLTEtMzM0MDAw_28c24a8e-6f5f-44f4-bcfd-b23e5a852971">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjAtOC0xLTEtMzM0MDA0_91bbaa0d-7c74-496d-8e1b-ac212fd5ec34">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef3599264dc4912b8aaad190f86b782_D20220101-20220402" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjUtMi0xLTEtMzM0MDA4_aa5364d2-e70f-4f22-9eea-3abc197d0d1c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c74f5dd34524d48896153867df4a030_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjUtNC0xLTEtMzM0MDE2_1c351e0d-4b59-495f-8548-7a05b4371217">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f3f8cdce8a5422aa8044ef1e7ea60f3_D20220101-20220402" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjUtNi0xLTEtMzQxMjY5_38273a03-7a82-4a08-be9a-9deb95c47559">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjUtOC0xLTEtMzQxMjY5_ac0e01fd-67fd-4adb-b449-67a1e0be22ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef3599264dc4912b8aaad190f86b782_D20220101-20220402" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjYtMi0xLTEtMzM0MDEy_051fe2b9-62c5-40e3-99a4-001f01193785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c74f5dd34524d48896153867df4a030_D20220101-20220402" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjYtNC0xLTEtMzM0MDIw_4f67bd1d-4a28-4283-8c2b-9b081e75ad1a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f3f8cdce8a5422aa8044ef1e7ea60f3_D20220101-20220402" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjYtNi0xLTEtMzQxMjY5_a283cb60-ca52-4526-b17b-27efd933f695">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402" decimals="-5" name="us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjYtOC0xLTEtMzM0MDI3_43d8c8ed-1537-4b7c-9894-eb0591162e8e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i860de82b30ab45b2a460cf624e3b5b40_D20220101-20220402" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjgtMi0xLTEtMzQxMjY5_56146918-7930-426c-b1c1-5250d24ecb80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddc45227f2cb42ecb959883c84daf958_D20220101-20220402" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjgtNC0xLTEtMzQxMjY5_dd9bfbe3-874a-4d77-bd22-f29c87981f50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66107ad7ba8046ec942972e9becaaff6_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjItNi0xLTEtMjk3NTAz_7eb10d5d-7025-44d6-a29c-a9f39287eaff">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26700cb91c4c4421814c6b2ef530c802_D20220101-20220402" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjgtOC0xLTEtMzM0MDM5_290c94d1-fe75-4402-9b6b-c5e3c58be3c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_73"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11</span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNDIyMQ_dac6d251-7e6b-43ad-8640-b2e98bca9395" continuedAt="ie9a0a69e4fa446eaad944c58b24ca418" escape="true">INDEBTEDNESS </ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie9a0a69e4fa446eaad944c58b24ca418" continuedAt="id5e32b19135c4250900d9d20e9ef63a8"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNDIyOA_23e23b54-249d-4d98-bb7b-5c01444fb4b8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total borrowings are summarized as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:0.1%"></td><td style="width:1.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan A due April 20, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26457665a374ac89c8e5ccd299aada6_I20230401" decimals="-5" name="us-gaap:LoansPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfNi01LTEtMS0yOTc1MDM_4c5535b0-e3f2-4da9-8267-705a7aa5568c">490.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5726a6ff23d34fe88fffbd72991b59b5_I20221231" decimals="-5" name="us-gaap:LoansPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfNi03LTEtMS0yOTc1MDM_4870da23-3a91-4a01-b0bc-d763afa90a48">493.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan B due April 20, 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e7bb0d19a14bc691198c0608792022_I20230401" decimals="-5" name="us-gaap:LoansPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfNy01LTEtMS0yOTc1MDM_5d400f40-2789-452f-8573-a7dadc900af1">1,091.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa673d76aaf84ba09e2965620bcb0d59_I20221231" decimals="-5" name="us-gaap:LoansPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfNy03LTEtMS0yOTc1MDM_724a4e59-ec91-4e16-b93b-b9a8e887304c">1,094.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total term loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LoansPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfOS01LTEtMS0yOTc1MDM_5c4264b5-a9b6-4683-a494-f73a0410cca8">1,582.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:LoansPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfOS03LTEtMS0yOTc1MDM_150c509c-eb13-475b-8b96-77cb431c9773">1,588.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes and Bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Coupon</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Due</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i54459b98d2974030b71e7ddc68bfe196_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjEtMS0xLTEtMjk3NTAz_c22f6ce5-7ce6-484f-96c6-300cbcb43e1d">3.900</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54459b98d2974030b71e7ddc68bfe196_I20230401" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjEtNS0xLTEtMjk3NTAz_7b21d54f-7d09-47b9-8254-fabd7f5f78d4">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4867f353b0c243f48a056129a364e474_I20221231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjEtNy0xLTEtMjk3NTAz_02d0744c-8756-4fcf-98fb-f94a9c590dcc">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e440215ed7c4652ba80460d905c0a7e_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjItMS0xLTEtMjk3NTAz_b7557b2c-a224-4c56-97ca-fd8338964bc8">4.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e440215ed7c4652ba80460d905c0a7e_I20230401" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjItNS0xLTEtMjk3NTAz_2dbe2e34-fd58-4208-8c82-f9f8ff3c1610">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5bf1b892ebf4c429b94a0def27e3812_I20221231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjItNy0xLTEtMjk3NTAz_d64f4dc5-3a39-401e-a2ec-87abd0d22e57">700.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c142977f87a47ad9f46502a682caac2_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjMtMS0xLTEtMjk3NTAz_6407e601-15ac-4657-a5dc-25cac527dd41">4.400</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 15, 2030</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c142977f87a47ad9f46502a682caac2_I20230401" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjMtNS0xLTEtMjk3NTAz_0c3581f2-8867-4012-9c65-a0962927aacc">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea71d3a2fb7f454e9569d20da14316f2_I20221231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjMtNy0xLTEtMjk3NTAz_b1f9975a-1967-4d3e-b139-87de0e448498">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ee3cba978c44e42a435b9406ceec87a_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjQtMS0xLTEtMjk3NTAz_9081fcc3-c96e-4f4d-b151-2722efcc49a3">5.300</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2043</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee3cba978c44e42a435b9406ceec87a_I20230401" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjQtNS0xLTEtMjk3NTAz_effc6111-3f51-4748-a96d-ea2ee7d0b177">90.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019d5a5f11b445d89d3eb9b704641a19_I20221231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjQtNy0xLTEtMjk3NTAz_fa0c6ea6-fb2c-4c2a-bd77-b132e35683c8">90.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c0b70f0dc5a4bb0a131daa51980752a_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjUtMS0xLTEtMjk3NTAz_70020d7e-1517-40a3-bba8-f79df41dc6e0">4.900</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2044</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c0b70f0dc5a4bb0a131daa51980752a_I20230401" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjUtNS0xLTEtMjk3NTAz_5aebce51-2a95-4516-9253-ef2c1f93fb74">303.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71904c9e6b7439192afc4e42bd89431_I20221231" decimals="-5" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjUtNy0xLTEtMjk3NTAz_529ab323-430d-4104-b289-fc306cfdb0af">303.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total notes and bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjYtNS0xLTEtMjk3NTAz_41300a9a-e0f1-4b28-afac-1c11cc993853">2,544.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjYtNy0xLTEtMjk3NTAz_ee7a4d44-7bc0-418b-9978-f703e380ed41">2,544.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjctNS0xLTEtMjk3NTAz_611b0a03-cc7c-4803-bc68-9801fdcab849">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjctNy0xLTEtMjk3NTAz_22b516e7-2a79-4dad-a345-4aa5e70d0070">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized premium (discount), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjgtNS0xLTEtMjk3NTAz_fe152643-7807-437f-8c23-3ec9581ba5f1">15.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjgtNy0xLTEtMjk3NTAz_d34ed0d0-9483-4f55-923c-796ca42121a8">15.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjktNS0xLTEtMjk3NTAz_dba47415-9b04-42ee-8e29-cbabf7389c5a">29.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjktNy0xLTEtMjk3NTAz_b1e20a86-0602-44f1-8f3e-c03cce0183ff">30.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total borrowings outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzAtNS0xLTEtMjk3NTAz_7427d623-8681-4aa4-9b5b-98670a397989">4,101.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzAtNy0xLTEtMjk3NTAz_81cd1daa-c6e4-4738-95f4-c82736c73ec3">4,106.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzEtNS0xLTEtMjk3NTAz_9c153aa5-9047-4d18-a36d-2e76e31d62fc">38.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzEtNy0xLTEtMjk3NTAz_13b41318-2ede-458f-8f9a-8ceb7cbfca03">36.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt less current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzItNS0xLTEtMjk3NTAz_d74698de-9637-4a79-94d5-0c664929acf6">4,062.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzItNy0xLTEtMjk3NTAz_4b9f1dfd-a281-497f-b1d5-6e51abcd84a3">4,070.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(1) The coupon rate noted above is as of April&#160;1, 2023, this will increase from <ix:nonFraction unitRef="number" contextRef="ib2fa7281600f4aa4a680f08c54770403_I20220615" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMTg3Nw_5a5ea84b-173e-413d-a4ef-8223ae98d1f2">4.400</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="if67b3d6fb8804d8b955cf3354d79349c_I20230615" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMTE1NDQ4NzIxMDc0MjU_e7487b5d-aee4-4379-a150-fe2f4c66b9c1">4.650</ix:nonFraction>% on payments starting after June 15, 2023, following a credit rating downgrade by Moody's in the first quarter of 2023. Future interest rate adjustments are subject to a <ix:nonFraction unitRef="number" contextRef="i65add94a2f11440981e032bdf4abf03a_I20230401" decimals="3" name="prgo:DebtInstrumentInterestRatePercentageCap" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNTQ5NzU1ODQ1NTYz_7d0725b6-949f-4298-b9f9-20e0a09e025c">2.0</ix:nonFraction>% total cap above the original <ix:nonFraction unitRef="number" contextRef="i65add94a2f11440981e032bdf4abf03a_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNTQ5NzU1ODQ1NTU1_00b20899-8e02-4d6e-b7a8-f592b83a55ac">3.150</ix:nonFraction>% interest rate based on certain rating events as specified in the Note&#8217;s Supplemental Indenture No. 3, dated as of June 19, 2020, among Perrigo Finance Unlimited Company, Perrigo Company plc and Wells Fargo Bank, National Association, as trustee.</span></div></ix:nonNumeric><div style="padding-left:13.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Credit Agreements</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2022, we and our wholly owned subsidiary, Perrigo Investments, LLC, entered into new senior secured credit facilities consisting of (i) a $<ix:nonFraction unitRef="usd" contextRef="i32ce52e94a304b5e9d295cbb2edf2771_I20220420" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMjUzNw_945fcfdb-e35d-4cee-86ef-3c8edc9e814b">1.0</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="idcb1e6845c364da39d5d2715c7c11d1a_D20220420-20220420" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMjE5OTAyMzI4NzI4OA_4dda7aeb-8934-4f86-aa81-54c5949cecdc">five-year</ix:nonNumeric> revolving credit facility (the &#8220;2022 Revolver&#8221;), (ii) a $<ix:nonFraction unitRef="usd" contextRef="i276b4c882ad542a0b4bc9186be63d917_I20220420" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMjYwNw_f32b529b-8dfb-4fcc-9d11-d7f645e08fb0">500</ix:nonFraction>&#160;million <ix:nonNumeric contextRef="i462a5d19445e4f4fb147359b0ef2c71a_D20220420-20220420" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMjE5OTAyMzI4NzMwMw_c3197971-c0af-402c-a54a-1770d91c2575">five-year</ix:nonNumeric> Term Loan A facility (the &#8220;2022 Term Loan A Facility&#8221;), and (iii) a $<ix:nonFraction unitRef="usd" contextRef="i9d64608f0d33471e9601e5e3541f2100_I20220420" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMjY4OQ_4e4c04e1-1696-42f1-9263-1ee69129dc77">1.1</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="ibe49dcf2409b417bb03e87a4807043ce_D20220420-20220420" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMjE5OTAyMzI4NzMxOQ_f317aef3-d86f-4645-beba-5c9ff450612a">seven-year</ix:nonNumeric> Term Loan B facility (the &#8220;2022 Term Loan B Facility&#8221; and, together with the 2022 Revolver and 2022 Term Loan A Facility, the &#8220;New Senior Secured Credit Facilities&#8221;), pursuant to a new Term Loan and Revolving Credit Agreement. The New Senior Secured Credit Facilities are guaranteed, along with any hedging or cash management obligations entered into with a lender, by us and certain of our direct and indirect wholly-owned subsidiaries organized in the United States, Ireland, Belgium and England and Wales (subject to certain exceptions) (the &#8220;Guarantor Subsidiaries&#8221;). The Guarantor Subsidiaries and Perrigo Investments, LLC provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the <ix:nonFraction unitRef="number" contextRef="i3ee3cba978c44e42a435b9406ceec87a_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMzQzNA_a8a6c2ca-f372-418a-a0c8-a7ffb23ac63b">5.300</ix:nonFraction>% Notes due 2043 issued by the Company, and the Guarantor Subsidiaries, Perrigo Investments, LLC and the Company provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the <ix:nonFraction unitRef="number" contextRef="i54459b98d2974030b71e7ddc68bfe196_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMzY1MQ_127d07b1-c858-44b2-b98e-fed7bb7cfb0b">3.900</ix:nonFraction>% Notes due 2024, the <ix:nonFraction unitRef="number" contextRef="i4e440215ed7c4652ba80460d905c0a7e_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMzY3NQ_43dbafd6-2e85-4077-94c7-8e0221a16e16">4.375</ix:nonFraction>% Notes due 2026, the <ix:nonFraction unitRef="number" contextRef="i2c142977f87a47ad9f46502a682caac2_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMzY5OQ_04bdc14c-1935-45df-bc7b-1cb76ac7b0c1">4.400</ix:nonFraction>% Notes due 2030 and the <ix:nonFraction unitRef="number" contextRef="i9c0b70f0dc5a4bb0a131daa51980752a_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMzcyNg_64e4bb75-0d77-4394-9151-db2dfbb9ae43">4.900</ix:nonFraction>% Notes due 2044 issued by Perrigo Finance Unlimited Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement also contains customary representations and warranties and customary affirmative and negative covenants applicable to the Borrower and its restricted subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, prepayment of junior indebtedness and dividends and other distributions. The Credit Agreement contains financial covenants that require the Borrower and its restricted subsidiaries to (a) not exceed a maximum first lien secured net leverage ratio of <ix:nonFraction unitRef="number" contextRef="i3050d0889c1b479ca3df780a8a2f67d3_I20230401" decimals="INF" name="prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxNDMyMQ_378b5f73-2dc7-45dd-a412-6bf9826d2279">3.00</ix:nonFraction> to 1.00 at the end of each fiscal quarter and (b) not fall below a minimum interest coverage ratio of <ix:nonFraction unitRef="number" contextRef="i3050d0889c1b479ca3df780a8a2f67d3_I20230401" decimals="INF" name="prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxNDQyNg_709890d2-9cc4-436a-a7f3-938486166836">3.00</ix:nonFraction> to 1.00 at the end of each fiscal quarter, provided that such covenants apply only to the 2022 Revolver and the 2022 Term Loan A Facility. If we consummate certain qualifying acquisitions during the term of the loan, the maximum first lien secured net leverage ratio covenant would increase to <ix:nonFraction unitRef="number" contextRef="i7ae59f1d38b94108baddcb6c4ce9ccc9_D20230101-20230401" decimals="INF" name="prgo:DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxNDcyMw_d9a39417-8f24-4b2c-967a-c07a21897173">3.25</ix:nonFraction> to 1.00 for such quarter and the three following fiscal quarters thereafter. The Credit Agreement also contains customary events of default relating to, among other things, failure to make payments, breach of covenants and breach of representations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="id5e32b19135c4250900d9d20e9ef63a8"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended April&#160;1, 2023, principal repayments o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f $<ix:nonFraction unitRef="usd" contextRef="i42813d6336b1446ea9d9766969a5d5d2_D20230101-20230401" decimals="-5" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNTQ5NzU1ODMwMDAw_5ab3dd5e-5ba5-4be7-a9e1-ba81d6c6369b"><ix:nonFraction unitRef="usd" contextRef="i909f5895c8934a849b1ce13d3e9b387a_D20230101-20230401" decimals="-5" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNTQ5NzU1ODMwMDAw_63e5d0ee-0ea0-4852-a91d-6e2fb59384ec">5.9</ix:nonFraction></ix:nonFraction> million were</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> made on the 2022 Term Loan A Facility and 2022 Term Loan B Facility. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There we</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">re <ix:nonFraction unitRef="usd" contextRef="i77ce2bbbf7924de9b72b6351123d25b7_I20230401" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMjE3NA_4b01ca68-b061-4f0b-a559-473aff8538c6"><ix:nonFraction unitRef="usd" contextRef="i3f539b72037a48c99b8a54e846db395d_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMjE3NA_e3496387-d304-4f07-85af-38f26e2e333c">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under the 2022 Revolver as of April&#160;1, 2023 or December&#160;31, 2022, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in compliance with all the covenants under our debt agreements as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;1, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Financing</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding under such facilities in the above table under "Other financing". Th</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ere were <ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNDAzMg_3f9aa387-0538-4b18-bbf6-156ef6b5a7ed"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNDAzMg_f2f54f1b-f24f-451e-90e9-cb4ce58e9141">no</ix:nonFraction></ix:nonFraction> borrowings o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">utstanding under the overdraft facilities as of April&#160;1, 2023 or December&#160;31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have financing leases that are reported in the above table under "Other financing" (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_70">Note 7</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div></ix:continuation><div><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_79"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RleHRyZWdpb246NTg5NDQyZGFhN2NkNDdiZTg4MzY5OTAyYzVkZTY3OWJfNTc4_78e7b358-fb37-46f9-9c7d-c50de2d5e0b1" continuedAt="ieeff899aec2547fb817d3b91530bdcf3" escape="true">EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ieeff899aec2547fb817d3b91530bdcf3" continuedAt="i4b9369b2e4664a1d891b80d898da6739"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RleHRyZWdpb246NTg5NDQyZGFhN2NkNDdiZTg4MzY5OTAyYzVkZTY3OWJfNTY4_c553f33b-3c34-4661-98c3-bfa87a3bd4f6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"></td><td style="width:69.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.302%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMy0xLTEtMS0yOTc1MDM_43f3cbaa-75af-4b7e-bdd3-52a0e43af07f">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMy0zLTEtMS0yOTc1MDM_7b222471-7584-4e74-b163-9aaa6ea505b1">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfNC0xLTEtMS0yOTc1MDM_2fa94107-7666-4aba-a0e8-ddfbf6b95eb1">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfNC0zLTEtMS0yOTc1MDM_af94a427-797b-461b-96fa-14c8a3021b2f">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfNS0xLTEtMS0yOTc1MDM_82a9b30b-8708-453b-b6c1-4b421a9dbe8b">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfNS0zLTEtMS0yOTc1MDM_69cdd12b-12f2-4b6f-88df-79c616dc2ba9">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic EPS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfOC0xLTEtMS0yOTc1MDM_c70335d3-c52d-4213-8e66-4d6fb1b5564d">134.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfOC0zLTEtMS0yOTc1MDM_9a51118c-97f6-491d-84b5-0b2ded9f278a">134.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for diluted EPS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMTAtMS0xLTEtMjk3NTAz_f37439f1-3c2d-4fe0-bada-4e5e66bfb8f3">134.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMTAtMy0xLTEtMjk3NTAz_f7976b9f-fa83-4970-a008-cb1d9ab37dbc">134.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anti-dilutive share-based awards excluded from computation of diluted EPS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMTItMS0xLTEtMjk3NTAz_5c714965-0bbf-4e04-8edf-27dd31cb7178">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMTItMy0xLTEtMjk3NTAz_399acf7e-dc84-4add-b658-9fa7871cfa8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) In the period of a net loss from continuing operations, diluted shares equal basic shares.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders' Equity</span></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4b9369b2e4664a1d891b80d898da6739">In October 2018, our Board of Directors authorized up to $<ix:nonFraction unitRef="usd" contextRef="i98abb9740a4644f0b0afc822f729d80e_I20181031" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RleHRyZWdpb246NTg5NDQyZGFhN2NkNDdiZTg4MzY5OTAyYzVkZTY3OWJfMjgz_b635af7b-29ff-42ea-baf3-34beb450b8ec">1.0</ix:nonFraction>&#160;billion of share repurchases with no expiration date, subject to the Board of Directors&#8217; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program (the "2018 Authorization"). We did <ix:nonFraction unitRef="shares" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RleHRyZWdpb246NTg5NDQyZGFhN2NkNDdiZTg4MzY5OTAyYzVkZTY3OWJfNTE3_291f624d-9572-4c93-bedb-452fb1e485ab"><ix:nonFraction unitRef="shares" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RleHRyZWdpb246NTg5NDQyZGFhN2NkNDdiZTg4MzY5OTAyYzVkZTY3OWJfNTE3_efee3d38-f9d3-4b1c-a4a5-443884c69a9e">no</ix:nonFraction></ix:nonFraction>t repurchase any shares during the three months ended April&#160;1, 2023 or April&#160;2, 2022.</ix:continuation> </span></div><div><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_85"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RleHRyZWdpb246YjIzMDJlZjFmNWFkNDg3M2FlZTgzM2QzZGRlNWU4N2VfMTk0_1a83bfb9-2fef-4e31-871c-34b8fbc4d49f" continuedAt="i7077c816f623484091a1f121ad28cd38" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7077c816f623484091a1f121ad28cd38"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RleHRyZWdpb246YjIzMDJlZjFmNWFkNDg3M2FlZTgzM2QzZGRlNWU4N2VfMTg3_c4351baf-1909-4109-87eb-f6fa2a905d64" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our AOCI balances, net of tax were as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:31.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.189%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.504%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivative Financial Instruments, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Employment Plan Adjustments, net of tax</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AOCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a686c929d27456898c40f7a87b08e15_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfMS0xLTEtMS0yOTc1MDM_54dc8b6a-442d-47c6-b2e1-d26141cc62bf">24.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a16530a4b74ab1ab2c00eb8e6c9b14_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfMS0zLTEtMS0yOTc1MDM_f5f24f16-0d19-47ec-981c-259283efe4e7">58.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcf2f305941145e58ac95b094337d8ae_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfMS03LTEtMS0yOTc1MDM_37d51368-8227-4818-bb4c-603072022070">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d376c6445864b46856bd7c9eca96a57_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfMS05LTEtMS0yOTc1MDM_741afac1-4e27-48ca-8494-a67ece9f19ad">27.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i432ffc96a54241f68ddc93d9513378cb_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNC0xLTEtMS0yOTc1MDM_90122ce8-73f1-4e2d-aa7a-a2899fe5a516">28.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9384c786716d42738630dbab4c03be2a_D20230101-20230401" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNC0zLTEtMS0yOTc1MDM_19e99c8b-d637-4f9c-9f1a-6e091dffccea">52.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57859208fac141e195976ff766745648_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNC03LTEtMS0yOTc1MDM_9da4a8bd-be31-41ef-a4d6-0c5fb2a0a495">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNC05LTEtMS0yOTc1MDM_fa80743d-cdea-4131-9c0f-bb9df9e15b46">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i432ffc96a54241f68ddc93d9513378cb_D20230101-20230401" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNS0xLTEtMS0yOTc1MDM_6b696e94-59ff-4746-8d4a-3d291d7fa4ad">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9384c786716d42738630dbab4c03be2a_D20230101-20230401" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNS0zLTEtMS0yOTc1MDM_76267039-770a-4611-8b55-fe72abb2e722">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57859208fac141e195976ff766745648_D20230101-20230401" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNS03LTEtMS0yOTc1MDM_f1ff0db5-9baa-477d-8b64-aa0c83ba3fd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNS05LTEtMS0yOTc1MDM_afaa6043-719a-4994-872d-775c1bf56826">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i432ffc96a54241f68ddc93d9513378cb_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNi0xLTEtMS0yOTc1MDM_a82571c9-5d6d-496b-8d03-1dbd7bc8be90">31.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9384c786716d42738630dbab4c03be2a_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNi0zLTEtMS0yOTc1MDM_84c262c3-a144-4289-96ad-4526826e6352">52.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57859208fac141e195976ff766745648_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNi03LTEtMS0yOTc1MDM_fd752253-4144-4165-85ec-322d4aabbddf">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNi05LTEtMS0yOTc1MDM_14054256-a6d6-4174-ac1f-96187d507220">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506dcfe48b094a3e931d739dfe711e08_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNy0xLTEtMS0yOTc1MDM_5daa4b0d-5050-4286-ad89-d0bc3e87da59">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i339887c74bba45cdaf9c842631f3e11f_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNy0zLTEtMS0yOTc1MDM_3232edcc-d7b2-49c3-87e3-22f4c2d9553b">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04473c0869bb4e9cb57c58ccae61c32f_I20230401" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNy03LTEtMS0yOTc1MDM_0e7dc074-ffc4-4206-a63c-b50b447c5993">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3cf13b5a219470a985bbaa83714a9e5_I20230401" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNy05LTEtMS0yOTc1MDM_0dc6fba9-77e8-43e0-888d-4530b49699f9">6.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_94"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 14</span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfNzQ2_335715ff-2448-44d4-b6af-70932d345613" continuedAt="iecac6f7110644317b58e52579a12a142" escape="true">RESTRUCTURING CHARGES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="iecac6f7110644317b58e52579a12a142"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, and related consulting fees. <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfNzM3_e3a606d2-63de-4932-afa4-25d76fa8000d" continuedAt="i90b8135ddab5441dbb52d6ff822d67f0" escape="true">The following reflects our restructuring activity (in millions):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i90b8135ddab5441dbb52d6ff822d67f0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.75pt"><tr><td style="width:1.0pt"></td><td style="width:105.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:47.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:82.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supply Chain Reinvention</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HRA Pharma Integration</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Initiatives</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13f0da93b3b4722b635937b8c483189_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfMy0xLTEtMS0yOTc1MDM_d75ec650-0a01-4cf6-9d6b-1598f8dbcb96">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife352f731243473cb38ff3a7c88ad094_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfMy0yLTEtMS0zNjM1OTQ_d36bf328-9fba-4703-aaf8-3d1fddd44596">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd510179d2634daf92fb0a1d857cf068_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfMy0yLTEtMS0yOTc1MDM_dc355d77-8733-498a-90ad-48d99914ef20">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfMy0zLTEtMS0yOTc1MDM_f926ce94-0c1e-4e48-af5b-623d749b92ef">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd18f1c6b0bf4007931565e3309d3a59_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfMy01LTEtMS0yOTc1MDM_4c50e9ef-d31d-4962-9db2-ab4e06ac2443">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d97e990bb9f45da875ed0019a943271_D20230101-20230401" decimals="-5" name="prgo:RestructuringAdditionalCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNC0xLTEtMS0yOTc1MDM_824de16e-2efb-4af7-b89a-fa742a9ccc58">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ad834796dd4944a10c88db4b09a61a_D20230101-20230401" decimals="-5" name="prgo:RestructuringAdditionalCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNC0yLTEtMS0zNjM1OTQ_33e5c66a-839a-48f8-bdf6-8604b9f3a06f">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95c3b6aef5f41e9a52f9f10c2866889_D20230101-20230401" decimals="-5" name="prgo:RestructuringAdditionalCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNC0yLTEtMS0yOTc1MDM_f7dc0cc8-e05d-4116-aa4f-d60d851ea5fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="prgo:RestructuringAdditionalCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNC0zLTEtMS0yOTc1MDM_22b6fb9d-b2d9-462c-aed3-24be4f7de9a1">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="prgo:RestructuringAdditionalCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNC01LTEtMS0yOTc1MDM_65e5166e-543e-4c2c-8d13-1ac6d0927c8e">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d97e990bb9f45da875ed0019a943271_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNS0xLTEtMS0yOTc1MDM_e9af44d7-0a4c-4c2c-9051-35d0df529e4f">4.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4ad834796dd4944a10c88db4b09a61a_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNS0yLTEtMS0zNjM1OTQ_7304ed4c-7185-41a6-836d-6d85d889d681">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib95c3b6aef5f41e9a52f9f10c2866889_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNS0yLTEtMS0yOTc1MDM_a754e9d5-8c6c-4cc7-85bc-b7f1f917f3d9">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNS0zLTEtMS0yOTc1MDM_c91e8491-e666-4630-a9e6-c168924583b4">8.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNS01LTEtMS0yOTc1MDM_3cd6576c-3adb-4687-80c6-acaefa5a3d5d">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d97e990bb9f45da875ed0019a943271_D20230101-20230401" decimals="-5" name="prgo:RestructuringReserveSettledWithoutCashNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNi0xLTEtMS0yOTc1MDM_0f4f6246-b875-4f94-ae12-8dcef4809bcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ad834796dd4944a10c88db4b09a61a_D20230101-20230401" decimals="-5" name="prgo:RestructuringReserveSettledWithoutCashNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNi0yLTEtMS0zNjM1OTQ_cd8cefef-3035-4eca-9b8b-dad4fe224e7f">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95c3b6aef5f41e9a52f9f10c2866889_D20230101-20230401" decimals="-5" name="prgo:RestructuringReserveSettledWithoutCashNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNi0yLTEtMS0yOTc1MDM_6c9b22af-426e-490b-b2b0-08a98f824fe8">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="prgo:RestructuringReserveSettledWithoutCashNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNi0zLTEtMS0yOTc1MDM_a65933f2-1718-4ded-9f16-31f7b46a3da4">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" sign="-" name="prgo:RestructuringReserveSettledWithoutCashNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNi01LTEtMS0yOTc1MDM_b7d9c85d-f239-4db8-918e-f38aa734aec6">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1391abd493480fb9acd3c58fcf9675_I20230401" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfOC0xLTEtMS0yOTc1MDM_61af9ed5-4dec-425f-9918-a552b33ec93d">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6134b75d6d3245a1b012e4facd40a083_I20230401" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfOC0yLTEtMS0zNjM1OTQ_01e0f5c5-5fd3-4303-a726-1463775d8181">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e874d379f764d87a630226253c6b16f_I20230401" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfOC0yLTEtMS0yOTc1MDM_96f6cd6e-8873-4cbe-b21a-37850f463bf1">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfOC0zLTEtMS0yOTc1MDM_ab51b6d1-c441-45a1-b0c6-7550362b01aa">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6955bfa807de4779804dcda471f50c60_I20220402" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfOC01LTEtMS0yOTc1MDM_a2e8bd67-dc33-45f9-b443-cadf265b39ec">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charges incurred during the three months ended April&#160;1, 2023 and April&#160;2, 2022 were primarily associated with actions taken on our multi-year supply chain restructuring program initiative started in 2022, and HRA Pharma integration activities associated with employee separation, continuity and other benefit-related costs. We have incurred $<ix:nonFraction unitRef="usd" contextRef="id44c0aea81d045e49ea119c7382cc4e4_D20220101-20230401" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfNTQ5NzU1ODE5NTc3_340cfaa6-da41-404a-9dbf-522731554dfb">13.5</ix:nonFraction>&#160;million of cumulative restructuring expense to date related to HRA Pharma integration. We expect that most of the HRA Pharma integration expenses will be incurred by the end of 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the amount recorded during the three months ended April&#160;1, 2023, $<ix:nonFraction unitRef="usd" contextRef="i817dfeec890e44ed95bda23a0c957cff_D20230101-20230401" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfMTY0OTI2NzQ0MjcxNA_0622674d-1fa5-49e0-9d9e-7c930f53eab1">0.9</ix:nonFraction> million was related to our CSCI segment, due primarily to supply chain restructuring and HRA Pharma integration initiatives, and $<ix:nonFraction unitRef="usd" contextRef="icfdccbcb51464df8bf6242647eb20916_D20230101-20230401" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfMTY0OTI2NzQ0Mjg4OQ_7a48e2a4-47f8-4174-bc8b-168a329babd1">1.2</ix:nonFraction> million related to our CSCA segment, also due primarily to supply chain restructuring initiatives. Remaining amounts recorded, including $<ix:nonFraction unitRef="usd" contextRef="idb86d716465f4a43b35ce7084bb1a35f_D20220101-20220402" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfNTQ5NzU1ODE5NTky_1f39a22f-033e-4a96-a5f5-a9cb3c661bd6">3.6</ix:nonFraction>&#160;million recorded during the three months ended April&#160;2, 2022, related to our Unallocated segment due primarily to supply chain restructuring. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other material restructuring programs for the periods presented. All charges are recorded in Restructuring expense on the Condensed Consolidated Statements of Operations. The remaining $<ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfNjI3_ab51b6d1-c441-45a1-b0c6-7550362b01aa">15.6</ix:nonFraction>&#160;million liability for employee severance benefits and consulting fees is expected to be paid within the next year.</span></div></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_88"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMTg1Mzc_e8cf46c1-eed3-44ba-937e-3dfc02e1acea" continuedAt="i4196b77e0e12445bb2ff72a3267626dd" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i4196b77e0e12445bb2ff72a3267626dd" continuedAt="i53276fa814b14cb69e0553e06dab4a7e"><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMTg1Mzk_7cb197cd-526e-433f-8065-4a3da2f72c7f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:143.25pt"><tr><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RhYmxlOjdkZTc0YTA5ZmViNDQxMjNhMjgzMjBhNGNkMjk2ZGE4L3RhYmxlcmFuZ2U6N2RlNzRhMDlmZWI0NDEyM2EyODMyMGE0Y2QyOTZkYThfMi0wLTEtMS0yOTc1MDM_319ee0bf-10ba-4337-b6b9-3f71b0143a35">123.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RhYmxlOjdkZTc0YTA5ZmViNDQxMjNhMjgzMjBhNGNkMjk2ZGE4L3RhYmxlcmFuZ2U6N2RlNzRhMDlmZWI0NDEyM2EyODMyMGE0Y2QyOTZkYThfMi0yLTEtMS0yOTc1MDM_b785d87a-6504-4869-b09c-fefaefb10413">90.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate on the pre-tax income for the three months ended April&#160;1, 2023 increased compared to the effective tax rate on the pre-tax loss for the three months ended April&#160;2, 2022, primarily due to the tax benefit of the loss on sale of our Latin American businesses recognized in the three months ended April&#160;2, 2022, offset by changes in the jurisdictional mix of earnings in the three months ended April&#160;1, 2023. The effective tax rate for this period differs from the statutory income tax rate of 12.5% primarily due to non-deductible expenses, as well as changes in our reserves for unrecognized tax benefits.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Revenue Service Audits of Perrigo Company, a U.S. Subsidiary</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company, our U.S. subsidiary ("Perrigo U.S."), is engaged in a series of tax disputes in the U.S. relating primarily to transfer pricing adjustments including income in connection with the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States, including the generic heartburn medication omeprazole. On August 27, 2014, we received a statutory notice of deficiency from the IRS relating to our fiscal tax years ended June 27, 2009, and June 26, 2010 (the &#8220;2009 tax year&#8221; and &#8220;2010 tax year&#8221;, respectively). On April 20, 2017, we received a statutory notice of deficiency from the IRS for the years ended June 25, 2011 and June 30, 2012 (the &#8220;2011 tax year&#8221; and &#8220;2012 tax year&#8221;, respectively). Specifically, both statutory notices proposed adjustments related to the offshore reporting of profits on sales of omeprazole in the United States resulting from </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 15</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i53276fa814b14cb69e0553e06dab4a7e" continuedAt="ief434a5bcc5443b79e8da443bc2618e8"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the assignment of an omeprazole distribution contract to an Israeli affiliate. In addition to the transfer pricing adjustments, which applied to all <ix:nonFraction unitRef="year" contextRef="i27edc1f6184c482f97b3b37c5afe0212_D20230101-20230401" decimals="INF" name="prgo:IncomeTaxExaminationNumberOfTaxableYears" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMjU5Nw_51a6b65d-95d2-4d41-b34e-c85a256bb53d">four</ix:nonFraction> tax years, the statutory notice of deficiency for the 2011 and 2012 tax years included adjustments requiring the capitalization and amortization of certain legal expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits related to ANDAs filed with a Paragraph IV Certification. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not agree with the audit adjustments proposed by the IRS in either of the notices of deficiency. We paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and timely filed claims for refund on June 11, 2015 for the 2009 and 2010 tax years, and on June 7, 2017, for the 2011 and 2012 tax years. On August 15, 2017, following disallowance of such refund claims, we timely filed a complaint in the United States District Court for the Western District of Michigan seeking refunds of tax, interest, and penalties of $<ix:nonFraction unitRef="usd" contextRef="i75ee84a7035145c0b2c910d5dc516972_D20090101-20091231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMzQ4Ng_69dfb022-de51-4be8-a504-32e3573540ec">27.5</ix:nonFraction> million for the 2009 tax year, $<ix:nonFraction unitRef="usd" contextRef="i309429068baf42d9b32476c47f52aaff_D20100101-20101231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMzUxMg_6cbfd10f-2b1b-464e-9b74-0482489cb730">41.8</ix:nonFraction> million for the 2010 tax year, $<ix:nonFraction unitRef="usd" contextRef="i8f277cfcb9db4505ad801732fd1320f1_D20110101-20111231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMzUzOA_43b56504-ea70-463e-865b-398789a37382">40.1</ix:nonFraction>&#160;million for the 2011 tax year, and $<ix:nonFraction unitRef="usd" contextRef="i201270c4e836404b9f18b06fd151647e_D20120101-20121231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMzU2OA_2fd25a16-02ff-4f8e-8f41-563391db3c40">24.7</ix:nonFraction> million for the 2012 tax year, for a total of $<ix:nonFraction unitRef="usd" contextRef="i08faba57c5a94a03969d96709d4fc35b_D20170815-20170815" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMzYwOQ_d706f24b-eca4-4ae7-8f1b-0e3b402da933">134.1</ix:nonFraction> million, plus statutory overpayment interest thereon from the dates of payment. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended July 1, 2017.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A bench trial was held during the period May 25, 2021 to June 7, 2021 for the refund case in the United States District Court for the Western District of Michigan. The total amount of cumulative deferred charge that we are seeking to receive in this litigation is approximately $<ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="prgo:CumulativeDeferredChargeTaxLitigation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNDM1OQ_d62420fe-acfc-4873-ad1c-be472e25e9c2">111.6</ix:nonFraction> million, which reflects the impact of conceding that Perrigo U.S. should have received a <ix:nonFraction unitRef="number" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="INF" name="prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNDQ0Mw_a5d42df8-1dca-4c32-a746-3fc133b16e7f">5.24</ix:nonFraction>% royalty on all omeprazole sales. That concession was previously paid and is the subject of the above refund claims. The issues outlined in the statutory notices of deficiency described above are continuing in nature, and the IRS will likely carry forward the adjustments set forth therein as long as the drug is sold, in the case of the omeprazole issue, and for all post-2012 Paragraph IV filings that trigger patent infringement suits, in the case of the ANDA issue. Post-trial briefings were completed on September 24, 2021 and the case is now fully submitted for the court&#8217;s decision. On April 30, 2021, we filed a Notice of New Authority in our refund case in the Western District of Michigan alerting the court to a United States Tax Court decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mylan v. Comm'r</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that ruled in favor of the taxpayer on nearly identical ANDA issues as we have before the court. On January 28, 2022, the IRS filed a Notice of Appeal with the United States Court of Appeals of the Third Circuit to appeal the United States Tax Court's decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mylan v. Comm'r. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Briefing to the appellate court was completed during 2022, oral argument was held before the Third Circuit on January 12, 2023, and the case is awaiting decision. On August 22, 2022, the parties filed a Notice of New Authority in the refund case alerting the court to a United States Court of Federal Claims decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Actavis Laboratories v. United States</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that also ruled in favor of the taxpayer on the ANDA issues. The government appealed the Actavis Laboratories decision to the United States court of Appeals for the Federal Circuit in December of 2022 and briefing to the appellate court is ongoing.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 13, 2021, the IRS issued a 30-day letter and Revenue Agent's Report ("RAR") with respect to its audit of our fiscal tax years ended June 29, 2013, June 28, 2014, and June 27, 2015. The 30-day letter proposed, among other modifications, transfer pricing adjustments in connection with the distribution of omeprazole in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i0064d9e4042944d58d1198901966263d_D20210113-20210113" decimals="-5" name="prgo:IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNjExMg_68280d20-b850-42bc-9706-9ff1e4886dee">141.6</ix:nonFraction> million and ANDA-related adjustments in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i0064d9e4042944d58d1198901966263d_D20210113-20210113" decimals="-5" name="prgo:IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNjE3MQ_cd0f53d1-89b3-464f-aeb8-0ccf0e2b4a74">21.9</ix:nonFraction> million. The 30-day letter also set forth adjustments described in the next two paragraphs. We timely filed a protest to the 30-day letter for those additional adjustments but noting that due to the pending refund litigation described above, IRS Appeals would not consider the merits of the omeprazole or ANDA matters. We believe that we should prevail on the merits on both carryforward issues and have reserved for taxes and interest payable on the <ix:nonFraction unitRef="number" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="INF" name="prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNjYxNw_a5d42df8-1dca-4c32-a746-3fc133b16e7f">5.24</ix:nonFraction>% deemed royalty on omeprazole through the tax year ended December 31, 2018. Beginning with the tax year ended December 31, 2019, we began reporting income commensurate with the <ix:nonFraction unitRef="number" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="INF" name="prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNjc5Ng_a5d42df8-1dca-4c32-a746-3fc133b16e7f">5.24</ix:nonFraction>% deemed royalty. We have not reserved for the ANDA-related issue described above. While we believe we should prevail on the merits of this case, the outcome remains uncertain. If our litigation position on the omeprazole issue is not sustained, the outcome for the 2009&#8211;2012 tax years could range from a reduction in the refund amount to denial of any refund. In addition, we expect that the outcome of the refund litigation could effectively bind future tax years. In that event, an adverse ruling on the omeprazole issue could have a material impact on subsequent periods, with additional tax liability in the range of $<ix:nonFraction unitRef="usd" contextRef="i13f377e048824747af8070c20b1f773d_D20210113-20210113" decimals="-5" name="us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNzQxOQ_19eced00-76e6-4392-94bf-9d84383eb443">24.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i799c30578ef443f59a649aaeb56da4a1_D20210113-20210113" decimals="-5" name="us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNzQyNQ_7febf0d4-92e3-46a6-9643-b38bdd321b7d">112.0</ix:nonFraction> million, not including interest and any applicable penalties.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 30-day letter for the 2013-2015 tax years also proposed to reduce Perrigo U.S.'s deductible interest expense for the 2014 tax year and the 2015 tax year on $<ix:nonFraction unitRef="usd" contextRef="i6df9a027c7764dc1882048b53958ed7f_I20210113" decimals="-8" name="prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNzY0Mw_d46d7e57-7935-4e88-927c-7d426cd8f93e">7.5</ix:nonFraction> billion in certain intercompany debts owed by it to Perrigo Company plc, which is the subject matter of a Notice of Proposed Adjustment, or "NOPA" issued on May 7, 2020. Subsequent to the end of the first quarter of fiscal 2023, we finalized an agreement with IRS Appeals providing for </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 15</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ief434a5bcc5443b79e8da443bc2618e8"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">settlement of the NOPA. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_1742">Note</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_1742"> 18 - Subsequent Events</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for additional details. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the 30-day letter for the 2013-2015 tax years expanded on a NOPA issued on December 11, 2019 and proposed to disallow reductions to gross sales income on the sale of prescription products to wholesalers for accrued wholesale customer pipeline chargebacks where the prescription products were not re-sold by such wholesalers to covered retailers by the end of the tax year. On December 28, 2022, we finalized an agreement with IRS Appeals providing for settlement of the December 11, 2019 NOPA, which would not only cover the 2013-2015 tax years but all of the remaining tax years through 2021, the last tax year with chargebacks due to the sale of the Rx business in July 2021. We made a settlement payment of $<ix:nonFraction unitRef="usd" contextRef="ia9a1e1741f134ef190ca8f40ceb9584d_D20221228-20221228" decimals="-5" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNTQ5NzU1ODM4NDQ4_4d07878b-2982-4137-a262-61f44f13d567">8.3</ix:nonFraction> million in 2022 which was fully covered by reserves for this issue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2021, the IRS commenced an audit of our federal income tax returns for the tax years ended December 31, 2015, through December 31, 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Revenue Service Audit of Athena Neurosciences, Inc., a U.S. Subsidiary&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subsequent to the end of the first quarter of fiscal 2023, we were notified by the IRS regarding the Competent Authority request filed for the Tysabri royalty issue, which concludes the competent authority process without the need for negotiations between the competent authorities and constitutes a full and final resolution of the April 26, 2019 NOPA received by Athena Neurosciences, Inc. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_1742">Note 18 - Subsequent Events</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  for additional details.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that our tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit and any related litigation could be materially different from our estimates or from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the final resolution of tax examinations, judicial or administrative proceedings, changes in facts or law, expirations of statute of limitations in specific jurisdictions or other resolutions of, or changes in, tax positions - one or more of which may occur within the next twelve months - it is reasonably possible that unrecognized tax benefits for certain tax positions taken on previously filed tax returns may change materially from those recorded as of April&#160;1, 2023. However, we are not able to estimate a reasonably possible range of how these events may impact our unrecognized tax benefits in the next twelve months.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_91"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1NjA_b2204ee6-c18b-449d-aee6-c5d9c5c20f56" continuedAt="i90ca6c289c44441593c4e55d1eaabe53" escape="true">CONTINGENCIES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i90ca6c289c44441593c4e55d1eaabe53" continuedAt="ia335ca04dc3f466da5167b7f1722b5a3"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of April&#160;1, 2023, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Price-Fixing Lawsuits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2013, the Company, along with other manufacturers, has been named as a defendant in lawsuits in the United States and Canada generally alleging anticompetitive conduct with respect to the sale of generic drugs by the Company&#8217;s former Rx business. The complaints &#8211; which have been filed by putative classes of direct purchasers, end payors, and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties - allege a conspiracy to fix, maintain, stabilize, and/or raise prices, rig bids, and allocate markets or customers for various generic drugs in violation of federal and state antitrust and consumer protection laws. While most of the complaints involve alleged single-drug conspiracy, the three putative classes have each filed an over-</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 16</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="ia335ca04dc3f466da5167b7f1722b5a3" continuedAt="iad703449626346d885cc2ad5b486cf44"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arching conspiracy complaint alleging that Perrigo and other manufacturers (and some individuals) entered into an &#8220;overarching conspiracy&#8221; that involved allocating customers, rigging bids, and raising, maintaining, and fixing prices for various products.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of the lawsuits described in this paragraph have been consolidated in the generic pricing multidistrict litigation ("MDL") MDL No. 2724 (United States District Court for Eastern District of Pennsylvania). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Court has ordered that the following cases involving Perrigo will proceed on a more expedited basis (as a bellwether) than the other cases in MDL No. 2724: (i) class actions alleging &#8220;single drug&#8221; conspiracies involving Clobetasol; and (ii) the State Attorney General Complaint (described below). The bellwether cases are proceeding in discovery, which must be completed by June 1, 2023 under the schedule set by the Court, and motions for summary judgment will be due on March 13, 2024. No trial dates have been set for any of the bellwether cases, or any of the other cases in the MDL.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Attorney General Complaint </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 10, 2020, the Connecticut Attorney General&#8217;s office filed a lawsuit on behalf of Connecticut and <ix:nonFraction unitRef="plaintiffgroup" contextRef="i28ca55466881480391b76ea7d3db52a4_I20200610" decimals="INF" name="prgo:NumberOfAdditionalStatesAndTerritories" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfMjkxNjA_c7f10431-ff71-4638-9344-2d8080fa3e6f">50</ix:nonFraction> other states and territories against Perrigo, <ix:nonFraction unitRef="manufacturer" contextRef="i28ca55466881480391b76ea7d3db52a4_I20200610" decimals="INF" name="prgo:LossContingencyNumberOfManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfMjkyMDk_60355cf9-f089-48b5-8460-89caf8077161">35</ix:nonFraction> other generic pharmaceutical manufacturers, and certain individuals (including <ix:nonFraction unitRef="retailer" contextRef="i28ca55466881480391b76ea7d3db52a4_I20200610" decimals="INF" name="prgo:LossContingencyNumberofFormerEmployees" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1Njg_626be8da-e76e-4dfb-abfc-eed15601d386">two</ix:nonFraction> former Perrigo employees), alleging an overarching conspiracy to allocate customers and/or fix, raise, or stabilize prices of <ix:nonFraction unitRef="pharmaceuticalproduct" contextRef="i28ca55466881480391b76ea7d3db52a4_I20200610" decimals="INF" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1NzM_74e4c4ea-df73-4529-a88a-8c70c4c95582">eighty</ix:nonFraction> products. This case is included among the &#8220;bellwether cases&#8221; designated to follow the expedited schedule described above. Like the other cases in the MDL, no trial date has been set for this case. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Class Action Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, an end payor filed a class action in Ontario, Canada against Perrigo and <ix:nonFraction unitRef="manufacturer" contextRef="ib8a4bae7a747476e97ac581edbcf809e_I20200630" decimals="INF" name="prgo:LossContingencyNumberOfManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfMzEwNzg_182ea19d-ea38-4296-a537-d9402c3e7b62">29</ix:nonFraction> other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise, or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. In December 2020, Plaintiffs amended their complaint to add additional claims based on the State Attorney General Complaint of June 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this stage, we cannot reasonably estimate the outcome of the liability if any, associated with the claims listed above.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Litigation</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In the United States (cases related to events in 2015-2017)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in May 2016, purported class action complaints were filed against the Company and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers&#8217; Pension Fund v. Papa, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) purporting to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The original complaint alleged violations of federal securities laws in connection with the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015. The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged business developments during the alleged class period including integration problems related to the Omega acquisition. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The operative complaint is the first amended complaint filed on June 21, 2017, and named as defendants us and <ix:nonFraction unitRef="individual" contextRef="ica2a115cf0034cd88c426dea96ad5c21_I20170621" decimals="INF" name="prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDMw_f2578f97-14f9-4c0b-920b-a8e2d4fd68b0">11</ix:nonFraction> current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The amended complaint alleges violations of federal securities laws arising out of the actions taken by us and the former directors and executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to the business developments during that period including purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to <ix:nonFraction unitRef="genericprescriptionpharmaceutical" contextRef="ica2a115cf0034cd88c426dea96ad5c21_I20170621" decimals="INF" name="prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDQ2_83a34523-c3b2-4d22-9b3c-063804403078">six</ix:nonFraction> generic prescription pharmaceuticals, and alleges improper accounting for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> royalty stream. During 2017, the defendants filed motions to dismiss, which the plaintiffs opposed. On July 27, 2018, the court issued an opinion and order granting the defendants&#8217; motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O&#8217;Connor, and Marc Coucke. The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 16</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="iad703449626346d885cc2ad5b486cf44" continuedAt="i358d38110cca4c638e334a0756235f39"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">court also dismissed without prejudice claims arising from the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are the Company, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issue regarding the Omega acquisition, the defense against the Mylan tender offer, and the alleged price fixing activities with respect to six generic prescription pharmaceuticals. The defendants who remain in the case (us, Mr. Papa, and Ms. Brown) have filed answers denying liability. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 14, 2019, the court granted the lead plaintiffs&#8217; motion and certified <ix:nonFraction unitRef="class" contextRef="i97aab9c2264f4b1d8268af34bd05d862_I20191114" decimals="INF" name="prgo:NumberofPutativeClasses" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDQ0_2be10be7-2f08-4550-bb31-32aa2b8fda2d">three</ix:nonFraction> classes for the case: (i) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on a U.S. exchange and were damaged thereby; (ii) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on the Tel Aviv exchange and were damaged thereby; and (iii) all those who owned shares as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered shares in response to the Mylan tender offer) (the "tender offer class"). Plaintiffs' counsels have sent notices to the alleged class. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties took discovery from 2018 through 2020. After discovery ended, defendants filed motions for summary judgement and to exclude plaintiffs' experts, which were fully briefed. The case was then re-assigned to a new federal judge, who heard oral argument on the motions in April 2022. The motions are pending. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the class action, the following opt-out cases have been filed against us, and in some cases, Mr. Papa and Ms. Brown, and contain factual allegations and claims that are similar to some or all of the factual allegations and claims in the class actions:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Filed</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Carmignac Gestion, S.A. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">First Manhattan Co. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/16/2018; amended 4/20/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Nationwide Mutual Funds, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/29/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Schwab Capital Trust, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Aberdeen Canada Funds -- Global Equity Fund, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/22/2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Funds, Inc., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/5/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Kuwait Investment Authority, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mason Capital L.P., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/26/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pentwater Equity Opportunities Master Fund Ltd., et al.  v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/26/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">WCM Alternatives: Event-Drive Fund, et al. v. Perrigo Co., plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/15/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Hudson Bay Master Fund Ltd., et al. v. Perrigo Co., plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/15/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Discovery Global Citizens Master Fund, Ltd., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/18/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">York Capital Management, L.P., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/20/2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Burlington Loan Management DAC v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Universities Superannuation Scheme Limited v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/2/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/13/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/20/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sculptor Master Fund (f/k/a OZ Master Fund, Ltd.), et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/6/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BlackRock Global Allocation Fund, Inc., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/21/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Starboard Value and Opportunity C LP, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/25/2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2020, three Highfields Capital entities filed a lawsuit in Massachusetts State Court with factual allegations that generally were similar to the factual allegations in the Amended Complaint in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Roofers' Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> case described above, except that the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Highfields</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> plaintiffs did not include allegations about alleged collusive pricing of generic prescription drugs, and alleged Massachusetts state law claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. In December 2021, the Massachusetts State Court granted Defendants&#8217; motion to dismiss in part and denied it in part. Defendants&#8217; filed </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 16</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i358d38110cca4c638e334a0756235f39" continuedAt="i910f8904f48f48ad90b9638a115ae26d"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">their answers in January 2022 denying liability. The discovery phase in this case has begun (including discovery related to some factual allegations that were not part of the discovery in the actions in New Jersey federal court). The Court held a discovery conference and approved fact discovery deadlines into May 2023 and later deadlines to complete expert discovery. Subsequently, the Court held a further conference in March 2023 and revised the schedule with fact discovery ending in October 2023 and expert discovery in May 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Israel (cases related to events in 2015-2017)</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Israel Elec. Corp. Employees&#8217; Educ. Fund v. Perrigo Company plc, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period from April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, Ernst &amp; Young LLP (the Company&#8217;s auditor), and <ix:nonFraction unitRef="individual" contextRef="i7b7f1a9b91944bd69726984aec58d65e_I20170628" decimals="INF" name="prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDIz_013bda6f-b136-4d6b-9e40-a74aaa682582">11</ix:nonFraction> current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The complaint alleges violations under Israeli securities laws that are similar to U.S. Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against all defendants and 20(a) control person liability against the <ix:nonFraction unitRef="individual" contextRef="i7b7f1a9b91944bd69726984aec58d65e_I20170628" decimals="INF" name="prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDE2_1d939f0d-de95-47b8-876c-ac42777e14bd">11</ix:nonFraction> individuals or, in the alternative, under other Israeli securities laws. In general, the allegations are similar to the factual allegations in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers' Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case in the U.S. as described above. The plaintiff indicates an initial, preliminary class damages estimate of <ix:nonFraction unitRef="ils" contextRef="ic803f010b538436e9209e345a0be08e1_D20170628-20170628" decimals="-8" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQzOTg0_aab4048d-a1b9-41f9-b2e0-356b64c9dbc3">2.7</ix:nonFraction>&#160;billion NIS (approximately $<ix:nonFraction unitRef="usd" contextRef="ic803f010b538436e9209e345a0be08e1_D20170628-20170628" decimals="-5" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQzOTU3_3c60cf35-cdfc-4145-9d51-7ef4afa870cf">760.0</ix:nonFraction>&#160;million at 1 NIS = <ix:nonFraction unitRef="usdPerILS" contextRef="i7b7f1a9b91944bd69726984aec58d65e_I20170628" decimals="2" name="us-gaap:ForeignCurrencyExchangeRateRemeasurement1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDA3_08553ad9-291c-40c3-9674-9fb16da0d1be">0.28</ix:nonFraction> cents). After the other <ix:nonFraction unitRef="case" contextRef="ic803f010b538436e9209e345a0be08e1_D20170628-20170628" decimals="INF" name="us-gaap:LossContingencyClaimsDismissedNumber" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDAw_b8589990-80c6-47f2-8d9d-dfc52b74bb58">two</ix:nonFraction> cases filed in Israel were voluntarily dismissed, the plaintiff in this case agreed to stay this case pending the outcome of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers&#8217; Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case in the U.S. (described above). The Israeli court approved the stay, and this case is now stayed. We intend to defend the lawsuit vigorously.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Israel (case related to Irish Tax events)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 31, 2018, a shareholder filed an action against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in Tel Aviv District Court (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Baton v. Perrigo Company plc, et. al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">). The case is a securities class action brought in Israel making similar factual allegations for the same period as those asserted in a securities class action case (for those who purchased on a U.S. exchange) in New York federal court in which the settlement received final approval in February 2022. The Baron case alleges that persons who purchased securities through the Tel Aviv stock exchange and suffered damages can assert claims under Israeli securities law that will follow the liability principles of Sections 10(b) and 20(a) of the U.S. Securities Exchange Act. The plaintiff does not provide an estimate of class damages. Since 2019, the court granted several requests by Perrigo to stay the proceedings pending the resolution of proceedings in the New York federal court. During 2022, the case was reassigned to a newly-appointed judge. After the settlement of the U.S. case in New York federal court, Perrigo's counsel informed the Israeli Court of the final approval of the settlement of the U.S. case. The parties then sought further stays of the case while they attempted mediation, which the Court granted. In April 2023, the parties reported to the Court that the mediation had led to a preliminary agreement on settlement; the Court ordered that a motion for approval of the settlement and related papers be filed no later than June 17, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Talcum Powder</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been named, together with other manufacturers, in product liability lawsuits in a variety of state courts alleging that the use of body powder products containing talcum powder causes mesothelioma and lung cancer due to the presence of asbestos. All but one of these cases involve legacy talcum powder products that have not been manufactured by the Company since 1999. One of the pending actions involves a current prescription product that contains talc as an excipient. As of April 24, 2023, the Company is currently named in <ix:nonFraction unitRef="lawsuit" contextRef="i1bfe66b50bea4a8aa93aa6ad4d382456_I20230401" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTY3Nzc_954229ba-45fe-4773-9348-9b49eb9b9add">90</ix:nonFraction> individual lawsuits seeking compensatory and punitive damages and has accepted a tender for a portion of the defense costs and liability from a retailer for <ix:nonFraction unitRef="tender" contextRef="i2c793269a6cc46b9b3333aaf587cd1d4_D20230101-20230401" decimals="INF" name="prgo:NumberofTendersAccepted" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1ODg_7753410f-e565-4f39-9414-73b444c78084">one</ix:nonFraction> additional matter. The Company has several defenses and intends to aggressively defend these lawsuits. Trials for these lawsuits are currently scheduled throughout 2023, 2024 and 2025, with the earliest trial date in May 2023. </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 16</span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="i910f8904f48f48ad90b9638a115ae26d" continuedAt="i3f206e4d01f542f1978e9b16e55c11b4"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ranitidine</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After regulatory bodies announced worldwide that ranitidine may potentially contain N-nitrosodimethylamine ("NDMA"), a known environmental contaminant, the Company promptly began testing its externally-sourced ranitidine API and ranitidine-based products. On October 8, 2019, the Company halted shipments of the product based upon preliminary results and on October 23, 2019, the Company made the decision to conduct a voluntary retail market withdrawal. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the resulting actions involving </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and other ranitidine products were transferred for coordinated pretrial proceedings to a Multi-District Litigation (In re </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/Ranitidine Products Liability Litigation MDL No. 2924) in the U.S. District Court for the Southern District of Florida. After the Company successfully moved to dismiss the first set of Master Complaints in the MDL, it now includes <ix:nonFraction unitRef="complaint" contextRef="i2649c54ab7c149678c1ae6e627aa140e_D20200201-20200229" decimals="INF" name="prgo:LossContingencyNumberofMasterComplaints" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1OTY_6673b1a9-6202-432c-b19d-a8bfecd337df">three</ix:nonFraction>: 1) an Amended Master Personal Injury Complaint; 2) a Consolidated Amended Consumer Economic Loss Class Action Complaint; and 3) a Consolidated Medical Monitoring Class Action Complaint. All <ix:nonFraction unitRef="complaint" contextRef="i2649c54ab7c149678c1ae6e627aa140e_D20200201-20200229" decimals="INF" name="prgo:LossContingencyNumberofMasterComplaintsNamingCompany" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1ODk_1c954e4a-fe58-4803-9c0a-22d267203031">three</ix:nonFraction> name the Company. Plaintiffs appealed <ix:nonFraction unitRef="complaint" contextRef="i2649c54ab7c149678c1ae6e627aa140e_D20200201-20200229" decimals="INF" name="prgo:NumberOfAppealsOfMasterComplaints" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1NzA_8f0c2c66-dae5-4e75-8f0f-eec954a66b8e">one</ix:nonFraction> of the original Master Complaints, the Third-Party Payor Complaint, and <ix:nonFraction unitRef="claim" contextRef="i2649c54ab7c149678c1ae6e627aa140e_D20200201-20200229" decimals="INF" name="prgo:NumberOfAppealsOfPersonalInjuryClaims" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1NTc_9788f313-6724-408f-8976-647dd6bacfa5">two</ix:nonFraction> individual plaintiffs appealed their individual personal injury claims on limited grounds. The Company is not named in the appeals.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2021, the Court dismissed all claims against the retail and distributor defendants with prejudice, thereby reducing the Company&#8217;s potential for exposure and liability related to possible indemnification. On July 8, 2021, the Court dismissed all claims against the Company with prejudice. Appeals of these dismissal orders to the U.S. Court of Appeals for the 11th Circuit have been filed, as well as several state level claims related to the theories advanced in the MDL litigation. The Company will continue to vigorously defend each of these lawsuits.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of April 1, 2023, the Company has been named in <ix:nonFraction unitRef="lawsuit" contextRef="id52764380c894cadb9ff29bc67bd9ba8_D20230101-20230401" decimals="INF" name="prgo:NumberOfPersonalInjuryLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTkxMzQ_1f794c4b-da71-4019-b867-4a4b75a66b63">352</ix:nonFraction> personal injury lawsuits, most of which are in the MDL tied to various federal courts alleging that plaintiffs developed various types of cancers or are placed at higher risk of developing cancer as a result of ingesting products containing ranitidine. The Company has also been named in a handful of similar lawsuits in the state courts of California, Illinois, Ohio, New Jersey, New York and Pennsylvania. The Company is named in these lawsuits with manufacturers of the national brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and other manufacturers of ranitidine products, as well as distributors, repackagers, and/or retailers. Plaintiffs seek compensatory and punitive damages, and in some instances seek applicable remedies under state consumer protection laws. The Company believes that it has strong defenses to such claims based on a significant body of scientific evidence, and pursuant to the doctrine of federal preemption. As noted above, the Company has won multiple motions to dismiss in the MDL, as well as additional state court actions in California and Maryland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has also been named in a Complaint brought by the New Mexico Attorney General based on the following theories: violation of a New Mexico public nuisance statute, NMSA 30-8-1 to -14; common law nuisance; and negligence and gross negligence. The Company is named in this lawsuit with manufacturers of the national brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and other manufacturers of ranitidine products and/or retailers. Brand name manufactures named in the lawsuit also face claims under the state&#8217;s Unfair Practices &amp; False Advertising acts. The Company filed motions to dismiss the action. The New Mexico District Court denied the Company&#8217;s Motion to Dismiss and litigation continues. The Company will continue to vigorously defend this lawsuit. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s retailer customers are seeking indemnity from the Company for a portion of their defense costs and liability relating to these cases. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acetaminophen</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022 the Judicial Panel on Multidistrict Litigation ("MDL") consolidated a number of pending actions filed in various federal courts alleging that prenatal exposure to acetaminophen is purportedly associated with the development of autism spectrum disorder (&#8220;ASD&#8221;) and attention-deficit/hyperactivity disorder (&#8220;ADHD&#8221;). The MDL is styled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Acetaminophen &#8211; ASD/ADHD Products Liability Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (MDL No. 3043) and is pending before the U.S. District Court for the Southern District of New York. Plaintiffs in the MDL have asserted claims against Johnson &amp; Johnson Consumer, Inc. (&#8220;JJCI&#8221;) and various retailer chains alleging that plaintiff-mothers took acetaminophen products while pregnant and that plaintiff-children developed ASD and/or ADHD as a result of prenatal exposure to these acetaminophen products. At this time, the MDL proceedings are in the early stages. Currently, it is not possible to assess reliably the outcome of these cases or any potential future financial impact on the Company. As of April 24, 2023 the Company has not been named as a defendant in any Complaints filed in the MDL. It is anticipated that some of the Company&#8217;s retailer customers may seek indemnity from the Company for a portion of their defense costs and potential liability relating to these cases. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 16</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i3f206e4d01f542f1978e9b16e55c11b4"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies Accruals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the matters discussed in this Note, the Company has established a loss accrual for litigation contingencies where we believe a loss to be probable and for which an amount of loss can be reasonably estimated. However, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to inherent uncertainties of litigation. At April&#160;1, 2023, the loss accrual for litigation contingencies reflected on the balance sheet in Other accrued liabilities was approximately $<ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjI1NDc_f00f7abe-6f5c-453d-aead-70b21ecbcbeb">67.6</ix:nonFraction>&#160;million. The Company also recorded an insurance recovery receivable reflected on the balance sheet in Prepaid expenses and other current assets of approximately $<ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:LossContingencyRelatedReceivableCarryingValueAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjI3MDM_07f40eeb-ace3-4c3b-8c2b-9196c073f010">37.2</ix:nonFraction>&#160;million related to these litigation contingencies because it believes such amount is recoverable based on communications with its insurers to date; however, the Company may erode this insurance receivable as it incurs defense costs associated with defending the matters. The Company&#8217;s management believes these accruals for contingencies are reasonable and sufficient based upon information currently available to management; however, there can be no assurance that final costs related to these contingencies will not exceed current estimates or that all of the final costs related to these contingencies will be covered by insurance. (See "</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Coverage Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," below.) In addition, we have other litigation matters pending for which we have not recorded any accruals because our potential liability for those matters is not probable or cannot be reasonably estimated based on currently available information. For those matters where we have not recorded an accrual but a loss is reasonably possible, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to the inherent uncertainties of litigation. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Coverage Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2021, insurers on multiple policies of D&amp;O insurance filed an action in the High Court in Dublin against the Company and multiple current and former directors and officers of the Company seeking declaratory judgments on certain coverage issues. Those coverage issues include claims that policies for periods beginning in December 2015 and December 2016, respectively, do not have to provide coverage for the securities actions described above pending in the District of New Jersey or in Massachusetts state court concerning the events of 2015-2017. The policy for the period beginning December 2014 is currently providing coverage for those matters, and the litigation would not affect that existing coverage. However, if the plaintiffs are successful, the total amount of insurance coverage available to defend such lawsuits and to satisfy any judgment or settlement costs thereunder would be limited to <ix:nonFraction unitRef="policyperiod" contextRef="i3b63510c803344a6ba94abfe031e6828_I20210531" decimals="INF" name="prgo:ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjQ4OTU_debcd8d0-8364-4122-8585-895d02d197aa">one</ix:nonFraction> policy period. The insurers&#8217; lawsuit also challenges coverage for Krueger derivatively on behalf of nominal defendant Perrigo Company plc v. Alford et al., a prior derivative action filed in the District of New Jersey that was dismissed in August 2020, and for the counterclaims brought in the Omega arbitration proceedings. Perrigo responded on November 1, 2021; Perrigo&#8217;s response includes its position that the policies for the periods beginning December 2015 and December 2016 provide coverage for the underlying litigation matters and seeks a ruling to that effect. The discovery stage of the case occurred in 2022. The Court has set a schedule for submissions by the parties during 2023 and for a bench trial in mid-November 2023. We intend to defend the lawsuit vigorously.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_100"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 17</span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 17 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90ZXh0cmVnaW9uOjRiODk2ZWNkYjljYjQ5YzI5NmZmMTE1YjIzN2Q1YTRiXzMxMQ_7c0e42ca-0e6c-40bf-a166-94cc76dcfdcd" continuedAt="i575bad3c41554dcdac60659ab5ecaa5a" escape="true">SEGMENT INFORMATION </ix:nonNumeric></span></div><ix:continuation id="i575bad3c41554dcdac60659ab5ecaa5a"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90ZXh0cmVnaW9uOjRiODk2ZWNkYjljYjQ5YzI5NmZmMTE1YjIzN2Q1YTRiXzMwNw_1d8c4703-562e-4301-bd7c-2adfd45bbe55" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below show select financial measures by reporting segment (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.438%"><tr><td style="width:1.0%"></td><td style="width:32.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.755%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib24332748044483db83ca8e301c719ca_I20230401" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzItMi0xLTEtMjk3NTAz_76d61661-17cc-4fb4-b38b-ba22eb989d24">5,057.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f3eb6af9f444b3e8326226555389980_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzItNC0xLTEtMjk3NTAz_92a13505-cf9a-47e9-a0d6-7c19690d973f">5,134.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc71f8f540634f1ea99e39a92c86aae5_I20230401" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzMtMi0xLTEtMjk3NTAz_6017795b-469d-4c38-9b74-92773cfa3227">5,897.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63eb2d1285fa4953907a861c6ea961bc_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzMtNC0xLTEtMjk3NTAz_9d7904f2-22e9-4514-b554-f1eff07aa2ff">5,883.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f467292f2f4ec28ff4898282903225_I20230401" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzgtMi0xLTEtMjk3NTAz_fa812175-faab-4224-a1bc-a483e529e177">10,954.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzgtNC0xLTEtMjk3NTAz_09c639b4-ab66-4dc1-acbd-34d3abb2d221">11,017.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net <br/>Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible Asset Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net <br/>Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible Asset Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b6ce8147676451896841efd4f59b711_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtMS0xLTEtMjk3NTAz_08f1a865-ee4e-4317-9d06-c3e49a469948">763.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b6ce8147676451896841efd4f59b711_D20230101-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtMy0xLTEtMjk3NTAz_42fd4fc1-9b96-4a9b-a66f-460a60380304">83.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b6ce8147676451896841efd4f59b711_D20230101-20230401" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtNS0xLTEtMjk3NTAz_9622e32b-ed79-4f77-84cb-8b97ea7edc85">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e0b17ca570e463d8112c9aa7539c783_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtNy0xLTEtMjk3NTAz_6762131e-02d2-4b73-b81c-3f343f9b103a">710.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e0b17ca570e463d8112c9aa7539c783_D20220101-20220402" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtOS0xLTEtMjk3NTAz_413c4e36-fa15-4052-8c18-8d24edb61648">78.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e0b17ca570e463d8112c9aa7539c783_D20220101-20220402" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtMTEtMS0xLTI5NzUwMw_6580d891-822b-4c34-aff0-1e5aa3907edc">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88323e455b54b5aae39a5550bdf99d6_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtMS0xLTEtMjk3NTAz_bf461970-4cb0-4804-88ca-ede0b6fd563f">418.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88323e455b54b5aae39a5550bdf99d6_D20230101-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtMy0xLTEtMjk3NTAz_5cdb63e6-eec8-4c85-ae86-a6a3d81d71a9">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88323e455b54b5aae39a5550bdf99d6_D20230101-20230401" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtNS0xLTEtMjk3NTAz_b4e86c72-cf43-4a2d-9b18-30c869482e84">51.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88afdc4249140efb878dc32ef2e31c3_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtNy0xLTEtMjk3NTAz_100c5d9c-d021-4b16-a08f-1937a8aca74f">364.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88afdc4249140efb878dc32ef2e31c3_D20220101-20220402" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtOS0xLTEtMjk3NTAz_ea2ed87e-3012-4425-8404-3553b1c8c046">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88afdc4249140efb878dc32ef2e31c3_D20220101-20220402" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtMTEtMS0xLTI5NzUwMw_1df534e7-0b63-4953-91b6-86cd89cf7cce">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76faace4db464da8a217c507ee330b44_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtMS0xLTEtMjk3NTAz_d34c6706-6f25-44c8-86ac-b77414815f04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76faace4db464da8a217c507ee330b44_D20230101-20230401" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtMy0xLTEtMjk3NTAz_fa7d044c-f559-4d6a-af9f-37caeaf8dbb4">56.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76faace4db464da8a217c507ee330b44_D20230101-20230401" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtNS0xLTEtMjk3NTAz_2055fb4b-40c0-44d7-b3c1-483f98abc139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4d7777405b48b5a6f0c5963e7e4b91_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtNy0xLTEtMjk3NTAz_a80cab8f-7d56-4ec6-8997-dafcc5665e23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c4d7777405b48b5a6f0c5963e7e4b91_D20220101-20220402" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtOS0xLTEtMjk3NTAz_c91b110c-fca7-4fb8-883a-5be9d31a2b13">73.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4d7777405b48b5a6f0c5963e7e4b91_D20220101-20220402" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtMTEtMS0xLTI5NzUwMw_eedafea1-fd78-45d8-93ea-833b30e21da6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing Operations Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktMS0xLTEtMjk3NTAz_c8361722-62d5-4bac-a1e4-414ce2081231">1,181.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktMy0xLTEtMjk3NTAz_85242892-d359-43eb-b1ce-4a4ccf471029">48.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktNS0xLTEtMjk3NTAz_6c3b1c6e-9534-4d16-bb38-9702abc2a770">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktNy0xLTEtMjk3NTAz_9982e0de-b991-489f-bdec-78cde51b6b9d">1,074.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktOS0xLTEtMjk3NTAz_99d70f6c-f79a-4ad0-94f8-da16dfda0cca">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktMTEtMS0xLTI5NzUwMw_876c45b0-c835-4698-96d2-7b51e2aa65a3">48.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_1742"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 18 - <ix:nonNumeric contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8yMTk5MDIzMjYyODYx_6965884e-4779-4d89-980d-11aa3f422624" continuedAt="ibb93f8969ff14f99802a48091f752258" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ibb93f8969ff14f99802a48091f752258" continuedAt="i593d867996104ef784d234975189a438"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Revenue Service Audit of Athena Neurosciences, Inc., a U.S. Subsidiary&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 26, 2019, we received a revised NOPA from the IRS regarding transfer pricing positions related to the IRS audit of Athena Neurosciences, LLC ("Athena") for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. The April 26, 2019 NOPA carried forward the IRS's theory from its 2017 draft NOPA that when Elan took over the future funding of Athena's in-process research and development after acquiring Athena in 1996, Elan should have paid a substantially higher royalty rate for the right to exploit Athena&#8217;s intellectual property in various developmental products, including the Multiple Sclerosis drug Tysabri, rather than rates based on transfer pricing documentation prepared by Elan's external tax advisors. The April 26, 2019 NOPA proposed a payment of $<ix:nonFraction unitRef="usd" contextRef="i24a3f5f031674ea3967941fe5f6e80e7_I20190426" decimals="-5" name="prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAyMzE5_78aa8819-c167-4ad3-9d19-792d9c6b1cba">843.0</ix:nonFraction>&#160;million, which represented additional tax based on imputing royalty income to Athena using a 24.7% royalty rate derived by the IRS and a <ix:nonFraction unitRef="number" contextRef="i24a3f5f031674ea3967941fe5f6e80e7_I20190426" decimals="3" name="prgo:IRSNoticeofProposedAdjustmentPenaltyPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAyNDUw_52714fe3-6a59-467e-8366-1a412cbb5947">40.0</ix:nonFraction>% accuracy-related penalty. This amount excluded consideration of offsetting tax attributes and any potential interest that may be imposed. We strongly disagreed with the IRS position. On December 22, 2016, we also received a NOPA for these years denying the deductibility of settlement costs incurred in 2011 by Athena's parent company Elan Pharmaceuticals, Inc. ("EPI") related to illegal marketing of Zonegran by EPI's employees in the United States raised in a Qui Tam action under the U.S. False Claims Act. We strongly disagreed with the IRS' position on this issue as well. Because we believed that any concession on these issues in Appeals would be contrary to our evaluation of the issues and to avoid double taxation of the same income in the United States and Ireland, we pursued our remedies under the Mutual Agreement Procedure ("MAP") of the U.S.-Ireland Income Tax Treaty to alleviate double taxation. On April 21 and 23, 2020, we filed requests for Competent Authority assistance with the IRS and Irish Revenue on the Tysabri royalty issue, and those MAP applications were accepted. On October 20, 2020, we amended our requests for Competent Authority assistance to include the Zonegran issue and these supplemental requests were also accepted. On April 24, 2023, we received a letter from the IRS regarding the Competent Authority request filed for the Tysabri royalty issue, which concludes the competent authority process commenced by such submissions without the need for negotiations between the competent authorities and constitutes a full and final resolution of the April 26, 2019 NOPA. In the second quarter of fiscal year 2023 we plan to adjust any previously established reserves related to this matter. The Zonegran deduction issue remains pending in the MAP case and is being considered by APMA and the Irish Competent Authority.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Internal Revenue Service Audits of Perrigo Company, a U.S. Subsidiary</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As detailed in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_88">Note 15. Income Taxes</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on January 13, 2021, the IRS issued a 30-day letter for the 2013-2015 tax years, which included a proposal to reduce Perrigo U.S.'s deductible interest expense for the 2014 tax year and the 2015 tax year on $<ix:nonFraction unitRef="usd" contextRef="i6df9a027c7764dc1882048b53958ed7f_I20210113" decimals="-8" name="prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0ODk5NTIw_d46d7e57-7935-4e88-927c-7d426cd8f93e">7.5</ix:nonFraction> billion in certain intercompany debts owed by it to Perrigo Company plc. The debts were incurred in connection with the 2013 Elan merger transaction. On May 7, 2020, the IRS issued a NOPA capping the interest rate on the debts for U.S. federal tax purposes at <ix:nonFraction unitRef="number" contextRef="ib61b709a6db3426a9ffb8c7d3ab7d06f_D20200507-20200507" decimals="INF" name="prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0ODk5Nzc5_5a4add62-fe95-46a0-badb-0e5c63c2be1a">130.0</ix:nonFraction>% of the Applicable Federal Rate ("AFR") (a blended </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 17</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i593d867996104ef784d234975189a438">rate reduction of <ix:nonFraction unitRef="number" contextRef="ib61b709a6db3426a9ffb8c7d3ab7d06f_D20200507-20200507" decimals="INF" name="prgo:IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0ODk5ODUx_e955c5de-254e-468c-ad37-09f40d1dff82">4.0</ix:nonFraction>% per annum) on the stated ground that the loans were not negotiated on an arms-length basis. The May 7, 2020 NOPA proposed a reduction in gross interest expense of approximately $<ix:nonFraction unitRef="usd" contextRef="ib61b709a6db3426a9ffb8c7d3ab7d06f_D20200507-20200507" decimals="-5" name="prgo:IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAwMDIw_722685e7-114a-4ef6-8402-26dbe7a4898a">414.7</ix:nonFraction> million for tax years 2014 and 2015. On January 13, 2021, we received a RAR, together with the 30-day letter, requiring our filing of a written protest to request IRS Appeals consideration. The protest was timely filed with the IRS on February 26, 2021. On January 20, 2022, the IRS responded to our protest with its rebuttal in which it revised its position on this interest rate issue by reasserting that implicit parental support considerations are necessary to determine the arm's length interest rates and proposed revised interest rates that are higher than the interest rates proposed under its <ix:nonFraction unitRef="number" contextRef="ib61b709a6db3426a9ffb8c7d3ab7d06f_D20200507-20200507" decimals="INF" name="prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAwNjE4_5a4add62-fe95-46a0-badb-0e5c63c2be1a">130.0</ix:nonFraction>% of AFR assertion. The blended interest rate proposed by the IRS rebuttal was <ix:nonFraction unitRef="number" contextRef="i6893406b8890440696557335070ce018_D20220120-20220120" decimals="4" name="prgo:BlendedInterestRateProposedOnDebtsForUSTaxPurposes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAwNjk5_e9a8355d-6c9c-4208-9cca-dab07d7efb29">4.36</ix:nonFraction>%, an increase from the blended interest rate in the RAR of <ix:nonFraction unitRef="number" contextRef="i6893406b8890440696557335070ce018_D20220120-20220120" decimals="4" name="prgo:BlendedInterestRateInRevenueAgentReport" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAwNzYx_d4ad96b1-5986-4e99-857c-5f32a192cfac">2.57</ix:nonFraction>% but lower than the stated blended interest rate of the loans of <ix:nonFraction unitRef="number" contextRef="i6893406b8890440696557335070ce018_D20220120-20220120" decimals="3" name="prgo:DebtStatedBlendedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAwODI5_49922961-b8c9-4908-bfa2-62aaf560ab78">6.8</ix:nonFraction>%. An IRS Appeals conference for the interest rate issue was held during March 7, 2023 through March 9, 2023. On May 5, 2023, we finalized an agreement with IRS Appeals providing for settlement of the May 7, 2020 NOPA of $<ix:nonFraction unitRef="usd" contextRef="ie669ed37287d49f79a13f8942d0d9e94_D20230505-20230505" decimals="-5" name="us-gaap:IncomeTaxExaminationInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV81NDk3NTU4Mzk1NTU_7ff9b6b7-a5bf-47c0-8830-f18c24fbc594">153.4</ix:nonFraction>&#160;million of gross interest expense reduction for the 2013-2015 tax years. This implies a blended interest rate of <ix:nonFraction unitRef="number" contextRef="ie669ed37287d49f79a13f8942d0d9e94_D20230505-20230505" decimals="4" name="prgo:BlendedInterestRateProposedOnDebtsForUSTaxPurposes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV81NDk3NTU4Mzk1OTU_d7994169-70bc-4940-840c-2969f1a855e6">5.44</ix:nonFraction>%. In addition, based on the above agreement with IRS Appeals, we will apply similar adjustments for all remaining tax years through 2018. In the second quarter of fiscal year 2023 we plan to adjust any previously established reserves related to this matter.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_106"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Overview</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </span></div><div style="text-align:center"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis ("MD&amp;A") is intended to provide readers with an understanding of our financial condition, results of operations, and cash flows by focusing on changes in certain key measures from year to year. This MD&amp;A is provided as a supplement to, and should be read in conjunction with our Condensed Consolidated Financial Statements and accompanying Notes found in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_13">Item I</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Form 10-Q, and our Form 10-K for the year ended December&#160;31, 2022 (the &#8220;2022 Form 10-K&#8221;). These historical financial statements may not be indicative of our future performance. This discussion contains a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risks referred to under &#8220;Risk Factors&#8221; in Item 1A of our 2022 Form 10-K and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_175">Part II. Item 1A</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OVERVIEW</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading provider of over-the-counter ("OTC") health and wellness solutions that are designed to enhance individual well-being and empower consumers to proactively prevent or treat conditions that can be self-managed. Our vision is </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to make lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We are headquartered in Ireland and sell our products primarily in North America and Europe, as well as in other markets around the world.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our core competencies are geared to fully take advantage of the massive global trend towards self-care. We define self-care as not just treating disease or helping individuals feel better after taking a product, but also maintaining and enhancing their overall health and wellness. Consistent with our vision, we recently completed our three-year strategy to transform the Company into a consumer self-care leader by reconfiguring our portfolio through the divestiture of our Rx business in 2021 and acquiring H&#233;ra SAS (&#8220;HRA Pharma&#8221;) in 2022. Additionally, we removed significant uncertainty in 2021 through final settlement of the Irish Revenue Notice of Amended Assessment. Upon completion of our transformation, we have transitioned our strategy to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8216;Optimizing&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> business and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8216;Accelerating&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> profitable growth. Several initiatives are anticipated to propel this strategy, including plans to achieve significant synergies from our acquisitions and implementation of our Supply Chain Reinvention Program. In addition, we continue to invest in other initiatives, including innovation, information systems and tools, and our people to drive consistent and sustainable results in line with consumer-packaged goods peers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on January 1 and ends on December 31. We end our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Segments</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting and operating segments reflect the way our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company. Our reporting and operating segments are: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:14.5pt">Consumer Self-Care Americas ("CSCA") </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care International ("CSCI") </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S. and other pharmaceuticals and diagnostic businesses in Israel, which have been divested. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Overview</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Highlights </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">On March 28, 2023 we announced that the FDA has rescheduled a joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee for May 9 and 10, 2023, to review the Company's application for Opill</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> daily oral contraceptive for OTC use. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">On March 1, 2023, we announced that we had received final approval from the FDA for our Abbreviated New Drug Application ("ANDA") for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg, the store brand OTC equivalent of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Advil</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Dual Action Tablets 250 mg/125 mg. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">On February 28, 2023, we presented the details of our three year </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">'Optimize and Accelerate' </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">strategy during our Virtual Investor Day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tax Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 26, 2019, we received a revised Notice of Proposed Assessment ("NOPA") from the IRS regarding transfer pricing positions related to the IRS audit of Athena Neurosciences, LLC ("Athena") for its 2013 to 2015 fiscal tax years. The April 26, 2019 NOPA carried forward the IRS's theory from its 2017 draft NOPA that when Elan took over the future funding of Athena's in-process research and development after acquiring Athena in 1996, Elan should have paid a substantially higher royalty rate for the right to exploit Athena&#8217;s intellectual property in various developmental products, including the Multiple Sclerosis drug Tysabri, rather than rates based on transfer pricing documentation prepared by Elan's external tax advisors. The April 26, 2019 NOPA proposed a payment of $843.0 million, which represented additional tax based on imputing royalty income to Athena using a 24.7% royalty rate derived by the IRS and a 40.0% accuracy-related penalty. On April 24, 2023, we received a letter from the IRS regarding the Competent Authority request filed by Athena concluding the competent authority process commenced by such submissions without the need for negotiations between the competent authorities and constitutes a full and final resolution of the April 26, 2019 NOPA. We believe that any prior uncertainty regarding the tax treatment of the Tysabri royalty is now resolved. In the second quarter of fiscal year 2023 we plan to adjust any previously established reserves related to this matter. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_88">Item 1. Note 15</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for additional information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 13, 2021, the IRS issued a 30-day letter and Revenue Agent's Report with respect to its audit of our 2013 to 2015 fiscal tax years. The 30-day letter proposed, among other modifications, to reduce Perrigo U.S.'s deductible interest expense for certain intercompany debts owed in connection with the 2013 Elan merger transaction. On May 5, 2023, we finalized an agreement with IRS Appeals providing for settlement of the May 7, 2020 NOPA. In addition, based on the agreement with IRS Appeals, we will apply similar adjustments for all remaining tax years through 2018. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_88">Item 1. Note 15</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for additional information. In the second quarter of fiscal year 2023 we plan to adjust any previously established reserves related to this matter.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Supply Chain Reinvention Program </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we initiated a Supply Chain Reinvention Program to reduce structural costs, improve profitability and our service levels to our retail partners, and strengthen our resiliency by streamlining and simplifying our global supply chain. Through this initiative, we plan to reduce portfolio complexity, invest in advanced planning capabilities, diversify sourcing, and optimize our manufacturing assets and distribution models. We have identified a total annual run-rate potential savings opportunity by the end of fiscal year 2028 of between an estimated $200 million to $300 million (not including related depreciation expense on capital investments) if all facets of the Program are successfully implemented and executed. To obtain these potential benefits, we anticipate incurring costs of between $350 million to $570 million by the end of fiscal year 2028 to complete the program implementation, including capital investments, restructuring expenses, and implementation costs. A significant portion of the annual run-rate potential savings of the Program, between $150 million to $200 million (not including related depreciation expense on capital investments), are anticipated by the end of fiscal year 2025, along with associated potential spend of between $300 million and $450 million. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_94">Item 1. Note 14</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details on restructuring charges. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We initiated the first phase of our Supply Chain Reinvention Program by announcing on November 1, 2022, a $170 million strategic investment to expand and strengthen our U.S. infant formula manufacturing. This strategic investment included the $110 million purchase of Nestl&#233;&#8217;s Gateway infant formula plant in Eau Claire, Wisconsin, along with the U.S. and Canadian rights to the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infant formula brand and other related formula brands ("Gateway"), and an additional $60 million investment into the plant to expand its capacity. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_46">Item </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_46">1</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_46">. Note 3</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further transaction details. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Overview</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Market Factors and Trends </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Infant Formula</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its efforts to prevent future </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cronobacter</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> spp. illnesses associated with powdered infant formula, in March 2023, the FDA released an "Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market" and issued a letter to the powdered infant formula industry to share information to assist the industry in improving the microbiologic safety of powdered infant formula. Out of an abundance of caution and based upon this new information, o</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n March 17, 2023 we initiated a voluntary recall of a specific infant formula brand that was manufactured at one of our U.S. facilities from January 2, 2023 to January 18, 2023. There were no sales of this impacted product in the prior year period as the brand and facility where this product was manufactured were acquired in November 2022. As a result of the FDA communications and our recall, our operations were negatively impacted during the quarter and we anticipate additional costs and lower production volumes associated with compliance with these new and evolving regulatory expectations going forward. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Economic Uncertainty</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current macroeconomic conditions remain very dynamic, including impacts from rising inflation and interest rates, volatile changes in foreign currency exchange rates, political unrest, recent developments in the global banking sector, COVID-19 and legislative and regulatory changes. Any causes of market size contraction could reduce our sales or erode our operating margin and consequently reduce our net earnings and cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest expense is impacted by the overall global economic and interest rate environment. We manage interest rate risk through our capital structure and the use of interest rate swaps to fix the interest rate on greater than 90% of our outstanding debt. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inflationary Costs and Supply Chain</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the course of 2022 and the first quarter of 2023, supply chain disruptions, including volatility in both cost and availability of agricultural, oil and paper based commodities driven by the war in Ukraine have led to higher input costs. Additionally, we experienced employment vacancies and attrition as the labor market negatively impacted productivity and drove the need for wage rate increases and other retention benefits. We implemented a series of actions to substantially mitigate these and other inflationary cost pressures such as strategic pricing and our Supply Chain Reinvention Program. Benefits from our actions have begun to substantially offset inflationary pressures, and the global freight constraints in availability of freight containers and truck drivers are starting to normalize. However, the duration and extent of inflation pressure, including impacts from the war in Ukraine, changes in labor market availability and wage rates, as well as the acceptance of any further pricing actions we may take in the markets we operate, is uncertain. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">War in Ukraine</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The invasion of Ukraine by Russia and resulting economic and political sanctions imposed by the United States, United Kingdom, European Union, and other countries on Russia, Belarus, and occupied regions in Ukraine have negatively impacted our results from operations in the region. We currently have 85 employees working in our Ukraine subsidiary. We do not have a subsidiary or employees in Russia. We have no manufacturing facilities in either Russia or Ukraine and we previously sold products into Russia entirely through distributors. In March 2022, we halted all sales to distributors in Russia and sales in Ukraine were severely depressed. For the three months ended April&#160;1, 2023, Ukraine operations accounted for approximately $3 million of net sales, $2 million of gross profit, and $1 million of operating income, and there were no sales in Russia. Future impacts are difficult to predict due to the high level of uncertainty related to the war&#8217;s duration, evolution and resolution. If the conflict spreads or materially escalates, or economic conditions deteriorate, the impact on our business and results of operations could be material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have both translation and transaction exposure to the fluctuation of exchange rates. Translation exposures relate to exchange rate impacts of measuring income statements of foreign subsidiaries that do not use the U.S. dollar as their functional currency. Transaction exposures relate to 1) the impact from input costs that are </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Overview</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">denominated in a currency other than the local reporting currency and 2) the revaluation of transaction-related working capital balances denominated in currencies other than the functional currency. Significant exchange rate fluctuations, especially in the Euro or the British Pound Sterling, have had, and could continue to have, a significant impact on our net sales, net earnings and cash flows, and have significantly impacted our historical net sales, costs and net earnings and could do so in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_112"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency Translation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Currency translation effects described below represent estimates of the net differences between translation of foreign currency transactions into U.S. dollars for the three months ended April&#160;1, 2023 at the average exchange rates for the reporting period and average exchange rates for the three months ended April&#160;2, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_115"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Financial Results</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.538%"><tr><td style="width:1.0%"></td><td style="width:58.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.782%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.491%"><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.017%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.492%"></div></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended April&#160;1, 2023 vs. Three Months Ended April&#160;2, 2022</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net sales increased $107.2 million, or 10.0%, due primarily to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">$67.6&#160;million increase, or 6.4%, due primarily to approximately $58&#160;million in strategic pricing actions in addition to higher sales volume with favorable mix across several of our product categories including Upper Respiratory due to a strong global cough, cold and flu season partially offset by declines in Nutrition excluding acquisitions; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">$89.0&#160;million increase from our acquisitions of HRA Pharma and Gateway, inclusive of a voluntary product recall within Nutrition and an unfavorable impact of $11.6 million from distributor transition sales returns as part of the integration strategy to capture synergies and a $2.6 million unfavorable effect of currency translation; partially offset by</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">$30.2 million decrease from unfavorable foreign currency translation excluding acquisitions;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">$19.1&#160;million decrease from the divestitures of the Latin American businesses and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:110%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> brand asset.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating income increased $26.8 million, or 123.5%, due primarily to: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$76.0 million increase in gross profit driven by higher gross profit flow-through resulting from positive sales pricing benefits and higher sales volume with favorable mix, as well as a $46.3 million increase from our acquisitions of HRA Pharma and Gateway inclusive of an unfavorable voluntary recall impact, distributor transition costs and unfavorable effect of currency translation; partially offset by $30.3 million of cost of goods sold inflation and increased labor costs, $15.0 million of unfavorable foreign currency translation excluding acquisitions, approximately $8 million of expense and lost gross profit flow-through from a voluntary product recall within Upper Respiratory in the first quarter of 2023, and $6.6 million related to the divestitures of the Latin American businesses and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> brand asset. Gross profit as a percentage of net sales increased 360 basis points compared to the prior year due to the same factors that drove gross profit.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$49.2 million increase in operating expenses due primarily to higher selling and administrative employee expenses and higher advertising and promotion expenses as a result of the acquisition of HRA Pharma and Gateway and related integration activities and an unfavorable effect of $10.9 million from foreign currency translation. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSUMER SELF-CARE AMERICAS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Financial Results</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.140%"><tr><td style="width:1.0%"></td><td style="width:45.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.941%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.943%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">763.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">710.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended April&#160;1, 2023 vs. Three Months Ended April&#160;2, 2022</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net sales increased $53.7 million, or 7.6%, due primarily to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">$27.6&#160;million increase, or 4.0%, due primarily to approximately $25 million of strategic pricing actions in addition to higher sales volume with favorable mix across several product categories; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">$45.2&#160;million increase from the addition of HRA Pharma and Gateway inclusive of a $0.5&#160;million unfavorable effect of currency translation and a voluntary product recall within Nutrition; partially offset by </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:14.5pt">$19.1&#160;million decrease from the divestitures of the Latin American businesses and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:110%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> brand asset and $9.5 million recall expense within Upper Respiratory during the first quarter of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:501.00pt"><tr><td style="width:1.0pt"></td><td style="width:201.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except percentages)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nutrition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vitamins, Minerals, and Supplements ("VMS")</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">763.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">710.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6%</span></td></tr></table></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(1) We updated our global reporting product categories as a result of our product portfolio reconfiguration. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CSCA</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sales drivers in each category are provided below:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:13.8pt">Upper Respiratory:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Net sales of $154.3&#160;million increased 1.0% due primarily to the launch of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Nasonex</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">24HR </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and higher net sales of allergy products. This growth was partially offset by the divested Latin American businesses, impacting growth by an unfavorable 1.8 percentage points, a voluntary OTC product recall and prolonged and elevated incidence of cough/cold and flu over the past year which led to lower inventory levels and the inability to meet current consumer demand for liquid cough/cold products;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Nutrition:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $139.9&#160;million increased 10.0% due primarily to the Gateway acquisition, despite an unfavorable impact due to a voluntary recall, and strong growth in the contract infant formula business. This growth was partially offset by lower net sales in the legacy Nutrition</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business as the Company benefited from a major national brand infant formula recall in the prior year;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Digestive Health:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $124.2&#160;million increased 4.7% due primarily to increased manufacturing capacity and demand for </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polyethylene Glycol 3350, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solid growth in the antacids business and new products, including </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Omeprazole Cool Mint, Omeprazole Mini Capsules and Polyethylene Glycol 3350 Orange</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Growth in this category was partially offset by an unfavorable 1.8 percentage points from the divested Latin American businesses;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Pain and Sleep-aids: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of $103.5&#160;million increased 0.6% due primarily to strong demand for children's analgesics products resulting from a relatively stronger cough/cold and flu season, partially offset by an unfavorable impact of 5.2 percentage points from the divested Latin American businesses;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Oral Care:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $84.4&#160;million increased 19.9% due primarily to the normalization of supply chain disruptions that impacted net sales in the prior year and strong consumer demand for oral care products, including both store brand offerings and brands such as </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plackers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Firefly</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">REACH</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Healthy Lifestyle: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of $73.4&#160;million increased 8.6% due primarily to increased distribution of store brand smoking cessation products; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Skin Care:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $52.3&#160;million increased 27.9% due primarily to the addition of HRA Pharma brands, including </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mederma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compeed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and higher net sales of minoxidil-based products stemming from increased manufacturing capacity, partially offset by the unfavorable impact of 6.1 percentage points from the divested Latin American businesses and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand asset;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Women's Health:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $11.9&#160;million increased 45.1% due primarily to the addition of HRA Pharma brands, including </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ella</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">VMS and Other:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $19.8&#160;million decreased 7.5% due primarily to the unfavorable impact of 29.0 percentage points from the divested Latin American businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating income increased $4.7 million, or 6.0%, due primarily to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$38.3 million increase in gross profit due primarily to strategic pricing actions, the addition of HRA Pharma and Gateway, and favorable product mix; partially offset by cost of goods sold inflation, the divestitures of the Latin American businesses and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> brand asset and two voluntary product recalls. Gross profit as a percentage of net sales increased 330 basis points compared to the prior year due to the same factors that drove gross profit. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$33.6&#160;million increase in operating expenses due primarily to the addition of HRA Pharma and Gateway as well as higher selling costs on branded business and administration costs, partially offset by the absence of the divested Latin American businesses and gain on the sale of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> asset brand in the prior year.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_121"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSUMER SELF-CARE INTERNATIONAL </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Financial Results</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CSCI</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.479%"><tr><td style="width:1.0%"></td><td style="width:47.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended April&#160;1, 2023 vs. Three Months Ended April&#160;2, 2022</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net sales increased $53.6 million, or 14.7%, due primarily to: </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$40.0&#160;million, or 11.0%, net increase due primarily to approximately $32 million of strategic pricing actions and higher volume sales across several CSCI product categories including Upper Respiratory due to a strong global cough, cold and flu season; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$45.9&#160;million increase from the addition of HRA Pharma inclusive of an unfavorable impact of $11.6 million from distributor transition sales returns as part of the integration strategy to capture synergies and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$2.1&#160;million unfavorable effect of currency translation; partially offset by</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$30.2&#160;million decrease from unfavorable foreign currency translation excluding acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:492.75pt"><tr><td style="width:1.0pt"></td><td style="width:193.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except percentages)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VMS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCI</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(1) We updated our global reporting product categories as a result of our product portfolio reconfiguration. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sales in each category were driven primarily by:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Upper Respiratory: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of $84.8&#160;million increased 27.5%, inclusive of an 8.4% unfavorable effect of currency translation, due primarily to strong demand for cough/cold products, including </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bronchostop </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coldrex, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stemming from a relatively stronger cough/cold and flu season. Net sales of the U.K. allergy brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beconase</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were also higher compared to the prior year period;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Skin Care:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $83.4&#160;million increased 12.9%, inclusive of a 13.2% unfavorable effect of currency translation, driven primarily by the addition of HRA Pharma brands, including </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compeed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, partially offset by the reclassification of anti-parasite offerings from the Skin Care category to the Healthy Lifestyle Category;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Healthy Lifestyle:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $66.4&#160;million increased 12.7%, inclusive of a 4.6% unfavorable effect of currency translation, due primarily to the reclassification of anti-parasite offerings from Skin Care to the Healthy Lifestyle category and higher net sales of anti-parasite offerings that continue to outpace strong category growth, partially offset by lower category consumption in weight management impacting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">XLS Medical;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CSCI</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Pain &amp; Sleep-Aids:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $49.9&#160;million decreased 7.6%, due primarily to a 7.8% unfavorable effect of currency translation and lower sales of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nytol</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to timing of shipments to customers, partially offset by higher demand for </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Solpadeine,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an analgesic product; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">VMS:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $47.8&#160;million decreased 3.4%, due primarily to a 4.8% unfavorable effect of currency translation, partially offset by improved sales of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davitamon</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Benelux stemming from higher promotions and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abtei</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Germany;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Women's Health:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $29.1&#160;million increased 112.4%, inclusive of a 13.1% unfavorable effect of currency translation, due primarily to the addition of HRA Pharma brands, including </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ellaOne</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NorLevo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">Oral Care</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Net sales of $29.1&#160;million increased 0.7%, inclusive of a 6.2% unfavorable effect of currency translation, due primarily to new products and market share gains;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Digestive Health and Other:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net sales of $27.6&#160;million increased 44.5%, inclusive of a 20.4% unfavorable effect of currency translation, due primarily to the addition of the HRA Pharma Rare Diseases portfolio in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> category.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating income increased $5.1 million, or 31.5%, due primarily to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$37.7&#160;million increase in gross profit due primarily to higher gross profit flow-through resulting from positive sales pricing benefits and the addition of HRA Pharma, partially offset by $17.2 million of unfavorable foreign currency translation and $9.0 million distributor transition sales returns. Gross profit as a percentage of net sales increased 330 basis points due primarily to the same factors that drove gross profit; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$32.6 million increase in operating expenses due primarily to higher selling and administrative employee expenses and higher advertising and promotion investments as a result of the integration of HRA Pharma, partially offset by a $9.8 million decrease from foreign currency translation.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_124"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unallocated Expenses</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unallocated expenses are comprised of certain corporate services not allocated to our reporting segments and are recorded in Operating income on the Consolidated Statements of Operations. Unallocated expenses were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:153.75pt"><tr><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The decrease of $17.0&#160;million in unallocated expenses during the three months ended April&#160;1, 2023 compared to the prior year period was due primarily to a decrease in acquisition expenses associated with HRA Pharma and certain unallocated restructuring expenses.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_127"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:232%">Interest expense, net, and Other (income) expense, net</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:321.75pt"><tr><td style="width:1.0pt"></td><td style="width:166.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $7.9&#160;million increase in Interest Expense, net during the three months ended April&#160;1, 2023, compared to the prior year period was due primarily to an increase in outstanding borrowings under our New Senior Secured Credit Facilities (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_73">Item 1. Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The $1.6 million increase in expense in Other (Income) Expense, net during the three months ended April&#160;1, 2023 compared to the prior year period was due primarily to the absence of a prior year favorable pension plan matter and current year foreign currency and hedging expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_130"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unallocated, Interest, Other, and Taxes</span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes (Consolidated) </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates were as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:153.75pt"><tr><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate on the pre-tax income for the three months ended April&#160;1, 2023, increased compared to the effective tax rate on the pre-tax loss for the three months ended April&#160;2, 2022, primarily due to the tax benefit of the loss on sale of our Latin American businesses recognized in the three months ended April&#160;2, 2022, offset by changes in the jurisdictional mix of earnings in the three months ended April&#160;1, 2023. The effective tax rate for this period differs from the statutory income tax rate of 12.5% primarily due to non-deductible expenses, as well as changes in our reserves for unrecognized tax benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_133"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We finance our operations with internally generated funds, supplemented by credit arrangements with third parties and capital market financing. We routinely monitor current and expected operational requirements and financial market conditions to evaluate other available financing sources including term and revolving bank credit and securities offerings. In determining our future capital requirements, we regularly consider, among other factors, known trends and uncertainties, such as tax disputes, the COVID-19 pandemic, the war in Ukraine, inflation and interest rates and other contingencies. We note that no payment of the additional amounts proposed by the IRS in our ongoing tax matters is currently required, and no such payment is expected to be required, unless and until a settlement or other final determination of the matter is reached that is adverse to us (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_88">Item 1. Note 15</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for additional information on ongoing tax matters). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Based on the foregoing, management believes that our operations and borrowing resources are sufficient to provide for our short-term and long-term capital requirements, as described below. However, an adverse result with respect to our appeal of any material outstanding tax assessments or litigation, including securities or drug pricing matters and product liability cases, damages resulting from third-party claims, and related interest and/or penalties, could ultimately require the use of corporate assets to pay such assessments and any such use of corporate assets would limit the assets available for other corporate purposes. As such, we continue to evaluate the impact of the above factors on liquidity and may determine that modifications to our capital structure are appropriate if market conditions deteriorate, favorable capital market opportunities become available, or any change in conditions relating to the COVID-19 pandemic, the war in Ukraine, inflation and interest rates or other contingencies have a material impact on our capital requirements. </span></div><div><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_136"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.637%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.391%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Working capital</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,139.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Working capital represents current assets less current liabilities, excluding cash and cash equivalents and excluding current indebtedness. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, cash flows from operations, and borrowings available under our credit facilities are expected to be sufficient to finance our liquidity and capital expenditures in both the short and long term. Although our lenders have made commitments to make funds available to us in a timely fashion under our revolving credit agreements and overdraft facilities, if economic conditions worsen or new information becomes publicly available impacting the institutions&#8217; credit rating or capital ratios, these lenders may be unable or unwilling to lend money pursuant to our existing credit facilities. Should our outlook on liquidity requirements change substantially from current projections, we may seek additional sources of liquidity in the future.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_139"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table includes summarized cash flow activities:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.391%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from (for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash from (for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash from (for) Operating Activities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $59.7 million decrease in operating cash flow was primarily driven by higher working capital, primarily related to increased sales versus the prior year and related to timing of sales and receipt of payments and higher inventory related to distributor transitions as part of the HRA Pharma integration strategy. This was partially offset by an increase in cash flow from the change in net earnings after adjustments for items including accrued income taxes and depreciation and amortization.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_142"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash from (for) Investing Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $82.3 million decrease in investing cash flow was due to the absence of proceeds that we had in the prior year from the sale of our Latin American businesses, an ANDA for a generic topical lotion related to our RX business sale, and from the sale of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand asset.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_145"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash from (for) Financing Activities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.2 million increase in financing cash flow was due primarily to installment and working capital proceeds in the current year from the sale of our Latin American businesses, partially offset by payments on our New Senior Secured Credit Facilities and an increase in dividend payments compared to the prior year.</span></div><div><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_148"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Borrowings and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 20, 2022, we entered into two new term loans consisting of (i) a $500&#160;million five-year term loan (the "2022 Term Loan A Facility"), and (ii) a $1.1 billion seven-year loan (the "2022 Term Loan B Facility" and, together with the 2022 Term Loan A Facility, the "2022 Term Loan Facilities"). Refer to Item I Note 11 for further information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of April&#160;1, 2023 and December&#160;31, 2022, we ha</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">d $1,582.4 million and $1,588.3 million outstanding under the 2022 Term Loan Facilities, respectively. Our short term debt as of April&#160;1, 2023 of $36.2 million is comprised of (i) principal payments of the 2022 Term Loan Facilities and (ii) leases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The interest rate net of derivatives results in a fixed rate on a substantial portion of our long-term debt, the earliest of which matures in 2024. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 20, 2022, we and our wholly owned subsidiary, Perrigo Investments, LLC, entered into a $1.0 billion five-year revolving credit facility (the "2022 Revolver") as part of its New Senior Secured Credit Facilities (as defined in  </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_73">Item 1. </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_73">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">). There were no borrowings outstanding under the 2022 Revolver as of April&#160;1, 2023 or December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in compliance with all the covenants under our debt agreements as of April&#160;1, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Financing </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have overdraft facilities available that we may use to support our cash management operations. There were no borrowings outstanding under the overdraft facilities as of April&#160;1, 2023 or December&#160;31, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $232.7 million and $238.6 million of lease liabilities and $232.7 million and $239.1 million of lease assets as of April&#160;1, 2023 and December&#160;31, 2022, respectively.</span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_1704"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span id="iff57b115e0e04eea859ac6149beff84a_882"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Ratings</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit ratings on April&#160;1, 2023 were Ba2 (negative), BB (stable), and BB+ (stable), by Moody's Investor Services, S&amp;P Global Ratings, and Fitch Ratings Inc., respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest of the 3.150% Senior Notes due 2030 stepped up from 3.900% to 4.400% on payments made after June 15, 2022 due to a credit ratings downgrade by Moody&#8217;s Investor Services in the first quarter of 2022. On March 15, 2023, Moody's downgraded our Corporate Family Rating to Ba2 from Ba1 and senior unsecured notes ratings to Ba3 from Ba2 and the rating outlooks remained negative. Due to the downgrade, the interest of the 3.150% Senior Notes due 2030 will be stepped up from 4.400% to 4.650% on payments made after June 15, 2023. Future interest rate adjustments are subject to a 2.0% total cap above the original 3.150% interest rate based on certain rating events as specified in the Note&#8217;s Supplemental Indenture No. 3, dated as of June 19, 2020, among Perrigo Finance Unlimited Company, Perrigo Company plc and Wells Fargo Bank, National Association, as trustee.</span></div><div><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_151"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantor Financial Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As detailed in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_73">Item 1. Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our Guarantor Subsidiaries and the Borrower under the New Senior Secured Credit Facilities provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 5.300% Notes due 2043 issued by the Company, and the Loan Parties provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 3.900% Notes due 2024, the 4.375% Notes due 2026, the 4.400% Notes due 2030 and the 4.900% Notes due 2044 issued by Perrigo Finance Unlimited Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guarantees of the Guarantor Subsidiaries, the Company and the Borrower are subject to release in limited circumstances only upon the occurrence of certain customary conditions. The guarantees of the Guarantor Subsidiaries, the Company and the Borrower rank senior in right of payment to any future subordinated indebtedness of the Company, equal in right of payment with all of the Company&#8217;s existing and future senior indebtedness and effectively subordinated to any of the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the collateral securing such indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Basis of Presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables include summarized financial information of the obligor groups of debt issued by Perrigo Finance Unlimited Company and Perrigo Company plc. The summarized financial information of each obligor group is presented on a combined basis with balances and transactions within the obligor group eliminated. Investments in and the equity in earnings of non-guarantor subsidiaries, which would otherwise be consolidated in accordance with U.S. GAAP, are excluded from the below summarized financial information pursuant to SEC Regulation S-X Rule 13-01.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized balance sheet information for the consolidated obligor group of debt issued by Perrigo Finance Unlimited Company and Perrigo Company plc is presented in the table below:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,908.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,735.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,819.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,017.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,036.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due to non-guarantors</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,329.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,346.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 2</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Condition, Liquidity and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized results of operations information for the consolidated obligor group of debt issued by Perrigo Finance Unlimited Company and Perrigo Company plc is presented in the table below:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">840.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross Profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue from non-guarantors</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense to non-guarantors</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_154"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no off-balance sheet arrangements that have a material current effect or that are reasonably likely to have a material future effect on our financial condition, changes in financial condition, net sales or expenses, results of operations, liquidity, capital expenditures, or capital resources. </span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_157"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material changes in contractual obligations as of April&#160;1, 2023 from those provided in our 2022 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_160"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the significant accounting policies as disclosed in our 2022 Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of certain amounts in our financial statements requires the use of estimates. These estimates are based upon our historical experiences combined with management&#8217;s understanding of current facts and circumstances. Although the estimates are considered reasonable based on the currently available information, actual results could differ from the estimates we have used. There have been no material changes to the critical accounting estimates as disclosed in our 2022 Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_163"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK </span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our quantitative or qualitative disclosures found in Item 7A,&#160;"Quantitative and Qualitative Disclosures about Market Risk," of our 2022 Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_166"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act) as of April&#160;1, 2023. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in ensuring that all material information relating to us and our consolidated subsidiaries required to be included in our periodic SEC filings would be made known to them by others within those entities in a timely manner and that no changes are required at this time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of the Effectiveness of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management assessed the effectiveness of our internal control over financial reporting as of April&#160;1, 2023. The framework used in carrying out our evaluation was the 2013 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#160;- Integrated Framework</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> published by the Committee of Sponsoring Organizations ("COSO") of the Treadway Commission. In evaluating our information </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 4</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology controls, we also used components of the framework contained in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Control Objectives for Information and related Technology</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was developed by the Information Systems Audit and Control Association&#8217;s IT Governance Institute, as a complement to the COSO internal control framework. Management has concluded that our internal control over financial reporting was effective as of April&#160;1, 2023. The results of management&#8217;s assessment have been reviewed with our Audit Committee.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting during the three months ended April&#160;1, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_169"></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. &#160;&#160;&#160;&#160;OTHER INFORMATION </span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_172"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS </span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_88">Item 1. Note 15</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i391fab8b65b648d5a5c27f0c2d5892b5_91">Item 1. Note 16</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to the Condensed Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_175"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Annual Report on Form 10-K for the year ended December&#160;31, 2022 includes a detailed discussion of our risk factors. At the time of this filing, there have been no material changes to the risk factors that were included in the Form 10-K, other than the risk factor as described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We operate in highly regulated industries, and any inability to timely meet current or future regulatory requirements could have a material adverse effect on our business and operating results.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We operate in highly regulated industries in numerous countries and are subject to the regulations of a variety of U.S. and non-U.S. agencies related to the manufacturing, processing, formulation, packaging, labeling, testing, storing, distribution, import, export, advertising, and sale (including cost, pricing and reimbursement) of our products, as described in detail in Item 1. of our Annual Report on Form 10-K for the year ended December 31, 2022. Changes in laws, regulations, and practices in the countries in which we operate, which may be impacted by political pressure and other factors outside of our control, may be difficult or expensive for us to comply with, could restrict or delay our ability to manufacture, distribute, sell or market our products, and may adversely affect our revenue, operating results, and financial condition or impose significant administrative burdens. Moreover, changes in the interpretation of existing regulations or practices by such regulators could result in changes in the legal requirements affecting us (including with retroactive effect). Divergence in regulatory approach from country to country, and between the EU and individual member states, adds cost and complexity to the compliance framework; and differences in requirements and/or implementation dates in different jurisdictions may provide competitive advantages to manufacturers that operate in other locations. If our products fail to meet regulatory requirements, our sales may be adversely affected, we may incur fines and penalties, and our exposure to liability relating to product-based claims may increase. Below are some examples of ways in which regulatory risk may impact us: </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 14, 2021, the European Commission adopted a set of proposals to ensure polices are aligned with the goal of reducing net greenhouse gas emissions by at least 55% by 2030 (the "EU Green Deal"). There is a growing focus on environmental impact of self-care products, their ingredients, components, packaging, manufacturing, and disposal. This focus could lead to new requirements and restrictions in the coming years across all product categories.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We must obtain approval from the appropriate regulatory agencies in order to manufacture and sell our products in the regions in which we operate. Obtaining this approval can be time consuming and costly. When we submit an application for market authorization, there can be no assurance that the regulator will approve that application on a timely basis or at all. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. law encourages generic competition by providing eligibility for first generic marketing exclusivity if certain conditions are met. If we are granted generic exclusivity, the exclusivity may be shared with other companies; or we may forfeit 180-day exclusivity if we fail to obtain regulatory approval and begin marketing within the statutory requirements. If we are not the first to file our ANDA, the FDA may grant 180-day </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 1A</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exclusivity to another company, thereby effectively delaying the launch of our product and/or possibly reducing our market share.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. and global regulatory agencies regularly inspect our manufacturing facilities and the facilities of our third-party suppliers for good manufacturing practices ("GMP") and other regulatory compliance. The failure of one of these facilities to comply with applicable laws and regulations may lead to a breach of representations made to our customers, or to regulatory or government action against us related to the products made in that facility, including suspension of or delay in regulatory approvals and product seizure, injunction, recall, suspension of production or distribution of our products, a total or partial shutdown of production in one or more facilities, loss of licenses or other governmental penalties, or civil or criminal prosecution, which could result in increased cost, lost revenue, or reputational damage.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. and global regulatory agencies regularly inspect our manufacturing facilities and the facilities of our third-party suppliers for GMP and other regulatory compliance. The failure of one of these facilities to comply with applicable laws and regulations may lead to a breach of representations made to our customers, or to regulatory or government action against us related to the products made in that facility, including suspension of or delay in regulatory approvals and product seizure, injunction, recall, suspension of production or distribution of our products, loss of licenses or other governmental penalties, or civil or criminal prosecution, which could result in increased cost, lost revenue, or reputational damage. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In 2020, regulatory agencies globally, including the FDA and the European Medicines Agency, issued guidance on assessing and controlling nitrosamine impurities in medicine products. We are continuing to undertake a review of our product portfolio in accordance with regulatory guidance to assess the risk of the presence of nitrosamine impurities. Any finding of nitrosamine impurities exceeding levels set by regulatory authorities may require us to adopt modified product sourcing and/or manufacturing processes or to initiate product withdrawal. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rx-to-OTC switches are part of our future growth. If regulatory agencies fail to approve Rx-to-OTC switches in new product categories or reassess the terms of existing OTC classifications, our growth prospects and product mix would be impaired. Further, regulatory agencies may reassess the terms of OTC classification if they perceive a shift in the previously assessed benefit/risk profile. Any such reassessment could lead to OTC products reverting to prescription. For example, as described in Item 1. of our Annual Report on Form 10-K for the year ended December 31, 2022, Irish regulators are undertaking a formal review of non-prescription codeine products, which could result in the reclassification of codeine to prescription only after a brief transition period. A final opinion is expected by the end of the third quarter of 2023. Sales of products containing codeine in Ireland were approximately $8 million in 2022. Moreover, a reclassification by Ireland could lead to reviews in other jurisdictions as well.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our infant formula products may be subject to barriers or sanctions imposed by countries or international organizations limiting international trade and dictating the content of such products. If governments enhance regulations on the infant formula industry by, for example, requiring additional testing or compulsory batch-by-batch inspection, or impose additional requirements on manufacturing practices, our sales and operating margins in this category could be adversely affected as it is costly to comply with such new regulations or requirements, and to develop compliant products and processes for our infant formula products.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The regulation of List I chemicals complicate our supply chain, and adverse regulatory actions may result in temporary or permanent interruption of distribution of our products, withdrawal of our products from the market, or other penalties. If we are unable to obtain necessary quotas for List I chemicals, we risk having delayed product launches or failing to meet commercial supply obligations.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Very recently the European Parliament voted of a proposal to extend the EU's Medical Device Regulation ("MDR") transition periods until 2027-2028, together with an extended validity of existing medical device certificates and the possibility to sell off existing medical device products until end of shelf-life. With this decision the European Parliament took into account that there is currently a shortage in the number of Notified Bodies authorized to carry out conformity assessments required under MDR.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased scrutiny of product classifications by government agencies can result in investigations and prosecutions, which carry the risk of significant civil and criminal penalties, including but not limited to, debarment from government business and prohibition to continue the business. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_178"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perrigo Company plc</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Item 6</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000119312513478578/d642570dex41.htm">Certificate of Incorporation of Perrigo Company plc (formerly known as Perrigo Company Limited) (incorporated by reference from Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-8 filed on December 19, 2013).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1585364/000158536417000136/cy17q210qex32memo.htm">Memorandum and Articles of Association of Perrigo Company plc, as amended and restated (incorporated by reference from Exhibit 3.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 10, 2017).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="ex101-perrigox2019aipamend.htm">Amendment No. 1 to Annual Incentive Plan (filed herewith).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="ex102-2023psusoigrantagree.htm">Forms of OI Performance-Based Restricted Stock Unit Award Agreement (filed herewith).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="ex103-2023psusrtsrgrantagr.htm">Forms of rTSR Performance-Based Restricted Stock Unit Award Agreement (filed herewith).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="ex104-2023rsusgrantagreeme.htm">Forms of Service-based Restricted Stock Unit Award Agreement (filed herewith).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="ex105-2023psusoipsurtsrand.htm">Forms of Performance-Based and Service-Based Restricted Stock Unit Award Agreements for Murray Kessler (filed herewith).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="cy23q110qex22.htm">List of Guarantor Subsidiaries</a></span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> (filed herewith).</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="cy23q110qex311.htm">Rule 13a-14(a) Certification by Murray S. Kessler, Chief Executive Officer (filed herewith).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="cy23q110qex312.htm">Rule 13a-14(a) Certification by E</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="cy23q110qex312.htm">duardo Bezerra</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="cy23q110qex312.htm">, Chief Financial Officer (filed herewith).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="cy23q110qex32.htm">Certification Pursuant to 18 United States Code 1350 and Rule 13a-14(b) of the Securities Exchange Act of 1934 (furnished herewith).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101. INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Date File, formatted in Inline XBRL (contained in Exhibit 101).</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i391fab8b65b648d5a5c27f0c2d5892b5_181"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PERRIGO COMPANY PLC</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 9, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Murray S. Kessler</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Murray S. Kessler</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer and President</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 9, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Eduardo Bezerra</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eduardo Bezerra</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Accounting and Financial Officer)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101-perrigox2019aipamend.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i76da29058a2940ceb155216eefdf6313_1"></div><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:178.17pt;padding-right:178.17pt;text-align:center"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">AMENDMENT NO. 1 TO THE </font></div><div style="margin-top:3.95pt;padding-left:178.17pt;padding-right:178.17pt;text-align:center"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">PERRIGO COMPANY PLC </font></div><div style="margin-top:0.5pt;padding-left:36.57pt;padding-right:36.57pt;text-align:center"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;text-decoration:underline">ANNUAL INCENTIVE PLAN </font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6.1pt;padding-right:6.5pt;text-align:justify;text-indent:36.4pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">WHEREAS, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Perrigo Company plc (the &#8220;</font><font style="color:#565659;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Company&#8221;) </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">sponsors the Perrigo Company PLC Annual Incentive Plan, As Amended and Restated February 13, 2019 (the &#34;Plan&#34;)&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.65pt;padding-right:5.8pt;text-align:justify;text-indent:36.6pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">WHEREAS, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">the Company desires to amend the Plan to change the eligibility requirement for payment of an Incentive Bonus.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.65pt;padding-right:5.8pt;text-align:justify;text-indent:36.3pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">NOW, THEREFORE, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">by virtue and in exercise of the amending authority reserved by the Plan sponsor pursuant to Section 13ba) of the Plan, amended and restated February 13, 2019, Section 6 is hereby amended to read as follows&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Termination of Employment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Unless determined otherwise by the Committee, if a Participant&#8217;s employment with the Company and its Affiliates terminates during the Performance Period due to Retirement, death, or Disability, the Participant shall be entitled to receive a pro rata portion of the Incentive Bonus for such Performance Period in an amount equal to the Incentive Bonus the Participant would have received had he or she remained employed until the end of the Performance Period and the Incentive Bonus payment date, based on actual performance for such Performance Period and pro-rated based on the number of days in the Performance Period prior to the Participant&#8217;s termination of employment.  Unless the Committee determines otherwise, if a Participant&#8217;s employment terminates prior to the Incentive Bonus payment date for any other reason, no Incentive Bonus will be payable to such Participant with respect to such Performance Period. </font></div><div style="padding-left:18.27pt;padding-right:18.27pt;text-align:center"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-top:11.7pt;padding-left:5.4pt;padding-right:4.95pt;text-indent:36.5pt"><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:174%">IN WITNESS WHEREOF, </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Perrigo Company plc has caused this Amendment No. 1 to be executed by its duly authorized officer this 7th day of February 2023.</font></div><div style="margin-top:11.7pt;padding-left:5.4pt;padding-right:4.95pt;text-indent:36.5pt"><font><br></font></div><div style="margin-top:11.7pt;padding-left:5.4pt;padding-right:4.95pt;text-indent:36.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PERRIGO COMPANY PLC</font></div><div style="padding-left:5.75pt;padding-right:5.05pt;text-indent:36.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">   &#47;s&#47; Kyle L.  Hanson&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:5.75pt;padding-right:5.05pt;text-indent:36.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Kyle L. Hanson</font></div><div style="margin-top:11.7pt;padding-left:5.4pt;padding-right:4.95pt;text-indent:36.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">EVP, General Counsel and Secretary </font></div><div style="margin-top:11.7pt;padding-left:5.4pt;padding-right:4.95pt;text-indent:36.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex102-2023psusoigrantagree.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3569fc85bbb94b1eb42a4efdc41a531e_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERRIGO COMPANY PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(PERFORMANCE-BASED)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Under the Perrigo Company plc 2019 Long-Term Incentive Plan)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant Name</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RE&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Restricted Stock Unit Award (Performance-Based)</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This is to notify you that Perrigo Company plc (the &#8220;Company&#8221;) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the &#8220;Plan&#8221;), effective as of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grant Date </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#8220;Grant Date&#8221;).  This Award consists of performance-based restricted stock units.  The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (&#8220;Appendix&#8221;) (collectively, the &#8220;Agreement&#8221;).  The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Units &#8211; Performance-Based Vesting</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As of the Grant Date, and subject to the terms and conditions of this Agreement and the Plan, the Company grants to you </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Number of Awards Granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> performance-based restricted stock units (&#8220;PSUs&#8221;).  The number of PSUs awarded in this Section 1.1 is referred to as the &#8220;Target Award.&#8221;  The Target Award may be increased or decreased depending on the level of attainment of Performance Goals for designated Performance Measures as described in Section 1.2.  Each PSU shall entitle you to one ordinary share of the Company, nominal value &#8364;0.001 per share (&#8220;Ordinary Share&#8221;) on the PSU Vesting Date set forth in Section 1.2, provided the applicable Performance Goals for each Performance Measure are satisfied.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The number of PSUs awarded in Section 1.1 vesting, if any, shall be determined as of the PSU Vesting Date.  That number will be determined based on the average level of attainment of annual Performance Measure(s) for each fiscal year in the Performance Period, in accordance with the schedule determined by the Committee at the time the Performance Measures and applicable Performance Goals are established by the Committee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Committee shall establish annually one or more Performance Measures and the Performance Goals with respect to each Performance Measure that must be attained for Threshold, Target and Maximum performance for a fiscal year.  The Performance Measure and Performance Goals for each fiscal year will be provided to you.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Following the end of each fiscal year in the Performance Period, the Committee will determine the percentage of Target Award PSUs that would be payable for such fiscal year, based on the attainment of the Performance Goals for each Performance Measure(s) established by the Committee for that fiscal year.  The percentage of the Target Award that would be payable under the schedule shall be adjusted, pro rata, to reflect the attained performance between Threshold and Target, and Target and Maximum.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At the end of the Performance Period, the percentage payout for each fiscal year in the Performance Period will be averaged to determine the actual percentage of Target Award PSUs that will vest and be payable on the PSU Vesting Date.  In no event will the calculation of a positive payout percentage for any fiscal year be construed to guarantee that any PSUs will vest on the PSU Vesting Date.  Payout percentages for the individual fiscal years are determined </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">solely for purposes of determining the average annual payout percentage for the three-year Performance Period.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as provided in Section 1.4, the PSUs will be permanently forfeited if your Termination Date occurs prior to the PSU Vesting Date.  If the average annual performance payout for the Performance Period is less than the Threshold performance level established by the Committee, all PSUs that have not previously been forfeited shall be forfeited as of the PSU Vesting Date.  If the average annual performance payout for the Performance Period exceeds the Maximum performance level established by the Committee, in no event will the number of PSUs vesting exceed 200% of the Target Award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following terms shall have the following meanings under this Section 1.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;&#8220;Performance Goal&#8221; means the level of performance that must be attained with respect to a Performance Measure for a fiscal year for Minimum, Target and Maximum payout.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#8220;Performance Measure&#8221; for any fiscal year means one or more financial measures, as determined by the Committee.  The Committee shall provide how the Performance Measure will be adjusted, if at all, as a result of extraordinary events or circumstances, as determined by the Committee, or to exclude the effects of extraordinary, unusual, or non-recurring items&#59; changes in applicable laws, regulations, or accounting principles&#59; currency fluctuations&#59; discontinued operations&#59; non-cash items, such as amortization, depreciation, or reserves&#59; asset impairment&#59; or any recapitalization, restructuring, reorganization, merger, acquisition, divestiture, consolidation, spin-off, split-up, combination, liquidation, dissolution, sale of assets, or other similar corporation transaction.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#8220;Performance Period&#8221; means a period of three consecutive fiscal years of the Company, beginning with the first day of the fiscal year of the Company in which the Grant Date occurs and ending on the last day of the third fiscal year in the 3-year period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;&#8220;PSU Vesting Date&#8221; means the last day of the Performance Period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;&#8220;Separation for Good Reason&#8221; means your voluntary resignation from the Company and the existence of one or more of the following conditions that arose without your consent&#58; (i) a material change in the geographic location at which you are required to perform services, such that your commute between home and your primary job site increases by more than 30 miles,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or (ii) a material diminution in your authority, duties or responsibilities or a material diminution in your base compensation or incentive compensation opportunities&#59; provided, however, that a voluntary resignation from the Company shall not be considered a Separation for Good Reason unless you provide the Company with notice, in writing, of your voluntary resignation and the existence of the condition(s) giving rise to the separation within 90 days of its initial existence.  The Company will then have 30 days to remedy the condition, in which case you will not be deemed to have incurred a Separation for Good Reason.  In the event the Company fails to cure the condition within the 30 day period, your Termination Date shall occur on the 31st day following the Company&#8217;s receipt of such written notice.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;&#8220;Termination without Cause&#8221; means the involuntary termination of your employment or contractual relationship by the Company without Cause, including, but not limited to, (i) a termination effective when you exhaust a leave of absence during, or at the end of, a notice period under the Worker Adjustment and Retraining Notification Act (&#8220;WARN&#8221;), and (ii) a situation where you are on an approved leave of absence during which your position is protected under applicable law (e.g., a leave under the Family Medical Leave Act), you return </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">from such leave, and you cannot be placed in employment or other form of contractual relationship with the Company.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Vesting Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding Section 1.2 above, if your Termination Date occurs by reason of a Termination without Cause or a Separation for Good Reason on or after a Change in Control (as defined in the Plan and as such definition may be amended hereafter) and prior to the two (2) year anniversary of the Change in Control, all of the PSUs awarded under Section 1.1 that have not previously been forfeited shall become fully vested as if Target performance had been obtained for the Performance Period effective as of your Termination Date.  If your Termination Date occurs because of death, Disability, or Retirement, the PSUs shall vest or be forfeited as of the PSU Vesting Date set forth in Section 1.2, based on the attainment of the performance goals.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If your Termination Date occurs in the 24-month period preceding the PSU Vesting Date because of an Involuntary Termination for Economic Reasons, all of the PSUs awarded hereunder shall vest or be forfeited as of the date set forth in Section 1.2, depending on the attainment of Performance Goals&#59; provided, however, that if your Termination Date occurs for a reason that is both described in this sentence and in the first sentence of this Section 1.4, the special vesting rules described in the first sentence of this Section 1.4 shall apply in lieu of the vesting rules described in this sentence.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as practicable following the date of the Committee&#8217;s first regularly scheduled meeting following the last day of the Performance Period at which the Committee certifies the average payout for each of the three years in the Performance Period (or, if earlier, the date on which the PSUs become vested pursuant to the special vesting rules described in Section 1.4), the Company shall transfer to you one Ordinary Share for each PSU, if any, that becomes vested pursuant to Section 1.2 or 1.4 of this Agreement (the date of any such transfer shall be the &#8220;settlement date&#8221; for purposes of this Agreement)&#59; provided, however, the Company in its discretion may settle PSUs in cash, based on the fair market value of the shares on the vesting date.  No fractional shares shall be transferred.  Any fractional share shall be rounded to the nearest whole share.  The income attributable to the vesting of PSUs and the amount of any required tax withholding will be determined based on the value of the shares on the settlement date.  PSUs are not eligible for dividend equivalents.  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">General Terms and Conditions</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nontransferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award under this Agreement shall not be transferable other than by will or by the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You shall not have any rights as a stockholder with respect to any Ordinary Shares subject to the PSU awarded under this Agreement prior to the date of issuance to you of a certificate or certificates for such shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If your Termination Date occurs for reasons of Cause, all of your rights under this Agreement, whether or not vested, shall terminate immediately.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The granting of the Award under this Agreement is being made pursuant to the Plan and the Award shall be payable only in accordance with the applicable terms of the Plan.  The Plan contains certain definitions, restrictions, limitations and other terms and conditions all of which shall be applicable to this Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ALL THE PROVISIONS OF THE PLAN ARE INCORPORATED HEREIN BY REFERENCE AND ARE MADE A PART OF THIS AGREEMENT IN THE SAME MANNER AS IF EACH AND EVERY SUCH PROVISION WERE FULLY WRITTEN INTO THIS AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Should the Plan become void or unenforceable by operation of law or judicial decision, this Agreement shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">have no force or effect.  Nothing set forth in this Agreement is intended, nor shall any of its provisions be construed, to limit or exclude any definition, restriction, limitation or other term or condition of the Plan as is relevant to this Agreement and as may be specifically applied to it by the Committee.  In the event of a conflict in the provisions of this Agreement and the Plan, as a rule of construction the terms of the Plan shall be deemed superior and apply.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments in Event of Change in Ordinary Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of a stock split, stock dividend, recapitalization, reclassification or combination of shares, merger, sale of assets or similar event, the number and kind of shares subject to Award under this Agreement will be appropriately adjusted in an equitable manner to prevent dilution or enlargement of the rights granted to or available for you.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and you agree that the PSUs are granted under and governed by the Notice of Grant, this Agreement (including the Appendix, if applicable) and by the provisions of the Plan (incorporated herein by reference).  You&#58; (i) acknowledge receipt of a copy of each of the foregoing documents, (ii) represent that you have carefully read and are familiar with their provisions, and (iii) hereby accept the PSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes and Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding (Only Applicable to Individuals Subject to U.S. Tax Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Award is subject to the withholding of all applicable taxes.  The Company may withhold, or permit you to remit to the Company, any Federal, state or local taxes applicable to the grant, vesting or other event giving rise to tax liability with respect to this Award.  If you have not remitted the full amount of applicable withholding taxes to the Company by the date the Company is required to pay such withholding to the appropriate taxing authority (or such earlier date that the Company may specify to assist it in timely meeting its withholding obligations), the Company shall have the unilateral right to withhold Ordinary Shares relating to this Award in the amount it determines is sufficient to satisfy the tax withholding required by law.  State taxes will be withheld at the appropriate rate set by the state in which you are employed or were last employed by the Company.  In no event may the number of shares withheld exceed the number necessary to satisfy the maximum Federal, state and local income and employment tax withholding requirements.  You may elect to surrender previously acquired Ordinary Shares or to have the Company withhold Ordinary Shares relating to this Award in an amount sufficient to satisfy all or a portion of the tax withholding required by law.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Responsibility for Taxes (Only Applicable to Individuals Subject to Tax Laws Outside the U.S.).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Regardless of any action the Company or, if different, the Affiliate employing or retaining you takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (&#8220;Tax-Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items is and remains your responsibility and may exceed the amount actually withheld by the Company or the Affiliate employing or retaining you.  You further acknowledge that the Company and&#47;or the Affiliate employing or retaining you (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PSUs, including, but not limited to, the grant, vesting or settlement of the PSUs, the subsequent sale of Ordinary Shares acquired pursuant to such settlement and the receipt of any dividends&#59; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the PSUs to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result.  Further, if you have become subject to tax in more than one jurisdiction between the PSU Grant Date and the date of any relevant taxable event, as applicable, you acknowledge that the Company and&#47;or the Affiliate employing or retaining you </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(or formerly employing or retaining you, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(1) &#160;&#160;&#160;&#160;Prior to any relevant taxable or tax withholding event, as applicable, you will pay or make adequate arrangements satisfactory to the Company and&#47;or the Affiliate employing or retaining you to satisfy all Tax-Related Items.  In this regard, you authorize the Company and&#47;or the Affiliate employing or retaining you, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58;  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;withholding from your wages or other cash compensation paid to you by the Company and&#47;or the Affiliate employing or retaining you&#59; or</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;withholding from proceeds of the sale of Ordinary Shares acquired upon settlement of the PSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization)&#59; or </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(C)&#160;&#160;&#160;&#160;withholding in Ordinary Shares to be issued upon settlement of the PSUs.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;To avoid negative accounting treatment, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates.  If the obligation for Tax-Related Items is satisfied by withholding in Ordinary Shares, for tax purposes, you are deemed to have been issued the full number of Ordinary Shares subject to the vested PSUs, notwithstanding that a number of the Ordinary Shares are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(3)&#160;&#160;&#160;&#160;Finally, you shall pay to the Company or the Affiliate employing or retaining you any amount of Tax-Related Items that the Company or the Affiliate employing or retaining you may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to issue or deliver the Ordinary Shares or the proceeds of the sale of Ordinary Shares, if you fail to comply with your obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The issuance of Ordinary Shares will be subject to and conditioned upon compliance by the Company and you, including any written representations, warranties and agreements as the Administrator may request of you for compliance with all (i) applicable U.S. state and federal laws and regulations, (ii) applicable laws of the country where you reside pertaining to the issuance or sale of Ordinary Shares, and (iii)&#160;applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Ordinary Shares may be listed or quoted at the time of such issuance or transfer.  Notwithstanding any other provision of this Agreement, the Company shall have no obligation to issue any Ordinary Shares under this Agreement if such issuance would violate any applicable law or any applicable regulation or requirement of any securities exchange or similar entity.</font></div><div style="margin-bottom:12pt;text-indent:31.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Short Term Deferral (Only Applicable to Individuals Subject to U.S. Federal Tax Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  PSUs payable under this Agreement are intended to be exempt from Code Section 409A under the exemption for short-term deferrals.  Accordingly, PSUs will be settled no later than the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of the third month following the later of (i) the end of the Employee&#8217;s taxable year in which the vesting date occurs, or (ii) the end of the fiscal year of the Company in which the vesting date occurs.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Data Privacy Rules (Only Applicable if this Award is Subject to U.S. Data Privacy Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By entering into this Agreement and accepting this Award, you (a) explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of any of your personal data that is necessary to facilitate the implementation, administration and management of the Award and the Plan, (b) understand that the Company may, for the purpose of implementing, administering and managing the Plan, hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, and details of all awards or entitlements to Shares granted to you under the Plan or otherwise (&#8220;Personal Data&#8221;), (c) understand that Personal Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including any broker with whom the Shares issued upon vesting of the Award may be deposited, and that these recipients may be located in your country or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than your country, (d) waive any data privacy rights you may have with respect to the data, and (e) authorize the Company, its Affiliates and its agents, to store and transmit such information in electronic form.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Data Privacy Rules (Only Applicable if this Award is Subject to Data Privacy Laws Outside of the U.S.)</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;By entering into this Agreement and accepting this Award, you hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other PSU grant materials by and among, as applicable, the Affiliate employing or retaining you, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;You understand that the Company and the Affiliate employing or retaining you may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Ordinary Shares or directorships held in the Company, details of all PSUs or any other entitlement to Ordinary Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (&#8220;Data&#8221;).  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;You understand that Data will be transferred to legal counsel or a broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients&#8217; country (e.g., the United States) may have different data privacy laws and protections than your country of residence.  You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local or Company human resources representative.  You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan.  You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local or Company human resources representative.  You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">withdrawal of consent, you understand that you may contact your local or Company human resources representative.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be binding upon any or all successors and assigns of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed and enforced in accordance with the applicable Code provisions to the maximum extent possible and otherwise by the laws of the State of Michigan without regard to principals of conflict of laws, provided that if you are a foreign national or employed outside the United States, this Agreement shall be governed by and construed and enforced in accordance with applicable foreign law to the extent that such law differs from the Code and Michigan law.  Any proceeding related to or arising out of this Agreement shall be commenced, prosecuted or continued in the Circuit Court in Kent County, Michigan located in Grand Rapids, Michigan or in the United Stated District Court for the Western District of Michigan, and in any appellate court thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Forfeiture of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company, as a result of misconduct, is required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, then (a) if your incentive or equity-based compensation is subject to automatic forfeiture due to such misconduct and restatement under Section 304 of the Sarbanes-Oxley Act of 2002, or (b) the Committee determines you either knowingly engaged in or failed to prevent the misconduct, or your actions or inactions with respect to the misconduct and restatement constituted gross negligence, you shall (i) be required to reimburse the Company the amount of any payment relating to any PSUs earned or accrued during the twelve month period following the first public issuance or filing with the SEC (whichever first occurred) of the financial document embodying such financial reporting requirement, and (ii) all outstanding PSUs that have not yet been settled shall be immediately forfeited.  In addition, Ordinary Shares acquired under this Agreement, and any gains or profits on the sale of such Ordinary Shares, shall be subject to any &#8220;clawback&#8221; or recoupment policy later adopted by the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Rules for Non-U.S. Grantees (Only Applicable if You Reside Outside of the U.S.)</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In accepting the grant, you acknowledge, understand and agree that&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, except as otherwise provided in the Plan. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;the grant of the PSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of PSUs, or benefits in lieu of the PSUs, even if PSUs have been granted repeatedly in the past&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;all decisions with respect to future PSU grants, if any, will be at the sole discretion of the Company&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;you are voluntarily participating in the Plan&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are an extraordinary item and which is outside the scope of your employment or service contract, if any&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(6)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are not intended to replace any pension rights or compensation&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Affiliate employing or retaining you or any other Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(8)&#160;&#160;&#160;&#160;the grant and your participation in the Plan will not be interpreted to form an employment or service contract with the Company or any Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(9)&#160;&#160;&#160;&#160;the future value of the underlying Ordinary Shares is unknown, indeterminable and cannot be predicted with certainty&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(10)&#160;&#160;&#160;&#160;no claim or entitlement to compensation or damages shall arise from forfeiture of the PSUs resulting from your Termination Date (for any reason whatsoever, whether or not later found to be invalid and whether or not in breach of employment laws in the jurisdiction where you are employed or rendering services, or the terms of your employment agreement, if any), and in consideration of the grant of the PSUs to which you are otherwise not entitled, you irrevocably agree never to institute any claim against the Company or the Affiliate employing or retaining you, waive your ability, if any, to bring any such claim, and release the Company and the Affiliate employing or retaining you from any such claim&#59; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, you shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim&#59; and</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(11)&#160;&#160;&#160;&#160;you acknowledge and agree that neither the Company, the Affiliate employing or retaining you nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the currency of the country in which you reside and the United States Dollar that may affect the value of the PSUs or of any amounts due to you pursuant to the settlement of the PSUs or the subsequent sale of any Ordinary Shares acquired upon settlement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provisions in this Agreement, the PSU grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement.  Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to you, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan.  If you relocate to the United States, the special terms and conditions in the Appendix will apply, or cease to apply, to you, to the extent the Company determines that the application or otherwise of such provisions is necessary or advisable in order to facilitate the administration of the Plan.  The Appendix constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company reserves the right to impose other requirements on your participation in the Plan, on the PSUs and on any Ordinary Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15&#160;&#160;&#160;&#160;&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Noncompetition and Nonsolicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Noncompetition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During your employment with the Company and its Affiliates and for a twelve (12) month period following your Termination Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), you shall not (i) directly or indirectly, without the prior written consent of the Company, engage in or invest &#91;a material or controlling interest in&#93; as an owner, partner, stockholder, licensor, director, officer, agent or consultant for any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the &#91;country or countries in which you regularly work or provide services&#93; &#91;world&#93;&#59; or (ii) accept employment or an engagement for the provision of services in any capacity, including as an employee, director, consultant or advisor, directly or indirectly, with any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the &#91;country or countries in which you regularly work or provide services&#93; &#91;world&#93; except where prohibited by local law. For purposes hereof, conducting a business that is in competition with a business conducted by the Company or any of its Affiliates shall include the sale, manufacture, distribution or research and development of any product or service that is similar to a product or service sold, distributed, marketed or being researched or developed (including through a joint venture or investment in another entity) by the Company or any of its Affiliates, including store brand and value brand OTC drug or nutritional products, extended topical generic prescription pharmaceutical products, infant nutrition products, oral care products, and any other product or products that the Company or an Affiliate is marketing or actively planning to market during your employment with the Company and during the oneyear period following your Termination Date. If there is a completed sale, transfer or other disposition of the Perrigo Prescription Pharmaceutical business during the Restricted Period, this Section 2.15(a) will not apply to the Perrigo Prescription Pharmaceutical business.  Notwithstanding the foregoing, nothing in this provision shall prevent you from passively owning two percent (2%) or less of the outstanding securities of any class of any company listed on a national securities exchange or quoted on an automated quotation system.  You may make a written request in writing to the CHRO of the Company for an exception to this Section 2.15(a) and such exception will not be unreasonably withheld&#91;, particularly where you are seeking employment with a business that does not compete with the segment of the Company where you worked or provided services during the last two years of your employment with the Company&#93;.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nonsolicitation of Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During your employment with the Company and its Affiliates and for the duration of the Restricted Period, you shall not, directly or indirectly, without the prior written consent of the Company, (i) actively solicit, recruit or hire any Person who is at such time, or who at any time during the 12month period prior to such solicitation or hiring had been, an employee or consultant of the Company or any of its Affiliates, (ii) solicit or encourage any employee of the Company or any of its Affiliates to leave the employment of the Company or any of its Affiliates or (iii) interfere with the relationship of the Company or any of its Affiliates with any Person or entity who or that is employed by or otherwise engaged to perform services for the Company or any of its Affiliates except where prohibited by local law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nonsolicitation of Clients</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During your employment with the Company and its Affiliates and for the duration of the Restricted Period, you shall not, directly or indirectly, alone or in association with any other Person, without the prior written consent of the Company, (i) induce or attempt to induce any client, customer (whether former or current), supplier, licensee, franchisee, joint venture partner or other business relation of the Company or any of its Affiliates (collectively, &#8220;Clients&#8221;) to cease doing business with the Company or any such Affiliate, (ii) divert all or any portion of a Client&#8217;s business with the Company to any competitor of the Company or any such Affiliate, or (iii) in any way interfere with the relationship between any Client, on the one hand, and the Company or any such Affiliate, on the other hand except where prohibited by local law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Remedies and Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that a violation by you of any of the covenants contained in this Section 2.15 would cause irreparable damage to the Company and its Affiliates in an amount that would be material but not readily ascertainable, and that any remedy at law (including the payment of damages) would be inadequate. Accordingly, you agree that, notwithstanding any provision of this Agreement to the contrary, in addition to any other damages it is able to show, the Company and its Affiliates shall be entitled (without the necessity of showing economic loss or other actual damage) to injunctive relief (including temporary restraining orders, preliminary injunctions and permanent injunctions), without posting a bond, in any court of competent jurisdiction for any actual or threatened breach of any of the covenants set forth in this Section 2.15 in addition to any other legal or equitable remedies it may have. In addition, in the event of your Willful Restrictive Covenant Breach (as defined in this Section 2.15), (i) all of your rights under this Agreement, whether or not vested, shall terminate immediately, and (ii) any Shares, cash or other property paid or delivered to you pursuant to this Agreement shall be forfeited and you shall be required to repay such Shares, cash or other property to the Company, no later than thirty (30) calendar days after the Company makes demand to you for repayment.  For purposes of this Agreement, &#8220;Willful Restrictive Covenant Breach&#8221; means your material breach of any of the covenants set forth in this Section 2.15 which you knew, or with due inquiry, should have known, would constitute such a material breach. The preceding sentences of this Section 2.15 shall not be construed as a waiver of the rights that the Company and its Affiliates may have for damages under this Agreement or otherwise, and all such rights shall be unrestricted. The Restricted Period shall be tolled during (and shall be deemed automatically extended by) any period during which you are in violation of the provisions of Section 2.15(a), (b) or (c), as applicable. In the event that a court of competent jurisdiction determines that any provision of this Section 2.15 is invalid or more restrictive than permitted under the governing law of such jurisdiction, then, only as to enforcement of this Section 2.15 within the jurisdiction of such court, such provision shall be interpreted and enforced as if it provided for the maximum restriction permitted under such governing law.</font><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;You acknowledge that the Company and its Affiliates have expended and will continue to expend substantial amounts of time, money and effort to develop business strategies, employee, customer and other relationships and goodwill to build an effective organization. You acknowledge that the Company and its Affiliates have a legitimate business interest in and right to protect its goodwill and employee, customer and other relationships, and that the Company and its Affiliates could be seriously damaged by the loss or deterioration of its employee, customer and other relationships. You further acknowledge that the Company and its Affiliates are entitled to protect and preserve the going concern value of the Company and its Affiliates to the extent permitted by law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;In light of the foregoing acknowledgments, you agree that the covenants contained in this Agreement are reasonable and properly required for the adequate protection of the businesses and goodwill of the Company and its Affiliates. You further acknowledge that, although your compliance with the covenants contained in this Agreement may prevent you from earning a livelihood in a business similar to the business of the Company and its Affiliates, your experience and capabilities are such that you have other opportunities to earn a livelihood and adequate means of support for you and your dependents.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3)&#160;&#160;&#160;&#160;In light of the acknowledgements contained in this Section 2.15, you agree not to challenge or contest the reasonableness, validity or enforceability of any limitations on, and obligations of, you contained in this Section 2.15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#93;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">****</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">We look forward to your continuing contribution to the growth of the Company.  Please acknowledge your receipt of the Plan and this Award.</font></div><div style="text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="text-indent:198pt"><font><br></font></div><div style="text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">APPENDIX</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PERRIGO COMPANY PLC</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Additional Terms and Provisions to</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Restricted Stock Unit Award Agreement (Performance-Based)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix (the &#8220;Appendix&#8221;) includes additional terms and conditions that govern the restricted stock units (Performance-Based) (&#8220;PSUs&#8221; or &#8220;Award&#8221;) granted to you under the Plan if you reside in one of the countries listed below. Certain capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan and&#47;or the Agreement.  The Award will not create any entitlement to receive any similar benefit in the future. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix also includes country-specific information of which you should be aware with respect to your participation in the Plan.  The information is based on the securities, exchange control and other laws in effect in the respective countries as of January 2023.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that you do not rely on the information noted herein as the only source of information relating to the consequences of your participation in the Plan because the information may be out of date at the time that you vest in the PSUs and Ordinary Shares are issued to you or the shares issued upon vesting of the PSUs are sold.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, the information is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of any particular result.  Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your particular situation.  Finally, please note that if you are a citizen or resident of a country other than the country in which you are currently working, or transfers employment after grant, the information contained in the Appendix may not be applicable.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Conditions et dispositions suppl&#233;mentaires &#224; l&#8217;</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Accord relatif &#224; l&#8217;attribution d&#8217;unit&#233;s d&#8217;action avec restrictions (r&#233;mun&#233;ration fond&#233;e sur les performances)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice (l&#8217;&#171;&#160;Appendice&#160;&#187;) comprend des conditions compl&#233;mentaires r&#233;gissant les Unit&#233;s d&#8217;action avec restrictions (r&#233;mun&#233;ration fond&#233;e sur les performances) (&#171;&#160;UARP&#160;&#187; ou &#171;&#160;Prime&#160;&#187;) qui vous sont attribu&#233;es en vertu du Plan si vous r&#233;sidez dans l&#8217;un des pays repris ci-dessous. Certains termes commen&#231;ant par une lettre majuscule utilis&#233;s dans le pr&#233;sent Accord mais qui n&#8217;y sont pas d&#233;finis ont le sens qui leur est attribu&#233; dans le Plan ou l&#8217;Accord. La Prime n&#8217;instaure aucun droit &#224; recevoir des avantages similaires &#224; l&#8217;avenir. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice comprend &#233;galement des informations sp&#233;cifiques aux pays dont vous devez avoir connaissance eu &#233;gard &#224; votre participation au Plan. Les informations se fondent sur les lois relatives aux valeurs mobili&#232;res, au contr&#244;le des &#233;changes et autres en vigueur dans les pays respectifs en janvier 2023. Souvent complexes, ces lois font l&#8217;objet de modifications fr&#233;quentes. Par cons&#233;quent, la Soci&#233;t&#233; vous recommande vivement de ne pas consid&#233;rer les renseignements repris aux pr&#233;sentes comme l&#8217;unique source d&#8217;information relative aux cons&#233;quences de votre participation au Plan, car ces renseignements peuvent &#234;tre obsol&#232;tes au moment de la d&#233;volution des UARP ou de l&#8217;&#233;mission des Actions ordinaires pour votre compte, ou de la vente des actions &#233;mises lors de la d&#233;volution des UARP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Par ailleurs, ces informations sont d&#8217;ordre g&#233;n&#233;ral et peuvent ne pas s&#8217;appliquer &#224; votre situation particuli&#232;re. De plus, la Soci&#233;t&#233; n&#8217;est pas en mesure de vous garantir un quelconque r&#233;sultat particulier. Par cons&#233;quent, il vous est conseill&#233; de demander des conseils professionnels appropri&#233;s quant &#224; la mani&#232;re dont les lois de votre pays en la mati&#232;re peuvent s&#8217;appliquer &#224; votre situation particuli&#232;re. Enfin, veuillez noter que si vous &#234;tes citoyen ou r&#233;sident d&#8217;un pays autre que celui dans lequel vous travaillez actuellement ou si votre emploi est transf&#233;r&#233; apr&#232;s l&#8217;octroi, les informations figurant dans l&#8217;Appendice peuvent ne pas appliquer.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Extra voorwaarden en voorzieningen bij</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">de Overeenkomst over voorwaardelijk toegekende aandelen (op basis van prestaties)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Algemene voorwaarden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage (de 'Bijlage') omvat extra algemene voorwaarden voor de voorwaardelijk toegekende aandelen (op basis van prestaties) ('PSU's' of 'Award') die u volgens het Plan zijn toegekend als u in een van onderstaande landen woont. Bepaalde termen in hoofdletters die in deze Bijlage werden </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">gebruikt maar niet gedefinieerd, hebben de betekenis die in het Plan en&#47;of de Overeenkomst is vermeld. De Award cre&#235;ert geen recht om een soortgelijk voordeel in de toekomst te krijgen. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage bevat ook landenspecifieke informatie waarvan u op de hoogte moet zijn met betrekking tot uw deelname aan het Plan. De informatie is gebaseerd op de effecten-, wisselcontrole- en andere wetten die in de respectieve landen sinds januari 2023 van kracht zijn.  Zulke wetten zijn vaak complex en worden regelmatig aangepast. Daarom raadt het Bedrijf u ten sterkste aan de informatie hierin niet te gebruiken als enige bron van informatie over de gevolgen van uw deelname aan het Plan, omdat de informatie verouderd kan zijn op het ogenblik dat uw toezegging in de PSU's en de Gewone aandelen u worden uitgekeerd of wanneer de bij de toezegging van de PSU's uitgegeven aandelen worden verkocht.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ook is de informatie algemeen van aard en mag u ze niet toepassen op uw specifieke situatie. Het Bedrijf bevindt zich evenmin in een positie om u een specifiek resultaat te verzekeren. We raden u dan ook aan om professioneel advies te vragen over hoe de relevante wetten in uw land van toepassing kunnen zijn op uw specifieke situatie. Ten slotte, merk op dat als u een burger of inwoner bent van een ander land dan het land waarin u op dit moment werkt, of uw tewerkstelling na de toekenning verhuist, de informatie in de Bijlage mogelijk niet van toepassing is.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Dodatkowe warunki i postanowienia</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Umowy przyznania jednostek akcyjnych o ograniczonych prawach (w oparciu o wyniki)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik (&#8222;Za&#322;&#261;cznik&#8221;) zawiera dodatkowe warunki, kt&#243;re reguluj&#261; jednostki akcyjne o ograniczonych prawach (&#8222;PSU&#8221; lub &#8222;Prawo&#8221;) przyznan&#261; w ramach Programu, je&#347;li mieszkasz w jednym z wymienionych poni&#380;ej kraj&#243;w. Okre&#347;lone terminy pisane wielk&#261; liter&#261;, kt&#243;re nie zosta&#322;y zdefiniowane w niniejszym Za&#322;&#261;czniku, maj&#261; znaczenie okre&#347;lone w Programie i&#47;lub Umowie. Prawo nie uprawnia do uzyskiwania podobnych korzy&#347;ci w przysz&#322;o&#347;ci. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik zawiera r&#243;wnie&#380; informacje dotycz&#261;ce poszczeg&#243;lnych kraj&#243;w, o kt&#243;rych powiniene&#347;(-as) wiedzie&#263; w zwi&#261;zku z uczestnictwem w Programie. Informacje oparte s&#261; na papierach warto&#347;ciowych, kontroli dewizowej i innych przepisach obowi&#261;zuj&#261;cych w odpowiednich krajach od stycznia 2023 r. Takie przepisy prawa s&#261; cz&#281;sto skomplikowane i cz&#281;sto si&#281; zmieniaj&#261;. W zwi&#261;zku z tym Sp&#243;&#322;ka zdecydowanie zaleca, aby nie polega&#263; na informacjach wymienionych w niniejszym dokumencie jako jedynym &#378;r&#243;dle informacji zwi&#261;zanych z konsekwencjami uczestnictwa w Programie, gdy&#380; informacje te mog&#261; by&#263; nieaktualne w momencie nabycia lub wykonywania PSU, a Akcje Zwyk&#322;e s&#261; Ci wydawane lub w przypadku sprzeda&#380;y PSU nabytych w ramach Programu.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto informacje maj&#261; charakter og&#243;lny i mog&#261; nie mie&#263; zastosowania do konkretnej sytuacji, a Sp&#243;&#322;ka nie jest w stanie zapewni&#263; Ci &#380;adnego konkretnego rezultatu. W zwi&#261;zku z tym zaleca si&#281; zasi&#281;gni&#281;cie odpowiedniej profesjonalnej porady dotycz&#261;cej tego, w jaki spos&#243;b odpowiednie przepisy w Twoim kraju mog&#261; mie&#263; zastosowanie do konkretnej sytuacji. Wreszcie nale&#380;y pami&#281;ta&#263;, &#380;e je&#347;li jeste&#347; obywatelem&#47;obywatelk&#261; lub rezydentem&#47;rezydentk&#261; kraju innego ni&#380; kraj, w kt&#243;rym obecnie pracujesz lub przenosisz si&#281; do nowego miejsca po przyznaniu, informacje zawarte w Za&#322;&#261;czniku mog&#261; nie mie&#263; zastosowania.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Australia</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Important Notice</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Important Notice </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">No financial product advice is provided in this Appendix, this Agreement or the Plan (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Plan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">) and nothing should be taken to constitute a recommendation or statement of opinion that is intended to influence a person or persons in making a decision to participate in the Plan. The Plan documents do not take into account your objectives, financial situation and needs. You should consider obtaining your own financial product advice from a person who is licensed by the Australian Securities and Investments Commission to give such advice. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">If you intend to apply to participate in the Plan, you must make your own independent assessment and investigation in relation to your legal and taxation position including seeking professional advice. You must base any decision you may make on such independent assessment, investigation or advice.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Offer made without disclosure </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A copy of the terms of the Plan will be provided to you with this Agreement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of the Plan, an offer to receive PSUs and participate in the Plan, if received in Australia, is made without disclosure to investors in reliance on the regulatory relief set out in Division 1A of Part 7.12, and for the purposes of section 1100N(b), of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Corporations Act 2001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Cth). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As set out in this Agreement, each PSU represents the right to receive one Ordinary Share subject to the relevant performance goals and performance measures being met, or otherwise waived, in accordance with the Plan and this Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The PSUs will be issued for nil consideration. You are not required to pay for a PSU or for the subsequent transfer of an Ordinary Share on vesting of that PSU, however your responsibility for any taxes is as set out in the terms of the Plan and this Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any discretion contained in the Plan, or any provision in this Agreement to the contrary, the number of PSUs granted to you will only be decreased depending on your level of attainment of performance goals against your designated performance measures. If you fully meet your performance goals against the designated performance measures, all of your PSUs will vest. However, if you only partially meet your performance goals against the designated performance measures, only a partial number of your PSUs will vest. You will be entitled to one Share for each vested PSU. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the avoidance of doubt, there will be no increase to the number of PSUs granted to you on the Grant Date. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company will not provide you with any loans or financial assistance under the Plan in connection with the offer of the PSUs. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No PSUs or Ordinary Shares transferred to you under the Plan will be held on your behalf, by a trustee&#47;nominee. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The indicative daily price of the Ordinary Shares on the New York Stock Exchange (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), quoted in US dollars, is available on the Company&#8217;s website at http&#58;&#47;&#47;perrigo.investorroom.com&#47;stock-information. The Ordinary Shares are also quoted on the NASDAQ Stock Market (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NASDAQ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) (refer to NASDAQ&#8217;s website at </font><font style="color:#0562c1;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">http&#58;&#47;&#47;www.nasdaq.com&#47;symbol&#47;prgo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Australian dollar equivalent of the Ordinary Shares can be determined using prevailing exchange rate published by Thomson Reuters (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Prevailing Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). Alternatively, the Company will advise you of the price of its Ordinary shares (in equivalent Australian dollars) as soon as possible following receipt of any request for such information. This information may be obtained by you contacting your local Human Resources representative. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Before accepting an offer to be granted PSUs, you should satisfy yourself that you have a sufficient understanding of the risks set out below and should consider if the PSUs are a suitable investment for you, having regard to your own investment objectives, financial circumstances and taxation position&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) the vesting conditions for your PSUs may not be satisfied for reasons beyond the Company&#8217;s or your control&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) you are not permitted to transfer your PSUs unless permitted under this Agreement or the Plan&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) you will have no voting, dividend, or other stockholder rights in any Shares until you become the registered holder of those Shares. Until you become the registered holder of Shares, you will have only the rights of an unsecured creditor with respect to those Shares </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) if your PSUs vest and you subsequently receive Ordinary Shares&#58; </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) the value of those shares may rise and fall according to investor sentiment, general economic conditions and outlook, international and local stock markets, employment, inflation, interest rates, government policy, taxation and regulation&#59; and </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) there is no guarantee that an active trading market for the shares will exist or that the price of the shares will increase. There may be relatively few potential buyers or sellers of the shares on the NYSE, NASDAQ, TASE or any other applicable market at any time and this may increase the volatility of the market price of the shares. It may also affect the prevailing market price at which you may be able to sell your shares&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) there may be taxation implications arising for you in participating under this Agreement and in the Plan. The tax consequences of participating in the Plan are based on complex tax laws, which may be subject to varying interpretations, and the application of such laws may depend, in large part, on the surrounding facts and circumstances. The tax regime applying to you may change. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the above risks are only general risks of acquiring and holding PSUs under the Plan. It does not purport to list every risk that may be associated with the Plan now or in the future. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, if at the time of vesting, the Company determines that it is not legal under Australian securities laws to issue shares, the outstanding PSUs will be cancelled, and no shares will be issued to you nor will any benefits in lieu of shares be paid to you. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Exchange Control Information </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control reporting mandates disclosure of payments equal to or exceeding AUD10,000 made to a foreign individual or entity. This reporting is generally done automatically by the financial institution making the transfer. </font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Austria</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of Austria, you must submit a report to the Austrian National Bank. An exemption applies if the value of the shares as of any given quarter is less than &#8364;5,000,000 (when converted to Euros if applicable). If the threshold is met or exceeded, quarterly reporting obligations exist If quarterly obligations apply, the reporting date is the end of each quarter and the deadline for filing the report is the 15th of the month following the end of the quarter.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When shares are sold, there may be exchange control obligations if the cash received is held in a bank account outside Austria.  If the volume of all your accounts abroad exceeds &#8364;10,000,000 (when converted to Euros if applicable), the balances of all accounts must be reported monthly, as of the last day of the month, on or before the fifteenth day of the following month.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Belgium </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to report any security or bank accounts (including brokerage accounts) you maintain outside of Belgium on your annual tax return.  In a separate report, you are required to provide the National Bank of Belgium with certain details regarding such foreign accounts (including the account number, bank name and country in which any such account was opened).  This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under Kredietcentrales &#47; Centrales des cr&#233;dits caption.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Stock Exchange Tax.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A stock exchange tax could apply for Belgian tax residents transacting through a non-Belgium broker once the shares are sold. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Communication d&#8217;informations relatives aux actifs ou comptes &#233;trangers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Vous &#234;tes tenu de d&#233;clarer, dans votre d&#233;claration fiscale annuelle, tout compte-titres ou compte en banque (y compris les comptes de courtage) que vous d&#233;tenez en dehors de la Belgique. Dans une d&#233;claration distincte, vous &#234;tes tenu de communiquer &#224; la Banque Nationale de Belgique certains d&#233;tails concernant les comptes &#233;trangers (notamment le num&#233;ro de compte, le nom de la banque et le pays o&#249; le compte a &#233;t&#233; ouvert). Cette d&#233;claration ainsi que toutes les informations indiquant comment la remplir sont disponibles sur le site web de la Banque Nationale de Belgique (www.nbb.be) &#224; la section &#171;&#160;Centrales des cr&#233;dits&#47;Kredietcentrales&#160;&#187;. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informatie over buitenlands vermogen&#47;rekeningrapportering.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> U moet alle garantie- of bankrekeningen (inclusief beleggingsrekeningen) die u buiten Belgi&#235; bezit, vermelden op uw jaarlijkse belastingsbrief. In een afzonderlijk overzicht moet u de Nationale Bank van Belgi&#235; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">informatie geven over zulke buitenlandse rekeningen (inclusief het rekeningnummer, de naam van de bank en het land waarin zulke rekening is geopend). Dit overzicht, evenals extra informatie over hoe u het moet opstellen, vindt u op de website van de Nationale Bank van Belgi&#235;, www.nbb.be, onder de titel Kredietcentrales.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Bermuda</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is not subject to and has not received approval from the Bermuda Monetary Authority and the Registrar of Companies in Bermuda, and no statement to the contrary, explicit or implicit, is authorized to be made in this regard.  The securities may be offered or sold in Bermuda only in compliance with the provisions of the Investment Business Act 2003 of Bermuda.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Brazil</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You agree that, for all legal purposes, (i) the benefits provided under the Plan are the result of commercial transactions unrelated to your employment&#59; (ii) the Plan is not a part of the terms and conditions of your employment&#59; and (iii) the income from the PSUs, if any, is not part of your remuneration from employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you agree to comply with Brazilian law when the PSUs vest and the shares are sold. You also agree to report and pay any and all taxes associated with the vesting of the PSUs, the sale of the PSUs acquired pursuant to the Plan, and the receipt of any dividends.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> If you are a resident or domiciled in Brazil and hold assets and rights outside Brazil with an aggregate value exceeding US$100,000, you will be required to prepare and submit to the Central Bank of Brazil an annual declaration of such assets and rights. Assets and rights that must be reported include PSUs.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Canada</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Payout of PSUs in Shares Only</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to all Employees residing in Canada, the Company will convert all vested PSUs only into an equivalent number of Shares and the Plan will not provide an option to settle the PSUs in cash. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Canadian residents may be required to report foreign property (including Shares) on an annual basis on form T1135 (Foreign Income Verification Statement) if the total cost of the foreign property exceeds CAD 100,000 at any time in the year. The grant of PSUs must be reported if the CAD 100,000 cost threshold is exceeded because of other foreign property held. PSUs may be reported at a nil cost. The form must be filed by April 30 of the following year. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Withholding will include both federal income tax as well as provincial tax.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Resale Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Ordinary Shares received by Canadian residents pursuant to this Plan will be subject to an indefinite holding period and the resale of the Ordinary Shares will be prohibited, unless certain conditions are met in respect of the Company in accordance with applicable Canadian securities laws or another applicable Canadian prospectus exemption is available.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Eligibility of Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding the terms of this Agreement or the Plan, no offers of PSUs or Ordinary Shares may be made to you if you are not an employee, executive officer, director or consultant of the Company or a related entity of the Company, in accordance with Section 2.24 of National Instrument 45-106.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employment Law Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the term &#8220;Termination Date&#8221; shall mean the earliest of&#58;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)&#160;&#160;&#160;&#160;Any date specified in this Agreement or the Plan&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)&#160;&#160;&#160;&#160;The date on which the Company or any applicable Affiliate delivers to you notice in a form prescribed by the Company that the Company is thereby terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)&#160;&#160;&#160;&#160;Except in the event of a Separation for Good Reason, the date on which you deliver notice in a form prescribed by the Company to the Company or any applicable Affiliate that you are terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)&#160;&#160;&#160;&#160;The date on which you cease to provide services to the Company or any applicable Affiliate, except where you are on an authorized leave of absence&#59; and</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)&#160;&#160;&#160;&#160;The date on which you cease to be considered an &#8220;employee&#8221; of the Company or any applicable Affiliate under applicable law.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the definitiona of &#8220;Cause&#8221; shall be determined in accordance with applicable laws in the jurisdiction of employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In accordance with Section 2.13, you consent and agree to the payment of the reimbursements set out therein, including through deductions of the amounts specified in paragraph 2.13 from any wages owed by the Company to the employee. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The provisions set out in Section 2.15(a) do not apply to employees in the province of Ontario other than executive employees who are exempted from XV.1 of the Ontario Employment Standards Act, 2000.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Czech Republic</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Documents in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Award, you confirm that you have read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">P&#345;ijet&#237;m tohoto Ozn&#225;men&#237; potvrzujete, &#382;e jste p&#345;e&#269;etl a porozum&#283;l jste Podm&#237;nk&#225;m pl&#225;nu (&#8220;Plan&#8221;) a Smlouv&#283; (&#8220;Agreement&#8221;), kter&#233; V&#225;m byly poskytnuty v anglick&#233;m jazyce. Z&#225;rove&#328; prohla&#353;ujete, &#382;e souhlas&#237;te s podm&#237;nkami uveden&#253;mi v t&#283;chto dokumentech.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restriction on cash payments.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Under Czech Act No. 235&#47;2004 Coll., on Cash Payments, as amended, it is prohibited to receive or provide payments in cash exceeding the amount of CZK 270.000 within one day. Payments exceeding this amount must be executed cashless. This restriction relates to payments from one contracting party to one other contracting party. Thus, it is not a restriction on the sum of all payments made by one individual or entity within one day.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nevertheless, since the restriction on cash payments may be subject to a change (especially a lower threshold might be set), we recommend consulting your personal legal advisor prior to receiving or providing a larger amount of cash payments.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Denmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is subject to the Danish Stock Option Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aktieoptionsloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), which applies on share option agreements entered into as part of an employment, if the ownership of the shares is obtained at a later point. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This act is based on a principle of the right to freely agree on the terms of the Award Agreement with certain exceptions stated in the act. In addition to the act, the Danish Contract Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aftaleloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and Danish case law also regulates the terms of the Award Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below, it is outlined when the Danish Stock Option Act, the Danish Contract Act, Danish case law and other applicable legislation deviate from terms stated in the Award Agreement&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Section 1.3(f) in the Award Agreement does not entail that applicable notice periods under Danish employment legislation and your employment agreement are deviated from to the detriment of you. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Section 1.3(g) litra 2 in the Award Agreement is amended to the following&#58; </font></div><div><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;(2) &#8220;Termination without Cause&#8221; means the involuntary termination of your employment or contractual relationship by the Company without any Cause. &#8220; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Regardless of section 2.3 in the Award Agreement, vested and acquired shares do not lapse as a consequence of your Termination Date for reasons of Cause. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In relation to Section 2.7 in the Award Agreement the following also applies, which supersedes section 2.7 in case of conflicting regulation&#58; </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;The Company is required to report the market value of the PSUs to the Danish tax authorities to both E-income and E-capital with the Danish tax authorities. For E-income, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the value of the PSUs should be reported as income art 50 in field 068 and should be reported by the Company in the month the shares vest. For E-capital, the value of the PSUs should be reported to the Danish tax authorities no later than the 20th of January the following year after the PSUs have vested. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The market value of the provided PSUs is to be reported by the Company as personal income in the year of vest and is subject to a marginal tax rate of 56% including labor market contribution. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The tax payment obligation for the value of the shares will be collected with the individual, and the responsibility to ensure that the correct amount is reported on the Danish tax assessment remains with the individual.</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At the time of sale you are subject to tax on the gain, if any, at a marginal tax rate of 42%. The capital gain is calculated as the difference between the average fair market value at vest and the sales price. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If there is a loss tied to the sale of the PSUs, the loss can be deducted in capital gain from other listed PSUs. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that it is mandatory for you to report information on PSUs from a foreign depot to the Danish tax authorities. If this information is not provided to the Danish tax authorities, a potential loss cannot be used for deduction. &#8220; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to section 2.10(b), all personal information will be managed in accordance with the European Data Protection Regulation (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">databeskyttelsesforordningen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and the Danish Data Protection Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">personbeskyttelsesloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.15(a)-(d) in the Award Agreement is void and unenforceable in Denmark and instead the following is agreed&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15 NON-COMPETITION AND NON-SOLICITATION </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.1. You will be covered by this non-competition and non-solicitation clause for 6 months after the effective date of termination. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.2. In this period, you are entitled to &#8211; only with the prior written consent of the affiliate employing or retaining you (the &#8220;Affiliate&#8221;) &#8211; be engaged or financially interested, directly or indirectly, in any business which develops and&#47;or distributes products or services that compete or may compete with the Affiliate or any group companies&#8217; products and&#47;or services or in any other business competing with the Affiliate or any group companies in any other way. This restriction includes any interest whatsoever by way of, for example, employment, ownership in full or in part, membership of a board, consultancy services and the like in Denmark and abroad. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.3. Conclusion of this non-competition clause is required because you hold a very special position of trust, and you will receive detailed knowledge about the Affiliate and group companies&#8217; affairs, including business secrets, market strategies and plans, information on customers and suppliers. This knowledge may be exploited to the detriment of the Affiliate or group companies, if you become employed with a competing company immediately after the effective date of termination. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.4. During 6 months after the effective date of termination, you are only with the prior written consent of the Affiliate entitled to be in contact with or have business relations, directly or indirectly, with customers, suppliers or cooperation partners, etc., with whom you have had </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">business relations within the last 12 months prior to the termination. In connection with the termination, the Affiliate will prepare a list of the customers, suppliers and cooperation partners covered by the restriction in this clause. In this connection, you must loyally contribute to the drafting of a thorough list covering all customers, suppliers and&#47;or cooperation partners with whom you have had business relations within the last 12 months prior to the termination. Your deliberate failure to contribute loyally to this list will be considered a material breach of the employment and the Award Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.5. The effective date of termination is to be construed as the date on which you may be ordered or entitled to resign after the expiry of the notice period, notwithstanding whether you actually end your work with the employing company at an earlier date. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.6. The non-competition part of this clause will cease to apply, if the Affiliate gives notice of termination to you without you having reasonably caused the termination. The non-competition part of this clause will also cease to apply, if you resign from the Affiliate for reasonable cause due to the employing company&#8217;s failure to fulfil its obligations, cf. section 11 (1) in the Danish Act on Employment Clauses (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">ans&#230;ttelsesklausulloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). In both situations, the non-solicitation part of this clause will be maintained. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.7. The Affiliate may terminate the clause with one month's notice to expire at the end of a month, cf. section 10 (1) in the Danish Act on Employment Clauses. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.8. As compensation for the clause, you will receive a monthly compensation in accordance with the Danish Act on Employment Clauses. Compensation currently amounts to 60 % of the monthly salary at the effective date of termination and is payable in the period in which the clause applies. At the effective date of termination, the first two months of compensation will be paid to you as a lump sum. If the clause applies, compensation will after the first two months be payable each month in arrears in the rest of the period in which the clause applies. If you obtain other appropriate paid work, compensation equivalent to 24 % of the monthly salary at the effective date of termination will be paid from the third month after the effective date of termination. You are obligated to actively seek other appropriate work and to notify the Affiliate in writing of any new work. Failure to observe the duty of mitigation will be considered a material breach of the employment with the effect that your right to compensation will lapse. The right to compensation will lapse, if the Affiliate has lawfully terminated your employment without notice. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.9. In the event of your breach of the clause, the Affiliate will be entitled to a penalty of &#91;between three and six&#93; months' salary for any one breach of the clause and compensation for any additional loss. In the event of a persistent breach of the clause, each month or part of a month is deemed to constitute an independent breach entitling the Affiliate to a new, independently agreed penalty. Any payment of the agreed penalty shall not lead to the discontinuance of your obligation to comply with the clause. The Affiliate may also seek to restrain any breach of the clause through the issue of an injunction. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.10. This clause may be invoked by the Affiliate from the date on which you have been employed with the employing company for six months.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Estonia</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Finland</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  If you hold Ordinary Shares acquiqred under the Plan, you are generally required to include those Ordinary Shares as assets in your individual tax return.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">France</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">En acceptant cette attribution gratuite d'actions, vous confirmez avoir lu et comprenez le Plan et ce Contrat, incluant tous leurs termes et conditions, qui ont &#233;t&#233; transmis en langue anglaise. Vous acceptez les dispositions de ces documents en connaissance de cause.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of France or maintain a foreign bank account, you are required to report such to the French tax authorities when you file your annual tax return.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The PSUs are not intended to qualify as a French tax qualified performance restricted stock units under French tax law.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a French resident and hold cash or Ordinary Shares outside of France, you must declare all foreign bank and brokerage accounts (including any accounts that were opened or closed during the tax year) on an annual basis on a special form, No. 3916, together with your income tax return.  </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Renseignements relatifs aux comptes et avoirs &#233;trangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Si vous &#234;tes r&#233;sident fran&#231;ais et que vous d&#233;tenez des liquidit&#233;s ou des Actions ordinaires en dehors de la France, vous &#234;tes tenu de d&#233;clarer chaque ann&#233;e, en m&#234;me temps que votre d&#233;claration de revenus, les r&#233;f&#233;rences de vos comptes bancaires et comptes-titres &#233;trangers (y compris les comptes qui ont &#233;t&#233; ouverts ou ferm&#233;s pendant l&#8217;exercice fiscal) par le biais d&#8217;un formulaire sp&#233;cifiquement pr&#233;vu &#224; cet effet, le formulaire N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">o&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3916. </font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Germany</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Cross-border payments related to securities transactions in excess of &#8364;12,500 must be reported by the fifth calendar day of the month following the respective payment to the German Central Bank (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Bundesbank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  If you use a German bank to transfer a cross-border payment related to securities transactions in excess of &#8364;12,500 (e.g. in connection with the sale of shares acquired under the Plan), the bank will make the report for you. In addition, you must report any receivables, payables, or debts in foreign currency exceeding an amount of &#8364;5,000,000 (by the tenth calendar day after the expiry of one month) and any cross-border shareholdings in companies if the share in the capital or the voting rights amount(s) to 10% or more and the investment object exceeds a balance sheet total of &#8364;3,000,000 (by the last working day of the sixth calendar month following December 31).n a monthly basis.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In case of an acquisition of shares in a foreign company with an overall investment amount of more than &#8364;150,000 (or in case of an acquisition of 10% or more of the shares in a foreign company), you should consult with your tax advisor whether the investment would have to be reported to your tax office.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Greece</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to your Award, if you withdraw funds of &#8364;15,000 or more from a bank in Greece and remit those funds out of Greece, you may be required to submit certain documentation&#47; information to the Greek bank to ensure that the transfer is not in violation of Greek anti-money laundering rules. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Hungary</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">India</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Notification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You understand that you must repatriate any proceeds from the sale of shares acquired under the Plan to India and convert the proceeds into local currency within 180 days of receipt assuming share holding is less than 10% of the company's share capital or as prescribed under applicable Indian exchange control laws as may be amended from time to time. You will receive a foreign inward remittance certificate (&#34;FIRC&#34;) from the bank where you deposit the foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or your employer requests proof of repatriation.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The amount subject to tax on receipt of the shares will partially be dependent upon a valuation that the Company or your employer will obtain from a Merchant Banker in India.  Neither the Company nor your employer has any responsibility or obligation to obtain the most favorable valuation possible, nor obtain valuations more frequently than required under Indian tax law.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to declare in the applicable schedules of your annual tax return (a) any foreign assets held by you (e.g., Ordinary Shares acquired under the Plan and, possibly, the Award), (b) any foreign bank accounts for which you have signing authority and (c) any foreign custodian accounts.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ireland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Director Notification Obligation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a director, shadow director or secretary of the Company's Irish Subsidiary or Affiliate, you must notify the Irish Subsidiary or Affiliate in writing within five business days of receiving or disposing of an interest exceeding 1% of the Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(e.g., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PSUs, shares, etc.), or within five business days of becoming aware of the event giving rise to the notification requirement or within five days of becoming a director or secretary if such an interest exists at the time. This notification requirement also applies with respect to the interests of a spouse or children under the age of 18 (whose interests will be attributed to the director, shadow director or secretary).</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Israel</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Type of Grant&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633; </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capital Gain Award (&#8220;CGA&#8221;)</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ordinary Income Award (&#8220;OIA&#8221;)</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 3(i) Award</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Unapproved 102 Award</font></div><div><font><br></font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Settlement of PSUs</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Agreement, if the PSUs granted hereunder are 102 Awards, the PSUs shall be settled in Ordinary Shares only.</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Trust. </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All Approved 102 Awards shall be held in trust by a trustee designated by the Company (</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;Trustee&#34;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or shall be supervised by the Trustee in accordance with the instructions set forth by the Israeli Tax Authority (&#8220;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITA</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), for the requisite lockup period prescribed by the Ordinance and the regulations promulgated thereunder, or such other period as may be required by the ITA, during which period Awards or Ordinary Shares issued thereunder, and all rights resulting from them, including bonus shares, must be held or supervised by the Trustee in accordance with the instructions set forth by the ITA. The Trustee shall not release any Approved 102 Awards, Ordinary Shares issued upon the exercise of any Approved 102 Awards, or any rights, including bonus shares, resulting from such Approved 102 Awards or Ordinary Shares, prior to the full payment of your tax liability. The Trustee or the Israeli Affiliate shall withhold any applicable taxes in accordance with Section 102 or any applicable tax ruling obtained by the Company. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without derogating from the foregoing, if your PSUs do&#160;not qualify as Approved&#160;102 Awards the Company may still at its sole discretion deposit your PSUs in trust to ensure that taxes are properly withheld. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby release the Trustee from any liability in respect of any action or decision duly taken and executed in good faith in relation to any PSUs or Ordinary Shares issued to you thereunder. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Without derogating from Section 2.7(b) above, you hereby agree to indemnify the Company and&#47;or its Affiliates and&#47;or the Trustee and hold them harmless against and from any and all liability for all such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to you.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you agree to comply with the provisions of Section 102 and the regulations and rules promulgated thereunder or any tax ruling to be obtained by the Company in connection with your PSUs. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Italy</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax&#47;Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You are required to report on your annual tax return&#58;  (a) any foreign investments or investments (including the Ordinary Shares issued at vesting of the PSUs, cash or proceeds from the sale of Ordinary Shares acquired under the Plan) held outside of Italy, if the investment may give rise to income in Italy (this will include reporting the Ordinary </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Shares issued at vesting of the PSUs if the fair market value of such Ordinary Shares combined with other foreign assets)&#59; and (b) any changes during the financial year which have had an impact during the calendar year on your foreign investments or investments held outside of Italy.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are exempt from these formalities if the investments are made through an authorized broker resident in Italy, as the broker will comply with the reporting obligation on your behalf.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Kazakhstan</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to report the acquisition of shares of a foreign company to the National Bank of Kazakhstan. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Latvia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Lithuania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Luxembourg</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are required to report any inward remittances of funds to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Banque Central de Luxembourg </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and&#47;or the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Service Central de La Statistique et des Etudes Economiques</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Luxembourg financial institution is involved in the transaction, it generally will fulfill the reporting obligation on your behalf. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Mexico</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you understand and agree that any modification of the Plan or the Agreement or its termination shall not constitute a change or impairment of the terms and conditions of employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan Document Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the award of the PSUs, you acknowledge that you have received copies of the Plan, have reviewed the Plan and the Agreement in their entirety and fully understand and accept all provisions of the Plan and the Agreement.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, by signing the Agreement, you further acknowledge that you have read and specifically and expressly approve the terms and conditions in the Agreement, in which the following is clearly described and established&#58;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Participation in the Plan does not constitute an acquired right&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">The Plan and participation in the Plan is offered by the Company on a wholly discretionary basis&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">Participation in the Plan is voluntary&#59; and </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">The Company and any Parent, Subsidiary or Affiliates are not responsible for any decrease in the value of the shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowlegement and Policy Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In accepting the PSUs, you expressly recognize the Company is solely responsible for the administration of the Plan and that your participation in the Plan and acquisition of Ordinary Shares does not constitute an employment relationship between you and the Company since you are participating in the Plan on a wholly commercial basis and on a wholly commercial basis and your sole employer is Perrigo de Mexico S.A. De C.V. (&#8220;Perrigo Mexico&#8221;). Based on the foregoing, you expressly recognize that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and your employer, Perrigo Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Perrigo Mexico and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of your employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company&#59; therefore, the Company reserves the absolute right to amend and&#47;or discontinue your participation at any time without any liability to you.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or damages as a result of your participation in the Plan and therefore grant a full and broad release to the Employer, the Company and any Parent, Subsidiary or Affiliates with respect to any claim that may arise under the Plan.</font></div><div style="margin-bottom:12pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Spanish Translation</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modificaci&#972;n</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;Al aceptar las Unidades de Acci&#243;n Restringida de Rendimiento (PSUs, por sus siglas en ingl&#233;s) usted entiende y esta de acuerdo que cualquier modificaci&#243;n del plan o del acuerdo o su terminaci&#243;n no constituir&#225; un cambio o detrimento de los t&#233;rminos y condiciones de su empleo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Confirmaci&#243;n del Documento del Plan. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Al aceptar el otorgamiento de las PSUs, usted reconoce que ha recibido copias y ha revisado dicho acuerdo en su totalidad y que ha entendido y aceptado completamente todas las disposiciones contenidas en el Plan y en el Acuerdo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adicionalmente, al firmar el acuerdo, usted reconoce que ha le&#237;do, y aprobado de manera espec&#237;fica y expresa los t&#233;rminos y condiciones en el acuerdo en el que se describe y establece claramente los siguiente&#58;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:25.17pt">La participaci&#243;n en el Plan no constituye un derecho adquirido&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.98pt">El plan y la participaci&#243;n en el mismo, son ofrecidos por la Compa&#241;&#237;a de manera totalmente discrecional&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.79pt">La participaci&#243;n en el Plan es voluntaria&#59; y</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.42pt">La Compa&#241;&#237;a, y cualquier Sociedad controladora, Subsidiaria o Filiales no son responsables por ning&#250;n decremento en el valor de las Acciones.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Constancia de aceptaci&#243;n de la ley laboral y declaraci&#243;n de la pol&#237;tica.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160; Al aceptar las PSUs, usted reconoce expresamente que la Compa&#241;&#237;a, es la &#250;nica responsable de la administraci&#243;n del Plan, y que su participaci&#243;n en el Plan y la adquisici&#243;n de las acciones comunes no constituyen una relaci&#243;n de trabajo entre usted y la Compa&#241;&#237;a dado que usted participa en el Plan de manera completamente comercial y el &#250;nico empleador que tiene es Perrigo de M&#233;xico, S.A. de C.V. (&#171; Perrigo de Mexico &#187;). Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que usted pueda obtener de la participaci&#243;n en el Plan, no establecen ning&#250;n derecho entre usted y su empleador Perrigo de M&#233;xico y no forman parte de las condiciones de trabajo ni de las prestaciones ofrecidas por Perrigo de M&#233;xico y cualquier modificaci&#243;n del Plan o la terminaci&#243;n de &#233;ste, no constituyen un cambio o deterioro de los t&#233;rminos y condiciones de su trabajo.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adem&#225;s, usted comprende que su participaci&#243;n en el Plan es el resultado de una decisi&#243;n unilateral y discrecional de la Compa&#241;&#237;a&#59; por lo tanto, la Compa&#241;&#237;a se reserva el derecho absoluto de modificar y&#47;o interrumpir la participaci&#243;n de usted en cualquier momento sin ninguna responsabilidad para usted.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finalmente, usted declara que no se reserva ninguna acci&#243;n o derecho de presentar alg&#250;n reclamo o demanda en contra de la Compa&#241;&#237;a por compensaci&#243;n, da&#241;o o perjuicio alguno como resultado de su participaci&#243;n en el Plan, en consecuencia, otorga el m&#225;s amplio finiquito al Empleador, as&#237; como a la Compa&#241;&#237;a, a su Sociedad controladora, Subsidiaria o Filiales con respecto a cualquier demanda que pudiera originarse en virtud del Plan.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Netherlands</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dutch insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Norway</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Norwegian insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor as well as the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Cross-border payments in excess of NOK 100,000 must be reported to the Norwegian foreign exchange register (Valutaregisteret). If you use a Norwegian bank to transfer a cross-border payment in excess of NOK 100,00 in connection with the sale of shares acquired under the Plan, the bank will make the report on your behalf. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In your Norwegian income tax return, each year you are required to report any security, shares or bank accounts (including brokerage accounts and the Company &#8220;Account&#8221; referenced in section 1.5 of the Agreement) you maintain outside of Norway. The Company &#8220;Account&#8221; should not be treated as taxable wealth, as long as the right to receive the dividends is conditional, but you must report it.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Poland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold foreign securities (including shares pursuant to the Award) and maintain accounts abroad, you may be required to file certain reports with the National Bank of Poland (&#8220;NBP&#8221;). Specifically, if the value of securities and cash held in such foreign accounts exceeds PLN 7,000,000 (or equivalent thereof in another currency) at the end of the year, you must file reports on the transactions and balances of the accounts on a quarterly basis by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26th day of the month following the end of each quarter. In case you are being in regime of a joint marital property, the above threshold shall apply to joint property of the spouses. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, if you hold, at the beginning or end of the year, at least 10% of votes in the decision-making body of the entity based abroad (and you are person meeting the prievusly mentioned criteria), an annual notification, on the official form, must be submitted by you to the NBP by May 31 of the following year.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If at the end of the year you did not reach the given threshold but in the next year, at the end of a calendar quarter, you reach the threshold, you are obliged to submit the appropriate form to NBP for this quarter and each of the following quarters of this calendar year (within 26 days from the end of each calendar quarter). Such reports are filed on special forms available on the website of the NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The foregoing duties represents personal responsibilities of each shareholder and cannot be fulfilled by any entity on your behalf.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, if you are a Polish citizen and you transfer funds abroad in excess of the PLN equivalent of &#8364;15,000, the transfer must be made through an authorized bank, a payment institution or an electronic money institution authorized to render payment services. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Furthermore, at the banks&#8217; request, you may be required to inform eligible banks, within the meaning of the Foreign Exchange Act, about all foreign exchange transactions performed through them.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are also required to retain the documents connected with foreign exchange transactions for a period of five years, as measured from the end of the year in which such transaction occurred.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Zgoda na otrzymywanie informacji w j&#281;zyku angielskim.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Akceptuj&#261;c Opcj&#281;, potwierdzasz przeczytanie i zrozumienie Programu i Umowy, kt&#243;re zosta&#322;y dostarczone w j&#281;zyku angielskim. W zwi&#261;zku z tym akceptujesz warunki tych dokument&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informacje o kontroli dewizowej. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li jeste&#347; w posiadaniu zagranicznych papier&#243;w warto&#347;ciowych (w tym akcji) i posiadasz rachunki za granic&#261;, mo&#380;esz by&#263; zobowi&#261;zany(-a) do z&#322;o&#380;enia okre&#347;lonych sprawozda&#324; w Narodowym Banku Polskim (&#8222;NBP&#8221;. W szczeg&#243;lno&#347;ci, je&#347;li warto&#347;&#263; papier&#243;w warto&#347;ciowych i &#347;rodk&#243;w pieni&#281;&#380;nych gromadzonych na takich rachunkach zagranicznych przekracza na koniec roku 7 000 000 PLN (lub ekwiwalent tej kwoty w innej walucie), nale&#380;y co kwarta&#322; sk&#322;ada&#263; raporty z transakcji i sald rachunk&#243;w do 26 dnia miesi&#261;ca nast&#281;puj&#261;cego po zako&#324;czeniu ka&#380;dego kwarta&#322;u. W przypadku pozostawania we wsp&#243;lno&#347;ci maj&#261;tkowej z ma&#322;&#380;onkiem, powy&#380;szy pr&#243;g dotyczy maj&#261;tku wsp&#243;lnego ma&#322;&#380;onk&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#380;eli posiadasz na pocz&#261;tek lub koniec roku co najmniej 10% g&#322;os&#243;w w organie stanowi&#261;cym podmiotu z siedzib&#261; za granic&#261; (i jeste&#347; osob&#261; spe&#322;niaj&#261;c&#261; wy&#380;ej wskazane warunki) musisz z&#322;o&#380;y&#263; w NBP do 31 maja nast&#281;pnego roku dodatkowy raport. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li pod koniec roku nie osi&#261;gn&#261;&#322;e&#347;(-a&#347;) okre&#347;lonego progu, ale w nast&#281;pnym roku, pod koniec kwarta&#322;u kalendarzowego, osi&#261;gniesz pr&#243;g, musisz z&#322;o&#380;y&#263; odpowiedni formularz do NBP za ten kwarta&#322; i ka&#380;dy z kolejnych kwarta&#322;&#243;w tego roku kalendarzowego (w ci&#261;gu 26 dni od zako&#324;czenia ka&#380;dego kwarta&#322;u kalendarzowego). Takie raporty s&#261; sk&#322;adane w specjalnych formularzach dost&#281;pnych na stronie internetowej NBP.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#347;li jeste&#347; obywatelem Polski i przekazujesz &#347;rodki za granic&#281; w wysoko&#347;ci przekraczaj&#261;cej r&#243;wnowarto&#347;&#263; 15 000 EUR w PLN, przelewu nale&#380;y dokona&#263; za po&#347;rednictwem upowa&#380;nionego banku, instytucji p&#322;atniczej lub instytucji pieni&#261;dza elektronicznego uprawnionej do &#347;wiadczenia us&#322;ug p&#322;atniczych. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto na &#380;&#261;danie bank&#243;w niezb&#281;dne mo&#380;e by&#263; poinformowanie uprawnionych bank&#243;w, w rozumieniu ustawy Prawo dewizowe (Foreign Exchange Act), o wszystkich transakcjach walutowych przeprowadzanych za ich po&#347;rednictwem.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Jeste&#347; r&#243;wnie&#380; zobowi&#261;zany(-a) do przechowywania dokument&#243;w zwi&#261;zanych z transakcjami wymiany walut przez okres pi&#281;ciu lat, mierzony od ko&#324;ca roku, w kt&#243;rym taka transakcja zosta&#322;a wykonana</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Portugal</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Language Consent.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You hereby expressly declare that you have full knowledge of the English language and have read, understood and fully accepted and agreed with the terms and conditions established in the Plan and Award Agreement.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Conhecimento da Lingua.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> O Contratado, pelo presente instrumento, declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo de Atribui&#231;&#227;o (Award Agreement em ingl&#234;s). </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Romania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Statistical Reporting.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">According to art. 92 of NBR Reg. 4&#47;2021, if you, as a resident of Romania within the meaning of NBR Reg. 4&#47;2021, acquire more than 10% of the share capital in a foreign company, the acquisition must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be reported to the National Bank of Romania (&#8220;NBR&#8221;) for statistical purposes within 30 calendar days of acquisiting the ownership right over the shares of the foreign company. You should consult your personal advisor to determine whether you will be required to submit such documentation to the NBR pursuant to your participation in the Plan. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Insider-trading rules prohibit you from carrying out  certain transactions involving shares if you have inside information about the Company (insider dealing). If you are uncertain whether the insider-trading rules apply to you, including with regard to the fact that the Company is listed on the New York Stock Exchange (NYSE), you should consult your personal legal advisor. Depending on the applicable market abuse legislation, you might be subject to certain restrictions on the freedom to trade the shares that are settled through the RSU award, including any applicable prohibition on insider dealing, market manipulation or the unlawful disclosure of inside information.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Serbia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovakia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset Reporting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a foreign asset reporting obligation if you are considered providing independent professional services &#8220;podnikatel&#8221;. You should consult with a personal tax advisor to understand your filing obligations.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovenia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">South Africa</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the PSUs, you agree that, immediately upon vesting of the PSUs, you may need to notify your employer of the amount of any gain realized. If you fail to advise your employer of the gain realized upon vesting, you may be liable for a fine. You will be solely responsible for paying any difference between the actual tax liability and the amount withheld by your employer. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Because no transfer of funds from South Africa is required under the PSUs, no filing or reporting requirements should apply when the award is granted nor when Ordinary Shares are issued upon vesting of the PSUs. However, because the exchange control regulations are subject to change, you should consult your personal advisor prior to vesting and settlement of the award to ensure compliance with current regulations. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Spain</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Entitlement for Claims or Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the award of PSUs, you consent to participation in the Plan, and acknowledge that you have received a copy of the Plan document.  You understand that the Company has unilaterally, gratuitously and in its sole discretion decided to make awards of PSUs under the Plan to individuals who may be employees, consultants and directors throughout the world. The decision is limited and entered into based upon the express assumption and condition that any PSUs will not economically or otherwise bind the Company or any Parent, Subsidiary or Affiliate, including your employer, on an ongoing basis, other than as expressly set forth in the Agreement. Consequently, you understand that the Award is given on the assumption and condition that the PSUs shall not become part of any employment contract (whether with the Company or any Parent, Subsidiary or Affiliate, including your employer) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever. Furthermore, you understand and freely accept that there is no guarantee that any benefit whatsoever shall arise from the award, which is gratuitous and discretionary, since the future value of the PSUs and the underlying shares is unknown and unpredictable. You also understand that this Award would not be made but for the assumptions and conditions set forth hereinabove&#59; thus, you understand, acknowledge and freely accept that, should </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the Award, the PSUs and any right to the underlying shares shall be null and void.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the PSUs, your termination of service for any reason other than death or disability (including for the reasons listed below) will automatically result in the cancellation and loss of any PSUs that may have been granted to you and that were not or did not become vested on the date of termination of service. In particular, you understand and agree that, unless otherwise expressly provided by the Company in this Agreement, the PSUs will be cancelled without entitlement to the Shares or to any amount as indemnification if you terminate service by reason of, but not limited to, the following&#58; resignation&#59; disciplinary dismissal adjudged to be with cause&#59; disciplinary dismissal adjudged or recognized to be without good cause (i.e., subject to a &#34;despido improcedente&#34;)&#59; individual or collective layoff on objective grounds, whether adjudged to be with cause or adjudged or recognized to be without cause&#59; material modification of the terms of employment under Article 41 of the Workers&#8217; Statute&#59; relocation under Article 40 of the Workers&#8217; Statute&#59; Article 50 of the Workers&#8217; Statute&#59; unilateral withdrawal by your employer&#59; and under Article 10.3 of Royal Decree 1382&#47;1985.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You must declare the acquisition, ownership and disposition of stock in a foreign company (including Ordinary Shares acquired under the Plan) to the Spanish Direcci&#243;n General de Comercio e Inversiones (the &#8220;DGCI&#8221;), the Bureau for Commerce and Investments, which is a department of the Ministry of Economy and Competitiveness, for statistical purposes.  Generally, the declaration must be made in January for Ordinary Shares acquired or sold during (or owned as of December 31 of) the prior year&#59; however, this obligation only applies in the cases in which you hold 10% or more of the sares capital of the Company or 10% or more of the voting tights of the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, you may be required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts held abroad), any foreign instruments (e.g., Ordinary Shares) and any transactions with non-Spanish residents (including any payments of cash or shares made to you by the Company) if the balances in such accounts together with the value of such instruments as of December 31, or the volume of transactions with non-Spanish residents during the prior or current year, exceeds &#8364;1,000,000.  Generally, you will only be required to report on an annual basis (by January 20 of each year).  Note that if the value is less than &#8364;1,000,000, there is only an obligation to declare this information to the Bank of Spain upon request from the Bank of Spain, in which case the deadline is two months since the request is received.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When receiving foreign currency payments derived from the ownership of Ordinary Shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">., dividends or sale proceeds), you must inform the financial institution receiving the payment of the basis upon which such payment is made. Should amounts exceed &#8364;12,500, you will need to provide the following information to the Spanish Registered Entity&#58; (i) your name, address, and fiscal identification number&#59; (ii) the name and corporate domicile of the Company&#59; (iii) the amount of the payment and the currency used&#59; (iv) the country of origin&#59; (v) the reasons for the payment&#59; and (vi) further information that may be required. Exceptions to this rule are when you move funds through a Spanish resident bank account opened abroad, or when collections and payments are carried out in cash. These exceptions, however, are subject to their own reporting requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold assets or rights outside of Spain (including shares acquired under the Plan), you may have to file an informational tax report, Form 720, with the tax authorities declaring such ownership by March 31st of the following year.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Generally, there is no obligation to file Form 720 if the total value of the following does not exceed Euro 50,000&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">the securities, shares, rights and participations held by you, on December 31 or at any time throughout the year, in any kind of entities or in investment funds located outside Spain&#59;</font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">any transfer of own capital to third parties located abroad&#59; and</font></div><div style="margin-bottom:12pt;padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">life and disability insurances in which the individual was policy holder on December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that if an asset is jointly owned, the value is not prorated. Please also note that the application of the rules in respect of valuation of assets and transfers during the year should be carefully analyzed. If the limit of Euro 50,000 euros is exceeded for this described group of assets, all the elements of this group must be reported.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For those taxpayers who have filed Form 720 in previous years, they will only be obliged to file it again&#58;</font></div><div style="padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.7pt">When the aggregated value of the assets included in the mentioned group (shares&#47;insurances) had increased in an amount higher than Euro 20,000 regarding the informative return filed in a previous year.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.02pt">When the individual&#8217;s condition (owner, co-owner, co-titleholder or co-authorized) had changed or was extinguished during the year, before 31st December, with regard to any of the assets.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the thresholds for annual filing requirements may change each year. Therefore, you should consult your personal advisor regarding whether you will be required to file an informational tax report for asset and rights that you hold abroad.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Sweden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The following shall apply in addition to what is set out under section 2.14 of the Award Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Forfeiture of entitlements under the Plan in case of termination shall apply in case of termination of employment regardless of whether such termination of employment may be justified under Swedish employment protection legislation, and regardless of whether such termination may be challenged by you, and regardless of whether such termination is invalidated by verdict or a court order.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax withholdings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You authorize the Company and&#47;or the Employing Company to withhold or sell shares otherwise distributable to you upon vesting or settlement to satisfy the Company&#8217;s payroll tax withholding obligations.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Switzerland</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securitities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The PSUs and the issuance of any Ordinary Shares thereunder is not intended to be publicly offered in or from Switzerland.  Neither this Award Agreement nor any other materials relating to the Award (1) constitute a prospectus as such term is understood pursuant to article 652a of the Swiss Code of Obligations, (2) may be publicly distributed nor otherwise made publicly available in Switzerland, or (3) have been or will be filed with, approved or supervised by any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are obliged to submit an ordinary annual tax return in Switzerland, you are required to file a salary certificate with the Swiss tax authorities together with your Swiss tax return. The Company or the Affiliate employing you is obliged to prepare a specific attachment regarding the PSUs to this salary certificate. Before Settlement, for wealth tax purposes, the number of PSUs should be declared with p.m (zero value) in the asset statement of the tax return. After Settlement the total number of Ordinary Shares received are subject to wealth tax at the end of the calendar year and must be declared in your Swiss tax return.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Turkey</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Under Turkish law, you are not permitted to sell Ordinary Shares acquired under the Plan in Turkey.  The Ordinary Shares are currently traded on the Nasdaq Global Select Market, which is located outside of Turkey, under the ticker symbol &#8220;PRGO&#8221; and the Ordinary Shares may be sold through this exchange.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ukraine </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to obtain a license for obtaining shares of a foreign company from the National Bank of Ukraine (NBU). </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award will be outside the scope of your employment or service contract (if any) and as such will not constitute a part of your compensation package under the respective employment or service contract.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">United Kingdom</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Income Tax and National Insurance Contribution Withholding.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The following provision supplements the terms in the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If payment or withholding of the income tax due in connection with the PSUs is not made within ninety (90) days of the end of the U.K. tax year in which the event giving rise to the income tax liability or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003 occurred (the &#8220;Due Date&#8221;), the amount of any uncollected income tax shall constitute a loan owed by you to your employer, effective as of the Due Date.  You agree that the loan will bear interest at the then-current official rate of His Majesty&#8217;s Revenue &#38; Customs (&#8220;HMRC&#8221;), it shall be immediately due and repayable, and the Company or your employer may recover it at any time thereafter by any of the means referred to in Section 2.7 of the Agreement.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if you are a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), you will not be eligible for a loan from the Company or your employer to cover the income tax liability.  In the event that you are a director or executive officer and the income tax is not collected from or paid by the Due Date, the amount of any uncollected income tax will constitute a benefit to you on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) will </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">33</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be payable.  You will be responsible for reporting any income tax for reimbursing the Company or your employer the value of any employee NICs due on this additional benefit. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*   *   *   *   *</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">34</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex103-2023psusrtsrgrantagr.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8c51cc1c1a2e4292b3e3e26e4c887b72_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERRIGO COMPANY PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(PERFORMANCE-BASED)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Under the Perrigo Company plc 2019 Long-Term Incentive Plan)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant Name</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RE&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Restricted Stock Unit Award (Performance-Based)</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This is to notify you that Perrigo Company plc (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), effective as of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grant Date </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  This Award consists of performance-based restricted stock units.  The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Units &#8211; Performance-Based Vesting</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As of the Grant Date, the Company grants to you </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Number of Awards Granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> performance-based restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), subject to the terms and conditions set forth in this Agreement.  The number of PSUs awarded in this Section 1.1 is referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Target Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;  The Target Award may be increased or decreased depending on the level of attainment of the Performance Goals described in Section 1.2.  Each PSU entitles you to one ordinary share of the Company, nominal value &#8364;0.001 per share (&#8220;Ordinary Share&#8221;) on the PSU Vesting Date set forth in Section 1.2, provided the applicable Performance Goals for the Performance Measure are satisfied.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The number of PSUs awarded in Section 1.1 vesting, if any, shall be determined as of the PSU Vesting Date.  That number will be determined based on the level of attainment of the Performance Goals for the Performance Period, in accordance with the schedule determined by the Committee at the time the Performance Goals for the Performance Measure are established by the Committee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At the beginning of a Performance Period, the Committee shall establish one or more Performance Goals for the Performance Measure that must be attained for Threshold, Target and Maximum performance for that Performance Period.  The Performance Goal(s) will be provided to you.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Following the end of the Performance Period, the Committee will determine the percentage of Target Award PSUs that would be payable for the Performance Period based on the attainment of the Performance Goals established for that Performance Period.  The percentage of the Target Award that would be payable under the schedule shall be adjusted, pro rata, to reflect the attained performance between Threshold and Target, and Target and Maximum.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as provided in Section 1.4, the PSUs will be permanently forfeited if your Termination Date occurs prior to the PSU Vesting Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following terms shall have the following meanings under this Section 1.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Index</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; for the Performance Period means the applicable index or the comparison group of peer companies selected by the Committee.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Goal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the level of performance that must be attained with respect to the Performance Measure for the Performance Period for Minimum, Target and Maximum payout.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Measure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means relative total shareholder return (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">rTSR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) which shall be based on (i) the 20-day trading price average of Ordinary Shares (as adjusted for dividends) at the end of the Performance Period (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Ending Average</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) over the 20-day trading price average of Ordinary Shares (as adjusted for dividends) at the beginning of the Performance Period (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beginning Average</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and (ii) the extent to which the Ending Average of the Applicable Index exceeds the Beginning Average of the Applicable Index.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Committee shall provide how the Performance Measure will be adjusted, if at all, as a result of extraordinary events or circumstances, as determined by the Committee, or to exclude the effects of extraordinary, unusual, or non-recurring items&#59; changes in applicable laws, regulations, or accounting principles&#59; currency fluctuations&#59; discontinued operations&#59; non-cash items, such as amortization, depreciation, or reserves&#59; asset impairment&#59; or any recapitalization, restructuring, reorganization, merger, acquisition, divestiture, consolidation, spin-off, split-up, combination, liquidation, dissolution, sale of assets, or other similar corporation transaction.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the three-consecutive fiscal year period of the Company beginning on January 1 of the year in which the Grant Date occurs and ending on December 31 of the third year in the three-year period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PSU Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the last day of the Performance Period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Separation for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means your voluntary resignation from the Company and the existence of one or more of the following conditions that arose without your consent&#58; (i) a material change in the geographic location at which you are required to perform services, such that your commute between home and your primary job site increases by more than 30 miles,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or (ii) a material diminution in your authority, duties or responsibilities or a material diminution in your base compensation or incentive compensation opportunities&#59; provided, however, that a voluntary resignation from the Company shall not be considered a Separation for Good Reason unless you provide the Company with notice, in writing, of your voluntary resignation and the existence of the condition(s) giving rise to the separation within 90 days of its initial existence.  The Company will then have 30 days to remedy the condition, in which case you will not be deemed to have incurred a Separation for Good Reason.  In the event the Company fails to cure the condition within the 30 day period, your Termination Date shall occur on the 31st day following the Company&#8217;s receipt of such written notice.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination without Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the involuntary termination of your employment or contractual relationship by the Company without Cause, including, but not limited to, (i) a termination effective when you exhaust a leave of absence during, or at the end of, a notice period under the Worker Adjustment and Retraining Notification Act (&#8220;WARN&#8221;), and (ii) a situation where you are on an approved leave of absence during which your position is protected under applicable law (e.g., a leave under the Family Medical Leave Act), you return from such leave, and you cannot be placed in employment or other form of contractual relationship with the Company.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Vesting Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding Section 1.2 above, if your Termination Date occurs by reason of a Termination without Cause or a Separation for Good Reason on or after a Change in Control (as defined in the Plan and as such definition may be amended </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">hereafter) and prior to the two (2) year anniversary of the Change in Control, all of the PSUs awarded under Section 1.1 that have not previously been forfeited shall become fully vested as if Target performance had been obtained for the Performance Period effective as of your Termination Date. If your Termination Date occurs because of death, Disability, or Retirement, the PSUs shall vest or be forfeited as of the PSU Vesting Date set forth in Section 1.2, based on the attainment of the performance goals.   If your Termination Date occurs in the 24-month period preceding the PSU Vesting Date because of an Involuntary Termination for Economic Reasons, all of the PSUs awarded hereunder shall vest or be forfeited as of the date set forth in Section 1.2, depending on the attainment of Performance Goals&#59; provided, however, that if your Termination Date occurs for a reason that is both described in this sentence and in the first sentence of this Section 1.4, the special vesting rules described in the first sentence of this Section 1.4 shall apply in lieu of the vesting rules described in this sentence.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as practicable following the date of the Committee&#8217;s first regularly scheduled meeting following the last day of the Performance Period at which the Committee certifies the attainment of the Performance Goals for the Performance Period (or, if earlier, the date on which the PSUs become vested pursuant to the special vesting rules described in Section 1.4), the Company shall transfer to you one Ordinary Share for each PSU, if any, that becomes vested pursuant to Section 1.2 or 1.4 of this Agreement (the date of any such transfer shall be the &#8220;settlement date&#8221; for purposes of this Agreement)&#59; provided, however, the Company in its discretion may settle PSUs in cash, based on the fair market value of the shares on the vesting date.  No fractional shares shall be transferred.  Any fractional share shall be rounded to the nearest whole share.  The income attributable to the vesting of PSUs and the amount of any required tax withholding will be determined based on the value of the shares on the settlement date.  PSUs are not eligible for dividend equivalents. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">General Terms and Conditions</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nontransferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award under this Agreement shall not be transferable other than by will or by the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You shall not have any rights as a stockholder with respect to any Ordinary Shares subject to the PSU awarded under this Agreement prior to the date of issuance to you of a certificate or certificates for such shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If your Termination Date occurs for reasons of Cause, all of your rights under this Agreement, whether or not vested, shall terminate immediately.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The granting of the Award under this Agreement is being made pursuant to the Plan and the Award shall be payable only in accordance with the applicable terms of the Plan.  The Plan contains certain definitions, restrictions, limitations and other terms and conditions all of which shall be applicable to this Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ALL THE PROVISIONS OF THE PLAN ARE INCORPORATED HEREIN BY REFERENCE AND ARE MADE A PART OF THIS AGREEMENT IN THE SAME MANNER AS IF EACH AND EVERY SUCH PROVISION WERE FULLY WRITTEN INTO THIS AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Should the Plan become void or unenforceable by operation of law or judicial decision, this Agreement shall have no force or effect.  Nothing set forth in this Agreement is intended, nor shall any of its provisions be construed, to limit or exclude any definition, restriction, limitation or other term or condition of the Plan as is relevant to this Agreement and as may be specifically applied to it by the Committee.  In the event of a conflict in the provisions of this Agreement and the Plan, as a rule of construction the terms of the Plan shall be deemed superior and apply.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments in Event of Change in Ordinary Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of a stock split, stock dividend, recapitalization, reclassification or combination of shares, merger, sale of assets or similar event, the number and kind of shares subject to Award under this Agreement will be appropriately adjusted in an equitable manner to prevent dilution or enlargement of the rights granted to or available for you.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and you agree that the PSUs are granted under and governed by the Notice of Grant, this Agreement (including the Appendix, if applicable) and by the provisions of the Plan (incorporated herein by reference).  You&#58; (i) acknowledge receipt of a copy of each of the foregoing documents, (ii) represent that you have carefully read and are familiar with their provisions, and (iii) hereby accept the PSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes and Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding (Only Applicable to Individuals Subject to U.S. Tax Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Award is subject to the withholding of all applicable taxes.  The Company may withhold, or permit you to remit to the Company, any Federal, state or local taxes applicable to the grant, vesting or other event giving rise to tax liability with respect to this Award.  If you have not remitted the full amount of applicable withholding taxes to the Company by the date the Company is required to pay such withholding to the appropriate taxing authority (or such earlier date that the Company may specify to assist it in timely meeting its withholding obligations), the Company shall have the unilateral right to withhold Ordinary Shares relating to this Award in the amount it determines is sufficient to satisfy the tax withholding required by law.  State taxes will be withheld at the appropriate rate set by the state in which you are employed or were last employed by the Company.  In no event may the number of shares withheld exceed the number necessary to satisfy the maximum Federal, state and local income and employment tax withholding requirements.  You may elect to surrender previously acquired Ordinary Shares or to have the Company withhold Ordinary Shares relating to this Award in an amount sufficient to satisfy all or a portion of the tax withholding required by law.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Responsibility for Taxes (Only Applicable to Individuals Subject to Tax Laws Outside the U.S.)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Regardless of any action the Company or, if different, the Affiliate employing or retaining you takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (&#8220;Tax-Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items is and remains your responsibility and may exceed the amount actually withheld by the Company or the Affiliate employing or retaining you.  You further acknowledge that the Company and&#47;or the Affiliate employing or retaining you (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PSUs, including, but not limited to, the grant, vesting or settlement of the PSUs, the subsequent sale of Ordinary Shares acquired pursuant to such settlement and the receipt of any dividends&#59; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the PSUs to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result.  Further, if you have become subject to tax in more than one jurisdiction between the PSU Grant Date and the date of any relevant taxable event, as applicable, you acknowledge that the Company and&#47;or the Affiliate employing or retaining you (or formerly employing or retaining you, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Prior to any relevant taxable or tax withholding event, as applicable, you will pay or make adequate arrangements satisfactory to the Company and&#47;or the Affiliate employing or retaining you to satisfy all Tax-Related Items.  In this regard, you authorize the Company and&#47;or the Affiliate employing or retaining you, or their respective </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58;  </font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;withholding from your wages or other cash compensation paid to you by the Company and&#47;or the Affiliate employing or retaining you&#59; or</font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;withholding from proceeds of the sale of Ordinary Shares acquired upon settlement of the PSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization)&#59; or </font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)&#160;&#160;&#160;&#160;withholding in Ordinary Shares to be issued upon settlement of the PSUs.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;To avoid negative accounting treatment, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates.  If the obligation for Tax-Related Items is satisfied by withholding in Ordinary Shares, for tax purposes, you are deemed to have been issued the full number of Ordinary Shares subject to the vested PSUs, notwithstanding that a number of the Ordinary Shares are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Finally, you shall pay to the Company or the Affiliate employing or retaining you any amount of Tax-Related Items that the Company or the Affiliate employing or retaining you may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to issue or deliver the Ordinary Shares or the proceeds of the sale of Ordinary Shares, if you fail to comply with your obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The issuance of Ordinary Shares will be subject to and conditioned upon compliance by the Company and you, including any written representations, warranties and agreements as the Administrator may request of you for compliance with all (i) applicable U.S. state and federal laws and regulations, (ii) applicable laws of the country where you reside pertaining to the issuance or sale of Ordinary Shares, and (iii)&#160;applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Ordinary Shares may be listed or quoted at the time of such issuance or transfer.  Notwithstanding any other provision of this Agreement, the Company shall have no obligation to issue any Ordinary Shares under this Agreement if such issuance would violate any applicable law or any applicable regulation or requirement of any securities exchange or similar entity.</font></div><div style="margin-bottom:12pt;text-indent:31.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Short Term Deferral (Only Applicable to Individuals Subject to U.S. Federal Tax Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  PSUs payable under this Agreement are intended to be exempt from Code Section 409A under the exemption for short-term deferrals.  Accordingly, PSUs will be settled no later than the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of the third month following the later of (i) the end of the Employee&#8217;s taxable year in which the vesting date occurs, or (ii) the end of the fiscal year of the Company in which the vesting date occurs.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Data Privacy Rules (Only Applicable if this Award is Subject to U.S. Data Privacy Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By entering into this Agreement and accepting this Award, you (a)&#160;explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of any of your personal data that is necessary to facilitate the implementation, administration and management of the Award and the Plan, (b) understand that the Company may, for the purpose of implementing, administering and managing the Plan, hold certain </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, and details of all awards or entitlements to Shares granted to you under the Plan or otherwise (&#8220;Personal Data&#8221;), (c) understand that Personal Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including any broker with whom the Shares issued upon vesting of the Award may be deposited, and that these recipients may be located in your country or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than your country, (d) waive any data privacy rights you may have with respect to the data, and (e) authorize the Company, its Affiliates and its agents, to store and transmit such information in electronic form.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Data Privacy Rules (Only Applicable if this Award is Subject to Data Privacy Laws Outside of the U.S.)</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;By entering into this Agreement and accepting this Award, you hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other PSU grant materials by and among, as applicable, the Affiliate employing or retaining you, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;You understand that the Company and the Affiliate employing or retaining you may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Ordinary Shares or directorships held in the Company, details of all PSUs or any other entitlement to Ordinary Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (&#8220;Data&#8221;).  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;You understand that Data will be transferred to legal counsel or a broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients&#8217; country (e.g., the United States) may have different data privacy laws and protections than your country of residence.  You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local or Company human resources representative.  You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan.  You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local or Company human resources representative.  You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local or Company human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be binding upon any or all successors and assigns of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed and enforced in accordance with the applicable Code provisions to the maximum extent possible and otherwise by the laws of the State of Michigan without regard to principals of conflict of laws, provided that if you are a foreign national or employed outside the United States, this Agreement shall be governed by and construed and enforced in accordance with applicable foreign law to the extent that such law differs from the Code and Michigan law.  Any proceeding related to or arising out of this Agreement shall be commenced, prosecuted or continued in the Circuit Court in Kent County, Michigan located in Grand Rapids, Michigan or in the United Stated District Court for the Western District of Michigan, and in any appellate court thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Forfeiture of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company, as a result of misconduct, is required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, then (a) if your incentive or equity-based compensation is subject to automatic forfeiture due to such misconduct and restatement under Section 304 of the Sarbanes-Oxley Act of 2002, or (b) the Committee determines you either knowingly engaged in or failed to prevent the misconduct, or your actions or inactions with respect to the misconduct and restatement constituted gross negligence, you shall (i) be required to reimburse the Company the amount of any payment relating to any PSUs earned or accrued during the twelve month period following the first public issuance or filing with the SEC (whichever first occurred) of the financial document embodying such financial reporting requirement, and (ii) all outstanding PSUs that have not yet been settled shall be immediately forfeited.  In addition, Ordinary Shares acquired under this Agreement, and any gains or profits on the sale of such Ordinary Shares, shall be subject to any &#8220;clawback&#8221; or recoupment policy later adopted by the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Rules for Non-U.S. Grantees (Only Applicable if You Reside Outside of the U.S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In accepting the grant, you acknowledge, understand and agree that&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, except as otherwise provided in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;the grant of the PSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of PSUs, or benefits in lieu of PSUs, even if PSUs have been granted repeatedly in the past&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;all decisions with respect to future PSUs grants, if any, will be at the sole discretion of the Company&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;you are voluntarily participating in the Plan&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are an extraordinary item and which is outside the scope of your employment or service contract, if any&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(6)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are not intended to replace any pension rights or compensation&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">considered as compensation for, or relating in any way to, past services for the Company, the Affiliate employing or retaining you or any other Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(8)&#160;&#160;&#160;&#160;the grant and your participation in the Plan will not be interpreted to form an employment or service contract with the Company or any Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(9)&#160;&#160;&#160;&#160;the future value of the underlying Ordinary Shares is unknown, indeterminable and cannot be predicted with certainty&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(10)&#160;&#160;&#160;&#160;no claim or entitlement to compensation or damages shall arise from forfeiture of the PSUs resulting from your Termination Date (for any reason whatsoever, whether or not later found to be invalid and whether or not in breach of employment laws in the jurisdiction where you are employed or rendering services, or the terms of your employment agreement, if any), and in consideration of the grant of the PSUs to which you are otherwise not entitled, you irrevocably agree never to institute any claim against the Company or the Affiliate employing or retaining you, waive your ability, if any, to bring any such claim, and release the Company and the Affiliate employing or retaining you from any such claim&#59; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, you shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim&#59; and</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(11)&#160;&#160;&#160;&#160;you acknowledge and agree that neither the Company, the Affiliate employing or retaining you nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the currency of the country in which you reside and the United States Dollar that may affect the value of the PSUs or of any amounts due to you pursuant to the settlement of the PSUs or the subsequent sale of any Ordinary Shares acquired upon settlement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Notwithstanding any provisions in this Agreement, the PSUs grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement.  Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to you, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan.  If you relocate to the United States, the special terms and conditions in the Appendix will apply, or cease to apply, to you, to the extent the Company determines that the application or otherwise of such provisions is necessary or advisable in order to facilitate the administration of the Plan.  The Appendix constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company reserves the right to impose other requirements on your participation in the Plan, on the PSUs and on any Ordinary Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.15&#160;&#160;&#160;&#160;&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Noncompetition and Nonsolicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Noncompetition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During your employment with the Company and its Affiliates and for a twelve (12) month period following your Termination Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), you shall not (i) directly or indirectly, without the prior written consent of the Company, engage in or invest as an owner, partner, stockholder, licensor, director, officer, agent or consultant for any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the world&#59; or (ii) accept </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">employment or an engagement for the provision of services in any capacity, including as an employee, director, consultant or advisor, directly or indirectly, with any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the world except where prohibited by local law . For purposes hereof, conducting a business that is in competition with a business conducted by the Company or any of its Affiliates shall include the sale, manufacture, distribution or research and development of any product or service that is similar to a product or service sold, distributed, marketed or being researched or developed (including through a joint venture or investment in another entity) by the Company or any of its Affiliates, including store brand and value brand OTC drug or nutritional products, extended topical generic prescription pharmaceutical products, infant nutrition products, oral care products, and any other product or products that the Company or an Affiliate is marketing or actively planning to market during your employment with the Company and during the oneyear period following your Termination Date. If there is a completed sale, transfer or other disposition of the Perrigo Prescription Pharmaceutical business during the Restricted Period, this Section 2.15(a) will not apply to the Perrigo Prescription Pharmaceutical business.  Notwithstanding the foregoing, nothing in this provision shall prevent you from passively owning two percent (2%) or less of the outstanding securities of any class of any company listed on a national securities exchange or quoted on an automated quotation system.  You may make a written request in writing to the CHRO of the Company for an exception to this Section 2.15(a) and such exception will not be unreasonably withheld.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nonsolicitation of Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During your employment with the Company and its Affiliates and for the duration of the Restricted Period, you shall not, directly or indirectly, without the prior written consent of the Company, (i) actively solicit, recruit or hire any Person who is at such time, or who at any time during the 12month period prior to such solicitation or hiring had been, an employee or consultant of the Company or any of its Affiliates, (ii) solicit or encourage any employee of the Company or any of its Affiliates to leave the employment of the Company or any of its Affiliates or (iii) interfere with the relationship of the Company or any of its Affiliates with any Person or entity who or that is employed by or otherwise engaged to perform services for the Company or any of its Affiliates except where prohibited by local law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nonsolicitation of Clients</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During your employment with the Company and its Affiliates and for the duration of the Restricted Period, you shall not, directly or indirectly, alone or in association with any other Person, without the prior written consent of the Company, (i) induce or attempt to induce any client, customer (whether former or current), supplier, licensee, franchisee, joint venture partner or other business relation of the Company or any of its Affiliates (collectively, &#8220;Clients&#8221;) to cease doing business with the Company or any such Affiliate, (ii) divert all or any portion of a Client&#8217;s business with the Company to any competitor of the Company or any such Affiliate, or (iii) in any way interfere with the relationship between any Client, on the one hand, and the Company or any such Affiliate, on the other hand except where prohibited by local law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Remedies and Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that a violation by you of any of the covenants contained in this Section 2.15 would cause irreparable damage to the Company and its Affiliates in an amount that would be material but not readily ascertainable, and that any remedy at law (including the payment of damages) would be inadequate. Accordingly, you agree that, notwithstanding any provision of this Agreement to the contrary, in addition to any other damages it is able to show, the Company and its Affiliates shall be entitled (without the necessity of showing economic loss or other actual damage) to injunctive relief (including temporary restraining orders, preliminary injunctions and permanent injunctions), without posting a bond, in any court of competent jurisdiction for any actual or threatened breach of any of the covenants set forth in this Section 2.15 in addition to any other legal or equitable remedies it may have. In addition, in the event of your Willful Restrictive Covenant Breach (as defined in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">this Section 2.15), (i) all of your rights under this Agreement, whether or not vested, shall terminate immediately, and (ii) any Shares, cash or other property paid or delivered to you pursuant to this Agreement shall be forfeited and you shall be required to repay such Shares, cash or other property to the Company, no later than thirty (30) calendar days after the Company makes demand to you for repayment. For purposes of this Agreement, &#8220;Willful Restrictive Covenant Breach&#8221; means your material breach of any of the covenants set forth in this Section 2.15 which you knew, or with due inquiry, should have known, would constitute such a material breach. The preceding sentences of this Section 2.15 shall not be construed as a waiver of the rights that the Company and its Affiliates may have for damages under this Agreement or otherwise, and all such rights shall be unrestricted. The Restricted Period shall be tolled during (and shall be deemed automatically extended by) any period during which you are in violation of the provisions of Section 2.15(a), (b) or (c), as applicable. In the event that a court of competent jurisdiction determines that any provision of this Section 2.15 is invalid or more restrictive than permitted under the governing law of such jurisdiction, then, only as to enforcement of this Section 2.15 within the jurisdiction of such court, such provision shall be interpreted and enforced as if it provided for the maximum restriction permitted under such governing law.</font><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;You acknowledge that the Company and its Affiliates have expended and will continue to expend substantial amounts of time, money and effort to develop business strategies, employee, customer and other relationships and goodwill to build an effective organization. You acknowledge that the Company and its Affiliates have a legitimate business interest in and right to protect its goodwill and employee, customer and other relationships, and that the Company and its Affiliates could be seriously damaged by the loss or deterioration of its employee, customer and other relationships. Executive further acknowledges that the Company and its Affiliates are entitled to protect and preserve the going concern value of the Company and its Affiliates to the extent permitted by law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;In light of the foregoing acknowledgments, you agree that the covenants contained in this Agreement are reasonable and properly required for the adequate protection of the businesses and goodwill of the Company and its Affiliates. You further acknowledge that, although your compliance with the covenants contained in this Agreement may prevent you from earning a livelihood in a business similar to the business of the Company and its Affiliates, your experience and capabilities are such that you have other opportunities to earn a livelihood and adequate means of support for you and your dependents.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3)&#160;&#160;&#160;&#160;In light of the acknowledgements contained in this Section 2.15, you agree not to challenge or contest the reasonableness, validity or enforceability of any limitations on, and obligations of, you contained in this Section 2.15.&#93;</font><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">****</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">We look forward to your continuing contribution to the growth of the Company.  Please acknowledge your receipt of the Plan and this Award.</font></div><div style="text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="text-align:justify;text-indent:198pt"><font><br></font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; </font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; </font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">APPENDIX</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PERRIGO COMPANY PLC</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Additional Terms and Provisions to</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Restricted Stock Unit Award Agreement (Performance-Based)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix (the &#8220;Appendix&#8221;) includes additional terms and conditions that govern the restricted stock units (Performance-Based) (&#8220;PSUs&#8221; or &#8220;Award&#8221;) granted to you under the Plan if you reside in one of the countries listed below. Certain capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan and&#47;or the Agreement.  The Award will not create any entitlement to receive any similar benefit in the future. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix also includes country-specific information of which you should be aware with respect to your participation in the Plan.  The information is based on the securities, exchange control and other laws in effect in the respective countries as of January 2023.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that you do not rely on the information noted herein as the only source of information relating to the consequences of your participation in the Plan because the information may be out of date at the time that you </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vest in the PSUs and Ordinary Shares are issued to you or the shares issued upon vesting of the PSUs are sold.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, the information is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of any particular result.  Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your particular situation.  Finally, please note that if you are a citizen or resident of a country other than the country in which you are currently working, or transfers employment after grant, the information contained in the Appendix may not be applicable.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Conditions et dispositions suppl&#233;mentaires &#224; l&#8217;</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Accord relatif &#224; l&#8217;attribution d&#8217;unit&#233;s d&#8217;action avec restrictions (r&#233;mun&#233;ration fond&#233;e sur les performances)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice (l&#8217;&#171;&#160;Appendice&#160;&#187;) comprend des conditions compl&#233;mentaires r&#233;gissant les Unit&#233;s d&#8217;action avec restrictions (r&#233;mun&#233;ration fond&#233;e sur les performances) (&#171;&#160;UARP&#160;&#187; ou &#171;&#160;Prime&#160;&#187;) qui vous sont attribu&#233;es en vertu du Plan si vous r&#233;sidez dans l&#8217;un des pays repris ci-dessous. Certains termes commen&#231;ant par une lettre majuscule utilis&#233;s dans le pr&#233;sent Accord mais qui n&#8217;y sont pas d&#233;finis ont le sens qui leur est attribu&#233; dans le Plan ou l&#8217;Accord. La Prime n&#8217;instaure aucun droit &#224; recevoir des avantages similaires &#224; l&#8217;avenir. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice comprend &#233;galement des informations sp&#233;cifiques aux pays dont vous devez avoir connaissance eu &#233;gard &#224; votre participation au Plan. Les informations se fondent sur les lois relatives aux valeurs mobili&#232;res, au contr&#244;le des &#233;changes et autres en vigueur dans les pays respectifs en janvier 2023. Souvent complexes, ces lois font l&#8217;objet de modifications fr&#233;quentes. Par cons&#233;quent, la Soci&#233;t&#233; vous recommande vivement de ne pas consid&#233;rer les renseignements repris aux pr&#233;sentes comme l&#8217;unique source d&#8217;information relative aux cons&#233;quences de votre participation au Plan, car ces renseignements peuvent &#234;tre obsol&#232;tes au moment de la d&#233;volution des UARP ou de l&#8217;&#233;mission des Actions ordinaires pour votre compte, ou de la vente des actions &#233;mises lors de la d&#233;volution des UARP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Par ailleurs, ces informations sont d&#8217;ordre g&#233;n&#233;ral et peuvent ne pas s&#8217;appliquer &#224; votre situation particuli&#232;re. De plus, la Soci&#233;t&#233; n&#8217;est pas en mesure de vous garantir un quelconque r&#233;sultat particulier. Par cons&#233;quent, il vous est conseill&#233; de demander des conseils professionnels appropri&#233;s quant &#224; la mani&#232;re dont les lois de votre pays en la mati&#232;re peuvent s&#8217;appliquer &#224; votre situation particuli&#232;re. Enfin, veuillez noter que si vous &#234;tes citoyen ou r&#233;sident d&#8217;un pays autre que celui dans lequel vous travaillez actuellement ou si votre emploi est transf&#233;r&#233; apr&#232;s l&#8217;octroi, les informations figurant dans l&#8217;Appendice peuvent ne pas appliquer.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Extra voorwaarden en voorzieningen bij</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">de Overeenkomst over voorwaardelijk toegekende aandelen (op basis van prestaties)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Algemene voorwaarden</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage (de 'Bijlage') omvat extra algemene voorwaarden voor de voorwaardelijk toegekende aandelen (op basis van prestaties) ('PSU's' of 'Award') die u volgens het Plan zijn toegekend als u in een van onderstaande landen woont. Bepaalde termen in hoofdletters die in deze Bijlage werden gebruikt maar niet gedefinieerd, hebben de betekenis die in het Plan en&#47;of de Overeenkomst is vermeld. De Award cre&#235;ert geen recht om een soortgelijk voordeel in de toekomst te krijgen. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage bevat ook landenspecifieke informatie waarvan u op de hoogte moet zijn met betrekking tot uw deelname aan het Plan. De informatie is gebaseerd op de effecten-, wisselcontrole- en andere wetten die in de respectieve landen sinds januari 2023 van kracht zijn.  Zulke wetten zijn vaak complex en worden regelmatig aangepast. Daarom raadt het Bedrijf u ten sterkste aan de informatie hierin niet te gebruiken als enige bron van informatie over de gevolgen van uw deelname aan het Plan, omdat de informatie verouderd kan zijn op het ogenblik dat uw toezegging in de PSU's en de Gewone aandelen u worden uitgekeerd of wanneer de bij de toezegging van de PSU's uitgegeven aandelen worden verkocht.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ook is de informatie algemeen van aard en mag u ze niet toepassen op uw specifieke situatie. Het Bedrijf bevindt zich evenmin in een positie om u een specifiek resultaat te verzekeren. We raden u dan ook aan om professioneel advies te vragen over hoe de relevante wetten in uw land van toepassing kunnen zijn op uw specifieke situatie. Ten slotte, merk op dat als u een burger of inwoner bent van een ander land dan het land waarin u op dit moment werkt, of uw tewerkstelling na de toekenning verhuist, de informatie in de Bijlage mogelijk niet van toepassing is.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Dodatkowe warunki i postanowienia</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Umowy przyznania jednostek akcyjnych o ograniczonych prawach (w oparciu o wyniki)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik (&#8222;Za&#322;&#261;cznik&#8221;) zawiera dodatkowe warunki, kt&#243;re reguluj&#261; jednostki akcyjne o ograniczonych prawach (&#8222;PSU&#8221; lub &#8222;Prawo&#8221;) przyznan&#261; w ramach Programu, je&#347;li mieszkasz w jednym z wymienionych poni&#380;ej kraj&#243;w. Okre&#347;lone terminy pisane wielk&#261; liter&#261;, kt&#243;re nie zosta&#322;y zdefiniowane w niniejszym Za&#322;&#261;czniku, maj&#261; znaczenie okre&#347;lone w Programie i&#47;lub Umowie. Prawo nie uprawnia do uzyskiwania podobnych korzy&#347;ci w przysz&#322;o&#347;ci. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik zawiera r&#243;wnie&#380; informacje dotycz&#261;ce poszczeg&#243;lnych kraj&#243;w, o kt&#243;rych powiniene&#347;(-as) wiedzie&#263; w zwi&#261;zku z uczestnictwem w Programie. Informacje oparte s&#261; na papierach warto&#347;ciowych, kontroli dewizowej i innych przepisach obowi&#261;zuj&#261;cych w odpowiednich krajach od stycznia 2023 r. Takie przepisy prawa s&#261; cz&#281;sto skomplikowane i cz&#281;sto si&#281; zmieniaj&#261;. W zwi&#261;zku z tym Sp&#243;&#322;ka zdecydowanie zaleca, aby nie polega&#263; na informacjach wymienionych w niniejszym dokumencie jako jedynym &#378;r&#243;dle informacji zwi&#261;zanych z konsekwencjami uczestnictwa w Programie, gdy&#380; informacje te mog&#261; by&#263; nieaktualne w momencie nabycia lub wykonywania PSU, a Akcje Zwyk&#322;e s&#261; Ci wydawane lub w przypadku sprzeda&#380;y PSU nabytych w ramach Programu.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto informacje maj&#261; charakter og&#243;lny i mog&#261; nie mie&#263; zastosowania do konkretnej sytuacji, a Sp&#243;&#322;ka nie jest w stanie zapewni&#263; Ci &#380;adnego konkretnego rezultatu. W zwi&#261;zku z tym zaleca si&#281; zasi&#281;gni&#281;cie odpowiedniej profesjonalnej porady dotycz&#261;cej tego, w jaki spos&#243;b odpowiednie przepisy w Twoim kraju mog&#261; mie&#263; zastosowanie do konkretnej sytuacji. Wreszcie nale&#380;y </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">pami&#281;ta&#263;, &#380;e je&#347;li jeste&#347; obywatelem&#47;obywatelk&#261; lub rezydentem&#47;rezydentk&#261; kraju innego ni&#380; kraj, w kt&#243;rym obecnie pracujesz lub przenosisz si&#281; do nowego miejsca po przyznaniu, informacje zawarte w Za&#322;&#261;czniku mog&#261; nie mie&#263; zastosowania.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Australia</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Important Notice</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Important Notice </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">No financial product advice is provided in this Appendix, this Agreement or the Plan (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Plan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">) and nothing should be taken to constitute a recommendation or statement of opinion that is intended to influence a person or persons in making a decision to participate in the Plan. The Plan documents do not take into account your objectives, financial situation and needs. You should consider obtaining your own financial product advice from a person who is licensed by the Australian Securities and Investments Commission to give such advice. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">If you intend to apply to participate in the Plan, you must make your own independent assessment and investigation in relation to your legal and taxation position including seeking professional advice. You must base any decision you may make on such independent assessment, investigation or advice.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Offer made without disclosure </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A copy of the terms of the Plan will be provided to you with this Agreement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of the Plan, an offer to receive PSUs and participate in the Plan, if received in Australia, is made without disclosure to investors in reliance on the regulatory relief set out in Division 1A of Part 7.12, and for the purposes of section 1100N(b), of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Corporations Act 2001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Cth). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As set out in this Agreement, each PSU represents the right to receive one Ordinary Share subject to the relevant performance goals and performance measures being met, or otherwise waived, in accordance with the Plan and this Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The PSUs will be issued for nil consideration. You are not required to pay for a PSU or for the subsequent transfer of an Ordinary Share on vesting of that PSU, however your responsibility for any taxes is as set out in the terms of the Plan and this Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any discretion contained in the Plan, or any provision in this Agreement to the contrary, the number of PSUs granted to you will only be decreased depending on your level of attainment of performance goals against your designated performance measures. If you fully meet your performance goals against the designated performance measures, all of your PSUs will vest. However, if you only partially meet your performance goals against the designated performance measures, only a partial number of your PSUs will vest. You will be entitled to one Share for each vested PSU. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the avoidance of doubt, there will be no increase to the number of PSUs granted to you on the Grant Date. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company will not provide you with any loans or financial assistance under the Plan in connection with the offer of the PSUs. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No PSUs or Ordinary Shares transferred to you under the Plan will be held on your behalf, by a trustee&#47;nominee. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The indicative daily price of the Ordinary Shares on the New York Stock Exchange (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), quoted in US dollars, is available on the Company&#8217;s website at http&#58;&#47;&#47;perrigo.investorroom.com&#47;stock-information. The Ordinary Shares are also quoted on the NASDAQ Stock Market (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NASDAQ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) (refer to NASDAQ&#8217;s website at </font><font style="color:#0562c1;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">http&#58;&#47;&#47;www.nasdaq.com&#47;symbol&#47;prgo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Australian dollar equivalent of the Ordinary Shares can be determined using prevailing exchange rate published by Thomson Reuters (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Prevailing Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). Alternatively, the Company will advise you of the price of its Ordinary shares (in equivalent Australian dollars) as soon as possible following receipt of any request for such information. This information may be obtained by you contacting your local Human Resources representative. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Before accepting an offer to be granted PSUs, you should satisfy yourself that you have a sufficient understanding of the risks set out below and should consider if the PSUs are a suitable investment for you, having regard to your own investment objectives, financial circumstances and taxation position&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) the vesting conditions for your PSUs may not be satisfied for reasons beyond the Company&#8217;s or your control&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) you are not permitted to transfer your PSUs unless permitted under this Agreement or the Plan&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) you will have no voting, dividend, or other stockholder rights in any Shares until you become the registered holder of those Shares. Until you become the registered holder of Shares, you will have only the rights of an unsecured creditor with respect to those Shares </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) if your PSUs vest and you subsequently receive Ordinary Shares&#58; </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) the value of those shares may rise and fall according to investor sentiment, general economic conditions and outlook, international and local stock markets, employment, inflation, interest rates, government policy, taxation and regulation&#59; and </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) there is no guarantee that an active trading market for the shares will exist or that the price of the shares will increase. There may be relatively few potential buyers or sellers of the shares on the NYSE, NASDAQ, TASE or any other applicable market at any time and this may increase the volatility of the market price of the shares. It may also affect the prevailing market price at which you may be able to sell your shares&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) there may be taxation implications arising for you in participating under this Agreement and in the Plan. The tax consequences of participating in the Plan are based on complex tax laws, which may be subject to varying interpretations, and the application of such laws may depend, in large part, on the surrounding facts and circumstances. The tax regime applying to you may change. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the above risks are only general risks of acquiring and holding PSUs under the Plan. It does not purport to list every risk that may be associated with the Plan now or in the future. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, if at the time of vesting, the Company determines that it is not legal under Australian securities laws to issue shares, the outstanding PSUs will be cancelled, and no shares will be issued to you nor will any benefits in lieu of shares be paid to you. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Exchange Control Information </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control reporting mandates disclosure of payments equal to or exceeding AUD10,000 made to a foreign individual or entity. This reporting is generally done automatically by the financial institution making the transfer. </font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Austria</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of Austria, you must submit a report to the Austrian National Bank. An exemption applies if the value of the shares as of any given quarter is less than &#8364;5,000,000 (when converted to Euros if applicable). If the threshold is met or exceeded, quarterly reporting obligations exist If quarterly obligations apply, the reporting date is the end of each quarter and the deadline for filing the report is the 15th of the month following the end of the quarter.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When shares are sold, there may be exchange control obligations if the cash received is held in a bank account outside Austria.  If the volume of all your accounts abroad exceeds &#8364;10,000,000 (when converted to Euros if applicable), the balances of all accounts must be reported monthly, as of the last day of the month, on or before the fifteenth day of the following month.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Belgium </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to report any security or bank accounts (including brokerage accounts) you maintain outside of Belgium on your annual tax return.  In a separate report, you are required to provide the National Bank of Belgium with certain details regarding such foreign accounts (including the account number, bank name and country in which any such account was opened).  This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under Kredietcentrales &#47; Centrales des cr&#233;dits caption.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Stock Exchange Tax.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A stock exchange tax could apply for Belgian tax residents transacting through a non-Belgium broker once the shares are sold. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Communication d&#8217;informations relatives aux actifs ou comptes &#233;trangers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Vous &#234;tes tenu de d&#233;clarer, dans votre d&#233;claration fiscale annuelle, tout compte-titres ou compte en banque (y compris les comptes de courtage) que vous d&#233;tenez en dehors de la Belgique. Dans une d&#233;claration distincte, vous &#234;tes tenu de communiquer &#224; la Banque Nationale de Belgique certains d&#233;tails concernant les comptes &#233;trangers (notamment le num&#233;ro de compte, le nom de la banque et le pays o&#249; le compte a &#233;t&#233; ouvert). Cette d&#233;claration ainsi que toutes les informations indiquant comment la remplir sont disponibles sur le site web de la Banque Nationale de Belgique (www.nbb.be) &#224; la section &#171;&#160;Centrales des cr&#233;dits&#47;Kredietcentrales&#160;&#187;. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informatie over buitenlands vermogen&#47;rekeningrapportering.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> U moet alle garantie- of bankrekeningen (inclusief beleggingsrekeningen) die u buiten Belgi&#235; bezit, vermelden op uw jaarlijkse belastingsbrief. In een afzonderlijk overzicht moet u de Nationale Bank van Belgi&#235; informatie geven over zulke buitenlandse rekeningen (inclusief het rekeningnummer, de naam van de bank en het land waarin zulke rekening is geopend). Dit overzicht, evenals extra informatie over hoe u het moet opstellen, vindt u op de website van de Nationale Bank van Belgi&#235;, www.nbb.be, onder de titel Kredietcentrales.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Bermuda</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is not subject to and has not received approval from the Bermuda Monetary Authority and the Registrar of Companies in Bermuda, and no statement to the contrary, explicit or implicit, is authorized to be made in this regard.  The securities may be offered or sold in Bermuda only in compliance with the provisions of the Investment Business Act 2003 of Bermuda.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Brazil</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You agree that, for all legal purposes, (i) the benefits provided under the Plan are the result of commercial transactions unrelated to your employment&#59; (ii) the Plan is not a part of the terms and conditions of your employment&#59; and (iii) the income from the PSUs, if any, is not part of your remuneration from employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you agree to comply with Brazilian law when the PSUs vest and the shares are sold. You also agree to report and pay any and all taxes associated with the vesting of the PSUs, the sale of the PSUs acquired pursuant to the Plan, and the receipt of any dividends.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> If you are a resident or domiciled in Brazil and hold assets and rights outside Brazil with an aggregate value exceeding US$100,000, you will be required to prepare and submit to the Central Bank of Brazil an annual declaration of such assets and rights. Assets and rights that must be reported include PSUs.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Canada</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Payout of PSUs in Shares Only</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to all Employees residing in Canada, the Company will convert all vested PSUs only into an equivalent number of Shares and the Plan will not provide an option to settle the PSUs in cash. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Canadian residents may be required to report foreign property (including Shares) on an annual basis on form T1135 (Foreign Income Verification Statement) if the total cost of the foreign property exceeds CAD 100,000 at any time in the year. The grant of PSUs must be reported if the CAD 100,000 cost threshold is exceeded because of other foreign property held. PSUs may be reported at a nil cost. The form must be filed by April 30 of the following year. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Withholding will include both federal income tax as well as provincial tax.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Resale Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Ordinary Shares received by Canadian residents pursuant to this Plan will be subject to an indefinite holding period and the resale of the Ordinary Shares will be prohibited, unless certain conditions are met in respect of the Company in accordance with applicable Canadian securities laws or another applicable Canadian prospectus exemption is available.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Eligibility of Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding the terms of this Agreement or the Plan, no offers of PSUs or Ordinary Shares may be made to you if you are not an employee, executive officer, director or consultant of the Company or a related entity of the Company, in accordance with Section 2.24 of National Instrument 45-106.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employment Law Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the term &#8220;Termination Date&#8221; shall mean the earliest of&#58;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)&#160;&#160;&#160;&#160;Any date specified in this Agreement or the Plan&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)&#160;&#160;&#160;&#160;The date on which the Company or any applicable Affiliate delivers to you notice in a form prescribed by the Company that the Company is thereby terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)&#160;&#160;&#160;&#160;Except in the event of a Separation for Good Reason, the date on which you deliver notice in a form prescribed by the Company to the Company or any applicable Affiliate that you are terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)&#160;&#160;&#160;&#160;The date on which you cease to provide services to the Company or any applicable Affiliate, except where you are on an authorized leave of absence&#59; and</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)&#160;&#160;&#160;&#160;The date on which you cease to be considered an &#8220;employee&#8221; of the Company or any applicable Affiliate under applicable law.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the definitiona of &#8220;Cause&#8221; shall be determined in accordance with applicable laws in the jurisdiction of employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In accordance with Section 2.13, you consent and agree to the payment of the reimbursements set out therein, including through deductions of the amounts specified in paragraph 2.13 from any wages owed by the Company to the employee. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The provisions set out in Section 2.15(a) do not apply to employees in the province of Ontario other than executive employees who are exempted from XV.1 of the Ontario Employment Standards Act, 2000.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Czech Republic</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Documents in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Award, you confirm that you have read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">P&#345;ijet&#237;m tohoto Ozn&#225;men&#237; potvrzujete, &#382;e jste p&#345;e&#269;etl a porozum&#283;l jste Podm&#237;nk&#225;m pl&#225;nu (&#8220;Plan&#8221;) a Smlouv&#283; (&#8220;Agreement&#8221;), kter&#233; V&#225;m byly poskytnuty v anglick&#233;m jazyce. Z&#225;rove&#328; prohla&#353;ujete, &#382;e souhlas&#237;te s podm&#237;nkami uveden&#253;mi v t&#283;chto dokumentech.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restriction on cash payments.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Under Czech Act No. 235&#47;2004 Coll., on Cash Payments, as amended, it is prohibited to receive or provide payments in cash exceeding the amount of CZK 270.000 within one day. Payments exceeding this amount must be executed cashless. This restriction relates to payments from one contracting party to one other contracting party. Thus, it is not a restriction on the sum of all payments made by one individual or entity within one day.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nevertheless, since the restriction on cash payments may be subject to a change (especially a lower threshold might be set), we recommend consulting your personal legal advisor prior to receiving or providing a larger amount of cash payments.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Denmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is subject to the Danish Stock Option Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aktieoptionsloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), which applies on share option agreements entered into as part of an employment, if the ownership of the shares is obtained at a later point. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This act is based on a principle of the right to freely agree on the terms of the Award Agreement with certain exceptions stated in the act. In addition to the act, the Danish Contract Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aftaleloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and Danish case law also regulates the terms of the Award Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below, it is outlined when the Danish Stock Option Act, the Danish Contract Act, Danish case law and other applicable legislation deviate from terms stated in the Award Agreement&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Section 1.3(f) in the Award Agreement does not entail that applicable notice periods under Danish employment legislation and your employment agreement are deviated from to the detriment of you. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Section 1.3(g) litra 2 in the Award Agreement is amended to the following&#58; </font></div><div><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;(2) &#8220;Termination without Cause&#8221; means the involuntary termination of your employment or contractual relationship by the Company without any Cause. &#8220; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Regardless of section 2.3 in the Award Agreement, vested and acquired shares do not lapse as a consequence of your Termination Date for reasons of Cause. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In relation to Section 2.7 in the Award Agreement the following also applies, which supersedes section 2.7 in case of conflicting regulation&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;The Company is required to report the market value of the PSUs to the Danish tax authorities to both E-income and E-capital with the Danish tax authorities. For E-income, the value of the PSUs should be reported as income art 50 in field 068 and should be reported by the Company in the month the shares vest. For E-capital, the value of the PSUs should be reported to the Danish tax authorities no later than the 20th of January the following year after the PSUs have vested. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The market value of the provided PSUs is to be reported by the Company as personal income in the year of vest and is subject to a marginal tax rate of 56% including labor market contribution. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The tax payment obligation for the value of the shares will be collected with the individual, and the responsibility to ensure that the correct amount is reported on the Danish tax assessment remains with the individual.</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At the time of sale you are subject to tax on the gain, if any, at a marginal tax rate of 42%. The capital gain is calculated as the difference between the average fair market value at vest and the sales price. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If there is a loss tied to the sale of the PSUs, the loss can be deducted in capital gain from other listed PSUs. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that it is mandatory for you to report information on PSUs from a foreign depot to the Danish tax authorities. If this information is not provided to the Danish tax authorities, a potential loss cannot be used for deduction. &#8220; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to section 2.10(b), all personal information will be managed in accordance with the European Data Protection Regulation (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">databeskyttelsesforordningen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and the Danish Data Protection Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">personbeskyttelsesloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.15(a)-(d) in the Award Agreement is void and unenforceable in Denmark and instead the following is agreed&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15 NON-COMPETITION AND NON-SOLICITATION </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.1. You will be covered by this non-competition and non-solicitation clause for 6 months after the effective date of termination. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.2. In this period, you are entitled to &#8211; only with the prior written consent of the affiliate employing or retaining you (the &#8220;Affiliate&#8221;) &#8211; be engaged or financially interested, directly or indirectly, in any business which develops and&#47;or distributes products or services that compete or may compete with the Affiliate or any group companies&#8217; products and&#47;or services or in any other business competing with the Affiliate or any group companies in any other way. This restriction includes any interest whatsoever by way of, for example, employment, ownership in full or in part, membership of a board, consultancy services and the like in Denmark and abroad. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.3. Conclusion of this non-competition clause is required because you hold a very special position of trust, and you will receive detailed knowledge about the Affiliate and group companies&#8217; affairs, including business secrets, market strategies and plans, information on customers and suppliers. This knowledge may be exploited to the detriment of the Affiliate or group companies, if you become employed with a competing company immediately after the effective date of termination. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.4. During 6 months after the effective date of termination, you are only with the prior written consent of the Affiliate entitled to be in contact with or have business relations, directly or indirectly, with customers, suppliers or cooperation partners, etc., with whom you have had business relations within the last 12 months prior to the termination. In connection with the termination, the Affiliate will prepare a list of the customers, suppliers and cooperation partners covered by the restriction in this clause. In this connection, you must loyally contribute to the drafting of a thorough list covering all customers, suppliers and&#47;or cooperation partners with whom you have had business relations within the last 12 months prior to the termination. Your deliberate failure to contribute loyally to this list will be considered a material breach of the employment and the Award Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.5. The effective date of termination is to be construed as the date on which you may be ordered or entitled to resign after the expiry of the notice period, notwithstanding whether you actually end your work with the employing company at an earlier date. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.6. The non-competition part of this clause will cease to apply, if the Affiliate gives notice of termination to you without you having reasonably caused the termination. The non-competition part of this clause will also cease to apply, if you resign from the Affiliate for reasonable cause due to the employing company&#8217;s failure to fulfil its obligations, cf. section 11 (1) in the Danish Act on Employment Clauses (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">ans&#230;ttelsesklausulloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). In both situations, the non-solicitation part of this clause will be maintained. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.7. The Affiliate may terminate the clause with one month's notice to expire at the end of a month, cf. section 10 (1) in the Danish Act on Employment Clauses. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.8. As compensation for the clause, you will receive a monthly compensation in accordance with the Danish Act on Employment Clauses. Compensation currently amounts to 60 % of the monthly salary at the effective date of termination and is payable in the period in which the clause applies. At the effective date of termination, the first two months of compensation will be paid to you as a lump sum. If the clause applies, compensation will after the first two months be payable each month in arrears in the rest of the period in which the clause applies. If you obtain other appropriate paid work, compensation equivalent to 24 % of the monthly salary at the effective date of termination will be paid from the third month after the effective date of termination. You are obligated to actively seek other appropriate work and to notify the Affiliate in writing of any new work. Failure to observe the duty of mitigation will be considered a material breach of the employment with the effect that your right to compensation will lapse. The right to compensation will lapse, if the Affiliate has lawfully terminated your employment without notice. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.9. In the event of your breach of the clause, the Affiliate will be entitled to a penalty of &#91;between three and six&#93; months' salary for any one breach of the clause and compensation for any additional loss. In the event of a persistent breach of the clause, each month or part of a month is deemed to constitute an independent breach entitling the Affiliate to a new, independently agreed penalty. Any payment of the agreed penalty shall not lead to the discontinuance of your obligation to comply with the clause. The Affiliate may also seek to restrain any breach of the clause through the issue of an injunction. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.10. This clause may be invoked by the Affiliate from the date on which you have been employed with the employing company for six months.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Estonia</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Finland</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  If you hold Ordinary Shares acquiqred under the Plan, you are generally required to include those Ordinary Shares as assets in your individual tax return.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">France</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">En acceptant cette attribution gratuite d'actions, vous confirmez avoir lu et comprenez le Plan et ce Contrat, incluant tous leurs termes et conditions, qui ont &#233;t&#233; transmis en langue anglaise. Vous acceptez les dispositions de ces documents en connaissance de cause.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of France or maintain a foreign bank account, you are required to report such to the French tax authorities when you file your annual tax return.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The PSUs are not intended to qualify as a French tax qualified performance restricted stock units under French tax law.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a French resident and hold cash or Ordinary Shares outside of France, you must declare all foreign bank and brokerage accounts (including any accounts that were opened or closed during the tax year) on an annual basis on a special form, No. 3916, together with your income tax return.  </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Renseignements relatifs aux comptes et avoirs &#233;trangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Si vous &#234;tes r&#233;sident fran&#231;ais et que vous d&#233;tenez des liquidit&#233;s ou des Actions ordinaires en dehors de la France, vous &#234;tes tenu de d&#233;clarer chaque ann&#233;e, en m&#234;me temps que votre d&#233;claration de revenus, les r&#233;f&#233;rences de vos comptes bancaires et comptes-titres &#233;trangers (y compris les comptes qui ont &#233;t&#233; ouverts ou ferm&#233;s pendant l&#8217;exercice fiscal) par le biais d&#8217;un formulaire sp&#233;cifiquement pr&#233;vu &#224; cet effet, le formulaire N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">o&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3916. </font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Germany</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Cross-border payments related to securities transactions in excess of &#8364;12,500 must be reported by the fifth calendar day of the month following the respective payment to the German Central Bank (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Bundesbank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  If you use a German bank to transfer a cross-border payment related to securities transactions in excess of &#8364;12,500 (e.g. in connection with the sale of shares acquired under the Plan), the bank will make the report for you. In addition, you must report any receivables, payables, or debts in foreign currency exceeding an amount of &#8364;5,000,000 (by the tenth calendar day after the expiry of one month) and any cross-border shareholdings in companies if the share in the capital or the voting rights amount(s) to 10% or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">more and the investment object exceeds a balance sheet total of &#8364;3,000,000 (by the last working day of the sixth calendar month following December 31).n a monthly basis.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In case of an acquisition of shares in a foreign company with an overall investment amount of more than &#8364;150,000 (or in case of an acquisition of 10% or more of the shares in a foreign company), you should consult with your tax advisor whether the investment would have to be reported to your tax office.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Greece</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to your Award, if you withdraw funds of &#8364;15,000 or more from a bank in Greece and remit those funds out of Greece, you may be required to submit certain documentation&#47; information to the Greek bank to ensure that the transfer is not in violation of Greek anti-money laundering rules. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Hungary</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">India</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Notification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You understand that you must repatriate any proceeds from the sale of shares acquired under the Plan to India and convert the proceeds into local currency within 180 days of receipt assuming share holding is less than 10% of the company's share capital or as prescribed under applicable Indian exchange control laws as may be amended from time to time. You will receive a foreign inward remittance certificate (&#34;FIRC&#34;) from the bank where you deposit the foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or your employer requests proof of repatriation.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The amount subject to tax on receipt of the shares will partially be dependent upon a valuation that the Company or your employer will obtain from a Merchant Banker in India.  Neither the Company nor your employer has any responsibility or obligation to obtain the most favorable valuation possible, nor obtain valuations more frequently than required under Indian tax law.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to declare in the applicable schedules of your annual tax return (a) any foreign assets held by you (e.g., Ordinary Shares acquired under the Plan and, possibly, the Award), (b) any foreign bank accounts for which you have signing authority and (c) any foreign custodian accounts.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ireland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Director Notification Obligation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a director, shadow director or secretary of the Company's Irish Subsidiary or Affiliate, you must notify the Irish Subsidiary or Affiliate in writing within five business days of receiving or disposing of an interest exceeding 1% of the Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(e.g., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PSUs, shares, etc.), or within five business days of becoming aware of the event giving rise to the notification requirement or within five days of becoming a director or secretary if such an interest exists at the time. This notification requirement also applies with respect to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">interests of a spouse or children under the age of 18 (whose interests will be attributed to the director, shadow director or secretary).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Israel</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Type of Grant&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633; </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capital Gain Award (&#8220;CGA&#8221;)</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ordinary Income Award (&#8220;OIA&#8221;)</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 3(i) Award</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Unapproved 102 Award</font></div><div><font><br></font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Settlement of PSUs</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Agreement, if the PSUs granted hereunder are 102 Awards, the PSUs shall be settled in Ordinary Shares only.</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Trust. </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All Approved 102 Awards shall be held in trust by a trustee designated by the Company (</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;Trustee&#34;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or shall be supervised by the Trustee in accordance with the instructions set forth by the Israeli Tax Authority (&#8220;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITA</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), for the requisite lockup period prescribed by the Ordinance and the regulations promulgated thereunder, or such other period as may be required by the ITA, during which period Awards or Ordinary Shares issued thereunder, and all rights resulting from them, including bonus shares, must be held or supervised by the Trustee in accordance with the instructions set forth by the ITA. The Trustee shall not release any Approved 102 Awards, Ordinary Shares issued upon the exercise of any Approved 102 Awards, or any rights, including bonus shares, resulting from such Approved 102 Awards or Ordinary Shares, prior to the full payment of your tax liability. The Trustee or the Israeli Affiliate shall withhold any applicable taxes in accordance with Section 102 or any applicable tax ruling obtained by the Company. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without derogating from the foregoing, if your PSUs do&#160;not qualify as Approved&#160;102 Awards the Company may still at its sole discretion deposit your PSUs in trust to ensure that taxes are properly withheld. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby release the Trustee from any liability in respect of any action or decision duly taken and executed in good faith in relation to any PSUs or Ordinary Shares issued to you thereunder. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Without derogating from Section 2.7(b) above, you hereby agree to indemnify the Company and&#47;or its Affiliates and&#47;or the Trustee and hold them harmless against and from any and all liability for all such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to you.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you agree to comply with the provisions of Section 102 and the regulations and rules promulgated thereunder or any tax ruling to be obtained by the Company in connection with your PSUs. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Italy</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax&#47;Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You are required to report on your annual tax return&#58;  (a) any foreign investments or investments (including the Ordinary Shares issued at vesting of the PSUs, cash or proceeds from the sale of Ordinary Shares acquired under the Plan) held outside of Italy, if the investment may give rise to income in Italy (this will include reporting the Ordinary Shares issued at vesting of the PSUs if the fair market value of such Ordinary Shares combined with other foreign assets)&#59; and (b) any changes during the financial year which have had an impact during the calendar year on your foreign investments or investments held outside of Italy.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are exempt from these formalities if the investments are made through an authorized broker resident in Italy, as the broker will comply with the reporting obligation on your behalf.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Kazakhstan</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to report the acquisition of shares of a foreign company to the National Bank of Kazakhstan. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Latvia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Lithuania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Luxembourg</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are required to report any inward remittances of funds to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Banque Central de Luxembourg </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and&#47;or the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Service Central de La Statistique et des Etudes Economiques</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Luxembourg financial institution is involved in the transaction, it generally will fulfill the reporting obligation on your behalf. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Mexico</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you understand and agree that any modification of the Plan or the Agreement or its termination shall not constitute a change or impairment of the terms and conditions of employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan Document Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the award of the PSUs, you acknowledge that you have received copies of the Plan, have reviewed the Plan and the Agreement in their entirety and fully understand and accept all provisions of the Plan and the Agreement.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, by signing the Agreement, you further acknowledge that you have read and specifically and expressly approve the terms and conditions in the Agreement, in which the following is clearly described and established&#58;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Participation in the Plan does not constitute an acquired right&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">The Plan and participation in the Plan is offered by the Company on a wholly discretionary basis&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">Participation in the Plan is voluntary&#59; and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">The Company and any Parent, Subsidiary or Affiliates are not responsible for any decrease in the value of the shares.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowlegement and Policy Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In accepting the PSUs, you expressly recognize the Company is solely responsible for the administration of the Plan and that your participation in the Plan and acquisition of Ordinary Shares does not constitute an employment relationship between you and the Company since you are participating in the Plan on a wholly commercial basis and on a wholly commercial basis and your sole employer is Perrigo de Mexico S.A. De C.V. (&#8220;Perrigo Mexico&#8221;). Based on the foregoing, you expressly recognize that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and your employer, Perrigo Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Perrigo Mexico and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of your employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company&#59; therefore, the Company reserves the absolute right to amend and&#47;or discontinue your participation at any time without any liability to you.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or damages as a result of your participation in the Plan and therefore grant a full and broad release to the Employer, the Company and any Parent, Subsidiary or Affiliates with respect to any claim that may arise under the Plan.</font></div><div style="margin-bottom:12pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Spanish Translation</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modificaci&#972;n</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;Al aceptar las Unidades de Acci&#243;n Restringida de Rendimiento (PSUs, por sus siglas en ingl&#233;s) usted entiende y esta de acuerdo que cualquier modificaci&#243;n del plan o del acuerdo o su terminaci&#243;n no constituir&#225; un cambio o detrimento de los t&#233;rminos y condiciones de su empleo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Confirmaci&#243;n del Documento del Plan. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Al aceptar el otorgamiento de las PSUs, usted reconoce que ha recibido copias y ha revisado dicho acuerdo en su totalidad y que ha entendido y aceptado completamente todas las disposiciones contenidas en el Plan y en el Acuerdo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adicionalmente, al firmar el acuerdo, usted reconoce que ha le&#237;do, y aprobado de manera espec&#237;fica y expresa los t&#233;rminos y condiciones en el acuerdo en el que se describe y establece claramente los siguiente&#58;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:25.17pt">La participaci&#243;n en el Plan no constituye un derecho adquirido&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.98pt">El plan y la participaci&#243;n en el mismo, son ofrecidos por la Compa&#241;&#237;a de manera totalmente discrecional&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.79pt">La participaci&#243;n en el Plan es voluntaria&#59; y</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.42pt">La Compa&#241;&#237;a, y cualquier Sociedad controladora, Subsidiaria o Filiales no son responsables por ning&#250;n decremento en el valor de las Acciones.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Constancia de aceptaci&#243;n de la ley laboral y declaraci&#243;n de la pol&#237;tica.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160; Al aceptar las PSUs, usted reconoce expresamente que la Compa&#241;&#237;a, es la &#250;nica responsable de la administraci&#243;n del Plan, y que su participaci&#243;n en el Plan y la adquisici&#243;n de las acciones comunes no constituyen una relaci&#243;n de trabajo entre usted y la Compa&#241;&#237;a dado que usted participa en el Plan de manera completamente comercial y el &#250;nico empleador que tiene es Perrigo de M&#233;xico, S.A. de C.V. (&#171; Perrigo de Mexico &#187;). Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que usted pueda obtener de la participaci&#243;n en el Plan, no establecen ning&#250;n derecho entre usted y su empleador Perrigo de M&#233;xico y no forman parte de las condiciones de trabajo ni </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">de las prestaciones ofrecidas por Perrigo de M&#233;xico y cualquier modificaci&#243;n del Plan o la terminaci&#243;n de &#233;ste, no constituyen un cambio o deterioro de los t&#233;rminos y condiciones de su trabajo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adem&#225;s, usted comprende que su participaci&#243;n en el Plan es el resultado de una decisi&#243;n unilateral y discrecional de la Compa&#241;&#237;a&#59; por lo tanto, la Compa&#241;&#237;a se reserva el derecho absoluto de modificar y&#47;o interrumpir la participaci&#243;n de usted en cualquier momento sin ninguna responsabilidad para usted.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finalmente, usted declara que no se reserva ninguna acci&#243;n o derecho de presentar alg&#250;n reclamo o demanda en contra de la Compa&#241;&#237;a por compensaci&#243;n, da&#241;o o perjuicio alguno como resultado de su participaci&#243;n en el Plan, en consecuencia, otorga el m&#225;s amplio finiquito al Empleador, as&#237; como a la Compa&#241;&#237;a, a su Sociedad controladora, Subsidiaria o Filiales con respecto a cualquier demanda que pudiera originarse en virtud del Plan.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Netherlands</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dutch insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Norway</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Norwegian insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor as well as the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Cross-border payments in excess of NOK 100,000 must be reported to the Norwegian foreign exchange register (Valutaregisteret). If you use a Norwegian bank to transfer a cross-border payment in excess of NOK 100,00 in connection with the sale of shares acquired under the Plan, the bank will make the report on your behalf. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In your Norwegian income tax return, each year you are required to report any security, shares or bank accounts (including brokerage accounts and the Company &#8220;Account&#8221; referenced in section 1.5 of the Agreement) you maintain outside of Norway. The Company &#8220;Account&#8221; should not be treated as taxable wealth, as long as the right to receive the dividends is conditional, but you must report it. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Poland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold foreign securities (including shares pursuant to the Award) and maintain accounts abroad, you may be required to file certain reports with the National </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Bank of Poland (&#8220;NBP&#8221;). Specifically, if the value of securities and cash held in such foreign accounts exceeds PLN 7,000,000 (or equivalent thereof in another currency) at the end of the year, you must file reports on the transactions and balances of the accounts on a quarterly basis by the 26th day of the month following the end of each quarter. In case you are being in regime of a joint marital property, the above threshold shall apply to joint property of the spouses. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, if you hold, at the beginning or end of the year, at least 10% of votes in the decision-making body of the entity based abroad (and you are person meeting the prievusly mentioned criteria), an annual notification, on the official form, must be submitted by you to the NBP by May 31 of the following year.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If at the end of the year you did not reach the given threshold but in the next year, at the end of a calendar quarter, you reach the threshold, you are obliged to submit the appropriate form to NBP for this quarter and each of the following quarters of this calendar year (within 26 days from the end of each calendar quarter). Such reports are filed on special forms available on the website of the NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The foregoing duties represents personal responsibilities of each shareholder and cannot be fulfilled by any entity on your behalf.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, if you are a Polish citizen and you transfer funds abroad in excess of the PLN equivalent of &#8364;15,000, the transfer must be made through an authorized bank, a payment institution or an electronic money institution authorized to render payment services. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Furthermore, at the banks&#8217; request, you may be required to inform eligible banks, within the meaning of the Foreign Exchange Act, about all foreign exchange transactions performed through them.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are also required to retain the documents connected with foreign exchange transactions for a period of five years, as measured from the end of the year in which such transaction occurred.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Zgoda na otrzymywanie informacji w j&#281;zyku angielskim.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Akceptuj&#261;c Opcj&#281;, potwierdzasz przeczytanie i zrozumienie Programu i Umowy, kt&#243;re zosta&#322;y dostarczone w j&#281;zyku angielskim. W zwi&#261;zku z tym akceptujesz warunki tych dokument&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informacje o kontroli dewizowej. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li jeste&#347; w posiadaniu zagranicznych papier&#243;w warto&#347;ciowych (w tym akcji) i posiadasz rachunki za granic&#261;, mo&#380;esz by&#263; zobowi&#261;zany(-a) do z&#322;o&#380;enia okre&#347;lonych sprawozda&#324; w Narodowym Banku Polskim (&#8222;NBP&#8221;. W szczeg&#243;lno&#347;ci, je&#347;li warto&#347;&#263; papier&#243;w warto&#347;ciowych i &#347;rodk&#243;w pieni&#281;&#380;nych gromadzonych na takich rachunkach zagranicznych przekracza na koniec roku 7 000 000 PLN (lub ekwiwalent tej kwoty w innej walucie), nale&#380;y co kwarta&#322; sk&#322;ada&#263; raporty z transakcji i sald rachunk&#243;w do 26 dnia miesi&#261;ca nast&#281;puj&#261;cego po zako&#324;czeniu ka&#380;dego kwarta&#322;u. W przypadku pozostawania we wsp&#243;lno&#347;ci maj&#261;tkowej z ma&#322;&#380;onkiem, powy&#380;szy pr&#243;g dotyczy maj&#261;tku wsp&#243;lnego ma&#322;&#380;onk&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#380;eli posiadasz na pocz&#261;tek lub koniec roku co najmniej 10% g&#322;os&#243;w w organie stanowi&#261;cym podmiotu z siedzib&#261; za granic&#261; (i jeste&#347; osob&#261; spe&#322;niaj&#261;c&#261; wy&#380;ej wskazane warunki) musisz z&#322;o&#380;y&#263; w NBP do 31 maja nast&#281;pnego roku dodatkowy raport. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li pod koniec roku nie osi&#261;gn&#261;&#322;e&#347;(-a&#347;) okre&#347;lonego progu, ale w nast&#281;pnym roku, pod koniec kwarta&#322;u kalendarzowego, osi&#261;gniesz pr&#243;g, musisz z&#322;o&#380;y&#263; odpowiedni formularz do NBP za ten </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">kwarta&#322; i ka&#380;dy z kolejnych kwarta&#322;&#243;w tego roku kalendarzowego (w ci&#261;gu 26 dni od zako&#324;czenia ka&#380;dego kwarta&#322;u kalendarzowego). Takie raporty s&#261; sk&#322;adane w specjalnych formularzach dost&#281;pnych na stronie internetowej NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#347;li jeste&#347; obywatelem Polski i przekazujesz &#347;rodki za granic&#281; w wysoko&#347;ci przekraczaj&#261;cej r&#243;wnowarto&#347;&#263; 15 000 EUR w PLN, przelewu nale&#380;y dokona&#263; za po&#347;rednictwem upowa&#380;nionego banku, instytucji p&#322;atniczej lub instytucji pieni&#261;dza elektronicznego uprawnionej do &#347;wiadczenia us&#322;ug p&#322;atniczych. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto na &#380;&#261;danie bank&#243;w niezb&#281;dne mo&#380;e by&#263; poinformowanie uprawnionych bank&#243;w, w rozumieniu ustawy Prawo dewizowe (Foreign Exchange Act), o wszystkich transakcjach walutowych przeprowadzanych za ich po&#347;rednictwem.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Jeste&#347; r&#243;wnie&#380; zobowi&#261;zany(-a) do przechowywania dokument&#243;w zwi&#261;zanych z transakcjami wymiany walut przez okres pi&#281;ciu lat, mierzony od ko&#324;ca roku, w kt&#243;rym taka transakcja zosta&#322;a wykonana</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Portugal</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Language Consent.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You hereby expressly declare that you have full knowledge of the English language and have read, understood and fully accepted and agreed with the terms and conditions established in the Plan and Award Agreement.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Conhecimento da Lingua.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> O Contratado, pelo presente instrumento, declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo de Atribui&#231;&#227;o (Award Agreement em ingl&#234;s). </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Romania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Statistical Reporting.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">According to art. 92 of NBR Reg. 4&#47;2021, if you, as a resident of Romania within the meaning of NBR Reg. 4&#47;2021, acquire more than 10% of the share capital in a foreign company, the acquisition must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be reported to the National Bank of Romania (&#8220;NBR&#8221;) for statistical purposes within 30 calendar days of acquisiting the ownership right over the shares of the foreign company. You should consult your personal advisor to determine whether you will be required to submit such documentation to the NBR pursuant to your participation in the Plan. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Insider-trading rules prohibit you from carrying out  certain transactions involving shares if you have inside information about the Company (insider dealing). If you are uncertain whether the insider-trading rules apply to you, including with regard to the fact that the Company is listed on the New York Stock Exchange (NYSE), you should consult your personal legal advisor. Depending on the applicable market abuse legislation, you might be subject to certain restrictions on the freedom to trade the shares that are settled through the RSU award, including any applicable prohibition on insider dealing, market manipulation or the unlawful disclosure of inside information.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Serbia</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovakia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset Reporting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a foreign asset reporting obligation if you are considered providing independent professional services &#8220;podnikatel&#8221;. You should consult with a personal tax advisor to understand your filing obligations.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovenia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">South Africa</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the PSUs, you agree that, immediately upon vesting of the PSUs, you may need to notify your employer of the amount of any gain realized. If you fail to advise your employer of the gain realized upon vesting, you may be liable for a fine. You will be solely responsible for paying any difference between the actual tax liability and the amount withheld by your employer. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Because no transfer of funds from South Africa is required under the PSUs, no filing or reporting requirements should apply when the award is granted nor when Ordinary Shares are issued upon vesting of the PSUs. However, because the exchange control regulations are subject to change, you should consult your personal advisor prior to vesting and settlement of the award to ensure compliance with current regulations. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Spain</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Entitlement for Claims or Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the award of PSUs, you consent to participation in the Plan, and acknowledge that you have received a copy of the Plan document.  You understand that the Company has unilaterally, gratuitously and in its sole discretion decided to make awards of PSUs under the Plan to individuals who may be employees, consultants and directors throughout the world. The decision is limited and entered into based upon the express assumption and condition that any PSUs will not economically or otherwise bind the Company or any Parent, Subsidiary or Affiliate, including your employer, on an ongoing basis, other than as expressly set forth in the Agreement. Consequently, you understand that the Award is given on the assumption and condition that the PSUs shall not become part of any employment contract (whether with the Company or any Parent, Subsidiary or Affiliate, including your employer) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever. Furthermore, you understand and freely accept that there is no guarantee that any benefit whatsoever shall arise from the award, which is gratuitous </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and discretionary, since the future value of the PSUs and the underlying shares is unknown and unpredictable. You also understand that this Award would not be made but for the assumptions and conditions set forth hereinabove&#59; thus, you understand, acknowledge and freely accept that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the Award, the PSUs and any right to the underlying shares shall be null and void.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the PSUs, your termination of service for any reason other than death or disability (including for the reasons listed below) will automatically result in the cancellation and loss of any PSUs that may have been granted to you and that were not or did not become vested on the date of termination of service. In particular, you understand and agree that, unless otherwise expressly provided by the Company in this Agreement, the PSUs will be cancelled without entitlement to the Shares or to any amount as indemnification if you terminate service by reason of, but not limited to, the following&#58; resignation&#59; disciplinary dismissal adjudged to be with cause&#59; disciplinary dismissal adjudged or recognized to be without good cause (i.e., subject to a &#34;despido improcedente&#34;)&#59; individual or collective layoff on objective grounds, whether adjudged to be with cause or adjudged or recognized to be without cause&#59; material modification of the terms of employment under Article 41 of the Workers&#8217; Statute&#59; relocation under Article 40 of the Workers&#8217; Statute&#59; Article 50 of the Workers&#8217; Statute&#59; unilateral withdrawal by your employer&#59; and under Article 10.3 of Royal Decree 1382&#47;1985.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You must declare the acquisition, ownership and disposition of stock in a foreign company (including Ordinary Shares acquired under the Plan) to the Spanish Direcci&#243;n General de Comercio e Inversiones (the &#8220;DGCI&#8221;), the Bureau for Commerce and Investments, which is a department of the Ministry of Economy and Competitiveness, for statistical purposes.  Generally, the declaration must be made in January for Ordinary Shares acquired or sold during (or owned as of December 31 of) the prior year&#59; however, this obligation only applies in the cases in which you hold 10% or more of the sares capital of the Company or 10% or more of the voting tights of the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, you may be required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts held abroad), any foreign instruments (e.g., Ordinary Shares) and any transactions with non-Spanish residents (including any payments of cash or shares made to you by the Company) if the balances in such accounts together with the value of such instruments as of December 31, or the volume of transactions with non-Spanish residents during the prior or current year, exceeds &#8364;1,000,000.  Generally, you will only be required to report on an annual basis (by January 20 of each year).  Note that if the value is less than &#8364;1,000,000, there is only an obligation to declare this information to the Bank of Spain upon request from the Bank of Spain, in which case the deadline is two months since the request is received.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When receiving foreign currency payments derived from the ownership of Ordinary Shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">., dividends or sale proceeds), you must inform the financial institution receiving the payment of the basis upon which such payment is made. Should amounts exceed &#8364;12,500, you will need to provide the following information to the Spanish Registered Entity&#58; (i) your name, address, and fiscal identification number&#59; (ii) the name and corporate domicile of the Company&#59; (iii) the amount of the payment and the currency used&#59; (iv) the country of origin&#59; (v) the reasons for the payment&#59; and (vi) further information that may be required. Exceptions to this rule are when you move funds through a Spanish resident bank account opened abroad, or when collections and payments are carried out in cash. These exceptions, however, are subject to their own reporting requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold assets or rights outside of Spain (including shares acquired under the Plan), you may have to file an informational tax report, Form 720, with the tax authorities declaring such ownership by March 31st of the following year.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Generally, there is no obligation to file Form 720 if the total value of the following does not exceed Euro 50,000&#58; </font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">the securities, shares, rights and participations held by you, on December 31 or at any time throughout the year, in any kind of entities or in investment funds located outside Spain&#59;</font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">any transfer of own capital to third parties located abroad&#59; and</font></div><div style="margin-bottom:12pt;padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">life and disability insurances in which the individual was policy holder on December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that if an asset is jointly owned, the value is not prorated. Please also note that the application of the rules in respect of valuation of assets and transfers during the year should be carefully analyzed. If the limit of Euro 50,000 euros is exceeded for this described group of assets, all the elements of this group must be reported.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For those taxpayers who have filed Form 720 in previous years, they will only be obliged to file it again&#58;</font></div><div style="padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.7pt">When the aggregated value of the assets included in the mentioned group (shares&#47;insurances) had increased in an amount higher than Euro 20,000 regarding the informative return filed in a previous year.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.02pt">When the individual&#8217;s condition (owner, co-owner, co-titleholder or co-authorized) had changed or was extinguished during the year, before 31st December, with regard to any of the assets.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the thresholds for annual filing requirements may change each year. Therefore, you should consult your personal advisor regarding whether you will be required to file an informational tax report for asset and rights that you hold abroad.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Sweden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The following shall apply in addition to what is set out under section 2.14 of the Award Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Forfeiture of entitlements under the Plan in case of termination shall apply in case of termination of employment regardless of whether such termination of employment may be justified under Swedish employment protection legislation, and regardless of whether such termination may be challenged by you, and regardless of whether such termination is invalidated by verdict or a court order.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax withholdings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You authorize the Company and&#47;or the Employing Company to withhold or sell shares otherwise distributable to you upon vesting or settlement to satisfy the Company&#8217;s payroll tax withholding obligations.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Switzerland</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securitities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The PSUs and the issuance of any Ordinary Shares thereunder is not intended to be publicly offered in or from Switzerland.  Neither this Award Agreement nor any other materials relating to the Award (1) constitute a prospectus as such term is understood pursuant to article 652a of the Swiss Code of Obligations, (2) may be publicly distributed nor otherwise made publicly available in Switzerland, or (3) have been or will be filed with, approved </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or supervised by any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are obliged to submit an ordinary annual tax return in Switzerland, you are required to file a salary certificate with the Swiss tax authorities together with your Swiss tax return. The Company or the Affiliate employing you is obliged to prepare a specific attachment regarding the PSUs to this salary certificate. Before Settlement, for wealth tax purposes, the number of PSUs should be declared with p.m (zero value) in the asset statement of the tax return. After Settlement the total number of Ordinary Shares received are subject to wealth tax at the end of the calendar year and must be declared in your Swiss tax return.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Turkey</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Under Turkish law, you are not permitted to sell Ordinary Shares acquired under the Plan in Turkey.  The Ordinary Shares are currently traded on the Nasdaq Global Select Market, which is located outside of Turkey, under the ticker symbol &#8220;PRGO&#8221; and the Ordinary Shares may be sold through this exchange.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ukraine </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to obtain a license for obtaining shares of a foreign company from the National Bank of Ukraine (NBU). </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award will be outside the scope of your employment or service contract (if any) and as such will not constitute a part of your compensation package under the respective employment or service contract.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">United Kingdom</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Income Tax and National Insurance Contribution Withholding.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The following provision supplements the terms in the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If payment or withholding of the income tax due in connection with the PSUs is not made within ninety (90) days of the end of the U.K. tax year in which the event giving rise to the income tax liability or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003 occurred (the &#8220;Due Date&#8221;), the amount of any uncollected income tax shall constitute a loan owed by you to your employer, effective as of the Due Date.  You agree that the loan will bear interest at the then-current official rate of His Majesty&#8217;s Revenue &#38; Customs (&#8220;HMRC&#8221;), it shall be immediately due and repayable, and the Company or your employer may recover it at any time thereafter by any of the means referred to in Section 2.7 of the Agreement.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if you are a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), you will not be eligible for a loan from the Company or your employer to cover the income tax liability.  In the event that you are a director or executive officer and the income tax is not collected from or paid by the Due Date, the amount of any uncollected income tax will constitute a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">33</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">benefit to you on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) will be payable.  You will be responsible for reporting any income tax for reimbursing the Company or your employer the value of any employee NICs due on this additional benefit. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*   *   *   *   *</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">34</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex104-2023rsusgrantagreeme.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6e44b52ea3a748e18628bd278fb6f4e5_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERRIGO COMPANY PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(SERVICE-BASED)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Under the Perrigo Company plc 2019 Long-Term Incentive Plan)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant Name</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RE&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Restricted Stock Unit Award (Service-Based)</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This is to notify you that Perrigo Company plc (the &#8220;Company&#8221;) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the &#8220;Plan&#8221;), effective as of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;Grant Date&#8221;).  This Award consists of service-based restricted stock units.  The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (&#8220;Appendix&#8221;) (collectively, the &#8220;Agreement&#8221;).  The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Units &#8211; Service-Based Vesting</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As of the Grant Date, and subject to the terms and conditions of this Agreement and the Plan, the Company grants you </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Number of Awards Granted </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(&#8220;Restricted Stock Units&#8221; or &#8220;RSUs&#8221;).  Each RSU shall entitle you to one ordinary share of the Company, nominal value &#8364;0.001 per share (&#8220;Ordinary Share&#8221;) on the applicable RSU Vesting Date, provided the vesting conditions described in Section 1.2 are satisfied.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as provided in Section 1.3, the RSUs awarded in Section 1.1 shall vest as follows following the Grant Date (&#8220;RSU Vesting Date(s)&#8221;)&#58; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vesting Schedule (Dates &#38; Quantities)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; provided, however, that you continue in the service of the Company from the Grant Date through the applicable RSU Vesting Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as provided in Section 1.3, if your Termination Date occurs prior to the RSU Vesting Date, any RSUs awarded under Section 1.1 that have not previously vested as of such Termination Date shall be permanently forfeited on your Termination Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Vesting Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding Section 1.2 above&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;If your Termination Date occurs by reason of death, Disability or Retirement with the Company&#8217;s consent, any RSUs awarded under Section 1.1 that have not vested prior to such Termination Date shall become fully vested.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;If your Termination Date occurs by reason of an Involuntary Termination for Economic Reasons, any RSUs awarded under Section 1.1 that would otherwise be scheduled to vest under Section 1.2 in the 24-month period following such Termination Date shall continue to vest during such 24-month period according to the vesting schedule in effect prior to such Termination Date&#59; provided, however, that if your Termination Date occurs for a reason that is both described in this subsection (b) and in subsection (c) below, the special vesting rules described in subsection (c) shall apply in lieu of the vesting rules described in this subsection (b).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any RSUs that are not scheduled to vest during such 24-month period will be permanently forfeited on the Termination Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;If your Termination Date occurs by reason of a Termination without Cause or a Separation for Good Reason on or after a Change in Control (as defined in the Plan and as such definition may be amended hereafter) and prior to the two (2) year anniversary of the Change in Control, all RSUs awarded under Section 1.1 that have not vested or been forfeited prior to such Termination Date shall become fully vested.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;As used in this Section 1.3, the following terms shall have the meanings set forth below&#58; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;&#8220;Separation for Good Reason&#8221; means your voluntary resignation from the Company and the existence of one or more of the following conditions that arose without your consent&#58; (i) a material change in the geographic location at which you are required to perform services, such that your commute between home and your primary job site increases by more than 30 miles,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or (ii) a material diminution in your authority, duties or responsibilities or a material diminution in your base compensation or incentive compensation opportunities&#59; provided, however, that a voluntary resignation from the Company shall not be considered a Separation for Good Reason unless you provide the Company with notice, in writing, of your voluntary resignation and the existence of the condition(s) giving rise to the separation within 90 days of its initial existence.  The Company will then have 30 days to remedy the condition, in which case you will not be deemed to have incurred a Separation for Good Reason.  In the event the Company fails to cure the condition within the 30 day period, your Termination Date shall occur on the 31st day following the Company&#8217;s receipt of such written notice.  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;&#8220;Termination without Cause&#8221; means the involuntary termination of your employment or contractual relationship by the Company without Cause, including, but not limited to, (i) a termination effective when you exhaust a leave of absence during, or at the end of, a notice period under the Worker Adjustment and Retraining Notification Act (&#8220;WARN&#8221;), and (ii) a situation where you are on an approved leave of absence during which your position is protected under applicable law (e.g., a leave under the Family Medical Leave Act), you return from such leave, and you cannot be placed in employment or other form of contractual relationship with the Company.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as practicable after the RSU Vesting Date, the Company shall transfer to you one Ordinary Share for each RSUs becoming vested on such date (the date of any such transfer shall be the &#8220;settlement date&#8221; for purposes of this Agreement)&#59; provided, however, the Company may withhold shares otherwise transferable to you to the extent necessary to satisfy withholding taxes due by reason of the vesting of the RSUs, in accordance with Section 2.6.  You shall have no rights as a stockholder with respect to the RSUs awarded hereunder prior to the date of issuance to you of a certificate or certificates for such shares.  Notwithstanding the foregoing, the Committee, in its sole discretion, may elect to settle RSUs in cash based on the fair market value of the Ordinary Shares on the RSU Vesting Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The RSUs awarded under Section 1.1 shall be eligible to receive dividend equivalents in accordance with the following&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;An &#8220;Account&#8221; will be established in your name.  Such Account shall be for recordkeeping purposes only, and no assets or other amounts shall be set aside from the Company&#8217;s general assets with respect to such Account.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;On each date that a cash dividend is paid with respect to Ordinary Shares, the Company shall credit your Account with the dollar amount of dividends you would have received if each RSU held by you on the record date for such dividend payment had been an Ordinary Share.  No interest or other earnings shall accrue on such Account.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;As of each RSU Vesting Date, you shall receive a payment equal to the amount of dividends that would have been paid on the RSUs vesting on such date had they been Ordinary Shares during the period beginning on the Grant Date and ending on the RSU Vesting Date, and the Account shall be debited appropriately.  If you forfeit RSUs, any amounts in the Account attributable to such RSUs shall also be forfeited.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;If dividends are paid in the form of Ordinary Shares rather than cash, then you will be credited with one additional RSU for each Ordinary Share that would have been received as a dividend had your outstanding RSUs been Ordinary Shares.  Such additional RSUs shall vest or be forfeited at the same time as the RSU to which they relate.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">General Terms and Conditions</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nontransferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award under this Agreement shall not be transferable other than by will or by the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You shall not have any rights as a stockholder with respect to any Ordinary Shares subject to the RSU awarded under this Agreement prior to the date of issuance to you of a certificate or certificates for such shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If your Termination Date occurs for reasons of Cause, all of your rights under this Agreement, whether or not vested, shall terminate immediately.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The granting of the Award under this Agreement is being made pursuant to the Plan and the Award shall be payable only in accordance with the applicable terms of the Plan.  The Plan contains certain definitions, restrictions, limitations and other terms and conditions all of which shall be applicable to this Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ALL THE PROVISIONS OF THE PLAN ARE INCORPORATED HEREIN BY REFERENCE AND ARE MADE A PART OF THIS AGREEMENT IN THE SAME MANNER AS IF EACH AND EVERY SUCH PROVISION WERE FULLY WRITTEN INTO THIS AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Should the Plan become void or unenforceable by operation of law or judicial decision, this Agreement shall have no force or effect.  Nothing set forth in this Agreement is intended, nor shall any of its provisions be construed, to limit or exclude any definition, restriction, limitation or other term or condition of the Plan as is relevant to this Agreement and as may be specifically applied to it by the Committee.  In the event of a conflict in the provisions of this Agreement and the Plan, as a rule of construction the terms of the Plan shall be deemed superior and apply.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments in Event of Change in Ordinary Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of a stock split, stock dividend, recapitalization, reclassification or combination of shares, merger, sale of assets or similar event, the number and kind of shares subject to Award under this Agreement will be appropriately adjusted in an equitable manner to prevent dilution or enlargement of the rights granted to or available for you.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and you agree that the RSUs are granted under and governed by the Notice of Grant, this Agreement (including the Appendix, if applicable) and by the provisions of the Plan (incorporated herein by reference).  You&#58; (i) acknowledge receipt of a copy of each of the foregoing documents, (ii) represent that you have carefully read and are familiar with their provisions, and (iii) hereby accept the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes and Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding (Only Applicable to Individuals Subject to U.S. Tax Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Award is subject to the withholding of all applicable taxes.  The Company may withhold, or permit you to remit to the Company, any Federal, state or local taxes applicable to the grant, vesting or other event giving rise to tax liability with respect to this Award.  If you have not remitted the full amount of applicable withholding taxes to the Company by the date the Company is required to pay such withholding to the appropriate taxing authority (or such earlier date that the Company may specify to assist it in timely meeting its withholding obligations), the Company shall have the unilateral right to withhold Ordinary Shares relating to this Award in the amount it determines is sufficient to satisfy the tax withholding required by law.  State taxes will be withheld at the appropriate rate set by the state in which you are employed or were last employed by the Company.  In no event may the number of shares withheld exceed the number necessary to satisfy the maximum Federal, state and local income and employment tax withholding requirements.  You may elect to surrender previously acquired Ordinary Shares or to have the Company withhold Ordinary Shares relating to this Award in an amount sufficient to satisfy all or a portion of the tax withholding required by law.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Responsibility for Taxes (Only Applicable to Individuals Subject to Tax Laws Outside the U.S.)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Regardless of any action the Company or, if different, the Affiliate employing or retaining you takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (&#8220;Tax-Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items is and remains your responsibility and may exceed the amount actually withheld by the Company or the Affiliate employing or retaining you.  You further acknowledge that the Company and&#47;or the Affiliate employing or retaining you (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant, vesting or settlement of the RSUs, the subsequent sale of Ordinary Shares acquired pursuant to such settlement and the receipt of any dividends&#59; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result.  Further, if you have become subject to tax in more than one jurisdiction between the RSU Grant Date and the date of any relevant taxable event, as applicable, you acknowledge that the Company and&#47;or the Affiliate employing or retaining you (or formerly employing or retaining you, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Prior to any relevant taxable or tax withholding event, as applicable, you will pay or make adequate arrangements satisfactory to the Company and&#47;or the Affiliate employing or retaining you to satisfy all Tax-Related Items.  In this regard, you authorize the Company and&#47;or the Affiliate employing or retaining you, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58;  </font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;withholding from your wages or other cash compensation paid to you by the Company and&#47;or the Affiliate employing or retaining you&#59; or</font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;withholding from proceeds of the sale of Ordinary Shares acquired upon settlement of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization)&#59; or </font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)&#160;&#160;&#160;&#160;withholding in Ordinary Shares to be issued upon settlement of the RSUs.  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;To avoid negative accounting treatment, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">amounts or other applicable withholding rates.  If the obligation for Tax-Related Items is satisfied by withholding in Ordinary Shares, for tax purposes, you are deemed to have been issued the full number of Ordinary Shares subject to the vested RSUs, notwithstanding that a number of the Ordinary Shares are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Finally, you shall pay to the Company or the Affiliate employing or retaining you any amount of Tax-Related Items that the Company or the Affiliate employing or retaining you may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to issue or deliver the Ordinary Shares or the proceeds of the sale of Ordinary Shares, if you fail to comply with your obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The issuance of Ordinary Shares will be subject to and conditioned upon compliance by the Company and you, including any written representations, warranties and agreements as the Administrator may request of you for compliance with all (i) applicable U.S. state and federal laws and regulations, (ii) applicable laws of the country where you reside pertaining to the issuance or sale of Ordinary Shares, and (iii)&#160;applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Ordinary Shares may be listed or quoted at the time of such issuance or transfer.  Notwithstanding any other provision of this Agreement, the Company shall have no obligation to issue any Ordinary Shares under this Agreement if such issuance would violate any applicable law or any applicable regulation or requirement of any securities exchange or similar entity.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code Section 409A (Only Applicable to Individuals Subject to U.S. Federal Tax Laws)</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;RSUs other than RSUs that continue to vest by reason of your Involuntary Termination for Economic Reasons and dividend equivalents payable under this Agreement are intended to be exempt from Code Section 409A under the exemption for short-term deferrals.  Accordingly, RSUs (other than RSUs that continue to vest by reason of your Involuntary Termination for Economic Reasons) will be settled and dividend equivalents will be paid no later than the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of the third month following the later of (i) the end of your taxable year in which the RSU Vesting Date occurs, or (ii) the end of the fiscal year of the Company in which the RSU Vesting Date occurs.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;RSUs that continue to vest by reason of your Involuntary Termination for Economic Reasons are subject to the provisions of this subsection (b).  Any distribution in settlement of such RSUs will occur provided your Involuntary Termination for Economic Reasons constitutes a &#8220;separation from service&#8221; as defined in Treasury Regulation &#167;1.409A-1(h).  If the Company determines that you are a &#8220;specified employee&#8221; as defined in Code Section 409A (i.e., an officer with annual compensation above $130,000 (as adjusted for inflation), a five-percent owner of the Company or a one-percent owner with annual compensation in excess of $150,000), distribution in settlement of any such RSUs that would be payable within six months of your separation from service shall be delayed to the first business day following the six-month anniversary of your separation from service.  Any distribution in settlement of such RSUs that would be made more than six months after your separation from service (without application of the six-month delay) shall not be subject to the six-month delay described in this subsection.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Data Privacy Rules (Only Applicable if this Award is Subject to U.S. Data Privacy Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By entering into this Agreement and accepting this Award, you (a)&#160;explicitly and unambiguously consent to the collection, use and transfer, in electronic or other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">form, of any of your personal data that is necessary to facilitate the implementation, administration and management of the Award and the Plan, (b) understand that the Company may, for the purpose of implementing, administering and managing the Plan, hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, and details of all awards or entitlements to Shares granted to you under the Plan or otherwise (&#8220;Personal Data&#8221;), (c) understand that Personal Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including any broker with whom the Shares issued upon vesting of the Award may be deposited, and that these recipients may be located in your country or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than your country, (d) waive any data privacy rights you may have with respect to the data, and (e) authorize the Company, its Affiliates and its agents, to store and transmit such information in electronic form.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Data Privacy Rules (Only Applicable if this Award is Subject to Data Privacy Laws Outside of the U.S.)</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;By entering into this Agreement and accepting this Award, you hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Affiliate employing or retaining you, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;You understand that the Company and the Affiliate employing or retaining you may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Ordinary Shares or directorships held in the Company, details of all RSUs or any other entitlement to Ordinary Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (&#8220;Data&#8221;).  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;You understand that Data will be transferred to legal counsel or a broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients&#8217; country (e.g., the United States) may have different data privacy laws and protections than your country of residence.  You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local or Company human resources representative.  You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan.  You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local or Company human resources representative.  You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local or Company human resources representative.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be binding upon any or all successors and assigns of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed and enforced in accordance with the applicable Code provisions to the maximum extent possible and otherwise by the laws of the State of Michigan without regard to principals of conflict of laws, provided that if you are a foreign national or employed outside the United States, this Agreement shall be governed by and construed and enforced in accordance with applicable foreign law to the extent that such law differs from the Code and Michigan law.  Any proceeding related to or arising out of this Agreement shall be commenced, prosecuted or continued in the Circuit Court in Kent County, Michigan located in Grand Rapids, Michigan or in the United Stated District Court for the Western District of Michigan, and in any appellate court thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Forfeiture of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company, as a result of misconduct, is required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, then (a) if your incentive or equity-based compensation is subject to automatic forfeiture due to such misconduct and restatement under Section 304 of the Sarbanes-Oxley Act of 2002, or (b) the Committee determines you either knowingly engaged in or failed to prevent the misconduct, or your actions or inactions with respect to the misconduct and restatement constituted gross negligence, you shall (i) be required to reimburse the Company the amount of any payment (including dividend equivalents) relating to any RSUs earned or accrued during the twelve month period following the first public issuance or filing with the SEC (whichever first occurred) of the financial document embodying such financial reporting requirement, and (ii) all outstanding RSUs (including related dividend equivalents) that have not yet been settled shall be immediately forfeited.  In addition, Ordinary Shares acquired under this Agreement, and any gains or profits on the sale of such Ordinary Shares, shall be subject to any &#8220;clawback&#8221; or recoupment policy later adopted by the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Rules for Non-U.S. Grantees (Only Applicable if You Reside Outside of the U.S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">)</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In accepting the grant, you acknowledge, understand and agree that&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, except as otherwise provided in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;the grant of the RSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted repeatedly in the past&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;all decisions with respect to future RSU grants, if any, will be at the sole discretion of the Company&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;you are voluntarily participating in the Plan&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)&#160;&#160;&#160;&#160;the RSUs and the Ordinary Shares subject to the RSUs are an extraordinary item and which is outside the scope of your employment or service contract, if any&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(6)&#160;&#160;&#160;&#160;the RSUs and the Ordinary Shares subject to the RSUs are not intended to replace any pension rights or compensation&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7)&#160;&#160;&#160;&#160;the RSUs and the Ordinary Shares subject to the RSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Affiliate employing or retaining you or any other Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(8)&#160;&#160;&#160;&#160;the grant and your participation in the Plan will not be interpreted to form an employment or service contract with the Company or any Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(9)&#160;&#160;&#160;&#160;the future value of the underlying Ordinary Shares is unknown, indeterminable and cannot be predicted with certainty&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(10)&#160;&#160;&#160;&#160;no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from your Termination Date (for any reason whatsoever, whether or not later found to be invalid and whether or not in breach of employment laws in the jurisdiction where you are employed or rendering services, or the terms of your employment agreement, if any), and in consideration of the grant of the RSUs to which you are otherwise not entitled, you irrevocably agree never to institute any claim against the Company or the Affiliate employing or retaining you, waive your ability, if any, to bring any such claim, and release the Company and the Affiliate employing or retaining you from any such claim&#59; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, you shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim&#59; and</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(11)&#160;&#160;&#160;&#160;you acknowledge and agree that neither the Company, the Affiliate employing or retaining you nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the currency of the country in which you reside and the United States Dollar that may affect the value of the RSUs or of any amounts due to you pursuant to the settlement of the RSUs or the subsequent sale of any Ordinary Shares acquired upon settlement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Notwithstanding any provisions in this Agreement, the RSU grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement for your country.  Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to you, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan.  If you relocate to the United States, the special terms and conditions in the Appendix will apply, or cease to apply, to you, to the extent the Company determines that the application or otherwise of such provisions is necessary or advisable in order to facilitate the administration of the Plan.  The Appendix constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company reserves the right to impose other requirements on your participation in the Plan, on the RSUs and on any Ordinary Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15&#160;&#160;&#160;&#160;&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Noncompetition and&#93; Nonsolicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Noncompetition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During your employment with the Company and its Affiliates and for a twelve (12) month period following your Termination Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), you shall not (i) directly or indirectly, without the prior written consent of the Company, engage in or invest &#91;a material or controlling interest in&#93; as an owner, partner, stockholder, licensor, director, officer, agent or consultant for any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the &#91;country or countries in which you regularly work or provide services&#93; &#91;world&#93;&#59; or (ii) accept employment or an engagement for the provision of services in any capacity, including as an employee, director, consultant or advisor, directly or indirectly, with any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the &#91;country or countries in which you regularly work or provide services&#93; &#91;world&#93; except where prohibited by local law. For purposes hereof, conducting a business that is in competition with a business conducted by the Company or any of its Affiliates shall include the sale, manufacture, distribution or research and development of any product or service that is similar to a product or service sold, distributed, marketed or being researched or developed (including through a joint venture or investment in another entity) by the Company or any of its Affiliates, including store brand and value brand OTC drug or nutritional products, extended topical generic prescription pharmaceutical products, infant nutrition products, oral care products, and any other product or products that the Company or an Affiliate is marketing or actively planning to market during your employment with the Company and during the oneyear period following your Termination Date. If there is a completed sale, transfer or other disposition of the Perrigo Prescription Pharmaceutical business during the Restricted Period, this Section 2.15(a) will not apply to the Perrigo Prescription Pharmaceutical business.  Notwithstanding the foregoing, nothing in this provision shall prevent you from passively owning two percent (2%) or less of the outstanding securities of any class of any company listed on a national securities exchange or quoted on an automated quotation system.  You may make a written request in writing to the CHRO of the Company for an exception to this Section 2.15(a) and such exception will not be unreasonably withheld&#91;, particularly where you are seeking employment with a business that does not compete with the segment of the Company where you worked or provided services during the last two years of your employment with the Company&#93;.&#93;  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nonsolicitation of Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During your employment with the Company and its Affiliates and for the duration of the Restricted Period, you shall not, directly or indirectly, without the prior written consent of the Company, (i) actively solicit, recruit or hire any Person who is at such time, or who at any time during the 12month period prior to such solicitation or hiring had been, an employee or consultant of the Company or any of its Affiliates, (ii) solicit or encourage any employee of the Company or any of its Affiliates to leave the employment of the Company or any of its Affiliates or (iii) interfere with the relationship of the Company or any of its Affiliates with any Person or entity who or that is employed by or otherwise engaged to perform services for the Company or any of its Affiliates except where prohibited by local law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nonsolicitation of Clients</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During your employment with the Company and its Affiliates and for the duration of the Restricted Period, you shall not, directly or indirectly, alone or in association with any other Person, without the prior written consent of the Company, (i) induce or attempt to induce any client, customer (whether former or current), supplier, licensee, franchisee, joint venture partner or other business relation of the Company or any of its Affiliates (collectively, &#8220;Clients&#8221;) to cease doing business with the Company or any such Affiliate, (ii) divert all or any portion of a Client&#8217;s business with the Company to any competitor of the Company or any such Affiliate, or (iii) in any way interfere with the relationship between any Client, on the one hand, and the Company or any such Affiliate, on the other hand except where prohibited by local law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Remedies and Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that a violation by you of any of the covenants contained in this Section 2.15 would cause irreparable damage to the Company and its Affiliates in an amount that would be material but not readily ascertainable, and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that any remedy at law (including the payment of damages) would be inadequate. Accordingly, you agree that, notwithstanding any provision of this Agreement to the contrary, in addition to any other damages it is able to show, the Company and its Affiliates shall be entitled (without the necessity of showing economic loss or other actual damage) to injunctive relief (including temporary restraining orders, preliminary injunctions and permanent injunctions), without posting a bond, in any court of competent jurisdiction for any actual or threatened breach of any of the covenants set forth in this Section 2.15 in addition to any other legal or equitable remedies it may have. In addition, in the event of your Willful Restrictive Covenant Breach (as defined in this Section 2.15), (i) all of your rights under this Agreement, whether or not vested, shall terminate immediately, and (ii) any Shares, cash or other property paid or delivered to you pursuant to this Agreement shall be forfeited and you shall be required to repay such Shares, cash or other property to the Company, no later than thirty (30) calendar days after the Company makes demand to you for repayment.  For purposes of this Agreement, &#8220;Willful Restrictive Covenant Breach&#8221; means your material breach of any of the covenants set forth in this Section 2.15 which you knew, or with due inquiry, should have known, would constitute such a material breach. The preceding sentences of this Section 2.15 shall not be construed as a waiver of the rights that the Company and its Affiliates may have for damages under this Agreement or otherwise, and all such rights shall be unrestricted. The Restricted Period shall be tolled during (and shall be deemed automatically extended by) any period during which you are in violation of the provisions of Section 2.15(a), (b) or (c), as applicable. In the event that a court of competent jurisdiction determines that any provision of this Section 2.15 is invalid or more restrictive than permitted under the governing law of such jurisdiction, then, only as to enforcement of this Section 2.15 within the jurisdiction of such court, such provision shall be interpreted and enforced as if it provided for the maximum restriction permitted under such governing law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;You acknowledge that the Company and its Affiliates have expended and will continue to expend substantial amounts of time, money and effort to develop business strategies, employee, customer and other relationships and goodwill to build an effective organization. You acknowledge that the Company and its Affiliates have a legitimate business interest in and right to protect its goodwill and employee, customer and other relationships, and that the Company and its Affiliates could be seriously damaged by the loss or deterioration of its employee, customer and other relationships. You further acknowledge that the Company and its Affiliates are entitled to protect and preserve the going concern value of the Company and its Affiliates to the extent permitted by law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;In light of the foregoing acknowledgments, you agree that the covenants contained in this Agreement are reasonable and properly required for the adequate protection of the businesses and goodwill of the Company and its Affiliates. You further acknowledge that, although your compliance with the covenants contained in this Agreement may prevent you from earning a livelihood in a business similar to the business of the Company and its Affiliates, your experience and capabilities are such that you have other opportunities to earn a livelihood and adequate means of support for you and your dependents.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3)&#160;&#160;&#160;&#160;In light of the acknowledgements contained in this Section 2.15, you agree not to challenge or contest the reasonableness, validity or enforceability of any limitations on, and obligations of, you contained in this Section 2.15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> &#93;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">****</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">We look forward to your continuing contribution to the growth of the Company.  Please acknowledge your receipt of the Plan and this Award.</font></div><div style="text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="text-indent:198pt"><font><br></font></div><div style="text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; </font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">APPENDIX</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PERRIGO COMPANY PLC<br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Additional Terms and Provisions to</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Restricted Stock Unit Award Agreement (Service-Based)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix (the &#8220;Appendix&#8221;) includes additional terms and conditions that govern the restricted stock units (&#8220;RSUs&#8221; or &#8220;Award&#8221;) granted to you under the Plan if you reside in one of the countries listed below. Certain capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan and&#47;or the Agreement.  The Award will not create any entitlement to receive any similar benefit in the future. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix also includes country-specific information of which you should be aware with respect to your participation in the Plan.  The information is based on the securities, exchange control and other laws in effect in the respective countries as of January 2023.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that you do not rely on the information noted herein as the only source of information relating to the consequences of your participation in the Plan because the information may be out of date at the time that you vest in the RSUs and Ordinary Shares are issued to you or the shares issued upon vesting of the RSUs are sold.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, the information is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of any particular result.  Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your particular situation.  Finally, please note that if you are a citizen or resident of a country other than the country in which you are currently working, or transfers employment after grant, the information contained in the Appendix may not be applicable.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Conditions et dispositions suppl&#233;mentaires &#224; l&#8217;</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Accord relatif &#224; l&#8217;attribution d&#8217;unit&#233;s d&#8217;action avec restrictions (r&#233;mun&#233;ration fond&#233;e sur les services)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice (l&#8217;&#171;&#160;Appendice&#160;&#187;) comprend des conditions compl&#233;mentaires r&#233;gissant les unit&#233;s d&#8217;action avec restrictions (&#171;&#160;UAR&#160;&#187; ou &#171;&#160;Prime&#160;&#187;) qui vous sont attribu&#233;es en vertu du Plan si vous r&#233;sidez dans l&#8217;un des pays repris ci-dessous. Certains termes commen&#231;ant par une lettre majuscule utilis&#233;s dans le pr&#233;sent Accord mais qui n&#8217;y sont pas d&#233;finis ont le sens qui leur est attribu&#233; dans le Plan ou l&#8217;Accord. La Prime n&#8217;instaure aucun droit &#224; recevoir des avantages similaires &#224; l&#8217;avenir. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice comprend &#233;galement des informations sp&#233;cifiques aux pays dont vous devez avoir connaissance eu &#233;gard &#224; votre participation au Plan. Les informations se fondent sur les lois relatives aux valeurs mobili&#232;res, au contr&#244;le des &#233;changes et autres en vigueur dans les pays respectifs en janvier 2023. Souvent complexes, ces lois font l&#8217;objet de modifications fr&#233;quentes. Par cons&#233;quent, la Soci&#233;t&#233; vous recommande vivement de ne pas consid&#233;rer les renseignements repris aux pr&#233;sentes comme l&#8217;unique source d&#8217;information relative aux cons&#233;quences de votre participation au Plan, car ces renseignements peuvent &#234;tre obsol&#232;tes au moment de la d&#233;volution des UAR ou de l&#8217;&#233;mission des Actions ordinaires pour votre compte, ou de la vente des actions &#233;mises lors de la d&#233;volution des UAR.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Par ailleurs, ces informations sont d&#8217;ordre g&#233;n&#233;ral et peuvent ne pas s&#8217;appliquer &#224; votre situation particuli&#232;re. De plus, la Soci&#233;t&#233; n&#8217;est pas en mesure de vous garantir un quelconque r&#233;sultat particulier. Par cons&#233;quent, il vous est conseill&#233; de demander des conseils professionnels appropri&#233;s quant &#224; la mani&#232;re dont les lois de votre pays en la mati&#232;re peuvent s&#8217;appliquer &#224; votre situation particuli&#232;re. Enfin, veuillez noter que si vous &#234;tes citoyen ou r&#233;sident d&#8217;un pays autre que celui dans lequel vous travaillez actuellement ou si votre emploi est transf&#233;r&#233; apr&#232;s l&#8217;octroi, les informations figurant dans l&#8217;Appendice peuvent ne pas appliquer.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Extra voorwaarden en voorzieningen bij</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">De Overeenkomst over voorwaardelijk toegekende aandelen (op basis van diensten)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Algemene voorwaarden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage (de 'Bijlage') omvat extra algemene voorwaarden voor de voorwaardelijk toegekende aandelen ('RSU's' of 'Award') die u volgens het Plan zijn toegekend als u in een van onderstaande landen woont. Bepaalde termen in hoofdletters die in deze Bijlage werden gebruikt maar niet gedefinieerd, hebben de betekenis die in het Plan en&#47;of de Overeenkomst is vermeld. De Award cre&#235;ert geen recht om een soortgelijk voordeel in de toekomst te krijgen. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage bevat ook landenspecifieke informatie waarvan u op de hoogte moet zijn met betrekking tot uw deelname aan het Plan. De informatie is gebaseerd op de effecten-, wisselcontrole- en andere wetten die in de respectieve landen sinds januari 2023 van kracht zijn.  Zulke wetten zijn vaak complex en worden regelmatig aangepast. Daarom raadt het Bedrijf u ten sterkste aan de informatie hierin niet te gebruiken als enige bron van informatie over de gevolgen van uw deelname aan het Plan, omdat de informatie verouderd kan zijn op het ogenblik dat uw toezegging in de RSU's en de Gewone aandelen u worden uitgekeerd of wanneer de bij de toezegging van de RSU's uitgegeven aandelen worden verkocht.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ook is de informatie algemeen van aard en mag u ze niet toepassen op uw specifieke situatie. Het Bedrijf bevindt zich evenmin in een positie om u een specifiek resultaat te verzekeren. We raden u dan ook aan om professioneel advies te vragen over hoe de relevante wetten in uw land van toepassing kunnen zijn op uw specifieke situatie. Ten slotte, merk op dat als u een burger of inwoner bent van een ander land dan het land waarin u op dit moment werkt, of uw tewerkstelling na de toekenning verhuist, de informatie in de Bijlage mogelijk niet van toepassing is.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Dodatkowe warunki i postanowienia</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Umowa przydzia&#322;u Akcji warunkowych (w oparciu o stosunek pracy)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik (&#8222;Za&#322;&#261;cznik&#8221;) zawiera dodatkowe warunki, kt&#243;re reguluj&#261; akcje warunkowe (&#8222;RSU&#8221;) przyznan&#261; w ramach Programu, je&#347;li mieszkasz w jednym z wymienionych poni&#380;ej kraj&#243;w. Okre&#347;lone terminy pisane wielk&#261; liter&#261;, kt&#243;re nie zosta&#322;y zdefiniowane w niniejszym Za&#322;&#261;czniku, maj&#261; znaczenie okre&#347;lone w Programie i&#47;lub Umowie. Prawo nie uprawnia do uzyskiwania podobnych korzy&#347;ci w przysz&#322;o&#347;ci. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik zawiera r&#243;wnie&#380; informacje dotycz&#261;ce poszczeg&#243;lnych kraj&#243;w, o kt&#243;rych powiniene&#347;(-as) wiedzie&#263; w zwi&#261;zku z uczestnictwem w Programie. Informacje oparte s&#261; na papierach warto&#347;ciowych, kontroli dewizowej i innych przepisach obowi&#261;zuj&#261;cych w odpowiednich krajach od stycznia 2023 r. Takie przepisy prawa s&#261; cz&#281;sto skomplikowane i cz&#281;sto si&#281; zmieniaj&#261;. W zwi&#261;zku z tym Sp&#243;&#322;ka zdecydowanie zaleca, aby nie polega&#263; na informacjach wymienionych w niniejszym dokumencie jako jedynym &#378;r&#243;dle informacji zwi&#261;zanych z konsekwencjami uczestnictwa w Programie, gdy&#380; informacje te mog&#261; by&#263; nieaktualne w momencie nabycia lub wykonywania opcji na akcje, a Akcje Zwyk&#322;e s&#261; Ci wydawane lub w przypadku sprzeda&#380;y Akcji Zwyk&#322;ych nabytych w ramach Programu.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto informacje maj&#261; charakter og&#243;lny i mog&#261; nie mie&#263; zastosowania do konkretnej sytuacji, a Sp&#243;&#322;ka nie jest w stanie zapewni&#263; Ci &#380;adnego konkretnego rezultatu. W zwi&#261;zku z tym zaleca si&#281; zasi&#281;gni&#281;cie odpowiedniej profesjonalnej porady dotycz&#261;cej tego, w jaki spos&#243;b odpowiednie przepisy w Twoim kraju mog&#261; mie&#263; zastosowanie do konkretnej sytuacji. Wreszcie nale&#380;y pami&#281;ta&#263;, &#380;e je&#347;li jeste&#347; obywatelem&#47;obywatelk&#261; lub rezydentem&#47;rezydentk&#261; kraju innego ni&#380; kraj, w kt&#243;rym obecnie pracujesz lub przenosisz si&#281; do nowego miejsca po przyznaniu, informacje zawarte w Za&#322;&#261;czniku mog&#261; nie mie&#263; zastosowania.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Australia</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:108%">Important Notice </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:108%">No financial product advice is provided in this Appendix, this Agreement or the Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:108%">Plan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:108%">&#8221;) and nothing should be taken to constitute a recommendation or statement of opinion that is intended to influence a person or persons in making a decision to participate in the Plan.The Plan Documents do not take into account your objectives, financial situation and needs. You should consider obtaining your own financial product advice from a person who is licensed by the Australian Securities and Investments Commission to give such advice.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:108%">If you intend to apply to participate in the Plan, you must make your own independent assessment and investigation in relation to your legal and taxation position including seeking professional advice.  You must base any decision you may make on such independent assessment, investigation or advice.</font></div></td></tr></table></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Offer made without disclosure</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A copy of the terms of the Plan will be provided to you with this Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of the Plan, an offer to receive RSUs and participate in the Plan, if received in Australia, is made without disclosure to investors in reliance on the regulatory relief set out in Division 1A of Part 7.12, and for the purposes of section 1100N(b), of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Corporations Act 2001</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Cth).</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As set out in this Agreement, an RSU represents the right to receive one Ordinary Share subject to all the relevant vesting conditions being met, or otherwise waived, in accordance with the Plan. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The RSUs will be issued for nil consideration. You are not required to pay for an RSU or for the subsequent issue or transfer of an Ordinary Share on vesting of that RSU, however your responsibility for any taxes will be as set out in the terms of the Plan and this Agreement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Clause 1.5(d) of this Agreement provides that you will be credited one additional RSU for each Ordinary Share that you would have received had your outstanding RSUs been Ordinary Shares. Notwithstanding that clause, for the purposes of complying with any applicable laws (including the conditions of  any applicable regulatory relief), the Company&#8217;s board of directors may determine, in its sole discretion, to pay any dividend equivalents to which you are entitled under clause 1.5 of this Agreement wholly in cash. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company will not provide you with any loans or financial assistance under the Plan in connection with the offer of the RSUs.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No RSUs or resulting Ordinary Shares provided to you under the Plan will be held by a trustee&#47;nominee.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The indicative daily price of the Ordinary Shares on the New York Stock Exchange (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), quoted in US dollars, is available on the Company&#8217;s website at http&#58;&#47;&#47;perrigo.investorroom.com&#47;stock-information. The Ordinary Shares are also quoted on the NASDAQ Stock Market (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NASDAQ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) (refer to NASDAQ&#8217;s website at </font><font style="color:#145da4;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">http&#58;&#47;&#47;www.nasdaq.com&#47;symbol&#47;prgo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Australian dollar equivalent of the Ordinary Shares can be determined using prevailing exchange rate published by Thomson Reuters (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Prevailing Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) Alternatively, the Company will advise you of the price of its Ordinary shares (in equivalent Australian dollars) as soon as possible following receipt of any request for such information. This information may be obtained by you contacting your local Human Resources representative.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Before accepting an offer to be granted RSUs, you should satisfy yourself that you have a sufficient understanding of the risks set out below and should consider if the RSUs are a suitable investment for you, having regard to your own investment objectives, financial circumstances and taxation position&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.8pt">the vesting conditions for your RSUs may not be satisfied for reasons beyond the Company or your control&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.18pt">you are not permitted to transfer your RSUs unless permitted under this Agreement or the Plan&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.8pt">if your RSUs vest and you subsequently receive Shares&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:63.8pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.98pt">the value of those shares may rise and fall according to investor sentiment, general economic conditions and outlook, international and local stock markets, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:63.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">employment, inflation, interest rates, government policy, taxation and regulation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:63.8pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.93pt">there is no guarantee that an active trading market for the shares will exist or that the price of the shares will increase. There may be relatively few potential buyers or sellers of the shares on the NYSE, NASDAQ, TASE or any other applicable market at any time and this may increase the volatility of the market price of the shares. It may also affect the prevailing market price at which you may be able to sell your Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:63.8pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:11.88pt">except as otherwise provided in this Agreement, you will have no voting, dividend, or other stockholder rights in any Shares until you become the registered holder of those Shares. Until you become the registered holder of Shares, you will have only the rights of an unsecured creditor with respect to those Shares&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.18pt">there may be taxation implications arising for you in participating under this Agreement and in the Plan. The tax consequences of participating in the Plan are based on complex tax laws, which may be subject to varying interpretations, and the application of such laws may depend, in large part, on the surrounding facts and circumstances. The tax regime applying to you may change.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the above risks are only general risks of acquiring and holding RSUs under the Plan. It does not purport to list every risk that may be associated with the Plan now or in the future. There may be other risks of participating in the Plan or holding shares that are specific to your circumstances.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you acquire Ordinary Shares following exercise of your RSU and you offer those shares for sale to a person or entity resident in Australia, then the offer may be subject to disclosure requirements under Australian law.  You should obtain legal advice on your disclosure obligations prior to making any such offer.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If at the time of vesting, the Company determines that it is not legal under Australian securities laws to issue or transfer the Ordinary Shares, the outstanding RSUs will be cancelled and no Shares will be issued or transferred to you nor will any benefits in lieu of shares be paid to you.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control reporting mandates disclosure of payments equal to or exceeding AUD10,000 made to a foreign individual or entity. This reporting is generally done automatically by the financial institution making the transfer.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Austria</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of Austria, you must submit a report to the Austrian National Bank. An exemption applies if the value of the shares as of any given quarter is less than &#8364;5,000,000 (when converted to Euros if applicable). If the threshold is met or exceeded, quarterly reporting obligations exist If quarterly obligations apply, the reporting date is the end of each quarter and the deadline for filing the report is the 15th of the month following the end of the quarter.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When shares are sold, there may be exchange control obligations if the cash received is held in a bank account outside Austria.  If the volume of all your accounts abroad exceeds &#8364;10,000,000 (when converted to Euros if applicable), the balances of all accounts must be reported monthly, as of the last day of the month, on or before the fifteenth day of the following month.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Belgium </font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to report any security or bank accounts (including brokerage accounts) you maintain outside of Belgium on your annual tax return.  In a separate report, you are required to provide the National Bank of Belgium with certain details regarding such foreign accounts (including the account number, bank name and country in which any such account was opened).  This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under Kredietcentrales &#47; Centrales des cr&#233;dits caption.</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Stock Exchange Tax.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A stock exchange tax could apply for Belgian tax residents transacting through a non-Belgium broker once the shares are sold. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Communication d&#8217;informations relatives aux actifs ou comptes &#233;trangers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Vous &#234;tes tenu de d&#233;clarer, dans votre d&#233;claration fiscale annuelle, tout compte-titres ou compte en banque (y compris les comptes de courtage) que vous d&#233;tenez en dehors de la Belgique. Dans une d&#233;claration distincte, vous &#234;tes tenu de communiquer &#224; la Banque Nationale de Belgique certains d&#233;tails concernant les comptes &#233;trangers (notamment le num&#233;ro de compte, le nom de la banque et le pays o&#249; le compte a &#233;t&#233; ouvert). Cette d&#233;claration ainsi que toutes les informations indiquant comment la remplir sont disponibles sur le site web de la Banque Nationale de Belgique (www.nbb.be) &#224; la section &#171;&#160;Centrales des cr&#233;dits&#47;Kredietcentrales&#160;&#187;.</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informatie over buitenlands vermogen&#47;rekeningrapportering.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> U moet alle garantie- of bankrekeningen (inclusief beleggingsrekeningen) die u buiten Belgi&#235; bezit, vermelden op uw jaarlijkse belastingsbrief.  In een afzonderlijk overzicht moet u de Nationale Bank van Belgi&#235; informatie geven over zulke buitenlandse rekeningen (inclusief het rekeningnummer, de naam van de bank en het land waarin zulke rekening is geopend).  Dit overzicht, evenals extra informatie over hoe u het moet opstellen, vindt u op de website van de Nationale Bank van Belgi&#235;, www.nbb.be, onder de titel Kredietcentrales.</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Bermuda</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is not subject to and has not received approval from the Bermuda Monetary Authority and the Registrar of Companies in Bermuda, and no statement to the contrary, explicit or implicit, is authorized to be made in this regard.  The securities may be offered or sold in Bermuda only in compliance with the provisions of the Investment Business Act 2003 of Bermuda.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Brazil</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You agree that, for all legal purposes, (i) the benefits provided under the Plan are the result of commercial transactions unrelated to your employment&#59; (ii) the Plan is not a part of the terms and conditions of your employment&#59; and (iii) the income from the RSUs, if any, is not part of your remuneration from employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the RSUs, you agree to comply with Brazilian law when the RSUs vest and the shares are sold. You also agree to report and pay any and all taxes associated with the vesting of the RSUs, the sale of the RSUs acquired pursuant to the Plan, and the receipt of any dividends.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> If you are a resident or domiciled in Brazil and hold assets and rights outside Brazil with an aggregate value exceeding US$100,000, you will be required to prepare and submit to the Central Bank of Brazil an annual declaration of such assets and rights. Assets and rights that must be reported include RSUs.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Canada</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Payout of RSUs in Shares Only</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to all Employees residing in Canada, the Company will convert all vested RSUs only into an equivalent number of Shares and the Plan will not provide an option to settle the RSUs in cash. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Canadian residents may be required to report foreign property (including Shares) on an annual basis on form T1135 (Foreign Income Verification Statement) if the total cost of the foreign property exceeds CAD 100,000 at any time in the year. The grant of RSUs must be reported if the CAD 100,000 cost threshold is exceeded because of other foreign property held. RSUs may be reported at a nil cost. The form must be filed by April 30 of the following year. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Withholding will include both federal income tax as well as provincial tax.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Resale Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Ordinary Shares received by Canadian residents pursuant to this Plan will be subject to an indefinite holding period and the resale of the Ordinary Shares will be prohibited, unless certain conditions are met in respect of the Company in accordance with applicable Canadian securities laws or another applicable Canadian prospectus exemption is available.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Eligibility of Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding the terms of this Agreement or the Plan, no offers of RSUs or Ordinary Shares may be made to you if you are not an employee, executive officer, director or consultant of the Company or a related entity of the Company, in accordance with Section 2.24 of National Instrument 45-106.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employment Law Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the term &#8220;Termination Date&#8221; shall mean the earliest of&#58;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)&#160;&#160;&#160;&#160;Any date specified in this Agreement or the Plan&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)&#160;&#160;&#160;&#160;The date on which the Company or any applicable Affiliate delivers to you notice in a form prescribed by the Company that the Company is thereby terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)&#160;&#160;&#160;&#160;Except in the event of a Separation for Good Reason, the date on which you deliver notice in a form prescribed by the Company to the Company or any applicable Affiliate that you are terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)&#160;&#160;&#160;&#160;The date on which you cease to provide services to the Company or any applicable Affiliate, except where you are on an authorized leave of absence&#59; and</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)&#160;&#160;&#160;&#160;The date on which you cease to be considered an &#8220;employee&#8221; of the Company or any applicable Affiliate under applicable law.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the definitiona of &#8220;Cause&#8221; shall be determined in accordance with applicable laws in the jurisdiction of employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In accordance with Section 2.13, you consent and agree to the payment of the reimbursements set out therein, including through deductions of the amounts specified in paragraph 2.13 from any wages owed by the Company to the employee. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The provisions set out in Section 2.15(a) do not apply to employees in the province of Ontario other than executive employees who are exempted from XV.1 of the Ontario Employment Standards Act, 2000.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Czech Republic</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Documents in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Award, you confirm that you have read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">P&#345;ijet&#237;m tohoto Ozn&#225;men&#237; potvrzujete, &#382;e jste p&#345;e&#269;etl a porozum&#283;l jste Podm&#237;nk&#225;m pl&#225;nu (&#8220;Plan&#8221;) a Smlouv&#283; (&#8220;Agreement&#8221;), kter&#233; V&#225;m byly poskytnuty v anglick&#233;m jazyce. Z&#225;rove&#328; prohla&#353;ujete, &#382;e souhlas&#237;te s podm&#237;nkami uveden&#253;mi v t&#283;chto dokumentech.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restriction on cash payments.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Under Czech Act No. 235&#47;2004 Coll., on Cash Payments, as amended, it is prohibited to receive or provide payments in cash exceeding the amount of CZK 270.000 within one day. Payments exceeding this amount must be executed cashless. This restriction relates to payments from one contracting party to one other contracting party. Thus, it is not a restriction on the sum of all payments made by one individual or entity within one day.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nevertheless, since the restriction on cash payments may be subject to a change (especially a lower threshold might be set), we recommend consulting your personal legal advisor prior to receiving or providing a larger amount of cash payments.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Denmark</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Danish Stock Options Act. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You acknowledge that you have received an Employer Statement translated in Danish, which will be provided to comply with the Danish Stock Options Act, to the extent it applies to RSUs. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have to report your</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">foreign broker accounts and shares held in a foreign bank or broker to the Danish tax administration. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is subject to the Danish Stock Option Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aktieoptionsloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), which applies on share option agreements entered into as part of an employment, if the ownership of the shares is obtained at a later point. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This act is based on a principle of the right to freely agree on the terms of the Award Agreement with certain exceptions stated in the act. In addition to the act, the Danish Contract Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aftaleloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and Danish case law also regulates the terms of the Award Agreement. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below, it is outlined when the Danish Stock Option Act, the Danish Contract Act, Danish case law and other applicable legislation deviate from terms stated in the Award Agreement&#58;  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.3, subsection d, litra 1 in the Award Agreement does not entail that applicable notice periods under Danish employment legislation and your employment agreements are deviated from to the detriment of you. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.3, subsection d, litra 2 (i and ii) in the Award Agreement is amended to the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:92.15pt;padding-right:-9.35pt;text-align:justify;text-indent:-26.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;(2) &#8220;Termination without Cause&#8221; means the involuntary termination of your employment or contractual relationship by the Company without any Cause.&#8221; </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Regardless of section 2.3 in the Award Agreement, vested and acquired shares do not lapse as a consequence of your Termination Date for reasons of Cause. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In relation to Section 2.7 in the Award Agreement the following also applies, which supersedes section 2.7 in case of conflicting regulation&#58; </font></div><div style="padding-left:65.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;The Company is required to report the market value of the RSUs to the Danish tax authorities to both E-income and E-capital with the Danish tax authorities. For E-income, the value of the RSUs should be reported as income art 50 in field 068 and should be reported by the Company in the month the shares vest. For E-capital, the value of the RSUs should be reported to the Danish tax authorities no later than the 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of January the following year after the RSUs have vested. </font></div><div style="padding-left:65.2pt;text-align:justify"><font><br></font></div><div style="padding-left:65.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The market value of the provided RSUs is to be reported by the Company as personal income in the year of vest and is subject to a marginal tax rate of 56% including labor market contribution.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:65.2pt;text-align:justify"><font><br></font></div><div style="padding-left:65.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The tax payment obligation for the value of the shares will be collected with the individual, and the responsibility to ensure that the correct amount is reported on the Danish tax assessment remains with the individual. </font></div><div style="padding-left:65.2pt;text-align:justify"><font><br></font></div><div style="padding-left:65.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At the time of sale, you are subject to tax on the gain, if any, at a marginal tax rate of 42%. The capital gain is calculated as the difference between the average fair market value at vest and the sales price. </font></div><div style="padding-left:65.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If there is a loss tied to the sale of the RSUs, the loss can be deducted in capital gain from other listed RSUs.</font></div><div style="padding-left:65.2pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:65.2pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that it is mandatory for you to report information on RSUs from a foreign depot to the Danish tax authorities. If this information is not provided to the Danish tax authorities, a potential loss cannot be used for deduction. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to section 2.10, subsection b, all personal information will be managed in accordance with the European Data Protection Regulation (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">databeskyttelsesforordningen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and the Danish Data Protection Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">personbeskyttelsesloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.15, subsection a &#8211; d in the Award Agreement is void and unenforceable in Denmark and instead the following is agreed&#58;  </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt">NON-COMPETITION AND NON-SOLICITATION</font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">You will be covered by this non-competition and non-solicitation clause for 6 months after the effective date of termination. </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">In this period, you are entitled to &#8211; only with the prior written consent of the affiliate employing or retaining you (the &#8220;Affiliate&#8221;) &#8211; be engaged or financially interested, directly or indirectly, in any business which develops and&#47;or distributes products or services that compete or may compete with the Affiliate or any group companies&#8217; products and&#47;or services or in any other business competing with the Affiliate or any group companies in any other way. This restriction includes any interest whatsoever by way of, for example, employment, ownership in full or in part, membership of a board, consultancy services and the like in Denmark and abroad. </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">Conclusion of this non-competition clause is required because you hold a very special position of trust, and you will receive detailed knowledge about the Affiliate and group companies&#8217; affairs, including business secrets, market strategies and plans, information on customers and suppliers. This knowledge may be exploited to the detriment of the Affiliate or group companies, if you become employed with a competing company immediately after the effective date of termination.</font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">During 6 months after the effective date of termination, you are only with the prior written consent of the Affiliate entitled to be in contact with or have business relations, directly or indirectly, with customers, suppliers or cooperation partners, etc., with whom you have had business relations within the last 12 months prior to the termination. In connection with the termination, the Affiliate will prepare a list of the customers, suppliers and cooperation partners covered by the restriction in this clause. In this connection, you must loyally contribute to the drafting of a thorough list covering all customers, suppliers and&#47;or cooperation partners with whom you have had business relations within the last 12 months prior to the termination. Your deliberate failure to contribute loyally to this list will be considered a material breach of the employment and the Award Agreement.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">The effective date of termination is to be construed as the date on which you may be ordered or entitled to resign after the expiry of the notice period, notwithstanding whether you actually end your work with the employing company at an earlier date. </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">The non-competition part of this clause will cease to apply, if the Affiliate gives notice of termination to you without you having reasonably caused the termination. The non-competition part of this clause will also cease to apply, if you resign from the Affiliate for reasonable cause due to the employing company&#8217;s failure to fulfil its obligations, cf. section 11 (1) in the Danish Act on Employment Clauses (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">ans&#230;ttelsesklausulloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). In both situations, the non-solicitation part of this clause will be maintained.  </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.55pt">The Affiliate may terminate the clause with one month's notice to expire at the end of a month, cf. section 10 (1) in the Danish Act on Employment Clauses.    </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.55pt">As compensation for the clause, you will receive a monthly compensation in accordance with the Danish Act on Employment Clauses. Compensation currently amounts to 60 % of the monthly salary at the effective date of termination and is payable in the period in which the clause applies. At the effective date of termination, the first two months of compensation will be paid to you as a lump sum. If the clause applies, compensation will after the first two months be payable each month in arrears in the rest of the period in which the clause applies. If you obtain other appropriate paid work, compensation equivalent to 24 % of the monthly salary at the effective date of termination will be paid from the third month after the effective date of termination. You are obligated to actively seek other appropriate work and to notify the Affiliate in writing of any new work. Failure to observe the duty of mitigation will be considered a material breach of the employment with the effect that your right to compensation will lapse. The right to compensation will lapse, if the Affiliate has lawfully terminated your employment without notice.   </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.55pt">In the event of your breach of the clause, the Affiliate will be entitled to a penalty of between three and six months' salary for any one breach of the clause and compensation for any additional loss. In the event of a persistent breach of the clause, each month or part of a month is deemed to constitute an independent breach entitling the Affiliate to a new, independently agreed penalty. Any payment of the agreed penalty shall not lead to the discontinuance of your obligation to comply with the clause. The Affiliate may also seek to restrain any breach of the clause through the issue of an injunction.  </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.55pt">This clause may be invoked by the Affiliate from the date on which you have been employed with the employing company for six months.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Estonia</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Finland</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  If you hold Ordinary Shares acquiqred under the Plan, you are generally required to include those Ordinary Shares as assets in your individual tax return.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">France</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">En acceptant cette attribution gratuite d'actions, vous confirmez avoir lu et comprenez le Plan et ce Contrat, incluant tous leurs termes et conditions, qui ont &#233;t&#233; transmis en langue anglaise. Vous acceptez les dispositions de ces documents en connaissance de cause.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of France or maintain a foreign bank account, you are required to report such to the French tax authorities when you file your annual tax return. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The RSUs are not intended to qualify as a French tax qualified restricted stock units under French tax law.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a French resident and hold cash or shares of Common Stock outside of France, you must declare all foreign bank and brokerage accounts (including any accounts that were opened or closed during the tax year) on an annual basis on a special form, No. 3916, together with your income tax return.  </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Renseignements relatifs aux comptes et avoirs &#233;trangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Si vous &#234;tes r&#233;sident fran&#231;ais et que vous d&#233;tenez des liquidit&#233;s ou des Actions ordinaires en dehors de la France, vous &#234;tes tenu de d&#233;clarer chaque ann&#233;e, en m&#234;me temps que votre d&#233;claration de revenus, les r&#233;f&#233;rences de vos comptes bancaires et comptes-titres &#233;trangers (y compris les comptes qui ont &#233;t&#233; ouverts ou ferm&#233;s pendant l&#8217;exercice fiscal) par le biais d&#8217;un formulaire sp&#233;cifiquement pr&#233;vu &#224; cet effet, le formulaire N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">o&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3916. </font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Germany</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Cross-border payments related to securities transactions in excess of &#8364;12,500 must be reported by the fifth calendar day of the month following the respective payment to the German Central Bank (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Bundesbank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  If you use a German bank to transfer a cross-border payment related to securities transactions in excess of &#8364;12,500 (e.g. in connection with the sale of shares acquired under the Plan), the bank will make the report for you. In addition, you must report any receivables, payables, or debts in foreign currency exceeding an amount of &#8364;5,000,000 (by the tenth calendar day after the expiry of one month) and any cross-border shareholdings in companies if the share in the capital or the voting rights amount(s) to 10% or more and the investment object exceeds a balance sheet total of &#8364;3,000,000 (by the last working day of the sixth calendar month following December 31) on a monthly basis.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In case of an acquisition of shares in a foreign company with an overall investment amount of more than &#8364;150,000 (or in case of an acquisition of 10% or more of the shares in a foreign company), you should consult with your tax advisor whether the investment would have to be reported to your tax office.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Greece</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to your Award, if you withdraw funds of &#8364;15,000 or more from a bank in Greece and remit those funds out of Greece, you may be required to submit certain documentation&#47; information to the Greek bank to ensure that the transfer is not in violation of Greek anti-money laundering rules. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Hungary</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">India</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Notification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You understand that you must repatriate any dividends and proceeds from the sale of shares acquired under the Plan to India and convert the proceeds into local currency within 180 days of receipt assuming share holding is less than 10% of the company's share capital or as prescribed under applicable Indian exchange control laws as may be amended from time to time. You will receive a foreign inward remittance certificate (&#34;FIRC&#34;) from the bank where you deposit the foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or your employer requests proof of repatriation.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The amount subject to tax on receipt of the shares will partially be dependent upon a valuation that the Company or your employer will obtain from a Merchant Banker in India.  Neither the Company nor your employer has any responsibility or obligation to obtain the most favorable valuation possible, nor obtain valuations more frequently than required under Indian tax law.</font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to declare in the applicable schedules of your annual tax return (a) any foreign assets held by you (e.g., Ordinary Shares acquired under the Plan and, possibly, the Award), (b) any foreign bank accounts for which you have signing authority and (c) any foreign custodian accounts.  </font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ireland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Director Notification Obligation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a director, shadow director or secretary of the Company's Irish Subsidiary or Affiliate, you must notify the Irish Subsidiary or Affiliate in writing within five business days of receiving or disposing of an interest exceeding 1% of the Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(e.g., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RSUs, shares, etc.), or within five business days of becoming aware of the event giving rise to the notification requirement or within five days of becoming a director or secretary if such an interest exists at the time. This notification requirement also applies with respect to the interests of a spouse or children under the age of 18 (whose interests will be attributed to the director, shadow director or secretary).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Israel</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Type of Grant&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633; </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capital Gain Award (&#8220;CGA&#8221;)</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ordinary Income Award (&#8220;OIA&#8221;)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 3(i) Award</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Unapproved 102 Award</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Settlement of RSUs</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Agreement, if the RSUs granted hereunder are 102 Awards, the RSUs shall be settled in Ordinary Shares only.</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Trust. </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All Approved 102 Awards shall be held in trust by a trustee designated by the Company (</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;Trustee&#34;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or shall be supervised by the Trustee in accordance with the instructions set forth by the Israeli Tax Authority (&#8220;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITA</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;),  for the requisite lockup period prescribed by the Ordinance and the regulations promulgated thereunder, or such other period as may be required by the ITA, during which period Awards or Ordinary Shares issued thereunder, and all rights resulting from them, including bonus shares, must be held by the Trustee. The Trustee shall not release any Approved 102 Awards, Ordinary Shares issued upon the exercise of any Approved 102 Awards, or any rights, including bonus shares, resulting from such Approved 102 Awards or Ordinary Shares, prior to the full payment of your tax liability. The Trustee or the Israeli Affiliate shall withhold any applicable taxes in accordance with Section 102 or any applicable tax ruling obtained by the Company. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without derogating from the foregoing, if your RSUs do&#160;not qualify as Approved&#160;102 Awards the Company may still at its sole discretion, deposit your RSUs in trust to ensure that taxes are properly withheld. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby release the Trustee from any liability in respect of any action or decision duly taken and executed in good faith in relation to any RSUs or Ordinary Shares issued to you thereunder.</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Without derogating from Section 2.7(b) above, you hereby agree to indemnify the Company and&#47;or its Affiliates and&#47;or the Trustee and hold them harmless against and from any and </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">all</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> liability for all such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to you.</font></div><div style="margin-bottom:10pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the RSUs, you agree to comply with the provisions of Section 102 and the regulations and rules promulgated thereunder or any tax ruling to be obtained by the Company in connection with your RSUs. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Italy</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan Document Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In accepting the RSUs, you acknowledge that you have received a copy of the Plan and the Agreement and have reviewed the Plan and the Agreement, including this Appendix, in their entirety and fully understand and accept all provisions of the Plan and the Agreement, including this Appendix.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax&#47;Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You are required to report on your annual tax return&#58;  (a) any foreign investments or investments (including the Ordinary Shares issued at vesting of the RSUs, cash or proceeds from the sale of Ordinary Shares acquired under the Plan) held outside of Italy, if the investment may give rise to income in Italy (this will include reporting the Ordinary Shares issued at vesting of the RSUs if the fair market value of such Ordinary Shares combined </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with other foreign assets)&#59; and (b) any changes during the financial year which have had an impact during the calendar year on your foreign investments or investments held outside of Italy.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are exempt from these formalities if the investments are made through an authorized broker resident in Italy, as the broker will comply with the reporting obligation on your behalf.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Kazakhstan</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to report the acquisition of shares of a foreign company to the National Bank of Kazakhstan. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Latvia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Lithuania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Luxembourg</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are required to report any inward remittances of funds to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Banque Central de Luxembourg </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and&#47;or the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Service Central de La Statistique et des Etudes Economiques</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Luxembourg financial institution is involved in the transaction, it generally will fulfill the reporting obligation on your behalf. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Mexico</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the RSUs, you understand and agree that any modification of the Plan or the Agreement or its termination shall not constitute a change or impairment of the terms and conditions of employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan Document Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the award of the RSUs, you acknowledge that you have received copies of the Plan, have reviewed the Plan and the Agreement in their entirety and fully understand and accept all provisions of the Plan and the Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, by signing the Agreement, you further acknowledge that you have read and specifically and expressly approve the terms and conditions in the Agreement, in which the following is clearly described and established&#58; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Participation in the Plan does not constitute an acquired right&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">The Plan and participation in the Plan is offered by the Company on a wholly discretionary basis&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">Participation in the Plan is voluntary&#59; and </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">The Company and any Parent, Subsidiary or Affiliates are not responsible for any decrease in the value of the shares.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowlegement and Policy Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In accepting the RSUs, you expressly recognize the Company is solely responsible for the administration of the Plan and that your participation in the Plan and acquisition of Ordinary Shares does not constitute an employment relationship between you and the Company since you are participating in the Plan on a wholly commercial basis and on a wholly commercial basis and your sole employer is Perrigo de Mexico S.A. De C.V. (&#8220;Perrigo Mexico&#8221;). Based on the foregoing, you expressly recognize that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and your employer, Perrigo Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Perrigo Mexico and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of your employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company&#59; therefore, the Company reserves the absolute right to amend and&#47;or discontinue your participation at any time without any liability to you.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or damages as a result of your participation in the Plan and therefore grant a full and broad release to the Employer, the Company and any Parent, Subsidiary or Affiliates with respect to any claim that may arise under the Plan.</font></div><div style="margin-bottom:12pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Spanish Translation</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modificaci&#972;n</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;Al aceptar las Unidades de Acci&#243;n Restringida (RSUs, por sus siglas en ingl&#233;s) usted entiende y esta de acuerdo que cualquier modificaci&#243;n del plan o del acuerdo o su terminaci&#243;n no constituir&#225; un cambio o detrimento de los t&#233;rminos y condiciones de su empleo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Confirmaci&#243;n del Documento del Plan. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Al aceptar el otorgamiento de las RSUs, usted reconoce que ha recibido copias y ha revisado dicho acuerdo en su totalidad y que ha entendido y aceptado completamente todas las disposiciones contenidas en el Plan y en el Acuerdo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adicionalmente, al firmar el acuerdo, usted reconoce que ha le&#237;do, y aprobado de manera espec&#237;fica y expresa los t&#233;rminos y condiciones en el acuerdo en el que se describe y establece claramente los siguiente&#58;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:25.17pt">La participaci&#243;n en el Plan no constituye un derecho adquirido&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.98pt">El plan y la participaci&#243;n en el mismo, son ofrecidos por la Compa&#241;&#237;a de manera totalmente discrecional&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.79pt">La participaci&#243;n en el Plan es voluntaria&#59; y</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.42pt">La Compa&#241;&#237;a, y cualquier Sociedad controladora, Subsidiaria o Filiales no son responsables por ning&#250;n decremento en el valor de las Acciones.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Constancia de aceptaci&#243;n de la ley laboral y declaraci&#243;n de la pol&#237;tica.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160; Al aceptar las RSUs, usted reconoce expresamente que la Compa&#241;&#237;a, es la &#250;nica responsable de la administraci&#243;n del Plan, y que su participaci&#243;n en el Plan y la adquisici&#243;n de las acciones comunes no constituyen una relaci&#243;n de trabajo entre usted y la Compa&#241;&#237;a dado que usted participa en el Plan de manera completamente comercial y el &#250;nico empleador que tiene es Perrigo de M&#233;xico, S.A. de C.V. (&#171; Perrigo de Mexico &#187;). Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que usted pueda obtener de la participaci&#243;n en el Plan, no establecen ning&#250;n derecho entre usted y su empleador Perrigo de M&#233;xico y no forman parte de las condiciones de trabajo ni de las prestaciones ofrecidas por Perrigo de M&#233;xico y cualquier modificaci&#243;n del Plan o la terminaci&#243;n de &#233;ste, no constituyen un cambio o deterioro de los t&#233;rminos y condiciones de su trabajo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adem&#225;s, usted comprende que su participaci&#243;n en el Plan es el resultado de una decisi&#243;n unilateral y discrecional de la Compa&#241;&#237;a&#59; por lo tanto, la Compa&#241;&#237;a se reserva el derecho absoluto de modificar y&#47;o interrumpir la participaci&#243;n de usted en cualquier momento sin ninguna responsabilidad para usted.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finalmente, usted declara que no se reserva ninguna acci&#243;n o derecho de presentar alg&#250;n reclamo o demanda en contra de la Compa&#241;&#237;a por compensaci&#243;n, da&#241;o o perjuicio alguno como resultado de su participaci&#243;n en el Plan, en consecuencia, otorga el m&#225;s amplio finiquito al Empleador, as&#237; como a la Compa&#241;&#237;a, a su Sociedad controladora, Subsidiaria o Filiales con respecto a cualquier demanda que pudiera originarse en virtud del Plan.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Netherlands</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dutch insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Norway</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Norwegian insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor as well as the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Cross-border payments in excess of NOK 100,000 must be reported to the Norwegian foreign exchange register (Valutaregisteret). If you use a Norwegian bank to transfer a cross-border payment in excess of NOK 100,00 in connection with the sale of shares acquired under the Plan, the bank will make the report on your behalf. </font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In your Norwegian income tax return, each year you are required to report any security, shares or bank accounts (including brokerage accounts and the Company &#8220;Account&#8221; referenced in section 1.5 of the Agreement) you maintain outside of Norway. The Company &#8220;Account&#8221; should not be treated as taxable wealth, as long as the right to receive the dividends is conditional, but you must report it.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Poland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold foreign securities (including shares pursuant to the Award) and maintain accounts abroad, you may be required to file certain reports with the National Bank of Poland (&#8220;NBP&#8221;). Specifically, if the value of securities and cash held in such foreign accounts exceeds PLN 7,000,000 (or equivalent thereof in another currency) at the end of the year, you must file reports on the transactions and balances of the accounts on a quarterly basis by the 26th day of the month following the end of each quarter. In case you are being in regime of a joint marital property, the above threshold shall apply to joint property of the spouses. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, if you hold, at the beginning or end of the year, at least 10% of votes in the decision-making body of the entity based abroad (and you are person meeting the prievusly mentioned criteria), an annual notification, on the official form, must be submitted by you to the NBP by May 31 of the following year.If at the end of the year you did not reach the given threshold but in the next year, at the end of a calendar quarter, you reach the threshold, you are obliged to submit the appropriate form to NBP for this quarter and each of the following quarters of this calendar year (within 26 days from the end of each calendar quarter). Such reports are filed on special forms available on the website of the NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The foregoing duties represents personal responsibilities of each shareholder and cannot be fulfilled by any entity on your behalf.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, if you are a Polish citizen and you transfer funds abroad in excess of the PLN equivalent of &#8364;15,000, the transfer must be made through an authorized bank, a payment institution or an electronic money institution authorized to render payment services. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Furthermore, at the banks&#8217; request, you may be required to inform eligible banks, within the meaning of the Foreign Exchange Act, about all foreign exchange transactions performed through them.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are also required to retain the documents connected with foreign exchange transactions for a period of five years, as measured from the end of the year in which such transaction occurred.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Zgoda na otrzymywanie informacji w j&#281;zyku angielskim.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Akceptuj&#261;c Opcj&#281;, potwierdzasz przeczytanie i zrozumienie Programu i Umowy, kt&#243;re zosta&#322;y dostarczone w j&#281;zyku angielskim. W zwi&#261;zku z tym akceptujesz warunki tych dokument&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informacje o kontroli dewizowej. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li jeste&#347; w posiadaniu zagranicznych papier&#243;w warto&#347;ciowych (w tym akcji) i posiadasz rachunki za granic&#261;, mo&#380;esz by&#263; zobowi&#261;zany(-a) do z&#322;o&#380;enia okre&#347;lonych sprawozda&#324; w Narodowym Banku Polskim (&#8222;NBP&#8221;. W szczeg&#243;lno&#347;ci, je&#347;li warto&#347;&#263; papier&#243;w warto&#347;ciowych i &#347;rodk&#243;w pieni&#281;&#380;nych gromadzonych na takich rachunkach zagranicznych przekracza na koniec roku 7 000 000 PLN (lub ekwiwalent tej kwoty w innej walucie), nale&#380;y co kwarta&#322; sk&#322;ada&#263; raporty z transakcji i sald rachunk&#243;w do 26 dnia miesi&#261;ca </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">nast&#281;puj&#261;cego po zako&#324;czeniu ka&#380;dego kwarta&#322;u. W przypadku pozostawania we wsp&#243;lno&#347;ci maj&#261;tkowej z ma&#322;&#380;onkiem, powy&#380;szy pr&#243;g dotyczy maj&#261;tku wsp&#243;lnego ma&#322;&#380;onk&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#380;eli posiadasz na pocz&#261;tek lub koniec roku co najmniej 10% g&#322;os&#243;w w organie stanowi&#261;cym podmiotu z siedzib&#261; za granic&#261; (i jeste&#347; osob&#261; spe&#322;niaj&#261;c&#261; wy&#380;ej wskazane warunki) musisz z&#322;o&#380;y&#263; w NBP do 31 maja nast&#281;pnego roku dodatkowy raport. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li pod koniec roku nie osi&#261;gn&#261;&#322;e&#347;(-a&#347;) okre&#347;lonego progu, ale w nast&#281;pnym roku, pod koniec kwarta&#322;u kalendarzowego, osi&#261;gniesz pr&#243;g, musisz z&#322;o&#380;y&#263; odpowiedni formularz do NBP za ten kwarta&#322; i ka&#380;dy z kolejnych kwarta&#322;&#243;w tego roku kalendarzowego (w ci&#261;gu 26 dni od zako&#324;czenia ka&#380;dego kwarta&#322;u kalendarzowego). Takie raporty s&#261; sk&#322;adane w specjalnych formularzach dost&#281;pnych na stronie internetowej NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#347;li jeste&#347; obywatelem Polski i przekazujesz &#347;rodki za granic&#281; w wysoko&#347;ci przekraczaj&#261;cej r&#243;wnowarto&#347;&#263; 15 000 EUR w PLN, przelewu nale&#380;y dokona&#263; za po&#347;rednictwem upowa&#380;nionego banku, instytucji p&#322;atniczej lub instytucji pieni&#261;dza elektronicznego uprawnionej do &#347;wiadczenia us&#322;ug p&#322;atniczych. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto na &#380;&#261;danie bank&#243;w niezb&#281;dne mo&#380;e by&#263; poinformowanie uprawnionych bank&#243;w, w rozumieniu ustawy Prawo dewizowe (Foreign Exchange Act), o wszystkich transakcjach walutowych przeprowadzanych za ich po&#347;rednictwem.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Jeste&#347; r&#243;wnie&#380; zobowi&#261;zany(-a) do przechowywania dokument&#243;w zwi&#261;zanych z transakcjami wymiany walut przez okres pi&#281;ciu lat, mierzony od ko&#324;ca roku, w kt&#243;rym taka transakcja zosta&#322;a wykonana</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Portugal</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Language Consent.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You hereby expressly declare that you have full knowledge of the English language and have read, understood and fully accepted and agreed with the terms and conditions established in the Plan and Award Agreement.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Conhecimento da Lingua.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> O Contratado, pelo presente instrumento, declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo de Atribui&#231;&#227;o (Award Agreement em ingl&#234;s). </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Romania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Statistical Reporting.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">According to art. 92 of NBR Reg. 4&#47;2021, if you, as a resident of Romania within the meaning of NBR Reg. 4&#47;2021, acquire more than 10% of the share capital in a foreign company, the acquisition must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be reported to the National Bank of Romania (&#8220;NBR&#8221;) for statistical purposes within 30 calendar days of acquisiting the ownership right over the shares of the foreign company. You should consult your personal advisor to determine whether you will be required to submit such documentation to the NBR pursuant to your participation in the Plan. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Insider-trading rules prohibit you from carrying out  certain transactions involving shares if you have inside information about the Company (insider dealing). If you are uncertain whether the insider-trading rules apply to you, including with regard to the fact that the Company is listed on the New York Stock Exchange (NYSE), you should consult your personal </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">legal advisor. Depending on the applicable market abuse legislation, you might be subject to certain restrictions on the freedom to trade the shares that are settled through the RSU award, including any applicable prohibition on insider dealing, market manipulation or the unlawful disclosure of inside information.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Serbia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovakia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset Reporting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a foreign asset reporting obligation if you are considered providing independent professional services &#8220;podnikatel&#8221;. You should consult with a personal tax advisor to understand your filing obligations.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovenia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">South Africa</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the RSUs, you agree that, immediately upon vesting of the RSUs, you may need to notify your employer of the amount of any gain realized. If you fail to advise your employer of the gain realized upon vesting, you may be liable for a fine. You will be solely responsible for paying any difference between the actual tax liability and the amount withheld by your employer. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Because no transfer of funds from South Africa is required under the RSUs, no filing or reporting requirements should apply when the award is granted nor when Ordinary Shares are issued upon vesting of the RSUs. However, because the exchange control regulations are subject to change, you should consult your personal advisor prior to vesting and settlement of the award to ensure compliance with current regulations. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Spain</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Entitlement for Claims or Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the award of RSUs, you consent to participation in the Plan, and acknowledge that you have received a copy of the Plan document.  You understand that the Company has unilaterally, gratuitously and in its sole discretion decided to make awards of RSUs under the Plan to individuals who may be employees, consultants and directors throughout the world. The decision is limited and entered into based upon the express assumption and condition that any RSUs will not economically or otherwise bind the Company or any Parent, Subsidiary or Affiliate, including your employer, on an ongoing basis, other than as expressly set forth in the Agreement. Consequently, you understand that the Award is given on the assumption and condition that the RSUs shall not become part of any employment contract (whether with the Company or any Parent, Subsidiary or Affiliate, including your employer) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever. Furthermore, you understand and freely accept that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">there is no guarantee that any benefit whatsoever shall arise from the award, which is gratuitous and discretionary, since the future value of the RSUs and the underlying shares is unknown and unpredictable. You also understand that this Award would not be made but for the assumptions and conditions set forth hereinabove&#59; thus, you understand, acknowledge and freely accept that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the Award, the RSUs and any right to the underlying shares shall be null and void.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the RSUs, your termination of service for any reason other than death or disability (including for the reasons listed below) will automatically result in the cancellation and loss of any RSUs that may have been granted to you and that were not or did not become vested on the date of termination of service. In particular, you understand and agree that, unless otherwise expressly provided by the Company in this Agreement, the RSUs will be cancelled without entitlement to the Shares or to any amount as indemnification if you terminate service by reason of, but not limited to, the following&#58; resignation&#59; disciplinary dismissal adjudged to be with cause&#59; disciplinary dismissal adjudged or recognized to be without good cause (i.e., subject to a &#34;despido improcedente&#34;)&#59; individual or collective layoff on objective grounds, whether adjudged to be with cause or adjudged or recognized to be without cause&#59; material modification of the terms of employment under Article 41 of the Workers&#8217; Statute&#59; relocation under Article 40 of the Workers&#8217; Statute&#59; Article 50 of the Workers&#8217; Statute&#59; unilateral withdrawal by your employer&#59; and under Article 10.3 of Royal Decree 1382&#47;1985.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You must declare the acquisition, ownership and disposition of stock in a foreign company (including Ordinary Shares acquired under the Plan) to the Spanish Direcci&#243;n General de Comercio e Inversiones (the &#8220;DGCI&#8221;), the Bureau for Commerce and Investments, which is a department of the Ministry of Economy and Competitiveness, for statistical purposes.  Generally, the declaration must be made in January for Ordinary Shares acquired or sold during (or owned as of December 31 of) the prior year&#59; however, this obligation only applies in the cases in which you hold 10% or more of the sares capital of the Company or 10% or more of the voting tights of the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, you may be required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts held abroad), any foreign instruments (e.g., Ordinary Shares) and any transactions with non-Spanish residents (including any payments of cash or shares made to you by the Company) if the balances in such accounts together with the value of such instruments as of December 31, or the volume of transactions with non-Spanish residents during the prior or current year, exceeds &#8364;1,000,000.  Generally, you will only be required to report on an annual basis (by January 20 of each year).  Note that if the value is less than &#8364;1,000,000, there is only an obligation to declare this information to the Bank of Spain upon request from the Bank of Spain, in which case the deadline is two months since the request is received.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When receiving foreign currency payments derived from the ownership of Ordinary Shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">., dividends or sale proceeds), you must inform the financial institution receiving the payment of the basis upon which such payment is made. Should amounts exceed &#8364;12,500, you will need to provide the following information to the Spanish Registered Entity&#58; (i) your name, address, and fiscal identification number&#59; (ii) the name and corporate domicile of the Company&#59; (iii) the amount of the payment and the currency used&#59; (iv) the country of origin&#59; (v) the reasons for the payment&#59; and (vi) further information that may be required. Exceptions to this rule are when you move funds through a Spanish resident bank account opened abroad, or when collections and payments are carried out in cash. These exceptions, however, are subject to their own reporting requirements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold assets or rights outside of Spain (including shares acquired under the Plan), you may have to file an informational tax report, Form 720, with the tax authorities declaring such ownership by March 31st of the following year.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Generally, there is no obligation to file Form 720 if the total value of the following does not exceed Euro 50,000&#58; </font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">the securities, shares, rights and participations held by you, on December 31 or at any time throughout the year, in any kind of entities or in investment funds located outside Spain&#59;</font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">any transfer of own capital to third parties located abroad&#59; and</font></div><div style="margin-bottom:12pt;padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">life and disability insurances in which the individual was policy holder on December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that if an asset is jointly owned, the value is not prorated. Please also note that the application of the rules in respect of valuation of assets and transfers during the year should be carefully analyzed. If the limit of Euro 50,000 euros is exceeded for this described group of assets, all the elements of this group must be reported.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For those taxpayers who have filed Form 720 in previous years, they will only be obliged to file it again&#58;</font></div><div style="padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.7pt">When the aggregated value of the assets included in the mentioned group (shares&#47;insurances) had increased in an amount higher than Euro 20,000 regarding the informative return filed in a previous year.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.02pt">When the individual&#8217;s condition (owner, co-owner, co-titleholder or co-authorized) had changed or was extinguished during the year, before 31st December, with regard to any of the assets.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the thresholds for annual filing requirements may change each year. Therefore, you should consult your personal advisor regarding whether you will be required to file an informational tax report for asset and rights that you hold abroad.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Sweden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The following shall apply in addition to what is set out under section 2.14 of the Award Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Forfeiture of entitlements under the Plan in case of termination shall apply in case of termination of employment regardless of whether such termination of employment may be justified under Swedish employment protection legislation, and regardless of whether such termination may be challenged by you, and regardless of whether such termination is invalidated by verdict or a court order.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax withholdings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You authorize the Company and&#47;or the Employing Company to withhold or sell shares otherwise distributable to you upon vesting or settlement to satisfy the Company&#8217;s payroll tax withholding obligations.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Switzerland</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securitities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The RSUs and the issuance of any Ordinary Shares thereunder is not intended to be publicly offered in or from Switzerland.  Neither this Award Agreement nor any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">33</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">other materials relating to the Award (1) constitute a prospectus as such term is understood pursuant to article 652a of the Swiss Code of Obligations, (2) may be publicly distributed nor otherwise made publicly available in Switzerland, or (3) have been or will be filed with, approved or supervised by any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are obliged to submit an ordinary annual tax return in Switzerland, you are required to file a salary certificate with the Swiss tax authorities together with your Swiss tax return. The Company or the Affiliate employing you is obliged to prepare a specific attachment regarding the RSUs to this salary certificate. Before Settlement, for wealth tax purposes, the number of RSUs should be declared with p.m (zero value) in the asset statement of the tax return. After Settlement the total number of Ordinary Shares received are subject to wealth tax at the end of the calendar year and must be declared in your Swiss tax return.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Turkey</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securitities Law Informations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Under Turkish law, you are not permitted to sell Ordinary Shares acquired under the Plan in Turkey.  The Ordinary Shares are currently traded on the Nasdaq Global Select Market, which is located outside of Turkey, under the ticker symbol &#8220;PRGO&#8221; and the Ordinary Shares may be sold through this exchange.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ukraine </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to obtain a license for obtaining shares of a foreign company from the National Bank of Ukraine (NBU). </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award will be outside the scope of your employment or service contract (if any) and as such will not constitute a part of your compensation package under the respective employment or service contract.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">United Kingdom</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Income Tax and National Insurance Contribution Withholding.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The following provision supplements the terms in the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If payment or withholding of the income tax due in connection with the RSUs is not made within ninety (90) days of the end of the U.K. tax year in which the event giving rise to the income tax liability or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003 occurred (the &#8220;Due Date&#8221;), the amount of any uncollected income tax shall constitute a loan owed by you to your employer, effective as of the Due Date.  You agree that the loan will bear interest at the then-current official rate of His Majesty&#8217;s Revenue &#38; Customs (&#8220;HMRC&#8221;), it shall be immediately due and repayable, and the Company or your employer may recover it at any time thereafter by any of the means referred to in Section 2.7 of the Agreement.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if you are a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), you </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">34</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">will not be eligible for a loan from the Company or your employer to cover the income tax liability.  In the event that you are a director or executive officer and the income tax is not collected from or paid by the Due Date, the amount of any uncollected income tax will constitute a benefit to you on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) will be payable.  You will be responsible for reporting any income tax for reimbursing the Company or your employer the value of any employee NICs due on this additional benefit. </font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">*   *   *   *   *</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">35</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>ex105-2023psusoipsurtsrand.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2f77d291d4554bfca08735971a0d9db5_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERRIGO COMPANY PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(PERFORMANCE-BASED)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Under the Perrigo Company plc 2019 Long-Term Incentive Plan)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant Name</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RE&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Restricted Stock Unit Award (Performance-Based)</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This is to notify you that Perrigo Company plc (the &#8220;Company&#8221;) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the &#8220;Plan&#8221;), effective as of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grant Date </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#8220;Grant Date&#8221;).  This Award consists of performance-based restricted stock units.  The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (&#8220;Appendix&#8221;) (collectively, the &#8220;Agreement&#8221;).  The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Units &#8211; Performance-Based Vesting</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As of the Grant Date, and subject to the terms and conditions of this Agreement and the Plan, the Company grants to you </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Number of Awards Granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> performance-based restricted stock units (&#8220;PSUs&#8221;).  The number of PSUs awarded in this Section 1.1 is referred to as the &#8220;Target Award.&#8221;  The Target Award may be increased or decreased depending on the level of attainment of Performance Goals for designated Performance Measures as described in Section 1.2.  Each PSU shall entitle you to one ordinary share of the Company, nominal value &#8364;0.001 per share (&#8220;Ordinary Share&#8221;) on the PSU Vesting Date set forth in Section 1.2, provided the applicable Performance Goals for each Performance Measure are satisfied.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The number of PSUs awarded in Section 1.1 vesting, if any, shall be determined as of the PSU Vesting Date.  That number will be determined based on the average level of attainment of annual Performance Measure(s) for each fiscal year in the Performance Period, in accordance with the schedule determined by the Committee at the time the Performance Measures and applicable Performance Goals are established by the Committee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Committee shall establish annually one or more Performance Measures and the Performance Goals with respect to each Performance Measure that must be attained for Threshold, Target and Maximum performance for a fiscal year.  The Performance Measure and Performance Goals for each fiscal year will be provided to you.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Following the end of each fiscal year in the Performance Period, the Committee will determine the percentage of Target Award PSUs that would be payable for such fiscal year, based on the attainment of the Performance Goals for each Performance Measure(s) established by the Committee for that fiscal year.  The percentage of the Target Award that would be payable under the schedule shall be adjusted, pro rata, to reflect the attained performance between Threshold and Target, and Target and Maximum.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At the end of the Performance Period, the percentage payout for each fiscal year in the Performance Period will be averaged to determine the actual percentage of Target Award PSUs that will vest and be payable on the PSU Vesting Date.  In no event will the calculation of a positive payout percentage for any fiscal year be construed to guarantee that any PSUs will vest on the PSU Vesting Date.  Payout percentages for the individual fiscal years are determined </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">solely for purposes of determining the average annual payout percentage for the three-year Performance Period.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as provided in Section 1.4, the PSUs will be permanently forfeited if your Termination Date occurs prior to the PSU Vesting Date.  If the average annual performance payout for the Performance Period is less than the Threshold performance level established by the Committee, all PSUs that have not previously been forfeited shall be forfeited as of the PSU Vesting Date.  If the average annual performance payout for the Performance Period exceeds the Maximum performance level established by the Committee, in no event will the number of PSUs vesting exceed 200% of the Target Award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following terms shall have the following meanings under this Section 1.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;&#8220;Performance Goal&#8221; means the level of performance that must be attained with respect to a Performance Measure for a fiscal year for Minimum, Target and Maximum payout.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#8220;Performance Measure&#8221; for any fiscal year means one or more financial measures, as determined by the Committee.  The Committee shall provide how the Performance Measure will be adjusted, if at all, as a result of extraordinary events or circumstances, as determined by the Committee, or to exclude the effects of extraordinary, unusual, or non-recurring items&#59; changes in applicable laws, regulations, or accounting principles&#59; currency fluctuations&#59; discontinued operations&#59; non-cash items, such as amortization, depreciation, or reserves&#59; asset impairment&#59; or any recapitalization, restructuring, reorganization, merger, acquisition, divestiture, consolidation, spin-off, split-up, combination, liquidation, dissolution, sale of assets, or other similar corporation transaction.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#8220;Performance Period&#8221; means a period of three consecutive fiscal years of the Company, beginning with the first day of the fiscal year of the Company in which the Grant Date occurs and ending on the last day of the third fiscal year in the 3-year period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;&#8220;PSU Vesting Date&#8221; means the last day of the Performance Period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;&#8220;Separation for Good Reason&#8221; means your voluntary resignation from the Company and the existence of one or more of the following conditions that arose without your consent&#58; (i) a material change in the geographic location at which you are required to perform services, such that your commute between home and your primary job site increases by more than 30 miles,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or (ii) a material diminution in your authority, duties or responsibilities or a material diminution in your base compensation or incentive compensation opportunities&#59; provided, however, that a voluntary resignation from the Company shall not be considered a Separation for Good Reason unless you provide the Company with notice, in writing, of your voluntary resignation and the existence of the condition(s) giving rise to the separation within 90 days of its initial existence.  The Company will then have 30 days to remedy the condition, in which case you will not be deemed to have incurred a Separation for Good Reason.  In the event the Company fails to cure the condition within the 30 day period, your Termination Date shall occur on the 31st day following the Company&#8217;s receipt of such written notice.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;&#8220;Termination without Cause&#8221; means the involuntary termination of your employment or contractual relationship by the Company without Cause, including, but not limited to, (i) a termination effective when you exhaust a leave of absence during, or at the end of, a notice period under the Worker Adjustment and Retraining Notification Act (&#8220;WARN&#8221;), and (ii) a situation where you are on an approved leave of absence during which your position is protected under applicable law (e.g., a leave under the Family Medical Leave Act), you return </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">from such leave, and you cannot be placed in employment or other form of contractual relationship with the Company.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Vesting Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding Section 1.2 above, if your Termination Date occurs by reason of a Termination without Cause or a Separation for Good Reason on or after a Change in Control (as defined in the Plan and as such definition may be amended hereafter) and prior to the two (2) year anniversary of the Change in Control, all of the PSUs awarded under Section 1.1 that have not previously been forfeited shall become fully vested as if Target performance had been obtained for the Performance Period effective as of your Termination Date.  If your Termination Date occurs because of death, Disability, or Retirement, the PSUs shall vest or be forfeited as of the PSU Vesting Date set forth in Section 1.2, based on the attainment of the performance goals. Notwithstanding the definition of &#8220;Retirement&#8221; in Section 2 of the Plan, &#8220;Retirement&#8221; means your Termination Date which occurs after attaining age 62.  If your Termination Date occurs in the 24-month period preceding the PSU Vesting Date because of an Involuntary Termination for Economic Reasons, all of the PSUs awarded hereunder shall vest or be forfeited as of the date set forth in Section 1.2, depending on the attainment of Performance Goals&#59; provided, however, that if your Termination Date occurs for a reason that is both described in this sentence and in the first sentence of this Section 1.4, the special vesting rules described in the first sentence of this Section 1.4 shall apply in lieu of the vesting rules described in this sentence.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as practicable following the date of the Committee&#8217;s first regularly scheduled meeting following the last day of the Performance Period at which the Committee certifies the average payout for each of the three years in the Performance Period (or, if earlier, the date on which the PSUs become vested pursuant to the special vesting rules described in Section 1.4), the Company shall transfer to you one Ordinary Share for each PSU, if any, that becomes vested pursuant to Section 1.2 or 1.4 of this Agreement (the date of any such transfer shall be the &#8220;settlement date&#8221; for purposes of this Agreement)&#59; provided, however, the Company in its discretion may settle PSUs in cash, based on the fair market value of the shares on the vesting date.  No fractional shares shall be transferred.  Any fractional share shall be rounded to the nearest whole share.  The income attributable to the vesting of PSUs and the amount of any required tax withholding will be determined based on the value of the shares on the settlement date.  PSUs are not eligible for dividend equivalents.  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">General Terms and Conditions</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nontransferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award under this Agreement shall not be transferable other than by will or by the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You shall not have any rights as a stockholder with respect to any Ordinary Shares subject to the PSU awarded under this Agreement prior to the date of issuance to you of a certificate or certificates for such shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If your Termination Date occurs for reasons of Cause, all of your rights under this Agreement, whether or not vested, shall terminate immediately.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The granting of the Award under this Agreement is being made pursuant to the Plan and the Award shall be payable only in accordance with the applicable terms of the Plan.  The Plan contains certain definitions, restrictions, limitations and other terms and conditions all of which shall be applicable to this Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ALL THE PROVISIONS OF THE PLAN ARE INCORPORATED HEREIN BY REFERENCE AND ARE MADE A PART OF THIS AGREEMENT IN THE SAME MANNER AS IF EACH AND EVERY </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SUCH PROVISION WERE FULLY WRITTEN INTO THIS AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Should the Plan become void or unenforceable by operation of law or judicial decision, this Agreement shall have no force or effect.  Nothing set forth in this Agreement is intended, nor shall any of its provisions be construed, to limit or exclude any definition, restriction, limitation or other term or condition of the Plan as is relevant to this Agreement and as may be specifically applied to it by the Committee.  In the event of a conflict in the provisions of this Agreement and the Plan, as a rule of construction the terms of the Plan shall be deemed superior and apply.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments in Event of Change in Ordinary Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of a stock split, stock dividend, recapitalization, reclassification or combination of shares, merger, sale of assets or similar event, the number and kind of shares subject to Award under this Agreement will be appropriately adjusted in an equitable manner to prevent dilution or enlargement of the rights granted to or available for you.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and you agree that the PSUs are granted under and governed by the Notice of Grant, this Agreement (including the Appendix, if applicable) and by the provisions of the Plan (incorporated herein by reference).  You&#58; (i) acknowledge receipt of a copy of each of the foregoing documents, (ii) represent that you have carefully read and are familiar with their provisions, and (iii) hereby accept the PSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes and Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding (Only Applicable to Individuals Subject to U.S. Tax Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Award is subject to the withholding of all applicable taxes.  The Company may withhold, or permit you to remit to the Company, any Federal, state or local taxes applicable to the grant, vesting or other event giving rise to tax liability with respect to this Award.  If you have not remitted the full amount of applicable withholding taxes to the Company by the date the Company is required to pay such withholding to the appropriate taxing authority (or such earlier date that the Company may specify to assist it in timely meeting its withholding obligations), the Company shall have the unilateral right to withhold Ordinary Shares relating to this Award in the amount it determines is sufficient to satisfy the tax withholding required by law.  State taxes will be withheld at the appropriate rate set by the state in which you are employed or were last employed by the Company.  In no event may the number of shares withheld exceed the number necessary to satisfy the maximum Federal, state and local income and employment tax withholding requirements.  You may elect to surrender previously acquired Ordinary Shares or to have the Company withhold Ordinary Shares relating to this Award in an amount sufficient to satisfy all or a portion of the tax withholding required by law.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Responsibility for Taxes (Only Applicable to Individuals Subject to Tax Laws Outside the U.S.).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Regardless of any action the Company or, if different, the Affiliate employing or retaining you takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (&#8220;Tax-Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items is and remains your responsibility and may exceed the amount actually withheld by the Company or the Affiliate employing or retaining you.  You further acknowledge that the Company and&#47;or the Affiliate employing or retaining you (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PSUs, including, but not limited to, the grant, vesting or settlement of the PSUs, the subsequent sale of Ordinary Shares acquired pursuant to such settlement and the receipt of any dividends&#59; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the PSUs to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result.  Further, if you have become subject to tax in more than one jurisdiction between the PSU Grant Date and the date of any relevant taxable event, as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">applicable, you acknowledge that the Company and&#47;or the Affiliate employing or retaining you (or formerly employing or retaining you, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(1) &#160;&#160;&#160;&#160;Prior to any relevant taxable or tax withholding event, as applicable, you will pay or make adequate arrangements satisfactory to the Company and&#47;or the Affiliate employing or retaining you to satisfy all Tax-Related Items.  In this regard, you authorize the Company and&#47;or the Affiliate employing or retaining you, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58;  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;withholding from your wages or other cash compensation paid to you by the Company and&#47;or the Affiliate employing or retaining you&#59; or</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;withholding from proceeds of the sale of Ordinary Shares acquired upon settlement of the PSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization)&#59; or </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(C)&#160;&#160;&#160;&#160;withholding in Ordinary Shares to be issued upon settlement of the PSUs.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;To avoid negative accounting treatment, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates.  If the obligation for Tax-Related Items is satisfied by withholding in Ordinary Shares, for tax purposes, you are deemed to have been issued the full number of Ordinary Shares subject to the vested PSUs, notwithstanding that a number of the Ordinary Shares are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(3)&#160;&#160;&#160;&#160;Finally, you shall pay to the Company or the Affiliate employing or retaining you any amount of Tax-Related Items that the Company or the Affiliate employing or retaining you may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to issue or deliver the Ordinary Shares or the proceeds of the sale of Ordinary Shares, if you fail to comply with your obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The issuance of Ordinary Shares will be subject to and conditioned upon compliance by the Company and you, including any written representations, warranties and agreements as the Administrator may request of you for compliance with all (i) applicable U.S. state and federal laws and regulations, (ii) applicable laws of the country where you reside pertaining to the issuance or sale of Ordinary Shares, and (iii)&#160;applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Ordinary Shares may be listed or quoted at the time of such issuance or transfer.  Notwithstanding any other provision of this Agreement, the Company shall have no obligation to issue any Ordinary Shares under this Agreement if such issuance would violate any applicable law or any applicable regulation or requirement of any securities exchange or similar entity.</font></div><div style="margin-bottom:12pt;text-indent:31.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Short Term Deferral (Only Applicable to Individuals Subject to U.S. Federal Tax Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  PSUs payable under this Agreement are intended to be exempt from Code Section 409A under the exemption for short-term deferrals.  Accordingly, PSUs will be settled no later than the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of the third month following the later of (i) the end of the Employee&#8217;s taxable year in which the vesting date occurs, or (ii) the end of the fiscal year of the Company in which the vesting date occurs.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Data Privacy Rules (Only Applicable if this Award is Subject to U.S. Data Privacy Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By entering into this Agreement and accepting this Award, you (a) explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of any of your personal data that is necessary to facilitate the implementation, administration and management of the Award and the Plan, (b) understand that the Company may, for the purpose of implementing, administering and managing the Plan, hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, and details of all awards or entitlements to Shares granted to you under the Plan or otherwise (&#8220;Personal Data&#8221;), (c) understand that Personal Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including any broker with whom the Shares issued upon vesting of the Award may be deposited, and that these recipients may be located in your country or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than your country, (d) waive any data privacy rights you may have with respect to the data, and (e) authorize the Company, its Affiliates and its agents, to store and transmit such information in electronic form.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Data Privacy Rules (Only Applicable if this Award is Subject to Data Privacy Laws Outside of the U.S.)</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;By entering into this Agreement and accepting this Award, you hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other PSU grant materials by and among, as applicable, the Affiliate employing or retaining you, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;You understand that the Company and the Affiliate employing or retaining you may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Ordinary Shares or directorships held in the Company, details of all PSUs or any other entitlement to Ordinary Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (&#8220;Data&#8221;).  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;You understand that Data will be transferred to legal counsel or a broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients&#8217; country (e.g., the United States) may have different data privacy laws and protections than your country of residence.  You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local or Company human resources representative.  You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan.  You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local or Company human resources representative.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local or Company human resources representative.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be binding upon any or all successors and assigns of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed and enforced in accordance with the applicable Code provisions to the maximum extent possible and otherwise by the laws of the State of Michigan without regard to principals of conflict of laws, provided that if you are a foreign national or employed outside the United States, this Agreement shall be governed by and construed and enforced in accordance with applicable foreign law to the extent that such law differs from the Code and Michigan law.  Any proceeding related to or arising out of this Agreement shall be commenced, prosecuted or continued in the Circuit Court in Kent County, Michigan located in Grand Rapids, Michigan or in the United Stated District Court for the Western District of Michigan, and in any appellate court thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Forfeiture of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company, as a result of misconduct, is required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, then (a) if your incentive or equity-based compensation is subject to automatic forfeiture due to such misconduct and restatement under Section 304 of the Sarbanes-Oxley Act of 2002, or (b) the Committee determines you either knowingly engaged in or failed to prevent the misconduct, or your actions or inactions with respect to the misconduct and restatement constituted gross negligence, you shall (i) be required to reimburse the Company the amount of any payment relating to any PSUs earned or accrued during the twelve month period following the first public issuance or filing with the SEC (whichever first occurred) of the financial document embodying such financial reporting requirement, and (ii) all outstanding PSUs that have not yet been settled shall be immediately forfeited.  In addition, Ordinary Shares acquired under this Agreement, and any gains or profits on the sale of such Ordinary Shares, shall be subject to any &#8220;clawback&#8221; or recoupment policy later adopted by the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Rules for Non-U.S. Grantees (Only Applicable if You Reside Outside of the U.S.)</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In accepting the grant, you acknowledge, understand and agree that&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, except as otherwise provided in the Plan. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;the grant of the PSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of PSUs, or benefits in lieu of the PSUs, even if PSUs have been granted repeatedly in the past&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;all decisions with respect to future PSU grants, if any, will be at the sole discretion of the Company&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;you are voluntarily participating in the Plan&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are an extraordinary item and which is outside the scope of your employment or service contract, if any&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(6)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are not intended to replace any pension rights or compensation&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Affiliate employing or retaining you or any other Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(8)&#160;&#160;&#160;&#160;the grant and your participation in the Plan will not be interpreted to form an employment or service contract with the Company or any Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(9)&#160;&#160;&#160;&#160;the future value of the underlying Ordinary Shares is unknown, indeterminable and cannot be predicted with certainty&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(10)&#160;&#160;&#160;&#160;no claim or entitlement to compensation or damages shall arise from forfeiture of the PSUs resulting from your Termination Date (for any reason whatsoever, whether or not later found to be invalid and whether or not in breach of employment laws in the jurisdiction where you are employed or rendering services, or the terms of your employment agreement, if any), and in consideration of the grant of the PSUs to which you are otherwise not entitled, you irrevocably agree never to institute any claim against the Company or the Affiliate employing or retaining you, waive your ability, if any, to bring any such claim, and release the Company and the Affiliate employing or retaining you from any such claim&#59; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, you shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim&#59; and</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(11)&#160;&#160;&#160;&#160;you acknowledge and agree that neither the Company, the Affiliate employing or retaining you nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the currency of the country in which you reside and the United States Dollar that may affect the value of the PSUs or of any amounts due to you pursuant to the settlement of the PSUs or the subsequent sale of any Ordinary Shares acquired upon settlement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provisions in this Agreement, the PSU grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement.  Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to you, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan.  If you relocate to the United States, the special terms and conditions in the Appendix will apply, or cease to apply, to you, to the extent the Company determines that the application or otherwise of such provisions is necessary or advisable in order to facilitate the administration of the Plan.  The Appendix constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company reserves the right to impose other requirements on your participation in the Plan, on the PSUs and on any Ordinary Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">****</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">We look forward to your continuing contribution to the growth of the Company.  Please acknowledge your receipt of the Plan and this Award.</font></div><div style="text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="text-indent:198pt"><font><br></font></div><div style="text-indent:198pt"><font><br></font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Orlando Ashford</font></div><div style="text-align:justify;text-indent:198pt"><font><br></font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Orlando Ashford</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chairman of the Board</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">APPENDIX</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PERRIGO COMPANY PLC</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Additional Terms and Provisions to</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Restricted Stock Unit Award Agreement (Performance-Based)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix (the &#8220;Appendix&#8221;) includes additional terms and conditions that govern the restricted stock units (Performance-Based) (&#8220;PSUs&#8221; or &#8220;Award&#8221;) granted to you under the Plan if you reside in one of the countries listed below. Certain capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan and&#47;or the Agreement.  The Award will not create any entitlement to receive any similar benefit in the future. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix also includes country-specific information of which you should be aware with respect to your participation in the Plan.  The information is based on the securities, exchange control and other laws in effect in the respective countries as of January 2023.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that you do not rely on the information noted herein as the only source of information relating to the consequences of your participation in the Plan because the information may be out of date at the time that you vest in the PSUs and Ordinary Shares are issued to you or the shares issued upon vesting of the PSUs are sold.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, the information is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of any particular result.  Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your particular situation.  Finally, please note that if you are a citizen or resident of a country other than the country in which you are currently working, or transfers employment after grant, the information contained in the Appendix may not be applicable.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Conditions et dispositions suppl&#233;mentaires &#224; l&#8217;</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Accord relatif &#224; l&#8217;attribution d&#8217;unit&#233;s d&#8217;action avec restrictions (r&#233;mun&#233;ration fond&#233;e sur les performances)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice (l&#8217;&#171;&#160;Appendice&#160;&#187;) comprend des conditions compl&#233;mentaires r&#233;gissant les Unit&#233;s d&#8217;action avec restrictions (r&#233;mun&#233;ration fond&#233;e sur les performances) (&#171;&#160;UARP&#160;&#187; ou &#171;&#160;Prime&#160;&#187;) qui vous sont attribu&#233;es en vertu du Plan si vous r&#233;sidez dans l&#8217;un des pays repris ci-dessous. Certains termes commen&#231;ant par une lettre majuscule utilis&#233;s dans le pr&#233;sent Accord mais qui n&#8217;y sont pas d&#233;finis ont le sens qui leur est attribu&#233; dans le Plan ou l&#8217;Accord. La Prime n&#8217;instaure aucun droit &#224; recevoir des avantages similaires &#224; l&#8217;avenir. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice comprend &#233;galement des informations sp&#233;cifiques aux pays dont vous devez avoir connaissance eu &#233;gard &#224; votre participation au Plan. Les informations se fondent sur les lois relatives aux valeurs mobili&#232;res, au contr&#244;le des &#233;changes et autres en vigueur dans les pays respectifs en janvier 2023. Souvent complexes, ces lois font l&#8217;objet de modifications fr&#233;quentes. Par cons&#233;quent, la Soci&#233;t&#233; vous recommande vivement de ne pas consid&#233;rer les renseignements repris aux pr&#233;sentes comme l&#8217;unique source d&#8217;information relative aux cons&#233;quences de votre participation au Plan, car ces renseignements peuvent &#234;tre obsol&#232;tes au moment de la d&#233;volution des UARP ou de l&#8217;&#233;mission des Actions ordinaires pour votre compte, ou de la vente des actions &#233;mises lors de la d&#233;volution des UARP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Par ailleurs, ces informations sont d&#8217;ordre g&#233;n&#233;ral et peuvent ne pas s&#8217;appliquer &#224; votre situation particuli&#232;re. De plus, la Soci&#233;t&#233; n&#8217;est pas en mesure de vous garantir un quelconque r&#233;sultat </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">particulier. Par cons&#233;quent, il vous est conseill&#233; de demander des conseils professionnels appropri&#233;s quant &#224; la mani&#232;re dont les lois de votre pays en la mati&#232;re peuvent s&#8217;appliquer &#224; votre situation particuli&#232;re. Enfin, veuillez noter que si vous &#234;tes citoyen ou r&#233;sident d&#8217;un pays autre que celui dans lequel vous travaillez actuellement ou si votre emploi est transf&#233;r&#233; apr&#232;s l&#8217;octroi, les informations figurant dans l&#8217;Appendice peuvent ne pas appliquer.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Extra voorwaarden en voorzieningen bij</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">de Overeenkomst over voorwaardelijk toegekende aandelen (op basis van prestaties)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Algemene voorwaarden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage (de 'Bijlage') omvat extra algemene voorwaarden voor de voorwaardelijk toegekende aandelen (op basis van prestaties) ('PSU's' of 'Award') die u volgens het Plan zijn toegekend als u in een van onderstaande landen woont. Bepaalde termen in hoofdletters die in deze Bijlage werden gebruikt maar niet gedefinieerd, hebben de betekenis die in het Plan en&#47;of de Overeenkomst is vermeld. De Award cre&#235;ert geen recht om een soortgelijk voordeel in de toekomst te krijgen. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage bevat ook landenspecifieke informatie waarvan u op de hoogte moet zijn met betrekking tot uw deelname aan het Plan. De informatie is gebaseerd op de effecten-, wisselcontrole- en andere wetten die in de respectieve landen sinds januari 2023 van kracht zijn.  Zulke wetten zijn vaak complex en worden regelmatig aangepast. Daarom raadt het Bedrijf u ten sterkste aan de informatie hierin niet te gebruiken als enige bron van informatie over de gevolgen van uw deelname aan het Plan, omdat de informatie verouderd kan zijn op het ogenblik dat uw toezegging in de PSU's en de Gewone aandelen u worden uitgekeerd of wanneer de bij de toezegging van de PSU's uitgegeven aandelen worden verkocht.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ook is de informatie algemeen van aard en mag u ze niet toepassen op uw specifieke situatie. Het Bedrijf bevindt zich evenmin in een positie om u een specifiek resultaat te verzekeren. We raden u dan ook aan om professioneel advies te vragen over hoe de relevante wetten in uw land van toepassing kunnen zijn op uw specifieke situatie. Ten slotte, merk op dat als u een burger of inwoner bent van een ander land dan het land waarin u op dit moment werkt, of uw tewerkstelling na de toekenning verhuist, de informatie in de Bijlage mogelijk niet van toepassing is.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Dodatkowe warunki i postanowienia</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Umowy przyznania jednostek akcyjnych o ograniczonych prawach (w oparciu o wyniki)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik (&#8222;Za&#322;&#261;cznik&#8221;) zawiera dodatkowe warunki, kt&#243;re reguluj&#261; jednostki akcyjne o ograniczonych prawach (&#8222;PSU&#8221; lub &#8222;Prawo&#8221;) przyznan&#261; w ramach Programu, je&#347;li mieszkasz w jednym z wymienionych poni&#380;ej kraj&#243;w. Okre&#347;lone terminy pisane wielk&#261; liter&#261;, kt&#243;re nie zosta&#322;y zdefiniowane w niniejszym Za&#322;&#261;czniku, maj&#261; znaczenie okre&#347;lone w Programie i&#47;lub Umowie. Prawo nie uprawnia do uzyskiwania podobnych korzy&#347;ci w przysz&#322;o&#347;ci. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik zawiera r&#243;wnie&#380; informacje dotycz&#261;ce poszczeg&#243;lnych kraj&#243;w, o kt&#243;rych powiniene&#347;(-as) wiedzie&#263; w zwi&#261;zku z uczestnictwem w Programie. Informacje oparte s&#261; na papierach warto&#347;ciowych, kontroli dewizowej i innych przepisach obowi&#261;zuj&#261;cych w odpowiednich krajach od stycznia 2023 r. Takie przepisy prawa s&#261; cz&#281;sto skomplikowane i cz&#281;sto si&#281; zmieniaj&#261;. W zwi&#261;zku z tym Sp&#243;&#322;ka zdecydowanie zaleca, aby nie polega&#263; na informacjach wymienionych w niniejszym dokumencie jako jedynym &#378;r&#243;dle informacji zwi&#261;zanych z konsekwencjami uczestnictwa w Programie, gdy&#380; informacje te mog&#261; by&#263; nieaktualne w momencie nabycia lub wykonywania PSU, a Akcje Zwyk&#322;e s&#261; Ci wydawane lub w przypadku sprzeda&#380;y PSU nabytych w ramach Programu.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto informacje maj&#261; charakter og&#243;lny i mog&#261; nie mie&#263; zastosowania do konkretnej sytuacji, a Sp&#243;&#322;ka nie jest w stanie zapewni&#263; Ci &#380;adnego konkretnego rezultatu. W zwi&#261;zku z tym zaleca si&#281; zasi&#281;gni&#281;cie odpowiedniej profesjonalnej porady dotycz&#261;cej tego, w jaki spos&#243;b odpowiednie przepisy w Twoim kraju mog&#261; mie&#263; zastosowanie do konkretnej sytuacji. Wreszcie nale&#380;y pami&#281;ta&#263;, &#380;e je&#347;li jeste&#347; obywatelem&#47;obywatelk&#261; lub rezydentem&#47;rezydentk&#261; kraju innego ni&#380; kraj, w kt&#243;rym obecnie pracujesz lub przenosisz si&#281; do nowego miejsca po przyznaniu, informacje zawarte w Za&#322;&#261;czniku mog&#261; nie mie&#263; zastosowania.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Australia</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Important Notice</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Important Notice </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">No financial product advice is provided in this Appendix, this Agreement or the Plan (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Plan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">) and nothing should be taken to constitute a recommendation or statement of opinion that is intended to influence a person or persons in making a decision to participate in the Plan. The Plan documents do not take into account your objectives, financial situation and needs. You should consider obtaining your own financial product advice from a person who is licensed by the Australian Securities and Investments Commission to give such advice. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">If you intend to apply to participate in the Plan, you must make your own independent assessment and investigation in relation to your legal and taxation position including seeking professional advice. You must base any decision you may make on such independent assessment, investigation or advice.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Offer made without disclosure </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A copy of the terms of the Plan will be provided to you with this Agreement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of the Plan, an offer to receive PSUs and participate in the Plan, if received in Australia, is made without disclosure to investors in reliance on the regulatory relief set out in Division 1A of Part 7.12, and for the purposes of section 1100N(b), of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Corporations Act 2001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Cth). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As set out in this Agreement, each PSU represents the right to receive one Ordinary Share subject to the relevant performance goals and performance measures being met, or otherwise waived, in accordance with the Plan and this Agreement. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The PSUs will be issued for nil consideration. You are not required to pay for a PSU or for the subsequent transfer of an Ordinary Share on vesting of that PSU, however your responsibility for any taxes is as set out in the terms of the Plan and this Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any discretion contained in the Plan, or any provision in this Agreement to the contrary, the number of PSUs granted to you will only be decreased depending on your level of attainment of performance goals against your designated performance measures. If you fully meet your performance goals against the designated performance measures, all of your PSUs will vest. However, if you only partially meet your performance goals against the designated performance measures, only a partial number of your PSUs will vest. You will be entitled to one Share for each vested PSU. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the avoidance of doubt, there will be no increase to the number of PSUs granted to you on the Grant Date. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company will not provide you with any loans or financial assistance under the Plan in connection with the offer of the PSUs. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No PSUs or Ordinary Shares transferred to you under the Plan will be held on your behalf, by a trustee&#47;nominee. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The indicative daily price of the Ordinary Shares on the New York Stock Exchange (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), quoted in US dollars, is available on the Company&#8217;s website at http&#58;&#47;&#47;perrigo.investorroom.com&#47;stock-information. The Ordinary Shares are also quoted on the NASDAQ Stock Market (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NASDAQ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) (refer to NASDAQ&#8217;s website at </font><font style="color:#0562c1;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">http&#58;&#47;&#47;www.nasdaq.com&#47;symbol&#47;prgo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Australian dollar equivalent of the Ordinary Shares can be determined using prevailing exchange rate published by Thomson Reuters (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Prevailing Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). Alternatively, the Company will advise you of the price of its Ordinary shares (in equivalent Australian dollars) as soon as possible following receipt of any request for such information. This information may be obtained by you contacting your local Human Resources representative. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Before accepting an offer to be granted PSUs, you should satisfy yourself that you have a sufficient understanding of the risks set out below and should consider if the PSUs are a suitable investment for you, having regard to your own investment objectives, financial circumstances and taxation position&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) the vesting conditions for your PSUs may not be satisfied for reasons beyond the Company&#8217;s or your control&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) you are not permitted to transfer your PSUs unless permitted under this Agreement or the Plan&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) you will have no voting, dividend, or other stockholder rights in any Shares until you become the registered holder of those Shares. Until you become the registered holder of Shares, you will have only the rights of an unsecured creditor with respect to those Shares </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) if your PSUs vest and you subsequently receive Ordinary Shares&#58; </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) the value of those shares may rise and fall according to investor sentiment, general economic conditions and outlook, international and local stock markets, employment, inflation, interest rates, government policy, taxation and regulation&#59; and </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) there is no guarantee that an active trading market for the shares will exist or that the price of the shares will increase. There may be relatively few potential buyers or sellers of the shares on the NYSE, NASDAQ, TASE or any other applicable market at any time and this may </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">increase the volatility of the market price of the shares. It may also affect the prevailing market price at which you may be able to sell your shares&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) there may be taxation implications arising for you in participating under this Agreement and in the Plan. The tax consequences of participating in the Plan are based on complex tax laws, which may be subject to varying interpretations, and the application of such laws may depend, in large part, on the surrounding facts and circumstances. The tax regime applying to you may change. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the above risks are only general risks of acquiring and holding PSUs under the Plan. It does not purport to list every risk that may be associated with the Plan now or in the future. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, if at the time of vesting, the Company determines that it is not legal under Australian securities laws to issue shares, the outstanding PSUs will be cancelled, and no shares will be issued to you nor will any benefits in lieu of shares be paid to you. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Exchange Control Information </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control reporting mandates disclosure of payments equal to or exceeding AUD10,000 made to a foreign individual or entity. This reporting is generally done automatically by the financial institution making the transfer. </font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Austria</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of Austria, you must submit a report to the Austrian National Bank. An exemption applies if the value of the shares as of any given quarter is less than &#8364;5,000,000 (when converted to Euros if applicable). If the threshold is met or exceeded, quarterly reporting obligations exist If quarterly obligations apply, the reporting date is the end of each quarter and the deadline for filing the report is the 15th of the month following the end of the quarter.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When shares are sold, there may be exchange control obligations if the cash received is held in a bank account outside Austria.  If the volume of all your accounts abroad exceeds &#8364;10,000,000 (when converted to Euros if applicable), the balances of all accounts must be reported monthly, as of the last day of the month, on or before the fifteenth day of the following month.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Belgium </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to report any security or bank accounts (including brokerage accounts) you maintain outside of Belgium on your annual tax return.  In a separate report, you are required to provide the National Bank of Belgium with certain details regarding such foreign accounts (including the account number, bank name and country in which any such account was opened).  This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under Kredietcentrales &#47; Centrales des cr&#233;dits caption.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Stock Exchange Tax.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A stock exchange tax could apply for Belgian tax residents transacting through a non-Belgium broker once the shares are sold. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Communication d&#8217;informations relatives aux actifs ou comptes &#233;trangers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Vous &#234;tes tenu de d&#233;clarer, dans votre d&#233;claration fiscale annuelle, tout compte-titres ou compte en banque (y compris les comptes de courtage) que vous d&#233;tenez en dehors de la Belgique. Dans une d&#233;claration distincte, vous &#234;tes tenu de communiquer &#224; la Banque Nationale de Belgique certains d&#233;tails concernant les comptes &#233;trangers (notamment le num&#233;ro de compte, le nom de la banque et le pays o&#249; le compte a &#233;t&#233; ouvert). Cette d&#233;claration ainsi que toutes les informations indiquant comment la remplir sont disponibles sur le site web de la Banque Nationale de Belgique (www.nbb.be) &#224; la section &#171;&#160;Centrales des cr&#233;dits&#47;Kredietcentrales&#160;&#187;. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informatie over buitenlands vermogen&#47;rekeningrapportering.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> U moet alle garantie- of bankrekeningen (inclusief beleggingsrekeningen) die u buiten Belgi&#235; bezit, vermelden op uw jaarlijkse belastingsbrief. In een afzonderlijk overzicht moet u de Nationale Bank van Belgi&#235; informatie geven over zulke buitenlandse rekeningen (inclusief het rekeningnummer, de naam van de bank en het land waarin zulke rekening is geopend). Dit overzicht, evenals extra informatie over hoe u het moet opstellen, vindt u op de website van de Nationale Bank van Belgi&#235;, www.nbb.be, onder de titel Kredietcentrales.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Bermuda</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is not subject to and has not received approval from the Bermuda Monetary Authority and the Registrar of Companies in Bermuda, and no statement to the contrary, explicit or implicit, is authorized to be made in this regard.  The securities may be offered or sold in Bermuda only in compliance with the provisions of the Investment Business Act 2003 of Bermuda.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Brazil</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You agree that, for all legal purposes, (i) the benefits provided under the Plan are the result of commercial transactions unrelated to your employment&#59; (ii) the Plan is not a part of the terms and conditions of your employment&#59; and (iii) the income from the PSUs, if any, is not part of your remuneration from employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you agree to comply with Brazilian law when the PSUs vest and the shares are sold. You also agree to report and pay any and all taxes associated with the vesting of the PSUs, the sale of the PSUs acquired pursuant to the Plan, and the receipt of any dividends.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> If you are a resident or domiciled in Brazil and hold assets and rights outside Brazil with an aggregate value exceeding US$100,000, you will be required to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">prepare and submit to the Central Bank of Brazil an annual declaration of such assets and rights. Assets and rights that must be reported include PSUs.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Canada</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Payout of PSUs in Shares Only</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to all Employees residing in Canada, the Company will convert all vested PSUs only into an equivalent number of Shares and the Plan will not provide an option to settle the PSUs in cash. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Canadian residents may be required to report foreign property (including Shares) on an annual basis on form T1135 (Foreign Income Verification Statement) if the total cost of the foreign property exceeds CAD 100,000 at any time in the year. The grant of PSUs must be reported if the CAD 100,000 cost threshold is exceeded because of other foreign property held. PSUs may be reported at a nil cost. The form must be filed by April 30 of the following year. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Withholding will include both federal income tax as well as provincial tax.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Resale Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Ordinary Shares received by Canadian residents pursuant to this Plan will be subject to an indefinite holding period and the resale of the Ordinary Shares will be prohibited, unless certain conditions are met in respect of the Company in accordance with applicable Canadian securities laws or another applicable Canadian prospectus exemption is available.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Eligibility of Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding the terms of this Agreement or the Plan, no offers of PSUs or Ordinary Shares may be made to you if you are not an employee, executive officer, director or consultant of the Company or a related entity of the Company, in accordance with Section 2.24 of National Instrument 45-106.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employment Law Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the term &#8220;Termination Date&#8221; shall mean the earliest of&#58;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)&#160;&#160;&#160;&#160;Any date specified in this Agreement or the Plan&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)&#160;&#160;&#160;&#160;The date on which the Company or any applicable Affiliate delivers to you notice in a form prescribed by the Company that the Company is thereby terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)&#160;&#160;&#160;&#160;Except in the event of a Separation for Good Reason, the date on which you deliver notice in a form prescribed by the Company to the Company or any applicable Affiliate that you are terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)&#160;&#160;&#160;&#160;The date on which you cease to provide services to the Company or any applicable Affiliate, except where you are on an authorized leave of absence&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)&#160;&#160;&#160;&#160;The date on which you cease to be considered an &#8220;employee&#8221; of the Company or any applicable Affiliate under applicable law.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the definitiona of &#8220;Cause&#8221; shall be determined in accordance with applicable laws in the jurisdiction of employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In accordance with Section 2.13, you consent and agree to the payment of the reimbursements set out therein, including through deductions of the amounts specified in paragraph 2.13 from any wages owed by the Company to the employee. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The provisions set out in Section 2.15(a) do not apply to employees in the province of Ontario other than executive employees who are exempted from XV.1 of the Ontario Employment Standards Act, 2000.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Czech Republic</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Documents in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Award, you confirm that you have read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">P&#345;ijet&#237;m tohoto Ozn&#225;men&#237; potvrzujete, &#382;e jste p&#345;e&#269;etl a porozum&#283;l jste Podm&#237;nk&#225;m pl&#225;nu (&#8220;Plan&#8221;) a Smlouv&#283; (&#8220;Agreement&#8221;), kter&#233; V&#225;m byly poskytnuty v anglick&#233;m jazyce. Z&#225;rove&#328; prohla&#353;ujete, &#382;e souhlas&#237;te s podm&#237;nkami uveden&#253;mi v t&#283;chto dokumentech.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restriction on cash payments.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Under Czech Act No. 235&#47;2004 Coll., on Cash Payments, as amended, it is prohibited to receive or provide payments in cash exceeding the amount of CZK 270.000 within one day. Payments exceeding this amount must be executed cashless. This restriction relates to payments from one contracting party to one other contracting party. Thus, it is not a restriction on the sum of all payments made by one individual or entity within one day.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nevertheless, since the restriction on cash payments may be subject to a change (especially a lower threshold might be set), we recommend consulting your personal legal advisor prior to receiving or providing a larger amount of cash payments.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Denmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is subject to the Danish Stock Option Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aktieoptionsloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), which applies on share option agreements entered into as part of an employment, if the ownership of the shares is obtained at a later point. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This act is based on a principle of the right to freely agree on the terms of the Award Agreement with certain exceptions stated in the act. In addition to the act, the Danish Contract Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aftaleloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and Danish case law also regulates the terms of the Award Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below, it is outlined when the Danish Stock Option Act, the Danish Contract Act, Danish case law and other applicable legislation deviate from terms stated in the Award Agreement&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Section 1.3(f) in the Award Agreement does not entail that applicable notice periods under Danish employment legislation and your employment agreement are deviated from to the detriment of you. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Section 1.3(g) litra 2 in the Award Agreement is amended to the following&#58; </font></div><div><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;(2) &#8220;Termination without Cause&#8221; means the involuntary termination of your employment or contractual relationship by the Company without any Cause. &#8220; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Regardless of section 2.3 in the Award Agreement, vested and acquired shares do not lapse as a consequence of your Termination Date for reasons of Cause. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In relation to Section 2.7 in the Award Agreement the following also applies, which supersedes section 2.7 in case of conflicting regulation&#58; </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;The Company is required to report the market value of the PSUs to the Danish tax authorities to both E-income and E-capital with the Danish tax authorities. For E-income, the value of the PSUs should be reported as income art 50 in field 068 and should be reported by the Company in the month the shares vest. For E-capital, the value of the PSUs should be reported to the Danish tax authorities no later than the 20th of January the following year after the PSUs have vested. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The market value of the provided PSUs is to be reported by the Company as personal income in the year of vest and is subject to a marginal tax rate of 56% including labor market contribution. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The tax payment obligation for the value of the shares will be collected with the individual, and the responsibility to ensure that the correct amount is reported on the Danish tax assessment remains with the individual.</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At the time of sale you are subject to tax on the gain, if any, at a marginal tax rate of 42%. The capital gain is calculated as the difference between the average fair market value at vest and the sales price. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If there is a loss tied to the sale of the PSUs, the loss can be deducted in capital gain from other listed PSUs. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that it is mandatory for you to report information on PSUs from a foreign depot to the Danish tax authorities. If this information is not provided to the Danish tax authorities, a potential loss cannot be used for deduction. &#8220; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to section 2.10(b), all personal information will be managed in accordance with the European Data Protection Regulation (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">databeskyttelsesforordningen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and the Danish Data Protection Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">personbeskyttelsesloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.15(a)-(d) in the Award Agreement is void and unenforceable in Denmark and instead the following is agreed&#58; </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15 NON-COMPETITION AND NON-SOLICITATION </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.1. You will be covered by this non-competition and non-solicitation clause for 6 months after the effective date of termination. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.2. In this period, you are entitled to &#8211; only with the prior written consent of the affiliate employing or retaining you (the &#8220;Affiliate&#8221;) &#8211; be engaged or financially interested, directly or indirectly, in any business which develops and&#47;or distributes products or services that compete or may compete with the Affiliate or any group companies&#8217; products and&#47;or services or in any other business competing with the Affiliate or any group companies in any other way. This restriction includes any interest whatsoever by way of, for example, employment, ownership in full or in part, membership of a board, consultancy services and the like in Denmark and abroad. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.3. Conclusion of this non-competition clause is required because you hold a very special position of trust, and you will receive detailed knowledge about the Affiliate and group companies&#8217; affairs, including business secrets, market strategies and plans, information on customers and suppliers. This knowledge may be exploited to the detriment of the Affiliate or group companies, if you become employed with a competing company immediately after the effective date of termination. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.4. During 6 months after the effective date of termination, you are only with the prior written consent of the Affiliate entitled to be in contact with or have business relations, directly or indirectly, with customers, suppliers or cooperation partners, etc., with whom you have had business relations within the last 12 months prior to the termination. In connection with the termination, the Affiliate will prepare a list of the customers, suppliers and cooperation partners covered by the restriction in this clause. In this connection, you must loyally contribute to the drafting of a thorough list covering all customers, suppliers and&#47;or cooperation partners with whom you have had business relations within the last 12 months prior to the termination. Your deliberate failure to contribute loyally to this list will be considered a material breach of the employment and the Award Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.5. The effective date of termination is to be construed as the date on which you may be ordered or entitled to resign after the expiry of the notice period, notwithstanding whether you actually end your work with the employing company at an earlier date. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.6. The non-competition part of this clause will cease to apply, if the Affiliate gives notice of termination to you without you having reasonably caused the termination. The non-competition part of this clause will also cease to apply, if you resign from the Affiliate for reasonable cause due to the employing company&#8217;s failure to fulfil its obligations, cf. section 11 (1) in the Danish Act on Employment Clauses (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">ans&#230;ttelsesklausulloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). In both situations, the non-solicitation part of this clause will be maintained. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.7. The Affiliate may terminate the clause with one month's notice to expire at the end of a month, cf. section 10 (1) in the Danish Act on Employment Clauses. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.8. As compensation for the clause, you will receive a monthly compensation in accordance with the Danish Act on Employment Clauses. Compensation currently amounts to 60 % of the monthly salary at the effective date of termination and is payable in the period in which the clause applies. At the effective date of termination, the first two months of compensation will be paid to you as a lump sum. If the clause applies, compensation will after the first two months be payable each month in arrears in the rest of the period in which the clause applies. If you obtain other appropriate paid work, compensation equivalent to 24 % of the monthly salary at the effective date of termination will be paid from the third month after the effective date of termination. You are obligated to actively seek other appropriate work and to notify the Affiliate in writing of any new work. Failure to observe the duty of mitigation will be considered a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">material breach of the employment with the effect that your right to compensation will lapse. The right to compensation will lapse, if the Affiliate has lawfully terminated your employment without notice. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.9. In the event of your breach of the clause, the Affiliate will be entitled to a penalty of &#91;between three and six&#93; months' salary for any one breach of the clause and compensation for any additional loss. In the event of a persistent breach of the clause, each month or part of a month is deemed to constitute an independent breach entitling the Affiliate to a new, independently agreed penalty. Any payment of the agreed penalty shall not lead to the discontinuance of your obligation to comply with the clause. The Affiliate may also seek to restrain any breach of the clause through the issue of an injunction. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.10. This clause may be invoked by the Affiliate from the date on which you have been employed with the employing company for six months.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Estonia</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Finland</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  If you hold Ordinary Shares acquiqred under the Plan, you are generally required to include those Ordinary Shares as assets in your individual tax return.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">France</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">En acceptant cette attribution gratuite d'actions, vous confirmez avoir lu et comprenez le Plan et ce Contrat, incluant tous leurs termes et conditions, qui ont &#233;t&#233; transmis en langue anglaise. Vous acceptez les dispositions de ces documents en connaissance de cause.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of France or maintain a foreign bank account, you are required to report such to the French tax authorities when you file your annual tax return.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The PSUs are not intended to qualify as a French tax qualified performance restricted stock units under French tax law.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a French resident and hold cash or Ordinary Shares outside of France, you must declare all foreign bank and brokerage accounts (including any accounts that were opened or closed during the tax year) on an annual basis on a special form, No. 3916, together with your income tax return.  </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Renseignements relatifs aux comptes et avoirs &#233;trangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Si vous &#234;tes r&#233;sident fran&#231;ais et que vous d&#233;tenez des liquidit&#233;s ou des Actions ordinaires en dehors de la France, vous &#234;tes tenu de </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d&#233;clarer chaque ann&#233;e, en m&#234;me temps que votre d&#233;claration de revenus, les r&#233;f&#233;rences de vos comptes bancaires et comptes-titres &#233;trangers (y compris les comptes qui ont &#233;t&#233; ouverts ou ferm&#233;s pendant l&#8217;exercice fiscal) par le biais d&#8217;un formulaire sp&#233;cifiquement pr&#233;vu &#224; cet effet, le formulaire N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">o&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3916. </font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Germany</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Cross-border payments related to securities transactions in excess of &#8364;12,500 must be reported by the fifth calendar day of the month following the respective payment to the German Central Bank (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Bundesbank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  If you use a German bank to transfer a cross-border payment related to securities transactions in excess of &#8364;12,500 (e.g. in connection with the sale of shares acquired under the Plan), the bank will make the report for you. In addition, you must report any receivables, payables, or debts in foreign currency exceeding an amount of &#8364;5,000,000 (by the tenth calendar day after the expiry of one month) and any cross-border shareholdings in companies if the share in the capital or the voting rights amount(s) to 10% or more and the investment object exceeds a balance sheet total of &#8364;3,000,000 (by the last working day of the sixth calendar month following December 31).n a monthly basis.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In case of an acquisition of shares in a foreign company with an overall investment amount of more than &#8364;150,000 (or in case of an acquisition of 10% or more of the shares in a foreign company), you should consult with your tax advisor whether the investment would have to be reported to your tax office.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Greece</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to your Award, if you withdraw funds of &#8364;15,000 or more from a bank in Greece and remit those funds out of Greece, you may be required to submit certain documentation&#47; information to the Greek bank to ensure that the transfer is not in violation of Greek anti-money laundering rules. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Hungary</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">India</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Notification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You understand that you must repatriate any proceeds from the sale of shares acquired under the Plan to India and convert the proceeds into local currency within 180 days of receipt assuming share holding is less than 10% of the company's share capital or as prescribed under applicable Indian exchange control laws as may be amended from time to time. You will receive a foreign inward remittance certificate (&#34;FIRC&#34;) from the bank where you deposit the foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or your employer requests proof of repatriation.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The amount subject to tax on receipt of the shares will partially be dependent upon a valuation that the Company or your employer will obtain from a Merchant Banker in India.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Neither the Company nor your employer has any responsibility or obligation to obtain the most favorable valuation possible, nor obtain valuations more frequently than required under Indian tax law.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to declare in the applicable schedules of your annual tax return (a) any foreign assets held by you (e.g., Ordinary Shares acquired under the Plan and, possibly, the Award), (b) any foreign bank accounts for which you have signing authority and (c) any foreign custodian accounts.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ireland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Director Notification Obligation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a director, shadow director or secretary of the Company's Irish Subsidiary or Affiliate, you must notify the Irish Subsidiary or Affiliate in writing within five business days of receiving or disposing of an interest exceeding 1% of the Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(e.g., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PSUs, shares, etc.), or within five business days of becoming aware of the event giving rise to the notification requirement or within five days of becoming a director or secretary if such an interest exists at the time. This notification requirement also applies with respect to the interests of a spouse or children under the age of 18 (whose interests will be attributed to the director, shadow director or secretary).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Israel</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Type of Grant&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633; </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capital Gain Award (&#8220;CGA&#8221;)</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ordinary Income Award (&#8220;OIA&#8221;)</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 3(i) Award</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Unapproved 102 Award</font></div><div><font><br></font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Settlement of PSUs</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Agreement, if the PSUs granted hereunder are 102 Awards, the PSUs shall be settled in Ordinary Shares only.</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Trust. </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All Approved 102 Awards shall be held in trust by a trustee designated by the Company (</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;Trustee&#34;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or shall be supervised by the Trustee in accordance with the instructions set forth by the Israeli Tax Authority (&#8220;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITA</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), for the requisite lockup period prescribed by the Ordinance and the regulations promulgated thereunder, or such other period as may be required by the ITA, during which period Awards or Ordinary Shares issued thereunder, and all rights resulting from them, including bonus shares, must be held or supervised by the Trustee in accordance with the instructions set forth by the ITA. The Trustee shall not release any Approved 102 Awards, Ordinary Shares issued upon the exercise of any Approved 102 Awards, or any rights, including bonus shares, resulting from such Approved 102 Awards or Ordinary Shares, prior to the full payment of your tax liability. The Trustee or the Israeli Affiliate shall withhold any applicable taxes in accordance with Section 102 or any applicable tax ruling obtained by the Company. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without derogating from the foregoing, if your PSUs do&#160;not qualify as Approved&#160;102 Awards the Company may still at its sole discretion deposit your PSUs in trust to ensure that taxes are properly withheld. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby release the Trustee from any liability in respect of any action or decision duly taken and executed in good faith in relation to any PSUs or Ordinary Shares issued to you thereunder. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Without derogating from Section 2.7(b) above, you hereby agree to indemnify the Company and&#47;or its Affiliates and&#47;or the Trustee and hold them harmless against and from any and all liability for all such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to you.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you agree to comply with the provisions of Section 102 and the regulations and rules promulgated thereunder or any tax ruling to be obtained by the Company in connection with your PSUs. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Italy</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax&#47;Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You are required to report on your annual tax return&#58;  (a) any foreign investments or investments (including the Ordinary Shares issued at vesting of the PSUs, cash or proceeds from the sale of Ordinary Shares acquired under the Plan) held outside of Italy, if the investment may give rise to income in Italy (this will include reporting the Ordinary Shares issued at vesting of the PSUs if the fair market value of such Ordinary Shares combined with other foreign assets)&#59; and (b) any changes during the financial year which have had an impact during the calendar year on your foreign investments or investments held outside of Italy.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are exempt from these formalities if the investments are made through an authorized broker resident in Italy, as the broker will comply with the reporting obligation on your behalf.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Kazakhstan</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to report the acquisition of shares of a foreign company to the National Bank of Kazakhstan. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Latvia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Lithuania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Luxembourg</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are required to report any inward remittances of funds to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Banque Central de Luxembourg </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and&#47;or the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Service Central de La Statistique et des Etudes Economiques</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Luxembourg financial institution is involved in the transaction, it generally will fulfill the reporting obligation on your behalf. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Mexico</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you understand and agree that any modification of the Plan or the Agreement or its termination shall not constitute a change or impairment of the terms and conditions of employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan Document Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the award of the PSUs, you acknowledge that you have received copies of the Plan, have reviewed the Plan and the Agreement in their entirety and fully understand and accept all provisions of the Plan and the Agreement.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, by signing the Agreement, you further acknowledge that you have read and specifically and expressly approve the terms and conditions in the Agreement, in which the following is clearly described and established&#58;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Participation in the Plan does not constitute an acquired right&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">The Plan and participation in the Plan is offered by the Company on a wholly discretionary basis&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">Participation in the Plan is voluntary&#59; and </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">The Company and any Parent, Subsidiary or Affiliates are not responsible for any decrease in the value of the shares.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowlegement and Policy Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In accepting the PSUs, you expressly recognize the Company is solely responsible for the administration of the Plan and that your participation in the Plan and acquisition of Ordinary Shares does not constitute an employment relationship between you and the Company since you are participating in the Plan on a wholly commercial basis and on a wholly commercial basis and your sole employer is Perrigo de Mexico S.A. De C.V. (&#8220;Perrigo Mexico&#8221;). Based on the foregoing, you expressly recognize that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and your employer, Perrigo Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Perrigo Mexico and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of your employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company&#59; therefore, the Company reserves the absolute right to amend and&#47;or discontinue your participation at any time without any liability to you.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or damages as a result of your participation in the Plan and therefore grant a full and broad release to the Employer, the Company and any Parent, Subsidiary or Affiliates with respect to any claim that may arise under the Plan.</font></div><div style="margin-bottom:12pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Spanish Translation</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modificaci&#972;n</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;Al aceptar las Unidades de Acci&#243;n Restringida de Rendimiento (PSUs, por sus siglas en ingl&#233;s) usted entiende y esta de acuerdo que cualquier modificaci&#243;n del plan o del acuerdo o su terminaci&#243;n no constituir&#225; un cambio o detrimento de los t&#233;rminos y condiciones de su empleo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Confirmaci&#243;n del Documento del Plan. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Al aceptar el otorgamiento de las PSUs, usted reconoce que ha recibido copias y ha revisado dicho acuerdo en su totalidad y que ha entendido y aceptado completamente todas las disposiciones contenidas en el Plan y en el Acuerdo.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adicionalmente, al firmar el acuerdo, usted reconoce que ha le&#237;do, y aprobado de manera espec&#237;fica y expresa los t&#233;rminos y condiciones en el acuerdo en el que se describe y establece claramente los siguiente&#58;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:25.17pt">La participaci&#243;n en el Plan no constituye un derecho adquirido&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.98pt">El plan y la participaci&#243;n en el mismo, son ofrecidos por la Compa&#241;&#237;a de manera totalmente discrecional&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.79pt">La participaci&#243;n en el Plan es voluntaria&#59; y</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.42pt">La Compa&#241;&#237;a, y cualquier Sociedad controladora, Subsidiaria o Filiales no son responsables por ning&#250;n decremento en el valor de las Acciones.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Constancia de aceptaci&#243;n de la ley laboral y declaraci&#243;n de la pol&#237;tica.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160; Al aceptar las PSUs, usted reconoce expresamente que la Compa&#241;&#237;a, es la &#250;nica responsable de la administraci&#243;n del Plan, y que su participaci&#243;n en el Plan y la adquisici&#243;n de las acciones comunes no constituyen una relaci&#243;n de trabajo entre usted y la Compa&#241;&#237;a dado que usted participa en el Plan de manera completamente comercial y el &#250;nico empleador que tiene es Perrigo de M&#233;xico, S.A. de C.V. (&#171; Perrigo de Mexico &#187;). Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que usted pueda obtener de la participaci&#243;n en el Plan, no establecen ning&#250;n derecho entre usted y su empleador Perrigo de M&#233;xico y no forman parte de las condiciones de trabajo ni de las prestaciones ofrecidas por Perrigo de M&#233;xico y cualquier modificaci&#243;n del Plan o la terminaci&#243;n de &#233;ste, no constituyen un cambio o deterioro de los t&#233;rminos y condiciones de su trabajo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adem&#225;s, usted comprende que su participaci&#243;n en el Plan es el resultado de una decisi&#243;n unilateral y discrecional de la Compa&#241;&#237;a&#59; por lo tanto, la Compa&#241;&#237;a se reserva el derecho absoluto de modificar y&#47;o interrumpir la participaci&#243;n de usted en cualquier momento sin ninguna responsabilidad para usted.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finalmente, usted declara que no se reserva ninguna acci&#243;n o derecho de presentar alg&#250;n reclamo o demanda en contra de la Compa&#241;&#237;a por compensaci&#243;n, da&#241;o o perjuicio alguno como resultado de su participaci&#243;n en el Plan, en consecuencia, otorga el m&#225;s amplio finiquito al Empleador, as&#237; como a la Compa&#241;&#237;a, a su Sociedad controladora, Subsidiaria o Filiales con respecto a cualquier demanda que pudiera originarse en virtud del Plan.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Netherlands</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dutch insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Norway</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Norwegian insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor as well as the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Cross-border payments in excess of NOK 100,000 must be reported to the Norwegian foreign exchange register (Valutaregisteret). If you use a Norwegian bank to transfer a cross-border payment in excess of NOK 100,00 in connection with the sale of shares acquired under the Plan, the bank will make the report on your behalf. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In your Norwegian income tax return, each year you are required to report any security, shares or bank accounts (including brokerage accounts and the Company &#8220;Account&#8221; referenced in section 1.5 of the Agreement) you maintain outside of Norway. The Company &#8220;Account&#8221; should not be treated as taxable wealth, as long as the right to receive the dividends is conditional, but you must report it.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Poland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold foreign securities (including shares pursuant to the Award) and maintain accounts abroad, you may be required to file certain reports with the National Bank of Poland (&#8220;NBP&#8221;). Specifically, if the value of securities and cash held in such foreign accounts exceeds PLN 7,000,000 (or equivalent thereof in another currency) at the end of the year, you must file reports on the transactions and balances of the accounts on a quarterly basis by the 26th day of the month following the end of each quarter. In case you are being in regime of a joint marital property, the above threshold shall apply to joint property of the spouses. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, if you hold, at the beginning or end of the year, at least 10% of votes in the decision-making body of the entity based abroad (and you are person meeting the prievusly mentioned criteria), an annual notification, on the official form, must be submitted by you to the NBP by May 31 of the following year.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If at the end of the year you did not reach the given threshold but in the next year, at the end of a calendar quarter, you reach the threshold, you are obliged to submit the appropriate form to NBP for this quarter and each of the following quarters of this calendar year (within 26 days from the end of each calendar quarter). Such reports are filed on special forms available on the website of the NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The foregoing duties represents personal responsibilities of each shareholder and cannot be fulfilled by any entity on your behalf.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, if you are a Polish citizen and you transfer funds abroad in excess of the PLN equivalent of &#8364;15,000, the transfer must be made through an authorized bank, a payment institution or an electronic money institution authorized to render payment services. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Furthermore, at the banks&#8217; request, you may be required to inform eligible banks, within the meaning of the Foreign Exchange Act, about all foreign exchange transactions performed through them.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are also required to retain the documents connected with foreign exchange transactions for a period of five years, as measured from the end of the year in which such transaction occurred.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Zgoda na otrzymywanie informacji w j&#281;zyku angielskim.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Akceptuj&#261;c Opcj&#281;, potwierdzasz przeczytanie i zrozumienie Programu i Umowy, kt&#243;re zosta&#322;y dostarczone w j&#281;zyku angielskim. W zwi&#261;zku z tym akceptujesz warunki tych dokument&#243;w.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informacje o kontroli dewizowej. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li jeste&#347; w posiadaniu zagranicznych papier&#243;w warto&#347;ciowych (w tym akcji) i posiadasz rachunki za granic&#261;, mo&#380;esz by&#263; zobowi&#261;zany(-a) do z&#322;o&#380;enia okre&#347;lonych sprawozda&#324; w Narodowym Banku Polskim (&#8222;NBP&#8221;. W szczeg&#243;lno&#347;ci, je&#347;li warto&#347;&#263; papier&#243;w warto&#347;ciowych i &#347;rodk&#243;w pieni&#281;&#380;nych gromadzonych na takich rachunkach zagranicznych przekracza na koniec roku 7 000 000 PLN (lub ekwiwalent tej kwoty w innej walucie), nale&#380;y co kwarta&#322; sk&#322;ada&#263; raporty z transakcji i sald rachunk&#243;w do 26 dnia miesi&#261;ca nast&#281;puj&#261;cego po zako&#324;czeniu ka&#380;dego kwarta&#322;u. W przypadku pozostawania we wsp&#243;lno&#347;ci maj&#261;tkowej z ma&#322;&#380;onkiem, powy&#380;szy pr&#243;g dotyczy maj&#261;tku wsp&#243;lnego ma&#322;&#380;onk&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#380;eli posiadasz na pocz&#261;tek lub koniec roku co najmniej 10% g&#322;os&#243;w w organie stanowi&#261;cym podmiotu z siedzib&#261; za granic&#261; (i jeste&#347; osob&#261; spe&#322;niaj&#261;c&#261; wy&#380;ej wskazane warunki) musisz z&#322;o&#380;y&#263; w NBP do 31 maja nast&#281;pnego roku dodatkowy raport. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li pod koniec roku nie osi&#261;gn&#261;&#322;e&#347;(-a&#347;) okre&#347;lonego progu, ale w nast&#281;pnym roku, pod koniec kwarta&#322;u kalendarzowego, osi&#261;gniesz pr&#243;g, musisz z&#322;o&#380;y&#263; odpowiedni formularz do NBP za ten kwarta&#322; i ka&#380;dy z kolejnych kwarta&#322;&#243;w tego roku kalendarzowego (w ci&#261;gu 26 dni od zako&#324;czenia ka&#380;dego kwarta&#322;u kalendarzowego). Takie raporty s&#261; sk&#322;adane w specjalnych formularzach dost&#281;pnych na stronie internetowej NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#347;li jeste&#347; obywatelem Polski i przekazujesz &#347;rodki za granic&#281; w wysoko&#347;ci przekraczaj&#261;cej r&#243;wnowarto&#347;&#263; 15 000 EUR w PLN, przelewu nale&#380;y dokona&#263; za po&#347;rednictwem upowa&#380;nionego banku, instytucji p&#322;atniczej lub instytucji pieni&#261;dza elektronicznego uprawnionej do &#347;wiadczenia us&#322;ug p&#322;atniczych. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto na &#380;&#261;danie bank&#243;w niezb&#281;dne mo&#380;e by&#263; poinformowanie uprawnionych bank&#243;w, w rozumieniu ustawy Prawo dewizowe (Foreign Exchange Act), o wszystkich transakcjach walutowych przeprowadzanych za ich po&#347;rednictwem.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Jeste&#347; r&#243;wnie&#380; zobowi&#261;zany(-a) do przechowywania dokument&#243;w zwi&#261;zanych z transakcjami wymiany walut przez okres pi&#281;ciu lat, mierzony od ko&#324;ca roku, w kt&#243;rym taka transakcja zosta&#322;a wykonana</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Portugal</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Language Consent.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You hereby expressly declare that you have full knowledge of the English language and have read, understood and fully accepted and agreed with the terms and conditions established in the Plan and Award Agreement.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Conhecimento da Lingua.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> O Contratado, pelo presente instrumento, declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo de Atribui&#231;&#227;o (Award Agreement em ingl&#234;s). </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Romania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Statistical Reporting.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">According to art. 92 of NBR Reg. 4&#47;2021, if you, as a resident of Romania within the meaning of NBR Reg. 4&#47;2021, acquire more than 10% of the share capital in a foreign company, the acquisition must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be reported to the National Bank of Romania (&#8220;NBR&#8221;) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">for statistical purposes within 30 calendar days of acquisiting the ownership right over the shares of the foreign company. You should consult your personal advisor to determine whether you will be required to submit such documentation to the NBR pursuant to your participation in the Plan. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Insider-trading rules prohibit you from carrying out  certain transactions involving shares if you have inside information about the Company (insider dealing). If you are uncertain whether the insider-trading rules apply to you, including with regard to the fact that the Company is listed on the New York Stock Exchange (NYSE), you should consult your personal legal advisor. Depending on the applicable market abuse legislation, you might be subject to certain restrictions on the freedom to trade the shares that are settled through the RSU award, including any applicable prohibition on insider dealing, market manipulation or the unlawful disclosure of inside information.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Serbia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovakia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset Reporting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a foreign asset reporting obligation if you are considered providing independent professional services &#8220;podnikatel&#8221;. You should consult with a personal tax advisor to understand your filing obligations.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovenia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">South Africa</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the PSUs, you agree that, immediately upon vesting of the PSUs, you may need to notify your employer of the amount of any gain realized. If you fail to advise your employer of the gain realized upon vesting, you may be liable for a fine. You will be solely responsible for paying any difference between the actual tax liability and the amount withheld by your employer. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Because no transfer of funds from South Africa is required under the PSUs, no filing or reporting requirements should apply when the award is granted nor when Ordinary Shares are issued upon vesting of the PSUs. However, because the exchange control regulations are subject to change, you should consult your personal advisor prior to vesting and settlement of the award to ensure compliance with current regulations. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Spain</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Entitlement for Claims or Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the award of PSUs, you consent to participation in the Plan, and acknowledge that you have received a copy of the Plan document.  You understand that the Company has unilaterally, gratuitously and in its sole discretion decided to make awards of PSUs under the Plan to individuals who may be employees, consultants and directors throughout the world. The decision is limited and entered into based upon the express assumption and condition that any PSUs will not economically or otherwise bind the Company or any Parent, Subsidiary or Affiliate, including your employer, on an ongoing basis, other than as expressly set forth in the Agreement. Consequently, you understand that the Award is given on the assumption and condition that the PSUs shall not become part of any employment contract (whether with the Company or any Parent, Subsidiary or Affiliate, including your employer) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever. Furthermore, you understand and freely accept that there is no guarantee that any benefit whatsoever shall arise from the award, which is gratuitous and discretionary, since the future value of the PSUs and the underlying shares is unknown and unpredictable. You also understand that this Award would not be made but for the assumptions and conditions set forth hereinabove&#59; thus, you understand, acknowledge and freely accept that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the Award, the PSUs and any right to the underlying shares shall be null and void.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the PSUs, your termination of service for any reason other than death or disability (including for the reasons listed below) will automatically result in the cancellation and loss of any PSUs that may have been granted to you and that were not or did not become vested on the date of termination of service. In particular, you understand and agree that, unless otherwise expressly provided by the Company in this Agreement, the PSUs will be cancelled without entitlement to the Shares or to any amount as indemnification if you terminate service by reason of, but not limited to, the following&#58; resignation&#59; disciplinary dismissal adjudged to be with cause&#59; disciplinary dismissal adjudged or recognized to be without good cause (i.e., subject to a &#34;despido improcedente&#34;)&#59; individual or collective layoff on objective grounds, whether adjudged to be with cause or adjudged or recognized to be without cause&#59; material modification of the terms of employment under Article 41 of the Workers&#8217; Statute&#59; relocation under Article 40 of the Workers&#8217; Statute&#59; Article 50 of the Workers&#8217; Statute&#59; unilateral withdrawal by your employer&#59; and under Article 10.3 of Royal Decree 1382&#47;1985.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You must declare the acquisition, ownership and disposition of stock in a foreign company (including Ordinary Shares acquired under the Plan) to the Spanish Direcci&#243;n General de Comercio e Inversiones (the &#8220;DGCI&#8221;), the Bureau for Commerce and Investments, which is a department of the Ministry of Economy and Competitiveness, for statistical purposes.  Generally, the declaration must be made in January for Ordinary Shares acquired or sold during (or owned as of December 31 of) the prior year&#59; however, this obligation only applies in the cases in which you hold 10% or more of the sares capital of the Company or 10% or more of the voting tights of the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, you may be required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts held abroad), any foreign instruments (e.g., Ordinary Shares) and any transactions with non-Spanish residents (including any payments of cash or shares made to you by the Company) if the balances in such accounts together with the value of such instruments as of December 31, or the volume of transactions with non-Spanish residents during the prior or current year, exceeds &#8364;1,000,000.  Generally, you will only be required to report on an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">annual basis (by January 20 of each year).  Note that if the value is less than &#8364;1,000,000, there is only an obligation to declare this information to the Bank of Spain upon request from the Bank of Spain, in which case the deadline is two months since the request is received.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When receiving foreign currency payments derived from the ownership of Ordinary Shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">., dividends or sale proceeds), you must inform the financial institution receiving the payment of the basis upon which such payment is made. Should amounts exceed &#8364;12,500, you will need to provide the following information to the Spanish Registered Entity&#58; (i) your name, address, and fiscal identification number&#59; (ii) the name and corporate domicile of the Company&#59; (iii) the amount of the payment and the currency used&#59; (iv) the country of origin&#59; (v) the reasons for the payment&#59; and (vi) further information that may be required. Exceptions to this rule are when you move funds through a Spanish resident bank account opened abroad, or when collections and payments are carried out in cash. These exceptions, however, are subject to their own reporting requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold assets or rights outside of Spain (including shares acquired under the Plan), you may have to file an informational tax report, Form 720, with the tax authorities declaring such ownership by March 31st of the following year.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Generally, there is no obligation to file Form 720 if the total value of the following does not exceed Euro 50,000&#58; </font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">the securities, shares, rights and participations held by you, on December 31 or at any time throughout the year, in any kind of entities or in investment funds located outside Spain&#59;</font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">any transfer of own capital to third parties located abroad&#59; and</font></div><div style="margin-bottom:12pt;padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">life and disability insurances in which the individual was policy holder on December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that if an asset is jointly owned, the value is not prorated. Please also note that the application of the rules in respect of valuation of assets and transfers during the year should be carefully analyzed. If the limit of Euro 50,000 euros is exceeded for this described group of assets, all the elements of this group must be reported.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For those taxpayers who have filed Form 720 in previous years, they will only be obliged to file it again&#58;</font></div><div style="padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.7pt">When the aggregated value of the assets included in the mentioned group (shares&#47;insurances) had increased in an amount higher than Euro 20,000 regarding the informative return filed in a previous year.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.02pt">When the individual&#8217;s condition (owner, co-owner, co-titleholder or co-authorized) had changed or was extinguished during the year, before 31st December, with regard to any of the assets.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the thresholds for annual filing requirements may change each year. Therefore, you should consult your personal advisor regarding whether you will be required to file an informational tax report for asset and rights that you hold abroad.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Sweden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The following shall apply in addition to what is set out under section 2.14 of the Award Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Forfeiture of entitlements under the Plan in case of termination shall apply in case of termination of employment regardless of whether such termination of employment may be justified under </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Swedish employment protection legislation, and regardless of whether such termination may be challenged by you, and regardless of whether such termination is invalidated by verdict or a court order.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax withholdings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You authorize the Company and&#47;or the Employing Company to withhold or sell shares otherwise distributable to you upon vesting or settlement to satisfy the Company&#8217;s payroll tax withholding obligations.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Switzerland</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securitities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The PSUs and the issuance of any Ordinary Shares thereunder is not intended to be publicly offered in or from Switzerland.  Neither this Award Agreement nor any other materials relating to the Award (1) constitute a prospectus as such term is understood pursuant to article 652a of the Swiss Code of Obligations, (2) may be publicly distributed nor otherwise made publicly available in Switzerland, or (3) have been or will be filed with, approved or supervised by any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are obliged to submit an ordinary annual tax return in Switzerland, you are required to file a salary certificate with the Swiss tax authorities together with your Swiss tax return. The Company or the Affiliate employing you is obliged to prepare a specific attachment regarding the PSUs to this salary certificate. Before Settlement, for wealth tax purposes, the number of PSUs should be declared with p.m (zero value) in the asset statement of the tax return. After Settlement the total number of Ordinary Shares received are subject to wealth tax at the end of the calendar year and must be declared in your Swiss tax return.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Turkey</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Under Turkish law, you are not permitted to sell Ordinary Shares acquired under the Plan in Turkey.  The Ordinary Shares are currently traded on the Nasdaq Global Select Market, which is located outside of Turkey, under the ticker symbol &#8220;PRGO&#8221; and the Ordinary Shares may be sold through this exchange.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ukraine </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to obtain a license for obtaining shares of a foreign company from the National Bank of Ukraine (NBU). </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award will be outside the scope of your employment or service contract (if any) and as such will not constitute a part of your compensation package under the respective employment or service contract.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">United Kingdom</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Income Tax and National Insurance Contribution Withholding.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The following provision supplements the terms in the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If payment or withholding of the income tax due in connection with the PSUs is not made within ninety (90) days of the end of the U.K. tax year in which the event giving rise to the income tax liability or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003 occurred (the &#8220;Due Date&#8221;), the amount of any uncollected income tax shall constitute a loan owed by you to your employer, effective as of the Due Date.  You agree that the loan will bear interest at the then-current official rate of His Majesty&#8217;s Revenue &#38; Customs (&#8220;HMRC&#8221;), it shall be immediately due and repayable, and the Company or your employer may recover it at any time thereafter by any of the means referred to in Section 2.7 of the Agreement.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if you are a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), you will not be eligible for a loan from the Company or your employer to cover the income tax liability.  In the event that you are a director or executive officer and the income tax is not collected from or paid by the Due Date, the amount of any uncollected income tax will constitute a benefit to you on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) will be payable.  You will be responsible for reporting any income tax for reimbursing the Company or your employer the value of any employee NICs due on this additional benefit. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*   *   *   *   *</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32</font></div><div><font><br></font></div></div></div><div id="i2f77d291d4554bfca08735971a0d9db5_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERRIGO COMPANY PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(PERFORMANCE-BASED)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Under the Perrigo Company plc 2019 Long-Term Incentive Plan)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant Name</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RE&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Restricted Stock Unit Award (Performance-Based)</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This is to notify you that Perrigo Company plc (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), effective as of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grant Date </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  This Award consists of performance-based restricted stock units.  The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Units &#8211; Performance-Based Vesting</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As of the Grant Date, the Company grants to you </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Number of Awards Granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> performance-based restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), subject to the terms and conditions set forth in this Agreement.  The number of PSUs awarded in this Section 1.1 is referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Target Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;  The Target Award may be increased or decreased depending on the level of attainment of the Performance Goals described in Section 1.2.  Each PSU entitles you to one ordinary share of the Company, nominal value &#8364;0.001 per share (&#8220;Ordinary Share&#8221;) on the PSU Vesting Date set forth in Section 1.2, provided the applicable Performance Goals for the Performance Measure are satisfied.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The number of PSUs awarded in Section 1.1 vesting, if any, shall be determined as of the PSU Vesting Date.  That number will be determined based on the level of attainment of the Performance Goals for the Performance Period, in accordance with the schedule determined by the Committee at the time the Performance Goals for the Performance Measure are established by the Committee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At the beginning of a Performance Period, the Committee shall establish one or more Performance Goals for the Performance Measure that must be attained for Threshold, Target and Maximum performance for that Performance Period.  The Performance Goal(s) will be provided to you.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Following the end of the Performance Period, the Committee will determine the percentage of Target Award PSUs that would be payable for the Performance Period based on the attainment of the Performance Goals established for that Performance Period.  The percentage of the Target Award that would be payable under the schedule shall be adjusted, pro rata, to reflect the attained performance between Threshold and Target, and Target and Maximum.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as provided in Section 1.4, the PSUs will be permanently forfeited if your Termination Date occurs prior to the PSU Vesting Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following terms shall have the following meanings under this Section 1.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Index</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; for the Performance Period means the applicable index or the comparison group of peer companies selected by the Committee.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Goal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the level of performance that must be attained with respect to the Performance Measure for the Performance Period for Minimum, Target and Maximum payout.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Measure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means relative total shareholder return (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">rTSR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) which shall be based on (i) the 20-day trading price average of Ordinary Shares (as adjusted for dividends) at the end of the Performance Period (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Ending Average</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) over the 20-day trading price average of Ordinary Shares (as adjusted for dividends) at the beginning of the Performance Period (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beginning Average</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and (ii) the extent to which the Ending Average of the Applicable Index exceeds the Beginning Average of the Applicable Index.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Committee shall provide how the Performance Measure will be adjusted, if at all, as a result of extraordinary events or circumstances, as determined by the Committee, or to exclude the effects of extraordinary, unusual, or non-recurring items&#59; changes in applicable laws, regulations, or accounting principles&#59; currency fluctuations&#59; discontinued operations&#59; non-cash items, such as amortization, depreciation, or reserves&#59; asset impairment&#59; or any recapitalization, restructuring, reorganization, merger, acquisition, divestiture, consolidation, spin-off, split-up, combination, liquidation, dissolution, sale of assets, or other similar corporation transaction.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the three-consecutive fiscal year period of the Company beginning on January 1 of the year in which the Grant Date occurs and ending on December 31 of the third year in the three-year period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PSU Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the last day of the Performance Period.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Separation for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means your voluntary resignation from the Company and the existence of one or more of the following conditions that arose without your consent&#58; (i) a material change in the geographic location at which you are required to perform services, such that your commute between home and your primary job site increases by more than 30 miles,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or (ii) a material diminution in your authority, duties or responsibilities or a material diminution in your base compensation or incentive compensation opportunities&#59; provided, however, that a voluntary resignation from the Company shall not be considered a Separation for Good Reason unless you provide the Company with notice, in writing, of your voluntary resignation and the existence of the condition(s) giving rise to the separation within 90 days of its initial existence.  The Company will then have 30 days to remedy the condition, in which case you will not be deemed to have incurred a Separation for Good Reason.  In the event the Company fails to cure the condition within the 30 day period, your Termination Date shall occur on the 31st day following the Company&#8217;s receipt of such written notice.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination without Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the involuntary termination of your employment or contractual relationship by the Company without Cause, including, but not limited to, (i) a termination effective when you exhaust a leave of absence during, or at the end of, a notice period under the Worker Adjustment and Retraining Notification Act (&#8220;WARN&#8221;), and (ii) a situation where you are on an approved leave of absence during which your position is protected under applicable law (e.g., a leave under the Family Medical Leave Act), you return from such leave, and you cannot be placed in employment or other form of contractual relationship with the Company.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Vesting Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding Section 1.2 above, if your Termination Date occurs by reason of a Termination without Cause or a Separation for Good Reason on or after a Change in Control (as defined in the Plan and as such definition may be amended </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">hereafter) and prior to the two (2) year anniversary of the Change in Control, all of the PSUs awarded under Section 1.1 that have not previously been forfeited shall become fully vested as if Target performance had been obtained for the Performance Period effective as of your Termination Date. If your Termination Date occurs because of death, Disability, or Retirement, the PSUs shall vest or be forfeited as of the PSU Vesting Date set forth in Section 1.2, based on the attainment of the performance goals.  Notwithstanding the definition of &#8220;Retirement&#8221; in Section 2 of the Plan, &#8220;Retirement&#8221; means your Termination Date which occurs after attaining age 62.  If your Termination Date occurs in the 24-month period preceding the PSU Vesting Date because of an Involuntary Termination for Economic Reasons, all of the PSUs awarded hereunder shall vest or be forfeited as of the date set forth in Section 1.2, depending on the attainment of Performance Goals&#59; provided, however, that if your Termination Date occurs for a reason that is both described in this sentence and in the first sentence of this Section 1.4, the special vesting rules described in the first sentence of this Section 1.4 shall apply in lieu of the vesting rules described in this sentence.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as practicable following the date of the Committee&#8217;s first regularly scheduled meeting following the last day of the Performance Period at which the Committee certifies the attainment of the Performance Goals for the Performance Period (or, if earlier, the date on which the PSUs become vested pursuant to the special vesting rules described in Section 1.4), the Company shall transfer to you one Ordinary Share for each PSU, if any, that becomes vested pursuant to Section 1.2 or 1.4 of this Agreement (the date of any such transfer shall be the &#8220;settlement date&#8221; for purposes of this Agreement)&#59; provided, however, the Company in its discretion may settle PSUs in cash, based on the fair market value of the shares on the vesting date.  No fractional shares shall be transferred.  Any fractional share shall be rounded to the nearest whole share.  The income attributable to the vesting of PSUs and the amount of any required tax withholding will be determined based on the value of the shares on the settlement date.  PSUs are not eligible for dividend equivalents. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">General Terms and Conditions</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nontransferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award under this Agreement shall not be transferable other than by will or by the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You shall not have any rights as a stockholder with respect to any Ordinary Shares subject to the PSU awarded under this Agreement prior to the date of issuance to you of a certificate or certificates for such shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If your Termination Date occurs for reasons of Cause, all of your rights under this Agreement, whether or not vested, shall terminate immediately.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The granting of the Award under this Agreement is being made pursuant to the Plan and the Award shall be payable only in accordance with the applicable terms of the Plan.  The Plan contains certain definitions, restrictions, limitations and other terms and conditions all of which shall be applicable to this Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ALL THE PROVISIONS OF THE PLAN ARE INCORPORATED HEREIN BY REFERENCE AND ARE MADE A PART OF THIS AGREEMENT IN THE SAME MANNER AS IF EACH AND EVERY SUCH PROVISION WERE FULLY WRITTEN INTO THIS AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Should the Plan become void or unenforceable by operation of law or judicial decision, this Agreement shall have no force or effect.  Nothing set forth in this Agreement is intended, nor shall any of its provisions be construed, to limit or exclude any definition, restriction, limitation or other term or condition of the Plan as is relevant to this Agreement and as may be specifically applied to it by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Committee.  In the event of a conflict in the provisions of this Agreement and the Plan, as a rule of construction the terms of the Plan shall be deemed superior and apply.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments in Event of Change in Ordinary Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of a stock split, stock dividend, recapitalization, reclassification or combination of shares, merger, sale of assets or similar event, the number and kind of shares subject to Award under this Agreement will be appropriately adjusted in an equitable manner to prevent dilution or enlargement of the rights granted to or available for you.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and you agree that the PSUs are granted under and governed by the Notice of Grant, this Agreement (including the Appendix, if applicable) and by the provisions of the Plan (incorporated herein by reference).  You&#58; (i) acknowledge receipt of a copy of each of the foregoing documents, (ii) represent that you have carefully read and are familiar with their provisions, and (iii) hereby accept the PSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes and Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding (Only Applicable to Individuals Subject to U.S. Tax Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Award is subject to the withholding of all applicable taxes.  The Company may withhold, or permit you to remit to the Company, any Federal, state or local taxes applicable to the grant, vesting or other event giving rise to tax liability with respect to this Award.  If you have not remitted the full amount of applicable withholding taxes to the Company by the date the Company is required to pay such withholding to the appropriate taxing authority (or such earlier date that the Company may specify to assist it in timely meeting its withholding obligations), the Company shall have the unilateral right to withhold Ordinary Shares relating to this Award in the amount it determines is sufficient to satisfy the tax withholding required by law.  State taxes will be withheld at the appropriate rate set by the state in which you are employed or were last employed by the Company.  In no event may the number of shares withheld exceed the number necessary to satisfy the maximum Federal, state and local income and employment tax withholding requirements.  You may elect to surrender previously acquired Ordinary Shares or to have the Company withhold Ordinary Shares relating to this Award in an amount sufficient to satisfy all or a portion of the tax withholding required by law.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Responsibility for Taxes (Only Applicable to Individuals Subject to Tax Laws Outside the U.S.)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Regardless of any action the Company or, if different, the Affiliate employing or retaining you takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (&#8220;Tax-Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items is and remains your responsibility and may exceed the amount actually withheld by the Company or the Affiliate employing or retaining you.  You further acknowledge that the Company and&#47;or the Affiliate employing or retaining you (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PSUs, including, but not limited to, the grant, vesting or settlement of the PSUs, the subsequent sale of Ordinary Shares acquired pursuant to such settlement and the receipt of any dividends&#59; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the PSUs to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result.  Further, if you have become subject to tax in more than one jurisdiction between the PSU Grant Date and the date of any relevant taxable event, as applicable, you acknowledge that the Company and&#47;or the Affiliate employing or retaining you (or formerly employing or retaining you, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Prior to any relevant taxable or tax withholding event, as applicable, you will pay or make adequate arrangements satisfactory to the Company and&#47;or the Affiliate employing or retaining you to satisfy all Tax-Related Items.  In this regard, you authorize the Company and&#47;or the Affiliate employing or retaining you, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58;  </font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;withholding from your wages or other cash compensation paid to you by the Company and&#47;or the Affiliate employing or retaining you&#59; or</font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;withholding from proceeds of the sale of Ordinary Shares acquired upon settlement of the PSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization)&#59; or </font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)&#160;&#160;&#160;&#160;withholding in Ordinary Shares to be issued upon settlement of the PSUs.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;To avoid negative accounting treatment, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates.  If the obligation for Tax-Related Items is satisfied by withholding in Ordinary Shares, for tax purposes, you are deemed to have been issued the full number of Ordinary Shares subject to the vested PSUs, notwithstanding that a number of the Ordinary Shares are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Finally, you shall pay to the Company or the Affiliate employing or retaining you any amount of Tax-Related Items that the Company or the Affiliate employing or retaining you may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to issue or deliver the Ordinary Shares or the proceeds of the sale of Ordinary Shares, if you fail to comply with your obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The issuance of Ordinary Shares will be subject to and conditioned upon compliance by the Company and you, including any written representations, warranties and agreements as the Administrator may request of you for compliance with all (i) applicable U.S. state and federal laws and regulations, (ii) applicable laws of the country where you reside pertaining to the issuance or sale of Ordinary Shares, and (iii)&#160;applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Ordinary Shares may be listed or quoted at the time of such issuance or transfer.  Notwithstanding any other provision of this Agreement, the Company shall have no obligation to issue any Ordinary Shares under this Agreement if such issuance would violate any applicable law or any applicable regulation or requirement of any securities exchange or similar entity.</font></div><div style="margin-bottom:12pt;text-indent:31.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Short Term Deferral (Only Applicable to Individuals Subject to U.S. Federal Tax Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  PSUs payable under this Agreement are intended to be exempt from Code Section 409A under the exemption for short-term deferrals.  Accordingly, PSUs will be settled no later than the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of the third month following the later of (i) the end of the Employee&#8217;s taxable year in which the vesting date occurs, or (ii) the end of the fiscal year of the Company in which the vesting date occurs.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Data Privacy Rules (Only Applicable if this Award is Subject to U.S. Data Privacy Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By entering into this Agreement and accepting this Award, you </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of any of your personal data that is necessary to facilitate the implementation, administration and management of the Award and the Plan, (b) understand that the Company may, for the purpose of implementing, administering and managing the Plan, hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, and details of all awards or entitlements to Shares granted to you under the Plan or otherwise (&#8220;Personal Data&#8221;), (c) understand that Personal Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including any broker with whom the Shares issued upon vesting of the Award may be deposited, and that these recipients may be located in your country or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than your country, (d) waive any data privacy rights you may have with respect to the data, and (e) authorize the Company, its Affiliates and its agents, to store and transmit such information in electronic form.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Data Privacy Rules (Only Applicable if this Award is Subject to Data Privacy Laws Outside of the U.S.)</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;By entering into this Agreement and accepting this Award, you hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other PSU grant materials by and among, as applicable, the Affiliate employing or retaining you, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;You understand that the Company and the Affiliate employing or retaining you may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Ordinary Shares or directorships held in the Company, details of all PSUs or any other entitlement to Ordinary Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (&#8220;Data&#8221;).  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;You understand that Data will be transferred to legal counsel or a broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients&#8217; country (e.g., the United States) may have different data privacy laws and protections than your country of residence.  You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local or Company human resources representative.  You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan.  You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local or Company human resources representative.  You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local or Company human resources representative.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be binding upon any or all successors and assigns of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed and enforced in accordance with the applicable Code provisions to the maximum extent possible and otherwise by the laws of the State of Michigan without regard to principals of conflict of laws, provided that if you are a foreign national or employed outside the United States, this Agreement shall be governed by and construed and enforced in accordance with applicable foreign law to the extent that such law differs from the Code and Michigan law.  Any proceeding related to or arising out of this Agreement shall be commenced, prosecuted or continued in the Circuit Court in Kent County, Michigan located in Grand Rapids, Michigan or in the United Stated District Court for the Western District of Michigan, and in any appellate court thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Forfeiture of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company, as a result of misconduct, is required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, then (a) if your incentive or equity-based compensation is subject to automatic forfeiture due to such misconduct and restatement under Section 304 of the Sarbanes-Oxley Act of 2002, or (b) the Committee determines you either knowingly engaged in or failed to prevent the misconduct, or your actions or inactions with respect to the misconduct and restatement constituted gross negligence, you shall (i) be required to reimburse the Company the amount of any payment relating to any PSUs earned or accrued during the twelve month period following the first public issuance or filing with the SEC (whichever first occurred) of the financial document embodying such financial reporting requirement, and (ii) all outstanding PSUs that have not yet been settled shall be immediately forfeited.  In addition, Ordinary Shares acquired under this Agreement, and any gains or profits on the sale of such Ordinary Shares, shall be subject to any &#8220;clawback&#8221; or recoupment policy later adopted by the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Rules for Non-U.S. Grantees (Only Applicable if You Reside Outside of the U.S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In accepting the grant, you acknowledge, understand and agree that&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, except as otherwise provided in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;the grant of the PSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of PSUs, or benefits in lieu of PSUs, even if PSUs have been granted repeatedly in the past&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;all decisions with respect to future PSUs grants, if any, will be at the sole discretion of the Company&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;you are voluntarily participating in the Plan&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are an extraordinary item and which is outside the scope of your employment or service contract, if any&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(6)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are not intended to replace any pension rights or compensation&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7)&#160;&#160;&#160;&#160;the PSUs and the Ordinary Shares subject to the PSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Affiliate employing or retaining you or any other Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(8)&#160;&#160;&#160;&#160;the grant and your participation in the Plan will not be interpreted to form an employment or service contract with the Company or any Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(9)&#160;&#160;&#160;&#160;the future value of the underlying Ordinary Shares is unknown, indeterminable and cannot be predicted with certainty&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(10)&#160;&#160;&#160;&#160;no claim or entitlement to compensation or damages shall arise from forfeiture of the PSUs resulting from your Termination Date (for any reason whatsoever, whether or not later found to be invalid and whether or not in breach of employment laws in the jurisdiction where you are employed or rendering services, or the terms of your employment agreement, if any), and in consideration of the grant of the PSUs to which you are otherwise not entitled, you irrevocably agree never to institute any claim against the Company or the Affiliate employing or retaining you, waive your ability, if any, to bring any such claim, and release the Company and the Affiliate employing or retaining you from any such claim&#59; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, you shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim&#59; and</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(11)&#160;&#160;&#160;&#160;you acknowledge and agree that neither the Company, the Affiliate employing or retaining you nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the currency of the country in which you reside and the United States Dollar that may affect the value of the PSUs or of any amounts due to you pursuant to the settlement of the PSUs or the subsequent sale of any Ordinary Shares acquired upon settlement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Notwithstanding any provisions in this Agreement, the PSUs grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement.  Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to you, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan.  If you relocate to the United States, the special terms and conditions in the Appendix will apply, or cease to apply, to you, to the extent the Company determines that the application or otherwise of such provisions is necessary or advisable in order to facilitate the administration of the Plan.  The Appendix constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company reserves the right to impose other requirements on your participation in the Plan, on the PSUs and on any Ordinary Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">****</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">We look forward to your continuing contribution to the growth of the Company.  Please acknowledge your receipt of the Plan and this Award.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Orlando Ashford</font></div><div style="text-align:justify;text-indent:198pt"><font><br></font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Orlando Ashford</font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chairman of the Board</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">APPENDIX</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PERRIGO COMPANY PLC</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Additional Terms and Provisions to</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Restricted Stock Unit Award Agreement (Performance-Based)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix (the &#8220;Appendix&#8221;) includes additional terms and conditions that govern the restricted stock units (Performance-Based) (&#8220;PSUs&#8221; or &#8220;Award&#8221;) granted to you under the Plan if you reside in one of the countries listed below. Certain capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan and&#47;or the Agreement.  The Award will not create any entitlement to receive any similar benefit in the future. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix also includes country-specific information of which you should be aware with respect to your participation in the Plan.  The information is based on the securities, exchange control and other laws in effect in the respective countries as of January 2023.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that you do not rely on the information noted herein as the only source of information relating to the consequences of your participation in the Plan because the information may be out of date at the time that you vest in the PSUs and Ordinary Shares are issued to you or the shares issued upon vesting of the PSUs are sold.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, the information is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of any particular result.  Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your particular situation.  Finally, please note that if you are a citizen or resident of a country other than the country in which you are currently working, or transfers employment after grant, the information contained in the Appendix may not be applicable.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Conditions et dispositions suppl&#233;mentaires &#224; l&#8217;</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Accord relatif &#224; l&#8217;attribution d&#8217;unit&#233;s d&#8217;action avec restrictions (r&#233;mun&#233;ration fond&#233;e sur les performances)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice (l&#8217;&#171;&#160;Appendice&#160;&#187;) comprend des conditions compl&#233;mentaires r&#233;gissant les Unit&#233;s d&#8217;action avec restrictions (r&#233;mun&#233;ration fond&#233;e sur les performances) (&#171;&#160;UARP&#160;&#187; ou &#171;&#160;Prime&#160;&#187;) qui vous sont attribu&#233;es en vertu du Plan si vous r&#233;sidez dans l&#8217;un des pays repris ci-dessous. Certains termes commen&#231;ant par une lettre majuscule utilis&#233;s dans le pr&#233;sent Accord mais qui n&#8217;y sont pas d&#233;finis ont le sens qui leur est attribu&#233; dans le Plan ou l&#8217;Accord. La Prime n&#8217;instaure aucun droit &#224; recevoir des avantages similaires &#224; l&#8217;avenir. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice comprend &#233;galement des informations sp&#233;cifiques aux pays dont vous devez avoir connaissance eu &#233;gard &#224; votre participation au Plan. Les informations se fondent sur les lois relatives aux valeurs mobili&#232;res, au contr&#244;le des &#233;changes et autres en vigueur dans les pays respectifs en janvier 2023. Souvent complexes, ces lois font l&#8217;objet de modifications fr&#233;quentes. Par cons&#233;quent, la Soci&#233;t&#233; vous recommande vivement de ne pas consid&#233;rer les renseignements repris aux pr&#233;sentes comme l&#8217;unique source d&#8217;information relative aux cons&#233;quences de votre participation au Plan, car ces renseignements peuvent &#234;tre obsol&#232;tes au moment de la d&#233;volution des UARP ou de l&#8217;&#233;mission des Actions ordinaires pour votre compte, ou de la vente des actions &#233;mises lors de la d&#233;volution des UARP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Par ailleurs, ces informations sont d&#8217;ordre g&#233;n&#233;ral et peuvent ne pas s&#8217;appliquer &#224; votre situation particuli&#232;re. De plus, la Soci&#233;t&#233; n&#8217;est pas en mesure de vous garantir un quelconque r&#233;sultat particulier. Par cons&#233;quent, il vous est conseill&#233; de demander des conseils professionnels appropri&#233;s quant &#224; la mani&#232;re dont les lois de votre pays en la mati&#232;re peuvent s&#8217;appliquer &#224; votre situation particuli&#232;re. Enfin, veuillez noter que si vous &#234;tes citoyen ou r&#233;sident d&#8217;un pays autre que celui dans lequel vous travaillez actuellement ou si votre emploi est transf&#233;r&#233; apr&#232;s l&#8217;octroi, les informations figurant dans l&#8217;Appendice peuvent ne pas appliquer.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Extra voorwaarden en voorzieningen bij</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">de Overeenkomst over voorwaardelijk toegekende aandelen (op basis van prestaties)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Algemene voorwaarden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage (de 'Bijlage') omvat extra algemene voorwaarden voor de voorwaardelijk toegekende aandelen (op basis van prestaties) ('PSU's' of 'Award') die u volgens het Plan zijn toegekend als u in een van onderstaande landen woont. Bepaalde termen in hoofdletters die in deze Bijlage werden gebruikt maar niet gedefinieerd, hebben de betekenis die in het Plan en&#47;of de Overeenkomst is vermeld. De Award cre&#235;ert geen recht om een soortgelijk voordeel in de toekomst te krijgen. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage bevat ook landenspecifieke informatie waarvan u op de hoogte moet zijn met betrekking tot uw deelname aan het Plan. De informatie is gebaseerd op de effecten-, wisselcontrole- en andere wetten die in de respectieve landen sinds januari 2023 van kracht zijn.  Zulke wetten zijn vaak complex en worden regelmatig aangepast. Daarom raadt het Bedrijf u ten sterkste aan de informatie hierin niet te gebruiken als enige bron van informatie over de gevolgen van uw deelname aan het Plan, omdat de informatie verouderd kan zijn op het ogenblik dat uw toezegging in de PSU's en de Gewone aandelen u worden uitgekeerd of wanneer de bij de toezegging van de PSU's uitgegeven aandelen worden verkocht.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ook is de informatie algemeen van aard en mag u ze niet toepassen op uw specifieke situatie. Het Bedrijf bevindt zich evenmin in een positie om u een specifiek resultaat te verzekeren. We raden u dan ook aan om professioneel advies te vragen over hoe de relevante wetten in uw land van toepassing kunnen zijn op uw specifieke situatie. Ten slotte, merk op dat als u een burger of inwoner bent van een ander land dan het land waarin u op dit moment werkt, of uw tewerkstelling na de toekenning verhuist, de informatie in de Bijlage mogelijk niet van toepassing is.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Dodatkowe warunki i postanowienia</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Umowy przyznania jednostek akcyjnych o ograniczonych prawach (w oparciu o wyniki)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik (&#8222;Za&#322;&#261;cznik&#8221;) zawiera dodatkowe warunki, kt&#243;re reguluj&#261; jednostki akcyjne o ograniczonych prawach (&#8222;PSU&#8221; lub &#8222;Prawo&#8221;) przyznan&#261; w ramach Programu, je&#347;li mieszkasz w jednym z wymienionych poni&#380;ej kraj&#243;w. Okre&#347;lone terminy pisane wielk&#261; liter&#261;, kt&#243;re nie zosta&#322;y zdefiniowane w niniejszym Za&#322;&#261;czniku, maj&#261; znaczenie okre&#347;lone w Programie i&#47;lub Umowie. Prawo nie uprawnia do uzyskiwania podobnych korzy&#347;ci w przysz&#322;o&#347;ci. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik zawiera r&#243;wnie&#380; informacje dotycz&#261;ce poszczeg&#243;lnych kraj&#243;w, o kt&#243;rych powiniene&#347;(-as) wiedzie&#263; w zwi&#261;zku z uczestnictwem w Programie. Informacje oparte s&#261; na papierach warto&#347;ciowych, kontroli dewizowej i innych przepisach obowi&#261;zuj&#261;cych w odpowiednich krajach od stycznia 2023 r. Takie przepisy prawa s&#261; cz&#281;sto skomplikowane i cz&#281;sto si&#281; zmieniaj&#261;. W zwi&#261;zku z tym Sp&#243;&#322;ka zdecydowanie zaleca, aby nie polega&#263; na informacjach wymienionych w niniejszym dokumencie jako jedynym &#378;r&#243;dle informacji zwi&#261;zanych z konsekwencjami uczestnictwa w Programie, gdy&#380; informacje te mog&#261; by&#263; nieaktualne w momencie nabycia lub wykonywania PSU, a Akcje Zwyk&#322;e s&#261; Ci wydawane lub w przypadku sprzeda&#380;y PSU nabytych w ramach Programu.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto informacje maj&#261; charakter og&#243;lny i mog&#261; nie mie&#263; zastosowania do konkretnej sytuacji, a Sp&#243;&#322;ka nie jest w stanie zapewni&#263; Ci &#380;adnego konkretnego rezultatu. W zwi&#261;zku z tym zaleca si&#281; zasi&#281;gni&#281;cie odpowiedniej profesjonalnej porady dotycz&#261;cej tego, w jaki spos&#243;b odpowiednie przepisy w Twoim kraju mog&#261; mie&#263; zastosowanie do konkretnej sytuacji. Wreszcie nale&#380;y pami&#281;ta&#263;, &#380;e je&#347;li jeste&#347; obywatelem&#47;obywatelk&#261; lub rezydentem&#47;rezydentk&#261; kraju innego ni&#380; kraj, w kt&#243;rym obecnie pracujesz lub przenosisz si&#281; do nowego miejsca po przyznaniu, informacje zawarte w Za&#322;&#261;czniku mog&#261; nie mie&#263; zastosowania.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Australia</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Important Notice</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Important Notice </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">No financial product advice is provided in this Appendix, this Agreement or the Plan (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Plan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">) and nothing should be taken to constitute a recommendation or statement of opinion that is intended to influence a person or persons in making a decision to participate in the Plan. The Plan documents do not take into account your objectives, financial situation and needs. You should consider obtaining your own financial product advice from a person who is licensed by the Australian Securities and Investments Commission to give such advice. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">If you intend to apply to participate in the Plan, you must make your own independent assessment and investigation in relation to your legal and taxation position including seeking professional advice. You must base any decision you may make on such independent assessment, investigation or advice.</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Offer made without disclosure </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A copy of the terms of the Plan will be provided to you with this Agreement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of the Plan, an offer to receive PSUs and participate in the Plan, if received in Australia, is made without disclosure to investors in reliance on the regulatory relief set out in Division 1A of Part 7.12, and for the purposes of section 1100N(b), of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Corporations Act 2001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Cth). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As set out in this Agreement, each PSU represents the right to receive one Ordinary Share subject to the relevant performance goals and performance measures being met, or otherwise waived, in accordance with the Plan and this Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The PSUs will be issued for nil consideration. You are not required to pay for a PSU or for the subsequent transfer of an Ordinary Share on vesting of that PSU, however your responsibility for any taxes is as set out in the terms of the Plan and this Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any discretion contained in the Plan, or any provision in this Agreement to the contrary, the number of PSUs granted to you will only be decreased depending on your level of attainment of performance goals against your designated performance measures. If you fully meet your performance goals against the designated performance measures, all of your PSUs will vest. However, if you only partially meet your performance goals against the designated performance measures, only a partial number of your PSUs will vest. You will be entitled to one Share for each vested PSU. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the avoidance of doubt, there will be no increase to the number of PSUs granted to you on the Grant Date. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company will not provide you with any loans or financial assistance under the Plan in connection with the offer of the PSUs. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No PSUs or Ordinary Shares transferred to you under the Plan will be held on your behalf, by a trustee&#47;nominee. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The indicative daily price of the Ordinary Shares on the New York Stock Exchange (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), quoted in US dollars, is available on the Company&#8217;s website at http&#58;&#47;&#47;perrigo.investorroom.com&#47;stock-information. The Ordinary Shares are also quoted on the NASDAQ Stock Market (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NASDAQ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) (refer to NASDAQ&#8217;s website at </font><font style="color:#0562c1;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">http&#58;&#47;&#47;www.nasdaq.com&#47;symbol&#47;prgo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Australian dollar equivalent of the Ordinary Shares can be determined using prevailing exchange rate published by Thomson Reuters (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Prevailing Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). Alternatively, the Company will advise you of the price of its Ordinary shares (in equivalent Australian dollars) as soon as possible following receipt of any request for such information. This information may be obtained by you contacting your local Human Resources representative. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Before accepting an offer to be granted PSUs, you should satisfy yourself that you have a sufficient understanding of the risks set out below and should consider if the PSUs are a suitable investment for you, having regard to your own investment objectives, financial circumstances and taxation position&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) the vesting conditions for your PSUs may not be satisfied for reasons beyond the Company&#8217;s or your control&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) you are not permitted to transfer your PSUs unless permitted under this Agreement or the Plan&#59; </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) you will have no voting, dividend, or other stockholder rights in any Shares until you become the registered holder of those Shares. Until you become the registered holder of Shares, you will have only the rights of an unsecured creditor with respect to those Shares </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) if your PSUs vest and you subsequently receive Ordinary Shares&#58; </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) the value of those shares may rise and fall according to investor sentiment, general economic conditions and outlook, international and local stock markets, employment, inflation, interest rates, government policy, taxation and regulation&#59; and </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) there is no guarantee that an active trading market for the shares will exist or that the price of the shares will increase. There may be relatively few potential buyers or sellers of the shares on the NYSE, NASDAQ, TASE or any other applicable market at any time and this may increase the volatility of the market price of the shares. It may also affect the prevailing market price at which you may be able to sell your shares&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) there may be taxation implications arising for you in participating under this Agreement and in the Plan. The tax consequences of participating in the Plan are based on complex tax laws, which may be subject to varying interpretations, and the application of such laws may depend, in large part, on the surrounding facts and circumstances. The tax regime applying to you may change. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the above risks are only general risks of acquiring and holding PSUs under the Plan. It does not purport to list every risk that may be associated with the Plan now or in the future. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, if at the time of vesting, the Company determines that it is not legal under Australian securities laws to issue shares, the outstanding PSUs will be cancelled, and no shares will be issued to you nor will any benefits in lieu of shares be paid to you. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Exchange Control Information </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control reporting mandates disclosure of payments equal to or exceeding AUD10,000 made to a foreign individual or entity. This reporting is generally done automatically by the financial institution making the transfer. </font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Austria</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of Austria, you must submit a report to the Austrian National Bank. An exemption applies if the value of the shares as of any given quarter is less than &#8364;5,000,000 (when converted to Euros if applicable). If the threshold is met or exceeded, quarterly reporting obligations exist If quarterly obligations apply, the reporting date is the end of each quarter and the deadline for filing the report is the 15th of the month following the end of the quarter.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When shares are sold, there may be exchange control obligations if the cash received is held in a bank account outside Austria.  If the volume of all your accounts abroad exceeds &#8364;10,000,000 (when converted to Euros if applicable), the balances of all accounts must be reported monthly, as of the last day of the month, on or before the fifteenth day of the following month.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Belgium </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to report any security or bank accounts (including brokerage accounts) you maintain outside of Belgium on your annual tax return.  In a separate report, you are required to provide the National Bank of Belgium with certain details regarding such foreign accounts (including the account number, bank name and country in which any such account was opened).  This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under Kredietcentrales &#47; Centrales des cr&#233;dits caption.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Stock Exchange Tax.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A stock exchange tax could apply for Belgian tax residents transacting through a non-Belgium broker once the shares are sold. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Communication d&#8217;informations relatives aux actifs ou comptes &#233;trangers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Vous &#234;tes tenu de d&#233;clarer, dans votre d&#233;claration fiscale annuelle, tout compte-titres ou compte en banque (y compris les comptes de courtage) que vous d&#233;tenez en dehors de la Belgique. Dans une d&#233;claration distincte, vous &#234;tes tenu de communiquer &#224; la Banque Nationale de Belgique certains d&#233;tails concernant les comptes &#233;trangers (notamment le num&#233;ro de compte, le nom de la banque et le pays o&#249; le compte a &#233;t&#233; ouvert). Cette d&#233;claration ainsi que toutes les informations indiquant comment la remplir sont disponibles sur le site web de la Banque Nationale de Belgique (www.nbb.be) &#224; la section &#171;&#160;Centrales des cr&#233;dits&#47;Kredietcentrales&#160;&#187;. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informatie over buitenlands vermogen&#47;rekeningrapportering.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> U moet alle garantie- of bankrekeningen (inclusief beleggingsrekeningen) die u buiten Belgi&#235; bezit, vermelden op uw jaarlijkse belastingsbrief. In een afzonderlijk overzicht moet u de Nationale Bank van Belgi&#235; informatie geven over zulke buitenlandse rekeningen (inclusief het rekeningnummer, de naam van de bank en het land waarin zulke rekening is geopend). Dit overzicht, evenals extra informatie over hoe u het moet opstellen, vindt u op de website van de Nationale Bank van Belgi&#235;, www.nbb.be, onder de titel Kredietcentrales.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Bermuda</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is not subject to and has not received approval from the Bermuda Monetary Authority and the Registrar of Companies in Bermuda, and no statement to the contrary, explicit or implicit, is authorized to be made in this regard.  The securities may be offered or sold in Bermuda only in compliance with the provisions of the Investment Business Act 2003 of Bermuda.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Brazil</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You agree that, for all legal purposes, (i) the benefits provided under the Plan are the result of commercial transactions unrelated to your employment&#59; (ii) the Plan is not a part of the terms and conditions of your employment&#59; and (iii) the income from the PSUs, if any, is not part of your remuneration from employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you agree to comply with Brazilian law when the PSUs vest and the shares are sold. You also agree to report and pay any and all taxes associated with the vesting of the PSUs, the sale of the PSUs acquired pursuant to the Plan, and the receipt of any dividends.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> If you are a resident or domiciled in Brazil and hold assets and rights outside Brazil with an aggregate value exceeding US$100,000, you will be required to prepare and submit to the Central Bank of Brazil an annual declaration of such assets and rights. Assets and rights that must be reported include PSUs.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Canada</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Payout of PSUs in Shares Only</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to all Employees residing in Canada, the Company will convert all vested PSUs only into an equivalent number of Shares and the Plan will not provide an option to settle the PSUs in cash. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Canadian residents may be required to report foreign property (including Shares) on an annual basis on form T1135 (Foreign Income Verification Statement) if the total cost of the foreign property exceeds CAD 100,000 at any time in the year. The grant of PSUs must be reported if the CAD 100,000 cost threshold is exceeded because of other foreign property held. PSUs may be reported at a nil cost. The form must be filed by April 30 of the following year. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Withholding will include both federal income tax as well as provincial tax.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Resale Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Ordinary Shares received by Canadian residents pursuant to this Plan will be subject to an indefinite holding period and the resale of the Ordinary Shares will be prohibited, unless certain conditions are met in respect of the Company in accordance with applicable Canadian securities laws or another applicable Canadian prospectus exemption is available.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Eligibility of Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding the terms of this Agreement or the Plan, no offers of PSUs or Ordinary Shares may be made to you if you are not an employee, executive officer, director or consultant of the Company or a related entity of the Company, in accordance with Section 2.24 of National Instrument 45-106.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employment Law Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the term &#8220;Termination Date&#8221; shall mean the earliest of&#58;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)&#160;&#160;&#160;&#160;Any date specified in this Agreement or the Plan&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)&#160;&#160;&#160;&#160;The date on which the Company or any applicable Affiliate delivers to you notice in a form prescribed by the Company that the Company is thereby terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)&#160;&#160;&#160;&#160;Except in the event of a Separation for Good Reason, the date on which you deliver notice in a form prescribed by the Company to the Company or any applicable Affiliate that you are terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)&#160;&#160;&#160;&#160;The date on which you cease to provide services to the Company or any applicable Affiliate, except where you are on an authorized leave of absence&#59; and</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)&#160;&#160;&#160;&#160;The date on which you cease to be considered an &#8220;employee&#8221; of the Company or any applicable Affiliate under applicable law.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the definitiona of &#8220;Cause&#8221; shall be determined in accordance with applicable laws in the jurisdiction of employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In accordance with Section 2.13, you consent and agree to the payment of the reimbursements set out therein, including through deductions of the amounts specified in paragraph 2.13 from any wages owed by the Company to the employee. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The provisions set out in Section 2.15(a) do not apply to employees in the province of Ontario other than executive employees who are exempted from XV.1 of the Ontario Employment Standards Act, 2000.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Czech Republic</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Documents in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Award, you confirm that you have read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">P&#345;ijet&#237;m tohoto Ozn&#225;men&#237; potvrzujete, &#382;e jste p&#345;e&#269;etl a porozum&#283;l jste Podm&#237;nk&#225;m pl&#225;nu (&#8220;Plan&#8221;) a Smlouv&#283; (&#8220;Agreement&#8221;), kter&#233; V&#225;m byly poskytnuty v anglick&#233;m jazyce. Z&#225;rove&#328; prohla&#353;ujete, &#382;e souhlas&#237;te s podm&#237;nkami uveden&#253;mi v t&#283;chto dokumentech.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restriction on cash payments.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Under Czech Act No. 235&#47;2004 Coll., on Cash Payments, as amended, it is prohibited to receive or provide payments in cash exceeding the amount of CZK 270.000 within one day. Payments exceeding this amount must be executed cashless. This restriction relates to payments from one contracting party to one other contracting party. Thus, it is not a restriction on the sum of all payments made by one individual or entity within one day.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nevertheless, since the restriction on cash payments may be subject to a change (especially a lower threshold might be set), we recommend consulting your personal legal advisor prior to receiving or providing a larger amount of cash payments.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Denmark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is subject to the Danish Stock Option Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aktieoptionsloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), which applies on share option agreements entered into as part of an employment, if the ownership of the shares is obtained at a later point. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This act is based on a principle of the right to freely agree on the terms of the Award Agreement with certain exceptions stated in the act. In addition to the act, the Danish Contract Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aftaleloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and Danish case law also regulates the terms of the Award Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below, it is outlined when the Danish Stock Option Act, the Danish Contract Act, Danish case law and other applicable legislation deviate from terms stated in the Award Agreement&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Section 1.3(f) in the Award Agreement does not entail that applicable notice periods under Danish employment legislation and your employment agreement are deviated from to the detriment of you. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Section 1.3(g) litra 2 in the Award Agreement is amended to the following&#58; </font></div><div><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;(2) &#8220;Termination without Cause&#8221; means the involuntary termination of your employment or contractual relationship by the Company without any Cause. &#8220; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226; Regardless of section 2.3 in the Award Agreement, vested and acquired shares do not lapse as a consequence of your Termination Date for reasons of Cause. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In relation to Section 2.7 in the Award Agreement the following also applies, which supersedes section 2.7 in case of conflicting regulation&#58; </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;The Company is required to report the market value of the PSUs to the Danish tax authorities to both E-income and E-capital with the Danish tax authorities. For E-income, the value of the PSUs should be reported as income art 50 in field 068 and should be reported by the Company in the month the shares vest. For E-capital, the value of the PSUs should be reported to the Danish tax authorities no later than the 20th of January the following year after the PSUs have vested. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The market value of the provided PSUs is to be reported by the Company as personal income in the year of vest and is subject to a marginal tax rate of 56% including labor market contribution. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The tax payment obligation for the value of the shares will be collected with the individual, and the responsibility to ensure that the correct amount is reported on the Danish tax assessment remains with the individual.</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At the time of sale you are subject to tax on the gain, if any, at a marginal tax rate of 42%. The capital gain is calculated as the difference between the average fair market value at vest and the sales price. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If there is a loss tied to the sale of the PSUs, the loss can be deducted in capital gain from other listed PSUs. </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that it is mandatory for you to report information on PSUs from a foreign depot to the Danish tax authorities. If this information is not provided to the Danish tax authorities, a potential loss cannot be used for deduction. &#8220; </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to section 2.10(b), all personal information will be managed in accordance with the European Data Protection Regulation (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">databeskyttelsesforordningen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and the Danish Data Protection Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">personbeskyttelsesloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.15(a)-(d) in the Award Agreement is void and unenforceable in Denmark and instead the following is agreed&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15 NON-COMPETITION AND NON-SOLICITATION </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.1. You will be covered by this non-competition and non-solicitation clause for 6 months after the effective date of termination. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.2. In this period, you are entitled to &#8211; only with the prior written consent of the affiliate employing or retaining you (the &#8220;Affiliate&#8221;) &#8211; be engaged or financially interested, directly or indirectly, in any business which develops and&#47;or distributes products or services that compete or may compete with the Affiliate or any group companies&#8217; products and&#47;or services or in any other business competing with the Affiliate or any group companies in any other way. This restriction includes any interest whatsoever by way of, for example, employment, ownership in full or in part, membership of a board, consultancy services and the like in Denmark and abroad. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.3. Conclusion of this non-competition clause is required because you hold a very special position of trust, and you will receive detailed knowledge about the Affiliate and group companies&#8217; affairs, including business secrets, market strategies and plans, information on customers and suppliers. This knowledge may be exploited to the detriment of the Affiliate or group companies, if you become employed with a competing company immediately after the effective date of termination. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.4. During 6 months after the effective date of termination, you are only with the prior written consent of the Affiliate entitled to be in contact with or have business relations, directly or indirectly, with customers, suppliers or cooperation partners, etc., with whom you have had business relations within the last 12 months prior to the termination. In connection with the termination, the Affiliate will prepare a list of the customers, suppliers and cooperation partners covered by the restriction in this clause. In this connection, you must loyally contribute to the drafting of a thorough list covering all customers, suppliers and&#47;or cooperation partners with whom you have had business relations within the last 12 months prior to the termination. Your deliberate failure to contribute loyally to this list will be considered a material breach of the employment and the Award Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.5. The effective date of termination is to be construed as the date on which you may be ordered or entitled to resign after the expiry of the notice period, notwithstanding whether you actually end your work with the employing company at an earlier date. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.6. The non-competition part of this clause will cease to apply, if the Affiliate gives notice of termination to you without you having reasonably caused the termination. The non-competition part of this clause will also cease to apply, if you resign from the Affiliate for reasonable cause due to the employing company&#8217;s failure to fulfil its obligations, cf. section 11 (1) in the Danish Act on Employment Clauses (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">ans&#230;ttelsesklausulloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). In both situations, the non-solicitation part of this clause will be maintained. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.7. The Affiliate may terminate the clause with one month's notice to expire at the end of a month, cf. section 10 (1) in the Danish Act on Employment Clauses. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.8. As compensation for the clause, you will receive a monthly compensation in accordance with the Danish Act on Employment Clauses. Compensation currently amounts to 60 % of the monthly salary at the effective date of termination and is payable in the period in which the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">clause applies. At the effective date of termination, the first two months of compensation will be paid to you as a lump sum. If the clause applies, compensation will after the first two months be payable each month in arrears in the rest of the period in which the clause applies. If you obtain other appropriate paid work, compensation equivalent to 24 % of the monthly salary at the effective date of termination will be paid from the third month after the effective date of termination. You are obligated to actively seek other appropriate work and to notify the Affiliate in writing of any new work. Failure to observe the duty of mitigation will be considered a material breach of the employment with the effect that your right to compensation will lapse. The right to compensation will lapse, if the Affiliate has lawfully terminated your employment without notice. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.9. In the event of your breach of the clause, the Affiliate will be entitled to a penalty of &#91;between three and six&#93; months' salary for any one breach of the clause and compensation for any additional loss. In the event of a persistent breach of the clause, each month or part of a month is deemed to constitute an independent breach entitling the Affiliate to a new, independently agreed penalty. Any payment of the agreed penalty shall not lead to the discontinuance of your obligation to comply with the clause. The Affiliate may also seek to restrain any breach of the clause through the issue of an injunction. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.10. This clause may be invoked by the Affiliate from the date on which you have been employed with the employing company for six months.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Estonia</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Finland</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  If you hold Ordinary Shares acquiqred under the Plan, you are generally required to include those Ordinary Shares as assets in your individual tax return.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">France</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">En acceptant cette attribution gratuite d'actions, vous confirmez avoir lu et comprenez le Plan et ce Contrat, incluant tous leurs termes et conditions, qui ont &#233;t&#233; transmis en langue anglaise. Vous acceptez les dispositions de ces documents en connaissance de cause.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of France or maintain a foreign bank account, you are required to report such to the French tax authorities when you file your annual tax return.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The PSUs are not intended to qualify as a French tax qualified performance restricted stock units under French tax law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a French resident and hold cash or Ordinary Shares outside of France, you must declare all foreign bank and brokerage accounts (including any accounts that were opened or closed during the tax year) on an annual basis on a special form, No. 3916, together with your income tax return.  </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Renseignements relatifs aux comptes et avoirs &#233;trangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Si vous &#234;tes r&#233;sident fran&#231;ais et que vous d&#233;tenez des liquidit&#233;s ou des Actions ordinaires en dehors de la France, vous &#234;tes tenu de d&#233;clarer chaque ann&#233;e, en m&#234;me temps que votre d&#233;claration de revenus, les r&#233;f&#233;rences de vos comptes bancaires et comptes-titres &#233;trangers (y compris les comptes qui ont &#233;t&#233; ouverts ou ferm&#233;s pendant l&#8217;exercice fiscal) par le biais d&#8217;un formulaire sp&#233;cifiquement pr&#233;vu &#224; cet effet, le formulaire N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">o&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3916. </font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Germany</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Cross-border payments related to securities transactions in excess of &#8364;12,500 must be reported by the fifth calendar day of the month following the respective payment to the German Central Bank (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Bundesbank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  If you use a German bank to transfer a cross-border payment related to securities transactions in excess of &#8364;12,500 (e.g. in connection with the sale of shares acquired under the Plan), the bank will make the report for you. In addition, you must report any receivables, payables, or debts in foreign currency exceeding an amount of &#8364;5,000,000 (by the tenth calendar day after the expiry of one month) and any cross-border shareholdings in companies if the share in the capital or the voting rights amount(s) to 10% or more and the investment object exceeds a balance sheet total of &#8364;3,000,000 (by the last working day of the sixth calendar month following December 31).n a monthly basis.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In case of an acquisition of shares in a foreign company with an overall investment amount of more than &#8364;150,000 (or in case of an acquisition of 10% or more of the shares in a foreign company), you should consult with your tax advisor whether the investment would have to be reported to your tax office.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Greece</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to your Award, if you withdraw funds of &#8364;15,000 or more from a bank in Greece and remit those funds out of Greece, you may be required to submit certain documentation&#47; information to the Greek bank to ensure that the transfer is not in violation of Greek anti-money laundering rules. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Hungary</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">India</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Notification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You understand that you must repatriate any proceeds from the sale of shares acquired under the Plan to India and convert the proceeds into local currency within 180 days of receipt assuming share holding is less than 10% of the company's share capital or as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">prescribed under applicable Indian exchange control laws as may be amended from time to time. You will receive a foreign inward remittance certificate (&#34;FIRC&#34;) from the bank where you deposit the foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or your employer requests proof of repatriation.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The amount subject to tax on receipt of the shares will partially be dependent upon a valuation that the Company or your employer will obtain from a Merchant Banker in India.  Neither the Company nor your employer has any responsibility or obligation to obtain the most favorable valuation possible, nor obtain valuations more frequently than required under Indian tax law.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to declare in the applicable schedules of your annual tax return (a) any foreign assets held by you (e.g., Ordinary Shares acquired under the Plan and, possibly, the Award), (b) any foreign bank accounts for which you have signing authority and (c) any foreign custodian accounts.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ireland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Director Notification Obligation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a director, shadow director or secretary of the Company's Irish Subsidiary or Affiliate, you must notify the Irish Subsidiary or Affiliate in writing within five business days of receiving or disposing of an interest exceeding 1% of the Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(e.g., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PSUs, shares, etc.), or within five business days of becoming aware of the event giving rise to the notification requirement or within five days of becoming a director or secretary if such an interest exists at the time. This notification requirement also applies with respect to the interests of a spouse or children under the age of 18 (whose interests will be attributed to the director, shadow director or secretary).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Israel</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Type of Grant&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633; </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capital Gain Award (&#8220;CGA&#8221;)</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ordinary Income Award (&#8220;OIA&#8221;)</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 3(i) Award</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Unapproved 102 Award</font></div><div><font><br></font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Settlement of PSUs</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Agreement, if the PSUs granted hereunder are 102 Awards, the PSUs shall be settled in Ordinary Shares only.</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Trust. </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All Approved 102 Awards shall be held in trust by a trustee designated by the Company (</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;Trustee&#34;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or shall be supervised by the Trustee in accordance with the instructions set forth by the Israeli Tax Authority (&#8220;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITA</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), for the requisite lockup period prescribed by the Ordinance and the regulations promulgated thereunder, or such other period as may be required by the ITA, during which period Awards or Ordinary Shares issued thereunder, and all rights resulting from them, including bonus shares, must be held or supervised by the Trustee in accordance with the instructions set forth by the ITA. The Trustee shall not release any Approved 102 Awards, Ordinary Shares issued upon the exercise of any Approved 102 Awards, or any rights, including bonus shares, resulting from such Approved 102 Awards or Ordinary Shares, prior to the full </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">payment of your tax liability. The Trustee or the Israeli Affiliate shall withhold any applicable taxes in accordance with Section 102 or any applicable tax ruling obtained by the Company. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without derogating from the foregoing, if your PSUs do&#160;not qualify as Approved&#160;102 Awards the Company may still at its sole discretion deposit your PSUs in trust to ensure that taxes are properly withheld. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby release the Trustee from any liability in respect of any action or decision duly taken and executed in good faith in relation to any PSUs or Ordinary Shares issued to you thereunder. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Without derogating from Section 2.7(b) above, you hereby agree to indemnify the Company and&#47;or its Affiliates and&#47;or the Trustee and hold them harmless against and from any and all liability for all such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to you.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you agree to comply with the provisions of Section 102 and the regulations and rules promulgated thereunder or any tax ruling to be obtained by the Company in connection with your PSUs. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Italy</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax&#47;Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You are required to report on your annual tax return&#58;  (a) any foreign investments or investments (including the Ordinary Shares issued at vesting of the PSUs, cash or proceeds from the sale of Ordinary Shares acquired under the Plan) held outside of Italy, if the investment may give rise to income in Italy (this will include reporting the Ordinary Shares issued at vesting of the PSUs if the fair market value of such Ordinary Shares combined with other foreign assets)&#59; and (b) any changes during the financial year which have had an impact during the calendar year on your foreign investments or investments held outside of Italy.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are exempt from these formalities if the investments are made through an authorized broker resident in Italy, as the broker will comply with the reporting obligation on your behalf.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Kazakhstan</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to report the acquisition of shares of a foreign company to the National Bank of Kazakhstan. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Latvia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Lithuania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Luxembourg</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are required to report any inward remittances of funds to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Banque Central de Luxembourg </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and&#47;or the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Service Central de La Statistique et des Etudes Economiques</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Luxembourg financial institution is involved in the transaction, it generally will fulfill the reporting obligation on your behalf. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Mexico</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the PSUs, you understand and agree that any modification of the Plan or the Agreement or its termination shall not constitute a change or impairment of the terms and conditions of employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan Document Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the award of the PSUs, you acknowledge that you have received copies of the Plan, have reviewed the Plan and the Agreement in their entirety and fully understand and accept all provisions of the Plan and the Agreement.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, by signing the Agreement, you further acknowledge that you have read and specifically and expressly approve the terms and conditions in the Agreement, in which the following is clearly described and established&#58;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Participation in the Plan does not constitute an acquired right&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">The Plan and participation in the Plan is offered by the Company on a wholly discretionary basis&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15.36pt">Participation in the Plan is voluntary&#59; and </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.03pt">The Company and any Parent, Subsidiary or Affiliates are not responsible for any decrease in the value of the shares.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowlegement and Policy Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In accepting the PSUs, you expressly recognize the Company is solely responsible for the administration of the Plan and that your participation in the Plan and acquisition of Ordinary Shares does not constitute an employment relationship between you and the Company since you are participating in the Plan on a wholly commercial basis and on a wholly commercial basis and your sole employer is Perrigo de Mexico S.A. De C.V. (&#8220;Perrigo Mexico&#8221;). Based on the foregoing, you expressly recognize that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and your employer, Perrigo Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Perrigo Mexico and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of your employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company&#59; therefore, the Company reserves the absolute right to amend and&#47;or discontinue your participation at any time without any liability to you.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or damages as a result of your participation in the Plan and therefore grant a full and broad release to the Employer, the Company and any Parent, Subsidiary or Affiliates with respect to any claim that may arise under the Plan.</font></div><div style="margin-bottom:12pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Spanish Translation</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modificaci&#972;n</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;Al aceptar las Unidades de Acci&#243;n Restringida de Rendimiento (PSUs, por sus siglas en ingl&#233;s) usted entiende y esta de acuerdo que cualquier modificaci&#243;n del plan o del </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">acuerdo o su terminaci&#243;n no constituir&#225; un cambio o detrimento de los t&#233;rminos y condiciones de su empleo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Confirmaci&#243;n del Documento del Plan. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Al aceptar el otorgamiento de las PSUs, usted reconoce que ha recibido copias y ha revisado dicho acuerdo en su totalidad y que ha entendido y aceptado completamente todas las disposiciones contenidas en el Plan y en el Acuerdo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adicionalmente, al firmar el acuerdo, usted reconoce que ha le&#237;do, y aprobado de manera espec&#237;fica y expresa los t&#233;rminos y condiciones en el acuerdo en el que se describe y establece claramente los siguiente&#58;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.42pt">La participaci&#243;n en el Plan no constituye un derecho adquirido&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.61pt">El plan y la participaci&#243;n en el mismo, son ofrecidos por la Compa&#241;&#237;a de manera totalmente discrecional&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.42pt">La participaci&#243;n en el Plan es voluntaria&#59; y</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.23pt">La Compa&#241;&#237;a, y cualquier Sociedad controladora, Subsidiaria o Filiales no son responsables por ning&#250;n decremento en el valor de las Acciones.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Constancia de aceptaci&#243;n de la ley laboral y declaraci&#243;n de la pol&#237;tica.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160; Al aceptar las PSUs, usted reconoce expresamente que la Compa&#241;&#237;a, es la &#250;nica responsable de la administraci&#243;n del Plan, y que su participaci&#243;n en el Plan y la adquisici&#243;n de las acciones comunes no constituyen una relaci&#243;n de trabajo entre usted y la Compa&#241;&#237;a dado que usted participa en el Plan de manera completamente comercial y el &#250;nico empleador que tiene es Perrigo de M&#233;xico, S.A. de C.V. (&#171; Perrigo de Mexico &#187;). Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que usted pueda obtener de la participaci&#243;n en el Plan, no establecen ning&#250;n derecho entre usted y su empleador Perrigo de M&#233;xico y no forman parte de las condiciones de trabajo ni de las prestaciones ofrecidas por Perrigo de M&#233;xico y cualquier modificaci&#243;n del Plan o la terminaci&#243;n de &#233;ste, no constituyen un cambio o deterioro de los t&#233;rminos y condiciones de su trabajo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adem&#225;s, usted comprende que su participaci&#243;n en el Plan es el resultado de una decisi&#243;n unilateral y discrecional de la Compa&#241;&#237;a&#59; por lo tanto, la Compa&#241;&#237;a se reserva el derecho absoluto de modificar y&#47;o interrumpir la participaci&#243;n de usted en cualquier momento sin ninguna responsabilidad para usted.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finalmente, usted declara que no se reserva ninguna acci&#243;n o derecho de presentar alg&#250;n reclamo o demanda en contra de la Compa&#241;&#237;a por compensaci&#243;n, da&#241;o o perjuicio alguno como resultado de su participaci&#243;n en el Plan, en consecuencia, otorga el m&#225;s amplio finiquito al Empleador, as&#237; como a la Compa&#241;&#237;a, a su Sociedad controladora, Subsidiaria o Filiales con respecto a cualquier demanda que pudiera originarse en virtud del Plan.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Netherlands</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dutch insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Norway</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Norwegian insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor as well as the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Cross-border payments in excess of NOK 100,000 must be reported to the Norwegian foreign exchange register (Valutaregisteret). If you use a Norwegian bank to transfer a cross-border payment in excess of NOK 100,00 in connection with the sale of shares acquired under the Plan, the bank will make the report on your behalf. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In your Norwegian income tax return, each year you are required to report any security, shares or bank accounts (including brokerage accounts and the Company &#8220;Account&#8221; referenced in section 1.5 of the Agreement) you maintain outside of Norway. The Company &#8220;Account&#8221; should not be treated as taxable wealth, as long as the right to receive the dividends is conditional, but you must report it. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Poland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold foreign securities (including shares pursuant to the Award) and maintain accounts abroad, you may be required to file certain reports with the National Bank of Poland (&#8220;NBP&#8221;). Specifically, if the value of securities and cash held in such foreign accounts exceeds PLN 7,000,000 (or equivalent thereof in another currency) at the end of the year, you must file reports on the transactions and balances of the accounts on a quarterly basis by the 26th day of the month following the end of each quarter. In case you are being in regime of a joint marital property, the above threshold shall apply to joint property of the spouses. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, if you hold, at the beginning or end of the year, at least 10% of votes in the decision-making body of the entity based abroad (and you are person meeting the prievusly mentioned criteria), an annual notification, on the official form, must be submitted by you to the NBP by May 31 of the following year.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If at the end of the year you did not reach the given threshold but in the next year, at the end of a calendar quarter, you reach the threshold, you are obliged to submit the appropriate form to NBP for this quarter and each of the following quarters of this calendar year (within 26 days from the end of each calendar quarter). Such reports are filed on special forms available on the website of the NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The foregoing duties represents personal responsibilities of each shareholder and cannot be fulfilled by any entity on your behalf.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, if you are a Polish citizen and you transfer funds abroad in excess of the PLN equivalent of &#8364;15,000, the transfer must be made through an authorized bank, a payment institution or an electronic money institution authorized to render payment services. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Furthermore, at the banks&#8217; request, you may be required to inform eligible banks, within the meaning of the Foreign Exchange Act, about all foreign exchange transactions performed through them.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are also required to retain the documents connected with foreign exchange transactions for a period of five years, as measured from the end of the year in which such transaction occurred.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Zgoda na otrzymywanie informacji w j&#281;zyku angielskim.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Akceptuj&#261;c Opcj&#281;, potwierdzasz przeczytanie i zrozumienie Programu i Umowy, kt&#243;re zosta&#322;y dostarczone w j&#281;zyku angielskim. W zwi&#261;zku z tym akceptujesz warunki tych dokument&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informacje o kontroli dewizowej. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li jeste&#347; w posiadaniu zagranicznych papier&#243;w warto&#347;ciowych (w tym akcji) i posiadasz rachunki za granic&#261;, mo&#380;esz by&#263; zobowi&#261;zany(-a) do z&#322;o&#380;enia okre&#347;lonych sprawozda&#324; w Narodowym Banku Polskim (&#8222;NBP&#8221;. W szczeg&#243;lno&#347;ci, je&#347;li warto&#347;&#263; papier&#243;w warto&#347;ciowych i &#347;rodk&#243;w pieni&#281;&#380;nych gromadzonych na takich rachunkach zagranicznych przekracza na koniec roku 7 000 000 PLN (lub ekwiwalent tej kwoty w innej walucie), nale&#380;y co kwarta&#322; sk&#322;ada&#263; raporty z transakcji i sald rachunk&#243;w do 26 dnia miesi&#261;ca nast&#281;puj&#261;cego po zako&#324;czeniu ka&#380;dego kwarta&#322;u. W przypadku pozostawania we wsp&#243;lno&#347;ci maj&#261;tkowej z ma&#322;&#380;onkiem, powy&#380;szy pr&#243;g dotyczy maj&#261;tku wsp&#243;lnego ma&#322;&#380;onk&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#380;eli posiadasz na pocz&#261;tek lub koniec roku co najmniej 10% g&#322;os&#243;w w organie stanowi&#261;cym podmiotu z siedzib&#261; za granic&#261; (i jeste&#347; osob&#261; spe&#322;niaj&#261;c&#261; wy&#380;ej wskazane warunki) musisz z&#322;o&#380;y&#263; w NBP do 31 maja nast&#281;pnego roku dodatkowy raport. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li pod koniec roku nie osi&#261;gn&#261;&#322;e&#347;(-a&#347;) okre&#347;lonego progu, ale w nast&#281;pnym roku, pod koniec kwarta&#322;u kalendarzowego, osi&#261;gniesz pr&#243;g, musisz z&#322;o&#380;y&#263; odpowiedni formularz do NBP za ten kwarta&#322; i ka&#380;dy z kolejnych kwarta&#322;&#243;w tego roku kalendarzowego (w ci&#261;gu 26 dni od zako&#324;czenia ka&#380;dego kwarta&#322;u kalendarzowego). Takie raporty s&#261; sk&#322;adane w specjalnych formularzach dost&#281;pnych na stronie internetowej NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#347;li jeste&#347; obywatelem Polski i przekazujesz &#347;rodki za granic&#281; w wysoko&#347;ci przekraczaj&#261;cej r&#243;wnowarto&#347;&#263; 15 000 EUR w PLN, przelewu nale&#380;y dokona&#263; za po&#347;rednictwem upowa&#380;nionego banku, instytucji p&#322;atniczej lub instytucji pieni&#261;dza elektronicznego uprawnionej do &#347;wiadczenia us&#322;ug p&#322;atniczych. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto na &#380;&#261;danie bank&#243;w niezb&#281;dne mo&#380;e by&#263; poinformowanie uprawnionych bank&#243;w, w rozumieniu ustawy Prawo dewizowe (Foreign Exchange Act), o wszystkich transakcjach walutowych przeprowadzanych za ich po&#347;rednictwem.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Jeste&#347; r&#243;wnie&#380; zobowi&#261;zany(-a) do przechowywania dokument&#243;w zwi&#261;zanych z transakcjami wymiany walut przez okres pi&#281;ciu lat, mierzony od ko&#324;ca roku, w kt&#243;rym taka transakcja zosta&#322;a wykonana</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Portugal</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Language Consent.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You hereby expressly declare that you have full knowledge of the English language and have read, understood and fully accepted and agreed with the terms and conditions established in the Plan and Award Agreement.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Conhecimento da Lingua.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> O Contratado, pelo presente instrumento, declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo de Atribui&#231;&#227;o (Award Agreement em ingl&#234;s). </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Romania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Statistical Reporting.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">According to art. 92 of NBR Reg. 4&#47;2021, if you, as a resident of Romania within the meaning of NBR Reg. 4&#47;2021, acquire more than 10% of the share capital in a foreign company, the acquisition must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be reported to the National Bank of Romania (&#8220;NBR&#8221;) for statistical purposes within 30 calendar days of acquisiting the ownership right over the shares of the foreign company. You should consult your personal advisor to determine whether you will be required to submit such documentation to the NBR pursuant to your participation in the Plan. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Insider-trading rules prohibit you from carrying out  certain transactions involving shares if you have inside information about the Company (insider dealing). If you are uncertain whether the insider-trading rules apply to you, including with regard to the fact that the Company is listed on the New York Stock Exchange (NYSE), you should consult your personal legal advisor. Depending on the applicable market abuse legislation, you might be subject to certain restrictions on the freedom to trade the shares that are settled through the RSU award, including any applicable prohibition on insider dealing, market manipulation or the unlawful disclosure of inside information.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Serbia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovakia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset Reporting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a foreign asset reporting obligation if you are considered providing independent professional services &#8220;podnikatel&#8221;. You should consult with a personal tax advisor to understand your filing obligations.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovenia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">South Africa</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the PSUs, you agree that, immediately upon vesting of the PSUs, you may need to notify your employer of the amount of any gain realized. If you fail to advise your employer of the gain realized upon vesting, you may be liable for a fine. You will be solely responsible for paying any difference between the actual tax liability and the amount </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">withheld by your employer. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Because no transfer of funds from South Africa is required under the PSUs, no filing or reporting requirements should apply when the award is granted nor when Ordinary Shares are issued upon vesting of the PSUs. However, because the exchange control regulations are subject to change, you should consult your personal advisor prior to vesting and settlement of the award to ensure compliance with current regulations. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Spain</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Entitlement for Claims or Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the award of PSUs, you consent to participation in the Plan, and acknowledge that you have received a copy of the Plan document.  You understand that the Company has unilaterally, gratuitously and in its sole discretion decided to make awards of PSUs under the Plan to individuals who may be employees, consultants and directors throughout the world. The decision is limited and entered into based upon the express assumption and condition that any PSUs will not economically or otherwise bind the Company or any Parent, Subsidiary or Affiliate, including your employer, on an ongoing basis, other than as expressly set forth in the Agreement. Consequently, you understand that the Award is given on the assumption and condition that the PSUs shall not become part of any employment contract (whether with the Company or any Parent, Subsidiary or Affiliate, including your employer) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever. Furthermore, you understand and freely accept that there is no guarantee that any benefit whatsoever shall arise from the award, which is gratuitous and discretionary, since the future value of the PSUs and the underlying shares is unknown and unpredictable. You also understand that this Award would not be made but for the assumptions and conditions set forth hereinabove&#59; thus, you understand, acknowledge and freely accept that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the Award, the PSUs and any right to the underlying shares shall be null and void.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the PSUs, your termination of service for any reason other than death or disability (including for the reasons listed below) will automatically result in the cancellation and loss of any PSUs that may have been granted to you and that were not or did not become vested on the date of termination of service. In particular, you understand and agree that, unless otherwise expressly provided by the Company in this Agreement, the PSUs will be cancelled without entitlement to the Shares or to any amount as indemnification if you terminate service by reason of, but not limited to, the following&#58; resignation&#59; disciplinary dismissal adjudged to be with cause&#59; disciplinary dismissal adjudged or recognized to be without good cause (i.e., subject to a &#34;despido improcedente&#34;)&#59; individual or collective layoff on objective grounds, whether adjudged to be with cause or adjudged or recognized to be without cause&#59; material modification of the terms of employment under Article 41 of the Workers&#8217; Statute&#59; relocation under Article 40 of the Workers&#8217; Statute&#59; Article 50 of the Workers&#8217; Statute&#59; unilateral withdrawal by your employer&#59; and under Article 10.3 of Royal Decree 1382&#47;1985.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You must declare the acquisition, ownership and disposition of stock in a foreign company (including Ordinary Shares acquired under the Plan) to the Spanish Direcci&#243;n General de Comercio e Inversiones (the &#8220;DGCI&#8221;), the Bureau for Commerce and Investments, which is a department of the Ministry of Economy and Competitiveness, for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">statistical purposes.  Generally, the declaration must be made in January for Ordinary Shares acquired or sold during (or owned as of December 31 of) the prior year&#59; however, this obligation only applies in the cases in which you hold 10% or more of the sares capital of the Company or 10% or more of the voting tights of the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, you may be required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts held abroad), any foreign instruments (e.g., Ordinary Shares) and any transactions with non-Spanish residents (including any payments of cash or shares made to you by the Company) if the balances in such accounts together with the value of such instruments as of December 31, or the volume of transactions with non-Spanish residents during the prior or current year, exceeds &#8364;1,000,000.  Generally, you will only be required to report on an annual basis (by January 20 of each year).  Note that if the value is less than &#8364;1,000,000, there is only an obligation to declare this information to the Bank of Spain upon request from the Bank of Spain, in which case the deadline is two months since the request is received.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When receiving foreign currency payments derived from the ownership of Ordinary Shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">., dividends or sale proceeds), you must inform the financial institution receiving the payment of the basis upon which such payment is made. Should amounts exceed &#8364;12,500, you will need to provide the following information to the Spanish Registered Entity&#58; (i) your name, address, and fiscal identification number&#59; (ii) the name and corporate domicile of the Company&#59; (iii) the amount of the payment and the currency used&#59; (iv) the country of origin&#59; (v) the reasons for the payment&#59; and (vi) further information that may be required. Exceptions to this rule are when you move funds through a Spanish resident bank account opened abroad, or when collections and payments are carried out in cash. These exceptions, however, are subject to their own reporting requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold assets or rights outside of Spain (including shares acquired under the Plan), you may have to file an informational tax report, Form 720, with the tax authorities declaring such ownership by March 31st of the following year.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Generally, there is no obligation to file Form 720 if the total value of the following does not exceed Euro 50,000&#58; </font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">the securities, shares, rights and participations held by you, on December 31 or at any time throughout the year, in any kind of entities or in investment funds located outside Spain&#59;</font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">any transfer of own capital to third parties located abroad&#59; and</font></div><div style="margin-bottom:12pt;padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">life and disability insurances in which the individual was policy holder on December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that if an asset is jointly owned, the value is not prorated. Please also note that the application of the rules in respect of valuation of assets and transfers during the year should be carefully analyzed. If the limit of Euro 50,000 euros is exceeded for this described group of assets, all the elements of this group must be reported.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For those taxpayers who have filed Form 720 in previous years, they will only be obliged to file it again&#58;</font></div><div style="padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.7pt">When the aggregated value of the assets included in the mentioned group (shares&#47;insurances) had increased in an amount higher than Euro 20,000 regarding the informative return filed in a previous year.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.02pt">When the individual&#8217;s condition (owner, co-owner, co-titleholder or co-authorized) had changed or was extinguished during the year, before 31st December, with regard to any of the assets.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the thresholds for annual filing requirements may change each year. Therefore, you should consult your personal advisor regarding whether you will be required to file an informational tax report for asset and rights that you hold abroad.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Sweden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The following shall apply in addition to what is set out under section 2.14 of the Award Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Forfeiture of entitlements under the Plan in case of termination shall apply in case of termination of employment regardless of whether such termination of employment may be justified under Swedish employment protection legislation, and regardless of whether such termination may be challenged by you, and regardless of whether such termination is invalidated by verdict or a court order.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax withholdings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You authorize the Company and&#47;or the Employing Company to withhold or sell shares otherwise distributable to you upon vesting or settlement to satisfy the Company&#8217;s payroll tax withholding obligations.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Switzerland</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securitities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The PSUs and the issuance of any Ordinary Shares thereunder is not intended to be publicly offered in or from Switzerland.  Neither this Award Agreement nor any other materials relating to the Award (1) constitute a prospectus as such term is understood pursuant to article 652a of the Swiss Code of Obligations, (2) may be publicly distributed nor otherwise made publicly available in Switzerland, or (3) have been or will be filed with, approved or supervised by any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are obliged to submit an ordinary annual tax return in Switzerland, you are required to file a salary certificate with the Swiss tax authorities together with your Swiss tax return. The Company or the Affiliate employing you is obliged to prepare a specific attachment regarding the PSUs to this salary certificate. Before Settlement, for wealth tax purposes, the number of PSUs should be declared with p.m (zero value) in the asset statement of the tax return. After Settlement the total number of Ordinary Shares received are subject to wealth tax at the end of the calendar year and must be declared in your Swiss tax return.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Turkey</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Under Turkish law, you are not permitted to sell Ordinary Shares acquired under the Plan in Turkey.  The Ordinary Shares are currently traded on the Nasdaq Global Select Market, which is located outside of Turkey, under the ticker symbol &#8220;PRGO&#8221; and the Ordinary Shares may be sold through this exchange.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ukraine </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to obtain a license for obtaining shares of a foreign company from the National Bank of Ukraine (NBU). </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award will be outside the scope of your employment or service contract (if any) and as such will not constitute a part of your compensation package under the respective employment or service contract.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">United Kingdom</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Income Tax and National Insurance Contribution Withholding.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The following provision supplements the terms in the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If payment or withholding of the income tax due in connection with the PSUs is not made within ninety (90) days of the end of the U.K. tax year in which the event giving rise to the income tax liability or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003 occurred (the &#8220;Due Date&#8221;), the amount of any uncollected income tax shall constitute a loan owed by you to your employer, effective as of the Due Date.  You agree that the loan will bear interest at the then-current official rate of His Majesty&#8217;s Revenue &#38; Customs (&#8220;HMRC&#8221;), it shall be immediately due and repayable, and the Company or your employer may recover it at any time thereafter by any of the means referred to in Section 2.7 of the Agreement.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if you are a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), you will not be eligible for a loan from the Company or your employer to cover the income tax liability.  In the event that you are a director or executive officer and the income tax is not collected from or paid by the Due Date, the amount of any uncollected income tax will constitute a benefit to you on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) will be payable.  You will be responsible for reporting any income tax for reimbursing the Company or your employer the value of any employee NICs due on this additional benefit. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*   *   *   *   *</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32</font></div><div><font><br></font></div></div></div><div id="i2f77d291d4554bfca08735971a0d9db5_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERRIGO COMPANY PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(SERVICE-BASED)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Under the Perrigo Company plc 2019 Long-Term Incentive Plan)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant Name</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RE&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Restricted Stock Unit Award (Service-Based)</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This is to notify you that Perrigo Company plc (the &#8220;Company&#8221;) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the &#8220;Plan&#8221;), effective as of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;Grant Date&#8221;).  This Award consists of service-based restricted stock units.  The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (&#8220;Appendix&#8221;) (collectively, the &#8220;Agreement&#8221;).  The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Units &#8211; Service-Based Vesting</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As of the Grant Date, and subject to the terms and conditions of this Agreement and the Plan, the Company grants you </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Number of Awards Granted </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(&#8220;Restricted Stock Units&#8221; or &#8220;RSUs&#8221;).  Each RSU shall entitle you to one ordinary share of the Company, nominal value &#8364;0.001 per share (&#8220;Ordinary Share&#8221;) on the applicable RSU Vesting Date, provided the vesting conditions described in Section 1.2 are satisfied.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as provided in Section 1.3, the RSUs awarded in Section 1.1 shall vest as follows following the Grant Date (&#8220;RSU Vesting Date(s)&#8221;)&#58; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vesting Schedule (Dates &#38; Quantities)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; provided, however, that you continue in the service of the Company from the Grant Date through the applicable RSU Vesting Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as provided in Section 1.3, if your Termination Date occurs prior to the RSU Vesting Date, any RSUs awarded under Section 1.1 that have not previously vested as of such Termination Date shall be permanently forfeited on your Termination Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Vesting Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding Section 1.2 above&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;If your Termination Date occurs by reason of death, Disability or Retirement with the Company&#8217;s consent, any RSUs awarded under Section 1.1 that have not vested prior to such Termination Date shall become fully vested.  Notwithstanding the definition of &#8220;Retirement&#8221; in Section 2 of the Plan, &#8220;Retirement&#8221; means your Termination Date which occurs after attaining age 62.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;If your Termination Date occurs by reason of an Involuntary Termination for Economic Reasons, any RSUs awarded under Section 1.1 that would otherwise be scheduled to vest under Section 1.2 in the 24-month period following such Termination Date shall continue to vest during such 24-month period according to the vesting schedule in effect prior to such Termination Date&#59; provided, however, that if your Termination Date occurs for a reason that is both described in this subsection (b) and in subsection (c) below, the special vesting rules described in subsection (c) shall apply in lieu of the vesting rules described in this subsection (b).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any RSUs that are not scheduled to vest during such 24-month period will be permanently forfeited on the Termination Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;If your Termination Date occurs by reason of a Termination without Cause or a Separation for Good Reason on or after a Change in Control (as defined in the Plan and as such definition may be amended hereafter) and prior to the two (2) year anniversary of the Change in Control, all RSUs awarded under Section 1.1 that have not vested or been forfeited prior to such Termination Date shall become fully vested.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;As used in this Section 1.3, the following terms shall have the meanings set forth below&#58; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;&#8220;Separation for Good Reason&#8221; means your voluntary resignation from the Company and the existence of one or more of the following conditions that arose without your consent&#58; (i) a material change in the geographic location at which you are required to perform services, such that your commute between home and your primary job site increases by more than 30 miles,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or (ii) a material diminution in your authority, duties or responsibilities or a material diminution in your base compensation or incentive compensation opportunities&#59; provided, however, that a voluntary resignation from the Company shall not be considered a Separation for Good Reason unless you provide the Company with notice, in writing, of your voluntary resignation and the existence of the condition(s) giving rise to the separation within 90 days of its initial existence.  The Company will then have 30 days to remedy the condition, in which case you will not be deemed to have incurred a Separation for Good Reason.  In the event the Company fails to cure the condition within the 30 day period, your Termination Date shall occur on the 31st day following the Company&#8217;s receipt of such written notice.  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;&#8220;Termination without Cause&#8221; means the involuntary termination of your employment or contractual relationship by the Company without Cause, including, but not limited to, (i) a termination effective when you exhaust a leave of absence during, or at the end of, a notice period under the Worker Adjustment and Retraining Notification Act (&#8220;WARN&#8221;), and (ii) a situation where you are on an approved leave of absence during which your position is protected under applicable law (e.g., a leave under the Family Medical Leave Act), you return from such leave, and you cannot be placed in employment or other form of contractual relationship with the Company.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as practicable after the RSU Vesting Date, the Company shall transfer to you one Ordinary Share for each RSUs becoming vested on such date (the date of any such transfer shall be the &#8220;settlement date&#8221; for purposes of this Agreement)&#59; provided, however, the Company may withhold shares otherwise transferable to you to the extent necessary to satisfy withholding taxes due by reason of the vesting of the RSUs, in accordance with Section 2.6.  You shall have no rights as a stockholder with respect to the RSUs awarded hereunder prior to the date of issuance to you of a certificate or certificates for such shares.  Notwithstanding the foregoing, the Committee, in its sole discretion, may elect to settle RSUs in cash based on the fair market value of the Ordinary Shares on the RSU Vesting Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The RSUs awarded under Section 1.1 shall be eligible to receive dividend equivalents in accordance with the following&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;An &#8220;Account&#8221; will be established in your name.  Such Account shall be for recordkeeping purposes only, and no assets or other amounts shall be set aside from the Company&#8217;s general assets with respect to such Account.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;On each date that a cash dividend is paid with respect to Ordinary Shares, the Company shall credit your Account with the dollar amount of dividends you would have received if each RSU held by you on the record date for such dividend payment had been an Ordinary Share.  No interest or other earnings shall accrue on such Account.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;As of each RSU Vesting Date, you shall receive a payment equal to the amount of dividends that would have been paid on the RSUs vesting on such date had they been Ordinary Shares during the period beginning on the Grant Date and ending on the RSU Vesting Date, and the Account shall be debited appropriately.  If you forfeit RSUs, any amounts in the Account attributable to such RSUs shall also be forfeited.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;If dividends are paid in the form of Ordinary Shares rather than cash, then you will be credited with one additional RSU for each Ordinary Share that would have been received as a dividend had your outstanding RSUs been Ordinary Shares.  Such additional RSUs shall vest or be forfeited at the same time as the RSU to which they relate.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECTION 2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">General Terms and Conditions</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nontransferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award under this Agreement shall not be transferable other than by will or by the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You shall not have any rights as a stockholder with respect to any Ordinary Shares subject to the RSU awarded under this Agreement prior to the date of issuance to you of a certificate or certificates for such shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If your Termination Date occurs for reasons of Cause, all of your rights under this Agreement, whether or not vested, shall terminate immediately.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Award Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The granting of the Award under this Agreement is being made pursuant to the Plan and the Award shall be payable only in accordance with the applicable terms of the Plan.  The Plan contains certain definitions, restrictions, limitations and other terms and conditions all of which shall be applicable to this Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ALL THE PROVISIONS OF THE PLAN ARE INCORPORATED HEREIN BY REFERENCE AND ARE MADE A PART OF THIS AGREEMENT IN THE SAME MANNER AS IF EACH AND EVERY SUCH PROVISION WERE FULLY WRITTEN INTO THIS AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Should the Plan become void or unenforceable by operation of law or judicial decision, this Agreement shall have no force or effect.  Nothing set forth in this Agreement is intended, nor shall any of its provisions be construed, to limit or exclude any definition, restriction, limitation or other term or condition of the Plan as is relevant to this Agreement and as may be specifically applied to it by the Committee.  In the event of a conflict in the provisions of this Agreement and the Plan, as a rule of construction the terms of the Plan shall be deemed superior and apply.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments in Event of Change in Ordinary Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of a stock split, stock dividend, recapitalization, reclassification or combination of shares, merger, sale of assets or similar event, the number and kind of shares subject to Award under this Agreement will be appropriately adjusted in an equitable manner to prevent dilution or enlargement of the rights granted to or available for you.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and you agree that the RSUs are granted under and governed by the Notice of Grant, this Agreement (including the Appendix, if applicable) and by the provisions of the Plan (incorporated herein by reference).  You&#58; (i) acknowledge receipt of a copy of each of the foregoing documents, (ii) represent that you have carefully read and are familiar with their provisions, and (iii) hereby accept the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes and Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding (Only Applicable to Individuals Subject to U.S. Tax Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Award is subject to the withholding of all applicable taxes.  The Company may withhold, or permit you to remit to the Company, any Federal, state or local taxes applicable to the grant, vesting or other event giving rise to tax liability with respect to this Award.  If you have not remitted the full amount of applicable withholding taxes to the Company by the date the Company is required to pay such withholding to the appropriate taxing authority (or such earlier date that the Company may specify to assist it in timely meeting its withholding obligations), the Company shall have the unilateral right to withhold Ordinary Shares relating to this Award in the amount it determines is sufficient to satisfy the tax withholding required by law.  State taxes will be withheld at the appropriate rate set by the state in which you are employed or were last employed by the Company.  In no event may the number of shares withheld exceed the number necessary to satisfy the maximum Federal, state and local income and employment tax withholding requirements.  You may elect to surrender previously acquired Ordinary Shares or to have the Company withhold Ordinary Shares relating to this Award in an amount sufficient to satisfy all or a portion of the tax withholding required by law.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Responsibility for Taxes (Only Applicable to Individuals Subject to Tax Laws Outside the U.S.)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Regardless of any action the Company or, if different, the Affiliate employing or retaining you takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (&#8220;Tax-Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items is and remains your responsibility and may exceed the amount actually withheld by the Company or the Affiliate employing or retaining you.  You further acknowledge that the Company and&#47;or the Affiliate employing or retaining you (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant, vesting or settlement of the RSUs, the subsequent sale of Ordinary Shares acquired pursuant to such settlement and the receipt of any dividends&#59; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result.  Further, if you have become subject to tax in more than one jurisdiction between the RSU Grant Date and the date of any relevant taxable event, as applicable, you acknowledge that the Company and&#47;or the Affiliate employing or retaining you (or formerly employing or retaining you, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Prior to any relevant taxable or tax withholding event, as applicable, you will pay or make adequate arrangements satisfactory to the Company and&#47;or the Affiliate employing or retaining you to satisfy all Tax-Related Items.  In this regard, you authorize the Company and&#47;or the Affiliate employing or retaining you, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58;  </font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;withholding from your wages or other cash compensation paid to you by the Company and&#47;or the Affiliate employing or retaining you&#59; or</font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;withholding from proceeds of the sale of Ordinary Shares acquired upon settlement of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization)&#59; or </font></div><div style="margin-bottom:12pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)&#160;&#160;&#160;&#160;withholding in Ordinary Shares to be issued upon settlement of the RSUs.  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;To avoid negative accounting treatment, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">amounts or other applicable withholding rates.  If the obligation for Tax-Related Items is satisfied by withholding in Ordinary Shares, for tax purposes, you are deemed to have been issued the full number of Ordinary Shares subject to the vested RSUs, notwithstanding that a number of the Ordinary Shares are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Finally, you shall pay to the Company or the Affiliate employing or retaining you any amount of Tax-Related Items that the Company or the Affiliate employing or retaining you may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to issue or deliver the Ordinary Shares or the proceeds of the sale of Ordinary Shares, if you fail to comply with your obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The issuance of Ordinary Shares will be subject to and conditioned upon compliance by the Company and you, including any written representations, warranties and agreements as the Administrator may request of you for compliance with all (i) applicable U.S. state and federal laws and regulations, (ii) applicable laws of the country where you reside pertaining to the issuance or sale of Ordinary Shares, and (iii)&#160;applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Ordinary Shares may be listed or quoted at the time of such issuance or transfer.  Notwithstanding any other provision of this Agreement, the Company shall have no obligation to issue any Ordinary Shares under this Agreement if such issuance would violate any applicable law or any applicable regulation or requirement of any securities exchange or similar entity.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code Section 409A (Only Applicable to Individuals Subject to U.S. Federal Tax Laws)</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;RSUs other than RSUs that continue to vest by reason of your Involuntary Termination for Economic Reasons and dividend equivalents payable under this Agreement are intended to be exempt from Code Section 409A under the exemption for short-term deferrals.  Accordingly, RSUs (other than RSUs that continue to vest by reason of your Involuntary Termination for Economic Reasons) will be settled and dividend equivalents will be paid no later than the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of the third month following the later of (i) the end of your taxable year in which the RSU Vesting Date occurs, or (ii) the end of the fiscal year of the Company in which the RSU Vesting Date occurs.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;RSUs that continue to vest by reason of your Involuntary Termination for Economic Reasons are subject to the provisions of this subsection (b).  Any distribution in settlement of such RSUs will occur provided your Involuntary Termination for Economic Reasons constitutes a &#8220;separation from service&#8221; as defined in Treasury Regulation &#167;1.409A-1(h).  If the Company determines that you are a &#8220;specified employee&#8221; as defined in Code Section 409A (i.e., an officer with annual compensation above $130,000 (as adjusted for inflation), a five-percent owner of the Company or a one-percent owner with annual compensation in excess of $150,000), distribution in settlement of any such RSUs that would be payable within six months of your separation from service shall be delayed to the first business day following the six-month anniversary of your separation from service.  Any distribution in settlement of such RSUs that would be made more than six months after your separation from service (without application of the six-month delay) shall not be subject to the six-month delay described in this subsection.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Data Privacy Rules (Only Applicable if this Award is Subject to U.S. Data Privacy Laws)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By entering into this Agreement and accepting this Award, you (a)&#160;explicitly and unambiguously consent to the collection, use and transfer, in electronic or other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">form, of any of your personal data that is necessary to facilitate the implementation, administration and management of the Award and the Plan, (b) understand that the Company may, for the purpose of implementing, administering and managing the Plan, hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, and details of all awards or entitlements to Shares granted to you under the Plan or otherwise (&#8220;Personal Data&#8221;), (c) understand that Personal Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including any broker with whom the Shares issued upon vesting of the Award may be deposited, and that these recipients may be located in your country or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than your country, (d) waive any data privacy rights you may have with respect to the data, and (e) authorize the Company, its Affiliates and its agents, to store and transmit such information in electronic form.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Data Privacy Rules (Only Applicable if this Award is Subject to Data Privacy Laws Outside of the U.S.)</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;By entering into this Agreement and accepting this Award, you hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Affiliate employing or retaining you, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;You understand that the Company and the Affiliate employing or retaining you may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Ordinary Shares or directorships held in the Company, details of all RSUs or any other entitlement to Ordinary Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (&#8220;Data&#8221;).  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;You understand that Data will be transferred to legal counsel or a broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan.  You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients&#8217; country (e.g., the United States) may have different data privacy laws and protections than your country of residence.  You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local or Company human resources representative.  You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan.  You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local or Company human resources representative.  You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local or Company human resources representative.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be binding upon any or all successors and assigns of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed and enforced in accordance with the applicable Code provisions to the maximum extent possible and otherwise by the laws of the State of Michigan without regard to principals of conflict of laws, provided that if you are a foreign national or employed outside the United States, this Agreement shall be governed by and construed and enforced in accordance with applicable foreign law to the extent that such law differs from the Code and Michigan law.  Any proceeding related to or arising out of this Agreement shall be commenced, prosecuted or continued in the Circuit Court in Kent County, Michigan located in Grand Rapids, Michigan or in the United Stated District Court for the Western District of Michigan, and in any appellate court thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Forfeiture of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company, as a result of misconduct, is required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, then (a) if your incentive or equity-based compensation is subject to automatic forfeiture due to such misconduct and restatement under Section 304 of the Sarbanes-Oxley Act of 2002, or (b) the Committee determines you either knowingly engaged in or failed to prevent the misconduct, or your actions or inactions with respect to the misconduct and restatement constituted gross negligence, you shall (i) be required to reimburse the Company the amount of any payment (including dividend equivalents) relating to any RSUs earned or accrued during the twelve month period following the first public issuance or filing with the SEC (whichever first occurred) of the financial document embodying such financial reporting requirement, and (ii) all outstanding RSUs (including related dividend equivalents) that have not yet been settled shall be immediately forfeited.  In addition, Ordinary Shares acquired under this Agreement, and any gains or profits on the sale of such Ordinary Shares, shall be subject to any &#8220;clawback&#8221; or recoupment policy later adopted by the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Rules for Non-U.S. Grantees (Only Applicable if You Reside Outside of the U.S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">)</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In accepting the grant, you acknowledge, understand and agree that&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, except as otherwise provided in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;the grant of the RSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted repeatedly in the past&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;all decisions with respect to future RSU grants, if any, will be at the sole discretion of the Company&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;you are voluntarily participating in the Plan&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)&#160;&#160;&#160;&#160;the RSUs and the Ordinary Shares subject to the RSUs are an extraordinary item and which is outside the scope of your employment or service contract, if any&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(6)&#160;&#160;&#160;&#160;the RSUs and the Ordinary Shares subject to the RSUs are not intended to replace any pension rights or compensation&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7)&#160;&#160;&#160;&#160;the RSUs and the Ordinary Shares subject to the RSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Affiliate employing or retaining you or any other Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(8)&#160;&#160;&#160;&#160;the grant and your participation in the Plan will not be interpreted to form an employment or service contract with the Company or any Affiliate&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(9)&#160;&#160;&#160;&#160;the future value of the underlying Ordinary Shares is unknown, indeterminable and cannot be predicted with certainty&#59; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(10)&#160;&#160;&#160;&#160;no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from your Termination Date (for any reason whatsoever, whether or not later found to be invalid and whether or not in breach of employment laws in the jurisdiction where you are employed or rendering services, or the terms of your employment agreement, if any), and in consideration of the grant of the RSUs to which you are otherwise not entitled, you irrevocably agree never to institute any claim against the Company or the Affiliate employing or retaining you, waive your ability, if any, to bring any such claim, and release the Company and the Affiliate employing or retaining you from any such claim&#59; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, you shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim&#59; and</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(11)&#160;&#160;&#160;&#160;you acknowledge and agree that neither the Company, the Affiliate employing or retaining you nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the currency of the country in which you reside and the United States Dollar that may affect the value of the RSUs or of any amounts due to you pursuant to the settlement of the RSUs or the subsequent sale of any Ordinary Shares acquired upon settlement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appendix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Notwithstanding any provisions in this Agreement, the RSU grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement for your country.  Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to you, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan.  If you relocate to the United States, the special terms and conditions in the Appendix will apply, or cease to apply, to you, to the extent the Company determines that the application or otherwise of such provisions is necessary or advisable in order to facilitate the administration of the Plan.  The Appendix constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company reserves the right to impose other requirements on your participation in the Plan, on the RSUs and on any Ordinary Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">****</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">We look forward to your continuing contribution to the growth of the Company.  Please acknowledge your receipt of the Plan and this Award.</font></div><div style="text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="text-indent:198pt"><font><br></font></div><div style="text-indent:198pt"><font><br></font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Orlando Ashford</font></div><div style="text-align:justify;text-indent:198pt"><font><br></font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Orlando Ashford</font></div><div style="text-align:justify;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chairman of the Board</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">APPENDIX</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PERRIGO COMPANY PLC<br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Additional Terms and Provisions to</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Restricted Stock Unit Award Agreement (Service-Based)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix (the &#8220;Appendix&#8221;) includes additional terms and conditions that govern the restricted stock units (&#8220;RSUs&#8221; or &#8220;Award&#8221;) granted to you under the Plan if you reside in one of the countries listed below. Certain capitalized terms used but not defined in this Appendix have the meanings set forth in the Plan and&#47;or the Agreement.  The Award will not create any entitlement to receive any similar benefit in the future. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Appendix also includes country-specific information of which you should be aware with respect to your participation in the Plan.  The information is based on the securities, exchange control and other laws in effect in the respective countries as of January 2023.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that you do not rely on the information noted herein as the only source of information relating to the consequences of your participation in the Plan because the information may be out of date at the time that you vest in the RSUs and Ordinary Shares are issued to you or the shares issued upon vesting of the RSUs are sold.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, the information is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of any particular result.  Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your particular situation.  Finally, please note that if you are a citizen or resident of a country other than the country in which you are currently working, or transfers employment after grant, the information contained in the Appendix may not be applicable.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Conditions et dispositions suppl&#233;mentaires &#224; l&#8217;</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Accord relatif &#224; l&#8217;attribution d&#8217;unit&#233;s d&#8217;action avec restrictions (r&#233;mun&#233;ration fond&#233;e sur les services)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice (l&#8217;&#171;&#160;Appendice&#160;&#187;) comprend des conditions compl&#233;mentaires r&#233;gissant les unit&#233;s d&#8217;action avec restrictions (&#171;&#160;UAR&#160;&#187; ou &#171;&#160;Prime&#160;&#187;) qui vous sont attribu&#233;es en vertu du Plan si vous r&#233;sidez dans l&#8217;un des pays repris ci-dessous. Certains termes commen&#231;ant par une lettre majuscule utilis&#233;s dans le pr&#233;sent Accord mais qui n&#8217;y sont pas d&#233;finis ont le sens qui leur est attribu&#233; dans le Plan ou l&#8217;Accord. La Prime n&#8217;instaure aucun droit &#224; recevoir des avantages similaires &#224; l&#8217;avenir. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Le pr&#233;sent Appendice comprend &#233;galement des informations sp&#233;cifiques aux pays dont vous devez avoir connaissance eu &#233;gard &#224; votre participation au Plan. Les informations se fondent sur les lois relatives aux valeurs mobili&#232;res, au contr&#244;le des &#233;changes et autres en vigueur dans les pays respectifs en janvier 2023. Souvent complexes, ces lois font l&#8217;objet de modifications fr&#233;quentes. Par cons&#233;quent, la Soci&#233;t&#233; vous recommande vivement de ne pas consid&#233;rer les renseignements repris aux pr&#233;sentes comme l&#8217;unique source d&#8217;information relative aux cons&#233;quences de votre participation au Plan, car ces renseignements peuvent &#234;tre obsol&#232;tes au moment de la d&#233;volution des UAR ou de l&#8217;&#233;mission des Actions ordinaires pour votre compte, ou de la vente des actions &#233;mises lors de la d&#233;volution des UAR.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Par ailleurs, ces informations sont d&#8217;ordre g&#233;n&#233;ral et peuvent ne pas s&#8217;appliquer &#224; votre situation particuli&#232;re. De plus, la Soci&#233;t&#233; n&#8217;est pas en mesure de vous garantir un quelconque r&#233;sultat particulier. Par cons&#233;quent, il vous est conseill&#233; de demander des conseils professionnels appropri&#233;s quant &#224; la mani&#232;re dont les lois de votre pays en la mati&#232;re peuvent s&#8217;appliquer &#224; votre situation particuli&#232;re. Enfin, veuillez noter que si vous &#234;tes citoyen ou r&#233;sident d&#8217;un pays autre que celui dans lequel vous travaillez actuellement ou si votre emploi est transf&#233;r&#233; apr&#232;s l&#8217;octroi, les informations figurant dans l&#8217;Appendice peuvent ne pas appliquer.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Extra voorwaarden en voorzieningen bij</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">De Overeenkomst over voorwaardelijk toegekende aandelen (op basis van diensten)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Algemene voorwaarden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage (de 'Bijlage') omvat extra algemene voorwaarden voor de voorwaardelijk toegekende aandelen ('RSU's' of 'Award') die u volgens het Plan zijn toegekend als u in een van onderstaande landen woont. Bepaalde termen in hoofdletters die in deze Bijlage werden gebruikt maar niet gedefinieerd, hebben de betekenis die in het Plan en&#47;of de Overeenkomst is vermeld. De Award cre&#235;ert geen recht om een soortgelijk voordeel in de toekomst te krijgen. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deze Bijlage bevat ook landenspecifieke informatie waarvan u op de hoogte moet zijn met betrekking tot uw deelname aan het Plan. De informatie is gebaseerd op de effecten-, wisselcontrole- en andere wetten die in de respectieve landen sinds januari 2023 van kracht zijn.  Zulke wetten zijn vaak complex en worden regelmatig aangepast. Daarom raadt het Bedrijf u ten sterkste aan de informatie hierin niet te gebruiken als enige bron van informatie over de gevolgen van uw deelname aan het Plan, omdat de informatie verouderd kan zijn op het ogenblik dat uw toezegging in de RSU's en de Gewone aandelen u worden uitgekeerd of wanneer de bij de toezegging van de RSU's uitgegeven aandelen worden verkocht.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ook is de informatie algemeen van aard en mag u ze niet toepassen op uw specifieke situatie. Het Bedrijf bevindt zich evenmin in een positie om u een specifiek resultaat te verzekeren. We raden u dan ook aan om professioneel advies te vragen over hoe de relevante wetten in uw land van toepassing kunnen zijn op uw specifieke situatie. Ten slotte, merk op dat als u een burger of inwoner bent van een ander land dan het land waarin u op dit moment werkt, of uw tewerkstelling na de toekenning verhuist, de informatie in de Bijlage mogelijk niet van toepassing is.</font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Dodatkowe warunki i postanowienia</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Umowa przydzia&#322;u Akcji warunkowych (w oparciu o stosunek pracy)</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik (&#8222;Za&#322;&#261;cznik&#8221;) zawiera dodatkowe warunki, kt&#243;re reguluj&#261; akcje warunkowe (&#8222;RSU&#8221;) przyznan&#261; w ramach Programu, je&#347;li mieszkasz w jednym z wymienionych poni&#380;ej kraj&#243;w. Okre&#347;lone terminy pisane wielk&#261; liter&#261;, kt&#243;re nie zosta&#322;y zdefiniowane w niniejszym Za&#322;&#261;czniku, maj&#261; znaczenie okre&#347;lone w Programie i&#47;lub Umowie. Prawo nie uprawnia do uzyskiwania podobnych korzy&#347;ci w przysz&#322;o&#347;ci. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Niniejszy Za&#322;&#261;cznik zawiera r&#243;wnie&#380; informacje dotycz&#261;ce poszczeg&#243;lnych kraj&#243;w, o kt&#243;rych powiniene&#347;(-as) wiedzie&#263; w zwi&#261;zku z uczestnictwem w Programie. Informacje oparte s&#261; na papierach warto&#347;ciowych, kontroli dewizowej i innych przepisach obowi&#261;zuj&#261;cych w odpowiednich krajach od stycznia 2023 r. Takie przepisy prawa s&#261; cz&#281;sto skomplikowane i cz&#281;sto si&#281; zmieniaj&#261;. W zwi&#261;zku z tym Sp&#243;&#322;ka zdecydowanie zaleca, aby nie polega&#263; na informacjach wymienionych w niniejszym dokumencie jako jedynym &#378;r&#243;dle informacji zwi&#261;zanych z konsekwencjami uczestnictwa w Programie, gdy&#380; informacje te mog&#261; by&#263; nieaktualne w momencie nabycia lub wykonywania opcji na akcje, a Akcje Zwyk&#322;e s&#261; Ci wydawane lub w przypadku sprzeda&#380;y Akcji Zwyk&#322;ych nabytych w ramach Programu.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto informacje maj&#261; charakter og&#243;lny i mog&#261; nie mie&#263; zastosowania do konkretnej sytuacji, a Sp&#243;&#322;ka nie jest w stanie zapewni&#263; Ci &#380;adnego konkretnego rezultatu. W zwi&#261;zku z tym zaleca si&#281; zasi&#281;gni&#281;cie odpowiedniej profesjonalnej porady dotycz&#261;cej tego, w jaki spos&#243;b odpowiednie przepisy w Twoim kraju mog&#261; mie&#263; zastosowanie do konkretnej sytuacji. Wreszcie nale&#380;y pami&#281;ta&#263;, &#380;e je&#347;li jeste&#347; obywatelem&#47;obywatelk&#261; lub rezydentem&#47;rezydentk&#261; kraju innego ni&#380; kraj, w kt&#243;rym obecnie pracujesz lub przenosisz si&#281; do nowego miejsca po przyznaniu, informacje zawarte w Za&#322;&#261;czniku mog&#261; nie mie&#263; zastosowania.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Australia</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:108%">Important Notice </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:108%">No financial product advice is provided in this Appendix, this Agreement or the Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:108%">Plan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:108%">&#8221;) and nothing should be taken to constitute a recommendation or statement of opinion that is intended to influence a person or persons in making a decision to participate in the Plan.The Plan Documents do not take into account your objectives, financial situation and needs. You should consider obtaining your own financial product advice from a person who is licensed by the Australian Securities and Investments Commission to give such advice.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:108%">If you intend to apply to participate in the Plan, you must make your own independent assessment and investigation in relation to your legal and taxation position including seeking professional advice.  You must base any decision you may make on such independent assessment, investigation or advice.</font></div></td></tr></table></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Offer made without disclosure</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A copy of the terms of the Plan will be provided to you with this Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of the Plan, an offer to receive RSUs and participate in the Plan, if received in Australia, is made without disclosure to investors in reliance on the regulatory relief set out in Division 1A of Part 7.12, and for the purposes of section 1100N(b), of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Corporations Act 2001</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Cth).</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As set out in this Agreement, an RSU represents the right to receive one Ordinary Share subject to all the relevant vesting conditions being met, or otherwise waived, in accordance with the Plan. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The RSUs will be issued for nil consideration. You are not required to pay for an RSU or for the subsequent issue or transfer of an Ordinary Share on vesting of that RSU, however your responsibility for any taxes will be as set out in the terms of the Plan and this Agreement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Clause 1.5(d) of this Agreement provides that you will be credited one additional RSU for each Ordinary Share that you would have received had your outstanding RSUs been Ordinary Shares. Notwithstanding that clause, for the purposes of complying with any applicable laws (including the conditions of  any applicable regulatory relief), the Company&#8217;s board of directors may determine, in its sole discretion, to pay any dividend equivalents to which you are entitled under clause 1.5 of this Agreement wholly in cash. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company will not provide you with any loans or financial assistance under the Plan in connection with the offer of the RSUs.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No RSUs or resulting Ordinary Shares provided to you under the Plan will be held by a trustee&#47;nominee.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The indicative daily price of the Ordinary Shares on the New York Stock Exchange (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), quoted in US dollars, is available on the Company&#8217;s website at http&#58;&#47;&#47;perrigo.investorroom.com&#47;stock-information. The Ordinary Shares are also quoted on the NASDAQ Stock Market (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NASDAQ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) (refer to NASDAQ&#8217;s website at </font><font style="color:#145da4;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">http&#58;&#47;&#47;www.nasdaq.com&#47;symbol&#47;prgo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Australian dollar equivalent of the Ordinary Shares can be determined using prevailing exchange rate published by Thomson Reuters (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Prevailing Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) Alternatively, the Company will advise you of the price of its Ordinary shares (in equivalent Australian dollars) as soon as possible following receipt of any request for such information. This information may be obtained by you contacting your local Human Resources representative.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Before accepting an offer to be granted RSUs, you should satisfy yourself that you have a sufficient understanding of the risks set out below and should consider if the RSUs are a suitable investment for you, having regard to your own investment objectives, financial circumstances and taxation position&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.8pt">the vesting conditions for your RSUs may not be satisfied for reasons beyond the Company or your control&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.18pt">you are not permitted to transfer your RSUs unless permitted under this Agreement or the Plan&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.8pt">if your RSUs vest and you subsequently receive Shares&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:63.8pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.98pt">the value of those shares may rise and fall according to investor sentiment, general economic conditions and outlook, international and local stock markets, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:63.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">employment, inflation, interest rates, government policy, taxation and regulation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:63.8pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.93pt">there is no guarantee that an active trading market for the shares will exist or that the price of the shares will increase. There may be relatively few potential buyers or sellers of the shares on the NYSE, NASDAQ ,TASE or any other applicable market at any time and this may increase the volatility of the market price of the shares. It may also affect the prevailing market price at which you may be able to sell your Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:63.8pt;text-align:justify;text-indent:-28.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:11.88pt">except as otherwise provided in this Agreement, you will have no voting, dividend, or other stockholder rights in any Shares until you become the registered holder of those Shares. Until you become the registered holder of Shares, you will have only the rights of an unsecured creditor with respect to those Shares&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.18pt">there may be taxation implications arising for you in participating under this Agreement and in the Plan. The tax consequences of participating in the Plan are based on complex tax laws, which may be subject to varying interpretations, and the application of such laws may depend, in large part, on the surrounding facts and circumstances. The tax regime applying to you may change.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the above risks are only general risks of acquiring and holding RSUs under the Plan. It does not purport to list every risk that may be associated with the Plan now or in the future. There may be other risks of participating in the Plan or holding shares that are specific to your circumstances.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you acquire Ordinary Shares following exercise of your RSU and you offer those shares for sale to a person or entity resident in Australia, then the offer may be subject to disclosure requirements under Australian law.  You should obtain legal advice on your disclosure obligations prior to making any such offer.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If at the time of vesting, the Company determines that it is not legal under Australian securities laws to issue or transfer the Ordinary Shares, the outstanding RSUs will be cancelled and no Shares will be issued or transferred to you nor will any benefits in lieu of shares be paid to you.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control reporting mandates disclosure of payments equal to or exceeding AUD10,000 made to a foreign individual or entity. This reporting is generally done automatically by the financial institution making the transfer.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Austria</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of Austria, you must submit a report to the Austrian National Bank. An exemption applies if the value of the shares as of any given quarter is less than &#8364;5,000,000 (when converted to Euros if applicable). If the threshold is met or exceeded, quarterly reporting obligations exist If quarterly obligations apply, the reporting date is the end of each quarter and the deadline for filing the report is the 15th of the month following the end of the quarter.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When shares are sold, there may be exchange control obligations if the cash received is held in a bank account outside Austria.  If the volume of all your accounts abroad exceeds &#8364;10,000,000 (when converted to Euros if applicable), the balances of all accounts must be reported monthly, as of the last day of the month, on or before the fifteenth day of the following month.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Belgium </font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to report any security or bank accounts (including brokerage accounts) you maintain outside of Belgium on your annual tax return.  In a separate report, you are required to provide the National Bank of Belgium with certain details regarding such foreign accounts (including the account number, bank name and country in which any such account was opened).  This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under Kredietcentrales &#47; Centrales des cr&#233;dits caption.</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Stock Exchange Tax.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A stock exchange tax could apply for Belgian tax residents transacting through a non-Belgium broker once the shares are sold. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Communication d&#8217;informations relatives aux actifs ou comptes &#233;trangers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Vous &#234;tes tenu de d&#233;clarer, dans votre d&#233;claration fiscale annuelle, tout compte-titres ou compte en banque (y compris les comptes de courtage) que vous d&#233;tenez en dehors de la Belgique. Dans une d&#233;claration distincte, vous &#234;tes tenu de communiquer &#224; la Banque Nationale de Belgique certains d&#233;tails concernant les comptes &#233;trangers (notamment le num&#233;ro de compte, le nom de la banque et le pays o&#249; le compte a &#233;t&#233; ouvert). Cette d&#233;claration ainsi que toutes les informations indiquant comment la remplir sont disponibles sur le site web de la Banque Nationale de Belgique (www.nbb.be) &#224; la section &#171;&#160;Centrales des cr&#233;dits&#47;Kredietcentrales&#160;&#187;.</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Meldingen</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informatie over buitenlands vermogen&#47;rekeningrapportering.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> U moet alle garantie- of bankrekeningen (inclusief beleggingsrekeningen) die u buiten Belgi&#235; bezit, vermelden op uw jaarlijkse belastingsbrief.  In een afzonderlijk overzicht moet u de Nationale Bank van Belgi&#235; informatie geven over zulke buitenlandse rekeningen (inclusief het rekeningnummer, de naam van de bank en het land waarin zulke rekening is geopend).  Dit overzicht, evenals extra informatie over hoe u het moet opstellen, vindt u op de website van de Nationale Bank van Belgi&#235;, www.nbb.be, onder de titel Kredietcentrales.</font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Bermuda</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is not subject to and has not received approval from the Bermuda Monetary Authority and the Registrar of Companies in Bermuda, and no statement to the contrary, explicit or implicit, is authorized to be made in this regard.  The securities may be offered or sold in Bermuda only in compliance with the provisions of the Investment Business Act 2003 of Bermuda.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Brazil</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You agree that, for all legal purposes, (i) the benefits provided under the Plan are the result of commercial transactions unrelated to your employment&#59; (ii) the Plan is not a part of the terms and conditions of your employment&#59; and (iii) the income from the RSUs, if any, is not part of your remuneration from employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the RSUs, you agree to comply with Brazilian law when the RSUs vest and the shares are sold. You also agree to report and pay any and all taxes associated with the vesting of the RSUs, the sale of the RSUs acquired pursuant to the Plan, and the receipt of any dividends.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> If you are a resident or domiciled in Brazil and hold assets and rights outside Brazil with an aggregate value exceeding US$100,000, you will be required to prepare and submit to the Central Bank of Brazil an annual declaration of such assets and rights. Assets and rights that must be reported include RSUs.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Canada</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Payout of RSUs in Shares Only</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to all Employees residing in Canada, the Company will convert all vested RSUs only into an equivalent number of Shares and the Plan will not provide an option to settle the RSUs in cash. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Canadian residents may be required to report foreign property (including Shares) on an annual basis on form T1135 (Foreign Income Verification Statement) if the total cost of the foreign property exceeds CAD 100,000 at any time in the year. The grant of RSUs must be reported if the CAD 100,000 cost threshold is exceeded because of other foreign property held. RSUs may be reported at a nil cost. The form must be filed by April 30 of the following year. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Withholding will include both federal income tax as well as provincial tax.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Resale Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Ordinary Shares received by Canadian residents pursuant to this Plan will be subject to an indefinite holding period and the resale of the Ordinary Shares will be prohibited, unless certain conditions are met in respect of the Company in accordance with applicable Canadian securities laws or another applicable Canadian prospectus exemption is available.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Eligibility of Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding the terms of this Agreement or the Plan, no offers of RSUs or Ordinary Shares may be made to you if you are not an employee, executive officer, director or consultant of the Company or a related entity of the Company, in accordance with Section 2.24 of National Instrument 45-106.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employment Law Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the term &#8220;Termination Date&#8221; shall mean the earliest of&#58;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)&#160;&#160;&#160;&#160;Any date specified in this Agreement or the Plan&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)&#160;&#160;&#160;&#160;The date on which the Company or any applicable Affiliate delivers to you notice in a form prescribed by the Company that the Company is thereby terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)&#160;&#160;&#160;&#160;Except in the event of a Separation for Good Reason, the date on which you deliver notice in a form prescribed by the Company to the Company or any applicable Affiliate that you are terminating the employment relationship (regardless of whether the notice or termination is lawful or unlawful or is in breach of any contract of employment)&#59;</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)&#160;&#160;&#160;&#160;The date on which you cease to provide services to the Company or any applicable Affiliate, except where you are on an authorized leave of absence&#59; and</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e)&#160;&#160;&#160;&#160;The date on which you cease to be considered an &#8220;employee&#8221; of the Company or any applicable Affiliate under applicable law.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of this Agreement or the Plan, the definitiona of &#8220;Cause&#8221; shall be determined in accordance with applicable laws in the jurisdiction of employment.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In accordance with Section 2.13, you consent and agree to the payment of the reimbursements set out therein, including through deductions of the amounts specified in paragraph 2.13 from any wages owed by the Company to the employee. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The provisions set out in Section 2.15(a) do not apply to employees in the province of Ontario other than executive employees who are exempted from XV.1 of the Ontario Employment Standards Act, 2000.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Czech Republic</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Documents in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Award, you confirm that you have read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">P&#345;ijet&#237;m tohoto Ozn&#225;men&#237; potvrzujete, &#382;e jste p&#345;e&#269;etl a porozum&#283;l jste Podm&#237;nk&#225;m pl&#225;nu (&#8220;Plan&#8221;) a Smlouv&#283; (&#8220;Agreement&#8221;), kter&#233; V&#225;m byly poskytnuty v anglick&#233;m jazyce. Z&#225;rove&#328; prohla&#353;ujete, &#382;e souhlas&#237;te s podm&#237;nkami uveden&#253;mi v t&#283;chto dokumentech.</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restriction on cash payments.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Under Czech Act No. 235&#47;2004 Coll., on Cash Payments, as amended, it is prohibited to receive or provide payments in cash exceeding the amount of CZK 270.000 within one day. Payments exceeding this amount must be executed cashless. This restriction relates to payments from one contracting party to one other contracting party. Thus, it is not a restriction on the sum of all payments made by one individual or entity within one day.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nevertheless, since the restriction on cash payments may be subject to a change (especially a lower threshold might be set), we recommend consulting your personal legal advisor prior to receiving or providing a larger amount of cash payments.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Denmark</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Danish Stock Options Act. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You acknowledge that you have received an Employer Statement translated in Danish, which will be provided to comply with the Danish Stock Options Act, to the extent it applies to RSUs. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have to report your</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">foreign broker accounts and shares held in a foreign bank or broker to the Danish tax administration. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award Agreement is subject to the Danish Stock Option Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aktieoptionsloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), which applies on share option agreements entered into as part of an employment, if the ownership of the shares is obtained at a later point. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This act is based on a principle of the right to freely agree on the terms of the Award Agreement with certain exceptions stated in the act. In addition to the act, the Danish Contract Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">aftaleloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and Danish case law also regulates the terms of the Award Agreement. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below, it is outlined when the Danish Stock Option Act, the Danish Contract Act, Danish case law and other applicable legislation deviate from terms stated in the Award Agreement&#58;  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.3, subsection d, litra 1 in the Award Agreement does not entail that applicable notice periods under Danish employment legislation and your employment agreements are deviated from to the detriment of you. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.3, subsection d, litra 2 (i and ii) in the Award Agreement is amended to the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:92.15pt;padding-right:-9.35pt;text-align:justify;text-indent:-26.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;(2) &#8220;Termination without Cause&#8221; means the involuntary termination of your employment or contractual relationship by the Company without any Cause.&#8221; </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Regardless of section 2.3 in the Award Agreement, vested and acquired shares do not lapse as a consequence of your Termination Date for reasons of Cause. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In relation to Section 2.7 in the Award Agreement the following also applies, which supersedes section 2.7 in case of conflicting regulation&#58; </font></div><div style="padding-left:65.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;The Company is required to report the market value of the RSUs to the Danish tax authorities to both E-income and E-capital with the Danish tax authorities. For E-income, the value of the RSUs should be reported as income art 50 in field 068 and should be reported by the Company in the month the shares vest. For E-capital, the value of the RSUs should be reported to the Danish tax authorities no later than the 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of January the following year after the RSUs have vested. </font></div><div style="padding-left:65.2pt;text-align:justify"><font><br></font></div><div style="padding-left:65.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The market value of the provided RSUs is to be reported by the Company as personal income in the year of vest and is subject to a marginal tax rate of 56% including labor market contribution.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:65.2pt;text-align:justify"><font><br></font></div><div style="padding-left:65.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The tax payment obligation for the value of the shares will be collected with the individual, and the responsibility to ensure that the correct amount is reported on the Danish tax assessment remains with the individual. </font></div><div style="padding-left:65.2pt;text-align:justify"><font><br></font></div><div style="padding-left:65.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At the time of sale, you are subject to tax on the gain, if any, at a marginal tax rate of 42%. The capital gain is calculated as the difference between the average fair market value at vest and the sales price. </font></div><div style="padding-left:65.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If there is a loss tied to the sale of the RSUs, the loss can be deducted in capital gain from other listed RSUs.</font></div><div style="padding-left:65.2pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:65.2pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that it is mandatory for you to report information on RSUs from a foreign depot to the Danish tax authorities. If this information is not provided to the Danish tax authorities, a potential loss cannot be used for deduction. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to section 2.10, subsection b, all personal information will be managed in accordance with the European Data Protection Regulation (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">databeskyttelsesforordningen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and the Danish Data Protection Act (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">personbeskyttelsesloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 2.15, subsection a &#8211; d in the Award Agreement is void and unenforceable in Denmark and instead the following is agreed&#58;  </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt">NON-COMPETITION AND NON-SOLICITATION</font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">You will be covered by this non-competition and non-solicitation clause for 6 months after the effective date of termination. </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">In this period, you are entitled to &#8211; only with the prior written consent of the affiliate employing or retaining you (the &#8220;Affiliate&#8221;) &#8211; be engaged or financially interested, directly or indirectly, in any business which develops and&#47;or distributes products or services that compete or may compete with the Affiliate or any group companies&#8217; products and&#47;or services or in any other business competing with the Affiliate or any group companies in any other way. This restriction includes any interest whatsoever by way of, for example, employment, ownership in full or in part, membership of a board, consultancy services and the like in Denmark and abroad. </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">Conclusion of this non-competition clause is required because you hold a very special position of trust, and you will receive detailed knowledge about the Affiliate and group companies&#8217; affairs, including business secrets, market strategies and plans, information on customers and suppliers. This knowledge may be exploited to the detriment of the Affiliate or group companies, if you become employed with a competing company immediately after the effective date of termination.</font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">During 6 months after the effective date of termination, you are only with the prior written consent of the Affiliate entitled to be in contact with or have business relations, directly or indirectly, with customers, suppliers or cooperation partners, etc., with whom you have had business relations within the last 12 months prior to the termination. In connection with the termination, the Affiliate will prepare a list of the customers, suppliers and cooperation partners covered by the restriction in this clause. In this connection, you must loyally contribute to the drafting of a thorough list covering all customers, suppliers and&#47;or cooperation partners with whom you have had business relations within the last 12 months prior to the termination. Your deliberate failure to contribute loyally to this list will be considered a material breach of the employment and the Award Agreement.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">The effective date of termination is to be construed as the date on which you may be ordered or entitled to resign after the expiry of the notice period, notwithstanding whether you actually end your work with the employing company at an earlier date. </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.55pt">The non-competition part of this clause will cease to apply, if the Affiliate gives notice of termination to you without you having reasonably caused the termination. The non-competition part of this clause will also cease to apply, if you resign from the Affiliate for reasonable cause due to the employing company&#8217;s failure to fulfil its obligations, cf. section 11 (1) in the Danish Act on Employment Clauses (in Danish&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">ans&#230;ttelsesklausulloven</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). In both situations, the non-solicitation part of this clause will be maintained.  </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.55pt">The Affiliate may terminate the clause with one month's notice to expire at the end of a month, cf. section 10 (1) in the Danish Act on Employment Clauses.    </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.55pt">As compensation for the clause, you will receive a monthly compensation in accordance with the Danish Act on Employment Clauses. Compensation currently amounts to 60 % of the monthly salary at the effective date of termination and is payable in the period in which the clause applies. At the effective date of termination, the first two months of compensation will be paid to you as a lump sum. If the clause applies, compensation will after the first two months be payable each month in arrears in the rest of the period in which the clause applies. If you obtain other appropriate paid work, compensation equivalent to 24 % of the monthly salary at the effective date of termination will be paid from the third month after the effective date of termination. You are obligated to actively seek other appropriate work and to notify the Affiliate in writing of any new work. Failure to observe the duty of mitigation will be considered a material breach of the employment with the effect that your right to compensation will lapse. The right to compensation will lapse, if the Affiliate has lawfully terminated your employment without notice.   </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.55pt">In the event of your breach of the clause, the Affiliate will be entitled to a penalty of between three and six months' salary for any one breach of the clause and compensation for any additional loss. In the event of a persistent breach of the clause, each month or part of a month is deemed to constitute an independent breach entitling the Affiliate to a new, independently agreed penalty. Any payment of the agreed penalty shall not lead to the discontinuance of your obligation to comply with the clause. The Affiliate may also seek to restrain any breach of the clause through the issue of an injunction.  </font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:42.55pt;text-align:justify;text-indent:-42.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.15.13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.55pt">This clause may be invoked by the Affiliate from the date on which you have been employed with the employing company for six months.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Estonia</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Finland</font></div><div style="margin-bottom:12pt;padding-right:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  If you hold Ordinary Shares acquiqred under the Plan, you are generally required to include those Ordinary Shares as assets in your individual tax return.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">France</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">En acceptant cette attribution gratuite d'actions, vous confirmez avoir lu et comprenez le Plan et ce Contrat, incluant tous leurs termes et conditions, qui ont &#233;t&#233; transmis en langue anglaise. Vous acceptez les dispositions de ces documents en connaissance de cause.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold Ordinary Shares outside of France or maintain a foreign bank account, you are required to report such to the French tax authorities when you file your annual tax return. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The RSUs are not intended to qualify as a French tax qualified restricted stock units under French tax law.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a French resident and hold cash or shares of Common Stock outside of France, you must declare all foreign bank and brokerage accounts (including any accounts that were opened or closed during the tax year) on an annual basis on a special form, No. 3916, together with your income tax return.  </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Renseignements relatifs aux comptes et avoirs &#233;trangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Si vous &#234;tes r&#233;sident fran&#231;ais et que vous d&#233;tenez des liquidit&#233;s ou des Actions ordinaires en dehors de la France, vous &#234;tes tenu de d&#233;clarer chaque ann&#233;e, en m&#234;me temps que votre d&#233;claration de revenus, les r&#233;f&#233;rences de vos comptes bancaires et comptes-titres &#233;trangers (y compris les comptes qui ont &#233;t&#233; ouverts ou ferm&#233;s pendant l&#8217;exercice fiscal) par le biais d&#8217;un formulaire sp&#233;cifiquement pr&#233;vu &#224; cet effet, le formulaire N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">o&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3916. </font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Germany</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Cross-border payments related to securities transactions in excess of &#8364;12,500 must be reported by the fifth calendar day of the month following the respective payment to the German Central Bank (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Bundesbank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).  If you use a German bank to transfer a cross-border payment related to securities transactions in excess of &#8364;12,500 (e.g. in connection with the sale of shares acquired under the Plan), the bank will make the report for you. In addition, you must report any receivables, payables, or debts in foreign currency exceeding an amount of &#8364;5,000,000 (by the tenth calendar day after the expiry of one month) and any cross-border shareholdings in companies if the share in the capital or the voting rights amount(s) to 10% or more and the investment object exceeds a balance sheet total of &#8364;3,000,000 (by the last working day of the sixth calendar month following December 31) on a monthly basis.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In case of an acquisition of shares in a foreign company with an overall investment amount of more than &#8364;150,000 (or in case of an acquisition of 10% or more of the shares in a foreign company), you should consult with your tax advisor whether the investment would have to be reported to your tax office.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Greece</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to your Award, if you withdraw funds of &#8364;15,000 or more from a bank in Greece and remit those funds out of Greece, you may be required to submit certain documentation&#47; information to the Greek bank to ensure that the transfer is not in violation of Greek anti-money laundering rules. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Hungary</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">India</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Notification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You understand that you must repatriate any dividends and proceeds from the sale of shares acquired under the Plan to India and convert the proceeds into local currency within 180 days of receipt assuming share holding is less than 10% of the company's share capital or as prescribed under applicable Indian exchange control laws as may be amended from time to time. You will receive a foreign inward remittance certificate (&#34;FIRC&#34;) from the bank where you deposit the foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or your employer requests proof of repatriation.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The amount subject to tax on receipt of the shareswill partially be dependent upon a valuation that the Company or your employer will obtain from a Merchant Banker in India.  Neither the Company nor your employer has any responsibility or obligation to obtain the most favorable valuation possible, nor obtain valuations more frequently than required under Indian tax law.</font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You are required to declare in the applicable schedules of your annual tax return (a) any foreign assets held by you (e.g., Ordinary Shares acquired under the Plan and, possibly, the Award), (b) any foreign bank accounts for which you have signing authority and (c) any foreign custodian accounts.  </font></div><div style="padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ireland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Director Notification Obligation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are a director, shadow director or secretary of the Company's Irish Subsidiary or Affiliate, you must notify the Irish Subsidiary or Affiliate in writing within five business days of receiving or disposing of an interest exceeding 1% of the Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(e.g., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RSUs, shares, etc.), or within five business days of becoming aware of the event giving rise to the notification requirement or within five days of becoming a director or secretary if such an interest exists at the time. This notification requirement also applies with respect to the interests of a spouse or children under the age of 18 (whose interests will be attributed to the director, shadow director or secretary).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Israel</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Type of Grant&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633; </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capital Gain Award (&#8220;CGA&#8221;)</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ordinary Income Award (&#8220;OIA&#8221;)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 3(i) Award</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9633;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Unapproved 102 Award</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Settlement of RSUs</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Agreement, if the RSUs granted hereunder are 102 Awards, the RSUs shall be settled in Ordinary Shares only.</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Trust. </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All Approved 102 Awards shall be held in trust by a trustee designated by the Company (</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#34;Trustee&#34;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or shall be supervised by the Trustee in accordance with the instructions set forth by the Israeli Tax Authority (&#8220;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITA</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;),  for the requisite lockup period prescribed by the Ordinance and the regulations promulgated thereunder, or such other period as may be required by the ITA, during which period Awards or Ordinary Shares issued thereunder, and all rights resulting from them, including bonus shares, must be held by the Trustee. The Trustee shall not release any Approved 102 Awards, Ordinary Shares issued upon the exercise of any Approved 102 Awards, or any rights, including bonus shares, resulting from such Approved 102 Awards or Ordinary Shares, prior to the full payment of your tax liability. The Trustee or the Israeli Affiliate shall withhold any applicable taxes in accordance with Section 102 or any applicable tax ruling obtained by the Company. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without derogating from the foregoing, if your RSUs do&#160;not qualify as Approved&#160;102 Awards the Company may still at its sole discretion, deposit your RSUs in trust to ensure that taxes are properly withheld. </font></div><div><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You hereby release the Trustee from any liability in respect of any action or decision duly taken and executed in good faith in relation to any RSUs or Ordinary Shares issued to you thereunder.</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Without derogating from Section 2.7(b) above, you hereby agree to indemnify the Company and&#47;or its Affiliates and&#47;or the Trustee and hold them harmless against and from any and </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">all</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> liability for all such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to you.</font></div><div style="margin-bottom:10pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compliance with Law.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the RSUs, you agree to comply with the provisions of Section 102 and the regulations and rules promulgated thereunder or any tax ruling to be obtained by the Company in connection with your RSUs. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Italy</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan Document Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  In accepting the RSUs, you acknowledge that you have received a copy of the Plan and the Agreement and have reviewed the Plan and the Agreement, including this Appendix, in their entirety and fully understand and accept all provisions of the Plan and the Agreement, including this Appendix.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax&#47;Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  You are required to report on your annual tax return&#58;  (a) any foreign investments or investments (including the Ordinary Shares issued at vesting of the RSUs, cash or proceeds from the sale of Ordinary Shares acquired under the Plan) held outside of Italy, if the investment may give rise to income in Italy (this will include reporting the Ordinary Shares issued at vesting of the RSUs if the fair market value of such Ordinary Shares combined </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with other foreign assets)&#59; and (b) any changes during the financial year which have had an impact during the calendar year on your foreign investments or investments held outside of Italy.  </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are exempt from these formalities if the investments are made through an authorized broker resident in Italy, as the broker will comply with the reporting obligation on your behalf.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Kazakhstan</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to report the acquisition of shares of a foreign company to the National Bank of Kazakhstan. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Latvia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Lithuania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Luxembourg</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are required to report any inward remittances of funds to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Banque Central de Luxembourg </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and&#47;or the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Service Central de La Statistique et des Etudes Economiques</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Luxembourg financial institution is involved in the transaction, it generally will fulfill the reporting obligation on your behalf. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Mexico</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the RSUs, you understand and agree that any modification of the Plan or the Agreement or its termination shall not constitute a change or impairment of the terms and conditions of employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan Document Acknowledgment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the award of the RSUs, you acknowledge that you have received copies of the Plan, have reviewed the Plan and the Agreement in their entirety and fully understand and accept all provisions of the Plan and the Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, by signing the Agreement, you further acknowledge that you have read and specifically and expressly approve the terms and conditions in the Agreement, in which the following is clearly described and established&#58; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.03pt">Participation in the Plan does not constitute an acquired right&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.69pt">The Plan and participation in the Plan is offered by the Company on a wholly discretionary basis&#59; </font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">Participation in the Plan is voluntary&#59; and </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.69pt">The Company and any Parent, Subsidiary or Affiliates are not responsible for any decrease in the value of the shares.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Labor Law Acknowlegement and Policy Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In accepting the RSUs, you expressly recognize the Company is solely responsible for the administration of the Plan and that your participation in the Plan and acquisition of Ordinary Shares does not constitute an employment relationship between you and the Company since you are participating in the Plan on a wholly commercial basis and on a wholly commercial basis and your sole employer is Perrigo de Mexico S.A. De C.V. (&#8220;Perrigo Mexico&#8221;). Based on the foregoing, you expressly recognize that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and your employer, Perrigo Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Perrigo Mexico and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of your employment.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company&#59; therefore, the Company reserves the absolute right to amend and&#47;or discontinue your participation at any time without any liability to you.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finally, you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or damages as a result of your participation in the Plan and therefore grant a full and broad release to the Employer, the Company and any Parent, Subsidiary or Affiliates with respect to any claim that may arise under the Plan.</font></div><div style="margin-bottom:12pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Spanish Translation</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modificaci&#972;n</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;Al aceptar las Unidades de Acci&#243;n Restringida (RSUs, por sus siglas en ingl&#233;s) usted entiende y esta de acuerdo que cualquier modificaci&#243;n del plan o del acuerdo o su terminaci&#243;n no constituir&#225; un cambio o detrimento de los t&#233;rminos y condiciones de su empleo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Confirmaci&#243;n del Documento del Plan. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Al aceptar el otorgamiento de las RSUs, usted reconoce que ha recibido copias y ha revisado dicho acuerdo en su totalidad y que ha entendido y aceptado completamente todas las disposiciones contenidas en el Plan y en el Acuerdo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adicionalmente, al firmar el acuerdo, usted reconoce que ha le&#237;do, y aprobado de manera espec&#237;fica y expresa los t&#233;rminos y condiciones en el acuerdo en el que se describe y establece claramente los siguiente&#58;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(xvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:10.48pt">La participaci&#243;n en el Plan no constituye un derecho adquirido&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(xviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.29pt">El plan y la participaci&#243;n en el mismo, son ofrecidos por la Compa&#241;&#237;a de manera totalmente discrecional&#59;&#160;</font></div><div style="padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(xix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.67pt">La participaci&#243;n en el Plan es voluntaria&#59; y</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:-9.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">(xx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.86pt">La Compa&#241;&#237;a, y cualquier Sociedad controladora, Subsidiaria o Filiales no son responsables por ning&#250;n decremento en el valor de las Acciones.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Constancia de aceptaci&#243;n de la ley laboral y declaraci&#243;n de la pol&#237;tica.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160; Al aceptar las RSUs, usted reconoce expresamente que la Compa&#241;&#237;a, es la &#250;nica responsable de la administraci&#243;n del Plan, y que su participaci&#243;n en el Plan y la adquisici&#243;n de las acciones comunes no constituyen una relaci&#243;n de trabajo entre usted y la Compa&#241;&#237;a dado que usted participa en el Plan de manera completamente comercial y el &#250;nico empleador que tiene es Perrigo de M&#233;xico, S.A. de C.V. (&#171; Perrigo de Mexico &#187;). Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que usted pueda obtener de la participaci&#243;n en el Plan, no establecen ning&#250;n derecho entre usted y su empleador Perrigo de M&#233;xico y no forman parte de las condiciones de trabajo ni de las prestaciones ofrecidas por Perrigo de M&#233;xico y cualquier modificaci&#243;n del Plan o la terminaci&#243;n de &#233;ste, no constituyen un cambio o deterioro de los t&#233;rminos y condiciones de su trabajo.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adem&#225;s, usted comprende que su participaci&#243;n en el Plan es el resultado de una decisi&#243;n unilateral y discrecional de la Compa&#241;&#237;a&#59; por lo tanto, la Compa&#241;&#237;a se reserva el derecho absoluto de modificar y&#47;o interrumpir la participaci&#243;n de usted en cualquier momento sin ninguna responsabilidad para usted.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Finalmente, usted declara que no se reserva ninguna acci&#243;n o derecho de presentar alg&#250;n reclamo o demanda en contra de la Compa&#241;&#237;a por compensaci&#243;n, da&#241;o o perjuicio alguno como resultado de su participaci&#243;n en el Plan, en consecuencia, otorga el m&#225;s amplio finiquito al Empleador, as&#237; como a la Compa&#241;&#237;a, a su Sociedad controladora, Subsidiaria o Filiales con respecto a cualquier demanda que pudiera originarse en virtud del Plan.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Netherlands</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dutch insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Norway</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading Notification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Norwegian insider-trading rules prohibit you from effectuating certain transactions involving shares if you have inside information about the Company. If you are uncertain whether the insider-trading rules apply to you, you should consult your personal legal advisor as well as the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Cross-border payments in excess of NOK 100,000 must be reported to the Norwegian foreign exchange register (Valutaregisteret). If you use a Norwegian bank to transfer a cross-border payment in excess of NOK 100,00 in connection with the sale of shares acquired under the Plan, the bank will make the report on your behalf. </font></div><div style="padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset&#47;Account Reporting Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In your Norwegian income tax return, each year you are required to report any security, shares or bank accounts (including brokerage accounts and the Company &#8220;Account&#8221; referenced in section 1.5 of the Agreement) you maintain outside of Norway. The Company &#8220;Account&#8221; should not be treated as taxable wealth, as long as the right to receive the dividends is conditional, but you must report it.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Poland</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Receive Information in English.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> By accepting the Award, you confirm having read and understood the Plan and the Agreement, which were provided in the English language. You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold foreign securities (including shares pursuant to the Award) and maintain accounts abroad, you may be required to file certain reports with the National Bank of Poland (&#8220;NBP&#8221;). Specifically, if the value of securities and cash held in such foreign accounts exceeds PLN 7,000,000 (or equivalent thereof in another currency) at the end of the year, you must file reports on the transactions and balances of the accounts on a quarterly basis by the 26th day of the month following the end of each quarter. In case you are being in regime of a joint marital property, the above threshold shall apply to joint property of the spouses. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, if you hold, at the beginning or end of the year, at least 10% of votes in the decision-making body of the entity based abroad (and you are person meeting the prievusly mentioned criteria), an annual notification, on the official form, must be submitted by you to the NBP by May 31 of the following year.If at the end of the year you did not reach the given threshold but in the next year, at the end of a calendar quarter, you reach the threshold, you are obliged to submit the appropriate form to NBP for this quarter and each of the following quarters of this calendar year (within 26 days from the end of each calendar quarter). Such reports are filed on special forms available on the website of the NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The foregoing duties represents personal responsibilities of each shareholder and cannot be fulfilled by any entity on your behalf.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, if you are a Polish citizen and you transfer funds abroad in excess of the PLN equivalent of &#8364;15,000, the transfer must be made through an authorized bank, a payment institution or an electronic money institution authorized to render payment services. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Furthermore, at the banks&#8217; request, you may be required to inform eligible banks, within the meaning of the Foreign Exchange Act, about all foreign exchange transactions performed through them.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You are also required to retain the documents connected with foreign exchange transactions for a period of five years, as measured from the end of the year in which such transaction occurred.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Warunki</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Zgoda na otrzymywanie informacji w j&#281;zyku angielskim.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Akceptuj&#261;c Opcj&#281;, potwierdzasz przeczytanie i zrozumienie Programu i Umowy, kt&#243;re zosta&#322;y dostarczone w j&#281;zyku angielskim. W zwi&#261;zku z tym akceptujesz warunki tych dokument&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Powiadomienia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Informacje o kontroli dewizowej. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li jeste&#347; w posiadaniu zagranicznych papier&#243;w warto&#347;ciowych (w tym akcji) i posiadasz rachunki za granic&#261;, mo&#380;esz by&#263; zobowi&#261;zany(-a) do z&#322;o&#380;enia okre&#347;lonych sprawozda&#324; w Narodowym Banku Polskim (&#8222;NBP&#8221;. W szczeg&#243;lno&#347;ci, je&#347;li warto&#347;&#263; papier&#243;w warto&#347;ciowych i &#347;rodk&#243;w pieni&#281;&#380;nych gromadzonych na takich rachunkach zagranicznych przekracza na koniec roku 7 000 000 PLN (lub ekwiwalent tej kwoty w innej walucie), nale&#380;y co kwarta&#322; sk&#322;ada&#263; raporty z transakcji i sald rachunk&#243;w do 26 dnia miesi&#261;ca </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">nast&#281;puj&#261;cego po zako&#324;czeniu ka&#380;dego kwarta&#322;u. W przypadku pozostawania we wsp&#243;lno&#347;ci maj&#261;tkowej z ma&#322;&#380;onkiem, powy&#380;szy pr&#243;g dotyczy maj&#261;tku wsp&#243;lnego ma&#322;&#380;onk&#243;w.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#380;eli posiadasz na pocz&#261;tek lub koniec roku co najmniej 10% g&#322;os&#243;w w organie stanowi&#261;cym podmiotu z siedzib&#261; za granic&#261; (i jeste&#347; osob&#261; spe&#322;niaj&#261;c&#261; wy&#380;ej wskazane warunki) musisz z&#322;o&#380;y&#263; w NBP do 31 maja nast&#281;pnego roku dodatkowy raport. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Je&#347;li pod koniec roku nie osi&#261;gn&#261;&#322;e&#347;(-a&#347;) okre&#347;lonego progu, ale w nast&#281;pnym roku, pod koniec kwarta&#322;u kalendarzowego, osi&#261;gniesz pr&#243;g, musisz z&#322;o&#380;y&#263; odpowiedni formularz do NBP za ten kwarta&#322; i ka&#380;dy z kolejnych kwarta&#322;&#243;w tego roku kalendarzowego (w ci&#261;gu 26 dni od zako&#324;czenia ka&#380;dego kwarta&#322;u kalendarzowego). Takie raporty s&#261; sk&#322;adane w specjalnych formularzach dost&#281;pnych na stronie internetowej NBP.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto, je&#347;li jeste&#347; obywatelem Polski i przekazujesz &#347;rodki za granic&#281; w wysoko&#347;ci przekraczaj&#261;cej r&#243;wnowarto&#347;&#263; 15 000 EUR w PLN, przelewu nale&#380;y dokona&#263; za po&#347;rednictwem upowa&#380;nionego banku, instytucji p&#322;atniczej lub instytucji pieni&#261;dza elektronicznego uprawnionej do &#347;wiadczenia us&#322;ug p&#322;atniczych. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ponadto na &#380;&#261;danie bank&#243;w niezb&#281;dne mo&#380;e by&#263; poinformowanie uprawnionych bank&#243;w, w rozumieniu ustawy Prawo dewizowe (Foreign Exchange Act), o wszystkich transakcjach walutowych przeprowadzanych za ich po&#347;rednictwem.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Jeste&#347; r&#243;wnie&#380; zobowi&#261;zany(-a) do przechowywania dokument&#243;w zwi&#261;zanych z transakcjami wymiany walut przez okres pi&#281;ciu lat, mierzony od ko&#324;ca roku, w kt&#243;rym taka transakcja zosta&#322;a wykonana</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Portugal</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Language Consent.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You hereby expressly declare that you have full knowledge of the English language and have read, understood and fully accepted and agreed with the terms and conditions established in the Plan and Award Agreement.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Conhecimento da Lingua.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> O Contratado, pelo presente instrumento, declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo de Atribui&#231;&#227;o (Award Agreement em ingl&#234;s). </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Romania</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Statistical Reporting.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">According to art. 92 of NBR Reg. 4&#47;2021, if you, as a resident of Romania within the meaning of NBR Reg. 4&#47;2021, acquire more than 10% of the share capital in a foreign company, the acquisition must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be reported to the National Bank of Romania (&#8220;NBR&#8221;) for statistical purposes within 30 calendar days of acquisiting the ownership right over the shares of the foreign company. You should consult your personal advisor to determine whether you will be required to submit such documentation to the NBR pursuant to your participation in the Plan. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider-Trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Insider-trading rules prohibit you from carrying out  certain transactions involving shares if you have inside information about the Company (insider dealing). If you are uncertain whether the insider-trading rules apply to you, including with regard to the fact that the Company is listed on the New York Stock Exchange (NYSE), you should consult your personal </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">legal advisor. Depending on the applicable market abuse legislation, you might be subject to certain restrictions on the freedom to trade the shares that are settled through the RSU award, including any applicable prohibition on insider dealing, market manipulation or the unlawful disclosure of inside information.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Serbia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovakia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Foreign Asset Reporting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a foreign asset reporting obligation if you are considered providing independent professional services &#8220;podnikatel&#8221;. You should consult with a personal tax advisor to understand your filing obligations.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Slovenia</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">South Africa</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the RSUs, you agree that, immediately upon vesting of the RSUs, you may need to notify your employer of the amount of any gain realized. If you fail to advise your employer of the gain realized upon vesting, you may be liable for a fine. You will be solely responsible for paying any difference between the actual tax liability and the amount withheld by your employer. It is recommended that you consult with your personal tax advisor with respect to your requirements.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Because no transfer of funds from South Africa is required under the RSUs, no filing or reporting requirements should apply when the award is granted nor when Ordinary Shares are issued upon vesting of the RSUs. However, because the exchange control regulations are subject to change, you should consult your personal advisor prior to vesting and settlement of the award to ensure compliance with current regulations. </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Spain</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No Entitlement for Claims or Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the award of RSUs, you consent to participation in the Plan, and acknowledge that you have received a copy of the Plan document.  You understand that the Company has unilaterally, gratuitously and in its sole discretion decided to make awards of RSUs under the Plan to individuals who may be employees, consultants and directors throughout the world. The decision is limited and entered into based upon the express assumption and condition that any RSUs will not economically or otherwise bind the Company or any Parent, Subsidiary or Affiliate, including your employer, on an ongoing basis, other than as expressly set forth in the Agreement. Consequently, you understand that the Award is given on the assumption and condition that the RSUs shall not become part of any employment contract (whether with the Company or any Parent, Subsidiary or Affiliate, including your employer) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever. Furthermore, you understand and freely accept that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">there is no guarantee that any benefit whatsoever shall arise from the award, which is gratuitous and discretionary, since the future value of the RSUs and the underlying shares is unknown and unpredictable. You also understand that this Award would not be made but for the assumptions and conditions set forth hereinabove&#59; thus, you understand, acknowledge and freely accept that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the Award, the RSUs and any right to the underlying shares shall be null and void.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the RSUs, your termination of service for any reason other than death or disability (including for the reasons listed below) will automatically result in the cancellation and loss of any RSUs that may have been granted to you and that were not or did not become vested on the date of termination of service. In particular, you understand and agree that, unless otherwise expressly provided by the Company in this Agreement, the RSUs will be cancelled without entitlement to the Shares or to any amount as indemnification if you terminate service by reason of, but not limited to, the following&#58; resignation&#59; disciplinary dismissal adjudged to be with cause&#59; disciplinary dismissal adjudged or recognized to be without good cause (i.e., subject to a &#34;despido improcedente&#34;)&#59; individual or collective layoff on objective grounds, whether adjudged to be with cause or adjudged or recognized to be without cause&#59; material modification of the terms of employment under Article 41 of the Workers&#8217; Statute&#59; relocation under Article 40 of the Workers&#8217; Statute&#59; Article 50 of the Workers&#8217; Statute&#59; unilateral withdrawal by your employer&#59; and under Article 10.3 of Royal Decree 1382&#47;1985.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You must declare the acquisition, ownership and disposition of stock in a foreign company (including Ordinary Shares acquired under the Plan) to the Spanish Direcci&#243;n General de Comercio e Inversiones (the &#8220;DGCI&#8221;), the Bureau for Commerce and Investments, which is a department of the Ministry of Economy and Competitiveness, for statistical purposes.  Generally, the declaration must be made in January for Ordinary Shares acquired or sold during (or owned as of December 31 of) the prior year&#59; however, this obligation only applies in the cases in which you hold 10% or more of the sares capital of the Company or 10% or more of the voting tights of the Company.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, you may be required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts held abroad), any foreign instruments (e.g., Ordinary Shares) and any transactions with non-Spanish residents (including any payments of cash or shares made to you by the Company) if the balances in such accounts together with the value of such instruments as of December 31, or the volume of transactions with non-Spanish residents during the prior or current year, exceeds &#8364;1,000,000.  Generally, you will only be required to report on an annual basis (by January 20 of each year).  Note that if the value is less than &#8364;1,000,000, there is only an obligation to declare this information to the Bank of Spain upon request from the Bank of Spain, in which case the deadline is two months since the request is received.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">When receiving foreign currency payments derived from the ownership of Ordinary Shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">., dividends or sale proceeds), you must inform the financial institution receiving the payment of the basis upon which such payment is made. Should amounts exceed &#8364;12,500, you will need to provide the following information to the Spanish Registered Entity&#58; (i) your name, address, and fiscal identification number&#59; (ii) the name and corporate domicile of the Company&#59; (iii) the amount of the payment and the currency used&#59; (iv) the country of origin&#59; (v) the reasons for the payment&#59; and (vi) further information that may be required. Exceptions to this rule are when you move funds through a Spanish resident bank account opened abroad, or when collections and payments are carried out in cash. These exceptions, however, are subject to their own reporting requirements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you hold assets or rights outside of Spain (including shares acquired under the Plan), you may have to file an informational tax report, Form 720, with the tax authorities declaring such ownership by March 31st of the following year.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Generally, there is no obligation to file Form 720 if the total value of the following does not exceed Euro 50,000&#58; </font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">the securities, shares, rights and participations held by you, on December 31 or at any time throughout the year, in any kind of entities or in investment funds located outside Spain&#59;</font></div><div style="padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">any transfer of own capital to third parties located abroad&#59; and</font></div><div style="margin-bottom:12pt;padding-left:39pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">life and disability insurances in which the individual was policy holder on December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that if an asset is jointly owned, the value is not prorated. Please also note that the application of the rules in respect of valuation of assets and transfers during the year should be carefully analyzed. If the limit of Euro 50,000 euros is exceeded for this described group of assets, all the elements of this group must be reported.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For those taxpayers who have filed Form 720 in previous years, they will only be obliged to file it again&#58;</font></div><div style="padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.7pt">When the aggregated value of the assets included in the mentioned group (shares&#47;insurances) had increased in an amount higher than Euro 20,000 regarding the informative return filed in a previous year.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:-9.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.03pt">When the individual&#8217;s condition (owner, co-owner, co-titleholder or co-authorized) had changed or was extinguished during the year, before 31st December, with regard to any of the assets.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Please note that the thresholds for annual filing requirements may change each year. Therefore, you should consult your personal advisor regarding whether you will be required to file an informational tax report for asset and rights that you hold abroad.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Sweden</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The following shall apply in addition to what is set out under section 2.14 of the Award Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Forfeiture of entitlements under the Plan in case of termination shall apply in case of termination of employment regardless of whether such termination of employment may be justified under Swedish employment protection legislation, and regardless of whether such termination may be challenged by you, and regardless of whether such termination is invalidated by verdict or a court order.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax withholdings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You authorize the Company and&#47;or the Employing Company to withhold or sell shares otherwise distributable to you upon vesting or settlement to satisfy the Company&#8217;s payroll tax withholding obligations.</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Switzerland</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securitities Law Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The RSUs and the issuance of any Ordinary Shares thereunder is not intended to be publicly offered in or from Switzerland.  Neither this Award Agreement nor any other materials relating to the Award (1) constitute a prospectus as such term is understood pursuant to article 652a of the Swiss Code of Obligations, (2) may be publicly distributed nor otherwise made publicly available in Switzerland, or (3) have been or will be filed with, approved or supervised by any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Tax Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you are obliged to submit an ordinary annual tax return in Switzerland, you are required to file a salary certificate with the Swiss tax authorities together with your Swiss tax return. The Company or the Affiliate employing you is obliged to prepare a specific attachment regarding the RSUs to this salary certificate. Before Settlement, for wealth tax purposes, the number of RSUs should be declared with p.m (zero value) in the asset statement of the tax return. After Settlement the total number of Ordinary Shares received are subject to wealth tax at the end of the calendar year and must be declared in your Swiss tax return.</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Turkey</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Securitities Law Informations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Under Turkish law, you are not permitted to sell Ordinary Shares acquired under the Plan in Turkey.  The Ordinary Shares are currently traded on the Nasdaq Global Select Market, which is located outside of Turkey, under the ticker symbol &#8220;PRGO&#8221; and the Ordinary Shares may be sold through this exchange.</font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Ukraine </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Notifications</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Control Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange control rules change frequently and you should consult your personal advisor to determine whether you are required to obtain a license for obtaining shares of a foreign company from the National Bank of Ukraine (NBU). </font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Award will be outside the scope of your employment or service contract (if any) and as such will not constitute a part of your compensation package under the respective employment or service contract.  </font></div><div style="margin-bottom:10pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">United Kingdom</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Terms and Conditions</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Income Tax and National Insurance Contribution Withholding.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The following provision supplements the terms in the Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If payment or withholding of the income tax due in connection with the RSUs is not made within ninety (90) days of the end of the U.K. tax year in which the event giving rise to the income tax liability or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003 occurred (the &#8220;Due Date&#8221;), the amount of any uncollected income tax shall constitute a loan owed by you to your employer, effective as of the Due Date.  You agree that the loan will bear interest at the then-current official rate of His Majesty&#8217;s Revenue &#38; Customs (&#8220;HMRC&#8221;), it shall be immediately due and repayable, and the Company or your employer may recover it at any time thereafter by any of the means referred to in Section 2.7 of the Agreement.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if you are a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), you will not be eligible for a loan from the Company or your employer to cover the income tax liability.  In the event that you are a director or executive officer and the income tax is not collected from or paid by the Due Date, the amount of any uncollected income tax will constitute a benefit to you on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) will be payable.  You will be responsible for reporting any income tax for reimbursing the Company or your employer the value of any employee NICs due on this additional benefit. </font></div><div style="margin-bottom:10pt;padding-right:-4.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">*   *   *   *   *</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:198pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">33</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>7
<FILENAME>cy23q110qex22.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iebe8b1388abe484d9336a7707acc78a2_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 22</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the obligors under (i) the 5.300% Notes due 2043 issued by the Company (the &#8220;Company Notes&#8221;) consisted of the subsidiaries listed in the following table and (ii) the 3.900% Notes due 2024, the 4.375% Notes due 2026, the 4.400% Notes due 2030 and the 4.900% Notes due 2044 issued by Perrigo Finance Unlimited Company (collectively, the &#8220;Perrigo Finance Notes&#8221;) consisted of the Company, as a guarantor, and its subsidiaries listed in the following table.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.619%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Name of Entity</font></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Obligor Type (Company Notes)</font></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Obligor Type (Perrigo Finance Notes)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Athena Neurosciences, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biover NV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chefaro Ireland DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Elan Pharmaceuticals, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Galpharm Healthcare Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Galpharm International Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gr8ness, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Habsont Unlimited Company </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Jaico R.D.P. NV </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">L. Perrigo Company </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Medgenix Benelux NV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">OCE-BIO BV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma Belgium NV </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma Capital NV </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma Innovation &#38; Development NV </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma International NV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Pharma Trading NV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega Teknika DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PBM Canada Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PBM Nutritionals, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PBM Products, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo America Holdings, Inc </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Company (USA)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Company plc</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Issuer</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Corporation DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Diabetes Care, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Direct, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Europe Invest NV</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Finance (US) LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Finance Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Issuer</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Florida, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Holding NV </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Holdings Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo International Finance DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo International Holdings II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.619%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo International Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo International, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Investments LLC </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 1 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 10 Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 11 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 12 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 13 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 2 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 3 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 4 Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 5 Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 6 UC </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 8 DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland 9 Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Ireland Management DAC </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Management Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Mexico Investment Holdings LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo New York, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Pharma International DAC </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Pharma Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Research &#38; Development Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Sales Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Science Eight Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo Science One DAC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Perrigo UK Acquisition Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PMI Branded Pharmaceuticals, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ranir Global Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ranir Holdings Limited (UK)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ranir Ltd. (UK)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ranir, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Solent Oral Care Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Learning Pharmacy Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Wrafton Laboratories Limited</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Guarantor</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>cy23q110qex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i87ff27569af9491087b76b71afdc39d1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Murray S. Kessler, certify that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this report on Form 10-Q of Perrigo Company plc&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;9, 2023</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.122%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Murray S. Kessler</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murray S. Kessler</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>cy23q110qex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i447052d43765485084ec0d7fa9423d55_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Eduardo Bezerra, certify that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this report on Form 10-Q of Perrigo Company plc&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;9, 2023 </font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.304%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Eduardo Bezerra</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eduardo Bezerra</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>10
<FILENAME>cy23q110qex32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3c5218a054e24a39a978fc0bbfbe0717_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32 </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The following statement is being made to the Securities and Exchange Commission solely for the purposes of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), which carries with it certain criminal penalties in the event of a knowing or willful misrepresentation. </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities and Exchange Commission </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450 100 F Street NE </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549 </font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.212%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Re&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perrigo Company plc</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), each of the undersigned hereby certifies that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.62pt">this Quarterly Report on Form 10-Q for the period ended April&#160;1, 2023 (the &#34;Report&#34;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d))&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.4pt">the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of Perrigo Company plc.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:67.5pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.705%"><tr><td style="width:1.0%"></td><td style="width:5.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.517%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Murray S. Kessler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murray S. Kessler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Eduardo Bezerra</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eduardo Bezerra</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>prgo-20230401.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d94275d0-2889-4bee-8a41-eed44cff1b4d,g:5de99725-025a-4d3c-a861-61491132bb43-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:prgo="http://www.perrigo.com/20230401" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.perrigo.com/20230401">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20230401_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20230401_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20230401_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prgo-20230401_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.perrigo.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>0000002 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000004 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquity" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityParenthetical" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical">
        <link:definition>0000007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.perrigo.com/role/RevenueRecognition">
        <link:definition>0000010 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestitures" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestitures">
        <link:definition>0000011 - Disclosure - Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperations" roleURI="http://www.perrigo.com/role/DiscontinuedOperations">
        <link:definition>0000012 - Disclosure - Discontinued Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.perrigo.com/role/Inventories">
        <link:definition>0000013 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.perrigo.com/role/Investments">
        <link:definition>0000014 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.perrigo.com/role/Leases">
        <link:definition>0000015 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssets">
        <link:definition>0000016 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.perrigo.com/role/FairValueMeasurements">
        <link:definition>0000017 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivities" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities">
        <link:definition>0000018 - Disclosure - Derivative Instruments and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Indebtedness" roleURI="http://www.perrigo.com/role/Indebtedness">
        <link:definition>0000019 - Disclosure - Indebtedness</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareandShareholdersEquity" roleURI="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquity">
        <link:definition>0000020 - Disclosure - Earnings Per Share and Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>0000021 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCharges" roleURI="http://www.perrigo.com/role/RestructuringCharges">
        <link:definition>0000022 - Disclosure - Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.perrigo.com/role/IncomeTaxes">
        <link:definition>0000023 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.perrigo.com/role/Contingencies">
        <link:definition>0000024 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.perrigo.com/role/SegmentInformation">
        <link:definition>0000025 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.perrigo.com/role/SubsequentEvents">
        <link:definition>0000026 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000027 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000028 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.perrigo.com/role/RevenueRecognitionTables">
        <link:definition>0000029 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsTables" roleURI="http://www.perrigo.com/role/BusinessCombinationsandAssetAcquisitionsTables">
        <link:definition>0000030 - Disclosure - Business Combinations and Asset Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.perrigo.com/role/InventoriesTables">
        <link:definition>0000031 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.perrigo.com/role/InvestmentsTables">
        <link:definition>0000032 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.perrigo.com/role/LeasesTables">
        <link:definition>0000033 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>0000034 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.perrigo.com/role/FairValueMeasurementsTables">
        <link:definition>0000035 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesTables" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables">
        <link:definition>0000036 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessTables" roleURI="http://www.perrigo.com/role/IndebtednessTables">
        <link:definition>0000037 - Disclosure - Indebtedness (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareandShareholdersEquityTables" roleURI="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityTables">
        <link:definition>0000038 - Disclosure - Earnings Per Share and Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>0000039 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesTables" roleURI="http://www.perrigo.com/role/RestructuringChargesTables">
        <link:definition>0000040 - Disclosure - Restructuring Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.perrigo.com/role/IncomeTaxesTables">
        <link:definition>0000041 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.perrigo.com/role/SegmentInformationTables">
        <link:definition>0000042 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails" roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails">
        <link:definition>0000043 - Disclosure - Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionScheduleofRevenuebyProductDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails">
        <link:definition>0000044 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionAdditionalInformationDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails">
        <link:definition>0000045 - Disclosure - Revenue Recognition - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionScheduleofContractBalancesDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails">
        <link:definition>0000046 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails" roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails">
        <link:definition>0000047 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresNarrativeDetails" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails">
        <link:definition>0000048 - Disclosure - Acquisitions and Divestitures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresProFormaDetails" roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaDetails">
        <link:definition>0000049 - Disclosure - Acquisitions and Divestitures - Pro Forma (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsNarrativeDetails" roleURI="http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails">
        <link:definition>0000050 - Disclosure - Discontinued Operations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.perrigo.com/role/InventoriesDetails">
        <link:definition>0000051 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDetails" roleURI="http://www.perrigo.com/role/InvestmentsDetails">
        <link:definition>0000052 - Disclosure - Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails">
        <link:definition>0000053 - Disclosure - Leases - Balance Sheet Location of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseExpenseDetails" roleURI="http://www.perrigo.com/role/LeasesLeaseExpenseDetails">
        <link:definition>0000054 - Disclosure - Leases - Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAnnualFutureMaturitiesofLeasesDetails" roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails">
        <link:definition>0000055 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAnnualFutureMaturitiesofLeasesDetails_1" roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1">
        <link:definition>0000055 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAnnualFutureMaturitiesofLeasesDetails_2" roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2">
        <link:definition>0000055 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesWeightedAverageLeaseTermsandDiscountRatesDetails" roleURI="http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails">
        <link:definition>0000056 - Disclosure - Leases - Weighted Average Lease Terms and Discount Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCashFlowClassificationsDetails" roleURI="http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails">
        <link:definition>0000057 - Disclosure - Leases - Lease Cash Flow Classifications (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGoodwillDetails" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails">
        <link:definition>0000058 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangiblecategoriesDetails" roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails">
        <link:definition>0000059 - Disclosure - Goodwill and Intangible Assets - Intangible categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialInstrumentsatFairValueDetails" roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails">
        <link:definition>0000060 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails" roleURI="http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails">
        <link:definition>0000061 - Disclosure - Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails">
        <link:definition>0000062 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails">
        <link:definition>0000063 - Disclosure - Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails">
        <link:definition>0000064 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails">
        <link:definition>0000065 - Disclosure - Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails">
        <link:definition>0000066 - Disclosure - Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails" roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails">
        <link:definition>0000067 - Disclosure - Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessScheduleofBorrowingsOutstandingDetails" roleURI="http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails">
        <link:definition>0000068 - Disclosure - Indebtedness - Schedule of Borrowings Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessNarrativeDetails" roleURI="http://www.perrigo.com/role/IndebtednessNarrativeDetails">
        <link:definition>0000069 - Disclosure - Indebtedness - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareandShareholdersEquityDetails" roleURI="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails">
        <link:definition>0000070 - Disclosure - Earnings Per Share and Shareholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>0000071 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesDetails" roleURI="http://www.perrigo.com/role/RestructuringChargesDetails">
        <link:definition>0000072 - Disclosure - Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesNarrativeDetails" roleURI="http://www.perrigo.com/role/RestructuringChargesNarrativeDetails">
        <link:definition>0000073 - Disclosure - Restructuring Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.perrigo.com/role/IncomeTaxesDetails">
        <link:definition>0000074 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesPriceFixingLawsuitsDetails" roleURI="http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails">
        <link:definition>0000075 - Disclosure - Contingencies - Price Fixing Lawsuits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesSecuritiesLitigationDetails" roleURI="http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails">
        <link:definition>0000076 - Disclosure - Contingencies - Securities Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOtherMattersDetails" roleURI="http://www.perrigo.com/role/ContingenciesOtherMattersDetails">
        <link:definition>0000077 - Disclosure - Contingencies - Other Matters (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://www.perrigo.com/role/SegmentInformationDetails">
        <link:definition>0000078 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.perrigo.com/role/SubsequentEventsDetails">
        <link:definition>0000079 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems" abstract="false" name="NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_OralSelfcareMember" abstract="true" name="OralSelfcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" abstract="true" name="FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" abstract="true" name="DerivativeInstrumentCoveredInterestRatePeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LossContingencyNumberofFormerEmployees" abstract="false" name="LossContingencyNumberofFormerEmployees" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_GoodwillAndIndefiniteLivedIntangibles" abstract="false" name="GoodwillAndIndefiniteLivedIntangibles" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A4.375seniornotedueMarch152026Member" abstract="true" name="A4.375seniornotedueMarch152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DebtStatedBlendedInterestRate" abstract="false" name="DebtStatedBlendedInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_NumberofPutativeClasses" abstract="false" name="NumberofPutativeClasses" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_DigestiveHealthMember" abstract="true" name="DigestiveHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_FinanceLeaseLiabilitytobePaidafterYearFour" abstract="false" name="FinanceLeaseLiabilitytobePaidafterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" abstract="false" name="LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_OtherCSCIMember" abstract="true" name="OtherCSCIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_June12022ThroughApril12029Member" abstract="true" name="June12022ThroughApril12029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueYearFour" abstract="false" name="LeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_TalcumPowderLitigationMember" abstract="true" name="TalcumPowderLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" abstract="false" name="ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_RXPharmaceuticalsMember" abstract="true" name="RXPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DebtInstrumentInterestRatePercentageCap" abstract="false" name="DebtInstrumentInterestRatePercentageCap" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prgo_OtherExpenseIncomeNetMember" abstract="true" name="OtherExpenseIncomeNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" abstract="false" name="IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IncreaseDecreaseInAccruedCustomerPrograms" abstract="false" name="IncreaseDecreaseInAccruedCustomerPrograms" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" abstract="false" name="IRSNoticeofProposedAdjustmentPenaltyPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationContingentConsideration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_RestructuringReserveSettledWithoutCashNet" abstract="false" name="RestructuringReserveSettledWithoutCashNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IncomeTaxExaminationNumberOfTaxableYears" abstract="false" name="IncomeTaxExaminationNumberOfTaxableYears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_NumberOfAdditionalStatesAndTerritories" abstract="false" name="NumberOfAdditionalStatesAndTerritories" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_NumberOfPersonalInjuryLawsuits" abstract="false" name="NumberOfPersonalInjuryLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_AccruedCustomerPrograms" abstract="false" name="AccruedCustomerPrograms" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" abstract="false" name="IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" abstract="false" name="ProceedsfromRoyaltiesReceivedInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_PublicBondsandPrivatePlacementMember" abstract="true" name="PublicBondsandPrivatePlacementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" abstract="true" name="ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prgo_BlendedInterestRateInRevenueAgentReport" abstract="false" name="BlendedInterestRateInRevenueAgentReport" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_LossContingencyNumberOfManufacturers" abstract="false" name="LossContingencyNumberOfManufacturers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_PainandSleepaidsMember" abstract="true" name="PainandSleepaidsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" abstract="false" name="ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_AssetsandLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsandLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_RightofUseAsset" abstract="false" name="RightofUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" abstract="false" name="IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_October252022ThroughDecember152024Member" abstract="true" name="October252022ThroughDecember152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_OtherGeographicalAreasMember" abstract="true" name="OtherGeographicalAreasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" abstract="false" name="LossContingencyNumberOfGenericPrescriptionPharmaceuticals" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ScarAwayMember" abstract="true" name="ScarAwayMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ConsumerSelfCareAmericasMember" abstract="true" name="ConsumerSelfCareAmericasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_RestructuringAdditionalCharges" abstract="false" name="RestructuringAdditionalCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_SupplyChainReinventionMember" abstract="true" name="SupplyChainReinventionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_RestructuringChargesContinuingOperations" abstract="false" name="RestructuringChargesContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LeaseLiabilitiesPaymentsDueAbstract" abstract="true" name="LeaseLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_DenominatorAbstract" abstract="true" name="DenominatorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" abstract="false" name="CashFlowHedgeGainLossReclassifiedtoEarningsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" abstract="false" name="IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_PaymentsForPremiumsOnDerivativeInstruments" abstract="false" name="PaymentsForPremiumsOnDerivativeInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_AdventInternationalMember" abstract="true" name="AdventInternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ControllingInterestAbstract" abstract="true" name="ControllingInterestAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_RanitidineLitigationMember" abstract="true" name="RanitidineLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_A2022RevolverMember" abstract="true" name="A2022RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_HRAPharmaMember" abstract="true" name="HRAPharmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_NumberOfAppealsOfMasterComplaints" abstract="false" name="NumberOfAppealsOfMasterComplaints" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_A4900SeniorLoanDue2044Member" abstract="true" name="A4900SeniorLoanDue2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_UpperRespiratoryMember" abstract="true" name="UpperRespiratoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_HealthyLifestyleMember" abstract="true" name="HealthyLifestyleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_NumberofTendersAccepted" abstract="false" name="NumberofTendersAccepted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_A4650SeniorNotesDueJune152030Member" abstract="true" name="A4650SeniorNotesDueJune152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_AccumulatedOtherComprehensiveIncomeRollForward" abstract="true" name="AccumulatedOtherComprehensiveIncomeRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_DerivativeInstrumentTermDomain" abstract="true" name="DerivativeInstrumentTermDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_SkinCareMember" abstract="true" name="SkinCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_CanadianClassActionComplaintMember" abstract="true" name="CanadianClassActionComplaintMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LossContingencyNumberofMasterComplaints" abstract="false" name="LossContingencyNumberofMasterComplaints" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_October252022ThroughMarch252026Member" abstract="true" name="October252022ThroughMarch252026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DerivativeNotionalAmountMaximumIndividualAmount" abstract="false" name="DerivativeNotionalAmountMaximumIndividualAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="prgo_A4400SeniorNotesDueJune152030Member" abstract="true" name="A4400SeniorNotesDueJune152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ContractManufacturingMember" abstract="true" name="ContractManufacturingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueYearOne" abstract="false" name="LeaseLiabilityPaymentsDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" abstract="false" name="LeaseLiabilityPaymentsRemainderofFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_June12022ThroughApril12027Member" abstract="true" name="June12022ThroughApril12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" abstract="false" name="DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="prgo_NewTermLoanBFacilityMember" abstract="true" name="NewTermLoanBFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueafterYearFour" abstract="false" name="LeaseLiabilityPaymentsDueafterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" abstract="true" name="A5300UnsecuredSeniorNotesDueNovember152043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LesseeCashFlowClassificationsTableTextBlock" abstract="false" name="LesseeCashFlowClassificationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_VitaminsMineralsandSupplementsMember" abstract="true" name="VitaminsMineralsandSupplementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilitytobePaidafterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_HRAPharmaIntegrationMember" abstract="true" name="HRAPharmaIntegrationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_StateAttorneyGeneralComplaintMember" abstract="true" name="StateAttorneyGeneralComplaintMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" abstract="true" name="IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LatinAmericaBusinessMember" abstract="true" name="LatinAmericaBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_TrademarksTradeNamesandBrandsMember" abstract="true" name="TrademarksTradeNamesandBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" abstract="false" name="ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_CumulativeDeferredChargeTaxLitigation" abstract="false" name="CumulativeDeferredChargeTaxLitigation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueYearTwo" abstract="false" name="LeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_WomensHealthMember" abstract="true" name="WomensHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" abstract="false" name="LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" abstract="false" name="InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ScheduleOfDebtInstrumentsTable" abstract="true" name="ScheduleOfDebtInstrumentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="prgo_UnallocatedSegmentMember" abstract="true" name="UnallocatedSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" abstract="false" name="BlendedInterestRateProposedOnDebtsForUSTaxPurposes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_A3900SeniorNoteDue2024Member" abstract="true" name="A3900SeniorNoteDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" abstract="false" name="GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" abstract="false" name="IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prgo_OtherCSCAMember" abstract="true" name="OtherCSCAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_October252022ThroughJune152030Member" abstract="true" name="October252022ThroughJune152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_A3150SeniorNotesDueJune152030Member" abstract="true" name="A3150SeniorNotesDueJune152030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" abstract="true" name="DerivativeInstrumentCoveredInterestRatePeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ConsumerSelfCareInternationalMember" abstract="true" name="ConsumerSelfCareInternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDue" abstract="false" name="LeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_LossContingencyNumberofMasterComplaintsNamingCompany" abstract="false" name="LossContingencyNumberofMasterComplaintsNamingCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_OrdinaryShares0001ParValueMember" abstract="true" name="OrdinaryShares0001ParValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" abstract="false" name="IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_OtherOperatingIncomeLossNet" abstract="false" name="OtherOperatingIncomeLossNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_NutritionMember" abstract="true" name="NutritionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_LeaseLiabilityPaymentsDueYearThree" abstract="false" name="LeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" abstract="true" name="NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" abstract="false" name="AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" abstract="false" name="ScheduleofForeignCurrencyForwardContractsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prgo_DerivativeInstrumentTermAxis" abstract="true" name="DerivativeInstrumentTermAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="prgo_NumberOfAppealsOfPersonalInjuryClaims" abstract="false" name="NumberOfAppealsOfPersonalInjuryClaims" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prgo_NetLossIncomeAttributableToParent" abstract="false" name="NetLossIncomeAttributableToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_NumeratorAbstract" abstract="true" name="NumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prgo_LeaseLiabilities" abstract="false" name="LeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prgo_NewTermLoanAFacilityMember" abstract="true" name="NewTermLoanAFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>prgo-20230401_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d94275d0-2889-4bee-8a41-eed44cff1b4d,g:5de99725-025a-4d3c-a861-61491132bb43-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_adb70277-6a3a-41e4-85ed-6f728e3490e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_8d7bbb55-180a-49c2-9053-7bcce2da1533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_adb70277-6a3a-41e4-85ed-6f728e3490e0" xlink:to="loc_us-gaap_GrossProfit_8d7bbb55-180a-49c2-9053-7bcce2da1533" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_32b0e59a-478b-40a7-92b1-d5eb8e85d390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_adb70277-6a3a-41e4-85ed-6f728e3490e0" xlink:to="loc_us-gaap_OperatingExpenses_32b0e59a-478b-40a7-92b1-d5eb8e85d390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8b41be8d-39ce-4f0b-ae6a-e49bad60ba09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_0c6bc4b3-b0f8-4778-8a97-c4c608fd6f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_8b41be8d-39ce-4f0b-ae6a-e49bad60ba09" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_0c6bc4b3-b0f8-4778-8a97-c4c608fd6f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_811c344d-dce8-47e3-80eb-776259b02755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_8b41be8d-39ce-4f0b-ae6a-e49bad60ba09" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_811c344d-dce8-47e3-80eb-776259b02755" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8a9468f9-04dd-43b8-b57c-e7612cae5444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_7f609b64-32da-4906-9990-586649252562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8a9468f9-04dd-43b8-b57c-e7612cae5444" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_7f609b64-32da-4906-9990-586649252562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_5407f69f-23b4-4653-bc57-b6b692dd4bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8a9468f9-04dd-43b8-b57c-e7612cae5444" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_5407f69f-23b4-4653-bc57-b6b692dd4bc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_8838ec12-9644-4fb3-b40b-7c840257869a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_137ce834-e205-4d6d-bbca-ed5f58903aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_8838ec12-9644-4fb3-b40b-7c840257869a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_137ce834-e205-4d6d-bbca-ed5f58903aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c25471e7-2b8d-426e-9ad3-942dc920ab72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_8838ec12-9644-4fb3-b40b-7c840257869a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c25471e7-2b8d-426e-9ad3-942dc920ab72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_dfc1a143-707e-42b1-b846-60799d690181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_35b87b66-c2d4-4e58-8e8f-734cfdf00a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_dfc1a143-707e-42b1-b846-60799d690181" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_35b87b66-c2d4-4e58-8e8f-734cfdf00a66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_368cf4b4-aa92-41c9-bf89-24c81eadc720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_dfc1a143-707e-42b1-b846-60799d690181" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_368cf4b4-aa92-41c9-bf89-24c81eadc720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cf559f38-0bf9-4947-b0ef-3f01e1cd9773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_dfc1a143-707e-42b1-b846-60799d690181" xlink:to="loc_us-gaap_OperatingIncomeLoss_cf559f38-0bf9-4947-b0ef-3f01e1cd9773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0bd8f676-bc9e-4752-bd6c-57a6d8a66a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionAndDistributionCosts_2977d6bb-be49-4fe1-a825-373588dcf129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionAndDistributionCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0bd8f676-bc9e-4752-bd6c-57a6d8a66a20" xlink:to="loc_us-gaap_ProductionAndDistributionCosts_2977d6bb-be49-4fe1-a825-373588dcf129" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_392ec88d-1e5a-414f-8150-1f84cb909c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0bd8f676-bc9e-4752-bd6c-57a6d8a66a20" xlink:to="loc_us-gaap_SellingAndMarketingExpense_392ec88d-1e5a-414f-8150-1f84cb909c38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherOperatingIncomeLossNet_fa06c530-8fb2-488f-a6a2-33a114b35091" xlink:href="prgo-20230401.xsd#prgo_OtherOperatingIncomeLossNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0bd8f676-bc9e-4752-bd6c-57a6d8a66a20" xlink:to="loc_prgo_OtherOperatingIncomeLossNet_fa06c530-8fb2-488f-a6a2-33a114b35091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4aa80f09-4e46-4e12-8bc1-e1837dff5a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0bd8f676-bc9e-4752-bd6c-57a6d8a66a20" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4aa80f09-4e46-4e12-8bc1-e1837dff5a3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a43691f5-7f2e-4a42-94ae-8080e8fc0cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0bd8f676-bc9e-4752-bd6c-57a6d8a66a20" xlink:to="loc_us-gaap_RestructuringCharges_a43691f5-7f2e-4a42-94ae-8080e8fc0cc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_73992f28-6858-4804-8f88-e1241cd641e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0bd8f676-bc9e-4752-bd6c-57a6d8a66a20" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_73992f28-6858-4804-8f88-e1241cd641e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_082856d7-9303-4ac1-b329-65ce001db5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_9b8e2d8a-e49c-4c1d-bb1d-268997e9ea7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_082856d7-9303-4ac1-b329-65ce001db5d8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_9b8e2d8a-e49c-4c1d-bb1d-268997e9ea7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_334eb8f2-7fbe-45cb-8b1b-44688922a00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_082856d7-9303-4ac1-b329-65ce001db5d8" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_334eb8f2-7fbe-45cb-8b1b-44688922a00c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_707ccb01-7127-49b4-bde2-03a52d23eaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a067100c-06e9-4b64-b814-6fabde91d30d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_707ccb01-7127-49b4-bde2-03a52d23eaf6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a067100c-06e9-4b64-b814-6fabde91d30d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_80ab456f-0d57-4f42-a103-ec97cbcac964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_707ccb01-7127-49b4-bde2-03a52d23eaf6" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_80ab456f-0d57-4f42-a103-ec97cbcac964" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ce0f340-015c-4267-b50c-cc6adfa1d4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_df6453af-cb4b-4110-967f-422255101494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ce0f340-015c-4267-b50c-cc6adfa1d4db" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_df6453af-cb4b-4110-967f-422255101494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c4ff5574-98d8-4817-a537-14e5e00b787f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ce0f340-015c-4267-b50c-cc6adfa1d4db" xlink:to="loc_us-gaap_NetIncomeLoss_c4ff5574-98d8-4817-a537-14e5e00b787f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e9498f84-fa75-4d9f-b07d-d707ffb94edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1f4d6350-6687-4df1-84f1-5abc5540de28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e9498f84-fa75-4d9f-b07d-d707ffb94edc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1f4d6350-6687-4df1-84f1-5abc5540de28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_bab0c35e-cf2c-43d0-bd5f-6f7a853e293a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e9498f84-fa75-4d9f-b07d-d707ffb94edc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_bab0c35e-cf2c-43d0-bd5f-6f7a853e293a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7032c81d-38b7-4d3a-a32d-0a9385ebff30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e9498f84-fa75-4d9f-b07d-d707ffb94edc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_7032c81d-38b7-4d3a-a32d-0a9385ebff30" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_359e4e8a-967d-4769-afc5-bc817fc78576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_521dce9a-d224-46f6-a104-c5719967077b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_359e4e8a-967d-4769-afc5-bc817fc78576" xlink:to="loc_us-gaap_LiabilitiesCurrent_521dce9a-d224-46f6-a104-c5719967077b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_7d37444c-c926-4db2-a2d2-91e1c7dce903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_359e4e8a-967d-4769-afc5-bc817fc78576" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_7d37444c-c926-4db2-a2d2-91e1c7dce903" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02b921a5-23c6-44a8-89ca-13a661379ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ffee0d4f-e514-4666-ab27-93477d9e615a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02b921a5-23c6-44a8-89ca-13a661379ea2" xlink:to="loc_us-gaap_PreferredStockValue_ffee0d4f-e514-4666-ab27-93477d9e615a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_250bd1f1-1152-467c-904f-f25a1de1db9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02b921a5-23c6-44a8-89ca-13a661379ea2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_250bd1f1-1152-467c-904f-f25a1de1db9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6f24c2f8-9c55-4015-a673-4ec7b8ad81c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02b921a5-23c6-44a8-89ca-13a661379ea2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6f24c2f8-9c55-4015-a673-4ec7b8ad81c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ae96f5b9-e42a-4f7b-8f19-4a657db3a7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02b921a5-23c6-44a8-89ca-13a661379ea2" xlink:to="loc_us-gaap_CommonStockValue_ae96f5b9-e42a-4f7b-8f19-4a657db3a7f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c92bf37d-1063-4d36-bc6f-256b5422459c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_fcdeefc3-0a22-418d-b2d6-73c0233b93fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c92bf37d-1063-4d36-bc6f-256b5422459c" xlink:to="loc_us-gaap_AssetsNoncurrent_fcdeefc3-0a22-418d-b2d6-73c0233b93fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8f410b7e-91e4-4850-b49b-2111c36fa722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c92bf37d-1063-4d36-bc6f-256b5422459c" xlink:to="loc_us-gaap_AssetsCurrent_8f410b7e-91e4-4850-b49b-2111c36fa722" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fa1af610-ecab-49a4-90eb-049b6a9b69c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5f5bd92a-fd4d-4f93-bea0-cec15319547f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fa1af610-ecab-49a4-90eb-049b6a9b69c0" xlink:to="loc_us-gaap_InventoryNet_5f5bd92a-fd4d-4f93-bea0-cec15319547f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b86ef6b-2822-468a-a00c-7463a35eaf03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fa1af610-ecab-49a4-90eb-049b6a9b69c0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b86ef6b-2822-468a-a00c-7463a35eaf03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_553f1645-3f32-4f43-9d19-75f7b370e3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fa1af610-ecab-49a4-90eb-049b6a9b69c0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_553f1645-3f32-4f43-9d19-75f7b370e3d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fe1dc3d4-2103-4e9f-bbee-f537415f7c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fa1af610-ecab-49a4-90eb-049b6a9b69c0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fe1dc3d4-2103-4e9f-bbee-f537415f7c78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_87823412-0d6c-4398-8b1c-8ffb76c7f9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d8db76ef-d96d-4af0-8e92-6e9360b42ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_87823412-0d6c-4398-8b1c-8ffb76c7f9dc" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d8db76ef-d96d-4af0-8e92-6e9360b42ffa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_eb41db13-57ca-48b2-8176-c204abdfeb65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_87823412-0d6c-4398-8b1c-8ffb76c7f9dc" xlink:to="loc_us-gaap_AccountsPayableCurrent_eb41db13-57ca-48b2-8176-c204abdfeb65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_fbc0464b-3b2a-4c2e-a9ea-f5d37fa33c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_87823412-0d6c-4398-8b1c-8ffb76c7f9dc" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_fbc0464b-3b2a-4c2e-a9ea-f5d37fa33c94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_fef6fbbc-c713-4dcb-8322-7f72df6a1246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_87823412-0d6c-4398-8b1c-8ffb76c7f9dc" xlink:to="loc_us-gaap_LongTermDebtCurrent_fef6fbbc-c713-4dcb-8322-7f72df6a1246" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1fd553d7-05a6-4ef2-a1e0-e848f217ccfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_87823412-0d6c-4398-8b1c-8ffb76c7f9dc" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1fd553d7-05a6-4ef2-a1e0-e848f217ccfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccruedCustomerPrograms_c8f47305-3fb2-4936-8dae-9394f2fdf037" xlink:href="prgo-20230401.xsd#prgo_AccruedCustomerPrograms"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_87823412-0d6c-4398-8b1c-8ffb76c7f9dc" xlink:to="loc_prgo_AccruedCustomerPrograms_c8f47305-3fb2-4936-8dae-9394f2fdf037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_a43796bb-85c9-4f68-9019-0fbbf804a47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8ff13dc5-e7f2-4096-b5f8-78a91a90d2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_a43796bb-85c9-4f68-9019-0fbbf804a47c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8ff13dc5-e7f2-4096-b5f8-78a91a90d2e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_315efd64-5b3e-4d01-bb41-77d797a7972a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_a43796bb-85c9-4f68-9019-0fbbf804a47c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_315efd64-5b3e-4d01-bb41-77d797a7972a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e14271a5-cfb5-44b5-968f-e90cae31cfbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_a43796bb-85c9-4f68-9019-0fbbf804a47c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e14271a5-cfb5-44b5-968f-e90cae31cfbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_cec8d7c2-6e92-42c8-be0e-3bf43a63b611" xlink:href="prgo-20230401.xsd#prgo_GoodwillAndIndefiniteLivedIntangibles"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_a43796bb-85c9-4f68-9019-0fbbf804a47c" xlink:to="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_cec8d7c2-6e92-42c8-be0e-3bf43a63b611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_abfeea46-118a-431d-ace7-e4333be5fc12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_a43796bb-85c9-4f68-9019-0fbbf804a47c" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_abfeea46-118a-431d-ace7-e4333be5fc12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_9036b5ea-f3e6-4aa4-ac46-8d7119376dd5" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_a43796bb-85c9-4f68-9019-0fbbf804a47c" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_9036b5ea-f3e6-4aa4-ac46-8d7119376dd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_64d8e462-1dbd-43b2-b926-e67f125b2b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b1a08941-d1b6-4875-95da-f50cc7fab45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_64d8e462-1dbd-43b2-b926-e67f125b2b6c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b1a08941-d1b6-4875-95da-f50cc7fab45b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f334c90b-9ca2-4484-a3ea-77c63a182da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_64d8e462-1dbd-43b2-b926-e67f125b2b6c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f334c90b-9ca2-4484-a3ea-77c63a182da7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e340f119-8acf-4fe5-9509-ca7ed08268b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_64d8e462-1dbd-43b2-b926-e67f125b2b6c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e340f119-8acf-4fe5-9509-ca7ed08268b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9e8addf-3d48-4b5e-8305-edce26a4533a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e39a69c2-b39c-43a5-9ea0-82a6e5893c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9e8addf-3d48-4b5e-8305-edce26a4533a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e39a69c2-b39c-43a5-9ea0-82a6e5893c00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d4baf2d4-a4ec-43b2-bcf9-ed48b487114b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9e8addf-3d48-4b5e-8305-edce26a4533a" xlink:to="loc_us-gaap_Liabilities_d4baf2d4-a4ec-43b2-bcf9-ed48b487114b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4f1494f0-ea69-4d95-b63b-a518430ee217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9e8addf-3d48-4b5e-8305-edce26a4533a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4f1494f0-ea69-4d95-b63b-a518430ee217" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_582470b3-3ae1-4d9a-8a8f-69b16e58148f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_08ffa77b-93f1-4c3b-bde3-cc2f9c1612ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_582470b3-3ae1-4d9a-8a8f-69b16e58148f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_08ffa77b-93f1-4c3b-bde3-cc2f9c1612ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_e1dea733-220d-463d-85d6-854abbed1c5e" xlink:href="prgo-20230401.xsd#prgo_IncreaseDecreaseInAccruedCustomerPrograms"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_582470b3-3ae1-4d9a-8a8f-69b16e58148f" xlink:to="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_e1dea733-220d-463d-85d6-854abbed1c5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_bdb106eb-677c-4525-a7b0-9ce530551570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_582470b3-3ae1-4d9a-8a8f-69b16e58148f" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_bdb106eb-677c-4525-a7b0-9ce530551570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_deb37199-ad11-46c3-a13e-c1077cdf014f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_582470b3-3ae1-4d9a-8a8f-69b16e58148f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_deb37199-ad11-46c3-a13e-c1077cdf014f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c156a892-4a7c-4324-8f34-046474affe0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_582470b3-3ae1-4d9a-8a8f-69b16e58148f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c156a892-4a7c-4324-8f34-046474affe0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_826a9959-fbf7-4a38-84bb-6059ea4172d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_582470b3-3ae1-4d9a-8a8f-69b16e58148f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_826a9959-fbf7-4a38-84bb-6059ea4172d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ac2b0191-3c11-40b4-b7bf-783a60dd17c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_582470b3-3ae1-4d9a-8a8f-69b16e58148f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ac2b0191-3c11-40b4-b7bf-783a60dd17c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b4cc80b1-bd3d-4c25-b154-e7f02f7272d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_582470b3-3ae1-4d9a-8a8f-69b16e58148f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b4cc80b1-bd3d-4c25-b154-e7f02f7272d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4f1d8006-3d62-435a-8816-9653a7370a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_582470b3-3ae1-4d9a-8a8f-69b16e58148f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4f1d8006-3d62-435a-8816-9653a7370a1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f7f2c5c2-6b51-4dcd-b896-3e0c816d440c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2fe8aca1-331c-40fe-8893-d623e8d55ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f7f2c5c2-6b51-4dcd-b896-3e0c816d440c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2fe8aca1-331c-40fe-8893-d623e8d55ed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60b18d09-e69d-4814-9818-e3df7c996680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f7f2c5c2-6b51-4dcd-b896-3e0c816d440c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60b18d09-e69d-4814-9818-e3df7c996680" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf898dcd-64cd-4f93-84a3-d58f16e2978d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f7f2c5c2-6b51-4dcd-b896-3e0c816d440c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf898dcd-64cd-4f93-84a3-d58f16e2978d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a0fb91fe-440a-4c06-9893-56422e1ee1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f7f2c5c2-6b51-4dcd-b896-3e0c816d440c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a0fb91fe-440a-4c06-9893-56422e1ee1ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be76be4b-0d74-4ac3-8f47-4314d9008998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_cec77daa-97e7-44e6-9c45-f0640b40669c" xlink:href="prgo-20230401.xsd#prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be76be4b-0d74-4ac3-8f47-4314d9008998" xlink:to="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_cec77daa-97e7-44e6-9c45-f0640b40669c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_7fe5ee4b-603b-4ed2-a955-342477d81f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_be76be4b-0d74-4ac3-8f47-4314d9008998" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_7fe5ee4b-603b-4ed2-a955-342477d81f71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7934703b-baea-409e-90ab-33b5b9ea35cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_8d8a10bc-3072-43d2-a218-f46f623f6533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7934703b-baea-409e-90ab-33b5b9ea35cc" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_8d8a10bc-3072-43d2-a218-f46f623f6533" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4c6d573b-97d4-4a6a-a34e-91afc4fe39bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7934703b-baea-409e-90ab-33b5b9ea35cc" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4c6d573b-97d4-4a6a-a34e-91afc4fe39bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b230612e-cb86-49c7-a6d2-6c0d3ee206a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7934703b-baea-409e-90ab-33b5b9ea35cc" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b230612e-cb86-49c7-a6d2-6c0d3ee206a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_02ba0723-826a-4e74-95af-50e11a17ef5b" xlink:href="prgo-20230401.xsd#prgo_ProceedsfromRoyaltiesReceivedInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7934703b-baea-409e-90ab-33b5b9ea35cc" xlink:to="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_02ba0723-826a-4e74-95af-50e11a17ef5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cb01314c-bb70-4705-b5d4-e8f1ce0fb103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_e2480bb5-faf1-4fd9-85f3-a51f7fa9914e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cb01314c-bb70-4705-b5d4-e8f1ce0fb103" xlink:to="loc_us-gaap_PaymentsOfDividends_e2480bb5-faf1-4fd9-85f3-a51f7fa9914e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_68def22d-6756-43db-88d2-f5f74568f0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cb01314c-bb70-4705-b5d4-e8f1ce0fb103" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_68def22d-6756-43db-88d2-f5f74568f0f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_2d80e8b1-fb6c-4494-b39e-013afdbe8523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cb01314c-bb70-4705-b5d4-e8f1ce0fb103" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_2d80e8b1-fb6c-4494-b39e-013afdbe8523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_9789e6a3-8950-47b8-a3ac-c88837a36dc6" xlink:href="prgo-20230401.xsd#prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_27bb0d17-f1a4-4e2e-ae82-e27b89907626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_9789e6a3-8950-47b8-a3ac-c88837a36dc6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_27bb0d17-f1a4-4e2e-ae82-e27b89907626" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_482cb6d6-d53a-46dc-8fd8-65063ee0e2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_9789e6a3-8950-47b8-a3ac-c88837a36dc6" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_482cb6d6-d53a-46dc-8fd8-65063ee0e2ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_6c9b0ff8-1e41-4608-b44a-d174df991fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_9789e6a3-8950-47b8-a3ac-c88837a36dc6" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_6c9b0ff8-1e41-4608-b44a-d174df991fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_22e628a2-1f89-4f3a-8ce5-5b6a90660268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_9789e6a3-8950-47b8-a3ac-c88837a36dc6" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_22e628a2-1f89-4f3a-8ce5-5b6a90660268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_55794040-0e63-49d0-9785-fa4866f92795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_9789e6a3-8950-47b8-a3ac-c88837a36dc6" xlink:to="loc_us-gaap_ShareBasedCompensation_55794040-0e63-49d0-9785-fa4866f92795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_45519dba-a3e5-4baf-bf35-25b41d44912a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_9789e6a3-8950-47b8-a3ac-c88837a36dc6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_45519dba-a3e5-4baf-bf35-25b41d44912a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringChargesContinuingOperations_e35e04b6-6c55-4fae-88c4-0fef10129f93" xlink:href="prgo-20230401.xsd#prgo_RestructuringChargesContinuingOperations"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_9789e6a3-8950-47b8-a3ac-c88837a36dc6" xlink:to="loc_prgo_RestructuringChargesContinuingOperations_e35e04b6-6c55-4fae-88c4-0fef10129f93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_3cf14a9a-6b2b-49dc-b03c-3d73f8d907e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_9789e6a3-8950-47b8-a3ac-c88837a36dc6" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_3cf14a9a-6b2b-49dc-b03c-3d73f8d907e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetLossIncomeAttributableToParent_3d17cd2d-5af9-4e9c-aee5-85094508d419" xlink:href="prgo-20230401.xsd#prgo_NetLossIncomeAttributableToParent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_9789e6a3-8950-47b8-a3ac-c88837a36dc6" xlink:to="loc_prgo_NetLossIncomeAttributableToParent_3d17cd2d-5af9-4e9c-aee5-85094508d419" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e72ba9cf-691a-4b71-ae0a-ae321e2adb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_cd1eb81e-7acc-4770-9731-afa246addf53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e72ba9cf-691a-4b71-ae0a-ae321e2adb4e" xlink:to="loc_us-gaap_InventoryFinishedGoods_cd1eb81e-7acc-4770-9731-afa246addf53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_b9204f07-a91c-4b2e-b786-61c0b42ea8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e72ba9cf-691a-4b71-ae0a-ae321e2adb4e" xlink:to="loc_us-gaap_InventoryWorkInProcess_b9204f07-a91c-4b2e-b786-61c0b42ea8a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_41d9ea7b-ee4e-457e-970e-43e8ad298d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e72ba9cf-691a-4b71-ae0a-ae321e2adb4e" xlink:to="loc_us-gaap_InventoryRawMaterials_41d9ea7b-ee4e-457e-970e-43e8ad298d9b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RightofUseAsset_9b15d6f6-cac5-4309-b497-d98df7f78080" xlink:href="prgo-20230401.xsd#prgo_RightofUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a8476a39-60e5-4567-9071-4220681b8fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_RightofUseAsset_9b15d6f6-cac5-4309-b497-d98df7f78080" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a8476a39-60e5-4567-9071-4220681b8fde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_567430d6-7290-4bd6-894c-0ab22494c27b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_RightofUseAsset_9b15d6f6-cac5-4309-b497-d98df7f78080" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_567430d6-7290-4bd6-894c-0ab22494c27b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_fba4db42-e11d-4fd1-bbf5-4a7d1df7c454" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e9470e11-cf31-4e2f-a96b-884c3ab16a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_fba4db42-e11d-4fd1-bbf5-4a7d1df7c454" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e9470e11-cf31-4e2f-a96b-884c3ab16a33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_f074c442-cbff-4c0b-a117-e8038df86024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_fba4db42-e11d-4fd1-bbf5-4a7d1df7c454" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_f074c442-cbff-4c0b-a117-e8038df86024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_eff63a8d-407a-4ff0-82cf-99356bf4fb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_fba4db42-e11d-4fd1-bbf5-4a7d1df7c454" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_eff63a8d-407a-4ff0-82cf-99356bf4fb0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6f329917-5654-4cfc-a6e2-15c70cf7299e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_fba4db42-e11d-4fd1-bbf5-4a7d1df7c454" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6f329917-5654-4cfc-a6e2-15c70cf7299e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FinanceLeaseCost_7808d6be-e0b3-4f35-bfd5-782f6bd3f87d" xlink:href="prgo-20230401.xsd#prgo_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b8ccdbc7-1696-4d77-8c25-0a12a5995c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_FinanceLeaseCost_7808d6be-e0b3-4f35-bfd5-782f6bd3f87d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b8ccdbc7-1696-4d77-8c25-0a12a5995c30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_02418dae-a9c3-4588-88c0-9055e42d0018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_FinanceLeaseCost_7808d6be-e0b3-4f35-bfd5-782f6bd3f87d" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_02418dae-a9c3-4588-88c0-9055e42d0018" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_9b73fb7e-d704-442c-9d93-31166e8d1c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_4986f57e-1d89-466c-a254-d21f02d82c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_9b73fb7e-d704-442c-9d93-31166e8d1c59" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_4986f57e-1d89-466c-a254-d21f02d82c35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_a72dab57-e2eb-4b21-86dd-527d3defdfcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_9b73fb7e-d704-442c-9d93-31166e8d1c59" xlink:to="loc_us-gaap_FinanceLeaseLiability_a72dab57-e2eb-4b21-86dd-527d3defdfcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree_46786fc3-c2f9-46c1-898a-94bbe44c59c8" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_100257c6-5de0-48c0-8c7f-79db3299687f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearThree_46786fc3-c2f9-46c1-898a-94bbe44c59c8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_100257c6-5de0-48c0-8c7f-79db3299687f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_69db78ea-bee3-4eaf-b110-a52f81391545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearThree_46786fc3-c2f9-46c1-898a-94bbe44c59c8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_69db78ea-bee3-4eaf-b110-a52f81391545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_6a4d0592-ebd4-4415-8243-c0a397d4c3cc" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_a3adce63-b81b-40e3-8754-53c4dce0ce40" xlink:href="prgo-20230401.xsd#prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_6a4d0592-ebd4-4415-8243-c0a397d4c3cc" xlink:to="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_a3adce63-b81b-40e3-8754-53c4dce0ce40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_a2a336da-8eb9-4208-8895-35922b3c526e" xlink:href="prgo-20230401.xsd#prgo_FinanceLeaseLiabilitytobePaidafterYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_6a4d0592-ebd4-4415-8243-c0a397d4c3cc" xlink:to="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_a2a336da-8eb9-4208-8895-35922b3c526e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_ba7baccf-f876-4e3f-90b4-7b8904cfb924" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_30c0269b-cf86-442e-ab4c-c44669315ef9" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsRemainderofFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ba7baccf-f876-4e3f-90b4-7b8904cfb924" xlink:to="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_30c0269b-cf86-442e-ab4c-c44669315ef9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearOne_b72a8c75-490d-42ae-977b-36374694b8f0" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearOne"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ba7baccf-f876-4e3f-90b4-7b8904cfb924" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearOne_b72a8c75-490d-42ae-977b-36374694b8f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_fc956667-8fea-4752-948c-afc1afb789ab" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ba7baccf-f876-4e3f-90b4-7b8904cfb924" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_fc956667-8fea-4752-948c-afc1afb789ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree_d789c9b7-d204-4b34-97ce-040d86f4c7dd" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ba7baccf-f876-4e3f-90b4-7b8904cfb924" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearThree_d789c9b7-d204-4b34-97ce-040d86f4c7dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour_04f30fa8-5e77-443a-83a7-ebb22a7230e3" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ba7baccf-f876-4e3f-90b4-7b8904cfb924" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearFour_04f30fa8-5e77-443a-83a7-ebb22a7230e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_f9e3b197-fd00-489c-acbb-672cc61ee875" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_ba7baccf-f876-4e3f-90b4-7b8904cfb924" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_f9e3b197-fd00-489c-acbb-672cc61ee875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_3ecd5c74-0441-400d-9224-30b959cd9b2e" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8993c6b5-10c0-474e-905d-6661778135d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_3ecd5c74-0441-400d-9224-30b959cd9b2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8993c6b5-10c0-474e-905d-6661778135d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_b727d555-d275-41a0-bc4b-36bbcd37dc12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_3ecd5c74-0441-400d-9224-30b959cd9b2e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_b727d555-d275-41a0-bc4b-36bbcd37dc12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearOne_bad6f1a9-7120-446a-8ee0-f7b5844ebd38" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearOne"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_63c55538-6480-473f-acf1-6da827e6f53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearOne_bad6f1a9-7120-446a-8ee0-f7b5844ebd38" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_63c55538-6480-473f-acf1-6da827e6f53b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_14cdb9c0-3d7f-4b53-8f1b-b2072d82d27c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearOne_bad6f1a9-7120-446a-8ee0-f7b5844ebd38" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_14cdb9c0-3d7f-4b53-8f1b-b2072d82d27c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_b141153d-1b7b-40b9-a754-2dccd025af05" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_744d63f6-cbb3-45e1-949e-353097266aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_b141153d-1b7b-40b9-a754-2dccd025af05" xlink:to="loc_us-gaap_OperatingLeaseLiability_744d63f6-cbb3-45e1-949e-353097266aea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_cfced0af-e451-4f08-be69-a98f3c5f9c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilities_b141153d-1b7b-40b9-a754-2dccd025af05" xlink:to="loc_us-gaap_FinanceLeaseLiability_cfced0af-e451-4f08-be69-a98f3c5f9c5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1ddfd041-8b3c-4349-94a2-cc76b72c23ba" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsRemainderofFiscalYear"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_aa5ecdaf-db0b-40a1-83e3-aa3ae151ec51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1ddfd041-8b3c-4349-94a2-cc76b72c23ba" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_aa5ecdaf-db0b-40a1-83e3-aa3ae151ec51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_028137f6-ac48-42d7-9aa2-f363b717c762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1ddfd041-8b3c-4349-94a2-cc76b72c23ba" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_028137f6-ac48-42d7-9aa2-f363b717c762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6bc28cf0-a8c0-4887-aaaf-6db8716989dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fa4a003b-37a8-423e-9bb2-0833c5152f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6bc28cf0-a8c0-4887-aaaf-6db8716989dd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fa4a003b-37a8-423e-9bb2-0833c5152f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b5c0be84-f040-4f00-affc-f75e5862ba5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6bc28cf0-a8c0-4887-aaaf-6db8716989dd" xlink:to="loc_us-gaap_OperatingLeaseLiability_b5c0be84-f040-4f00-affc-f75e5862ba5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour_23758e85-8cd8-4be9-a9f9-fa5fe23965f1" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ec880598-02a0-4b26-b0ac-306783c7f342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFour_23758e85-8cd8-4be9-a9f9-fa5fe23965f1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ec880598-02a0-4b26-b0ac-306783c7f342" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_73bf2e9b-70f6-4a63-ade1-853836e7721d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFour_23758e85-8cd8-4be9-a9f9-fa5fe23965f1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_73bf2e9b-70f6-4a63-ade1-853836e7721d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_c45f0e8e-e12a-4fbb-a734-91fad439d094" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ccd0fe17-724a-4942-802f-cdbaf77b3852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_c45f0e8e-e12a-4fbb-a734-91fad439d094" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ccd0fe17-724a-4942-802f-cdbaf77b3852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9ce2c25a-8e9d-4222-9980-fcfcd7d85984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_c45f0e8e-e12a-4fbb-a734-91fad439d094" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9ce2c25a-8e9d-4222-9980-fcfcd7d85984" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6aaff782-a162-4859-bcc5-6a6ca3da88f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_41ac3b68-4cf2-4165-8262-dd0f5d2150d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6aaff782-a162-4859-bcc5-6a6ca3da88f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_41ac3b68-4cf2-4165-8262-dd0f5d2150d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e274b831-9fb6-4552-9a22-3aa33b114ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6aaff782-a162-4859-bcc5-6a6ca3da88f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e274b831-9fb6-4552-9a22-3aa33b114ee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_bbd03aa6-6d9a-4598-a1e9-ff7888243006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6aaff782-a162-4859-bcc5-6a6ca3da88f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_bbd03aa6-6d9a-4598-a1e9-ff7888243006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_bcb01101-d52a-4768-9a01-6084bb413dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6aaff782-a162-4859-bcc5-6a6ca3da88f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_bcb01101-d52a-4768-9a01-6084bb413dc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5edc355e-c441-4aa5-b629-9d13e2de3346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6aaff782-a162-4859-bcc5-6a6ca3da88f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5edc355e-c441-4aa5-b629-9d13e2de3346" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_cbf1a0da-847c-4ff0-9342-b2a155d7e148" xlink:href="prgo-20230401.xsd#prgo_FinanceLeaseLiabilitytobePaidafterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6aaff782-a162-4859-bcc5-6a6ca3da88f7" xlink:to="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_cbf1a0da-847c-4ff0-9342-b2a155d7e148" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7456fdce-c1f0-489a-b928-7525e825b4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ee6cb01c-5b97-4fc9-84f6-1e89839506e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7456fdce-c1f0-489a-b928-7525e825b4f5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ee6cb01c-5b97-4fc9-84f6-1e89839506e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6ebe8037-c6a0-4e1f-b6dd-02e7993f3e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7456fdce-c1f0-489a-b928-7525e825b4f5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6ebe8037-c6a0-4e1f-b6dd-02e7993f3e59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5837acf7-e3c2-487e-9830-0070bc21b7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7456fdce-c1f0-489a-b928-7525e825b4f5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5837acf7-e3c2-487e-9830-0070bc21b7d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4fd9d51a-3b5c-43b9-b508-75496ad66045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7456fdce-c1f0-489a-b928-7525e825b4f5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4fd9d51a-3b5c-43b9-b508-75496ad66045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cbb5ab14-472d-4111-b9e9-45558d7b892f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7456fdce-c1f0-489a-b928-7525e825b4f5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cbb5ab14-472d-4111-b9e9-45558d7b892f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_a7de96c7-0059-4729-b946-f2a57d61a3a6" xlink:href="prgo-20230401.xsd#prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7456fdce-c1f0-489a-b928-7525e825b4f5" xlink:to="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_a7de96c7-0059-4729-b946-f2a57d61a3a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_c91bf99d-4929-4a8c-af7e-abdf105df8e8" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c4b8163e-7abf-41e7-8370-9b2460ccfb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_c91bf99d-4929-4a8c-af7e-abdf105df8e8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c4b8163e-7abf-41e7-8370-9b2460ccfb7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3f35d431-149e-44f9-a4c6-376bf33420c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_c91bf99d-4929-4a8c-af7e-abdf105df8e8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3f35d431-149e-44f9-a4c6-376bf33420c7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails_2"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_061b0a71-5213-4156-816c-e4853c6c6ee1" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_0350e9b4-67bd-4ca0-bb41-9c80b5986721" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_061b0a71-5213-4156-816c-e4853c6c6ee1" xlink:to="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_0350e9b4-67bd-4ca0-bb41-9c80b5986721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_f1068244-90c2-4320-88b4-c8d9d47c050d" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue_061b0a71-5213-4156-816c-e4853c6c6ee1" xlink:to="loc_prgo_LeaseLiabilities_f1068244-90c2-4320-88b4-c8d9d47c050d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#GoodwillandIntangibleAssetsIntangiblecategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1a7dab56-f574-4de4-b2f0-75813b4611c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_589d7c49-758f-434a-b964-8853047140a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1a7dab56-f574-4de4-b2f0-75813b4611c2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_589d7c49-758f-434a-b964-8853047140a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3f94fd5f-07b7-44af-93d8-4b59b9df6049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1a7dab56-f574-4de4-b2f0-75813b4611c2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3f94fd5f-07b7-44af-93d8-4b59b9df6049" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#FairValueMeasurementsFinancialInstrumentsatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_1f664e61-938e-4cf3-a767-912ab27fb30b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_711a66a3-0c3e-48fa-a80f-a7ed017760fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_1f664e61-938e-4cf3-a767-912ab27fb30b" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_711a66a3-0c3e-48fa-a80f-a7ed017760fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_3b96100a-03af-4d49-bfbb-e8d962602881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_1f664e61-938e-4cf3-a767-912ab27fb30b" xlink:to="loc_us-gaap_DerivativeAssets_3b96100a-03af-4d49-bfbb-e8d962602881" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_e85a29f1-d8f7-4085-a7f5-4165e06b3b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_8f950426-ad38-4faf-b695-985e0691f430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e85a29f1-d8f7-4085-a7f5-4165e06b3b2b" xlink:to="loc_us-gaap_DerivativeLiabilities_8f950426-ad38-4faf-b695-985e0691f430" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_dba0ef42-3a05-4386-9c24-f917f4af8e58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_2ba9663e-a3f8-46c2-ab3b-6888dc6146f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_dba0ef42-3a05-4386-9c24-f917f4af8e58" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_2ba9663e-a3f8-46c2-ab3b-6888dc6146f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_356ed577-4e25-4e8e-8db0-d76c9f48da74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_dba0ef42-3a05-4386-9c24-f917f4af8e58" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_356ed577-4e25-4e8e-8db0-d76c9f48da74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_29704a5d-2582-41f4-98cf-0066c5ee433b" xlink:href="prgo-20230401.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_5ded67a2-44b0-4125-86cb-3ddef71545b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_29704a5d-2582-41f4-98cf-0066c5ee433b" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_5ded67a2-44b0-4125-86cb-3ddef71545b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8cc5cc1f-bcba-4694-9bd1-6e554328a22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_29704a5d-2582-41f4-98cf-0066c5ee433b" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_8cc5cc1f-bcba-4694-9bd1-6e554328a22c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#IndebtednessScheduleofBorrowingsOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_8a13bca5-812d-4a07-8c31-249f30329928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_5b7c2fae-79ad-4e4e-9d3a-4c4773b6fe08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_8a13bca5-812d-4a07-8c31-249f30329928" xlink:to="loc_us-gaap_DebtCurrent_5b7c2fae-79ad-4e4e-9d3a-4c4773b6fe08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d1532a09-142d-4e59-9418-9b94c522cc47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_8a13bca5-812d-4a07-8c31-249f30329928" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d1532a09-142d-4e59-9418-9b94c522cc47" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#EarningsPerShareandShareholdersEquityDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0c5c0c1b-c139-4006-8b5c-f3b0826c4df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d97d4ba9-7e68-41b0-8c65-cb23c89415f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0c5c0c1b-c139-4006-8b5c-f3b0826c4df3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d97d4ba9-7e68-41b0-8c65-cb23c89415f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6548e78c-62ca-437f-baf8-96bbbf83a5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_97586683-e500-478c-ab00-feba5354a926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6548e78c-62ca-437f-baf8-96bbbf83a5e5" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_97586683-e500-478c-ab00-feba5354a926" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_9b2c9a33-630f-45a9-b0aa-ca1ea7257d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6548e78c-62ca-437f-baf8-96bbbf83a5e5" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_9b2c9a33-630f-45a9-b0aa-ca1ea7257d78" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>prgo-20230401_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d94275d0-2889-4bee-8a41-eed44cff1b4d,g:5de99725-025a-4d3c-a861-61491132bb43-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.perrigo.com/role/CoverPage" xlink:type="simple" xlink:href="prgo-20230401.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CoverPage" xlink:type="extended" id="i044aa2ad1515451a9b380d991440b967_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_84631de3-5d0e-45ad-b12e-1dd0a74f67cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentType_84631de3-5d0e-45ad-b12e-1dd0a74f67cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d587a223-79fb-436f-a2a4-8db977a35ad6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentQuarterlyReport_d587a223-79fb-436f-a2a4-8db977a35ad6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b5de3d1d-d1dd-42ba-8c7e-cd4efa3f036c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentPeriodEndDate_b5de3d1d-d1dd-42ba-8c7e-cd4efa3f036c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_c2730842-4df0-4bbc-8a6e-33d8d8611f76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentTransitionReport_c2730842-4df0-4bbc-8a6e-33d8d8611f76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_fa0006d6-f30b-4538-a8fd-3d4f0f344631" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityFileNumber_fa0006d6-f30b-4538-a8fd-3d4f0f344631" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8cc6f0c4-3419-4c7c-b153-b80aa4672739" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityRegistrantName_8cc6f0c4-3419-4c7c-b153-b80aa4672739" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3089f5e7-635a-45bb-8a8e-615e256f57f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3089f5e7-635a-45bb-8a8e-615e256f57f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7828f1c4-cdf2-4d92-b3b0-e18a7d51ea26" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityAddressAddressLine1_7828f1c4-cdf2-4d92-b3b0-e18a7d51ea26" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_d9d4771f-95f0-42e0-833d-b34ac2d20a9b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityAddressAddressLine2_d9d4771f-95f0-42e0-833d-b34ac2d20a9b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_23a41526-8897-40cb-9f61-5a5c5d89d87c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityAddressCityOrTown_23a41526-8897-40cb-9f61-5a5c5d89d87c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_ba86fdd0-6c28-4d11-8754-f729f11c9cec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityAddressCountry_ba86fdd0-6c28-4d11-8754-f729f11c9cec" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_187b193a-8585-49e2-b291-4dbf7eeb09b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityAddressPostalZipCode_187b193a-8585-49e2-b291-4dbf7eeb09b2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_53fee3d5-d25f-4296-97cd-d7f198c8ad88" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_CountryRegion_53fee3d5-d25f-4296-97cd-d7f198c8ad88" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ca1be1f2-abd5-4b33-be66-826f4e33fb10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_CityAreaCode_ca1be1f2-abd5-4b33-be66-826f4e33fb10" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_86e955e0-4bdb-4ef0-84df-fb9c26ddc768" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_LocalPhoneNumber_86e955e0-4bdb-4ef0-84df-fb9c26ddc768" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_2ac37026-bcf4-4273-9466-2d6bc9aabd37" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_Security12bTitle_2ac37026-bcf4-4273-9466-2d6bc9aabd37" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_dd906bc3-5b68-48ce-b821-2337844d9155" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_TradingSymbol_dd906bc3-5b68-48ce-b821-2337844d9155" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_eecb073f-64d3-460c-b4bb-88cdae6cb1a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_SecurityExchangeName_eecb073f-64d3-460c-b4bb-88cdae6cb1a3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_28ed8d4b-ee53-4260-9542-7f248720e93b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityCurrentReportingStatus_28ed8d4b-ee53-4260-9542-7f248720e93b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_599b88cd-3380-45c4-bf52-229bd6c0a8e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityInteractiveDataCurrent_599b88cd-3380-45c4-bf52-229bd6c0a8e4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_50ffd4cc-7813-44e7-848f-c7cbecaebeee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityFilerCategory_50ffd4cc-7813-44e7-848f-c7cbecaebeee" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_65d6e5e4-8f5c-42a4-a675-16185fbeabc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntitySmallBusiness_65d6e5e4-8f5c-42a4-a675-16185fbeabc0" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4a4b07f6-997e-49dd-b8de-101bb640d711" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityEmergingGrowthCompany_4a4b07f6-997e-49dd-b8de-101bb640d711" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4ede98ac-2ebf-4a07-9398-0569f9a680a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityShellCompany_4ede98ac-2ebf-4a07-9398-0569f9a680a9" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_139331a2-0644-4dea-9524-bfe7323603f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_139331a2-0644-4dea-9524-bfe7323603f5" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7b495f54-ea5f-467f-8f05-40ac80bc0401" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityCentralIndexKey_7b495f54-ea5f-467f-8f05-40ac80bc0401" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b1836450-f4d9-4fdd-bae2-bc806368991c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_CurrentFiscalYearEndDate_b1836450-f4d9-4fdd-bae2-bc806368991c" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_256ef3c9-779f-41ca-a9c3-92c967d48b2a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentFiscalYearFocus_256ef3c9-779f-41ca-a9c3-92c967d48b2a" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_eee994e1-2fdf-4a4d-b32c-fa260b393bfe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentFiscalPeriodFocus_eee994e1-2fdf-4a4d-b32c-fa260b393bfe" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_cf956af4-5059-428b-a695-724f8f19bc74" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_AmendmentFlag_cf956af4-5059-428b-a695-724f8f19bc74" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_280c6fce-0d85-47a2-9974-b7cc41e45fcb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentInformationTable_280c6fce-0d85-47a2-9974-b7cc41e45fcb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_56239599-1b3a-4b4e-b961-e71d5f0c60e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_280c6fce-0d85-47a2-9974-b7cc41e45fcb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_56239599-1b3a-4b4e-b961-e71d5f0c60e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_56239599-1b3a-4b4e-b961-e71d5f0c60e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_56239599-1b3a-4b4e-b961-e71d5f0c60e0" xlink:to="loc_us-gaap_ClassOfStockDomain_56239599-1b3a-4b4e-b961-e71d5f0c60e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_56239599-1b3a-4b4e-b961-e71d5f0c60e0" xlink:to="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OrdinaryShares0001ParValueMember_4315de6a-8bde-4706-b424-9dbdc84344b2" xlink:href="prgo-20230401.xsd#prgo_OrdinaryShares0001ParValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_OrdinaryShares0001ParValueMember_4315de6a-8bde-4706-b424-9dbdc84344b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member_b9f1b52a-bbbe-4eb9-8eb0-ccc059e710ee" xlink:href="prgo-20230401.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_A3900SeniorNoteDue2024Member_b9f1b52a-bbbe-4eb9-8eb0-ccc059e710ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_20687f50-9bc9-4319-8f25-686825629810" xlink:href="prgo-20230401.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_20687f50-9bc9-4319-8f25-686825629810" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member_c1e221f9-43b1-493f-8f1f-bd0b6cad8bef" xlink:href="prgo-20230401.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_A4400SeniorNotesDueJune152030Member_c1e221f9-43b1-493f-8f1f-bd0b6cad8bef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_5d1dfa5e-5528-4e95-a819-fe7727a4d4f2" xlink:href="prgo-20230401.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_5d1dfa5e-5528-4e95-a819-fe7727a4d4f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member_7607b2e3-57cd-4cf7-bf84-dcc47aef5dbf" xlink:href="prgo-20230401.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_A4900SeniorLoanDue2044Member_7607b2e3-57cd-4cf7-bf84-dcc47aef5dbf" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="i8b0ef38f31fb4335ac7095def6805c43_CondensedConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9015b65e-b097-4617-94e9-546805836ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9015b65e-b097-4617-94e9-546805836ac3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_73cb47b8-805d-423d-a562-f9a051b06293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_SharesOutstanding_73cb47b8-805d-423d-a562-f9a051b06293" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e0400776-b119-4a26-ba09-51bde4cb8256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_StockholdersEquity_e0400776-b119-4a26-ba09-51bde4cb8256" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0aff6144-6811-4220-8522-5b692f65b401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_NetIncomeLoss_0aff6144-6811-4220-8522-5b692f65b401" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cf11ae46-86a2-4907-a006-23c3411ae7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cf11ae46-86a2-4907-a006-23c3411ae7e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_13ed0e1a-43d4-4864-b7ac-fc3c6ece58c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_13ed0e1a-43d4-4864-b7ac-fc3c6ece58c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_0d7f019c-8384-46d7-99b1-c7c6484356d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_0d7f019c-8384-46d7-99b1-c7c6484356d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_0760feaa-0f1d-48b0-9e17-8f2c57f4b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_DividendsCommonStockCash_0760feaa-0f1d-48b0-9e17-8f2c57f4b54d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9ebfeb9a-200a-4886-a539-d013faad9c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9ebfeb9a-200a-4886-a539-d013faad9c03" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23735b6a-a310-43c8-81ed-36ea65569a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23735b6a-a310-43c8-81ed-36ea65569a97" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4508d331-fb69-40b4-8cd7-9128fc7b6eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_af25425f-4882-445f-b9c2-a4022295b38b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dbe6249e-9452-4a8a-844b-6406d6d64f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9015b65e-b097-4617-94e9-546805836ac3" xlink:to="loc_us-gaap_StatementTable_dbe6249e-9452-4a8a-844b-6406d6d64f04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c06edd4c-f84c-4586-be95-e14839fa8cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dbe6249e-9452-4a8a-844b-6406d6d64f04" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c06edd4c-f84c-4586-be95-e14839fa8cff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c06edd4c-f84c-4586-be95-e14839fa8cff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c06edd4c-f84c-4586-be95-e14839fa8cff" xlink:to="loc_us-gaap_EquityComponentDomain_c06edd4c-f84c-4586-be95-e14839fa8cff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_226f6454-8fe5-4035-82fe-068d2bc914ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c06edd4c-f84c-4586-be95-e14839fa8cff" xlink:to="loc_us-gaap_EquityComponentDomain_226f6454-8fe5-4035-82fe-068d2bc914ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b8a3a936-e130-48a5-b0ca-fb50a901cc96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_226f6454-8fe5-4035-82fe-068d2bc914ef" xlink:to="loc_us-gaap_CommonStockMember_b8a3a936-e130-48a5-b0ca-fb50a901cc96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e77d6526-c6ef-4f37-9db6-d4b1b3990022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_226f6454-8fe5-4035-82fe-068d2bc914ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e77d6526-c6ef-4f37-9db6-d4b1b3990022" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b651bc41-ccf2-4622-a675-1e84a0c0b9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_226f6454-8fe5-4035-82fe-068d2bc914ef" xlink:to="loc_us-gaap_RetainedEarningsMember_b651bc41-ccf2-4622-a675-1e84a0c0b9db" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RevenueRecognitionScheduleofRevenuebyProductDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails" xlink:type="extended" id="i43dc3289bf9a4a7cbc31dc92791e93a1_RevenueRecognitionScheduleofRevenuebyProductDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3672e78a-ce0e-4465-98aa-ef421c99e8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_08840394-f865-4363-b07a-5a3452355ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3672e78a-ce0e-4465-98aa-ef421c99e8a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_08840394-f865-4363-b07a-5a3452355ccf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_501ddb74-9655-4b56-abb7-68073d19ffbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3672e78a-ce0e-4465-98aa-ef421c99e8a9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_501ddb74-9655-4b56-abb7-68073d19ffbd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eab438f9-4412-45fe-9509-cf0bbddd88db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_501ddb74-9655-4b56-abb7-68073d19ffbd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eab438f9-4412-45fe-9509-cf0bbddd88db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eab438f9-4412-45fe-9509-cf0bbddd88db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eab438f9-4412-45fe-9509-cf0bbddd88db" xlink:to="loc_us-gaap_SegmentDomain_eab438f9-4412-45fe-9509-cf0bbddd88db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0aab937c-36ad-44f8-a6f3-b086c5c9e575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eab438f9-4412-45fe-9509-cf0bbddd88db" xlink:to="loc_us-gaap_SegmentDomain_0aab937c-36ad-44f8-a6f3-b086c5c9e575" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_01ca6a52-d4cb-4add-9a4a-fb1de83879cc" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0aab937c-36ad-44f8-a6f3-b086c5c9e575" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_01ca6a52-d4cb-4add-9a4a-fb1de83879cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_8f1717ee-24a3-4e04-80a4-4fd00c27dde5" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0aab937c-36ad-44f8-a6f3-b086c5c9e575" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_8f1717ee-24a3-4e04-80a4-4fd00c27dde5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4aa41529-9294-4797-adc0-684710e4ca23" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_501ddb74-9655-4b56-abb7-68073d19ffbd" xlink:to="loc_srt_ProductOrServiceAxis_4aa41529-9294-4797-adc0-684710e4ca23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4aa41529-9294-4797-adc0-684710e4ca23_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4aa41529-9294-4797-adc0-684710e4ca23" xlink:to="loc_srt_ProductsAndServicesDomain_4aa41529-9294-4797-adc0-684710e4ca23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4aa41529-9294-4797-adc0-684710e4ca23" xlink:to="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_UpperRespiratoryMember_6569fbb5-9b8b-4acd-936b-9f027df9d83c" xlink:href="prgo-20230401.xsd#prgo_UpperRespiratoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_UpperRespiratoryMember_6569fbb5-9b8b-4acd-936b-9f027df9d83c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NutritionMember_27e43b54-3fd8-4cb7-a14f-cf4003bd9e61" xlink:href="prgo-20230401.xsd#prgo_NutritionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_NutritionMember_27e43b54-3fd8-4cb7-a14f-cf4003bd9e61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DigestiveHealthMember_6242aabf-a2da-4968-ba9f-8d69ca292391" xlink:href="prgo-20230401.xsd#prgo_DigestiveHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_DigestiveHealthMember_6242aabf-a2da-4968-ba9f-8d69ca292391" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PainandSleepaidsMember_c51411ce-eaf0-4aff-8b68-2a77905c3bfc" xlink:href="prgo-20230401.xsd#prgo_PainandSleepaidsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_PainandSleepaidsMember_c51411ce-eaf0-4aff-8b68-2a77905c3bfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralSelfcareMember_ebfb594f-766c-47ef-b833-28f43c2d3ef1" xlink:href="prgo-20230401.xsd#prgo_OralSelfcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_OralSelfcareMember_ebfb594f-766c-47ef-b833-28f43c2d3ef1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HealthyLifestyleMember_5d250e9a-45bf-4c71-b842-43c1c966a4c9" xlink:href="prgo-20230401.xsd#prgo_HealthyLifestyleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_HealthyLifestyleMember_5d250e9a-45bf-4c71-b842-43c1c966a4c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SkinCareMember_385f2f49-9248-42b2-b7b8-402c806d8df4" xlink:href="prgo-20230401.xsd#prgo_SkinCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_SkinCareMember_385f2f49-9248-42b2-b7b8-402c806d8df4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_WomensHealthMember_89835f29-7ab6-42c2-b12e-93ac4890a080" xlink:href="prgo-20230401.xsd#prgo_WomensHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_WomensHealthMember_89835f29-7ab6-42c2-b12e-93ac4890a080" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_VitaminsMineralsandSupplementsMember_29349ce2-dc0e-4d9e-8e2c-15d8bea38389" xlink:href="prgo-20230401.xsd#prgo_VitaminsMineralsandSupplementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_VitaminsMineralsandSupplementsMember_29349ce2-dc0e-4d9e-8e2c-15d8bea38389" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCAMember_3b6fe753-526e-488e-9c30-b76d8a0940ef" xlink:href="prgo-20230401.xsd#prgo_OtherCSCAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_OtherCSCAMember_3b6fe753-526e-488e-9c30-b76d8a0940ef" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCIMember_636f6abb-53c8-4f57-9f08-b04d26aa09b3" xlink:href="prgo-20230401.xsd#prgo_OtherCSCIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_OtherCSCIMember_636f6abb-53c8-4f57-9f08-b04d26aa09b3" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RevenueRecognitionAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="extended" id="idd1892c7244948e4adfccd38d241af9a_RevenueRecognitionAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ec3e4828-ca1b-4cbb-93f0-04a33e90e92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f589b4df-8423-4e0d-9855-660c3ca4bf28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ec3e4828-ca1b-4cbb-93f0-04a33e90e92d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f589b4df-8423-4e0d-9855-660c3ca4bf28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bf21b5d5-61cf-4e83-a311-2883a9876337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ec3e4828-ca1b-4cbb-93f0-04a33e90e92d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bf21b5d5-61cf-4e83-a311-2883a9876337" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4cc7ac89-b988-4c28-8af0-f321074503b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bf21b5d5-61cf-4e83-a311-2883a9876337" xlink:to="loc_srt_ProductOrServiceAxis_4cc7ac89-b988-4c28-8af0-f321074503b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4cc7ac89-b988-4c28-8af0-f321074503b0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4cc7ac89-b988-4c28-8af0-f321074503b0" xlink:to="loc_srt_ProductsAndServicesDomain_4cc7ac89-b988-4c28-8af0-f321074503b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8a1037f3-c6a6-4cbf-8aaf-980dbe3eeb62" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4cc7ac89-b988-4c28-8af0-f321074503b0" xlink:to="loc_srt_ProductsAndServicesDomain_8a1037f3-c6a6-4cbf-8aaf-980dbe3eeb62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContractManufacturingMember_f455360d-1d3c-40dd-a82f-3b644ef8e91b" xlink:href="prgo-20230401.xsd#prgo_ContractManufacturingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8a1037f3-c6a6-4cbf-8aaf-980dbe3eeb62" xlink:to="loc_prgo_ContractManufacturingMember_f455360d-1d3c-40dd-a82f-3b644ef8e91b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails" xlink:type="extended" id="ida44dbed5d9041af9738baa58e2d984a_RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ae30e29b-07df-4d04-ad9e-d7e2d5a8b42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_53ce9e96-24b1-48fc-862f-1dbf1fda568a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ae30e29b-07df-4d04-ad9e-d7e2d5a8b42c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_53ce9e96-24b1-48fc-862f-1dbf1fda568a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3b0573d7-b3fe-4761-97f0-1337ed2cac1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ae30e29b-07df-4d04-ad9e-d7e2d5a8b42c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3b0573d7-b3fe-4761-97f0-1337ed2cac1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b0a9eb82-ff39-48a6-8d41-2b5c58f9f679" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3b0573d7-b3fe-4761-97f0-1337ed2cac1c" xlink:to="loc_srt_StatementGeographicalAxis_b0a9eb82-ff39-48a6-8d41-2b5c58f9f679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b0a9eb82-ff39-48a6-8d41-2b5c58f9f679_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b0a9eb82-ff39-48a6-8d41-2b5c58f9f679" xlink:to="loc_srt_SegmentGeographicalDomain_b0a9eb82-ff39-48a6-8d41-2b5c58f9f679_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b0a9eb82-ff39-48a6-8d41-2b5c58f9f679" xlink:to="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cb4f162f-5f88-43c3-8fdc-ec92da18b69e" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:to="loc_country_US_cb4f162f-5f88-43c3-8fdc-ec92da18b69e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_2c06c798-3c37-4b6d-9dc0-58b4b59f2e26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:to="loc_srt_EuropeMember_2c06c798-3c37-4b6d-9dc0-58b4b59f2e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherGeographicalAreasMember_95713dbb-5cec-4f08-9f0e-2d55c17d28b8" xlink:href="prgo-20230401.xsd#prgo_OtherGeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:to="loc_prgo_OtherGeographicalAreasMember_95713dbb-5cec-4f08-9f0e-2d55c17d28b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_c5ec377b-3b3c-4654-8a7d-e0f668797f61" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:to="loc_country_IE_c5ec377b-3b3c-4654-8a7d-e0f668797f61" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#AcquisitionsandDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="extended" id="ib089d8b0779446f2bea248d5a78abcf0_AcquisitionsandDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_cff032d8-ffd0-4617-8b90-22f55f10528c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_cff032d8-ffd0-4617-8b90-22f55f10528c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fbab0b57-b237-4adb-9707-9c80c1636798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fbab0b57-b237-4adb-9707-9c80c1636798" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f95627a2-c619-45c6-97e8-ec560a4335a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_Goodwill_f95627a2-c619-45c6-97e8-ec560a4335a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_ef66f703-50d1-4379-8791-79f3b6bb31ab" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_ef66f703-50d1-4379-8791-79f3b6bb31ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_3156aa00-1e31-4036-9082-45be4e2d28e5" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_3156aa00-1e31-4036-9082-45be4e2d28e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_9abe7b76-07c9-4a64-806c-20cd05fa19dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_9abe7b76-07c9-4a64-806c-20cd05fa19dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5a10aae7-4cbf-4c48-82f9-29fb60228617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5a10aae7-4cbf-4c48-82f9-29fb60228617" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_7f22e485-53ac-4557-999b-dd4caca8711d" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_7f22e485-53ac-4557-999b-dd4caca8711d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d45b42b2-e1ce-48ee-965e-848c099e489f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d45b42b2-e1ce-48ee-965e-848c099e489f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_fcb8f707-f945-448d-a7f1-5576ba8d99ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_fcb8f707-f945-448d-a7f1-5576ba8d99ca" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_1bc4c5c5-f540-4fcb-8845-fc4da9669c66" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_1bc4c5c5-f540-4fcb-8845-fc4da9669c66" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_f534f8aa-eb7f-4368-b871-3f2ebbb68d7c" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_f534f8aa-eb7f-4368-b871-3f2ebbb68d7c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_148f8881-c04a-437e-9ad2-67f93f5b0dc3" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_148f8881-c04a-437e-9ad2-67f93f5b0dc3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_f2155ef0-4c1d-4003-a910-82ab4c812280" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_f2155ef0-4c1d-4003-a910-82ab4c812280" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_53023296-8520-41ef-abb3-bcf49b43df3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_53023296-8520-41ef-abb3-bcf49b43df3b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e22718e7-b05b-4a02-a3aa-ae75dfc81994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e22718e7-b05b-4a02-a3aa-ae75dfc81994" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e22718e7-b05b-4a02-a3aa-ae75dfc81994_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e22718e7-b05b-4a02-a3aa-ae75dfc81994" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e22718e7-b05b-4a02-a3aa-ae75dfc81994_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e31a4b06-9870-4732-ae0d-28e1ade69585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e22718e7-b05b-4a02-a3aa-ae75dfc81994" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e31a4b06-9870-4732-ae0d-28e1ade69585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaMember_bc239b9e-5244-4133-a313-3d7718a6d1fe" xlink:href="prgo-20230401.xsd#prgo_HRAPharmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e31a4b06-9870-4732-ae0d-28e1ade69585" xlink:to="loc_prgo_HRAPharmaMember_bc239b9e-5244-4133-a313-3d7718a6d1fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_2d884593-80b9-4081-9f58-4de3f3bcf680" xlink:href="prgo-20230401.xsd#prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e31a4b06-9870-4732-ae0d-28e1ade69585" xlink:to="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_2d884593-80b9-4081-9f58-4de3f3bcf680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_50708edc-4de6-43d9-9300-91dc3ecb9a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_50708edc-4de6-43d9-9300-91dc3ecb9a70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_50708edc-4de6-43d9-9300-91dc3ecb9a70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_50708edc-4de6-43d9-9300-91dc3ecb9a70" xlink:to="loc_us-gaap_SegmentDomain_50708edc-4de6-43d9-9300-91dc3ecb9a70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cf3236e5-3fd1-4185-a6bf-4508e1706f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_50708edc-4de6-43d9-9300-91dc3ecb9a70" xlink:to="loc_us-gaap_SegmentDomain_cf3236e5-3fd1-4185-a6bf-4508e1706f0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_637126c8-3902-4a37-b563-7cd58fa48a41" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cf3236e5-3fd1-4185-a6bf-4508e1706f0b" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_637126c8-3902-4a37-b563-7cd58fa48a41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_a3e8c634-a4cc-4627-a8ee-9835ff4565a5" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cf3236e5-3fd1-4185-a6bf-4508e1706f0b" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_a3e8c634-a4cc-4627-a8ee-9835ff4565a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b97ce78b-b3dd-4f9c-845a-dab936d145cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b97ce78b-b3dd-4f9c-845a-dab936d145cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b97ce78b-b3dd-4f9c-845a-dab936d145cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b97ce78b-b3dd-4f9c-845a-dab936d145cc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b97ce78b-b3dd-4f9c-845a-dab936d145cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f4de1124-7925-422b-a491-635ebad28146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b97ce78b-b3dd-4f9c-845a-dab936d145cc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f4de1124-7925-422b-a491-635ebad28146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_d7303661-08ea-44e9-8541-6895251890a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f4de1124-7925-422b-a491-635ebad28146" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_d7303661-08ea-44e9-8541-6895251890a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2f59ec9-ccc0-4d61-8d4a-23e6187dafbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2f59ec9-ccc0-4d61-8d4a-23e6187dafbd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e2f59ec9-ccc0-4d61-8d4a-23e6187dafbd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2f59ec9-ccc0-4d61-8d4a-23e6187dafbd" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e2f59ec9-ccc0-4d61-8d4a-23e6187dafbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_feef9724-f38b-4ed6-b217-619d069f80e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2f59ec9-ccc0-4d61-8d4a-23e6187dafbd" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_feef9724-f38b-4ed6-b217-619d069f80e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AdventInternationalMember_fd3db771-d9f9-44ad-9228-76a771af3517" xlink:href="prgo-20230401.xsd#prgo_AdventInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_feef9724-f38b-4ed6-b217-619d069f80e3" xlink:to="loc_prgo_AdventInternationalMember_fd3db771-d9f9-44ad-9228-76a771af3517" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessMember_1285d53b-4f21-4796-bdb1-109833432f2c" xlink:href="prgo-20230401.xsd#prgo_LatinAmericaBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_feef9724-f38b-4ed6-b217-619d069f80e3" xlink:to="loc_prgo_LatinAmericaBusinessMember_1285d53b-4f21-4796-bdb1-109833432f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScarAwayMember_a9e5ba58-f772-4615-9b6e-38b8a380c100" xlink:href="prgo-20230401.xsd#prgo_ScarAwayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_feef9724-f38b-4ed6-b217-619d069f80e3" xlink:to="loc_prgo_ScarAwayMember_a9e5ba58-f772-4615-9b6e-38b8a380c100" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DiscontinuedOperationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="extended" id="i9c48f164af2547e99fd406fd4455dbb1_DiscontinuedOperationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8857c858-0085-46e5-81a9-0274b0b6ebcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8857c858-0085-46e5-81a9-0274b0b6ebcf" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25397d74-5052-4d31-af5e-d6ca31b7d0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25397d74-5052-4d31-af5e-d6ca31b7d0c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_d290201b-fb68-455e-bf05-6fa41bd3511f" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_d290201b-fb68-455e-bf05-6fa41bd3511f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_9416cc81-4c76-4544-b2c4-2ba41694465d" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_9416cc81-4c76-4544-b2c4-2ba41694465d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_bea0169f-1f4b-486f-a790-4b4525cc8b43" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_bea0169f-1f4b-486f-a790-4b4525cc8b43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_3c627a8d-b801-4857-a124-3fe47cf1ad29" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_3c627a8d-b801-4857-a124-3fe47cf1ad29" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_ab46cb83-302b-4e62-8fa6-efe5594fedc6" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_ab46cb83-302b-4e62-8fa6-efe5594fedc6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8857c858-0085-46e5-81a9-0274b0b6ebcf" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d5071f72-0304-4e3f-8e08-5d4f762e6ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d5071f72-0304-4e3f-8e08-5d4f762e6ee4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d5071f72-0304-4e3f-8e08-5d4f762e6ee4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d5071f72-0304-4e3f-8e08-5d4f762e6ee4" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d5071f72-0304-4e3f-8e08-5d4f762e6ee4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3256b0c6-2048-4d89-b6ab-91fbe196ba7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d5071f72-0304-4e3f-8e08-5d4f762e6ee4" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3256b0c6-2048-4d89-b6ab-91fbe196ba7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_3c9960e6-a65c-4efb-8119-a01d6eb10e64" xlink:href="prgo-20230401.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3256b0c6-2048-4d89-b6ab-91fbe196ba7c" xlink:to="loc_prgo_RXPharmaceuticalsMember_3c9960e6-a65c-4efb-8119-a01d6eb10e64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_952fb628-eaf1-4659-bce4-c44f1aba607f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_952fb628-eaf1-4659-bce4-c44f1aba607f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_952fb628-eaf1-4659-bce4-c44f1aba607f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_952fb628-eaf1-4659-bce4-c44f1aba607f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_952fb628-eaf1-4659-bce4-c44f1aba607f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8f397071-caa4-41d3-b9d9-64cc548009e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_952fb628-eaf1-4659-bce4-c44f1aba607f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8f397071-caa4-41d3-b9d9-64cc548009e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_001e179b-b596-450e-84cf-fbeb85a07409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_8f397071-caa4-41d3-b9d9-64cc548009e4" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_001e179b-b596-450e-84cf-fbeb85a07409" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d17dfaab-e286-45da-bd61-4f04e3df4918" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:to="loc_srt_CounterpartyNameAxis_d17dfaab-e286-45da-bd61-4f04e3df4918" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d17dfaab-e286-45da-bd61-4f04e3df4918_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d17dfaab-e286-45da-bd61-4f04e3df4918" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d17dfaab-e286-45da-bd61-4f04e3df4918_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1f957797-641c-4dc0-a6b8-6ea85cd0ccd3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d17dfaab-e286-45da-bd61-4f04e3df4918" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1f957797-641c-4dc0-a6b8-6ea85cd0ccd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_b7c2223a-316f-4b8e-99e3-37a151d1786e" xlink:href="prgo-20230401.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1f957797-641c-4dc0-a6b8-6ea85cd0ccd3" xlink:to="loc_prgo_RXPharmaceuticalsMember_b7c2223a-316f-4b8e-99e3-37a151d1786e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#InvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="extended" id="i1e1e13c32dd8436297d14f670b15b42f_InvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3f42da89-2652-45d6-a742-c01beb9c21ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3f42da89-2652-45d6-a742-c01beb9c21ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_aeedec4b-f081-4f56-b2f1-e345c0e027b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:to="loc_us-gaap_EquityMethodInvestments_aeedec4b-f081-4f56-b2f1-e345c0e027b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8776a786-2b3b-4d3f-bd30-f6a06d1965aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8776a786-2b3b-4d3f-bd30-f6a06d1965aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2328e100-00cd-45cd-b5a0-05bd73c86cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2328e100-00cd-45cd-b5a0-05bd73c86cbf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_07c28d84-d80b-4ebc-9811-724200b852a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_07c28d84-d80b-4ebc-9811-724200b852a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_20ebd119-1b0d-42c9-994a-82a120d4666c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_07c28d84-d80b-4ebc-9811-724200b852a0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_20ebd119-1b0d-42c9-994a-82a120d4666c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_20ebd119-1b0d-42c9-994a-82a120d4666c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_20ebd119-1b0d-42c9-994a-82a120d4666c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_20ebd119-1b0d-42c9-994a-82a120d4666c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9d29d69f-c348-4b4a-9d49-d27b80bd0bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_20ebd119-1b0d-42c9-994a-82a120d4666c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9d29d69f-c348-4b4a-9d49-d27b80bd0bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_39fbb2b4-769e-42ae-b494-903dc047b836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9d29d69f-c348-4b4a-9d49-d27b80bd0bc9" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_39fbb2b4-769e-42ae-b494-903dc047b836" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_1ac6210d-3bd8-43de-b06d-571f1219fca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9d29d69f-c348-4b4a-9d49-d27b80bd0bc9" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_1ac6210d-3bd8-43de-b06d-571f1219fca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_171937b3-5e56-49a9-b361-ac646a76862e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_07c28d84-d80b-4ebc-9811-724200b852a0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_171937b3-5e56-49a9-b361-ac646a76862e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_171937b3-5e56-49a9-b361-ac646a76862e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_171937b3-5e56-49a9-b361-ac646a76862e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_171937b3-5e56-49a9-b361-ac646a76862e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c41fe227-60fd-4e54-abad-b866ad6f0b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_171937b3-5e56-49a9-b361-ac646a76862e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c41fe227-60fd-4e54-abad-b866ad6f0b1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_fc5cf044-ccfc-48af-b047-6fa0d3ba13cb" xlink:href="prgo-20230401.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c41fe227-60fd-4e54-abad-b866ad6f0b1a" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_fc5cf044-ccfc-48af-b047-6fa0d3ba13cb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="extended" id="i279cb035498b4a45a4e6692a3b6927a2_LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_46acbb36-e035-4f3c-9a7c-bd689a5cd755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_46acbb36-e035-4f3c-9a7c-bd689a5cd755" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_a6d8a4d5-586e-4996-969c-67db5ca1b33f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_a6d8a4d5-586e-4996-969c-67db5ca1b33f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_703b814a-2da1-4ae1-b87b-e61b939b2de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_703b814a-2da1-4ae1-b87b-e61b939b2de0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RightofUseAsset_b6954df6-0faf-4019-b062-597220f59cac" xlink:href="prgo-20230401.xsd#prgo_RightofUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_prgo_RightofUseAsset_b6954df6-0faf-4019-b062-597220f59cac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_c75061a6-f907-4c10-bbfd-33fe741a3afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_c75061a6-f907-4c10-bbfd-33fe741a3afd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_aca71932-4834-4e29-8a35-9a2f90df4c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_aca71932-4834-4e29-8a35-9a2f90df4c25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_2348a708-b7cf-4c53-beca-4a4265b33119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_2348a708-b7cf-4c53-beca-4a4265b33119" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_02228878-c591-43c8-88a5-5296787fab67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_02228878-c591-43c8-88a5-5296787fab67" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_6507c499-3dfa-4060-bc68-97032b01c803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_6507c499-3dfa-4060-bc68-97032b01c803" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_46438447-1d4a-446e-baa3-c1046a2c417b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_46438447-1d4a-446e-baa3-c1046a2c417b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_c94e8b9d-7259-4ef1-86f8-4b747d1c3ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_c94e8b9d-7259-4ef1-86f8-4b747d1c3ccf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_efb2378a-e2e8-4f77-9c05-3dd8fcfbf5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_efb2378a-e2e8-4f77-9c05-3dd8fcfbf5b2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_9f2b142b-29c2-4e2b-92bd-b752e240e557" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_prgo_LeaseLiabilities_9f2b142b-29c2-4e2b-92bd-b752e240e557" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2ad86615-b7ea-470b-b9f9-bf455f1d8cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseLiability_2ad86615-b7ea-470b-b9f9-bf455f1d8cca" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_1ad26317-f353-4185-bab1-ae884c8ba774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseLiability_1ad26317-f353-4185-bab1-ae884c8ba774" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_96f8ee68-701d-422c-afac-601c44674dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_96f8ee68-701d-422c-afac-601c44674dd2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e59e333c-c3d8-4d78-b418-ffab79fb09a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_96f8ee68-701d-422c-afac-601c44674dd2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e59e333c-c3d8-4d78-b418-ffab79fb09a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e59e333c-c3d8-4d78-b418-ffab79fb09a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e59e333c-c3d8-4d78-b418-ffab79fb09a8" xlink:to="loc_us-gaap_SegmentDomain_e59e333c-c3d8-4d78-b418-ffab79fb09a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_280291b1-27c9-495e-a7ca-10a7b32289ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e59e333c-c3d8-4d78-b418-ffab79fb09a8" xlink:to="loc_us-gaap_SegmentDomain_280291b1-27c9-495e-a7ca-10a7b32289ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_c79180e3-5647-4d88-b335-266c4b1e854e" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_280291b1-27c9-495e-a7ca-10a7b32289ba" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_c79180e3-5647-4d88-b335-266c4b1e854e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_ef51cb03-21f0-4459-8a24-dd5d92dbcd8a" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_280291b1-27c9-495e-a7ca-10a7b32289ba" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_ef51cb03-21f0-4459-8a24-dd5d92dbcd8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_125acbd9-6ead-4a10-a9d6-e2f1d1454ab8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_96f8ee68-701d-422c-afac-601c44674dd2" xlink:to="loc_srt_ConsolidationItemsAxis_125acbd9-6ead-4a10-a9d6-e2f1d1454ab8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_125acbd9-6ead-4a10-a9d6-e2f1d1454ab8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_125acbd9-6ead-4a10-a9d6-e2f1d1454ab8" xlink:to="loc_srt_ConsolidationItemsDomain_125acbd9-6ead-4a10-a9d6-e2f1d1454ab8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a9925093-c8aa-43ba-9b57-d91ccf63a718" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_125acbd9-6ead-4a10-a9d6-e2f1d1454ab8" xlink:to="loc_srt_ConsolidationItemsDomain_a9925093-c8aa-43ba-9b57-d91ccf63a718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_144fe132-3074-4c02-aebc-5d59e86157f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a9925093-c8aa-43ba-9b57-d91ccf63a718" xlink:to="loc_us-gaap_OperatingSegmentsMember_144fe132-3074-4c02-aebc-5d59e86157f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_a6e83855-9711-4323-a0bc-62ce1fc6fd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a9925093-c8aa-43ba-9b57-d91ccf63a718" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_a6e83855-9711-4323-a0bc-62ce1fc6fd36" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended" id="idcbda7bf8c684615a1210d97c5ac591f_GoodwillandIntangibleAssetsGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_0973b24d-9667-4746-9011-d85aea994b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0973b24d-9667-4746-9011-d85aea994b86" xlink:to="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b7beb92c-db18-4191-9491-276e37d8032b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:to="loc_us-gaap_Goodwill_b7beb92c-db18-4191-9491-276e37d8032b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f94e9ab0-4266-41b1-9102-3f78cf1a5071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f94e9ab0-4266-41b1-9102-3f78cf1a5071" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3c50bede-fc47-4dc0-8a36-2a3897650cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3c50bede-fc47-4dc0-8a36-2a3897650cb4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4b0e3308-6e90-416a-a09a-8472a91db9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c6890301-1ac2-4cea-aa38-5a2e65dfaa20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0973b24d-9667-4746-9011-d85aea994b86" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c6890301-1ac2-4cea-aa38-5a2e65dfaa20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_4903dc4f-2b77-4cf2-a680-3e2bc58b6543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_0973b24d-9667-4746-9011-d85aea994b86" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_4903dc4f-2b77-4cf2-a680-3e2bc58b6543" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6ac7abe9-321c-411d-b84f-af1f0fa9191e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4903dc4f-2b77-4cf2-a680-3e2bc58b6543" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6ac7abe9-321c-411d-b84f-af1f0fa9191e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6ac7abe9-321c-411d-b84f-af1f0fa9191e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6ac7abe9-321c-411d-b84f-af1f0fa9191e" xlink:to="loc_us-gaap_SegmentDomain_6ac7abe9-321c-411d-b84f-af1f0fa9191e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_57c008f4-b8ab-4b76-bc53-678892ce2971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6ac7abe9-321c-411d-b84f-af1f0fa9191e" xlink:to="loc_us-gaap_SegmentDomain_57c008f4-b8ab-4b76-bc53-678892ce2971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_7039874d-ce7e-492e-8dca-251130fad688" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_57c008f4-b8ab-4b76-bc53-678892ce2971" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_7039874d-ce7e-492e-8dca-251130fad688" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_cd62bbe0-81a6-4368-b016-a56b7885029b" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_57c008f4-b8ab-4b76-bc53-678892ce2971" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_cd62bbe0-81a6-4368-b016-a56b7885029b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#GoodwillandIntangibleAssetsIntangiblecategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails" xlink:type="extended" id="if37efa097fb04ee89f17950fbed68df0_GoodwillandIntangibleAssetsIntangiblecategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:href="prgo-20230401.xsd#prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8f8dff6c-760f-4d8e-ab6f-a514e10ff995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8f8dff6c-760f-4d8e-ab6f-a514e10ff995" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4899883a-6ac8-49d2-9f97-35a06ef91bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4899883a-6ac8-49d2-9f97-35a06ef91bf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ebb5a429-7fe0-4758-b065-ad2aaf8ccfff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ebb5a429-7fe0-4758-b065-ad2aaf8ccfff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b174ee3c-e59c-4208-9191-491a5a6b56d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b174ee3c-e59c-4208-9191-491a5a6b56d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0dd03420-2a1d-40ca-8413-e0003c340c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0dd03420-2a1d-40ca-8413-e0003c340c08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_bb648f2b-293a-4b59-8d7f-428f53ded6d7" xlink:href="prgo-20230401.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_bb648f2b-293a-4b59-8d7f-428f53ded6d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5c998f88-c01e-4b61-8b6e-8bd52e497553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_bb648f2b-293a-4b59-8d7f-428f53ded6d7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5c998f88-c01e-4b61-8b6e-8bd52e497553" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5c998f88-c01e-4b61-8b6e-8bd52e497553_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5c998f88-c01e-4b61-8b6e-8bd52e497553" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5c998f88-c01e-4b61-8b6e-8bd52e497553_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c08a1bef-a3dc-4b7f-b6ee-40509b2bb45d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5c998f88-c01e-4b61-8b6e-8bd52e497553" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c08a1bef-a3dc-4b7f-b6ee-40509b2bb45d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_5e38b215-a8fe-4c40-8ea0-8e4550fa5502" xlink:href="prgo-20230401.xsd#prgo_TrademarksTradeNamesandBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c08a1bef-a3dc-4b7f-b6ee-40509b2bb45d" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_5e38b215-a8fe-4c40-8ea0-8e4550fa5502" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_64b4d4fe-7897-4bb1-84cb-5f48e8f6639b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c08a1bef-a3dc-4b7f-b6ee-40509b2bb45d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_64b4d4fe-7897-4bb1-84cb-5f48e8f6639b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dd3e6d9-e92e-4531-99df-2c3ae300bd17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_bb648f2b-293a-4b59-8d7f-428f53ded6d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dd3e6d9-e92e-4531-99df-2c3ae300bd17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1dd3e6d9-e92e-4531-99df-2c3ae300bd17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dd3e6d9-e92e-4531-99df-2c3ae300bd17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1dd3e6d9-e92e-4531-99df-2c3ae300bd17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dd3e6d9-e92e-4531-99df-2c3ae300bd17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_5d8a3b27-c327-41db-b08a-134984ff163e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:to="loc_us-gaap_LicensingAgreementsMember_5d8a3b27-c327-41db-b08a-134984ff163e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_09672aad-d487-4562-be0f-3f54bb44075f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_09672aad-d487-4562-be0f-3f54bb44075f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c9b4ef81-0bdd-47f6-bb3c-7b66a3073cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c9b4ef81-0bdd-47f6-bb3c-7b66a3073cae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_ec8c375b-187c-41e9-927d-0998616a00e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_ec8c375b-187c-41e9-927d-0998616a00e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_8b34be06-d4ec-42a9-aaad-cc46d1aa08c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_8b34be06-d4ec-42a9-aaad-cc46d1aa08c5" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#FairValueMeasurementsFinancialInstrumentsatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="extended" id="ia00bd072f3534755a7a309666e892612_FairValueMeasurementsFinancialInstrumentsatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_84e57421-0942-4af6-88c9-f4a87e7bc03d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_dcc929a8-1ba4-451a-9fcd-8bf018645eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_84e57421-0942-4af6-88c9-f4a87e7bc03d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_dcc929a8-1ba4-451a-9fcd-8bf018645eca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_51ef94f9-94f1-4700-8c1a-efbacee8c9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_dcc929a8-1ba4-451a-9fcd-8bf018645eca" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_51ef94f9-94f1-4700-8c1a-efbacee8c9a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_a0edc33c-e181-49cc-99d1-d054f040d1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_51ef94f9-94f1-4700-8c1a-efbacee8c9a2" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_a0edc33c-e181-49cc-99d1-d054f040d1ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d804de64-301d-4821-b28f-e47243a25dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_51ef94f9-94f1-4700-8c1a-efbacee8c9a2" xlink:to="loc_us-gaap_DerivativeAssets_d804de64-301d-4821-b28f-e47243a25dc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_f35040a5-385f-45eb-8e62-a4919dd5aaee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_51ef94f9-94f1-4700-8c1a-efbacee8c9a2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_f35040a5-385f-45eb-8e62-a4919dd5aaee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ff5bee1b-fcc0-447e-8dc1-96bcc3d1f08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_dcc929a8-1ba4-451a-9fcd-8bf018645eca" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ff5bee1b-fcc0-447e-8dc1-96bcc3d1f08a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a1a68b35-3a42-4aba-8500-b94b3dbefd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ff5bee1b-fcc0-447e-8dc1-96bcc3d1f08a" xlink:to="loc_us-gaap_DerivativeLiabilities_a1a68b35-3a42-4aba-8500-b94b3dbefd97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_10caea04-05fe-438a-96e5-788247efecd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ff5bee1b-fcc0-447e-8dc1-96bcc3d1f08a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_10caea04-05fe-438a-96e5-788247efecd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_84e57421-0942-4af6-88c9-f4a87e7bc03d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1d88621-1f38-4388-9b9a-2ad8eebd522e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1d88621-1f38-4388-9b9a-2ad8eebd522e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b1d88621-1f38-4388-9b9a-2ad8eebd522e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1d88621-1f38-4388-9b9a-2ad8eebd522e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b1d88621-1f38-4388-9b9a-2ad8eebd522e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1f53411a-b280-4a0f-af9a-44e487ec450f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1d88621-1f38-4388-9b9a-2ad8eebd522e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1f53411a-b280-4a0f-af9a-44e487ec450f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_bc6e9bf3-51b4-4a2c-ad9b-99a34e2eff9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1f53411a-b280-4a0f-af9a-44e487ec450f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_bc6e9bf3-51b4-4a2c-ad9b-99a34e2eff9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32c4e4b4-14ce-4a04-8e19-413926962a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32c4e4b4-14ce-4a04-8e19-413926962a53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32c4e4b4-14ce-4a04-8e19-413926962a53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32c4e4b4-14ce-4a04-8e19-413926962a53" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32c4e4b4-14ce-4a04-8e19-413926962a53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e32655a-3bcd-4031-b60c-e0969884ae89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32c4e4b4-14ce-4a04-8e19-413926962a53" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e32655a-3bcd-4031-b60c-e0969884ae89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4ebd9a83-9996-4370-b2d9-6a3eea761a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e32655a-3bcd-4031-b60c-e0969884ae89" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4ebd9a83-9996-4370-b2d9-6a3eea761a8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1afff4b6-1834-49a7-a1b2-3e816f140b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e32655a-3bcd-4031-b60c-e0969884ae89" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1afff4b6-1834-49a7-a1b2-3e816f140b01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1a877b92-268f-49e5-9dcc-b9af46d91686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e32655a-3bcd-4031-b60c-e0969884ae89" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1a877b92-268f-49e5-9dcc-b9af46d91686" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_41bee99c-0386-40e9-a7d3-53fd2d9becb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_41bee99c-0386-40e9-a7d3-53fd2d9becb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_41bee99c-0386-40e9-a7d3-53fd2d9becb3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_41bee99c-0386-40e9-a7d3-53fd2d9becb3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_41bee99c-0386-40e9-a7d3-53fd2d9becb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_183f0295-2311-4e40-bf36-27a811a3258d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_41bee99c-0386-40e9-a7d3-53fd2d9becb3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_183f0295-2311-4e40-bf36-27a811a3258d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6609f5a4-ff3a-4422-9d91-4791232467e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_183f0295-2311-4e40-bf36-27a811a3258d" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6609f5a4-ff3a-4422-9d91-4791232467e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_15588c09-5373-4c37-9d88-ecd3971cf830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_183f0295-2311-4e40-bf36-27a811a3258d" xlink:to="loc_us-gaap_InterestRateSwapMember_15588c09-5373-4c37-9d88-ecd3971cf830" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_252bc28d-553e-45d9-b12a-44078e884b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_183f0295-2311-4e40-bf36-27a811a3258d" xlink:to="loc_us-gaap_CurrencySwapMember_252bc28d-553e-45d9-b12a-44078e884b6e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails" xlink:type="extended" id="ia91bd9df0283498faa82e5967daba675_FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4361ffc1-3dba-44e5-8413-9bdbadfa7181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_95b80d67-220f-482f-964b-6b74f65f95d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4361ffc1-3dba-44e5-8413-9bdbadfa7181" xlink:to="loc_us-gaap_SeniorNotes_95b80d67-220f-482f-964b-6b74f65f95d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4361ffc1-3dba-44e5-8413-9bdbadfa7181" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_9fdc943c-1d13-4fab-bec6-b08f20b4d7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_9fdc943c-1d13-4fab-bec6-b08f20b4d7b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9fdc943c-1d13-4fab-bec6-b08f20b4d7b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9fdc943c-1d13-4fab-bec6-b08f20b4d7b0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9fdc943c-1d13-4fab-bec6-b08f20b4d7b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c20f9634-df35-4514-8b57-4289c1b31fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9fdc943c-1d13-4fab-bec6-b08f20b4d7b0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c20f9634-df35-4514-8b57-4289c1b31fee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bb15fdb6-f5fb-4f43-a486-ff4db20f03ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c20f9634-df35-4514-8b57-4289c1b31fee" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bb15fdb6-f5fb-4f43-a486-ff4db20f03ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9aea8eb9-bcf2-4fb0-a6ce-291c48bdb4df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bb15fdb6-f5fb-4f43-a486-ff4db20f03ea" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9aea8eb9-bcf2-4fb0-a6ce-291c48bdb4df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dac82328-3009-4ff5-a3ee-94a811bf5c29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:to="loc_us-gaap_DebtInstrumentAxis_dac82328-3009-4ff5-a3ee-94a811bf5c29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dac82328-3009-4ff5-a3ee-94a811bf5c29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dac82328-3009-4ff5-a3ee-94a811bf5c29" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dac82328-3009-4ff5-a3ee-94a811bf5c29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4784b5a8-d608-413a-b57e-211a1632a5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dac82328-3009-4ff5-a3ee-94a811bf5c29" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4784b5a8-d608-413a-b57e-211a1632a5bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PublicBondsandPrivatePlacementMember_500bdd3d-1ca1-42fb-b0ab-96df3b1c9553" xlink:href="prgo-20230401.xsd#prgo_PublicBondsandPrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4784b5a8-d608-413a-b57e-211a1632a5bd" xlink:to="loc_prgo_PublicBondsandPrivatePlacementMember_500bdd3d-1ca1-42fb-b0ab-96df3b1c9553" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2edb2448-2a2a-4569-bfc7-a597ad3068f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2edb2448-2a2a-4569-bfc7-a597ad3068f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2edb2448-2a2a-4569-bfc7-a597ad3068f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2edb2448-2a2a-4569-bfc7-a597ad3068f6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2edb2448-2a2a-4569-bfc7-a597ad3068f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98aa639e-fd14-4b2a-94c7-06b17a0efba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2edb2448-2a2a-4569-bfc7-a597ad3068f6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98aa639e-fd14-4b2a-94c7-06b17a0efba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_841d4eb6-d8eb-4214-be9b-f6d472f04a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98aa639e-fd14-4b2a-94c7-06b17a0efba1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_841d4eb6-d8eb-4214-be9b-f6d472f04a0d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="extended" id="i9f8f22d6b3104eb2b913ce0af3cd398c_DerivativeInstrumentsandHedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_d4105c0e-6d6b-4ca2-9e51-11247264e1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_d4105c0e-6d6b-4ca2-9e51-11247264e1a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a3577c1f-8283-4d3c-aa2d-2a2667411fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a3577c1f-8283-4d3c-aa2d-2a2667411fca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments_b9fb07b4-0988-478a-9bdd-98f3664cfce6" xlink:href="prgo-20230401.xsd#prgo_PaymentsForPremiumsOnDerivativeInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:to="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments_b9fb07b4-0988-478a-9bdd-98f3664cfce6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c5ce63f3-97dd-4ebf-bd70-c47478c72d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c5ce63f3-97dd-4ebf-bd70-c47478c72d4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6aacc105-da2c-4f63-a06c-7ec5b9cab759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6aacc105-da2c-4f63-a06c-7ec5b9cab759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6aacc105-da2c-4f63-a06c-7ec5b9cab759_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6aacc105-da2c-4f63-a06c-7ec5b9cab759" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6aacc105-da2c-4f63-a06c-7ec5b9cab759_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1bd0a62-f29b-41ee-8a83-900dbd7bd0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6aacc105-da2c-4f63-a06c-7ec5b9cab759" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1bd0a62-f29b-41ee-8a83-900dbd7bd0c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_56d7449f-1509-4272-ac46-c4a53b9e7a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1bd0a62-f29b-41ee-8a83-900dbd7bd0c6" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_56d7449f-1509-4272-ac46-c4a53b9e7a95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_29a578d0-695d-42fc-addf-8ea8716ff6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1bd0a62-f29b-41ee-8a83-900dbd7bd0c6" xlink:to="loc_us-gaap_InterestRateSwapMember_29a578d0-695d-42fc-addf-8ea8716ff6fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ddd35450-119f-491f-bb3a-08e439df1ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_us-gaap_HedgingDesignationAxis_ddd35450-119f-491f-bb3a-08e439df1ef0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ddd35450-119f-491f-bb3a-08e439df1ef0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_ddd35450-119f-491f-bb3a-08e439df1ef0" xlink:to="loc_us-gaap_HedgingDesignationDomain_ddd35450-119f-491f-bb3a-08e439df1ef0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5fb99a73-f20b-4d81-a6ec-814d6cba05e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_ddd35450-119f-491f-bb3a-08e439df1ef0" xlink:to="loc_us-gaap_HedgingDesignationDomain_5fb99a73-f20b-4d81-a6ec-814d6cba05e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d2482f61-22a8-41a4-955e-46d70b31d08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5fb99a73-f20b-4d81-a6ec-814d6cba05e3" xlink:to="loc_us-gaap_NondesignatedMember_d2482f61-22a8-41a4-955e-46d70b31d08d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_be79b04a-7c18-4c9a-b384-e5f6737d55ee" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_be79b04a-7c18-4c9a-b384-e5f6737d55ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_be79b04a-7c18-4c9a-b384-e5f6737d55ee_default" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_be79b04a-7c18-4c9a-b384-e5f6737d55ee" xlink:to="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_be79b04a-7c18-4c9a-b384-e5f6737d55ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_c724c5a2-6e3f-4cbd-890a-a663179bda1c" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_be79b04a-7c18-4c9a-b384-e5f6737d55ee" xlink:to="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_c724c5a2-6e3f-4cbd-890a-a663179bda1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member_4afa8976-1faf-49bf-9f68-6018097368c5" xlink:href="prgo-20230401.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_c724c5a2-6e3f-4cbd-890a-a663179bda1c" xlink:to="loc_prgo_June12022ThroughApril12029Member_4afa8976-1faf-49bf-9f68-6018097368c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member_feeee5ac-99fb-478e-86e5-08b56a82b3e6" xlink:href="prgo-20230401.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_c724c5a2-6e3f-4cbd-890a-a663179bda1c" xlink:to="loc_prgo_June12022ThroughApril12027Member_feeee5ac-99fb-478e-86e5-08b56a82b3e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_41f74faf-a4df-4d51-81cf-ea5c6665a743" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_srt_RangeAxis_41f74faf-a4df-4d51-81cf-ea5c6665a743" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_41f74faf-a4df-4d51-81cf-ea5c6665a743_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_41f74faf-a4df-4d51-81cf-ea5c6665a743" xlink:to="loc_srt_RangeMember_41f74faf-a4df-4d51-81cf-ea5c6665a743_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d32cc357-26cf-45ed-8227-f7222a6fde8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_41f74faf-a4df-4d51-81cf-ea5c6665a743" xlink:to="loc_srt_RangeMember_d32cc357-26cf-45ed-8227-f7222a6fde8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c5e4c90e-c7bf-46f4-8624-e9642545da91" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d32cc357-26cf-45ed-8227-f7222a6fde8d" xlink:to="loc_srt_MaximumMember_c5e4c90e-c7bf-46f4-8624-e9642545da91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ff482b77-23fb-4c56-883b-9e51c94f83dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d32cc357-26cf-45ed-8227-f7222a6fde8d" xlink:to="loc_srt_MinimumMember_ff482b77-23fb-4c56-883b-9e51c94f83dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d22c2866-883c-4461-a65b-568dad80b852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d22c2866-883c-4461-a65b-568dad80b852" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d22c2866-883c-4461-a65b-568dad80b852_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d22c2866-883c-4461-a65b-568dad80b852" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d22c2866-883c-4461-a65b-568dad80b852_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_65bfb889-a4fa-488b-8947-19a93dfa4fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d22c2866-883c-4461-a65b-568dad80b852" xlink:to="loc_us-gaap_HedgingRelationshipDomain_65bfb889-a4fa-488b-8947-19a93dfa4fc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_682cf131-a1c0-4e4e-8861-cc73435f7e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_65bfb889-a4fa-488b-8947-19a93dfa4fc4" xlink:to="loc_us-gaap_CashFlowHedgingMember_682cf131-a1c0-4e4e-8861-cc73435f7e42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a1e38f1c-679e-40af-b5b2-c5887751cdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_65bfb889-a4fa-488b-8947-19a93dfa4fc4" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a1e38f1c-679e-40af-b5b2-c5887751cdc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermAxis_c9d6c8d8-226a-4d5a-85dc-495e843b5f61" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_prgo_DerivativeInstrumentTermAxis_c9d6c8d8-226a-4d5a-85dc-495e843b5f61" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermDomain_c9d6c8d8-226a-4d5a-85dc-495e843b5f61_default" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_prgo_DerivativeInstrumentTermAxis_c9d6c8d8-226a-4d5a-85dc-495e843b5f61" xlink:to="loc_prgo_DerivativeInstrumentTermDomain_c9d6c8d8-226a-4d5a-85dc-495e843b5f61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermDomain_d3dc489e-ca98-4ba2-841b-8e942e425de1" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_prgo_DerivativeInstrumentTermAxis_c9d6c8d8-226a-4d5a-85dc-495e843b5f61" xlink:to="loc_prgo_DerivativeInstrumentTermDomain_d3dc489e-ca98-4ba2-841b-8e942e425de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughDecember152024Member_945edb3b-d4e0-4819-ab7d-2f3b683b13f5" xlink:href="prgo-20230401.xsd#prgo_October252022ThroughDecember152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_d3dc489e-ca98-4ba2-841b-8e942e425de1" xlink:to="loc_prgo_October252022ThroughDecember152024Member_945edb3b-d4e0-4819-ab7d-2f3b683b13f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughMarch252026Member_ccb13a90-eb4a-4cb4-ac2f-e43df378a438" xlink:href="prgo-20230401.xsd#prgo_October252022ThroughMarch252026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_d3dc489e-ca98-4ba2-841b-8e942e425de1" xlink:to="loc_prgo_October252022ThroughMarch252026Member_ccb13a90-eb4a-4cb4-ac2f-e43df378a438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughJune152030Member_8924d43f-b772-4995-8cc0-d5e042aafe0f" xlink:href="prgo-20230401.xsd#prgo_October252022ThroughJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_d3dc489e-ca98-4ba2-841b-8e942e425de1" xlink:to="loc_prgo_October252022ThroughJune152030Member_8924d43f-b772-4995-8cc0-d5e042aafe0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_585fd15f-dc26-4f1c-bb04-63ad1c7bf453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_us-gaap_DebtInstrumentAxis_585fd15f-dc26-4f1c-bb04-63ad1c7bf453" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_585fd15f-dc26-4f1c-bb04-63ad1c7bf453_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_585fd15f-dc26-4f1c-bb04-63ad1c7bf453" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_585fd15f-dc26-4f1c-bb04-63ad1c7bf453_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3e37aaf4-6a19-4717-be36-9b95bb3744ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_585fd15f-dc26-4f1c-bb04-63ad1c7bf453" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3e37aaf4-6a19-4717-be36-9b95bb3744ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanBFacilityMember_72532eb1-e0e9-4071-8fc9-2b11077f2ad7" xlink:href="prgo-20230401.xsd#prgo_NewTermLoanBFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e37aaf4-6a19-4717-be36-9b95bb3744ff" xlink:to="loc_prgo_NewTermLoanBFacilityMember_72532eb1-e0e9-4071-8fc9-2b11077f2ad7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanAFacilityMember_231d05b5-1c50-4615-8071-1e30146cb6b6" xlink:href="prgo-20230401.xsd#prgo_NewTermLoanAFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e37aaf4-6a19-4717-be36-9b95bb3744ff" xlink:to="loc_prgo_NewTermLoanAFacilityMember_231d05b5-1c50-4615-8071-1e30146cb6b6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="extended" id="i10ce22c1780d42c8810483b2345c142e_DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_b590797d-121f-46dc-b633-925ace6cbbff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_df43689f-4802-4414-9922-5c3c5d17842f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_b590797d-121f-46dc-b633-925ace6cbbff" xlink:to="loc_us-gaap_DerivativeNotionalAmount_df43689f-4802-4414-9922-5c3c5d17842f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount_57f2bc3c-133d-47df-a051-1ad4a7671b30" xlink:href="prgo-20230401.xsd#prgo_DerivativeNotionalAmountMaximumIndividualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_b590797d-121f-46dc-b633-925ace6cbbff" xlink:to="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount_57f2bc3c-133d-47df-a051-1ad4a7671b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_ae129786-ebfe-405f-854f-0c3c05f0244d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_b590797d-121f-46dc-b633-925ace6cbbff" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_ae129786-ebfe-405f-854f-0c3c05f0244d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_15f22b28-69eb-4941-bad4-364a8e0d0998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_b590797d-121f-46dc-b633-925ace6cbbff" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_15f22b28-69eb-4941-bad4-364a8e0d0998" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_72476d05-0340-4ca6-b0a5-8de7b5a1d2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_15f22b28-69eb-4941-bad4-364a8e0d0998" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_72476d05-0340-4ca6-b0a5-8de7b5a1d2dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_72476d05-0340-4ca6-b0a5-8de7b5a1d2dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_72476d05-0340-4ca6-b0a5-8de7b5a1d2dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_72476d05-0340-4ca6-b0a5-8de7b5a1d2dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d15a1f5f-42e4-4d6c-96bf-60dcd6d374e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_72476d05-0340-4ca6-b0a5-8de7b5a1d2dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d15a1f5f-42e4-4d6c-96bf-60dcd6d374e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_09db0c3a-b08b-4f64-a712-66d14a4a92b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d15a1f5f-42e4-4d6c-96bf-60dcd6d374e1" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_09db0c3a-b08b-4f64-a712-66d14a4a92b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_7aaecd92-ef08-4db8-8d7c-f5fa92c39265" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_15f22b28-69eb-4941-bad4-364a8e0d0998" xlink:to="loc_srt_CurrencyAxis_7aaecd92-ef08-4db8-8d7c-f5fa92c39265" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_7aaecd92-ef08-4db8-8d7c-f5fa92c39265_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_7aaecd92-ef08-4db8-8d7c-f5fa92c39265" xlink:to="loc_currency_AllCurrenciesDomain_7aaecd92-ef08-4db8-8d7c-f5fa92c39265_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_7aaecd92-ef08-4db8-8d7c-f5fa92c39265" xlink:to="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_5c2c43ba-533d-4072-b661-d863ebb1c99b" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_GBP_5c2c43ba-533d-4072-b661-d863ebb1c99b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_38d1aa6a-749b-4a54-a871-75a1f82d9f4e" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_EUR_38d1aa6a-749b-4a54-a871-75a1f82d9f4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK_a23351d6-01b4-4fec-b214-e8848a9bc23a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_SEK_a23351d6-01b4-4fec-b214-e8848a9bc23a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_7d02ea05-ce0e-4bcf-9ff6-76ef9a56260d" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_USD_7d02ea05-ce0e-4bcf-9ff6-76ef9a56260d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_52ab915e-aadc-44a6-a8ab-a636139a1850" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_CNY_52ab915e-aadc-44a6-a8ab-a636139a1850" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK_960054b8-c10d-4a56-a39e-aa07b869623a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_DKK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_DKK_960054b8-c10d-4a56-a39e-aa07b869623a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_cd597c22-1053-4c88-a857-2cc579b5fb0c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_CAD_cd597c22-1053-4c88-a857-2cc579b5fb0c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_a9e5c349-81fa-43cd-a22d-27cf3b0d35a6" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_MXN_a9e5c349-81fa-43cd-a22d-27cf3b0d35a6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_HUF_e828aa32-4c4a-40ab-8f7e-b00958b4f7c4" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_HUF"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_HUF_e828aa32-4c4a-40ab-8f7e-b00958b4f7c4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN_c56a35b6-c153-4d36-8f15-054d6762d2e7" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_PLN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_PLN_c56a35b6-c153-4d36-8f15-054d6762d2e7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_NOK_0de711a1-c918-415c-9f5b-49a43c7e1162" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_NOK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_NOK_0de711a1-c918-415c-9f5b-49a43c7e1162" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX_55399aa3-816b-4a4d-8abe-45c33b4e1b5c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_XXX_55399aa3-816b-4a4d-8abe-45c33b4e1b5c" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" xlink:type="extended" id="id0c185f59a5b431e91497ec02caf6187_DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_415535bf-6235-49f8-8e1b-780bd7f4e814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_5c7ec72b-8de5-4ff9-80cb-ddb67903c7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_415535bf-6235-49f8-8e1b-780bd7f4e814" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_5c7ec72b-8de5-4ff9-80cb-ddb67903c7cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_bfad5e4e-14c0-436a-8b6c-49230345705f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_415535bf-6235-49f8-8e1b-780bd7f4e814" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_bfad5e4e-14c0-436a-8b6c-49230345705f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_415535bf-6235-49f8-8e1b-780bd7f4e814" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c39cf7d4-0f30-4465-9dbc-5081a6c310ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:to="loc_us-gaap_HedgingDesignationAxis_c39cf7d4-0f30-4465-9dbc-5081a6c310ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c39cf7d4-0f30-4465-9dbc-5081a6c310ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_c39cf7d4-0f30-4465-9dbc-5081a6c310ee" xlink:to="loc_us-gaap_HedgingDesignationDomain_c39cf7d4-0f30-4465-9dbc-5081a6c310ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3dd599aa-bf2f-417d-8f96-d0f6608dcdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_c39cf7d4-0f30-4465-9dbc-5081a6c310ee" xlink:to="loc_us-gaap_HedgingDesignationDomain_3dd599aa-bf2f-417d-8f96-d0f6608dcdb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_66c024fb-f983-43fa-919a-af16f2d5d16e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_3dd599aa-bf2f-417d-8f96-d0f6608dcdb9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_66c024fb-f983-43fa-919a-af16f2d5d16e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_6c657df1-ed62-4e4a-8012-a29e8a8b55cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_3dd599aa-bf2f-417d-8f96-d0f6608dcdb9" xlink:to="loc_us-gaap_NondesignatedMember_6c657df1-ed62-4e4a-8012-a29e8a8b55cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d1b1a765-6e99-48c2-849e-a7002f3f9352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d1b1a765-6e99-48c2-849e-a7002f3f9352" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d1b1a765-6e99-48c2-849e-a7002f3f9352_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d1b1a765-6e99-48c2-849e-a7002f3f9352" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d1b1a765-6e99-48c2-849e-a7002f3f9352_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_deb68493-4004-4654-82b3-eedd239658cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d1b1a765-6e99-48c2-849e-a7002f3f9352" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_deb68493-4004-4654-82b3-eedd239658cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_2c2c57b6-8bd5-4642-8e81-b3dd481e5417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_deb68493-4004-4654-82b3-eedd239658cc" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_2c2c57b6-8bd5-4642-8e81-b3dd481e5417" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_6b057411-6540-40f6-81e7-d61844ab72f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_deb68493-4004-4654-82b3-eedd239658cc" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_6b057411-6540-40f6-81e7-d61844ab72f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_73c2942c-1542-4f3b-b87d-ff2fb7ee7b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_deb68493-4004-4654-82b3-eedd239658cc" xlink:to="loc_us-gaap_OtherLiabilitiesMember_73c2942c-1542-4f3b-b87d-ff2fb7ee7b1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ac13dc86-a5ea-4371-bc48-0ba689860e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ac13dc86-a5ea-4371-bc48-0ba689860e9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac13dc86-a5ea-4371-bc48-0ba689860e9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ac13dc86-a5ea-4371-bc48-0ba689860e9d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac13dc86-a5ea-4371-bc48-0ba689860e9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_87dd46f0-37fc-4851-80e6-c09da766fdba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ac13dc86-a5ea-4371-bc48-0ba689860e9d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_87dd46f0-37fc-4851-80e6-c09da766fdba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_df750c4e-8336-4b21-acbd-0dddd26a64cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87dd46f0-37fc-4851-80e6-c09da766fdba" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_df750c4e-8336-4b21-acbd-0dddd26a64cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ad3659e9-13d3-450f-9fce-b83842ebc4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87dd46f0-37fc-4851-80e6-c09da766fdba" xlink:to="loc_us-gaap_InterestRateSwapMember_ad3659e9-13d3-450f-9fce-b83842ebc4a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2dbe6085-5ba4-41ec-bfcf-8b6caafc978d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87dd46f0-37fc-4851-80e6-c09da766fdba" xlink:to="loc_us-gaap_CurrencySwapMember_2dbe6085-5ba4-41ec-bfcf-8b6caafc978d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails" xlink:type="extended" id="ifd0b1857e3d746f2964523b45e5eafb5_DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3ce8f44a-4e85-4e33-8cd8-5742390af667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_14b645b5-3285-4cce-a05c-b4e369e929ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3ce8f44a-4e85-4e33-8cd8-5742390af667" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_14b645b5-3285-4cce-a05c-b4e369e929ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3ce8f44a-4e85-4e33-8cd8-5742390af667" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7f3ef66c-40b8-42c4-a07c-5d41f3389fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7f3ef66c-40b8-42c4-a07c-5d41f3389fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7f3ef66c-40b8-42c4-a07c-5d41f3389fd3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7f3ef66c-40b8-42c4-a07c-5d41f3389fd3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7f3ef66c-40b8-42c4-a07c-5d41f3389fd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4b243df1-60a5-41d0-ad71-563153df02ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7f3ef66c-40b8-42c4-a07c-5d41f3389fd3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4b243df1-60a5-41d0-ad71-563153df02ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_e0927a5d-530b-491a-92c2-67c0ef720b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4b243df1-60a5-41d0-ad71-563153df02ef" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_e0927a5d-530b-491a-92c2-67c0ef720b10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_a11cdc86-763d-425f-aee2-b114aeeea633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4b243df1-60a5-41d0-ad71-563153df02ef" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_a11cdc86-763d-425f-aee2-b114aeeea633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3cea3003-571c-41bf-a799-9859f4a450b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3cea3003-571c-41bf-a799-9859f4a450b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3cea3003-571c-41bf-a799-9859f4a450b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3cea3003-571c-41bf-a799-9859f4a450b8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3cea3003-571c-41bf-a799-9859f4a450b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1a32d1cd-7579-4c2b-a2c6-f17d3e7c3760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3cea3003-571c-41bf-a799-9859f4a450b8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1a32d1cd-7579-4c2b-a2c6-f17d3e7c3760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_ac782eba-d85f-4a38-bb78-a5732227c542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1a32d1cd-7579-4c2b-a2c6-f17d3e7c3760" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_ac782eba-d85f-4a38-bb78-a5732227c542" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_32b5fb53-bbeb-4e71-ac04-c6ec031b2f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1a32d1cd-7579-4c2b-a2c6-f17d3e7c3760" xlink:to="loc_us-gaap_InterestExpenseMember_32b5fb53-bbeb-4e71-ac04-c6ec031b2f73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_21da4f4c-0f0f-47f3-9e1c-e6997e2418cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:to="loc_us-gaap_HedgingDesignationAxis_21da4f4c-0f0f-47f3-9e1c-e6997e2418cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_21da4f4c-0f0f-47f3-9e1c-e6997e2418cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_21da4f4c-0f0f-47f3-9e1c-e6997e2418cf" xlink:to="loc_us-gaap_HedgingDesignationDomain_21da4f4c-0f0f-47f3-9e1c-e6997e2418cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a6179540-b2c7-4533-acb5-6017787511af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_21da4f4c-0f0f-47f3-9e1c-e6997e2418cf" xlink:to="loc_us-gaap_HedgingDesignationDomain_a6179540-b2c7-4533-acb5-6017787511af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5f399831-0b63-4316-8510-be1904098773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a6179540-b2c7-4533-acb5-6017787511af" xlink:to="loc_us-gaap_NondesignatedMember_5f399831-0b63-4316-8510-be1904098773" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails" xlink:type="extended" id="i85b0a4f4df4749d38f4192ce384e6b5e_DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_73808208-3d52-4a6c-b3f6-3ef98cff6b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_73808208-3d52-4a6c-b3f6-3ef98cff6b5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_168dd049-949f-4c96-a997-fb124cbc6d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_168dd049-949f-4c96-a997-fb124cbc6d0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_6c8398c5-b6b8-4885-ab26-3596c750313b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_6c8398c5-b6b8-4885-ab26-3596c750313b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_d2b47809-9ee7-47af-b4c6-b9e1be6f8b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_d2b47809-9ee7-47af-b4c6-b9e1be6f8b30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_0ef1e0d8-f348-4345-ac30-6f4c1622f088" xlink:href="prgo-20230401.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_0ef1e0d8-f348-4345-ac30-6f4c1622f088" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_5711e7aa-f8ce-44a8-832b-e1732bbd6435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_5711e7aa-f8ce-44a8-832b-e1732bbd6435" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_d04b362c-a2c5-44b4-8e22-2aabc6f4d744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_d04b362c-a2c5-44b4-8e22-2aabc6f4d744" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_0d94141a-3fbe-4867-817d-3b284bd9308f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_0d94141a-3fbe-4867-817d-3b284bd9308f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_1d03df90-99e1-416e-b9ce-dd9d36c8ad06" xlink:href="prgo-20230401.xsd#prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_1d03df90-99e1-416e-b9ce-dd9d36c8ad06" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_f21b8088-a84f-47a4-815d-265372259d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_f21b8088-a84f-47a4-815d-265372259d23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3388e6f8-ef07-4891-ac07-83651604bbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3388e6f8-ef07-4891-ac07-83651604bbf1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f610c8cf-1f96-4c5a-b43e-d423cc1eb673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3388e6f8-ef07-4891-ac07-83651604bbf1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f610c8cf-1f96-4c5a-b43e-d423cc1eb673" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f610c8cf-1f96-4c5a-b43e-d423cc1eb673_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f610c8cf-1f96-4c5a-b43e-d423cc1eb673" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f610c8cf-1f96-4c5a-b43e-d423cc1eb673_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f3269453-e8c3-4de6-9e59-dab3ae529ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f610c8cf-1f96-4c5a-b43e-d423cc1eb673" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f3269453-e8c3-4de6-9e59-dab3ae529ce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_19a206b5-7d94-4bc3-b5d2-edc872db43a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f3269453-e8c3-4de6-9e59-dab3ae529ce7" xlink:to="loc_us-gaap_InterestRateSwapMember_19a206b5-7d94-4bc3-b5d2-edc872db43a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_70613216-611f-43e9-8760-65e4c99f05b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f3269453-e8c3-4de6-9e59-dab3ae529ce7" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_70613216-611f-43e9-8760-65e4c99f05b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2923223e-7193-4f88-80f0-0b066d292681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f3269453-e8c3-4de6-9e59-dab3ae529ce7" xlink:to="loc_us-gaap_CurrencySwapMember_2923223e-7193-4f88-80f0-0b066d292681" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_99f7c327-de16-4e21-833c-cfafbb3ee35c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3388e6f8-ef07-4891-ac07-83651604bbf1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_99f7c327-de16-4e21-833c-cfafbb3ee35c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_99f7c327-de16-4e21-833c-cfafbb3ee35c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_99f7c327-de16-4e21-833c-cfafbb3ee35c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_99f7c327-de16-4e21-833c-cfafbb3ee35c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_99f7c327-de16-4e21-833c-cfafbb3ee35c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_4c54dca9-2a54-4acd-a68b-b601266ed879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:to="loc_us-gaap_InterestExpenseMember_4c54dca9-2a54-4acd-a68b-b601266ed879" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d057f6e9-f708-431e-88e9-f9a2647a1a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:to="loc_us-gaap_SalesRevenueNetMember_d057f6e9-f708-431e-88e9-f9a2647a1a6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_5bd8a094-222e-4c53-9ea9-36b036d81907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:to="loc_us-gaap_CostOfSalesMember_5bd8a094-222e-4c53-9ea9-36b036d81907" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_de551f7d-d6ab-4a6c-beac-952cbd624cfc" xlink:href="prgo-20230401.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_de551f7d-d6ab-4a6c-beac-952cbd624cfc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails" xlink:type="extended" id="i362c94654db940b287d373df1a41dc55_DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_058927ed-19fb-4397-9828-5200a9e39584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_058927ed-19fb-4397-9828-5200a9e39584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_477ff30f-b588-4484-baae-53466fa41631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_477ff30f-b588-4484-baae-53466fa41631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_24819dde-071f-4f8e-9e8a-b62cb79bc73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_24819dde-071f-4f8e-9e8a-b62cb79bc73d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3b9da1ee-d41e-4b77-997b-3a22f38de4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3b9da1ee-d41e-4b77-997b-3a22f38de4f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_f265c26a-2f5f-46ce-a54a-a2f745c38575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_f265c26a-2f5f-46ce-a54a-a2f745c38575" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_9a05e214-585b-41f1-be28-f7b0a3cfadeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_f265c26a-2f5f-46ce-a54a-a2f745c38575" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_9a05e214-585b-41f1-be28-f7b0a3cfadeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_55516276-bc43-483d-905b-a666273a472e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_9a05e214-585b-41f1-be28-f7b0a3cfadeb" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_55516276-bc43-483d-905b-a666273a472e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_2dca9c2c-d2c1-4120-a7e0-f673e406617e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_9a05e214-585b-41f1-be28-f7b0a3cfadeb" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_2dca9c2c-d2c1-4120-a7e0-f673e406617e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgesAbstract_8db20383-499a-4399-84e7-58f553749e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_f265c26a-2f5f-46ce-a54a-a2f745c38575" xlink:to="loc_us-gaap_InterestRateCashFlowHedgesAbstract_8db20383-499a-4399-84e7-58f553749e94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_0a1097a6-6b84-44fe-9f86-48aed4ba8fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateCashFlowHedgesAbstract_8db20383-499a-4399-84e7-58f553749e94" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_0a1097a6-6b84-44fe-9f86-48aed4ba8fb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0cdda967-1173-48f5-9be0-1d980733acec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0cdda967-1173-48f5-9be0-1d980733acec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4681e6b8-4dfe-473a-8da6-90647e80a464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0cdda967-1173-48f5-9be0-1d980733acec" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4681e6b8-4dfe-473a-8da6-90647e80a464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4681e6b8-4dfe-473a-8da6-90647e80a464_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4681e6b8-4dfe-473a-8da6-90647e80a464" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4681e6b8-4dfe-473a-8da6-90647e80a464_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d7a77295-6488-4a89-bb3a-d75c9f3282fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4681e6b8-4dfe-473a-8da6-90647e80a464" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d7a77295-6488-4a89-bb3a-d75c9f3282fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f1650671-95da-4f3e-9f5f-b3d197fed933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d7a77295-6488-4a89-bb3a-d75c9f3282fa" xlink:to="loc_us-gaap_InterestRateSwapMember_f1650671-95da-4f3e-9f5f-b3d197fed933" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3470b12a-f2bf-452d-b72e-aeb5e645a19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0cdda967-1173-48f5-9be0-1d980733acec" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3470b12a-f2bf-452d-b72e-aeb5e645a19f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3470b12a-f2bf-452d-b72e-aeb5e645a19f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3470b12a-f2bf-452d-b72e-aeb5e645a19f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3470b12a-f2bf-452d-b72e-aeb5e645a19f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3470b12a-f2bf-452d-b72e-aeb5e645a19f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d6729c89-496c-4235-bff6-b7002cdcb845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:to="loc_us-gaap_SalesRevenueNetMember_d6729c89-496c-4235-bff6-b7002cdcb845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_8047cd3c-ad18-44af-b0c7-5b75599d1723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:to="loc_us-gaap_CostOfSalesMember_8047cd3c-ad18-44af-b0c7-5b75599d1723" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_183f9518-2ecd-4125-86b5-9460ee71992b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:to="loc_us-gaap_InterestExpenseMember_183f9518-2ecd-4125-86b5-9460ee71992b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_a4623aaf-1147-417d-a03b-555f7a08cff2" xlink:href="prgo-20230401.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_a4623aaf-1147-417d-a03b-555f7a08cff2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#IndebtednessScheduleofBorrowingsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails" xlink:type="extended" id="i23f43ea586314941811857a9684f5255_IndebtednessScheduleofBorrowingsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable_9d0f98db-8a78-4bae-8cd9-867c08c34cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_LoansPayable_9d0f98db-8a78-4bae-8cd9-867c08c34cf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_07115d23-d75d-494d-9e30-c0093afb6616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_07115d23-d75d-494d-9e30-c0093afb6616" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_9d9bbc8f-d9f2-4008-a641-ee964209463d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_SeniorNotes_9d9bbc8f-d9f2-4008-a641-ee964209463d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_2e2f05a4-86ea-4481-a270-45be01f2abe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_OtherLongTermDebt_2e2f05a4-86ea-4481-a270-45be01f2abe9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_f0403b8c-faa4-4d4c-aff8-9e7ca77cbf5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_f0403b8c-faa4-4d4c-aff8-9e7ca77cbf5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_6460d82b-1a4a-42ac-882e-2b90fe5f0800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_6460d82b-1a4a-42ac-882e-2b90fe5f0800" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_c6056e54-02e6-4f12-9b65-2306332c8a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_c6056e54-02e6-4f12-9b65-2306332c8a61" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_ef242985-9d85-4400-9047-9320a20d1d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_DebtCurrent_ef242985-9d85-4400-9047-9320a20d1d11" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8f92fad1-00bc-476f-814c-7fc1f765d184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8f92fad1-00bc-476f-814c-7fc1f765d184" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtInstrumentInterestRatePercentageCap_10322a1c-30d9-436c-9aa0-a2c8ac6ffc53" xlink:href="prgo-20230401.xsd#prgo_DebtInstrumentInterestRatePercentageCap"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_prgo_DebtInstrumentInterestRatePercentageCap_10322a1c-30d9-436c-9aa0-a2c8ac6ffc53" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfDebtInstrumentsTable_6722ca0f-b73e-4c8c-b01c-9f0414ba78ae" xlink:href="prgo-20230401.xsd#prgo_ScheduleOfDebtInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_prgo_ScheduleOfDebtInstrumentsTable_6722ca0f-b73e-4c8c-b01c-9f0414ba78ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_06588abe-5329-401a-9211-b8d2116a3fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfDebtInstrumentsTable_6722ca0f-b73e-4c8c-b01c-9f0414ba78ae" xlink:to="loc_us-gaap_DebtInstrumentAxis_06588abe-5329-401a-9211-b8d2116a3fd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_06588abe-5329-401a-9211-b8d2116a3fd7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_06588abe-5329-401a-9211-b8d2116a3fd7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_06588abe-5329-401a-9211-b8d2116a3fd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_06588abe-5329-401a-9211-b8d2116a3fd7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member_2708f114-084e-424b-b1ce-98b614392669" xlink:href="prgo-20230401.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_June12022ThroughApril12027Member_2708f114-084e-424b-b1ce-98b614392669" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member_c4b56078-08b9-4a41-a868-a96cea5f759b" xlink:href="prgo-20230401.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_June12022ThroughApril12029Member_c4b56078-08b9-4a41-a868-a96cea5f759b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member_956ffc0e-1dd7-4afa-94a5-a427439f8bbd" xlink:href="prgo-20230401.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A3900SeniorNoteDue2024Member_956ffc0e-1dd7-4afa-94a5-a427439f8bbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_306dccd5-6f69-4eac-9408-b106c5f42e70" xlink:href="prgo-20230401.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_306dccd5-6f69-4eac-9408-b106c5f42e70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member_13232104-bd8e-4a66-b872-00a165d26897" xlink:href="prgo-20230401.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A4400SeniorNotesDueJune152030Member_13232104-bd8e-4a66-b872-00a165d26897" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_34ba6bdb-6f97-42a2-b365-a902b1eef554" xlink:href="prgo-20230401.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_34ba6bdb-6f97-42a2-b365-a902b1eef554" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member_93e30344-a277-4147-a774-32b87eb39272" xlink:href="prgo-20230401.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A4900SeniorLoanDue2044Member_93e30344-a277-4147-a774-32b87eb39272" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4650SeniorNotesDueJune152030Member_123ce153-a84f-4d26-b0e8-4edee813b1ad" xlink:href="prgo-20230401.xsd#prgo_A4650SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A4650SeniorNotesDueJune152030Member_123ce153-a84f-4d26-b0e8-4edee813b1ad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3150SeniorNotesDueJune152030Member_f5f7bb21-adec-4e7a-a560-3aa2a55ed92e" xlink:href="prgo-20230401.xsd#prgo_A3150SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A3150SeniorNotesDueJune152030Member_f5f7bb21-adec-4e7a-a560-3aa2a55ed92e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ad0a832f-5b63-44f8-88f8-bf9f39e74787" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_prgo_ScheduleOfDebtInstrumentsTable_6722ca0f-b73e-4c8c-b01c-9f0414ba78ae" xlink:to="loc_srt_StatementScenarioAxis_ad0a832f-5b63-44f8-88f8-bf9f39e74787" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ad0a832f-5b63-44f8-88f8-bf9f39e74787_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_ad0a832f-5b63-44f8-88f8-bf9f39e74787" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ad0a832f-5b63-44f8-88f8-bf9f39e74787_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_eecf0c53-7f95-4aa0-aad6-58b6c1f35afb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_ad0a832f-5b63-44f8-88f8-bf9f39e74787" xlink:to="loc_srt_ScenarioUnspecifiedDomain_eecf0c53-7f95-4aa0-aad6-58b6c1f35afb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_d7f03167-d478-4af7-8aa1-bb452ef5c001" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_eecf0c53-7f95-4aa0-aad6-58b6c1f35afb" xlink:to="loc_srt_ScenarioForecastMember_d7f03167-d478-4af7-8aa1-bb452ef5c001" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessNarrativeDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#IndebtednessNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IndebtednessNarrativeDetails" xlink:type="extended" id="ie6147a4c5c4e4c518fb4ac2a72056698_IndebtednessNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_80141236-0025-4ac2-84a6-d3cc4d890678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_80141236-0025-4ac2-84a6-d3cc4d890678" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ec3c63cc-95f1-4b24-bf7d-9690a0bbbf35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_DebtInstrumentTerm_ec3c63cc-95f1-4b24-bf7d-9690a0bbbf35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d6e5bc0b-d6a0-4be6-89df-5e90f7500e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d6e5bc0b-d6a0-4be6-89df-5e90f7500e4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_65f4c9f4-6898-4833-bf7a-fccb9583ea18" xlink:href="prgo-20230401.xsd#prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_65f4c9f4-6898-4833-bf7a-fccb9583ea18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_99213728-5a43-4022-b920-e6299cd2259d" xlink:href="prgo-20230401.xsd#prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_99213728-5a43-4022-b920-e6299cd2259d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_4a9bad98-d58e-4472-a1ae-1e24da33f70b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_4a9bad98-d58e-4472-a1ae-1e24da33f70b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_dc301202-3fc7-4c7e-848e-c5f93fdce12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_LineOfCredit_dc301202-3fc7-4c7e-848e-c5f93fdce12e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_e0e7cd93-a11b-4944-b1f3-7f40a4a64cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_e0e7cd93-a11b-4944-b1f3-7f40a4a64cff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e3e91546-2fd3-444c-9239-2fd147029165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:to="loc_us-gaap_DebtInstrumentAxis_e3e91546-2fd3-444c-9239-2fd147029165" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e3e91546-2fd3-444c-9239-2fd147029165_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e3e91546-2fd3-444c-9239-2fd147029165" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e3e91546-2fd3-444c-9239-2fd147029165_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e3e91546-2fd3-444c-9239-2fd147029165" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2022RevolverMember_c59a2121-5ca1-4d3c-9ee2-3534e6d4e7cc" xlink:href="prgo-20230401.xsd#prgo_A2022RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A2022RevolverMember_c59a2121-5ca1-4d3c-9ee2-3534e6d4e7cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanAFacilityMember_88d8692e-0adb-481f-993a-d32da9d6685b" xlink:href="prgo-20230401.xsd#prgo_NewTermLoanAFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_NewTermLoanAFacilityMember_88d8692e-0adb-481f-993a-d32da9d6685b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanBFacilityMember_e5e04b6d-351c-4c44-953a-37eaf4510796" xlink:href="prgo-20230401.xsd#prgo_NewTermLoanBFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_NewTermLoanBFacilityMember_e5e04b6d-351c-4c44-953a-37eaf4510796" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_4f001ddc-1a50-437a-af2c-fc35534c8139" xlink:href="prgo-20230401.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_4f001ddc-1a50-437a-af2c-fc35534c8139" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member_163ba29b-ed5a-470e-a34f-6d54c2800135" xlink:href="prgo-20230401.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A3900SeniorNoteDue2024Member_163ba29b-ed5a-470e-a34f-6d54c2800135" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_68ef7f5a-225c-461e-bf28-71b2b56a4ece" xlink:href="prgo-20230401.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_68ef7f5a-225c-461e-bf28-71b2b56a4ece" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member_db6cabf4-11f3-4198-bf7d-2c27fd8c3f79" xlink:href="prgo-20230401.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A4400SeniorNotesDueJune152030Member_db6cabf4-11f3-4198-bf7d-2c27fd8c3f79" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member_87b8ff6b-90ab-4e2e-8f15-e919a7291264" xlink:href="prgo-20230401.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A4900SeniorLoanDue2044Member_87b8ff6b-90ab-4e2e-8f15-e919a7291264" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c4cab1a2-a378-4c7b-860a-1c99c73b173d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:to="loc_us-gaap_CreditFacilityAxis_c4cab1a2-a378-4c7b-860a-1c99c73b173d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c4cab1a2-a378-4c7b-860a-1c99c73b173d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c4cab1a2-a378-4c7b-860a-1c99c73b173d" xlink:to="loc_us-gaap_CreditFacilityDomain_c4cab1a2-a378-4c7b-860a-1c99c73b173d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_635bdb5b-a754-42b6-9b4b-96fdb7a3e95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c4cab1a2-a378-4c7b-860a-1c99c73b173d" xlink:to="loc_us-gaap_CreditFacilityDomain_635bdb5b-a754-42b6-9b4b-96fdb7a3e95f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_a9b59b41-c03b-4b43-b2d7-a5e6c5f83dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_635bdb5b-a754-42b6-9b4b-96fdb7a3e95f" xlink:to="loc_us-gaap_SecuredDebtMember_a9b59b41-c03b-4b43-b2d7-a5e6c5f83dfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1ced9f4a-21f9-481a-8840-4f6cf4df743c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1ced9f4a-21f9-481a-8840-4f6cf4df743c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1ced9f4a-21f9-481a-8840-4f6cf4df743c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1ced9f4a-21f9-481a-8840-4f6cf4df743c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1ced9f4a-21f9-481a-8840-4f6cf4df743c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_954d7083-2a9e-4ccf-9b0b-16f3884a16a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1ced9f4a-21f9-481a-8840-4f6cf4df743c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_954d7083-2a9e-4ccf-9b0b-16f3884a16a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_79be636b-9ef6-4607-ad45-f9080d9006a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_954d7083-2a9e-4ccf-9b0b-16f3884a16a9" xlink:to="loc_us-gaap_LineOfCreditMember_79be636b-9ef6-4607-ad45-f9080d9006a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_89a70f22-5868-4560-a54e-4584610bfb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_954d7083-2a9e-4ccf-9b0b-16f3884a16a9" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_89a70f22-5868-4560-a54e-4584610bfb52" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="ie525d3504d694d028e8d00094e3e4dfe_AccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_afc120fc-3918-42f3-b28b-03cb963a35b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:href="prgo-20230401.xsd#prgo_AccumulatedOtherComprehensiveIncomeRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_afc120fc-3918-42f3-b28b-03cb963a35b5" xlink:to="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b9277f33-74d2-4757-8540-7d5754f9b902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:to="loc_us-gaap_StockholdersEquity_b9277f33-74d2-4757-8540-7d5754f9b902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_83c8f863-5251-411e-99e4-9ecfce7587b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_83c8f863-5251-411e-99e4-9ecfce7587b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4ae13971-d79e-423f-854b-a7b9637b7140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4ae13971-d79e-423f-854b-a7b9637b7140" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cb00ecbc-a54f-4f9d-b359-38aaea74582d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cb00ecbc-a54f-4f9d-b359-38aaea74582d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_30cbc72e-f19d-493d-9e67-c00c86d1bd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b9d0302b-72bc-448d-b98c-65e4c98de957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_afc120fc-3918-42f3-b28b-03cb963a35b5" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b9d0302b-72bc-448d-b98c-65e4c98de957" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9965ce79-6046-48c1-9378-5d3d19cea8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b9d0302b-72bc-448d-b98c-65e4c98de957" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9965ce79-6046-48c1-9378-5d3d19cea8a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9965ce79-6046-48c1-9378-5d3d19cea8a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9965ce79-6046-48c1-9378-5d3d19cea8a4" xlink:to="loc_us-gaap_EquityComponentDomain_9965ce79-6046-48c1-9378-5d3d19cea8a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7bf6e129-b898-4c42-9cf7-71a3c3731972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9965ce79-6046-48c1-9378-5d3d19cea8a4" xlink:to="loc_us-gaap_EquityComponentDomain_7bf6e129-b898-4c42-9cf7-71a3c3731972" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34df595d-d33f-46ec-bc89-1a5dcafffd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7bf6e129-b898-4c42-9cf7-71a3c3731972" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34df595d-d33f-46ec-bc89-1a5dcafffd36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_22363c73-7cda-4506-a907-522bf00ff408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34df595d-d33f-46ec-bc89-1a5dcafffd36" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_22363c73-7cda-4506-a907-522bf00ff408" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_aee70c77-879a-4a9b-af96-ab6e490c8c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34df595d-d33f-46ec-bc89-1a5dcafffd36" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_aee70c77-879a-4a9b-af96-ab6e490c8c10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e289c757-b3ba-475f-b053-5e2a921c4f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34df595d-d33f-46ec-bc89-1a5dcafffd36" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e289c757-b3ba-475f-b053-5e2a921c4f9f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="extended" id="i7043627de21240f39e10f4b03086be53_RestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_28d570bd-c2e9-4c7b-a864-478de05ea156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:to="loc_us-gaap_RestructuringReserve_28d570bd-c2e9-4c7b-a864-478de05ea156" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringAdditionalCharges_d7e40576-60a2-4bcb-b462-efecfe19f073" xlink:href="prgo-20230401.xsd#prgo_RestructuringAdditionalCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:to="loc_prgo_RestructuringAdditionalCharges_d7e40576-60a2-4bcb-b462-efecfe19f073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_6143f966-73ff-41bc-b349-6800d9b5db6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:to="loc_us-gaap_PaymentsForRestructuring_6143f966-73ff-41bc-b349-6800d9b5db6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringReserveSettledWithoutCashNet_64e374d8-e92a-4f5e-8c3b-6934da730681" xlink:href="prgo-20230401.xsd#prgo_RestructuringReserveSettledWithoutCashNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:to="loc_prgo_RestructuringReserveSettledWithoutCashNet_64e374d8-e92a-4f5e-8c3b-6934da730681" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_3fc5ae5e-f234-46f8-908b-8512768ea6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ce245695-44a7-40a4-843f-73093a978c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ce245695-44a7-40a4-843f-73093a978c36" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_a8d596b1-7dd9-48c8-9dc1-0d1c92b7a944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ce245695-44a7-40a4-843f-73093a978c36" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_a8d596b1-7dd9-48c8-9dc1-0d1c92b7a944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_a8d596b1-7dd9-48c8-9dc1-0d1c92b7a944_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_a8d596b1-7dd9-48c8-9dc1-0d1c92b7a944" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_a8d596b1-7dd9-48c8-9dc1-0d1c92b7a944_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7883192d-5066-4dce-a068-2630d0a026d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_a8d596b1-7dd9-48c8-9dc1-0d1c92b7a944" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7883192d-5066-4dce-a068-2630d0a026d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SupplyChainReinventionMember_f014c552-ee7c-4635-ae05-26d14f356243" xlink:href="prgo-20230401.xsd#prgo_SupplyChainReinventionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7883192d-5066-4dce-a068-2630d0a026d2" xlink:to="loc_prgo_SupplyChainReinventionMember_f014c552-ee7c-4635-ae05-26d14f356243" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaIntegrationMember_04d69599-6f6a-4d50-a0fa-f46f480afe60" xlink:href="prgo-20230401.xsd#prgo_HRAPharmaIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7883192d-5066-4dce-a068-2630d0a026d2" xlink:to="loc_prgo_HRAPharmaIntegrationMember_04d69599-6f6a-4d50-a0fa-f46f480afe60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_fa118d77-2dee-457e-ab5a-f1c4b8cc3e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7883192d-5066-4dce-a068-2630d0a026d2" xlink:to="loc_us-gaap_OtherRestructuringMember_fa118d77-2dee-457e-ab5a-f1c4b8cc3e4f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesNarrativeDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RestructuringChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/RestructuringChargesNarrativeDetails" xlink:type="extended" id="i3224e5c033fb464fbc0ef97966f1f714_RestructuringChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c2763eb1-e30a-45a7-b83d-e901e4037276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_663c19ae-80d1-4e49-adc4-0fad5eda1a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c2763eb1-e30a-45a7-b83d-e901e4037276" xlink:to="loc_us-gaap_RestructuringCharges_663c19ae-80d1-4e49-adc4-0fad5eda1a77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b5d4380b-7b23-4151-8c72-fd29a0bbf908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c2763eb1-e30a-45a7-b83d-e901e4037276" xlink:to="loc_us-gaap_RestructuringReserve_b5d4380b-7b23-4151-8c72-fd29a0bbf908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eec17b52-8069-4c96-b94f-a55761853df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c2763eb1-e30a-45a7-b83d-e901e4037276" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eec17b52-8069-4c96-b94f-a55761853df4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_317db401-1be2-4068-98a8-782e8ad862d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eec17b52-8069-4c96-b94f-a55761853df4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_317db401-1be2-4068-98a8-782e8ad862d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_317db401-1be2-4068-98a8-782e8ad862d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_317db401-1be2-4068-98a8-782e8ad862d5" xlink:to="loc_us-gaap_SegmentDomain_317db401-1be2-4068-98a8-782e8ad862d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bfc8df1b-90b4-472a-b52d-2137a1c8cd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_317db401-1be2-4068-98a8-782e8ad862d5" xlink:to="loc_us-gaap_SegmentDomain_bfc8df1b-90b4-472a-b52d-2137a1c8cd36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_ac2c3ed4-aa54-4cd1-ae06-65b250decb8c" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bfc8df1b-90b4-472a-b52d-2137a1c8cd36" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_ac2c3ed4-aa54-4cd1-ae06-65b250decb8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_2315bf6c-1f04-46bc-b189-02780f2dc316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bfc8df1b-90b4-472a-b52d-2137a1c8cd36" xlink:to="loc_us-gaap_CorporateAndOtherMember_2315bf6c-1f04-46bc-b189-02780f2dc316" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_UnallocatedSegmentMember_bb63a250-706b-4447-831f-7caabbc1e580" xlink:href="prgo-20230401.xsd#prgo_UnallocatedSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bfc8df1b-90b4-472a-b52d-2137a1c8cd36" xlink:to="loc_prgo_UnallocatedSegmentMember_bb63a250-706b-4447-831f-7caabbc1e580" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_5f6a23bc-dea4-4cf1-a538-b4121a9fcdda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eec17b52-8069-4c96-b94f-a55761853df4" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_5f6a23bc-dea4-4cf1-a538-b4121a9fcdda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5f6a23bc-dea4-4cf1-a538-b4121a9fcdda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5f6a23bc-dea4-4cf1-a538-b4121a9fcdda" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5f6a23bc-dea4-4cf1-a538-b4121a9fcdda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_63cf6ee3-9994-4b07-b3af-8634ba4c5c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5f6a23bc-dea4-4cf1-a538-b4121a9fcdda" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_63cf6ee3-9994-4b07-b3af-8634ba4c5c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaIntegrationMember_257fe4a1-5466-442f-9cbd-cf8622bb00cd" xlink:href="prgo-20230401.xsd#prgo_HRAPharmaIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_63cf6ee3-9994-4b07-b3af-8634ba4c5c48" xlink:to="loc_prgo_HRAPharmaIntegrationMember_257fe4a1-5466-442f-9cbd-cf8622bb00cd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/IncomeTaxesDetails" xlink:type="extended" id="i678a6c7fa6974bf3b260ed38aca0929c_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e4f38f7d-26c9-4e43-82f4-656d8dc4b026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e4f38f7d-26c9-4e43-82f4-656d8dc4b026" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationNumberOfTaxableYears_e02b56e2-493e-4b81-8bc9-74b91e8e75b7" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationNumberOfTaxableYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_IncomeTaxExaminationNumberOfTaxableYears_e02b56e2-493e-4b81-8bc9-74b91e8e75b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_c26b028d-836b-40cf-a6e7-8e2db056c6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_c26b028d-836b-40cf-a6e7-8e2db056c6df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CumulativeDeferredChargeTaxLitigation_f231420e-f618-4289-bb4c-d77513732341" xlink:href="prgo-20230401.xsd#prgo_CumulativeDeferredChargeTaxLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_CumulativeDeferredChargeTaxLitigation_f231420e-f618-4289-bb4c-d77513732341" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_6145653e-50b9-44d0-8563-39e8debd811d" xlink:href="prgo-20230401.xsd#prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_6145653e-50b9-44d0-8563-39e8debd811d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_a7b5bb26-7387-443b-8821-033cd9484803" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_a7b5bb26-7387-443b-8821-033cd9484803" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_7efa1b58-883d-4125-99d2-e6a063399c21" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_7efa1b58-883d-4125-99d2-e6a063399c21" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_9131b6c4-bac0-46a5-8c91-060d342b6bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_9131b6c4-bac0-46a5-8c91-060d342b6bb2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_f4a283e2-e844-4f1e-9247-b610c5d9c03d" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_f4a283e2-e844-4f1e-9247-b610c5d9c03d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_760c52fd-f1c8-42c9-a60c-a7ab3cf11014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_760c52fd-f1c8-42c9-a60c-a7ab3cf11014" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7c5ca124-b946-4905-84e8-77911a5bf9a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:to="loc_srt_RangeAxis_7c5ca124-b946-4905-84e8-77911a5bf9a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c5ca124-b946-4905-84e8-77911a5bf9a9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7c5ca124-b946-4905-84e8-77911a5bf9a9" xlink:to="loc_srt_RangeMember_7c5ca124-b946-4905-84e8-77911a5bf9a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5ce6e7c3-11f2-4ab3-9e6f-508200c566e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7c5ca124-b946-4905-84e8-77911a5bf9a9" xlink:to="loc_srt_RangeMember_5ce6e7c3-11f2-4ab3-9e6f-508200c566e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ca900ef1-3e31-4690-97eb-b0a7cb5eec36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5ce6e7c3-11f2-4ab3-9e6f-508200c566e2" xlink:to="loc_srt_MinimumMember_ca900ef1-3e31-4690-97eb-b0a7cb5eec36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ebc8f1eb-72b0-4667-93bf-164849292639" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5ce6e7c3-11f2-4ab3-9e6f-508200c566e2" xlink:to="loc_srt_MaximumMember_ebc8f1eb-72b0-4667-93bf-164849292639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_78e576fe-4c4e-410a-9523-d27ccea7bf56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_78e576fe-4c4e-410a-9523-d27ccea7bf56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_78e576fe-4c4e-410a-9523-d27ccea7bf56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_78e576fe-4c4e-410a-9523-d27ccea7bf56" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_78e576fe-4c4e-410a-9523-d27ccea7bf56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_945d58ee-3820-40b1-83ed-8ec53994a45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_78e576fe-4c4e-410a-9523-d27ccea7bf56" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_945d58ee-3820-40b1-83ed-8ec53994a45b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_f9257d10-3027-4aa7-8d01-fc3e13085e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_945d58ee-3820-40b1-83ed-8ec53994a45b" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_f9257d10-3027-4aa7-8d01-fc3e13085e50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7caa104b-590f-4c4d-96b6-31a65785723b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:to="loc_srt_StatementScenarioAxis_7caa104b-590f-4c4d-96b6-31a65785723b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7caa104b-590f-4c4d-96b6-31a65785723b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7caa104b-590f-4c4d-96b6-31a65785723b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7caa104b-590f-4c4d-96b6-31a65785723b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_37bfad78-15b2-4053-89ca-f107318f2573" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7caa104b-590f-4c4d-96b6-31a65785723b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_37bfad78-15b2-4053-89ca-f107318f2573" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_cf311edc-2856-4c48-9e28-f77b89a1e3eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_37bfad78-15b2-4053-89ca-f107318f2573" xlink:to="loc_srt_ScenarioForecastMember_cf311edc-2856-4c48-9e28-f77b89a1e3eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3cead1cd-fb0e-451b-9e78-832d98529e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3cead1cd-fb0e-451b-9e78-832d98529e21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3cead1cd-fb0e-451b-9e78-832d98529e21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3cead1cd-fb0e-451b-9e78-832d98529e21" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3cead1cd-fb0e-451b-9e78-832d98529e21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4e28f95c-4583-47e8-9c97-20c587c49242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3cead1cd-fb0e-451b-9e78-832d98529e21" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4e28f95c-4583-47e8-9c97-20c587c49242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9f9d2160-1055-4626-aa37-f74b49c9a963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4e28f95c-4583-47e8-9c97-20c587c49242" xlink:to="loc_us-gaap_SubsequentEventMember_9f9d2160-1055-4626-aa37-f74b49c9a963" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#ContingenciesPriceFixingLawsuitsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails" xlink:type="extended" id="if09d938ccd464e0f931a522825c9e8b4_ContingenciesPriceFixingLawsuitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAdditionalStatesAndTerritories_7cfaf06b-168c-4b5b-8a98-8150d2212f73" xlink:href="prgo-20230401.xsd#prgo_NumberOfAdditionalStatesAndTerritories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:to="loc_prgo_NumberOfAdditionalStatesAndTerritories_7cfaf06b-168c-4b5b-8a98-8150d2212f73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfManufacturers_097b0a36-7fd2-4ec8-b96b-a93a331d467a" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberOfManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:to="loc_prgo_LossContingencyNumberOfManufacturers_097b0a36-7fd2-4ec8-b96b-a93a331d467a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofFormerEmployees_7d15bada-6e30-42e4-887f-4242fb97a645" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofFormerEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:to="loc_prgo_LossContingencyNumberofFormerEmployees_7d15bada-6e30-42e4-887f-4242fb97a645" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_dc5c1538-2f20-49a5-9b77-d71998369a59" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:to="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_dc5c1538-2f20-49a5-9b77-d71998369a59" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_cf3ee235-412f-42cd-b1b7-c8ba547b4005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:to="loc_us-gaap_LossContingenciesTable_cf3ee235-412f-42cd-b1b7-c8ba547b4005" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_69c82cc0-69cf-40cc-a5af-8d7050a518fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_cf3ee235-412f-42cd-b1b7-c8ba547b4005" xlink:to="loc_srt_LitigationCaseAxis_69c82cc0-69cf-40cc-a5af-8d7050a518fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_69c82cc0-69cf-40cc-a5af-8d7050a518fe_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_69c82cc0-69cf-40cc-a5af-8d7050a518fe" xlink:to="loc_srt_LitigationCaseTypeDomain_69c82cc0-69cf-40cc-a5af-8d7050a518fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_fff1e768-7c30-4a56-ad6c-e259f42a27a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_69c82cc0-69cf-40cc-a5af-8d7050a518fe" xlink:to="loc_srt_LitigationCaseTypeDomain_fff1e768-7c30-4a56-ad6c-e259f42a27a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_StateAttorneyGeneralComplaintMember_017413fa-40b8-40ff-a4a8-b1d052f1b0a4" xlink:href="prgo-20230401.xsd#prgo_StateAttorneyGeneralComplaintMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_fff1e768-7c30-4a56-ad6c-e259f42a27a6" xlink:to="loc_prgo_StateAttorneyGeneralComplaintMember_017413fa-40b8-40ff-a4a8-b1d052f1b0a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CanadianClassActionComplaintMember_fd315638-e882-4fc2-88e0-2ceef03bf9d4" xlink:href="prgo-20230401.xsd#prgo_CanadianClassActionComplaintMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_fff1e768-7c30-4a56-ad6c-e259f42a27a6" xlink:to="loc_prgo_CanadianClassActionComplaintMember_fd315638-e882-4fc2-88e0-2ceef03bf9d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#ContingenciesSecuritiesLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails" xlink:type="extended" id="i6f7611fb68984ca3b3f5d91281c3c873_ContingenciesSecuritiesLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_8169306b-e032-41e0-a635-cde7faf82e6a" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_8169306b-e032-41e0-a635-cde7faf82e6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_2bc28956-710b-4162-82d5-802acd2e9aa5" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_2bc28956-710b-4162-82d5-802acd2e9aa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofPutativeClasses_aaa6ae10-6a69-40a4-9024-ba1b94122c7d" xlink:href="prgo-20230401.xsd#prgo_NumberofPutativeClasses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_prgo_NumberofPutativeClasses_aaa6ae10-6a69-40a4-9024-ba1b94122c7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_0ae94d1d-1239-405a-920f-dc9fda168a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_0ae94d1d-1239-405a-920f-dc9fda168a35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_97e3758c-b006-4b86-840e-ce84dc1c55af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_97e3758c-b006-4b86-840e-ce84dc1c55af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_8fa45062-9b56-4f63-9131-a5934e727397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_8fa45062-9b56-4f63-9131-a5934e727397" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_af23dc66-165f-457d-a1eb-3a7bcc201cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_us-gaap_LossContingenciesTable_af23dc66-165f-457d-a1eb-3a7bcc201cfa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6d30553f-b08d-4c35-aefe-62ddaa2f3bae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_af23dc66-165f-457d-a1eb-3a7bcc201cfa" xlink:to="loc_srt_LitigationCaseAxis_6d30553f-b08d-4c35-aefe-62ddaa2f3bae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6d30553f-b08d-4c35-aefe-62ddaa2f3bae_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_6d30553f-b08d-4c35-aefe-62ddaa2f3bae" xlink:to="loc_srt_LitigationCaseTypeDomain_6d30553f-b08d-4c35-aefe-62ddaa2f3bae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2da216e8-83f7-4dca-8255-e1fb8cef5dbc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_6d30553f-b08d-4c35-aefe-62ddaa2f3bae" xlink:to="loc_srt_LitigationCaseTypeDomain_2da216e8-83f7-4dca-8255-e1fb8cef5dbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_23b23a48-af82-4e4c-bebe-8ce1f8b1a0f9" xlink:href="prgo-20230401.xsd#prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2da216e8-83f7-4dca-8255-e1fb8cef5dbc" xlink:to="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_23b23a48-af82-4e4c-bebe-8ce1f8b1a0f9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ContingenciesOtherMattersDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#ContingenciesOtherMattersDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/ContingenciesOtherMattersDetails" xlink:type="extended" id="i874af50156b74804865a60ec5e507a73_ContingenciesOtherMattersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_dfc73955-ca2f-443b-a7c9-0174bdcbfecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_dfc73955-ca2f-443b-a7c9-0174bdcbfecc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofTendersAccepted_68c7c9b0-31d3-40c2-ac04-6438f234951b" xlink:href="prgo-20230401.xsd#prgo_NumberofTendersAccepted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_NumberofTendersAccepted_68c7c9b0-31d3-40c2-ac04-6438f234951b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaints_50138b75-04c8-4bf8-bf26-93eaae1986b3" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofMasterComplaints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaints_50138b75-04c8-4bf8-bf26-93eaae1986b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_d1ecb86f-ddd9-4c87-8200-2d730503243b" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofMasterComplaintsNamingCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_d1ecb86f-ddd9-4c87-8200-2d730503243b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfMasterComplaints_377042a0-4227-4ab6-808b-133d243b2705" xlink:href="prgo-20230401.xsd#prgo_NumberOfAppealsOfMasterComplaints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_NumberOfAppealsOfMasterComplaints_377042a0-4227-4ab6-808b-133d243b2705" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims_bf171c33-807e-43b6-bc17-bf1c77ad24c2" xlink:href="prgo-20230401.xsd#prgo_NumberOfAppealsOfPersonalInjuryClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims_bf171c33-807e-43b6-bc17-bf1c77ad24c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfPersonalInjuryLawsuits_6b269255-95ba-453d-8206-d71c7efe3bff" xlink:href="prgo-20230401.xsd#prgo_NumberOfPersonalInjuryLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_NumberOfPersonalInjuryLawsuits_6b269255-95ba-453d-8206-d71c7efe3bff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_ecfdafbe-5e2c-4621-831e-a507af2dfbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_us-gaap_LitigationReserve_ecfdafbe-5e2c-4621-831e-a507af2dfbd0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_1cb354dc-b9de-4216-92c9-a50cba9f5340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_1cb354dc-b9de-4216-92c9-a50cba9f5340" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_f0c5edb2-583f-4f3a-96f4-e59603188f4c" xlink:href="prgo-20230401.xsd#prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_f0c5edb2-583f-4f3a-96f4-e59603188f4c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1b9ef454-dfc4-48d2-89ce-e4198aade3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_us-gaap_LossContingenciesTable_1b9ef454-dfc4-48d2-89ce-e4198aade3f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_53fb4808-c581-4bdc-afb5-a3b4972cbc9e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1b9ef454-dfc4-48d2-89ce-e4198aade3f6" xlink:to="loc_srt_LitigationCaseAxis_53fb4808-c581-4bdc-afb5-a3b4972cbc9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_53fb4808-c581-4bdc-afb5-a3b4972cbc9e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_53fb4808-c581-4bdc-afb5-a3b4972cbc9e" xlink:to="loc_srt_LitigationCaseTypeDomain_53fb4808-c581-4bdc-afb5-a3b4972cbc9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_37991ef9-9824-4da2-9e29-257e5c079995" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_53fb4808-c581-4bdc-afb5-a3b4972cbc9e" xlink:to="loc_srt_LitigationCaseTypeDomain_37991ef9-9824-4da2-9e29-257e5c079995" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TalcumPowderLitigationMember_15ea9adb-e2d3-49bb-ac89-e21d1905d804" xlink:href="prgo-20230401.xsd#prgo_TalcumPowderLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_37991ef9-9824-4da2-9e29-257e5c079995" xlink:to="loc_prgo_TalcumPowderLitigationMember_15ea9adb-e2d3-49bb-ac89-e21d1905d804" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanitidineLitigationMember_99f9481a-d205-4d33-bdae-a3d3d494fc42" xlink:href="prgo-20230401.xsd#prgo_RanitidineLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_37991ef9-9824-4da2-9e29-257e5c079995" xlink:to="loc_prgo_RanitidineLitigationMember_99f9481a-d205-4d33-bdae-a3d3d494fc42" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#SegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SegmentInformationDetails" xlink:type="extended" id="i441b2ba3a7284a63a5ab87157d5fa102_SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6d8ac878-3e38-4bc7-a114-4a394dc5c0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:to="loc_us-gaap_Assets_6d8ac878-3e38-4bc7-a114-4a394dc5c0d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3190b1f2-ce12-470c-b36a-7197b67c73a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3190b1f2-ce12-470c-b36a-7197b67c73a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6ad9fdfc-c8ba-4eff-887f-96e6fdf05043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:to="loc_us-gaap_OperatingIncomeLoss_6ad9fdfc-c8ba-4eff-887f-96e6fdf05043" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_505b5f83-b613-4994-8f0d-16309bde15b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_505b5f83-b613-4994-8f0d-16309bde15b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_39461a09-09d4-4e97-b024-9f02fe535200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_39461a09-09d4-4e97-b024-9f02fe535200" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_094cab63-4418-48dc-80a6-c2de5f77e9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_39461a09-09d4-4e97-b024-9f02fe535200" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_094cab63-4418-48dc-80a6-c2de5f77e9b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_094cab63-4418-48dc-80a6-c2de5f77e9b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_094cab63-4418-48dc-80a6-c2de5f77e9b1" xlink:to="loc_us-gaap_SegmentDomain_094cab63-4418-48dc-80a6-c2de5f77e9b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_48f79f9b-a6e9-4dfe-8ba1-f8f9083f70eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_094cab63-4418-48dc-80a6-c2de5f77e9b1" xlink:to="loc_us-gaap_SegmentDomain_48f79f9b-a6e9-4dfe-8ba1-f8f9083f70eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_419f4c9b-b921-4e4b-b6da-f30c130cc408" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_48f79f9b-a6e9-4dfe-8ba1-f8f9083f70eb" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_419f4c9b-b921-4e4b-b6da-f30c130cc408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_49036cf0-51aa-45be-8fd9-879c45ba2012" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_48f79f9b-a6e9-4dfe-8ba1-f8f9083f70eb" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_49036cf0-51aa-45be-8fd9-879c45ba2012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d569acc5-923f-43da-9687-238aa2b2ebd6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_39461a09-09d4-4e97-b024-9f02fe535200" xlink:to="loc_srt_ConsolidationItemsAxis_d569acc5-923f-43da-9687-238aa2b2ebd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d569acc5-923f-43da-9687-238aa2b2ebd6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_d569acc5-923f-43da-9687-238aa2b2ebd6" xlink:to="loc_srt_ConsolidationItemsDomain_d569acc5-923f-43da-9687-238aa2b2ebd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ceb554a0-f282-44ba-8949-e9b08dfe843b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_d569acc5-923f-43da-9687-238aa2b2ebd6" xlink:to="loc_srt_ConsolidationItemsDomain_ceb554a0-f282-44ba-8949-e9b08dfe843b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7aaadfd1-e677-48ae-8282-4d6c4522dec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ceb554a0-f282-44ba-8949-e9b08dfe843b" xlink:to="loc_us-gaap_OperatingSegmentsMember_7aaadfd1-e677-48ae-8282-4d6c4522dec4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_56a3fea3-2873-4a8a-a1a3-90d1a31ba1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ceb554a0-f282-44ba-8949-e9b08dfe843b" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_56a3fea3-2873-4a8a-a1a3-90d1a31ba1e4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.perrigo.com/role/SubsequentEventsDetails" xlink:type="extended" id="i194cc7e233034ae18b7b2d99e95ef15a_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_33a8f1b1-1e2e-45cb-ba1b-6d0ba2bc9020" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_33a8f1b1-1e2e-45cb-ba1b-6d0ba2bc9020" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_0876a9dc-064f-44b0-a265-31f6fd75a3f4" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeofProposedAdjustmentPenaltyPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_0876a9dc-064f-44b0-a265-31f6fd75a3f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_3996d2f2-77da-48f9-b56a-4cb36be15913" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_3996d2f2-77da-48f9-b56a-4cb36be15913" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_6969e86e-c7cb-48bb-b5e4-7fb19b74ba07" xlink:href="prgo-20230401.xsd#prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_6969e86e-c7cb-48bb-b5e4-7fb19b74ba07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_0300e76c-00ae-4d72-b6fe-17e5cf8c36d9" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_0300e76c-00ae-4d72-b6fe-17e5cf8c36d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_5405307f-2c43-41f3-9519-4dfccead4b40" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_5405307f-2c43-41f3-9519-4dfccead4b40" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_e095fe8a-0d55-4002-b0e0-68483ab50ea1" xlink:href="prgo-20230401.xsd#prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_e095fe8a-0d55-4002-b0e0-68483ab50ea1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateInRevenueAgentReport_8c7fd428-a005-42a3-a572-1ee940df2f4c" xlink:href="prgo-20230401.xsd#prgo_BlendedInterestRateInRevenueAgentReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_BlendedInterestRateInRevenueAgentReport_8c7fd428-a005-42a3-a572-1ee940df2f4c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtStatedBlendedInterestRate_e29f607e-2c4a-42a2-ad3d-27d8165b17ff" xlink:href="prgo-20230401.xsd#prgo_DebtStatedBlendedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_DebtStatedBlendedInterestRate_e29f607e-2c4a-42a2-ad3d-27d8165b17ff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationInterestExpense_b45d91eb-5d13-43f7-a6f8-4e45acd1ba46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_us-gaap_IncomeTaxExaminationInterestExpense_b45d91eb-5d13-43f7-a6f8-4e45acd1ba46" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_14c542d8-7ee5-4f3a-855a-ea59059250a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_us-gaap_SubsequentEventTable_14c542d8-7ee5-4f3a-855a-ea59059250a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_82f747bb-6691-491f-a4d2-2f0ec61ca687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_14c542d8-7ee5-4f3a-855a-ea59059250a6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_82f747bb-6691-491f-a4d2-2f0ec61ca687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_82f747bb-6691-491f-a4d2-2f0ec61ca687_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_82f747bb-6691-491f-a4d2-2f0ec61ca687" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_82f747bb-6691-491f-a4d2-2f0ec61ca687_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b2b28051-ff86-40cd-938f-2784af466f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_82f747bb-6691-491f-a4d2-2f0ec61ca687" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b2b28051-ff86-40cd-938f-2784af466f78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_efc9881b-65aa-4432-b7a6-06970056f73a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b2b28051-ff86-40cd-938f-2784af466f78" xlink:to="loc_us-gaap_SubsequentEventMember_efc9881b-65aa-4432-b7a6-06970056f73a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>prgo-20230401_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d94275d0-2889-4bee-8a41-eed44cff1b4d,g:5de99725-025a-4d3c-a861-61491132bb43-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_1451808d-54e7-4c75-a4b9-4bb58b8af1d0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc5b4616-8825-4340-b206-305861df7b09_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b2c2d3d4-5e5e-4263-a53a-f55328abc0f8_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_9385c9db-0cdf-4911-8157-ca573b5ff627_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation and Transactions</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_c294b9fe-120b-4a99-a47e-58ad1af2eb93_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims, number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_c723afc0-e99a-47c2-9be8-e1815e413271_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses, net</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_GBP_81439d0b-547b-4d49-b2dd-565b8cdd6cb9_terseLabel_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound (GBP)</link:label>
    <link:label id="lab_currency_GBP_label_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP" xlink:to="lab_currency_GBP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_d3fd2191-9394-464b-a779-ef6c097feb34_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_ba3248fb-3633-40cd-b76a-f72e8a4270e3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OralSelfcareMember_fb80d5af-75fc-4755-999b-772567efb403_terseLabel_en-US" xlink:label="lab_prgo_OralSelfcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care</link:label>
    <link:label id="lab_prgo_OralSelfcareMember_label_en-US" xlink:label="lab_prgo_OralSelfcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Self-care [Member]</link:label>
    <link:label id="lab_prgo_OralSelfcareMember_documentation_en-US" xlink:label="lab_prgo_OralSelfcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Self-care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralSelfcareMember" xlink:href="prgo-20230401.xsd#prgo_OralSelfcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OralSelfcareMember" xlink:to="lab_prgo_OralSelfcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6f9b308b-784f-426a-b8e1-552e4b5d2b06_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_f2b86039-e86b-493f-b45a-280e808405ae_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A4650SeniorNotesDueJune152030Member_0eb544df-a1dc-40ee-86d7-598d8c36f177_terseLabel_en-US" xlink:label="lab_prgo_A4650SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.650% Senior Notes due June 15, 2030</link:label>
    <link:label id="lab_prgo_A4650SeniorNotesDueJune152030Member_label_en-US" xlink:label="lab_prgo_A4650SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.650% Senior Notes due June 15, 2030 [Member]</link:label>
    <link:label id="lab_prgo_A4650SeniorNotesDueJune152030Member_documentation_en-US" xlink:label="lab_prgo_A4650SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.650% Senior Notes due June 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4650SeniorNotesDueJune152030Member" xlink:href="prgo-20230401.xsd#prgo_A4650SeniorNotesDueJune152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4650SeniorNotesDueJune152030Member" xlink:to="lab_prgo_A4650SeniorNotesDueJune152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PainandSleepaidsMember_9574c592-01d1-405f-8455-fbcec5b8f7f9_terseLabel_en-US" xlink:label="lab_prgo_PainandSleepaidsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pain and Sleep-Aids</link:label>
    <link:label id="lab_prgo_PainandSleepaidsMember_label_en-US" xlink:label="lab_prgo_PainandSleepaidsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pain and Sleep-aids [Member]</link:label>
    <link:label id="lab_prgo_PainandSleepaidsMember_documentation_en-US" xlink:label="lab_prgo_PainandSleepaidsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pain and Sleep-aids [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PainandSleepaidsMember" xlink:href="prgo-20230401.xsd#prgo_PainandSleepaidsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PainandSleepaidsMember" xlink:to="lab_prgo_PainandSleepaidsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_9ba3f5ad-5c40-4193-bcaf-b1087fd717dd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_56c08ec6-10e6-4d41-ad51-8aa94e6e141c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_ecac8939-99dd-47a7-ab2b-ec75ed3b73f2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_d584ffde-a256-4349-a724-dbc2dbfaf089_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_4d2c6834-a213-42f3-9709-8d11a25f6863_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3453a26e-6b32-4c9e-aa13-37ab95cdba44_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_f870d35d-f40c-405b-b711-7e004ef22e0c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_4d410ef2-09c2-4b86-9ea4-41b290bb3e7c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Other Assets, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NewTermLoanAFacilityMember_cd63f82f-1fc4-41ac-992d-35f62dd9c74d_terseLabel_en-US" xlink:label="lab_prgo_NewTermLoanAFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan A Facility</link:label>
    <link:label id="lab_prgo_NewTermLoanAFacilityMember_label_en-US" xlink:label="lab_prgo_NewTermLoanAFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan A Facility [Member]</link:label>
    <link:label id="lab_prgo_NewTermLoanAFacilityMember_documentation_en-US" xlink:label="lab_prgo_NewTermLoanAFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan A Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanAFacilityMember" xlink:href="prgo-20230401.xsd#prgo_NewTermLoanAFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NewTermLoanAFacilityMember" xlink:to="lab_prgo_NewTermLoanAFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_752ebf31-bc4a-4857-a861-b4480409789d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, receivable, additions</link:label>
    <link:label id="lab_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_label_en-US" xlink:label="lab_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Receivable, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions" xlink:to="lab_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_d183c070-61e7-4729-9b6b-fcbc1d05d149_terseLabel_en-US" xlink:label="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite And Indefinite Lived Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_documentation_en-US" xlink:label="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite and Indefinite-Lived Assets By Major Class [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:href="prgo-20230401.xsd#prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:to="lab_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_7c1fe0c6-6687-4ac8-abf8-52b2fc70d02e_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_a4acd7bf-7a9f-48d6-bc62-d9a56a2f825c_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_92267d75-fae0-4b52-b87c-f8e943f81969_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims_cd3ff28d-a42d-4295-8234-f48ec36470c1_terseLabel_en-US" xlink:label="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of appeals of personal injury claims</link:label>
    <link:label id="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims_label_en-US" xlink:label="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Appeals of Personal Injury Claims</link:label>
    <link:label id="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims_documentation_en-US" xlink:label="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Appeals of Personal Injury Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:href="prgo-20230401.xsd#prgo_NumberOfAppealsOfPersonalInjuryClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:to="lab_prgo_NumberOfAppealsOfPersonalInjuryClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RestructuringAdditionalCharges_70f301bf-8267-4199-b4b4-1bb587e32b8f_terseLabel_en-US" xlink:label="lab_prgo_RestructuringAdditionalCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional charges</link:label>
    <link:label id="lab_prgo_RestructuringAdditionalCharges_label_en-US" xlink:label="lab_prgo_RestructuringAdditionalCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Additional Charges</link:label>
    <link:label id="lab_prgo_RestructuringAdditionalCharges_documentation_en-US" xlink:label="lab_prgo_RestructuringAdditionalCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Additional Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringAdditionalCharges" xlink:href="prgo-20230401.xsd#prgo_RestructuringAdditionalCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RestructuringAdditionalCharges" xlink:to="lab_prgo_RestructuringAdditionalCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_SkinCareMember_85bf2aa3-ede2-4c70-9f59-70a2b468fd49_terseLabel_en-US" xlink:label="lab_prgo_SkinCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skin Care</link:label>
    <link:label id="lab_prgo_SkinCareMember_label_en-US" xlink:label="lab_prgo_SkinCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skin Care [Member]</link:label>
    <link:label id="lab_prgo_SkinCareMember_documentation_en-US" xlink:label="lab_prgo_SkinCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skincare and Personal Hygiene [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SkinCareMember" xlink:href="prgo-20230401.xsd#prgo_SkinCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SkinCareMember" xlink:to="lab_prgo_SkinCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ControllingInterestAbstract_4c8daf78-c289-4c1b-9b91-160fa0e7606d_terseLabel_en-US" xlink:label="lab_prgo_ControllingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Controlling interests:</link:label>
    <link:label id="lab_prgo_ControllingInterestAbstract_label_en-US" xlink:label="lab_prgo_ControllingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Controlling Interest [Abstract]</link:label>
    <link:label id="lab_prgo_ControllingInterestAbstract_documentation_en-US" xlink:label="lab_prgo_ControllingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Controlling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ControllingInterestAbstract" xlink:href="prgo-20230401.xsd#prgo_ControllingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ControllingInterestAbstract" xlink:to="lab_prgo_ControllingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_d8239e32-8df3-4004-9783-f0ecbb1f9412_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_1cfea78a-5c37-4882-ae5c-5be0f7f3d2af_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsRemainderofFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" xlink:to="lab_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_fc49bf1f-aabe-46cf-825b-5b5c659ecb22_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_179fe856-ae3c-4358-8221-569ce95606e2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_03fa620e-7e98-43d5-b849-ceed6abcc45e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangibles:(1)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_eac22d03-bf2c-46ef-8972-69eee76583d4_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_02e7ad79-855e-4bc1-918b-322c37c090ce_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock plan (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_60b8f7f2-73b2-44bd-8171-fe5ea71005f7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3975c7de-1212-490f-b324-6d3f51d74a8f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate - Operating lease (percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_0db2d762-a7ca-4aa2-bec3-9eac1619b9d9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange rate, remeasurement</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Exchange Rate, Remeasurement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:to="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_0259e4ed-f7e8-4c66-ac28-e4f2afccb826_terseLabel_en-US" xlink:label="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</link:label>
    <link:label id="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_label_en-US" xlink:label="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness</link:label>
    <link:label id="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_documentation_en-US" xlink:label="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:href="prgo-20230401.xsd#prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:to="lab_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_4c5b22ba-f070-4e3d-bfee-612a719a83dc_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration, installment receivables</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivables</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherCSCAMember_ff22d57d-fb06-45fe-882f-25ede3608411_terseLabel_en-US" xlink:label="lab_prgo_OtherCSCAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSCA</link:label>
    <link:label id="lab_prgo_OtherCSCAMember_label_en-US" xlink:label="lab_prgo_OtherCSCAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSCA [Member]</link:label>
    <link:label id="lab_prgo_OtherCSCAMember_documentation_en-US" xlink:label="lab_prgo_OtherCSCAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCAMember" xlink:href="prgo-20230401.xsd#prgo_OtherCSCAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherCSCAMember" xlink:to="lab_prgo_OtherCSCAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_414eef4f-2f78-4bce-8521-adfbf7105431_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_93ea7bf1-d87c-42c8-b518-c562117ced93_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_8435a444-5973-4123-b38e-0a216451ed5b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_b816f402-8256-4684-807b-14f3f4fd2aef_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_c4087f48-c269-49a2-b50e-35097fa48549_periodStartLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents held for sale, beginning of period</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_543b98a1-0537-412e-813b-9d0d8a1bdcfa_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less cash and cash equivalents held for sale, end of period</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_84164487-0160-43c9-9ecc-6b9e358b8186_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive share-based awards excluded from computation of diluted EPS (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_88ed67bb-0246-41e2-8f5e-dfec72e91b39_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_ea79c038-b7e9-4043-930a-984fb2d7a386_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_a5c1b020-7ed6-41f9-8c3d-2de1bcc2fd91_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_7b517f94-b91f-4aef-a8b6-bd553a7799af_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_baf0fbde-ea8b-4a04-8951-b3df795db95d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_beec0c71-ab82-4189-a72b-31012c1a67d3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_c88b8bfa-75d6-48d9-9f75-1eea3dc7a45c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour_d8b35854-9572-491a-86fc-c2e6cced0d90_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2027</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due after Year Four</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueafterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_9c21992d-52b9-4720-97a7-f13773ee2633_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_d6402e11-ba9d-4a51-b6c6-040c010e5a3a_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_3fab83a1-8737-4088-ba09-c988a8744ad7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_0d4075bc-d066-46d4-a5f0-a406643c4419_totalLabel_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from components excluded from assessment of cash flow hedge effectiveness, net, total</link:label>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_label_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:to="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_TalcumPowderLitigationMember_98591759-8811-4d1a-8f93-1e668611d350_terseLabel_en-US" xlink:label="lab_prgo_TalcumPowderLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talcum Powder Litigation</link:label>
    <link:label id="lab_prgo_TalcumPowderLitigationMember_label_en-US" xlink:label="lab_prgo_TalcumPowderLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talcum Powder Litigation [Member]</link:label>
    <link:label id="lab_prgo_TalcumPowderLitigationMember_documentation_en-US" xlink:label="lab_prgo_TalcumPowderLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talcum Powder Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TalcumPowderLitigationMember" xlink:href="prgo-20230401.xsd#prgo_TalcumPowderLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_TalcumPowderLitigationMember" xlink:to="lab_prgo_TalcumPowderLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_093ab415-ccf3-47fa-af2d-6f52ff1bb2e7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_5f7c5fb5-59d3-4035-8e3e-f6fdf5c6ddc8_terseLabel_en-US" xlink:label="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Lease Terms and Discount Rates</link:label>
    <link:label id="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_label_en-US" xlink:label="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]</link:label>
    <link:label id="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_documentation_en-US" xlink:label="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:href="prgo-20230401.xsd#prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:to="lab_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_f2e63776-de23-45be-999f-94d6fa0cec45_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4602398a-47b8-408c-b3fd-47cc9b780173_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_84118f60-2887-453f-a4b0-d95608ae6d15_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_5938bcd8-976b-403f-9477-d50ead3cf47e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_68397a5c-d21b-423f-b310-cb131ad1143f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2f3a72a8-e9a7-43d7-927d-d39d3f96b3df_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_d44a1d34-f52d-439c-8bcf-808280c53051_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_62beffd2-427b-4bee-b1a3-179c7a154edf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_516b2b3c-dc47-4ee5-a5a8-337b99dca4b1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_b6aa345a-e3a9-4bdb-9c39-d6e7d80532fe_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_1693a3f9-146c-41a8-87ab-1c243c64ab14_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_label_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets</link:label>
    <link:label id="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:to="lab_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a2dcc7b8-8e0a-4486-be9a-6d6701990dd9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_a743fba2-6012-4b78-afd9-b700452d7ae1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings on line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_HRAPharmaIntegrationMember_4a607475-6f63-49c6-9ece-b630ac7020e8_terseLabel_en-US" xlink:label="lab_prgo_HRAPharmaIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Pharma Integration</link:label>
    <link:label id="lab_prgo_HRAPharmaIntegrationMember_label_en-US" xlink:label="lab_prgo_HRAPharmaIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Pharma Integration [Member]</link:label>
    <link:label id="lab_prgo_HRAPharmaIntegrationMember_documentation_en-US" xlink:label="lab_prgo_HRAPharmaIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Pharma Integration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaIntegrationMember" xlink:href="prgo-20230401.xsd#prgo_HRAPharmaIntegrationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_HRAPharmaIntegrationMember" xlink:to="lab_prgo_HRAPharmaIntegrationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_7ae87a61-3bd8-4592-bc51-1dd4ae73af53_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A4900SeniorLoanDue2044Member_b5eeecc9-dffc-4c38-8b45-3ee6adfbfe62_terseLabel_en-US" xlink:label="lab_prgo_A4900SeniorLoanDue2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.900% Senior Loan due 2044</link:label>
    <link:label id="lab_prgo_A4900SeniorLoanDue2044Member_label_en-US" xlink:label="lab_prgo_A4900SeniorLoanDue2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.900% Senior Loan due 2044 [Member]</link:label>
    <link:label id="lab_prgo_A4900SeniorLoanDue2044Member_documentation_en-US" xlink:label="lab_prgo_A4900SeniorLoanDue2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.9% Senior Loan due 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member" xlink:href="prgo-20230401.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4900SeniorLoanDue2044Member" xlink:to="lab_prgo_A4900SeniorLoanDue2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f6825bff-95f4-4608-89e9-9055ff3feab4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_78324462-c031-4966-b384-36d73e02bc15_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS notice of proposed audit adjustment to reduce deductible interest expense for fiscal years 2014 and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_label_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_documentation_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:to="lab_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilities_1dceef04-407c-4ebc-9228-f9a15ba7f121_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_prgo_LeaseLiabilities_label_en-US" xlink:label="lab_prgo_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities</link:label>
    <link:label id="lab_prgo_LeaseLiabilities_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilities" xlink:to="lab_prgo_LeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_ba72be36-beda-4e1e-84a2-25285792aed5_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS notice of proposed adjustment, penalty (percent)</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_label_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Adjustment, Penalty, Percent</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_documentation_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Adjustment, Penalty, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeofProposedAdjustmentPenaltyPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:to="lab_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DerivativeInstrumentTermAxis_be467ba7-919e-446f-98b7-f176a65ea63d_terseLabel_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term [Axis]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentTermAxis_label_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term [Axis]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentTermAxis_documentation_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermAxis" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DerivativeInstrumentTermAxis" xlink:to="lab_prgo_DerivativeInstrumentTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0861191-7378-4633-b311-f72e43f04a43_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash from (for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_01392b32-8c4c-4493-ac90-1dfdf0db520c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_948ebf92-3f7c-4c82-82bf-2b67733e5cb8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_38da83bc-7a4b-48b5-84bb-5aa440d72d75_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c0ec3ed6-de2d-4789-b5e9-8ad1f5e02efd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to derive cash flows:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_bab0fafe-9951-40e8-a7d0-3924a3a56c79_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from sale of businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_4040eae9-e274-453d-9fb3-4dcc432b87c9_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ddb48086-3878-420d-81be-ec278fed0703_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_c815c779-cacc-4cf4-a0f2-6813caefaaa9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_72fdb0a2-c254-48dd-9533-a5af4c15f8ba_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fdf2eeac-849d-4599-a7aa-ceeb4f229dc3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term - Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3d35230f-47b4-4c36-9ed3-8e001ad0aa83_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DebtStatedBlendedInterestRate_633fd132-e0ac-4b97-b013-5655ad376988_terseLabel_en-US" xlink:label="lab_prgo_DebtStatedBlendedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated blended interest rate</link:label>
    <link:label id="lab_prgo_DebtStatedBlendedInterestRate_label_en-US" xlink:label="lab_prgo_DebtStatedBlendedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Stated Blended Interest Rate</link:label>
    <link:label id="lab_prgo_DebtStatedBlendedInterestRate_documentation_en-US" xlink:label="lab_prgo_DebtStatedBlendedInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Stated Blended Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtStatedBlendedInterestRate" xlink:href="prgo-20230401.xsd#prgo_DebtStatedBlendedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DebtStatedBlendedInterestRate" xlink:to="lab_prgo_DebtStatedBlendedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_13fdca26-0fe2-4b6e-8b97-308243f2c4d4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase accounting adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed937b0c-97d0-4693-9bfc-84eeb9e55d50_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From (For) Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayable_3936d236-23a4-4d11-a10e-7ab7a0930acb_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loans</link:label>
    <link:label id="lab_us-gaap_LoansPayable_label_en-US" xlink:label="lab_us-gaap_LoansPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayable" xlink:to="lab_us-gaap_LoansPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b6eee6e9-6f17-4547-b76c-43067e1d1a0f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding equity interest acquired (percent)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1ed6a680-d5a1-4d85-a468-e4b0047382aa_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9aeaeee-6295-4221-8acf-e5fb6134a8e7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_06971959-e958-4989-b13a-0c02fd44d315_totalLabel_en-US" xlink:label="lab_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_label_en-US" xlink:label="lab_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Loss After Adjustments For Non-Cash And Nonoperating Items</link:label>
    <link:label id="lab_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_documentation_en-US" xlink:label="lab_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) after adjustments for noncash and nonoperating items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:href="prgo-20230401.xsd#prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:to="lab_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_f61b6ddb-fbc8-4c0d-9714-ac68d6f6763b_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_1a3d9590-0956-47d3-9cfa-75a587dc0343_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, issued and outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_fcaec24b-0182-40da-ad6a-fd65b98cce83_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_5cfece4d-c9ee-47f3-97b8-f49f9ba51271_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_f6dd96e7-b8cf-42db-9ae4-1ca198e9cf8d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_bb5a9b88-f5a5-44bb-b81e-5637e8cd3e5f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_69c063a2-aa36-4edc-8181-56a862e74b52_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangibles:</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_9db604de-3c2d-4bb3-b2b9-a581d1f6f748_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_386fcdae-e01f-4d11-be6c-1835fc6803e5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indebtedness</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_b1f1554b-de97-4ea7-bfc6-39f415fc238c_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit</link:label>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticLineOfCreditMember" xlink:to="lab_us-gaap_DomesticLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_2d806f0d-8416-42ce-832a-6b75906f1d80_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_4069cace-bc14-4b1a-a9e0-226f0b8d9bcf_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e4dac532-a725-4456-91f6-59e8fb9e47dc_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_f868629e-4844-4608-85b3-13189419c51e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_c872cf9b-e921-467f-8f6b-e41a1c2ce347_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ConsumerSelfCareInternationalMember_1eede70f-d207-411d-9436-e363e787ba71_terseLabel_en-US" xlink:label="lab_prgo_ConsumerSelfCareInternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CSCI</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareInternationalMember_label_en-US" xlink:label="lab_prgo_ConsumerSelfCareInternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Self-Care International [Member]</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareInternationalMember_documentation_en-US" xlink:label="lab_prgo_ConsumerSelfCareInternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Self-Care International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ConsumerSelfCareInternationalMember" xlink:to="lab_prgo_ConsumerSelfCareInternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_a16060bc-1cbe-4ed4-963f-ba3956d81121_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bbbfbc47-cbbc-4506-a92d-d30c0d258a1f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_NOK_a82d5c99-1ba8-4896-89bd-fb42a8ea296e_terseLabel_en-US" xlink:label="lab_currency_NOK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Krone (NOK)</link:label>
    <link:label id="lab_currency_NOK_label_en-US" xlink:label="lab_currency_NOK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norway, Krone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_NOK" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_NOK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_NOK" xlink:to="lab_currency_NOK" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ConsumerSelfCareAmericasMember_a7bf2484-f40c-4434-906c-61cd91b0946a_terseLabel_en-US" xlink:label="lab_prgo_ConsumerSelfCareAmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CSCA</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareAmericasMember_label_en-US" xlink:label="lab_prgo_ConsumerSelfCareAmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Self-Care Americas [Member]</link:label>
    <link:label id="lab_prgo_ConsumerSelfCareAmericasMember_documentation_en-US" xlink:label="lab_prgo_ConsumerSelfCareAmericasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Self-Care Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ConsumerSelfCareAmericasMember" xlink:to="lab_prgo_ConsumerSelfCareAmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_d5afe206-1fb1-4785-a169-f76310c004bf_terseLabel_en-US" xlink:label="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Currency Forward Contracts</link:label>
    <link:label id="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_label_en-US" xlink:label="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Currency Forward Contracts [Table Text Block]</link:label>
    <link:label id="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_documentation_en-US" xlink:label="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Currency Forward Contracts [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:href="prgo-20230401.xsd#prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:to="lab_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_498baeb0-e123-49b1-887f-2329528fd4d1_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed product technology, formulations, and product rights</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_bac7c9a2-924d-46e9-9f54-330b364baec6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_ae28d830-9e0f-4268-aa93-1d4ce7f0be9d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_204d06f0-03d8-422d-b1ad-83f2ef078e1d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_c1a9c9a3-b849-4790-804d-64993917f8a3_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_22ca1b69-81ae-4292-ab52-03aa05423201_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_beff1924-7931-49ae-ba1d-a9fb347c31f8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Contract with Customer Balances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4c196e97-7c1b-4058-9665-46c0c85d5c86_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherExpenseIncomeNetMember_b82f2399-f6b0-4856-b96d-54ddf3f74c2b_terseLabel_en-US" xlink:label="lab_prgo_OtherExpenseIncomeNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_prgo_OtherExpenseIncomeNetMember_label_en-US" xlink:label="lab_prgo_OtherExpenseIncomeNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income), Net [Member]</link:label>
    <link:label id="lab_prgo_OtherExpenseIncomeNetMember_documentation_en-US" xlink:label="lab_prgo_OtherExpenseIncomeNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income), Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember" xlink:href="prgo-20230401.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherExpenseIncomeNetMember" xlink:to="lab_prgo_OtherExpenseIncomeNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_c5f9b1ea-e1b7-40f4-93af-c9149a5bc22e_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment receivable, period one</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period One</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_7f864a80-146e-47a1-a851-3a9359016fd7_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency cash flow hedge loss to be reclassified during next 12 months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66a75d83-8960-4512-a369-9ea8c3286f2c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f140871c-15c3-440b-828d-280daa96c5ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_bcdf1580-d0c6-40b4-ad92-f5157a462078_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_34d48ff1-591f-4644-bc50-20f548211236_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_bbe7d782-4e48-49ae-99be-98bdb2860156_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables written-off</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_21771a79-3bc0-4742-a307-5a0fd607ce5a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e3b00a99-24e3-4d44-8063-de07ac76a023_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5b92c3e4-f6f4-4a3a-a13b-276bcaf45a2d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_375c8c82-d9f1-4164-af6e-410e21f2425a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination, penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DerivativeInstrumentTermDomain_c940e55a-258f-4886-9ee8-3629e48cddc1_terseLabel_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term [Domain]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentTermDomain_label_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term [Domain]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentTermDomain_documentation_en-US" xlink:label="lab_prgo_DerivativeInstrumentTermDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermDomain" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DerivativeInstrumentTermDomain" xlink:to="lab_prgo_DerivativeInstrumentTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_6c045dac-e4f6-4b3b-9064-b90c9a1d631f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency options</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeOptionMember" xlink:to="lab_us-gaap_ForeignExchangeOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_380989d3-a94f-49fc-83bf-3df904e7d047_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of master complaints naming company</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Master Complaints Naming Company</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Master Complaints Naming Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofMasterComplaintsNamingCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:to="lab_prgo_LossContingencyNumberofMasterComplaintsNamingCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_3a650c28-0daf-4b4c-b128-4e01f38f600a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, fair value method</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_d100e586-a0d3-4239-b7a4-bb0c1059d44a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_7ee275e7-a517-446d-8ff9-ca0f9e8c8134_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1c35380c-68b4-47d4-bca6-c1e8af148306_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_938269bc-c136-4335-b32f-3671256f9eba_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current indebtedness</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment_1bbac6d9-48b1-4f30-b517-caa9c1badf76_terseLabel_en-US" xlink:label="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:href="prgo-20230401.xsd#prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:to="lab_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ba498ce-dc0a-4045-83f7-1ee4b55d5831_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash from (for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_263801fc-e45e-4282-ae32-e189d706f65b_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment receivable, period two</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period Two</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_b1451954-4d7f-49b5-ac23-e442f5167f3d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ddbdc266-ad11-463b-a7a6-38571ca7e1a8_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_caa6e639-d2a7-4379-864d-fdfe7f98a4fb_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_5fc59af4-d22b-4f8b-b19a-bc0b52504606_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related taxes</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_c80d4728-a4f5-44d7-9a18-a11008462aa6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_84e64f79-7161-4411-83a7-b82aac19444a_terseLabel_en-US" xlink:label="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2027</link:label>
    <link:label id="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_label_en-US" xlink:label="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_documentation_en-US" xlink:label="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour" xlink:href="prgo-20230401.xsd#prgo_FinanceLeaseLiabilitytobePaidafterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour" xlink:to="lab_prgo_FinanceLeaseLiabilitytobePaidafterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_fec6d979-88fd-4f6d-b56e-20e618f2c56d_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_f7090b3a-e187-473b-82cb-85fcf8f46217_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_2cd8361e-aec1-41fe-ad69-261c4547d281_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_8506468a-a307-4749-9012-a985c35ece45_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4daa22bd-c6be-4064-923a-bbc5a7d8707e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_9f73dd32-a22f-4cf4-a254-66425ad4c30f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_e339bf4d-ebca-43e6-a850-8272b28c5d14_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_50658c42-9f2e-4c11-b09d-1c041c073f13_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share and Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_21cb56b0-3426-4d25-a090-5895038948ba_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearThree_deca48d0-e3e7-4ddb-962f-1bbae6ce5488_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_265a501d-0dab-45b8-be1f-f4a8cbcbae71_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain/(Loss) Recorded in OCI, Net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5628f2b0-804e-480f-b4c8-96f309bfbf2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberOfAppealsOfMasterComplaints_a8601b58-4be3-47ca-b4c2-9a202d8ee85e_terseLabel_en-US" xlink:label="lab_prgo_NumberOfAppealsOfMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of appeals of master complaints</link:label>
    <link:label id="lab_prgo_NumberOfAppealsOfMasterComplaints_label_en-US" xlink:label="lab_prgo_NumberOfAppealsOfMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Appeals of Master Complaints</link:label>
    <link:label id="lab_prgo_NumberOfAppealsOfMasterComplaints_documentation_en-US" xlink:label="lab_prgo_NumberOfAppealsOfMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Appeals of Master Complaints</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfMasterComplaints" xlink:href="prgo-20230401.xsd#prgo_NumberOfAppealsOfMasterComplaints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberOfAppealsOfMasterComplaints" xlink:to="lab_prgo_NumberOfAppealsOfMasterComplaints" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_bc753b9c-272c-4713-b5e5-00f8a11d9453_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DenominatorAbstract_adbfc2ba-b9be-415b-8a2c-a1a6c118898b_terseLabel_en-US" xlink:label="lab_prgo_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_prgo_DenominatorAbstract_label_en-US" xlink:label="lab_prgo_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:label id="lab_prgo_DenominatorAbstract_documentation_en-US" xlink:label="lab_prgo_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DenominatorAbstract" xlink:href="prgo-20230401.xsd#prgo_DenominatorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DenominatorAbstract" xlink:to="lab_prgo_DenominatorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_69a5ad92-aff2-4d7e-b5fd-e34ce0634d1f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classification of Gain (Loss) Recognized in Earnings on Fair Value and Cash Flow Hedging Relationships</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_01a2beac-fc2f-462a-ad00-452970b9f5a7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_b6c26cf0-7b26-4373-9118-369e80017beb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_6515ff26-13ec-45da-95b4-37e2a7bf92b9_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_e3fb5f17-1727-4a2d-a69b-1a69ce86a8b4_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_81b078c3-a82d-4bfa-a98d-eb28700227e5_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_b56da310-f333-4e4d-aece-10e12974ff07_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_6d154512-d335-48a7-b758-a7d1a2baf9f3_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of assets</link:label>
    <link:label id="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_label_en-US" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Changes in Fair Value, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_79e08256-8db3-419e-9d50-ead357a350f6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_61b82762-3daf-4937-b550-affe0d999c83_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_cf02db0b-f48c-47c6-86c9-02ed0d4bc52d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_87930964-0db3-4030-b07b-1ea4906e0e68_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships and distribution networks</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_6b0353ab-f7a2-445a-87b7-17404a27285a_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply agreement, extension period</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Supply Agreement, Extension Term</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Supply Agreement, Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7cc5e9de-e52d-4976-8201-67b56b1d7add_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_c2502da6-2661-4662-8d5c-5a20b4cb3275_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Derivative Financial Instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_80abe2ed-4f9a-433c-bcb6-70058278520a_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberOfAdditionalStatesAndTerritories_5db4d0cc-3d54-4a94-9d41-136f63092c5a_terseLabel_en-US" xlink:label="lab_prgo_NumberOfAdditionalStatesAndTerritories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional states and territories</link:label>
    <link:label id="lab_prgo_NumberOfAdditionalStatesAndTerritories_label_en-US" xlink:label="lab_prgo_NumberOfAdditionalStatesAndTerritories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Additional States and Territories</link:label>
    <link:label id="lab_prgo_NumberOfAdditionalStatesAndTerritories_documentation_en-US" xlink:label="lab_prgo_NumberOfAdditionalStatesAndTerritories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Additional States and Territories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAdditionalStatesAndTerritories" xlink:href="prgo-20230401.xsd#prgo_NumberOfAdditionalStatesAndTerritories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberOfAdditionalStatesAndTerritories" xlink:to="lab_prgo_NumberOfAdditionalStatesAndTerritories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_276ff186-91b2-4f23-b544-0b2fdd306eeb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_740a0399-f0f6-4d1c-a57b-1f0d0b8dce7e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_06ce4140-19d8-4848-a5d1-2dc0aa4cc2ba_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_MXN_e46b7293-990a-406f-b811-5a15417f430d_terseLabel_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexican Peso (MXN)</link:label>
    <link:label id="lab_currency_MXN_label_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico, Pesos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_MXN" xlink:to="lab_currency_MXN" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_6c5684eb-8b07-47a6-b9af-0954510bdcae_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b272feb6-e50b-42e4-aae5-2c7a115ba6ff_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a5807c52-0b09-41d5-a2e5-81eaf13afd42_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_c76b2d2f-6308-49ef-bd95-fdcb02d31b8a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value (in EUR per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_96685d40-e1ac-4abe-851c-e3193df60ea2_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_fcc8b50d-9508-4ac6-99fa-27382c3b8eff_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings, Interest rate swap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_9a676434-3865-4508-848a-db2d4e31e041_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c0664b2d-8e4e-4ddf-b40d-e6a5be5f2a4d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da9c014e-f6fb-445b-8ba8-39d08a6c54b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_36dbc005-0297-44a1-b680-3fa909fdd6ed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_44f71ff3-4fb7-4f4e-a737-a09d59e83202_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_92e1aec8-8fcf-449a-b776-4bd62ab20ade_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_765b5f57-69e9-4b4e-8733-f0969f43b7e9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_842469e4-5787-4d20-a85d-150327642784_terseLabel_en-US" xlink:label="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.300% Unsecured Senior Notes due November 15, 2043</link:label>
    <link:label id="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_label_en-US" xlink:label="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.300% Unsecured Senior Notes due November 15, 2043 [Member]</link:label>
    <link:label id="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_documentation_en-US" xlink:label="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.30% Unsecured Senior Notes due November 15, 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:href="prgo-20230401.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:to="lab_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_73ba4c86-b020-4e7a-a180-3256225e4d95_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_198fef44-25db-4df8-b5ee-50fe6f98f4cb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_ea10e149-0658-4953-9ee5-b21b7e08e669_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9b026c9e-434d-4d11-a09e-18113c9645c7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RXPharmaceuticalsMember_ed9bd52d-ee6e-4c00-ac90-dabe9796e538_terseLabel_en-US" xlink:label="lab_prgo_RXPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Pharmaceuticals</link:label>
    <link:label id="lab_prgo_RXPharmaceuticalsMember_label_en-US" xlink:label="lab_prgo_RXPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Pharmaceuticals [Member]</link:label>
    <link:label id="lab_prgo_RXPharmaceuticalsMember_documentation_en-US" xlink:label="lab_prgo_RXPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Pharmaceuticals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember" xlink:href="prgo-20230401.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RXPharmaceuticalsMember" xlink:to="lab_prgo_RXPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_June12022ThroughApril12027Member_d5cbe768-ff92-4816-90d5-3685a88642f1_terseLabel_en-US" xlink:label="lab_prgo_June12022ThroughApril12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2027</link:label>
    <link:label id="lab_prgo_June12022ThroughApril12027Member_label_en-US" xlink:label="lab_prgo_June12022ThroughApril12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2027 [Member]</link:label>
    <link:label id="lab_prgo_June12022ThroughApril12027Member_documentation_en-US" xlink:label="lab_prgo_June12022ThroughApril12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member" xlink:href="prgo-20230401.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_June12022ThroughApril12027Member" xlink:to="lab_prgo_June12022ThroughApril12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_29d9f2d3-c467-47a7-a87b-38f07dd451c2_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate cap on buyer's obligation for certain pre-closing liabilities (percent)</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_ef9c3c0c-b161-42b5-98b8-ca4b2269b2ce_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_13bd725a-3b87-4a1a-b95b-eec9fa0236e9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_6265f079-2510-4836-bd6a-d5f0f57e9be9_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_6ca1e9fe-04c8-4a8c-b7a2-e92d5472582d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative financial instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_eb371cc4-a2e2-4c3a-886b-0f74a1462720_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings , Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_6477fdc9-7813-406b-9778-f086db3c5220_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain or (loss) reclassified from AOCI into earnings</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_54148ad5-3bd6-4729-bfbc-0cac0a222d05_terseLabel_en-US" xlink:label="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of policy periods</link:label>
    <link:label id="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_label_en-US" xlink:label="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency Loss, Coverage Available to Satisfy Judgements, Number of Policy Periods</link:label>
    <link:label id="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_documentation_en-US" xlink:label="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency Loss, Coverage Available to Satisfy Judgements, Number of Policy Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:href="prgo-20230401.xsd#prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:to="lab_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_ea7db3a9-bb4d-48bb-915b-428b5c54e494_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_894c5cd4-dba4-4766-9854-8624b8336df4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing fees</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SEK_443015cb-e71c-409c-b952-40e9f5b07b50_terseLabel_en-US" xlink:label="lab_currency_SEK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swedish Krona (SEK)</link:label>
    <link:label id="lab_currency_SEK_label_en-US" xlink:label="lab_currency_SEK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sweden, Kronor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SEK" xlink:to="lab_currency_SEK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_43182301-d442-41ed-977d-179775b19d89_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8c64f4e4-4d88-433d-945d-d7ecf7d696ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_7b3fd7c0-7b15-417f-a819-2385869e0ec7_terseLabel_en-US" xlink:label="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum leverage ratio, subject to consummation of qualifying acquisitions</link:label>
    <link:label id="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_label_en-US" xlink:label="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Leverage Ratio, Subject to Consummation of Qualifying Acquisitions</link:label>
    <link:label id="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_documentation_en-US" xlink:label="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Leverage Ratio, Subject to Consummation of Qualifying Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:href="prgo-20230401.xsd#prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:to="lab_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_41a7f494-8235-4be9-8b20-d05e2e64595c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_d69d994d-bb36-4b98-973f-774aeb0c3c8c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_70316403-5a7d-4e32-9882-be4b05c88384_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_d12d5ddd-4088-4dac-91ea-aaf73536db99_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_95b7acbf-01aa-4577-86fa-30ccaf4025d9_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_October252022ThroughDecember152024Member_bbc3a407-bd9e-4ff2-96d0-110e3079f967_terseLabel_en-US" xlink:label="lab_prgo_October252022ThroughDecember152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 Through December 15, 2024</link:label>
    <link:label id="lab_prgo_October252022ThroughDecember152024Member_label_en-US" xlink:label="lab_prgo_October252022ThroughDecember152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 Through December 15, 2024 [Member]</link:label>
    <link:label id="lab_prgo_October252022ThroughDecember152024Member_documentation_en-US" xlink:label="lab_prgo_October252022ThroughDecember152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 Through December 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughDecember152024Member" xlink:href="prgo-20230401.xsd#prgo_October252022ThroughDecember152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_October252022ThroughDecember152024Member" xlink:to="lab_prgo_October252022ThroughDecember152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_7bdbb96b-dc11-4302-9df4-acd70de5832c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_0c4cc528-305d-4f6c-959b-9f0338475bec_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumeratorAbstract_ef7d4fdc-faa4-44de-ae31-880f20a32d8d_terseLabel_en-US" xlink:label="lab_prgo_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_prgo_NumeratorAbstract_label_en-US" xlink:label="lab_prgo_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:label id="lab_prgo_NumeratorAbstract_documentation_en-US" xlink:label="lab_prgo_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator: [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumeratorAbstract" xlink:href="prgo-20230401.xsd#prgo_NumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumeratorAbstract" xlink:to="lab_prgo_NumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_80f37c7e-ab67-4a18-8b39-008e2edef41b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_dc462394-b017-4da9-8718-e1be977d62ec_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total borrowings outstanding</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_3f174e88-1080-461e-b355-11df80f31903_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_UpperRespiratoryMember_9d480146-03d4-4169-acc8-b9ae9201159e_terseLabel_en-US" xlink:label="lab_prgo_UpperRespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upper Respiratory</link:label>
    <link:label id="lab_prgo_UpperRespiratoryMember_label_en-US" xlink:label="lab_prgo_UpperRespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upper Respiratory [Member]</link:label>
    <link:label id="lab_prgo_UpperRespiratoryMember_documentation_en-US" xlink:label="lab_prgo_UpperRespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upper Respiratory [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_UpperRespiratoryMember" xlink:href="prgo-20230401.xsd#prgo_UpperRespiratoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_UpperRespiratoryMember" xlink:to="lab_prgo_UpperRespiratoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3656db36-88db-49b1-bf02-e3582a0faa72_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Posey-Retirement and Pension Liability Adjustments, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_79584977-a65c-463a-bbf1-99e84e208d04_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_961beb2a-fede-41c3-86ad-201ed2642156_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_label_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:to="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_1eb4ce19-7652-4814-8afe-7e6a808fd3a7_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_d5e76907-3041-4ccc-8e1b-6fe6bae3218b_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_15351634-0746-48a3-bcf4-586d71bcd085_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_39d13f2d-3a9f-4980-a649-0fc674620cd6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preliminary class damages</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3c1b125d-e42a-4736-891f-0cf30ccbfe0a_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_075b9855-7878-4292-9872-fcf2887ad919_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6ad26816-fe00-4987-b05c-3944021537fc_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_e821a18a-4b91-4373-8841-4be0ada464b8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberofFormerEmployees_b98f85b8-b16e-4449-8573-8803a3df7eaa_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormerEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of former employees</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofFormerEmployees_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormerEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Former Employees</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofFormerEmployees_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofFormerEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Former Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofFormerEmployees" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofFormerEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofFormerEmployees" xlink:to="lab_prgo_LossContingencyNumberofFormerEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_80d64c66-95fa-465e-9f22-4d8c68861faa_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_713e5d21-38f8-4daa-8149-caafa616cd66_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_6f7d6f80-71cc-4621-a3fa-e4e056462d6a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DigestiveHealthMember_6f9e79d8-78dd-4819-b77c-1891cd768bb0_terseLabel_en-US" xlink:label="lab_prgo_DigestiveHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Health</link:label>
    <link:label id="lab_prgo_DigestiveHealthMember_label_en-US" xlink:label="lab_prgo_DigestiveHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Health [Member]</link:label>
    <link:label id="lab_prgo_DigestiveHealthMember_documentation_en-US" xlink:label="lab_prgo_DigestiveHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DigestiveHealthMember" xlink:href="prgo-20230401.xsd#prgo_DigestiveHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DigestiveHealthMember" xlink:to="lab_prgo_DigestiveHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d1ef0900-7f40-4f97-8641-a536a1466151_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8b46c8b2-7782-4d6f-a9c2-e4fb7b0d0fc3_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4052af8b-92f8-44a3-8fac-b52569558fb7_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CanadianClassActionComplaintMember_ddd3bee5-f68a-4415-9bb5-395a7e1fee20_terseLabel_en-US" xlink:label="lab_prgo_CanadianClassActionComplaintMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Class Action Complaint</link:label>
    <link:label id="lab_prgo_CanadianClassActionComplaintMember_label_en-US" xlink:label="lab_prgo_CanadianClassActionComplaintMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Class Action Complaint [Member]</link:label>
    <link:label id="lab_prgo_CanadianClassActionComplaintMember_documentation_en-US" xlink:label="lab_prgo_CanadianClassActionComplaintMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Class Action Complaint [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CanadianClassActionComplaintMember" xlink:href="prgo-20230401.xsd#prgo_CanadianClassActionComplaintMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CanadianClassActionComplaintMember" xlink:to="lab_prgo_CanadianClassActionComplaintMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f7ca9cb8-8f3e-4393-a2da-cef451246609_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash due to:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NewTermLoanBFacilityMember_2cba1746-2fe3-481f-a372-b3aade39ec74_terseLabel_en-US" xlink:label="lab_prgo_NewTermLoanBFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan B Facility</link:label>
    <link:label id="lab_prgo_NewTermLoanBFacilityMember_label_en-US" xlink:label="lab_prgo_NewTermLoanBFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan B Facility [Member]</link:label>
    <link:label id="lab_prgo_NewTermLoanBFacilityMember_documentation_en-US" xlink:label="lab_prgo_NewTermLoanBFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan B Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanBFacilityMember" xlink:href="prgo-20230401.xsd#prgo_NewTermLoanBFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NewTermLoanBFacilityMember" xlink:to="lab_prgo_NewTermLoanBFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RightofUseAsset_dc30162f-f5e3-41b8-9788-6bc7fe2c36df_totalLabel_en-US" xlink:label="lab_prgo_RightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_prgo_RightofUseAsset_label_en-US" xlink:label="lab_prgo_RightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:label id="lab_prgo_RightofUseAsset_documentation_en-US" xlink:label="lab_prgo_RightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RightofUseAsset" xlink:href="prgo-20230401.xsd#prgo_RightofUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RightofUseAsset" xlink:to="lab_prgo_RightofUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c82090b-5fdd-4392-9dba-e431e0052d92_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_HRAPharmaMember_6e3f6edd-5596-46ef-a58e-380da66af25f_terseLabel_en-US" xlink:label="lab_prgo_HRAPharmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Pharma</link:label>
    <link:label id="lab_prgo_HRAPharmaMember_label_en-US" xlink:label="lab_prgo_HRAPharmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Pharma [Member]</link:label>
    <link:label id="lab_prgo_HRAPharmaMember_documentation_en-US" xlink:label="lab_prgo_HRAPharmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Pharma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaMember" xlink:href="prgo-20230401.xsd#prgo_HRAPharmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_HRAPharmaMember" xlink:to="lab_prgo_HRAPharmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_f9997967-fd1a-4f7e-a8b7-e94c1a7f35fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_faea6d09-baa4-483e-bf42-3220a89839a3_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_234d88ce-07c8-42e3-b1c2-5df9c69c5ccb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_696989e5-f1c8-4ca9-9283-01d1696b89e9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_bc4119a6-e29a-413d-9a30-1e71f48dc744_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_a847e9e0-8efc-459e-9d54-fac34f127dd6_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Contingent Consideration</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_364487d0-f794-4be2-b9a8-f9c4e74b3166_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberOfPersonalInjuryLawsuits_e7caa8e6-694d-4f85-9fa7-78bc4b530c38_terseLabel_en-US" xlink:label="lab_prgo_NumberOfPersonalInjuryLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of personal injury lawsuits</link:label>
    <link:label id="lab_prgo_NumberOfPersonalInjuryLawsuits_label_en-US" xlink:label="lab_prgo_NumberOfPersonalInjuryLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Personal Injury Lawsuits</link:label>
    <link:label id="lab_prgo_NumberOfPersonalInjuryLawsuits_documentation_en-US" xlink:label="lab_prgo_NumberOfPersonalInjuryLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Personal Injury Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfPersonalInjuryLawsuits" xlink:href="prgo-20230401.xsd#prgo_NumberOfPersonalInjuryLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberOfPersonalInjuryLawsuits" xlink:to="lab_prgo_NumberOfPersonalInjuryLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ca2b033c-cf07-4f11-9221-8a72d75c5216_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_46f8aef5-05ff-4e57-93b4-1494915a5b5c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_5b717967-4ee3-4c77-b31c-b378eb94f664_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_9d2b3b57-bfc9-4691-a8c8-728a2f8c5cb3_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_774adab2-cf6e-401c-b045-6f6bbd8d35d0_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_f67e3611-058f-4c2d-be2a-0a6e23f15c59_terseLabel_en-US" xlink:label="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty conceded on all omeprazole sales as a percent of refund claims (percent)</link:label>
    <link:label id="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_label_en-US" xlink:label="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concession of Royalty Due on Sales as Percent of Refund Claims, Percent</link:label>
    <link:label id="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_documentation_en-US" xlink:label="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concession of Royalty Due on Sales as Percent of Refund Claims, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:href="prgo-20230401.xsd#prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:to="lab_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_bb7093de-1052-450e-a131-238d42312447_terseLabel_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period [Member]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_label_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period [Axis]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_documentation_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:to="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_def1d30e-b25d-4ec4-9cc6-724fab1e5392_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_c7681593-27f8-455e-9d7d-dc70e8335a27_terseLabel_en-US" xlink:label="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2027</link:label>
    <link:label id="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_label_en-US" xlink:label="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_documentation_en-US" xlink:label="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" xlink:href="prgo-20230401.xsd#prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" xlink:to="lab_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_c1661471-6551-4835-9b0d-30cf5667efa9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LatinAmericaBusinessMember_bf81cb67-785c-4680-9d7e-d465574e3324_terseLabel_en-US" xlink:label="lab_prgo_LatinAmericaBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America Business</link:label>
    <link:label id="lab_prgo_LatinAmericaBusinessMember_label_en-US" xlink:label="lab_prgo_LatinAmericaBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America Business [Member]</link:label>
    <link:label id="lab_prgo_LatinAmericaBusinessMember_documentation_en-US" xlink:label="lab_prgo_LatinAmericaBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessMember" xlink:href="prgo-20230401.xsd#prgo_LatinAmericaBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LatinAmericaBusinessMember" xlink:to="lab_prgo_LatinAmericaBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_271cd0ef-f7a2-4857-9539-d89b1ec7b902_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e199ff79-d208-4a0d-b117-f3ce1751fc05_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_45bbd595-c5c7-4fba-812c-f6a6ceed61cc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_23cf9e7d-40f4-40da-8abe-07abc9f0b22b_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment, cost of sales</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_label_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cost of Sales</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cost of Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:to="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9d084e0f-3b07-45ba-b528-a4d2c1e7effa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in post-retirement and pension liability, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b0ddd811-92d2-47e7-8634-7a2a33ffcf13_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_25f4c55e-7825-4c16-acf0-145a716f83b1_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1fbe6ae9-505b-4d2e-b88e-c0ad1936d03f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7ae098fc-04d2-4171-ac2a-bf2d8a634c16_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_fd8ffa06-9650-4c14-b61c-21c05f88a660_terseLabel_en-US" xlink:label="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalty rights</link:label>
    <link:label id="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_label_en-US" xlink:label="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received, Investing Activities</link:label>
    <link:label id="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_documentation_en-US" xlink:label="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:href="prgo-20230401.xsd#prgo_ProceedsfromRoyaltiesReceivedInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:to="lab_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_7f3dc3a7-78bd-4045-b210-fd647550aeca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash adjustments, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_72f0ff13-6522-4183-8495-16916f3ef7b4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $7.1 and $6.8, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_fef000a8-12ac-41ad-a748-b30c292b5eca_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A4400SeniorNotesDueJune152030Member_5fbb92a8-9455-4d48-beb4-4d3759e8dc7b_terseLabel_en-US" xlink:label="lab_prgo_A4400SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.400% Senior Notes due June 15, 2030</link:label>
    <link:label id="lab_prgo_A4400SeniorNotesDueJune152030Member_label_en-US" xlink:label="lab_prgo_A4400SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.400% Senior Notes due June 15, 2030 [Member]</link:label>
    <link:label id="lab_prgo_A4400SeniorNotesDueJune152030Member_documentation_en-US" xlink:label="lab_prgo_A4400SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.4% Senior Notes due June 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member" xlink:href="prgo-20230401.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4400SeniorNotesDueJune152030Member" xlink:to="lab_prgo_A4400SeniorNotesDueJune152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_2e059989-4a2c-4552-a43e-60c170ef87f7_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_af76732d-7dcb-4681-a23d-27fd90816e47_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_75cd6aed-4cf5-4b06-89cb-b920fd56ab28_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_4a02cbac-31cc-4058-a47d-73346d2d490d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_84c997d3-40cc-4730-89a6-17e067d06a1d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Impact of Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_04c54a68-7977-4560-b86e-f8600daffa4e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation for restricted stock</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_StateAttorneyGeneralComplaintMember_dbc00dad-40a5-4bf9-86f8-4e1c76ed1139_terseLabel_en-US" xlink:label="lab_prgo_StateAttorneyGeneralComplaintMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Attorney General Complaint</link:label>
    <link:label id="lab_prgo_StateAttorneyGeneralComplaintMember_label_en-US" xlink:label="lab_prgo_StateAttorneyGeneralComplaintMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Attorney General Complaint [Member]</link:label>
    <link:label id="lab_prgo_StateAttorneyGeneralComplaintMember_documentation_en-US" xlink:label="lab_prgo_StateAttorneyGeneralComplaintMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Attorney General Complaint [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_StateAttorneyGeneralComplaintMember" xlink:href="prgo-20230401.xsd#prgo_StateAttorneyGeneralComplaintMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_StateAttorneyGeneralComplaintMember" xlink:to="lab_prgo_StateAttorneyGeneralComplaintMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_8ddde07a-c9b7-4d52-a371-d641c07bed7f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PublicBondsandPrivatePlacementMember_bc0ccc0d-5152-4a82-badb-1b74355cfc78_verboseLabel_en-US" xlink:label="lab_prgo_PublicBondsandPrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Bonds</link:label>
    <link:label id="lab_prgo_PublicBondsandPrivatePlacementMember_label_en-US" xlink:label="lab_prgo_PublicBondsandPrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Bonds and Private Placement [Member]</link:label>
    <link:label id="lab_prgo_PublicBondsandPrivatePlacementMember_documentation_en-US" xlink:label="lab_prgo_PublicBondsandPrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Bonds and Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PublicBondsandPrivatePlacementMember" xlink:href="prgo-20230401.xsd#prgo_PublicBondsandPrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PublicBondsandPrivatePlacementMember" xlink:to="lab_prgo_PublicBondsandPrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1812e51a-c570-48c1-b202-9c515996c976_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From (For) Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_43ce89f0-2be5-49eb-be77-4f21c852088b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_151e9046-0353-433e-9ca6-e12acd32cfe1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_177fa270-2ef3-4810-a089-e862a20857d5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_9603fcf9-f1b7-4253-8d65-ce97d8fe8246_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_896bf2ac-920b-47e8-bbc1-3e190480c90f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_69f527c7-6df8-4716-9dfe-37afc3b89ec5_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CAD_222683f9-c36a-4c1e-a6e5-bf5f29e890b7_terseLabel_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Dollar (CAD)</link:label>
    <link:label id="lab_currency_CAD_label_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD" xlink:to="lab_currency_CAD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_4a0f4b4c-f18d-46c0-8aa4-6443b9fb5c0f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_8fb4d931-1383-41b1-a83d-d653fe90363d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2803ab2a-8597-4b0b-bf13-ff61d2cc192d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ce62847d-7cdc-461f-a908-a0f9d749a17a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total AOCI</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_a27d0520-6fcb-453d-be4b-bcac8b790fd8_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_fa16fa48-35de-4abc-8d6e-f70f9b45c0ba_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_fc11dcd1-5a90-474c-b60d-afbff8b628a2_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_b7e59390-e974-4590-be5f-0346d6461ae3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_363bf956-281c-4cd3-9c3d-6a77cd16d17b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_c33cc179-955e-4c79-a22a-994cb3311081_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination, debts subject to limit of deductibility of interest expense</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:to="lab_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_b1d25820-b7b4-4c6f-9fb2-725b233e3292_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_label_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_documentation_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:to="lab_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDue_f9005e14-9370-454d-9d09-9267028693b1_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDue" xlink:to="lab_prgo_LeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1e3e4a9a-b4d7-40f8-9fe6-efde1271c507_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_33dddc6d-aec0-4a17-be20-f19651e9131e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_40d4cd06-66b1-4cb3-9889-9f450ebec18d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_b104369c-8e23-486a-8919-29107dbae1a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized premium (discount), net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_0f370e28-14ea-44e0-9434-3e1a64b02ce5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_WomensHealthMember_bfb7f700-3ef3-45a3-88ac-5429423110f7_terseLabel_en-US" xlink:label="lab_prgo_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health</link:label>
    <link:label id="lab_prgo_WomensHealthMember_label_en-US" xlink:label="lab_prgo_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:label id="lab_prgo_WomensHealthMember_documentation_en-US" xlink:label="lab_prgo_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_WomensHealthMember" xlink:href="prgo-20230401.xsd#prgo_WomensHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_WomensHealthMember" xlink:to="lab_prgo_WomensHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_dc796009-5af9-4090-b1f2-9f3b94175fb7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_28a2830b-d4f8-4b0b-b533-ac7c78d16ebf_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ContractManufacturingMember_5d6011ee-8fb7-4b33-96f3-417c60eb5c97_terseLabel_en-US" xlink:label="lab_prgo_ContractManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract manufacturing</link:label>
    <link:label id="lab_prgo_ContractManufacturingMember_label_en-US" xlink:label="lab_prgo_ContractManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufacturing [Member]</link:label>
    <link:label id="lab_prgo_ContractManufacturingMember_documentation_en-US" xlink:label="lab_prgo_ContractManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufacturing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContractManufacturingMember" xlink:href="prgo-20230401.xsd#prgo_ContractManufacturingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ContractManufacturingMember" xlink:to="lab_prgo_ContractManufacturingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_978f505e-c9c0-40f9-a2f8-8efffe7887d2_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_26c2ae44-aa9e-4e0a-b6cb-44c4a7024d65_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_d271c156-1049-4a03-97d2-76a731faf61b_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5c9db916-3149-4119-9fd4-8a83d4e9fa15_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosures of Balance Sheet Information</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_fde03259-6cb9-498c-84bb-fb23ce0beea3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_c8e8fd5b-6973-4d08-b011-7cea7ab39cd9_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of ordinary shares (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4651603a-360a-40cc-8765-7ef732a332b4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1c4ffa17-27bc-4628-85bb-90efbacb907a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_0f6e8159-da7a-461d-b91c-d37f2177d0c0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_dc04cb52-9f57-40e8-bf66-9dd3c4753974_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_7a783f79-9d64-439f-a906-e6f993ab1f11_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ebd561a6-a145-4afc-a8a1-6789a2b076db_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f77f56f8-e783-4716-9b01-9177abdd4b77_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_51fdd643-ae59-468a-999f-20fe49157394_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_HUF_9ff1790e-a956-4022-8e44-c03452689e3d_terseLabel_en-US" xlink:label="lab_currency_HUF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hungarian Forint (HUF)</link:label>
    <link:label id="lab_currency_HUF_label_en-US" xlink:label="lab_currency_HUF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hungary, Forint</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_HUF" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_HUF"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_HUF" xlink:to="lab_currency_HUF" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d49a06e6-cfb4-49c5-a906-226b58ab4894_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_68069d29-805d-4f12-a85b-73199ef89429_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate cap on buyer's obligation for certain pre-closing liabilities</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Indemnification Asset</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Indemnification Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_0db118d9-ac6b-441d-a197-331931a1d4c3_verboseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and license agreements and supply agreements</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_207fbbe2-f4f7-4ec1-974f-a9403015fc93_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_4353d813-ad17-46fa-b3e3-80d270c44475_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_975b7973-680c-4266-88e6-e07a1e3f2f44_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_9e6a0c8d-6f5b-4d89-8a0c-8f65823f3b20_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_SupplyChainReinventionMember_5ef112e9-bc6b-4edd-a8cf-848e86db52e0_terseLabel_en-US" xlink:label="lab_prgo_SupplyChainReinventionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain Reinvention</link:label>
    <link:label id="lab_prgo_SupplyChainReinventionMember_label_en-US" xlink:label="lab_prgo_SupplyChainReinventionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain Reinvention [Member]</link:label>
    <link:label id="lab_prgo_SupplyChainReinventionMember_documentation_en-US" xlink:label="lab_prgo_SupplyChainReinventionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain Reinvention</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SupplyChainReinventionMember" xlink:href="prgo-20230401.xsd#prgo_SupplyChainReinventionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_SupplyChainReinventionMember" xlink:to="lab_prgo_SupplyChainReinventionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_5787d6f6-6a7d-4b2c-8cbe-b9258a73691d_terseLabel_en-US" xlink:label="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al.</link:label>
    <link:label id="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_label_en-US" xlink:label="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]</link:label>
    <link:label id="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_documentation_en-US" xlink:label="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:href="prgo-20230401.xsd#prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:to="lab_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21303881-22c4-4917-97d9-00dd36b4e77c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_64258bbd-dfa5-42d1-935b-32e18e2469ff_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding for diluted EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_e425a27f-b1b1-47a3-8e1d-a4d237800ebd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_691d3f5d-d097-4f75-84e3-ba1a9b75d932_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Components of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_3616c2a9-d3cc-464b-af36-4620ba1e05fd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_42f98bdd-769f-4855-b9b2-d41b829babea_terseLabel_en-US" xlink:label="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location of Lease Assets and Liabilities</link:label>
    <link:label id="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:href="prgo-20230401.xsd#prgo_AssetsandLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:to="lab_prgo_AssetsandLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A2022RevolverMember_0278034d-1c94-4d47-b8ea-75a66d8e7386_terseLabel_en-US" xlink:label="lab_prgo_A2022RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Revolver</link:label>
    <link:label id="lab_prgo_A2022RevolverMember_label_en-US" xlink:label="lab_prgo_A2022RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Revolver [Member]</link:label>
    <link:label id="lab_prgo_A2022RevolverMember_documentation_en-US" xlink:label="lab_prgo_A2022RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2022RevolverMember" xlink:href="prgo-20230401.xsd#prgo_A2022RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A2022RevolverMember" xlink:to="lab_prgo_A2022RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount_9b144054-9946-4ebe-a338-3a1e2489175c_terseLabel_en-US" xlink:label="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum individual amount</link:label>
    <link:label id="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount_label_en-US" xlink:label="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Maximum Individual Amount</link:label>
    <link:label id="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount_documentation_en-US" xlink:label="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Maximum Individual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:href="prgo-20230401.xsd#prgo_DerivativeNotionalAmountMaximumIndividualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:to="lab_prgo_DerivativeNotionalAmountMaximumIndividualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_adb71423-c66a-483f-9741-4a952f3e5f0c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_VitaminsMineralsandSupplementsMember_c5f30196-9c8d-4cb7-bce8-66f8e847ea49_terseLabel_en-US" xlink:label="lab_prgo_VitaminsMineralsandSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals, and Supplements ("VMS")</link:label>
    <link:label id="lab_prgo_VitaminsMineralsandSupplementsMember_label_en-US" xlink:label="lab_prgo_VitaminsMineralsandSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements [Member]</link:label>
    <link:label id="lab_prgo_VitaminsMineralsandSupplementsMember_documentation_en-US" xlink:label="lab_prgo_VitaminsMineralsandSupplementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vitamins, Minerals and Supplements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_VitaminsMineralsandSupplementsMember" xlink:href="prgo-20230401.xsd#prgo_VitaminsMineralsandSupplementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_VitaminsMineralsandSupplementsMember" xlink:to="lab_prgo_VitaminsMineralsandSupplementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_11f1c157-d0ca-46a0-ad31-2e4ca4a1a86b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, &#8364;0.001 par value per share, 10,000 shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_June12022ThroughApril12029Member_47aa0d11-27cc-48f0-bfd5-cec0423046b2_terseLabel_en-US" xlink:label="lab_prgo_June12022ThroughApril12029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2029</link:label>
    <link:label id="lab_prgo_June12022ThroughApril12029Member_label_en-US" xlink:label="lab_prgo_June12022ThroughApril12029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2029 [Member]</link:label>
    <link:label id="lab_prgo_June12022ThroughApril12029Member_documentation_en-US" xlink:label="lab_prgo_June12022ThroughApril12029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 1, 2022 Through April 1, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member" xlink:href="prgo-20230401.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_June12022ThroughApril12029Member" xlink:to="lab_prgo_June12022ThroughApril12029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_065aa57f-0304-4269-9944-9b0e3e2ebf04_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_FinanceLeaseCost_e886dbdc-1fc5-4033-b1d7-c5d3d7bdf21b_totalLabel_en-US" xlink:label="lab_prgo_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance leases</link:label>
    <link:label id="lab_prgo_FinanceLeaseCost_label_en-US" xlink:label="lab_prgo_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_prgo_FinanceLeaseCost_documentation_en-US" xlink:label="lab_prgo_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FinanceLeaseCost" xlink:href="prgo-20230401.xsd#prgo_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_FinanceLeaseCost" xlink:to="lab_prgo_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a096ba0f-2dcd-48c8-aaab-47ebec778b9c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_57b38f5c-30ec-4688-a1b5-4d187045add9_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</link:label>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_label_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Foreign Currency Cash Flow Hedge Effectiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:to="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_d504d6f5-8bc1-42d1-ad91-041741d797a7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_94f117c7-3a73-463a-ab8c-387b9e09cc42_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_e5924266-6c66-4db4-80dd-e44953fb30d6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberofTendersAccepted_58a224d9-76ec-4bc4-b17b-70a935a31fc0_terseLabel_en-US" xlink:label="lab_prgo_NumberofTendersAccepted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of tenders accepted</link:label>
    <link:label id="lab_prgo_NumberofTendersAccepted_label_en-US" xlink:label="lab_prgo_NumberofTendersAccepted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Tenders Accepted</link:label>
    <link:label id="lab_prgo_NumberofTendersAccepted_documentation_en-US" xlink:label="lab_prgo_NumberofTendersAccepted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Tenders Accepted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofTendersAccepted" xlink:href="prgo-20230401.xsd#prgo_NumberofTendersAccepted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofTendersAccepted" xlink:to="lab_prgo_NumberofTendersAccepted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_c18b08f7-3182-4b52-b3b3-76c6c6124ad5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cac341f7-0d9d-4adf-893a-2d1b82db87cf_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents of continuing operations, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e53d060-c3cf-485e-86b9-df4c04463e79_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents of continuing operations, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_e432af9b-b0c3-4616-9174-a868d583366d_terseLabel_en-US" xlink:label="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued customer programs</link:label>
    <link:label id="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_label_en-US" xlink:label="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accrued Customer Programs</link:label>
    <link:label id="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms_documentation_en-US" xlink:label="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:href="prgo-20230401.xsd#prgo_IncreaseDecreaseInAccruedCustomerPrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:to="lab_prgo_IncreaseDecreaseInAccruedCustomerPrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_cc477ab2-91f6-4732-ae43-3dba0bec5a29_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f47f5ecc-4d4d-4bb2-9646-ceccc6aee319_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_2339b5ec-205e-43c0-a2df-bca23b1706fa_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_f31eba3f-a976-4f0f-bc75-71af72ff8133_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Security Expense (Income)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_fed5390f-9cf6-4e6d-a712-8753402ec115_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, issued and outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_46bddfde-21cd-4bb8-9495-2ba2a981b2c8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, equity method, other non-current assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_69763424-2005-4740-9fc5-d72e6b32b049_terseLabel_en-US" xlink:label="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nestl&#233;&#8217;s Gateway Infant Formula Plant and Good Start&#174; infant formula</link:label>
    <link:label id="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_label_en-US" xlink:label="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nestl&#233;&#8217;s Gateway Infant Formula Plant and Good Start&#174; infant formula [Member]</link:label>
    <link:label id="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_documentation_en-US" xlink:label="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nestl&#233;&#8217;s Gateway Infant Formula Plant and Good Start&#174; infant formula</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:href="prgo-20230401.xsd#prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:to="lab_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_4fe7bff8-0999-4125-b4e9-515413daeeb0_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite and Indefinite-lived Intangible Assets</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="prgo-20230401.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_1f60b6f7-165b-44c6-bafe-10defb849150_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_7447cbd8-c2e3-4dc2-bae3-d0ddb47900cf_totalLabel_en-US" xlink:label="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount</link:label>
    <link:label id="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_label_en-US" xlink:label="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:label id="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_documentation_en-US" xlink:label="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:href="prgo-20230401.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:to="lab_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_dd2d4399-8767-43c8-836b-b37297462501_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_b86debcc-5642-45e2-a68b-5fb7eb41e893_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A3150SeniorNotesDueJune152030Member_ec607348-32ec-4466-88b3-dfdf67449195_terseLabel_en-US" xlink:label="lab_prgo_A3150SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.150% Senior Notes due June 15, 2030</link:label>
    <link:label id="lab_prgo_A3150SeniorNotesDueJune152030Member_label_en-US" xlink:label="lab_prgo_A3150SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.150% Senior Notes due June 15, 2030 [Member]</link:label>
    <link:label id="lab_prgo_A3150SeniorNotesDueJune152030Member_documentation_en-US" xlink:label="lab_prgo_A3150SeniorNotesDueJune152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.150% Senior Notes due June 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3150SeniorNotesDueJune152030Member" xlink:href="prgo-20230401.xsd#prgo_A3150SeniorNotesDueJune152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3150SeniorNotesDueJune152030Member" xlink:to="lab_prgo_A3150SeniorNotesDueJune152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_389a8d04-fb13-4078-b6d0-b8ef399a60c8_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_bb86bebf-1406-4725-8dbd-e7695da16f8d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liability, current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_338dca5e-58fc-45de-a1ca-d05372f5a5dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2e1aa23d-1532-4b6b-b721-d001cf44f3e2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f0417d99-6b8a-4a6e-8421-d7c6492bf29e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash from (for) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_64eb467c-ee53-4ea2-9c22-0de19d9e7f8f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_5dac3aba-0176-442a-9398-54edad14580e_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014 and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_label_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014 and 2015</link:label>
    <link:label id="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_documentation_en-US" xlink:label="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014 and 2015</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:to="lab_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_d9fcb9f6-c8b1-4754-9f37-90a6b2a9ef85_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS)</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_1ba772af-93e5-4358-817b-94e2fa0ca621_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other</link:label>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_label_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateAndOtherMember" xlink:to="lab_us-gaap_CorporateAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e4d53c32-b5e7-4af9-8eb9-1355da657b1d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_0953f13a-f58a-4643-9e15-d8e53cee4bcd_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_a410a76a-d9d5-4994-9a20-2dfdf1904a7e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_fc70a2cd-ab2d-465e-a198-072e714a72da_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6bdbd740-6f71-4404-b4a8-890d7482c3f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_137bc08b-07e5-4324-b17c-4f2aa725436a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2415c238-bc5d-461d-aece-24725b1ea78f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_75ee873e-2ae4-4637-8093-3f96d3000d31_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a43d465c-322f-43ad-8a6e-79c98892f263_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_2d2dc8c3-014d-4783-9aac-1806bbf06b29_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_2d2d3bd9-9c93-4e6c-b117-e31c9fb1530e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_e01f6ca7-9754-4059-9961-8af3596fb6a1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings (repayments) of revolving credit agreements and other financing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_4b0419a3-5bc2-4dba-82a0-06b1858d8189_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_78830363-0d46-485f-942f-6d821462b97f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CNY_56940c2e-bf31-4f3a-9b12-5b6343b50506_terseLabel_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chinese Yuan (CNH)</link:label>
    <link:label id="lab_currency_CNY_label_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CNY" xlink:to="lab_currency_CNY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_d9fad531-c886-4bc3-a00f-be1293ec5710_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BlendedInterestRateInRevenueAgentReport_e7085891-2a33-4726-924b-bd4f029f0fe0_terseLabel_en-US" xlink:label="lab_prgo_BlendedInterestRateInRevenueAgentReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended interest rate in revenue agent report</link:label>
    <link:label id="lab_prgo_BlendedInterestRateInRevenueAgentReport_label_en-US" xlink:label="lab_prgo_BlendedInterestRateInRevenueAgentReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended Interest Rate In Revenue Agent Report</link:label>
    <link:label id="lab_prgo_BlendedInterestRateInRevenueAgentReport_documentation_en-US" xlink:label="lab_prgo_BlendedInterestRateInRevenueAgentReport" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended Interest Rate In Revenue Agent Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateInRevenueAgentReport" xlink:href="prgo-20230401.xsd#prgo_BlendedInterestRateInRevenueAgentReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BlendedInterestRateInRevenueAgentReport" xlink:to="lab_prgo_BlendedInterestRateInRevenueAgentReport" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_CumulativeDeferredChargeTaxLitigation_a66d7a91-af1b-4bf2-a061-c8a252520dbc_terseLabel_en-US" xlink:label="lab_prgo_CumulativeDeferredChargeTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative deferred charge related to tax litigation</link:label>
    <link:label id="lab_prgo_CumulativeDeferredChargeTaxLitigation_label_en-US" xlink:label="lab_prgo_CumulativeDeferredChargeTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Deferred Charge, Tax Litigation</link:label>
    <link:label id="lab_prgo_CumulativeDeferredChargeTaxLitigation_documentation_en-US" xlink:label="lab_prgo_CumulativeDeferredChargeTaxLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Deferred Charge, Tax Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CumulativeDeferredChargeTaxLitigation" xlink:href="prgo-20230401.xsd#prgo_CumulativeDeferredChargeTaxLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_CumulativeDeferredChargeTaxLitigation" xlink:to="lab_prgo_CumulativeDeferredChargeTaxLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_f2ed8e24-46e4-4a93-90a1-2e8eb95a8c7c_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_a3129831-f65c-4e0b-89ab-d15216dd0cc0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination, estimate of additional tax expense, excluding interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:to="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_e91549bc-f347-4cdb-b797-e4faca2491cb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OrdinaryShares0001ParValueMember_67cfa1e3-eeec-4063-9461-18bdce85412e_terseLabel_en-US" xlink:label="lab_prgo_OrdinaryShares0001ParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares, 0.001 Par Value</link:label>
    <link:label id="lab_prgo_OrdinaryShares0001ParValueMember_label_en-US" xlink:label="lab_prgo_OrdinaryShares0001ParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares, 0.001 Par Value [Member]</link:label>
    <link:label id="lab_prgo_OrdinaryShares0001ParValueMember_documentation_en-US" xlink:label="lab_prgo_OrdinaryShares0001ParValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares, 0.001 Par Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OrdinaryShares0001ParValueMember" xlink:href="prgo-20230401.xsd#prgo_OrdinaryShares0001ParValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OrdinaryShares0001ParValueMember" xlink:to="lab_prgo_OrdinaryShares0001ParValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_52c096af-35dc-4a36-b79f-fd4b5c40207f_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationInterestExpense_de39fdc9-e3ff-4652-858f-1d473c66bcfc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationInterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationInterestExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationInterestExpense" xlink:to="lab_us-gaap_IncomeTaxExaminationInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_557f4c5c-055c-4429-adc5-404570e16cd5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of instruments held</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_83e7a7be-4bbf-4b51-be1c-cb42490b89a0_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7a29b508-b990-46d9-aed8-5683c83d36e0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d7791dbe-d218-46f5-9a53-0eb3a2cc0f45_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_69022265-0cf6-4043-94c8-451342c6306e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_961d850f-11ff-4d9a-8466-b91b0ab97786_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherCSCIMember_fc37aaca-3023-42ba-9003-36e797476e77_terseLabel_en-US" xlink:label="lab_prgo_OtherCSCIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSCI</link:label>
    <link:label id="lab_prgo_OtherCSCIMember_label_en-US" xlink:label="lab_prgo_OtherCSCIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSCI [Member]</link:label>
    <link:label id="lab_prgo_OtherCSCIMember_documentation_en-US" xlink:label="lab_prgo_OtherCSCIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other CSCI [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCIMember" xlink:href="prgo-20230401.xsd#prgo_OtherCSCIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherCSCIMember" xlink:to="lab_prgo_OtherCSCIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_5d20c67c-a525-44c7-b23b-ded7d5dd5462_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_0b016b91-e8ca-4eee-bdca-b373a7c1d53f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_739aaae7-e81e-4b8c-b4d1-dcf345d232ec_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_c130e83a-901d-4c16-8a60-8ea6afc75252_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_0f194c03-a61a-4074-8881-7d83e62ccb29_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on cash flow hedging relationships</link:label>
    <link:label id="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Cash Flow Hedges on Results of Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:to="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_a63ccbf6-80dd-474f-836f-bed1b726e4a4_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in earnings on derivatives related to amounts excluded from effectiveness testing, Interest rate swap agreements</link:label>
    <link:label id="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_label_en-US" xlink:label="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:to="lab_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_93b17010-5b2a-4db7-b7f8-2b5fc4263979_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_2d6cdd2d-a0ce-468e-a0d0-cbc12f856cb3_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_42fda6d1-13de-4b30-a5b1-a3b131febf79_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_bd0c5e15-9681-4ac2-a7d2-8665fed02473_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_6a12228a-1cbd-4dc1-a154-fc4f8416c431_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f931d364-c66f-47a3-9572-a8da7e2ea880_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_5875029a-a9ca-4870-aaf1-2b32f05a7cbb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DebtInstrumentInterestRatePercentageCap_eaace8ba-82da-495a-b106-3b14ceea9e7b_terseLabel_en-US" xlink:label="lab_prgo_DebtInstrumentInterestRatePercentageCap" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Percentage Cap</link:label>
    <link:label id="lab_prgo_DebtInstrumentInterestRatePercentageCap_label_en-US" xlink:label="lab_prgo_DebtInstrumentInterestRatePercentageCap" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Percentage Cap</link:label>
    <link:label id="lab_prgo_DebtInstrumentInterestRatePercentageCap_documentation_en-US" xlink:label="lab_prgo_DebtInstrumentInterestRatePercentageCap" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Percentage Cap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtInstrumentInterestRatePercentageCap" xlink:href="prgo-20230401.xsd#prgo_DebtInstrumentInterestRatePercentageCap"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DebtInstrumentInterestRatePercentageCap" xlink:to="lab_prgo_DebtInstrumentInterestRatePercentageCap" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_3ec32da7-7a15-4102-bf00-5331dbc24ff9_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_db4f7d60-974c-4024-9809-e688e4b53854_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a9b0e5c1-fda1-4109-8e72-e9f933cec80c_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_daf90bdc-37d4-400a-9fe2-e8466b7bd5e7_terseLabel_en-US" xlink:label="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured net leverage ratio, maximum</link:label>
    <link:label id="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_label_en-US" xlink:label="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Secured Net Leverage Ratio, Maximum</link:label>
    <link:label id="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_documentation_en-US" xlink:label="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Secured Net Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:href="prgo-20230401.xsd#prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:to="lab_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_d0b2b83a-4b4d-4775-856f-82f1e472b96b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_28651833-bee4-468a-9953-8db31fbdbdfb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_57e10d59-99ae-4b06-b795-f73d8637b5d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain/(Loss) Recognized against Earnings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_dc0b2b2e-a3c6-4951-ae44-92d8382269e7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_a47c5654-e416-4fee-b9e6-a0d31275801c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_f8144767-862f-41ed-88c3-e2dd1b33a299_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring and Nonrecurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_846ab695-4caf-4360-96da-a4567a265a14_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, fair value method, other expense (income)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_2b79dbdd-5214-438d-a8b6-1a55460b59fd_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_3b0f925a-4370-45f5-b8e5-c4d473f80a76_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_6e92e13e-8ece-47b2-8c6e-f7e324a7f5a8_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement payment</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_551231e4-a97e-4afa-9f41-2c241e68bb44_terseLabel_en-US" xlink:label="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended interest rate proposed on debts</link:label>
    <link:label id="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_label_en-US" xlink:label="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended Interest Rate Proposed On Debts For U.S. Tax Purposes</link:label>
    <link:label id="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_documentation_en-US" xlink:label="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blended Interest Rate Proposed On Debts For U.S. Tax Purposes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:href="prgo-20230401.xsd#prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:to="lab_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_46fad945-9ce0-4db2-9d25-c26cb63212d8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_9f819542-3f15-4096-8c18-71c5bc2cd099_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_275e38e0-dfd4-4368-9677-992bfaa3da9d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_e64cc9e4-a6b3-4ce8-9d99-df752fcdf75e_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_fa60ad5f-b299-4ad1-a19f-bf66d2618c2d_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_4374f3a2-e386-4630-9d9b-3f796fcc92a2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_dabcf95f-8846-41ae-b7d2-2c3551c9eac6_verboseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Bonds</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_3b6bc1ae-f44d-4ab3-b1ff-9480a7b84397_netLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_a82db7ac-4e6b-4906-9a08-cdf413bdc233_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_390c12ee-1ef2-4991-a5ea-72673b383a3f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6dca7abf-a6c8-4845-9352-379de00ce95b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_16068b98-08bf-4591-9df7-1cfc8785e92e_terseLabel_en-US" xlink:label="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap on debts for U.S. Federal tax purposes, as percent of Applicable Federal Rate</link:label>
    <link:label id="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_label_en-US" xlink:label="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate</link:label>
    <link:label id="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_documentation_en-US" xlink:label="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:href="prgo-20230401.xsd#prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:to="lab_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScarAwayMember_78a09ffa-b1bc-4c34-ae49-c9aa29a0a35e_terseLabel_en-US" xlink:label="lab_prgo_ScarAwayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScarAway Member</link:label>
    <link:label id="lab_prgo_ScarAwayMember_label_en-US" xlink:label="lab_prgo_ScarAwayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScarAway [Member]</link:label>
    <link:label id="lab_prgo_ScarAwayMember_documentation_en-US" xlink:label="lab_prgo_ScarAwayMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScarAway</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScarAwayMember" xlink:href="prgo-20230401.xsd#prgo_ScarAwayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScarAwayMember" xlink:to="lab_prgo_ScarAwayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_5edf234a-05b6-450d-9478-d20a92a19e2f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount (premium)</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NutritionMember_eae1f849-60f9-4e17-a647-6c2a7f3e05c9_terseLabel_en-US" xlink:label="lab_prgo_NutritionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition</link:label>
    <link:label id="lab_prgo_NutritionMember_label_en-US" xlink:label="lab_prgo_NutritionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition [Member]</link:label>
    <link:label id="lab_prgo_NutritionMember_documentation_en-US" xlink:label="lab_prgo_NutritionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nutrition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NutritionMember" xlink:href="prgo-20230401.xsd#prgo_NutritionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NutritionMember" xlink:to="lab_prgo_NutritionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebt_3f51fb19-9e79-4055-b083-143143325f5d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt" xlink:to="lab_us-gaap_OtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_cb1a3363-1290-47d8-89c9-1fec370e3e8b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract" xlink:to="lab_us-gaap_RestructuringChargesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_7bbc4f70-3b52-4a10-8e61-c71539b7f25e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_01902681-9b66-452f-b9be-c37ebcd838c7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_DKK_6b8ed61a-d536-4182-b7cd-09c4605cd57c_terseLabel_en-US" xlink:label="lab_currency_DKK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Danish Krone (DKK)</link:label>
    <link:label id="lab_currency_DKK_label_en-US" xlink:label="lab_currency_DKK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denmark, Kroner</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_DKK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_DKK" xlink:to="lab_currency_DKK" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NumberofPutativeClasses_fdad399f-9f01-4925-87a0-1f96f1cbfb8e_terseLabel_en-US" xlink:label="lab_prgo_NumberofPutativeClasses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of classes</link:label>
    <link:label id="lab_prgo_NumberofPutativeClasses_label_en-US" xlink:label="lab_prgo_NumberofPutativeClasses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Putative Classes</link:label>
    <link:label id="lab_prgo_NumberofPutativeClasses_documentation_en-US" xlink:label="lab_prgo_NumberofPutativeClasses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Putative Classes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofPutativeClasses" xlink:href="prgo-20230401.xsd#prgo_NumberofPutativeClasses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NumberofPutativeClasses" xlink:to="lab_prgo_NumberofPutativeClasses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_b05611bb-c521-4169-af75-f2ed9e0aeb83_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_October252022ThroughMarch252026Member_4244518d-b9d1-44bf-a7fd-c3d834351b2a_terseLabel_en-US" xlink:label="lab_prgo_October252022ThroughMarch252026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through March 25, 2026</link:label>
    <link:label id="lab_prgo_October252022ThroughMarch252026Member_label_en-US" xlink:label="lab_prgo_October252022ThroughMarch252026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through March 25, 2026 [Member]</link:label>
    <link:label id="lab_prgo_October252022ThroughMarch252026Member_documentation_en-US" xlink:label="lab_prgo_October252022ThroughMarch252026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through March 25, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughMarch252026Member" xlink:href="prgo-20230401.xsd#prgo_October252022ThroughMarch252026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_October252022ThroughMarch252026Member" xlink:to="lab_prgo_October252022ThroughMarch252026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_87e0ca64-c8e1-4751-8f42-a59dd526d47c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_ae260a3c-2c0f-4a61-ae78-1d243e5078ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_95da0756-6c07-4466-a51d-4630182af109_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_116a69a3-592d-45fb-acb9-aed3a598d0ad_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_3c8c95e2-4639-4f11-8015-5c4a5f272230_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_2d1be6fa-398d-4345-b170-1c8a75a2aa4a_terseLabel_en-US" xlink:label="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:label id="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_prgo_LeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_aa67662a-3235-4397-9890-55dd75de8609_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_7c32d846-4e5e-45a9-859f-451b9aeea78e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_a060850a-28c6-4c7e-b3db-b6ffdb8331d3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RestructuringReserveSettledWithoutCashNet_a9bdb943-dd7a-445d-8428-a058a0b8990d_terseLabel_en-US" xlink:label="lab_prgo_RestructuringReserveSettledWithoutCashNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash adjustments</link:label>
    <link:label id="lab_prgo_RestructuringReserveSettledWithoutCashNet_label_en-US" xlink:label="lab_prgo_RestructuringReserveSettledWithoutCashNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled Without Cash, Net</link:label>
    <link:label id="lab_prgo_RestructuringReserveSettledWithoutCashNet_documentation_en-US" xlink:label="lab_prgo_RestructuringReserveSettledWithoutCashNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled Without Cash, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringReserveSettledWithoutCashNet" xlink:href="prgo-20230401.xsd#prgo_RestructuringReserveSettledWithoutCashNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RestructuringReserveSettledWithoutCashNet" xlink:to="lab_prgo_RestructuringReserveSettledWithoutCashNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_797fd87c-184f-47ca-a9a9-ac2f1dd5ddd5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_5d3a1384-df2d-472c-bdb9-70801458e994_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of option contract</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A3900SeniorNoteDue2024Member_fc1e5af9-b53d-44a6-a1df-69972338b02f_terseLabel_en-US" xlink:label="lab_prgo_A3900SeniorNoteDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.900% senior note due 2024</link:label>
    <link:label id="lab_prgo_A3900SeniorNoteDue2024Member_label_en-US" xlink:label="lab_prgo_A3900SeniorNoteDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.900% senior note due 2024 [Member]</link:label>
    <link:label id="lab_prgo_A3900SeniorNoteDue2024Member_documentation_en-US" xlink:label="lab_prgo_A3900SeniorNoteDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.9% senior note due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member" xlink:href="prgo-20230401.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A3900SeniorNoteDue2024Member" xlink:to="lab_prgo_A3900SeniorNoteDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductionAndDistributionCosts_4e1db446-7977-447c-9e59-e8029d147b1c_terseLabel_en-US" xlink:label="lab_us-gaap_ProductionAndDistributionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution</link:label>
    <link:label id="lab_us-gaap_ProductionAndDistributionCosts_label_en-US" xlink:label="lab_us-gaap_ProductionAndDistributionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production and Distribution Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionAndDistributionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionAndDistributionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductionAndDistributionCosts" xlink:to="lab_us-gaap_ProductionAndDistributionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2408587e-5b46-41c4-8853-95ccb3a35e8c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b21203ac-0395-43fe-806f-8c9788daf23a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2d13d6d7-eae4-475a-9fbe-b420d3307b29_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3888239f-5d5f-4fb8-9fd3-1ff17417cdb9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_238eecf3-79ad-4d38-bf1e-ecc6db1a1816_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_9e67d869-d06f-4996-b566-771b4b925c78_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_48f091de-aa08-430b-831c-c7ab253f41eb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_a486fab7-e645-44b9-91ab-9751aebd5d40_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_4e8cbd2e-c1e8-4a6c-aafc-f24677d19373_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleOfDebtInstrumentsTable_dd43dcde-a535-4c1c-a133-c279bd42bbfb_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfDebtInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instruments [Table]</link:label>
    <link:label id="lab_prgo_ScheduleOfDebtInstrumentsTable_label_en-US" xlink:label="lab_prgo_ScheduleOfDebtInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instruments [Table]</link:label>
    <link:label id="lab_prgo_ScheduleOfDebtInstrumentsTable_documentation_en-US" xlink:label="lab_prgo_ScheduleOfDebtInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfDebtInstrumentsTable" xlink:href="prgo-20230401.xsd#prgo_ScheduleOfDebtInstrumentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfDebtInstrumentsTable" xlink:to="lab_prgo_ScheduleOfDebtInstrumentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_8310c11b-cbcb-408a-9061-e35cad74d46b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_ba2518b5-6226-41da-b498-116fcf632ea6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Fair Value Hedge Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:to="lab_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_bcb27f1e-488e-44cc-b7f6-0cd9e7edce76_terseLabel_en-US" xlink:label="lab_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and indefinite-lived intangible assets</link:label>
    <link:label id="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_label_en-US" xlink:label="lab_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill And Indefinite Lived Intangibles</link:label>
    <link:label id="lab_prgo_GoodwillAndIndefiniteLivedIntangibles_documentation_en-US" xlink:label="lab_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:href="prgo-20230401.xsd#prgo_GoodwillAndIndefiniteLivedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:to="lab_prgo_GoodwillAndIndefiniteLivedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_PLN_9517d68c-f11d-4e74-83ba-a106dfebca8a_terseLabel_en-US" xlink:label="lab_currency_PLN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polish Zloty (PLZ)</link:label>
    <link:label id="lab_currency_PLN_label_en-US" xlink:label="lab_currency_PLN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Poland, Zlotych</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_PLN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_PLN" xlink:to="lab_currency_PLN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_035cfd3d-9542-491b-9a32-5e6534cacfdc_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_a1a247d8-3e0d-4d0a-be58-ae26f55739d2_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_aee00a67-db3a-471e-b38f-b64815f0c406_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AccruedCustomerPrograms_e3967e85-b0ac-4403-88f6-83f0ac2c2532_terseLabel_en-US" xlink:label="lab_prgo_AccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued customer programs</link:label>
    <link:label id="lab_prgo_AccruedCustomerPrograms_label_en-US" xlink:label="lab_prgo_AccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Customer Programs</link:label>
    <link:label id="lab_prgo_AccruedCustomerPrograms_documentation_en-US" xlink:label="lab_prgo_AccruedCustomerPrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccruedCustomerPrograms" xlink:href="prgo-20230401.xsd#prgo_AccruedCustomerPrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AccruedCustomerPrograms" xlink:to="lab_prgo_AccruedCustomerPrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c5a131d4-8843-473b-9c96-55482cadc410_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_27ae163e-f585-4c98-a6e1-47950703a344_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f0ae34cd-f34a-4020-b232-0a285ee043ac_netLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2d6adb28-15fa-44e7-871c-6fa49dc0d93b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding for basic EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6b563395-3895-45e4-85d7-9b30e624e872_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_04fc2c3c-eaa5-492f-bf20-182373f2113f_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_d2836e36-5b3d-4012-b04d-bbb0e5110d23_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_2264feb9-5a4e-49aa-8a33-298e2460e94c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies - Refer to Note 16</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_20b303b6-5316-448c-9773-a3bf284fb6c6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_757b72ab-0658-4dd8-b092-29e76db589a5_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply agreement term</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Supply Agreement Term</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Supply Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_7c85b2f9-f70a-4ae4-88ba-0695d574f1ba_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_48b73cf3-86d1-4776-af8e-b2108d18958e_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, $0.0001 par value per share, 10 shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherOperatingIncomeLossNet_e87db5c3-74af-410c-92a7-671201264672_verboseLabel_en-US" xlink:label="lab_prgo_OtherOperatingIncomeLossNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating (income) expense, net</link:label>
    <link:label id="lab_prgo_OtherOperatingIncomeLossNet_label_en-US" xlink:label="lab_prgo_OtherOperatingIncomeLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating (Income) Loss, Net</link:label>
    <link:label id="lab_prgo_OtherOperatingIncomeLossNet_documentation_en-US" xlink:label="lab_prgo_OtherOperatingIncomeLossNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating (Income) Loss, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherOperatingIncomeLossNet" xlink:href="prgo-20230401.xsd#prgo_OtherOperatingIncomeLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherOperatingIncomeLossNet" xlink:to="lab_prgo_OtherOperatingIncomeLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_26ec33f9-f14a-439c-a898-c85160e9b38c_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_fd7b89da-f38a-4b5f-8cc7-1f6f15fa890c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_4afb9027-e675-4845-ad04-029f29225e19_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_29d8ba6b-5555-4bf9-a3d7-10a1659dddc9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bceb71f0-bab6-4604-b0d9-b4de7cd30021_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_26170b0e-5d83-441f-8e3a-8bf9aaec954a_terseLabel_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS notice of proposed adjustment amount from 2011,2012 and 2013 audit of Athena, including penalty</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_label_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment Amount, Including Penalty</link:label>
    <link:label id="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_documentation_en-US" xlink:label="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRS Notice of Proposed Audit Adjustment Amount, Including Penalty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:to="lab_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_b350dea6-78d4-47a0-87aa-2810b5e90563_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current indebtedness</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_66de1ee9-e59f-4bac-bdf8-69c48d862e93_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_d547c0ab-331d-4497-bf68-536055dc3aa6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_cd429cc3-259a-4ba6-860f-fc8760ac896c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_5d531dcc-ed03-4e09-b504-4ca4d05afba4_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_00ef9e78-ae3c-4cf1-83b1-c3528a02c9a5_verboseLabel_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, trade names, and brands</link:label>
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_label_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, Trade Names, and Brands [Member]</link:label>
    <link:label id="lab_prgo_TrademarksTradeNamesandBrandsMember_documentation_en-US" xlink:label="lab_prgo_TrademarksTradeNamesandBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, Trade Names, and Brands [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember" xlink:href="prgo-20230401.xsd#prgo_TrademarksTradeNamesandBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_TrademarksTradeNamesandBrandsMember" xlink:to="lab_prgo_TrademarksTradeNamesandBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e7794621-e24a-41dd-b5db-d361c9a70f23_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_20b176a3-e679-41a8-b893-33a3cc94670e_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_d3f7d831-366f-462e-8c9f-5ceaab2e53c6_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_f8b84f70-2bd7-4262-8ec5-091f617dbbec_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_f4e2c8aa-69f8-434e-8dca-fbeb649bea62_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate - Finance lease (percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_71886b63-0e49-47c0-8a4a-5f96dc014866_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_13bde0d7-2020-45a2-a74e-afb4950fbd4e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberOfManufacturers_c26953e2-b28a-4a94-9c48-40fd75cc3584_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of manufacturers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfManufacturers_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Manufacturers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfManufacturers_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfManufacturers" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberOfManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfManufacturers" xlink:to="lab_prgo_LossContingencyNumberOfManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_b0f42e20-9e11-4830-92c4-6b69028a69ec_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_4228c025-ea12-41b6-b276-719a393edd2a_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_98ad6b13-883c-4ba8-bd01-ca30a31790a5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_657713d7-0f7a-476a-bca2-0e18c17a47ed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_3679ecd1-ddb6-4de0-981a-573ca132435d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_b68abd1a-c98a-445e-ac03-9a479c245db2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_d0fc4aa6-9c9f-419f-a293-0628615dbe6c_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal repayments</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_e7b8a8d4-4e27-4710-8b54-ca9e0bc87fa6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_8a10ea8a-0499-4a96-91d4-8918cf3b7219_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_80e65ba3-2a43-4216-a740-35f430c30d92_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncomeTaxExaminationNumberOfTaxableYears_f3bdbbcd-677e-4c9e-8604-4766ec16c893_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationNumberOfTaxableYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination, number of taxable years</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationNumberOfTaxableYears_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationNumberOfTaxableYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Number of Taxable Years</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationNumberOfTaxableYears_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationNumberOfTaxableYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Number of Taxable Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationNumberOfTaxableYears" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationNumberOfTaxableYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationNumberOfTaxableYears" xlink:to="lab_prgo_IncomeTaxExaminationNumberOfTaxableYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_41f7ba5a-d7fa-4c07-af99-a35ddd0ac98a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d2e2b5c2-a320-4d16-9250-d46dd462036d_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_4ae9301c-19a7-4d38-81bd-a31d9444f721_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_prgo_LeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_prgo_LeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaints_8a0dced3-67a6-4c88-8704-198b99d9ffc3_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of master complaints</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaints_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Master Complaints</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofMasterComplaints_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofMasterComplaints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Master Complaints</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaints" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofMasterComplaints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofMasterComplaints" xlink:to="lab_prgo_LossContingencyNumberofMasterComplaints" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_af87b84a-9d31-4d3f-bd9e-d2c52bd19ba7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_58e5532d-7606-4e66-97e3-fc7611abd8dc_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2714df64-210d-46c9-8d64-b2aa5f3a431d_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgesAbstract_a6740f68-b561-462b-a721-c41b91bf52c7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgesAbstract_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgesAbstract" xlink:to="lab_us-gaap_InterestRateCashFlowHedgesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_b5bbf79d-2caa-4f34-8478-48b65eb0cc9c_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, trade names, and brands</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_2794ecd5-7aa6-48a7-bd8c-59237648dff1_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_b4bd539b-88c9-4ad2-b97a-f9f5b6ede091_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_e8b6ff32-cc4c-46f6-ad25-5124690e0ac2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_ad10dabd-758b-4223-af42-33814affe875_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Initiatives</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9c5b28b1-2031-4d4c-9e49-28ecba425864_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_96582c3b-ffa5-4c23-ae79-dcafa268f78e_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of generic prescription pharmaceuticals</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_label_en-US" xlink:label="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Generic Prescription Pharmaceuticals</link:label>
    <link:label id="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Generic Prescription Pharmaceuticals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:to="lab_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_UnallocatedSegmentMember_f289bb98-49cf-4292-95ab-5adbeb880118_terseLabel_en-US" xlink:label="lab_prgo_UnallocatedSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated Segment</link:label>
    <link:label id="lab_prgo_UnallocatedSegmentMember_label_en-US" xlink:label="lab_prgo_UnallocatedSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated Segment [Member]</link:label>
    <link:label id="lab_prgo_UnallocatedSegmentMember_documentation_en-US" xlink:label="lab_prgo_UnallocatedSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_UnallocatedSegmentMember" xlink:href="prgo-20230401.xsd#prgo_UnallocatedSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_UnallocatedSegmentMember" xlink:to="lab_prgo_UnallocatedSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_924e8761-749d-454f-bbe8-c6c15a6be2d9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_a284b767-3ebc-44c4-ba70-f66e5fbfa804_terseLabel_en-US" xlink:label="lab_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Cash Flow Classifications</link:label>
    <link:label id="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_label_en-US" xlink:label="lab_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Cash Flow Classifications [Table Text Block]</link:label>
    <link:label id="lab_prgo_LesseeCashFlowClassificationsTableTextBlock_documentation_en-US" xlink:label="lab_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Cash Flow Classifications [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:href="prgo-20230401.xsd#prgo_LesseeCashFlowClassificationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:to="lab_prgo_LesseeCashFlowClassificationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_OtherGeographicalAreasMember_af908b45-dca7-4d67-8a0c-5f0ccc5927c1_terseLabel_en-US" xlink:label="lab_prgo_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other countries</link:label>
    <link:label id="lab_prgo_OtherGeographicalAreasMember_label_en-US" xlink:label="lab_prgo_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographical Areas [Member]</link:label>
    <link:label id="lab_prgo_OtherGeographicalAreasMember_documentation_en-US" xlink:label="lab_prgo_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographical Areas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherGeographicalAreasMember" xlink:href="prgo-20230401.xsd#prgo_OtherGeographicalAreasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_OtherGeographicalAreasMember" xlink:to="lab_prgo_OtherGeographicalAreasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_a706ce38-6658-4bf2-a361-07403c87c7fe_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7f535a21-5a2b-496d-afe9-534cbb10beb9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b45bdae8-edf9-4bcd-ba62-49b0dc8fd445_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward_5785c1a6-507c-45c8-bbc4-feb04723b161_terseLabel_en-US" xlink:label="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward_label_en-US" xlink:label="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward_documentation_en-US" xlink:label="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward" xlink:href="prgo-20230401.xsd#prgo_AccumulatedOtherComprehensiveIncomeRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward" xlink:to="lab_prgo_AccumulatedOtherComprehensiveIncomeRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_1d19d5bc-f58b-4bb3-a23b-c750cc98a1d8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_78775715-0236-46c6-9851-a8fb1be4dab6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_5adfc9a6-f3b8-4853-bdc5-9629ac066070_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b6a6f6ac-3ba1-4508-b0f2-21d2310eeba5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_A4.375seniornotedueMarch152026Member_722f60a1-e8e1-4d2a-a8e9-47aced8f681f_terseLabel_en-US" xlink:label="lab_prgo_A4.375seniornotedueMarch152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% senior note due March 15, 2026</link:label>
    <link:label id="lab_prgo_A4.375seniornotedueMarch152026Member_label_en-US" xlink:label="lab_prgo_A4.375seniornotedueMarch152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% senior note due March 15, 2026 [Member]</link:label>
    <link:label id="lab_prgo_A4.375seniornotedueMarch152026Member_documentation_en-US" xlink:label="lab_prgo_A4.375seniornotedueMarch152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% senior note due March 15, 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member" xlink:href="prgo-20230401.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_A4.375seniornotedueMarch152026Member" xlink:to="lab_prgo_A4.375seniornotedueMarch152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_25a0d947-33d4-46e3-a01d-b43c696c0818_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_7e2bf7a4-9b45-4785-81bb-1a42de303bd0_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_011f9ce5-2c99-4c1f-998c-1dda0ed63972_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_beea4fad-e5e3-48f5-9842-cd751f8b3aab_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_de19d527-23b0-4b2e-a2f7-863cbd8ccce2_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_988d87b8-42e1-4dfc-98c3-51e3bef3fd79_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_XXX_d4ce3ea2-9065-429c-bfa3-d60227913e9c_terseLabel_en-US" xlink:label="lab_currency_XXX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_currency_XXX_label_en-US" xlink:label="lab_currency_XXX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No currency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_XXX" xlink:to="lab_currency_XXX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_c7387ac9-c956-4b73-a4a1-e706e658ba92_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average lease term - Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_16320c8c-a327-498b-a086-d0d905be2534_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e58db365-d4f7-4d15-8b44-c00167db9351_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_527b32f7-043c-48c3-abed-98e40996c3d2_terseLabel_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_label_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]</link:label>
    <link:label id="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_documentation_en-US" xlink:label="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:href="prgo-20230401.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:to="lab_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_5bf5cf68-74f0-4f2e-bf31-3953befc9f20_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_NetLossIncomeAttributableToParent_ae0f689b-f9d9-4031-8c7f-4d60c4802f50_terseLabel_en-US" xlink:label="lab_prgo_NetLossIncomeAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_prgo_NetLossIncomeAttributableToParent_label_en-US" xlink:label="lab_prgo_NetLossIncomeAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss (Income) Attributable to Parent</link:label>
    <link:label id="lab_prgo_NetLossIncomeAttributableToParent_documentation_en-US" xlink:label="lab_prgo_NetLossIncomeAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss (Income) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetLossIncomeAttributableToParent" xlink:href="prgo-20230401.xsd#prgo_NetLossIncomeAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_NetLossIncomeAttributableToParent" xlink:to="lab_prgo_NetLossIncomeAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RanitidineLitigationMember_0d1e6ee9-be2f-41ae-8f32-c52524fa307c_terseLabel_en-US" xlink:label="lab_prgo_RanitidineLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranitidine Litigation</link:label>
    <link:label id="lab_prgo_RanitidineLitigationMember_label_en-US" xlink:label="lab_prgo_RanitidineLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranitidine Litigation [Member]</link:label>
    <link:label id="lab_prgo_RanitidineLitigationMember_documentation_en-US" xlink:label="lab_prgo_RanitidineLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ranitidine Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanitidineLitigationMember" xlink:href="prgo-20230401.xsd#prgo_RanitidineLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RanitidineLitigationMember" xlink:to="lab_prgo_RanitidineLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_8cbad2d1-a4c0-4210-a126-0f3c9d7b9688_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_a0d6f533-e887-46e3-8482-5f01db3ed3a4_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Dollar (USD)</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_October252022ThroughJune152030Member_9ab0c7b8-9fb6-46ed-bf18-1b6548314588_terseLabel_en-US" xlink:label="lab_prgo_October252022ThroughJune152030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through June 15, 2030</link:label>
    <link:label id="lab_prgo_October252022ThroughJune152030Member_label_en-US" xlink:label="lab_prgo_October252022ThroughJune152030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through June 15, 2030 [Member]</link:label>
    <link:label id="lab_prgo_October252022ThroughJune152030Member_documentation_en-US" xlink:label="lab_prgo_October252022ThroughJune152030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 25, 2022 through June 15, 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughJune152030Member" xlink:href="prgo-20230401.xsd#prgo_October252022ThroughJune152030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_October252022ThroughJune152030Member" xlink:to="lab_prgo_October252022ThroughJune152030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_a442e47b-cbb7-4bfd-aa44-fe7420f83d39_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_8032f73f-3270-4057-9b32-b63e096e9e94_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_a2faebc9-794d-4fcb-95dd-be06d016ff21_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_2039eee8-8b01-4899-a28a-89c8d7470315_terseLabel_en-US" xlink:label="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of current or former directors and officers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_label_en-US" xlink:label="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Current Or Former Directors And Officers</link:label>
    <link:label id="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_documentation_en-US" xlink:label="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Current Or Former Directors And Officers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:to="lab_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_a8bc9205-4c48-4f72-9289-961d7c31f7cb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments_80903668-7eb1-4a97-a7e1-35f26b5b1b7a_terseLabel_en-US" xlink:label="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for premiums</link:label>
    <link:label id="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments_label_en-US" xlink:label="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Premiums On Derivative Instruments</link:label>
    <link:label id="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments_documentation_en-US" xlink:label="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Premiums On Derivative Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:href="prgo-20230401.xsd#prgo_PaymentsForPremiumsOnDerivativeInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:to="lab_prgo_PaymentsForPremiumsOnDerivativeInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_c4e2a3a3-90b5-458d-9c00-cad2e068f374_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum remaining maturity of foreign currency derivatives</link:label>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_label_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:to="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_160c0e33-4b77-47e5-8916-52a00cf6dd9c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_1fb1c9ae-6424-4561-b313-e5608364c469_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_dbe26e65-d93b-4626-aff5-965f70751b96_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_216958e1-5031-4d98-847d-b4e8629a0f08_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_fcfcc067-ea1e-4eb3-83bd-36375c1ff3c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld for payment of employees' withholding tax liability (shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_99ff0019-accd-4d75-9bc4-0f5648128845_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_8eb902cc-10cb-408c-a41e-4b297f8e0383_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f98940ab-73cf-42b5-8692-990c3bb97b4b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of effective income tax rate reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32e8fa91-faed-4fd4-9e38-796380c3ce8e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFour_a7ceb317-b445-4352-9831-1d595755ea99_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_1eae48ff-ab36-4028-b508-4ef62fdf9cc8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c1457688-54f0-4317-8256-f09932f2fc20_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_60868602-31b2-4391-9cb2-0432d42eb0f3_terseLabel_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period [Domain]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_label_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period [Domain]</link:label>
    <link:label id="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_documentation_en-US" xlink:label="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Covered Interest Rate Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:to="lab_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_32f9bcd7-9f80-44ea-92ce-eeb0815d412e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5c7632d2-7ec5-4dd6-86f9-058801e5511e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_579820eb-7818-4485-b53d-446dd8aeedf8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld for payment of employees' withholding tax liability</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_5b0296a2-6866-4102-bf05-f23974d10cbc_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_3ee9061a-068d-4f4a-8384-1bd1ea24d136_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated litigation liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_bfcc7fed-819a-4166-954d-b3bbcd84076d_terseLabel_en-US" xlink:label="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax examination, reduction in blended interest rate due to cap for U.S. Federal tax purposes</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_label_en-US" xlink:label="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes</link:label>
    <link:label id="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_documentation_en-US" xlink:label="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:to="lab_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_47b215b7-ff54-4ada-965c-b85d8fbc48c4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_068db31a-6306-4063-a121-5b4941dce47c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_d2b8c964-62f2-433a-b539-972716fa5b95_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administration</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_1c4843cc-026c-4656-8c4b-7dfdbfaf8c37_terseLabel_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangibles</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_label_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In-Definite Lived Intangibles</link:label>
    <link:label id="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_documentation_en-US" xlink:label="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In-Definite Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:to="lab_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_HealthyLifestyleMember_736d12b7-8ce2-4f7e-99bf-005c7737b91b_terseLabel_en-US" xlink:label="lab_prgo_HealthyLifestyleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthy Lifestyle</link:label>
    <link:label id="lab_prgo_HealthyLifestyleMember_label_en-US" xlink:label="lab_prgo_HealthyLifestyleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthy Lifestyle [Member]</link:label>
    <link:label id="lab_prgo_HealthyLifestyleMember_documentation_en-US" xlink:label="lab_prgo_HealthyLifestyleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthy Lifestyle [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HealthyLifestyleMember" xlink:href="prgo-20230401.xsd#prgo_HealthyLifestyleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_HealthyLifestyleMember" xlink:to="lab_prgo_HealthyLifestyleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9635dec6-df67-4d3a-9c7d-e2c6229008f3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8d681121-0f37-4510-bbb0-96d0c34756a5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_2f3fdb3d-3718-4cdd-a9c7-dd5321f9273b_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Euro (EUR)</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_e4ae9159-66d2-424a-b6da-303c7ba241ad_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_472f1553-0374-44fb-918f-d92e0777e738_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From (For) Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_237e4d7f-e126-4e6a-96d6-5500e0a120d8_terseLabel_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential R&amp;D milestone payments and contingent purchase obligations assumed by purchaser</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_label_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Contingent Liabilities Assumed by Purchaser</link:label>
    <link:label id="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_documentation_en-US" xlink:label="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Contingent Liabilities Assumed by Purchaser</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:to="lab_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_dce3a051-33aa-4e43-bda6-a90aaa700c52_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearOne_1c18023f-6a86-4a40-9951-cdae3ee88277_totalLabel_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearOne_label_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year One</link:label>
    <link:label id="lab_prgo_LeaseLiabilityPaymentsDueYearOne_documentation_en-US" xlink:label="lab_prgo_LeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearOne" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_LeaseLiabilityPaymentsDueYearOne" xlink:to="lab_prgo_LeaseLiabilityPaymentsDueYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_208644da-ce3d-4d86-b284-18b31d772eca_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7021c2bf-2e3c-4a8b-8847-2ca1b572ab83_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_b9240dda-aee3-489a-8942-8ec15633eeab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, equity method, other expense (income)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_c6b7e097-5cb9-4f5b-a38c-27b7ed87a875_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0fb62c60-20ba-4d32-9b72-9ed0256ac304_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_f1bcc36a-77f4-4829-8044-b2d2741992a0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_RestructuringChargesContinuingOperations_5d5e273a-44ad-4801-b00f-f8efb2a5d8b9_terseLabel_en-US" xlink:label="lab_prgo_RestructuringChargesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_prgo_RestructuringChargesContinuingOperations_label_en-US" xlink:label="lab_prgo_RestructuringChargesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Continuing Operations</link:label>
    <link:label id="lab_prgo_RestructuringChargesContinuingOperations_documentation_en-US" xlink:label="lab_prgo_RestructuringChargesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringChargesContinuingOperations" xlink:href="prgo-20230401.xsd#prgo_RestructuringChargesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_RestructuringChargesContinuingOperations" xlink:to="lab_prgo_RestructuringChargesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_10fd9cd2-2b31-4d70-b1c0-b678ed982cc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b09e891a-7505-4b4e-aa8e-e870b2bc672d_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_2c2a460b-66fe-4bcc-a635-7ce50bfe6c16_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prgo_AdventInternationalMember_14cd7158-ba45-45cc-ade9-77d1f9d1367c_terseLabel_en-US" xlink:label="lab_prgo_AdventInternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advent International</link:label>
    <link:label id="lab_prgo_AdventInternationalMember_label_en-US" xlink:label="lab_prgo_AdventInternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advent International [Member]</link:label>
    <link:label id="lab_prgo_AdventInternationalMember_documentation_en-US" xlink:label="lab_prgo_AdventInternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advent International</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AdventInternationalMember" xlink:href="prgo-20230401.xsd#prgo_AdventInternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prgo_AdventInternationalMember" xlink:to="lab_prgo_AdventInternationalMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>prgo-20230401_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d94275d0-2889-4bee-8a41-eed44cff1b4d,g:5de99725-025a-4d3c-a861-61491132bb43-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.perrigo.com/role/CoverPage" xlink:type="simple" xlink:href="prgo-20230401.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e06227c9-1a35-4f0a-b7d9-e34735c712c4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_280c6fce-0d85-47a2-9974-b7cc41e45fcb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e06227c9-1a35-4f0a-b7d9-e34735c712c4" xlink:to="loc_dei_DocumentInformationTable_280c6fce-0d85-47a2-9974-b7cc41e45fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_56239599-1b3a-4b4e-b961-e71d5f0c60e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_280c6fce-0d85-47a2-9974-b7cc41e45fcb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_56239599-1b3a-4b4e-b961-e71d5f0c60e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_56239599-1b3a-4b4e-b961-e71d5f0c60e0" xlink:to="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OrdinaryShares0001ParValueMember_4315de6a-8bde-4706-b424-9dbdc84344b2" xlink:href="prgo-20230401.xsd#prgo_OrdinaryShares0001ParValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_OrdinaryShares0001ParValueMember_4315de6a-8bde-4706-b424-9dbdc84344b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member_b9f1b52a-bbbe-4eb9-8eb0-ccc059e710ee" xlink:href="prgo-20230401.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_A3900SeniorNoteDue2024Member_b9f1b52a-bbbe-4eb9-8eb0-ccc059e710ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_20687f50-9bc9-4319-8f25-686825629810" xlink:href="prgo-20230401.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_20687f50-9bc9-4319-8f25-686825629810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member_c1e221f9-43b1-493f-8f1f-bd0b6cad8bef" xlink:href="prgo-20230401.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_A4400SeniorNotesDueJune152030Member_c1e221f9-43b1-493f-8f1f-bd0b6cad8bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_5d1dfa5e-5528-4e95-a819-fe7727a4d4f2" xlink:href="prgo-20230401.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_5d1dfa5e-5528-4e95-a819-fe7727a4d4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member_7607b2e3-57cd-4cf7-bf84-dcc47aef5dbf" xlink:href="prgo-20230401.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb329820-9238-4dfd-811a-04f8c1a6d5d1" xlink:to="loc_prgo_A4900SeniorLoanDue2044Member_7607b2e3-57cd-4cf7-bf84-dcc47aef5dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_280c6fce-0d85-47a2-9974-b7cc41e45fcb" xlink:to="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_84631de3-5d0e-45ad-b12e-1dd0a74f67cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentType_84631de3-5d0e-45ad-b12e-1dd0a74f67cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d587a223-79fb-436f-a2a4-8db977a35ad6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentQuarterlyReport_d587a223-79fb-436f-a2a4-8db977a35ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b5de3d1d-d1dd-42ba-8c7e-cd4efa3f036c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentPeriodEndDate_b5de3d1d-d1dd-42ba-8c7e-cd4efa3f036c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_c2730842-4df0-4bbc-8a6e-33d8d8611f76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentTransitionReport_c2730842-4df0-4bbc-8a6e-33d8d8611f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_fa0006d6-f30b-4538-a8fd-3d4f0f344631" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityFileNumber_fa0006d6-f30b-4538-a8fd-3d4f0f344631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8cc6f0c4-3419-4c7c-b153-b80aa4672739" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityRegistrantName_8cc6f0c4-3419-4c7c-b153-b80aa4672739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3089f5e7-635a-45bb-8a8e-615e256f57f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3089f5e7-635a-45bb-8a8e-615e256f57f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7828f1c4-cdf2-4d92-b3b0-e18a7d51ea26" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityAddressAddressLine1_7828f1c4-cdf2-4d92-b3b0-e18a7d51ea26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_d9d4771f-95f0-42e0-833d-b34ac2d20a9b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityAddressAddressLine2_d9d4771f-95f0-42e0-833d-b34ac2d20a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_23a41526-8897-40cb-9f61-5a5c5d89d87c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityAddressCityOrTown_23a41526-8897-40cb-9f61-5a5c5d89d87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_ba86fdd0-6c28-4d11-8754-f729f11c9cec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityAddressCountry_ba86fdd0-6c28-4d11-8754-f729f11c9cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_187b193a-8585-49e2-b291-4dbf7eeb09b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityAddressPostalZipCode_187b193a-8585-49e2-b291-4dbf7eeb09b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_53fee3d5-d25f-4296-97cd-d7f198c8ad88" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_CountryRegion_53fee3d5-d25f-4296-97cd-d7f198c8ad88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ca1be1f2-abd5-4b33-be66-826f4e33fb10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_CityAreaCode_ca1be1f2-abd5-4b33-be66-826f4e33fb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_86e955e0-4bdb-4ef0-84df-fb9c26ddc768" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_LocalPhoneNumber_86e955e0-4bdb-4ef0-84df-fb9c26ddc768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_2ac37026-bcf4-4273-9466-2d6bc9aabd37" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_Security12bTitle_2ac37026-bcf4-4273-9466-2d6bc9aabd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_dd906bc3-5b68-48ce-b821-2337844d9155" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_TradingSymbol_dd906bc3-5b68-48ce-b821-2337844d9155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_eecb073f-64d3-460c-b4bb-88cdae6cb1a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_SecurityExchangeName_eecb073f-64d3-460c-b4bb-88cdae6cb1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_28ed8d4b-ee53-4260-9542-7f248720e93b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityCurrentReportingStatus_28ed8d4b-ee53-4260-9542-7f248720e93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_599b88cd-3380-45c4-bf52-229bd6c0a8e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityInteractiveDataCurrent_599b88cd-3380-45c4-bf52-229bd6c0a8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_50ffd4cc-7813-44e7-848f-c7cbecaebeee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityFilerCategory_50ffd4cc-7813-44e7-848f-c7cbecaebeee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_65d6e5e4-8f5c-42a4-a675-16185fbeabc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntitySmallBusiness_65d6e5e4-8f5c-42a4-a675-16185fbeabc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4a4b07f6-997e-49dd-b8de-101bb640d711" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityEmergingGrowthCompany_4a4b07f6-997e-49dd-b8de-101bb640d711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4ede98ac-2ebf-4a07-9398-0569f9a680a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityShellCompany_4ede98ac-2ebf-4a07-9398-0569f9a680a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_139331a2-0644-4dea-9524-bfe7323603f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_139331a2-0644-4dea-9524-bfe7323603f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7b495f54-ea5f-467f-8f05-40ac80bc0401" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_EntityCentralIndexKey_7b495f54-ea5f-467f-8f05-40ac80bc0401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b1836450-f4d9-4fdd-bae2-bc806368991c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_CurrentFiscalYearEndDate_b1836450-f4d9-4fdd-bae2-bc806368991c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_256ef3c9-779f-41ca-a9c3-92c967d48b2a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentFiscalYearFocus_256ef3c9-779f-41ca-a9c3-92c967d48b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_eee994e1-2fdf-4a4d-b32c-fa260b393bfe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_DocumentFiscalPeriodFocus_eee994e1-2fdf-4a4d-b32c-fa260b393bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_cf956af4-5059-428b-a695-724f8f19bc74" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c2764363-f06d-48b5-b11d-133d9751a163" xlink:to="loc_dei_AmendmentFlag_cf956af4-5059-428b-a695-724f8f19bc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d2fd4ddb-6e1c-4de3-82d5-b2ee16e9dfab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d2fd4ddb-6e1c-4de3-82d5-b2ee16e9dfab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2ede4809-a069-47ef-bf0c-8004ebb249d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2ede4809-a069-47ef-bf0c-8004ebb249d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4b1bc7c3-f196-4108-a57f-6636efd80fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_GrossProfit_4b1bc7c3-f196-4108-a57f-6636efd80fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_b6081e29-744e-4bd3-adec-ec03d3551ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_OperatingExpensesAbstract_b6081e29-744e-4bd3-adec-ec03d3551ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionAndDistributionCosts_3c751f5c-a55b-4ffe-ab0f-b4c2bad00668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionAndDistributionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b6081e29-744e-4bd3-adec-ec03d3551ba6" xlink:to="loc_us-gaap_ProductionAndDistributionCosts_3c751f5c-a55b-4ffe-ab0f-b4c2bad00668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ea3c300f-348f-4934-9621-54f0c85fc2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b6081e29-744e-4bd3-adec-ec03d3551ba6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ea3c300f-348f-4934-9621-54f0c85fc2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_92cf35b8-bfd2-466e-abb3-d552b5739068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b6081e29-744e-4bd3-adec-ec03d3551ba6" xlink:to="loc_us-gaap_SellingAndMarketingExpense_92cf35b8-bfd2-466e-abb3-d552b5739068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_18ea43e6-6e70-46e6-810d-3de577b9c066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b6081e29-744e-4bd3-adec-ec03d3551ba6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_18ea43e6-6e70-46e6-810d-3de577b9c066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c2e3569a-cb2c-4385-b055-4f1692fb89e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b6081e29-744e-4bd3-adec-ec03d3551ba6" xlink:to="loc_us-gaap_RestructuringCharges_c2e3569a-cb2c-4385-b055-4f1692fb89e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherOperatingIncomeLossNet_595167a4-c897-4f7d-88aa-c1e6624d4b28" xlink:href="prgo-20230401.xsd#prgo_OtherOperatingIncomeLossNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b6081e29-744e-4bd3-adec-ec03d3551ba6" xlink:to="loc_prgo_OtherOperatingIncomeLossNet_595167a4-c897-4f7d-88aa-c1e6624d4b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_940f67ec-7d69-4131-9b6d-0b30ede48d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b6081e29-744e-4bd3-adec-ec03d3551ba6" xlink:to="loc_us-gaap_OperatingExpenses_940f67ec-7d69-4131-9b6d-0b30ede48d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fd2ad5de-fa3c-40a5-89f6-8950ba8791e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_OperatingIncomeLoss_fd2ad5de-fa3c-40a5-89f6-8950ba8791e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_3cccd4d4-6002-4ce5-a56a-d3087fe1901b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_3cccd4d4-6002-4ce5-a56a-d3087fe1901b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b660fd22-f4c3-483e-815f-e0c3391d8996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b660fd22-f4c3-483e-815f-e0c3391d8996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_53cb38a3-6326-48da-aa7c-7dc4a0949a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_53cb38a3-6326-48da-aa7c-7dc4a0949a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e043b421-cd04-41c0-8909-e997e144081c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e043b421-cd04-41c0-8909-e997e144081c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_ae82e723-d1ca-4c6c-bfc2-23cd101a159f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_ae82e723-d1ca-4c6c-bfc2-23cd101a159f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_b69e427a-f252-492c-b3ae-fea3db6400ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_b69e427a-f252-492c-b3ae-fea3db6400ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e540490d-8a47-4f07-a64e-a079879c8c89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_NetIncomeLoss_e540490d-8a47-4f07-a64e-a079879c8c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_90e42ff9-e133-40b2-a3ac-11462ed8480a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_EarningsPerShareAbstract_90e42ff9-e133-40b2-a3ac-11462ed8480a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_3d0c1c85-50d9-4543-9fda-4d332e6b86f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_90e42ff9-e133-40b2-a3ac-11462ed8480a" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_3d0c1c85-50d9-4543-9fda-4d332e6b86f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_30195b17-f7ce-4e48-997a-926a6f4289b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_3d0c1c85-50d9-4543-9fda-4d332e6b86f6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_30195b17-f7ce-4e48-997a-926a6f4289b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_849b00f1-ec76-4ece-a328-190b6e61fdbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_3d0c1c85-50d9-4543-9fda-4d332e6b86f6" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_849b00f1-ec76-4ece-a328-190b6e61fdbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e94e0488-f2a8-4719-af1c-9f7b605c96d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_3d0c1c85-50d9-4543-9fda-4d332e6b86f6" xlink:to="loc_us-gaap_EarningsPerShareBasic_e94e0488-f2a8-4719-af1c-9f7b605c96d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_4b8a03b4-21b7-4fcc-867a-7129969f92d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_90e42ff9-e133-40b2-a3ac-11462ed8480a" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_4b8a03b4-21b7-4fcc-867a-7129969f92d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_9f6da888-6d5a-4b01-8124-46ab295b4336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_4b8a03b4-21b7-4fcc-867a-7129969f92d0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_9f6da888-6d5a-4b01-8124-46ab295b4336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_ad26b32a-e4f2-424f-a3e5-d9ea40338bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_4b8a03b4-21b7-4fcc-867a-7129969f92d0" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_ad26b32a-e4f2-424f-a3e5-d9ea40338bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8b40d90c-5cf1-44fc-aa7d-a5e135226146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_4b8a03b4-21b7-4fcc-867a-7129969f92d0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8b40d90c-5cf1-44fc-aa7d-a5e135226146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9dc6c2f3-85ba-49bb-8c91-031f8f046eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd3b6d03-2902-4da0-8e4c-19c4c6f74cd3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9dc6c2f3-85ba-49bb-8c91-031f8f046eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_706098b2-6ec1-4893-8ae5-7ee07f3fd456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9dc6c2f3-85ba-49bb-8c91-031f8f046eec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_706098b2-6ec1-4893-8ae5-7ee07f3fd456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0902b4c5-8acc-46a5-b0dd-2d292460e85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9dc6c2f3-85ba-49bb-8c91-031f8f046eec" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0902b4c5-8acc-46a5-b0dd-2d292460e85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_44506ad0-6dc5-4bec-ac65-317b7906f8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e7b1efb7-1d02-4ee1-bd28-86ac5711afde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_44506ad0-6dc5-4bec-ac65-317b7906f8f9" xlink:to="loc_us-gaap_NetIncomeLoss_e7b1efb7-1d02-4ee1-bd28-86ac5711afde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_dbfc0724-4fae-4ca0-9623-bbd9432a1f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_44506ad0-6dc5-4bec-ac65-317b7906f8f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_dbfc0724-4fae-4ca0-9623-bbd9432a1f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_04bdee98-2fce-483b-a0d0-d9fe8df45a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_dbfc0724-4fae-4ca0-9623-bbd9432a1f05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_04bdee98-2fce-483b-a0d0-d9fe8df45a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ff6cfbb3-3122-416e-8185-37fa250ea1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_dbfc0724-4fae-4ca0-9623-bbd9432a1f05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ff6cfbb3-3122-416e-8185-37fa250ea1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_bb3c57dc-de27-4c7d-8c0c-a2ec41d18cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_dbfc0724-4fae-4ca0-9623-bbd9432a1f05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_bb3c57dc-de27-4c7d-8c0c-a2ec41d18cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76848f83-22be-43fc-aa23-e5c691ca0c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_44506ad0-6dc5-4bec-ac65-317b7906f8f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_76848f83-22be-43fc-aa23-e5c691ca0c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1f2d6e43-02f0-4b46-85ba-478d58664e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_44506ad0-6dc5-4bec-ac65-317b7906f8f9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1f2d6e43-02f0-4b46-85ba-478d58664e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_97c0ae14-d648-4475-a9e6-1aa58798b84d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97c0ae14-d648-4475-a9e6-1aa58798b84d" xlink:to="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b1f8c3e2-7432-4e9f-80b5-1405441d32dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b1f8c3e2-7432-4e9f-80b5-1405441d32dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2ac2c65f-93f5-4497-a196-111a436d3dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2ac2c65f-93f5-4497-a196-111a436d3dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_55b49ed3-2741-407e-91c2-c5bc9e3f6d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_InventoryNet_55b49ed3-2741-407e-91c2-c5bc9e3f6d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_409aac01-fdc6-4a79-8905-b1dd5d9f63fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_409aac01-fdc6-4a79-8905-b1dd5d9f63fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7db528f5-6971-4ccf-8854-9fc931affe1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_AssetsCurrent_7db528f5-6971-4ccf-8854-9fc931affe1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e01325d8-acea-42ee-84ec-39ed706f0e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e01325d8-acea-42ee-84ec-39ed706f0e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_eaedb7aa-c253-4ca1-bad3-95418e0d7d91" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets_eaedb7aa-c253-4ca1-bad3-95418e0d7d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_3a91e7e2-1610-4d1b-95cf-a999c0a7be85" xlink:href="prgo-20230401.xsd#prgo_GoodwillAndIndefiniteLivedIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_prgo_GoodwillAndIndefiniteLivedIntangibles_3a91e7e2-1610-4d1b-95cf-a999c0a7be85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9dca2d6e-9146-4dfd-8aeb-13a1ba944d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9dca2d6e-9146-4dfd-8aeb-13a1ba944d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_d84fd6ba-fb91-40e0-826c-ddd67c36e8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_d84fd6ba-fb91-40e0-826c-ddd67c36e8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bb27cbca-802a-492d-94e3-b52dae8a380a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bb27cbca-802a-492d-94e3-b52dae8a380a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_22213556-4a3b-4fff-addc-53b1f0e2710b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_AssetsNoncurrent_22213556-4a3b-4fff-addc-53b1f0e2710b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b67f0a8d-ba92-4f89-93db-ddc48d7ec342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ade24ee6-a3df-485e-a469-4937f63cc9b0" xlink:to="loc_us-gaap_Assets_b67f0a8d-ba92-4f89-93db-ddc48d7ec342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97c0ae14-d648-4475-a9e6-1aa58798b84d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_93f72c39-4379-49a7-82fc-666848130e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_AccountsPayableCurrent_93f72c39-4379-49a7-82fc-666848130e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ce62db95-12e4-4e84-9898-e39a24cfc24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ce62db95-12e4-4e84-9898-e39a24cfc24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccruedCustomerPrograms_ca7dfd4c-b7fe-4d25-a467-71d6fc816003" xlink:href="prgo-20230401.xsd#prgo_AccruedCustomerPrograms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_prgo_AccruedCustomerPrograms_ca7dfd4c-b7fe-4d25-a467-71d6fc816003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d81e619c-41f7-4169-985e-664dbd1eb1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d81e619c-41f7-4169-985e-664dbd1eb1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_3f5adb99-b23f-495e-a4d0-36f9f3cc1706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_3f5adb99-b23f-495e-a4d0-36f9f3cc1706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f06eb5d0-c982-4171-8b80-64449179394c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_LongTermDebtCurrent_f06eb5d0-c982-4171-8b80-64449179394c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b2c2df42-97ad-49ba-90cc-49e4e48dbb40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_LiabilitiesCurrent_b2c2df42-97ad-49ba-90cc-49e4e48dbb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ca516609-6280-4302-a5dc-48b74d275ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ca516609-6280-4302-a5dc-48b74d275ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fa16c851-316a-4cec-a81a-402fa7774f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fa16c851-316a-4cec-a81a-402fa7774f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4fa3720e-5952-4edf-ae39-dbd2f3efaf9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4fa3720e-5952-4edf-ae39-dbd2f3efaf9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_3c3dbbd8-088d-423a-bc6b-f56fff4dcaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_3c3dbbd8-088d-423a-bc6b-f56fff4dcaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_98766007-71cf-453e-a13c-a9c73e79bb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_Liabilities_98766007-71cf-453e-a13c-a9c73e79bb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_320034eb-cce4-4908-b261-c3fbec153a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_CommitmentsAndContingencies_320034eb-cce4-4908-b261-c3fbec153a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_e8068ee8-8051-4b9c-9cf1-d4f043e79c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3f0b3d3-3666-4d95-8e86-04483bd2c658" xlink:to="loc_us-gaap_StockholdersEquityAbstract_e8068ee8-8051-4b9c-9cf1-d4f043e79c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ControllingInterestAbstract_5b76b6b8-d857-4fa1-b89e-678601f0a818" xlink:href="prgo-20230401.xsd#prgo_ControllingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e8068ee8-8051-4b9c-9cf1-d4f043e79c20" xlink:to="loc_prgo_ControllingInterestAbstract_5b76b6b8-d857-4fa1-b89e-678601f0a818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_15040ee6-7294-4d61-af29-1fe14952b202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ControllingInterestAbstract_5b76b6b8-d857-4fa1-b89e-678601f0a818" xlink:to="loc_us-gaap_PreferredStockValue_15040ee6-7294-4d61-af29-1fe14952b202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_474eb131-68ad-44e1-9105-3121b51c50de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ControllingInterestAbstract_5b76b6b8-d857-4fa1-b89e-678601f0a818" xlink:to="loc_us-gaap_CommonStockValue_474eb131-68ad-44e1-9105-3121b51c50de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b762e8ad-42cf-403b-8cc6-978b53540fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ControllingInterestAbstract_5b76b6b8-d857-4fa1-b89e-678601f0a818" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b762e8ad-42cf-403b-8cc6-978b53540fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ddcfec83-1fd7-48d9-86fe-44e5c3f38272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ControllingInterestAbstract_5b76b6b8-d857-4fa1-b89e-678601f0a818" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ddcfec83-1fd7-48d9-86fe-44e5c3f38272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ea86600a-bfb5-4c27-85fb-c07325545c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e8068ee8-8051-4b9c-9cf1-d4f043e79c20" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ea86600a-bfb5-4c27-85fb-c07325545c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_497520c2-fce1-4763-8770-65239bb2784f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e8068ee8-8051-4b9c-9cf1-d4f043e79c20" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_497520c2-fce1-4763-8770-65239bb2784f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_638d92be-6ebf-4aa9-b8b0-166040be0059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97c0ae14-d648-4475-a9e6-1aa58798b84d" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_638d92be-6ebf-4aa9-b8b0-166040be0059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4f6f57f1-6cb3-4cd4-9632-51065c036df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_638d92be-6ebf-4aa9-b8b0-166040be0059" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4f6f57f1-6cb3-4cd4-9632-51065c036df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0da1e45d-1964-4a8d-9c4f-3df938350e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_638d92be-6ebf-4aa9-b8b0-166040be0059" xlink:to="loc_us-gaap_CommonStockSharesIssued_0da1e45d-1964-4a8d-9c4f-3df938350e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a5e2a524-4d6e-42cb-8ab5-d0f8e91defb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_51c846e9-a5e2-4979-b72d-cb8c1b7a6113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a5e2a524-4d6e-42cb-8ab5-d0f8e91defb0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_51c846e9-a5e2-4979-b72d-cb8c1b7a6113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f2fac9ee-2577-4a4a-899e-dfb1826c8a43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a5e2a524-4d6e-42cb-8ab5-d0f8e91defb0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f2fac9ee-2577-4a4a-899e-dfb1826c8a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5e88b5bc-df6a-4a29-8281-ef5172622b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f2fac9ee-2577-4a4a-899e-dfb1826c8a43" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5e88b5bc-df6a-4a29-8281-ef5172622b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7cba6cd2-d6b6-441f-a826-79c621f60b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f2fac9ee-2577-4a4a-899e-dfb1826c8a43" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7cba6cd2-d6b6-441f-a826-79c621f60b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3310ea17-f0be-4e20-977c-079473d02726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f2fac9ee-2577-4a4a-899e-dfb1826c8a43" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3310ea17-f0be-4e20-977c-079473d02726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_18274149-d2fa-4d5a-8cd2-cff857227a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f2fac9ee-2577-4a4a-899e-dfb1826c8a43" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_18274149-d2fa-4d5a-8cd2-cff857227a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b5e1e787-e7e9-4dcd-bdd2-e4fc0ec690e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dbe6249e-9452-4a8a-844b-6406d6d64f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b5e1e787-e7e9-4dcd-bdd2-e4fc0ec690e3" xlink:to="loc_us-gaap_StatementTable_dbe6249e-9452-4a8a-844b-6406d6d64f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c06edd4c-f84c-4586-be95-e14839fa8cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dbe6249e-9452-4a8a-844b-6406d6d64f04" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c06edd4c-f84c-4586-be95-e14839fa8cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_226f6454-8fe5-4035-82fe-068d2bc914ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c06edd4c-f84c-4586-be95-e14839fa8cff" xlink:to="loc_us-gaap_EquityComponentDomain_226f6454-8fe5-4035-82fe-068d2bc914ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b8a3a936-e130-48a5-b0ca-fb50a901cc96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_226f6454-8fe5-4035-82fe-068d2bc914ef" xlink:to="loc_us-gaap_CommonStockMember_b8a3a936-e130-48a5-b0ca-fb50a901cc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e77d6526-c6ef-4f37-9db6-d4b1b3990022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_226f6454-8fe5-4035-82fe-068d2bc914ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e77d6526-c6ef-4f37-9db6-d4b1b3990022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b651bc41-ccf2-4622-a675-1e84a0c0b9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_226f6454-8fe5-4035-82fe-068d2bc914ef" xlink:to="loc_us-gaap_RetainedEarningsMember_b651bc41-ccf2-4622-a675-1e84a0c0b9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9015b65e-b097-4617-94e9-546805836ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dbe6249e-9452-4a8a-844b-6406d6d64f04" xlink:to="loc_us-gaap_StatementLineItems_9015b65e-b097-4617-94e9-546805836ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9015b65e-b097-4617-94e9-546805836ac3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_73cb47b8-805d-423d-a562-f9a051b06293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_SharesOutstanding_73cb47b8-805d-423d-a562-f9a051b06293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e0400776-b119-4a26-ba09-51bde4cb8256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_StockholdersEquity_e0400776-b119-4a26-ba09-51bde4cb8256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0aff6144-6811-4220-8522-5b692f65b401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_NetIncomeLoss_0aff6144-6811-4220-8522-5b692f65b401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cf11ae46-86a2-4907-a006-23c3411ae7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cf11ae46-86a2-4907-a006-23c3411ae7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_13ed0e1a-43d4-4864-b7ac-fc3c6ece58c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_13ed0e1a-43d4-4864-b7ac-fc3c6ece58c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_0d7f019c-8384-46d7-99b1-c7c6484356d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_0d7f019c-8384-46d7-99b1-c7c6484356d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_0760feaa-0f1d-48b0-9e17-8f2c57f4b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_DividendsCommonStockCash_0760feaa-0f1d-48b0-9e17-8f2c57f4b54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9ebfeb9a-200a-4886-a539-d013faad9c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9ebfeb9a-200a-4886-a539-d013faad9c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23735b6a-a310-43c8-81ed-36ea65569a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23735b6a-a310-43c8-81ed-36ea65569a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4508d331-fb69-40b4-8cd7-9128fc7b6eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_SharesOutstanding_4508d331-fb69-40b4-8cd7-9128fc7b6eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_af25425f-4882-445f-b9c2-a4022295b38b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4f8b0e45-ba66-4e30-ad97-cae6dc4b504f" xlink:to="loc_us-gaap_StockholdersEquity_af25425f-4882-445f-b9c2-a4022295b38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedStatementsofShareholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_afcfeebd-b71c-4707-99db-e90b4a2725f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_d30d63c9-4714-43d4-8f81-c7ff4befa660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_afcfeebd-b71c-4707-99db-e90b4a2725f6" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_d30d63c9-4714-43d4-8f81-c7ff4befa660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="prgo-20230401.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_3fb68755-9117-4048-87e8-654a8330dbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dda09715-f309-441e-a868-90faa3d12d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fb68755-9117-4048-87e8-654a8330dbe5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dda09715-f309-441e-a868-90faa3d12d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetLossIncomeAttributableToParent_4425c60e-3551-4c59-94d9-eaaf538cf41c" xlink:href="prgo-20230401.xsd#prgo_NetLossIncomeAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dda09715-f309-441e-a868-90faa3d12d94" xlink:to="loc_prgo_NetLossIncomeAttributableToParent_4425c60e-3551-4c59-94d9-eaaf538cf41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d82f721b-8055-427a-a08e-fdf1cdc4a41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dda09715-f309-441e-a868-90faa3d12d94" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d82f721b-8055-427a-a08e-fdf1cdc4a41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_60c278d3-74c7-4744-a715-cc567ba5a368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d82f721b-8055-427a-a08e-fdf1cdc4a41a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_60c278d3-74c7-4744-a715-cc567ba5a368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_feaf316c-606f-47f1-a0b3-edbfcbbde111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d82f721b-8055-427a-a08e-fdf1cdc4a41a" xlink:to="loc_us-gaap_ShareBasedCompensation_feaf316c-606f-47f1-a0b3-edbfcbbde111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringChargesContinuingOperations_79190aed-5867-411a-ac26-8163aaec2b70" xlink:href="prgo-20230401.xsd#prgo_RestructuringChargesContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d82f721b-8055-427a-a08e-fdf1cdc4a41a" xlink:to="loc_prgo_RestructuringChargesContinuingOperations_79190aed-5867-411a-ac26-8163aaec2b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_94e10abc-e7cb-4264-a85f-feff3002ed17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d82f721b-8055-427a-a08e-fdf1cdc4a41a" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_94e10abc-e7cb-4264-a85f-feff3002ed17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_cc8b7eab-b4e1-4f70-8357-f1c8201941ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d82f721b-8055-427a-a08e-fdf1cdc4a41a" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_cc8b7eab-b4e1-4f70-8357-f1c8201941ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_a61ff7e0-c913-4109-8761-aa6b026559c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d82f721b-8055-427a-a08e-fdf1cdc4a41a" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_a61ff7e0-c913-4109-8761-aa6b026559c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c065abe8-f478-4675-b523-027c85a123eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d82f721b-8055-427a-a08e-fdf1cdc4a41a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c065abe8-f478-4675-b523-027c85a123eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0dcd878c-ed5a-4d05-98dc-ddaab5448b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d82f721b-8055-427a-a08e-fdf1cdc4a41a" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0dcd878c-ed5a-4d05-98dc-ddaab5448b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_4b6b5b3f-3db7-4d99-b950-2f62a21b4ee6" xlink:href="prgo-20230401.xsd#prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dda09715-f309-441e-a868-90faa3d12d94" xlink:to="loc_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems_4b6b5b3f-3db7-4d99-b950-2f62a21b4ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dda09715-f309-441e-a868-90faa3d12d94" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f3b6ddd6-08f0-45d5-9a29-a992c84977bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f3b6ddd6-08f0-45d5-9a29-a992c84977bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_403a6172-23ea-42ff-bee4-1916ad5c8a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_403a6172-23ea-42ff-bee4-1916ad5c8a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_93033fdb-8e41-4725-b6b5-54c8ffb5d185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_93033fdb-8e41-4725-b6b5-54c8ffb5d185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_08a00ba2-259d-48a8-a848-442d47715ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_08a00ba2-259d-48a8-a848-442d47715ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_3b64789c-0cdd-4b79-9be4-8e0cd686d797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_3b64789c-0cdd-4b79-9be4-8e0cd686d797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_dad52e36-6366-4ff7-ac14-e32e8572424e" xlink:href="prgo-20230401.xsd#prgo_IncreaseDecreaseInAccruedCustomerPrograms"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:to="loc_prgo_IncreaseDecreaseInAccruedCustomerPrograms_dad52e36-6366-4ff7-ac14-e32e8572424e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1a4699ff-8416-46a0-8b64-847a2911d16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1a4699ff-8416-46a0-8b64-847a2911d16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1f9109f2-976a-4e1a-bbf6-f2fb3c0482ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1f9109f2-976a-4e1a-bbf6-f2fb3c0482ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_a409d21a-3cd0-4319-9aaf-20d21bb497d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_a409d21a-3cd0-4319-9aaf-20d21bb497d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_18e4c2e7-4eae-42bb-9845-f652fa18721e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_963a1f8c-89b0-440a-b001-e1ec2bc7c4d6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_18e4c2e7-4eae-42bb-9845-f652fa18721e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fa2780dc-c0e5-4e10-853f-84859a451879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dda09715-f309-441e-a868-90faa3d12d94" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fa2780dc-c0e5-4e10-853f-84859a451879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15f2d964-162f-4b3f-a12d-d77da517e793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fb68755-9117-4048-87e8-654a8330dbe5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15f2d964-162f-4b3f-a12d-d77da517e793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8b54e5d2-d936-4ed7-bd1c-d521cdb2ff94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15f2d964-162f-4b3f-a12d-d77da517e793" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8b54e5d2-d936-4ed7-bd1c-d521cdb2ff94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_c55c8edd-6a15-4177-bf6e-3c6cd959a574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15f2d964-162f-4b3f-a12d-d77da517e793" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_c55c8edd-6a15-4177-bf6e-3c6cd959a574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_4f9637c8-29f5-41dc-a589-f2afbd8372d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15f2d964-162f-4b3f-a12d-d77da517e793" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_4f9637c8-29f5-41dc-a589-f2afbd8372d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_9b29ef5e-c8b2-4318-909c-437d215d7e1e" xlink:href="prgo-20230401.xsd#prgo_ProceedsfromRoyaltiesReceivedInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15f2d964-162f-4b3f-a12d-d77da517e793" xlink:to="loc_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities_9b29ef5e-c8b2-4318-909c-437d215d7e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce3493aa-e4b4-4920-8d5b-68225dc78134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15f2d964-162f-4b3f-a12d-d77da517e793" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce3493aa-e4b4-4920-8d5b-68225dc78134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_270d140a-87e9-459c-ba37-a05a7dd401ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fb68755-9117-4048-87e8-654a8330dbe5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_270d140a-87e9-459c-ba37-a05a7dd401ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_404f489e-f214-4d61-845d-d8a46044012f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_270d140a-87e9-459c-ba37-a05a7dd401ae" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_404f489e-f214-4d61-845d-d8a46044012f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_5b31737d-30e8-4045-9d63-1e160b1db288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_270d140a-87e9-459c-ba37-a05a7dd401ae" xlink:to="loc_us-gaap_PaymentsOfDividends_5b31737d-30e8-4045-9d63-1e160b1db288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_34a0e539-cb78-4911-b1e4-b8f601bfa772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_270d140a-87e9-459c-ba37-a05a7dd401ae" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_34a0e539-cb78-4911-b1e4-b8f601bfa772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2b6bfe19-a8e4-4645-8f24-87f80f26a2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_270d140a-87e9-459c-ba37-a05a7dd401ae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2b6bfe19-a8e4-4645-8f24-87f80f26a2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e44f6b1-c667-4d5c-8864-a832f5092b97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fb68755-9117-4048-87e8-654a8330dbe5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e44f6b1-c667-4d5c-8864-a832f5092b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6ea8a519-2fcb-47e9-baeb-99a604a3deb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fb68755-9117-4048-87e8-654a8330dbe5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6ea8a519-2fcb-47e9-baeb-99a604a3deb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f79b505b-5fcd-48b6-a8e2-8cc3f322bf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fb68755-9117-4048-87e8-654a8330dbe5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f79b505b-5fcd-48b6-a8e2-8cc3f322bf77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_0630ca89-6382-4b8d-ae76-ec7adb62c42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fb68755-9117-4048-87e8-654a8330dbe5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_0630ca89-6382-4b8d-ae76-ec7adb62c42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_c86e80ad-c90f-45c9-9ff3-aaf58d608a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fb68755-9117-4048-87e8-654a8330dbe5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_c86e80ad-c90f-45c9-9ff3-aaf58d608a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b52c1a0e-f39e-47e9-af56-bb234bfc010d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3fb68755-9117-4048-87e8-654a8330dbe5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b52c1a0e-f39e-47e9-af56-bb234bfc010d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="prgo-20230401.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8f01e382-404e-47cd-aeab-8180e2b9753a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_dc648454-abe5-443f-bd8a-c382b806c089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f01e382-404e-47cd-aeab-8180e2b9753a" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_dc648454-abe5-443f-bd8a-c382b806c089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognition" xlink:type="simple" xlink:href="prgo-20230401.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6daa634e-4d87-4c7c-a756-0fe8af50c98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1d4178c5-c7c4-4aa8-a1d1-ec13f075ac5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6daa634e-4d87-4c7c-a756-0fe8af50c98a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1d4178c5-c7c4-4aa8-a1d1-ec13f075ac5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestitures" xlink:type="simple" xlink:href="prgo-20230401.xsd#AcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1eea5d24-3c48-438d-863d-5582c7e0a56e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_b06f7322-260b-4537-97c6-dce532f446d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1eea5d24-3c48-438d-863d-5582c7e0a56e" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_b06f7322-260b-4537-97c6-dce532f446d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperations" xlink:type="simple" xlink:href="prgo-20230401.xsd#DiscontinuedOperations"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_35390dc8-fae2-4bef-a68c-19aeea20bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_71d45187-9645-452d-a31b-4a64adbb6768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_35390dc8-fae2-4bef-a68c-19aeea20bd1c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_71d45187-9645-452d-a31b-4a64adbb6768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/Inventories" xlink:type="simple" xlink:href="prgo-20230401.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_109fc7fb-4996-4285-b644-96f61f5ae5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_5dc5d9a0-ae3e-4bc4-b28a-447c28526550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_109fc7fb-4996-4285-b644-96f61f5ae5fa" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_5dc5d9a0-ae3e-4bc4-b28a-447c28526550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/Investments" xlink:type="simple" xlink:href="prgo-20230401.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_0100d56c-e6ab-4d82-a8a3-e36a7f3bb919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_9c6615bd-f806-48ea-9517-1080c079fab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_0100d56c-e6ab-4d82-a8a3-e36a7f3bb919" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_9c6615bd-f806-48ea-9517-1080c079fab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/Leases" xlink:type="simple" xlink:href="prgo-20230401.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c729d4c1-28e7-483c-8c2f-b8c8a6218738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_30f3eafa-81e2-4e93-801e-ff252c541705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c729d4c1-28e7-483c-8c2f-b8c8a6218738" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_30f3eafa-81e2-4e93-801e-ff252c541705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_0bff3e44-ffb1-4afe-aade-4842e0301ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c729d4c1-28e7-483c-8c2f-b8c8a6218738" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_0bff3e44-ffb1-4afe-aade-4842e0301ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="prgo-20230401.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8079aedd-c710-40b3-860b-871efab27547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_40c4ef82-943f-4b18-9f33-8634cd1b5736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8079aedd-c710-40b3-860b-871efab27547" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_40c4ef82-943f-4b18-9f33-8634cd1b5736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="prgo-20230401.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1c2d2441-7e91-4729-a7f4-96b2de83433f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_bb086d80-38bd-42a1-bf9d-af0c161dce4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c2d2441-7e91-4729-a7f4-96b2de83433f" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_bb086d80-38bd-42a1-bf9d-af0c161dce4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivities"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c2017c72-3985-49e5-a675-6d03f0d3b998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_32acc841-318c-46b1-95e2-f97821fda71d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c2017c72-3985-49e5-a675-6d03f0d3b998" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_32acc841-318c-46b1-95e2-f97821fda71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/Indebtedness" xlink:type="simple" xlink:href="prgo-20230401.xsd#Indebtedness"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Indebtedness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_de0a8cd2-4d50-43fe-85fb-45a107c0f393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_480a6434-6550-4bb4-b335-c813ed95e00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_de0a8cd2-4d50-43fe-85fb-45a107c0f393" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_480a6434-6550-4bb4-b335-c813ed95e00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquity" xlink:type="simple" xlink:href="prgo-20230401.xsd#EarningsPerShareandShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_36640eda-f32e-4fae-844e-b072a398b156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_dfb5557d-759f-48b5-a300-a2cfc0507063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_36640eda-f32e-4fae-844e-b072a398b156" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_dfb5557d-759f-48b5-a300-a2cfc0507063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="prgo-20230401.xsd#AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_03a072df-f9b8-45a6-986a-f6708b52fde5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_2e8511f2-693a-4369-8895-5ca7f48af75c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_03a072df-f9b8-45a6-986a-f6708b52fde5" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_2e8511f2-693a-4369-8895-5ca7f48af75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringCharges" xlink:type="simple" xlink:href="prgo-20230401.xsd#RestructuringCharges"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RestructuringCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_cd7d589c-bdf6-42c8-b073-ac1a370d3a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_82047363-a487-4398-b13b-78bd3f8cae87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_cd7d589c-bdf6-42c8-b073-ac1a370d3a42" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_82047363-a487-4398-b13b-78bd3f8cae87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxes" xlink:type="simple" xlink:href="prgo-20230401.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0c6f35d1-26e5-4e74-a30e-2b459a29c09a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1ce8eb51-5102-4b36-85bc-a88418ee5ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c6f35d1-26e5-4e74-a30e-2b459a29c09a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1ce8eb51-5102-4b36-85bc-a88418ee5ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/Contingencies" xlink:type="simple" xlink:href="prgo-20230401.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b4bcafa3-f94a-4a85-be01-fce4d98d8abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_331ef0e6-c7db-419a-96ee-acea76b84863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b4bcafa3-f94a-4a85-be01-fce4d98d8abf" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_331ef0e6-c7db-419a-96ee-acea76b84863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformation" xlink:type="simple" xlink:href="prgo-20230401.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c850bd81-a9ca-4392-928f-845ce66e0a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0866ca24-b86c-4a34-a09e-7b55b0fa0a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c850bd81-a9ca-4392-928f-845ce66e0a14" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0866ca24-b86c-4a34-a09e-7b55b0fa0a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SubsequentEvents" xlink:type="simple" xlink:href="prgo-20230401.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_29170851-b25e-498e-b6d3-7ca05c14dd01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_6af57a2f-acde-4e1c-a0e1-cbbdd3fba528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_29170851-b25e-498e-b6d3-7ca05c14dd01" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_6af57a2f-acde-4e1c-a0e1-cbbdd3fba528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="prgo-20230401.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d420e06d-b290-4c86-b495-e422c50ec4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_38aca58c-6503-45de-bb84-db857ba0507d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d420e06d-b290-4c86-b495-e422c50ec4ec" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_38aca58c-6503-45de-bb84-db857ba0507d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_3ae3d5f5-b340-43e7-a062-06251c1c15cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d420e06d-b290-4c86-b495-e422c50ec4ec" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_3ae3d5f5-b340-43e7-a062-06251c1c15cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_973af08a-a5ca-41c3-9186-ba3ca068b9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d420e06d-b290-4c86-b495-e422c50ec4ec" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_973af08a-a5ca-41c3-9186-ba3ca068b9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_8a075c47-442c-488b-be10-e53bd15fc43c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d420e06d-b290-4c86-b495-e422c50ec4ec" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_8a075c47-442c-488b-be10-e53bd15fc43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8575fe7f-8b26-4479-a971-b6720373fbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_b6f31de9-b4e7-40c7-b4ac-45259788fdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8575fe7f-8b26-4479-a971-b6720373fbcb" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_b6f31de9-b4e7-40c7-b4ac-45259788fdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_98d54de6-4b85-4d0b-abdb-e686d64796dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ebbd8db1-49b7-41b9-9c4a-b3e25dd60765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_98d54de6-4b85-4d0b-abdb-e686d64796dc" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ebbd8db1-49b7-41b9-9c4a-b3e25dd60765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_b163437f-45c6-47ea-91fe-60e1e0f40a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_98d54de6-4b85-4d0b-abdb-e686d64796dc" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_b163437f-45c6-47ea-91fe-60e1e0f40a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/BusinessCombinationsandAssetAcquisitionsTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#BusinessCombinationsandAssetAcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/BusinessCombinationsandAssetAcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2fe99164-2c4b-458f-a350-2c2dd3a5fb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_f110259b-98a7-4364-9765-ddd88175e391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2fe99164-2c4b-458f-a350-2c2dd3a5fb4d" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_f110259b-98a7-4364-9765-ddd88175e391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8b2eaf77-5f5c-4d7c-ad7f-4d221c9d8015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_07b63b81-15f9-4c93-bbf1-6cba879688a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8b2eaf77-5f5c-4d7c-ad7f-4d221c9d8015" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_07b63b81-15f9-4c93-bbf1-6cba879688a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_edbe381d-3821-4fe7-8c3b-e02928e052bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_8cc34362-fed2-4660-b8af-a11e696bafc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_edbe381d-3821-4fe7-8c3b-e02928e052bb" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_8cc34362-fed2-4660-b8af-a11e696bafc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_89444223-6ded-41d1-9904-64c6f8853a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_edbe381d-3821-4fe7-8c3b-e02928e052bb" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_89444223-6ded-41d1-9904-64c6f8853a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c314f36a-5a39-4319-ab26-cc7458876071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock_0be3dad6-477f-450a-8eaa-f26659e29554" xlink:href="prgo-20230401.xsd#prgo_AssetsandLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c314f36a-5a39-4319-ab26-cc7458876071" xlink:to="loc_prgo_AssetsandLiabilitiesLesseeTableTextBlock_0be3dad6-477f-450a-8eaa-f26659e29554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_137a71bb-5abc-4593-b9b6-8da89ab7ea66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c314f36a-5a39-4319-ab26-cc7458876071" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_137a71bb-5abc-4593-b9b6-8da89ab7ea66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_b3fb2e99-1155-4871-8e7e-954a3f219367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c314f36a-5a39-4319-ab26-cc7458876071" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_b3fb2e99-1155-4871-8e7e-954a3f219367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6f818634-afc1-47ec-a834-6bda1e88359f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c314f36a-5a39-4319-ab26-cc7458876071" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6f818634-afc1-47ec-a834-6bda1e88359f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_b439b7ba-d51f-4fce-8b80-235a8b6142ad" xlink:href="prgo-20230401.xsd#prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c314f36a-5a39-4319-ab26-cc7458876071" xlink:to="loc_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock_b439b7ba-d51f-4fce-8b80-235a8b6142ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeCashFlowClassificationsTableTextBlock_ea26a711-dda3-4e06-a03c-3019298ec6cf" xlink:href="prgo-20230401.xsd#prgo_LesseeCashFlowClassificationsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c314f36a-5a39-4319-ab26-cc7458876071" xlink:to="loc_prgo_LesseeCashFlowClassificationsTableTextBlock_ea26a711-dda3-4e06-a03c-3019298ec6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_78ea6f20-39fe-4d8a-87dd-490a1c8ca588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_37885e8d-812b-4218-a384-7544615164a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_78ea6f20-39fe-4d8a-87dd-490a1c8ca588" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_37885e8d-812b-4218-a384-7544615164a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_2fc63fe4-ac79-43c7-9fcd-e872b54d766d" xlink:href="prgo-20230401.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_78ea6f20-39fe-4d8a-87dd-490a1c8ca588" xlink:to="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock_2fc63fe4-ac79-43c7-9fcd-e872b54d766d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_788aef5b-55cd-4496-a5a5-546cd99a7d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_294b2391-0001-4c61-be25-f00787e709e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_788aef5b-55cd-4496-a5a5-546cd99a7d45" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_294b2391-0001-4c61-be25-f00787e709e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_248581ad-7e80-474f-adcb-0e65380d7315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_788aef5b-55cd-4496-a5a5-546cd99a7d45" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_248581ad-7e80-474f-adcb-0e65380d7315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0175c10f-f5c0-44b0-81d0-6bbadb86eebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_d699b5f6-8d21-4ab4-a8a1-8d11ff229598" xlink:href="prgo-20230401.xsd#prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0175c10f-f5c0-44b0-81d0-6bbadb86eebd" xlink:to="loc_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock_d699b5f6-8d21-4ab4-a8a1-8d11ff229598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_017e8772-de0a-4a0a-8e61-003eb0159976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0175c10f-f5c0-44b0-81d0-6bbadb86eebd" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_017e8772-de0a-4a0a-8e61-003eb0159976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2eec4c4d-16b2-4a38-8983-719d4ea173d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0175c10f-f5c0-44b0-81d0-6bbadb86eebd" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_2eec4c4d-16b2-4a38-8983-719d4ea173d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_681e868a-b9cc-4ced-8b3d-85a9a1d6e37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0175c10f-f5c0-44b0-81d0-6bbadb86eebd" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_681e868a-b9cc-4ced-8b3d-85a9a1d6e37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5bf9a2e5-5c6e-4c07-9df3-498523f488ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0175c10f-f5c0-44b0-81d0-6bbadb86eebd" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5bf9a2e5-5c6e-4c07-9df3-498523f488ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#IndebtednessTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IndebtednessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_368aa597-f888-4e94-96d1-9aaf660f58e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_30201e9f-f6c2-4184-b0fc-a654b7e0ad17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_368aa597-f888-4e94-96d1-9aaf660f58e2" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_30201e9f-f6c2-4184-b0fc-a654b7e0ad17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#EarningsPerShareandShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7ba877bd-77de-4aac-91cb-b552c5ed82a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_95131317-3be8-45e3-a1bf-c582d335b729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7ba877bd-77de-4aac-91cb-b552c5ed82a1" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_95131317-3be8-45e3-a1bf-c582d335b729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2ae99ad5-d5dc-4bc6-ba01-4b18dc8714d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_97056291-c0aa-43db-b51e-bdaa08b35420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2ae99ad5-d5dc-4bc6-ba01-4b18dc8714d3" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_97056291-c0aa-43db-b51e-bdaa08b35420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#RestructuringChargesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RestructuringChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_e437ca6c-75ce-41df-8825-10c5a58487bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_75395399-bb3b-4c35-8dbf-6994afd43544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_e437ca6c-75ce-41df-8825-10c5a58487bb" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_75395399-bb3b-4c35-8dbf-6994afd43544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_65d81ce1-4f02-4160-bb49-c764a0c21b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b491a297-245c-4d93-a308-9eed93fbc8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_65d81ce1-4f02-4160-bb49-c764a0c21b2e" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b491a297-245c-4d93-a308-9eed93fbc8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="prgo-20230401.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d5699316-d514-49a1-a9b5-d01395b219fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_e6e484dd-ed68-44cf-a1d9-0d51746c5df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d5699316-d514-49a1-a9b5-d01395b219fc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_e6e484dd-ed68-44cf-a1d9-0d51746c5df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d4250dfc-07fb-40f9-8333-936ca35681b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d9d1f3c8-d4f6-4c3a-91e2-9c1fc189012e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d4250dfc-07fb-40f9-8333-936ca35681b8" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d9d1f3c8-d4f6-4c3a-91e2-9c1fc189012e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6e3a94db-0044-4078-ae4c-104959c44ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d9d1f3c8-d4f6-4c3a-91e2-9c1fc189012e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6e3a94db-0044-4078-ae4c-104959c44ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_e658f646-3cb3-4585-aba6-a8875a6383c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d9d1f3c8-d4f6-4c3a-91e2-9c1fc189012e" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_e658f646-3cb3-4585-aba6-a8875a6383c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_0ac38e25-9f9f-495f-a0e9-d330a7ecbdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d9d1f3c8-d4f6-4c3a-91e2-9c1fc189012e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_0ac38e25-9f9f-495f-a0e9-d330a7ecbdc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment_6f842234-61f9-4c1a-abcf-71e5b14359d3" xlink:href="prgo-20230401.xsd#prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d9d1f3c8-d4f6-4c3a-91e2-9c1fc189012e" xlink:to="loc_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment_6f842234-61f9-4c1a-abcf-71e5b14359d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_08f8b7e6-6b26-42ee-a932-d05578db6826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d9d1f3c8-d4f6-4c3a-91e2-9c1fc189012e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_08f8b7e6-6b26-42ee-a932-d05578db6826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RevenueRecognitionScheduleofRevenuebyProductDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_93724cac-ac0f-429b-80f2-ea2878217177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_501ddb74-9655-4b56-abb7-68073d19ffbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_93724cac-ac0f-429b-80f2-ea2878217177" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_501ddb74-9655-4b56-abb7-68073d19ffbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eab438f9-4412-45fe-9509-cf0bbddd88db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_501ddb74-9655-4b56-abb7-68073d19ffbd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eab438f9-4412-45fe-9509-cf0bbddd88db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0aab937c-36ad-44f8-a6f3-b086c5c9e575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eab438f9-4412-45fe-9509-cf0bbddd88db" xlink:to="loc_us-gaap_SegmentDomain_0aab937c-36ad-44f8-a6f3-b086c5c9e575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_01ca6a52-d4cb-4add-9a4a-fb1de83879cc" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0aab937c-36ad-44f8-a6f3-b086c5c9e575" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_01ca6a52-d4cb-4add-9a4a-fb1de83879cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_8f1717ee-24a3-4e04-80a4-4fd00c27dde5" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0aab937c-36ad-44f8-a6f3-b086c5c9e575" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_8f1717ee-24a3-4e04-80a4-4fd00c27dde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4aa41529-9294-4797-adc0-684710e4ca23" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_501ddb74-9655-4b56-abb7-68073d19ffbd" xlink:to="loc_srt_ProductOrServiceAxis_4aa41529-9294-4797-adc0-684710e4ca23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4aa41529-9294-4797-adc0-684710e4ca23" xlink:to="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_UpperRespiratoryMember_6569fbb5-9b8b-4acd-936b-9f027df9d83c" xlink:href="prgo-20230401.xsd#prgo_UpperRespiratoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_UpperRespiratoryMember_6569fbb5-9b8b-4acd-936b-9f027df9d83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NutritionMember_27e43b54-3fd8-4cb7-a14f-cf4003bd9e61" xlink:href="prgo-20230401.xsd#prgo_NutritionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_NutritionMember_27e43b54-3fd8-4cb7-a14f-cf4003bd9e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DigestiveHealthMember_6242aabf-a2da-4968-ba9f-8d69ca292391" xlink:href="prgo-20230401.xsd#prgo_DigestiveHealthMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_DigestiveHealthMember_6242aabf-a2da-4968-ba9f-8d69ca292391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PainandSleepaidsMember_c51411ce-eaf0-4aff-8b68-2a77905c3bfc" xlink:href="prgo-20230401.xsd#prgo_PainandSleepaidsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_PainandSleepaidsMember_c51411ce-eaf0-4aff-8b68-2a77905c3bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OralSelfcareMember_ebfb594f-766c-47ef-b833-28f43c2d3ef1" xlink:href="prgo-20230401.xsd#prgo_OralSelfcareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_OralSelfcareMember_ebfb594f-766c-47ef-b833-28f43c2d3ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HealthyLifestyleMember_5d250e9a-45bf-4c71-b842-43c1c966a4c9" xlink:href="prgo-20230401.xsd#prgo_HealthyLifestyleMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_HealthyLifestyleMember_5d250e9a-45bf-4c71-b842-43c1c966a4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SkinCareMember_385f2f49-9248-42b2-b7b8-402c806d8df4" xlink:href="prgo-20230401.xsd#prgo_SkinCareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_SkinCareMember_385f2f49-9248-42b2-b7b8-402c806d8df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_WomensHealthMember_89835f29-7ab6-42c2-b12e-93ac4890a080" xlink:href="prgo-20230401.xsd#prgo_WomensHealthMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_WomensHealthMember_89835f29-7ab6-42c2-b12e-93ac4890a080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_VitaminsMineralsandSupplementsMember_29349ce2-dc0e-4d9e-8e2c-15d8bea38389" xlink:href="prgo-20230401.xsd#prgo_VitaminsMineralsandSupplementsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_VitaminsMineralsandSupplementsMember_29349ce2-dc0e-4d9e-8e2c-15d8bea38389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCAMember_3b6fe753-526e-488e-9c30-b76d8a0940ef" xlink:href="prgo-20230401.xsd#prgo_OtherCSCAMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_OtherCSCAMember_3b6fe753-526e-488e-9c30-b76d8a0940ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherCSCIMember_636f6abb-53c8-4f57-9f08-b04d26aa09b3" xlink:href="prgo-20230401.xsd#prgo_OtherCSCIMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cad1cff7-ae01-42c5-9ec1-289efa27b0ab" xlink:to="loc_prgo_OtherCSCIMember_636f6abb-53c8-4f57-9f08-b04d26aa09b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3672e78a-ce0e-4465-98aa-ef421c99e8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_501ddb74-9655-4b56-abb7-68073d19ffbd" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_3672e78a-ce0e-4465-98aa-ef421c99e8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_08840394-f865-4363-b07a-5a3452355ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3672e78a-ce0e-4465-98aa-ef421c99e8a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_08840394-f865-4363-b07a-5a3452355ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RevenueRecognitionAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_391a065c-134d-4ce9-8637-83840aef5b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bf21b5d5-61cf-4e83-a311-2883a9876337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_391a065c-134d-4ce9-8637-83840aef5b0f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bf21b5d5-61cf-4e83-a311-2883a9876337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4cc7ac89-b988-4c28-8af0-f321074503b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bf21b5d5-61cf-4e83-a311-2883a9876337" xlink:to="loc_srt_ProductOrServiceAxis_4cc7ac89-b988-4c28-8af0-f321074503b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8a1037f3-c6a6-4cbf-8aaf-980dbe3eeb62" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4cc7ac89-b988-4c28-8af0-f321074503b0" xlink:to="loc_srt_ProductsAndServicesDomain_8a1037f3-c6a6-4cbf-8aaf-980dbe3eeb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContractManufacturingMember_f455360d-1d3c-40dd-a82f-3b644ef8e91b" xlink:href="prgo-20230401.xsd#prgo_ContractManufacturingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8a1037f3-c6a6-4cbf-8aaf-980dbe3eeb62" xlink:to="loc_prgo_ContractManufacturingMember_f455360d-1d3c-40dd-a82f-3b644ef8e91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ec3e4828-ca1b-4cbb-93f0-04a33e90e92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bf21b5d5-61cf-4e83-a311-2883a9876337" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_ec3e4828-ca1b-4cbb-93f0-04a33e90e92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f589b4df-8423-4e0d-9855-660c3ca4bf28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ec3e4828-ca1b-4cbb-93f0-04a33e90e92d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f589b4df-8423-4e0d-9855-660c3ca4bf28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RevenueRecognitionScheduleofContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_888e2199-544a-4d51-bfb7-b8d832e90c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_0b0124b9-8428-47e5-94d4-28f243f043ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_888e2199-544a-4d51-bfb7-b8d832e90c8c" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_0b0124b9-8428-47e5-94d4-28f243f043ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d8fef3cc-761b-4616-9ba4-2e22fbd9fe32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3b0573d7-b3fe-4761-97f0-1337ed2cac1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d8fef3cc-761b-4616-9ba4-2e22fbd9fe32" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3b0573d7-b3fe-4761-97f0-1337ed2cac1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b0a9eb82-ff39-48a6-8d41-2b5c58f9f679" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3b0573d7-b3fe-4761-97f0-1337ed2cac1c" xlink:to="loc_srt_StatementGeographicalAxis_b0a9eb82-ff39-48a6-8d41-2b5c58f9f679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b0a9eb82-ff39-48a6-8d41-2b5c58f9f679" xlink:to="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cb4f162f-5f88-43c3-8fdc-ec92da18b69e" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:to="loc_country_US_cb4f162f-5f88-43c3-8fdc-ec92da18b69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_2c06c798-3c37-4b6d-9dc0-58b4b59f2e26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:to="loc_srt_EuropeMember_2c06c798-3c37-4b6d-9dc0-58b4b59f2e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherGeographicalAreasMember_95713dbb-5cec-4f08-9f0e-2d55c17d28b8" xlink:href="prgo-20230401.xsd#prgo_OtherGeographicalAreasMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:to="loc_prgo_OtherGeographicalAreasMember_95713dbb-5cec-4f08-9f0e-2d55c17d28b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_c5ec377b-3b3c-4654-8a7d-e0f668797f61" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0bf80536-ea6d-4640-b17e-cdd69bdb2471" xlink:to="loc_country_IE_c5ec377b-3b3c-4654-8a7d-e0f668797f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ae30e29b-07df-4d04-ad9e-d7e2d5a8b42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3b0573d7-b3fe-4761-97f0-1337ed2cac1c" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_ae30e29b-07df-4d04-ad9e-d7e2d5a8b42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_53ce9e96-24b1-48fc-862f-1dbf1fda568a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ae30e29b-07df-4d04-ad9e-d7e2d5a8b42c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_53ce9e96-24b1-48fc-862f-1dbf1fda568a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#AcquisitionsandDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d790b8fd-c056-4c7c-a8aa-7be8d8f37e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d790b8fd-c056-4c7c-a8aa-7be8d8f37e13" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e22718e7-b05b-4a02-a3aa-ae75dfc81994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e22718e7-b05b-4a02-a3aa-ae75dfc81994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e31a4b06-9870-4732-ae0d-28e1ade69585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e22718e7-b05b-4a02-a3aa-ae75dfc81994" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e31a4b06-9870-4732-ae0d-28e1ade69585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaMember_bc239b9e-5244-4133-a313-3d7718a6d1fe" xlink:href="prgo-20230401.xsd#prgo_HRAPharmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e31a4b06-9870-4732-ae0d-28e1ade69585" xlink:to="loc_prgo_HRAPharmaMember_bc239b9e-5244-4133-a313-3d7718a6d1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_2d884593-80b9-4081-9f58-4de3f3bcf680" xlink:href="prgo-20230401.xsd#prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e31a4b06-9870-4732-ae0d-28e1ade69585" xlink:to="loc_prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember_2d884593-80b9-4081-9f58-4de3f3bcf680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_50708edc-4de6-43d9-9300-91dc3ecb9a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_50708edc-4de6-43d9-9300-91dc3ecb9a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cf3236e5-3fd1-4185-a6bf-4508e1706f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_50708edc-4de6-43d9-9300-91dc3ecb9a70" xlink:to="loc_us-gaap_SegmentDomain_cf3236e5-3fd1-4185-a6bf-4508e1706f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_637126c8-3902-4a37-b563-7cd58fa48a41" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cf3236e5-3fd1-4185-a6bf-4508e1706f0b" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_637126c8-3902-4a37-b563-7cd58fa48a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_a3e8c634-a4cc-4627-a8ee-9835ff4565a5" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cf3236e5-3fd1-4185-a6bf-4508e1706f0b" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_a3e8c634-a4cc-4627-a8ee-9835ff4565a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b97ce78b-b3dd-4f9c-845a-dab936d145cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b97ce78b-b3dd-4f9c-845a-dab936d145cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f4de1124-7925-422b-a491-635ebad28146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b97ce78b-b3dd-4f9c-845a-dab936d145cc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f4de1124-7925-422b-a491-635ebad28146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_d7303661-08ea-44e9-8541-6895251890a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f4de1124-7925-422b-a491-635ebad28146" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_d7303661-08ea-44e9-8541-6895251890a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2f59ec9-ccc0-4d61-8d4a-23e6187dafbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2f59ec9-ccc0-4d61-8d4a-23e6187dafbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_feef9724-f38b-4ed6-b217-619d069f80e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2f59ec9-ccc0-4d61-8d4a-23e6187dafbd" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_feef9724-f38b-4ed6-b217-619d069f80e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AdventInternationalMember_fd3db771-d9f9-44ad-9228-76a771af3517" xlink:href="prgo-20230401.xsd#prgo_AdventInternationalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_feef9724-f38b-4ed6-b217-619d069f80e3" xlink:to="loc_prgo_AdventInternationalMember_fd3db771-d9f9-44ad-9228-76a771af3517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LatinAmericaBusinessMember_1285d53b-4f21-4796-bdb1-109833432f2c" xlink:href="prgo-20230401.xsd#prgo_LatinAmericaBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_feef9724-f38b-4ed6-b217-619d069f80e3" xlink:to="loc_prgo_LatinAmericaBusinessMember_1285d53b-4f21-4796-bdb1-109833432f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScarAwayMember_a9e5ba58-f772-4615-9b6e-38b8a380c100" xlink:href="prgo-20230401.xsd#prgo_ScarAwayMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_feef9724-f38b-4ed6-b217-619d069f80e3" xlink:to="loc_prgo_ScarAwayMember_a9e5ba58-f772-4615-9b6e-38b8a380c100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fd483778-b97e-40fe-bcaa-15e716d3a33b" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_cff032d8-ffd0-4617-8b90-22f55f10528c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_cff032d8-ffd0-4617-8b90-22f55f10528c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fbab0b57-b237-4adb-9707-9c80c1636798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fbab0b57-b237-4adb-9707-9c80c1636798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f95627a2-c619-45c6-97e8-ec560a4335a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_Goodwill_f95627a2-c619-45c6-97e8-ec560a4335a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_ef66f703-50d1-4379-8791-79f3b6bb31ab" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles_ef66f703-50d1-4379-8791-79f3b6bb31ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_3156aa00-1e31-4036-9082-45be4e2d28e5" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_3156aa00-1e31-4036-9082-45be4e2d28e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_9abe7b76-07c9-4a64-806c-20cd05fa19dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_9abe7b76-07c9-4a64-806c-20cd05fa19dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5a10aae7-4cbf-4c48-82f9-29fb60228617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5a10aae7-4cbf-4c48-82f9-29fb60228617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_7f22e485-53ac-4557-999b-dd4caca8711d" xlink:href="prgo-20230401.xsd#prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales_7f22e485-53ac-4557-999b-dd4caca8711d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d45b42b2-e1ce-48ee-965e-848c099e489f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d45b42b2-e1ce-48ee-965e-848c099e489f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_fcb8f707-f945-448d-a7f1-5576ba8d99ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_fcb8f707-f945-448d-a7f1-5576ba8d99ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_1bc4c5c5-f540-4fcb-8845-fc4da9669c66" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne_1bc4c5c5-f540-4fcb-8845-fc4da9669c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_f534f8aa-eb7f-4368-b871-3f2ebbb68d7c" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo_f534f8aa-eb7f-4368-b871-3f2ebbb68d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_148f8881-c04a-437e-9ad2-67f93f5b0dc3" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables_148f8881-c04a-437e-9ad2-67f93f5b0dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_f2155ef0-4c1d-4003-a910-82ab4c812280" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration_f2155ef0-4c1d-4003-a910-82ab4c812280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_53023296-8520-41ef-abb3-bcf49b43df3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_32e62900-6c07-4869-9b41-e6430c7361e6" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_53023296-8520-41ef-abb3-bcf49b43df3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#AcquisitionsandDivestituresProFormaDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b25b6dc0-80d5-4c4e-9099-d627f1fc789d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_7d767f30-0e4c-404e-8127-367a55553651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b25b6dc0-80d5-4c4e-9099-d627f1fc789d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_7d767f30-0e4c-404e-8127-367a55553651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_86f931d6-3e87-49d3-b9ba-d5a1a07f77d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b25b6dc0-80d5-4c4e-9099-d627f1fc789d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_86f931d6-3e87-49d3-b9ba-d5a1a07f77d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DiscontinuedOperationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_9819b11d-553e-4fd6-833d-76660cdeb586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_9819b11d-553e-4fd6-833d-76660cdeb586" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d5071f72-0304-4e3f-8e08-5d4f762e6ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d5071f72-0304-4e3f-8e08-5d4f762e6ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3256b0c6-2048-4d89-b6ab-91fbe196ba7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d5071f72-0304-4e3f-8e08-5d4f762e6ee4" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3256b0c6-2048-4d89-b6ab-91fbe196ba7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_3c9960e6-a65c-4efb-8119-a01d6eb10e64" xlink:href="prgo-20230401.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3256b0c6-2048-4d89-b6ab-91fbe196ba7c" xlink:to="loc_prgo_RXPharmaceuticalsMember_3c9960e6-a65c-4efb-8119-a01d6eb10e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_952fb628-eaf1-4659-bce4-c44f1aba607f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_952fb628-eaf1-4659-bce4-c44f1aba607f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8f397071-caa4-41d3-b9d9-64cc548009e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_952fb628-eaf1-4659-bce4-c44f1aba607f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8f397071-caa4-41d3-b9d9-64cc548009e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_001e179b-b596-450e-84cf-fbeb85a07409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_8f397071-caa4-41d3-b9d9-64cc548009e4" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_001e179b-b596-450e-84cf-fbeb85a07409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d17dfaab-e286-45da-bd61-4f04e3df4918" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:to="loc_srt_CounterpartyNameAxis_d17dfaab-e286-45da-bd61-4f04e3df4918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1f957797-641c-4dc0-a6b8-6ea85cd0ccd3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d17dfaab-e286-45da-bd61-4f04e3df4918" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1f957797-641c-4dc0-a6b8-6ea85cd0ccd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RXPharmaceuticalsMember_b7c2223a-316f-4b8e-99e3-37a151d1786e" xlink:href="prgo-20230401.xsd#prgo_RXPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1f957797-641c-4dc0-a6b8-6ea85cd0ccd3" xlink:to="loc_prgo_RXPharmaceuticalsMember_b7c2223a-316f-4b8e-99e3-37a151d1786e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8857c858-0085-46e5-81a9-0274b0b6ebcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5c21c1a8-f44f-4e7b-9948-6f04e7203f9b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8857c858-0085-46e5-81a9-0274b0b6ebcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8857c858-0085-46e5-81a9-0274b0b6ebcf" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25397d74-5052-4d31-af5e-d6ca31b7d0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_25397d74-5052-4d31-af5e-d6ca31b7d0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_d290201b-fb68-455e-bf05-6fa41bd3511f" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser_d290201b-fb68-455e-bf05-6fa41bd3511f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_9416cc81-4c76-4544-b2c4-2ba41694465d" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm_9416cc81-4c76-4544-b2c4-2ba41694465d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_bea0169f-1f4b-486f-a790-4b4525cc8b43" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm_bea0169f-1f4b-486f-a790-4b4525cc8b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_3c627a8d-b801-4857-a124-3fe47cf1ad29" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities_3c627a8d-b801-4857-a124-3fe47cf1ad29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_ab46cb83-302b-4e62-8fa6-efe5594fedc6" xlink:href="prgo-20230401.xsd#prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_4e869f54-8c15-426a-a1c5-0da6756c75ff" xlink:to="loc_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset_ab46cb83-302b-4e62-8fa6-efe5594fedc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InventoriesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_620be2a6-c37d-4251-93f4-1b85553cca96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_04365952-559d-4e4e-bc58-d485eac9f7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_620be2a6-c37d-4251-93f4-1b85553cca96" xlink:to="loc_us-gaap_InventoryFinishedGoods_04365952-559d-4e4e-bc58-d485eac9f7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_c0301c6a-b222-4817-a067-d01b2fbf1d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_620be2a6-c37d-4251-93f4-1b85553cca96" xlink:to="loc_us-gaap_InventoryWorkInProcess_c0301c6a-b222-4817-a067-d01b2fbf1d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_ee598ce5-f3aa-47b0-91c4-824e639c7068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_620be2a6-c37d-4251-93f4-1b85553cca96" xlink:to="loc_us-gaap_InventoryRawMaterials_ee598ce5-f3aa-47b0-91c4-824e639c7068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_58beb809-53d1-4fc2-8de5-a8bb909d14b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_620be2a6-c37d-4251-93f4-1b85553cca96" xlink:to="loc_us-gaap_InventoryNet_58beb809-53d1-4fc2-8de5-a8bb909d14b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#InvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/InvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_4752e4c9-d29d-4ada-a762-2968d85b8f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_07c28d84-d80b-4ebc-9811-724200b852a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_4752e4c9-d29d-4ada-a762-2968d85b8f66" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_07c28d84-d80b-4ebc-9811-724200b852a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_20ebd119-1b0d-42c9-994a-82a120d4666c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_07c28d84-d80b-4ebc-9811-724200b852a0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_20ebd119-1b0d-42c9-994a-82a120d4666c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9d29d69f-c348-4b4a-9d49-d27b80bd0bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_20ebd119-1b0d-42c9-994a-82a120d4666c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9d29d69f-c348-4b4a-9d49-d27b80bd0bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_39fbb2b4-769e-42ae-b494-903dc047b836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9d29d69f-c348-4b4a-9d49-d27b80bd0bc9" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_39fbb2b4-769e-42ae-b494-903dc047b836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_1ac6210d-3bd8-43de-b06d-571f1219fca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9d29d69f-c348-4b4a-9d49-d27b80bd0bc9" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_1ac6210d-3bd8-43de-b06d-571f1219fca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_171937b3-5e56-49a9-b361-ac646a76862e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_07c28d84-d80b-4ebc-9811-724200b852a0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_171937b3-5e56-49a9-b361-ac646a76862e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c41fe227-60fd-4e54-abad-b866ad6f0b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_171937b3-5e56-49a9-b361-ac646a76862e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c41fe227-60fd-4e54-abad-b866ad6f0b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_fc5cf044-ccfc-48af-b047-6fa0d3ba13cb" xlink:href="prgo-20230401.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c41fe227-60fd-4e54-abad-b866ad6f0b1a" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_fc5cf044-ccfc-48af-b047-6fa0d3ba13cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_07c28d84-d80b-4ebc-9811-724200b852a0" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3f42da89-2652-45d6-a742-c01beb9c21ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3f42da89-2652-45d6-a742-c01beb9c21ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_aeedec4b-f081-4f56-b2f1-e345c0e027b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:to="loc_us-gaap_EquityMethodInvestments_aeedec4b-f081-4f56-b2f1-e345c0e027b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8776a786-2b3b-4d3f-bd30-f6a06d1965aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8776a786-2b3b-4d3f-bd30-f6a06d1965aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2328e100-00cd-45cd-b5a0-05bd73c86cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_77e93a90-5091-4c90-840c-a013d5c4acd7" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2328e100-00cd-45cd-b5a0-05bd73c86cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bfe9ccb7-46e5-4ecc-a1f2-cf81f966b1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_96f8ee68-701d-422c-afac-601c44674dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bfe9ccb7-46e5-4ecc-a1f2-cf81f966b1f0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_96f8ee68-701d-422c-afac-601c44674dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e59e333c-c3d8-4d78-b418-ffab79fb09a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_96f8ee68-701d-422c-afac-601c44674dd2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e59e333c-c3d8-4d78-b418-ffab79fb09a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_280291b1-27c9-495e-a7ca-10a7b32289ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e59e333c-c3d8-4d78-b418-ffab79fb09a8" xlink:to="loc_us-gaap_SegmentDomain_280291b1-27c9-495e-a7ca-10a7b32289ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_c79180e3-5647-4d88-b335-266c4b1e854e" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_280291b1-27c9-495e-a7ca-10a7b32289ba" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_c79180e3-5647-4d88-b335-266c4b1e854e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_ef51cb03-21f0-4459-8a24-dd5d92dbcd8a" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_280291b1-27c9-495e-a7ca-10a7b32289ba" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_ef51cb03-21f0-4459-8a24-dd5d92dbcd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_125acbd9-6ead-4a10-a9d6-e2f1d1454ab8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_96f8ee68-701d-422c-afac-601c44674dd2" xlink:to="loc_srt_ConsolidationItemsAxis_125acbd9-6ead-4a10-a9d6-e2f1d1454ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a9925093-c8aa-43ba-9b57-d91ccf63a718" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_125acbd9-6ead-4a10-a9d6-e2f1d1454ab8" xlink:to="loc_srt_ConsolidationItemsDomain_a9925093-c8aa-43ba-9b57-d91ccf63a718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_144fe132-3074-4c02-aebc-5d59e86157f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a9925093-c8aa-43ba-9b57-d91ccf63a718" xlink:to="loc_us-gaap_OperatingSegmentsMember_144fe132-3074-4c02-aebc-5d59e86157f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_a6e83855-9711-4323-a0bc-62ce1fc6fd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a9925093-c8aa-43ba-9b57-d91ccf63a718" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_a6e83855-9711-4323-a0bc-62ce1fc6fd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_96f8ee68-701d-422c-afac-601c44674dd2" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_46acbb36-e035-4f3c-9a7c-bd689a5cd755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_46acbb36-e035-4f3c-9a7c-bd689a5cd755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_a6d8a4d5-586e-4996-969c-67db5ca1b33f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_a6d8a4d5-586e-4996-969c-67db5ca1b33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_703b814a-2da1-4ae1-b87b-e61b939b2de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_703b814a-2da1-4ae1-b87b-e61b939b2de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RightofUseAsset_b6954df6-0faf-4019-b062-597220f59cac" xlink:href="prgo-20230401.xsd#prgo_RightofUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_prgo_RightofUseAsset_b6954df6-0faf-4019-b062-597220f59cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_c75061a6-f907-4c10-bbfd-33fe741a3afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_c75061a6-f907-4c10-bbfd-33fe741a3afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_aca71932-4834-4e29-8a35-9a2f90df4c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_aca71932-4834-4e29-8a35-9a2f90df4c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_2348a708-b7cf-4c53-beca-4a4265b33119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_2348a708-b7cf-4c53-beca-4a4265b33119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_02228878-c591-43c8-88a5-5296787fab67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_02228878-c591-43c8-88a5-5296787fab67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_6507c499-3dfa-4060-bc68-97032b01c803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_6507c499-3dfa-4060-bc68-97032b01c803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_46438447-1d4a-446e-baa3-c1046a2c417b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_46438447-1d4a-446e-baa3-c1046a2c417b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_c94e8b9d-7259-4ef1-86f8-4b747d1c3ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_c94e8b9d-7259-4ef1-86f8-4b747d1c3ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_efb2378a-e2e8-4f77-9c05-3dd8fcfbf5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_efb2378a-e2e8-4f77-9c05-3dd8fcfbf5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_9f2b142b-29c2-4e2b-92bd-b752e240e557" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_prgo_LeaseLiabilities_9f2b142b-29c2-4e2b-92bd-b752e240e557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2ad86615-b7ea-470b-b9f9-bf455f1d8cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_OperatingLeaseLiability_2ad86615-b7ea-470b-b9f9-bf455f1d8cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_1ad26317-f353-4185-bab1-ae884c8ba774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_1e9db62a-9939-4509-9ccd-77b3670797bf" xlink:to="loc_us-gaap_FinanceLeaseLiability_1ad26317-f353-4185-bab1-ae884c8ba774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2df7b5de-4467-4a0f-9574-ae39414a0e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_b33b09a1-0288-4bb9-9b0f-22e15b07e54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2df7b5de-4467-4a0f-9574-ae39414a0e7b" xlink:to="loc_us-gaap_OperatingLeaseCost_b33b09a1-0288-4bb9-9b0f-22e15b07e54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_6d87ef54-539a-4d0b-9fc6-0efdd63c381e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2df7b5de-4467-4a0f-9574-ae39414a0e7b" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_6d87ef54-539a-4d0b-9fc6-0efdd63c381e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a8b7f904-7dcc-4cf6-854f-d79b7dbed1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_6d87ef54-539a-4d0b-9fc6-0efdd63c381e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a8b7f904-7dcc-4cf6-854f-d79b7dbed1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_39e42097-6458-444a-a097-4823bf937830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_6d87ef54-539a-4d0b-9fc6-0efdd63c381e" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_39e42097-6458-444a-a097-4823bf937830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FinanceLeaseCost_e8448834-0c04-4246-9244-5a80c945f154" xlink:href="prgo-20230401.xsd#prgo_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_6d87ef54-539a-4d0b-9fc6-0efdd63c381e" xlink:to="loc_prgo_FinanceLeaseCost_e8448834-0c04-4246-9244-5a80c945f154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fe1d1516-273a-47ab-a869-a2b742a28a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe1d1516-273a-47ab-a869-a2b742a28a7f" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_aac3674c-14dc-4c07-a123-d26f1130044a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_aac3674c-14dc-4c07-a123-d26f1130044a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a334dad6-22b8-4937-a97b-7e3b37731816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a334dad6-22b8-4937-a97b-7e3b37731816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_dea954e9-7ee1-4b54-af36-08484c9d089c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_dea954e9-7ee1-4b54-af36-08484c9d089c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_217bfc82-91ff-4623-a9af-736abe5f3441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_217bfc82-91ff-4623-a9af-736abe5f3441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fa337cb5-6643-45bf-a524-2c5630d0fbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fa337cb5-6643-45bf-a524-2c5630d0fbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_95c197e5-c6c2-473e-bd25-119f041b614b" xlink:href="prgo-20230401.xsd#prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:to="loc_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour_95c197e5-c6c2-473e-bd25-119f041b614b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a5410c6f-5bf9-4e03-b87b-b1a8d3c47dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a5410c6f-5bf9-4e03-b87b-b1a8d3c47dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_20a57c23-2b42-4912-a416-7568e3300bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_20a57c23-2b42-4912-a416-7568e3300bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a81d590a-31f0-4e17-93c6-4b65991b8fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9129bd5a-2729-45a8-af36-f43db91a279f" xlink:to="loc_us-gaap_OperatingLeaseLiability_a81d590a-31f0-4e17-93c6-4b65991b8fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe1d1516-273a-47ab-a869-a2b742a28a7f" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_9de905f9-c0c3-43ab-a386-a2d39ba78d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_9de905f9-c0c3-43ab-a386-a2d39ba78d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b8e33266-4b90-4654-8f59-808152295427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b8e33266-4b90-4654-8f59-808152295427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_26768555-c977-45e7-91c4-140ec05b14c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_26768555-c977-45e7-91c4-140ec05b14c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_019d2dcf-c664-432a-a4c4-cddad13ef55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_019d2dcf-c664-432a-a4c4-cddad13ef55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_b15945ca-cc40-4b9c-a211-1bf67834f0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_b15945ca-cc40-4b9c-a211-1bf67834f0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_b2d38c03-dae9-4cb5-91b7-fee160bd4460" xlink:href="prgo-20230401.xsd#prgo_FinanceLeaseLiabilitytobePaidafterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:to="loc_prgo_FinanceLeaseLiabilitytobePaidafterYearFour_b2d38c03-dae9-4cb5-91b7-fee160bd4460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_60103ae8-eea7-42d4-9b7d-7f2a4972ec23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_60103ae8-eea7-42d4-9b7d-7f2a4972ec23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_555e62c0-c55b-4b94-b3e9-2a5f2ea659cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_555e62c0-c55b-4b94-b3e9-2a5f2ea659cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b7d4c860-0ddd-4f18-b407-25b80cbcc5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_04290707-3a1c-40fa-8588-8a9aa48d0744" xlink:to="loc_us-gaap_FinanceLeaseLiability_b7d4c860-0ddd-4f18-b407-25b80cbcc5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe1d1516-273a-47ab-a869-a2b742a28a7f" xlink:to="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_a079da18-a6c0-4bb7-b4e5-d002c2be5d9a" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsRemainderofFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:to="loc_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear_a079da18-a6c0-4bb7-b4e5-d002c2be5d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearOne_f2b3415d-8089-4111-befa-d6c4045708ed" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearOne_f2b3415d-8089-4111-befa-d6c4045708ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_8cb94f29-4ca3-44c4-8595-a0283d0d43b1" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearTwo_8cb94f29-4ca3-44c4-8595-a0283d0d43b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearThree_76ac8eda-25e4-453c-a42c-e25942048a70" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearThree_76ac8eda-25e4-453c-a42c-e25942048a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueYearFour_dfb3fac5-e4e7-45d1-af01-556066a0bf44" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueYearFour_dfb3fac5-e4e7-45d1-af01-556066a0bf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_daa3f1b4-224b-47f5-81ad-83fbe19d9d73" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDueafterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:to="loc_prgo_LeaseLiabilityPaymentsDueafterYearFour_daa3f1b4-224b-47f5-81ad-83fbe19d9d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityPaymentsDue_14f0a89c-9df9-4e25-9826-497ded75b2e9" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:to="loc_prgo_LeaseLiabilityPaymentsDue_14f0a89c-9df9-4e25-9826-497ded75b2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_41d37590-4cc3-48ec-91e4-682711c8b5ba" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:to="loc_prgo_LeaseLiabilityUndiscountedExcessAmount_41d37590-4cc3-48ec-91e4-682711c8b5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LeaseLiabilities_714d8256-5106-4f3e-8347-718d56d3aa76" xlink:href="prgo-20230401.xsd#prgo_LeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_LeaseLiabilitiesPaymentsDueAbstract_43bad025-03c4-409a-887d-79c8bf88b08a" xlink:to="loc_prgo_LeaseLiabilities_714d8256-5106-4f3e-8347-718d56d3aa76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails_1"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesAnnualFutureMaturitiesofLeasesDetails_2"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9150bbbe-d6f3-420b-8db9-cd8f78053e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_bd4fda6e-80bb-4e64-8e25-ce2bb6045781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9150bbbe-d6f3-420b-8db9-cd8f78053e6f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_bd4fda6e-80bb-4e64-8e25-ce2bb6045781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b5c87611-82b0-4851-81ab-42381964ff19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9150bbbe-d6f3-420b-8db9-cd8f78053e6f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b5c87611-82b0-4851-81ab-42381964ff19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a062e2d6-7bf3-4dfa-b31c-5adad7a4ddc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9150bbbe-d6f3-420b-8db9-cd8f78053e6f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a062e2d6-7bf3-4dfa-b31c-5adad7a4ddc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ce46c5a1-f8ff-49d5-9b12-2f750777cf58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9150bbbe-d6f3-420b-8db9-cd8f78053e6f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ce46c5a1-f8ff-49d5-9b12-2f750777cf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#LeasesLeaseCashFlowClassificationsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5588553d-e965-4d81-8a29-94a6c605a8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ebd553e3-8031-41a2-ad57-5166c8742bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5588553d-e965-4d81-8a29-94a6c605a8d6" xlink:to="loc_us-gaap_OperatingLeasePayments_ebd553e3-8031-41a2-ad57-5166c8742bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_475adb49-bac0-48cd-9c6f-8b557341393c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5588553d-e965-4d81-8a29-94a6c605a8d6" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_475adb49-bac0-48cd-9c6f-8b557341393c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_85ac2168-6bce-4f77-8c4b-1696ffb2d323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5588553d-e965-4d81-8a29-94a6c605a8d6" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_85ac2168-6bce-4f77-8c4b-1696ffb2d323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7448d9db-d93c-437c-ac0c-f633c15b2bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5588553d-e965-4d81-8a29-94a6c605a8d6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7448d9db-d93c-437c-ac0c-f633c15b2bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c2c58773-439f-4574-bc8b-016cede9a4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_4903dc4f-2b77-4cf2-a680-3e2bc58b6543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c2c58773-439f-4574-bc8b-016cede9a4fc" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_4903dc4f-2b77-4cf2-a680-3e2bc58b6543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6ac7abe9-321c-411d-b84f-af1f0fa9191e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4903dc4f-2b77-4cf2-a680-3e2bc58b6543" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6ac7abe9-321c-411d-b84f-af1f0fa9191e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_57c008f4-b8ab-4b76-bc53-678892ce2971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6ac7abe9-321c-411d-b84f-af1f0fa9191e" xlink:to="loc_us-gaap_SegmentDomain_57c008f4-b8ab-4b76-bc53-678892ce2971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_7039874d-ce7e-492e-8dca-251130fad688" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_57c008f4-b8ab-4b76-bc53-678892ce2971" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_7039874d-ce7e-492e-8dca-251130fad688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_cd62bbe0-81a6-4368-b016-a56b7885029b" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_57c008f4-b8ab-4b76-bc53-678892ce2971" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_cd62bbe0-81a6-4368-b016-a56b7885029b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_0973b24d-9667-4746-9011-d85aea994b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4903dc4f-2b77-4cf2-a680-3e2bc58b6543" xlink:to="loc_us-gaap_GoodwillLineItems_0973b24d-9667-4746-9011-d85aea994b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0973b24d-9667-4746-9011-d85aea994b86" xlink:to="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b7beb92c-db18-4191-9491-276e37d8032b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:to="loc_us-gaap_Goodwill_b7beb92c-db18-4191-9491-276e37d8032b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f94e9ab0-4266-41b1-9102-3f78cf1a5071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_f94e9ab0-4266-41b1-9102-3f78cf1a5071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3c50bede-fc47-4dc0-8a36-2a3897650cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3c50bede-fc47-4dc0-8a36-2a3897650cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4b0e3308-6e90-416a-a09a-8472a91db9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0c572541-8a8d-4710-943a-049e15a89b03" xlink:to="loc_us-gaap_Goodwill_4b0e3308-6e90-416a-a09a-8472a91db9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c6890301-1ac2-4cea-aa38-5a2e65dfaa20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_0973b24d-9667-4746-9011-d85aea994b86" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c6890301-1ac2-4cea-aa38-5a2e65dfaa20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#GoodwillandIntangibleAssetsIntangiblecategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_157ff644-8176-4952-b9e9-b778edff188d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_bb648f2b-293a-4b59-8d7f-428f53ded6d7" xlink:href="prgo-20230401.xsd#prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_157ff644-8176-4952-b9e9-b778edff188d" xlink:to="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_bb648f2b-293a-4b59-8d7f-428f53ded6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5c998f88-c01e-4b61-8b6e-8bd52e497553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_bb648f2b-293a-4b59-8d7f-428f53ded6d7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5c998f88-c01e-4b61-8b6e-8bd52e497553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c08a1bef-a3dc-4b7f-b6ee-40509b2bb45d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5c998f88-c01e-4b61-8b6e-8bd52e497553" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c08a1bef-a3dc-4b7f-b6ee-40509b2bb45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TrademarksTradeNamesandBrandsMember_5e38b215-a8fe-4c40-8ea0-8e4550fa5502" xlink:href="prgo-20230401.xsd#prgo_TrademarksTradeNamesandBrandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c08a1bef-a3dc-4b7f-b6ee-40509b2bb45d" xlink:to="loc_prgo_TrademarksTradeNamesandBrandsMember_5e38b215-a8fe-4c40-8ea0-8e4550fa5502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_64b4d4fe-7897-4bb1-84cb-5f48e8f6639b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c08a1bef-a3dc-4b7f-b6ee-40509b2bb45d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_64b4d4fe-7897-4bb1-84cb-5f48e8f6639b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dd3e6d9-e92e-4531-99df-2c3ae300bd17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_bb648f2b-293a-4b59-8d7f-428f53ded6d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dd3e6d9-e92e-4531-99df-2c3ae300bd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dd3e6d9-e92e-4531-99df-2c3ae300bd17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_5d8a3b27-c327-41db-b08a-134984ff163e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:to="loc_us-gaap_LicensingAgreementsMember_5d8a3b27-c327-41db-b08a-134984ff163e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_09672aad-d487-4562-be0f-3f54bb44075f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_09672aad-d487-4562-be0f-3f54bb44075f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c9b4ef81-0bdd-47f6-bb3c-7b66a3073cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c9b4ef81-0bdd-47f6-bb3c-7b66a3073cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_ec8c375b-187c-41e9-927d-0998616a00e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_ec8c375b-187c-41e9-927d-0998616a00e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_8b34be06-d4ec-42a9-aaad-cc46d1aa08c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_789f6951-2ad4-4b6e-a3a0-e0940f284933" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_8b34be06-d4ec-42a9-aaad-cc46d1aa08c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:href="prgo-20230401.xsd#prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable_bb648f2b-293a-4b59-8d7f-428f53ded6d7" xlink:to="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8f8dff6c-760f-4d8e-ab6f-a514e10ff995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8f8dff6c-760f-4d8e-ab6f-a514e10ff995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4899883a-6ac8-49d2-9f97-35a06ef91bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4899883a-6ac8-49d2-9f97-35a06ef91bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ebb5a429-7fe0-4758-b065-ad2aaf8ccfff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ebb5a429-7fe0-4758-b065-ad2aaf8ccfff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b174ee3c-e59c-4208-9191-491a5a6b56d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b174ee3c-e59c-4208-9191-491a5a6b56d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0dd03420-2a1d-40ca-8413-e0003c340c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems_f2e506fb-8bdc-4c3e-bf42-cace8d102ca0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0dd03420-2a1d-40ca-8413-e0003c340c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#FairValueMeasurementsFinancialInstrumentsatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b1d4d162-7842-4c5e-bfb6-b3604e39303a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b1d4d162-7842-4c5e-bfb6-b3604e39303a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1d88621-1f38-4388-9b9a-2ad8eebd522e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1d88621-1f38-4388-9b9a-2ad8eebd522e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1f53411a-b280-4a0f-af9a-44e487ec450f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1d88621-1f38-4388-9b9a-2ad8eebd522e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1f53411a-b280-4a0f-af9a-44e487ec450f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_bc6e9bf3-51b4-4a2c-ad9b-99a34e2eff9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1f53411a-b280-4a0f-af9a-44e487ec450f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_bc6e9bf3-51b4-4a2c-ad9b-99a34e2eff9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32c4e4b4-14ce-4a04-8e19-413926962a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32c4e4b4-14ce-4a04-8e19-413926962a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e32655a-3bcd-4031-b60c-e0969884ae89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_32c4e4b4-14ce-4a04-8e19-413926962a53" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e32655a-3bcd-4031-b60c-e0969884ae89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4ebd9a83-9996-4370-b2d9-6a3eea761a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e32655a-3bcd-4031-b60c-e0969884ae89" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4ebd9a83-9996-4370-b2d9-6a3eea761a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1afff4b6-1834-49a7-a1b2-3e816f140b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e32655a-3bcd-4031-b60c-e0969884ae89" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1afff4b6-1834-49a7-a1b2-3e816f140b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1a877b92-268f-49e5-9dcc-b9af46d91686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e32655a-3bcd-4031-b60c-e0969884ae89" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1a877b92-268f-49e5-9dcc-b9af46d91686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_41bee99c-0386-40e9-a7d3-53fd2d9becb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_41bee99c-0386-40e9-a7d3-53fd2d9becb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_183f0295-2311-4e40-bf36-27a811a3258d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_41bee99c-0386-40e9-a7d3-53fd2d9becb3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_183f0295-2311-4e40-bf36-27a811a3258d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6609f5a4-ff3a-4422-9d91-4791232467e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_183f0295-2311-4e40-bf36-27a811a3258d" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6609f5a4-ff3a-4422-9d91-4791232467e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_15588c09-5373-4c37-9d88-ecd3971cf830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_183f0295-2311-4e40-bf36-27a811a3258d" xlink:to="loc_us-gaap_InterestRateSwapMember_15588c09-5373-4c37-9d88-ecd3971cf830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_252bc28d-553e-45d9-b12a-44078e884b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_183f0295-2311-4e40-bf36-27a811a3258d" xlink:to="loc_us-gaap_CurrencySwapMember_252bc28d-553e-45d9-b12a-44078e884b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_84e57421-0942-4af6-88c9-f4a87e7bc03d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1073c4b1-55b2-4aae-a317-0fcc58486ed6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_84e57421-0942-4af6-88c9-f4a87e7bc03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_dcc929a8-1ba4-451a-9fcd-8bf018645eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_84e57421-0942-4af6-88c9-f4a87e7bc03d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_dcc929a8-1ba4-451a-9fcd-8bf018645eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_51ef94f9-94f1-4700-8c1a-efbacee8c9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_dcc929a8-1ba4-451a-9fcd-8bf018645eca" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_51ef94f9-94f1-4700-8c1a-efbacee8c9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_a0edc33c-e181-49cc-99d1-d054f040d1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_51ef94f9-94f1-4700-8c1a-efbacee8c9a2" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_a0edc33c-e181-49cc-99d1-d054f040d1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d804de64-301d-4821-b28f-e47243a25dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_51ef94f9-94f1-4700-8c1a-efbacee8c9a2" xlink:to="loc_us-gaap_DerivativeAssets_d804de64-301d-4821-b28f-e47243a25dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_f35040a5-385f-45eb-8e62-a4919dd5aaee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_51ef94f9-94f1-4700-8c1a-efbacee8c9a2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_f35040a5-385f-45eb-8e62-a4919dd5aaee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ff5bee1b-fcc0-447e-8dc1-96bcc3d1f08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_dcc929a8-1ba4-451a-9fcd-8bf018645eca" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ff5bee1b-fcc0-447e-8dc1-96bcc3d1f08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a1a68b35-3a42-4aba-8500-b94b3dbefd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ff5bee1b-fcc0-447e-8dc1-96bcc3d1f08a" xlink:to="loc_us-gaap_DerivativeLiabilities_a1a68b35-3a42-4aba-8500-b94b3dbefd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_10caea04-05fe-438a-96e5-788247efecd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_ff5bee1b-fcc0-447e-8dc1-96bcc3d1f08a" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_10caea04-05fe-438a-96e5-788247efecd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_910ae380-ce49-4a19-bace-5d5171df1c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_910ae380-ce49-4a19-bace-5d5171df1c00" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_9fdc943c-1d13-4fab-bec6-b08f20b4d7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_9fdc943c-1d13-4fab-bec6-b08f20b4d7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c20f9634-df35-4514-8b57-4289c1b31fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9fdc943c-1d13-4fab-bec6-b08f20b4d7b0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c20f9634-df35-4514-8b57-4289c1b31fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bb15fdb6-f5fb-4f43-a486-ff4db20f03ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c20f9634-df35-4514-8b57-4289c1b31fee" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bb15fdb6-f5fb-4f43-a486-ff4db20f03ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9aea8eb9-bcf2-4fb0-a6ce-291c48bdb4df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bb15fdb6-f5fb-4f43-a486-ff4db20f03ea" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9aea8eb9-bcf2-4fb0-a6ce-291c48bdb4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dac82328-3009-4ff5-a3ee-94a811bf5c29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:to="loc_us-gaap_DebtInstrumentAxis_dac82328-3009-4ff5-a3ee-94a811bf5c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4784b5a8-d608-413a-b57e-211a1632a5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dac82328-3009-4ff5-a3ee-94a811bf5c29" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4784b5a8-d608-413a-b57e-211a1632a5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PublicBondsandPrivatePlacementMember_500bdd3d-1ca1-42fb-b0ab-96df3b1c9553" xlink:href="prgo-20230401.xsd#prgo_PublicBondsandPrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4784b5a8-d608-413a-b57e-211a1632a5bd" xlink:to="loc_prgo_PublicBondsandPrivatePlacementMember_500bdd3d-1ca1-42fb-b0ab-96df3b1c9553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2edb2448-2a2a-4569-bfc7-a597ad3068f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2edb2448-2a2a-4569-bfc7-a597ad3068f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98aa639e-fd14-4b2a-94c7-06b17a0efba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2edb2448-2a2a-4569-bfc7-a597ad3068f6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98aa639e-fd14-4b2a-94c7-06b17a0efba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_841d4eb6-d8eb-4214-be9b-f6d472f04a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98aa639e-fd14-4b2a-94c7-06b17a0efba1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_841d4eb6-d8eb-4214-be9b-f6d472f04a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4361ffc1-3dba-44e5-8413-9bdbadfa7181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a31f617a-1d72-4663-bc69-94dd0aafed1a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4361ffc1-3dba-44e5-8413-9bdbadfa7181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_95b80d67-220f-482f-964b-6b74f65f95d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4361ffc1-3dba-44e5-8413-9bdbadfa7181" xlink:to="loc_us-gaap_SeniorNotes_95b80d67-220f-482f-964b-6b74f65f95d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_65f6af04-ebd4-477f-9d48-625189a93fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_65f6af04-ebd4-477f-9d48-625189a93fa7" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6aacc105-da2c-4f63-a06c-7ec5b9cab759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6aacc105-da2c-4f63-a06c-7ec5b9cab759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1bd0a62-f29b-41ee-8a83-900dbd7bd0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6aacc105-da2c-4f63-a06c-7ec5b9cab759" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1bd0a62-f29b-41ee-8a83-900dbd7bd0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_56d7449f-1509-4272-ac46-c4a53b9e7a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1bd0a62-f29b-41ee-8a83-900dbd7bd0c6" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_56d7449f-1509-4272-ac46-c4a53b9e7a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_29a578d0-695d-42fc-addf-8ea8716ff6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a1bd0a62-f29b-41ee-8a83-900dbd7bd0c6" xlink:to="loc_us-gaap_InterestRateSwapMember_29a578d0-695d-42fc-addf-8ea8716ff6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ddd35450-119f-491f-bb3a-08e439df1ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_us-gaap_HedgingDesignationAxis_ddd35450-119f-491f-bb3a-08e439df1ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5fb99a73-f20b-4d81-a6ec-814d6cba05e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_ddd35450-119f-491f-bb3a-08e439df1ef0" xlink:to="loc_us-gaap_HedgingDesignationDomain_5fb99a73-f20b-4d81-a6ec-814d6cba05e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d2482f61-22a8-41a4-955e-46d70b31d08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5fb99a73-f20b-4d81-a6ec-814d6cba05e3" xlink:to="loc_us-gaap_NondesignatedMember_d2482f61-22a8-41a4-955e-46d70b31d08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_be79b04a-7c18-4c9a-b384-e5f6737d55ee" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_be79b04a-7c18-4c9a-b384-e5f6737d55ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_c724c5a2-6e3f-4cbd-890a-a663179bda1c" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis_be79b04a-7c18-4c9a-b384-e5f6737d55ee" xlink:to="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_c724c5a2-6e3f-4cbd-890a-a663179bda1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member_4afa8976-1faf-49bf-9f68-6018097368c5" xlink:href="prgo-20230401.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_c724c5a2-6e3f-4cbd-890a-a663179bda1c" xlink:to="loc_prgo_June12022ThroughApril12029Member_4afa8976-1faf-49bf-9f68-6018097368c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member_feeee5ac-99fb-478e-86e5-08b56a82b3e6" xlink:href="prgo-20230401.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain_c724c5a2-6e3f-4cbd-890a-a663179bda1c" xlink:to="loc_prgo_June12022ThroughApril12027Member_feeee5ac-99fb-478e-86e5-08b56a82b3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_41f74faf-a4df-4d51-81cf-ea5c6665a743" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_srt_RangeAxis_41f74faf-a4df-4d51-81cf-ea5c6665a743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d32cc357-26cf-45ed-8227-f7222a6fde8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_41f74faf-a4df-4d51-81cf-ea5c6665a743" xlink:to="loc_srt_RangeMember_d32cc357-26cf-45ed-8227-f7222a6fde8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c5e4c90e-c7bf-46f4-8624-e9642545da91" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d32cc357-26cf-45ed-8227-f7222a6fde8d" xlink:to="loc_srt_MaximumMember_c5e4c90e-c7bf-46f4-8624-e9642545da91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ff482b77-23fb-4c56-883b-9e51c94f83dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d32cc357-26cf-45ed-8227-f7222a6fde8d" xlink:to="loc_srt_MinimumMember_ff482b77-23fb-4c56-883b-9e51c94f83dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d22c2866-883c-4461-a65b-568dad80b852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d22c2866-883c-4461-a65b-568dad80b852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_65bfb889-a4fa-488b-8947-19a93dfa4fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d22c2866-883c-4461-a65b-568dad80b852" xlink:to="loc_us-gaap_HedgingRelationshipDomain_65bfb889-a4fa-488b-8947-19a93dfa4fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_682cf131-a1c0-4e4e-8861-cc73435f7e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_65bfb889-a4fa-488b-8947-19a93dfa4fc4" xlink:to="loc_us-gaap_CashFlowHedgingMember_682cf131-a1c0-4e4e-8861-cc73435f7e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a1e38f1c-679e-40af-b5b2-c5887751cdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_65bfb889-a4fa-488b-8947-19a93dfa4fc4" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a1e38f1c-679e-40af-b5b2-c5887751cdc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermAxis_c9d6c8d8-226a-4d5a-85dc-495e843b5f61" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentTermAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_prgo_DerivativeInstrumentTermAxis_c9d6c8d8-226a-4d5a-85dc-495e843b5f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeInstrumentTermDomain_d3dc489e-ca98-4ba2-841b-8e942e425de1" xlink:href="prgo-20230401.xsd#prgo_DerivativeInstrumentTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentTermAxis_c9d6c8d8-226a-4d5a-85dc-495e843b5f61" xlink:to="loc_prgo_DerivativeInstrumentTermDomain_d3dc489e-ca98-4ba2-841b-8e942e425de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughDecember152024Member_945edb3b-d4e0-4819-ab7d-2f3b683b13f5" xlink:href="prgo-20230401.xsd#prgo_October252022ThroughDecember152024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_d3dc489e-ca98-4ba2-841b-8e942e425de1" xlink:to="loc_prgo_October252022ThroughDecember152024Member_945edb3b-d4e0-4819-ab7d-2f3b683b13f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughMarch252026Member_ccb13a90-eb4a-4cb4-ac2f-e43df378a438" xlink:href="prgo-20230401.xsd#prgo_October252022ThroughMarch252026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_d3dc489e-ca98-4ba2-841b-8e942e425de1" xlink:to="loc_prgo_October252022ThroughMarch252026Member_ccb13a90-eb4a-4cb4-ac2f-e43df378a438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_October252022ThroughJune152030Member_8924d43f-b772-4995-8cc0-d5e042aafe0f" xlink:href="prgo-20230401.xsd#prgo_October252022ThroughJune152030Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DerivativeInstrumentTermDomain_d3dc489e-ca98-4ba2-841b-8e942e425de1" xlink:to="loc_prgo_October252022ThroughJune152030Member_8924d43f-b772-4995-8cc0-d5e042aafe0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_585fd15f-dc26-4f1c-bb04-63ad1c7bf453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_us-gaap_DebtInstrumentAxis_585fd15f-dc26-4f1c-bb04-63ad1c7bf453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3e37aaf4-6a19-4717-be36-9b95bb3744ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_585fd15f-dc26-4f1c-bb04-63ad1c7bf453" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3e37aaf4-6a19-4717-be36-9b95bb3744ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanBFacilityMember_72532eb1-e0e9-4071-8fc9-2b11077f2ad7" xlink:href="prgo-20230401.xsd#prgo_NewTermLoanBFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e37aaf4-6a19-4717-be36-9b95bb3744ff" xlink:to="loc_prgo_NewTermLoanBFacilityMember_72532eb1-e0e9-4071-8fc9-2b11077f2ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanAFacilityMember_231d05b5-1c50-4615-8071-1e30146cb6b6" xlink:href="prgo-20230401.xsd#prgo_NewTermLoanAFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e37aaf4-6a19-4717-be36-9b95bb3744ff" xlink:to="loc_prgo_NewTermLoanAFacilityMember_231d05b5-1c50-4615-8071-1e30146cb6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a7b5dfbc-75fa-4cae-9dc3-099915ff49f4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_d4105c0e-6d6b-4ca2-9e51-11247264e1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_d4105c0e-6d6b-4ca2-9e51-11247264e1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a3577c1f-8283-4d3c-aa2d-2a2667411fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a3577c1f-8283-4d3c-aa2d-2a2667411fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments_b9fb07b4-0988-478a-9bdd-98f3664cfce6" xlink:href="prgo-20230401.xsd#prgo_PaymentsForPremiumsOnDerivativeInstruments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:to="loc_prgo_PaymentsForPremiumsOnDerivativeInstruments_b9fb07b4-0988-478a-9bdd-98f3664cfce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c5ce63f3-97dd-4ebf-bd70-c47478c72d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_acc5502f-4ef8-482d-a15d-0f11ddbf30f7" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c5ce63f3-97dd-4ebf-bd70-c47478c72d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3cc53db3-4f82-4693-841b-c0667407bc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_15f22b28-69eb-4941-bad4-364a8e0d0998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3cc53db3-4f82-4693-841b-c0667407bc9e" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_15f22b28-69eb-4941-bad4-364a8e0d0998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_72476d05-0340-4ca6-b0a5-8de7b5a1d2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_15f22b28-69eb-4941-bad4-364a8e0d0998" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_72476d05-0340-4ca6-b0a5-8de7b5a1d2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d15a1f5f-42e4-4d6c-96bf-60dcd6d374e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_72476d05-0340-4ca6-b0a5-8de7b5a1d2dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d15a1f5f-42e4-4d6c-96bf-60dcd6d374e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_09db0c3a-b08b-4f64-a712-66d14a4a92b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d15a1f5f-42e4-4d6c-96bf-60dcd6d374e1" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_09db0c3a-b08b-4f64-a712-66d14a4a92b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_7aaecd92-ef08-4db8-8d7c-f5fa92c39265" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_15f22b28-69eb-4941-bad4-364a8e0d0998" xlink:to="loc_srt_CurrencyAxis_7aaecd92-ef08-4db8-8d7c-f5fa92c39265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_7aaecd92-ef08-4db8-8d7c-f5fa92c39265" xlink:to="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_5c2c43ba-533d-4072-b661-d863ebb1c99b" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_GBP_5c2c43ba-533d-4072-b661-d863ebb1c99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_38d1aa6a-749b-4a54-a871-75a1f82d9f4e" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_EUR_38d1aa6a-749b-4a54-a871-75a1f82d9f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK_a23351d6-01b4-4fec-b214-e8848a9bc23a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_SEK_a23351d6-01b4-4fec-b214-e8848a9bc23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_7d02ea05-ce0e-4bcf-9ff6-76ef9a56260d" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_USD_7d02ea05-ce0e-4bcf-9ff6-76ef9a56260d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_52ab915e-aadc-44a6-a8ab-a636139a1850" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_CNY_52ab915e-aadc-44a6-a8ab-a636139a1850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK_960054b8-c10d-4a56-a39e-aa07b869623a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_DKK"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_DKK_960054b8-c10d-4a56-a39e-aa07b869623a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_cd597c22-1053-4c88-a857-2cc579b5fb0c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_CAD_cd597c22-1053-4c88-a857-2cc579b5fb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_a9e5c349-81fa-43cd-a22d-27cf3b0d35a6" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MXN"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_MXN_a9e5c349-81fa-43cd-a22d-27cf3b0d35a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_HUF_e828aa32-4c4a-40ab-8f7e-b00958b4f7c4" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_HUF"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_HUF_e828aa32-4c4a-40ab-8f7e-b00958b4f7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN_c56a35b6-c153-4d36-8f15-054d6762d2e7" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_PLN"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_PLN_c56a35b6-c153-4d36-8f15-054d6762d2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_NOK_0de711a1-c918-415c-9f5b-49a43c7e1162" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_NOK"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_NOK_0de711a1-c918-415c-9f5b-49a43c7e1162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX_55399aa3-816b-4a4d-8abe-45c33b4e1b5c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_ead8aeab-7a29-4445-9bff-3965185b51be" xlink:to="loc_currency_XXX_55399aa3-816b-4a4d-8abe-45c33b4e1b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_b590797d-121f-46dc-b633-925ace6cbbff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable_15f22b28-69eb-4941-bad4-364a8e0d0998" xlink:to="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_b590797d-121f-46dc-b633-925ace6cbbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_df43689f-4802-4414-9922-5c3c5d17842f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_b590797d-121f-46dc-b633-925ace6cbbff" xlink:to="loc_us-gaap_DerivativeNotionalAmount_df43689f-4802-4414-9922-5c3c5d17842f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount_57f2bc3c-133d-47df-a051-1ad4a7671b30" xlink:href="prgo-20230401.xsd#prgo_DerivativeNotionalAmountMaximumIndividualAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_b590797d-121f-46dc-b633-925ace6cbbff" xlink:to="loc_prgo_DerivativeNotionalAmountMaximumIndividualAmount_57f2bc3c-133d-47df-a051-1ad4a7671b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_ae129786-ebfe-405f-854f-0c3c05f0244d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems_b590797d-121f-46dc-b633-925ace6cbbff" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_ae129786-ebfe-405f-854f-0c3c05f0244d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d86c4443-a09e-48c6-88b6-c2a1de55c403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d86c4443-a09e-48c6-88b6-c2a1de55c403" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c39cf7d4-0f30-4465-9dbc-5081a6c310ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:to="loc_us-gaap_HedgingDesignationAxis_c39cf7d4-0f30-4465-9dbc-5081a6c310ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3dd599aa-bf2f-417d-8f96-d0f6608dcdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_c39cf7d4-0f30-4465-9dbc-5081a6c310ee" xlink:to="loc_us-gaap_HedgingDesignationDomain_3dd599aa-bf2f-417d-8f96-d0f6608dcdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_66c024fb-f983-43fa-919a-af16f2d5d16e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_3dd599aa-bf2f-417d-8f96-d0f6608dcdb9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_66c024fb-f983-43fa-919a-af16f2d5d16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_6c657df1-ed62-4e4a-8012-a29e8a8b55cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_3dd599aa-bf2f-417d-8f96-d0f6608dcdb9" xlink:to="loc_us-gaap_NondesignatedMember_6c657df1-ed62-4e4a-8012-a29e8a8b55cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d1b1a765-6e99-48c2-849e-a7002f3f9352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d1b1a765-6e99-48c2-849e-a7002f3f9352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_deb68493-4004-4654-82b3-eedd239658cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d1b1a765-6e99-48c2-849e-a7002f3f9352" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_deb68493-4004-4654-82b3-eedd239658cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_2c2c57b6-8bd5-4642-8e81-b3dd481e5417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_deb68493-4004-4654-82b3-eedd239658cc" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_2c2c57b6-8bd5-4642-8e81-b3dd481e5417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_6b057411-6540-40f6-81e7-d61844ab72f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_deb68493-4004-4654-82b3-eedd239658cc" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_6b057411-6540-40f6-81e7-d61844ab72f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_73c2942c-1542-4f3b-b87d-ff2fb7ee7b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_deb68493-4004-4654-82b3-eedd239658cc" xlink:to="loc_us-gaap_OtherLiabilitiesMember_73c2942c-1542-4f3b-b87d-ff2fb7ee7b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ac13dc86-a5ea-4371-bc48-0ba689860e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ac13dc86-a5ea-4371-bc48-0ba689860e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_87dd46f0-37fc-4851-80e6-c09da766fdba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ac13dc86-a5ea-4371-bc48-0ba689860e9d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_87dd46f0-37fc-4851-80e6-c09da766fdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_df750c4e-8336-4b21-acbd-0dddd26a64cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87dd46f0-37fc-4851-80e6-c09da766fdba" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_df750c4e-8336-4b21-acbd-0dddd26a64cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ad3659e9-13d3-450f-9fce-b83842ebc4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87dd46f0-37fc-4851-80e6-c09da766fdba" xlink:to="loc_us-gaap_InterestRateSwapMember_ad3659e9-13d3-450f-9fce-b83842ebc4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2dbe6085-5ba4-41ec-bfcf-8b6caafc978d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87dd46f0-37fc-4851-80e6-c09da766fdba" xlink:to="loc_us-gaap_CurrencySwapMember_2dbe6085-5ba4-41ec-bfcf-8b6caafc978d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_415535bf-6235-49f8-8e1b-780bd7f4e814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b9e15c11-3c9d-44c5-b7b1-979fa0808b62" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_415535bf-6235-49f8-8e1b-780bd7f4e814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_5c7ec72b-8de5-4ff9-80cb-ddb67903c7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_415535bf-6235-49f8-8e1b-780bd7f4e814" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_5c7ec72b-8de5-4ff9-80cb-ddb67903c7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_bfad5e4e-14c0-436a-8b6c-49230345705f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_415535bf-6235-49f8-8e1b-780bd7f4e814" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_bfad5e4e-14c0-436a-8b6c-49230345705f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_479fef06-7de7-4d79-bdc0-613c5aa3c4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_479fef06-7de7-4d79-bdc0-613c5aa3c4d0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7f3ef66c-40b8-42c4-a07c-5d41f3389fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7f3ef66c-40b8-42c4-a07c-5d41f3389fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4b243df1-60a5-41d0-ad71-563153df02ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7f3ef66c-40b8-42c4-a07c-5d41f3389fd3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4b243df1-60a5-41d0-ad71-563153df02ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_e0927a5d-530b-491a-92c2-67c0ef720b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4b243df1-60a5-41d0-ad71-563153df02ef" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_e0927a5d-530b-491a-92c2-67c0ef720b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_a11cdc86-763d-425f-aee2-b114aeeea633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4b243df1-60a5-41d0-ad71-563153df02ef" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_a11cdc86-763d-425f-aee2-b114aeeea633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3cea3003-571c-41bf-a799-9859f4a450b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3cea3003-571c-41bf-a799-9859f4a450b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1a32d1cd-7579-4c2b-a2c6-f17d3e7c3760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3cea3003-571c-41bf-a799-9859f4a450b8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1a32d1cd-7579-4c2b-a2c6-f17d3e7c3760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_ac782eba-d85f-4a38-bb78-a5732227c542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1a32d1cd-7579-4c2b-a2c6-f17d3e7c3760" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_ac782eba-d85f-4a38-bb78-a5732227c542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_32b5fb53-bbeb-4e71-ac04-c6ec031b2f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1a32d1cd-7579-4c2b-a2c6-f17d3e7c3760" xlink:to="loc_us-gaap_InterestExpenseMember_32b5fb53-bbeb-4e71-ac04-c6ec031b2f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_21da4f4c-0f0f-47f3-9e1c-e6997e2418cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:to="loc_us-gaap_HedgingDesignationAxis_21da4f4c-0f0f-47f3-9e1c-e6997e2418cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a6179540-b2c7-4533-acb5-6017787511af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_21da4f4c-0f0f-47f3-9e1c-e6997e2418cf" xlink:to="loc_us-gaap_HedgingDesignationDomain_a6179540-b2c7-4533-acb5-6017787511af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5f399831-0b63-4316-8510-be1904098773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a6179540-b2c7-4533-acb5-6017787511af" xlink:to="loc_us-gaap_NondesignatedMember_5f399831-0b63-4316-8510-be1904098773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3ce8f44a-4e85-4e33-8cd8-5742390af667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_26288e32-5825-4a29-8641-93ceaede79b9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3ce8f44a-4e85-4e33-8cd8-5742390af667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_14b645b5-3285-4cce-a05c-b4e369e929ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_3ce8f44a-4e85-4e33-8cd8-5742390af667" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_14b645b5-3285-4cce-a05c-b4e369e929ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0b339938-6aa0-4219-bf7d-f88270f59d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3388e6f8-ef07-4891-ac07-83651604bbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0b339938-6aa0-4219-bf7d-f88270f59d12" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3388e6f8-ef07-4891-ac07-83651604bbf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f610c8cf-1f96-4c5a-b43e-d423cc1eb673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3388e6f8-ef07-4891-ac07-83651604bbf1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f610c8cf-1f96-4c5a-b43e-d423cc1eb673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f3269453-e8c3-4de6-9e59-dab3ae529ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f610c8cf-1f96-4c5a-b43e-d423cc1eb673" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f3269453-e8c3-4de6-9e59-dab3ae529ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_19a206b5-7d94-4bc3-b5d2-edc872db43a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f3269453-e8c3-4de6-9e59-dab3ae529ce7" xlink:to="loc_us-gaap_InterestRateSwapMember_19a206b5-7d94-4bc3-b5d2-edc872db43a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_70613216-611f-43e9-8760-65e4c99f05b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f3269453-e8c3-4de6-9e59-dab3ae529ce7" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_70613216-611f-43e9-8760-65e4c99f05b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2923223e-7193-4f88-80f0-0b066d292681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f3269453-e8c3-4de6-9e59-dab3ae529ce7" xlink:to="loc_us-gaap_CurrencySwapMember_2923223e-7193-4f88-80f0-0b066d292681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_99f7c327-de16-4e21-833c-cfafbb3ee35c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3388e6f8-ef07-4891-ac07-83651604bbf1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_99f7c327-de16-4e21-833c-cfafbb3ee35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_99f7c327-de16-4e21-833c-cfafbb3ee35c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_4c54dca9-2a54-4acd-a68b-b601266ed879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:to="loc_us-gaap_InterestExpenseMember_4c54dca9-2a54-4acd-a68b-b601266ed879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d057f6e9-f708-431e-88e9-f9a2647a1a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:to="loc_us-gaap_SalesRevenueNetMember_d057f6e9-f708-431e-88e9-f9a2647a1a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_5bd8a094-222e-4c53-9ea9-36b036d81907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:to="loc_us-gaap_CostOfSalesMember_5bd8a094-222e-4c53-9ea9-36b036d81907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_de551f7d-d6ab-4a6c-beac-952cbd624cfc" xlink:href="prgo-20230401.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b1607245-a9ef-4fd3-a1bb-e11ab170c163" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_de551f7d-d6ab-4a6c-beac-952cbd624cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_3388e6f8-ef07-4891-ac07-83651604bbf1" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_73808208-3d52-4a6c-b3f6-3ef98cff6b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_73808208-3d52-4a6c-b3f6-3ef98cff6b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_168dd049-949f-4c96-a997-fb124cbc6d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_168dd049-949f-4c96-a997-fb124cbc6d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_6c8398c5-b6b8-4885-ab26-3596c750313b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_6c8398c5-b6b8-4885-ab26-3596c750313b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_d2b47809-9ee7-47af-b4c6-b9e1be6f8b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_d2b47809-9ee7-47af-b4c6-b9e1be6f8b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_0ef1e0d8-f348-4345-ac30-6f4c1622f088" xlink:href="prgo-20230401.xsd#prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet_0ef1e0d8-f348-4345-ac30-6f4c1622f088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_5711e7aa-f8ce-44a8-832b-e1732bbd6435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness_5711e7aa-f8ce-44a8-832b-e1732bbd6435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_d04b362c-a2c5-44b4-8e22-2aabc6f4d744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_d04b362c-a2c5-44b4-8e22-2aabc6f4d744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_0d94141a-3fbe-4867-817d-3b284bd9308f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_0d94141a-3fbe-4867-817d-3b284bd9308f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_1d03df90-99e1-416e-b9ce-dd9d36c8ad06" xlink:href="prgo-20230401.xsd#prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness_1d03df90-99e1-416e-b9ce-dd9d36c8ad06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_f21b8088-a84f-47a4-815d-265372259d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_66b33ccb-5447-43fb-bb9e-b69e7009de1a" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_f21b8088-a84f-47a4-815d-265372259d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ef081941-7ad1-4a88-a389-da0765ec6bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0cdda967-1173-48f5-9be0-1d980733acec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ef081941-7ad1-4a88-a389-da0765ec6bef" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0cdda967-1173-48f5-9be0-1d980733acec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4681e6b8-4dfe-473a-8da6-90647e80a464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0cdda967-1173-48f5-9be0-1d980733acec" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4681e6b8-4dfe-473a-8da6-90647e80a464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d7a77295-6488-4a89-bb3a-d75c9f3282fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4681e6b8-4dfe-473a-8da6-90647e80a464" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d7a77295-6488-4a89-bb3a-d75c9f3282fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f1650671-95da-4f3e-9f5f-b3d197fed933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d7a77295-6488-4a89-bb3a-d75c9f3282fa" xlink:to="loc_us-gaap_InterestRateSwapMember_f1650671-95da-4f3e-9f5f-b3d197fed933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3470b12a-f2bf-452d-b72e-aeb5e645a19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0cdda967-1173-48f5-9be0-1d980733acec" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3470b12a-f2bf-452d-b72e-aeb5e645a19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3470b12a-f2bf-452d-b72e-aeb5e645a19f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d6729c89-496c-4235-bff6-b7002cdcb845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:to="loc_us-gaap_SalesRevenueNetMember_d6729c89-496c-4235-bff6-b7002cdcb845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_8047cd3c-ad18-44af-b0c7-5b75599d1723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:to="loc_us-gaap_CostOfSalesMember_8047cd3c-ad18-44af-b0c7-5b75599d1723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_183f9518-2ecd-4125-86b5-9460ee71992b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:to="loc_us-gaap_InterestExpenseMember_183f9518-2ecd-4125-86b5-9460ee71992b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_OtherExpenseIncomeNetMember_a4623aaf-1147-417d-a03b-555f7a08cff2" xlink:href="prgo-20230401.xsd#prgo_OtherExpenseIncomeNetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3e04b988-3d5b-4fc8-a7bc-2b528f38a96e" xlink:to="loc_prgo_OtherExpenseIncomeNetMember_a4623aaf-1147-417d-a03b-555f7a08cff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0cdda967-1173-48f5-9be0-1d980733acec" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_058927ed-19fb-4397-9828-5200a9e39584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_058927ed-19fb-4397-9828-5200a9e39584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_477ff30f-b588-4484-baae-53466fa41631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_477ff30f-b588-4484-baae-53466fa41631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_24819dde-071f-4f8e-9e8a-b62cb79bc73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_24819dde-071f-4f8e-9e8a-b62cb79bc73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3b9da1ee-d41e-4b77-997b-3a22f38de4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3b9da1ee-d41e-4b77-997b-3a22f38de4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_f265c26a-2f5f-46ce-a54a-a2f745c38575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6cdc594e-b3cf-4f1d-9a0a-74f69ba66181" xlink:to="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_f265c26a-2f5f-46ce-a54a-a2f745c38575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_9a05e214-585b-41f1-be28-f7b0a3cfadeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_f265c26a-2f5f-46ce-a54a-a2f745c38575" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_9a05e214-585b-41f1-be28-f7b0a3cfadeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_55516276-bc43-483d-905b-a666273a472e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_9a05e214-585b-41f1-be28-f7b0a3cfadeb" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet_55516276-bc43-483d-905b-a666273a472e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_2dca9c2c-d2c1-4120-a7e0-f673e406617e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgesAbstract_9a05e214-585b-41f1-be28-f7b0a3cfadeb" xlink:to="loc_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness_2dca9c2c-d2c1-4120-a7e0-f673e406617e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgesAbstract_8db20383-499a-4399-84e7-58f553749e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_f265c26a-2f5f-46ce-a54a-a2f745c38575" xlink:to="loc_us-gaap_InterestRateCashFlowHedgesAbstract_8db20383-499a-4399-84e7-58f553749e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_0a1097a6-6b84-44fe-9f86-48aed4ba8fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateCashFlowHedgesAbstract_8db20383-499a-4399-84e7-58f553749e94" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_0a1097a6-6b84-44fe-9f86-48aed4ba8fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#IndebtednessScheduleofBorrowingsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_88812f4b-32a9-488c-94b1-c50fe6846cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ScheduleOfDebtInstrumentsTable_6722ca0f-b73e-4c8c-b01c-9f0414ba78ae" xlink:href="prgo-20230401.xsd#prgo_ScheduleOfDebtInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_88812f4b-32a9-488c-94b1-c50fe6846cbd" xlink:to="loc_prgo_ScheduleOfDebtInstrumentsTable_6722ca0f-b73e-4c8c-b01c-9f0414ba78ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_06588abe-5329-401a-9211-b8d2116a3fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfDebtInstrumentsTable_6722ca0f-b73e-4c8c-b01c-9f0414ba78ae" xlink:to="loc_us-gaap_DebtInstrumentAxis_06588abe-5329-401a-9211-b8d2116a3fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_06588abe-5329-401a-9211-b8d2116a3fd7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12027Member_2708f114-084e-424b-b1ce-98b614392669" xlink:href="prgo-20230401.xsd#prgo_June12022ThroughApril12027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_June12022ThroughApril12027Member_2708f114-084e-424b-b1ce-98b614392669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_June12022ThroughApril12029Member_c4b56078-08b9-4a41-a868-a96cea5f759b" xlink:href="prgo-20230401.xsd#prgo_June12022ThroughApril12029Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_June12022ThroughApril12029Member_c4b56078-08b9-4a41-a868-a96cea5f759b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member_956ffc0e-1dd7-4afa-94a5-a427439f8bbd" xlink:href="prgo-20230401.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A3900SeniorNoteDue2024Member_956ffc0e-1dd7-4afa-94a5-a427439f8bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_306dccd5-6f69-4eac-9408-b106c5f42e70" xlink:href="prgo-20230401.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_306dccd5-6f69-4eac-9408-b106c5f42e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member_13232104-bd8e-4a66-b872-00a165d26897" xlink:href="prgo-20230401.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A4400SeniorNotesDueJune152030Member_13232104-bd8e-4a66-b872-00a165d26897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_34ba6bdb-6f97-42a2-b365-a902b1eef554" xlink:href="prgo-20230401.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_34ba6bdb-6f97-42a2-b365-a902b1eef554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member_93e30344-a277-4147-a774-32b87eb39272" xlink:href="prgo-20230401.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A4900SeniorLoanDue2044Member_93e30344-a277-4147-a774-32b87eb39272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4650SeniorNotesDueJune152030Member_123ce153-a84f-4d26-b0e8-4edee813b1ad" xlink:href="prgo-20230401.xsd#prgo_A4650SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A4650SeniorNotesDueJune152030Member_123ce153-a84f-4d26-b0e8-4edee813b1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3150SeniorNotesDueJune152030Member_f5f7bb21-adec-4e7a-a560-3aa2a55ed92e" xlink:href="prgo-20230401.xsd#prgo_A3150SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b3db9d1-0c1a-405c-b17c-527aedaf1e88" xlink:to="loc_prgo_A3150SeniorNotesDueJune152030Member_f5f7bb21-adec-4e7a-a560-3aa2a55ed92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ad0a832f-5b63-44f8-88f8-bf9f39e74787" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfDebtInstrumentsTable_6722ca0f-b73e-4c8c-b01c-9f0414ba78ae" xlink:to="loc_srt_StatementScenarioAxis_ad0a832f-5b63-44f8-88f8-bf9f39e74787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_eecf0c53-7f95-4aa0-aad6-58b6c1f35afb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_ad0a832f-5b63-44f8-88f8-bf9f39e74787" xlink:to="loc_srt_ScenarioUnspecifiedDomain_eecf0c53-7f95-4aa0-aad6-58b6c1f35afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_d7f03167-d478-4af7-8aa1-bb452ef5c001" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_eecf0c53-7f95-4aa0-aad6-58b6c1f35afb" xlink:to="loc_srt_ScenarioForecastMember_d7f03167-d478-4af7-8aa1-bb452ef5c001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_ScheduleOfDebtInstrumentsTable_6722ca0f-b73e-4c8c-b01c-9f0414ba78ae" xlink:to="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayable_9d0f98db-8a78-4bae-8cd9-867c08c34cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_LoansPayable_9d0f98db-8a78-4bae-8cd9-867c08c34cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_07115d23-d75d-494d-9e30-c0093afb6616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_07115d23-d75d-494d-9e30-c0093afb6616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_9d9bbc8f-d9f2-4008-a641-ee964209463d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_SeniorNotes_9d9bbc8f-d9f2-4008-a641-ee964209463d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_2e2f05a4-86ea-4481-a270-45be01f2abe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_OtherLongTermDebt_2e2f05a4-86ea-4481-a270-45be01f2abe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_f0403b8c-faa4-4d4c-aff8-9e7ca77cbf5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_f0403b8c-faa4-4d4c-aff8-9e7ca77cbf5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_6460d82b-1a4a-42ac-882e-2b90fe5f0800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_6460d82b-1a4a-42ac-882e-2b90fe5f0800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_c6056e54-02e6-4f12-9b65-2306332c8a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_c6056e54-02e6-4f12-9b65-2306332c8a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_ef242985-9d85-4400-9047-9320a20d1d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_DebtCurrent_ef242985-9d85-4400-9047-9320a20d1d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8f92fad1-00bc-476f-814c-7fc1f765d184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8f92fad1-00bc-476f-814c-7fc1f765d184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtInstrumentInterestRatePercentageCap_10322a1c-30d9-436c-9aa0-a2c8ac6ffc53" xlink:href="prgo-20230401.xsd#prgo_DebtInstrumentInterestRatePercentageCap"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_99447e34-b8b5-4243-8c8b-edd39f8f163f" xlink:to="loc_prgo_DebtInstrumentInterestRatePercentageCap_10322a1c-30d9-436c-9aa0-a2c8ac6ffc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IndebtednessNarrativeDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#IndebtednessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IndebtednessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_920c3620-8cd5-4e17-8642-b1be4ff7e917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_920c3620-8cd5-4e17-8642-b1be4ff7e917" xlink:to="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e3e91546-2fd3-444c-9239-2fd147029165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:to="loc_us-gaap_DebtInstrumentAxis_e3e91546-2fd3-444c-9239-2fd147029165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e3e91546-2fd3-444c-9239-2fd147029165" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A2022RevolverMember_c59a2121-5ca1-4d3c-9ee2-3534e6d4e7cc" xlink:href="prgo-20230401.xsd#prgo_A2022RevolverMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A2022RevolverMember_c59a2121-5ca1-4d3c-9ee2-3534e6d4e7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanAFacilityMember_88d8692e-0adb-481f-993a-d32da9d6685b" xlink:href="prgo-20230401.xsd#prgo_NewTermLoanAFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_NewTermLoanAFacilityMember_88d8692e-0adb-481f-993a-d32da9d6685b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NewTermLoanBFacilityMember_e5e04b6d-351c-4c44-953a-37eaf4510796" xlink:href="prgo-20230401.xsd#prgo_NewTermLoanBFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_NewTermLoanBFacilityMember_e5e04b6d-351c-4c44-953a-37eaf4510796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_4f001ddc-1a50-437a-af2c-fc35534c8139" xlink:href="prgo-20230401.xsd#prgo_A5300UnsecuredSeniorNotesDueNovember152043Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A5300UnsecuredSeniorNotesDueNovember152043Member_4f001ddc-1a50-437a-af2c-fc35534c8139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A3900SeniorNoteDue2024Member_163ba29b-ed5a-470e-a34f-6d54c2800135" xlink:href="prgo-20230401.xsd#prgo_A3900SeniorNoteDue2024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A3900SeniorNoteDue2024Member_163ba29b-ed5a-470e-a34f-6d54c2800135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4.375seniornotedueMarch152026Member_68ef7f5a-225c-461e-bf28-71b2b56a4ece" xlink:href="prgo-20230401.xsd#prgo_A4.375seniornotedueMarch152026Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A4.375seniornotedueMarch152026Member_68ef7f5a-225c-461e-bf28-71b2b56a4ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4400SeniorNotesDueJune152030Member_db6cabf4-11f3-4198-bf7d-2c27fd8c3f79" xlink:href="prgo-20230401.xsd#prgo_A4400SeniorNotesDueJune152030Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A4400SeniorNotesDueJune152030Member_db6cabf4-11f3-4198-bf7d-2c27fd8c3f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_A4900SeniorLoanDue2044Member_87b8ff6b-90ab-4e2e-8f15-e919a7291264" xlink:href="prgo-20230401.xsd#prgo_A4900SeniorLoanDue2044Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7fd180a7-f9e4-4839-b886-7568c7bc97c6" xlink:to="loc_prgo_A4900SeniorLoanDue2044Member_87b8ff6b-90ab-4e2e-8f15-e919a7291264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c4cab1a2-a378-4c7b-860a-1c99c73b173d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:to="loc_us-gaap_CreditFacilityAxis_c4cab1a2-a378-4c7b-860a-1c99c73b173d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_635bdb5b-a754-42b6-9b4b-96fdb7a3e95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c4cab1a2-a378-4c7b-860a-1c99c73b173d" xlink:to="loc_us-gaap_CreditFacilityDomain_635bdb5b-a754-42b6-9b4b-96fdb7a3e95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_a9b59b41-c03b-4b43-b2d7-a5e6c5f83dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_635bdb5b-a754-42b6-9b4b-96fdb7a3e95f" xlink:to="loc_us-gaap_SecuredDebtMember_a9b59b41-c03b-4b43-b2d7-a5e6c5f83dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1ced9f4a-21f9-481a-8840-4f6cf4df743c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1ced9f4a-21f9-481a-8840-4f6cf4df743c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_954d7083-2a9e-4ccf-9b0b-16f3884a16a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1ced9f4a-21f9-481a-8840-4f6cf4df743c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_954d7083-2a9e-4ccf-9b0b-16f3884a16a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_79be636b-9ef6-4607-ad45-f9080d9006a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_954d7083-2a9e-4ccf-9b0b-16f3884a16a9" xlink:to="loc_us-gaap_LineOfCreditMember_79be636b-9ef6-4607-ad45-f9080d9006a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_89a70f22-5868-4560-a54e-4584610bfb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_954d7083-2a9e-4ccf-9b0b-16f3884a16a9" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_89a70f22-5868-4560-a54e-4584610bfb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_66b2ade8-a133-4ded-8ffe-7784a4bab736" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_80141236-0025-4ac2-84a6-d3cc4d890678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_80141236-0025-4ac2-84a6-d3cc4d890678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ec3c63cc-95f1-4b24-bf7d-9690a0bbbf35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_DebtInstrumentTerm_ec3c63cc-95f1-4b24-bf7d-9690a0bbbf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d6e5bc0b-d6a0-4be6-89df-5e90f7500e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d6e5bc0b-d6a0-4be6-89df-5e90f7500e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_65f4c9f4-6898-4833-bf7a-fccb9583ea18" xlink:href="prgo-20230401.xsd#prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum_65f4c9f4-6898-4833-bf7a-fccb9583ea18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_99213728-5a43-4022-b920-e6299cd2259d" xlink:href="prgo-20230401.xsd#prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions_99213728-5a43-4022-b920-e6299cd2259d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_4a9bad98-d58e-4472-a1ae-1e24da33f70b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_4a9bad98-d58e-4472-a1ae-1e24da33f70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_dc301202-3fc7-4c7e-848e-c5f93fdce12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_LineOfCredit_dc301202-3fc7-4c7e-848e-c5f93fdce12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_e0e7cd93-a11b-4944-b1f3-7f40a4a64cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f46636d0-a54b-4ac8-9854-1ad69756bedf" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_e0e7cd93-a11b-4944-b1f3-7f40a4a64cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#EarningsPerShareandShareholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_740e002f-7d6f-465e-b890-3780b345b0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumeratorAbstract_ac9ded53-4753-4c94-866c-ad660243ead0" xlink:href="prgo-20230401.xsd#prgo_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_740e002f-7d6f-465e-b890-3780b345b0f8" xlink:to="loc_prgo_NumeratorAbstract_ac9ded53-4753-4c94-866c-ad660243ead0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_6fef9114-e65e-42e4-96f4-fe898445f688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_NumeratorAbstract_ac9ded53-4753-4c94-866c-ad660243ead0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_6fef9114-e65e-42e4-96f4-fe898445f688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_8b95785d-b308-4a57-96e1-6ca2d2469c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_NumeratorAbstract_ac9ded53-4753-4c94-866c-ad660243ead0" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_8b95785d-b308-4a57-96e1-6ca2d2469c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f6e3f82d-2b28-40be-a70f-f5705eb1f55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_NumeratorAbstract_ac9ded53-4753-4c94-866c-ad660243ead0" xlink:to="loc_us-gaap_NetIncomeLoss_f6e3f82d-2b28-40be-a70f-f5705eb1f55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DenominatorAbstract_b2865ed0-bc16-4127-bc53-7ab0f21e6116" xlink:href="prgo-20230401.xsd#prgo_DenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_740e002f-7d6f-465e-b890-3780b345b0f8" xlink:to="loc_prgo_DenominatorAbstract_b2865ed0-bc16-4127-bc53-7ab0f21e6116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f816b48-29bc-4f9e-a7d4-c4b4eb285ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DenominatorAbstract_b2865ed0-bc16-4127-bc53-7ab0f21e6116" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f816b48-29bc-4f9e-a7d4-c4b4eb285ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_993b0a2c-3107-454b-b53f-4a9a2c880b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_DenominatorAbstract_b2865ed0-bc16-4127-bc53-7ab0f21e6116" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_993b0a2c-3107-454b-b53f-4a9a2c880b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_275b041c-fa54-4e60-aebe-658eea568862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_740e002f-7d6f-465e-b890-3780b345b0f8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_275b041c-fa54-4e60-aebe-658eea568862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f44ebf77-dcf9-4848-9810-09e2a9c906b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_740e002f-7d6f-465e-b890-3780b345b0f8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f44ebf77-dcf9-4848-9810-09e2a9c906b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_63a9c897-8328-4677-afb9-698b580a6651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_740e002f-7d6f-465e-b890-3780b345b0f8" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_63a9c897-8328-4677-afb9-698b580a6651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f9ee3298-7d93-42fd-a875-61a16e7f6690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b9d0302b-72bc-448d-b98c-65e4c98de957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_f9ee3298-7d93-42fd-a875-61a16e7f6690" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b9d0302b-72bc-448d-b98c-65e4c98de957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9965ce79-6046-48c1-9378-5d3d19cea8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b9d0302b-72bc-448d-b98c-65e4c98de957" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9965ce79-6046-48c1-9378-5d3d19cea8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7bf6e129-b898-4c42-9cf7-71a3c3731972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9965ce79-6046-48c1-9378-5d3d19cea8a4" xlink:to="loc_us-gaap_EquityComponentDomain_7bf6e129-b898-4c42-9cf7-71a3c3731972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34df595d-d33f-46ec-bc89-1a5dcafffd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7bf6e129-b898-4c42-9cf7-71a3c3731972" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34df595d-d33f-46ec-bc89-1a5dcafffd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_22363c73-7cda-4506-a907-522bf00ff408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34df595d-d33f-46ec-bc89-1a5dcafffd36" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_22363c73-7cda-4506-a907-522bf00ff408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_aee70c77-879a-4a9b-af96-ab6e490c8c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34df595d-d33f-46ec-bc89-1a5dcafffd36" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_aee70c77-879a-4a9b-af96-ab6e490c8c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e289c757-b3ba-475f-b053-5e2a921c4f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34df595d-d33f-46ec-bc89-1a5dcafffd36" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e289c757-b3ba-475f-b053-5e2a921c4f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_afc120fc-3918-42f3-b28b-03cb963a35b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_b9d0302b-72bc-448d-b98c-65e4c98de957" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_afc120fc-3918-42f3-b28b-03cb963a35b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:href="prgo-20230401.xsd#prgo_AccumulatedOtherComprehensiveIncomeRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_afc120fc-3918-42f3-b28b-03cb963a35b5" xlink:to="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b9277f33-74d2-4757-8540-7d5754f9b902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:to="loc_us-gaap_StockholdersEquity_b9277f33-74d2-4757-8540-7d5754f9b902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_83c8f863-5251-411e-99e4-9ecfce7587b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_83c8f863-5251-411e-99e4-9ecfce7587b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4ae13971-d79e-423f-854b-a7b9637b7140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4ae13971-d79e-423f-854b-a7b9637b7140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cb00ecbc-a54f-4f9d-b359-38aaea74582d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cb00ecbc-a54f-4f9d-b359-38aaea74582d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_30cbc72e-f19d-493d-9e67-c00c86d1bd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prgo_AccumulatedOtherComprehensiveIncomeRollForward_41aff1e8-3652-4840-8247-05eb3d472f1e" xlink:to="loc_us-gaap_StockholdersEquity_30cbc72e-f19d-493d-9e67-c00c86d1bd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_89a149e4-b8ed-4e5d-b4bc-674840746991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_a8f3fefc-f4b5-418f-9901-9487a11a7325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_89a149e4-b8ed-4e5d-b4bc-674840746991" xlink:to="loc_us-gaap_RestructuringReserveRollForward_a8f3fefc-f4b5-418f-9901-9487a11a7325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ce245695-44a7-40a4-843f-73093a978c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_a8f3fefc-f4b5-418f-9901-9487a11a7325" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ce245695-44a7-40a4-843f-73093a978c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_a8d596b1-7dd9-48c8-9dc1-0d1c92b7a944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ce245695-44a7-40a4-843f-73093a978c36" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_a8d596b1-7dd9-48c8-9dc1-0d1c92b7a944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7883192d-5066-4dce-a068-2630d0a026d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_a8d596b1-7dd9-48c8-9dc1-0d1c92b7a944" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7883192d-5066-4dce-a068-2630d0a026d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_SupplyChainReinventionMember_f014c552-ee7c-4635-ae05-26d14f356243" xlink:href="prgo-20230401.xsd#prgo_SupplyChainReinventionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7883192d-5066-4dce-a068-2630d0a026d2" xlink:to="loc_prgo_SupplyChainReinventionMember_f014c552-ee7c-4635-ae05-26d14f356243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaIntegrationMember_04d69599-6f6a-4d50-a0fa-f46f480afe60" xlink:href="prgo-20230401.xsd#prgo_HRAPharmaIntegrationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7883192d-5066-4dce-a068-2630d0a026d2" xlink:to="loc_prgo_HRAPharmaIntegrationMember_04d69599-6f6a-4d50-a0fa-f46f480afe60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_fa118d77-2dee-457e-ab5a-f1c4b8cc3e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7883192d-5066-4dce-a068-2630d0a026d2" xlink:to="loc_us-gaap_OtherRestructuringMember_fa118d77-2dee-457e-ab5a-f1c4b8cc3e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ce245695-44a7-40a4-843f-73093a978c36" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_28d570bd-c2e9-4c7b-a864-478de05ea156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:to="loc_us-gaap_RestructuringReserve_28d570bd-c2e9-4c7b-a864-478de05ea156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringAdditionalCharges_d7e40576-60a2-4bcb-b462-efecfe19f073" xlink:href="prgo-20230401.xsd#prgo_RestructuringAdditionalCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:to="loc_prgo_RestructuringAdditionalCharges_d7e40576-60a2-4bcb-b462-efecfe19f073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_6143f966-73ff-41bc-b349-6800d9b5db6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:to="loc_us-gaap_PaymentsForRestructuring_6143f966-73ff-41bc-b349-6800d9b5db6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RestructuringReserveSettledWithoutCashNet_64e374d8-e92a-4f5e-8c3b-6934da730681" xlink:href="prgo-20230401.xsd#prgo_RestructuringReserveSettledWithoutCashNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:to="loc_prgo_RestructuringReserveSettledWithoutCashNet_64e374d8-e92a-4f5e-8c3b-6934da730681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_3fc5ae5e-f234-46f8-908b-8512768ea6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_06c95146-506c-4384-94bf-dababaf15767" xlink:to="loc_us-gaap_RestructuringReserve_3fc5ae5e-f234-46f8-908b-8512768ea6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/RestructuringChargesNarrativeDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#RestructuringChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/RestructuringChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_770b4e88-fcc1-4f26-8f1a-86814d049fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eec17b52-8069-4c96-b94f-a55761853df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_770b4e88-fcc1-4f26-8f1a-86814d049fef" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eec17b52-8069-4c96-b94f-a55761853df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_317db401-1be2-4068-98a8-782e8ad862d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eec17b52-8069-4c96-b94f-a55761853df4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_317db401-1be2-4068-98a8-782e8ad862d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bfc8df1b-90b4-472a-b52d-2137a1c8cd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_317db401-1be2-4068-98a8-782e8ad862d5" xlink:to="loc_us-gaap_SegmentDomain_bfc8df1b-90b4-472a-b52d-2137a1c8cd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_ac2c3ed4-aa54-4cd1-ae06-65b250decb8c" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bfc8df1b-90b4-472a-b52d-2137a1c8cd36" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_ac2c3ed4-aa54-4cd1-ae06-65b250decb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_2315bf6c-1f04-46bc-b189-02780f2dc316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bfc8df1b-90b4-472a-b52d-2137a1c8cd36" xlink:to="loc_us-gaap_CorporateAndOtherMember_2315bf6c-1f04-46bc-b189-02780f2dc316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_UnallocatedSegmentMember_bb63a250-706b-4447-831f-7caabbc1e580" xlink:href="prgo-20230401.xsd#prgo_UnallocatedSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bfc8df1b-90b4-472a-b52d-2137a1c8cd36" xlink:to="loc_prgo_UnallocatedSegmentMember_bb63a250-706b-4447-831f-7caabbc1e580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_5f6a23bc-dea4-4cf1-a538-b4121a9fcdda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eec17b52-8069-4c96-b94f-a55761853df4" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_5f6a23bc-dea4-4cf1-a538-b4121a9fcdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_63cf6ee3-9994-4b07-b3af-8634ba4c5c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5f6a23bc-dea4-4cf1-a538-b4121a9fcdda" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_63cf6ee3-9994-4b07-b3af-8634ba4c5c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_HRAPharmaIntegrationMember_257fe4a1-5466-442f-9cbd-cf8622bb00cd" xlink:href="prgo-20230401.xsd#prgo_HRAPharmaIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_63cf6ee3-9994-4b07-b3af-8634ba4c5c48" xlink:to="loc_prgo_HRAPharmaIntegrationMember_257fe4a1-5466-442f-9cbd-cf8622bb00cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c2763eb1-e30a-45a7-b83d-e901e4037276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eec17b52-8069-4c96-b94f-a55761853df4" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_c2763eb1-e30a-45a7-b83d-e901e4037276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_663c19ae-80d1-4e49-adc4-0fad5eda1a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c2763eb1-e30a-45a7-b83d-e901e4037276" xlink:to="loc_us-gaap_RestructuringCharges_663c19ae-80d1-4e49-adc4-0fad5eda1a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b5d4380b-7b23-4151-8c72-fd29a0bbf908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c2763eb1-e30a-45a7-b83d-e901e4037276" xlink:to="loc_us-gaap_RestructuringReserve_b5d4380b-7b23-4151-8c72-fd29a0bbf908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5626259a-0020-4a15-bdff-502c7367b94a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5626259a-0020-4a15-bdff-502c7367b94a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7c5ca124-b946-4905-84e8-77911a5bf9a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:to="loc_srt_RangeAxis_7c5ca124-b946-4905-84e8-77911a5bf9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5ce6e7c3-11f2-4ab3-9e6f-508200c566e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7c5ca124-b946-4905-84e8-77911a5bf9a9" xlink:to="loc_srt_RangeMember_5ce6e7c3-11f2-4ab3-9e6f-508200c566e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ca900ef1-3e31-4690-97eb-b0a7cb5eec36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5ce6e7c3-11f2-4ab3-9e6f-508200c566e2" xlink:to="loc_srt_MinimumMember_ca900ef1-3e31-4690-97eb-b0a7cb5eec36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ebc8f1eb-72b0-4667-93bf-164849292639" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5ce6e7c3-11f2-4ab3-9e6f-508200c566e2" xlink:to="loc_srt_MaximumMember_ebc8f1eb-72b0-4667-93bf-164849292639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_78e576fe-4c4e-410a-9523-d27ccea7bf56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_78e576fe-4c4e-410a-9523-d27ccea7bf56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_945d58ee-3820-40b1-83ed-8ec53994a45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_78e576fe-4c4e-410a-9523-d27ccea7bf56" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_945d58ee-3820-40b1-83ed-8ec53994a45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_f9257d10-3027-4aa7-8d01-fc3e13085e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_945d58ee-3820-40b1-83ed-8ec53994a45b" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_f9257d10-3027-4aa7-8d01-fc3e13085e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7caa104b-590f-4c4d-96b6-31a65785723b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:to="loc_srt_StatementScenarioAxis_7caa104b-590f-4c4d-96b6-31a65785723b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_37bfad78-15b2-4053-89ca-f107318f2573" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7caa104b-590f-4c4d-96b6-31a65785723b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_37bfad78-15b2-4053-89ca-f107318f2573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_cf311edc-2856-4c48-9e28-f77b89a1e3eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_37bfad78-15b2-4053-89ca-f107318f2573" xlink:to="loc_srt_ScenarioForecastMember_cf311edc-2856-4c48-9e28-f77b89a1e3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3cead1cd-fb0e-451b-9e78-832d98529e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3cead1cd-fb0e-451b-9e78-832d98529e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4e28f95c-4583-47e8-9c97-20c587c49242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3cead1cd-fb0e-451b-9e78-832d98529e21" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4e28f95c-4583-47e8-9c97-20c587c49242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9f9d2160-1055-4626-aa37-f74b49c9a963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4e28f95c-4583-47e8-9c97-20c587c49242" xlink:to="loc_us-gaap_SubsequentEventMember_9f9d2160-1055-4626-aa37-f74b49c9a963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_7d5a6e2d-802d-4ed9-91e5-80b2ecae66b7" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e4f38f7d-26c9-4e43-82f4-656d8dc4b026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e4f38f7d-26c9-4e43-82f4-656d8dc4b026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationNumberOfTaxableYears_e02b56e2-493e-4b81-8bc9-74b91e8e75b7" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationNumberOfTaxableYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_IncomeTaxExaminationNumberOfTaxableYears_e02b56e2-493e-4b81-8bc9-74b91e8e75b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_c26b028d-836b-40cf-a6e7-8e2db056c6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_c26b028d-836b-40cf-a6e7-8e2db056c6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CumulativeDeferredChargeTaxLitigation_f231420e-f618-4289-bb4c-d77513732341" xlink:href="prgo-20230401.xsd#prgo_CumulativeDeferredChargeTaxLitigation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_CumulativeDeferredChargeTaxLitigation_f231420e-f618-4289-bb4c-d77513732341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_6145653e-50b9-44d0-8563-39e8debd811d" xlink:href="prgo-20230401.xsd#prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent_6145653e-50b9-44d0-8563-39e8debd811d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_a7b5bb26-7387-443b-8821-033cd9484803" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015_a7b5bb26-7387-443b-8821-033cd9484803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_7efa1b58-883d-4125-99d2-e6a063399c21" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015_7efa1b58-883d-4125-99d2-e6a063399c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_9131b6c4-bac0-46a5-8c91-060d342b6bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_9131b6c4-bac0-46a5-8c91-060d342b6bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_f4a283e2-e844-4f1e-9247-b610c5d9c03d" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_f4a283e2-e844-4f1e-9247-b610c5d9c03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_760c52fd-f1c8-42c9-a60c-a7ab3cf11014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_370437ac-a9e0-41eb-8342-23aaca26669a" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_760c52fd-f1c8-42c9-a60c-a7ab3cf11014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#ContingenciesPriceFixingLawsuitsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_20f9f062-9e74-42a4-9de5-d908abb1d3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_cf3ee235-412f-42cd-b1b7-c8ba547b4005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_20f9f062-9e74-42a4-9de5-d908abb1d3d3" xlink:to="loc_us-gaap_LossContingenciesTable_cf3ee235-412f-42cd-b1b7-c8ba547b4005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_69c82cc0-69cf-40cc-a5af-8d7050a518fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cf3ee235-412f-42cd-b1b7-c8ba547b4005" xlink:to="loc_srt_LitigationCaseAxis_69c82cc0-69cf-40cc-a5af-8d7050a518fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_fff1e768-7c30-4a56-ad6c-e259f42a27a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_69c82cc0-69cf-40cc-a5af-8d7050a518fe" xlink:to="loc_srt_LitigationCaseTypeDomain_fff1e768-7c30-4a56-ad6c-e259f42a27a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_StateAttorneyGeneralComplaintMember_017413fa-40b8-40ff-a4a8-b1d052f1b0a4" xlink:href="prgo-20230401.xsd#prgo_StateAttorneyGeneralComplaintMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_fff1e768-7c30-4a56-ad6c-e259f42a27a6" xlink:to="loc_prgo_StateAttorneyGeneralComplaintMember_017413fa-40b8-40ff-a4a8-b1d052f1b0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_CanadianClassActionComplaintMember_fd315638-e882-4fc2-88e0-2ceef03bf9d4" xlink:href="prgo-20230401.xsd#prgo_CanadianClassActionComplaintMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_fff1e768-7c30-4a56-ad6c-e259f42a27a6" xlink:to="loc_prgo_CanadianClassActionComplaintMember_fd315638-e882-4fc2-88e0-2ceef03bf9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cf3ee235-412f-42cd-b1b7-c8ba547b4005" xlink:to="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAdditionalStatesAndTerritories_7cfaf06b-168c-4b5b-8a98-8150d2212f73" xlink:href="prgo-20230401.xsd#prgo_NumberOfAdditionalStatesAndTerritories"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:to="loc_prgo_NumberOfAdditionalStatesAndTerritories_7cfaf06b-168c-4b5b-8a98-8150d2212f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfManufacturers_097b0a36-7fd2-4ec8-b96b-a93a331d467a" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberOfManufacturers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:to="loc_prgo_LossContingencyNumberOfManufacturers_097b0a36-7fd2-4ec8-b96b-a93a331d467a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofFormerEmployees_7d15bada-6e30-42e4-887f-4242fb97a645" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofFormerEmployees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:to="loc_prgo_LossContingencyNumberofFormerEmployees_7d15bada-6e30-42e4-887f-4242fb97a645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_dc5c1538-2f20-49a5-9b77-d71998369a59" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3808a03c-a02a-42e2-97e4-b0ed6bb4618f" xlink:to="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_dc5c1538-2f20-49a5-9b77-d71998369a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#ContingenciesSecuritiesLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2013870b-afe3-4c83-94d1-a9f4fbf5427a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_af23dc66-165f-457d-a1eb-3a7bcc201cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2013870b-afe3-4c83-94d1-a9f4fbf5427a" xlink:to="loc_us-gaap_LossContingenciesTable_af23dc66-165f-457d-a1eb-3a7bcc201cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6d30553f-b08d-4c35-aefe-62ddaa2f3bae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_af23dc66-165f-457d-a1eb-3a7bcc201cfa" xlink:to="loc_srt_LitigationCaseAxis_6d30553f-b08d-4c35-aefe-62ddaa2f3bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2da216e8-83f7-4dca-8255-e1fb8cef5dbc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_6d30553f-b08d-4c35-aefe-62ddaa2f3bae" xlink:to="loc_srt_LitigationCaseTypeDomain_2da216e8-83f7-4dca-8255-e1fb8cef5dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_23b23a48-af82-4e4c-bebe-8ce1f8b1a0f9" xlink:href="prgo-20230401.xsd#prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_2da216e8-83f7-4dca-8255-e1fb8cef5dbc" xlink:to="loc_prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member_23b23a48-af82-4e4c-bebe-8ce1f8b1a0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_af23dc66-165f-457d-a1eb-3a7bcc201cfa" xlink:to="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_8169306b-e032-41e0-a635-cde7faf82e6a" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers_8169306b-e032-41e0-a635-cde7faf82e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_2bc28956-710b-4162-82d5-802acd2e9aa5" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals_2bc28956-710b-4162-82d5-802acd2e9aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofPutativeClasses_aaa6ae10-6a69-40a4-9024-ba1b94122c7d" xlink:href="prgo-20230401.xsd#prgo_NumberofPutativeClasses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_prgo_NumberofPutativeClasses_aaa6ae10-6a69-40a4-9024-ba1b94122c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_0ae94d1d-1239-405a-920f-dc9fda168a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_0ae94d1d-1239-405a-920f-dc9fda168a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_97e3758c-b006-4b86-840e-ce84dc1c55af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_97e3758c-b006-4b86-840e-ce84dc1c55af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_8fa45062-9b56-4f63-9131-a5934e727397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7354525a-6e69-4e1e-b489-6a7dfbf696ad" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_8fa45062-9b56-4f63-9131-a5934e727397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/ContingenciesOtherMattersDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#ContingenciesOtherMattersDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/ContingenciesOtherMattersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a86d5f72-4e9b-46a4-8e3f-ef89a53ad33c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1b9ef454-dfc4-48d2-89ce-e4198aade3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a86d5f72-4e9b-46a4-8e3f-ef89a53ad33c" xlink:to="loc_us-gaap_LossContingenciesTable_1b9ef454-dfc4-48d2-89ce-e4198aade3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_53fb4808-c581-4bdc-afb5-a3b4972cbc9e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1b9ef454-dfc4-48d2-89ce-e4198aade3f6" xlink:to="loc_srt_LitigationCaseAxis_53fb4808-c581-4bdc-afb5-a3b4972cbc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_37991ef9-9824-4da2-9e29-257e5c079995" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_53fb4808-c581-4bdc-afb5-a3b4972cbc9e" xlink:to="loc_srt_LitigationCaseTypeDomain_37991ef9-9824-4da2-9e29-257e5c079995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_TalcumPowderLitigationMember_15ea9adb-e2d3-49bb-ac89-e21d1905d804" xlink:href="prgo-20230401.xsd#prgo_TalcumPowderLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_37991ef9-9824-4da2-9e29-257e5c079995" xlink:to="loc_prgo_TalcumPowderLitigationMember_15ea9adb-e2d3-49bb-ac89-e21d1905d804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_RanitidineLitigationMember_99f9481a-d205-4d33-bdae-a3d3d494fc42" xlink:href="prgo-20230401.xsd#prgo_RanitidineLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_37991ef9-9824-4da2-9e29-257e5c079995" xlink:to="loc_prgo_RanitidineLitigationMember_99f9481a-d205-4d33-bdae-a3d3d494fc42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1b9ef454-dfc4-48d2-89ce-e4198aade3f6" xlink:to="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_dfc73955-ca2f-443b-a7c9-0174bdcbfecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_dfc73955-ca2f-443b-a7c9-0174bdcbfecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberofTendersAccepted_68c7c9b0-31d3-40c2-ac04-6438f234951b" xlink:href="prgo-20230401.xsd#prgo_NumberofTendersAccepted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_NumberofTendersAccepted_68c7c9b0-31d3-40c2-ac04-6438f234951b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaints_50138b75-04c8-4bf8-bf26-93eaae1986b3" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofMasterComplaints"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaints_50138b75-04c8-4bf8-bf26-93eaae1986b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_d1ecb86f-ddd9-4c87-8200-2d730503243b" xlink:href="prgo-20230401.xsd#prgo_LossContingencyNumberofMasterComplaintsNamingCompany"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_LossContingencyNumberofMasterComplaintsNamingCompany_d1ecb86f-ddd9-4c87-8200-2d730503243b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfMasterComplaints_377042a0-4227-4ab6-808b-133d243b2705" xlink:href="prgo-20230401.xsd#prgo_NumberOfAppealsOfMasterComplaints"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_NumberOfAppealsOfMasterComplaints_377042a0-4227-4ab6-808b-133d243b2705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims_bf171c33-807e-43b6-bc17-bf1c77ad24c2" xlink:href="prgo-20230401.xsd#prgo_NumberOfAppealsOfPersonalInjuryClaims"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_NumberOfAppealsOfPersonalInjuryClaims_bf171c33-807e-43b6-bc17-bf1c77ad24c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_NumberOfPersonalInjuryLawsuits_6b269255-95ba-453d-8206-d71c7efe3bff" xlink:href="prgo-20230401.xsd#prgo_NumberOfPersonalInjuryLawsuits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_NumberOfPersonalInjuryLawsuits_6b269255-95ba-453d-8206-d71c7efe3bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_ecfdafbe-5e2c-4621-831e-a507af2dfbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_us-gaap_LitigationReserve_ecfdafbe-5e2c-4621-831e-a507af2dfbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_1cb354dc-b9de-4216-92c9-a50cba9f5340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions_1cb354dc-b9de-4216-92c9-a50cba9f5340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_f0c5edb2-583f-4f3a-96f4-e59603188f4c" xlink:href="prgo-20230401.xsd#prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6eb99387-63d8-480d-aaa9-b2e2f0906890" xlink:to="loc_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods_f0c5edb2-583f-4f3a-96f4-e59603188f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#SegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fb08cf73-0288-4495-ac46-6a5ca1463f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_39461a09-09d4-4e97-b024-9f02fe535200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fb08cf73-0288-4495-ac46-6a5ca1463f89" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_39461a09-09d4-4e97-b024-9f02fe535200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_094cab63-4418-48dc-80a6-c2de5f77e9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_39461a09-09d4-4e97-b024-9f02fe535200" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_094cab63-4418-48dc-80a6-c2de5f77e9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_48f79f9b-a6e9-4dfe-8ba1-f8f9083f70eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_094cab63-4418-48dc-80a6-c2de5f77e9b1" xlink:to="loc_us-gaap_SegmentDomain_48f79f9b-a6e9-4dfe-8ba1-f8f9083f70eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareAmericasMember_419f4c9b-b921-4e4b-b6da-f30c130cc408" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_48f79f9b-a6e9-4dfe-8ba1-f8f9083f70eb" xlink:to="loc_prgo_ConsumerSelfCareAmericasMember_419f4c9b-b921-4e4b-b6da-f30c130cc408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_ConsumerSelfCareInternationalMember_49036cf0-51aa-45be-8fd9-879c45ba2012" xlink:href="prgo-20230401.xsd#prgo_ConsumerSelfCareInternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_48f79f9b-a6e9-4dfe-8ba1-f8f9083f70eb" xlink:to="loc_prgo_ConsumerSelfCareInternationalMember_49036cf0-51aa-45be-8fd9-879c45ba2012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d569acc5-923f-43da-9687-238aa2b2ebd6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_39461a09-09d4-4e97-b024-9f02fe535200" xlink:to="loc_srt_ConsolidationItemsAxis_d569acc5-923f-43da-9687-238aa2b2ebd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ceb554a0-f282-44ba-8949-e9b08dfe843b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_d569acc5-923f-43da-9687-238aa2b2ebd6" xlink:to="loc_srt_ConsolidationItemsDomain_ceb554a0-f282-44ba-8949-e9b08dfe843b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7aaadfd1-e677-48ae-8282-4d6c4522dec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ceb554a0-f282-44ba-8949-e9b08dfe843b" xlink:to="loc_us-gaap_OperatingSegmentsMember_7aaadfd1-e677-48ae-8282-4d6c4522dec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_56a3fea3-2873-4a8a-a1a3-90d1a31ba1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ceb554a0-f282-44ba-8949-e9b08dfe843b" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_56a3fea3-2873-4a8a-a1a3-90d1a31ba1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_39461a09-09d4-4e97-b024-9f02fe535200" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6d8ac878-3e38-4bc7-a114-4a394dc5c0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:to="loc_us-gaap_Assets_6d8ac878-3e38-4bc7-a114-4a394dc5c0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3190b1f2-ce12-470c-b36a-7197b67c73a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3190b1f2-ce12-470c-b36a-7197b67c73a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6ad9fdfc-c8ba-4eff-887f-96e6fdf05043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:to="loc_us-gaap_OperatingIncomeLoss_6ad9fdfc-c8ba-4eff-887f-96e6fdf05043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_505b5f83-b613-4994-8f0d-16309bde15b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_931e10b1-9a1d-45fd-bd11-124d5c263757" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_505b5f83-b613-4994-8f0d-16309bde15b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.perrigo.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="prgo-20230401.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.perrigo.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_7c160641-c9b7-4c11-bde8-af955d48f3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_14c542d8-7ee5-4f3a-855a-ea59059250a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_7c160641-c9b7-4c11-bde8-af955d48f3f8" xlink:to="loc_us-gaap_SubsequentEventTable_14c542d8-7ee5-4f3a-855a-ea59059250a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_82f747bb-6691-491f-a4d2-2f0ec61ca687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_14c542d8-7ee5-4f3a-855a-ea59059250a6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_82f747bb-6691-491f-a4d2-2f0ec61ca687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b2b28051-ff86-40cd-938f-2784af466f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_82f747bb-6691-491f-a4d2-2f0ec61ca687" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b2b28051-ff86-40cd-938f-2784af466f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_efc9881b-65aa-4432-b7a6-06970056f73a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b2b28051-ff86-40cd-938f-2784af466f78" xlink:to="loc_us-gaap_SubsequentEventMember_efc9881b-65aa-4432-b7a6-06970056f73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_14c542d8-7ee5-4f3a-855a-ea59059250a6" xlink:to="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_33a8f1b1-1e2e-45cb-ba1b-6d0ba2bc9020" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty_33a8f1b1-1e2e-45cb-ba1b-6d0ba2bc9020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_0876a9dc-064f-44b0-a265-31f6fd75a3f4" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeofProposedAdjustmentPenaltyPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent_0876a9dc-064f-44b0-a265-31f6fd75a3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_3996d2f2-77da-48f9-b56a-4cb36be15913" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense_3996d2f2-77da-48f9-b56a-4cb36be15913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_6969e86e-c7cb-48bb-b5e4-7fb19b74ba07" xlink:href="prgo-20230401.xsd#prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate_6969e86e-c7cb-48bb-b5e4-7fb19b74ba07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_0300e76c-00ae-4d72-b6fe-17e5cf8c36d9" xlink:href="prgo-20230401.xsd#prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes_0300e76c-00ae-4d72-b6fe-17e5cf8c36d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_5405307f-2c43-41f3-9519-4dfccead4b40" xlink:href="prgo-20230401.xsd#prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense_5405307f-2c43-41f3-9519-4dfccead4b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_e095fe8a-0d55-4002-b0e0-68483ab50ea1" xlink:href="prgo-20230401.xsd#prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes_e095fe8a-0d55-4002-b0e0-68483ab50ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_BlendedInterestRateInRevenueAgentReport_8c7fd428-a005-42a3-a572-1ee940df2f4c" xlink:href="prgo-20230401.xsd#prgo_BlendedInterestRateInRevenueAgentReport"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_BlendedInterestRateInRevenueAgentReport_8c7fd428-a005-42a3-a572-1ee940df2f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prgo_DebtStatedBlendedInterestRate_e29f607e-2c4a-42a2-ad3d-27d8165b17ff" xlink:href="prgo-20230401.xsd#prgo_DebtStatedBlendedInterestRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_prgo_DebtStatedBlendedInterestRate_e29f607e-2c4a-42a2-ad3d-27d8165b17ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationInterestExpense_b45d91eb-5d13-43f7-a6f8-4e45acd1ba46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationInterestExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_320f8558-012b-4390-b9ae-53afd5f303b9" xlink:to="loc_us-gaap_IncomeTaxExaminationInterestExpense_b45d91eb-5d13-43f7-a6f8-4e45acd1ba46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790318256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>May 05, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Perrigo Company plc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">The Sharp Building,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Hogan Place,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02 TY74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">7094000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,325,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001585364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_OrdinaryShares0001ParValueMember', window );">Ordinary Shares, 0.001 Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, &#8364;0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_A3900SeniorNoteDue2024Member', window );">3.900% senior note due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.900% Notes due 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_A4.375seniornotedueMarch152026Member', window );">4.375% senior note due March 15, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">4.375% Notes due 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_A4400SeniorNotesDueJune152030Member', window );">4.400% Senior Notes due June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">4.400% Notes due 2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member', window );">5.300% Unsecured Senior Notes due November 15, 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.300% Notes due 2043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=prgo_A4900SeniorLoanDue2044Member', window );">4.900% Senior Loan due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">4.900% Notes due 2044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRGO44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_OrdinaryShares0001ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_OrdinaryShares0001ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_A3900SeniorNoteDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_A3900SeniorNoteDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_A4.375seniornotedueMarch152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_A4.375seniornotedueMarch152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_A4400SeniorNotesDueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_A4400SeniorNotesDueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=prgo_A4900SeniorLoanDue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=prgo_A4900SeniorLoanDue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671786744432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,181.7<span></span>
</td>
<td class="nump">$ 1,074.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">767.9<span></span>
</td>
<td class="nump">736.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">413.8<span></span>
</td>
<td class="nump">337.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductionAndDistributionCosts', window );">Distribution</a></td>
<td class="nump">28.6<span></span>
</td>
<td class="nump">24.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">31.1<span></span>
</td>
<td class="nump">29.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling</a></td>
<td class="nump">167.9<span></span>
</td>
<td class="nump">135.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Administration</a></td>
<td class="nump">135.0<span></span>
</td>
<td class="nump">122.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_OtherOperatingIncomeLossNet', window );">Other operating (income) expense, net</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">365.3<span></span>
</td>
<td class="nump">316.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">48.5<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">43.7<span></span>
</td>
<td class="nump">35.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="num">(11.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income (loss) from discontinued operations, net of tax</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (3.0)<span></span>
</td>
<td class="num">$ (2.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (loss) per share (in dollars per share)</a></td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per share (in dollars per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">134.9<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">134.9<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_OtherOperatingIncomeLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Operating (Income) Loss, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_OtherOperatingIncomeLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionAndDistributionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to the production and distribution of goods or services to customers and clients.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionAndDistributionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790165232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (3.0)<span></span>
</td>
<td class="num">$ (2.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">52.7<span></span>
</td>
<td class="num">(24.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Change in fair value of derivative financial instruments, net of tax</a></td>
<td class="num">(31.5)<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Change in post-retirement and pension liability, net of tax</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="num">(20.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 17.7<span></span>
</td>
<td class="num">$ (22.9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671782744656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 553.0<span></span>
</td>
<td class="nump">$ 600.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $7.1 and $6.8, respectively</a></td>
<td class="nump">738.7<span></span>
</td>
<td class="nump">697.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,183.0<span></span>
</td>
<td class="nump">1,150.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">266.0<span></span>
</td>
<td class="nump">271.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,740.7<span></span>
</td>
<td class="nump">2,719.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">919.3<span></span>
</td>
<td class="nump">926.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets', window );">Operating lease assets</a></td>
<td class="nump">211.7<span></span>
</td>
<td class="nump">217.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_GoodwillAndIndefiniteLivedIntangibles', window );">Goodwill and indefinite-lived intangible assets</a></td>
<td class="nump">3,650.4<span></span>
</td>
<td class="nump">3,549.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Definite-lived intangible assets, net</a></td>
<td class="nump">3,083.9<span></span>
</td>
<td class="nump">3,230.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">342.8<span></span>
</td>
<td class="nump">367.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">8,214.2<span></span>
</td>
<td class="nump">8,297.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">10,954.9<span></span>
</td>
<td class="nump">11,017.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Shareholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">505.2<span></span>
</td>
<td class="nump">537.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related taxes</a></td>
<td class="nump">106.5<span></span>
</td>
<td class="nump">136.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AccruedCustomerPrograms', window );">Accrued customer programs</a></td>
<td class="nump">146.7<span></span>
</td>
<td class="nump">139.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">272.0<span></span>
</td>
<td class="nump">250.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued income taxes</a></td>
<td class="nump">17.6<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current indebtedness</a></td>
<td class="nump">38.8<span></span>
</td>
<td class="nump">36.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,086.8<span></span>
</td>
<td class="nump">1,113.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">4,062.8<span></span>
</td>
<td class="nump">4,070.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">333.8<span></span>
</td>
<td class="nump">368.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">637.6<span></span>
</td>
<td class="nump">623.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">5,034.2<span></span>
</td>
<td class="nump">5,061.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">6,121.0<span></span>
</td>
<td class="nump">6,175.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies - Refer to Note 16</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ControllingInterestAbstract', window );"><strong>Controlling interests:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, $0.0001 par value per share, 10 shares authorized</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, &#8364;0.001 par value per share, 10,000 shares authorized</a></td>
<td class="nump">6,910.8<span></span>
</td>
<td class="nump">6,936.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(27.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="num">(2,070.6)<span></span>
</td>
<td class="num">(2,067.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">4,833.9<span></span>
</td>
<td class="nump">4,842.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 10,954.9<span></span>
</td>
<td class="nump">$ 11,017.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Supplemental Disclosures of Balance Sheet Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued and outstanding (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued and outstanding (in shares)</a></td>
<td class="nump">135.3<span></span>
</td>
<td class="nump">134.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AccruedCustomerPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AccruedCustomerPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ControllingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Controlling Interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ControllingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_GoodwillAndIndefiniteLivedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_GoodwillAndIndefiniteLivedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790070880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, authorized (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in EUR per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, authorized (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671786689568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Ordinary Shares Issued</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 5,151.7<span></span>
</td>
<td class="nump">$ 7,043.2<span></span>
</td>
<td class="nump">$ 35.5<span></span>
</td>
<td class="num">$ (1,927.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(20.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">26.3<span></span>
</td>
<td class="nump">$ 26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(34.2)<span></span>
</td>
<td class="num">$ (34.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">(16.4)<span></span>
</td>
<td class="num">$ (16.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Apr. 02, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Apr. 02, 2022</a></td>
<td class="nump">5,104.5<span></span>
</td>
<td class="nump">$ 7,018.9<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="num">(1,929.4)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">4,842.1<span></span>
</td>
<td class="nump">$ 6,936.7<span></span>
</td>
<td class="num">(27.0)<span></span>
</td>
<td class="num">(2,067.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Compensation for restricted stock</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">$ 24.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">(36.2)<span></span>
</td>
<td class="num">$ (36.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for payment of employees' withholding tax liability</a></td>
<td class="num">(14.6)<span></span>
</td>
<td class="num">$ (14.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Apr. 01, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Apr. 01, 2023</a></td>
<td class="nump">$ 4,833.9<span></span>
</td>
<td class="nump">$ 6,910.8<span></span>
</td>
<td class="num">$ (6.3)<span></span>
</td>
<td class="num">$ (2,070.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671789121536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends paid (in dollars per share)</a></td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671785732816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From (For) Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NetLossIncomeAttributableToParent', window );">Net income (loss)</a></td>
<td class="num">$ (3.0)<span></span>
</td>
<td class="num">$ (2.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to derive cash flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">88.7<span></span>
</td>
<td class="nump">69.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">26.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringChargesContinuingOperations', window );">Restructuring charges</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss on sale of business</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount (premium)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Gain on sale of assets</a></td>
<td class="num">(3.9)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(9.9)<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other non-cash adjustments, net</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="num">(17.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems', window );">Subtotal</a></td>
<td class="nump">107.3<span></span>
</td>
<td class="nump">80.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (decrease) in cash due to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(39.8)<span></span>
</td>
<td class="num">(38.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(28.6)<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">17.1<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(29.8)<span></span>
</td>
<td class="nump">72.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Payroll and related taxes</a></td>
<td class="num">(34.3)<span></span>
</td>
<td class="num">(31.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncreaseDecreaseInAccruedCustomerPrograms', window );">Accrued customer programs</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">23.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Accrued income taxes</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="num">(33.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other, net</a></td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapital', window );">Subtotal</a></td>
<td class="num">(87.9)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash from (for) operating activities</a></td>
<td class="nump">19.4<span></span>
</td>
<td class="nump">79.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From (For) Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="num">(23.2)<span></span>
</td>
<td class="num">(20.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">58.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Proceeds from sale of assets</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">22.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities', window );">Proceeds from royalty rights</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash from (for) investing activities</a></td>
<td class="num">(19.6)<span></span>
</td>
<td class="nump">62.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From (For) Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess', window );">Borrowings (repayments) of revolving credit agreements and other financing, net</a></td>
<td class="num">(5.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends</a></td>
<td class="num">(36.2)<span></span>
</td>
<td class="num">(34.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing, net</a></td>
<td class="num">(8.6)<span></span>
</td>
<td class="num">(17.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash from (for) financing activities</a></td>
<td class="num">(50.7)<span></span>
</td>
<td class="num">(51.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(47.7)<span></span>
</td>
<td class="nump">86.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents of continuing operations, beginning of period</a></td>
<td class="nump">600.7<span></span>
</td>
<td class="nump">1,864.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents held for sale, beginning of period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Less cash and cash equivalents held for sale, end of period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents of continuing operations, end of period</a></td>
<td class="nump">$ 553.0<span></span>
</td>
<td class="nump">$ 1,965.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncreaseDecreaseInAccruedCustomerPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncreaseDecreaseInAccruedCustomerPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net income (loss) after adjustments for noncash and nonoperating items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NetLossIncomeAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Loss (Income) Attributable to Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NetLossIncomeAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ProceedsfromRoyaltiesReceivedInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Royalties Received, Investing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ProceedsfromRoyaltiesReceivedInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_RestructuringChargesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges, Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_RestructuringChargesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of other assets recognized in investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788109008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Information</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading provider of over-the-counter ("OTC") health and wellness solutions that are designed to enhance individual well-being and empower consumers to proactively prevent or treat conditions that can be self-managed. Our vision is t</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">o make lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;We are headquartered in Ireland and sell our products primarily in North America and Europe as well as in other markets around the world.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unaudited Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022. In the opinion of management, all adjustments considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Some amounts in this report may not add due to rounding. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting and operating segments are as follows: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:14.5pt">Consumer Self-Care Americas ("CSCA") </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care International ("CSCI") </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic business in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_61" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note </a></span><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_61" style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our segments reflect the way in which our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company. Financial information related to our business segments and geographic locations can be found in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_43" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2 </a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_100" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 17</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation and Transactions </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate our non-U.S. dollar-denominated operations&#8217; assets and liabilities into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of Accumulated other comprehensive income (loss) ("AOCI"). Gains or losses from foreign currency transactions are included in Other (income) expense, net.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. Historical credit loss experience provides the primary basis for estimation of expected credit losses and is adjusted for current conditions and for reasonable and supportable forecasts. Receivables that do not share risk characteristics are evaluated on an individual basis and are not included in the collective evaluation. The following table presents the allowance for credit losses activity (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.222%"><tr><td style="width:1.0%"/><td style="width:61.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.322%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for credit losses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables written-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788260128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">REVENUE RECOGNITION <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our net sales by category</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.00pt"><tr><td style="width:1.0pt"/><td style="width:226.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vitamins, Minerals, and Supplements ("VMS")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCA</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">763.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">710.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VMS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCI</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(1) We updated our global reporting product categories as a result of our product portfolio reconfiguration. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(2) Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">than 10% of the segment net sales. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized over time. Customer contracts recognized over time exist predominately in contract manufacturing arrangements, which occur in both the CSCA and CSCI segments. Contract manufacturing revenue was $90.0&#160;million for the three months ended April&#160;1, 2023, and $70.8&#160;million for the three months ended April&#160;2, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also recognize a portion of the store brand OTC product revenues in the CSCA segment on an over time basis; however, the timing difference between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract assets from contracts with customers (in millions):</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:24.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term contract assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated net sales in the following geographic locations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:366.00pt"><tr><td style="width:1.0pt"/><td style="width:220.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other countries</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The net sales by geography are derived from the location of the entity that sells to a third party.  </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Includes Ireland net sales of $7.3 million and $6.6&#160;million for the three months ended April&#160;1, 2023 and April&#160;2, 2022, respectively. </span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Includes net sales generated primarily in Australia and Canada.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788399712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisitions and Divestitures</a></td>
<td class="text">ACQUISITIONS AND DIVESTITURES<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Acquisitions During the Year Ended December 31, 2022</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">H&#233;ra SAS ("</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">HRA Pharma")</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On April 29, 2022, we completed the previously announced acquisition of 100% of the outstanding equity interest in HRA Pharma for total consideration of &#8364;1.8&#160;billion, or approximately $1.9&#160;billion. We funded the transaction with cash on hand and borrowings under our New Senior Secured Credit Facilities (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_73" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">). The acquisition of HRA Pharma was accounted for as a business combination and has been reported in our Condensed Consolidated Statements of Operations as of the acquisition date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">HRA Pharma is a self-care based company with consumer brands such as </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Compeed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">, ellaOne</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"> and Mederma</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">, as well as a trusted rare disease portfolio. The acquisition completed our transformation to a consumer self-care company. HRA Pharma&#8217;s operations are reported in both our CSCA and CSCI segments. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We recorded the preliminary purchase price allocation in the second quarter of 2022. During the first quarter of 2023, we recorded measurement period adjustments resulting in an increase to goodwill of $80.6&#160;million, which consisted of a $104.3&#160;million decrease in definite-lived intangibles, $27.2&#160;million decrease in net Deferred income tax liabilities, a net increase of $2.0&#160;million to other non-current liabilities, and a $1.5&#160;million decrease in Prepaid expenses and other current assets. Current period earnings adjustments of $3.5&#160;million to Cost of sales were recorded that would have been recognized during the year-ended December 31, 2022, if the measurement period adjustments to the provisional opening balance sheet were reflected as of the acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Nestl&#233;&#8217;s Gateway Infant Formula Plant and GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> infant formula brand Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we purchased Nestl&#233;&#8217;s Gateway infant formula plant in Eau Claire, Wisconsin, along with the U.S. and Canadian rights to the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GoodStart</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infant formula brand ("Gateway"), for $110.0&#160;million in cash, subject to customary post-closing adjustments. The acquisition was accounted for as a business combination and operating results attributable to the products are included in our CSCA segment in the Nutrition product category. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are in the process of finalizing the valuation for the assets acquired. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired will be finalized as soon as possible but no later than one year from the acquisition date. The final determination may result in asset fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Pro Forma Impact of Business Combinations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents unaudited pro forma information as if the HRA Pharma and Gateway acquisitions had occurred on January 1, 2021 and had been combined with the results reported in our Condensed Consolidated Statements of Operations for the three months ended April&#160;2, 2022 (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:305.25pt"><tr><td style="width:1.0pt"/><td style="width:208.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:93.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma information is presented for information purposes only and is not indicative of the results that would have been achieved if the acquisition had taken place at such time. The unaudited pro forma information presented above includes adjustments primarily for amortization charges for acquired intangible assets, depreciation of property, plant and equipment that have been revalued, certain acquisition-related charges, and related tax effects.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures During the Year Ended December 31, 2022 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Latin American businesses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2022, we completed the sale of our Mexico and Brazil-based OTC businesses ("Latin American businesses"), both within our CSCA segment, to Advent International for total consideration of $23.9 million, consisting of $5.4 million in cash, installment receivables due 12 and 18 months from completion totaling $11.3 million based on the Mexican peso exchange rate at the time of sale, and contingent consideration of $7.2 million based on the Brazilian real exchange rate at the time of sale. The sale resulted in a pre-tax loss of $1.4 million, net of professional fees, recorded in Other operating expense, net on the Condensed Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2022, we completed the sale of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ScarAway</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand asset, a leading U.S. OTC scar management brand, to Alliance Pharmaceuticals Ltd. for cash consideration of $20.7 million. The sale resulted in a pre-tax gain of $3.6 million recorded in our CSCA segment in Other operating expense, net on the Condensed Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788260128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Discontinued Operations</a></td>
<td class="text">DISCONTINUED OPERATIONS<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discontinued operations consist of our generic prescription pharmaceuticals business in the U.S. and our pharmaceuticals and diagnostic businesses in Israel (collectively, the &#8220;Rx business&#8221;).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July&#160;6, 2021, we completed the sale of the Rx business to Altaris Capital Partners, LLC ("Altaris") for aggregate consideration of $1.55 billion. The consideration included a $53.3 million reimbursement related to an Abbreviated New Drug Application (&#8220;ANDA") for a generic topical lotion which Altaris delivered in cash to Perrigo pursuant to the terms of the definitive agreement during the three months ended April 2, 2022. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of a transition services agreement ("TSA"), we provided transition services which were substantially completed as of the end of the third quarter of 2022. We also entered into reciprocal supply agreements pursuant to which Perrigo will supply certain products to the Rx business and the Rx business will supply certain products to Perrigo. The supply agreements have a term of four years, extendable up to seven years by the party who is the purchaser of the products under such agreement. We also extended distribution rights to the Rx business for certain OTC products owned and manufactured by Perrigo that may be fulfilled through pharmacy channels, in return for a share of the net profits.</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale, Perrigo retained certain pre-closing liabilities arising out of antitrust (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_91" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 16 - Contingencies</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the header "Price-Fixing Lawsuits") and opioid matters and the Company&#8217;s Albuterol recall, subject to, in each case, Altaris' obligation to indemnify the Company for fifty percent of these liabilities up to an aggregate cap on Altaris' obligation of $50.0&#160;million. We have not requested payments from Altaris related to the indemnity of these liabilities during the three months ended April&#160;1, 2023.</span>Current and prior period reported net loss from discontinued operations primarily relates to legal fees, partially offset by an income tax benefit.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788149536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">INVENTORIES <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major components of inventory were as follows (in millions):</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.602%"><tr><td style="width:1.0%"/><td style="width:42.808%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.343%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">674.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,183.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,150.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788399712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">INVESTMENTS <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"/><td style="width:26.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.823%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.594%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Measured at fair value using the Net Asset Value practical expedient.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expense recognized in earnings of our equity securities (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"/><td style="width:25.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.422%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.364%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671876489120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LEASES<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"><tr><td style="width:1.0pt"/><td style="width:124.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:178.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_8393b283-e363-4504-b231-143478dd2c5f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_87043135-b949-45d0-9eae-f1b4645419a9">Other non-current assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"><tr><td style="width:1.0pt"/><td style="width:124.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:178.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_05036283-a810-4bae-854e-92b3df99922c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_b5e2a70c-b3bd-48c1-b7a0-2aff813e9b08">Other accrued liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_1a147768-c056-425b-af34-6db715980677"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_7a7ad5f3-7e3d-4fd6-b39b-bd13f91b4653">Current indebtedness</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_156cee65-de81-4dfd-849e-fc62e3c9dfcf"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_88c5c5e3-521f-44d6-b6d7-0639e3d6ce44">Other non-current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_3eb3333f-44a6-4a5b-bef2-60d0ef263f0a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_f509a7f0-b2aa-4888-9b39-8d9314e7b4c4">Long-term debt, less current portion</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables show our lease assets and liabilities by reporting segment (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"><tr><td style="width:1.0pt"/><td style="width:133.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"><tr><td style="width:1.0pt"/><td style="width:133.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:306.00pt"><tr><td style="width:1.0pt"/><td style="width:133.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  Includes short-term leases and variable lease costs, which are immaterial.</span></div><div style="text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our leases as of April&#160;1, 2023 are as follows (in millions):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:351.00pt"><tr><td style="width:1.0pt"/><td style="width:142.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our weighted average lease terms and discount rates are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"/><td style="width:352.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.85</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.09</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.28</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease cash flow classifications are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"/><td style="width:352.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">LEASES<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"><tr><td style="width:1.0pt"/><td style="width:124.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:178.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_8393b283-e363-4504-b231-143478dd2c5f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_87043135-b949-45d0-9eae-f1b4645419a9">Other non-current assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"><tr><td style="width:1.0pt"/><td style="width:124.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:178.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_05036283-a810-4bae-854e-92b3df99922c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_b5e2a70c-b3bd-48c1-b7a0-2aff813e9b08">Other accrued liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_1a147768-c056-425b-af34-6db715980677"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_7a7ad5f3-7e3d-4fd6-b39b-bd13f91b4653">Current indebtedness</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_156cee65-de81-4dfd-849e-fc62e3c9dfcf"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_88c5c5e3-521f-44d6-b6d7-0639e3d6ce44">Other non-current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_3eb3333f-44a6-4a5b-bef2-60d0ef263f0a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_f509a7f0-b2aa-4888-9b39-8d9314e7b4c4">Long-term debt, less current portion</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables show our lease assets and liabilities by reporting segment (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"><tr><td style="width:1.0pt"/><td style="width:133.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"><tr><td style="width:1.0pt"/><td style="width:133.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:306.00pt"><tr><td style="width:1.0pt"/><td style="width:133.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  Includes short-term leases and variable lease costs, which are immaterial.</span></div><div style="text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our leases as of April&#160;1, 2023 are as follows (in millions):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:351.00pt"><tr><td style="width:1.0pt"/><td style="width:142.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our weighted average lease terms and discount rates are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"/><td style="width:352.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.85</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.09</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.28</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease cash flow classifications are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"/><td style="width:352.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788144944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:14.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.423%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.681%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purchase accounting adjustments </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,079.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,446.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,511.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,490.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,591.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  We had accumulated goodwill impairments of $6.1 million as of April&#160;1, 2023 and December 31, 2022.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)  We had accumulated goodwill impairments of $878.4 million as of April&#160;1, 2023 and December 31, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and related accumulated amortization consisted of the following (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangibles:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total indefinite-lived intangibles</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite-lived intangibles:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">484.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,844.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,006.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,825.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">965.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,462.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">509.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,542.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total definite-lived intangibles</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,879.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,795.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,949.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,938.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,795.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,007.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements. </span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded amortization expense of $65.4&#160;million and $48.5&#160;million for the three months ended April&#160;1, 2023 and April&#160;2, 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788322928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Measured at fair value on a recurring basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers within Level 3 fair value measurements during the three months ended April&#160;1, 2023 or the</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-recurring Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-recurring fair values represent only those assets whose carrying values were adjusted to fair value during the reporting period.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed Rate Long-term Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed rate long-term debt consisted of the following (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.00pt"><tr><td style="width:1.0pt"/><td style="width:172.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:93.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:93.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public Bonds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value (excluding discount)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,315.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,225.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities.</span></div>The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt, revolving credit agreements, and variable rate long-term debt, approximate their fair value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788159728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES &#160;&#160;&#160;&#160; <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Option Contracts </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price for HRA Pharma, we entered into two non-designated currency option contracts with a total notional amount of $1.1 billion that were scheduled to mature in September 2022. In April 2022, due to market conditions, we unwound the two options and entered into two new undesignated options to economically hedge the purchase price for HRA Pharma for a total notional amount of $2.0&#160;billion. All premiums associated with the HRA Pharma related currency options were settled in April 2022 for $37.1&#160;million. Within Other (income) expense we recorded a $3.5 million loss for the three months ended April&#160;2, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, to economically hedge the interest rate risk of the New Senior Secured Credit Facilities (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_73" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), we entered into five variable-to-fixed interest rate swap agreements. Three of the interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan B Facility (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_73" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2029, on notional balances that decline from $1.0&#160;billion to $812.5&#160;million over the term. The other two interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan A Facility (as defined in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_73" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2027, on notional balances that decline from $487.5&#160;million to $387.5&#160;million over the term. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a designated cash flow hedge, gains and losses will be deferred in AOCI and recognized within Interest expense, net when interest is paid on the New Senior Secured Credit Facilities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-currency Swaps </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2022, we entered into three fixed-for-fixed cross currency interest rate swaps designated as net investment hedge to hedge the EUR currency exposure of our investment in European operations. In October 2022, we replaced those swaps by entering into three fixed-for-fixed cross currency interest rate swaps at market rates and designated the instruments as net investment hedges on our investment in European operations. The following are the terms and notional amounts outstanding: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$700&#160;million notional amount outstanding from October 25, 2022 through December 15, 2024; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$700&#160;million notional amount outstanding from October 25, 2022 through March 15, 2026; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$100&#160;million notional amount outstanding from October 25, 2022 through June 15, 2030.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forwards</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notional amounts of foreign currency forward contracts were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.894%"><tr><td style="width:1.0%"/><td style="width:38.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.943%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Pound (GBP)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European Euro (EUR)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Swedish Krona (SEK)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States Dollar (USD)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan (CNH)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Danish Krone (DKK)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canadian Dollar (CAD)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexican Peso (MXN)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungarian Forint (HUF)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Polish Zloty (PLZ)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Norwegian Krone (NOK)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">593.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Number consists of various currencies notional amounts, none of which individually exceed $10 million in either period presented.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum term of our forward currency exchange contracts is 60 months.</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Derivatives on the Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects. The balance sheet location and gross fair value of our derivative instruments were as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.75pt"><tr><td style="width:1.0pt"/><td style="width:164.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:175.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivative assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-designated derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Consolidated Statements of Operations were as follows (in millions): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"/><td style="width:34.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.368%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.937%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Designated Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effect of derivative instruments designated as hedging instruments in AOCI (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:570.75pt"><tr><td style="width:1.0pt"/><td style="width:150.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:90.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:117.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain/(Loss)</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reclassified from AOCI into Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Related to Amounts Excluded from Effectiveness Testing</span></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recorded in OCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in Earnings on Derivatives</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Net loss of $1.6 million is expected to be reclassified out of AOCI into earnings during the next 12 months.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:246.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost of Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other (Income) Expense, net</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:39pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">767.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:39pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">736.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788167088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Indebtedness</a></td>
<td class="text">INDEBTEDNESS <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total borrowings are summarized as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:0.1%"/><td style="width:1.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan A due April 20, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">490.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">493.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan B due April 20, 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,091.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,094.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total term loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,582.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,588.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes and Bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Coupon</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Due</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.900%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.400%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 15, 2030</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.300%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2043</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.900%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2044</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total notes and bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized premium (discount), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total borrowings outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,101.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,106.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt less current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,062.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,070.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(1) The coupon rate noted above is as of April&#160;1, 2023, this will increase from 4.400% to 4.650% on payments starting after June 15, 2023, following a credit rating downgrade by Moody's in the first quarter of 2023. Future interest rate adjustments are subject to a 2.0% total cap above the original 3.150% interest rate based on certain rating events as specified in the Note&#8217;s Supplemental Indenture No. 3, dated as of June 19, 2020, among Perrigo Finance Unlimited Company, Perrigo Company plc and Wells Fargo Bank, National Association, as trustee.</span></div><div style="padding-left:13.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Credit Agreements</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2022, we and our wholly owned subsidiary, Perrigo Investments, LLC, entered into new senior secured credit facilities consisting of (i) a $1.0&#160;billion five-year revolving credit facility (the &#8220;2022 Revolver&#8221;), (ii) a $500&#160;million five-year Term Loan A facility (the &#8220;2022 Term Loan A Facility&#8221;), and (iii) a $1.1&#160;billion seven-year Term Loan B facility (the &#8220;2022 Term Loan B Facility&#8221; and, together with the 2022 Revolver and 2022 Term Loan A Facility, the &#8220;New Senior Secured Credit Facilities&#8221;), pursuant to a new Term Loan and Revolving Credit Agreement. The New Senior Secured Credit Facilities are guaranteed, along with any hedging or cash management obligations entered into with a lender, by us and certain of our direct and indirect wholly-owned subsidiaries organized in the United States, Ireland, Belgium and England and Wales (subject to certain exceptions) (the &#8220;Guarantor Subsidiaries&#8221;). The Guarantor Subsidiaries and Perrigo Investments, LLC provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 5.300% Notes due 2043 issued by the Company, and the Guarantor Subsidiaries, Perrigo Investments, LLC and the Company provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 3.900% Notes due 2024, the 4.375% Notes due 2026, the 4.400% Notes due 2030 and the 4.900% Notes due 2044 issued by Perrigo Finance Unlimited Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement also contains customary representations and warranties and customary affirmative and negative covenants applicable to the Borrower and its restricted subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, prepayment of junior indebtedness and dividends and other distributions. The Credit Agreement contains financial covenants that require the Borrower and its restricted subsidiaries to (a) not exceed a maximum first lien secured net leverage ratio of 3.00 to 1.00 at the end of each fiscal quarter and (b) not fall below a minimum interest coverage ratio of 3.00 to 1.00 at the end of each fiscal quarter, provided that such covenants apply only to the 2022 Revolver and the 2022 Term Loan A Facility. If we consummate certain qualifying acquisitions during the term of the loan, the maximum first lien secured net leverage ratio covenant would increase to 3.25 to 1.00 for such quarter and the three following fiscal quarters thereafter. The Credit Agreement also contains customary events of default relating to, among other things, failure to make payments, breach of covenants and breach of representations.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended April&#160;1, 2023, principal repayments o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f $5.9 million were</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> made on the 2022 Term Loan A Facility and 2022 Term Loan B Facility. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There we</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">re no borrowings outstanding under the 2022 Revolver as of April&#160;1, 2023 or December&#160;31, 2022, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in compliance with all the covenants under our debt agreements as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;1, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Financing</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding under such facilities in the above table under "Other financing". Th</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ere were no borrowings o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">utstanding under the overdraft facilities as of April&#160;1, 2023 or December&#160;31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have financing leases that are reported in the above table under "Other financing" (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_70" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788143360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share and Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share and Shareholders' Equity</a></td>
<td class="text">EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"/><td style="width:69.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.302%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic EPS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for diluted EPS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anti-dilutive share-based awards excluded from computation of diluted EPS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) In the period of a net loss from continuing operations, diluted shares equal basic shares.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholders' Equity</span></div>In October 2018, our Board of Directors authorized up to $1.0&#160;billion of share repurchases with no expiration date, subject to the Board of Directors&#8217; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program (the "2018 Authorization"). We did not repurchase any shares during the three months ended April&#160;1, 2023 or April&#160;2, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788140128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our AOCI balances, net of tax were as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:31.348%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.189%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.504%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivative Financial Instruments, net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Employment Plan Adjustments, net of tax</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AOCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671792261088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Charges</a></td>
<td class="text">RESTRUCTURING CHARGES<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, and related consulting fees. The following reflects our restructuring activity (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.75pt"><tr><td style="width:1.0pt"/><td style="width:105.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:47.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:82.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supply Chain Reinvention</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HRA Pharma Integration</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Initiatives</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charges incurred during the three months ended April&#160;1, 2023 and April&#160;2, 2022 were primarily associated with actions taken on our multi-year supply chain restructuring program initiative started in 2022, and HRA Pharma integration activities associated with employee separation, continuity and other benefit-related costs. We have incurred $13.5&#160;million of cumulative restructuring expense to date related to HRA Pharma integration. We expect that most of the HRA Pharma integration expenses will be incurred by the end of 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the amount recorded during the three months ended April&#160;1, 2023, $0.9 million was related to our CSCI segment, due primarily to supply chain restructuring and HRA Pharma integration initiatives, and $1.2 million related to our CSCA segment, also due primarily to supply chain restructuring initiatives. Remaining amounts recorded, including $3.6&#160;million recorded during the three months ended April&#160;2, 2022, related to our Unallocated segment due primarily to supply chain restructuring. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other material restructuring programs for the periods presented. All charges are recorded in Restructuring expense on the Condensed Consolidated Statements of Operations. The remaining $15.6&#160;million liability for employee severance benefits and consulting fees is expected to be paid within the next year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671783379776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:143.25pt"><tr><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate on the pre-tax income for the three months ended April&#160;1, 2023 increased compared to the effective tax rate on the pre-tax loss for the three months ended April&#160;2, 2022, primarily due to the tax benefit of the loss on sale of our Latin American businesses recognized in the three months ended April&#160;2, 2022, offset by changes in the jurisdictional mix of earnings in the three months ended April&#160;1, 2023. The effective tax rate for this period differs from the statutory income tax rate of 12.5% primarily due to non-deductible expenses, as well as changes in our reserves for unrecognized tax benefits.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Revenue Service Audits of Perrigo Company, a U.S. Subsidiary</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perrigo Company, our U.S. subsidiary ("Perrigo U.S."), is engaged in a series of tax disputes in the U.S. relating primarily to transfer pricing adjustments including income in connection with the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States, including the generic heartburn medication omeprazole. On August 27, 2014, we received a statutory notice of deficiency from the IRS relating to our fiscal tax years ended June 27, 2009, and June 26, 2010 (the &#8220;2009 tax year&#8221; and &#8220;2010 tax year&#8221;, respectively). On April 20, 2017, we received a statutory notice of deficiency from the IRS for the years ended June 25, 2011 and June 30, 2012 (the &#8220;2011 tax year&#8221; and &#8220;2012 tax year&#8221;, respectively). Specifically, both statutory notices proposed adjustments related to the offshore reporting of profits on sales of omeprazole in the United States resulting from </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the assignment of an omeprazole distribution contract to an Israeli affiliate. In addition to the transfer pricing adjustments, which applied to all four tax years, the statutory notice of deficiency for the 2011 and 2012 tax years included adjustments requiring the capitalization and amortization of certain legal expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits related to ANDAs filed with a Paragraph IV Certification. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not agree with the audit adjustments proposed by the IRS in either of the notices of deficiency. We paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and timely filed claims for refund on June 11, 2015 for the 2009 and 2010 tax years, and on June 7, 2017, for the 2011 and 2012 tax years. On August 15, 2017, following disallowance of such refund claims, we timely filed a complaint in the United States District Court for the Western District of Michigan seeking refunds of tax, interest, and penalties of $27.5 million for the 2009 tax year, $41.8 million for the 2010 tax year, $40.1&#160;million for the 2011 tax year, and $24.7 million for the 2012 tax year, for a total of $134.1 million, plus statutory overpayment interest thereon from the dates of payment. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended July 1, 2017.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A bench trial was held during the period May 25, 2021 to June 7, 2021 for the refund case in the United States District Court for the Western District of Michigan. The total amount of cumulative deferred charge that we are seeking to receive in this litigation is approximately $111.6 million, which reflects the impact of conceding that Perrigo U.S. should have received a 5.24% royalty on all omeprazole sales. That concession was previously paid and is the subject of the above refund claims. The issues outlined in the statutory notices of deficiency described above are continuing in nature, and the IRS will likely carry forward the adjustments set forth therein as long as the drug is sold, in the case of the omeprazole issue, and for all post-2012 Paragraph IV filings that trigger patent infringement suits, in the case of the ANDA issue. Post-trial briefings were completed on September 24, 2021 and the case is now fully submitted for the court&#8217;s decision. On April 30, 2021, we filed a Notice of New Authority in our refund case in the Western District of Michigan alerting the court to a United States Tax Court decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mylan v. Comm'r</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that ruled in favor of the taxpayer on nearly identical ANDA issues as we have before the court. On January 28, 2022, the IRS filed a Notice of Appeal with the United States Court of Appeals of the Third Circuit to appeal the United States Tax Court's decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mylan v. Comm'r. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Briefing to the appellate court was completed during 2022, oral argument was held before the Third Circuit on January 12, 2023, and the case is awaiting decision. On August 22, 2022, the parties filed a Notice of New Authority in the refund case alerting the court to a United States Court of Federal Claims decision in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Actavis Laboratories v. United States</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that also ruled in favor of the taxpayer on the ANDA issues. The government appealed the Actavis Laboratories decision to the United States court of Appeals for the Federal Circuit in December of 2022 and briefing to the appellate court is ongoing.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 13, 2021, the IRS issued a 30-day letter and Revenue Agent's Report ("RAR") with respect to its audit of our fiscal tax years ended June 29, 2013, June 28, 2014, and June 27, 2015. The 30-day letter proposed, among other modifications, transfer pricing adjustments in connection with the distribution of omeprazole in the aggregate amount of $141.6 million and ANDA-related adjustments in the aggregate amount of $21.9 million. The 30-day letter also set forth adjustments described in the next two paragraphs. We timely filed a protest to the 30-day letter for those additional adjustments but noting that due to the pending refund litigation described above, IRS Appeals would not consider the merits of the omeprazole or ANDA matters. We believe that we should prevail on the merits on both carryforward issues and have reserved for taxes and interest payable on the 5.24% deemed royalty on omeprazole through the tax year ended December 31, 2018. Beginning with the tax year ended December 31, 2019, we began reporting income commensurate with the 5.24% deemed royalty. We have not reserved for the ANDA-related issue described above. While we believe we should prevail on the merits of this case, the outcome remains uncertain. If our litigation position on the omeprazole issue is not sustained, the outcome for the 2009&#8211;2012 tax years could range from a reduction in the refund amount to denial of any refund. In addition, we expect that the outcome of the refund litigation could effectively bind future tax years. In that event, an adverse ruling on the omeprazole issue could have a material impact on subsequent periods, with additional tax liability in the range of $24.0 million to $112.0 million, not including interest and any applicable penalties.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 30-day letter for the 2013-2015 tax years also proposed to reduce Perrigo U.S.'s deductible interest expense for the 2014 tax year and the 2015 tax year on $7.5 billion in certain intercompany debts owed by it to Perrigo Company plc, which is the subject matter of a Notice of Proposed Adjustment, or "NOPA" issued on May 7, 2020. Subsequent to the end of the first quarter of fiscal 2023, we finalized an agreement with IRS Appeals providing for </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">settlement of the NOPA. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_1742" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Note</a><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_1742" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> 18 - Subsequent Events</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for additional details. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the 30-day letter for the 2013-2015 tax years expanded on a NOPA issued on December 11, 2019 and proposed to disallow reductions to gross sales income on the sale of prescription products to wholesalers for accrued wholesale customer pipeline chargebacks where the prescription products were not re-sold by such wholesalers to covered retailers by the end of the tax year. On December 28, 2022, we finalized an agreement with IRS Appeals providing for settlement of the December 11, 2019 NOPA, which would not only cover the 2013-2015 tax years but all of the remaining tax years through 2021, the last tax year with chargebacks due to the sale of the Rx business in July 2021. We made a settlement payment of $8.3 million in 2022 which was fully covered by reserves for this issue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2021, the IRS commenced an audit of our federal income tax returns for the tax years ended December 31, 2015, through December 31, 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Revenue Service Audit of Athena Neurosciences, Inc., a U.S. Subsidiary&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subsequent to the end of the first quarter of fiscal 2023, we were notified by the IRS regarding the Competent Authority request filed for the Tysabri royalty issue, which concludes the competent authority process without the need for negotiations between the competent authorities and constitutes a full and final resolution of the April 26, 2019 NOPA received by Athena Neurosciences, Inc. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_1742" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Note 18 - Subsequent Events</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  for additional details.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that our tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit and any related litigation could be materially different from our estimates or from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the final resolution of tax examinations, judicial or administrative proceedings, changes in facts or law, expirations of statute of limitations in specific jurisdictions or other resolutions of, or changes in, tax positions - one or more of which may occur within the next twelve months - it is reasonably possible that unrecognized tax benefits for certain tax positions taken on previously filed tax returns may change materially from those recorded as of April&#160;1, 2023. However, we are not able to estimate a reasonably possible range of how these events may impact our unrecognized tax benefits in the next twelve months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788167088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">CONTINGENCIES<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of April&#160;1, 2023, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Price-Fixing Lawsuits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2013, the Company, along with other manufacturers, has been named as a defendant in lawsuits in the United States and Canada generally alleging anticompetitive conduct with respect to the sale of generic drugs by the Company&#8217;s former Rx business. The complaints &#8211; which have been filed by putative classes of direct purchasers, end payors, and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties - allege a conspiracy to fix, maintain, stabilize, and/or raise prices, rig bids, and allocate markets or customers for various generic drugs in violation of federal and state antitrust and consumer protection laws. While most of the complaints involve alleged single-drug conspiracy, the three putative classes have each filed an over-</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arching conspiracy complaint alleging that Perrigo and other manufacturers (and some individuals) entered into an &#8220;overarching conspiracy&#8221; that involved allocating customers, rigging bids, and raising, maintaining, and fixing prices for various products.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of the lawsuits described in this paragraph have been consolidated in the generic pricing multidistrict litigation ("MDL") MDL No. 2724 (United States District Court for Eastern District of Pennsylvania). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Court has ordered that the following cases involving Perrigo will proceed on a more expedited basis (as a bellwether) than the other cases in MDL No. 2724: (i) class actions alleging &#8220;single drug&#8221; conspiracies involving Clobetasol; and (ii) the State Attorney General Complaint (described below). The bellwether cases are proceeding in discovery, which must be completed by June 1, 2023 under the schedule set by the Court, and motions for summary judgment will be due on March 13, 2024. No trial dates have been set for any of the bellwether cases, or any of the other cases in the MDL.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Attorney General Complaint </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 10, 2020, the Connecticut Attorney General&#8217;s office filed a lawsuit on behalf of Connecticut and 50 other states and territories against Perrigo, 35 other generic pharmaceutical manufacturers, and certain individuals (including two former Perrigo employees), alleging an overarching conspiracy to allocate customers and/or fix, raise, or stabilize prices of eighty products. This case is included among the &#8220;bellwether cases&#8221; designated to follow the expedited schedule described above. Like the other cases in the MDL, no trial date has been set for this case. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Class Action Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, an end payor filed a class action in Ontario, Canada against Perrigo and 29 other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise, or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. In December 2020, Plaintiffs amended their complaint to add additional claims based on the State Attorney General Complaint of June 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this stage, we cannot reasonably estimate the outcome of the liability if any, associated with the claims listed above.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Litigation</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In the United States (cases related to events in 2015-2017)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in May 2016, purported class action complaints were filed against the Company and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers&#8217; Pension Fund v. Papa, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) purporting to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The original complaint alleged violations of federal securities laws in connection with the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015. The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged business developments during the alleged class period including integration problems related to the Omega acquisition. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The operative complaint is the first amended complaint filed on June 21, 2017, and named as defendants us and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The amended complaint alleges violations of federal securities laws arising out of the actions taken by us and the former directors and executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to the business developments during that period including purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to six generic prescription pharmaceuticals, and alleges improper accounting for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> royalty stream. During 2017, the defendants filed motions to dismiss, which the plaintiffs opposed. On July 27, 2018, the court issued an opinion and order granting the defendants&#8217; motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O&#8217;Connor, and Marc Coucke. The </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">court also dismissed without prejudice claims arising from the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tysabri</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are the Company, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issue regarding the Omega acquisition, the defense against the Mylan tender offer, and the alleged price fixing activities with respect to six generic prescription pharmaceuticals. The defendants who remain in the case (us, Mr. Papa, and Ms. Brown) have filed answers denying liability. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 14, 2019, the court granted the lead plaintiffs&#8217; motion and certified three classes for the case: (i) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on a U.S. exchange and were damaged thereby; (ii) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on the Tel Aviv exchange and were damaged thereby; and (iii) all those who owned shares as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered shares in response to the Mylan tender offer) (the "tender offer class"). Plaintiffs' counsels have sent notices to the alleged class. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties took discovery from 2018 through 2020. After discovery ended, defendants filed motions for summary judgement and to exclude plaintiffs' experts, which were fully briefed. The case was then re-assigned to a new federal judge, who heard oral argument on the motions in April 2022. The motions are pending. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the class action, the following opt-out cases have been filed against us, and in some cases, Mr. Papa and Ms. Brown, and contain factual allegations and claims that are similar to some or all of the factual allegations and claims in the class actions:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.042%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Case</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Filed</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Carmignac Gestion, S.A. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">First Manhattan Co. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/16/2018; amended 4/20/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Nationwide Mutual Funds, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/29/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Schwab Capital Trust, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Aberdeen Canada Funds -- Global Equity Fund, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/22/2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Funds, Inc., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/5/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Kuwait Investment Authority, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mason Capital L.P., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/26/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pentwater Equity Opportunities Master Fund Ltd., et al.  v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/26/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">WCM Alternatives: Event-Drive Fund, et al. v. Perrigo Co., plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/15/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Hudson Bay Master Fund Ltd., et al. v. Perrigo Co., plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/15/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Discovery Global Citizens Master Fund, Ltd., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/18/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">York Capital Management, L.P., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/20/2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Burlington Loan Management DAC v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Universities Superannuation Scheme Limited v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/2/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/13/2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/20/2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sculptor Master Fund (f/k/a OZ Master Fund, Ltd.), et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/6/2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BlackRock Global Allocation Fund, Inc., et al. v. Perrigo Co. plc, et al.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/21/2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Starboard Value and Opportunity C LP, et al. v. Perrigo Company plc, et al.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/25/2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2020, three Highfields Capital entities filed a lawsuit in Massachusetts State Court with factual allegations that generally were similar to the factual allegations in the Amended Complaint in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Roofers' Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> case described above, except that the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Highfields</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> plaintiffs did not include allegations about alleged collusive pricing of generic prescription drugs, and alleged Massachusetts state law claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. In December 2021, the Massachusetts State Court granted Defendants&#8217; motion to dismiss in part and denied it in part. Defendants&#8217; filed </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">their answers in January 2022 denying liability. The discovery phase in this case has begun (including discovery related to some factual allegations that were not part of the discovery in the actions in New Jersey federal court). The Court held a discovery conference and approved fact discovery deadlines into May 2023 and later deadlines to complete expert discovery. Subsequently, the Court held a further conference in March 2023 and revised the schedule with fact discovery ending in October 2023 and expert discovery in May 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Israel (cases related to events in 2015-2017)</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Israel Elec. Corp. Employees&#8217; Educ. Fund v. Perrigo Company plc, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period from April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, Ernst &amp; Young LLP (the Company&#8217;s auditor), and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#8217;Connor). The complaint alleges violations under Israeli securities laws that are similar to U.S. Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against all defendants and 20(a) control person liability against the 11 individuals or, in the alternative, under other Israeli securities laws. In general, the allegations are similar to the factual allegations in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers' Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case in the U.S. as described above. The plaintiff indicates an initial, preliminary class damages estimate of 2.7&#160;billion NIS (approximately $760.0&#160;million at 1 NIS = 0.28 cents). After the other two cases filed in Israel were voluntarily dismissed, the plaintiff in this case agreed to stay this case pending the outcome of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Roofers&#8217; Pension Fund</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case in the U.S. (described above). The Israeli court approved the stay, and this case is now stayed. We intend to defend the lawsuit vigorously.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Israel (case related to Irish Tax events)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 31, 2018, a shareholder filed an action against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in Tel Aviv District Court (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Baton v. Perrigo Company plc, et. al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">). The case is a securities class action brought in Israel making similar factual allegations for the same period as those asserted in a securities class action case (for those who purchased on a U.S. exchange) in New York federal court in which the settlement received final approval in February 2022. The Baron case alleges that persons who purchased securities through the Tel Aviv stock exchange and suffered damages can assert claims under Israeli securities law that will follow the liability principles of Sections 10(b) and 20(a) of the U.S. Securities Exchange Act. The plaintiff does not provide an estimate of class damages. Since 2019, the court granted several requests by Perrigo to stay the proceedings pending the resolution of proceedings in the New York federal court. During 2022, the case was reassigned to a newly-appointed judge. After the settlement of the U.S. case in New York federal court, Perrigo's counsel informed the Israeli Court of the final approval of the settlement of the U.S. case. The parties then sought further stays of the case while they attempted mediation, which the Court granted. In April 2023, the parties reported to the Court that the mediation had led to a preliminary agreement on settlement; the Court ordered that a motion for approval of the settlement and related papers be filed no later than June 17, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Talcum Powder</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been named, together with other manufacturers, in product liability lawsuits in a variety of state courts alleging that the use of body powder products containing talcum powder causes mesothelioma and lung cancer due to the presence of asbestos. All but one of these cases involve legacy talcum powder products that have not been manufactured by the Company since 1999. One of the pending actions involves a current prescription product that contains talc as an excipient. As of April 24, 2023, the Company is currently named in 90 individual lawsuits seeking compensatory and punitive damages and has accepted a tender for a portion of the defense costs and liability from a retailer for one additional matter. The Company has several defenses and intends to aggressively defend these lawsuits. Trials for these lawsuits are currently scheduled throughout 2023, 2024 and 2025, with the earliest trial date in May 2023. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ranitidine</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After regulatory bodies announced worldwide that ranitidine may potentially contain N-nitrosodimethylamine ("NDMA"), a known environmental contaminant, the Company promptly began testing its externally-sourced ranitidine API and ranitidine-based products. On October 8, 2019, the Company halted shipments of the product based upon preliminary results and on October 23, 2019, the Company made the decision to conduct a voluntary retail market withdrawal. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the resulting actions involving </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and other ranitidine products were transferred for coordinated pretrial proceedings to a Multi-District Litigation (In re </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/Ranitidine Products Liability Litigation MDL No. 2924) in the U.S. District Court for the Southern District of Florida. After the Company successfully moved to dismiss the first set of Master Complaints in the MDL, it now includes three: 1) an Amended Master Personal Injury Complaint; 2) a Consolidated Amended Consumer Economic Loss Class Action Complaint; and 3) a Consolidated Medical Monitoring Class Action Complaint. All three name the Company. Plaintiffs appealed one of the original Master Complaints, the Third-Party Payor Complaint, and two individual plaintiffs appealed their individual personal injury claims on limited grounds. The Company is not named in the appeals.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2021, the Court dismissed all claims against the retail and distributor defendants with prejudice, thereby reducing the Company&#8217;s potential for exposure and liability related to possible indemnification. On July 8, 2021, the Court dismissed all claims against the Company with prejudice. Appeals of these dismissal orders to the U.S. Court of Appeals for the 11th Circuit have been filed, as well as several state level claims related to the theories advanced in the MDL litigation. The Company will continue to vigorously defend each of these lawsuits.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of April 1, 2023, the Company has been named in 352 personal injury lawsuits, most of which are in the MDL tied to various federal courts alleging that plaintiffs developed various types of cancers or are placed at higher risk of developing cancer as a result of ingesting products containing ranitidine. The Company has also been named in a handful of similar lawsuits in the state courts of California, Illinois, Ohio, New Jersey, New York and Pennsylvania. The Company is named in these lawsuits with manufacturers of the national brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and other manufacturers of ranitidine products, as well as distributors, repackagers, and/or retailers. Plaintiffs seek compensatory and punitive damages, and in some instances seek applicable remedies under state consumer protection laws. The Company believes that it has strong defenses to such claims based on a significant body of scientific evidence, and pursuant to the doctrine of federal preemption. As noted above, the Company has won multiple motions to dismiss in the MDL, as well as additional state court actions in California and Maryland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has also been named in a Complaint brought by the New Mexico Attorney General based on the following theories: violation of a New Mexico public nuisance statute, NMSA 30-8-1 to -14; common law nuisance; and negligence and gross negligence. The Company is named in this lawsuit with manufacturers of the national brand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Zantac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and other manufacturers of ranitidine products and/or retailers. Brand name manufactures named in the lawsuit also face claims under the state&#8217;s Unfair Practices &amp; False Advertising acts. The Company filed motions to dismiss the action. The New Mexico District Court denied the Company&#8217;s Motion to Dismiss and litigation continues. The Company will continue to vigorously defend this lawsuit. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s retailer customers are seeking indemnity from the Company for a portion of their defense costs and liability relating to these cases. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acetaminophen</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022 the Judicial Panel on Multidistrict Litigation ("MDL") consolidated a number of pending actions filed in various federal courts alleging that prenatal exposure to acetaminophen is purportedly associated with the development of autism spectrum disorder (&#8220;ASD&#8221;) and attention-deficit/hyperactivity disorder (&#8220;ADHD&#8221;). The MDL is styled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Acetaminophen &#8211; ASD/ADHD Products Liability Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (MDL No. 3043) and is pending before the U.S. District Court for the Southern District of New York. Plaintiffs in the MDL have asserted claims against Johnson &amp; Johnson Consumer, Inc. (&#8220;JJCI&#8221;) and various retailer chains alleging that plaintiff-mothers took acetaminophen products while pregnant and that plaintiff-children developed ASD and/or ADHD as a result of prenatal exposure to these acetaminophen products. At this time, the MDL proceedings are in the early stages. Currently, it is not possible to assess reliably the outcome of these cases or any potential future financial impact on the Company. As of April 24, 2023 the Company has not been named as a defendant in any Complaints filed in the MDL. It is anticipated that some of the Company&#8217;s retailer customers may seek indemnity from the Company for a portion of their defense costs and potential liability relating to these cases. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies Accruals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the matters discussed in this Note, the Company has established a loss accrual for litigation contingencies where we believe a loss to be probable and for which an amount of loss can be reasonably estimated. However, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to inherent uncertainties of litigation. At April&#160;1, 2023, the loss accrual for litigation contingencies reflected on the balance sheet in Other accrued liabilities was approximately $67.6&#160;million. The Company also recorded an insurance recovery receivable reflected on the balance sheet in Prepaid expenses and other current assets of approximately $37.2&#160;million related to these litigation contingencies because it believes such amount is recoverable based on communications with its insurers to date; however, the Company may erode this insurance receivable as it incurs defense costs associated with defending the matters. The Company&#8217;s management believes these accruals for contingencies are reasonable and sufficient based upon information currently available to management; however, there can be no assurance that final costs related to these contingencies will not exceed current estimates or that all of the final costs related to these contingencies will be covered by insurance. (See "</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Coverage Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," below.) In addition, we have other litigation matters pending for which we have not recorded any accruals because our potential liability for those matters is not probable or cannot be reasonably estimated based on currently available information. For those matters where we have not recorded an accrual but a loss is reasonably possible, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to the inherent uncertainties of litigation. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Coverage Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2021, insurers on multiple policies of D&amp;O insurance filed an action in the High Court in Dublin against the Company and multiple current and former directors and officers of the Company seeking declaratory judgments on certain coverage issues. Those coverage issues include claims that policies for periods beginning in December 2015 and December 2016, respectively, do not have to provide coverage for the securities actions described above pending in the District of New Jersey or in Massachusetts state court concerning the events of 2015-2017. The policy for the period beginning December 2014 is currently providing coverage for those matters, and the litigation would not affect that existing coverage. However, if the plaintiffs are successful, the total amount of insurance coverage available to defend such lawsuits and to satisfy any judgment or settlement costs thereunder would be limited to one policy period. The insurers&#8217; lawsuit also challenges coverage for Krueger derivatively on behalf of nominal defendant Perrigo Company plc v. Alford et al., a prior derivative action filed in the District of New Jersey that was dismissed in August 2020, and for the counterclaims brought in the Omega arbitration proceedings. Perrigo responded on November 1, 2021; Perrigo&#8217;s response includes its position that the policies for the periods beginning December 2015 and December 2016 provide coverage for the underlying litigation matters and seeks a ruling to that effect. The discovery stage of the case occurred in 2022. The Court has set a schedule for submissions by the parties during 2023 and for a bench trial in mid-November 2023. We intend to defend the lawsuit vigorously.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788167088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">SEGMENT INFORMATION <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below show select financial measures by reporting segment (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.438%"><tr><td style="width:1.0%"/><td style="width:32.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.755%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,057.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,134.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,897.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,883.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,954.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,017.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.895%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net <br/>Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible Asset Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net <br/>Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible Asset Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">763.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">710.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing Operations Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788205632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">SUBSEQUENT EVENTS<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Revenue Service Audit of Athena Neurosciences, Inc., a U.S. Subsidiary&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 26, 2019, we received a revised NOPA from the IRS regarding transfer pricing positions related to the IRS audit of Athena Neurosciences, LLC ("Athena") for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. The April 26, 2019 NOPA carried forward the IRS's theory from its 2017 draft NOPA that when Elan took over the future funding of Athena's in-process research and development after acquiring Athena in 1996, Elan should have paid a substantially higher royalty rate for the right to exploit Athena&#8217;s intellectual property in various developmental products, including the Multiple Sclerosis drug Tysabri, rather than rates based on transfer pricing documentation prepared by Elan's external tax advisors. The April 26, 2019 NOPA proposed a payment of $843.0&#160;million, which represented additional tax based on imputing royalty income to Athena using a 24.7% royalty rate derived by the IRS and a 40.0% accuracy-related penalty. This amount excluded consideration of offsetting tax attributes and any potential interest that may be imposed. We strongly disagreed with the IRS position. On December 22, 2016, we also received a NOPA for these years denying the deductibility of settlement costs incurred in 2011 by Athena's parent company Elan Pharmaceuticals, Inc. ("EPI") related to illegal marketing of Zonegran by EPI's employees in the United States raised in a Qui Tam action under the U.S. False Claims Act. We strongly disagreed with the IRS' position on this issue as well. Because we believed that any concession on these issues in Appeals would be contrary to our evaluation of the issues and to avoid double taxation of the same income in the United States and Ireland, we pursued our remedies under the Mutual Agreement Procedure ("MAP") of the U.S.-Ireland Income Tax Treaty to alleviate double taxation. On April 21 and 23, 2020, we filed requests for Competent Authority assistance with the IRS and Irish Revenue on the Tysabri royalty issue, and those MAP applications were accepted. On October 20, 2020, we amended our requests for Competent Authority assistance to include the Zonegran issue and these supplemental requests were also accepted. On April 24, 2023, we received a letter from the IRS regarding the Competent Authority request filed for the Tysabri royalty issue, which concludes the competent authority process commenced by such submissions without the need for negotiations between the competent authorities and constitutes a full and final resolution of the April 26, 2019 NOPA. In the second quarter of fiscal year 2023 we plan to adjust any previously established reserves related to this matter. The Zonegran deduction issue remains pending in the MAP case and is being considered by APMA and the Irish Competent Authority.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Internal Revenue Service Audits of Perrigo Company, a U.S. Subsidiary</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As detailed in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_88" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Note 15. Income Taxes</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on January 13, 2021, the IRS issued a 30-day letter for the 2013-2015 tax years, which included a proposal to reduce Perrigo U.S.'s deductible interest expense for the 2014 tax year and the 2015 tax year on $7.5 billion in certain intercompany debts owed by it to Perrigo Company plc. The debts were incurred in connection with the 2013 Elan merger transaction. On May 7, 2020, the IRS issued a NOPA capping the interest rate on the debts for U.S. federal tax purposes at 130.0% of the Applicable Federal Rate ("AFR") (a blended </span></div>rate reduction of 4.0% per annum) on the stated ground that the loans were not negotiated on an arms-length basis. The May 7, 2020 NOPA proposed a reduction in gross interest expense of approximately $414.7 million for tax years 2014 and 2015. On January 13, 2021, we received a RAR, together with the 30-day letter, requiring our filing of a written protest to request IRS Appeals consideration. The protest was timely filed with the IRS on February 26, 2021. On January 20, 2022, the IRS responded to our protest with its rebuttal in which it revised its position on this interest rate issue by reasserting that implicit parental support considerations are necessary to determine the arm's length interest rates and proposed revised interest rates that are higher than the interest rates proposed under its 130.0% of AFR assertion. The blended interest rate proposed by the IRS rebuttal was 4.36%, an increase from the blended interest rate in the RAR of 2.57% but lower than the stated blended interest rate of the loans of 6.8%. An IRS Appeals conference for the interest rate issue was held during March 7, 2023 through March 9, 2023. On May 5, 2023, we finalized an agreement with IRS Appeals providing for settlement of the May 7, 2020 NOPA of $153.4&#160;million of gross interest expense reduction for the 2013-2015 tax years. This implies a blended interest rate of 5.44%. In addition, based on the above agreement with IRS Appeals, we will apply similar adjustments for all remaining tax years through 2018. In the second quarter of fiscal year 2023 we plan to adjust any previously established reserves related to this matter.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671783595024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationOur unaudited Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text">In the opinion of management, all adjustments considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Some amounts in this report may not add due to rounding.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting and operating segments are as follows: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:14.5pt">Consumer Self-Care Americas ("CSCA") </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Consumer Self-Care International ("CSCI") </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic business in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_61" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note </a></span><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i391fab8b65b648d5a5c27f0c2d5892b5_61" style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">4</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>Our segments reflect the way in which our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation and Transactions</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation and Transactions </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate our non-U.S. dollar-denominated operations&#8217; assets and liabilities into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of Accumulated other comprehensive income (loss) ("AOCI"). Gains or losses from foreign currency transactions are included in Other (income) expense, net.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788205632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Summary of Allowance for Credit Losses</a></td>
<td class="text">The following table presents the allowance for credit losses activity (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.222%"><tr><td style="width:1.0%"/><td style="width:61.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.322%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for credit losses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables written-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788281568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of Disaggregation of Revenue</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our net sales by category</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.00pt"><tr><td style="width:1.0pt"/><td style="width:226.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vitamins, Minerals, and Supplements ("VMS")</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCA</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">763.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">710.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upper Respiratory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthy Lifestyle</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pain and Sleep-Aids</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VMS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Digestive Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total CSCI</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(1) We updated our global reporting product categories as a result of our product portfolio reconfiguration. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(2) Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">than 10% of the segment net sales. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated net sales in the following geographic locations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:366.00pt"><tr><td style="width:1.0pt"/><td style="width:220.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other countries</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The net sales by geography are derived from the location of the entity that sells to a third party.  </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Includes Ireland net sales of $7.3 million and $6.6&#160;million for the three months ended April&#160;1, 2023 and April&#160;2, 2022, respectively. </span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Includes net sales generated primarily in Australia and Canada.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Contract with Customer Balances</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract assets from contracts with customers (in millions):</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:24.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term contract assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788084960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro Forma Impact of Business Combinations</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents unaudited pro forma information as if the HRA Pharma and Gateway acquisitions had occurred on January 1, 2021 and had been combined with the results reported in our Condensed Consolidated Statements of Operations for the three months ended April&#160;2, 2022 (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:305.25pt"><tr><td style="width:1.0pt"/><td style="width:208.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:93.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788114496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Major Components of Inventory</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major components of inventory were as follows (in millions):</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.602%"><tr><td style="width:1.0%"/><td style="width:42.808%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.343%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">674.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,183.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,150.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788161952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Equity Securities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"/><td style="width:26.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.823%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.594%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Measured at fair value using the Net Asset Value practical expedient.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Security Expense (Income)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expense recognized in earnings of our equity securities (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"><tr><td style="width:1.0%"/><td style="width:25.802%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.422%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.364%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671782778576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AssetsandLiabilitiesLesseeTableTextBlock', window );">Balance Sheet Location of Lease Assets and Liabilities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet locations of our lease assets and liabilities were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"><tr><td style="width:1.0pt"/><td style="width:124.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:178.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_8393b283-e363-4504-b231-143478dd2c5f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_87043135-b949-45d0-9eae-f1b4645419a9">Other non-current assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"><tr><td style="width:1.0pt"/><td style="width:124.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:178.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_05036283-a810-4bae-854e-92b3df99922c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_b5e2a70c-b3bd-48c1-b7a0-2aff813e9b08">Other accrued liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_1a147768-c056-425b-af34-6db715980677"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_7a7ad5f3-7e3d-4fd6-b39b-bd13f91b4653">Current indebtedness</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_156cee65-de81-4dfd-849e-fc62e3c9dfcf"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_88c5c5e3-521f-44d6-b6d7-0639e3d6ce44">Other non-current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_3eb3333f-44a6-4a5b-bef2-60d0ef263f0a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_f509a7f0-b2aa-4888-9b39-8d9314e7b4c4">Long-term debt, less current portion</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables show our lease assets and liabilities by reporting segment (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"><tr><td style="width:1.0pt"/><td style="width:133.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"><tr><td style="width:1.0pt"/><td style="width:133.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expense was as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:306.00pt"><tr><td style="width:1.0pt"/><td style="width:133.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:75.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  Includes short-term leases and variable lease costs, which are immaterial.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease Maturity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our leases as of April&#160;1, 2023 are as follows (in millions):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:351.00pt"><tr><td style="width:1.0pt"/><td style="width:142.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating Lease Liability Maturity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual future maturities of our leases as of April&#160;1, 2023 are as follows (in millions):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:351.00pt"><tr><td style="width:1.0pt"/><td style="width:142.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:63.25pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock', window );">Weighted Average Lease Terms and Discount Rates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our weighted average lease terms and discount rates are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"/><td style="width:352.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.85</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.09</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.28</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LesseeCashFlowClassificationsTableTextBlock', window );">Lease Cash Flow Classifications</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease cash flow classifications are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"/><td style="width:352.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AssetsandLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AssetsandLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LesseeCashFlowClassificationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Cash Flow Classifications [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LesseeCashFlowClassificationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790057408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:14.009%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.423%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.681%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Purchase accounting adjustments </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,079.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,446.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,511.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,490.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,591.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)  We had accumulated goodwill impairments of $6.1 million as of April&#160;1, 2023 and December 31, 2022.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)  We had accumulated goodwill impairments of $878.4 million as of April&#160;1, 2023 and December 31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite and Indefinite-lived Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets and related accumulated amortization consisted of the following (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangibles:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total indefinite-lived intangibles</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite-lived intangibles:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distribution and license agreements and supply agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed product technology, formulations, and product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">484.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and distribution networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,844.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,006.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,825.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">965.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks, trade names, and brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,462.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">509.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,542.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total definite-lived intangibles</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,879.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,795.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,949.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,938.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,795.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,007.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671787492624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Fair Value, Assets Measured on Recurring and Nonrecurring Basis</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Measured at fair value on a recurring basis:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed rate long-term debt consisted of the following (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.00pt"><tr><td style="width:1.0pt"/><td style="width:172.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:93.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:93.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public Bonds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value (excluding discount)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,315.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,225.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671783511968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock', window );">Schedule of Foreign Currency Forward Contracts</a></td>
<td class="text">oreign currency forward contracts were as follows (in millions):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.894%"><tr><td style="width:1.0%"/><td style="width:38.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.943%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Pound (GBP)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European Euro (EUR)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Swedish Krona (SEK)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States Dollar (USD)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan (CNH)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Danish Krone (DKK)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canadian Dollar (CAD)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexican Peso (MXN)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungarian Forint (HUF)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Polish Zloty (PLZ)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Norwegian Krone (NOK)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">593.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Number consists of various currencies notional amounts, none of which individually exceed $10 million in either period presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text">The balance sheet location and gross fair value of our derivative instruments were as follows (in millions): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.75pt"><tr><td style="width:1.0pt"/><td style="width:164.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:175.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:84.25pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivative assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-designated derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Designated derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total designated derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-designated derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Amount of Gain/(Loss) Recognized against Earnings</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Consolidated Statements of Operations were as follows (in millions): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"><tr><td style="width:1.0%"/><td style="width:34.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.368%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.937%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Designated Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effect of derivative instruments designated as hedging instruments in AOCI (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:570.75pt"><tr><td style="width:1.0pt"/><td style="width:150.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:90.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:117.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:66.25pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain/(Loss)</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reclassified from AOCI into Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Related to Amounts Excluded from Effectiveness Testing</span></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recorded in OCI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in Earnings on Derivatives</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Net loss of $1.6 million is expected to be reclassified out of AOCI into earnings during the next 12 months.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Classification of Gain (Loss) Recognized in Earnings on Fair Value and Cash Flow Hedging Relationships</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:246.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost of Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other (Income) Expense, net</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:39pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">767.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:39pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">736.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amount of gain or (loss) reclassified from AOCI into earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Foreign Currency Forward Contracts [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788195040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total borrowings are summarized as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:0.1%"/><td style="width:1.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.320%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan A due April 20, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">490.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">493.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022 Term loan B due April 20, 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,091.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,094.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total term loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,582.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,588.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes and Bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Coupon</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Due</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.900%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.400%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 15, 2030</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.300%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2043</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.900%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 15, 2044</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total notes and bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized premium (discount), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total borrowings outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,101.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,106.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current indebtedness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt less current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,062.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,070.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(1) The coupon rate noted above is as of April&#160;1, 2023, this will increase from 4.400% to 4.650% on payments starting after June 15, 2023, following a credit rating downgrade by Moody's in the first quarter of 2023. Future interest rate adjustments are subject to a 2.0% total cap above the original 3.150% interest rate based on certain rating events as specified in the Note&#8217;s Supplemental Indenture No. 3, dated as of June 19, 2020, among Perrigo Finance Unlimited Company, Perrigo Company plc and Wells Fargo Bank, National Association, as trustee.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788220128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share and Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings per Share, Basic and Diluted</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"/><td style="width:69.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.302%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic EPS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding for diluted EPS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anti-dilutive share-based awards excluded from computation of diluted EPS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) In the period of a net loss from continuing operations, diluted shares equal basic shares.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788100048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our AOCI balances, net of tax were as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:31.348%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.189%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.504%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value of Derivative Financial Instruments, net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Employment Plan Adjustments, net of tax</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AOCI</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788212928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text">The following reflects our restructuring activity (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.75pt"><tr><td style="width:1.0pt"/><td style="width:105.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:47.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:82.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supply Chain Reinvention</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HRA Pharma Integration</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Initiatives</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788363280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of effective income tax rate reconciliation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:143.25pt"><tr><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:67.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671788224848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below show select financial measures by reporting segment (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.438%"><tr><td style="width:1.0%"/><td style="width:32.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.755%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,057.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,134.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,897.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,883.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,954.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,017.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.895%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net <br/>Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible Asset Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net <br/>Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intangible Asset Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">763.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">710.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CSCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unallocated</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing Operations Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671783455360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Allowance for Credit Losses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at beginning of period</a></td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Receivables written-off</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at end of period</a></td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="nump">$ 7.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671785967376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of Revenue by Product (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,181.7<span></span>
</td>
<td class="nump">$ 1,074.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">763.7<span></span>
</td>
<td class="nump">710.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Upper Respiratory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">154.3<span></span>
</td>
<td class="nump">152.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Nutrition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">139.9<span></span>
</td>
<td class="nump">127.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Digestive Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">124.2<span></span>
</td>
<td class="nump">118.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Pain and Sleep-Aids</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">103.5<span></span>
</td>
<td class="nump">102.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">84.4<span></span>
</td>
<td class="nump">70.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Healthy Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">73.4<span></span>
</td>
<td class="nump">67.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Skin Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">52.3<span></span>
</td>
<td class="nump">40.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Vitamins, Minerals, and Supplements ("VMS")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Other CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">15.8<span></span>
</td>
<td class="nump">13.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">418.1<span></span>
</td>
<td class="nump">364.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Upper Respiratory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">84.8<span></span>
</td>
<td class="nump">66.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Digestive Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Pain and Sleep-Aids</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">49.9<span></span>
</td>
<td class="nump">54.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">28.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Healthy Lifestyle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">66.4<span></span>
</td>
<td class="nump">58.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Skin Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">83.4<span></span>
</td>
<td class="nump">73.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">13.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Vitamins, Minerals, and Supplements ("VMS")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">47.8<span></span>
</td>
<td class="nump">49.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Other CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_UpperRespiratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_UpperRespiratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_NutritionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_NutritionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_DigestiveHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_DigestiveHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_PainandSleepaidsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_PainandSleepaidsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_OralSelfcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_OralSelfcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_HealthyLifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_HealthyLifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_SkinCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_SkinCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_WomensHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_WomensHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_VitaminsMineralsandSupplementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_VitaminsMineralsandSupplementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_OtherCSCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_OtherCSCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_OtherCSCIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_OtherCSCIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671792212848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,181.7<span></span>
</td>
<td class="nump">$ 1,074.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=prgo_ContractManufacturingMember', window );">Contract manufacturing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 90.0<span></span>
</td>
<td class="nump">$ 70.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prgo_ContractManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prgo_ContractManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790283584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Short-term contract assets</a></td>
<td class="nump">$ 31.7<span></span>
</td>
<td class="nump">$ 41.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671789928624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Schedule of Revenue by Geographic Location (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,181.7<span></span>
</td>
<td class="nump">$ 1,074.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">750.0<span></span>
</td>
<td class="nump">683.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">407.3<span></span>
</td>
<td class="nump">351.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=prgo_OtherGeographicalAreasMember', window );">All other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">24.4<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 7.3<span></span>
</td>
<td class="nump">$ 6.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=prgo_OtherGeographicalAreasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=prgo_OtherGeographicalAreasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671787228800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Narrative (Details)<br> $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 24, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 09, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,591.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,490.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales', window );">Adjustment, cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 58.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">$ (1.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne', window );">Installment receivable, period one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo', window );">Installment receivable, period two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables', window );">Consideration, installment receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Advent International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Latin America Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,079.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,044.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,511.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,446.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | ScarAway Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember', window );">HRA Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Outstanding equity interest acquired (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900.0<span></span>
</td>
<td class="nump">&#8364; 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles', window );">Definite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes', window );">Deferred income tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember', window );">Nestl&#233;&#8217;s Gateway Infant Formula Plant and Good Start&#174; infant formula</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="nump">$ 110.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cost of Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In-Definite Lived Intangibles</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Installment Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_AdventInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_AdventInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_LatinAmericaBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_LatinAmericaBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_ScarAwayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_ScarAwayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790057536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Pro Forma (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 02, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Net sales</a></td>
<td class="nump">$ 1,209.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Income (loss) from continuing operations</a></td>
<td class="nump">$ 10.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671782800848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Discontinued Operations - Narrative (Details) - RX Pharmaceuticals - Discontinued Operations, Disposed of by Sale<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jul. 06, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Discontinued Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Total consideration</a></td>
<td class="nump">$ 1,550.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser', window );">Potential R&amp;D milestone payments and contingent purchase obligations assumed by purchaser</a></td>
<td class="nump">$ 53.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm', window );">Supply agreement term</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm', window );">Supply agreement, extension period</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities', window );">Aggregate cap on buyer's obligation for certain pre-closing liabilities (percent)</a></td>
<td class="nump">5000.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset', window );">Aggregate cap on buyer's obligation for certain pre-closing liabilities</a></td>
<td class="nump">$ 50.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Contingent Liabilities Assumed by Purchaser</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Indemnification Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Supply Agreement, Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Supply Agreement Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=prgo_RXPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671789932864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 674.7<span></span>
</td>
<td class="nump">$ 620.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">251.1<span></span>
</td>
<td class="nump">262.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">257.2<span></span>
</td>
<td class="nump">267.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 1,183.0<span></span>
</td>
<td class="nump">$ 1,150.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790150576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember', window );">Other expense (income), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Equity securities, fair value method, other expense (income)</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity securities, equity method, other expense (income)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, fair value method</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, fair value method</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity securities, equity method, other non-current assets</a></td>
<td class="nump">$ 62.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671783613520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Balance Sheet Location of Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 211.7<span></span>
</td>
<td class="nump">$ 217.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other non-current assets<span></span>
</td>
<td class="text">Other non-current assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">$ 21.0<span></span>
</td>
<td class="nump">$ 22.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RightofUseAsset', window );">Right-of-use asset</a></td>
<td class="nump">$ 232.7<span></span>
</td>
<td class="nump">$ 239.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other accrued liabilities<span></span>
</td>
<td class="text">Other accrued liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">$ 28.3<span></span>
</td>
<td class="nump">$ 28.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Current indebtedness<span></span>
</td>
<td class="text">Current indebtedness<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liability, current</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other non-current liabilities<span></span>
</td>
<td class="text">Other non-current liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">$ 184.7<span></span>
</td>
<td class="nump">$ 189.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Long-term debt, less current portion<span></span>
</td>
<td class="text">Long-term debt, less current portion<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liability, noncurrent</a></td>
<td class="nump">$ 16.9<span></span>
</td>
<td class="nump">$ 17.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilities', window );">Present value of lease liabilities</a></td>
<td class="nump">232.7<span></span>
</td>
<td class="nump">238.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">213.0<span></span>
</td>
<td class="nump">217.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="nump">20.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Unallocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">65.4<span></span>
</td>
<td class="nump">67.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">62.6<span></span>
</td>
<td class="nump">64.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">97.9<span></span>
</td>
<td class="nump">100.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">99.4<span></span>
</td>
<td class="nump">102.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">14.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">48.4<span></span>
</td>
<td class="nump">49.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">51.0<span></span>
</td>
<td class="nump">51.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_RightofUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_RightofUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671782746240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating leases</a></td>
<td class="nump">$ 12.0<span></span>
</td>
<td class="nump">$ 9.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FinanceLeaseCost', window );">Total finance leases</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671785902736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Annual Future Maturities of Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 24.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">29.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">27.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">22.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">21.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour', window );">After 2027</a></td>
<td class="nump">117.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">243.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">30.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">213.0<span></span>
</td>
<td class="nump">$ 217.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FinanceLeaseLiabilitytobePaidafterYearFour', window );">After 2027</a></td>
<td class="nump">11.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">22.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="nump">20.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear', window );">2023</a></td>
<td class="nump">27.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearOne', window );">2024</a></td>
<td class="nump">31.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">29.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">24.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">23.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDueafterYearFour', window );">After 2027</a></td>
<td class="nump">129.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">266.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">34.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LeaseLiabilities', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 232.7<span></span>
</td>
<td class="nump">$ 238.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FinanceLeaseLiabilitytobePaidafterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FinanceLeaseLiabilitytobePaidafterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Payments, Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsDueafterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsDueafterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityPaymentsRemainderofFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Remainder of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityPaymentsRemainderofFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671786665632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Weighted Average Lease Terms and Discount Rates (Details)<br></strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term - Operating leases</a></td>
<td class="text">10 years 10 months 6 days<span></span>
</td>
<td class="text">12 years 1 month 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average lease term - Finance leases</a></td>
<td class="text">9 years 5 months 26 days<span></span>
</td>
<td class="text">9 years 3 months 10 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - Operating lease (percent)</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - Finance lease (percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790473952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cash Flow Classifications (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows for operating leases</a></td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows for finance leases</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows for finance leases</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 31.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671785895504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning of period</a></td>
<td class="nump">$ 3,490.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="nump">80.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="nump">20.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, end of period</a></td>
<td class="nump">3,591.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning of period</a></td>
<td class="nump">2,044.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="nump">35.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, end of period</a></td>
<td class="nump">2,079.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairments</a></td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">$ (6.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning of period</a></td>
<td class="nump">1,446.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="nump">45.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="nump">20.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, end of period</a></td>
<td class="nump">1,511.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairments</a></td>
<td class="num">$ (878.4)<span></span>
</td>
<td class="num">$ (878.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671785775952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Intangible categories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">$ 59.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">4,879.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,949.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,795.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,718.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets</a></td>
<td class="nump">4,938.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,007.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible assets amortization expense</a></td>
<td class="nump">65.4<span></span>
</td>
<td class="nump">$ 48.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Distribution and license agreements and supply agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">95.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">59.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed product technology, formulations, and product rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">474.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">484.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">218.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships and distribution networks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">1,844.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,825.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,006.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">965.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks, trade names, and brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">2,462.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,542.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">509.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember', window );">Trademarks, trade names, and brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems', window );"><strong>Finite And Indefinite Lived Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">$ 56.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite and Indefinite-Lived Assets By Major Class [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671783299808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Instruments at Fair Value (Details) - Measured at fair value on a recurring basis - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">28.3<span></span>
</td>
<td class="nump">54.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">114.4<span></span>
</td>
<td class="nump">101.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">50.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">111.3<span></span>
</td>
<td class="nump">96.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790447664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Public Bonds</a></td>
<td class="nump">$ 2,544.4<span></span>
</td>
<td class="nump">$ 2,544.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_PublicBondsandPrivatePlacementMember', window );">Public Bonds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Public Bonds</a></td>
<td class="nump">2,315.0<span></span>
</td>
<td class="nump">2,225.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement | Public Bonds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Public Bonds</a></td>
<td class="nump">$ 2,544.4<span></span>
</td>
<td class="nump">$ 2,544.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_PublicBondsandPrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_PublicBondsandPrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671782590304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($) </div>
<div>derivative </div>
<div>brand</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 25, 2022 </div>
<div>USD ($) </div>
<div>derivative</div>
</th>
<th class="th">
<div>Jun. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>derivative</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | derivative</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 2,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_PaymentsForPremiumsOnDerivativeInstruments', window );">Payments for premiums</a></td>
<td class="nump">$ 37.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency options | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of option contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | derivative</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cash Flow Hedging | New Term Loan B Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | derivative</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cash Flow Hedging | New Term Loan A Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | brand</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | derivative</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Investment Hedging | October 25, 2022 Through December 15, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Investment Hedging | October 25, 2022 through March 25, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Investment Hedging | October 25, 2022 through June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | June 1, 2022 Through April 1, 2029 | Maximum | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | June 1, 2022 Through April 1, 2029 | Minimum | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 812.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | June 1, 2022 Through April 1, 2027 | Maximum | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 487.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | June 1, 2022 Through April 1, 2027 | Minimum | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 387.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_PaymentsForPremiumsOnDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Premiums On Derivative Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_PaymentsForPremiumsOnDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughDecember152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughDecember152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughMarch252026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughMarch252026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeInstrumentTermAxis=prgo_October252022ThroughJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis=prgo_June12022ThroughApril12029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis=prgo_June12022ThroughApril12029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis=prgo_June12022ThroughApril12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis=prgo_June12022ThroughApril12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671782419360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details) - Foreign currency forward contracts - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 559.5<span></span>
</td>
<td class="nump">$ 593.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maximum remaining maturity of foreign currency derivatives</a></td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">British Pound (GBP)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">$ 213.1<span></span>
</td>
<td class="nump">224.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">European Euro (EUR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">65.8<span></span>
</td>
<td class="nump">61.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Swedish Krona (SEK)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">65.6<span></span>
</td>
<td class="nump">56.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">United States Dollar (USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">54.8<span></span>
</td>
<td class="nump">51.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Chinese Yuan (CNH)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">26.5<span></span>
</td>
<td class="nump">34.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Danish Krone (DKK)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">26.3<span></span>
</td>
<td class="nump">51.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Canadian Dollar (CAD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Mexican Peso (MXN)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">19.4<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Hungarian Forint (HUF)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">15.8<span></span>
</td>
<td class="nump">10.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Polish Zloty (PLZ)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">15.7<span></span>
</td>
<td class="nump">25.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Norwegian Krone (NOK)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems', window );"><strong>Foreign Currency Fair Value Hedge Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivatives</a></td>
<td class="nump">26.3<span></span>
</td>
<td class="nump">25.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DerivativeNotionalAmountMaximumIndividualAmount', window );">Maximum individual amount</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DerivativeNotionalAmountMaximumIndividualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Notional Amount, Maximum Individual Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DerivativeNotionalAmountMaximumIndividualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SEK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SEK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_DKK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_DKK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_MXN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_MXN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_HUF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_HUF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_PLN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_PLN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_NOK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_NOK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_XXX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_XXX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671785758688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Balance Sheet Location (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">$ 27.2<span></span>
</td>
<td class="nump">$ 52.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Liability derivative</a></td>
<td class="nump">113.6<span></span>
</td>
<td class="nump">100.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Prepaid expenses and other current assets | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Prepaid expenses and other current assets | Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other non-current assets | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other non-current assets | Interest rate swap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">47.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other accrued liabilities | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Liability derivative</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other accrued liabilities | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Liability derivative</a></td>
<td class="nump">111.3<span></span>
</td>
<td class="nump">96.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Prepaid expenses and other current assets | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Asset Derivatives</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other accrued liabilities | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Liability derivative</a></td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671782752464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details) - Not Designated as Hedging Instrument - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of option contract</a></td>
<td class="num">$ (1.8)<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Other expense (income), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of option contract</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Interest Expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of option contract</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of option contract</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671781263568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="nump">$ 18.2<span></span>
</td>
<td class="num">$ (7.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet', window );">Amount</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet', window );">Gain (loss) from components excluded from assessment of cash flow hedge effectiveness, net, total</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign currency cash flow hedge loss to be reclassified during next 12 months</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest Expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings , Foreign currency forward contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness', window );">Gain (loss) recognized in earnings on derivatives related to amounts excluded from effectiveness testing, Interest rate swap agreements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember', window );">Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings , Foreign currency forward contracts</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings , Foreign currency forward contracts</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember', window );">Other expense (income), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings , Foreign currency forward contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Interest Expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings, Interest rate swap agreements</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings, Interest rate swap agreements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings, Interest rate swap agreements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Other expense (income), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings, Interest rate swap agreements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(7.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain/(Loss) Recorded in OCI, Net investment hedges</a></td>
<td class="num">(23.7)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross-currency swap | Interest Expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="num">$ (6.5)<span></span>
</td>
<td class="num">$ (0.5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on foreign currency cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on the cash flow hedging instrument excluded from the assessment of cash flow hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) included in earnings for the period relating to components of the gain (loss) on interest rate cash flow hedging instruments excluded from the assessment of fair value hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671785861376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,181.7<span></span>
</td>
<td class="nump">$ 1,074.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">767.9<span></span>
</td>
<td class="nump">736.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">43.7<span></span>
</td>
<td class="nump">35.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember', window );">Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgesAbstract', window );"><strong>Foreign currency forward contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgesAbstract', window );"><strong>Foreign currency forward contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest Expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgesAbstract', window );"><strong>Foreign currency forward contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember', window );">Other expense (income), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgesAbstract', window );"><strong>Foreign currency forward contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness', window );">Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Net Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgesAbstract', window );"><strong>Interest rate swap agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgesAbstract', window );"><strong>Interest rate swap agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Interest Expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgesAbstract', window );"><strong>Interest rate swap agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap agreements | Other expense (income), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgesAbstract', window );"><strong>Interest rate swap agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet', window );">Amount of gain or (loss) reclassified from AOCI into earnings</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on foreign currency cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=prgo_OtherExpenseIncomeNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790378560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Indebtedness - Schedule of Borrowings Outstanding (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 15, 2023</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,582.4<span></span>
</td>
<td class="nump">$ 1,588.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,544.4<span></span>
</td>
<td class="nump">2,544.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.4<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized premium (discount), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.3)<span></span>
</td>
<td class="num">(15.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Deferred financing fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.3)<span></span>
</td>
<td class="num">(30.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total borrowings outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,101.6<span></span>
</td>
<td class="nump">4,106.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current indebtedness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38.8)<span></span>
</td>
<td class="num">(36.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,062.8<span></span>
</td>
<td class="nump">4,070.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12027Member', window );">June 1, 2022 Through April 1, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490.6<span></span>
</td>
<td class="nump">493.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12029Member', window );">June 1, 2022 Through April 1, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,091.8<span></span>
</td>
<td class="nump">1,094.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3900SeniorNoteDue2024Member', window );">3.900% senior note due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="nump">700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member', window );">4.375% senior note due March 15, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700.0<span></span>
</td>
<td class="nump">700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4400SeniorNotesDueJune152030Member', window );">4.400% Senior Notes due June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750.0<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member', window );">5.300% Unsecured Senior Notes due November 15, 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90.5<span></span>
</td>
<td class="nump">90.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4900SeniorLoanDue2044Member', window );">4.900% Senior Loan due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 303.9<span></span>
</td>
<td class="nump">$ 303.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4650SeniorNotesDueJune152030Member', window );">4.650% Senior Notes due June 15, 2030 | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3150SeniorNotesDueJune152030Member', window );">3.150% Senior Notes due June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DebtInstrumentInterestRatePercentageCap', window );">Debt Instrument, Interest Rate, Percentage Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DebtInstrumentInterestRatePercentageCap">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Percentage Cap</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DebtInstrumentInterestRatePercentageCap</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_June12022ThroughApril12029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3900SeniorNoteDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3900SeniorNoteDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4400SeniorNotesDueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4400SeniorNotesDueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4900SeniorLoanDue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4900SeniorLoanDue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4650SeniorNotesDueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4650SeniorNotesDueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3150SeniorNotesDueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3150SeniorNotesDueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671783022816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 20, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DomesticLineOfCreditMember', window );">Domestic Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum', window );">Secured net leverage ratio, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions', window );">Maximum leverage ratio, subject to consummation of qualifying acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2022RevolverMember', window );">2022 Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings on line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A2022RevolverMember', window );">2022 Revolver | Secured Debt | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember', window );">New Term Loan A Facility | Secured Debt | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Principal repayments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember', window );">New Term Loan B Facility | Secured Debt | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Principal repayments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member', window );">5.300% Unsecured Senior Notes due November 15, 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A3900SeniorNoteDue2024Member', window );">3.900% senior note due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member', window );">4.375% senior note due March 15, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4400SeniorNotesDueJune152030Member', window );">4.400% Senior Notes due June 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prgo_A4900SeniorLoanDue2044Member', window );">4.900% Senior Loan due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant, Leverage Ratio, Subject to Consummation of Qualifying Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Secured Net Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DomesticLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_DomesticLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A2022RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A2022RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A5300UnsecuredSeniorNotesDueNovember152043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A3900SeniorNoteDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A3900SeniorNoteDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4.375seniornotedueMarch152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4400SeniorNotesDueJune152030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4400SeniorNotesDueJune152030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prgo_A4900SeniorLoanDue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prgo_A4900SeniorLoanDue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671782749584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share and Shareholders' Equity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations</a></td>
<td class="num">$ (1.1)<span></span>
</td>
<td class="num">$ (1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income (loss) from discontinued operations, net of tax</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (3.0)<span></span>
</td>
<td class="num">$ (2.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding for basic EPS (in shares)</a></td>
<td class="nump">134,900,000<span></span>
</td>
<td class="nump">134,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding for diluted EPS (in shares)</a></td>
<td class="nump">134,900,000<span></span>
</td>
<td class="nump">134,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive share-based awards excluded from computation of diluted EPS (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of ordinary shares (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Denominator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Numerator: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671781262352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 4,842.1<span></span>
</td>
<td class="nump">$ 5,151.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="nump">23.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(3.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="num">(20.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">4,833.9<span></span>
</td>
<td class="nump">5,104.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(27.0)<span></span>
</td>
<td class="nump">35.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="num">(20.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(6.3)<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Fair Value of Derivative Financial Instruments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">24.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="num">(28.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(3.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(31.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(7.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(58.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="nump">52.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">52.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(5.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Posey-Retirement and Pension Liability Adjustments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">OCI before reclassifications</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_AccumulatedOtherComprehensiveIncomeRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_AccumulatedOtherComprehensiveIncomeRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790493792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 19.8<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringAdditionalCharges', window );">Additional charges</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(8.0)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringReserveSettledWithoutCashNet', window );">Non-cash adjustments</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="nump">$ 8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=prgo_SupplyChainReinventionMember', window );">Supply Chain Reinvention</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringAdditionalCharges', window );">Additional charges</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(4.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringReserveSettledWithoutCashNet', window );">Non-cash adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=prgo_HRAPharmaIntegrationMember', window );">HRA Pharma Integration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringAdditionalCharges', window );">Additional charges</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringReserveSettledWithoutCashNet', window );">Non-cash adjustments</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Initiatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringAdditionalCharges', window );">Additional charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_RestructuringReserveSettledWithoutCashNet', window );">Non-cash adjustments</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_RestructuringAdditionalCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Additional Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_RestructuringAdditionalCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_RestructuringReserveSettledWithoutCashNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve, Settled Without Cash, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_RestructuringReserveSettledWithoutCashNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=prgo_SupplyChainReinventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=prgo_SupplyChainReinventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=prgo_HRAPharmaIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=prgo_HRAPharmaIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671783004192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">$ 15.6<span></span>
</td>
<td class="nump">$ 19.8<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=prgo_HRAPharmaIntegrationMember', window );">HRA Pharma Integration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.8<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Corporate and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_UnallocatedSegmentMember', window );">Unallocated Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=prgo_HRAPharmaIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=prgo_HRAPharmaIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_UnallocatedSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_UnallocatedSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671787359312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 13, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 15, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($) </div>
<div>year</div>
</th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2011 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2010 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2009 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate reconciliation, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123.80%<span></span>
</td>
<td class="nump">90.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax examination, penalties and interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.7<span></span>
</td>
<td class="nump">$ 40.1<span></span>
</td>
<td class="nump">$ 41.8<span></span>
</td>
<td class="nump">$ 27.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_CumulativeDeferredChargeTaxLitigation', window );">Cumulative deferred charge related to tax litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent', window );">Royalty conceded on all omeprazole sales as a percent of refund claims (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.24%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015', window );">IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015', window );">IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014 and 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense', window );">Income tax examination, debts subject to limit of deductibility of interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Settlement payment</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service (IRS)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeTaxExaminationNumberOfTaxableYears', window );">Income tax examination, number of taxable years | year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss', window );">Income tax examination, estimate of additional tax expense, excluding interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss', window );">Income tax examination, estimate of additional tax expense, excluding interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Concession of Royalty Due on Sales as Percent of Refund Claims, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_CumulativeDeferredChargeTaxLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative Deferred Charge, Tax Litigation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_CumulativeDeferredChargeTaxLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014 and 2015</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationNumberOfTaxableYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Number of Taxable Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationNumberOfTaxableYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated amount of loss resulting from an adverse tax position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671790371120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies - Price Fixing Lawsuits (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>Jun. 10, 2020 </div>
<div>retailer </div>
<div>pharmaceuticalProduct </div>
<div>manufacturer </div>
<div>plaintiffGroup</div>
</th>
<th class="th">
<div>Jun. 21, 2017 </div>
<div>genericPrescriptionPharmaceutical</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | genericPrescriptionPharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_StateAttorneyGeneralComplaintMember', window );">State Attorney General Complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberOfAdditionalStatesAndTerritories', window );">Number of additional states and territories | plaintiffGroup</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberofFormerEmployees', window );">Number of former employees | retailer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | pharmaceuticalProduct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_CanadianClassActionComplaintMember', window );">Canadian Class Action Complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberOfManufacturers', window );">Number of manufacturers</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Generic Prescription Pharmaceuticals</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofFormerEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Former Employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofFormerEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberOfAdditionalStatesAndTerritories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Additional States and Territories</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberOfAdditionalStatesAndTerritories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_StateAttorneyGeneralComplaintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_StateAttorneyGeneralComplaintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_CanadianClassActionComplaintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_CanadianClassActionComplaintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671783088544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies - Securities Litigation (Details)<br> $ in Millions, &#8362; in Billions</strong></div></th>
<th class="th">
<div>Jun. 28, 2017 </div>
<div>ILS (&#8362;) </div>
<div>individual </div>
<div>case </div>
<div>$ / &#8362;</div>
</th>
<th class="th">
<div>Jun. 28, 2017 </div>
<div>USD ($) </div>
<div>individual </div>
<div>case </div>
<div>$ / &#8362;</div>
</th>
<th class="th">
<div>Nov. 14, 2019 </div>
<div>class</div>
</th>
<th class="th">
<div>Jun. 21, 2017 </div>
<div>individual </div>
<div>genericPrescriptionPharmaceutical</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers', window );">Number of current or former directors and officers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals', window );">Number of generic prescription pharmaceuticals | genericPrescriptionPharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberofPutativeClasses', window );">Number of classes | class</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member', window );">Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers', window );">Number of current or former directors and officers</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Preliminary class damages</a></td>
<td class="nump">&#8362; 2.7<span></span>
</td>
<td class="nump">$ 760.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateRemeasurement1', window );">Foreign currency exchange rate, remeasurement | $ / &#8362;</a></td>
<td class="nump">0.28<span></span>
</td>
<td class="nump">0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Number of cases dismissed | case</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Generic Prescription Pharmaceuticals</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Current Or Former Directors And Officers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofPutativeClasses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Putative Classes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofPutativeClasses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateRemeasurement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateRemeasurement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671789293920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies - Other Matters (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 29, 2020 </div>
<div>complaint </div>
<div>claim</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($) </div>
<div>lawsuit </div>
<div>tender</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>policyPeriod</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated litigation liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions', window );">Loss contingency, receivable, additions | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods', window );">Number of policy periods | policyPeriod</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_TalcumPowderLitigationMember', window );">Talcum Powder Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims, number | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberofTendersAccepted', window );">Number of tenders accepted | tender</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=prgo_RanitidineLitigationMember', window );">Ranitidine Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberofMasterComplaints', window );">Number of master complaints</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_LossContingencyNumberofMasterComplaintsNamingCompany', window );">Number of master complaints naming company</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberOfAppealsOfMasterComplaints', window );">Number of appeals of master complaints</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberOfAppealsOfPersonalInjuryClaims', window );">Number of appeals of personal injury claims | claim</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_NumberOfPersonalInjuryLawsuits', window );">Number of personal injury lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingency Loss, Coverage Available to Satisfy Judgements, Number of Policy Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofMasterComplaints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Master Complaints</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofMasterComplaints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_LossContingencyNumberofMasterComplaintsNamingCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Master Complaints Naming Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_LossContingencyNumberofMasterComplaintsNamingCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberOfAppealsOfMasterComplaints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Appeals of Master Complaints</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberOfAppealsOfMasterComplaints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberOfAppealsOfPersonalInjuryClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Appeals of Personal Injury Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberOfAppealsOfPersonalInjuryClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberOfPersonalInjuryLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Personal Injury Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberOfPersonalInjuryLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_NumberofTendersAccepted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Tenders Accepted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_NumberofTendersAccepted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of additions to receivables pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_TalcumPowderLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_TalcumPowderLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=prgo_RanitidineLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=prgo_RanitidineLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671787388048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 10,954.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,017.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,181.7<span></span>
</td>
<td class="nump">$ 1,074.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">48.5<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible Asset Amortization</a></td>
<td class="nump">65.4<span></span>
</td>
<td class="nump">48.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Unallocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="num">(56.0)<span></span>
</td>
<td class="num">(73.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible Asset Amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">5,057.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,134.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">763.7<span></span>
</td>
<td class="nump">710.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember', window );">CSCA | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">763.7<span></span>
</td>
<td class="nump">710.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">83.2<span></span>
</td>
<td class="nump">78.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible Asset Amortization</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">5,897.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,883.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">418.1<span></span>
</td>
<td class="nump">364.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember', window );">CSCI | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">418.1<span></span>
</td>
<td class="nump">364.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">21.3<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible Asset Amortization</a></td>
<td class="nump">$ 51.5<span></span>
</td>
<td class="nump">$ 36.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140671792137168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>May 05, 2023</div></th>
<th class="th"><div>Jan. 20, 2022</div></th>
<th class="th"><div>May 07, 2020</div></th>
<th class="th"><div>Jan. 13, 2021</div></th>
<th class="th"><div>Apr. 26, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty', window );">IRS notice of proposed adjustment amount from 2011,2012 and 2013 audit of Athena, including penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 843.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent', window );">IRS notice of proposed adjustment, penalty (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense', window );">Income tax examination, debts subject to limit of deductibility of interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate', window );">Interest rate cap on debts for U.S. Federal tax purposes, as percent of Applicable Federal Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes', window );">Income tax examination, reduction in blended interest rate due to cap for U.S. Federal tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense', window );">IRS notice of proposed audit adjustment to reduce deductible interest expense for fiscal years 2014 and 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes', window );">Blended interest rate proposed on debts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BlendedInterestRateInRevenueAgentReport', window );">Blended interest rate in revenue agent report</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_DebtStatedBlendedInterestRate', window );">Stated blended interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes', window );">Blended interest rate proposed on debts</a></td>
<td class="nump">5.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationInterestExpense', window );">Interest expense</a></td>
<td class="num">$ (153.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BlendedInterestRateInRevenueAgentReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Blended Interest Rate In Revenue Agent Report</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BlendedInterestRateInRevenueAgentReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Blended Interest Rate Proposed On Debts For U.S. Tax Purposes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_DebtStatedBlendedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt, Stated Blended Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_DebtStatedBlendedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeofProposedAdjustmentPenaltyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Adjustment, Penalty, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeofProposedAdjustmentPenaltyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment Amount, Including Penalty</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prgo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>prgo-20230401_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:prgo="http://www.perrigo.com/20230401"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="prgo-20230401.xsd" xlink:type="simple"/>
    <context id="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i8661025121e9419ab6b60b4f10d5e2b8_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:OrdinaryShares0001ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i0b69715b8beb4265b311eb807fec1768_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A3900SeniorNoteDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i32b30e53a37f41a1ac98e8fb9995ca4e_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i765e63eea0a54636a90ce216a325be3a_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib67f1fede03d484bba024eb3d57f031f_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A5300UnsecuredSeniorNotesDueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i95b2b593633042b4b81a8353b11811f5_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">prgo:A4900SeniorLoanDue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="id1979f160e0c4d1697ab4c57477e38d1_I20230505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i09f467292f2f4ec28ff4898282903225_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iafa30a67b78141b8a9689bcf457bb312_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8ec02b3dd484b4e8275f17f1949e2de_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07bcc81fd19e45bdb8acb5118329924f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04cfa05f5fd341f898c851d834e5a6ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd18f1c6b0bf4007931565e3309d3a59_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i712e3d08fced4870b5dd4e881cd7d98a_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i47510622497c47db87a31fe64fc51a88_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i8a185df6ddcb4f0db8975f91beef3d79_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ib43124566cd24715b45ad75e52af2328_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="id761e753820a44cea1db50ca513e11e5_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i6955bfa807de4779804dcda471f50c60_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ie326fc7603fc47d2829c2df0bcf4817d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0d376c6445864b46856bd7c9eca96a57_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5aed5796cb6f4c748a6fbc6e5733a7b5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if7e7884fe5fe439cbb60a14a0bfa25da_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if52e0bee33a840b6b04f0e23c7814541_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i6b9dd69bc08149889b61d83c2b89ce51_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="if3cf13b5a219470a985bbaa83714a9e5_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2716fca3625c46c785d6b90d8eb978c4_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i47f5c13d45a9489b800b1fdca5125d08_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="icf374477ec7c4dc8a274c7c5c8b33a4e_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i67e110cebac446599cfeea238f5aca8e_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i40d57b17ab9441e0830bda17d8d7302a_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:NutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ib41c767804e04e74b0d0675fae86b3e6_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i70d2639683f947f1b1d6e8865ba5ab42_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i3deb497865334700bccbc0cb9af79e11_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i52ca79a594274f7d986860796f5bf5c4_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ibe154ddc08314c818219ab4974f9b334_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i423427f446af435a8a099e8e39407244_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i4f4328ac279d49ba94fa79ccb58cca12_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i65f795e573b74139b0597df57a87597e_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="iedde1896a9a744229692a430d32ed377_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkinCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i023898292ce644d4920385454d5ee04c_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkinCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="idf8cd73c20df4eb1818e515fc7c9333a_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ibd70fd42144a4756be4ac24e92e7858a_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i05a97c7cd9bf4ae49aef6276d404df59_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i89b3d9701d1f4e7aad3538d9f6e954f9_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i2cbf1a7074ed45a3a1f504b48f430acf_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4aed093d915e4cb8a09ef81ab74849f2_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i73e4fca1b9404a29b27348e58f4f2456_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i7a41be8290854dd7b445442e9fce77b4_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i4f64d6970e5341198837503d0ac5e982_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib9230b63081f4a419d17b4423287f16d_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:UpperRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="id72e917daad64a05bf29a7fa65162e54_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkinCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i8aeac51b11cd4427af639bde4e8f879a_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:SkinCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i935b53becd594afcbffb2058d5cf3b02_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia7bbc6f93b654156afae3a426cf64660_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:HealthyLifestyleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i153d82f41fd34b13bb9cdb1b721635fa_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i08ee092ef6164e56bd199362643c5c7f_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:PainandSleepaidsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="id8ee1193579b4eae9c065c0476e1af27_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i6c3401426e894533be11508ed857acc6_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:VitaminsMineralsandSupplementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i7c62f3bb392741fda84f5cd9e3a30ea0_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i5ec2b2f9ab6446b7aee5b5a487b367d9_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ic8e25af889154d1bb960e56417630fde_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i5eb71bb33d314222ab57e0143395957a_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OralSelfcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i86ac2754d6fd4df6b38298e67a72bf14_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i810f1ba4bfdd4a278d0a9f1e7f9c9a68_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:DigestiveHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ib811602f7ff24efc831c6c1156046949_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia940558c4b3444388c68c903c7078507_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:OtherCSCIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i817dfeec890e44ed95bda23a0c957cff_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="icc50f621c6924bbf8a473a58178c820b_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i4e003873c79f4b258525ee8b81660c16_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i687906ed625e459a9c846fd176504670_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prgo:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ibe0cdbd5f85948e995c7dc28b6cb4f45_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ic8ac8cde05224960aeb104a710acfa0d_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ia14a583947bd41cda0620726204c97bf_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="id685e682ee6d45c885e9bd25d7d82f62_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i2df41325723f4515a100896e6f2804d2_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ibe10084d8d8e4b8ea8a1ba4efd5d12ce_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prgo:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ic077248bde32442796615d79eeb0a55f_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i3597c655dd73488a968ca15c3fa79180_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i16e4dfbabc1449fdb44f59c5ebd68d88_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i09b56fa39043421e9d4157b4a80c13b3_D20220429-20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-29</startDate>
            <endDate>2022-04-29</endDate>
        </period>
    </context>
    <context id="iad94f9c92d974bc2b0f1da3daa6ff5db_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i297276a0f2644603919916e9535ffb86_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:HRAPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4a4e7b481e564ec396c3dee7669dcf4a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i49b813746d944e9caa272f8a6edd60db_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prgo:NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="i71d0d200110e4e108b8f68acd92ba5e1_I20220309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:AdventInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="i1f76ed2554e846f0acf432bf5b3cc813_D20220309-20220309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:AdventInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-09</startDate>
            <endDate>2022-03-09</endDate>
        </period>
    </context>
    <context id="i5495ecbabeb74464bd45155077e348aa_I20220309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="ib8a0f1a3d9cf416fbceebe5198581d19_D20220309-20220309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:LatinAmericaBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-09</startDate>
            <endDate>2022-03-09</endDate>
        </period>
    </context>
    <context id="i3ec5ffca5e044c25af00f0856f31cc69_D20220324-20220324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:ScarAwayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-24</startDate>
            <endDate>2022-03-24</endDate>
        </period>
    </context>
    <context id="ife7f164c6edf47848398641f9ffd17b1_I20210706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="i6c40483c42aa43999f3d00d21dcd2535_D20210706-20210706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">prgo:RXPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="i4ebf7e0bc9094fd6a3ac5764350b0544_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i9eb38aa56dcf402bb0bb2637e8d49b4d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if103d7bf645e4b24ac84251cdaf12b33_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i3fd779f91b674ece84c54eb308733a1d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="if7ca477c08d84a82a9de72b2c524c103_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0244fe0ff77440b9929d419ff9c9da9b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i620cef7dc50148d7a2222193971d347f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i8af8f32782cc4ff0b482a38bac5b723b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4c25260d2b6b4edab1b3611171d1ce25_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie4e56b5dd90f4224b8c29c7ef31fe2a5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4f3eb6af9f444b3e8326226555389980_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib24332748044483db83ca8e301c719ca_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i63eb2d1285fa4953907a861c6ea961bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc71f8f540634f1ea99e39a92c86aae5_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iebce178fd4714f5f92bb9fbec5a443e3_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i10071a3c442e4192b302e7657ea94c8c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">prgo:TrademarksTradeNamesandBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07824618f65645f69731a6aa1568cec3_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i1fc973b59afa4340b4dea988d2ff81c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifc8978c331594327a5fb3a589e575a4f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i1e68ee7033cc4aadb5686e063eb8d555_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id55a788697874c2bacf296adc61ea0b7_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i13378a6ed8a844e6ab6a6cf5ba0bee6b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ae35b7343b14c67a3ee371bf5c1469e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i491ee1dd84214e7cb151e35c302d008c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ied803c95feec417dbbc3ce5403e02dfc_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i8bc5f5344063450db6361f3d577c9287_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifa4f6696fa504105b9bc1e35d5f422b5_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie898e8edfbf646baa27f1856bdfdd572_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia38fe8e9a9f04f668590d3cd5af1bea2_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i323e00f452604c9e8efdeea764a4c5b9_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie008783b9a804da39b8b478db605bf2e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ide9fb602617c4361b1e1413aad64fba1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i41c166f0f4ac4071b5451ad221b1c85b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i04725fb2248c4ebeabaaa3e07ead859d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i42c93a65a4db40e38259118bf87ca950_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iec4efa57993147ecbf3218e1e2ad5e1d_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i54d490f02cff46969dc0d4b06f3a6c1a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i1480475fcfcf4911a302de8597350461_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9220abdafe514bd1bc03b527e4e345fe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9993c7a02a6a4c7ea61954c3d40b6757_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idcd10964e4444c5aa7f56a883baa41b4_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i92e48502376142e5ac4f235d7f18af12_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ibede6d5d7f6e435d97c1430b6dee57cf_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i182417c07231420c9b57037a5f01eef3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i04a834f03a804608931a9b7597442b59_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i55e23d064ac94e579d65b01ab85c557a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e1c235573a44397aede9c7af5b6226c_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i50a400f80e334fac81f4e0f510dd26d4_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie79b2663ac03492fa74b7ec953837986_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i7ed8e3a070954dd99dcac4657d4e487f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i850a948962d64a65adff8d59644ca588_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24fce60834ce4f74a2d6fdbbbe84bbf8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc98dc57d99e4819af454bec68b9436c_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i4e444dcadb33488daa64185519d1ac50_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i39273b39b09344b1a7df355b3202f917_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ibfb63dc591b74a43a816a11b9df7a30b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:PublicBondsandPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0391704d774f4479b2bd6287047b946b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i863dc014fe5a4fd69e51cabe6ed66bef_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i703d29ff729d4c809efa88132b4033f6_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ie73d3af15eaf44a38b8cd158e74b7934_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="if59013eda0ee4c9783bb2aa14130c446_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i69de5a172d6c4557ac718e348bdb6557_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i4fe60b7eb3e54bf4bec247c65d45ad0d_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i8d3d3fb12721426a98d72c0b4de560d8_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ib95874ed8320453c88600e7dd3a13d14_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ideed9f35811341b6987034ed4edf23a9_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i579bce87d950488c9440b6afa28de94c_I20220601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-01</instant>
        </period>
    </context>
    <context id="i231ffb94f5014c56bb9ab4f128394b92_I20220601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentCoveredInterestRatePeriodAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-01</instant>
        </period>
    </context>
    <context id="id158617640374c9fa1495cf02188a911_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ib6f681b4b8d84632a9cc71f98e1bb3d6_I20221025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-25</instant>
        </period>
    </context>
    <context id="iea716b8db0224b21bca000c2d1d526a3_I20221025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughDecember152024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-25</instant>
        </period>
    </context>
    <context id="ie8461440591543a29bafbb6383d528eb_I20221025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughMarch252026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-25</instant>
        </period>
    </context>
    <context id="i55284888fcd34a93ba5adfc643dfd08e_I20221025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="prgo:DerivativeInstrumentTermAxis">prgo:October252022ThroughJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-25</instant>
        </period>
    </context>
    <context id="i7c0c512854e04191adfce17ad716634b_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i72e0c6387a644ace96085e11f8e677ed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5d39d66893f44acf940bd4020fe80a61_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2cd991dd16c04acca9ac92cc1bede2e8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1d7962673e54ecf9e8c6b4bf23987b5_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i28f2b3c78bed464c913866d5104a819f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id143f134d71c4b3eab34c1f0ee8afdab_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="if7f5b573a7f14d31b174ed365e23e979_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i52a46e2bb32541beba33898f230357f7_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie6c621b427f04e8796899f12e0d2010e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc816fb252f242b985c969760b37834f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i7f6d73713f78476b8e8534d2a1895b4c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2aa8244a981b494783cc178b23ffb387_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i9413936dee484f3c8c6f293e20f8e318_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic3d2ba962fcb47f197b0697553afd857_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i141d55293db343b9858355f37d0a46e6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf4d615378ef46f4bcb95c10b96705e6_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HUF</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ic48b9d0358ef4fc9b04eadf1f455b1f1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:HUF</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4570a0e785e400a97404bd558852b0a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ibf3ff649eb5e43a89fb4b4cc0dcb1556_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:PLN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24abf1ca03e84edba4b6d0d18c9fcd6a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i02c31ca1b12a4d6081f2a49aba1e6718_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:NOK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iefefab2c0f7c4ccaacc90d873855372d_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i7136cb4396ad4a658534b085e82dbfc7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i58e9f89e450b4789b74027090e527fd2_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie2e286c007514bd88ef38594ee3f765b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9a74650587a0467ab9f464dd51bad8b6_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i548d3c81888a421d840889bc4a3e1068_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0cb6d2a114c44f87b07e610ccad0481a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0255c8396730441fab6e09dbb1afb422_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2e0b4d9aeda94165b64f6361c52863a1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i055ddb3eb7864ddbb72cc19e608e8248_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id3b19260e3134f8eac6745ebd39cfaba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if0e4ace05b3746aab7f10dd86bdf5642_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i6d974173dfdd4a52a46760690fe23666_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0eccd056afc545b39529ed76bdd93865_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ibc338e7d11bb49c0b3dd26e0b630ceaf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i72ca5dc3f5a248a1ad6f808b50351d6a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i4006135836b64c4a9a25d99b7b066e0d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i883728cd2fe84026a4db286c1fb80ffe_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i56e2de60b8a148eeb14a18745abe9a02_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d46728e14d44678a73c2145851d2fb6_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ida370fe5573e4ed7ba48cf6fe97b5c67_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ec0d02e7d8d49f2aa9b45ada2bfaef8_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iae577995f42d4580ba2516f347bba679_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19bf4a75be9945638b85dd2447d4ad7f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="if48bc899a04941fcaa88ed2870642735_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1eee7139231548609a6bed77c36f242c_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i415d640a98a648a49bb88703fc4bf417_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i86211ac950df4f52b3bdb376967439bd_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="idb2d9216b7b04cf0a3ecb3d790f50e69_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="id11eac94d9bd4b9b8ae0373021cc6731_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i0d55a845d92a4d0bbc62c63895976038_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i794270c4878944cab78f1bdba967d567_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iaec9a490f09d45b88e90070c6c101e1d_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i170e5f4e14d94ed2bf2f5e30f221c7a3_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i8be97fbfb6bc4fdc93582f7325963e07_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ieecd1150963c4685ab0218460f0f71ce_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if2e5203a533d4aee8b2fdbcf22b56556_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i22e1c81f675a48eaa5a572a21687d185_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i66107ad7ba8046ec942972e9becaaff6_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i3f3f8cdce8a5422aa8044ef1e7ea60f3_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ibd5c9b62aef54b399eed74960e878654_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i8ef3599264dc4912b8aaad190f86b782_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i6c74f5dd34524d48896153867df4a030_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i5dae718ccbd74caa8a4114db6e48afcd_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="if02007e835294982ad3505eac48241f5_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i76e87de477904785908596a6978421c3_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia295c3555b08448eafa786c04116bed5_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if9e9d75fab66455da7ef57faeb376f99_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i860de82b30ab45b2a460cf624e3b5b40_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="iddc45227f2cb42ecb959883c84daf958_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i26700cb91c4c4421814c6b2ef530c802_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">prgo:OtherExpenseIncomeNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ic26457665a374ac89c8e5ccd299aada6_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i5726a6ff23d34fe88fffbd72991b59b5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic7e7bb0d19a14bc691198c0608792022_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iaa673d76aaf84ba09e2965620bcb0d59_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:June12022ThroughApril12029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i54459b98d2974030b71e7ddc68bfe196_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3900SeniorNoteDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i4867f353b0c243f48a056129a364e474_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3900SeniorNoteDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e440215ed7c4652ba80460d905c0a7e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ic5bf1b892ebf4c429b94a0def27e3812_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4.375seniornotedueMarch152026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2c142977f87a47ad9f46502a682caac2_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iea71d3a2fb7f454e9569d20da14316f2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3ee3cba978c44e42a435b9406ceec87a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5300UnsecuredSeniorNotesDueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i019d5a5f11b445d89d3eb9b704641a19_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A5300UnsecuredSeniorNotesDueNovember152043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c0b70f0dc5a4bb0a131daa51980752a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4900SeniorLoanDue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ia71904c9e6b7439192afc4e42bd89431_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4900SeniorLoanDue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2fa7281600f4aa4a680f08c54770403_I20220615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4400SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-15</instant>
        </period>
    </context>
    <context id="if67b3d6fb8804d8b955cf3354d79349c_I20230615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A4650SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-15</instant>
        </period>
    </context>
    <context id="i65add94a2f11440981e032bdf4abf03a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A3150SeniorNotesDueJune152030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i32ce52e94a304b5e9d295cbb2edf2771_I20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2022RevolverMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-20</instant>
        </period>
    </context>
    <context id="idcb1e6845c364da39d5d2715c7c11d1a_D20220420-20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2022RevolverMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-20</startDate>
            <endDate>2022-04-20</endDate>
        </period>
    </context>
    <context id="i276b4c882ad542a0b4bc9186be63d917_I20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-20</instant>
        </period>
    </context>
    <context id="i462a5d19445e4f4fb147359b0ef2c71a_D20220420-20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-20</startDate>
            <endDate>2022-04-20</endDate>
        </period>
    </context>
    <context id="i9d64608f0d33471e9601e5e3541f2100_I20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-20</instant>
        </period>
    </context>
    <context id="ibe49dcf2409b417bb03e87a4807043ce_D20220420-20220420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-20</startDate>
            <endDate>2022-04-20</endDate>
        </period>
    </context>
    <context id="i3050d0889c1b479ca3df780a8a2f67d3_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i7ae59f1d38b94108baddcb6c4ce9ccc9_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i42813d6336b1446ea9d9766969a5d5d2_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanBFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i909f5895c8934a849b1ce13d3e9b387a_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:NewTermLoanAFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i77ce2bbbf7924de9b72b6351123d25b7_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2022RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i3f539b72037a48c99b8a54e846db395d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prgo:A2022RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i98abb9740a4644f0b0afc822f729d80e_I20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="i3a686c929d27456898c40f7a87b08e15_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i70a16530a4b74ab1ab2c00eb8e6c9b14_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifcf2f305941145e58ac95b094337d8ae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i432ffc96a54241f68ddc93d9513378cb_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i9384c786716d42738630dbab4c03be2a_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i57859208fac141e195976ff766745648_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i506dcfe48b094a3e931d739dfe711e08_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i339887c74bba45cdaf9c842631f3e11f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i04473c0869bb4e9cb57c58ccae61c32f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie13f0da93b3b4722b635937b8c483189_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife352f731243473cb38ff3a7c88ad094_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:HRAPharmaIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibd510179d2634daf92fb0a1d857cf068_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3d97e990bb9f45da875ed0019a943271_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib4ad834796dd4944a10c88db4b09a61a_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:HRAPharmaIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib95c3b6aef5f41e9a52f9f10c2866889_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ibd1391abd493480fb9acd3c58fcf9675_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:SupplyChainReinventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i6134b75d6d3245a1b012e4facd40a083_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:HRAPharmaIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2e874d379f764d87a630226253c6b16f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id44c0aea81d045e49ea119c7382cc4e4_D20220101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">prgo:HRAPharmaIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="icfdccbcb51464df8bf6242647eb20916_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="idb86d716465f4a43b35ce7084bb1a35f_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:UnallocatedSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i27edc1f6184c482f97b3b37c5afe0212_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i75ee84a7035145c0b2c910d5dc516972_D20090101-20091231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2009-01-01</startDate>
            <endDate>2009-12-31</endDate>
        </period>
    </context>
    <context id="i309429068baf42d9b32476c47f52aaff_D20100101-20101231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-12-31</endDate>
        </period>
    </context>
    <context id="i8f277cfcb9db4505ad801732fd1320f1_D20110101-20111231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2011-01-01</startDate>
            <endDate>2011-12-31</endDate>
        </period>
    </context>
    <context id="i201270c4e836404b9f18b06fd151647e_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="i08faba57c5a94a03969d96709d4fc35b_D20170815-20170815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2017-08-15</startDate>
            <endDate>2017-08-15</endDate>
        </period>
    </context>
    <context id="i0064d9e4042944d58d1198901966263d_D20210113-20210113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2021-01-13</startDate>
            <endDate>2021-01-13</endDate>
        </period>
    </context>
    <context id="i13f377e048824747af8070c20b1f773d_D20210113-20210113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-13</startDate>
            <endDate>2021-01-13</endDate>
        </period>
    </context>
    <context id="i799c30578ef443f59a649aaeb56da4a1_D20210113-20210113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-13</startDate>
            <endDate>2021-01-13</endDate>
        </period>
    </context>
    <context id="i6df9a027c7764dc1882048b53958ed7f_I20210113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2021-01-13</instant>
        </period>
    </context>
    <context id="ia9a1e1741f134ef190ca8f40ceb9584d_D20221228-20221228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="i28ca55466881480391b76ea7d3db52a4_I20200610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:StateAttorneyGeneralComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-10</instant>
        </period>
    </context>
    <context id="ib8a4bae7a747476e97ac581edbcf809e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:CanadianClassActionComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ica2a115cf0034cd88c426dea96ad5c21_I20170621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2017-06-21</instant>
        </period>
    </context>
    <context id="i97aab9c2264f4b1d8268af34bd05d862_I20191114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-11-14</instant>
        </period>
    </context>
    <context id="i7b7f1a9b91944bd69726984aec58d65e_I20170628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-28</instant>
        </period>
    </context>
    <context id="ic803f010b538436e9209e345a0be08e1_D20170628-20170628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-28</startDate>
            <endDate>2017-06-28</endDate>
        </period>
    </context>
    <context id="i1bfe66b50bea4a8aa93aa6ad4d382456_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:TalcumPowderLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2c793269a6cc46b9b3333aaf587cd1d4_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:TalcumPowderLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i2649c54ab7c149678c1ae6e627aa140e_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="id52764380c894cadb9ff29bc67bd9ba8_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">prgo:RanitidineLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i3b63510c803344a6ba94abfe031e6828_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i0b6ce8147676451896841efd4f59b711_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i0e0b17ca570e463d8112c9aa7539c783_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareAmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="if88323e455b54b5aae39a5550bdf99d6_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia88afdc4249140efb878dc32ef2e31c3_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prgo:ConsumerSelfCareInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i76faace4db464da8a217c507ee330b44_D20230101-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i5c4d7777405b48b5a6f0c5963e7e4b91_D20220101-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i24a3f5f031674ea3967941fe5f6e80e7_I20190426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <instant>2019-04-26</instant>
        </period>
    </context>
    <context id="ib61b709a6db3426a9ffb8c7d3ab7d06f_D20200507-20200507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2020-05-07</startDate>
            <endDate>2020-05-07</endDate>
        </period>
    </context>
    <context id="i6893406b8890440696557335070ce018_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="ie669ed37287d49f79a13f8942d0d9e94_D20230505-20230505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001585364</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-05</startDate>
            <endDate>2023-05-05</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="derivative">
        <measure>prgo:derivative</measure>
    </unit>
    <unit id="brand">
        <measure>prgo:brand</measure>
    </unit>
    <unit id="year">
        <measure>prgo:year</measure>
    </unit>
    <unit id="plaintiffgroup">
        <measure>prgo:plaintiffGroup</measure>
    </unit>
    <unit id="manufacturer">
        <measure>prgo:manufacturer</measure>
    </unit>
    <unit id="retailer">
        <measure>prgo:retailer</measure>
    </unit>
    <unit id="pharmaceuticalproduct">
        <measure>prgo:pharmaceuticalProduct</measure>
    </unit>
    <unit id="individual">
        <measure>prgo:individual</measure>
    </unit>
    <unit id="genericprescriptionpharmaceutical">
        <measure>prgo:genericPrescriptionPharmaceutical</measure>
    </unit>
    <unit id="class">
        <measure>prgo:class</measure>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="usdPerILS">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:ILS</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="case">
        <measure>prgo:case</measure>
    </unit>
    <unit id="lawsuit">
        <measure>prgo:lawsuit</measure>
    </unit>
    <unit id="tender">
        <measure>prgo:tender</measure>
    </unit>
    <unit id="complaint">
        <measure>prgo:complaint</measure>
    </unit>
    <unit id="claim">
        <measure>prgo:claim</measure>
    </unit>
    <unit id="policyperiod">
        <measure>prgo:policyPeriod</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80L2ZyYWc6YzA2MjY0ZmYzNDc0NDFiYjgzYThmNzRkZmY3MTc3MzMvdGFibGU6OTYzODNiMzU1NWJjNGE1M2FmY2IwNTIxOTcyZDdjNjgvdGFibGVyYW5nZTo5NjM4M2IzNTU1YmM0YTUzYWZjYjA1MjE5NzJkN2M2OF80LTEtMS0xLTI5NzUwMw_832fe373-2b3a-4861-aa15-908b77731cd4">0001585364</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80L2ZyYWc6YzA2MjY0ZmYzNDc0NDFiYjgzYThmNzRkZmY3MTc3MzMvdGFibGU6OTYzODNiMzU1NWJjNGE1M2FmY2IwNTIxOTcyZDdjNjgvdGFibGVyYW5nZTo5NjM4M2IzNTU1YmM0YTUzYWZjYjA1MjE5NzJkN2M2OF81LTEtMS0xLTI5NzUwMw_b8e0b064-292c-4489-9f8a-e1e02e8ce0c2">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80L2ZyYWc6YzA2MjY0ZmYzNDc0NDFiYjgzYThmNzRkZmY3MTc3MzMvdGFibGU6OTYzODNiMzU1NWJjNGE1M2FmY2IwNTIxOTcyZDdjNjgvdGFibGVyYW5nZTo5NjM4M2IzNTU1YmM0YTUzYWZjYjA1MjE5NzJkN2M2OF85LTEtMS0xLTI5NzUwMw_399cdc34-8a4d-424d-89e8-7683e1113b28">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80L2ZyYWc6YzA2MjY0ZmYzNDc0NDFiYjgzYThmNzRkZmY3MTc3MzMvdGFibGU6OTYzODNiMzU1NWJjNGE1M2FmY2IwNTIxOTcyZDdjNjgvdGFibGVyYW5nZTo5NjM4M2IzNTU1YmM0YTUzYWZjYjA1MjE5NzJkN2M2OF8xMC0xLTEtMS0yOTc1MDM_62d11935-99b2-4620-a8eb-d76c84d90bfa">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80L2ZyYWc6YzA2MjY0ZmYzNDc0NDFiYjgzYThmNzRkZmY3MTc3MzMvdGFibGU6OTYzODNiMzU1NWJjNGE1M2FmY2IwNTIxOTcyZDdjNjgvdGFibGVyYW5nZTo5NjM4M2IzNTU1YmM0YTUzYWZjYjA1MjE5NzJkN2M2OF8xMS0xLTEtMS0yOTc1MDM_d869671c-51a1-4b50-8fc3-1b198d7fb8fc">false</dei:AmendmentFlag>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_8393b283-e363-4504-b231-143478dd2c5f">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_87043135-b949-45d0-9eae-f1b4645419a9">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_05036283-a810-4bae-854e-92b3df99922c">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_b5e2a70c-b3bd-48c1-b7a0-2aff813e9b08">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_1a147768-c056-425b-af34-6db715980677">http://fasb.org/us-gaap/2022#LongTermDebtCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_7a7ad5f3-7e3d-4fd6-b39b-bd13f91b4653">http://fasb.org/us-gaap/2022#LongTermDebtCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_156cee65-de81-4dfd-849e-fc62e3c9dfcf">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_88c5c5e3-521f-44d6-b6d7-0639e3d6ce44">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_3eb3333f-44a6-4a5b-bef2-60d0ef263f0a">http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_f509a7f0-b2aa-4888-9b39-8d9314e7b4c4">http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDI0_96c0ea1e-02ae-49c1-b8b6-97039e4d4b20">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6OTI2ZjVmNjFhNGYwNGE4ZDhjOGE4YmQzMzhmYTJkYWEvdGFibGVyYW5nZTo5MjZmNWY2MWE0ZjA0YThkOGM4YThiZDMzOGZhMmRhYV8wLTAtMS0xLTI5NzUwMw_f0256076-1b57-408e-9251-dddc5e5bdd86">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMjA_d8fc34ac-0c4f-491a-8a81-1fd6924450f0">2023-04-01</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6YzU0ZGJiMWIxMTk3NDU5Y2IwNjg4YTcxOTJiOTRkNDcvdGFibGVyYW5nZTpjNTRkYmIxYjExOTc0NTljYjA2ODhhNzE5MmI5NGQ0N18wLTAtMS0xLTI5NzUwMw_431345d0-bc02-45a6-9b26-9ae2cf87f4d4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDI5_d3a312aa-7217-4f2c-857c-1b5987641b26">001-36353</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDMw_59862c19-d7fb-4f47-84f4-e7881e6eb8cc">Perrigo Company plc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MjFiMjQ2Zjc0NTIzNDkwYzllZThjMTc1MWE4MjE3NjMvdGFibGVyYW5nZToyMWIyNDZmNzQ1MjM0OTBjOWVlOGMxNzUxYTgyMTc2M18wLTAtMS0xLTI5NzUwMw_142de3f9-e629-4aa0-8c72-3ee36107fd70">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF80OTc_99732258-94b0-4322-99a4-6354850d5960">The Sharp Building,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF81MDA_f382ac2d-ce81-41b0-b955-fb4506d49c21">Hogan Place,</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF81MDM_e647d153-1061-4c0b-9791-fef680f80006">Dublin 2,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF81MDY_bcf2962b-51cb-4c4a-92d1-4b104fcf001d">IE</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF81MDk_09240cb4-0cb5-4959-9ec8-3bc408f33616">D02 TY74</dei:EntityAddressPostalZipCode>
    <dei:CountryRegion
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDMx_9c9b3fe3-f139-496f-81a3-b52a9942437b">353</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDMy_0e3940d0-af79-44cb-b577-b71062c4f331">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDI1_a76971f9-98af-4f9c-babf-5da021aefe28">7094000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8661025121e9419ab6b60b4f10d5e2b8_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8xLTAtMS0xLTI5NzUwMw_6a768457-0ac5-421f-a8bb-b1969bfed7b8">Ordinary shares, &#x20ac;0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8661025121e9419ab6b60b4f10d5e2b8_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8xLTEtMS0xLTI5NzUwMw_2a584828-35c3-4a9f-bc49-edc046ecc425">PRGO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8661025121e9419ab6b60b4f10d5e2b8_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8xLTItMS0xLTI5NzUwMw_812e2645-4cda-41aa-94e8-53bbded0a1bf">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0b69715b8beb4265b311eb807fec1768_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8yLTAtMS0xLTI5NzUwMw_8f2cdda8-2cbb-4e09-ab80-2a696fc6e507">3.900% Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0b69715b8beb4265b311eb807fec1768_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8yLTEtMS0xLTI5NzUwMw_6e3eb9a9-f9f0-4331-a4eb-8143b4680731">PRGO24</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0b69715b8beb4265b311eb807fec1768_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8yLTItMS0xLTI5NzUwMw_7d31bde2-ef36-44d2-857b-ad0d16118962">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i32b30e53a37f41a1ac98e8fb9995ca4e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8zLTAtMS0xLTI5NzUwMw_15d64780-ef5b-42a3-9766-ee90c68a63ec">4.375% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i32b30e53a37f41a1ac98e8fb9995ca4e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8zLTEtMS0xLTI5NzUwMw_0c77fcc3-4933-407c-a095-86ad61427672">PRGO26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i32b30e53a37f41a1ac98e8fb9995ca4e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl8zLTItMS0xLTI5NzUwMw_cfe14177-129e-4110-b858-3413bb08aaae">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i765e63eea0a54636a90ce216a325be3a_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl80LTAtMS0xLTI5NzUwMw_eca9af60-16f9-4f76-8173-419e2c15e38c">4.400% Notes due 2030</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i765e63eea0a54636a90ce216a325be3a_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl80LTEtMS0xLTI5NzUwMw_aa9b4045-569b-4057-8b89-76a2280e4cb9">PRGO30</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i765e63eea0a54636a90ce216a325be3a_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl80LTItMS0xLTI5NzUwMw_5bfbdc34-a32f-4088-93eb-5ce0e5fcf0f8">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib67f1fede03d484bba024eb3d57f031f_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl81LTAtMS0xLTI5NzUwMw_7065f2e2-d599-4ccf-8fcc-9448e7432641">5.300% Notes due 2043</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib67f1fede03d484bba024eb3d57f031f_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl81LTEtMS0xLTI5NzUwMw_9ff44c43-1f27-441f-9ac9-6b8c413e058a">PRGO43</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib67f1fede03d484bba024eb3d57f031f_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl81LTItMS0xLTI5NzUwMw_3a66e255-79d0-4dac-b0fa-b0d623e5d5b8">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i95b2b593633042b4b81a8353b11811f5_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl82LTAtMS0xLTI5NzUwMw_890f74d9-9fa8-4d1d-9a51-d485b3c32410">4.900% Notes due 2044</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i95b2b593633042b4b81a8353b11811f5_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl82LTEtMS0xLTI5NzUwMw_a806893e-fc17-4c6e-bcc4-5cfd4217260f">PRGO44</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i95b2b593633042b4b81a8353b11811f5_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6MDU1MzNjMzUyNTkwNDc2NGJkNzgyNDBkMWIzMDdhNjYvdGFibGVyYW5nZTowNTUzM2MzNTI1OTA0NzY0YmQ3ODI0MGQxYjMwN2E2Nl82LTItMS0xLTI5NzUwMw_3a0b4054-98ac-4b92-a916-eefe1c57f548">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDMz_9cb8ea67-76b5-44e4-985c-ab882097dd30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDI2_e0a7fcfa-0cd3-4bba-ae46-0114fa992185">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6OTBiMGMzZWQ5NTk5NDg2ZmFlNDdmN2QwNmVmZmNhMTUvdGFibGVyYW5nZTo5MGIwYzNlZDk1OTk0ODZmYWU0N2Y3ZDA2ZWZmY2ExNV8wLTAtMS0xLTI5NzUwMw_1939805a-f0a0-4291-a27c-eaf552abc954">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6OTBiMGMzZWQ5NTk5NDg2ZmFlNDdmN2QwNmVmZmNhMTUvdGFibGVyYW5nZTo5MGIwYzNlZDk1OTk0ODZmYWU0N2Y3ZDA2ZWZmY2ExNV8wLTEwLTEtMS0yOTc1MDM_83997201-d48f-4f51-a0c9-33739ffc6e42">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGFibGU6OTBiMGMzZWQ5NTk5NDg2ZmFlNDdmN2QwNmVmZmNhMTUvdGFibGVyYW5nZTo5MGIwYzNlZDk1OTk0ODZmYWU0N2Y3ZDA2ZWZmY2ExNV8xLTEtMS0xLTI5NzUwMw_857eee77-9429-435f-9b7a-d06d9e1033bb">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8yMDI3_a717a1e0-d0e6-4684-9abb-cb8322aac3a7">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="id1979f160e0c4d1697ab4c57477e38d1_I20230505"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xL2ZyYWc6Mjc0OTEyMjQ2YTBiNDI4OWFmYzIxODk0M2Y5MWVkYTAvdGV4dHJlZ2lvbjoyNzQ5MTIyNDZhMGI0Mjg5YWZjMjE4OTQzZjkxZWRhMF8xOTkz_2240da14-2ebe-45a3-a009-f3000a300cfe"
      unitRef="shares">135325847</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMi0xLTEtMS0yOTc1MDM_6b7b8cdd-8904-4c94-9512-4ca254f6626f"
      unitRef="usd">1181700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMi0zLTEtMS0yOTc1MDM_35163a52-6869-4071-93b4-b6b19bf8404d"
      unitRef="usd">1074500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMy0xLTEtMS0yOTc1MDM_7a944686-d9e1-474d-ac40-0f1a40719323"
      unitRef="usd">767900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMy0zLTEtMS0yOTc1MDM_68bec5e3-0d35-4891-86c1-263f823cb795"
      unitRef="usd">736700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNC0xLTEtMS0yOTc1MDM_8c42d56a-0add-4c54-8663-ba39e30c5890"
      unitRef="usd">413800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNC0zLTEtMS0yOTc1MDM_7ab02870-600d-4757-8075-64d1104131b0"
      unitRef="usd">337800000</us-gaap:GrossProfit>
    <us-gaap:ProductionAndDistributionCosts
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNy0xLTEtMS0yOTc1MDM_4939e0f2-413d-4db7-9e3f-46b663bd74b1"
      unitRef="usd">28600000</us-gaap:ProductionAndDistributionCosts>
    <us-gaap:ProductionAndDistributionCosts
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNy0zLTEtMS0yOTc1MDM_b433482e-316f-4880-ac27-22dad8bba961"
      unitRef="usd">24400000</us-gaap:ProductionAndDistributionCosts>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfOC0xLTEtMS0yOTc1MDM_48f5804c-ed00-4bc3-89dc-9661485422fa"
      unitRef="usd">31100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfOC0zLTEtMS0yOTc1MDM_55a0e70a-324e-41c6-871c-a35c76c594e0"
      unitRef="usd">29300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfOS0xLTEtMS0yOTc1MDM_d497b2f3-8a2f-4154-930f-5c81e3cd3385"
      unitRef="usd">167900000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfOS0zLTEtMS0yOTc1MDM_be03c8e9-8a52-44bd-a4cc-28a234207caa"
      unitRef="usd">135600000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTAtMS0xLTEtMjk3NTAz_7de8356f-ddfe-4351-b20d-d10e7843a995"
      unitRef="usd">135000000.0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTAtMy0xLTEtMjk3NTAz_ae4d1aaa-75fa-4cfc-aef4-00b1d1cfdfd8"
      unitRef="usd">122300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCharges
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTItMS0xLTEtMjk3NTAz_8fbe666e-a267-4008-9755-849ca2580f0f"
      unitRef="usd">3400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTItMy0xLTEtMjk3NTAz_1550290b-3027-4b13-b863-25e865a61636"
      unitRef="usd">3600000</us-gaap:RestructuringCharges>
    <prgo:OtherOperatingIncomeLossNet
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTMtMS0xLTEtMjk3NTAz_76d7a983-e5b1-4a47-b7c0-2ef08ab84ee6"
      unitRef="usd">-700000</prgo:OtherOperatingIncomeLossNet>
    <prgo:OtherOperatingIncomeLossNet
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTMtMy0xLTEtMjk3NTAz_fecaf1f2-5a84-4c73-8bd6-d01bd16c3af5"
      unitRef="usd">900000</prgo:OtherOperatingIncomeLossNet>
    <us-gaap:OperatingExpenses
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTQtMS0xLTEtMjk3NTAz_da825609-ef75-46c6-b3f6-84839df4b725"
      unitRef="usd">365300000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTQtMy0xLTEtMjk3NTAz_bf088ee1-846c-4c3d-8b45-d1582035d4be"
      unitRef="usd">316100000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTYtMS0xLTEtMjk3NTAz_0ea64157-071e-4b5a-a234-976ae11ebdb1"
      unitRef="usd">48500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTYtMy0xLTEtMjk3NTAz_42fff2f2-4b0e-4690-a233-ec52c195f689"
      unitRef="usd">21700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTktMS0xLTEtMjk3NTAz_f5827849-3445-47e0-b347-26aaaa28d40d"
      unitRef="usd">-43700000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMTktMy0xLTEtMjk3NTAz_28c24a8e-6f5f-44f4-bcfd-b23e5a852971"
      unitRef="usd">-35800000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjAtMS0xLTEtMjk3NTAz_e098e497-b59a-4b6d-948a-b7dea7f2c91c"
      unitRef="usd">-500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjAtMy0xLTEtMjk3NTAz_91bbaa0d-7c74-496d-8e1b-ac212fd5ec34"
      unitRef="usd">1100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjItMS0xLTEtMjk3NTAz_7fa47ce8-9a83-4943-a211-ba18c2eb41bd"
      unitRef="usd">4300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjItMy0xLTEtMjk3NTAz_82daf7ff-f090-42c9-92b5-4d43c09491de"
      unitRef="usd">-13000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjMtMS0xLTEtMjk3NTAz_c6feabe3-0ebe-4169-8f9f-0a9f6702f12f"
      unitRef="usd">5400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjMtMy0xLTEtMjk3NTAz_cd80b042-4d4d-46d4-a7f4-dab4498b373a"
      unitRef="usd">-11700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjQtMS0xLTEtMjk3NTAz_43f3cbaa-75af-4b7e-bdd3-52a0e43af07f"
      unitRef="usd">-1100000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjQtMy0xLTEtMjk3NTAz_7b222471-7584-4e74-b163-9aaa6ea505b1"
      unitRef="usd">-1300000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjUtMS0xLTEtMjk3NTAz_2fa94107-7666-4aba-a0e8-ddfbf6b95eb1"
      unitRef="usd">-1900000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjUtMy0xLTEtMjk3NTAz_af94a427-797b-461b-96fa-14c8a3021b2f"
      unitRef="usd">-1100000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjYtMS0xLTEtMjk3NTAz_82a9b30b-8708-453b-b6c1-4b421a9dbe8b"
      unitRef="usd">-3000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMjYtMy0xLTEtMjk3NTAz_69cdd12b-12f2-4b6f-88df-79c616dc2ba9"
      unitRef="usd">-2400000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzAtMS0xLTEtMjk3NTAz_64e0a748-0545-4e3c-b8ef-730dfa8cd81a"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzAtMy0xLTEtMjk3NTAz_4ba5aa60-c9a9-47cd-8917-0e3c8a5db3d0"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzEtMS0xLTEtMjk3NTAz_5bee3080-7c6f-4190-bfa8-2c323c39944c"
      unitRef="usdPerShare">-0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzEtMy0xLTEtMjk3NTAz_8d3d7140-7e93-4019-a235-a6c66d3a8d87"
      unitRef="usdPerShare">-0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzItMS0xLTEtMjk3NTAz_fafa55fe-82c5-4c7b-9c9e-03e72e668f46"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzItMy0xLTEtMjk3NTAz_e62f7bf6-8b45-438d-834c-236267001e68"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzQtMS0xLTEtMjk3NTAz_c442e6e5-b717-4f62-94db-5d613b9ba006"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzQtMy0xLTEtMjk3NTAz_bf462af5-8bf5-4027-a55c-f0509cb5d768"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzUtMS0xLTEtMjk3NTAz_fe90e1f0-1b9a-4578-9bfd-05ef5cf80f8c"
      unitRef="usdPerShare">-0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzUtMy0xLTEtMjk3NTAz_f8fe49eb-c5b3-493e-a04c-5f290dc90c52"
      unitRef="usdPerShare">-0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzYtMS0xLTEtMjk3NTAz_7eb82774-5873-4860-b48b-d87e06f3d9e6"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzYtMy0xLTEtMjk3NTAz_e86884f3-aa12-43c4-bdc8-ae92448931a4"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzktMS0xLTEtMjk3NTAz_c70335d3-c52d-4213-8e66-4d6fb1b5564d"
      unitRef="shares">134900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfMzktMy0xLTEtMjk3NTAz_9a51118c-97f6-491d-84b5-0b2ded9f278a"
      unitRef="shares">134000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNDAtMS0xLTEtMjk3NTAz_f37439f1-3c2d-4fe0-bada-4e5e66bfb8f3"
      unitRef="shares">134900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNi9mcmFnOmU4ZDAxZjg5NjY5MzQ1ODM4ZmVlMmRlNTllYTU5MDIzL3RhYmxlOmM3NzUyNmE1YWQ3NDQ1MDE4MjRkMDVhZmJlZTNlMWVkL3RhYmxlcmFuZ2U6Yzc3NTI2YTVhZDc0NDUwMTgyNGQwNWFmYmVlM2UxZWRfNDAtMy0xLTEtMjk3NTAz_f7976b9f-fa83-4970-a008-cb1d9ab37dbc"
      unitRef="shares">134000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfMi0xLTEtMS0yOTc1MDM_82a9b30b-8708-453b-b6c1-4b421a9dbe8b"
      unitRef="usd">-3000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfMi0zLTEtMS0yOTc1MDM_69cdd12b-12f2-4b6f-88df-79c616dc2ba9"
      unitRef="usd">-2400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNC0xLTEtMS0yOTc1MDM_d83ee2b3-810a-42bc-b0de-2c0f2f69c28e"
      unitRef="usd">52700000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNC0zLTEtMS0yOTc1MDM_b3630b11-f61f-44ac-99a3-44f5d72beaa1"
      unitRef="usd">-24600000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNS0xLTEtMS0yOTc1MDM_321b2322-6e04-4ac1-b332-75c50f8bb5a1"
      unitRef="usd">-31500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNS0zLTEtMS0yOTc1MDM_37647005-197f-4830-8ca6-32198ae6024a"
      unitRef="usd">10400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNy0xLTEtMS0yOTc1MDM_e38d256c-8149-49f7-b20e-b1cb509b5c31"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfNy0zLTEtMS0yOTc1MDM_c4742023-0fd0-4c3a-8b7e-db6637ce3f89"
      unitRef="usd">6300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfOC0xLTEtMS0yOTc1MDM_48e14606-46a4-4c4c-a40f-4e7bad4ec75b"
      unitRef="usd">20700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfOC0zLTEtMS0yOTc1MDM_2c388533-a597-456a-b7b1-67a208ef90eb"
      unitRef="usd">-20500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfOS0xLTEtMS0yOTc1MDM_0c48b992-aea1-4304-b522-cc68b775b2a7"
      unitRef="usd">17700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xOS9mcmFnOmYzMWMwODdhY2E4MzQ4YmViNzdmMjYxYmFjNzBjZWIzL3RhYmxlOjJmODhkMDBhNzgyYzQ3OTliNmYzMDg0NDY1YjZhNjBhL3RhYmxlcmFuZ2U6MmY4OGQwMGE3ODJjNDc5OWI2ZjMwODQ0NjViNmE2MGFfOS0zLTEtMS0yOTc1MDM_7d6fa2dd-3a59-4a9d-b1d4-3a47850f039a"
      unitRef="usd">-22900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMy0xLTEtMS0yOTc1MDM_2e3f07bb-6e9b-41d5-9f7f-329e567c0943"
      unitRef="usd">553000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMy0zLTEtMS0yOTc1MDM_1df5aabe-c9a2-45fc-8dbb-fe0c95cc60f8"
      unitRef="usd">600700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNS0wLTEtMS0yOTc1MDMvdGV4dHJlZ2lvbjo4ZTg3YzM3OGU1Njk0NmVlOTIyNDA0NDE5NWRjODhmNV82NA_a8dab228-5163-4f0d-9133-4e6a4dd7050b"
      unitRef="usd">7100000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNS0wLTEtMS0yOTc1MDMvdGV4dHJlZ2lvbjo4ZTg3YzM3OGU1Njk0NmVlOTIyNDA0NDE5NWRjODhmNV83Mg_274951ac-674a-4d5d-b98c-4bc5f1f6d9f4"
      unitRef="usd">6800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNS0xLTEtMS0yOTc1MDM_b5a4a2ec-9e5f-4afa-b136-5794003aced6"
      unitRef="usd">738700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNS0zLTEtMS0yOTc1MDM_7658effd-d0c0-4af4-92ad-20bd6437d2e6"
      unitRef="usd">697100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNi0xLTEtMS0yOTc1MDM_0c516abd-2f1a-4016-b81a-52f5652da337"
      unitRef="usd">1183000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNi0zLTEtMS0yOTc1MDM_a6f78685-7c0c-42af-b6da-e0a65f702ca6"
      unitRef="usd">1150300000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfOC0xLTEtMS0yOTc1MDM_ad12a6ed-e166-422e-a8cc-e4076c03a0a1"
      unitRef="usd">266000000.0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfOC0zLTEtMS0yOTc1MDM_63a4dfdd-f3bc-446e-9c0f-d22aebad8744"
      unitRef="usd">271800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTAtMS0xLTEtMjk3NTAz_832e3620-bbec-4fcc-8efd-267adaf3fa26"
      unitRef="usd">2740700000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTAtMy0xLTEtMjk3NTAz_51cf3125-043d-49cf-995b-44d262272b5f"
      unitRef="usd">2719900000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTItMS0xLTEtMjk3NTAz_7c42c0da-0b81-4dd8-b88b-a61924539ebd"
      unitRef="usd">919300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTItMy0xLTEtMjk3NTAz_42d7690d-3ef6-4ed6-b53f-4ad1ba9ac50a"
      unitRef="usd">926300000</us-gaap:PropertyPlantAndEquipmentNet>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTMtMS0xLTEtMjk3NTAz_7b54c93f-6a7d-4797-b706-26ba4a4c737a"
      unitRef="usd">211700000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets>
    <prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTMtMy0xLTEtMjk3NTAz_6744cf6b-8ded-44d0-a7c4-657a0a1fc056"
      unitRef="usd">217100000</prgo:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets>
    <prgo:GoodwillAndIndefiniteLivedIntangibles
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTUtMS0xLTEtMjk3NTAz_09d19fba-3f55-49a2-8972-084377785f74"
      unitRef="usd">3650400000</prgo:GoodwillAndIndefiniteLivedIntangibles>
    <prgo:GoodwillAndIndefiniteLivedIntangibles
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTUtMy0xLTEtMjk3NTAz_e6b93272-8cec-4233-98ff-ea425b7e8ed6"
      unitRef="usd">3549000000</prgo:GoodwillAndIndefiniteLivedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTYtMS0xLTEtMjk3NTAz_5524cd96-3a34-4151-94c0-a621618f2634"
      unitRef="usd">3083900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTYtMy0xLTEtMjk3NTAz_77047f88-4365-4e8d-a654-c6ff7b0cacd3"
      unitRef="usd">3230200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTctMS0xLTEtMjk3NTAz_db8869a5-10b4-4cda-a2cd-b6b69074666e"
      unitRef="usd">6100000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTctMy0xLTEtMjk3NTAz_8b851e5f-8aa4-48c1-89ca-04d71887b86c"
      unitRef="usd">7100000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTktMS0xLTEtMjk3NTAz_9324f999-5216-48ef-9e92-a5d888dd3434"
      unitRef="usd">342800000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMTktMy0xLTEtMjk3NTAz_fc7f9e98-760d-4776-9bb8-87bd3d4706f6"
      unitRef="usd">367700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjAtMS0xLTEtMjk3NTAz_936728cb-0fba-4527-82f6-bbb2ab1fc971"
      unitRef="usd">8214200000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjAtMy0xLTEtMjk3NTAz_f0d15060-b438-48e6-8b85-039b74ddc42a"
      unitRef="usd">8297400000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjEtMS0xLTEtMjk3NTAz_05071493-3648-4b7c-b8db-4762eff83fb0"
      unitRef="usd">10954900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjEtMy0xLTEtMjk3NTAz_2175375a-6ae3-4c4d-98b0-c857c1e06fee"
      unitRef="usd">11017300000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjQtMS0xLTEtMjk3NTAz_f581ce18-7409-4ed6-9601-3f36f4000ede"
      unitRef="usd">505200000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjQtMy0xLTEtMjk3NTAz_8eb2ef15-0eb9-4d55-b93c-46dc5eff51d6"
      unitRef="usd">537300000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjUtMS0xLTEtMjk3NTAz_4b3874c7-7be0-4fa0-8520-770c4d1072bd"
      unitRef="usd">106500000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjUtMy0xLTEtMjk3NTAz_6eb92e9d-9b89-4f89-b0fa-1985d8e4bbab"
      unitRef="usd">136400000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <prgo:AccruedCustomerPrograms
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjYtMS0xLTEtMjk3NTAz_261e0168-e08f-4537-aae5-115d89d9aeb2"
      unitRef="usd">146700000</prgo:AccruedCustomerPrograms>
    <prgo:AccruedCustomerPrograms
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjYtMy0xLTEtMjk3NTAz_2ba911e7-f728-4b22-bb7b-aa615d520bcc"
      unitRef="usd">139100000</prgo:AccruedCustomerPrograms>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjctMS0xLTEtMjk3NTAz_d89631f8-a3a1-478e-85d8-ee8b5200f7f9"
      unitRef="usd">272000000.0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjctMy0xLTEtMjk3NTAz_cec59732-db07-4c8f-a953-fe5255b2f6f4"
      unitRef="usd">250200000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjgtMS0xLTEtMjk3NTAz_4faa9189-cd37-4c1f-932d-8c306cb7bf2d"
      unitRef="usd">17600000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMjgtMy0xLTEtMjk3NTAz_b0105d2d-422c-4558-97c7-b49e39e7dbb6"
      unitRef="usd">14400000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzAtMS0xLTEtMjk3NTAz_10cb4e73-fab8-4501-8db8-79c6fb64b5e9"
      unitRef="usd">38800000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzAtMy0xLTEtMjk3NTAz_458dc340-1aef-4f5e-94b4-8c5dc776cadd"
      unitRef="usd">36200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzItMS0xLTEtMjk3NTAz_33fd2f58-028d-4eb3-ad4f-1c5eeb458291"
      unitRef="usd">1086800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzItMy0xLTEtMjk3NTAz_5b8c4e57-98e6-411c-9335-727b67a2a0ed"
      unitRef="usd">1113600000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzQtMS0xLTEtMjk3NTAz_88848381-37e5-4669-b79a-786decd29ac8"
      unitRef="usd">4062800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzQtMy0xLTEtMjk3NTAz_76074cbb-a040-4eba-a36a-dca59b4dbafb"
      unitRef="usd">4070400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzUtMS0xLTEtMjk3NTAz_9952e7da-c2db-422d-aad2-d66f492f8da1"
      unitRef="usd">333800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzUtMy0xLTEtMjk3NTAz_7982319e-f74e-4490-a7b6-e4064a5d8633"
      unitRef="usd">368200000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzctMS0xLTEtMjk3NTAz_49eec53e-5382-4095-a359-9e799d1a8b8c"
      unitRef="usd">637600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzctMy0xLTEtMjk3NTAz_78aaa8bb-56bb-48da-95d0-1adea5473c38"
      unitRef="usd">623000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzgtMS0xLTEtMjk3NTAz_a6412823-d00e-40a2-95c3-badb0fa5ab1f"
      unitRef="usd">5034200000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzgtMy0xLTEtMjk3NTAz_a335457e-6c84-4e40-81bf-340d90e463f3"
      unitRef="usd">5061600000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzktMS0xLTEtMjk3NTAz_b3ad7ecb-3054-4972-938f-4664a5db4518"
      unitRef="usd">6121000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfMzktMy0xLTEtMjk3NTAz_a21cb2a6-0be5-4341-936a-435085ebce25"
      unitRef="usd">6175200000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDAtMS0xLTEtMjk3NTAz_0defdd2b-7e65-4463-85ef-603691fcee31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDAtMy0xLTEtMjk3NTAz_987c635a-8327-48a6-ad36-1f74da193114"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ODFmZDdiMWNiOTg4NGJmZGI0ZTE4OWU1YWY3MDQyOGZfMjI_36887c2a-5aa8-4d53-84b0-5359299db6a3"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ODFmZDdiMWNiOTg4NGJmZGI0ZTE4OWU1YWY3MDQyOGZfMjI_d471cc41-ddaa-46ff-ba23-cbe2b7e85317"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ODFmZDdiMWNiOTg4NGJmZGI0ZTE4OWU1YWY3MDQyOGZfNDY_60d4c15b-bb28-45df-a0d3-709b67608484"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ODFmZDdiMWNiOTg4NGJmZGI0ZTE4OWU1YWY3MDQyOGZfNDY_9cd49b0b-92e0-46d1-8ac7-b0ba13e75b43"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockValue
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMS0xLTEtMjk3NTAz_09049043-f359-40e6-82a8-86cd6340c5be"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDMtMy0xLTEtMjk3NTAz_08a77bce-3714-4bc8-8613-097af42de15f"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ZTRlZWE2Y2Q2NGUyNGY5OTg1YTYzZjgyNzdmYTE4NWZfMjE_33c1e464-9e50-42d7-9570-bea11b0c8e27"
      unitRef="eurPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ZTRlZWE2Y2Q2NGUyNGY5OTg1YTYzZjgyNzdmYTE4NWZfMjE_5e25f42e-767b-41b4-bfee-8230cc168866"
      unitRef="eurPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ZTRlZWE2Y2Q2NGUyNGY5OTg1YTYzZjgyNzdmYTE4NWZfNDU_068e7db9-17a4-4143-b2ce-9c225827edec"
      unitRef="shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246ZTRlZWE2Y2Q2NGUyNGY5OTg1YTYzZjgyNzdmYTE4NWZfNDU_d3d5b2e5-4243-4604-862c-353c5225ff8b"
      unitRef="shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockValue
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMS0xLTEtMjk3NTAz_fcc32172-6ad0-48d5-b8c6-851eac6ff652"
      unitRef="usd">6910800000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDQtMy0xLTEtMjk3NTAz_d68499b7-fca8-4699-9079-c0d055a7d940"
      unitRef="usd">6936700000</us-gaap:CommonStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDUtMS0xLTEtMjk3NTAz_fb69ea56-c3bd-477f-a252-db5a1ee150de"
      unitRef="usd">-6300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDUtMy0xLTEtMjk3NTAz_40d11ade-7ecc-4dff-bff4-393f087e7ef3"
      unitRef="usd">-27000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDYtMS0xLTEtMjk3NTAz_a8f779b5-730e-4026-9c8f-eef0a4c4bdb8"
      unitRef="usd">-2070600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDYtMy0xLTEtMjk3NTAz_f493b9b3-bf40-4f53-bcb7-943ec39bab3d"
      unitRef="usd">-2067600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDktMS0xLTEtMjk3NTAz_235854ce-b6df-4db3-9830-3fe5a394015d"
      unitRef="usd">4833900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNDktMy0xLTEtMjk3NTAz_ff31d77a-a7f9-4916-83f5-e8fbbce65ff9"
      unitRef="usd">4842100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTAtMS0xLTEtMjk3NTAz_e0dbcbd2-f34d-4d32-997a-92f628926015"
      unitRef="usd">10954900000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTAtMy0xLTEtMjk3NTAz_6fd7f568-bcb4-4908-921c-2e4d3ee26c59"
      unitRef="usd">11017300000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTMtMS0xLTEtMjk3NTAz_1d2d6108-823e-4101-aedb-a75ec3b9080e"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTMtMy0xLTEtMjk3NTAz_28543fb5-c032-4f62-b850-f9977c20bfde"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTQtMS0xLTEtMjk3NTAz_36268493-9612-4623-aa86-e957cd57f2c0"
      unitRef="shares">135300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yMi9mcmFnOjBiYzhiZWFiNGQyMTRhODE5ODBkZmE0NTI1Y2JkZGFjL3RhYmxlOmY2MjBkMDJmODY2ODQwMDE4ZWNkYTgwNjRmN2IzYTg2L3RhYmxlcmFuZ2U6ZjYyMGQwMmY4NjY4NDAwMThlY2RhODA2NGY3YjNhODZfNTQtMy0xLTEtMjk3NTAz_495c87d7-d14c-455e-9340-113b62d27109"
      unitRef="shares">134700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="ic8ec02b3dd484b4e8275f17f1949e2de_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMi0xLTEtMS0yOTc1MDM_2f01b1ec-62dd-4fc5-88c3-a8ea52f5c817"
      unitRef="shares">133800000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic8ec02b3dd484b4e8275f17f1949e2de_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMi0zLTEtMS0yOTc1MDM_9d64b979-6965-421e-943f-3c367a193e13"
      unitRef="usd">7043200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i07bcc81fd19e45bdb8acb5118329924f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMi01LTEtMS0yOTc1MDM_318cf015-3b6c-4ca6-b275-3eba6ac02010"
      unitRef="usd">35500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i04cfa05f5fd341f898c851d834e5a6ed_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMi03LTEtMS0yOTc1MDM_29e257bf-a239-4ff3-b449-c884ea23e85d"
      unitRef="usd">-1927000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idd18f1c6b0bf4007931565e3309d3a59_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMi05LTEtMS0yOTc1MDM_ec7da91f-b57e-45dc-9d3c-89236c1b2d30"
      unitRef="usd">5151700000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i712e3d08fced4870b5dd4e881cd7d98a_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfNC03LTEtMS0yOTc1MDM_f881e9fc-acbc-40ab-afd7-adad431b8853"
      unitRef="usd">-2400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfNC05LTEtMS0yOTc1MDM_3f42887c-e7ef-4fde-887d-ea7879f93aa3"
      unitRef="usd">-2400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i47510622497c47db87a31fe64fc51a88_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfNS01LTEtMS0yOTc1MDM_03abbac0-da18-412c-9157-69c7a32c5992"
      unitRef="usd">-20500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfNS05LTEtMS0yOTc1MDM_7ba72850-3dd6-4808-bb0f-9d4572a0e6c8"
      unitRef="usd">-20500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfNy0xLTEtMS0yOTc1MDM_cc047ba8-452e-4631-9b2b-28728b498a2e"
      unitRef="shares">1200000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfOS0zLTEtMS0yOTc1MDM_1043480b-d949-4760-903c-23de575ce47e"
      unitRef="usd">26300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfOS05LTEtMS0yOTc1MDM_3f72610b-7050-416b-a85b-633db48c9d0b"
      unitRef="usd">26300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTAtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246MTNmMTljNTAzOGU0NDJiZmI3YTc4OTdiOWI5YzYxYWNfMjA_834c3dc9-f308-480c-b1f5-48466cf5f0df"
      unitRef="usdPerShare">0.26</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTAtMy0xLTEtMjk3NTAz_4aa34ba8-bf09-417b-af8d-049dfe678586"
      unitRef="usd">34200000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTAtOS0xLTEtMjk3NTAz_a5ec2f55-e8d8-44d7-82f1-0881e2afb06a"
      unitRef="usd">34200000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTEtMS0xLTEtMjk3NTAz_a807c29f-95d2-4e54-8693-31b886c98515"
      unitRef="shares">400000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib07edfebcc8f409588ce74330a5680ad_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTEtMy0xLTEtMjk3NTAz_de53c016-1a5f-4ff3-8504-3d563d939433"
      unitRef="usd">16400000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTEtOS0xLTEtMjk3NTAz_7f0551a7-7d66-40e3-a17e-91f5e0255d6b"
      unitRef="usd">16400000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="i8a185df6ddcb4f0db8975f91beef3d79_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTMtMS0xLTEtMjk3NTAz_e04d7a6d-4892-4b92-9620-e9b99b3d29f0"
      unitRef="shares">134600000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8a185df6ddcb4f0db8975f91beef3d79_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTMtMy0xLTEtMjk3NTAz_db31a840-b988-47f2-b1e2-0b17c5f10d55"
      unitRef="usd">7018900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib43124566cd24715b45ad75e52af2328_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTMtNS0xLTEtMjk3NTAz_dee921ca-c1da-4474-996c-3d352a9e921a"
      unitRef="usd">15000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id761e753820a44cea1db50ca513e11e5_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTMtNy0xLTEtMjk3NTAz_3e24ebea-b749-440e-b02d-0d781ba95e39"
      unitRef="usd">-1929400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6955bfa807de4779804dcda471f50c60_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjBkYWEyYjM4MTU1NDQ2NGM5NzQ3NDc4OWU0ZjQzY2MzL3RhYmxlcmFuZ2U6MGRhYTJiMzgxNTU0NDY0Yzk3NDc0Nzg5ZTRmNDNjYzNfMTMtOS0xLTEtMjk3NTAz_c4d91822-e3f2-4336-92c3-1ac180066a49"
      unitRef="usd">5104500000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ie326fc7603fc47d2829c2df0bcf4817d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMi0xLTEtMS0yOTc1MDM_0ed123d4-19a3-4b8b-b227-ed1d356666c4"
      unitRef="shares">134700000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie326fc7603fc47d2829c2df0bcf4817d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMi0zLTEtMS0yOTc1MDM_57c5cdb4-dc15-4817-9149-2476a442c436"
      unitRef="usd">6936700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d376c6445864b46856bd7c9eca96a57_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMi01LTEtMS0yOTc1MDM_ece2f0fc-f5e8-43d9-b52c-264c779cd5b4"
      unitRef="usd">-27000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5aed5796cb6f4c748a6fbc6e5733a7b5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMi03LTEtMS0yOTc1MDM_397f8588-d8f3-4527-833f-4c75245761a0"
      unitRef="usd">-2067600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMi05LTEtMS0yOTc1MDM_a521aac7-8380-47de-8e36-dafa043852de"
      unitRef="usd">4842100000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="if7e7884fe5fe439cbb60a14a0bfa25da_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfNC03LTEtMS0yOTc1MDM_d17ccbc3-2b1a-4506-bdb6-79fec73ac0c1"
      unitRef="usd">-3000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfNC05LTEtMS0yOTc1MDM_9418c733-e21d-4e78-abb2-15c1b36415cf"
      unitRef="usd">-3000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if52e0bee33a840b6b04f0e23c7814541_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfNS01LTEtMS0yOTc1MDM_c808c6c3-051a-442d-96e0-846fb603bdb8"
      unitRef="usd">20700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfNS05LTEtMS0yOTc1MDM_fd1dc13e-feff-41c6-a129-eabdf4b978ef"
      unitRef="usd">20700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfNy0xLTEtMS0yOTc1MDM_5d7ad7a5-9687-47df-b9d8-bf83aeff94b3"
      unitRef="shares">1000000.0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfOS0zLTEtMS0yOTc1MDM_14c97373-a19a-4e20-a697-f86465e9978b"
      unitRef="usd">24900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfOS05LTEtMS0yOTc1MDM_eb60c5b7-af07-42c5-8149-669099cb98ab"
      unitRef="usd">24900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTAtMC0xLTEtMjk3NTAzL3RleHRyZWdpb246MDgzODYyZjFiMjVmNDQ3MGFhODJlZjJiNDJjOGQxYjFfMjA_e9b2fc3c-ad3b-498e-bdd4-a3fd44c928b3"
      unitRef="usdPerShare">0.27</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTAtMy0xLTEtMjk3NTAz_ab22e5ea-dcf0-4782-9da1-befe05b1e2b1"
      unitRef="usd">36200000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTAtOS0xLTEtMjk3NTAz_3ec35108-7726-4649-b2ff-10a0376c8c95"
      unitRef="usd">36200000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTEtMS0xLTEtMjk3NTAz_87c6efd3-5c7f-41e2-a127-24b856b2abab"
      unitRef="shares">400000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia3eea27a2ee443f4b07e001c034ac883_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTEtMy0xLTEtMjk3NTAz_adba50b7-9926-4e06-a6c7-1b811f13601e"
      unitRef="usd">14600000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTEtOS0xLTEtMjk3NTAz_6117a094-60f4-4aef-b3ed-1ba02276987e"
      unitRef="usd">14600000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="i6b9dd69bc08149889b61d83c2b89ce51_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTItMS0xLTEtMjk3NTAz_4a862785-035d-4ad1-a7ab-ceed3e6f7fc9"
      unitRef="shares">135300000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6b9dd69bc08149889b61d83c2b89ce51_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTItMy0xLTEtMjk3NTAz_9279c3ef-5cd0-451c-a662-7782b40b0148"
      unitRef="usd">6910800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3cf13b5a219470a985bbaa83714a9e5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTItNS0xLTEtMjk3NTAz_9d8ff2f8-79aa-4b4d-a725-36dfd9d31129"
      unitRef="usd">-6300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2716fca3625c46c785d6b90d8eb978c4_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTItNy0xLTEtMjk3NTAz_57205b4b-de12-49a9-b870-fa784a9a13c4"
      unitRef="usd">-2070600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8yOC9mcmFnOmUwNThlY2IzMjg2NDQ2NThiNjI5NjRhOWRlMzY4YTk2L3RhYmxlOjM5M2U5MjJjN2E3NDQ5MTZiMWRhYTYyZjM3ZjU0OWQ3L3RhYmxlcmFuZ2U6MzkzZTkyMmM3YTc0NDkxNmIxZGFhNjJmMzdmNTQ5ZDdfMTItOS0xLTEtMjk3NTAz_2df1865b-16ef-4a07-890a-6efe4f5045e8"
      unitRef="usd">4833900000</us-gaap:StockholdersEquity>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMy0xLTEtMS0yOTc1MDM_2b3f26af-c978-4da0-a219-626eb916c953"
      unitRef="usd">-3000000.0</prgo:NetLossIncomeAttributableToParent>
    <prgo:NetLossIncomeAttributableToParent
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMy0zLTEtMS0yOTc1MDM_e2b655b1-722c-458a-9d77-419f8c4fead5"
      unitRef="usd">-2400000</prgo:NetLossIncomeAttributableToParent>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNS0xLTEtMS0yOTc1MDM_a90fae2a-1ed4-44d5-a7b2-9a0ead35ffe0"
      unitRef="usd">88700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNS0zLTEtMS0yOTc1MDM_212db0c6-e8b5-471f-923e-7df293914945"
      unitRef="usd">69500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNi0xLTEtMS0yOTc1MDM_4dd4b1fc-fdaf-44e8-b59a-a9a35ed3a16d"
      unitRef="usd">24900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNi0zLTEtMS0yOTc1MDM_1d50adce-a78b-4871-87d8-73d50cadcc2c"
      unitRef="usd">26300000</us-gaap:ShareBasedCompensation>
    <prgo:RestructuringChargesContinuingOperations
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfOC0xLTEtMS0yOTc1MDM_49dd3cc6-5aa1-40d1-91b2-492eb1ddf0b0"
      unitRef="usd">3400000</prgo:RestructuringChargesContinuingOperations>
    <prgo:RestructuringChargesContinuingOperations
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfOC0zLTEtMS0yOTc1MDM_19427b58-ad39-48e0-afeb-642bd674df11"
      unitRef="usd">3600000</prgo:RestructuringChargesContinuingOperations>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfOS0xLTEtMS0yOTc1MDM_9b1c996d-218f-46dd-977e-b14f14c50758"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfOS0zLTEtMS0yOTc1MDM_7f58ee3b-ffc8-4e66-b1de-86c5b82f0f9e"
      unitRef="usd">-1400000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTEtMS0xLTEtMjk3NTAz_58937de6-9086-40df-97d3-6e2b527fa41d"
      unitRef="usd">700000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTEtMy0xLTEtMjk3NTAz_05651c79-67a6-4881-9050-fb412bce1f26"
      unitRef="usd">-200000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTItMS0xLTEtMjk3NTAz_65f827e7-24d0-4c97-8948-1054ae5ad805"
      unitRef="usd">3900000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTItMy0xLTEtMjk3NTAz_02c0d7fa-3b52-41c1-84cc-3d7d39131451"
      unitRef="usd">5800000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTMtMS0xLTEtMjk3NTAz_8b8087e2-3354-439d-97b3-4264dafbc434"
      unitRef="usd">-9900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTMtMy0xLTEtMjk3NTAz_054b2d3c-a223-4bc0-a8da-5913d60f647c"
      unitRef="usd">5100000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTQtMS0xLTEtMjk3NTAz_076f89ab-42d0-47b5-9c43-599ac1c776cb"
      unitRef="usd">6400000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTQtMy0xLTEtMjk3NTAz_d5596b6b-f1eb-449a-863b-8aebcb18561a"
      unitRef="usd">-17500000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <prgo:NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTUtMS0xLTEtMjk3NTAz_a0729082-f083-4031-9783-27c73c15d365"
      unitRef="usd">107300000</prgo:NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems>
    <prgo:NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTUtMy0xLTEtMjk3NTAz_37f8e4cc-0d56-4e73-a8fe-7119f7151ce5"
      unitRef="usd">80000000.0</prgo:NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTctMS0xLTEtMjk3NTAz_415a8013-ab62-42f6-9d45-81da6325624f"
      unitRef="usd">39800000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTctMy0xLTEtMjk3NTAz_a0c0d245-4ae3-4638-be1d-f85cab3806dd"
      unitRef="usd">38100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTgtMS0xLTEtMjk3NTAz_58a7c194-a777-47ef-a6a7-d6a90147c01b"
      unitRef="usd">28600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTgtMy0xLTEtMjk3NTAz_21511c06-abb8-4288-93c7-826584d386b4"
      unitRef="usd">10500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTktMS0xLTEtMjk3NTAz_60d14b34-eff5-4972-adb2-1467b6df5693"
      unitRef="usd">-17100000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMTktMy0xLTEtMjk3NTAz_05c03cb5-59d3-41e1-a908-bbe5e96edc92"
      unitRef="usd">-8100000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjAtMS0xLTEtMjk3NTAz_b5bff0ce-ccec-443f-b4c9-7ab9a6fb2939"
      unitRef="usd">-29800000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjAtMy0xLTEtMjk3NTAz_4427ee4b-ab78-403d-81fc-5b8c96ffd8c8"
      unitRef="usd">72600000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjEtMS0xLTEtMjk3NTAz_50d67a71-651a-4ae6-8679-f881f1eb4f76"
      unitRef="usd">-34300000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjEtMy0xLTEtMjk3NTAz_7813b46e-b265-4a7a-84e7-c65e515bcf20"
      unitRef="usd">-31800000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <prgo:IncreaseDecreaseInAccruedCustomerPrograms
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjItMS0xLTEtMjk3NTAz_1f59ac97-d932-4b9b-b31a-91052eaf707c"
      unitRef="usd">6800000</prgo:IncreaseDecreaseInAccruedCustomerPrograms>
    <prgo:IncreaseDecreaseInAccruedCustomerPrograms
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjItMy0xLTEtMjk3NTAz_9d129325-0908-4bb4-bb43-d1bad45a6e37"
      unitRef="usd">8900000</prgo:IncreaseDecreaseInAccruedCustomerPrograms>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjMtMS0xLTEtMjk3NTAz_1d0263fa-8b7e-4125-9866-968be773a3ab"
      unitRef="usd">8000000.0</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjMtMy0xLTEtMjk3NTAz_3d2d6733-5a2d-40ce-b009-92c5cb708407"
      unitRef="usd">23700000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjQtMS0xLTEtMjk3NTAz_85c871b5-ac7f-44da-96c6-32a869f4f98d"
      unitRef="usd">2500000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjQtMy0xLTEtMjk3NTAz_fd94f521-cd67-448c-bc1e-2be7b952468e"
      unitRef="usd">-33900000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjYtMS0xLTEtMjk3NTAz_7286ae8c-78db-46c7-8ff4-57f3ea136a4a"
      unitRef="usd">-10200000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjYtMy0xLTEtMjk3NTAz_91d12fc6-7cdc-4e4e-85ca-a55b916b52fb"
      unitRef="usd">-100000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjctMS0xLTEtMjk3NTAz_77f00073-2052-4727-b8d0-2b799e2035c1"
      unitRef="usd">87900000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjctMy0xLTEtMjk3NTAz_c635efb4-3c70-4ced-934a-4793a7db85eb"
      unitRef="usd">900000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjgtMS0xLTEtMjk3NTAz_c8341545-b4c0-4e77-9a7f-8e3754f8b333"
      unitRef="usd">19400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMjgtMy0xLTEtMjk3NTAz_225ebc43-c4ab-4f62-b0ce-24eaf9528a65"
      unitRef="usd">79100000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzItMS0xLTEtMjk3NTAz_58034274-672d-45ac-af8c-d16dafd886c1"
      unitRef="usd">23200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzItMy0xLTEtMjk3NTAz_adc749b6-ec9e-4611-aded-aa7e748d5f9a"
      unitRef="usd">20300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzUtMS0xLTEtMjk3NTAz_90d7a4f1-fda7-4c43-9f56-cf537c38e2c1"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzUtMy0xLTEtMjk3NTAz_874716ee-3873-483a-b075-242f924069cb"
      unitRef="usd">58700000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzYtMS0xLTEtMjk3NTAz_ada82ac0-24ad-45ab-acfe-3366de06fe13"
      unitRef="usd">1800000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzYtMy0xLTEtMjk3NTAz_1e0b8380-b0d2-4a87-883d-30bf9fefa5fe"
      unitRef="usd">22900000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <prgo:ProceedsfromRoyaltiesReceivedInvestingActivities
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzctMS0xLTEtMjk3NTAz_ab795841-c8f0-4da3-a96e-93996350f09c"
      unitRef="usd">1800000</prgo:ProceedsfromRoyaltiesReceivedInvestingActivities>
    <prgo:ProceedsfromRoyaltiesReceivedInvestingActivities
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzctMy0xLTEtMjk3NTAz_12759b60-2887-45eb-9b43-1cff9f53e943"
      unitRef="usd">1400000</prgo:ProceedsfromRoyaltiesReceivedInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzktMS0xLTEtMjk3NTAz_2eef8112-c7fd-4e3c-84d9-907da8affea5"
      unitRef="usd">-19600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfMzktMy0xLTEtMjk3NTAz_a07a5722-0aeb-480d-b48a-c25ac4f1a67b"
      unitRef="usd">62700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNDMtMS0xLTEtMjk3NTAz_bd058cc3-d183-4965-a61e-3917aa222031"
      unitRef="usd">-5900000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNDMtMy0xLTEtMjk3NTAz_1730f6e2-0631-48f8-89c4-db23429550a0"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:PaymentsOfDividends
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTAtMS0xLTEtMjk3NTAz_eb8fdc9f-e65e-4f25-8640-084c487572bf"
      unitRef="usd">36200000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTAtMy0xLTEtMjk3NTAz_56a06cf5-d1c7-4788-ac27-7bd74fa77665"
      unitRef="usd">34200000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTItMS0xLTEtMjk3NTAz_66f8e562-7699-494a-85d0-b12826979142"
      unitRef="usd">-8600000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTItMy0xLTEtMjk3NTAz_145efd85-0053-4375-a151-4cccd655cf6a"
      unitRef="usd">-17700000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTMtMS0xLTEtMjk3NTAz_c351f934-230c-4143-b78c-b51adaf00ef3"
      unitRef="usd">-50700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTMtMy0xLTEtMjk3NTAz_a9f86839-a5a1-4c3c-8c67-1b5f42b6fcb6"
      unitRef="usd">-51900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTQtMS0xLTEtMjk3NTAz_0dfdf865-abe2-4502-84ad-edc816ef4e7a"
      unitRef="usd">3200000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTQtMy0xLTEtMjk3NTAz_15c681a5-00b7-4090-8bd5-fa9576979f67"
      unitRef="usd">-3700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTUtMS0xLTEtMjk3NTAz_202259ec-d10c-48c7-b0f8-05d340ebeade"
      unitRef="usd">-47700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTUtMy0xLTEtMjk3NTAz_9af07769-6612-4e0c-a886-93b5116a55cf"
      unitRef="usd">86200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTYtMS0xLTEtMjk3NTAz_b2627e96-b580-4f0a-a67f-1e431460f5e9"
      unitRef="usd">600700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idd18f1c6b0bf4007931565e3309d3a59_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTYtMy0xLTEtMjk3NTAz_3f929033-a893-4546-804a-53a3217eaa0b"
      unitRef="usd">1864900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTctMS0xLTEtMjk3NTAz_72f2b3ff-c8e8-483d-b8d6-ac7f08f3031c"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="idd18f1c6b0bf4007931565e3309d3a59_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTctMy0xLTEtMjk3NTAz_d0e3d2dd-d9c0-4ac0-9efa-9c2fc06932ac"
      unitRef="usd">14400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTgtMS0xLTEtMjk3NTAz_0305f8e1-aded-4c19-9302-20945de6736e"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i6955bfa807de4779804dcda471f50c60_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTgtMy0xLTEtMjk3NTAz_5255fc46-39b7-4199-9b78-3bb04c9035ed"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTktMS0xLTEtMjk3NTAz_40965803-4d40-40c3-ba71-b9c1d3518954"
      unitRef="usd">553000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6955bfa807de4779804dcda471f50c60_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8zNC9mcmFnOjA5NDg5ZDY1N2ViMDRmM2NhZDEyNTk0YjU4NDI4MjhhL3RhYmxlOmFlNGRlOTNiZmViZDQ1NTI5Y2ZhYzllOTkzMmE0MDdlL3RhYmxlcmFuZ2U6YWU0ZGU5M2JmZWJkNDU1MjljZmFjOWU5OTMyYTQwN2VfNTktMy0xLTEtMjk3NTAz_08dc70e1-e87e-43d2-a0dd-61b532b66c01"
      unitRef="usd">1965500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDc0Nw_f2064144-ae77-46a6-9e71-2417db155f04">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a leading provider of over-the-counter ("OTC") health and wellness solutions that are designed to enhance individual well-being and empower consumers to proactively prevent or treat conditions that can be self-managed. Our vision is t&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;o make lives better by bringing Quality, Affordable Self-Care Products that consumers trust everywhere they are sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;We are headquartered in Ireland and sell our products primarily in North America and Europe as well as in other markets around the world.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our unaudited Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022. In the opinion of management, all adjustments considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Some amounts in this report may not add due to rounding. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our reporting and operating segments are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:14.5pt"&gt;Consumer Self-Care Americas ("CSCA") &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Consumer Self-Care International ("CSCI") &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic business in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_61" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note &lt;/a&gt;&lt;/span&gt;&lt;span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_61" style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;4&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our segments reflect the way in which our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company. Financial information related to our business segments and geographic locations can be found in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_43" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2 &lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_100" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 17&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Translation and Transactions &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We translate our non-U.S. dollar-denominated operations&#x2019; assets and liabilities into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of Accumulated other comprehensive income (loss) ("AOCI"). Gains or losses from foreign currency transactions are included in Other (income) expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected credit losses on trade receivables and contract assets are measured collectively by geographic location. Historical credit loss experience provides the primary basis for estimation of expected credit losses and is adjusted for current conditions and for reasonable and supportable forecasts. Receivables that do not share risk characteristics are evaluated on an individual basis and are not included in the collective evaluation. The following table presents the allowance for credit losses activity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for credit losses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivables written-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDc1Nw_aeb3d42f-d867-4fbd-808f-1ffe77c363f2">Basis of PresentationOur unaudited Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDc0OQ_76bbf253-949b-442d-91bb-c48d5d9311b9">In the opinion of management, all adjustments considered necessary for a fair presentation of the unaudited Condensed Consolidated Financial Statements have been included and include our accounts and accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Some amounts in this report may not add due to rounding.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDc0Mw_a386e664-015e-4e29-b916-6fc3cf080bcc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our reporting and operating segments are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:14.5pt"&gt;Consumer Self-Care Americas ("CSCA") &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;comprises our consumer self-care business in the U.S. and Canada. CSCA previously included our Latin American businesses until they were disposed on March 9, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Consumer Self-Care International ("CSCI") &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;comprises our consumer self-care business outside of the U.S. and Canada, primarily in Europe and Australia.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We previously had an Rx segment which was comprised of our generic prescription pharmaceuticals business in the U.S., and other pharmaceuticals and diagnostic business in Israel, which have been divested. Following the divestiture, there were no substantial assets or operations left in this segment. The Rx segment was reported as Discontinued Operations in 2021, and is presented as such for all periods in this report (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_61" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note &lt;/a&gt;&lt;/span&gt;&lt;span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_61" style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;4&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;Our segments reflect the way in which our chief operating decision maker, who is our CEO, makes operating decisions, allocates resources and manages the growth and profitability of the Company.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDc2NQ_ab51c34f-ed00-4876-b62d-f93d15878ec7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Translation and Transactions &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We translate our non-U.S. dollar-denominated operations&#x2019; assets and liabilities into U.S. dollars at current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of Accumulated other comprehensive income (loss) ("AOCI"). Gains or losses from foreign currency transactions are included in Other (income) expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RleHRyZWdpb246M2Y5Y2MzMDNmNzZiNGFjNGEwM2ZkNTBhMDZjZWJhYThfNDczNA_0cdc3f55-85c1-41b7-af79-aab1c494df71">The following table presents the allowance for credit losses activity (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for credit losses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivables written-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfMi0xLTEtMS0yOTc1MDM_2133746e-f76e-4571-9774-3fa2a1dd8d6d"
      unitRef="usd">6800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="idd18f1c6b0bf4007931565e3309d3a59_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfMi0zLTEtMS0yOTc1MDM_db135ad1-d085-4aa2-b4c0-849368167c3c"
      unitRef="usd">7200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfMy0xLTEtMS0yOTc1MDM_51f3fe24-e3b3-442d-90aa-ac9cd51c1a81"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfMy0zLTEtMS0yOTc1MDM_2db44edc-a60a-4d65-b773-d66549b1d4b5"
      unitRef="usd">300000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfNC0xLTEtMS0yOTc1MDM_a3a44b7e-2d8a-4325-b549-ca4a3f206f3b"
      unitRef="usd">300000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfNC0zLTEtMS0yOTc1MDM_639fd1ec-4fe9-42f9-b19b-64c24623d680"
      unitRef="usd">800000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfNy0xLTEtMS0yOTc1MDM_23d3e6ba-9f7b-4c47-82aa-7295fccd624d"
      unitRef="usd">600000</prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment>
    <prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfNy0zLTEtMS0yOTc1MDM_1cf8e0c3-8b1d-4757-9573-bd0fc50a8d4b"
      unitRef="usd">400000</prgo:AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfOC0xLTEtMS0yOTc1MDM_5cff8b20-4d0d-4340-ad06-bb7852dce456"
      unitRef="usd">7100000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i6955bfa807de4779804dcda471f50c60_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80MC9mcmFnOjNmOWNjMzAzZjc2YjRhYzRhMDNmZDUwYTA2Y2ViYWE4L3RhYmxlOmUzMDQ2MmQzOTQ3YTQzOWM5Y2JmOTA0NTk5YzYzNDNlL3RhYmxlcmFuZ2U6ZTMwNDYyZDM5NDdhNDM5YzljYmY5MDQ1OTljNjM0M2VfOC0zLTEtMS0yOTc1MDM_03ba0ed2-f59b-46d3-9a69-8341324907c4"
      unitRef="usd">7100000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMzA2Mw_0bbc2dc7-7231-4f26-abd8-caa04a3f8da5">REVENUE RECOGNITION &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our net sales by category&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:226.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Upper Respiratory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nutrition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Digestive Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pain and Sleep-Aids&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthy Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Skin Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vitamins, Minerals, and Supplements ("VMS")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other CSCA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;763.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;710.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Upper Respiratory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Skin Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthy Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pain and Sleep-Aids&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;VMS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Digestive Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other CSCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;418.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;364.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,074.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(1) We updated our global reporting product categories as a result of our product portfolio reconfiguration. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(2) Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3) Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;than 10% of the segment net sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the majority of revenue is recognized at a point in time, certain of our product revenue is recognized over time. Customer contracts recognized over time exist predominately in contract manufacturing arrangements, which occur in both the CSCA and CSCI segments. Contract manufacturing revenue was $90.0&#160;million for the three months ended April&#160;1, 2023, and $70.8&#160;million for the three months ended April&#160;2, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also recognize a portion of the store brand OTC product revenues in the CSCA segment on an over time basis; however, the timing difference between over time and point in time revenue recognition for store brand contracts is not significant due to the short time period between the customization of the product and shipment or delivery. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about contract assets from contracts with customers (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generated net sales in the following geographic locations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:366.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:220.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;683.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;407.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;351.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other countries&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,074.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The net sales by geography are derived from the location of the entity that sells to a third party.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2) Includes Ireland net sales of $7.3 million and $6.6&#160;million for the three months ended April&#160;1, 2023 and April&#160;2, 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3) Includes net sales generated primarily in Australia and Canada.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMzA5NQ_ad15d210-d94e-4427-a21b-c717f3f406d3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our net sales by category&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:226.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Upper Respiratory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nutrition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Digestive Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pain and Sleep-Aids&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthy Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Skin Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vitamins, Minerals, and Supplements ("VMS")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other CSCA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;763.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;710.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Upper Respiratory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Skin Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthy Lifestyle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pain and Sleep-Aids&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;VMS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Digestive Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other CSCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;418.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;364.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,074.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(1) We updated our global reporting product categories as a result of our product portfolio reconfiguration. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%"&gt;(2) Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3) Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;than 10% of the segment net sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generated net sales in the following geographic locations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:366.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:220.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;683.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;407.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;351.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other countries&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,074.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The net sales by geography are derived from the location of the entity that sells to a third party.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2) Includes Ireland net sales of $7.3 million and $6.6&#160;million for the three months ended April&#160;1, 2023 and April&#160;2, 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3) Includes net sales generated primarily in Australia and Canada.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47f5c13d45a9489b800b1fdca5125d08_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMy0xLTEtMS0yOTc1MDM_d3d63fe4-6a26-4c56-a391-c36dafeb072a"
      unitRef="usd">154300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf374477ec7c4dc8a274c7c5c8b33a4e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMy0zLTEtMS0yOTc1MDM_ac1f0e1d-cc66-4ec2-839d-ab31655ff42e"
      unitRef="usd">152800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67e110cebac446599cfeea238f5aca8e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNC0xLTEtMS0yOTc1MDM_1af93b18-12dd-480c-bcf6-9cdfec4ea1b4"
      unitRef="usd">139900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40d57b17ab9441e0830bda17d8d7302a_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNC0zLTEtMS0yOTc1MDM_92607010-78d8-4e76-be34-e8fa67bddfcb"
      unitRef="usd">127200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib41c767804e04e74b0d0675fae86b3e6_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNS0xLTEtMS0yOTc1MDM_e403619b-eb6c-4f1c-a860-83a2582594b6"
      unitRef="usd">124200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70d2639683f947f1b1d6e8865ba5ab42_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNS0zLTEtMS0yOTc1MDM_c89117bc-f0df-42da-ada5-ab37812dc557"
      unitRef="usd">118600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3deb497865334700bccbc0cb9af79e11_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNi0xLTEtMS0yOTc1MDM_5fac3580-1348-41e2-9b13-8e62323a9c56"
      unitRef="usd">103500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52ca79a594274f7d986860796f5bf5c4_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNi0zLTEtMS0yOTc1MDM_3e6481c5-bdcb-491e-91ec-2168e04601e3"
      unitRef="usd">102900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe154ddc08314c818219ab4974f9b334_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNy0xLTEtMS0yOTc1MDM_a98e17fc-8275-4b53-adb9-e4368a51940d"
      unitRef="usd">84400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i423427f446af435a8a099e8e39407244_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfNy0zLTEtMS0yOTc1MDM_3bd9dc5c-8432-4c34-b57e-c076f60608e2"
      unitRef="usd">70400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f4328ac279d49ba94fa79ccb58cca12_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfOC0xLTEtMS0yOTc1MDM_2a8b3077-22a1-40cd-a138-656d8252e184"
      unitRef="usd">73400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65f795e573b74139b0597df57a87597e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfOC0zLTEtMS0yOTc1MDM_1cd688cb-7c87-40f2-870d-e345e855c120"
      unitRef="usd">67600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedde1896a9a744229692a430d32ed377_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfOS0xLTEtMS0yOTc1MDM_60bd8f89-588e-47a9-99a0-ce27e6414c67"
      unitRef="usd">52300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i023898292ce644d4920385454d5ee04c_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfOS0zLTEtMS0yOTc1MDM_da13faa0-e9ae-4c8a-840a-841154cacc1e"
      unitRef="usd">40900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf8cd73c20df4eb1818e515fc7c9333a_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTAtMS0xLTEtMjk3NTAz_ee910e7f-c8f7-48ad-9ac7-53aeab0e08cb"
      unitRef="usd">11900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd70fd42144a4756be4ac24e92e7858a_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTAtMy0xLTEtMjk3NTAz_2057e6b3-d9a8-4010-9234-a7388f63d1f5"
      unitRef="usd">8200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05a97c7cd9bf4ae49aef6276d404df59_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTEtMS0xLTEtMjk3NTAz_8f2fc260-25c5-4c61-9dff-531290851da4"
      unitRef="usd">4000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89b3d9701d1f4e7aad3538d9f6e954f9_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTEtMy0xLTEtMjk3NTAz_69bcea0f-e074-4db5-a9a1-1d9370afc1d0"
      unitRef="usd">7700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cbf1a7074ed45a3a1f504b48f430acf_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTItMS0xLTEtMjk3NTAz_e79cddee-e12b-4b7c-b1f9-475e70de1760"
      unitRef="usd">15800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4aed093d915e4cb8a09ef81ab74849f2_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTItMy0xLTEtMjk3NTAz_dd01069a-e20f-4020-abb5-5973460445b5"
      unitRef="usd">13700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73e4fca1b9404a29b27348e58f4f2456_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTMtMS0xLTEtMjk3NTAz_2cdd7c7a-bb89-4883-b3fb-5170990d5e99"
      unitRef="usd">763700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a41be8290854dd7b445442e9fce77b4_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTMtMy0xLTEtMjk3NTAz_e4aa69f2-32f2-46f6-bdec-cbf995a3300a"
      unitRef="usd">710000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f64d6970e5341198837503d0ac5e982_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTUtMS0xLTEtMzYxMTUx_0dd64f87-e804-4e12-aef1-c6f8f30084bc"
      unitRef="usd">84800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9230b63081f4a419d17b4423287f16d_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTUtMy0xLTEtMzYxMTUx_65c58035-51fd-49d9-b8a6-e9e69e767b8a"
      unitRef="usd">66500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id72e917daad64a05bf29a7fa65162e54_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTUtMS0xLTEtMjk3NTAz_71465664-4808-4686-85de-776d866777d6"
      unitRef="usd">83400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8aeac51b11cd4427af639bde4e8f879a_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTUtMy0xLTEtMjk3NTAz_9b1872ed-09a3-40e1-8457-02b715f2d936"
      unitRef="usd">73900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i935b53becd594afcbffb2058d5cf3b02_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTgtMS0xLTEtMzU1MDk3_34960d6c-a08e-4f34-b4bb-acab133f298e"
      unitRef="usd">66400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7bbc6f93b654156afae3a426cf64660_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTgtMy0xLTEtMzU1MDk3_e327ba1d-bebe-4aeb-bc8e-54b41d70b141"
      unitRef="usd">58900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i153d82f41fd34b13bb9cdb1b721635fa_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTktMS0xLTEtMzYxMTU4_83144d4f-1647-4f05-a74f-80cf600d49f4"
      unitRef="usd">49900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08ee092ef6164e56bd199362643c5c7f_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTktMy0xLTEtMzYxMTU4_28ff5ace-7efd-4c74-b028-0398bcf94ce0"
      unitRef="usd">54000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8ee1193579b4eae9c065c0476e1af27_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTgtMS0xLTEtMjk3NTAz_528b64cc-4129-4300-a3cd-033eb4beb24c"
      unitRef="usd">47800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c3401426e894533be11508ed857acc6_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMTgtMy0xLTEtMjk3NTAz_c775b5ce-be6f-4731-b61c-7c719b641ccb"
      unitRef="usd">49500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c62f3bb392741fda84f5cd9e3a30ea0_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjAtMS0xLTEtMjk3NTAz_78578f53-4181-42d2-853a-b8e3c48bb8b8"
      unitRef="usd">29100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ec2b2f9ab6446b7aee5b5a487b367d9_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjAtMy0xLTEtMjk3NTAz_42951ff3-e9f1-474a-ad43-bcc6f9760817"
      unitRef="usd">13700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8e25af889154d1bb960e56417630fde_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjEtMS0xLTEtMjk3NTAz_3ef43417-4938-4694-8f6c-de33c3f3c8ed"
      unitRef="usd">29100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5eb71bb33d314222ab57e0143395957a_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjEtMy0xLTEtMjk3NTAz_079b1700-dec0-4cd7-b08d-0aed801808d2"
      unitRef="usd">28900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86ac2754d6fd4df6b38298e67a72bf14_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjItMS0xLTEtMjk3NTAz_74796625-fe70-4a27-8de1-4bef2b315419"
      unitRef="usd">8800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i810f1ba4bfdd4a278d0a9f1e7f9c9a68_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjItMy0xLTEtMjk3NTAz_6a23d755-6d32-47d1-9cdc-7fd3b6a36300"
      unitRef="usd">9200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib811602f7ff24efc831c6c1156046949_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjMtMS0xLTEtMjk3NTAz_6646ef3a-a9dd-4d1a-ab6a-21bfbf229d99"
      unitRef="usd">18800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia940558c4b3444388c68c903c7078507_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjMtMy0xLTEtMjk3NTAz_b9f02052-1efc-4925-ab25-2c8f5cd2320b"
      unitRef="usd">9900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i817dfeec890e44ed95bda23a0c957cff_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjQtMS0xLTEtMjk3NTAz_c52268ba-695f-431d-8906-9e6895385347"
      unitRef="usd">418100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc50f621c6924bbf8a473a58178c820b_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjQtMy0xLTEtMjk3NTAz_399fe741-81fc-4f2d-9f35-8f96e2128847"
      unitRef="usd">364500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjYtMS0xLTEtMjk3NTAz_266a6fc9-d9ad-4267-8a6e-0a3ccc6c35c9"
      unitRef="usd">1181700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmRkZmJjNTU3N2RhNTRjODFhMDE0ZThlOGM3MTRlN2M2L3RhYmxlcmFuZ2U6ZGRmYmM1NTc3ZGE1NGM4MWEwMTRlOGU4YzcxNGU3YzZfMjYtMy0xLTEtMjk3NTAz_d8dea0a7-20d4-44eb-8a4e-60e2c4666207"
      unitRef="usd">1074500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e003873c79f4b258525ee8b81660c16_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMjUyNA_65bc0f84-0db0-49fb-9346-4e6ed896aac5"
      unitRef="usd">90000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i687906ed625e459a9c846fd176504670_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMjU2MA_508620a5-457e-48ff-949d-a25cadc77fb0"
      unitRef="usd">70800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMzEwNA_9f265dc6-bc07-49a6-8ea7-f0898874ff8e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about contract assets from contracts with customers (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOjMxMzQzYzc0YTNjZDQxOTVhODQ4YjQ5NmZhODVmMjNiL3RhYmxlcmFuZ2U6MzEzNDNjNzRhM2NkNDE5NWE4NDhiNDk2ZmE4NWYyM2JfMS0zLTEtMS0yOTc1MDM_21f39250-e009-4e91-8dd0-545fba94111b"
      unitRef="usd">31700000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOjMxMzQzYzc0YTNjZDQxOTVhODQ4YjQ5NmZhODVmMjNiL3RhYmxlcmFuZ2U6MzEzNDNjNzRhM2NkNDE5NWE4NDhiNDk2ZmE4NWYyM2JfMS01LTEtMS0yOTc1MDM_5fea8be0-3680-4e06-8d81-21e478124abe"
      unitRef="usd">41500000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe0cdbd5f85948e995c7dc28b6cb4f45_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfMi0xLTEtMS0zNTU0Mzc_5092ce7d-3c79-4d7c-afbb-932407918e8d"
      unitRef="usd">750000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8ac8cde05224960aeb104a710acfa0d_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfMi0zLTEtMS0zNTU0Mzc_bdb4c5d3-96ac-4564-9058-26013c6fec7c"
      unitRef="usd">683100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia14a583947bd41cda0620726204c97bf_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfMy0xLTEtMS0zNTU0Mzc_4d844778-9a29-411c-8963-ef496404cdb7"
      unitRef="usd">407300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id685e682ee6d45c885e9bd25d7d82f62_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfMy0zLTEtMS0zNTU0Mzc_d06f1623-fbe7-4c7b-b973-ade4f4e08c92"
      unitRef="usd">351700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2df41325723f4515a100896e6f2804d2_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfNC0xLTEtMS0zNTU0Mzc_98bbc5d9-d2d9-4629-a59e-82aac12abc47"
      unitRef="usd">24400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe10084d8d8e4b8ea8a1ba4efd5d12ce_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfNC0zLTEtMS0zNTU0Mzc_60dbbe32-966b-4052-b683-d12b65afe740"
      unitRef="usd">39700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfNS0xLTEtMS0zNTU0Mzc_7003984a-b1a3-4af2-8851-79a6daeff2aa"
      unitRef="usd">1181700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RhYmxlOmZjODUxOWFiYzYzZjRjODhhMzVmYzE5MWI4ZWY3NDViL3RhYmxlcmFuZ2U6ZmM4NTE5YWJjNjNmNGM4OGEzNWZjMTkxYjhlZjc0NWJfNS0zLTEtMS0zNTU0Mzc_fd85289e-c085-47ed-8ee1-6be7f6c71191"
      unitRef="usd">1074500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic077248bde32442796615d79eeb0a55f_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMzI5ODUzNDg5MzI0Ng_a8cfff81-e17c-436c-a6d3-152e4b608206"
      unitRef="usd">7300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3597c655dd73488a968ca15c3fa79180_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80My9mcmFnOjU3YmExYmJkZDQyZjQzNmFiODFiMDExNjUxMmE3YzVjL3RleHRyZWdpb246NTdiYTFiYmRkNDJmNDM2YWI4MWIwMTE2NTEyYTdjNWNfMzI5ODUzNDg5MzI1NA_7b9a0132-8be5-4dd0-96f3-d45066150af6"
      unitRef="usd">6600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTkwNg_75013f17-e66f-40ee-aa05-d248ce5b98b9">ACQUISITIONS AND DIVESTITURES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Acquisitions During the Year Ended December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;H&#xe9;ra SAS ("&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;HRA Pharma")&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;On April 29, 2022, we completed the previously announced acquisition of 100% of the outstanding equity interest in HRA Pharma for total consideration of &#x20ac;1.8&#160;billion, or approximately $1.9&#160;billion. We funded the transaction with cash on hand and borrowings under our New Senior Secured Credit Facilities (as defined in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_73" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;). The acquisition of HRA Pharma was accounted for as a business combination and has been reported in our Condensed Consolidated Statements of Operations as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;HRA Pharma is a self-care based company with consumer brands such as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Compeed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;, ellaOne&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt; and Mederma&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;, as well as a trusted rare disease portfolio. The acquisition completed our transformation to a consumer self-care company. HRA Pharma&#x2019;s operations are reported in both our CSCA and CSCI segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;We recorded the preliminary purchase price allocation in the second quarter of 2022. During the first quarter of 2023, we recorded measurement period adjustments resulting in an increase to goodwill of $80.6&#160;million, which consisted of a $104.3&#160;million decrease in definite-lived intangibles, $27.2&#160;million decrease in net Deferred income tax liabilities, a net increase of $2.0&#160;million to other non-current liabilities, and a $1.5&#160;million decrease in Prepaid expenses and other current assets. Current period earnings adjustments of $3.5&#160;million to Cost of sales were recorded that would have been recognized during the year-ended December 31, 2022, if the measurement period adjustments to the provisional opening balance sheet were reflected as of the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Nestl&#xe9;&#x2019;s Gateway Infant Formula Plant and GoodStart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; infant formula brand Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we purchased Nestl&#xe9;&#x2019;s Gateway infant formula plant in Eau Claire, Wisconsin, along with the U.S. and Canadian rights to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;GoodStart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; infant formula brand ("Gateway"), for $110.0&#160;million in cash, subject to customary post-closing adjustments. The acquisition was accounted for as a business combination and operating results attributable to the products are included in our CSCA segment in the Nutrition product category. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We are in the process of finalizing the valuation for the assets acquired. As a result, the initial accounting for the acquisition is incomplete. The provisional acquisition amounts recognized for assets acquired will be finalized as soon as possible but no later than one year from the acquisition date. The final determination may result in asset fair values and tax bases that differ from the preliminary estimates and require changes to the preliminary amounts recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Pro Forma Impact of Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents unaudited pro forma information as if the HRA Pharma and Gateway acquisitions had occurred on January 1, 2021 and had been combined with the results reported in our Condensed Consolidated Statements of Operations for the three months ended April&#160;2, 2022 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:305.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:208.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:93.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,209.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma information is presented for information purposes only and is not indicative of the results that would have been achieved if the acquisition had taken place at such time. The unaudited pro forma information presented above includes adjustments primarily for amortization charges for acquired intangible assets, depreciation of property, plant and equipment that have been revalued, certain acquisition-related charges, and related tax effects.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestitures During the Year Ended December 31, 2022 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Latin American businesses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2022, we completed the sale of our Mexico and Brazil-based OTC businesses ("Latin American businesses"), both within our CSCA segment, to Advent International for total consideration of $23.9 million, consisting of $5.4 million in cash, installment receivables due 12 and 18 months from completion totaling $11.3 million based on the Mexican peso exchange rate at the time of sale, and contingent consideration of $7.2 million based on the Brazilian real exchange rate at the time of sale. The sale resulted in a pre-tax loss of $1.4 million, net of professional fees, recorded in Other operating expense, net on the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ScarAway&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 24, 2022, we completed the sale of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ScarAway&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;brand asset, a leading U.S. OTC scar management brand, to Alliance Pharmaceuticals Ltd. for cash consideration of $20.7 million. The sale resulted in a pre-tax gain of $3.6 million recorded in our CSCA segment in Other operating expense, net on the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i16e4dfbabc1449fdb44f59c5ebd68d88_I20220429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMTI0_cf79d5b8-8c32-4059-a484-e82038ff7749"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i09b56fa39043421e9d4157b4a80c13b3_D20220429-20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjAz_410ad0b3-501a-46e7-b85f-4d6d2d1d8f0d"
      unitRef="eur">1800000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i09b56fa39043421e9d4157b4a80c13b3_D20220429-20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjI0_9aae4da5-ad16-496c-b426-072221cb6de5"
      unitRef="usd">1900000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:Goodwill
      contextRef="iad94f9c92d974bc2b0f1da3daa6ff5db_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjMzNw_c47c23f8-e86e-4750-bfd9-4dd0b0c95cae"
      unitRef="usd">80600000</us-gaap:Goodwill>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles
      contextRef="i297276a0f2644603919916e9535ffb86_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjM2Mg_ddcd1cbb-c949-4e8e-8910-ffd78e15aefa"
      unitRef="usd">104300000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes
      contextRef="i297276a0f2644603919916e9535ffb86_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjM4OA_c213cc73-153b-4ba9-865c-1c285f32a222"
      unitRef="usd">27200000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="iad94f9c92d974bc2b0f1da3daa6ff5db_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjQ2Mg_1d0b0abf-0255-4afa-8c7b-f16f7a78d217"
      unitRef="usd">2000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="iad94f9c92d974bc2b0f1da3daa6ff5db_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMjUwOQ_dd3cdb03-c519-441f-8fe1-2f7a0668b682"
      unitRef="usd">1500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales
      contextRef="i4a4e7b481e564ec396c3dee7669dcf4a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfMTE1NDQ4NzIxMjg5OTM_7cd79c21-8736-4c3f-b384-3820d3e7aae0"
      unitRef="usd">3500000</prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i49b813746d944e9caa272f8a6edd60db_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODIzMjMw_89e9caed-110e-4c6e-9a99-8dc6487bdb6c"
      unitRef="usd">110000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTkwNQ_fddfb82b-611a-44ca-a85d-938c8ddb0880">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents unaudited pro forma information as if the HRA Pharma and Gateway acquisitions had occurred on January 1, 2021 and had been combined with the results reported in our Condensed Consolidated Statements of Operations for the three months ended April&#160;2, 2022 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:305.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:208.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:93.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,209.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RhYmxlOmVhMjFkY2IyNDVkZDRmMDFhYzUyMWVmOTIzMjQ0YmMyL3RhYmxlcmFuZ2U6ZWEyMWRjYjI0NWRkNGYwMWFjNTIxZWY5MjMyNDRiYzJfMi0zLTEtMS0yOTc1MDM_440cb485-2add-4fb1-9fd0-762bf5fcee88"
      unitRef="usd">1209300000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RhYmxlOmVhMjFkY2IyNDVkZDRmMDFhYzUyMWVmOTIzMjQ0YmMyL3RhYmxlcmFuZ2U6ZWEyMWRjYjI0NWRkNGYwMWFjNTIxZWY5MjMyNDRiYzJfMy0zLTEtMS0yOTc1MDM_1081a9d5-a4d8-45bf-822c-3edc5cc93063"
      unitRef="usd">10800000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i71d0d200110e4e108b8f68acd92ba5e1_I20220309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1NjQx_66f5b307-d04a-4c43-b80e-b9d42ceff73b"
      unitRef="usd">23900000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i1f76ed2554e846f0acf432bf5b3cc813_D20220309-20220309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1NjYw_7c2c4783-6074-4e04-87ea-c0782a733490"
      unitRef="usd">5400000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne
      contextRef="i5495ecbabeb74464bd45155077e348aa_I20220309"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1NzAx_77e30a8e-6347-4552-8196-d97e5959fb60">P12M</prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne>
    <prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo
      contextRef="i5495ecbabeb74464bd45155077e348aa_I20220309"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1NzA5_70a9af9e-ad50-47fc-9a22-2c9bf8b599c0">P18M</prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo>
    <prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables
      contextRef="i5495ecbabeb74464bd45155077e348aa_I20220309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1NzQ1_83935eb7-f825-4caa-977c-3ebd507027a7"
      unitRef="usd">11300000</prgo:DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables>
    <prgo:DisposalGroupIncludingDiscontinuedOperationContingentConsideration
      contextRef="i5495ecbabeb74464bd45155077e348aa_I20220309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1ODQy_e4372176-8dd1-4810-9948-6d7f7424ecac"
      unitRef="usd">7200000</prgo:DisposalGroupIncludingDiscontinuedOperationContingentConsideration>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ib8a0f1a3d9cf416fbceebe5198581d19_D20220309-20220309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI1OTQ4_05412e55-3dac-4987-a869-f4845a7f3ca0"
      unitRef="usd">-1400000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i3ec5ffca5e044c25af00f0856f31cc69_D20220324-20220324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI3MDY3_45891bb7-6d33-41fe-816c-07c13a004d2a"
      unitRef="usd">20700000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i3ec5ffca5e044c25af00f0856f31cc69_D20220324-20220324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80Ni9mcmFnOmE3MTdjYjkxNWIwNzRjMjE4YWEzZmJmMmFmMmZiNmM1L3RleHRyZWdpb246YTcxN2NiOTE1YjA3NGMyMThhYTNmYmYyYWYyZmI2YzVfNTQ5NzU1ODI3MTEx_34a57761-5048-4db6-961c-05bb1a5c276e"
      unitRef="usd">3600000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfNDE1NA_4361fac0-9708-485b-951b-12810b8c3755">DISCONTINUED OPERATIONS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our discontinued operations consist of our generic prescription pharmaceuticals business in the U.S. and our pharmaceuticals and diagnostic businesses in Israel (collectively, the &#x201c;Rx business&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July&#160;6, 2021, we completed the sale of the Rx business to Altaris Capital Partners, LLC ("Altaris") for aggregate consideration of $1.55 billion. The consideration included a $53.3 million reimbursement related to an Abbreviated New Drug Application (&#x201c;ANDA") for a generic topical lotion which Altaris delivered in cash to Perrigo pursuant to the terms of the definitive agreement during the three months ended April 2, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Under the terms of a transition services agreement ("TSA"), we provided transition services which were substantially completed as of the end of the third quarter of 2022. We also entered into reciprocal supply agreements pursuant to which Perrigo will supply certain products to the Rx business and the Rx business will supply certain products to Perrigo. The supply agreements have a term of four years, extendable up to seven years by the party who is the purchaser of the products under such agreement. We also extended distribution rights to the Rx business for certain OTC products owned and manufactured by Perrigo that may be fulfilled through pharmacy channels, in return for a share of the net profits.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the sale, Perrigo retained certain pre-closing liabilities arising out of antitrust (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_91" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 16 - Contingencies&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; under the header "Price-Fixing Lawsuits") and opioid matters and the Company&#x2019;s Albuterol recall, subject to, in each case, Altaris' obligation to indemnify the Company for fifty percent of these liabilities up to an aggregate cap on Altaris' obligation of $50.0&#160;million. We have not requested payments from Altaris related to the indemnity of these liabilities during the three months ended April&#160;1, 2023.&lt;/span&gt;Current and prior period reported net loss from discontinued operations primarily relates to legal fees, partially offset by an income tax benefit.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ife7f164c6edf47848398641f9ffd17b1_I20210706"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfMTA5OTUxMTYzMjk0Ng_362d5b62-7ef6-4f55-8b49-bf98959a34a2"
      unitRef="usd">1550000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <prgo:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser
      contextRef="ife7f164c6edf47848398641f9ffd17b1_I20210706"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfMTA5OTUxMTYzMjk1MQ_7a719469-e1d8-4e64-8d03-8a31e43df573"
      unitRef="usd">53300000</prgo:DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser>
    <prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm
      contextRef="i6c40483c42aa43999f3d00d21dcd2535_D20210706-20210706"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfNDE1OA_d6ee3d13-fcb7-4bd3-bee7-9dba1747258b">P4Y</prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm>
    <prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm
      contextRef="i6c40483c42aa43999f3d00d21dcd2535_D20210706-20210706"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfNDE0Nw_35733226-9285-40d9-ab4a-f971da8d5a88">P7Y</prgo:DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm>
    <prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities
      contextRef="ife7f164c6edf47848398641f9ffd17b1_I20210706"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfNDE0OQ_8e954d0b-b35e-4887-a44b-082b279fbf71"
      unitRef="number">50</prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities>
    <prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset
      contextRef="ife7f164c6edf47848398641f9ffd17b1_I20210706"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82MS9mcmFnOjAwOGFiM2QwMmFjOTQyYWM4ZDMzNDE1NmYzYjQwMzk0L3RleHRyZWdpb246MDA4YWIzZDAyYWM5NDJhYzhkMzM0MTU2ZjNiNDAzOTRfMjk1MQ_60d7e409-fd36-4bc8-9737-2d923be52742"
      unitRef="usd">50000000</prgo:DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RleHRyZWdpb246MDc0ZWI2YjI0NWJmNDhhNTgyYzY3MWZiYjY4YmIwYjVfODU_2916244d-fbf0-41f3-bea7-e13e0da5c73c">INVENTORIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Major components of inventory were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.602%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;674.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;620.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;267.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,183.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,150.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RleHRyZWdpb246MDc0ZWI2YjI0NWJmNDhhNTgyYzY3MWZiYjY4YmIwYjVfODk_385eebb2-15dc-4c2f-a6b3-bfc37f66b2a6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Major components of inventory were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.602%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;674.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;620.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;267.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,183.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,150.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMS0xLTEtMS0yOTc1MDM_ef752770-ee09-4f94-aa24-20a437000b74"
      unitRef="usd">674700000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMS0zLTEtMS0yOTc1MDM_83595890-d537-411f-a0b0-9c7722f76100"
      unitRef="usd">620300000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMi0xLTEtMS0yOTc1MDM_d10ba943-0719-4f66-9782-a9f1357ced0e"
      unitRef="usd">251100000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMi0zLTEtMS0yOTc1MDM_6ecb173b-fd80-49e5-9a93-7099dc6e96db"
      unitRef="usd">262200000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMy0xLTEtMS0yOTc1MDM_1693dce9-e82e-4e1f-96f5-095bfe3b6885"
      unitRef="usd">257200000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfMy0zLTEtMS0yOTc1MDM_94200391-95d5-4a10-88ac-357df6bf610d"
      unitRef="usd">267800000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryNet
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfNC0xLTEtMS0yOTc1MDM_d690e09b-0359-454f-acc7-f6d8b913670c"
      unitRef="usd">1183000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81Mi9mcmFnOjA3NGViNmIyNDViZjQ4YTU4MmM2NzFmYmI2OGJiMGI1L3RhYmxlOjJmOGY3NWVhNmM2YTQ4NGNhYTBmZWJhYzBhOWFiYmVlL3RhYmxlcmFuZ2U6MmY4Zjc1ZWE2YzZhNDg0Y2FhMGZlYmFjMGE5YWJiZWVfNC0zLTEtMS0yOTc1MDM_0dfeda83-616e-47c9-bc17-ab9bd6896126"
      unitRef="usd">1150300000</us-gaap:InventoryNet>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RleHRyZWdpb246Y2U0YWZjOGQwMmU1NGQ3MjgzMTU1NjkxZTY4NjE0ODZfMzUz_728438b4-e050-47f3-9540-6d94119fe279">INVESTMENTS &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Measured at fair value using the Net Asset Value practical expedient.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the expense recognized in earnings of our equity securities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income Statement Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RleHRyZWdpb246Y2U0YWZjOGQwMmU1NGQ3MjgzMTU1NjkxZTY4NjE0ODZfMzU3_453d2271-a2df-44b5-9f75-a6fc4dee5010">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Measured at fair value using the Net Asset Value practical expedient.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4ebf7e0bc9094fd6a3ac5764350b0544_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMS00LTEtMS0yOTc1MDM_74223cba-c3c8-4996-9a18-4cf3e50582b2"
      unitRef="usd">100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9eb38aa56dcf402bb0bb2637e8d49b4d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMS02LTEtMS0yOTc1MDM_1a0c2805-e949-4468-897e-a09d7596c6a1"
      unitRef="usd">100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if103d7bf645e4b24ac84251cdaf12b33_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMi00LTEtMS0yOTc1MDM_587429ab-0152-4c62-ba2e-354b86ad51aa"
      unitRef="usd">1700000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3fd779f91b674ece84c54eb308733a1d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMi02LTEtMS0yOTc1MDM_11b4fc3b-792a-4bb6-a947-2cbd10bb1e76"
      unitRef="usd">1700000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquityMethodInvestments
      contextRef="if103d7bf645e4b24ac84251cdaf12b33_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMy00LTEtMS0yOTc1MDM_e8e9f753-d3c8-4807-a008-f3c3fe661fca"
      unitRef="usd">62700000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i3fd779f91b674ece84c54eb308733a1d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOmE2ODM0ZWFjNjAwMzQ3Y2NiOTQ3OGJjMzgwNTI2MjZkL3RhYmxlcmFuZ2U6YTY4MzRlYWM2MDAzNDdjY2I5NDc4YmMzODA1MjYyNmRfMy02LTEtMS0yOTc1MDM_9ecc9824-081a-4897-9400-3070ec905216"
      unitRef="usd">63400000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RleHRyZWdpb246Y2U0YWZjOGQwMmU1NGQ3MjgzMTU1NjkxZTY4NjE0ODZfMzUw_57a01cb7-437d-476e-adf8-0e31f52d798b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the expense recognized in earnings of our equity securities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.602%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income Statement Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOjllNjJkNTA1OTkwNTRkYzY4ZTY0ZTdlYzc4OWQwZTE1L3RhYmxlcmFuZ2U6OWU2MmQ1MDU5OTA1NGRjNjhlNjRlN2VjNzg5ZDBlMTVfMi00LTEtMS0yOTc1MDM_60345042-8a9b-41bb-94cd-077614e0efc9"
      unitRef="usd">-100000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOjllNjJkNTA1OTkwNTRkYzY4ZTY0ZTdlYzc4OWQwZTE1L3RhYmxlcmFuZ2U6OWU2MmQ1MDU5OTA1NGRjNjhlNjRlN2VjNzg5ZDBlMTVfMi02LTEtMS0yOTc1MDM_ae1db83a-3780-47ca-a513-1587d1b6e666"
      unitRef="usd">-200000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOjllNjJkNTA1OTkwNTRkYzY4ZTY0ZTdlYzc4OWQwZTE1L3RhYmxlcmFuZ2U6OWU2MmQ1MDU5OTA1NGRjNjhlNjRlN2VjNzg5ZDBlMTVfNC00LTEtMS0yOTc1MDM_72f4a323-063a-4b2c-b163-160270b8f2a8"
      unitRef="usd">-700000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81OC9mcmFnOmNlNGFmYzhkMDJlNTRkNzI4MzE1NTY5MWU2ODYxNDg2L3RhYmxlOjllNjJkNTA1OTkwNTRkYzY4ZTY0ZTdlYzc4OWQwZTE1L3RhYmxlcmFuZ2U6OWU2MmQ1MDU5OTA1NGRjNjhlNjRlN2VjNzg5ZDBlMTVfNC02LTEtMS0yOTc1MDM_976435c0-2de2-46b1-b613-2517cb762947"
      unitRef="usd">-700000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNDkw_6a3f0aba-51b4-43a4-8bdc-652825a55ff8">LEASES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The balance sheet locations of our lease assets and liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:124.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:178.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_8393b283-e363-4504-b231-143478dd2c5f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_87043135-b949-45d0-9eae-f1b4645419a9"&gt;Other non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:124.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:178.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_05036283-a810-4bae-854e-92b3df99922c"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_b5e2a70c-b3bd-48c1-b7a0-2aff813e9b08"&gt;Other accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_1a147768-c056-425b-af34-6db715980677"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_7a7ad5f3-7e3d-4fd6-b39b-bd13f91b4653"&gt;Current indebtedness&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_156cee65-de81-4dfd-849e-fc62e3c9dfcf"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_88c5c5e3-521f-44d6-b6d7-0639e3d6ce44"&gt;Other non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_3eb3333f-44a6-4a5b-bef2-60d0ef263f0a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_f509a7f0-b2aa-4888-9b39-8d9314e7b4c4"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below tables show our lease assets and liabilities by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:133.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:133.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:306.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:133.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)  Includes short-term leases and variable lease costs, which are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual future maturities of our leases as of April&#160;1, 2023 are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:351.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:142.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our weighted average lease terms and discount rates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:352.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.09&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease cash flow classifications are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:352.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNTAw_6dc833d9-7d0a-4bb5-bc4f-fa7b5ebf2ae0">LEASES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The balance sheet locations of our lease assets and liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:124.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:178.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_8393b283-e363-4504-b231-143478dd2c5f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_87043135-b949-45d0-9eae-f1b4645419a9"&gt;Other non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:124.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:178.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_05036283-a810-4bae-854e-92b3df99922c"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_b5e2a70c-b3bd-48c1-b7a0-2aff813e9b08"&gt;Other accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_1a147768-c056-425b-af34-6db715980677"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_7a7ad5f3-7e3d-4fd6-b39b-bd13f91b4653"&gt;Current indebtedness&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_156cee65-de81-4dfd-849e-fc62e3c9dfcf"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_88c5c5e3-521f-44d6-b6d7-0639e3d6ce44"&gt;Other non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_3eb3333f-44a6-4a5b-bef2-60d0ef263f0a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_f509a7f0-b2aa-4888-9b39-8d9314e7b4c4"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below tables show our lease assets and liabilities by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:133.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:133.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:306.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:133.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)  Includes short-term leases and variable lease costs, which are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual future maturities of our leases as of April&#160;1, 2023 are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:351.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:142.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our weighted average lease terms and discount rates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:352.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.09&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease cash flow classifications are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:352.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <prgo:AssetsandLiabilitiesLesseeTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNDk0_6ec20517-e7ef-42e8-99df-68a1e5050c29">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The balance sheet locations of our lease assets and liabilities were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:124.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:178.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_8393b283-e363-4504-b231-143478dd2c5f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi0yLTEtMS0yOTc1MDM_87043135-b949-45d0-9eae-f1b4645419a9"&gt;Other non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:474.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:124.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:178.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_05036283-a810-4bae-854e-92b3df99922c"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi0yLTEtMS0yOTc1MDM_b5e2a70c-b3bd-48c1-b7a0-2aff813e9b08"&gt;Other accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_1a147768-c056-425b-af34-6db715980677"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy0yLTEtMS0yOTc1MDM_7a7ad5f3-7e3d-4fd6-b39b-bd13f91b4653"&gt;Current indebtedness&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_156cee65-de81-4dfd-849e-fc62e3c9dfcf"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS0yLTEtMS0yOTc1MDM_88c5c5e3-521f-44d6-b6d7-0639e3d6ce44"&gt;Other non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_3eb3333f-44a6-4a5b-bef2-60d0ef263f0a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi0yLTEtMS0yOTc1MDM_f509a7f0-b2aa-4888-9b39-8d9314e7b4c4"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below tables show our lease assets and liabilities by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:133.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:133.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</prgo:AssetsandLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMS00LTEtMS0yOTc1MDM_0f31b42b-4541-4a81-8f43-6b47e73acbf4"
      unitRef="usd">211700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMS02LTEtMS0yOTc1MDM_ea25b1fd-afcc-43b5-9a09-2de6cafadd6b"
      unitRef="usd">217100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi00LTEtMS0yOTc1MDM_8dbbcfeb-e1dc-4e28-8bf7-d88efeb6d398"
      unitRef="usd">21000000.0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMi02LTEtMS0yOTc1MDM_79ec7a2f-4764-4b9b-a0d8-151c4b230b0a"
      unitRef="usd">22000000.0</us-gaap:FinanceLeaseRightOfUseAsset>
    <prgo:RightofUseAsset
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMy00LTEtMS0yOTc1MDM_0aa1a718-0dfc-4652-b82d-95c94f972dd7"
      unitRef="usd">232700000</prgo:RightofUseAsset>
    <prgo:RightofUseAsset
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjAwZjUxNjBmYTg5OTRlN2NiNjkxMmUzMTA5Y2VkNzYzL3RhYmxlcmFuZ2U6MDBmNTE2MGZhODk5NGU3Y2I2OTEyZTMxMDljZWQ3NjNfMy02LTEtMS0yOTc1MDM_af40e278-78d2-47f9-8cb6-1a028e3f32f1"
      unitRef="usd">239100000</prgo:RightofUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi00LTEtMS0yOTc1MDM_796d1c1c-5921-49a8-bb6a-47493001a7bc"
      unitRef="usd">28300000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMi02LTEtMS0yOTc1MDM_0b834893-b4a6-434b-a8d8-8868fcbd5edc"
      unitRef="usd">28400000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy00LTEtMS0yOTc1MDM_4f61627c-394f-46ad-b4bc-cafe93f981fa"
      unitRef="usd">2800000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfMy02LTEtMS0yOTc1MDM_92427d4c-50b4-49e5-b376-2f181ea78635"
      unitRef="usd">3300000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS00LTEtMS0yOTc1MDM_5f755899-55c7-4494-9524-e1d201017359"
      unitRef="usd">184700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNS02LTEtMS0yOTc1MDM_c54bfc93-a043-4c99-8c13-2e46aaacc9e6"
      unitRef="usd">189500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi00LTEtMS0yOTc1MDM_b04d9b99-96ae-44c2-bc16-f9b57ca31a91"
      unitRef="usd">16900000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNi02LTEtMS0yOTc1MDM_707487ea-d52b-4c43-b4f9-e776c09ea421"
      unitRef="usd">17400000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <prgo:LeaseLiabilities
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNy00LTEtMS0yOTc1MDM_362d368d-3129-4c2f-b009-8bf402dc74d3"
      unitRef="usd">232700000</prgo:LeaseLiabilities>
    <prgo:LeaseLiabilities
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjJmOTE5MmE3MWU1YjQwNGQ4MzdmMzJkOTZiNTI2MmY4L3RhYmxlcmFuZ2U6MmY5MTkyYTcxZTViNDA0ZDgzN2YzMmQ5NmI1MjYyZjhfNy02LTEtMS0yOTc1MDM_d1784b16-2a18-4396-9d38-c952ce4041db"
      unitRef="usd">238600000</prgo:LeaseLiabilities>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if7ca477c08d84a82a9de72b2c524c103_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfMy0yLTEtMS0yOTc1MDM_e78bfd7e-6e12-48c1-8d22-73d967029cf9"
      unitRef="usd">97900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0244fe0ff77440b9929d419ff9c9da9b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfMy00LTEtMS0yOTc1MDM_a78717ed-6cd8-4e75-8590-691d0ffeab5b"
      unitRef="usd">100500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="if7ca477c08d84a82a9de72b2c524c103_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfMy02LTEtMS0yOTc1MDM_623deda7-6cec-4477-8077-2f9444c66b01"
      unitRef="usd">13500000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i0244fe0ff77440b9929d419ff9c9da9b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfMy04LTEtMS0yOTc1MDM_9fbf94bd-e33a-430d-8eff-f7319e1a9bb7"
      unitRef="usd">13800000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i620cef7dc50148d7a2222193971d347f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNC0yLTEtMS0yOTc1MDM_41cf9ccf-f13d-49cb-892b-b61d038b0cd0"
      unitRef="usd">48400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i8af8f32782cc4ff0b482a38bac5b723b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNC00LTEtMS0yOTc1MDM_4c527802-c545-4661-af47-c5c9ff21a87e"
      unitRef="usd">49500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i620cef7dc50148d7a2222193971d347f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNC02LTEtMS0yOTc1MDM_339415d9-dd42-432a-b212-f19c26a3cf8b"
      unitRef="usd">6500000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i8af8f32782cc4ff0b482a38bac5b723b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNC04LTEtMS0yOTc1MDM_3ddbd168-5cb0-46d3-bd8d-7d1a53ae6211"
      unitRef="usd">6600000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4c25260d2b6b4edab1b3611171d1ce25_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNy0yLTEtMS0yOTc1MDM_d13390b0-5393-4f1b-afbd-8255320f890f"
      unitRef="usd">65400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ie4e56b5dd90f4224b8c29c7ef31fe2a5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNy00LTEtMS0yOTc1MDM_4c4e7cb8-313a-4c56-b9f1-0edb16f44390"
      unitRef="usd">67100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i4c25260d2b6b4edab1b3611171d1ce25_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNy02LTEtMS0yOTc1MDM_8228a539-639c-445b-8d36-2133a677692e"
      unitRef="usd">1000000.0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ie4e56b5dd90f4224b8c29c7ef31fe2a5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfNy04LTEtMS0yOTc1MDM_9d6b5ae9-530d-43aa-8186-effafb51e117"
      unitRef="usd">1600000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfOC0yLTEtMS0yOTc1MDM_02699f4f-1267-4ded-bc64-f3cc0e9c7f03"
      unitRef="usd">211700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfOC00LTEtMS0yOTc1MDM_10155d25-f07c-4465-bc82-e84650b18ae5"
      unitRef="usd">217100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfOC02LTEtMS0yOTc1MDM_55ddf3e1-2866-41b1-8681-2f85d1eb4a89"
      unitRef="usd">21000000.0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjZkMjUzYWU5Njc5NzRjNTBhNTg1MDRkMDRkNmM1ZDQwL3RhYmxlcmFuZ2U6NmQyNTNhZTk2Nzk3NGM1MGE1ODUwNGQwNGQ2YzVkNDBfOC04LTEtMS0yOTc1MDM_4a5ee6fc-8cce-4f7a-9912-ed3cd56f5a14"
      unitRef="usd">22000000.0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="if7ca477c08d84a82a9de72b2c524c103_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfMy0yLTEtMS0yOTc1MDM_a12ef98a-a0a7-4257-b653-24602cfabbe5"
      unitRef="usd">99400000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i0244fe0ff77440b9929d419ff9c9da9b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfMy00LTEtMS0yOTc1MDM_f0c55f70-859f-4549-a57a-988323198417"
      unitRef="usd">102200000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="if7ca477c08d84a82a9de72b2c524c103_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfMy02LTEtMS0yOTc1MDM_46070f74-13b2-45d1-8c78-6e572abbbb6d"
      unitRef="usd">14600000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i0244fe0ff77440b9929d419ff9c9da9b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfMy04LTEtMS0yOTc1MDM_0e0ab830-a44b-4951-a6c5-1e67066313fd"
      unitRef="usd">14900000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i620cef7dc50148d7a2222193971d347f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNC0yLTEtMS0yOTc1MDM_457643af-b0cc-45de-b587-132f05eb2ae3"
      unitRef="usd">51000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i8af8f32782cc4ff0b482a38bac5b723b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNC00LTEtMS0yOTc1MDM_9e409328-4bf5-4f07-8fd4-4244b81d5cae"
      unitRef="usd">51700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i620cef7dc50148d7a2222193971d347f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNC02LTEtMS0yOTc1MDM_845e9a16-e738-45eb-871f-096ea76d6cc4"
      unitRef="usd">4000000.0</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i8af8f32782cc4ff0b482a38bac5b723b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNC04LTEtMS0yOTc1MDM_a1604c56-3069-4f36-9c18-0e5f20f97649"
      unitRef="usd">4100000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i4c25260d2b6b4edab1b3611171d1ce25_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNy0yLTEtMS0yOTc1MDM_63889f5e-d4d8-4b62-8657-d58db2b9e17c"
      unitRef="usd">62600000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ie4e56b5dd90f4224b8c29c7ef31fe2a5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNy00LTEtMS0yOTc1MDM_bab0452b-ffb4-44cd-8ffa-c5474ab114e5"
      unitRef="usd">64000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i4c25260d2b6b4edab1b3611171d1ce25_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNy02LTEtMS0yOTc1MDM_b9e8fe40-7dd2-4449-bf5f-2fbe3fec1570"
      unitRef="usd">1100000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ie4e56b5dd90f4224b8c29c7ef31fe2a5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfNy04LTEtMS0yOTc1MDM_da7283c2-316d-4452-895d-40583e8ea27e"
      unitRef="usd">1700000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfOC0yLTEtMS0yOTc1MDM_9ff65a08-862d-4c71-8c36-dd74d3c33173"
      unitRef="usd">213000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfOC00LTEtMS0yOTc1MDM_cffa4229-9e33-4a64-a083-a9d639cec262"
      unitRef="usd">217900000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfOC02LTEtMS0yOTc1MDM_0aada447-24e1-4b3c-81ec-98e0bf8867e3"
      unitRef="usd">19700000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjkwZTg4YTM1NDU5MDQ2MzNhYzcyZDI0ZjkzOTQ3YjMwL3RhYmxlcmFuZ2U6OTBlODhhMzU0NTkwNDYzM2FjNzJkMjRmOTM5NDdiMzBfOC04LTEtMS0yOTc1MDM_e88f49e1-e053-4577-96d9-eee4bb8c1d3b"
      unitRef="usd">20700000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNDk1_64de758e-3d87-4da1-94a6-ac7bf44a4c38">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease expense was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:306.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:133.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:75.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)  Includes short-term leases and variable lease costs, which are immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfMi0yLTEtMS0yOTc1MDM_54c404cf-1f7e-4cb1-bedf-867e8f260502"
      unitRef="usd">12000000.0</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfMi00LTEtMS0yOTc1MDM_b5f6ea1a-baba-46de-887a-20d62a983304"
      unitRef="usd">9700000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNS0yLTEtMS0yOTc1MDM_ef1121f0-2fd7-446e-b372-e6697125c17f"
      unitRef="usd">1100000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNS00LTEtMS0yOTc1MDM_4fe6f3c4-7aa1-4abe-b6c4-4aabc705aa1f"
      unitRef="usd">1500000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNi0yLTEtMS0yOTc1MDM_6cb374e0-7eea-4509-8d62-c58749fc71f0"
      unitRef="usd">100000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNi00LTEtMS0yOTc1MDM_657fba34-edf6-4551-979d-02f5f8864cb9"
      unitRef="usd">200000</us-gaap:FinanceLeaseInterestExpense>
    <prgo:FinanceLeaseCost
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNy0yLTEtMS0yOTc1MDM_15fae78d-194c-4eb4-b6a6-00465cc18394"
      unitRef="usd">1200000</prgo:FinanceLeaseCost>
    <prgo:FinanceLeaseCost
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmM0NWY2MTE5NmQyODQ2OGU4NGVmODU3ZTc4MzQxYTEwL3RhYmxlcmFuZ2U6YzQ1ZjYxMTk2ZDI4NDY4ZTg0ZWY4NTdlNzgzNDFhMTBfNy00LTEtMS0yOTc1MDM_a8248226-dc86-4211-b858-dbc0d220ed8b"
      unitRef="usd">1700000</prgo:FinanceLeaseCost>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNTA1_933da41d-0f15-4c61-aae7-d828c60caf9f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual future maturities of our leases as of April&#160;1, 2023 are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:351.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:142.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNTA3_d3dadce5-a694-4d0a-9881-3491727e9c6d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual future maturities of our leases as of April&#160;1, 2023 are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:351.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:142.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:63.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMS0yLTEtMS0yOTc1MDM_0f2b5e82-1f16-4862-b7ac-ba13f1f52ef1"
      unitRef="usd">24700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMS00LTEtMS0yOTc1MDM_6451da4e-3cf0-481f-9871-be1d7a3ce876"
      unitRef="usd">2700000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <prgo:LeaseLiabilityPaymentsRemainderofFiscalYear
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMS02LTEtMS0yOTc1MDM_e8cfed1c-98be-4dd7-ac3a-6df11eecb937"
      unitRef="usd">27400000</prgo:LeaseLiabilityPaymentsRemainderofFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMi0yLTEtMS0yOTc1MDM_85b7d96a-cc3e-4ba0-a781-6653ffc5a376"
      unitRef="usd">29500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMi00LTEtMS0yOTc1MDM_c0c52ac2-aa8f-45d8-958a-e0c0d0f512cb"
      unitRef="usd">2400000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <prgo:LeaseLiabilityPaymentsDueYearOne
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMi02LTEtMS0yOTc1MDM_e6e600df-4752-4196-aa67-b13655017198"
      unitRef="usd">31900000</prgo:LeaseLiabilityPaymentsDueYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMy0yLTEtMS0yOTc1MDM_5e20037d-cd15-48b3-801f-398424dc3bd6"
      unitRef="usd">27600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMy00LTEtMS0yOTc1MDM_9a74a6d0-3bbf-4fac-a040-7133d27c401f"
      unitRef="usd">2200000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <prgo:LeaseLiabilityPaymentsDueYearTwo
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfMy02LTEtMS0yOTc1MDM_d02f29bf-d52f-420b-b7a0-da4101095457"
      unitRef="usd">29800000</prgo:LeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNC0yLTEtMS0yOTc1MDM_f272f1ef-b472-4a20-b55a-503f5b775268"
      unitRef="usd">22400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNC00LTEtMS0yOTc1MDM_2b595af3-d755-4c2a-9f67-370e6c9f9872"
      unitRef="usd">2000000.0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <prgo:LeaseLiabilityPaymentsDueYearThree
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNC02LTEtMS0yOTc1MDM_61f53eaa-4278-4456-a8fb-39cdd5205260"
      unitRef="usd">24400000</prgo:LeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNS0yLTEtMS0yOTc1MDM_69028c56-e6b3-47c9-a224-e2fd1b6c3041"
      unitRef="usd">21700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNS00LTEtMS0yOTc1MDM_1d0a8cd6-a72d-4a1d-81f5-fc45019133b1"
      unitRef="usd">2000000.0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <prgo:LeaseLiabilityPaymentsDueYearFour
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNS02LTEtMS0yOTc1MDM_dc6dba96-5f0d-4efd-b6ec-4f54d1855a55"
      unitRef="usd">23700000</prgo:LeaseLiabilityPaymentsDueYearFour>
    <prgo:LesseeOperatingLeaseLiabilitytobePaidafterYearFour
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNi0yLTEtMS0yOTc1MDM_017808e6-e651-43c9-9e54-e1e9c0960fb1"
      unitRef="usd">117900000</prgo:LesseeOperatingLeaseLiabilitytobePaidafterYearFour>
    <prgo:FinanceLeaseLiabilitytobePaidafterYearFour
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNi00LTEtMS0yOTc1MDM_fd247dcd-f373-4ecc-bdd6-f70c093f14cf"
      unitRef="usd">11600000</prgo:FinanceLeaseLiabilitytobePaidafterYearFour>
    <prgo:LeaseLiabilityPaymentsDueafterYearFour
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNi02LTEtMS0yOTc1MDM_3826fa9c-6e8a-4fd4-842f-407be475941d"
      unitRef="usd">129500000</prgo:LeaseLiabilityPaymentsDueafterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNy0yLTEtMS0yOTc1MDM_2e7b6b6c-dfb6-4aa8-a5b4-2872f4cce1ca"
      unitRef="usd">243800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNy00LTEtMS0yOTc1MDM_3a7aaed7-2fca-49f6-b303-9a06e293dd3a"
      unitRef="usd">22900000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <prgo:LeaseLiabilityPaymentsDue
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfNy02LTEtMS0yOTc1MDM_5e3921df-9c97-4f23-89c0-9e0a419c94f3"
      unitRef="usd">266700000</prgo:LeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOC0yLTEtMS0yOTc1MDM_b835fea2-2cd2-4bc6-a366-d06aff2f3589"
      unitRef="usd">30800000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOC00LTEtMS0yOTc1MDM_29d856da-3606-44af-98b9-71896df69bc9"
      unitRef="usd">3200000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <prgo:LeaseLiabilityUndiscountedExcessAmount
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOC02LTEtMS0yOTc1MDM_0684eae4-1f7d-48db-8616-cd48bc4e4f0c"
      unitRef="usd">34000000.0</prgo:LeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOS0yLTEtMS0yOTc1MDM_dc300268-f80d-40b6-b825-8d7029e2302e"
      unitRef="usd">213000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOS00LTEtMS0yOTc1MDM_0f5f04c1-0ffb-40d0-ae7c-b013944587fe"
      unitRef="usd">19700000</us-gaap:FinanceLeaseLiability>
    <prgo:LeaseLiabilities
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOmZmNmVjNjJlOTJmOTQ2YjdhMDIxNDMxZDI2NGZjZjJlL3RhYmxlcmFuZ2U6ZmY2ZWM2MmU5MmY5NDZiN2EwMjE0MzFkMjY0ZmNmMmVfOS02LTEtMS0yOTc1MDM_601385f1-91a4-4ad0-902b-ba01f98f122c"
      unitRef="usd">232700000</prgo:LeaseLiabilities>
    <prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNDk2_55a6a7d6-af7f-4f23-b265-80f715eaebf2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our weighted average lease terms and discount rates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:352.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.09&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfMi0yLTEtMS0yOTc1MDM_adcd6713-8c04-4b92-bec0-3c15bbd159b5">P10Y10M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6955bfa807de4779804dcda471f50c60_I20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfMi00LTEtMS0yOTc1MDM_a9b649ea-1ad1-4b23-a525-039bb47aabfa">P12Y1M2D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfMy0yLTEtMS0yOTc1MDM_271df5af-4c9d-408f-bee8-dee7a9f567fb">P9Y5M26D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6955bfa807de4779804dcda471f50c60_I20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfMy00LTEtMS0yOTc1MDM_89fcfd8e-24af-402a-bc61-21d8cf35a396">P9Y3M10D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfNS0yLTEtMS0yOTc1MDM_da77b082-8e65-4d1f-be5b-9332ab38c2e6"
      unitRef="number">0.025</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i6955bfa807de4779804dcda471f50c60_I20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfNS00LTEtMS0yOTc1MDM_aa01aae9-5f7c-45e9-859f-931219d4cf77"
      unitRef="number">0.026</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfNi0yLTEtMS0yOTc1MDM_190c8df4-63b8-41d0-a71b-e9ef17510496"
      unitRef="number">0.030</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i6955bfa807de4779804dcda471f50c60_I20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjc3MmVjYTA0MzZmMzQyMDY4YzMyMjVmZTA1MzliZDg3L3RhYmxlcmFuZ2U6NzcyZWNhMDQzNmYzNDIwNjhjMzIyNWZlMDUzOWJkODdfNi00LTEtMS0yOTc1MDM_ae9dab5f-9779-4aed-b462-7a2a5f971875"
      unitRef="number">0.028</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <prgo:LesseeCashFlowClassificationsTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RleHRyZWdpb246OTEzZTYwMjQzYzcyNDlhOWJjZDA1Nzc3ZDBiZmU3YzRfNDk5_1989a6cb-a5e4-452d-9ab3-89e09ffa651f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease cash flow classifications are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:352.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</prgo:LesseeCashFlowClassificationsTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfMy0yLTEtMS0yOTc1MDM_b2b18eec-cc69-4bec-89d0-5735a8bdbc80"
      unitRef="usd">9000000.0</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfMy00LTEtMS0yOTc1MDM_51285e7b-9cef-4944-88dd-d4ec98e14cbc"
      unitRef="usd">8500000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfNC0yLTEtMS0yOTc1MDM_d2d117a9-7ea5-443a-bd00-090ddfdbd7da"
      unitRef="usd">100000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfNC00LTEtMS0yOTc1MDM_08ae4fb0-0c3b-4623-ae21-3f9136b701e2"
      unitRef="usd">200000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfNS0yLTEtMS0yOTc1MDM_ba0c065e-5c2f-460c-93f3-8c0d11100d32"
      unitRef="usd">1000000.0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfNS00LTEtMS0yOTc1MDM_d03d816d-a9d4-405e-8505-be8c0ce00510"
      unitRef="usd">1300000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfOC0yLTEtMS0yOTc1MDM_6734951c-b880-4885-a56d-949e76676ff4"
      unitRef="usd">1400000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83MC9mcmFnOjkxM2U2MDI0M2M3MjQ5YTliY2QwNTc3N2QwYmZlN2M0L3RhYmxlOjNjNDQ3NWNkNjMxNzRhOTJiNTliZWNjZDM2NjQ1YjMyL3RhYmxlcmFuZ2U6M2M0NDc1Y2Q2MzE3NGE5MmI1OWJlY2NkMzY2NDViMzJfOC00LTEtMS0yOTc1MDM_4796b5cb-d058-47d4-92cc-2f074d2fa984"
      unitRef="usd">31600000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfOTA0_13d254ad-3d02-4249-90bb-b7a0b076b751">GOODWILL AND INTANGIBLE ASSETS &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.179%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Purchase accounting adjustments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,079.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,446.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,511.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,490.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,591.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)  We had accumulated goodwill impairments of $6.1 million as of April&#160;1, 2023 and December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)  We had accumulated goodwill impairments of $878.4 million as of April&#160;1, 2023 and December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets and related accumulated amortization consisted of the following (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangibles:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total indefinite-lived intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite-lived intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;474.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;484.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,844.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,006.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,825.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;965.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,462.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;509.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,542.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;481.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total definite-lived intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,879.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,795.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,949.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,718.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,938.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,795.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,007.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,718.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded amortization expense of $65.4&#160;million and $48.5&#160;million for the three months ended April&#160;1, 2023 and April&#160;2, 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfOTIw_2ed49e23-6b2a-4c53-8281-e1314b4d1918">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.179%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Purchase accounting adjustments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,079.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,446.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,511.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,490.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,591.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)  We had accumulated goodwill impairments of $6.1 million as of April&#160;1, 2023 and December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)  We had accumulated goodwill impairments of $878.4 million as of April&#160;1, 2023 and December 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i4f3eb6af9f444b3e8326226555389980_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMS0yLTEtMS0yOTc1MDM_0daa66dc-7887-4053-b3aa-920d9f9c107d"
      unitRef="usd">2044400000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i73e4fca1b9404a29b27348e58f4f2456_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMS00LTEtMS0yOTc1MDM_97d8671d-8263-4332-a5dc-d2cbe1127a48"
      unitRef="usd">35200000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i73e4fca1b9404a29b27348e58f4f2456_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMS0xNS0xLTEtMjk3NTAz_af7628e6-ff94-42d1-b5bb-d1d3a8d0618a"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ib24332748044483db83ca8e301c719ca_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMS0xNy0xLTEtMjk3NTAz_8d4add57-e4ea-4c51-aeeb-f612318c9513"
      unitRef="usd">2079600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i63eb2d1285fa4953907a861c6ea961bc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMi0yLTEtMS0yOTc1MDM_e60a01ec-614b-4b55-ad9e-a00884513b26"
      unitRef="usd">1446000000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i817dfeec890e44ed95bda23a0c957cff_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMi00LTEtMS0yOTc1MDM_ff03fd0e-bbab-49e7-bd4b-8c28b7f0bbd1"
      unitRef="usd">45400000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i817dfeec890e44ed95bda23a0c957cff_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMi0xNS0xLTEtMjk3NTAz_64139d4e-6243-41ed-95de-41a8dc5f3d81"
      unitRef="usd">20200000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="idc71f8f540634f1ea99e39a92c86aae5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfMi0xNy0xLTEtMjk3NTAz_8aeacaeb-965b-44b7-8f73-1df94cc871b5"
      unitRef="usd">1511600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfNC0yLTEtMS0yOTc1MDM_e5e99b27-3ce8-4f69-8ba1-716c52f6e5ee"
      unitRef="usd">3490400000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfNC00LTEtMS0yOTc1MDM_e1b1486a-b1a6-4547-a350-63c99a36c9d6"
      unitRef="usd">80600000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfNC0xNS0xLTEtMjk3NTAz_ec7ddc0c-ee00-41d7-b4d4-a6c5278fe969"
      unitRef="usd">20200000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOmY4Y2M0Y2FhZWQzMDQyZDJhZTA3OGQwN2E0OGY1MjhlL3RhYmxlcmFuZ2U6ZjhjYzRjYWFlZDMwNDJkMmFlMDc4ZDA3YTQ4ZjUyOGVfNC0xNy0xLTEtMjk3NTAz_60c10172-ca08-4619-8e97-39c86226451a"
      unitRef="usd">3591200000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ib24332748044483db83ca8e301c719ca_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfMTg1_9200cc09-e2f3-478d-9e06-cef4f81df659"
      unitRef="usd">-6100000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i4f3eb6af9f444b3e8326226555389980_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfMTg1_a2f77c25-5ad5-47ea-b161-ab9287f65cf3"
      unitRef="usd">-6100000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i63eb2d1285fa4953907a861c6ea961bc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfMjYx_3aa044ad-2ad2-4c50-9bd6-501f8954f3b9"
      unitRef="usd">-878400000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="idc71f8f540634f1ea99e39a92c86aae5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfMjYx_f5b8b36d-8014-47fb-9473-87f038c2b291"
      unitRef="usd">-878400000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfOTE1_1a0486eb-d6ab-489b-a2cf-d0923547e500">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets and related accumulated amortization consisted of the following (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangibles:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total indefinite-lived intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite-lived intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distribution and license agreements and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed product technology, formulations, and product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;474.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;484.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.76pt;text-align:left;text-indent:-5.76pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and distribution networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,844.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,006.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,825.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;965.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names, and brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,462.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;509.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,542.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;481.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total definite-lived intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,879.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,795.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,949.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,718.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,938.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,795.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,007.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,718.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.</prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iebce178fd4714f5f92bb9fbec5a443e3_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMy0xLTEtMS0yOTc1MDM_df6b5958-47f3-405d-aaa6-4051dd5ac564"
      unitRef="usd">3200000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i10071a3c442e4192b302e7657ea94c8c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMy01LTEtMS0yOTc1MDM_04dbc1a6-b276-4f1d-bb09-ab1557157ac7"
      unitRef="usd">3200000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i07824618f65645f69731a6aa1568cec3_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNC0xLTEtMS0yOTc1MDM_666c06c3-4f57-4297-90e6-b71d9237a938"
      unitRef="usd">56000000.0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1fc973b59afa4340b4dea988d2ff81c3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNC01LTEtMS0yOTc1MDM_45313e88-9eb0-4b49-b773-622706abd87d"
      unitRef="usd">55400000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNS0xLTEtMS0yOTc1MDM_19aa10a0-a02f-48ac-97cf-ff3b543ca2fd"
      unitRef="usd">59200000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNS01LTEtMS0yOTc1MDM_835a990b-dcba-4130-bc21-326466dd9170"
      unitRef="usd">58600000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifc8978c331594327a5fb3a589e575a4f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNy0xLTEtMS0yOTc1MDM_38c961ec-e84c-4f1f-9da5-dbb3e8cdd0f9"
      unitRef="usd">95100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifc8978c331594327a5fb3a589e575a4f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNy0zLTEtMS0yOTc1MDM_0a86b3c7-3c5f-4de8-ad76-6ab902059a41"
      unitRef="usd">59200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1e68ee7033cc4aadb5686e063eb8d555_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNy01LTEtMS0yOTc1MDM_427ed9d8-e00d-4471-afc1-78d744846141"
      unitRef="usd">94900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1e68ee7033cc4aadb5686e063eb8d555_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfNy03LTEtMS0yOTc1MDM_b79f6549-14af-4852-8d8e-ea79fcde3e2f"
      unitRef="usd">58100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id55a788697874c2bacf296adc61ea0b7_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOC0xLTEtMS0yOTc1MDM_e30fa731-0056-48c9-a075-08016c8e58fa"
      unitRef="usd">474900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id55a788697874c2bacf296adc61ea0b7_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOC0zLTEtMS0yOTc1MDM_c53be361-6c3c-48a5-9b3e-0c23501ff811"
      unitRef="usd">218200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i13378a6ed8a844e6ab6a6cf5ba0bee6b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOC01LTEtMS0yOTc1MDM_041307b2-9883-4241-99e7-108abe52744f"
      unitRef="usd">484800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i13378a6ed8a844e6ab6a6cf5ba0bee6b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOC03LTEtMS0yOTc1MDM_6f248183-74e4-455b-95f8-98844b204c68"
      unitRef="usd">211800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5ae35b7343b14c67a3ee371bf5c1469e_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOS0xLTEtMS0yOTc1MDM_b0181b4c-ec27-43cf-af50-f8f1046729be"
      unitRef="usd">1844700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5ae35b7343b14c67a3ee371bf5c1469e_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOS0zLTEtMS0yOTc1MDM_dcea6535-7aac-4cc0-8c97-7071e89ca4df"
      unitRef="usd">1006800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i491ee1dd84214e7cb151e35c302d008c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOS01LTEtMS0yOTc1MDM_9559e0a0-fcee-42f1-8bc8-fec094121f91"
      unitRef="usd">1825100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i491ee1dd84214e7cb151e35c302d008c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfOS03LTEtMS0yOTc1MDM_99e3fe33-99a5-47dc-8f58-57f7584f8b38"
      unitRef="usd">965900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ied803c95feec417dbbc3ce5403e02dfc_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTAtMS0xLTEtMjk3NTAz_f26cfe01-6299-4267-a600-f8bff782e725"
      unitRef="usd">2462400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ied803c95feec417dbbc3ce5403e02dfc_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTAtMy0xLTEtMjk3NTAz_5b9e9d58-3195-435b-8ac7-bb887a194566"
      unitRef="usd">509000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8bc5f5344063450db6361f3d577c9287_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTAtNS0xLTEtMjk3NTAz_7c601d11-f2d8-47ab-86cc-ff000e803cb3"
      unitRef="usd">2542200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8bc5f5344063450db6361f3d577c9287_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTAtNy0xLTEtMjk3NTAz_c58171e2-fd4e-4638-8826-828beab275cd"
      unitRef="usd">481000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifa4f6696fa504105b9bc1e35d5f422b5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTEtMS0xLTEtMjk3NTAz_d209b32a-9bc6-4935-8714-080e5b6b5b4e"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifa4f6696fa504105b9bc1e35d5f422b5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTEtMy0xLTEtMjk3NTAz_d376b92f-ea58-4a79-a05f-d29ecd28c952"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie898e8edfbf646baa27f1856bdfdd572_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTEtNS0xLTEtMjk3NTAz_ab53a550-1087-4007-8e84-e7a366c337d3"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie898e8edfbf646baa27f1856bdfdd572_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTEtNy0xLTEtMjk3NTAz_8f069c03-eaaa-408c-8c76-0c3c23c228a8"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTItMS0xLTEtMjk3NTAz_444e5156-213e-4951-91b7-084103ea29fe"
      unitRef="usd">4879100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTItMy0xLTEtMjk3NTAz_9eef5e7b-d2a4-4a82-b4d0-825da65421f4"
      unitRef="usd">1795200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTItNS0xLTEtMjk3NTAz_802fae5a-6ca9-4208-9a39-b1363cae2b5a"
      unitRef="usd">4949000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTItNy0xLTEtMjk3NTAz_cf150320-daad-448f-8346-8ab96b955349"
      unitRef="usd">1718800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTMtMS0xLTEtMjk3NTAz_34a122b5-a441-4091-8f3e-9d1b0a33b32d"
      unitRef="usd">4938300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTMtMy0xLTEtMjk3NTAz_4e465ce1-d578-45b4-9b4f-bbdcdd0d3522"
      unitRef="usd">1795200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTMtNS0xLTEtMjk3NTAz_e1b53691-ad3f-4ec4-841c-f3c50193a5d9"
      unitRef="usd">5007600000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RhYmxlOjIwMzU0NjE1MmIxMjQzYzI5M2Q5ZmNjMmQ1MDU1YzIwL3RhYmxlcmFuZ2U6MjAzNTQ2MTUyYjEyNDNjMjkzZDlmY2MyZDUwNTVjMjBfMTMtNy0xLTEtMjk3NTAz_83fa2dcb-c728-454f-911e-68b9f54a42d8"
      unitRef="usd">1718800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfNDU4_edb1fdea-c2fa-4986-8c64-3b4b171ab782"
      unitRef="usd">65400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV80OS9mcmFnOjJjYWRiZDAxOWJjYTQ5N2E5MWYwYjdiN2QxNDIyMDk2L3RleHRyZWdpb246MmNhZGJkMDE5YmNhNDk3YTkxZjBiN2I3ZDE0MjIwOTZfMzI5ODUzNDg4NTUxNg_94422812-22fa-4276-a4c9-abb12727c9fc"
      unitRef="usd">48500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RleHRyZWdpb246MjYwODdiZDk4OGNmNDRhNGJjM2ZkMzMyN2ZhMzI4MWRfMTMzNw_9726dba7-62b9-435e-8bb7-c3a48b9e11af">FAIR VALUE MEASUREMENTS &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.825%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Measured at fair value on a recurring basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investment securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers within Level 3 fair value measurements during the three months ended April&#160;1, 2023 or the&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The non-recurring fair values represent only those assets whose carrying values were adjusted to fair value during the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fixed Rate Long-term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fixed rate long-term debt consisted of the following (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:172.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:93.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:93.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Public Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Carrying value (excluding discount)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,315.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,225.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of our public bonds for all periods were based on quoted market prices. The fair values of our private placement note for all periods were based on interest rates offered for borrowings of a similar nature and remaining maturities.&lt;/span&gt;&lt;/div&gt;The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt, revolving credit agreements, and variable rate long-term debt, approximate their fair value.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RleHRyZWdpb246MjYwODdiZDk4OGNmNDRhNGJjM2ZkMzMyN2ZhMzI4MWRfMTM1Mg_9567486f-a260-4523-b8e7-3a3f76fc7c38">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the valuation of our financial instruments carried at fair value by the applicable pricing categories (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.825%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Measured at fair value on a recurring basis:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investment securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia38fe8e9a9f04f668590d3cd5af1bea2_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC0yLTEtMS0yOTc1MDM_e259067d-e2cf-4ec6-9378-132e26541030"
      unitRef="usd">100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i323e00f452604c9e8efdeea764a4c5b9_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC00LTEtMS0yOTc1MDM_46942d19-63fc-4c53-ad98-a742c68dd01b"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie008783b9a804da39b8b478db605bf2e_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC02LTEtMS0yOTc1MDM_5144f449-d279-4c69-ae62-12fec9251ef5"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ide9fb602617c4361b1e1413aad64fba1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC04LTEtMS0yOTc1MDM_9483075c-b550-4bb4-962c-fabbe6dff69f"
      unitRef="usd">100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i41c166f0f4ac4071b5451ad221b1c85b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC0xMC0xLTEtMjk3NTAz_50e91e51-19fa-4af2-a616-544576e07d0b"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i04725fb2248c4ebeabaaa3e07ead859d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNC0xMi0xLTEtMjk3NTAz_9b4ca5a5-0a23-4ad6-82fe-87cdfcbe79cb"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssets
      contextRef="i42c93a65a4db40e38259118bf87ca950_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS0yLTEtMS0yOTc1MDM_cca87c2a-18be-47de-b2fa-f6dd6a1efb76"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iec4efa57993147ecbf3218e1e2ad5e1d_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS00LTEtMS0yOTc1MDM_d7be2090-073e-4433-b88c-50827ea6222b"
      unitRef="usd">3400000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i54d490f02cff46969dc0d4b06f3a6c1a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS02LTEtMS0yOTc1MDM_f8b37f52-deea-4c56-b5c2-ad692e3dc160"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1480475fcfcf4911a302de8597350461_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS04LTEtMS0yOTc1MDM_01b8f755-c906-4721-8202-14afb1467408"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i9220abdafe514bd1bc03b527e4e345fe_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS0xMC0xLTEtMjk3NTAz_7fc41065-9d7b-4bc2-974b-704a4d651039"
      unitRef="usd">4200000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i9993c7a02a6a4c7ea61954c3d40b6757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfNS0xMi0xLTEtMjk3NTAz_e64df5a7-1dac-4ee6-bb41-8e83bbc752f9"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="idcd10964e4444c5aa7f56a883baa41b4_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS0yLTEtMS0yOTc1MDM_468f9c47-d365-4ae5-bfdf-ee86effd2ba8"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i92e48502376142e5ac4f235d7f18af12_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS00LTEtMS0yOTc1MDM_363157f4-993e-4e5f-9433-adf51629dd79"
      unitRef="usd">24900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ibede6d5d7f6e435d97c1430b6dee57cf_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS02LTEtMS0yOTc1MDM_aee3d154-9e16-4934-b2ee-6749b75d985e"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i182417c07231420c9b57037a5f01eef3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS04LTEtMS0yOTc1MDM_2355be5b-64fc-493a-a2b3-3117e90d3d39"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i04a834f03a804608931a9b7597442b59_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS0xMC0xLTEtMjk3NTAz_de96adf2-b393-4b51-8ecf-bdc971fac97d"
      unitRef="usd">50500000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i55e23d064ac94e579d65b01ab85c557a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfOS0xMi0xLTEtMjk3NTAz_8947889b-6adb-4de0-8582-082288f55b4d"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia38fe8e9a9f04f668590d3cd5af1bea2_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtMi0xLTEtMjk3NTAz_e6ad8918-715e-4a75-b9c9-1440a0987e70"
      unitRef="usd">100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i323e00f452604c9e8efdeea764a4c5b9_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtNC0xLTEtMjk3NTAz_94c8aabb-33b5-4a79-8115-12231e05fcd2"
      unitRef="usd">28300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie008783b9a804da39b8b478db605bf2e_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtNi0xLTEtMjk3NTAz_08af4153-f317-4c44-84f6-f327748bfac0"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ide9fb602617c4361b1e1413aad64fba1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtOC0xLTEtMjk3NTAz_ac451cf5-b597-4f64-9f99-aa5b4b10bacd"
      unitRef="usd">100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i41c166f0f4ac4071b5451ad221b1c85b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtMTAtMS0xLTI5NzUwMw_8fcf3c56-0222-4abc-b585-25fb6a42d8a1"
      unitRef="usd">54700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i04725fb2248c4ebeabaaa3e07ead859d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTEtMTItMS0xLTI5NzUwMw_330d18b2-4fb3-4c48-81cb-34d10f49dfcd"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="i8e1c235573a44397aede9c7af5b6226c_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtMi0xLTEtMjk3NTAz_335f4f7c-6f0f-43db-ad2d-03de8ada4113"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i50a400f80e334fac81f4e0f510dd26d4_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtNC0xLTEtMjk3NTAz_8972fef2-b1f7-46f1-9483-fa06ea465004"
      unitRef="usd">111300000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ie79b2663ac03492fa74b7ec953837986_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtNi0xLTEtMjk3NTAz_67697d18-5fac-46e5-b575-cf8d0fe4b6fc"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i7ed8e3a070954dd99dcac4657d4e487f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtOC0xLTEtMjk3NTAz_3330eaa2-e821-4f81-9d97-1770eb817d57"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i850a948962d64a65adff8d59644ca588_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtMTAtMS0xLTI5NzUwMw_13a932aa-f426-431e-8d59-ea41d3cbc879"
      unitRef="usd">96100000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i24fce60834ce4f74a2d6fdbbbe84bbf8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTQtMTItMS0xLTI5NzUwMw_91219e45-268e-4436-9db4-b67a065be369"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i42c93a65a4db40e38259118bf87ca950_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtMi0xLTEtMjk3NTAz_73958a39-d96d-447c-a190-ff8652382113"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="iec4efa57993147ecbf3218e1e2ad5e1d_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtNC0xLTEtMjk3NTAz_160f6a5b-de23-444e-88a6-530b5210d4a4"
      unitRef="usd">3100000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i54d490f02cff46969dc0d4b06f3a6c1a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtNi0xLTEtMjk3NTAz_d64d4bce-bee0-4dc3-ac37-db9ef180121e"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1480475fcfcf4911a302de8597350461_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtOC0xLTEtMjk3NTAz_9f157e90-6127-44dd-8652-065e753ae61f"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i9220abdafe514bd1bc03b527e4e345fe_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtMTAtMS0xLTI5NzUwMw_8bba9eeb-c12d-41f4-afe6-ccbb7464affe"
      unitRef="usd">5200000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i9993c7a02a6a4c7ea61954c3d40b6757_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTUtMTItMS0xLTI5NzUwMw_96660001-1eac-4abc-a9d1-05a482597da7"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia38fe8e9a9f04f668590d3cd5af1bea2_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtMi0xLTEtMjk3NTAz_535aaf21-31a7-476e-8eae-99549c3287dc"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i323e00f452604c9e8efdeea764a4c5b9_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtNC0xLTEtMjk3NTAz_1f0d26c4-59ec-44e0-a759-32a76b08dcb0"
      unitRef="usd">114400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie008783b9a804da39b8b478db605bf2e_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtNi0xLTEtMjk3NTAz_76c815f5-abff-4e54-8e09-52fe42d93232"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ide9fb602617c4361b1e1413aad64fba1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtOC0xLTEtMjk3NTAz_90f8cd5c-af00-438a-b16e-272528816b1e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i41c166f0f4ac4071b5451ad221b1c85b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtMTAtMS0xLTI5NzUwMw_dbc3c1c4-e7f4-41b2-a510-f5eb7f18432a"
      unitRef="usd">101300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i04725fb2248c4ebeabaaa3e07ead859d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOjk3NjhiZmExOTcxNjQwZGZhYzdmNWFkMmIzYzJjYTdlL3RhYmxlcmFuZ2U6OTc2OGJmYTE5NzE2NDBkZmFjN2Y1YWQyYjNjMmNhN2VfMTgtMTItMS0xLTI5NzUwMw_ec501a30-2597-44b7-b71c-f4c074349eb2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RleHRyZWdpb246MjYwODdiZDk4OGNmNDRhNGJjM2ZkMzMyN2ZhMzI4MWRfMTMzNA_f4d1716a-669c-44f1-a1d1-34eef8b07403">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fixed rate long-term debt consisted of the following (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:369.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:172.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:93.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:93.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Public Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Carrying value (excluding discount)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,315.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,225.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:SeniorNotes
      contextRef="ibc98dc57d99e4819af454bec68b9436c_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOmM3MzM0NTIzMWIyZjQyN2FhYmI3NjIyZGM0ZDkzMmRiL3RhYmxlcmFuZ2U6YzczMzQ1MjMxYjJmNDI3YWFiYjc2MjJkYzRkOTMyZGJfMy0xLTEtMS0yOTc1MDM_7792ab6e-ace2-4cdb-bd86-ceddd01ac5ca"
      unitRef="usd">2544400000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i4e444dcadb33488daa64185519d1ac50_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOmM3MzM0NTIzMWIyZjQyN2FhYmI3NjIyZGM0ZDkzMmRiL3RhYmxlcmFuZ2U6YzczMzQ1MjMxYjJmNDI3YWFiYjc2MjJkYzRkOTMyZGJfMy01LTEtMS0yOTc1MDM_d8b35eb6-225e-416e-9554-5d3521872aca"
      unitRef="usd">2544400000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i39273b39b09344b1a7df355b3202f917_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOmM3MzM0NTIzMWIyZjQyN2FhYmI3NjIyZGM0ZDkzMmRiL3RhYmxlcmFuZ2U6YzczMzQ1MjMxYjJmNDI3YWFiYjc2MjJkYzRkOTMyZGJfNC0xLTEtMS0yOTc1MDM_16228b4e-8e52-4d41-98f1-ffe13fbb177d"
      unitRef="usd">2315000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="ibfb63dc591b74a43a816a11b9df7a30b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV81NS9mcmFnOjI2MDg3YmQ5ODhjZjQ0YTRiYzNmZDMzMjdmYTMyODFkL3RhYmxlOmM3MzM0NTIzMWIyZjQyN2FhYmI3NjIyZGM0ZDkzMmRiL3RhYmxlcmFuZ2U6YzczMzQ1MjMxYjJmNDI3YWFiYjc2MjJkYzRkOTMyZGJfNC01LTEtMS0yOTc1MDM_28121546-12f0-49cc-baf8-7357e14c9164"
      unitRef="usd">2225400000</us-gaap:SeniorNotes>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTcxMw_7dbc4241-1686-4ac9-87fc-a551d7c194d2">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES &#160;&#160;&#160;&#160; &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Option Contracts &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price for HRA Pharma, we entered into two non-designated currency option contracts with a total notional amount of $1.1 billion that were scheduled to mature in September 2022. In April 2022, due to market conditions, we unwound the two options and entered into two new undesignated options to economically hedge the purchase price for HRA Pharma for a total notional amount of $2.0&#160;billion. All premiums associated with the HRA Pharma related currency options were settled in April 2022 for $37.1&#160;million. Within Other (income) expense we recorded a $3.5 million loss for the three months ended April&#160;2, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swaps &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, to economically hedge the interest rate risk of the New Senior Secured Credit Facilities (as defined in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_73" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), we entered into five variable-to-fixed interest rate swap agreements. Three of the interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan B Facility (as defined in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_73" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2029, on notional balances that decline from $1.0&#160;billion to $812.5&#160;million over the term. The other two interest rate swaps were designated as cash flow hedges to fix the interest rate on a substantial portion of the 2022 Term Loan A Facility (as defined in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_73" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The interest rate swaps cover an interest period ranging from June 1, 2022, through April 1, 2027, on notional balances that decline from $487.5&#160;million to $387.5&#160;million over the term. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a designated cash flow hedge, gains and losses will be deferred in AOCI and recognized within Interest expense, net when interest is paid on the New Senior Secured Credit Facilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross-currency Swaps &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In April 2022, we entered into three fixed-for-fixed cross currency interest rate swaps designated as net investment hedge to hedge the EUR currency exposure of our investment in European operations. In October 2022, we replaced those swaps by entering into three fixed-for-fixed cross currency interest rate swaps at market rates and designated the instruments as net investment hedges on our investment in European operations. The following are the terms and notional amounts outstanding: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;$700&#160;million notional amount outstanding from October 25, 2022 through December 15, 2024; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;$700&#160;million notional amount outstanding from October 25, 2022 through March 15, 2026; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;$100&#160;million notional amount outstanding from October 25, 2022 through June 15, 2030.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Forwards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notional amounts of foreign currency forward contracts were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.894%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;British Pound (GBP)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;224.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;European Euro (EUR)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Swedish Krona (SEK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States Dollar (USD)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Chinese Yuan (CNH)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Danish Krone (DKK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canadian Dollar (CAD)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mexican Peso (MXN)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Hungarian Forint (HUF)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Polish Zloty (PLZ)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Norwegian Krone (NOK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;559.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;593.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Number consists of various currencies notional amounts, none of which individually exceed $10 million in either period presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maximum term of our forward currency exchange contracts is 60 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effects of Derivatives on the Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects. The balance sheet location and gross fair value of our derivative instruments were as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:164.50pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:175.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Designated derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total designated derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-designated derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total non-designated derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Designated derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total designated derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-designated derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Consolidated Statements of Operations were as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-Designated Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income Statement Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the effect of derivative instruments designated as hedging instruments in AOCI (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:570.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:150.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:90.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:117.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:39pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recorded in OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Classification &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in Earnings on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Net loss of $1.6 million is expected to be reclassified out of AOCI into earnings during the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:246.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:32pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest Expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:39pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;767.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:39pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,074.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;736.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i0391704d774f4479b2bd6287047b946b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY2Nw_000491ca-73fc-413c-bc52-468a7a8dc8c5"
      unitRef="derivative">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i863dc014fe5a4fd69e51cabe6ed66bef_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMzA1_1e59a164-8cbe-4353-816a-9070bb1b777c"
      unitRef="usd">1100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i703d29ff729d4c809efa88132b4033f6_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY4OA_e258225e-eaa7-4d85-8526-7bb6f766dd32"
      unitRef="derivative">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i703d29ff729d4c809efa88132b4033f6_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY2MA_57a59663-2c71-4920-9555-f27e341d6511"
      unitRef="derivative">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i703d29ff729d4c809efa88132b4033f6_I20220430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTU4_d8827702-4d8d-4aee-bef4-4f2b9b07e3f5"
      unitRef="usd">2000000000</us-gaap:DerivativeNotionalAmount>
    <prgo:PaymentsForPremiumsOnDerivativeInstruments
      contextRef="ie73d3af15eaf44a38b8cd158e74b7934_D20220401-20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNjYy_d5eff91f-1ebb-44b0-9b17-ac6535259590"
      unitRef="usd">37100000</prgo:PaymentsForPremiumsOnDerivativeInstruments>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="if59013eda0ee4c9783bb2aa14130c446_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTQ5NzU1ODI1NjI2_ce770e65-dd10-4d67-b6d7-1814a40c2498"
      unitRef="usd">3500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i69de5a172d6c4557ac718e348bdb6557_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTM4OA_aa066b52-1d0f-483a-a64a-08a6bfb3596c"
      unitRef="derivative">5</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i4fe60b7eb3e54bf4bec247c65d45ad0d_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTQ0MA_480a58c0-6d5f-4b37-8769-709a27a35206"
      unitRef="derivative">3</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8d3d3fb12721426a98d72c0b4de560d8_I20220430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTc1Mg_dc58d25c-27b8-4594-baa4-add8d25c99b9"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib95874ed8320453c88600e7dd3a13d14_I20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTc1OA_f79f8919-4e7b-4926-9ac7-eb066c6e11f8"
      unitRef="usd">812500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="ideed9f35811341b6987034ed4edf23a9_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTc4Ng_daff888a-1fce-423d-a324-66076ff36488"
      unitRef="brand">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i579bce87d950488c9440b6afa28de94c_I20220601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMjA5MQ_7d34a74a-fde4-499c-aadf-36f00a1b4a0f"
      unitRef="usd">487500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i231ffb94f5014c56bb9ab4f128394b92_I20220601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMjA5Nw_dc2287ab-7de5-4631-b6d2-99d61a397256"
      unitRef="usd">387500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="id158617640374c9fa1495cf02188a911_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMjQwMg_4b5dfd26-beeb-4f5d-aa2f-efff3f305dbe"
      unitRef="derivative">3</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="ib6f681b4b8d84632a9cc71f98e1bb3d6_I20221025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMzMwOA_f19d3129-5817-40d3-bb8f-aaec01a45bac"
      unitRef="derivative">3</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iea716b8db0224b21bca000c2d1d526a3_I20221025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMzU0NA_7a682bfa-37ef-48d2-96a2-0095995e4efe"
      unitRef="usd">700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie8461440591543a29bafbb6383d528eb_I20221025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMzYyNQ_37cb4c2b-5b14-4c60-abff-61b230ba1d24"
      unitRef="usd">700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i55284888fcd34a93ba5adfc643dfd08e_I20221025"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMzcwNw_4fd49c7d-a8f0-45a7-882e-799ff18ac8ff"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY3NQ_fbd5b480-04cf-4869-afed-031e4ebafc3f">oreign currency forward contracts were as follows (in millions):&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.894%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;British Pound (GBP)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;224.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;European Euro (EUR)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Swedish Krona (SEK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States Dollar (USD)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Chinese Yuan (CNH)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Danish Krone (DKK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canadian Dollar (CAD)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mexican Peso (MXN)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Hungarian Forint (HUF)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Polish Zloty (PLZ)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Norwegian Krone (NOK)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;559.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;593.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Number consists of various currencies notional amounts, none of which individually exceed $10 million in either period presented.&lt;/span&gt;&lt;/div&gt;</prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7c0c512854e04191adfce17ad716634b_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMi0yLTEtMS0yOTc1MDM_30ccb7df-a455-4747-9117-bf86264ae723"
      unitRef="usd">213100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i72e0c6387a644ace96085e11f8e677ed_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMi00LTEtMS0yOTc1MDM_54c0c269-06cb-460d-b068-d315f0359837"
      unitRef="usd">224900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5d39d66893f44acf940bd4020fe80a61_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMi0yLTEtMS0zNTUxODI_10b7ef25-22c2-4e91-b7ab-aeed84c092b9"
      unitRef="usd">65800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2cd991dd16c04acca9ac92cc1bede2e8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMi00LTEtMS0zNTUxODI_bfe3941f-7853-4fd8-a7b2-53e0371c370e"
      unitRef="usd">61700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib1d7962673e54ecf9e8c6b4bf23987b5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMy0yLTEtMS0yOTc1MDM_7996acf4-f503-4eab-be2d-06fe63ba6b81"
      unitRef="usd">65600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i28f2b3c78bed464c913866d5104a819f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMy00LTEtMS0yOTc1MDM_c0d69c17-e833-49c8-9e8d-4d1155703141"
      unitRef="usd">56900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id143f134d71c4b3eab34c1f0ee8afdab_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNC0yLTEtMS0yOTc1MDM_8821fd4e-2cc1-4329-a8e6-f81e6a54d46c"
      unitRef="usd">54800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if7f5b573a7f14d31b174ed365e23e979_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNC00LTEtMS0yOTc1MDM_311ee8ef-8a03-438d-9b10-74694490d81a"
      unitRef="usd">51700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i52a46e2bb32541beba33898f230357f7_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNS0yLTEtMS0zNTUxOTI_a6489f1d-f76b-4981-ad65-231d1661a4bf"
      unitRef="usd">26500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie6c621b427f04e8796899f12e0d2010e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNS00LTEtMS0zNTUxOTI_f0bf6d76-7362-4cdc-8e14-9cb90c236339"
      unitRef="usd">34400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idc816fb252f242b985c969760b37834f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNS0yLTEtMS0yOTc1MDM_ca6a77e4-7dad-4a12-a5f0-68368c57f85b"
      unitRef="usd">26300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7f6d73713f78476b8e8534d2a1895b4c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNS00LTEtMS0yOTc1MDM_c76e1e53-b5b3-4d71-9155-6aea0a19d37a"
      unitRef="usd">51700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2aa8244a981b494783cc178b23ffb387_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNi0yLTEtMS0yOTc1MDM_e63938e7-b2df-41e7-b4ea-ec06e12435c8"
      unitRef="usd">19700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9413936dee484f3c8c6f293e20f8e318_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNi00LTEtMS0yOTc1MDM_35b4ea94-f8a6-4a87-9170-d730ca099ff0"
      unitRef="usd">24900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic3d2ba962fcb47f197b0697553afd857_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNy0yLTEtMS0yOTc1MDM_f8d0196b-f350-4adb-a5ca-f04eb053aa31"
      unitRef="usd">19400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i141d55293db343b9858355f37d0a46e6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfNy00LTEtMS0yOTc1MDM_f4e2c48d-8396-4148-b881-00fd52362278"
      unitRef="usd">13300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icf4d615378ef46f4bcb95c10b96705e6_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTAtMi0xLTEtMjk3NTAz_b6c39857-cd3c-4d59-a17b-f2b059848aa7"
      unitRef="usd">15800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic48b9d0358ef4fc9b04eadf1f455b1f1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTAtNC0xLTEtMjk3NTAz_afbd4823-deeb-4c67-b79e-1bcbcaf34c6b"
      unitRef="usd">10600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id4570a0e785e400a97404bd558852b0a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTEtMi0xLTEtMjk3NTAz_855644d8-dcfe-4662-8a3d-d58bd616d4fa"
      unitRef="usd">15700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibf3ff649eb5e43a89fb4b4cc0dcb1556_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTEtNC0xLTEtMjk3NTAz_68496fa7-9a9c-4b2a-bd18-fa1c0109173d"
      unitRef="usd">25200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i24abf1ca03e84edba4b6d0d18c9fcd6a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTItMi0xLTEtMjk3NTAz_687c8de9-0855-40c6-9cad-532126957d62"
      unitRef="usd">10500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i02c31ca1b12a4d6081f2a49aba1e6718_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTItNC0xLTEtMjk3NTAz_a0bf2867-1846-4eb8-a4ac-c5e56c136a5b"
      unitRef="usd">12400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iefefab2c0f7c4ccaacc90d873855372d_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTktMi0xLTEtMjk3NTAz_32c0b48c-2eca-42b5-950a-1ab9d856518c"
      unitRef="usd">26300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7136cb4396ad4a658534b085e82dbfc7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMTktNC0xLTEtMjk3NTAz_ad22d30e-dbb4-464d-88ab-19d738498d88"
      unitRef="usd">25900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i58e9f89e450b4789b74027090e527fd2_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMjItMi0xLTEtMjk3NTAz_97e8958b-1248-448c-a8a3-1e0db457a09d"
      unitRef="usd">559500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie2e286c007514bd88ef38594ee3f765b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmQ2YjFmMzA4OTQ0YTRlNGFhNjRhZjVkNzM3N2JiYjFkL3RhYmxlcmFuZ2U6ZDZiMWYzMDg5NDRhNGU0YWE2NGFmNWQ3Mzc3YmJiMWRfMjItNC0xLTEtMjk3NTAz_37169959-6abf-4529-a079-9c4207e6e06f"
      unitRef="usd">593600000</us-gaap:DerivativeNotionalAmount>
    <prgo:DerivativeNotionalAmountMaximumIndividualAmount
      contextRef="iefefab2c0f7c4ccaacc90d873855372d_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTQ5NzU1ODE5OTcx_3d237e89-f83f-4d9b-9200-5c6cb419684d"
      unitRef="usd">10000000</prgo:DerivativeNotionalAmountMaximumIndividualAmount>
    <prgo:DerivativeNotionalAmountMaximumIndividualAmount
      contextRef="i7136cb4396ad4a658534b085e82dbfc7_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTQ5NzU1ODE5OTcx_b5faf703-c666-49b8-83ad-aed9a4f54dcb"
      unitRef="usd">10000000</prgo:DerivativeNotionalAmountMaximumIndividualAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="i9a74650587a0467ab9f464dd51bad8b6_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNDczNw_dda37a53-78f5-4fcf-9e88-b5b4dbb6edb8">P60M</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY2MQ_65d670d7-a983-4920-a96b-ff6edfba4159">The balance sheet location and gross fair value of our derivative instruments were as follows (in millions): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:164.50pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:175.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:84.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Designated derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total designated derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-designated derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total non-designated derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Designated derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total designated derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-designated derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i548d3c81888a421d840889bc4a3e1068_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNC0zLTEtMS0yOTc1MDM_632d1165-1b13-4fe1-ad90-ac5df8d7df42"
      unitRef="usd">1600000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i0cb6d2a114c44f87b07e610ccad0481a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNC01LTEtMS0yOTc1MDM_bd2445a0-b8da-4710-8a62-79e6a6209f09"
      unitRef="usd">1100000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i0255c8396730441fab6e09dbb1afb422_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNS0zLTEtMS0yOTc1MDM_2387a974-3b35-4fcd-987e-aa3ffd72d85b"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i2e0b4d9aeda94165b64f6361c52863a1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNS01LTEtMS0yOTc1MDM_edc73dab-c6e0-4198-aca1-0da3cbc1e7fb"
      unitRef="usd">3000000.0</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i055ddb3eb7864ddbb72cc19e608e8248_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNi0zLTEtMS0yOTc1MDM_87baf576-eb78-431b-9621-179863533e4d"
      unitRef="usd">700000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="id3b19260e3134f8eac6745ebd39cfaba_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfNi01LTEtMS0yOTc1MDM_2ed30539-2fde-44b6-bd82-5f2b8a1d45ab"
      unitRef="usd">700000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="if0e4ace05b3746aab7f10dd86bdf5642_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfOS0zLTEtMS0yOTc1MDM_2c646e17-9678-4265-b9c3-86f40df4b389"
      unitRef="usd">24900000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i6d974173dfdd4a52a46760690fe23666_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfOS01LTEtMS0yOTc1MDM_10d95d2e-7f60-4afd-a6dd-5dedc0aa3ccc"
      unitRef="usd">47500000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i0eccd056afc545b39529ed76bdd93865_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTAtMy0xLTEtMjk3NTAz_2797712a-cd91-4918-a956-7e0aad9de0b3"
      unitRef="usd">27200000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="ibc338e7d11bb49c0b3dd26e0b630ceaf_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTAtNS0xLTEtMjk3NTAz_37872d32-bc54-4c93-9316-09e22645c467"
      unitRef="usd">52300000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i72ca5dc3f5a248a1ad6f808b50351d6a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTItMy0xLTEtMjk3NTAz_5edae56f-1664-46c7-94d5-cb1a95c5522d"
      unitRef="usd">1100000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i4006135836b64c4a9a25d99b7b066e0d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTItNS0xLTEtMjk3NTAz_8dac300f-5114-4085-a7b5-a759c91c1207"
      unitRef="usd">2400000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i883728cd2fe84026a4db286c1fb80ffe_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTQtMy0xLTEtMjk3NTAz_1d5d2a12-d011-4cce-97e9-ef0c20b480c2"
      unitRef="usd">1100000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i56e2de60b8a148eeb14a18745abe9a02_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTQtNS0xLTEtMjk3NTAz_bc360dbb-9a71-4c5d-bf49-13ea22ad584d"
      unitRef="usd">2400000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i7d46728e14d44678a73c2145851d2fb6_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTctMy0xLTEtMzQxMjU4_66c782a6-b77c-4596-ac28-5dc52f75a0b5"
      unitRef="usd">2300000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="ida370fe5573e4ed7ba48cf6fe97b5c67_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTctNS0xLTEtMzExNzA5_a6986248-cb54-499a-9421-8caa7774c72b"
      unitRef="usd">4200000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i1ec0d02e7d8d49f2aa9b45ada2bfaef8_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTgtMy0xLTEtMzQxMjU4_dacc3070-a282-4738-9020-494532d01aa8"
      unitRef="usd">111300000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="iae577995f42d4580ba2516f347bba679_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMTgtNS0xLTEtMzExNzI0_6a559ae7-e55e-49aa-8fab-5df43922b8f9"
      unitRef="usd">96100000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i0eccd056afc545b39529ed76bdd93865_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMjAtMy0xLTEtMzQxMjU4_ebcc8766-f04e-498a-aac4-83611385fee3"
      unitRef="usd">113600000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="ibc338e7d11bb49c0b3dd26e0b630ceaf_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMjAtNS0xLTEtMzExNzM3_0eaa2603-7cba-4c2c-89fe-73717c44d366"
      unitRef="usd">100300000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i19bf4a75be9945638b85dd2447d4ad7f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMjItMy0xLTEtMzQxMjU4_86969b1e-5bb9-4ba7-919b-0af08074fac9"
      unitRef="usd">800000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="if48bc899a04941fcaa88ed2870642735_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJkMGU3NjQ0NzA4NTRkMDM5YjAxNDg3NWI3MmRjY2M2L3RhYmxlcmFuZ2U6YmQwZTc2NDQ3MDg1NGQwMzliMDE0ODc1YjcyZGNjYzZfMjItNS0xLTEtMzExNzcy_8da19d35-2027-448b-8cc9-1d0f4ebcbeaa"
      unitRef="usd">1000000.0</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMjE5OTAyMzI2MzQ0MQ_62502fbe-6d9c-451b-a2b5-3afa9baa8d1b">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts of (income)/expense recognized in earnings related to our non-designated derivatives on the Consolidated Statements of Operations were as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.824%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-Designated Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income Statement Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i1eee7139231548609a6bed77c36f242c_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfMi00LTEtMS0zMTIzMTg_371de3ce-51b1-4682-9141-16c840864276"
      unitRef="usd">-1200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i415d640a98a648a49bb88703fc4bf417_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfMi02LTEtMS0zMTIyNTI_7bfb1c8c-af2a-4cfd-8bb8-c3c2e1e9a414"
      unitRef="usd">500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i86211ac950df4f52b3bdb376967439bd_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfMy00LTEtMS0zMTIzMjg_cc371716-95a0-4bb3-8ebb-af3c91ae1604"
      unitRef="usd">-600000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="idb2d9216b7b04cf0a3ecb3d790f50e69_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfMy02LTEtMS0zMTIyNjk_4c4766fc-2991-402f-9e89-365512174998"
      unitRef="usd">-400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="id11eac94d9bd4b9b8ae0373021cc6731_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfNC00LTEtMS0zMTIzNDM_0c229edc-8e1d-470f-99b4-be17a684a843"
      unitRef="usd">-1800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0d55a845d92a4d0bbc62c63895976038_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfNC02LTEtMS0zMTIyODI_7cabe964-a918-4fec-a90f-1f27e1a029df"
      unitRef="usd">100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i794270c4878944cab78f1bdba967d567_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfNi00LTEtMS0zMTIzNjY_a2f0a678-46ee-4d12-b3d3-9956a13a8a6c"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="if59013eda0ee4c9783bb2aa14130c446_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmFkOGU0ZDdlZTRmZTQ2OTg5ZTI4NWNiOWU2ZWYzNTVmL3RhYmxlcmFuZ2U6YWQ4ZTRkN2VlNGZlNDY5ODllMjg1Y2I5ZTZlZjM1NWZfNi02LTEtMS0zMTIzMDA_8b8952a9-2fd5-403e-95e0-aa4feb52251b"
      unitRef="usd">3500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTY4OQ_1fbb62f2-4321-4d1d-9c29-997b32ca9759">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the effect of derivative instruments designated as hedging instruments in AOCI (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:570.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:150.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:90.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:117.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:66.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Related to Amounts Excluded from Effectiveness Testing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:39pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recorded in OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Classification &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in Earnings on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Net loss of $1.6 million is expected to be reclassified out of AOCI into earnings during the next 12 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iaec9a490f09d45b88e90070c6c101e1d_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNi0yLTEtMS0yOTc1MDM_a34914df-d39c-43d4-8f1f-b486e1849d96"
      unitRef="usd">24900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="iaec9a490f09d45b88e90070c6c101e1d_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNi02LTEtMS0yOTc1MDM_96286daf-8b8a-4da9-b4a3-008e180390d1"
      unitRef="usd">2900000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="i170e5f4e14d94ed2bf2f5e30f221c7a3_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNi0xMC0xLTEtMjk3NTAz_808bd76a-8dff-4f06-8ff4-9154db52b5d8"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9a74650587a0467ab9f464dd51bad8b6_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNy0yLTEtMS0yOTc1MDM_f263c606-8e36-4614-9193-a8121390657c"
      unitRef="usd">-6700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i8be97fbfb6bc4fdc93582f7325963e07_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNy02LTEtMS0yOTc1MDM_f76060c0-106f-409e-be8e-3c58b3c88e9d"
      unitRef="usd">400000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i8be97fbfb6bc4fdc93582f7325963e07_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfNy0xMC0xLTEtMjk3NTAz_87809c7c-3aa4-47c0-a28b-1862c87806d9"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ieecd1150963c4685ab0218460f0f71ce_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfOC02LTEtMS0yOTc1MDM_eab326f2-9acf-4be6-92d0-e8d8f34e1e10"
      unitRef="usd">-200000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="ieecd1150963c4685ab0218460f0f71ce_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfOC0xMC0xLTEtMjk3NTAz_25dca020-987b-419d-a8fb-2c8594fb4f2e"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfOS0xMC0xLTEtMjk3NTAz_ed12fb4f-530a-45e3-81d1-6c3199e6840b"
      unitRef="usd">100000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTAtMi0xLTEtMjk3NTAz_e20ae864-af91-4a7a-8915-8b12ab47b3a0"
      unitRef="usd">18200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTAtNi0xLTEtMjk3NTAz_f27309a6-d454-48bd-b8ad-597f2c429dbb"
      unitRef="usd">3100000</prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTAtMTAtMS0xLTI5NzUwMw_6718220a-e806-495c-ac4b-d30d314e0ea8"
      unitRef="usd">100000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if2e5203a533d4aee8b2fdbcf22b56556_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTItMi0xLTEtMjk3NTAz_7f2b095f-86be-4a5d-9164-3147a27d8f74"
      unitRef="usd">-23700000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="i22e1c81f675a48eaa5a572a21687d185_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTItMTAtMS0xLTI5NzUwMw_af65abab-649e-4850-bd9b-dd693b31d96f"
      unitRef="usd">-6500000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i66107ad7ba8046ec942972e9becaaff6_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTktMi0xLTEtMzMyODk2_458c9073-f634-4194-970c-f19ed7bce197"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i66107ad7ba8046ec942972e9becaaff6_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTktNi0xLTEtMzMyOTY1_7eb10d5d-7025-44d6-a29c-a9f39287eaff"
      unitRef="usd">-500000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness
      contextRef="i3f3f8cdce8a5422aa8044ef1e7ea60f3_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMTktMTAtMS0xLTMzMjk5MA_dd1476b5-11a7-46c1-a28f-aaf4a67ccd43"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ibd5c9b62aef54b399eed74960e878654_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjAtMi0xLTEtMzMyOTAw_4059d61a-3ebc-4ac3-b3da-de2d05bc0582"
      unitRef="usd">-7200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i8ef3599264dc4912b8aaad190f86b782_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjAtNi0xLTEtMzMyOTcw_aa5364d2-e70f-4f22-9eea-3abc197d0d1c"
      unitRef="usd">300000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i8ef3599264dc4912b8aaad190f86b782_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjAtMTAtMS0xLTMzMjk5NA_051fe2b9-62c5-40e3-99a4-001f01193785"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i6c74f5dd34524d48896153867df4a030_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjEtNi0xLTEtMzMyOTc1_1c351e0d-4b59-495f-8548-7a05b4371217"
      unitRef="usd">-400000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i6c74f5dd34524d48896153867df4a030_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjEtMTAtMS0xLTMzMjk5OA_4f67bd1d-4a28-4283-8c2b-9b081e75ad1a"
      unitRef="usd">100000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjItMTAtMS0xLTMzMzAwMg_43d8c8ed-1537-4b7c-9894-eb0591162e8e"
      unitRef="usd">100000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjMtMi0xLTEtMzMyOTA0_e7a1bcd2-0355-4c6e-9a80-e5ac3cf0089b"
      unitRef="usd">-7200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjMtNi0xLTEtMzMyOTg2_de670354-eb4d-43f8-92c0-7773ab7c41f8"
      unitRef="usd">-600000</prgo:CashFlowHedgeGainLossReclassifiedtoEarningsNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjMtMTAtMS0xLTMzMzAwNg_0a90dd58-7e8a-49a0-a4aa-eeced635c495"
      unitRef="usd">200000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5dae718ccbd74caa8a4114db6e48afcd_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjUtMi0xLTEtMzMyOTA5_bd58e44f-7546-4ec7-a066-59e7e332545d"
      unitRef="usd">-4600000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness
      contextRef="if02007e835294982ad3505eac48241f5_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOjM0YTg5MjVlZTQ5NTQ2OWFhY2RjMWY1NjIyMTMxZjk4L3RhYmxlcmFuZ2U6MzRhODkyNWVlNDk1NDY5YWFjZGMxZjU2MjIxMzFmOThfMjUtMTAtMS0xLTMzMzAxMA_5508a720-26b9-463f-91c7-49e788746ab9"
      unitRef="usd">-500000</prgo:GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfMTA5OTUxMTYzOTQxOQ_c62922e3-3309-4a23-bc6a-6383850aed06"
      unitRef="usd">-1600000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RleHRyZWdpb246NTRkMmM1YzJmYzg5NDgxZmFlNGFmOWNiODIxY2IxOGRfNTcxNA_f1463495-3b8e-46eb-9c6c-bebe3430aa34">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification and amount of gain/(loss) recognized in earnings on fair value and hedging relationships were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:246.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:32pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest Expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other (Income) Expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:39pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;767.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Three Months Ended April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:39pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented on the Condensed Consolidated Statements of Operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,074.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;736.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amount of gain or (loss) reclassified from AOCI into earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMy0yLTEtMS0yOTc1MDM_6b7b8cdd-8904-4c94-9512-4ca254f6626f"
      unitRef="usd">1181700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMy00LTEtMS0yOTc1MDM_7a944686-d9e1-474d-ac40-0f1a40719323"
      unitRef="usd">767900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMy02LTEtMS0yOTc1MDM_f5827849-3445-47e0-b347-26aaaa28d40d"
      unitRef="usd">-43700000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMy04LTEtMS0yOTc1MDM_e098e497-b59a-4b6d-948a-b7dea7f2c91c"
      unitRef="usd">-500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i8be97fbfb6bc4fdc93582f7325963e07_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOC0yLTEtMS0yOTc1MDM_f76060c0-106f-409e-be8e-3c58b3c88e9d"
      unitRef="usd">400000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ieecd1150963c4685ab0218460f0f71ce_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOC00LTEtMS0yOTc1MDM_eab326f2-9acf-4be6-92d0-e8d8f34e1e10"
      unitRef="usd">-200000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i170e5f4e14d94ed2bf2f5e30f221c7a3_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOC02LTEtMS0yOTc1MDM_97172a6d-783d-4a17-821a-ce4e13869ff5"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOC04LTEtMS0yOTc1MDM_0c0e7eee-7a17-4a5a-918e-161f714e1e3b"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i8be97fbfb6bc4fdc93582f7325963e07_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOS0yLTEtMS0yOTc1MDM_87809c7c-3aa4-47c0-a28b-1862c87806d9"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="ieecd1150963c4685ab0218460f0f71ce_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOS00LTEtMS0yOTc1MDM_25dca020-987b-419d-a8fb-2c8594fb4f2e"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i170e5f4e14d94ed2bf2f5e30f221c7a3_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOS02LTEtMS0yOTc1MDM_ef13196e-ec72-426a-9353-b5f324a02f0e"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfOS04LTEtMS0yOTc1MDM_ed12fb4f-530a-45e3-81d1-6c3199e6840b"
      unitRef="usd">100000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i76e87de477904785908596a6978421c3_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMTYtMi0xLTEtMjk3NTAz_3791ed77-a923-4ab2-a6ae-ae0d2b068405"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="ia295c3555b08448eafa786c04116bed5_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMTYtNC0xLTEtMjk3NTAz_8919e124-d923-4dbc-b1e1-3b2a2e9cdec8"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="iaec9a490f09d45b88e90070c6c101e1d_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMTYtNi0xLTEtMjk3NTAz_96286daf-8b8a-4da9-b4a3-008e180390d1"
      unitRef="usd">2900000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="if9e9d75fab66455da7ef57faeb376f99_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMTYtOC0xLTEtMjk3NTAz_6cfa8c8c-9d09-40f5-a2c9-80dcbb1ba74e"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjAtMi0xLTEtMzMzOTky_35163a52-6869-4071-93b4-b6b19bf8404d"
      unitRef="usd">1074500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjAtNC0xLTEtMzMzOTk2_68bec5e3-0d35-4891-86c1-263f823cb795"
      unitRef="usd">736700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjAtNi0xLTEtMzM0MDAw_28c24a8e-6f5f-44f4-bcfd-b23e5a852971"
      unitRef="usd">-35800000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjAtOC0xLTEtMzM0MDA0_91bbaa0d-7c74-496d-8e1b-ac212fd5ec34"
      unitRef="usd">1100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i8ef3599264dc4912b8aaad190f86b782_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjUtMi0xLTEtMzM0MDA4_aa5364d2-e70f-4f22-9eea-3abc197d0d1c"
      unitRef="usd">300000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i6c74f5dd34524d48896153867df4a030_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjUtNC0xLTEtMzM0MDE2_1c351e0d-4b59-495f-8548-7a05b4371217"
      unitRef="usd">-400000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i3f3f8cdce8a5422aa8044ef1e7ea60f3_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjUtNi0xLTEtMzQxMjY5_38273a03-7a82-4a08-be9a-9deb95c47559"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjUtOC0xLTEtMzQxMjY5_ac0e01fd-67fd-4adb-b449-67a1e0be22ed"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i8ef3599264dc4912b8aaad190f86b782_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjYtMi0xLTEtMzM0MDEy_051fe2b9-62c5-40e3-99a4-001f01193785"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i6c74f5dd34524d48896153867df4a030_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjYtNC0xLTEtMzM0MDIw_4f67bd1d-4a28-4283-8c2b-9b081e75ad1a"
      unitRef="usd">100000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i3f3f8cdce8a5422aa8044ef1e7ea60f3_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjYtNi0xLTEtMzQxMjY5_a283cb60-ca52-4526-b17b-27efd933f695"
      unitRef="usd">0</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness
      contextRef="i7ce02af6c84c408a8645eb437f2a1294_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjYtOC0xLTEtMzM0MDI3_43d8c8ed-1537-4b7c-9894-eb0591162e8e"
      unitRef="usd">100000</us-gaap:GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i860de82b30ab45b2a460cf624e3b5b40_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjgtMi0xLTEtMzQxMjY5_56146918-7930-426c-b1c1-5250d24ecb80"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="iddc45227f2cb42ecb959883c84daf958_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjgtNC0xLTEtMzQxMjY5_dd9bfbe3-874a-4d77-bd22-f29c87981f50"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i66107ad7ba8046ec942972e9becaaff6_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjItNi0xLTEtMjk3NTAz_7eb10d5d-7025-44d6-a29c-a9f39287eaff"
      unitRef="usd">-500000</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
      contextRef="i26700cb91c4c4421814c6b2ef530c802_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV82Ny9mcmFnOjU0ZDJjNWMyZmM4OTQ4MWZhZTRhZjljYjgyMWNiMThkL3RhYmxlOmJiYmNjYjc0MmJiNzQ4MDA4ZjE3NWU2Y2UyYmFmMmViL3RhYmxlcmFuZ2U6YmJiY2NiNzQyYmI3NDgwMDhmMTc1ZTZjZTJiYWYyZWJfMjgtOC0xLTEtMzM0MDM5_290c94d1-fe75-4402-9b6b-c5e3c58be3c2"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNDIyMQ_dac6d251-7e6b-43ad-8640-b2e98bca9395">INDEBTEDNESS &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total borrowings are summarized as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022 Term loan A due April 20, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;490.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;493.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022 Term loan B due April 20, 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,091.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,094.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,582.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,588.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Notes and Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Coupon&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;June 15, 2030&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.300%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 15, 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 15, 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized premium (discount), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total borrowings outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,101.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,106.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current indebtedness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt less current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,062.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,070.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;(1) The coupon rate noted above is as of April&#160;1, 2023, this will increase from 4.400% to 4.650% on payments starting after June 15, 2023, following a credit rating downgrade by Moody's in the first quarter of 2023. Future interest rate adjustments are subject to a 2.0% total cap above the original 3.150% interest rate based on certain rating events as specified in the Note&#x2019;s Supplemental Indenture No. 3, dated as of June 19, 2020, among Perrigo Finance Unlimited Company, Perrigo Company plc and Wells Fargo Bank, National Association, as trustee.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Credit Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 20, 2022, we and our wholly owned subsidiary, Perrigo Investments, LLC, entered into new senior secured credit facilities consisting of (i) a $1.0&#160;billion five-year revolving credit facility (the &#x201c;2022 Revolver&#x201d;), (ii) a $500&#160;million five-year Term Loan A facility (the &#x201c;2022 Term Loan A Facility&#x201d;), and (iii) a $1.1&#160;billion seven-year Term Loan B facility (the &#x201c;2022 Term Loan B Facility&#x201d; and, together with the 2022 Revolver and 2022 Term Loan A Facility, the &#x201c;New Senior Secured Credit Facilities&#x201d;), pursuant to a new Term Loan and Revolving Credit Agreement. The New Senior Secured Credit Facilities are guaranteed, along with any hedging or cash management obligations entered into with a lender, by us and certain of our direct and indirect wholly-owned subsidiaries organized in the United States, Ireland, Belgium and England and Wales (subject to certain exceptions) (the &#x201c;Guarantor Subsidiaries&#x201d;). The Guarantor Subsidiaries and Perrigo Investments, LLC provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 5.300% Notes due 2043 issued by the Company, and the Guarantor Subsidiaries, Perrigo Investments, LLC and the Company provide full and unconditional guarantees, jointly and severally, on a senior unsecured basis, of the 3.900% Notes due 2024, the 4.375% Notes due 2026, the 4.400% Notes due 2030 and the 4.900% Notes due 2044 issued by Perrigo Finance Unlimited Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement also contains customary representations and warranties and customary affirmative and negative covenants applicable to the Borrower and its restricted subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, prepayment of junior indebtedness and dividends and other distributions. The Credit Agreement contains financial covenants that require the Borrower and its restricted subsidiaries to (a) not exceed a maximum first lien secured net leverage ratio of 3.00 to 1.00 at the end of each fiscal quarter and (b) not fall below a minimum interest coverage ratio of 3.00 to 1.00 at the end of each fiscal quarter, provided that such covenants apply only to the 2022 Revolver and the 2022 Term Loan A Facility. If we consummate certain qualifying acquisitions during the term of the loan, the maximum first lien secured net leverage ratio covenant would increase to 3.25 to 1.00 for such quarter and the three following fiscal quarters thereafter. The Credit Agreement also contains customary events of default relating to, among other things, failure to make payments, breach of covenants and breach of representations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended April&#160;1, 2023, principal repayments o&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;f $5.9 million were&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; made on the 2022 Term Loan A Facility and 2022 Term Loan B Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There we&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;re no borrowings outstanding under the 2022 Revolver as of April&#160;1, 2023 or December&#160;31, 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are in compliance with all the covenants under our debt agreements as of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;April&#160;1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Financing&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding under such facilities in the above table under "Other financing". Th&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ere were no borrowings o&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;utstanding under the overdraft facilities as of April&#160;1, 2023 or December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have financing leases that are reported in the above table under "Other financing" (refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_70" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNDIyOA_23e23b54-249d-4d98-bb7b-5c01444fb4b8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total borrowings are summarized as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022 Term loan A due April 20, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;490.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;493.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022 Term loan B due April 20, 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,091.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,094.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total term loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,582.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,588.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Notes and Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Coupon&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;June 15, 2030&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.300%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 15, 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 15, 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,544.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized premium (discount), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total borrowings outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,101.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,106.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current indebtedness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt less current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,062.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,070.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"&gt;(1) The coupon rate noted above is as of April&#160;1, 2023, this will increase from 4.400% to 4.650% on payments starting after June 15, 2023, following a credit rating downgrade by Moody's in the first quarter of 2023. Future interest rate adjustments are subject to a 2.0% total cap above the original 3.150% interest rate based on certain rating events as specified in the Note&#x2019;s Supplemental Indenture No. 3, dated as of June 19, 2020, among Perrigo Finance Unlimited Company, Perrigo Company plc and Wells Fargo Bank, National Association, as trustee.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LoansPayable
      contextRef="ic26457665a374ac89c8e5ccd299aada6_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfNi01LTEtMS0yOTc1MDM_4c5535b0-e3f2-4da9-8267-705a7aa5568c"
      unitRef="usd">490600000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="i5726a6ff23d34fe88fffbd72991b59b5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfNi03LTEtMS0yOTc1MDM_4870da23-3a91-4a01-b0bc-d763afa90a48"
      unitRef="usd">493800000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="ic7e7bb0d19a14bc691198c0608792022_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfNy01LTEtMS0yOTc1MDM_5d400f40-2789-452f-8573-a7dadc900af1"
      unitRef="usd">1091800000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="iaa673d76aaf84ba09e2965620bcb0d59_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfNy03LTEtMS0yOTc1MDM_724a4e59-ec91-4e16-b93b-b9a8e887304c"
      unitRef="usd">1094500000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfOS01LTEtMS0yOTc1MDM_5c4264b5-a9b6-4683-a494-f73a0410cca8"
      unitRef="usd">1582400000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfOS03LTEtMS0yOTc1MDM_150c509c-eb13-475b-8b96-77cb431c9773"
      unitRef="usd">1588300000</us-gaap:LoansPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i54459b98d2974030b71e7ddc68bfe196_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjEtMS0xLTEtMjk3NTAz_c22f6ce5-7ce6-484f-96c6-300cbcb43e1d"
      unitRef="number">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i54459b98d2974030b71e7ddc68bfe196_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjEtNS0xLTEtMjk3NTAz_7b21d54f-7d09-47b9-8254-fabd7f5f78d4"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i4867f353b0c243f48a056129a364e474_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjEtNy0xLTEtMjk3NTAz_02d0744c-8756-4fcf-98fb-f94a9c590dcc"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4e440215ed7c4652ba80460d905c0a7e_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjItMS0xLTEtMjk3NTAz_b7557b2c-a224-4c56-97ca-fd8338964bc8"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i4e440215ed7c4652ba80460d905c0a7e_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjItNS0xLTEtMjk3NTAz_2dbe2e34-fd58-4208-8c82-f9f8ff3c1610"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="ic5bf1b892ebf4c429b94a0def27e3812_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjItNy0xLTEtMjk3NTAz_d64f4dc5-3a39-401e-a2ec-87abd0d22e57"
      unitRef="usd">700000000.0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2c142977f87a47ad9f46502a682caac2_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjMtMS0xLTEtMjk3NTAz_6407e601-15ac-4657-a5dc-25cac527dd41"
      unitRef="number">0.04400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i2c142977f87a47ad9f46502a682caac2_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjMtNS0xLTEtMjk3NTAz_0c3581f2-8867-4012-9c65-a0962927aacc"
      unitRef="usd">750000000.0</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="iea71d3a2fb7f454e9569d20da14316f2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjMtNy0xLTEtMjk3NTAz_b1f9975a-1967-4d3e-b139-87de0e448498"
      unitRef="usd">750000000.0</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3ee3cba978c44e42a435b9406ceec87a_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjQtMS0xLTEtMjk3NTAz_9081fcc3-c96e-4f4d-b151-2722efcc49a3"
      unitRef="number">0.05300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i3ee3cba978c44e42a435b9406ceec87a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjQtNS0xLTEtMjk3NTAz_effc6111-3f51-4748-a96d-ea2ee7d0b177"
      unitRef="usd">90500000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i019d5a5f11b445d89d3eb9b704641a19_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjQtNy0xLTEtMjk3NTAz_fa0c6ea6-fb2c-4c2a-bd77-b132e35683c8"
      unitRef="usd">90500000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9c0b70f0dc5a4bb0a131daa51980752a_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjUtMS0xLTEtMjk3NTAz_70020d7e-1517-40a3-bba8-f79df41dc6e0"
      unitRef="number">0.04900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i9c0b70f0dc5a4bb0a131daa51980752a_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjUtNS0xLTEtMjk3NTAz_5aebce51-2a95-4516-9253-ef2c1f93fb74"
      unitRef="usd">303900000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="ia71904c9e6b7439192afc4e42bd89431_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjUtNy0xLTEtMjk3NTAz_529ab323-430d-4104-b289-fc306cfdb0af"
      unitRef="usd">303900000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjYtNS0xLTEtMjk3NTAz_41300a9a-e0f1-4b28-afac-1c11cc993853"
      unitRef="usd">2544400000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjYtNy0xLTEtMjk3NTAz_ee7a4d44-7bc0-418b-9978-f703e380ed41"
      unitRef="usd">2544400000</us-gaap:SeniorNotes>
    <us-gaap:OtherLongTermDebt
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjctNS0xLTEtMjk3NTAz_611b0a03-cc7c-4803-bc68-9801fdcab849"
      unitRef="usd">19400000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjctNy0xLTEtMjk3NTAz_22b516e7-2a79-4dad-a345-4aa5e70d0070"
      unitRef="usd">20600000</us-gaap:OtherLongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjgtNS0xLTEtMjk3NTAz_fe152643-7807-437f-8c23-3ec9581ba5f1"
      unitRef="usd">15300000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjgtNy0xLTEtMjk3NTAz_d34ed0d0-9483-4f55-923c-796ca42121a8"
      unitRef="usd">15900000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjktNS0xLTEtMjk3NTAz_dba47415-9b04-42ee-8e29-cbabf7389c5a"
      unitRef="usd">29300000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMjktNy0xLTEtMjk3NTAz_b1e20a86-0602-44f1-8f3e-c03cce0183ff"
      unitRef="usd">30800000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzAtNS0xLTEtMjk3NTAz_7427d623-8681-4aa4-9b5b-98670a397989"
      unitRef="usd">4101600000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzAtNy0xLTEtMjk3NTAz_81cd1daa-c6e4-4738-95f4-c82736c73ec3"
      unitRef="usd">4106600000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtCurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzEtNS0xLTEtMjk3NTAz_9c153aa5-9047-4d18-a36d-2e76e31d62fc"
      unitRef="usd">38800000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzEtNy0xLTEtMjk3NTAz_13b41318-2ede-458f-8f9a-8ceb7cbfca03"
      unitRef="usd">36200000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzItNS0xLTEtMjk3NTAz_d74698de-9637-4a79-94d5-0c664929acf6"
      unitRef="usd">4062800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RhYmxlOmQ4N2I2N2QyYTI2ZjRkNGRhMDlmOWI0ODA5NWYzODk2L3RhYmxlcmFuZ2U6ZDg3YjY3ZDJhMjZmNGQ0ZGEwOWY5YjQ4MDk1ZjM4OTZfMzItNy0xLTEtMjk3NTAz_4b9f1dfd-a281-497f-b1d5-6e51abcd84a3"
      unitRef="usd">4070400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib2fa7281600f4aa4a680f08c54770403_I20220615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMTg3Nw_5a5ea84b-173e-413d-a4ef-8223ae98d1f2"
      unitRef="number">0.04400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if67b3d6fb8804d8b955cf3354d79349c_I20230615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMTE1NDQ4NzIxMDc0MjU_e7487b5d-aee4-4379-a150-fe2f4c66b9c1"
      unitRef="number">0.04650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <prgo:DebtInstrumentInterestRatePercentageCap
      contextRef="i65add94a2f11440981e032bdf4abf03a_I20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNTQ5NzU1ODQ1NTYz_7d0725b6-949f-4298-b9f9-20e0a09e025c"
      unitRef="number">0.020</prgo:DebtInstrumentInterestRatePercentageCap>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i65add94a2f11440981e032bdf4abf03a_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNTQ5NzU1ODQ1NTU1_00b20899-8e02-4d6e-b7a8-f592b83a55ac"
      unitRef="number">0.03150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i32ce52e94a304b5e9d295cbb2edf2771_I20220420"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMjUzNw_945fcfdb-e35d-4cee-86ef-3c8edc9e814b"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="idcb1e6845c364da39d5d2715c7c11d1a_D20220420-20220420"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMjE5OTAyMzI4NzI4OA_4dda7aeb-8934-4f86-aa81-54c5949cecdc">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i276b4c882ad542a0b4bc9186be63d917_I20220420"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMjYwNw_f32b529b-8dfb-4fcc-9d11-d7f645e08fb0"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i462a5d19445e4f4fb147359b0ef2c71a_D20220420-20220420"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMjE5OTAyMzI4NzMwMw_c3197971-c0af-402c-a54a-1770d91c2575">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9d64608f0d33471e9601e5e3541f2100_I20220420"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMjY4OQ_4e4c04e1-1696-42f1-9263-1ee69129dc77"
      unitRef="usd">1100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ibe49dcf2409b417bb03e87a4807043ce_D20220420-20220420"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMjE5OTAyMzI4NzMxOQ_f317aef3-d86f-4645-beba-5c9ff450612a">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3ee3cba978c44e42a435b9406ceec87a_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMzQzNA_a8a6c2ca-f372-418a-a0c8-a7ffb23ac63b"
      unitRef="number">0.05300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i54459b98d2974030b71e7ddc68bfe196_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMzY1MQ_127d07b1-c858-44b2-b98e-fed7bb7cfb0b"
      unitRef="number">0.03900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4e440215ed7c4652ba80460d905c0a7e_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMzY3NQ_43dbafd6-2e85-4077-94c7-8e0221a16e16"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2c142977f87a47ad9f46502a682caac2_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMzY5OQ_04bdc14c-1935-45df-bc7b-1cb76ac7b0c1"
      unitRef="number">0.04400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9c0b70f0dc5a4bb0a131daa51980752a_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxMzcyNg_64e4bb75-0d77-4394-9151-db2dfbb9ae43"
      unitRef="number">0.04900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum
      contextRef="i3050d0889c1b479ca3df780a8a2f67d3_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxNDMyMQ_378b5f73-2dc7-45dd-a412-6bf9826d2279"
      unitRef="number">3.00</prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum>
    <prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum
      contextRef="i3050d0889c1b479ca3df780a8a2f67d3_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxNDQyNg_709890d2-9cc4-436a-a7f3-938486166836"
      unitRef="number">3.00</prgo:DebtInstrumentCovenantSecuredNetLeverageRatioMaximum>
    <prgo:DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions
      contextRef="i7ae59f1d38b94108baddcb6c4ce9ccc9_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMzI5ODUzNDkxNDcyMw_d9a39417-8f24-4b2c-967a-c07a21897173"
      unitRef="number">3.25</prgo:DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i42813d6336b1446ea9d9766969a5d5d2_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNTQ5NzU1ODMwMDAw_5ab3dd5e-5ba5-4be7-a9e1-ba81d6c6369b"
      unitRef="usd">5900000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i909f5895c8934a849b1ce13d3e9b387a_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNTQ5NzU1ODMwMDAw_63e5d0ee-0ea0-4852-a91d-6e2fb59384ec"
      unitRef="usd">5900000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i77ce2bbbf7924de9b72b6351123d25b7_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMjE3NA_4b01ca68-b061-4f0b-a559-473aff8538c6"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3f539b72037a48c99b8a54e846db395d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfMjE3NA_e3496387-d304-4f07-85af-38f26e2e333c"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNDAzMg_3f9aa387-0538-4b18-bbf6-156ef6b5a7ed"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83My9mcmFnOjA1MDQzMTNmMGQyOTRmMjI4MmZjYTdhNjBjZDM1Y2M5L3RleHRyZWdpb246MDUwNDMxM2YwZDI5NGYyMjgyZmNhN2E2MGNkMzVjYzlfNDAzMg_f2f54f1b-f24f-451e-90e9-cb4ce58e9141"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RleHRyZWdpb246NTg5NDQyZGFhN2NkNDdiZTg4MzY5OTAyYzVkZTY3OWJfNTc4_78e7b358-fb37-46f9-9c7d-c50de2d5e0b1">EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for diluted EPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Anti-dilutive share-based awards excluded from computation of diluted EPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) In the period of a net loss from continuing operations, diluted shares equal basic shares.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholders' Equity&lt;/span&gt;&lt;/div&gt;In October 2018, our Board of Directors authorized up to $1.0&#160;billion of share repurchases with no expiration date, subject to the Board of Directors&#x2019; approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program (the "2018 Authorization"). We did not repurchase any shares during the three months ended April&#160;1, 2023 or April&#160;2, 2022.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RleHRyZWdpb246NTg5NDQyZGFhN2NkNDdiZTg4MzY5OTAyYzVkZTY3OWJfNTY4_c553f33b-3c34-4661-98c3-bfa87a3bd4f6">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for diluted EPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Anti-dilutive share-based awards excluded from computation of diluted EPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) In the period of a net loss from continuing operations, diluted shares equal basic shares.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMy0xLTEtMS0yOTc1MDM_43f3cbaa-75af-4b7e-bdd3-52a0e43af07f"
      unitRef="usd">-1100000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMy0zLTEtMS0yOTc1MDM_7b222471-7584-4e74-b163-9aaa6ea505b1"
      unitRef="usd">-1300000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfNC0xLTEtMS0yOTc1MDM_2fa94107-7666-4aba-a0e8-ddfbf6b95eb1"
      unitRef="usd">-1900000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfNC0zLTEtMS0yOTc1MDM_af94a427-797b-461b-96fa-14c8a3021b2f"
      unitRef="usd">-1100000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfNS0xLTEtMS0yOTc1MDM_82a9b30b-8708-453b-b6c1-4b421a9dbe8b"
      unitRef="usd">-3000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfNS0zLTEtMS0yOTc1MDM_69cdd12b-12f2-4b6f-88df-79c616dc2ba9"
      unitRef="usd">-2400000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfOC0xLTEtMS0yOTc1MDM_c70335d3-c52d-4213-8e66-4d6fb1b5564d"
      unitRef="shares">134900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfOC0zLTEtMS0yOTc1MDM_9a51118c-97f6-491d-84b5-0b2ded9f278a"
      unitRef="shares">134000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMTAtMS0xLTEtMjk3NTAz_f37439f1-3c2d-4fe0-bada-4e5e66bfb8f3"
      unitRef="shares">134900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMTAtMy0xLTEtMjk3NTAz_f7976b9f-fa83-4970-a008-cb1d9ab37dbc"
      unitRef="shares">134000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMTItMS0xLTEtMjk3NTAz_5c714965-0bbf-4e04-8edf-27dd31cb7178"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RhYmxlOmZlZmIxN2E1YzZlZTQ2OWJiMjI1NTJjOWYyMTE5NjE5L3RhYmxlcmFuZ2U6ZmVmYjE3YTVjNmVlNDY5YmIyMjU1MmM5ZjIxMTk2MTlfMTItMy0xLTEtMjk3NTAz_399acf7e-dc84-4add-b658-9fa7871cfa8f"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i98abb9740a4644f0b0afc822f729d80e_I20181031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RleHRyZWdpb246NTg5NDQyZGFhN2NkNDdiZTg4MzY5OTAyYzVkZTY3OWJfMjgz_b635af7b-29ff-42ea-baf3-34beb450b8ec"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RleHRyZWdpb246NTg5NDQyZGFhN2NkNDdiZTg4MzY5OTAyYzVkZTY3OWJfNTE3_291f624d-9572-4c93-bedb-452fb1e485ab"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV83OS9mcmFnOjU4OTQ0MmRhYTdjZDQ3YmU4ODM2OTkwMmM1ZGU2NzliL3RleHRyZWdpb246NTg5NDQyZGFhN2NkNDdiZTg4MzY5OTAyYzVkZTY3OWJfNTE3_efee3d38-f9d3-4b1c-a4a5-443884c69a9e"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RleHRyZWdpb246YjIzMDJlZjFmNWFkNDg3M2FlZTgzM2QzZGRlNWU4N2VfMTk0_1a83bfb9-2fef-4e31-871c-34b8fbc4d49f">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our AOCI balances, net of tax were as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value of Derivative Financial Instruments, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Post-Employment Plan Adjustments, net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RleHRyZWdpb246YjIzMDJlZjFmNWFkNDg3M2FlZTgzM2QzZGRlNWU4N2VfMTg3_c4351baf-1909-4109-87eb-f6fa2a905d64">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our AOCI balances, net of tax were as follows (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value of Derivative Financial Instruments, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Post-Employment Plan Adjustments, net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;OCI before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i3a686c929d27456898c40f7a87b08e15_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfMS0xLTEtMS0yOTc1MDM_54dc8b6a-442d-47c6-b2e1-d26141cc62bf"
      unitRef="usd">24500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70a16530a4b74ab1ab2c00eb8e6c9b14_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfMS0zLTEtMS0yOTc1MDM_f5f24f16-0d19-47ec-981c-259283efe4e7"
      unitRef="usd">-58600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifcf2f305941145e58ac95b094337d8ae_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfMS03LTEtMS0yOTc1MDM_37d51368-8227-4818-bb4c-603072022070"
      unitRef="usd">7100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d376c6445864b46856bd7c9eca96a57_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfMS05LTEtMS0yOTc1MDM_741afac1-4e27-48ca-8494-a67ece9f19ad"
      unitRef="usd">-27000000.0</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i432ffc96a54241f68ddc93d9513378cb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNC0xLTEtMS0yOTc1MDM_90122ce8-73f1-4e2d-aa7a-a2899fe5a516"
      unitRef="usd">-28400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i9384c786716d42738630dbab4c03be2a_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNC0zLTEtMS0yOTc1MDM_19e99c8b-d637-4f9c-9f1a-6e091dffccea"
      unitRef="usd">52700000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i57859208fac141e195976ff766745648_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNC03LTEtMS0yOTc1MDM_9da4a8bd-be31-41ef-a4d6-0c5fb2a0a495"
      unitRef="usd">-500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNC05LTEtMS0yOTc1MDM_fa80743d-cdea-4131-9c0f-bb9df9e15b46"
      unitRef="usd">23800000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i432ffc96a54241f68ddc93d9513378cb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNS0xLTEtMS0yOTc1MDM_6b696e94-59ff-4746-8d4a-3d291d7fa4ad"
      unitRef="usd">3100000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i9384c786716d42738630dbab4c03be2a_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNS0zLTEtMS0yOTc1MDM_76267039-770a-4611-8b55-fe72abb2e722"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i57859208fac141e195976ff766745648_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNS03LTEtMS0yOTc1MDM_f1ff0db5-9baa-477d-8b64-aa0c83ba3fd5"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNS05LTEtMS0yOTc1MDM_afaa6043-719a-4994-872d-775c1bf56826"
      unitRef="usd">3100000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i432ffc96a54241f68ddc93d9513378cb_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNi0xLTEtMS0yOTc1MDM_a82571c9-5d6d-496b-8d03-1dbd7bc8be90"
      unitRef="usd">-31500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9384c786716d42738630dbab4c03be2a_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNi0zLTEtMS0yOTc1MDM_84c262c3-a144-4289-96ad-4526826e6352"
      unitRef="usd">52700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i57859208fac141e195976ff766745648_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNi03LTEtMS0yOTc1MDM_fd752253-4144-4165-85ec-322d4aabbddf"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNi05LTEtMS0yOTc1MDM_14054256-a6d6-4174-ac1f-96187d507220"
      unitRef="usd">20700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i506dcfe48b094a3e931d739dfe711e08_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNy0xLTEtMS0yOTc1MDM_5daa4b0d-5050-4286-ad89-d0bc3e87da59"
      unitRef="usd">-7000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i339887c74bba45cdaf9c842631f3e11f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNy0zLTEtMS0yOTc1MDM_3232edcc-d7b2-49c3-87e3-22f4c2d9553b"
      unitRef="usd">-5900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i04473c0869bb4e9cb57c58ccae61c32f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNy03LTEtMS0yOTc1MDM_0e7dc074-ffc4-4206-a63c-b50b447c5993"
      unitRef="usd">6600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3cf13b5a219470a985bbaa83714a9e5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84NS9mcmFnOmIyMzAyZWYxZjVhZDQ4NzNhZWU4MzNkM2RkZTVlODdlL3RhYmxlOjM3ZGIzY2RjODU1MzRhM2RhZTAyYWJiODJlM2E3YzA5L3RhYmxlcmFuZ2U6MzdkYjNjZGM4NTUzNGEzZGFlMDJhYmI4MmUzYTdjMDlfNy05LTEtMS0yOTc1MDM_0dc6fba9-77e8-43e0-888d-4530b49699f9"
      unitRef="usd">-6300000</us-gaap:StockholdersEquity>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfNzQ2_335715ff-2448-44d4-b6af-70932d345613">RESTRUCTURING CHARGES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, and related consulting fees. The following reflects our restructuring activity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:105.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:47.50pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:82.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supply Chain Reinvention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;HRA Pharma Integration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Initiatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The charges incurred during the three months ended April&#160;1, 2023 and April&#160;2, 2022 were primarily associated with actions taken on our multi-year supply chain restructuring program initiative started in 2022, and HRA Pharma integration activities associated with employee separation, continuity and other benefit-related costs. We have incurred $13.5&#160;million of cumulative restructuring expense to date related to HRA Pharma integration. We expect that most of the HRA Pharma integration expenses will be incurred by the end of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the amount recorded during the three months ended April&#160;1, 2023, $0.9 million was related to our CSCI segment, due primarily to supply chain restructuring and HRA Pharma integration initiatives, and $1.2 million related to our CSCA segment, also due primarily to supply chain restructuring initiatives. Remaining amounts recorded, including $3.6&#160;million recorded during the three months ended April&#160;2, 2022, related to our Unallocated segment due primarily to supply chain restructuring. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other material restructuring programs for the periods presented. All charges are recorded in Restructuring expense on the Condensed Consolidated Statements of Operations. The remaining $15.6&#160;million liability for employee severance benefits and consulting fees is expected to be paid within the next year.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfNzM3_e3a606d2-63de-4932-afa4-25d76fa8000d">The following reflects our restructuring activity (in millions):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:444.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:105.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:47.50pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:82.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supply Chain Reinvention&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;HRA Pharma Integration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Initiatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="ie13f0da93b3b4722b635937b8c483189_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfMy0xLTEtMS0yOTc1MDM_d75ec650-0a01-4cf6-9d6b-1598f8dbcb96"
      unitRef="usd">2200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ife352f731243473cb38ff3a7c88ad094_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfMy0yLTEtMS0zNjM1OTQ_d36bf328-9fba-4703-aaf8-3d1fddd44596"
      unitRef="usd">13300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ibd510179d2634daf92fb0a1d857cf068_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfMy0yLTEtMS0yOTc1MDM_dc355d77-8733-498a-90ad-48d99914ef20"
      unitRef="usd">4300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfMy0zLTEtMS0yOTc1MDM_f926ce94-0c1e-4e48-af5b-623d749b92ef"
      unitRef="usd">19800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="idd18f1c6b0bf4007931565e3309d3a59_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfMy01LTEtMS0yOTc1MDM_4c50e9ef-d31d-4962-9db2-ab4e06ac2443"
      unitRef="usd">6900000</us-gaap:RestructuringReserve>
    <prgo:RestructuringAdditionalCharges
      contextRef="i3d97e990bb9f45da875ed0019a943271_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNC0xLTEtMS0yOTc1MDM_824de16e-2efb-4af7-b89a-fa742a9ccc58"
      unitRef="usd">2600000</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="ib4ad834796dd4944a10c88db4b09a61a_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNC0yLTEtMS0zNjM1OTQ_33e5c66a-839a-48f8-bdf6-8604b9f3a06f"
      unitRef="usd">800000</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="ib95c3b6aef5f41e9a52f9f10c2866889_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNC0yLTEtMS0yOTc1MDM_f7dc0cc8-e05d-4116-aa4f-d60d851ea5fe"
      unitRef="usd">0</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNC0zLTEtMS0yOTc1MDM_22b6fb9d-b2d9-462c-aed3-24be4f7de9a1"
      unitRef="usd">3400000</prgo:RestructuringAdditionalCharges>
    <prgo:RestructuringAdditionalCharges
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNC01LTEtMS0yOTc1MDM_65e5166e-543e-4c2c-8d13-1ac6d0927c8e"
      unitRef="usd">3600000</prgo:RestructuringAdditionalCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i3d97e990bb9f45da875ed0019a943271_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNS0xLTEtMS0yOTc1MDM_e9af44d7-0a4c-4c2c-9051-35d0df529e4f"
      unitRef="usd">4400000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib4ad834796dd4944a10c88db4b09a61a_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNS0yLTEtMS0zNjM1OTQ_7304ed4c-7185-41a6-836d-6d85d889d681"
      unitRef="usd">2600000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib95c3b6aef5f41e9a52f9f10c2866889_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNS0yLTEtMS0yOTc1MDM_a754e9d5-8c6c-4cc7-85bc-b7f1f917f3d9"
      unitRef="usd">1000000.0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNS0zLTEtMS0yOTc1MDM_c91e8491-e666-4630-a9e6-c168924583b4"
      unitRef="usd">8000000.0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNS01LTEtMS0yOTc1MDM_3cd6576c-3adb-4687-80c6-acaefa5a3d5d"
      unitRef="usd">2100000</us-gaap:PaymentsForRestructuring>
    <prgo:RestructuringReserveSettledWithoutCashNet
      contextRef="i3d97e990bb9f45da875ed0019a943271_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNi0xLTEtMS0yOTc1MDM_0f4f6246-b875-4f94-ae12-8dcef4809bcf"
      unitRef="usd">0</prgo:RestructuringReserveSettledWithoutCashNet>
    <prgo:RestructuringReserveSettledWithoutCashNet
      contextRef="ib4ad834796dd4944a10c88db4b09a61a_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNi0yLTEtMS0zNjM1OTQ_cd8cefef-3035-4eca-9b8b-dad4fe224e7f"
      unitRef="usd">300000</prgo:RestructuringReserveSettledWithoutCashNet>
    <prgo:RestructuringReserveSettledWithoutCashNet
      contextRef="ib95c3b6aef5f41e9a52f9f10c2866889_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNi0yLTEtMS0yOTc1MDM_6c9b22af-426e-490b-b2b0-08a98f824fe8"
      unitRef="usd">100000</prgo:RestructuringReserveSettledWithoutCashNet>
    <prgo:RestructuringReserveSettledWithoutCashNet
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNi0zLTEtMS0yOTc1MDM_a65933f2-1718-4ded-9f16-31f7b46a3da4"
      unitRef="usd">400000</prgo:RestructuringReserveSettledWithoutCashNet>
    <prgo:RestructuringReserveSettledWithoutCashNet
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfNi01LTEtMS0yOTc1MDM_b7d9c85d-f239-4db8-918e-f38aa734aec6"
      unitRef="usd">-200000</prgo:RestructuringReserveSettledWithoutCashNet>
    <us-gaap:RestructuringReserve
      contextRef="ibd1391abd493480fb9acd3c58fcf9675_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfOC0xLTEtMS0yOTc1MDM_61af9ed5-4dec-425f-9918-a552b33ec93d"
      unitRef="usd">400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6134b75d6d3245a1b012e4facd40a083_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfOC0yLTEtMS0zNjM1OTQ_01e0f5c5-5fd3-4303-a726-1463775d8181"
      unitRef="usd">11800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2e874d379f764d87a630226253c6b16f_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfOC0yLTEtMS0yOTc1MDM_96f6cd6e-8873-4cbe-b21a-37850f463bf1"
      unitRef="usd">3400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfOC0zLTEtMS0yOTc1MDM_ab51b6d1-c441-45a1-b0c6-7550362b01aa"
      unitRef="usd">15600000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6955bfa807de4779804dcda471f50c60_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RhYmxlOmJmMGI2ZjAxMTFlMTQxNmU5Y2JhNDVjMjBlZDZhYTk1L3RhYmxlcmFuZ2U6YmYwYjZmMDExMWUxNDE2ZTljYmE0NWMyMGVkNmFhOTVfOC01LTEtMS0yOTc1MDM_a2e8bd67-dc33-45f9-b443-cadf265b39ec"
      unitRef="usd">8200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="id44c0aea81d045e49ea119c7382cc4e4_D20220101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfNTQ5NzU1ODE5NTc3_340cfaa6-da41-404a-9dbf-522731554dfb"
      unitRef="usd">13500000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i817dfeec890e44ed95bda23a0c957cff_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfMTY0OTI2NzQ0MjcxNA_0622674d-1fa5-49e0-9d9e-7c930f53eab1"
      unitRef="usd">900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icfdccbcb51464df8bf6242647eb20916_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfMTY0OTI2NzQ0Mjg4OQ_7a48e2a4-47f8-4174-bc8b-168a329babd1"
      unitRef="usd">1200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="idb86d716465f4a43b35ce7084bb1a35f_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfNTQ5NzU1ODE5NTky_1f39a22f-033e-4a96-a5f5-a9cb3c661bd6"
      unitRef="usd">3600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85NC9mcmFnOjRlY2E1ZjczNzFjMzQ4ZWE5MGVhZjU3YTJiZDU4MjBlL3RleHRyZWdpb246NGVjYTVmNzM3MWMzNDhlYTkwZWFmNTdhMmJkNTgyMGVfNjI3_ab51b6d1-c441-45a1-b0c6-7550362b01aa"
      unitRef="usd">15600000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMTg1Mzc_e8cf46c1-eed3-44ba-937e-3dfc02e1acea">INCOME TAXES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rates were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:143.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate on the pre-tax income for the three months ended April&#160;1, 2023 increased compared to the effective tax rate on the pre-tax loss for the three months ended April&#160;2, 2022, primarily due to the tax benefit of the loss on sale of our Latin American businesses recognized in the three months ended April&#160;2, 2022, offset by changes in the jurisdictional mix of earnings in the three months ended April&#160;1, 2023. The effective tax rate for this period differs from the statutory income tax rate of 12.5% primarily due to non-deductible expenses, as well as changes in our reserves for unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal Revenue Service Audits of Perrigo Company, a U.S. Subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Perrigo Company, our U.S. subsidiary ("Perrigo U.S."), is engaged in a series of tax disputes in the U.S. relating primarily to transfer pricing adjustments including income in connection with the purchase, distribution, and sale of store-brand OTC pharmaceutical products in the United States, including the generic heartburn medication omeprazole. On August 27, 2014, we received a statutory notice of deficiency from the IRS relating to our fiscal tax years ended June 27, 2009, and June 26, 2010 (the &#x201c;2009 tax year&#x201d; and &#x201c;2010 tax year&#x201d;, respectively). On April 20, 2017, we received a statutory notice of deficiency from the IRS for the years ended June 25, 2011 and June 30, 2012 (the &#x201c;2011 tax year&#x201d; and &#x201c;2012 tax year&#x201d;, respectively). Specifically, both statutory notices proposed adjustments related to the offshore reporting of profits on sales of omeprazole in the United States resulting from &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the assignment of an omeprazole distribution contract to an Israeli affiliate. In addition to the transfer pricing adjustments, which applied to all four tax years, the statutory notice of deficiency for the 2011 and 2012 tax years included adjustments requiring the capitalization and amortization of certain legal expenses that were deducted when paid or incurred in defending against certain patent infringement lawsuits related to ANDAs filed with a Paragraph IV Certification. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not agree with the audit adjustments proposed by the IRS in either of the notices of deficiency. We paid the assessed amounts of tax, interest, and penalties set forth in the statutory notices and timely filed claims for refund on June 11, 2015 for the 2009 and 2010 tax years, and on June 7, 2017, for the 2011 and 2012 tax years. On August 15, 2017, following disallowance of such refund claims, we timely filed a complaint in the United States District Court for the Western District of Michigan seeking refunds of tax, interest, and penalties of $27.5 million for the 2009 tax year, $41.8 million for the 2010 tax year, $40.1&#160;million for the 2011 tax year, and $24.7 million for the 2012 tax year, for a total of $134.1 million, plus statutory overpayment interest thereon from the dates of payment. The amounts sought in the complaint for the 2009 and 2010 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended March 28, 2015, and the amounts sought in the complaint for the 2011 and 2012 tax years were recorded as deferred charges in Other non-current assets on our balance sheet during the three months ended July 1, 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A bench trial was held during the period May 25, 2021 to June 7, 2021 for the refund case in the United States District Court for the Western District of Michigan. The total amount of cumulative deferred charge that we are seeking to receive in this litigation is approximately $111.6 million, which reflects the impact of conceding that Perrigo U.S. should have received a 5.24% royalty on all omeprazole sales. That concession was previously paid and is the subject of the above refund claims. The issues outlined in the statutory notices of deficiency described above are continuing in nature, and the IRS will likely carry forward the adjustments set forth therein as long as the drug is sold, in the case of the omeprazole issue, and for all post-2012 Paragraph IV filings that trigger patent infringement suits, in the case of the ANDA issue. Post-trial briefings were completed on September 24, 2021 and the case is now fully submitted for the court&#x2019;s decision. On April 30, 2021, we filed a Notice of New Authority in our refund case in the Western District of Michigan alerting the court to a United States Tax Court decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mylan v. Comm'r&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; that ruled in favor of the taxpayer on nearly identical ANDA issues as we have before the court. On January 28, 2022, the IRS filed a Notice of Appeal with the United States Court of Appeals of the Third Circuit to appeal the United States Tax Court's decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mylan v. Comm'r. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Briefing to the appellate court was completed during 2022, oral argument was held before the Third Circuit on January 12, 2023, and the case is awaiting decision. On August 22, 2022, the parties filed a Notice of New Authority in the refund case alerting the court to a United States Court of Federal Claims decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Actavis Laboratories v. United States&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; that also ruled in favor of the taxpayer on the ANDA issues. The government appealed the Actavis Laboratories decision to the United States court of Appeals for the Federal Circuit in December of 2022 and briefing to the appellate court is ongoing.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 13, 2021, the IRS issued a 30-day letter and Revenue Agent's Report ("RAR") with respect to its audit of our fiscal tax years ended June 29, 2013, June 28, 2014, and June 27, 2015. The 30-day letter proposed, among other modifications, transfer pricing adjustments in connection with the distribution of omeprazole in the aggregate amount of $141.6 million and ANDA-related adjustments in the aggregate amount of $21.9 million. The 30-day letter also set forth adjustments described in the next two paragraphs. We timely filed a protest to the 30-day letter for those additional adjustments but noting that due to the pending refund litigation described above, IRS Appeals would not consider the merits of the omeprazole or ANDA matters. We believe that we should prevail on the merits on both carryforward issues and have reserved for taxes and interest payable on the 5.24% deemed royalty on omeprazole through the tax year ended December 31, 2018. Beginning with the tax year ended December 31, 2019, we began reporting income commensurate with the 5.24% deemed royalty. We have not reserved for the ANDA-related issue described above. While we believe we should prevail on the merits of this case, the outcome remains uncertain. If our litigation position on the omeprazole issue is not sustained, the outcome for the 2009&#x2013;2012 tax years could range from a reduction in the refund amount to denial of any refund. In addition, we expect that the outcome of the refund litigation could effectively bind future tax years. In that event, an adverse ruling on the omeprazole issue could have a material impact on subsequent periods, with additional tax liability in the range of $24.0 million to $112.0 million, not including interest and any applicable penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The 30-day letter for the 2013-2015 tax years also proposed to reduce Perrigo U.S.'s deductible interest expense for the 2014 tax year and the 2015 tax year on $7.5 billion in certain intercompany debts owed by it to Perrigo Company plc, which is the subject matter of a Notice of Proposed Adjustment, or "NOPA" issued on May 7, 2020. Subsequent to the end of the first quarter of fiscal 2023, we finalized an agreement with IRS Appeals providing for &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;settlement of the NOPA. Refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_1742" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;Note&lt;/a&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_1742" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt; 18 - Subsequent Events&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; for additional details. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the 30-day letter for the 2013-2015 tax years expanded on a NOPA issued on December 11, 2019 and proposed to disallow reductions to gross sales income on the sale of prescription products to wholesalers for accrued wholesale customer pipeline chargebacks where the prescription products were not re-sold by such wholesalers to covered retailers by the end of the tax year. On December 28, 2022, we finalized an agreement with IRS Appeals providing for settlement of the December 11, 2019 NOPA, which would not only cover the 2013-2015 tax years but all of the remaining tax years through 2021, the last tax year with chargebacks due to the sale of the Rx business in July 2021. We made a settlement payment of $8.3 million in 2022 which was fully covered by reserves for this issue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 2, 2021, the IRS commenced an audit of our federal income tax returns for the tax years ended December 31, 2015, through December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal Revenue Service Audit of Athena Neurosciences, Inc., a U.S. Subsidiary&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Subsequent to the end of the first quarter of fiscal 2023, we were notified by the IRS regarding the Competent Authority request filed for the Tysabri royalty issue, which concludes the competent authority process without the need for negotiations between the competent authorities and constitutes a full and final resolution of the April 26, 2019 NOPA received by Athena Neurosciences, Inc. Refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_1742" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;Note 18 - Subsequent Events&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;.  for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although we believe that our tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit and any related litigation could be materially different from our estimates or from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the final resolution of tax examinations, judicial or administrative proceedings, changes in facts or law, expirations of statute of limitations in specific jurisdictions or other resolutions of, or changes in, tax positions - one or more of which may occur within the next twelve months - it is reasonably possible that unrecognized tax benefits for certain tax positions taken on previously filed tax returns may change materially from those recorded as of April&#160;1, 2023. However, we are not able to estimate a reasonably possible range of how these events may impact our unrecognized tax benefits in the next twelve months.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMTg1Mzk_7cb197cd-526e-433f-8065-4a3da2f72c7f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rates were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:143.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:67.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RhYmxlOjdkZTc0YTA5ZmViNDQxMjNhMjgzMjBhNGNkMjk2ZGE4L3RhYmxlcmFuZ2U6N2RlNzRhMDlmZWI0NDEyM2EyODMyMGE0Y2QyOTZkYThfMi0wLTEtMS0yOTc1MDM_319ee0bf-10ba-4337-b6b9-3f71b0143a35"
      unitRef="number">1.238</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RhYmxlOjdkZTc0YTA5ZmViNDQxMjNhMjgzMjBhNGNkMjk2ZGE4L3RhYmxlcmFuZ2U6N2RlNzRhMDlmZWI0NDEyM2EyODMyMGE0Y2QyOTZkYThfMi0yLTEtMS0yOTc1MDM_b785d87a-6504-4869-b09c-fefaefb10413"
      unitRef="number">0.902</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <prgo:IncomeTaxExaminationNumberOfTaxableYears
      contextRef="i27edc1f6184c482f97b3b37c5afe0212_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMjU5Nw_51a6b65d-95d2-4d41-b34e-c85a256bb53d"
      unitRef="year">4</prgo:IncomeTaxExaminationNumberOfTaxableYears>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i75ee84a7035145c0b2c910d5dc516972_D20090101-20091231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMzQ4Ng_69dfb022-de51-4be8-a504-32e3573540ec"
      unitRef="usd">27500000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i309429068baf42d9b32476c47f52aaff_D20100101-20101231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMzUxMg_6cbfd10f-2b1b-464e-9b74-0482489cb730"
      unitRef="usd">41800000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i8f277cfcb9db4505ad801732fd1320f1_D20110101-20111231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMzUzOA_43b56504-ea70-463e-865b-398789a37382"
      unitRef="usd">40100000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i201270c4e836404b9f18b06fd151647e_D20120101-20121231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMzU2OA_2fd25a16-02ff-4f8e-8f41-563391db3c40"
      unitRef="usd">24700000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i08faba57c5a94a03969d96709d4fc35b_D20170815-20170815"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfMzYwOQ_d706f24b-eca4-4ae7-8f1b-0e3b402da933"
      unitRef="usd">134100000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <prgo:CumulativeDeferredChargeTaxLitigation
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNDM1OQ_d62420fe-acfc-4873-ad1c-be472e25e9c2"
      unitRef="usd">111600000</prgo:CumulativeDeferredChargeTaxLitigation>
    <prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNDQ0Mw_a5d42df8-1dca-4c32-a746-3fc133b16e7f"
      unitRef="number">0.0524</prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent>
    <prgo:IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015
      contextRef="i0064d9e4042944d58d1198901966263d_D20210113-20210113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNjExMg_68280d20-b850-42bc-9706-9ff1e4886dee"
      unitRef="usd">141600000</prgo:IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015>
    <prgo:IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015
      contextRef="i0064d9e4042944d58d1198901966263d_D20210113-20210113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNjE3MQ_cd0f53d1-89b3-464f-aeb8-0ccf0e2b4a74"
      unitRef="usd">21900000</prgo:IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015>
    <prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNjYxNw_a5d42df8-1dca-4c32-a746-3fc133b16e7f"
      unitRef="number">0.0524</prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent>
    <prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNjc5Ng_a5d42df8-1dca-4c32-a746-3fc133b16e7f"
      unitRef="number">0.0524</prgo:ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent>
    <us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss
      contextRef="i13f377e048824747af8070c20b1f773d_D20210113-20210113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNzQxOQ_19eced00-76e6-4392-94bf-9d84383eb443"
      unitRef="usd">24000000</us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss>
    <us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss
      contextRef="i799c30578ef443f59a649aaeb56da4a1_D20210113-20210113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNzQyNQ_7febf0d4-92e3-46a6-9643-b38bdd321b7d"
      unitRef="usd">112000000</us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss>
    <prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense
      contextRef="i6df9a027c7764dc1882048b53958ed7f_I20210113"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNzY0Mw_d46d7e57-7935-4e88-927c-7d426cd8f93e"
      unitRef="usd">7500000000</prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="ia9a1e1741f134ef190ca8f40ceb9584d_D20221228-20221228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV84OC9mcmFnOjdiNTc0ZTFkZjVjZjRlMTg4MWVkYTg0ZGVjNGMxM2JhL3RleHRyZWdpb246N2I1NzRlMWRmNWNmNGUxODgxZWRhODRkZWM0YzEzYmFfNTQ5NzU1ODM4NDQ4_4d07878b-2982-4137-a262-61f44f13d567"
      unitRef="usd">8300000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1NjA_b2204ee6-c18b-449d-aee6-c5d9c5c20f56">CONTINGENCIES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated as of April&#160;1, 2023, we have not recorded a loss reserve. If certain of these matters are determined against us, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Price-Fixing Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in 2013, the Company, along with other manufacturers, has been named as a defendant in lawsuits in the United States and Canada generally alleging anticompetitive conduct with respect to the sale of generic drugs by the Company&#x2019;s former Rx business. The complaints &#x2013; which have been filed by putative classes of direct purchasers, end payors, and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties - allege a conspiracy to fix, maintain, stabilize, and/or raise prices, rig bids, and allocate markets or customers for various generic drugs in violation of federal and state antitrust and consumer protection laws. While most of the complaints involve alleged single-drug conspiracy, the three putative classes have each filed an over-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;arching conspiracy complaint alleging that Perrigo and other manufacturers (and some individuals) entered into an &#x201c;overarching conspiracy&#x201d; that involved allocating customers, rigging bids, and raising, maintaining, and fixing prices for various products.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The vast majority of the lawsuits described in this paragraph have been consolidated in the generic pricing multidistrict litigation ("MDL") MDL No. 2724 (United States District Court for Eastern District of Pennsylvania). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Court has ordered that the following cases involving Perrigo will proceed on a more expedited basis (as a bellwether) than the other cases in MDL No. 2724: (i) class actions alleging &#x201c;single drug&#x201d; conspiracies involving Clobetasol; and (ii) the State Attorney General Complaint (described below). The bellwether cases are proceeding in discovery, which must be completed by June 1, 2023 under the schedule set by the Court, and motions for summary judgment will be due on March 13, 2024. No trial dates have been set for any of the bellwether cases, or any of the other cases in the MDL.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;State Attorney General Complaint &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On June 10, 2020, the Connecticut Attorney General&#x2019;s office filed a lawsuit on behalf of Connecticut and 50 other states and territories against Perrigo, 35 other generic pharmaceutical manufacturers, and certain individuals (including two former Perrigo employees), alleging an overarching conspiracy to allocate customers and/or fix, raise, or stabilize prices of eighty products. This case is included among the &#x201c;bellwether cases&#x201d; designated to follow the expedited schedule described above. Like the other cases in the MDL, no trial date has been set for this case. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Canadian Class Action Complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, an end payor filed a class action in Ontario, Canada against Perrigo and 29 other manufacturers alleging an overarching conspiracy to allocate customers and/or fix, raise, or stabilize prices of dozens of products, most of which Perrigo neither makes nor sells. The product conspiracies allegedly involving Perrigo focus on the same products as those involved in other MDL complaints naming Perrigo: Clobetasol, Desonide, Econazole, and Nystatin. In December 2020, Plaintiffs amended their complaint to add additional claims based on the State Attorney General Complaint of June 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At this stage, we cannot reasonably estimate the outcome of the liability if any, associated with the claims listed above.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securities Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In the United States (cases related to events in 2015-2017)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in May 2016, purported class action complaints were filed against the Company and our former CEO, Joseph Papa, in the U.S. District Court for the District of New Jersey (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Roofers&#x2019; Pension Fund v. Papa, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) purporting to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The original complaint alleged violations of federal securities laws in connection with the actions taken by us and the former executive to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015. The plaintiff also alleged that the defendants provided inadequate disclosure concerning alleged business developments during the alleged class period including integration problems related to the Omega acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The operative complaint is the first amended complaint filed on June 21, 2017, and named as defendants us and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#x2019;Connor). The amended complaint alleges violations of federal securities laws arising out of the actions taken by us and the former directors and executives to defend against the unsolicited takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015 and the allegedly inadequate disclosure throughout the entire class period related to the business developments during that period including purported integration problems related to the Omega acquisition, alleges incorrect reporting of organic growth at the Company and at Omega, alleges price fixing activities with respect to six generic prescription pharmaceuticals, and alleges improper accounting for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Tysabri&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; royalty stream. During 2017, the defendants filed motions to dismiss, which the plaintiffs opposed. On July 27, 2018, the court issued an opinion and order granting the defendants&#x2019; motions to dismiss in part and denying the motions to dismiss in part. The court dismissed without prejudice defendants Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, Donal O&#x2019;Connor, and Marc Coucke. The &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;court also dismissed without prejudice claims arising from the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Tysabri&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; accounting issue described above and claims alleging incorrect disclosure of organic growth described above. The defendants who were not dismissed are the Company, Joe Papa, and Judy Brown. The claims (described above) that were not dismissed relate to the integration issue regarding the Omega acquisition, the defense against the Mylan tender offer, and the alleged price fixing activities with respect to six generic prescription pharmaceuticals. The defendants who remain in the case (us, Mr. Papa, and Ms. Brown) have filed answers denying liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 14, 2019, the court granted the lead plaintiffs&#x2019; motion and certified three classes for the case: (i) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on a U.S. exchange and were damaged thereby; (ii) all those who purchased shares between April 21, 2015 through May 2, 2017 inclusive on the Tel Aviv exchange and were damaged thereby; and (iii) all those who owned shares as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered shares in response to the Mylan tender offer) (the "tender offer class"). Plaintiffs' counsels have sent notices to the alleged class. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The parties took discovery from 2018 through 2020. After discovery ended, defendants filed motions for summary judgement and to exclude plaintiffs' experts, which were fully briefed. The case was then re-assigned to a new federal judge, who heard oral argument on the motions in April 2022. The motions are pending. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In addition to the class action, the following opt-out cases have been filed against us, and in some cases, Mr. Papa and Ms. Brown, and contain factual allegations and claims that are similar to some or all of the factual allegations and claims in the class actions:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Case&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Filed&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Carmignac Gestion, S.A. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/1/2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;First Manhattan Co. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/16/2018; amended 4/20/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Nationwide Mutual Funds, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10/29/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Schwab Capital Trust, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Aberdeen Canada Funds -- Global Equity Fund, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/22/2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Principal Funds, Inc., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/5/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Kuwait Investment Authority, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/31/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Mason Capital L.P., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/26/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pentwater Equity Opportunities Master Fund Ltd., et al.  v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/26/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;WCM Alternatives: Event-Drive Fund, et al. v. Perrigo Co., plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/15/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Hudson Bay Master Fund Ltd., et al. v. Perrigo Co., plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/15/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Discovery Global Citizens Master Fund, Ltd., et al. v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/18/2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;York Capital Management, L.P., et al. v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/20/2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Burlington Loan Management DAC v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/12/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Universities Superannuation Scheme Limited v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/2/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Harel Insurance Company, Ltd., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/13/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;TIAA-CREF Investment Management, LLC., et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4/20/2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sculptor Master Fund (f/k/a OZ Master Fund, Ltd.), et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/6/2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;BlackRock Global Allocation Fund, Inc., et al. v. Perrigo Co. plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4/21/2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Starboard Value and Opportunity C LP, et al. v. Perrigo Company plc, et al.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/25/2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2020, three Highfields Capital entities filed a lawsuit in Massachusetts State Court with factual allegations that generally were similar to the factual allegations in the Amended Complaint in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; case described above, except that the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Highfields&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; plaintiffs did not include allegations about alleged collusive pricing of generic prescription drugs, and alleged Massachusetts state law claims under the Massachusetts Unfair Business Methods Law (chapter 93A) and Massachusetts common law claims of tortious interference with prospective economic advantage, common law fraud, negligent misrepresentation, and unjust enrichment. In December 2021, the Massachusetts State Court granted Defendants&#x2019; motion to dismiss in part and denied it in part. Defendants&#x2019; filed &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;their answers in January 2022 denying liability. The discovery phase in this case has begun (including discovery related to some factual allegations that were not part of the discovery in the actions in New Jersey federal court). The Court held a discovery conference and approved fact discovery deadlines into May 2023 and later deadlines to complete expert discovery. Subsequently, the Court held a further conference in March 2023 and revised the schedule with fact discovery ending in October 2023 and expert discovery in May 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In Israel (cases related to events in 2015-2017)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 28, 2017, a plaintiff filed a complaint in Tel Aviv District Court styled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Israel Elec. Corp. Employees&#x2019; Educ. Fund v. Perrigo Company plc, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The lead plaintiff seeks to represent a class of shareholders who purchased Perrigo stock on the Tel Aviv exchange during the period from April 24, 2015 through May 3, 2017 and also a claim for those that owned shares on the final day of the Mylan tender offer (November 13, 2015). The amended complaint names as defendants the Company, Ernst &amp;amp; Young LLP (the Company&#x2019;s auditor), and 11 current or former directors and officers of Perrigo (Mses. Judy Brown, Laurie Brlas, Jacqualyn Fouse, Ellen Hoffing, and Messrs. Joe Papa, Marc Coucke, Gary Cohen, Michael Jandernoa, Gerald Kunkle, Herman Morris, and Donal O&#x2019;Connor). The complaint alleges violations under Israeli securities laws that are similar to U.S. Securities Exchange Act sections 10(b) (and Rule 10b&#x2011;5) and 14(e) against all defendants and 20(a) control person liability against the 11 individuals or, in the alternative, under other Israeli securities laws. In general, the allegations are similar to the factual allegations in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Roofers' Pension Fund&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case in the U.S. as described above. The plaintiff indicates an initial, preliminary class damages estimate of 2.7&#160;billion NIS (approximately $760.0&#160;million at 1 NIS = 0.28 cents). After the other two cases filed in Israel were voluntarily dismissed, the plaintiff in this case agreed to stay this case pending the outcome of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Roofers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case in the U.S. (described above). The Israeli court approved the stay, and this case is now stayed. We intend to defend the lawsuit vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In Israel (case related to Irish Tax events)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On December 31, 2018, a shareholder filed an action against the Company, our CEO Murray Kessler, and our former CFO Ronald Winowiecki in Tel Aviv District Court (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Baton v. Perrigo Company plc, et. al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;). The case is a securities class action brought in Israel making similar factual allegations for the same period as those asserted in a securities class action case (for those who purchased on a U.S. exchange) in New York federal court in which the settlement received final approval in February 2022. The Baron case alleges that persons who purchased securities through the Tel Aviv stock exchange and suffered damages can assert claims under Israeli securities law that will follow the liability principles of Sections 10(b) and 20(a) of the U.S. Securities Exchange Act. The plaintiff does not provide an estimate of class damages. Since 2019, the court granted several requests by Perrigo to stay the proceedings pending the resolution of proceedings in the New York federal court. During 2022, the case was reassigned to a newly-appointed judge. After the settlement of the U.S. case in New York federal court, Perrigo's counsel informed the Israeli Court of the final approval of the settlement of the U.S. case. The parties then sought further stays of the case while they attempted mediation, which the Court granted. In April 2023, the parties reported to the Court that the mediation had led to a preliminary agreement on settlement; the Court ordered that a motion for approval of the settlement and related papers be filed no later than June 17, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Talcum Powder&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been named, together with other manufacturers, in product liability lawsuits in a variety of state courts alleging that the use of body powder products containing talcum powder causes mesothelioma and lung cancer due to the presence of asbestos. All but one of these cases involve legacy talcum powder products that have not been manufactured by the Company since 1999. One of the pending actions involves a current prescription product that contains talc as an excipient. As of April 24, 2023, the Company is currently named in 90 individual lawsuits seeking compensatory and punitive damages and has accepted a tender for a portion of the defense costs and liability from a retailer for one additional matter. The Company has several defenses and intends to aggressively defend these lawsuits. Trials for these lawsuits are currently scheduled throughout 2023, 2024 and 2025, with the earliest trial date in May 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ranitidine&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After regulatory bodies announced worldwide that ranitidine may potentially contain N-nitrosodimethylamine ("NDMA"), a known environmental contaminant, the Company promptly began testing its externally-sourced ranitidine API and ranitidine-based products. On October 8, 2019, the Company halted shipments of the product based upon preliminary results and on October 23, 2019, the Company made the decision to conduct a voluntary retail market withdrawal. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the resulting actions involving &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and other ranitidine products were transferred for coordinated pretrial proceedings to a Multi-District Litigation (In re &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;/Ranitidine Products Liability Litigation MDL No. 2924) in the U.S. District Court for the Southern District of Florida. After the Company successfully moved to dismiss the first set of Master Complaints in the MDL, it now includes three: 1) an Amended Master Personal Injury Complaint; 2) a Consolidated Amended Consumer Economic Loss Class Action Complaint; and 3) a Consolidated Medical Monitoring Class Action Complaint. All three name the Company. Plaintiffs appealed one of the original Master Complaints, the Third-Party Payor Complaint, and two individual plaintiffs appealed their individual personal injury claims on limited grounds. The Company is not named in the appeals.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2021, the Court dismissed all claims against the retail and distributor defendants with prejudice, thereby reducing the Company&#x2019;s potential for exposure and liability related to possible indemnification. On July 8, 2021, the Court dismissed all claims against the Company with prejudice. Appeals of these dismissal orders to the U.S. Court of Appeals for the 11th Circuit have been filed, as well as several state level claims related to the theories advanced in the MDL litigation. The Company will continue to vigorously defend each of these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of April 1, 2023, the Company has been named in 352 personal injury lawsuits, most of which are in the MDL tied to various federal courts alleging that plaintiffs developed various types of cancers or are placed at higher risk of developing cancer as a result of ingesting products containing ranitidine. The Company has also been named in a handful of similar lawsuits in the state courts of California, Illinois, Ohio, New Jersey, New York and Pennsylvania. The Company is named in these lawsuits with manufacturers of the national brand &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and other manufacturers of ranitidine products, as well as distributors, repackagers, and/or retailers. Plaintiffs seek compensatory and punitive damages, and in some instances seek applicable remedies under state consumer protection laws. The Company believes that it has strong defenses to such claims based on a significant body of scientific evidence, and pursuant to the doctrine of federal preemption. As noted above, the Company has won multiple motions to dismiss in the MDL, as well as additional state court actions in California and Maryland.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has also been named in a Complaint brought by the New Mexico Attorney General based on the following theories: violation of a New Mexico public nuisance statute, NMSA 30-8-1 to -14; common law nuisance; and negligence and gross negligence. The Company is named in this lawsuit with manufacturers of the national brand &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Zantac&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and other manufacturers of ranitidine products and/or retailers. Brand name manufactures named in the lawsuit also face claims under the state&#x2019;s Unfair Practices &amp;amp; False Advertising acts. The Company filed motions to dismiss the action. The New Mexico District Court denied the Company&#x2019;s Motion to Dismiss and litigation continues. The Company will continue to vigorously defend this lawsuit. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s retailer customers are seeking indemnity from the Company for a portion of their defense costs and liability relating to these cases. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acetaminophen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2022 the Judicial Panel on Multidistrict Litigation ("MDL") consolidated a number of pending actions filed in various federal courts alleging that prenatal exposure to acetaminophen is purportedly associated with the development of autism spectrum disorder (&#x201c;ASD&#x201d;) and attention-deficit/hyperactivity disorder (&#x201c;ADHD&#x201d;). The MDL is styled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re: Acetaminophen &#x2013; ASD/ADHD Products Liability Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (MDL No. 3043) and is pending before the U.S. District Court for the Southern District of New York. Plaintiffs in the MDL have asserted claims against Johnson &amp;amp; Johnson Consumer, Inc. (&#x201c;JJCI&#x201d;) and various retailer chains alleging that plaintiff-mothers took acetaminophen products while pregnant and that plaintiff-children developed ASD and/or ADHD as a result of prenatal exposure to these acetaminophen products. At this time, the MDL proceedings are in the early stages. Currently, it is not possible to assess reliably the outcome of these cases or any potential future financial impact on the Company. As of April 24, 2023 the Company has not been named as a defendant in any Complaints filed in the MDL. It is anticipated that some of the Company&#x2019;s retailer customers may seek indemnity from the Company for a portion of their defense costs and potential liability relating to these cases. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies Accruals&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the matters discussed in this Note, the Company has established a loss accrual for litigation contingencies where we believe a loss to be probable and for which an amount of loss can be reasonably estimated. However, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to inherent uncertainties of litigation. At April&#160;1, 2023, the loss accrual for litigation contingencies reflected on the balance sheet in Other accrued liabilities was approximately $67.6&#160;million. The Company also recorded an insurance recovery receivable reflected on the balance sheet in Prepaid expenses and other current assets of approximately $37.2&#160;million related to these litigation contingencies because it believes such amount is recoverable based on communications with its insurers to date; however, the Company may erode this insurance receivable as it incurs defense costs associated with defending the matters. The Company&#x2019;s management believes these accruals for contingencies are reasonable and sufficient based upon information currently available to management; however, there can be no assurance that final costs related to these contingencies will not exceed current estimates or that all of the final costs related to these contingencies will be covered by insurance. (See "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Insurance Coverage Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;," below.) In addition, we have other litigation matters pending for which we have not recorded any accruals because our potential liability for those matters is not probable or cannot be reasonably estimated based on currently available information. For those matters where we have not recorded an accrual but a loss is reasonably possible, we cannot determine a reasonable estimate of the maximum possible loss or range of loss for these matters given that they are at various stages of the litigation process and each case is subject to the inherent uncertainties of litigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Insurance Coverage Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In May 2021, insurers on multiple policies of D&amp;amp;O insurance filed an action in the High Court in Dublin against the Company and multiple current and former directors and officers of the Company seeking declaratory judgments on certain coverage issues. Those coverage issues include claims that policies for periods beginning in December 2015 and December 2016, respectively, do not have to provide coverage for the securities actions described above pending in the District of New Jersey or in Massachusetts state court concerning the events of 2015-2017. The policy for the period beginning December 2014 is currently providing coverage for those matters, and the litigation would not affect that existing coverage. However, if the plaintiffs are successful, the total amount of insurance coverage available to defend such lawsuits and to satisfy any judgment or settlement costs thereunder would be limited to one policy period. The insurers&#x2019; lawsuit also challenges coverage for Krueger derivatively on behalf of nominal defendant Perrigo Company plc v. Alford et al., a prior derivative action filed in the District of New Jersey that was dismissed in August 2020, and for the counterclaims brought in the Omega arbitration proceedings. Perrigo responded on November 1, 2021; Perrigo&#x2019;s response includes its position that the policies for the periods beginning December 2015 and December 2016 provide coverage for the underlying litigation matters and seeks a ruling to that effect. The discovery stage of the case occurred in 2022. The Court has set a schedule for submissions by the parties during 2023 and for a bench trial in mid-November 2023. We intend to defend the lawsuit vigorously.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <prgo:NumberOfAdditionalStatesAndTerritories
      contextRef="i28ca55466881480391b76ea7d3db52a4_I20200610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfMjkxNjA_c7f10431-ff71-4638-9344-2d8080fa3e6f"
      unitRef="plaintiffgroup">50</prgo:NumberOfAdditionalStatesAndTerritories>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="i28ca55466881480391b76ea7d3db52a4_I20200610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfMjkyMDk_60355cf9-f089-48b5-8460-89caf8077161"
      unitRef="manufacturer">35</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberofFormerEmployees
      contextRef="i28ca55466881480391b76ea7d3db52a4_I20200610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1Njg_626be8da-e76e-4dfb-abfc-eed15601d386"
      unitRef="retailer">2</prgo:LossContingencyNumberofFormerEmployees>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="i28ca55466881480391b76ea7d3db52a4_I20200610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1NzM_74e4c4ea-df73-4529-a88a-8c70c4c95582"
      unitRef="pharmaceuticalproduct">80</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:LossContingencyNumberOfManufacturers
      contextRef="ib8a4bae7a747476e97ac581edbcf809e_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfMzEwNzg_182ea19d-ea38-4296-a537-d9402c3e7b62"
      unitRef="manufacturer">29</prgo:LossContingencyNumberOfManufacturers>
    <prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers
      contextRef="ica2a115cf0034cd88c426dea96ad5c21_I20170621"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDMw_f2578f97-14f9-4c0b-920b-a8e2d4fd68b0"
      unitRef="individual">11</prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers>
    <prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals
      contextRef="ica2a115cf0034cd88c426dea96ad5c21_I20170621"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDQ2_83a34523-c3b2-4d22-9b3c-063804403078"
      unitRef="genericprescriptionpharmaceutical">6</prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals>
    <prgo:NumberofPutativeClasses
      contextRef="i97aab9c2264f4b1d8268af34bd05d862_I20191114"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDQ0_2be10be7-2f08-4550-bb31-32aa2b8fda2d"
      unitRef="class">3</prgo:NumberofPutativeClasses>
    <prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers
      contextRef="i7b7f1a9b91944bd69726984aec58d65e_I20170628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDIz_013bda6f-b136-4d6b-9e40-a74aaa682582"
      unitRef="individual">11</prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers>
    <prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers
      contextRef="i7b7f1a9b91944bd69726984aec58d65e_I20170628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDE2_1d939f0d-de95-47b8-876c-ac42777e14bd"
      unitRef="individual">11</prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ic803f010b538436e9209e345a0be08e1_D20170628-20170628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQzOTg0_aab4048d-a1b9-41f9-b2e0-356b64c9dbc3"
      unitRef="ils">2700000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ic803f010b538436e9209e345a0be08e1_D20170628-20170628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQzOTU3_3c60cf35-cdfc-4145-9d51-7ef4afa870cf"
      unitRef="usd">760000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:ForeignCurrencyExchangeRateRemeasurement1
      contextRef="i7b7f1a9b91944bd69726984aec58d65e_I20170628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDA3_08553ad9-291c-40c3-9674-9fb16da0d1be"
      unitRef="usdPerILS">0.28</us-gaap:ForeignCurrencyExchangeRateRemeasurement1>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="ic803f010b538436e9209e345a0be08e1_D20170628-20170628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTQ5NzU1OTQ0MDAw_b8589990-80c6-47f2-8d9d-dfc52b74bb58"
      unitRef="case">2</us-gaap:LossContingencyClaimsDismissedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i1bfe66b50bea4a8aa93aa6ad4d382456_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTY3Nzc_954229ba-45fe-4773-9348-9b49eb9b9add"
      unitRef="lawsuit">90</us-gaap:LossContingencyPendingClaimsNumber>
    <prgo:NumberofTendersAccepted
      contextRef="i2c793269a6cc46b9b3333aaf587cd1d4_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1ODg_7753410f-e565-4f39-9414-73b444c78084"
      unitRef="tender">1</prgo:NumberofTendersAccepted>
    <prgo:LossContingencyNumberofMasterComplaints
      contextRef="i2649c54ab7c149678c1ae6e627aa140e_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1OTY_6673b1a9-6202-432c-b19d-a8bfecd337df"
      unitRef="complaint">3</prgo:LossContingencyNumberofMasterComplaints>
    <prgo:LossContingencyNumberofMasterComplaintsNamingCompany
      contextRef="i2649c54ab7c149678c1ae6e627aa140e_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1ODk_1c954e4a-fe58-4803-9c0a-22d267203031"
      unitRef="complaint">3</prgo:LossContingencyNumberofMasterComplaintsNamingCompany>
    <prgo:NumberOfAppealsOfMasterComplaints
      contextRef="i2649c54ab7c149678c1ae6e627aa140e_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1NzA_8f0c2c66-dae5-4e75-8f0f-eec954a66b8e"
      unitRef="complaint">1</prgo:NumberOfAppealsOfMasterComplaints>
    <prgo:NumberOfAppealsOfPersonalInjuryClaims
      contextRef="i2649c54ab7c149678c1ae6e627aa140e_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjU1NTc_9788f313-6724-408f-8976-647dd6bacfa5"
      unitRef="claim">2</prgo:NumberOfAppealsOfPersonalInjuryClaims>
    <prgo:NumberOfPersonalInjuryLawsuits
      contextRef="id52764380c894cadb9ff29bc67bd9ba8_D20230101-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNTkxMzQ_1f794c4b-da71-4019-b867-4a4b75a66b63"
      unitRef="lawsuit">352</prgo:NumberOfPersonalInjuryLawsuits>
    <us-gaap:LitigationReserve
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjI1NDc_f00f7abe-6f5c-453d-aead-70b21ecbcbeb"
      unitRef="usd">67600000</us-gaap:LitigationReserve>
    <us-gaap:LossContingencyRelatedReceivableCarryingValueAdditions
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjI3MDM_07f40eeb-ace3-4c3b-8c2b-9196c073f010"
      unitRef="usd">37200000</us-gaap:LossContingencyRelatedReceivableCarryingValueAdditions>
    <prgo:ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods
      contextRef="i3b63510c803344a6ba94abfe031e6828_I20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV85MS9mcmFnOjlhN2NjNmRlMjI0NjQzOWY4ODRlN2VjYTI0MmNlNmRmL3RleHRyZWdpb246OWE3Y2M2ZGUyMjQ2NDM5Zjg4NGU3ZWNhMjQyY2U2ZGZfNjQ4OTU_debcd8d0-8364-4122-8585-895d02d197aa"
      unitRef="policyperiod">1</prgo:ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90ZXh0cmVnaW9uOjRiODk2ZWNkYjljYjQ5YzI5NmZmMTE1YjIzN2Q1YTRiXzMxMQ_7c0e42ca-0e6c-40bf-a166-94cc76dcfdcd">SEGMENT INFORMATION &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below show select financial measures by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.438%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.755%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,057.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,134.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,897.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,883.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,954.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,017.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net &lt;br/&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net &lt;br/&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;763.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;710.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;418.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;364.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(56.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(73.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing Operations Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,074.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90ZXh0cmVnaW9uOjRiODk2ZWNkYjljYjQ5YzI5NmZmMTE1YjIzN2Q1YTRiXzMwNw_1d8c4703-562e-4301-bd7c-2adfd45bbe55">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below show select financial measures by reporting segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.438%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.755%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,057.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,134.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,897.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,883.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,954.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,017.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net &lt;br/&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net &lt;br/&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intangible Asset Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;763.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;710.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CSCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;418.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;364.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(56.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(73.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing Operations Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,074.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Assets
      contextRef="ib24332748044483db83ca8e301c719ca_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzItMi0xLTEtMjk3NTAz_76d61661-17cc-4fb4-b38b-ba22eb989d24"
      unitRef="usd">5057700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4f3eb6af9f444b3e8326226555389980_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzItNC0xLTEtMjk3NTAz_92a13505-cf9a-47e9-a0d6-7c19690d973f"
      unitRef="usd">5134100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idc71f8f540634f1ea99e39a92c86aae5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzMtMi0xLTEtMjk3NTAz_6017795b-469d-4c38-9b74-92773cfa3227"
      unitRef="usd">5897200000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i63eb2d1285fa4953907a861c6ea961bc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzMtNC0xLTEtMjk3NTAz_9d7904f2-22e9-4514-b554-f1eff07aa2ff"
      unitRef="usd">5883200000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i09f467292f2f4ec28ff4898282903225_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzgtMi0xLTEtMjk3NTAz_fa812175-faab-4224-a1bc-a483e529e177"
      unitRef="usd">10954900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iafa30a67b78141b8a9689bcf457bb312_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZToyMTg5MzM1MTgwYmM0ZmQ5ODNlYmY0NTQ0YWVkYmQ2Zi90YWJsZXJhbmdlOjIxODkzMzUxODBiYzRmZDk4M2ViZjQ1NDRhZWRiZDZmXzgtNC0xLTEtMjk3NTAz_09c639b4-ab66-4dc1-acbd-34d3abb2d221"
      unitRef="usd">11017300000</us-gaap:Assets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b6ce8147676451896841efd4f59b711_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtMS0xLTEtMjk3NTAz_08f1a865-ee4e-4317-9d06-c3e49a469948"
      unitRef="usd">763700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0b6ce8147676451896841efd4f59b711_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtMy0xLTEtMjk3NTAz_42fd4fc1-9b96-4a9b-a66f-460a60380304"
      unitRef="usd">83200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0b6ce8147676451896841efd4f59b711_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtNS0xLTEtMjk3NTAz_9622e32b-ed79-4f77-84cb-8b97ea7edc85"
      unitRef="usd">13900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e0b17ca570e463d8112c9aa7539c783_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtNy0xLTEtMjk3NTAz_6762131e-02d2-4b73-b81c-3f343f9b103a"
      unitRef="usd">710000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0e0b17ca570e463d8112c9aa7539c783_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtOS0xLTEtMjk3NTAz_413c4e36-fa15-4052-8c18-8d24edb61648"
      unitRef="usd">78500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0e0b17ca570e463d8112c9aa7539c783_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzMtMTEtMS0xLTI5NzUwMw_6580d891-822b-4c34-aff0-1e5aa3907edc"
      unitRef="usd">12400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if88323e455b54b5aae39a5550bdf99d6_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtMS0xLTEtMjk3NTAz_bf461970-4cb0-4804-88ca-ede0b6fd563f"
      unitRef="usd">418100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="if88323e455b54b5aae39a5550bdf99d6_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtMy0xLTEtMjk3NTAz_5cdb63e6-eec8-4c85-ae86-a6a3d81d71a9"
      unitRef="usd">21300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if88323e455b54b5aae39a5550bdf99d6_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtNS0xLTEtMjk3NTAz_b4e86c72-cf43-4a2d-9b18-30c869482e84"
      unitRef="usd">51500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia88afdc4249140efb878dc32ef2e31c3_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtNy0xLTEtMjk3NTAz_100c5d9c-d021-4b16-a08f-1937a8aca74f"
      unitRef="usd">364500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia88afdc4249140efb878dc32ef2e31c3_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtOS0xLTEtMjk3NTAz_ea2ed87e-3012-4425-8404-3553b1c8c046"
      unitRef="usd">16200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia88afdc4249140efb878dc32ef2e31c3_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzQtMTEtMS0xLTI5NzUwMw_1df534e7-0b63-4953-91b6-86cd89cf7cce"
      unitRef="usd">36100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76faace4db464da8a217c507ee330b44_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtMS0xLTEtMjk3NTAz_d34c6706-6f25-44c8-86ac-b77414815f04"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i76faace4db464da8a217c507ee330b44_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtMy0xLTEtMjk3NTAz_fa7d044c-f559-4d6a-af9f-37caeaf8dbb4"
      unitRef="usd">-56000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i76faace4db464da8a217c507ee330b44_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtNS0xLTEtMjk3NTAz_2055fb4b-40c0-44d7-b3c1-483f98abc139"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c4d7777405b48b5a6f0c5963e7e4b91_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtNy0xLTEtMjk3NTAz_a80cab8f-7d56-4ec6-8997-dafcc5665e23"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5c4d7777405b48b5a6f0c5963e7e4b91_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtOS0xLTEtMjk3NTAz_c91b110c-fca7-4fb8-883a-5be9d31a2b13"
      unitRef="usd">-73000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5c4d7777405b48b5a6f0c5963e7e4b91_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzgtMTEtMS0xLTI5NzUwMw_eedafea1-fd78-45d8-93ea-833b30e21da6"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktMS0xLTEtMjk3NTAz_c8361722-62d5-4bac-a1e4-414ce2081231"
      unitRef="usd">1181700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktMy0xLTEtMjk3NTAz_85242892-d359-43eb-b1ce-4a4ccf471029"
      unitRef="usd">48500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktNS0xLTEtMjk3NTAz_6c3b1c6e-9534-4d16-bb38-9702abc2a770"
      unitRef="usd">65400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktNy0xLTEtMjk3NTAz_9982e0de-b991-489f-bdec-78cde51b6b9d"
      unitRef="usd">1074500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktOS0xLTEtMjk3NTAz_99d70f6c-f79a-4ad0-94f8-da16dfda0cca"
      unitRef="usd">21700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xMDAvZnJhZzo0Yjg5NmVjZGI5Y2I0OWMyOTZmZjExNWIyMzdkNWE0Yi90YWJsZTo2MDQ3MDQ1NDI2YWM0MWY2OWMxNDcxYWVhYzNlMGQ4My90YWJsZXJhbmdlOjYwNDcwNDU0MjZhYzQxZjY5YzE0NzFhZWFjM2UwZDgzXzktMTEtMS0xLTI5NzUwMw_876c45b0-c835-4698-96d2-7b51e2aa65a3"
      unitRef="usd">48500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8yMTk5MDIzMjYyODYx_6965884e-4779-4d89-980d-11aa3f422624">SUBSEQUENT EVENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Internal Revenue Service Audit of Athena Neurosciences, Inc., a U.S. Subsidiary&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April 26, 2019, we received a revised NOPA from the IRS regarding transfer pricing positions related to the IRS audit of Athena Neurosciences, LLC ("Athena") for the years ended December 31, 2011, December 31, 2012, and December 31, 2013. The April 26, 2019 NOPA carried forward the IRS's theory from its 2017 draft NOPA that when Elan took over the future funding of Athena's in-process research and development after acquiring Athena in 1996, Elan should have paid a substantially higher royalty rate for the right to exploit Athena&#x2019;s intellectual property in various developmental products, including the Multiple Sclerosis drug Tysabri, rather than rates based on transfer pricing documentation prepared by Elan's external tax advisors. The April 26, 2019 NOPA proposed a payment of $843.0&#160;million, which represented additional tax based on imputing royalty income to Athena using a 24.7% royalty rate derived by the IRS and a 40.0% accuracy-related penalty. This amount excluded consideration of offsetting tax attributes and any potential interest that may be imposed. We strongly disagreed with the IRS position. On December 22, 2016, we also received a NOPA for these years denying the deductibility of settlement costs incurred in 2011 by Athena's parent company Elan Pharmaceuticals, Inc. ("EPI") related to illegal marketing of Zonegran by EPI's employees in the United States raised in a Qui Tam action under the U.S. False Claims Act. We strongly disagreed with the IRS' position on this issue as well. Because we believed that any concession on these issues in Appeals would be contrary to our evaluation of the issues and to avoid double taxation of the same income in the United States and Ireland, we pursued our remedies under the Mutual Agreement Procedure ("MAP") of the U.S.-Ireland Income Tax Treaty to alleviate double taxation. On April 21 and 23, 2020, we filed requests for Competent Authority assistance with the IRS and Irish Revenue on the Tysabri royalty issue, and those MAP applications were accepted. On October 20, 2020, we amended our requests for Competent Authority assistance to include the Zonegran issue and these supplemental requests were also accepted. On April 24, 2023, we received a letter from the IRS regarding the Competent Authority request filed for the Tysabri royalty issue, which concludes the competent authority process commenced by such submissions without the need for negotiations between the competent authorities and constitutes a full and final resolution of the April 26, 2019 NOPA. In the second quarter of fiscal year 2023 we plan to adjust any previously established reserves related to this matter. The Zonegran deduction issue remains pending in the MAP case and is being considered by APMA and the Irish Competent Authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Internal Revenue Service Audits of Perrigo Company, a U.S. Subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As detailed in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;&lt;a href="#i391fab8b65b648d5a5c27f0c2d5892b5_88" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"&gt;Note 15. Income Taxes&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, on January 13, 2021, the IRS issued a 30-day letter for the 2013-2015 tax years, which included a proposal to reduce Perrigo U.S.'s deductible interest expense for the 2014 tax year and the 2015 tax year on $7.5 billion in certain intercompany debts owed by it to Perrigo Company plc. The debts were incurred in connection with the 2013 Elan merger transaction. On May 7, 2020, the IRS issued a NOPA capping the interest rate on the debts for U.S. federal tax purposes at 130.0% of the Applicable Federal Rate ("AFR") (a blended &lt;/span&gt;&lt;/div&gt;rate reduction of 4.0% per annum) on the stated ground that the loans were not negotiated on an arms-length basis. The May 7, 2020 NOPA proposed a reduction in gross interest expense of approximately $414.7 million for tax years 2014 and 2015. On January 13, 2021, we received a RAR, together with the 30-day letter, requiring our filing of a written protest to request IRS Appeals consideration. The protest was timely filed with the IRS on February 26, 2021. On January 20, 2022, the IRS responded to our protest with its rebuttal in which it revised its position on this interest rate issue by reasserting that implicit parental support considerations are necessary to determine the arm's length interest rates and proposed revised interest rates that are higher than the interest rates proposed under its 130.0% of AFR assertion. The blended interest rate proposed by the IRS rebuttal was 4.36%, an increase from the blended interest rate in the RAR of 2.57% but lower than the stated blended interest rate of the loans of 6.8%. An IRS Appeals conference for the interest rate issue was held during March 7, 2023 through March 9, 2023. On May 5, 2023, we finalized an agreement with IRS Appeals providing for settlement of the May 7, 2020 NOPA of $153.4&#160;million of gross interest expense reduction for the 2013-2015 tax years. This implies a blended interest rate of 5.44%. In addition, based on the above agreement with IRS Appeals, we will apply similar adjustments for all remaining tax years through 2018. In the second quarter of fiscal year 2023 we plan to adjust any previously established reserves related to this matter.</us-gaap:SubsequentEventsTextBlock>
    <prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty
      contextRef="i24a3f5f031674ea3967941fe5f6e80e7_I20190426"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAyMzE5_78aa8819-c167-4ad3-9d19-792d9c6b1cba"
      unitRef="usd">843000000</prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty>
    <prgo:IRSNoticeofProposedAdjustmentPenaltyPercent
      contextRef="i24a3f5f031674ea3967941fe5f6e80e7_I20190426"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAyNDUw_52714fe3-6a59-467e-8366-1a412cbb5947"
      unitRef="number">0.400</prgo:IRSNoticeofProposedAdjustmentPenaltyPercent>
    <prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense
      contextRef="i6df9a027c7764dc1882048b53958ed7f_I20210113"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0ODk5NTIw_d46d7e57-7935-4e88-927c-7d426cd8f93e"
      unitRef="usd">7500000000</prgo:IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense>
    <prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate
      contextRef="ib61b709a6db3426a9ffb8c7d3ab7d06f_D20200507-20200507"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0ODk5Nzc5_5a4add62-fe95-46a0-badb-0e5c63c2be1a"
      unitRef="number">1.300</prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate>
    <prgo:IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes
      contextRef="ib61b709a6db3426a9ffb8c7d3ab7d06f_D20200507-20200507"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0ODk5ODUx_e955c5de-254e-468c-ad37-09f40d1dff82"
      unitRef="number">0.040</prgo:IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes>
    <prgo:IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense
      contextRef="ib61b709a6db3426a9ffb8c7d3ab7d06f_D20200507-20200507"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAwMDIw_722685e7-114a-4ef6-8402-26dbe7a4898a"
      unitRef="usd">414700000</prgo:IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense>
    <prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate
      contextRef="ib61b709a6db3426a9ffb8c7d3ab7d06f_D20200507-20200507"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAwNjE4_5a4add62-fe95-46a0-badb-0e5c63c2be1a"
      unitRef="number">1.300</prgo:InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate>
    <prgo:BlendedInterestRateProposedOnDebtsForUSTaxPurposes
      contextRef="i6893406b8890440696557335070ce018_D20220120-20220120"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAwNjk5_e9a8355d-6c9c-4208-9cca-dab07d7efb29"
      unitRef="number">0.0436</prgo:BlendedInterestRateProposedOnDebtsForUSTaxPurposes>
    <prgo:BlendedInterestRateInRevenueAgentReport
      contextRef="i6893406b8890440696557335070ce018_D20220120-20220120"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAwNzYx_d4ad96b1-5986-4e99-857c-5f32a192cfac"
      unitRef="number">0.0257</prgo:BlendedInterestRateInRevenueAgentReport>
    <prgo:DebtStatedBlendedInterestRate
      contextRef="i6893406b8890440696557335070ce018_D20220120-20220120"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV8zMjk4NTM0OTAwODI5_49922961-b8c9-4908-bfa2-62aaf560ab78"
      unitRef="number">0.068</prgo:DebtStatedBlendedInterestRate>
    <us-gaap:IncomeTaxExaminationInterestExpense
      contextRef="ie669ed37287d49f79a13f8942d0d9e94_D20230505-20230505"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV81NDk3NTU4Mzk1NTU_7ff9b6b7-a5bf-47c0-8830-f18c24fbc594"
      unitRef="usd">153400000</us-gaap:IncomeTaxExaminationInterestExpense>
    <prgo:BlendedInterestRateProposedOnDebtsForUSTaxPurposes
      contextRef="ie669ed37287d49f79a13f8942d0d9e94_D20230505-20230505"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MWZhYjhiNjViNjQ4ZDVhNWMyN2YwYzJkNTg5MmI1L3NlYzozOTFmYWI4YjY1YjY0OGQ1YTVjMjdmMGMyZDU4OTJiNV8xNzQyL2ZyYWc6NTk2NTk0ZTQ5ZDEwNDAyNmFiZTcxZGQ4MGMwZjEwNWEvdGV4dHJlZ2lvbjo1OTY1OTRlNDlkMTA0MDI2YWJlNzFkZDgwYzBmMTA1YV81NDk3NTU4Mzk1OTU_d7994169-70bc-4940-840c-2969f1a855e6"
      unitRef="number">0.0544</prgo:BlendedInterestRateProposedOnDebtsForUSTaxPurposes>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>96
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MX4AC,4MD>67^CYW\HH*FZ#83$G<2=6%A=-P2KI3M4*AYN9I:;G\ZL2508._
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MS97;\+ -CY#.P!$#CYS+KQ+'C3J*KO 1.ZNUHBK1N82Z0F>X#'LI8_E1[9E
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M$(GB(TAQH_@A_XZPYDKQ-+_<,QHQH07@]RWGZG2C%Z@^12W_ U!+ P04
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M:[HOU%?^\ MK#9IH?2DO9/T;/;2RT0"E>ZEXV2X&!&5>-7_I8^N(W@+0XUZ
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MI8(-=;/.$&02,)CT@IQ9S\?):'$"TB$T'1$WR'D'<AX$^95))?:IV@M=W2E
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MH G)2C-9$JCNN1 ,A(X!X"V"+K3TR)8!"Y3&0)@J5 (U/ ,E.TEKGTH8BM\
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M/"W >SKGM#>DH/N^?O$?4$L#!!0    ( *%HJ5;0KGVZ 0<  %$0   9
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M\#;LK62J(N.5-<)1?IS,QN].]_A\//"GHJ7?>A8<R<+:+_QRGATG(P9$FM+
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M!+&#/8;[Q8H+B]DS/A"OQ3R.;W1ZRJI-WU E]C8\)E<8 /3Z@WI@BQ_ETC=
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M]=YK=6:+="=93B\@O8Z> 5>.4+,*Z6*B61+:<F7*^@@Z#^_S^K21(D,R;L8
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M&@;ZOA)"[R_&0+?23_X!4$L#!!0    ( *%HJ5:14S>GB 0  /L*   9
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M\@':GQMR2SMA!5V_._T/4$L#!!0    ( *%HJ59GE=2H)0L  ,XD   9
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M8]_>PCY@GU2:S0P;I9&(5NE;4+72MUWJ>];>R7 PUTWF^8>L[;6#'?R"RO[
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MK-L#[9=44JJ.,YO YU"28][Y,CX_8-T.6'2)Q1"HA'F?_2N'D/WAU<4!:_<
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MM.A*EQ57#Z..I/G JB+U!?$1P]NR&V[P;\[5YQ&[Y90GT./26IU*_S8BZ<[
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M=3NU-2)D4M0$J]IAJ7W# W0![!IUZ[R>B$\?8XU8(;%7)AZ]U"B%60J#!\#
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M\P(ELZ'>H:(_&VTD<V2:;61W!MFZ<I(B2N*X&TG&53#L5VMS,^SKT@FN<&[
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MW$/O)(EWPO1.'A1/O;8^*RK?.*/^/9O[VL$A_G-(9*%X>I@B!<D/?J,S\V*
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M%'KK&]OWA]F[US.D=5O0,92[M/J@G5XZO5FIR]_4!>BQTQ'7(_4[N*(*4N-
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ML",_S^,LIIV-2!-Q)KKO<Q>;JR&A!>K?&3NMJSSU:M3IWC_'.CBVZK7H!R<
M>HG.;TF*;H'*H\EI!TJP".0\1['1W#OX3C+3R>AII')(;';>MH1VR;:%.QQ0
MFAM895M1A$HA]-Q8[O5*T&3-D%[<J'^>.&5%L1H&$91L.J="40PD(B[J#*HW
MH3,/$=]!8GL88\AN&.-@RUB*.FR8QZ,&2%C0(+OV!S  ..0X!:@#QR+BW!36
M7+<@,0 T0E4:93.$=R19RBR)<4N$+;'8E G6\0 XU&:Z Q%,%ALBY U-P^1
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M2U71#Y@S;HT_V[ZRTR)3O:9=X;HP )@(H&_ANKE)B(N^7^&O7T@SC#J)WU9
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M.EJ ]XL*^3O\H /2E]LO_PM02P,$%     @ H6BI5J3PN<DO(@  .F<  !D
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MT MC<EQ6/39(8H!+$C*$M@)I$\X+SSAR[3@E( ]?!^'4A7#"251>R =%:]6
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MA,=2='KEUP_!P!_SS]876^!A4@2LO3S96=)]3KW+NN[3)P#8*,Q@@<.RB/M
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MM#?:01^(=(O^#O6TN\.0)1!ITJ]$/:XK32F=23+ORB&=YWP/%#HM83J2V_J
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M J>8YI/"$RXD7IG4C%0]VW&"/WW((U4S4GU]!+,Z7 N=@W8%_=W5]NXJB&#
M*"E#F]AA2/Z>\/3>*,UK)ZV&19BS2:-D)\M4N""&!)?!U)TN.R[1N&;+@6_/
M@C=!+'PDL)ET#/J8^%X]5MPXV35]2?@/WUN-EUP KM2RU#/-)<W8:/OZ#QS.
MHZ][!. :1EUTB]Q*Z*+6N;MB(0ARB '\:UZ41R-8]ES7&>8Y-CJ!.A/VWE"[
MZAMV>7MP-SJUX3\W XGEKRQ2&_5,'$3N<@?%H1G=/\-.87)WA3/[-%P>CAO-
M_Z3OQI!FL<M_1FA.7HRWV-@ON#GYACY$<H!&\TG]='<G)MOTGM-2*??%8Z?
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MNP44WRAECX;;H/_O3;\"4$L#!!0    ( *%HJ59:T76T(@@  '02   9
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M'QWVTH3?_HFNDO<*"Q>C*^3GFC1\Y@6XOW1@<O.'#^A>-)W^'U!+ P04
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M%SYVBF7*#)XJ\8OGMAA$QQ'D.&.UL#=J\15#/%Y@IH3Q(RR:O6D:058;J\H
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M"\H*X/Y*2K.?6 -=>SS[#U!+ P04    " "B:*E6RQ?_>N8#  "L"0  &0
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MD<S!J$9MI83X',!!4Y,?WU5L;#!V4_J^#\K#$51MBL&F,-\/'20]KS$47]-
M#U7>N-0C#:5O5)6^46/IF]AZ;"K'#YC2^YV/<%F7W+!(+#+^.V33!35%A%Q0
MF6'0V3H*-(K87=J*7F"$HQ9%(F7=?@% S/25!J;V%\*QG%C7:F$KW4[H@6E&
MX$,SPB@TPYA6S=QE(F1^1BNQ->[-TGBW1 :3U VIS RI-M0U+)_7)%]94VKM
M8D<M=4]!44?W!D7IH=)E:*6HUVTTXU[0M? 8OE2AXK [T\%HT#6?@ZX[?^#.
M^U\*%ROGF&:19?%LHWP.F] XKM XWKL13RDFF/<(AYVQG5^3/': F$11GN8.
M"T['J4B!KJ6Y$MK6;6/@X+P-LLUZ&'0Z+)C97MN+37$W!20ML-A\CLNC471'
MNZWA$LA:%O<$OCE33#Y/KUZC[54B)JBB?,[!9BY%ZB@P\XDJ(W&H2HI)D5(7
M3X6O+,V%U14*8EA5Y [ L%<6E_HFUV7A5JL-AKII(;3$K3NY??5F(U,KI7"@
MGA0NA>KWO%?98,,]-^%>VG ?O=%*VZYG;D>ZZ0*[]TK8[I%RG5%OC!D79(H:
M#"!W:D\EHZE0%@EN%0F&1-Q<*T\6LW611YN*>57G>>T+4^X/;,=WMQMSTFC!
M,[A6VQI3.FU;ST.N!Z&Q8Y=#8.6PNSM$98GZ\R$JS=XIV#."OT*<P&ILO%Z/
M5%A[:N^.U>!UK)Q_FRM?8ZR<*NVBWIK#P9\,U\ 0-CO-WKWLC4#9;M8VLW%U
M75*6*"JJPH/MIR^%1.36W)=24O77.)>VXJ' 9>Q)XT)8M+VF:]9!5=T/&JOJ
MJ_I1S!SDRYGC51UYN5?9L72S,1AU;0$TU7/)5UL'E$:]=@\HT:;"1CBMYJ6%
M+=.)U7W'M *:VNW,D)=M0-8U?FO\,&&^M= L@>J>*H!<U %2E)BKHL1L[+U9
MA1VF:X.9P[W5O<P%XS[",=NHEUMX;=R*S:%XS\$+AKI_ +RT5'ND?JG%%>1U
MCE'I)D3;MU <W_D'YI\J;3(>C5'X,?Z']M',0@YC+D[0<I/7E['8H]A,-C!@
M%'R!P<YN78&B;9M(NV@3]2&J_%7P9QL]G&WT<%WT\!KP<F46*%'/"KZ&19&-
MFO.T"ZK4_/<"RJN5%!1^WR:__LM[\Z[]5[VQ36I@@U@^O]F8_JVH]<8#^]^T
M<3BR< V']FJ'R1S%_9^(V]#A=O#/PJUGAZ*_&[.N+;^L;&N8_=K+F)3)A7WE
MI! B:./>RU2KU5NMB7N9\W+<O1+[1"50H$C"YB#U>N-ABTCWFLD]:+&RKW8>
MA-8BM3^7C.*R8@Y@?RZ$+A^,@.I=W^D?4$L#!!0    ( *)HJ588O_C]F00
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M:+<@3M</Q3[0\MD22I$:2==-?_V.I*RZF^L!^R+RCG</G^=(GJ8'J3[K&M'
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MBP='K1XJ3MX$:YH5RA]\I'Z8;Z0K52+UWA--:&+=7)HXV!0UM<H776AB&[B
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M$N1!3^62?%C+="%CU79.R$OS!)TCOM4LNW[(I;G&=H]XC ==*@;5.%3SH9I
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MMZP09B7W'['V9V3U0BET^85]O=9S("RTD6EM3 0ISZH_>ZGC<&3@^R<,_-K
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M,2^9JK:%36USSG!E=]<[]=?^Y4UU6O!L4QU>W!&QI$Q"A@MMJ1=/>O4HJO.
MJJ!X87?(CUSI_;:]3)$D*$P#?7_!N=H43(#F5&;^+U!+ P04    " "B:*E6
ML[C<P\D%  !F'P  &0   'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6RU65UO
MVS84_2N$5PPMD,@2Z<_.-I X*QH@78-ZV1Z&/= R;0N51(^DDQ38CQ\I*:)D
M4HSM*7Y()/O>J\-S+R\/J<D39=_YEA !GI,XY=/.5HC=QVZ7AUN28.[1'4GE
M+VO*$BSD+=MT^8X1O,J<DK@+?7_037"4=F:3[+M[-IO0O8BCE-PSP/=)@MF/
M:Q+3IVDGZ+Q\\2W:;(7ZHCN;[/"&+(AXV-TS>=<MHZRBA*0\HBE@9#WM7 4?
MYZBO'#*+/R+RQ"O70 UE2>EW=7.[FG9\A8C$)!0J!);_'LF<Q+&*)''\4P3M
ME,]4CM7KE^B?LL'+P2PQ)W,:_QFMQ';:&77 BJSQ/A;?Z--G4@PH QC2F&=_
MP5-AZW= N.>")H6S1)!$:?X?/Q=$5!S0L,$!%@[P6 =4.*!LH#FR;%@W6.#9
MA-$GP)2UC*8N,FXR;SF:*%5I7 @F?XVDGYC=$<D!!Y?@&L<X#0E89,5S1T.<
MT4S7X(IS(CC Z0K<17@9Q9&(I,O[&R)P%/,/TOEA<0/>O_L WH$H!5^B.):N
M?-(5$J!Z3#<LP%SG8& #F*L=\X ?7 #H0V1QG[O=;TCH 92[P[I[5])2<@-+
M;F 6#S5R(T=.+D#&T06X(3QDT2ZCY:\[:0MN!4GXW[9QYH%[]L!J:G[D.QR2
M:4?./4[8(^G,?OXI&/B_V$;=4K :!ZCD +FBS[[N").5D&Y K%@ ."L&VY#S
M.(,LCFH>CS,8!-YPTGVLCL5F-?2"TJH&LE>"[#E!?HK2K':+1&6]Z)*N+Q\D
MX*QZ+\!"8)DLD@I5T;E]A&-P3WF4)_379Z&:TS*682(NK%EUH_@JMH2!E*:7
MX9XQ]:A&LN9M1*I1U2^IZA]%599-:QYS_U$M0P=)M)A >P8'):R!$U:9LOU+
MC=F@#<SB0= H,9O5N*G$AB7 X9'SH"BREU;XXP+,\R2U5&2OX,A* X<AVY,5
MB'4_ME59*Z%J=(U*ND8GM8U8LU64M&WH(S-S(P\=I-=JU+-G=US"'9_20-XL
MMVX4Q;/D&KHB2T%6J5Q_;&G]OU%J% 6^5@K^\:WCR(P6(6O9\D8'&;48H4K:
MZW KPB8X>\;^1M.PU<2^AL5HZ*_,W/;BU=G3TB=PJ@K7!$Y+\JQ,0".9P:AG
M-&FKV=CK-V1=RY7 K5>:9W+[.7<CN:/IYE(0E@ U#R\DCYR_3!6PHTP]R)KZ
MML/6F=2:*CA.5)V:_YZ9V($W/DR_Q6K8U,4#+6X"M[JY5P)8\O"(XSU1N:V#
MMT^VZR+H\!5=834;>8,&T%KZ!&[M\SL5LO9HPX1KPIS'[-=DVN%261C5$$N:
MQPV(M18*W,HA1[RV%D@3WJ$!)1B;%)M6T*]8U?%J,1*XU<A#BN-8[6C)RHK-
MZ7WJ;JVM:/6Q:B43C-]JTQHXA<7)/+04K;YUUVH%NM7*\1O7(E"UZ 9]K^=7
M/H<;()O+T//'U8^]:*'6+]"]QK^^4RL"5'N  30PIUU3QX*5<Q&W.#BK8Q4Q
M:YS!"I8",#3&-&A8%J 6!="]9I[1KXJ(=>(,=FU&#=T*ZH47NA?>^6)^!?X%
MNH 79*.TBAVG,];))TTM1:N/7"_?L/]F!VY.87 R#RU%J_.@%0%T*X(3>I>Y
MPH_E N_L7:9+X/M-RAMJ40#=HN"(?F71 *CRX *?U6K4 $]K .C6 .?UK)%)
M[_B5I<%T"7SH-9R/0;VN0_>V_IP>-C:A],R.:[5J6+Z07G^1>_V57>SVZ"[F
MCG7J[&TK6GWD>N%&P5MU,>24!"?ST%*T.@]:):#3CA <KPY,:="KGND5P[%8
M-9X8H,H+CN-.#)K[%C*7^8'1MJQ&#4H+:2V W%K@K*Y5Q*QJJ/YAFRILAC6;
M)NV"] J.W!OP,[H4,M\F&)GO&Z<%/>- OUMY":K>0'_!;!.E7()82R^YBY1!
M6/Y2-[\1=)>]%UU2(6B276X)7A&F#.3O:TK%RXUZU5J^6I_]!U!+ P04
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MKQ>W!*\(DPW$_C6E_&5%?E#H/B M_@=02P,$%     @ HFBI5H7:D_>L @
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M9.O"7,OM1VCT3"Q?*@OM?LFV/AN=>B1=:R/+!HP9E%S4_^R^\6$'0*,] -H
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M!F4#<+^0TNPG]H"VQZ=_ %!+ P04    " "B:*E6=E%6 ?@#   (%   &0
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MK@W4^\L\ET]/]&79^G+T[']02P,$%     @ HFBI5J %; [J @  $0L  !D
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MJ"12>3>8#XR<NX;J41IJS]SKC#IH5-: OD^D-.N!7:#LR4>_ 5!+ P04
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MMVD8KZ9TBJ(477V<W**C&RI)%(O7,.[+W0TZ>O4:O5)W/T1Q#',H+GH2(*A
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M/Q .F2-03&?@LM\=P>3Q[!AZ]D6RI3[)?<^D9(G^N*!D2KDR@/LSQN33%_6
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M&F>'<R !L-1 _CZE5*Q/T@'*#T9&_P)02P,$%     @ HFBI5GY$&K6+!P
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M7_30M'5':+$K!<N;8-F#/"WVK\F71HB# "]X),!O OQ3 W 3@$\-")J X-2
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M]E4W+V2UJ#<.3RLIJZ)^.F?)C'%]@/K\ME(SL/:%;F"]NWWR+U!+ P04
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M5]!CF<L4^F8BM &\7W&N=C=Z@*83G_\'4$L#!!0    ( *)HJ587LGT;9P4
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M(T=OHK62X]3)<0:3\_7I%CVJD9D2=)])NLN7-I;U96>0,W;V@81YD# ?$A8
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M<%86=T!CD.8!O)\(H0\5<UAOON:L?@!02P,$%     @ HFBI5M?LY<DA!
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M*J.;YF@TW9YX$,;)ZH_#,P]YS^>V/^+X_(X#R-&HF, -%])8UU_1WY\#XT;
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M?U]?_P902P$"% ,4    " "A:*E6!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *%HJ58/!@2:[P
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( *%HJ5:97)PC$ 8  )PG   3              "  <T!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ H6BI5J  WU8*"   +#D  !@
M             ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( *%HJ593M,.XQP4  )8:   8              " @4X0  !X;"]W
M;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "A:*E6]2/;JE\#  !_
M"@  &               @(%+%@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
M4$L! A0#%     @ H6BI5G0BFEA'!P  C!\  !@              ("!X!D
M 'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( *%HJ59>>-($
M; ,  )L.   8              " @5TA  !X;"]W;W)K<VAE971S+W-H965T
M-2YX;6Q02P$"% ,4    " "A:*E6L]K[E0@&   D)0  &
M@('_)   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ H6BI
M5ECY:-QU @  X@4  !@              ("!/2L  'AL+W=O<FMS:&5E=',O
M<VAE970W+GAM;%!+ 0(4 Q0    ( *%HJ58L\6Y>F0<  "LB   8
M      " @>@M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M" "A:*E6W"?001X*  !K%P  &               @(&W-0  >&PO=V]R:W-H
M965T<R]S:&5E=#DN>&UL4$L! A0#%     @ H6BI5M"N?;H!!P  41   !D
M             ("!"T   'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"
M% ,4    " "A:*E6#;-H*W )  "2%P  &0              @(%#1P  >&PO
M=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( *%HJ5:Y$%)8AP4
M #D,   9              " @>I0  !X;"]W;W)K<VAE971S+W-H965T,3(N
M>&UL4$L! A0#%     @ H6BI5J\-EL6) @  ? 4  !D              ("!
MJ%8  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "A:*E6
M.,FE8"8#  "G!P  &0              @(%H60  >&PO=V]R:W-H965T<R]S
M:&5E=#$T+GAM;%!+ 0(4 Q0    ( *%HJ5:;F'1,HP4  ) 8   9
M      " @<5<  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%
M  @ H6BI5HHC1VX<!0  W@L  !D              ("!GV(  'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "A:*E6D5,WIX@$  #["@
M&0              @('R9P  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+
M 0(4 Q0    ( *%HJ59GE=2H)0L  ,XD   9              " @;%L  !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ H6BI5C75N\(V
M"0  6!<  !D              ("!#7@  'AL+W=O<FMS:&5E=',O<VAE970Q
M.2YX;6Q02P$"% ,4    " "A:*E6T/%_*V #  #.!P  &0
M@(%Z@0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( *%H
MJ58J%ZIO60,  "0'   9              " @1&%  !X;"]W;W)K<VAE971S
M+W-H965T,C$N>&UL4$L! A0#%     @ H6BI5A-8W$\E!0  2PP  !D
M         ("!H8@  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
M    " "A:*E6TZ*;B&L0  #%+0  &0              @(']C0  >&PO=V]R
M:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( *%HJ5:D\+G)+R(  #IG
M   9              " @9^>  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL
M4$L! A0#%     @ H6BI5O&W=-LL P   P<  !D              ("!!<$
M 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "A:*E66M%U
MM"((  !T$@  &0              @(%HQ   >&PO=V]R:W-H965T<R]S:&5E
M=#(V+GAM;%!+ 0(4 Q0    ( *%HJ58AGJ0LF 8  (X0   9
M  " @<',  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @
MHFBI5N;IOI+( @  )P8  !D              ("!D-,  'AL+W=O<FMS:&5E
M=',O<VAE970R."YX;6Q02P$"% ,4    " "B:*E6=,R';P0&   5#@  &0
M            @(&/U@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4
M Q0    ( *)HJ5:]<Q+J^P(  )$&   9              " @<K<  !X;"]W
M;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ HFBI5E_ITK6, @
MBP4  !D              ("!_-\  'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6Q02P$"% ,4    " "B:*E6?HV=VST#   ^"   &0              @(&_
MX@  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( *)HJ5;0
MJ*YG"08   P3   9              " @3/F  !X;"]W;W)K<VAE971S+W-H
M965T,S,N>&UL4$L! A0#%     @ HFBI5L)R=N:2!   *@L  !D
M     ("!<^P  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *)HJ5;_LCB"0P,   L'   9              "
M@4(& 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ HFBI
M5J6!?PSZ @  9@8  !D              ("!O D! 'AL+W=O<FMS:&5E=',O
M<VAE970T,"YX;6Q02P$"% ,4    " "B:*E6T-.2U$\"   =!0  &0
M        @('M# $ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0
M   ( *)HJ5:.G-(6, ,  !H'   9              " @7,/ 0!X;"]W;W)K
M<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ HFBI5E*SRL\3 P  F @
M !D              ("!VA(! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q0
M2P$"% ,4    " "B:*E6]6\AMH$'  "J/   &0              @($D%@$
M>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( *)HJ5;Q6+<C
MMP(  $8(   9              " @=P= 0!X;"]W;W)K<VAE971S+W-H965T
M-#4N>&UL4$L! A0#%     @ HFBI5M1S"[A# @  - 4  !D
M ("!RB ! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "B
M:*E6'&)UO7T#  #I#P  &0              @(%$(P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( *)HJ584V'S%Y@D  ']S   9
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M970U,BYX;6Q02P$"% ,4    " "B:*E6L[C<P\D%  !F'P  &0
M    @(%H/0$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    (
M *)HJ58C[9[JOP(  %,(   9              " @6A# 0!X;"]W;W)K<VAE
M971S+W-H965T-30N>&UL4$L! A0#%     @ HFBI5D$0EW]4!   3!H  !D
M             ("!7D8! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"
M% ,4    " "B:*E6A=J3]ZP"   ""   &0              @('I2@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( *)HJ5;[N*( V0(
M .\'   9              " @<Q- 0!X;"]W;W)K<VAE971S+W-H965T-3<N
M>&UL4$L! A0#%     @ HFBI5G915@'X P  "!0  !D              ("!
MW% ! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " "B:*E6
M.JU4C3$&   ^*@  &0              @($+50$ >&PO=V]R:W-H965T<R]S
M:&5E=#4Y+GAM;%!+ 0(4 Q0    ( *)HJ5:3V$+B$P8  "@M   9
M      " @7-; 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%
M  @ HFBI5J %; [J @  $0L  !D              ("!O6$! 'AL+W=O<FMS
M:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " "B:*E6"E[#/GL(  #%9
M&0              @('>9 $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+
M 0(4 Q0    ( *)HJ5;N6!@#' 8  )@H   9              " @9!M 0!X
M;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ HFBI5F1":&/_
M!   V2   !D              ("!XW,! 'AL+W=O<FMS:&5E=',O<VAE970V
M-"YX;6Q02P$"% ,4    " "B:*E60$L2.),#  "?#P  &0
M@($9>0$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( *)H
MJ5;JN9 !WP8  !@P   9              " @>-\ 0!X;"]W;W)K<VAE971S
M+W-H965T-C8N>&UL4$L! A0#%     @ HFBI5M?'N *G!0  /"(  !D
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M=#<Q+GAM;%!+ 0(4 Q0    ( *)HJ5:,,W;TI@0  -89   9
M  " @9^B 0!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @
MHFBI5F[FW+]R!   IB$  !D              ("!?*<! 'AL+W=O<FMS:&5E
M=',O<VAE970W,RYX;6Q02P$"% ,4    " "B:*E6F,-QE?\&  "?/@  &0
M            @($EK $ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4
M Q0    ( *)HJ5:!L$94GP,  -D1   9              " @5NS 0!X;"]W
M;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ HFBI5M?LY<DA!
MDA,  !D              ("!,;<! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX
M;6Q02P$"% ,4    " "B:*E6G<3>ZVT$  #C%@  &0              @(&)
MNP$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( *)HJ5:M
M_^0J*04  )8B   9              " @2W  0!X;"]W;W)K<VAE971S+W-H
M965T-S@N>&UL4$L! A0#%     @ HFBI5JOH[?O[!   \!X  !D
M     ("!C<4! 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4
M" "B:*E6>VPTX(P#  "=&0  #0              @ &_R@$ >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( *)HJ5:7BKL<P    !,"   +              "
M 7;. 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *)HJ5;@V(Q5V 4  -DS   /
M              "  5_/ 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "B
M:*E6NTG2WV("  "T+@  &@              @ %DU0$ >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "B:*E6W2=K"Q@"  "%+0  $P
M            @ '^UP$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     5P!7
+ -@7  !'V@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>327</ContextCount>
  <ElementCount>369</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>115</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>24</UnitCount>
  <MyReports>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestitures</Role>
      <ShortName>Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DiscontinuedOperations</Role>
      <ShortName>Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Derivative Instruments and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities</Role>
      <ShortName>Derivative Instruments and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Indebtedness</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Indebtedness</Role>
      <ShortName>Indebtedness</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Earnings Per Share and Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareandShareholdersEquity</Role>
      <ShortName>Earnings Per Share and Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RestructuringCharges</Role>
      <ShortName>Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/RevenueRecognition</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Business Combinations and Asset Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/BusinessCombinationsandAssetAcquisitionsTables</Role>
      <ShortName>Business Combinations and Asset Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Inventories</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Investments</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Leases</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/FairValueMeasurements</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables</Role>
      <ShortName>Derivative Instruments and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Indebtedness (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IndebtednessTables</Role>
      <ShortName>Indebtedness (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/Indebtedness</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Earnings Per Share and Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityTables</Role>
      <ShortName>Earnings Per Share and Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/EarningsPerShareandShareholdersEquity</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Restructuring Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RestructuringChargesTables</Role>
      <ShortName>Restructuring Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/RestructuringCharges</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SegmentInformation</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails</Role>
      <ShortName>Revenue Recognition - Schedule of Revenue by Product (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Revenue Recognition - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails</Role>
      <ShortName>Revenue Recognition - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails</Role>
      <ShortName>Revenue Recognition - Schedule of Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails</Role>
      <ShortName>Revenue Recognition - Schedule of Revenue by Geographic Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Acquisitions and Divestitures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails</Role>
      <ShortName>Acquisitions and Divestitures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Acquisitions and Divestitures - Pro Forma (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaDetails</Role>
      <ShortName>Acquisitions and Divestitures - Pro Forma (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Discontinued Operations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails</Role>
      <ShortName>Discontinued Operations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/InventoriesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/InvestmentsDetails</Role>
      <ShortName>Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/InvestmentsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Leases - Balance Sheet Location of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails</Role>
      <ShortName>Leases - Balance Sheet Location of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Leases - Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesLeaseExpenseDetails</Role>
      <ShortName>Leases - Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Leases - Annual Future Maturities of Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails</Role>
      <ShortName>Leases - Annual Future Maturities of Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Leases - Weighted Average Lease Terms and Discount Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails</Role>
      <ShortName>Leases - Weighted Average Lease Terms and Discount Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Leases - Lease Cash Flow Classifications (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails</Role>
      <ShortName>Leases - Lease Cash Flow Classifications (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Goodwill and Intangible Assets - Intangible categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Intangible categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Financial Instruments at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Indebtedness - Schedule of Borrowings Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails</Role>
      <ShortName>Indebtedness - Schedule of Borrowings Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Indebtedness - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IndebtednessNarrativeDetails</Role>
      <ShortName>Indebtedness - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Earnings Per Share and Shareholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails</Role>
      <ShortName>Earnings Per Share and Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RestructuringChargesDetails</Role>
      <ShortName>Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/RestructuringChargesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Restructuring Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/RestructuringChargesNarrativeDetails</Role>
      <ShortName>Restructuring Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/IncomeTaxesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Contingencies - Price Fixing Lawsuits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails</Role>
      <ShortName>Contingencies - Price Fixing Lawsuits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Contingencies - Securities Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails</Role>
      <ShortName>Contingencies - Securities Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Contingencies - Other Matters (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/ContingenciesOtherMattersDetails</Role>
      <ShortName>Contingencies - Other Matters (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SegmentInformationTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="prgo-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perrigo.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.perrigo.com/role/SubsequentEvents</ParentRole>
      <Position>79</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0547-EntityTaxIdentificationNumber-Missing] Submission type 10-Q should have a non-empty value for EntityTaxIdentificationNumber in the Required Context. prgo-20230401.htm </Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="prgo-20230401.htm">prgo-20230401.htm</File>
    <File>cy23q110qex22.htm</File>
    <File>cy23q110qex311.htm</File>
    <File>cy23q110qex312.htm</File>
    <File>cy23q110qex32.htm</File>
    <File>ex101-perrigox2019aipamend.htm</File>
    <File>ex102-2023psusoigrantagree.htm</File>
    <File>ex103-2023psusrtsrgrantagr.htm</File>
    <File>ex104-2023rsusgrantagreeme.htm</File>
    <File>ex105-2023psusoipsurtsrand.htm</File>
    <File>prgo-20230401.xsd</File>
    <File>prgo-20230401_cal.xml</File>
    <File>prgo-20230401_def.xml</File>
    <File>prgo-20230401_lab.xml</File>
    <File>prgo-20230401_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="867">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="45">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>102
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "prgo-20230401.htm": {
   "axisCustom": 2,
   "axisStandard": 29,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 867,
    "http://xbrl.sec.gov/dei/2022": 45
   },
   "contextCount": 327,
   "dts": {
    "calculationLink": {
     "local": [
      "prgo-20230401_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "prgo-20230401_def.xml"
     ]
    },
    "inline": {
     "local": [
      "prgo-20230401.htm"
     ]
    },
    "labelLink": {
     "local": [
      "prgo-20230401_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prgo-20230401_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "prgo-20230401.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 643,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 10,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 15
   },
   "keyCustom": 76,
   "keyStandard": 293,
   "memberCustom": 48,
   "memberStandard": 60,
   "nsprefix": "prgo",
   "nsuri": "http://www.perrigo.com/20230401",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.perrigo.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Revenue Recognition",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.perrigo.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Acquisitions and Divestitures",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestitures",
     "shortName": "Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Discontinued Operations",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.perrigo.com/role/DiscontinuedOperations",
     "shortName": "Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.perrigo.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.perrigo.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.perrigo.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Goodwill and Intangible Assets",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.perrigo.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Derivative Instruments and Hedging Activities",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities",
     "shortName": "Derivative Instruments and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Indebtedness",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.perrigo.com/role/Indebtedness",
     "shortName": "Indebtedness",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Earnings Per Share and Shareholders' Equity",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquity",
     "shortName": "Earnings Per Share and Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Restructuring Charges",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.perrigo.com/role/RestructuringCharges",
     "shortName": "Restructuring Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.perrigo.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Contingencies",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.perrigo.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Segment Information",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.perrigo.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.perrigo.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "27",
     "role": "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Revenue Recognition (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.perrigo.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Business Combinations and Asset Acquisitions (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.perrigo.com/role/BusinessCombinationsandAssetAcquisitionsTables",
     "shortName": "Business Combinations and Asset Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.perrigo.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.perrigo.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.perrigo.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Derivative Instruments and Hedging Activities (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables",
     "shortName": "Derivative Instruments and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "prgo:ScheduleofForeignCurrencyForwardContractsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Indebtedness (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.perrigo.com/role/IndebtednessTables",
     "shortName": "Indebtedness (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Earnings Per Share and Shareholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityTables",
     "shortName": "Earnings Per Share and Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Restructuring Charges (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.perrigo.com/role/RestructuringChargesTables",
     "shortName": "Restructuring Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.perrigo.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Segment Information (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.perrigo.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "iafa30a67b78141b8a9689bcf457bb312_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails",
     "shortName": "Summary of Significant Accounting Policies - Allowance for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "idd18f1c6b0bf4007931565e3309d3a59_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Revenue Recognition - Schedule of Revenue by Product (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
     "shortName": "Revenue Recognition - Schedule of Revenue by Product (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i47f5c13d45a9489b800b1fdca5125d08_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Revenue Recognition - Additional Information (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
     "shortName": "Revenue Recognition - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i4e003873c79f4b258525ee8b81660c16_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Revenue Recognition - Schedule of Contract Balances (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails",
     "shortName": "Revenue Recognition - Schedule of Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Revenue Recognition - Schedule of Revenue by Geographic Location (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
     "shortName": "Revenue Recognition - Schedule of Revenue by Geographic Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "ibe0cdbd5f85948e995c7dc28b6cb4f45_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Acquisitions and Divestitures - Narrative (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
     "shortName": "Acquisitions and Divestitures - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i4a4e7b481e564ec396c3dee7669dcf4a_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "prgo:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Acquisitions and Divestitures - Pro Forma (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaDetails",
     "shortName": "Acquisitions and Divestitures - Pro Forma (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i5a0ae8f88c134273a3a78b75a7b8294e_D20220101-20220402",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "ife7f164c6edf47848398641f9ffd17b1_I20210706",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Discontinued Operations - Narrative (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails",
     "shortName": "Discontinued Operations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "ife7f164c6edf47848398641f9ffd17b1_I20210706",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Inventories (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.perrigo.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Investments (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.perrigo.com/role/InvestmentsDetails",
     "shortName": "Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "if562d2da54df4a299c27576b2a86b7ed_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Leases - Balance Sheet Location of Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
     "shortName": "Leases - Balance Sheet Location of Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:AssetsandLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Leases - Lease Expense (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.perrigo.com/role/LeasesLeaseExpenseDetails",
     "shortName": "Leases - Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Leases - Annual Future Maturities of Leases (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails",
     "shortName": "Leases - Annual Future Maturities of Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Leases - Weighted Average Lease Terms and Discount Rates (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails",
     "shortName": "Leases - Weighted Average Lease Terms and Discount Rates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:LesseeCashFlowClassificationsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Leases - Lease Cash Flow Classifications (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails",
     "shortName": "Leases - Lease Cash Flow Classifications (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:LesseeCashFlowClassificationsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "iafa30a67b78141b8a9689bcf457bb312_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Goodwill and Intangible Assets - Intangible categories (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails",
     "shortName": "Goodwill and Intangible Assets - Intangible categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prgo:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "ic8ec02b3dd484b4e8275f17f1949e2de_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Shareholders' Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "ic8ec02b3dd484b4e8275f17f1949e2de_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "ia38fe8e9a9f04f668590d3cd5af1bea2_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Fair Value Measurements - Financial Instruments at Fair Value (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
     "shortName": "Fair Value Measurements - Financial Instruments at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "ia38fe8e9a9f04f668590d3cd5af1bea2_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeniorNotes",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails",
     "shortName": "Fair Value Measurements - Schedule of Fixed Rate Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i39273b39b09344b1a7df355b3202f917_I20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:SeniorNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i703d29ff729d4c809efa88132b4033f6_I20220430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNumberOfInstrumentsHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "derivative",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i703d29ff729d4c809efa88132b4033f6_I20220430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNumberOfInstrumentsHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "derivative",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i58e9f89e450b4789b74027090e527fd2_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Foreign Currency Forward Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i58e9f89e450b4789b74027090e527fd2_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i0eccd056afc545b39529ed76bdd93865_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Balance Sheet Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i0eccd056afc545b39529ed76bdd93865_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "id11eac94d9bd4b9b8ae0373021cc6731_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Non-designated Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "id11eac94d9bd4b9b8ae0373021cc6731_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Effect of Cash Flow Hedges Included in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
     "shortName": "Derivative Instruments and Hedging Activities - Classification of Gain (Loss) of Cash Flow And Fair Value Hedging Relationships (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Indebtedness - Schedule of Borrowings Outstanding (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails",
     "shortName": "Indebtedness - Schedule of Borrowings Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Indebtedness - Narrative (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.perrigo.com/role/IndebtednessNarrativeDetails",
     "shortName": "Indebtedness - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Earnings Per Share and Shareholders' Equity (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails",
     "shortName": "Earnings Per Share and Shareholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "iafa30a67b78141b8a9689bcf457bb312_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "iafa30a67b78141b8a9689bcf457bb312_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Restructuring Charges (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.perrigo.com/role/RestructuringChargesDetails",
     "shortName": "Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "prgo:RestructuringAdditionalCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Restructuring Charges - Narrative (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails",
     "shortName": "Restructuring Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "id44c0aea81d045e49ea119c7382cc4e4_D20220101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.perrigo.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "ica2a115cf0034cd88c426dea96ad5c21_I20170621",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "prgo:LossContingencyNumberOfGenericPrescriptionPharmaceuticals",
      "reportCount": 1,
      "unitRef": "genericprescriptionpharmaceutical",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Contingencies - Price Fixing Lawsuits (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails",
     "shortName": "Contingencies - Price Fixing Lawsuits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i28ca55466881480391b76ea7d3db52a4_I20200610",
      "decimals": "INF",
      "lang": "en-US",
      "name": "prgo:NumberOfAdditionalStatesAndTerritories",
      "reportCount": 1,
      "unique": true,
      "unitRef": "plaintiffgroup",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "ica2a115cf0034cd88c426dea96ad5c21_I20170621",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "individual",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Contingencies - Securities Litigation (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails",
     "shortName": "Contingencies - Securities Litigation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "ica2a115cf0034cd88c426dea96ad5c21_I20170621",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "prgo:LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "individual",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Contingencies - Other Matters (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.perrigo.com/role/ContingenciesOtherMattersDetails",
     "shortName": "Contingencies - Other Matters (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i09f467292f2f4ec28ff4898282903225_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Segment Information (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.perrigo.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i76faace4db464da8a217c507ee330b44_D20230101-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i24a3f5f031674ea3967941fe5f6e80e7_I20190426",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.perrigo.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i24a3f5f031674ea3967941fe5f6e80e7_I20190426",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "prgo:IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "prgo:NetLossIncomeAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "prgo:NetLossIncomeAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prgo-20230401.htm",
      "contextRef": "i3533a6b42bf94061b1a6e129e014062e_D20230101-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 115,
   "tag": {
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CAD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars",
        "terseLabel": "Canadian Dollar (CAD)"
       }
      }
     },
     "localname": "CAD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CNY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "China, Yuan Renminbi",
        "terseLabel": "Chinese Yuan (CNH)"
       }
      }
     },
     "localname": "CNY",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_DKK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denmark, Kroner",
        "terseLabel": "Danish Krone (DKK)"
       }
      }
     },
     "localname": "DKK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "European Euro (EUR)"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "British Pound (GBP)"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_HUF": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hungary, Forint",
        "terseLabel": "Hungarian Forint (HUF)"
       }
      }
     },
     "localname": "HUF",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_MXN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mexico, Pesos",
        "terseLabel": "Mexican Peso (MXN)"
       }
      }
     },
     "localname": "MXN",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_NOK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Norway, Krone",
        "terseLabel": "Norwegian Krone (NOK)"
       }
      }
     },
     "localname": "NOK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_PLN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Poland, Zlotych",
        "terseLabel": "Polish Zloty (PLZ)"
       }
      }
     },
     "localname": "PLN",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SEK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sweden, Kronor",
        "terseLabel": "Swedish Krona (SEK)"
       }
      }
     },
     "localname": "SEK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States Dollar (USD)"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_XXX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "No currency",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "XXX",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "prgo_A2022RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Revolver [Member]",
        "label": "2022 Revolver [Member]",
        "terseLabel": "2022 Revolver"
       }
      }
     },
     "localname": "A2022RevolverMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3150SeniorNotesDueJune152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.150% Senior Notes due June 15, 2030",
        "label": "3.150% Senior Notes due June 15, 2030 [Member]",
        "terseLabel": "3.150% Senior Notes due June 15, 2030"
       }
      }
     },
     "localname": "A3150SeniorNotesDueJune152030Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A3900SeniorNoteDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.9% senior note due 2024 [Member]",
        "label": "3.900% senior note due 2024 [Member]",
        "terseLabel": "3.900% senior note due 2024"
       }
      }
     },
     "localname": "A3900SeniorNoteDue2024Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage",
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4.375seniornotedueMarch152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.375% senior note due March 15, 2026 [Member]",
        "label": "4.375% senior note due March 15, 2026 [Member]",
        "terseLabel": "4.375% senior note due March 15, 2026"
       }
      }
     },
     "localname": "A4.375seniornotedueMarch152026Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage",
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4400SeniorNotesDueJune152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.4% Senior Notes due June 15, 2030",
        "label": "4.400% Senior Notes due June 15, 2030 [Member]",
        "terseLabel": "4.400% Senior Notes due June 15, 2030"
       }
      }
     },
     "localname": "A4400SeniorNotesDueJune152030Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage",
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4650SeniorNotesDueJune152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.650% Senior Notes due June 15, 2030",
        "label": "4.650% Senior Notes due June 15, 2030 [Member]",
        "terseLabel": "4.650% Senior Notes due June 15, 2030"
       }
      }
     },
     "localname": "A4650SeniorNotesDueJune152030Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A4900SeniorLoanDue2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.9% Senior Loan due 2044 [Member]",
        "label": "4.900% Senior Loan due 2044 [Member]",
        "terseLabel": "4.900% Senior Loan due 2044"
       }
      }
     },
     "localname": "A4900SeniorLoanDue2044Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage",
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_A5300UnsecuredSeniorNotesDueNovember152043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.30% Unsecured Senior Notes due November 15, 2043 [Member]",
        "label": "5.300% Unsecured Senior Notes due November 15, 2043 [Member]",
        "terseLabel": "5.300% Unsecured Senior Notes due November 15, 2043"
       }
      }
     },
     "localname": "A5300UnsecuredSeniorNotesDueNovember152043Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage",
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation Adjustment",
        "label": "Accounts Receivable, Allowance for Credit Loss, Foreign Currency Translation Adjustment",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustment",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_AccruedCustomerPrograms": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable.",
        "label": "Accrued Customer Programs",
        "terseLabel": "Accrued customer programs"
       }
      }
     },
     "localname": "AccruedCustomerPrograms",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_AccumulatedOtherComprehensiveIncomeRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income [Roll Forward]",
        "label": "Accumulated Other Comprehensive Income [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeRollForward",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_AdventInternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advent International",
        "label": "Advent International [Member]",
        "terseLabel": "Advent International"
       }
      }
     },
     "localname": "AdventInternationalMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_AssetsandLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities, Lessee [Table Text Block]",
        "label": "Assets and Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Balance Sheet Location of Lease Assets and Liabilities"
       }
      }
     },
     "localname": "AssetsandLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_BlendedInterestRateInRevenueAgentReport": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blended Interest Rate In Revenue Agent Report",
        "label": "Blended Interest Rate In Revenue Agent Report",
        "terseLabel": "Blended interest rate in revenue agent report"
       }
      }
     },
     "localname": "BlendedInterestRateInRevenueAgentReport",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_BlendedInterestRateProposedOnDebtsForUSTaxPurposes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blended Interest Rate Proposed On Debts For U.S. Tax Purposes",
        "label": "Blended Interest Rate Proposed On Debts For U.S. Tax Purposes",
        "terseLabel": "Blended interest rate proposed on debts"
       }
      }
     },
     "localname": "BlendedInterestRateProposedOnDebtsForUSTaxPurposes",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cost of Sales",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cost of Sales",
        "terseLabel": "Adjustment, cost of sales"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCostOfSales",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In-Definite Lived Intangibles",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In-Definite Lived Intangibles",
        "terseLabel": "Definite-lived intangibles"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInDefiniteLivedIntangibles",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseAssets",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_CanadianClassActionComplaintMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Class Action Complaint [Member]",
        "label": "Canadian Class Action Complaint [Member]",
        "terseLabel": "Canadian Class Action Complaint"
       }
      }
     },
     "localname": "CanadianClassActionComplaintMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "label": "Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "totalLabel": "Amount"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossReclassifiedtoEarningsNet",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concession of Royalty Due on Sales as Percent of Refund Claims, Percent",
        "label": "Concession of Royalty Due on Sales as Percent of Refund Claims, Percent",
        "terseLabel": "Royalty conceded on all omeprazole sales as a percent of refund claims (percent)"
       }
      }
     },
     "localname": "ConcessionofRoyaltyDueonSalesasPercentofRefundClaimsPercent",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_ConsumerSelfCareAmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumer Self-Care Americas [Member]",
        "label": "Consumer Self-Care Americas [Member]",
        "terseLabel": "CSCA"
       }
      }
     },
     "localname": "ConsumerSelfCareAmericasMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ConsumerSelfCareInternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumer Self-Care International [Member]",
        "label": "Consumer Self-Care International [Member]",
        "terseLabel": "CSCI"
       }
      }
     },
     "localname": "ConsumerSelfCareInternationalMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingency Loss, Coverage Available to Satisfy Judgements, Number of Policy Periods",
        "label": "Contingency Loss, Coverage Available to Satisfy Judgements, Number of Policy Periods",
        "terseLabel": "Number of policy periods"
       }
      }
     },
     "localname": "ContingencyLossCoverageAvailableToSatisfyJudgementsNumberOfPolicyPeriods",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_ContractManufacturingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Manufacturing [Member]",
        "label": "Contract Manufacturing [Member]",
        "terseLabel": "Contract manufacturing"
       }
      }
     },
     "localname": "ContractManufacturingMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ControllingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Controlling Interest [Abstract]",
        "label": "Controlling Interest [Abstract]",
        "terseLabel": "Controlling interests:"
       }
      }
     },
     "localname": "ControllingInterestAbstract",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_CumulativeDeferredChargeTaxLitigation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Deferred Charge, Tax Litigation",
        "label": "Cumulative Deferred Charge, Tax Litigation",
        "terseLabel": "Cumulative deferred charge related to tax litigation"
       }
      }
     },
     "localname": "CumulativeDeferredChargeTaxLitigation",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Leverage Ratio, Subject to Consummation of Qualifying Acquisitions",
        "label": "Debt Covenant, Leverage Ratio, Subject to Consummation of Qualifying Acquisitions",
        "terseLabel": "Maximum leverage ratio, subject to consummation of qualifying acquisitions"
       }
      }
     },
     "localname": "DebtCovenantLeverageRatioSubjectToConsummationOfQualifyingAcquisitions",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "prgo_DebtInstrumentCovenantSecuredNetLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Secured Net Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Secured Net Leverage Ratio, Maximum",
        "terseLabel": "Secured net leverage ratio, maximum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantSecuredNetLeverageRatioMaximum",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "prgo_DebtInstrumentInterestRatePercentageCap": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Percentage Cap",
        "label": "Debt Instrument, Interest Rate, Percentage Cap",
        "terseLabel": "Debt Instrument, Interest Rate, Percentage Cap"
       }
      }
     },
     "localname": "DebtInstrumentInterestRatePercentageCap",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "prgo_DebtStatedBlendedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt, Stated Blended Interest Rate",
        "label": "Debt, Stated Blended Interest Rate",
        "terseLabel": "Stated blended interest rate"
       }
      }
     },
     "localname": "DebtStatedBlendedInterestRate",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_DenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator [Abstract]",
        "label": "Denominator [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "DenominatorAbstract",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instrument, Covered Interest Rate Period",
        "label": "Derivative Instrument, Covered Interest Rate Period [Axis]",
        "terseLabel": "Derivative Instrument, Covered Interest Rate Period [Member]"
       }
      }
     },
     "localname": "DerivativeInstrumentCoveredInterestRatePeriodAxis",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_DerivativeInstrumentCoveredInterestRatePeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instrument, Covered Interest Rate Period [Domain]",
        "label": "Derivative Instrument, Covered Interest Rate Period [Domain]",
        "terseLabel": "Derivative Instrument, Covered Interest Rate Period [Domain]"
       }
      }
     },
     "localname": "DerivativeInstrumentCoveredInterestRatePeriodDomain",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DerivativeInstrumentTermAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instrument, Term",
        "label": "Derivative Instrument, Term [Axis]",
        "terseLabel": "Derivative Instrument, Term [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentTermAxis",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_DerivativeInstrumentTermDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instrument, Term [Domain]",
        "label": "Derivative Instrument, Term [Domain]",
        "terseLabel": "Derivative Instrument, Term [Domain]"
       }
      }
     },
     "localname": "DerivativeInstrumentTermDomain",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DerivativeNotionalAmountMaximumIndividualAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Notional Amount, Maximum Individual Amount",
        "label": "Derivative, Notional Amount, Maximum Individual Amount",
        "terseLabel": "Maximum individual amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmountMaximumIndividualAmount",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DigestiveHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Digestive Health [Member]",
        "label": "Digestive Health [Member]",
        "terseLabel": "Digestive Health"
       }
      }
     },
     "localname": "DigestiveHealthMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period One",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period One",
        "terseLabel": "Installment receivable, period one"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodOne",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period Two",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivable, Period Two",
        "terseLabel": "Installment receivable, period two"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivablePeriodTwo",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivables",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Installment Receivables",
        "terseLabel": "Consideration, installment receivables"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationInstallmentReceivables",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Contingent Consideration",
        "label": "Disposal Group, Including Discontinued Operation, Contingent Consideration",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationContingentConsideration",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Contingent Liabilities Assumed by Purchaser",
        "label": "Disposal Group, Including Discontinued Operation, Contingent Liabilities Assumed by Purchaser",
        "terseLabel": "Potential R&amp;D milestone payments and contingent purchase obligations assumed by purchaser"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationContingentLiabilitiesAssumedByPurchaser",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Indemnification Asset",
        "label": "Disposal Group, Including Discontinued Operation, Indemnification Asset",
        "terseLabel": "Aggregate cap on buyer's obligation for certain pre-closing liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIndemnificationAsset",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Indemnification Asset, as Percent of Certain Pre-closing Liabilities",
        "terseLabel": "Aggregate cap on buyer's obligation for certain pre-closing liabilities (percent)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIndemnificationAssetAsPercentOfCertainPreClosingLiabilities",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Supply Agreement, Extension Term",
        "label": "Disposal Group, Including Discontinued Operation, Supply Agreement, Extension Term",
        "terseLabel": "Supply agreement, extension period"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSupplyAgreementExtensionTerm",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prgo_DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Supply Agreement Term",
        "label": "Disposal Group, Including Discontinued Operation, Supply Agreement Term",
        "terseLabel": "Supply agreement term"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSupplyAgreementTerm",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prgo_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance leases"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_FinanceLeaseLiabilitytobePaidafterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueafterYearFour",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, to be Paid, after Year Four",
        "label": "Finance Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "After 2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitytobePaidafterYearFour",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite and Indefinite-Lived Assets By Major Class [Line Items]",
        "label": "Finite And Indefinite Lived Assets By Major Class [Line Items]",
        "terseLabel": "Finite And Indefinite Lived Assets By Major Class [Line Items]"
       }
      }
     },
     "localname": "FiniteAndIndefiniteLivedAssetsByMajorClassLineItems",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness",
        "label": "Gain (Loss) on Components Excluded from Assessment of Net Investment Hedge Effectiveness",
        "terseLabel": "Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach"
       }
      }
     },
     "localname": "GainLossonComponentsExcludedfromAssessmentofNetInvestmentHedgeEffectiveness",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_GoodwillAndIndefiniteLivedIntangibles": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements.",
        "label": "Goodwill And Indefinite Lived Intangibles",
        "terseLabel": "Goodwill and indefinite-lived intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIndefiniteLivedIntangibles",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_HRAPharmaIntegrationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HRA Pharma Integration",
        "label": "HRA Pharma Integration [Member]",
        "terseLabel": "HRA Pharma Integration"
       }
      }
     },
     "localname": "HRAPharmaIntegrationMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_HRAPharmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HRA Pharma",
        "label": "HRA Pharma [Member]",
        "terseLabel": "HRA Pharma"
       }
      }
     },
     "localname": "HRAPharmaMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_HealthyLifestyleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthy Lifestyle [Member]",
        "label": "Healthy Lifestyle [Member]",
        "terseLabel": "Healthy Lifestyle"
       }
      }
     },
     "localname": "HealthyLifestyleMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014 and 2015",
        "label": "IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014 and 2015",
        "terseLabel": "IRS Notice of Proposed Audit Adjustment for ANDA from 2013, 2014 and 2015"
       }
      }
     },
     "localname": "IRSNoticeOfProposedAuditAdjustmentForANDAFrom20132014And2015",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015",
        "label": "IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015",
        "terseLabel": "IRS Notice of Proposed Audit Adjustment from 2013, 2014 and 2015"
       }
      }
     },
     "localname": "IRSNoticeOfProposedAuditAdjustmentFrom20132014And2015",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IRSNoticeofProposedAdjustmentPenaltyPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Adjustment, Penalty, Percent",
        "label": "IRS Notice of Proposed Adjustment, Penalty, Percent",
        "terseLabel": "IRS notice of proposed adjustment, penalty (percent)"
       }
      }
     },
     "localname": "IRSNoticeofProposedAdjustmentPenaltyPercent",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment Amount, Including Penalty",
        "label": "IRS Notice of Proposed Audit Adjustment Amount, Including Penalty",
        "terseLabel": "IRS notice of proposed adjustment amount from 2011,2012 and 2013 audit of Athena, including penalty"
       }
      }
     },
     "localname": "IRSNoticeofProposedAuditAdjustmentAmountIncludingPenalty",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense",
        "label": "IRS Notice of Proposed Audit Adjustment, Deductible Interest Expense",
        "terseLabel": "IRS notice of proposed audit adjustment to reduce deductible interest expense for fiscal years 2014 and 2015"
       }
      }
     },
     "localname": "IRSNoticeofProposedAuditAdjustmentDeductibleInterestExpense",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense",
        "label": "Income Tax Examination, Debts Subject to Limit of Deductibility of Interest Expense",
        "terseLabel": "Income tax examination, debts subject to limit of deductibility of interest expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationDebtsSubjecttoLimitofDeductibilityofInterestExpense",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails",
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_IncomeTaxExaminationNumberOfTaxableYears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Number of Taxable Years",
        "label": "Income Tax Examination, Number of Taxable Years",
        "terseLabel": "Income tax examination, number of taxable years"
       }
      }
     },
     "localname": "IncomeTaxExaminationNumberOfTaxableYears",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes",
        "label": "Income Tax Examination, Reduction in Blended Interest Rate due to Cap for U.S. Federal Tax Purposes",
        "terseLabel": "Income tax examination, reduction in blended interest rate due to cap for U.S. Federal tax purposes"
       }
      }
     },
     "localname": "IncomeTaxExaminationReductioninBlendedInterestRateduetoCapforU.S.FederalTaxPurposes",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_IncreaseDecreaseInAccruedCustomerPrograms": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables.",
        "label": "Increase Decrease In Accrued Customer Programs",
        "terseLabel": "Accrued customer programs"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedCustomerPrograms",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate",
        "label": "Interest Rate Cap on Debts for U.S. Tax Purposes, as Percent of Applicable Federal Rate",
        "terseLabel": "Interest rate cap on debts for U.S. Federal tax purposes, as percent of Applicable Federal Rate"
       }
      }
     },
     "localname": "InterestRateCaponDebtsforU.S.TaxPurposesasPercentofApplicableFederalRate",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prgo_IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]",
        "label": "Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al. [Member]",
        "terseLabel": "Israel Elec. Corp. Employees' Educ. Fund v. Perrigo Company plc, et al."
       }
      }
     },
     "localname": "IsraelElec.Corp.EmployeesEduc.Fundv.PerrigoCompanyplcetal.Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_June12022ThroughApril12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 1, 2022 Through April 1, 2027",
        "label": "June 1, 2022 Through April 1, 2027 [Member]",
        "terseLabel": "June 1, 2022 Through April 1, 2027"
       }
      }
     },
     "localname": "June12022ThroughApril12027Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_June12022ThroughApril12029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 1, 2022 Through April 1, 2029",
        "label": "June 1, 2022 Through April 1, 2029 [Member]",
        "terseLabel": "June 1, 2022 Through April 1, 2029"
       }
      }
     },
     "localname": "June12022ThroughApril12029Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_LatinAmericaBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America Business",
        "label": "Latin America Business [Member]",
        "terseLabel": "Latin America Business"
       }
      }
     },
     "localname": "LatinAmericaBusinessMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_LeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities",
        "label": "Lease Liabilities",
        "totalLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities, Payments, Due [Abstract]",
        "label": "Lease Liabilities, Payments, Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_LeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due",
        "label": "Lease, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDue",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 5.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Four",
        "label": "Lease, Liability, Payments, Due Year Four",
        "totalLabel": "2027"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year One",
        "label": "Lease, Liability, Payments, Due Year One",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearOne",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 4.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Three",
        "label": "Lease, Liability, Payments, Due Year Three",
        "totalLabel": "2026"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 3.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Two",
        "label": "Lease, Liability, Payments, Due Year Two",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsDueafterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 6.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due after Year Four",
        "label": "Lease, Liability, Payments, Due after Year Four",
        "totalLabel": "After 2027"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueafterYearFour",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityPaymentsRemainderofFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Remainder of Fiscal Year",
        "label": "Lease, Liability, Payments, Remainder of Fiscal Year",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsRemainderofFiscalYear",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_2": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Undiscounted Excess Amount",
        "label": "Lease, Liability, Undiscounted Excess Amount",
        "totalLabel": "Less: Interest"
       }
      }
     },
     "localname": "LeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LesseeCashFlowClassificationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Cash Flow Classifications [Table Text Block]",
        "label": "Lessee, Cash Flow Classifications [Table Text Block]",
        "terseLabel": "Lease Cash Flow Classifications"
       }
      }
     },
     "localname": "LesseeCashFlowClassificationsTableTextBlock",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_LesseeOperatingLeaseLiabilitytobePaidafterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueafterYearFour",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "After 2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilitytobePaidafterYearFour",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]",
        "label": "Lessee, Weighted Average Lease Terms and Discount Rates [Table Text Block]",
        "terseLabel": "Weighted Average Lease Terms and Discount Rates"
       }
      }
     },
     "localname": "LesseeWeightedAverageLeaseTermsandDiscountRatesTableTextBlock",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_LossContingencyNumberOfGenericPrescriptionPharmaceuticals": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Generic Prescription Pharmaceuticals",
        "label": "Loss Contingency, Number Of Generic Prescription Pharmaceuticals",
        "terseLabel": "Number of generic prescription pharmaceuticals"
       }
      }
     },
     "localname": "LossContingencyNumberOfGenericPrescriptionPharmaceuticals",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberOfManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Manufacturers",
        "label": "Loss Contingency, Number Of Manufacturers",
        "terseLabel": "Number of manufacturers"
       }
      }
     },
     "localname": "LossContingencyNumberOfManufacturers",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Current Or Former Directors And Officers",
        "label": "Loss Contingency, Number of Current Or Former Directors And Officers",
        "terseLabel": "Number of current or former directors and officers"
       }
      }
     },
     "localname": "LossContingencyNumberofCurrentOrFormerDirectorsAndOfficers",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofFormerEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Former Employees",
        "label": "Loss Contingency, Number of Former Employees",
        "terseLabel": "Number of former employees"
       }
      }
     },
     "localname": "LossContingencyNumberofFormerEmployees",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofMasterComplaints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Master Complaints",
        "label": "Loss Contingency, Number of Master Complaints",
        "terseLabel": "Number of master complaints"
       }
      }
     },
     "localname": "LossContingencyNumberofMasterComplaints",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_LossContingencyNumberofMasterComplaintsNamingCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Master Complaints Naming Company",
        "label": "Loss Contingency, Number of Master Complaints Naming Company",
        "terseLabel": "Number of master complaints naming company"
       }
      }
     },
     "localname": "LossContingencyNumberofMasterComplaintsNamingCompany",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nestl\u00e9\u2019s Gateway Infant Formula Plant and Good Start\u00ae infant formula",
        "label": "Nestl\u00e9\u2019s Gateway Infant Formula Plant and Good Start\u00ae infant formula [Member]",
        "terseLabel": "Nestl\u00e9\u2019s Gateway Infant Formula Plant and Good Start\u00ae infant formula"
       }
      }
     },
     "localname": "NestlesGatewayInfantFormulaPlantAndGoodStartInfantFormulaMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net income (loss) after adjustments for noncash and nonoperating items.",
        "label": "Net Income Loss After Adjustments For Non-Cash And Nonoperating Items",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_NetLossIncomeAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Loss (Income) Attributable to Parent",
        "label": "Net Loss (Income) Attributable to Parent",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetLossIncomeAttributableToParent",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_NewTermLoanAFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Term Loan A Facility",
        "label": "New Term Loan A Facility [Member]",
        "terseLabel": "New Term Loan A Facility"
       }
      }
     },
     "localname": "NewTermLoanAFacilityMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NewTermLoanBFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Term Loan B Facility",
        "label": "New Term Loan B Facility [Member]",
        "terseLabel": "New Term Loan B Facility"
       }
      }
     },
     "localname": "NewTermLoanBFacilityMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_NumberOfAdditionalStatesAndTerritories": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Additional States and Territories",
        "label": "Number of Additional States and Territories",
        "terseLabel": "Number of additional states and territories"
       }
      }
     },
     "localname": "NumberOfAdditionalStatesAndTerritories",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberOfAppealsOfMasterComplaints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Appeals of Master Complaints",
        "label": "Number of Appeals of Master Complaints",
        "terseLabel": "Number of appeals of master complaints"
       }
      }
     },
     "localname": "NumberOfAppealsOfMasterComplaints",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberOfAppealsOfPersonalInjuryClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Appeals of Personal Injury Claims",
        "label": "Number of Appeals of Personal Injury Claims",
        "terseLabel": "Number of appeals of personal injury claims"
       }
      }
     },
     "localname": "NumberOfAppealsOfPersonalInjuryClaims",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberOfPersonalInjuryLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Personal Injury Lawsuits",
        "label": "Number of Personal Injury Lawsuits",
        "terseLabel": "Number of personal injury lawsuits"
       }
      }
     },
     "localname": "NumberOfPersonalInjuryLawsuits",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofPutativeClasses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Putative Classes",
        "label": "Number of Putative Classes",
        "terseLabel": "Number of classes"
       }
      }
     },
     "localname": "NumberofPutativeClasses",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumberofTendersAccepted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Tenders Accepted",
        "label": "Number of Tenders Accepted",
        "terseLabel": "Number of tenders accepted"
       }
      }
     },
     "localname": "NumberofTendersAccepted",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prgo_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator: [Abstract]",
        "label": "Numerator [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_NutritionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nutrition [Member]",
        "label": "Nutrition [Member]",
        "terseLabel": "Nutrition"
       }
      }
     },
     "localname": "NutritionMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_October252022ThroughDecember152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 25, 2022 Through December 15, 2024",
        "label": "October 25, 2022 Through December 15, 2024 [Member]",
        "terseLabel": "October 25, 2022 Through December 15, 2024"
       }
      }
     },
     "localname": "October252022ThroughDecember152024Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_October252022ThroughJune152030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 25, 2022 through June 15, 2030",
        "label": "October 25, 2022 through June 15, 2030 [Member]",
        "terseLabel": "October 25, 2022 through June 15, 2030"
       }
      }
     },
     "localname": "October252022ThroughJune152030Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_October252022ThroughMarch252026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 25, 2022 through March 25, 2026",
        "label": "October 25, 2022 through March 25, 2026 [Member]",
        "terseLabel": "October 25, 2022 through March 25, 2026"
       }
      }
     },
     "localname": "October252022ThroughMarch252026Member",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OralSelfcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral Self-care [Member]",
        "label": "Oral Self-care [Member]",
        "terseLabel": "Oral Care"
       }
      }
     },
     "localname": "OralSelfcareMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OrdinaryShares0001ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares, 0.001 Par Value",
        "label": "Ordinary Shares, 0.001 Par Value [Member]",
        "terseLabel": "Ordinary Shares, 0.001 Par Value"
       }
      }
     },
     "localname": "OrdinaryShares0001ParValueMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherCSCAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other CSC [Member]",
        "label": "Other CSCA [Member]",
        "terseLabel": "Other CSCA"
       }
      }
     },
     "localname": "OtherCSCAMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherCSCIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other CSCI [Member]",
        "label": "Other CSCI [Member]",
        "terseLabel": "Other CSCI"
       }
      }
     },
     "localname": "OtherCSCIMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherExpenseIncomeNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Expense (Income), Net [Member]",
        "label": "Other Expense (Income), Net [Member]",
        "terseLabel": "Other expense (income), net"
       }
      }
     },
     "localname": "OtherExpenseIncomeNetMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherGeographicalAreasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Geographical Areas [Member]",
        "label": "Other Geographical Areas [Member]",
        "terseLabel": "All other countries"
       }
      }
     },
     "localname": "OtherGeographicalAreasMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_OtherOperatingIncomeLossNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Operating (Income) Loss, Net",
        "label": "Other Operating (Income) Loss, Net",
        "verboseLabel": "Other operating (income) expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeLossNet",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PainandSleepaidsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pain and Sleep-aids [Member]",
        "label": "Pain and Sleep-aids [Member]",
        "terseLabel": "Pain and Sleep-Aids"
       }
      }
     },
     "localname": "PainandSleepaidsMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_PaymentsForPremiumsOnDerivativeInstruments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Premiums On Derivative Instruments",
        "label": "Payments For Premiums On Derivative Instruments",
        "terseLabel": "Payments for premiums"
       }
      }
     },
     "localname": "PaymentsForPremiumsOnDerivativeInstruments",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ProceedsfromRoyaltiesReceivedInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Royalties Received, Investing Activities",
        "label": "Proceeds from Royalties Received, Investing Activities",
        "terseLabel": "Proceeds from royalty rights"
       }
      }
     },
     "localname": "ProceedsfromRoyaltiesReceivedInvestingActivities",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_PublicBondsandPrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Bonds and Private Placement",
        "label": "Public Bonds and Private Placement [Member]",
        "verboseLabel": "Public Bonds"
       }
      }
     },
     "localname": "PublicBondsandPrivatePlacementMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RXPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RX Pharmaceuticals [Member]",
        "label": "RX Pharmaceuticals [Member]",
        "terseLabel": "RX Pharmaceuticals"
       }
      }
     },
     "localname": "RXPharmaceuticalsMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RanitidineLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ranitidine Litigation [Member]",
        "label": "Ranitidine Litigation [Member]",
        "terseLabel": "Ranitidine Litigation"
       }
      }
     },
     "localname": "RanitidineLitigationMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_RestructuringAdditionalCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, Additional Charges",
        "label": "Restructuring, Additional Charges",
        "terseLabel": "Additional charges"
       }
      }
     },
     "localname": "RestructuringAdditionalCharges",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_RestructuringChargesContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges, Continuing Operations",
        "label": "Restructuring Charges, Continuing Operations",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringChargesContinuingOperations",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_RestructuringReserveSettledWithoutCashNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve, Settled Without Cash, Net",
        "label": "Restructuring Reserve, Settled Without Cash, Net",
        "terseLabel": "Non-cash adjustments"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCashNet",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_RightofUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset",
        "label": "Right-of-Use Asset",
        "totalLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "RightofUseAsset",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prgo_ScarAwayMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ScarAway",
        "label": "ScarAway [Member]",
        "terseLabel": "ScarAway Member"
       }
      }
     },
     "localname": "ScarAwayMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_ScheduleOfDebtInstrumentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Instruments [Table]",
        "label": "Schedule of Debt Instruments [Table]",
        "terseLabel": "Schedule of Debt Instruments [Table]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTable",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]",
        "label": "Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]",
        "terseLabel": "Schedule Of Finite And Indefinite Lived Assets By Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedAssetsByMajorClassTable",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]",
        "label": "Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite and Indefinite-lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_ScheduleofForeignCurrencyForwardContractsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Foreign Currency Forward Contracts [Table Text Block]",
        "label": "Schedule of Foreign Currency Forward Contracts [Table Text Block]",
        "terseLabel": "Schedule of Foreign Currency Forward Contracts"
       }
      }
     },
     "localname": "ScheduleofForeignCurrencyForwardContractsTableTextBlock",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prgo_SkinCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skincare and Personal Hygiene [Member]",
        "label": "Skin Care [Member]",
        "terseLabel": "Skin Care"
       }
      }
     },
     "localname": "SkinCareMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_StateAttorneyGeneralComplaintMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State Attorney General Complaint [Member]",
        "label": "State Attorney General Complaint [Member]",
        "terseLabel": "State Attorney General Complaint"
       }
      }
     },
     "localname": "StateAttorneyGeneralComplaintMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_SupplyChainReinventionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supply Chain Reinvention",
        "label": "Supply Chain Reinvention [Member]",
        "terseLabel": "Supply Chain Reinvention"
       }
      }
     },
     "localname": "SupplyChainReinventionMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_TalcumPowderLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Talcum Powder Litigation [Member]",
        "label": "Talcum Powder Litigation [Member]",
        "terseLabel": "Talcum Powder Litigation"
       }
      }
     },
     "localname": "TalcumPowderLitigationMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_TrademarksTradeNamesandBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks, Trade Names, and Brands [Member]",
        "label": "Trademarks, Trade Names, and Brands [Member]",
        "verboseLabel": "Trademarks, trade names, and brands"
       }
      }
     },
     "localname": "TrademarksTradeNamesandBrandsMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_UnallocatedSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unallocated Segment",
        "label": "Unallocated Segment [Member]",
        "terseLabel": "Unallocated Segment"
       }
      }
     },
     "localname": "UnallocatedSegmentMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_UpperRespiratoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper Respiratory [Member]",
        "label": "Upper Respiratory [Member]",
        "terseLabel": "Upper Respiratory"
       }
      }
     },
     "localname": "UpperRespiratoryMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_VitaminsMineralsandSupplementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vitamins, Minerals and Supplements [Member]",
        "label": "Vitamins, Minerals and Supplements [Member]",
        "terseLabel": "Vitamins, Minerals, and Supplements (\"VMS\")"
       }
      }
     },
     "localname": "VitaminsMineralsandSupplementsMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prgo_WomensHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Women's Health",
        "label": "Women's Health [Member]",
        "terseLabel": "Women's Health"
       }
      }
     },
     "localname": "WomensHealthMember",
     "nsuri": "http://www.perrigo.com/20230401",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r272",
      "r307",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r335",
      "r394",
      "r395",
      "r396",
      "r397",
      "r399",
      "r400",
      "r402",
      "r404",
      "r405",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r272",
      "r307",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r335",
      "r394",
      "r395",
      "r396",
      "r397",
      "r399",
      "r400",
      "r402",
      "r404",
      "r405",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r270",
      "r271",
      "r410",
      "r436",
      "r591",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails",
      "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails",
      "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r460",
      "r552",
      "r566",
      "r584",
      "r585",
      "r609",
      "r622",
      "r628",
      "r690",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r460",
      "r552",
      "r566",
      "r584",
      "r585",
      "r609",
      "r622",
      "r628",
      "r690",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r337",
      "r553",
      "r610",
      "r626",
      "r685",
      "r686",
      "r695",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r337",
      "r553",
      "r610",
      "r626",
      "r685",
      "r686",
      "r695",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r453",
      "r460",
      "r462",
      "r463",
      "r464",
      "r551",
      "r552",
      "r566",
      "r584",
      "r585",
      "r609",
      "r622",
      "r628",
      "r680",
      "r690",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r453",
      "r460",
      "r462",
      "r463",
      "r464",
      "r551",
      "r552",
      "r566",
      "r584",
      "r585",
      "r609",
      "r622",
      "r628",
      "r680",
      "r690",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r270",
      "r271",
      "r410",
      "r436",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r461",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r286",
      "r461",
      "r636",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r338",
      "r339",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r611",
      "r627",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r338",
      "r339",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r611",
      "r627",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r286",
      "r461",
      "r636",
      "r637",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r40",
      "r625"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Summary of Allowance for Credit Losses"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $7.1 and $6.8, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r28",
      "r197",
      "r212"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r56",
      "r61",
      "r157",
      "r643",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Posey-Retirement and Pension Liability Adjustments, net of tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r251",
      "r258",
      "r259",
      "r493",
      "r594",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Fair Value of Derivative Financial Instruments, net of tax"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r243",
      "r561",
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r58",
      "r61",
      "r157",
      "r544",
      "r567",
      "r568",
      "r643",
      "r644",
      "r645",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income",
        "verboseLabel": "Total AOCI"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r55",
      "r61",
      "r157",
      "r258",
      "r259",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to derive cash flows:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares withheld for payment of employees' withholding tax liability"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition",
        "terseLabel": "Compensation for restricted stock"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r244",
      "r345",
      "r348",
      "r349",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Receivables written-off"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r71",
      "r82",
      "r189",
      "r429"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt discount (premium)"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r82",
      "r99",
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Intangible assets amortization expense",
        "verboseLabel": "Intangible Asset Amortization"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive share-based awards excluded from computation of diluted EPS (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r195",
      "r211",
      "r236",
      "r266",
      "r315",
      "r327",
      "r333",
      "r346",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r405",
      "r406",
      "r491",
      "r495",
      "r516",
      "r625",
      "r688",
      "r689",
      "r709"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r230",
      "r246",
      "r266",
      "r346",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r405",
      "r406",
      "r491",
      "r495",
      "r516",
      "r625",
      "r688",
      "r689",
      "r709"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r182"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r266",
      "r346",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r405",
      "r406",
      "r491",
      "r495",
      "r516",
      "r688",
      "r689",
      "r709"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r165",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Supplemental Disclosures of Balance Sheet Information"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r490",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r490",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Outstanding equity interest acquired (percent)"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Pro Forma Impact of Business Combinations"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/BusinessCombinationsandAssetAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r488",
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r488",
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r146",
      "r147",
      "r148"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "verboseLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Reported Value Measurement"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r84",
      "r232",
      "r588"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r78",
      "r84",
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents of continuing operations, end of period",
        "periodStartLabel": "Cash and cash equivalents of continuing operations, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r78",
      "r188"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r266",
      "r289",
      "r290",
      "r292",
      "r294",
      "r301",
      "r302",
      "r346",
      "r394",
      "r397",
      "r398",
      "r399",
      "r405",
      "r406",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r516",
      "r586",
      "r635",
      "r654",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r50",
      "r201",
      "r217"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Contingencies - Refer to Note 16"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r116",
      "r387",
      "r388",
      "r574",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends paid (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r658",
      "r659",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Shares Issued"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (in EUR per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares, authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Ordinary shares, issued and outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r32",
      "r625"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Ordinary shares, \u20ac0.001 par value per share, 10,000 shares authorized"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r62",
      "r254",
      "r256",
      "r261",
      "r558",
      "r563"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r73",
      "r260",
      "r557",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r155",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Summary of Contract with Customer Balances"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetGrossCurrent": {
     "auth_ref": [
      "r692",
      "r693"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current",
        "terseLabel": "Short-term contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateAndOtherMember": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate and Other [Member]",
        "terseLabel": "Corporate and Other"
       }
      }
     },
     "localname": "CorporateAndOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r69",
      "r553"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships and distribution networks"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r238"
     ],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "negatedLabel": "Current indebtedness"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r265",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r423",
      "r430",
      "r431",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Indebtedness"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Indebtedness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r196",
      "r198",
      "r210",
      "r272",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r413",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r527",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails",
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "negatedTerseLabel": "Deferred financing fees"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r46",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r48",
      "r272",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r413",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r527",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails",
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r48",
      "r122",
      "r123",
      "r124",
      "r125",
      "r189",
      "r190",
      "r193",
      "r208",
      "r272",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r413",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r432",
      "r527",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of debt"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r691"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedTerseLabel": "Unamortized premium (discount), net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "totalLabel": "Total borrowings outstanding"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r468",
      "r469"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r82",
      "r135",
      "r475",
      "r480",
      "r481",
      "r657"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r468",
      "r469"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r82",
      "r310"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r247",
      "r248",
      "r515",
      "r593"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r52",
      "r53",
      "r54",
      "r177"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral",
        "terseLabel": "Asset Derivatives"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r52",
      "r53",
      "r54",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral",
        "terseLabel": "Liability derivative"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r701"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Change in fair value of option contract"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r166",
      "r168",
      "r174",
      "r176",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r181",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r164",
      "r166",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r164",
      "r166",
      "r174",
      "r176",
      "r178",
      "r179",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r247",
      "r248",
      "r515",
      "r593"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount of derivatives"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r160",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Number of instruments held"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed product technology, formulations, and product rights"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r450",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Summary of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "negatedPeriodEndLabel": "Less cash and cash equivalents held for sale, end of period",
        "periodStartLabel": "Cash and cash equivalents held for sale, beginning of period"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r21",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.",
        "label": "Domestic Line of Credit [Member]",
        "terseLabel": "Domestic Line of Credit"
       }
      }
     },
     "localname": "DomesticLineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r262",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r287",
      "r289",
      "r292",
      "r293",
      "r294",
      "r298",
      "r504",
      "r505",
      "r559",
      "r564",
      "r596"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Basic earnings (loss) per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r262",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r289",
      "r292",
      "r293",
      "r294",
      "r298",
      "r504",
      "r505",
      "r559",
      "r564",
      "r596"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Diluted earnings (loss) per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share and Shareholders' Equity"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]",
        "terseLabel": "Gain (loss) on cash flow hedging relationships"
       }
      }
     },
     "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r517"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate reconciliation, percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related taxes"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r121",
      "r225",
      "r257",
      "r258",
      "r259",
      "r273",
      "r274",
      "r275",
      "r277",
      "r283",
      "r285",
      "r300",
      "r347",
      "r440",
      "r465",
      "r466",
      "r467",
      "r476",
      "r477",
      "r503",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r544",
      "r567",
      "r568",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r94",
      "r316",
      "r638"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity securities, equity method, other non-current assets"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Security Expense (Income)"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r237",
      "r513",
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities, fair value method"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "negatedTerseLabel": "Equity securities, fair value method, other expense (income)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r506",
      "r507",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "verboseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r182",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.",
        "label": "Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring and Nonrecurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r421",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r507",
      "r548",
      "r549",
      "r550",
      "r605",
      "r606",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r182",
      "r184",
      "r421",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r506",
      "r507",
      "r508",
      "r509",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r421",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "verboseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r421",
      "r454",
      "r459",
      "r507",
      "r548",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r421",
      "r454",
      "r459",
      "r507",
      "r549",
      "r605",
      "r606",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r421",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r507",
      "r550",
      "r605",
      "r606",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r421",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r548",
      "r549",
      "r550",
      "r605",
      "r606",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r510",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "verboseLabel": "Measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOptionChangesInFairValueGainLoss1": {
     "auth_ref": [
      "r187"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.",
        "label": "Fair Value, Option, Changes in Fair Value, Gain (Loss)",
        "negatedLabel": "Gain on sale of assets"
       }
      }
     },
     "localname": "FairValueOptionChangesInFairValueGainLoss1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r165",
      "r170",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r531",
      "r536",
      "r624"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "prgo_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r533",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r529",
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total finance lease liabilities",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liability, current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liability, noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearOne",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r708"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsRemainderofFiscalYear",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "prgo_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r532",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r528"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "prgo_RightofUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r531",
      "r536",
      "r624"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "prgo_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r541",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate - Finance lease (percent)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r540",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average lease term - Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r234",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r366",
      "r368",
      "r369",
      "r371",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r104",
      "r555"
     ],
     "calculation": {
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Definite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r100",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Definite-lived intangibles:"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r104",
      "r554"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Definite-lived intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet": {
     "auth_ref": [
      "r171"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails": {
       "order": 2.0,
       "parentTag": "prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net gains or losses on foreign currency cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "terseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings",
        "verboseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings , Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r180"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "negatedLabel": "Foreign currency cash flow hedge loss to be reclassified during next 12 months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Cash Flow Hedges [Abstract]",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyExchangeRateRemeasurement1": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.",
        "label": "Foreign Currency Exchange Rate, Remeasurement",
        "terseLabel": "Foreign currency exchange rate, remeasurement"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateRemeasurement1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Line Items]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Line Items]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyFairValueHedgeDerivativeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative instruments designated as foreign currency fair value hedging instruments.",
        "label": "Foreign Currency Fair Value Hedge Derivative [Table]",
        "terseLabel": "Foreign Currency Fair Value Hedge Derivative [Table]"
       }
      }
     },
     "localname": "ForeignCurrencyFairValueHedgeDerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation and Transactions"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).",
        "label": "Foreign Exchange Option [Member]",
        "terseLabel": "Foreign currency options"
       }
      }
     },
     "localname": "ForeignExchangeOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet": {
     "auth_ref": [
      "r172"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) relating to components of the gain (loss) on the cash flow hedging instrument excluded from the assessment of cash flow hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net",
        "totalLabel": "Gain (loss) from components excluded from assessment of cash flow hedge effectiveness, net, total"
       }
      }
     },
     "localname": "GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness": {
     "auth_ref": [
      "r172"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) relating to components of the gain (loss) on foreign currency cash flow hedging instruments excluded from the assessment of hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) on Components Excluded from Assessment of Foreign Currency Cash Flow Hedge Effectiveness",
        "terseLabel": "Amount excluded from effectiveness testing recognized using a systematic and rational amortization approach"
       }
      }
     },
     "localname": "GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness": {
     "auth_ref": [
      "r172"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) included in earnings for the period relating to components of the gain (loss) on interest rate cash flow hedging instruments excluded from the assessment of fair value hedge effectiveness.",
        "label": "Gain (Loss) on Components Excluded from Assessment of Interest Rate Cash Flow Hedge Effectiveness",
        "terseLabel": "Gain (loss) recognized in earnings on derivatives related to amounts excluded from effectiveness testing, Interest rate swap agreements"
       }
      }
     },
     "localname": "GainLossOnComponentsExcludedFromAssessmentOfInterestRateCashFlowHedgeEffectiveness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r494",
      "r652"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "Loss on sale of business",
        "terseLabel": "Gain on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "Administration"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r233",
      "r354",
      "r556",
      "r599",
      "r625",
      "r669",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, end of period",
        "periodStartLabel": "Goodwill, beginning of period",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r355",
      "r362",
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated impairments"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r136",
      "r675"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Purchase accounting adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r67",
      "r266",
      "r315",
      "r326",
      "r332",
      "r335",
      "r346",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r405",
      "r406",
      "r516",
      "r598",
      "r688"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r164",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r68",
      "r83",
      "r152",
      "r278",
      "r279",
      "r280",
      "r281",
      "r291",
      "r294"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income (loss) from continuing operations",
        "totalLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r267",
      "r482"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "totalLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r64",
      "r202",
      "r204",
      "r220",
      "r262",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r289",
      "r292",
      "r293",
      "r505",
      "r559"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r64",
      "r220",
      "r222",
      "r262",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r289",
      "r292",
      "r293",
      "r294",
      "r505",
      "r559",
      "r564"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r14",
      "r17",
      "r153"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income (loss) from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r65",
      "r82",
      "r94",
      "r203",
      "r219",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity securities, equity method, other expense (income)"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r16",
      "r18",
      "r19",
      "r20",
      "r110",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r372",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r131",
      "r132",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r268",
      "r472",
      "r473",
      "r474",
      "r478",
      "r483",
      "r485",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated amount of loss resulting from an adverse tax position.",
        "label": "Income Tax Examination, Estimate of Possible Loss",
        "terseLabel": "Income tax examination, estimate of additional tax expense, excluding interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExaminationInterestExpense": {
     "auth_ref": [
      "r696"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r696"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "terseLabel": "Income tax examination, penalties and interest expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r269",
      "r284",
      "r285",
      "r313",
      "r470",
      "r479",
      "r484",
      "r565"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Payroll and related taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapital": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.",
        "label": "Increase (Decrease) in Operating Capital",
        "negatedTotalLabel": "Subtotal"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Increase (decrease) in cash due to:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r367",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "verboseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r101",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived intangibles:(1)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r98",
      "r102"
     ],
     "calculation": {
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Total intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense, net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet": {
     "auth_ref": [
      "r171"
     ],
     "calculation": {
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails": {
       "order": 1.0,
       "parentTag": "prgo_CashFlowHedgeGainLossReclassifiedtoEarningsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "terseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings",
        "verboseLabel": "Amount of gain or (loss) reclassified from AOCI into earnings, Interest rate swap agreements"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Cash Flow Hedges [Abstract]",
        "terseLabel": "Interest rate swap agreements"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap agreements"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS)"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r639"
     ],
     "calculation": {
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r245",
      "r589",
      "r625"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r641"
     ],
     "calculation": {
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r640"
     ],
     "calculation": {
      "http://www.perrigo.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investment securities"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r93",
      "r194",
      "r207",
      "r223",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Finance Lease, Description [Abstract]",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Operating Lease Liability Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearOne",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r708"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityPaymentsRemainderofFiscalYear",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r43",
      "r266",
      "r346",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r405",
      "r406",
      "r492",
      "r495",
      "r496",
      "r516",
      "r597",
      "r688",
      "r709",
      "r710"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r36",
      "r199",
      "r215",
      "r625",
      "r656",
      "r667",
      "r704"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r45",
      "r231",
      "r266",
      "r346",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r405",
      "r406",
      "r492",
      "r495",
      "r496",
      "r516",
      "r625",
      "r688",
      "r709",
      "r710"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r182"
     ],
     "calculation": {
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsFinancialInstrumentsatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r29",
      "r30",
      "r266",
      "r346",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r405",
      "r406",
      "r492",
      "r495",
      "r496",
      "r516",
      "r688",
      "r709",
      "r710"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "verboseLabel": "Distribution and license agreements and supply agreements"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r29",
      "r198",
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Borrowings on line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Outstanding balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r50",
      "r682"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated litigation liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayable": {
     "auth_ref": [
      "r29",
      "r198",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Loans Payable",
        "terseLabel": "Term loans"
       }
      }
     },
     "localname": "LoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current indebtedness"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r48",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails",
      "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r117",
      "r118",
      "r389",
      "r390",
      "r391",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails",
      "http://www.perrigo.com/role/ContingenciesPriceFixingLawsuitsDetails",
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyClaimsDismissedNumber": {
     "auth_ref": [
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims dismissed.",
        "label": "Loss Contingency, Claims Dismissed, Number",
        "terseLabel": "Number of cases dismissed"
       }
      }
     },
     "localname": "LossContingencyClaimsDismissedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r682",
      "r683",
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Preliminary class damages"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesSecuritiesLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims, number"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyRelatedReceivableCarryingValueAdditions": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additions to receivables pertaining to a loss contingency.",
        "label": "Loss Contingency, Receivable, Additions",
        "terseLabel": "Loss contingency, receivable, additions"
       }
      }
     },
     "localname": "LossContingencyRelatedReceivableCarryingValueAdditions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/ContingenciesOtherMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Unallocated"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Remaining Maturity of Foreign Currency Derivatives",
        "terseLabel": "Maximum remaining maturity of foreign currency derivatives"
       }
      }
     },
     "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r21",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash from (for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash Flows From (For) Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash from (for) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows From (For) Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r78",
      "r80",
      "r83"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash from (for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows From (For) Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r66",
      "r83",
      "r205",
      "r221",
      "r229",
      "r252",
      "r255",
      "r259",
      "r266",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r284",
      "r285",
      "r291",
      "r315",
      "r326",
      "r332",
      "r335",
      "r346",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r405",
      "r406",
      "r505",
      "r516",
      "r598",
      "r688"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r61",
      "r63"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "OCI before reclassifications"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r315",
      "r326",
      "r332",
      "r335",
      "r598"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating Income (Loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r537",
      "r624"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "netLabel": "Present value of lease liabilities",
        "verboseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesAnnualFutureMaturitiesofLeasesDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liability, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "prgo_LeaseLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liability, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r534",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r528"
     ],
     "calculation": {
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "prgo_RightofUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r541",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate - Operating lease (percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r540",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term - Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r22",
      "r86",
      "r87",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r57",
      "r59",
      "r153",
      "r156"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedTerseLabel": "Change in post-retirement and pension liability, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r153",
      "r154",
      "r156"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r249",
      "r250"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Change in fair value of derivative financial instruments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r249",
      "r250",
      "r497",
      "r498",
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Amount of Gain/(Loss) Recorded in OCI, Cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Amount of Gain/(Loss) Recorded in OCI, Net investment hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r153",
      "r154",
      "r156",
      "r253",
      "r256"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r165",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "verboseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r29",
      "r198",
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-Term Debt",
        "terseLabel": "Other financing"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other expense (income), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "verboseLabel": "Other expense (income), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesNondesignatedDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other non-cash adjustments, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r600",
      "r601",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Initiatives"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Settlement payment"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r376",
      "r651"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r31",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred shares, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r31",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, issued and outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r31",
      "r625"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred shares, $0.0001 par value per share, 10 shares authorized"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r642"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets",
        "verboseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesBalanceSheetLocationDetails",
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Net proceeds from sale of businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r648",
      "r650"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": {
     "auth_ref": [
      "r647",
      "r649",
      "r653"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.",
        "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less",
        "terseLabel": "Borrowings (repayments) of revolving credit agreements and other financing, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities": {
     "auth_ref": [
      "r646"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale of other assets recognized in investing activities.",
        "label": "Proceeds from Sale of Other Assets, Investing Activities",
        "terseLabel": "Proceeds from sale of assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfOtherAssetsInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductionAndDistributionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to the production and distribution of goods or services to customers and clients.",
        "label": "Production and Distribution Costs",
        "terseLabel": "Distribution"
       }
      }
     },
     "localname": "ProductionAndDistributionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r108",
      "r216",
      "r560",
      "r625"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r263",
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses, net"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r61",
      "r63"
     ],
     "calculation": {
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-Term Lines of Credit",
        "terseLabel": "Principal repayments"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r127",
      "r224",
      "r717"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r374",
      "r376",
      "r379",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r82",
      "r380",
      "r382",
      "r681"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges",
        "verboseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Charges [Abstract]",
        "terseLabel": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r375",
      "r376",
      "r382",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r376",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r33",
      "r126",
      "r214",
      "r570",
      "r572",
      "r625"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r225",
      "r273",
      "r274",
      "r275",
      "r277",
      "r283",
      "r285",
      "r347",
      "r465",
      "r466",
      "r467",
      "r476",
      "r477",
      "r503",
      "r567",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r306",
      "r307",
      "r325",
      "r330",
      "r331",
      "r337",
      "r338",
      "r341",
      "r449",
      "r450",
      "r553"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyGeographicLocationDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r539",
      "r624"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/LeasesLeaseCashFlowClassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r341",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Net Sales"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesClassificationofGainLossofCashFlowAndFairValueHedgingRelationshipsDetails",
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesEffectofCashFlowHedgesIncludedinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r61",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r138",
      "r139",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Classification of Gain (Loss) Recognized in Earnings on Fair Value and Cash Flow Hedging Relationships"
       }
      }
     },
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of effective income tax rate reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r95",
      "r229",
      "r266",
      "r346",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r599",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r23",
      "r37",
      "r38",
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Major Components of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r173",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Amount of Gain/(Loss) Recognized against Earnings"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378",
      "r382",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r113",
      "r114",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r303",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r378",
      "r384",
      "r599",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r303",
      "r304",
      "r305",
      "r315",
      "r318",
      "r329",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r340",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r200",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "netLabel": "Senior notes",
        "verboseLabel": "Public Bonds"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/FairValueMeasurementsScheduleofFixedRateLongtermDebtDetails",
      "http://www.perrigo.com/role/IndebtednessScheduleofBorrowingsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "prgo_NetIncomeLossAfterAdjustmentsForNonCashAndNonoperatingItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares withheld for payment of employees' withholding tax liability (shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r227",
      "r303",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r373",
      "r378",
      "r384",
      "r599",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.perrigo.com/role/LeasesBalanceSheetLocationofAssetsandLiabilitiesDetails",
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails",
      "http://www.perrigo.com/role/RevenueRecognitionScheduleofRevenuebyProductDetails",
      "http://www.perrigo.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r266",
      "r289",
      "r290",
      "r292",
      "r294",
      "r301",
      "r302",
      "r346",
      "r394",
      "r397",
      "r398",
      "r399",
      "r405",
      "r406",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r516",
      "r586",
      "r635",
      "r654",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r51",
      "r121",
      "r225",
      "r257",
      "r258",
      "r259",
      "r273",
      "r274",
      "r275",
      "r277",
      "r283",
      "r285",
      "r300",
      "r347",
      "r440",
      "r465",
      "r466",
      "r467",
      "r476",
      "r477",
      "r503",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r544",
      "r567",
      "r568",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r300",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r31",
      "r32",
      "r121",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Restricted stock plan (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r31",
      "r32",
      "r121",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "verboseLabel": "Repurchases of ordinary shares (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r32",
      "r34",
      "r35",
      "r92",
      "r625",
      "r656",
      "r667",
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r150",
      "r151",
      "r158",
      "r225",
      "r226",
      "r258",
      "r273",
      "r274",
      "r275",
      "r277",
      "r283",
      "r347",
      "r440",
      "r465",
      "r466",
      "r467",
      "r476",
      "r477",
      "r503",
      "r518",
      "r519",
      "r523",
      "r544",
      "r568",
      "r569",
      "r656",
      "r667",
      "r704"
     ],
     "calculation": {
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r524",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails",
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r524",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r524",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails",
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r524",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/IncomeTaxesDetails",
      "http://www.perrigo.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r545",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks, trade names, and brands"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/GoodwillandIntangibleAssetsIntangiblecategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r375",
      "r376",
      "r382",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/RestructuringChargesDetails",
      "http://www.perrigo.com/role/RestructuringChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r288",
      "r294"
     ],
     "calculation": {
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average shares outstanding for diluted EPS (in shares)",
        "verboseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r287",
      "r294"
     ],
     "calculation": {
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "netLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding for basic EPS (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.perrigo.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.perrigo.com/role/EarningsPerShareandShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 24
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r629": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r631": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r632": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r633": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r634": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>103
<FILENAME>0001585364-23-000058-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001585364-23-000058-xbrl.zip
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M=ZT^LFD8M(=&:'P#&L\BW$<>^J#/K;[KW\E^\/>(9_?'QA4:( 1"=PA/NN3
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ML=ELM,LR0Y;A5%;A_ZFJ!>I$)&V$M(THE$8AY2 0",.$;:76(&WP81\-C>M
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MCTE@B<PQZ@2@993K"$@4QV:STB[S!%F&4U6%_\>J%*@3D;02TCJB4!J%E(-
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MJODEMWP64E^KCU3,YS*[_P%02P,$%     @ HFBI5DA_\#9/!@  !Q\  !X
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M-KMV4\DV?U]'I4R;=WKBU.SF=GN 4/_ IR6AC,4&4PB!FX'N(RJP2#%)F.9
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MO/QN%A#>_AN9[R#*1A'3N]R3(51",'K6"F,G&OHDS.\BC5)?-LL6GA4.IC>
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M='HF%6?(,L7Q(0O-EK'IGEVF!IB^+SHBTEFF,&SC!3C</]XNX_TYHB#BT-P
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M"UHO0/%A;$+&$&D1#=M4)1C2'0(8YME8O)!+4W8<LDA;D(;:<+A=NB31B^Q
M"P$L\0_917I:+,(T#YJ?R^"HA4Y'9 UD1@QL@:B5#>YG@+C-I0/(XQE\98UN
MH/&X2?R$R5-;,Q1N=64S,O4(A4!= 9VM[)%J!L$NGJ'DAY.[W%^[15$]##:<
M2F"1>$/$S4OA?8(O%:0/U9SHW=N!B<*']&X4Q)9<*9MN@WP57X*Q8N,FFLN"
MV"6F:7*]-37#0$"K#-+"&4@!N]T_9@DZ.A():\,>21;0@80JEA-!+ %YP-=5
MH7/F?L+XE$3I:OB5S12E%V'9L:#"B;;U"+EJ16KTJFUJ6]$+8;N[-('^3\N3
MCR[,F(B7"XXU82WV?C9[%33[,LU&; VIC^*42#QG-B17565=91HM363!&E^;
M1=Q;&93O@]YXN@+$#4IV\F<%76"$K@:0.569Y_(Q_2(^B,)BP 2.S_C='E],
M>#< XA+9WR1Q@%B![>1D*\0[=DM.^^#<G.XTL8(=AQ?_;N]"QWPAR#6VN)+Y
M;& /.M'6YB2XL$->PH]TW0O#079@)M*61=$6JB[MX7/F=)[E*L.1>K1\[MER
MK]15"U@><FC*4D=MQ5N[=&6!D?_5ET^>G3QB^&CG<)=6<<UN=F?_:@R1(T(I
MXH[7C/M5,7U:"[]!ZT,/J3U?MHL<ORPTE98)C^<IM!=40=Q;[KM<E:L[N>%^
M,!:_[; FULWQ*/7R]86'DT)A<%?R5?S UI ._0J(!*@CTN(-P=8_VHU2[A?%
M !69WBYQ%HACA3;9JT?\-H4=,HN^=%ZNA2Q:W#)1D]-6 R/8+,YT8%+MDOCB
MP3!RTU5F-+-(KB.2T5G\"4054=Y/0G6V/D[DLL8,0Q. GJ&C]L@:R,)^VY)6
MG4I\Q %UV-RC "_'[F^81NVC(O$[OO[JC8U##?^.J_XA%^)SV-(*I">?PY;O
M";902H&R06W':E+KT?.N#?6%=IY3?#W6VHHK?><%W$:LI)4Z*TFL59^]MFF+
M2[E(62UH]ZL9"YM\,+,!D@0!&:=T+LRQJ@H1-(FLB3E!$K\4"^M#V4_/0EDX
M9QLHRZPX5C8H!OZM^= )#%0YR2JK(W(U[5C<Y,)?LRHH,AGT[<K _K>ZYIBA
MZ,L5NM;0M7&(^_$Z\==K*93X^]_;_#H\^&[S:/ETI?T54BG#);!@GS'&N=.T
M&2>Q@YPTC3.K9O>USO>@!@N;^$GM^8\/W_-I50H\LRW]N4^3;,E"6*&61B;3
MDH"J;,=7'> J&3?\C)9/&E%I/U.>LV!)[)067<M<Q?FHEZ8(*T89 U/'KH/!
M_*0.].Q!![J8\(!-0CNQNF[O/KKMQ'Q:N5]'*_?KDG@T)P,69AP+Y_< K\[@
MZWIU0U?^_6H*T:_%7F/'M#?QX7YLF>+#4Q.3.F!Y*YSI\+[6'I,]L+)6J$NU
M[U@F!3IW4<I 0"=(>;!%F@/GT.V!H#%6A9*4BP5XA^T]A1E:B2IF;-$#+E&\
M.S\8GEA@130E\3G$2)[QW1,XXBZS9[SJ>&XM^44EXU.B]N.5U/X3.NZAQ>W<
M%=Q X>MI<8_1WEC,NKC/(M4M6*B/&?P1YD$/:?H>GQO/RB,O=>X%1PH8^2UP
MW[L2[251/:1*2#2-+X&T:,R!-K.47"UA/DS0.D\$D (9*)#>K(XV666H?2YQ
M/WU<<E]K4L1WV^6Y!XT0B;LBB,!5_W,\6WMTV_CJMB5<VL;_PHR=,$''J@^)
M7^2B\BWF5;>9M\66[+E>!Z3H5URJ8OO_V3RKVG9./4W1_:9N*FB)>O/^TS)H
MC%X127_L;#I8'"=,^<WG+ ,?^AM)-% J5,4%'B"^"VIA%Q3>8Y=*7W$/9 C(
MTY1QBBP;4];JM[I:?=-=^I10=?#6,.3HD!<X/=2\4^CADF%KRPE?\O^TI>9F
MUW,2KY,N4$4?_K-_]LIV\XPE,PV,X4S:Z=UHH4+#A=EJX"4(9,SY69MQ^6*+
M6=@K8^<+3F1AM,O*/I<7-O4G*_WAB+GG0@7S/F"D=4*'1S!V/<"J\$#<>:"S
M@" #AX?BTFO1(/<#\L /]Y^MD?5^OUVL]PU9@ T78$;/N04SW>_'YB%IEL#&
MY".Q1=WO9]@M8JB,J_]02\^\(_6J$=/^K"369%%>GAQ\?QK@H,KWK/%08_OV
MN)HCU>V#I7'*57UTG:%!=KIKB1&9XJ)R@DODFED=/OU#MNW9_G</(9'%J$53
M3G_8>[*/7;]!X782YQIY /R)4$]SM=:H^$+'! %JZP,D-6(10;CQ"?KVC.>2
M6N/1EZP[V/9<\*(@A+C1^F3VA[+8ZPW[T-802\;<3GWS\&"[N-[SN(FCUU5V
M$R?K!A'Y'%.TF_%TZV.*FW(A/YGL:%8OPLLJH,&+&DIF-62;A=S743J#;(*2
M\N,\XLLF3L45)9Y<%"*"S"Y./%)TDJ2)8/D9^G3BRVT13X;9N!4WC+9@L585
M+2PW6H\*%PQG5J@1PIT<.">S*HLLZ0)I#ZS2[EQ%IJH9J2W%CEI STXFZ2A.
MD&!BTY0S$K*\)JW%B[UU:AM>T(;&W<(U.<ANL>G.<%<4,3:6EB8F#Y:Y,]T$
M.(7(OEZ=S/;M#M"57\6.,PNKX):<%0QX*-,>:KN;>_.3>-OH<,Q F]&D:84\
M/EX#[?OT"B%.\=P.7*[+,*N +=Q/M7,>7GM(R#0*.@O88<ATYJYN$B^-!9P8
M76_(MLH55#V%"S&O75H^MKR60D+^EAC1 #P4BS&H(@0->IV8/85V1C,DS._X
M'EVR=;A_/A%O)UD\R<Y7K64=8 7:T+UH>NRQA .$L\_5,__>U":'WG6_#*OR
MVB(HS:ZT88SN1!@6"N %/>'J]%/#8AAEXR'%UIPREDTSWF#K1$#_(ZGYU$9&
MXC/A#*[:L.ND.XP?Q.FO]B&,R0X!EPLJ]W6J'-"Y<+0=1*;MG+KOIH-*=Z-9
MG&DN6&<(+2VUWF=^VV)9!"=OQ>JQ08G?LF2$ 1<*.$>WS Q_LKD%G V'#!;'
MMY!")YZ*X$YV^1C^OHW1BJU+O'Y9%GL?15(O"&F7AJV7BS.QMS$^O7.X\DP_
M3!'0\M$_3Q=8H@3$RZ"P>PMP7DVD>$KZJFT(QH%?_A*9[^.%A*N'9R?U?>H]
MIF(U P;MJ,'3WD='N#M>]M[\9JW$N3KH_[N5\RM4+H=R]= @Y5] L5ITM3.\
M+PEK$F%H0%-+$#XKNC*PIXZQVU"]ZUJ7Z-4RW.6%Z+Z -@X0KDUH^?23>6>J
MA/2Q=.#0[]I"\PBP4.*N-NY@U8Y1?(,RDH]S69QR:/7!4 W\@,R9M=Z6U4D#
MRVX+RS3K_>VILUS,PLI6;;3B3+5.6XFI[7TY@#5E !WI>VGQOJL0!HCY]F(>
MF.U\T$H[8G$_9J'JW"^G^S!%6LM2EK&-0.O5!T)E/]" 6=@7?-.YUK)^D!I<
MJQ[LU&#M9K8PVNY'4I"Q"HED2M.'9>O6K 0->)9A75DXI8%CD396&W-<T1\(
M.)U&?(71&1?AG-(<"V[NN&*');6J0<V8E6%2R$G;:D_^JJ7SQ#SITX3K)WW<
M^<:N;F4R<1BX+(FR)!+H)B-4A^5IO7 G4U%?E,^E[V= K[NR_L=S'"Z!24R&
M%DZ8$.T7JSL#%4H=M<=MU#WZC^6*2)WZ([2'Y13482$L.A@]DFY^7N(%]8('
MQLTGG$QP9=]O'H^E9,X)9Y,]@XR^R8@!RR8[$D\E1V*I"L ;32(3\]6;B"6J
MK>T'RBJQ3OT.<,\KY[W@[6-E9*1MN$!2:17/5!UF[;A6])2!% C/I:NI[>"5
ME#7M9?<6^9ZN'W*A_";W.^OP?%61LC-V+[,Z/=\H1K[3AKQ:V\4X /9X3>]P
M?RJUN7.XZ5I+R@.C-BXQODT63R76K"IY\5V)PG^YT,6W6Q^Z6-/&6;J.<PL@
MR$QKOH3[6/&H-_#][MQV1E>WK%'#FS8!)R9CA_GV:8WNUNN&$+Q<AD-+\G28
MB?W#OMR@WKWN+B*61?3"^5M*3UO6C&'#TD&7TU&(B:?YGX(8*R I@IV</@#R
MFY./ O@[]=I92!;:)F["8'5L!^;-<9=>#Q$.633J^/B%-/!L'/NVI+[XCJR>
M IJ">!\<'JP .Y-"9[M+=?1 )%'%#)E'-\/Y0]A0<S@VJW7$I;C0'[2/P1[:
M22%!4?=/]XT7(-V%Z3,Q_FK)^I)[G<J6NLT27!=TJ=(\= %^<9@58!=5)GI:
MVRP!S'4K0^$_U*J4]Q-)D.J&@43+BM9;OF=9E;190[-I*X95^B\,= :;DY1J
M/S5O+Z-H/HTNXFF6UL$WO#45[GZ*CJ6,3ZQOL&;-;_ ,587_.*":@6W*J-F>
M)N>,T(0' /V9<K2E['#+NGC\)"T_ 0RQ&5T/7W1DXJ!?83+):B3#MPDI=GVH
ML@KMD T#,OEB,J!G$VU)W[26TT]MK" JRF(A<1T=Y+*"_B .$ 9MZJ)/!;'J
M(/E8>!O]L>!\"MO)E%@A+/D; <\ ]NY\3SJ^=:IINU!WFE$N84=[/#IY9C=^
M%S1UWJ^QVS/Y^.")8]UQ-8P+4^^]>I>;>70J-_+HX.!(4@^'NW;CM:5C@' &
M#JU5I4#!X%Q48I_C>"P< S@$<9:[<[@1[F@ZQR7PP)5B#=7"3^PORX*]=ZR2
M&3GM"_C/F/@?7!9C,MT, PCY,BND:?9*F8B93X9M57>=3BPW.SW\+/!0B/R%
MOTN);<QB1:JA6*"D;>4 :V8FIP/O-/KMII%*7\YI.R09T\GE1^"#VP2J*']S
M?A;ML+L+MKP^Q\F=M)I=GR)J"=8BS9+4')8I1TZ88.XA:5<$L2MP98$K7R!@
M.FVWY\">0_6AS3]V4BGH?N.;"0N2@/7.#.ZH:5[:>,>Z \<,D%1R*<,(T3C;
M%U'K.GB="\4=;FJ=BIJY[9*9T+5%_:)MC\F>'>(=4VE.5=+YS#7I-T[+Z:)#
M?$NEU)9U^7FC#5PE#0 :ADL38(0?LR(Y #ZQ"_$P?LS@_SKS.;8MZ_)E;)6+
M+B[T.C9/&%&0_N"POGH(3X/08>3*XI@-,CC(5H8:5V>-N#@'<5X(61)+]16Q
M.HL;09/IL;T!0[2&/8#!=#.VW%I-K<H:&XN;E"EZ0R-Q;:)M4NJVGDK%3%GY
M]FD+X<:.SQ\ >-.&>],[&]49DQVG]%:>S^K$"4>H'9@/VGX/[,&6>Y+$M=C-
MG)%9TN08) YX"A+6@'58"6R@#T<Y4%R-<6FT3%Y96[N %;BA*0P+WUXO>_D"
M]#ZP79Z>!RFPJ9ZD>F B:>["R-.X;@0J9"M/;'7P'DJ';5NUJ-SJ_KKLI=JW
M"W<]/!H?&PP:;7<]AEN\=4]6;IWU!H7,)P@N^N1<7/4MWH&G=[/CL+GX_4U6
M!8X#[5W>T?TN[?<!BLJCN#R-T(E&UM74N+!< +W,B)>2&F(9AJ70+=[P;S_^
MAH.[AJ6?Q.'R.%&L2S+N<64UM5F+Y*W%?\\^_N6"GL^V/NBY.83^[(\A=#!A
M<(L"47YQS;^;2I)8QY<%\\RB%W$$(,Z35GTH4K%_8Q3I&=D?XT)SPAK?N'?
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MA7P5_)LFVYVI],[3,Q$3F!5S?I)/C>G"0A6EAL4#[=1?ZH*MALCL7[" ^J3
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M0/YR5*+,[_#U_/5<F8?;[\K<)&;82?GM7P9B28S8$>>];GZX)1W A^"V 0^
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MW47?CY[3$'E;K[@H5N9!;.)-=(EI-R#\F";I%A&#0O$"Q#I)69,3]8+8[7T
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M9GB9GX-$+DAT]#E(]#'W<VR&59M=HW2+-+@B(SH?&\[$R S1WH H?S@TH$J
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M6^N >$5W3 S>X"!$7](SA&K$=GX\IJVD2RJ448+0:L-'1"<2W% U>LG"_5=
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M?.SNHZ_)^8K_Q];!F8K%.ID/#*D&7\NH,_ZGDD.RWK FYY"H0;D(>FVOS!*
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M4!L;WX'5'";=14F=F0X'[SB_U"-BA;.-+)_(J>K7X%NSDTK6?8,7,K>Y4?Y
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MC]R39^=T9Y*)F8^SDD>@U<QY^FA97!)'UW;!- []M1(!.R%BD[V@ET"^VO(
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M)1A^&N @MY<!YN#K8 ]E1=K?XQ7Z_)7SU=)>9MP"\.N^1L@]65JDCG3PD@]
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MI#V!^%9ZD0[7GHMD"AU)YWAQ;J6[[Y>%_"N;IC\B)B__,^@R=>8"I&:U (2
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M8EY)7%_(E :2;(2MFY15D]WP5P<((U9(T9/?2DAB.NHK^_*X1M@M(PLDJ^"
ME+]BPL6,ONKRI/1Y#MQCEA7'22I35F.R7>S'$T,J8D5'D?RGS<3('X"!P1U%
MS] A(*.QS+-4'ZBG1-;E:(2?\JS9::?XRF2H7JY!E&<TDOTV;0<[#.31..>[
MQ"N03>:TK:C.B,YCV%755'D/V&]1Q^S8V$AM-=U\;54$TQHP^L"::BXJ8W9
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MY&%+U>UO U?DPXDSW,/.HLF[DME>VKXDAVMN>,:X')S*3[]?%[!N(-_Y!P:
M '0*?B'.9HC! =)$044 S#.BO](/C)BE-2[P\<:V!06RLAEN1:2<)HVC<&"(
M*F/@IE@\R*R(0I8J.?_^:_KH?#*8=;Z,Y@EX)A)>593KLLI3U[1(4JHYZ^]K
M1-61X+.O$=7WV[AN4 Y1.KYF_ >'+QKB_+L0JBO\GY+>R7YS#PA8^WB?,>'-
M"^Z957_]U5S,)=;P,MK<3?F$MN<B&V8ZJI3IHWIOEY$#7'*'U* -[!QXGS[#
M H0=JT?'E3<, &W1HHLGH]RD7%$W;'U/A-K$57*AP)=7)B^G88,$6C(7T01Q
M7+L FQ ".V#1]XBAI,$+$?BARW!IM-AP:+3$BM\O?],)&-23.!KS7>+>DFW1
M1$@VX<"=%0[2+@)$&N!!S;;ONW$A/0N:XK"R^=/B?9;?7YV?1&G5LGN]:)O*
M&DZZ="22OG,I55. U$<D=.BR)@C0 @=.P/JG9&).XL2T#&0?/)X5(UP7-W;P
M48FF!DDL-*A_ZX'+^ .P7XGF8,GDXGO_?U;KD6C4(.:6J$A<)./1MD*1;]@B
MI7LI:D%!4UD8!I^_GT*VJS5\%<\M%@.9*49HV0'3N Q@HJ_0G\&6KZFJ;%Q&
MK\-=?]W==7?/@JG.J5I:'&P+XF )HC[/94 X9^=#W[J@V4HO\ =2=I&ZK XX
MLW8 TT(Y%V"< KF!SXZ4)![PNL2F0UA'6P=_V\:6Y5BQ[E)8J!74(NJ]3_*X
M]K_HT=KF,@7ZN-DRZR4M5+3]#)N>MS2Y4;07.!>D$W'0:TC"@@&<C&UY]J^S
M5_UF!B.5:<RNM>',PL,#>;+CTW\US&AI"XGJ<^33-J+_ $2V=317-RT"U/-;
MX.C?J(QYK7!O*_9:?@0C%E\C7M1QX2U@2!V[ZW9UZF%&%_?;LNQ?MQOYIDD%
M   :X,+B2:F&=GU1,H]6% ,I=<&+Z.]!^4O(8/</.L;YU'8TYP&Z1\SOPW,7
M<<KE&(-0T>P9<CU>L%S0LTFE+Y+T(610")#6+!C]?N,)5"%2(]@E'.C7]WQ>
MC#R:$N?1 6[/DXS8<+3&BVQZ[P'[6K3-D)KQJ925T]U<LM!PU@T+V<+LAH4'
M)_0M2Z5</HW[*,U?DHMXXV) "SCJ29ZM/OJS=GPTSK7W.LR+FK%Q VO-@S?S
M=7M?MIO!TI-F@/1=M/[B)#C^H^AB&2<4)"V9)Q-ZW9;-',3]%&58<G":;50H
M(N3K'6(PRT<H+"!M"#]WC2AUI7E]VBG&E@'=F_EL60!MB)"!]:HJ75G/(4>]
M.+*=0M'UKUN6%,RRP;U%67B*1JV-X W(UQB80"8;*RT[\/_E[] 4#&N'EW,]
MLI9,(F#<+O7\+AYN,Z;P_1,]48U&@L8N&.G0ID?=]7Y]CD_L@O&('L)R/^WE
M?KHX@V:)W^YSSV-Y*&_=&/@W_]A*-TRNG"%YU#:#?5&\;0MF!\2 B>!'*\XL
M^+.78:D-R:6A*.<TSJ3NP_6&DE \L4HN)F:,SJP(L/Q#VU+;DR8QL%21/DN<
ME>/]DH/>;]>]0()E8BH+D Q/[MH65#G4(0OW3D9JFC'6K2;[2T\ ARLJV1-T
M&%R*#A]EQZ'F2L2P2DV2W_:OH^%2LK[9']/I'\E)JBXI=3Y[N9,4MP""S'5:
M0"5(-1-,64U!L,Q8W3J:N2^I%+;U9WU17M_9S\ EVMF$<Y*7@5R6! ;HQ/!Q
M7X@SBJBY*"=90LRRKKTPU')SF<RVB&5'U!43=6=C27B76!CC#56:@,O9'HQ=
M9X#2KX@#,@S2KAC#UU1$XN+'=)]L>X5B6M;6CUQ"3EB7_.WYWR["Y<OFFPNN
MJ&=<.U=LL)#<.ZF'\^2^].0$O-TB5FD;7F4+"JV =/+=+K"/.MW%J66K$_[(
M\GS4YDY_PZZ?Z 2CGV7Z6]QE8V3OY== F>5X/VY(H&PUNS-'T-OJ LESC^XL
M%="+H:5ZQ3NVC80P'P<,$J):A4!9A4>92N+ZPG,<XIYH1(Z"C4Q#(CF47=]>
MK)OAOACAT>%GV8(^_U$7SHS$@"B7=\RF*[T&<SV#,WQIZW!O&V7-IDAC</ 9
M\;91TRU:8"\O;NQ$,]-L#WB>B^0Q=X)I"QJ.JV5Q#^Y@H;DFADA%#M6+T@]B
M?[ZPX;(PUP-;LL*E"%F!+9X-;$4T5\]H'9]J"2X55G8_[D]KE_,@IT U40<]
MJO638#\ZL_&9&$,3 I4BA,*%3\ZP49I>V+"F)T==*XA14$FWL(=UZ$$:N'(?
M7IF^SY$?_.O6&)=%SAGG_LL-#$H73=IBUWVO4,G!'=*?9SX -YQM*Y@!CZ@C
M=*O3Z%R][J?;$V1#LY>Y$SN09IVP_9+M7CLFEF9>@*EJ>9=X[B=L+U:?NF*W
M=B6$I8+55P']\W6$,@&O0YB]*FBVV 0H@S;Y>U&QF.VA@"(N ;GU/LVY6Y A
M2L4OZ"S,E6QA P:]1/, \B\H'^Z ZJ)U _P+'B;)NG8L^K!;=#F_7GY=9\$+
M+5]@]XTKU&;NJ-09T?](6GRY)O'#W)IK/KTUG_:6V3#C_=C9QNM0![ FI[BA
MQ/?0:2^-;"PO6%WH3KE#I6!U O X+*2Y!AZQ=XL[+H7#^)0K,Q';@TIDRSPA
M@CC*.$%2B4B,$70T/*>I0][9R_409IQ!J_4):LZ'[N#J.UY:L<;'99GRQ% 8
MWF9YRK%'KDD5-.9Q7&0W_-#N8K?2??8AAJE,1B54/S]MEHF:]\#EY[;L11MN
M\5!N@KP']UY<KS_8+1-,K"L(]"?=,D4#=.EHUE'".DQ6^H +1KK_E':C4ZX4
M%^R^2KTN;C?OIZDR_(%U]@1;)=V1I(A(M2 H!$1N"=#E.Z7%MPS?K?GQVL9P
MMCB0N=3FW7QVL!SH\050%4&J%E?:YC(%QZF@5%TOXIU>UJ!C*FN[FI[CFE]-
M@9_B[5JK*5H79M"ISL[-7C;3N^YWDH+<]@5TJO[0.(>[;GQA>U%U\>'OOU"8
M7G,97L -%Q\@/ )Y=D'39BX1\#R?DAFN\^Z%:=-0,-\J@Z&I"#-3P<K(])))
MIH=M7,5<3.YT.44 KBWDJV#C--GN3*5!GYZ)&.1L)O"3?&I,%Q: *#4L)6BG
M_E(7;#DV9_^"!=0G57NWQR?":Z<0'@GL,*/Y>GC:U+9QI+UC!;<'9'N3/>:5
MM=%L/S5UGW#[V5BQ^;7LL!S2?.W?1O+^V^>X^]VW/QXNU([7T%9[>&GR8H*]
M7[.VE;J2_Q_ZW\>8]_MMP.KS?OZ NE->@DE=:Z,BVVP0>JOJ%#ZO7MDO$>QU
M<]%OI19%KP50*!0?VDTP,=FTTS-6%3;;VWQYTE0'XN;'U4'<_-N@,KAJ<XZE
M5O7@:T#&;LW^WH9$9.YWLQ>UCPPI[_;+_H"!UL=#\MVWCYX>U?SOQQ+XR_Y=
M+F^^_"- [X6)X88%'V4;/O?LSV&(WC']WMW: Q-$-+P8[[#%_]/.H]TG3S^6
M+/TZ_-?AOPY_G^$_(Z]X^HAXQ?'KUZ<OG[_X/U_$BIC[O3X].WOQSU?1R:O?
M7A^__#-Z_>O)1BV.1_R)K-D\2^ZQW&./H'/N4+Y>AUU3O^35!\'[-\!B8! T
ML54"=];6:RDE@2MLYV=T,-Q^B!78VY0?=P\??TK9OG0+%GL&_*F?.&RW-5[=
M[9H+6YH6L"T$1[%_='G\6F=>AQ!2"V'NV%THT7AU+CF28?B."%[#>A&-1%OZ
M<J!U!5WV[)1 96X^MEN/IA1U<;L\'B*C: %99!$:HM:W#DU>7N]&)Y)9"R\H
M$\,-1N<5MNC!:5-Q@^3#IK-]%[8R#,Y.QM'JY11Y$Y]-"@MG'  Z(C]&+I.K
M40TZ(O7 KVT+)"X84$>P-G"P[Q, \H>!+ZWW[7M9DNJO (=?R+6+\[KTUTNA
MX'882G*$EI\%7Q,;S_ Y3;[_!OI[F+GV3;=#XRFUA:/3I*3=K.V6Z2J]![[4
MFQU?91[$]RQ>N01,[3MT(B!0?^%BC@'\5URT2(H^V#LXI&F\T:;8$G(H1U(^
M!1R =\);Y,6C2I![<[C4CGVGWVY^./&:DCO.HC4GVEZGM0]@I*4FTZ/P2Z89
MKK_@"G94U'#UEY;J<'EL6R7,/\*OA\U>-<M=P(4U;>^.O@I#([4#_5DH[I[V
M]$[Y\HN;GLMKW6*^.MJ<HVU_\QUMZ\2>KC0=H0F!,^<0,QFRHVZ]"+88V[:9
M!7_&"-H8D"LC D1N#B^6^2TN[C7?I4XY0_\2$RME+)@X[S6;Q.WN0(D$7**%
M!*?+UVKSIWYQ8%;;OA%QY#!04(M!6ZU8GZX?M1M/F"18YEQA#Z8$G"8YPMJ8
M2TRK*J=5IG'T$2IG!"TTE4Y2'.R]**]MO:.YBH.6%1HE$3!3!G:_<YDTLU^(
ML'+,:BJ!$O!AK5P?^9E&"2WXQE@4HRRUJ$7NA2*.-$-]"2P]AM+:60!^E-4E
MPZ^ =A5JINXTR>!\=FV^VC_D7G S@#ZVISPT8<[P5R?)>]N=WM2*3!-B -52
M__S=MP>'AT<XLC@#]Z'?#QX=1;G6!'_)6R/W6K6147_E<>/#E*G^#0:8;%CM
M_A9+5)Y,F"3,M28[K=*];0OYH;)=N6#&X ]($V&H(8L@ 9.N_H(L_LVW\W\%
M-]<C!UM31D4,?<L2RG??[C_=UV"4^]A%J)X])9,;2CDZ#45BI[@;R<IZ_P;J
MZ\;H\ ()07_Z_;/0';P(?BF_'Y^]#E=!>G44?OZZRB:]9?ZGS:*KLB7.@I/2
M"Z2O)/8#=:9JR)AH18^O]=MV?TDPW9#:3DO(W7WC'9NB0*HR)%UIR[(=^A/9
M%;7S.]3L;."=A=V"T?:/L'4D-:.V,+12F@HJ(MZV-0E1$]&MSK/:[2B_LG_0
MPAPF,;T3ZRIT2C-9W#3FD\#71X 4CTH^*I0?R?=S@RRQNK<-[EV\ ;2C=J7R
MNMWHUSCBC77O0R^GF'6@-L%V5&766%8%/\95F56\23'T">GAQ2Z-1=R<B*7(
MJJ]>C8UA,HYQ*$^(U8F5<A6\4ZCHS*?R#7@^@ 9'Y/).[DV*!?$]0^+W#=$)
M*(:84!$SAZ&WF-:-7Z669J[*1E%/O!4>M^H!^77N_8;Y"]=6*F_)R\QBHUSI
MA*YB7(LZFI1(BL,[#XZXF#*6A#=LPJ-'1\ "$.+%BMB)P=I+W#:5,I)LW.*"
MZ75R+$(\)R/^SMNXN,I(!Q5GR9NRY211]8]P!:>=))^YO2/E\"T4)=O37DDK
M&ND!L2<%^:VO8T'6"OX\('6>7I1D\C=EV<KDV*M"AHFAR5_94XP*[I&N?>.4
M71O9OPJ0-*0V:=*B\C\^UX!8+-L+>"8(P'I>4L=&^NX7^#_;=[TE)%QQ>MO9
MH_"UXJWKS6]J9(,QV*,C/%_"#2*'S+GG+6VI73=ME"X77<"UQH\$'0D=L,74
MKT>%6<;V%'_I6 6=-,%F/C>%D22SQ@$S\DNK[\&LA*!B?= -R010U7=,:&,-
M;9!HG.5\YX3<NW<64[($0IM)FS>6+7"*0XYK9T]6:;6VP@3V&1%-U>48SCYU
M1JN[Z+O1<QHB;^LE%\7*/(A-O(DN,>T&A!_3)-TB8E H=8%8)REK<J)>$+N]
M#T"Y:_Q[3;7DFF:Y#(<7L?.1-LD*:*,EUZ:RVAH^K@.COC!Y[>Q]JT3\ARO-
MK;Q%F7+AUBT\V/'$X(+->)'\]<9_W6[XA^ST:4%ZR8"(OP4!W+!K %BCQJE=
M>E&QQJPI9X;UD4 7"XBC+62NS(!YD,3DI.0H^\5)R)A-16J(O!!(&B:W'>5:
M>6UCVV]FO/?B.5!BTP.(A;L=''DUL$P:4GL&O(,="AZ1&."681VMT8O/'N6Z
M??SJ4'A_J_GT'9T:'24R?$E=, 7+8_KU)C,(WM%OP^SME[P#=']? 6C"%)?E
MA*@8$=M@0_+L[674E&9L+E&7$<5@)CEMRQ:*[N*:., 5:L]AM,6($7U!!O]Q
MSC46)J2/K^$6%VXY^!IN^9C[^=S<F.CG[&T.V+ MNFK?ZR_?;T?EY(I4 </,
M*EY E?RSB.+WO[C1UO>OW_S^??T]W.G?<_[!]\!<-%%+X]);"_0X:,3:O\G>
M%GYX!*_I6XC^8C+P!D#GH)'91LCQ;Q%=ER72&WXVTSC.4^E);3@:>E&6HQ2.
M#?C=\<8,"FNP']>&ESDVPZK-+E$I1YI0D=%LQH8S,3)#WQC0_(9#@V>!NXBI
M96X\-W4X59!W,8KZO ][@CD!^ONY3<%(*@,1_O@(T)-CPQ#E">JQ)KS8FG:\
M&<MV8_=38W*9/K9'QB6-_;+*WM(.?DG>BM]HGUA$KO&2[G_CA@97#.4^0JV:
M>$$TY+4THD.B.Y!W&]$MHB,FPAVCKK$DXN(K,3$(]Y!F>'DI.0%-U%X#M28O
MX@G?0D>(3&/!V!PL1.8%4;(.+[D4IM@!)%Q=LXF M NS$S&D:,JXHX:A9MVU
M<9X#<^6N7ITA ^(M9UQD[$3@6WI9Q2!ES'PWBOZGS2_=<+R:JSB^=$D8?(/Y
M&E9T[7-,>HP%C>D^UW2OG]/>T*6HXCAM>)$_FY2H?D2;A0%KNMR7=2-[D'96
M?I&A:[W<9_J"WG*L,(=)D>%XJE(82_ 8JRHIOB_LB3]?MMMD0T_2N.F]F48H
MVQ0;?FF9&NT\GBEIP&&>72+U H/29;XQX[$V9T@Y?/T]&SST\S_--3++'(]M
M[4ZU60,.R2<Z(NHA<TOF3%JEL@@[ZE4<#,O/C5$)[ ?5(6G*ER6=VL8:\J_H
MCHGA&!R$2#4]0P@PMI?C,6TE75*AC!*$5AL^(CJ1X(:J\4B6XK\"NJ,K360/
M\D;?!]I+TB6LC!)]RX"+M\+'[6@:*H]CID7:[1MZ0P76_0<:HO.IPD1C7@$*
M0Q<.9TZ#^R-(CG)H>AH@\X40ZD5IY')*L-Q=M(QI-I>V,X5=)2CBLB5R\52Y
M;,GGF'U.APV(#"(.YAV E6*9C+4-VVHL6&!9 4+E!,&&7V<L'Y$9I'IC^!<P
MN\SR.F XBL.+9/$E0(Q'?"W,M5SK/,>4B]@*/B.-9&CE%VU6 VN[R^R8V"WS
MG90J0?F@>]N0+2@%_VKAWM>^>UX2+5R6UY!=55M<9E'&L*)Q45[#QHV_Y,7_
M/BFO :EP,[LI8EIK]-:D!2T>*2Z7R>QM,0,4(/'ZBCY-;DK^?5K%UPPQ>DV$
M'U=)1A<@NIX5V67V!1FW?P@UK/&";B\5A,K_MKZ91?\3?_?MX<$!7.M/]H^2
M&SHGS2 _.%KPF<L<OXF)_LF>2OL79!!=PH?[",$+J#IMWKZ5 2SYT"42\C'+
MB4=G0.+<IK#G[3"R?Z5OE6XFEC[U)=<D9288XW6%L2?M@-Y+ZR";)<^B"8F6
MF\NXOJ'O83JS240_SB:XRSJ%$L[:PV=[1^8M-+RWLICKW>C5964'@KHB*(1T
M/S(Z"20.F_Q2YY!G]*'\W-D.VO3H!MQ#]G46W8CU55[S"/2Y'LMDT;FT: 5G
M]Y)6G-P8#%AVIW5M%PXQP:8:=@Y7&=*.MX[GT6*O<:G3,FIO9O5E=LUW?%JF
MY9!WXK*DG961DXS&Q4;7-S*MTO[]2S+)7M,>Q6DY>1!CWZRK;:]MI51-WQ5B
MM]I%\A8ABF:6W.AC!O+NAFAM+(_D0AO^8I NXVE<;M UYE H56[MQ(!)STQZ
M@Y<=/#G$);VYSN0%-Y>DHT8MO:!NB!$TUV82TC P0MW$(%" _JIW@-2E:3S%
M>NBMQ'X:1Y4DMY(+NGIB[V6D+%UG-\2DWI+XS@IE-3<&5Q<B;%BZV5AFE> [
M),)2K(881::+YN^C"&>&#8W%&*Q(C8PO,V,'G0DC<Q/ES7RV?U0C0_22 8XN
MY<YGW<\R^3FZ$1K4N9#NW-^OAEC$FZELNISR90QNDLQ2# P^$^<FB0=1/)SQ
M?9^6P!C7_:>=<^?-FQ=RP X?2LO+EO36A$9X&U^68)HS<$UZZ=-G1TI&:6[\
M>%DPUY@'O,%!U.;RFL9Y2X<:GG8<'O8@&J>S>7ID%\%8]W(XLVO(3'P)A'9F
M>JQ=8Y8%+3BA@P'7NY[1BV?"UTB4T&9$QY<8\7_H$]DV3TTGQ.-F:<S'P@\S
MPZ.K31M>XV#36*8VPUC\GD:VJR=P-M:T?%T6<<IP_6[KO<!)+N**]AN&D.<$
M1+_^9$!E$W?%;V*BZ+J4S2<90R=!@JHIZ [6,SHV(A2<QQP18Y2W" B2O=8H
M)4_--4=0,2X=DQQ#G!9F'(P[1C'7#8=]VR4W1NY$<,UB^^.XT!] 0O[2TV3%
M.'V+_&W,':T*TEF/1;XE$AV7 ^@4Q 8BY-7*JH;A6)X[7$?GUV4V88;2!CNX
M</?,DMVC-9*M?2,TGQM+FU]#+"[$<O@UQ/(Q]W-*@\HE:52.#/0JFE#%QN75
MWTBR$O=M3&XF$C307YV>3&R6[NP,"0;Z%?NK_8I<$9+9N-]6,^>_XKIYO6-"
M[S*)W+(X:6D2-SP\[AP9'1G]ZJX]5[!=8\ )Q%P"I=>;N>T@9( W* N$NVFA
M1GXO[O?1Y,&'>EO62MV^%52Y!0YMOD )_\??I3F*XTYH$P-TNSR>UN8G^\,1
MBAOR>/935O![^:&C[@[15APA"1DH^,JN>$KRL;_&NWMRE1O:^R:U;]:/=_FC
M'YIT_K,?G^W^N+?\X[W=???9#SRVC$]+J*=Q\;^_.?RFMTK+BG=IYMR/,XWL
ML>DW<C-J;OM<Z."6+S3E=.''2D@_'4S?1?OT*?Y[N/NTY[["Z^>VM)RN"<%]
M\X\7:#3$O4^1*IP81UWN#'Y@0GD?8,QC]*%8-N&]CS3ASXCO_4!7X<LR&F7$
M/9/,-V>WY6ZV$7>ZH-Y_L* KABON92B%3XRH_E 7 >;UO$S:SX'V_L SD#;=
MM@>Z+VQO8@0# 5WJ&ZC$OK3;]0Y&)H-K6U%.X9<J7.];(&PS_KC8!WDK>+>H
M&M&>N?(35S!.XDO!W"7V+MTK@"_M4HA-MX3^W)YW:O?5UIACYGAS&<4)%R)*
M!232LKDHOAX$5.=3('D;C$D5>5AW0O*J8;\,&VTR)J-=%\MIES&$W2JU>[.V
M"'6HWDY<%0!FM7W=I9L?JG9E32>TW9JY3 L:(^E:VMCPFQ;XT;[*NJ^R[KV9
MP0LI^I5KR_7-MHAXR3V4<N8)D3)WF_)W ]B BBJ-(FE3UU+4"SAL)F_%*\9@
MKOVM+5:6OG9<@QV_TP1E6W3M6P"B:AK_75 L+5>8IS5D_-=BYKD*SSB6]EC
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M6S#[C+<9IV;J^:9<<!=*-S3A<H!&)Q)'I+#2GG/H0ET@0;#6;I$1"U02K/:
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MF*[C 3.[?;N*4NU73BG!%P_VI/W-?\5%RZ)PKJPW8IKU+^50H?#N]U2IUH5
MSY?0G0MF"DQ K:F!RPXRKKWW5*DB*/:V?2.EWVK==>.*H].VB(BEM\'C)W\+
M<K%RAA/3:;(:D@W;;DGIQFX^5NV2U%RC(=<6>5%3*]<&DVB4MC'$,?)Q@!"*
M"(C7M:WF0MY5P9WY7,)\4E:H6;(.;->[PKBV$^%=JFM2<#0A>L* X@M>OSP
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M"[LC7<>S!>EZBO-41^)PDEVEK8J;NC3<+0956D#?$$1P\RY&#\9!)T/"IT9
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M\[,HR<P&\5Q"MD^R<9:6G)XP.$;^\#JK#7U(YWE9>L(A @7E8!X=2)ZNU9M
M_-'9TR5K74NJ?5FV@89O(.U3NCM6HWBU2BA0]A8<Q/2O&PI:YS_>RI,/@()V
MG(TPA,EY$\BJSA.F*#XJW=9=)Y-;\->K<UR!Q$-5COE(4"^-]'C"2D^N =]C
MT]C+,)_E3MG<Z%CI+SRUMCX7H>*&_$G,D\  <SE'W)KD50L"LX>2GS@>O3BX
M#,6+T?$K;,4/)AA<01!%O!()[C7,'/B*EMDV1:HB0X\_&>B?::T^Q,/:H],Z
M'KUYC;UXIQH7D[]VG]LBJQ?$U36[4I# *7$5K 'Z$5O N/SX7'C;1"S/LE<8
M45PSD2Y?[0'OSPD?OQZ]>G,G?K0AH9$9\8U_5S?L(1W4'H7+WXS.3O2<-ED)
MFC18S!?E)+,P9+3)@=1K92)?$Y.(DK_!T\PYQLD,JY%6GI#-/(N" [K]B^=L
M'TX$5-UIU6N3,Z('6S[P#J!_#\"<V6D0([PTR=0-@:47&\>07SE//1R7""&Y
MT,7&1<LREQ,A/C(/&GX7J9GT?+JM%K-:5R)^82YME=9#" #Z1DD"AEE$,OK^
M(33?]2VD*DCL:C*U;Q<T:[D31^=[&XR^3V]@+]I"R#>8"0!B-QR8[_R0UC,V
M5Z#=IK+Z^NM=2LFH!RJ7^:7&*PR*J^L,H']40O)K7.NWJA2/$7S(MX;G:[&?
M<61>[%J)4G-\/@WQ^>-7Q^=;POCTQ>M7"-$3 2,+8+'(',&B!E!FU>>/.MKS
MLM;X-FUP'>] 2[($L! H7G5T?ML!8HI4,+*+GB 1&ZY[$LZEY@W:OB<)9F!)
MTV7!C[>.(GKNN3OK(GM*MH=D^\NO)]F^#_ZODAZ8"9J":4\M7B/:<R<5?RZP
M)3DB,-E&*(ONI4&TAD>U]01?)Z;%_'^/D):RS0&H\%T1";N0Z)Y7<)#-%8<8
M[Z1V$#_(-2>@ 0DH$TD.N>NC/-*ZXZJH8-Q4*&(ILQ.$H8-D0@UW:)[::N;#
M8"'>VQ49(P$2I9@J64M>2>"CJG:QS*H=<CFU/N#:H3VQYNI,Y+.H357GF83!
MZ&9&?GNP5,%9)XU1R2ZHX<8D <LW[+G;!A/%NDM_#*EE;L><;8!X>856X7X+
M83I:;LIV@H \[R0)I@:7F?(/&Y+I(9?A;DM;7;5@43RL95Y?E%WJ_!Q%#W4I
MM9VT%L;M4*.H[*HKLR0&T%@E>EHR(@UDFG+.7;$R!AR!+%J>;W;9A@:KN9_?
M,2D]5B!N'&C3;22.:-FF&>RLDJ@)Y1EBXEQG5=.F(4[]&/IB/G!7.>;[[7.'
MXF-LO'Q? ,2C>O9S91C_IC.^^D%3*-^WS01 FK*^1M?G8>$NL[' F$K]C9U.
MB1=;J4O"J&6>&QM:V%Q_FQ\L72OHJK09R&/H']]U"D#&MI.7'R71@,*V< ]Q
MD F*:;QEM<#1=340P\\#,^1V%N 9'H=X*"NRQY]8Z,MW_%<K.\MX$N'C9B/4
MS*PL2EXZ>,D'8!O>OU_^81N.OZO*NJ9]JU#9HSBLW(&%R:<UE_E]^.E?"5T^
MI*5X&'EI(0Y#!0/I.D 9ZUZYHL_)'*Z2H_\QY%P8][=M!IZV,.+01#?AZ<RX
M-4AYBHZS9+)EH;O6N0U - 9XJV_%=9,J*EX"MTXOS-Q&?=.'U"G]]8P??Z^;
M'LM(AM +0(+D@QA,\ :,W"V 2%PE36X*AF<,/192U9L('F$,"CP:9FWZ;_M5
MUUK5K/NGY<ST0/12D<CD)OW:H>B.7KCB3]_A.- B97*Q(5PC4#O1M3)+X/:G
MJ71%4>,8H4G+*+P0H.8_'#9?69,WEXSZEI>H:A39ZFL=M<M6AX2BYABH&%D=
MJGY-/DS&;1.F,NN69LU><\$7,WP^EE_7S/,#@^7];%X-*H$(^9,2<B2\P(#O
MBAD*^O>L&9ZG0HA]-)%:.=AF;$:Y7FJM2<>X@MW]YT/MD%[9RH:> :TLUE=/
MZ)>SEB392)!:I<L]E/BS6,(<X53K\VJ=.X*:RKVVOAYC+&!_09C4JN/I!<X>
M5)4+^(9(MZKZ7;95W9K"3TMGIA@PD7NE&)0OU\ /?5_/N*OFIQGI.N>FB(*J
M@PGH@0V?$G8^8??J*6'W)??306:*M>!;WCY\^S'TN5U$\!@>,#I - =>X:XK
M(%:[P7P,W^RAF1U/P L"EO7''SXDK^"IL;=V1&8M..,:$,N-SOJ8\CBI0C">
MZ3FP4->#1/OHT$JDUBD,Z6&P]9BO'#^5&Z!3LM2QR3VJFB"/Z@*YG?#?+9+I
M@.N0-D(%&3AY2<R9$B?KCQ:TQ9<1S$>T+K;P]38C. 435"(X:W]LM<T1/N9"
M!H8E5V7&"-P5C^&6X4BP_*692H!(2 :QL)+F.!^YD)^ZG_BVWF5)_NH]!E'L
M&X%V$%^R(*N'C@C&M'T%@\" @/H401>A^Z@A9_M_X9OK$DU$:FFX_K9GY#7+
M^+74;QS:,!H^>S@FTLETY,!ON5V5@T')PEIO'BVKS%ZW:/J$/8(L,O$#'26]
MN1D,&4U$ .6+2*4/'7V64Y28H&*<%&,8@E>W8^#_24\ECW'2*,:W'_')CT2*
MI\=NU8$.\?K[; 1]3B=O9W'IALM2;8<SBK(#N/HB8@WX?7K&!2FN0 O1+4T
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MU-C2U2SF.R862 -W ;A?WX.3V98HVF%Z^D+K%%5JV;CE3@I76M-M8J[BGF%
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MF/1#\TN,.,Y-)70Z)*,L->+GL'GMK.S048>S=IM+!Y#%,_B;:MU 4SE+BM]
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M G1/ZI++$@NU+$FY @HMW0SG;6 SR&&2K=; EN+D_ZE]#/;03@I9\>W&Y+P
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M'SQRK#LN^W%NJKU7[S(SCT[E1AX='!Q)EG9_UVZ\-,P(,V/!H17' F!'7#=
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M'P];EVJ&J*#T:F;4'0T*^D;RL[NS4, Z;6&=\.47ARV7,+K%7&O<L YQ 1<
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M(U%*\@!VP>XRP5CUE8ST74!E50\XVUZDB)PS+EVWAZR^49]@EQD&LJ3-[U>
M(W0Y%-NZV>9]-[MO7,L5!KFR(MY:)5:T+[$X5MTOR9II=ZG< @/B(^A,ZM&
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MO:CO3&&,*<UCMD#W)G3H,ZZ8-!<&EAQ_[8D1?VS32")EM=6"I,",C$Q/DE.
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MRF)#_;>,"EVI @\(!+78<>'/@YAD5S'UU3LBQL4M6F$96-S!(&[ND[ICF?E
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M^W=@#S05A=_]!2_";HNC?,6P2?3Z>Q([V9P2<9[3&J#[VY@[JV7.N;3N2L5
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M/$4G4#)9L]!-ZUP'"!S#$=:WHA!*^1$O@5NJ9^;*1OW4=^^@WB4*_$&/Y1P
M<>S0G4\8=B1YY[O$=P;U\K7N<"P0&=TQ8%R2PV'(WF <NEM0D;B6F'P2S-\9
M>D"D2D[7R YTX"\%7PW#F_VW_=IDK?W5_=.B7_I!]+.0?.1._=I!8(^>N1))
MWV8VT%)>\J<A22-4/%&L,M3D]E]348K2OS&B198AM"$MS>\<R5Q8DS>7#!N7
MEZC]$T'J*P*U&94_))(%VEQ:<Z.;JXTU^3 9MTV8WJY;FMV]0O931LY]IRCL
MK<7TMH0SM</:ZVL"$#R\Q-:+Q\36ETYL0=N3V'JG8BM251"WKXH+-#GL&$(
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MVS& ^:0;D">N:1CAV[?XY"<BQ>-#M^I AWC]$9#3UK**]$-EJ39$&87QP)2
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M6G:V3H*G8WB-E4?)X#8?-4R#*0(-#VD$J%'NT)5&N)0EKY4FMJFM:_$%7(N
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MIP_&:N!'V-9KO2VKDP:6W1:6:<[[VU-GN9B%E:W::L69:IVN$E.[[W( :\8
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MT@!-4Y>2SM/K92[^S7'9%@Z_(BOH]+-45<?.E]$BK7)MSJ(KQ%%BO8$=2.X
MT]/O2B+M.J2[JO!!!PH; ,K[JJD)CF%12'=]+-$QXPZHZZ+9##2S3J.4X$S
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M',_/V/G!M_2B,B!ES'PO2?ZGS2_\<+R:2V,N?(B?;S!?PXJN?8Y)3["@B05
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MX3JC*PPX!3,:07D,YF([B,GT&L5;<-LLU6SO1*.?[-9^K-=BH]36&[%R6\
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M3<@<[<W"Y<(^/WZ1J,[5*?S5(JVY-944SC%6BF<IBR)+WA,/Q^_O9'*[%&[
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ML4"K#$/O8AE2CMO[RM)>"V\U^^IP[_ 1ON_SUE\6Q/&X%UCRZ/&#@_TGF^Q
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MB+*[V>#>:H?B1@;5 T(HR!HW+U0DN\8%L0O991M)X2U][9+#ZC'IA,O!Q,4
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M28X>%)I;Q "T#% #/*JQQOL"!:XDK@:BQZZ1_@S$-VDWU%RT=7_/!QUFNOX
M!EYS5U*DO75*;3013#2C0:>V\$0@OXJFYU8DL^0?D496EXKEK1">G2WFWS =
M:9AY=;_EO&G< CG#>.BJS'8:8>36^$#O6L2^&<YS"US'^45P+U;<,Y5K&.9^
MJ@&!WN['/#2UAJ@'[1:SVCDXHGOO:% >]+']H<W+Q:%(!=/2MII&18*T)W(\
M> 26D6OX&BO+2\%O\H*%KX(/CPSA>'&FH;@[$G]A&*$5),6S36-F"V,LI!RD
M1G'(UFX& RN*SH$:O+5\*3Z ML@9=,H+NB!S/%RL0CWZ)(A";W< F?5$[GQ2
MNC6:FPZI;B/53HG_O0?9AI\,&03B<S(U!X%FA7>8N*"16[/U9S\,QSX6%&IL
MG-,3D%W= 9;C]M2<6#F1K1-V H:9D0G+)CK]09>_9K/XLDT5WV[H;%M8XG=[
MBMT'HW)2.-0L'0/;,4%6OUCU!]F1/1K$=CN7@3U^D=IZCA[WV8R.8F13Z:]-
M7QS*^X.^E7"_K1SX74 WRLVR'(]!,"6/B<\FI%\5*1"I5#)O7!QSO+NL(=J*
MF6%4Q]QW<(NOLX<1CC0%T1Y/0:>D=3[VB(V_EM64:-6A;B&AMVWT)17=2QVY
M]_C#NSSN?OWD3K^.&N%AO6E%,C=?\8+*;ST<LW_'\<.C1Y(1NJ2G7J$'+'WX
MZ-D)Y^<>/W_V9)<Y^C?7YB[A)K.2Q0!_H;BHDY@]B/(]5?US3C&6#)R:MB[%
M.Y:%*Q[*]7U*#CWSI@%0O/0*)ESHSO<C6IU*M\B7TM(512*O"U)E:VG'>8"G
M-83_ZL>7KUV&M'#J[TD_-:T8_X@K5"-1Y3!"W;#S-=)[T8(0PBYV3OXL;719
M8SMC>VZI#A)2[4D&P?PA 3=(-B7:DE&MJ\@U"5X+='P2O%=D:5/_VQ2M,R\V
M[B'>!"#6M*VPU\!VQI%Q'P::)O$'.QO2+C-R[6&BX+FEH)T*C[EPSF"6O5$^
M15GDFGL7D'R!K%P'X#H/N\T% )54!+A" )ZI*P30#R-C;<TC5Z7X/D"C=>^1
M769K]P#RW #RZ"Y@0,IDM5"OA"L#8!]CW%"$P<#OUD*$8VV""<H0R4M_9T/)
M&(UACR:D,O3H[=#;&)T,7);L15D\<%?6U95TYL*FL6O%1(M@X/*R<F:) (N*
MSMK5!P\=!+K'#W=(YWY133GI>0,"7'HK#?S\TE9NQ,!EAEZ5>2O X'==GEZW
M<)W*RL<F! /98:\[;%4'O][E 3ZQG>_:<&W_&''G? MR^"#'\_T.<NP:?U*H
M= '?/Z KZ 3/R4./P@R:/B32)85,G4J=[@1PH,+88].X3_&#X)L2B5+$0B;B
M?2Q_XHS]M=R/7;&*F1O\5IW?#(* XDX (FE-BK5C&LVBE'8"=>3!<D-*Y@$[
MR/=6Y/R*R+"L0KT1HIQI7X? CDD!XTB W\>@[]%F]K6.@]]96=UH':Q?)5FW
M6RUF&41=JR#/C-0G,-\_C'ID*( SNPMH/PN&@X\1L,-)L4!1Z.O2"3_<2Z;Z
M""S88VV+ #VB(Q+OXRQN_>'OXLG@"2ZB%S<N%TD],5U7QKH[Z$3@N6MWF$I(
M;2E^CX/L4,S7PLP <YVF%6O"["O-:BC!+#F#!5^TD,*B@1YDF:BF>%I]M:0Q
M5W#' 'USE.6VIPWZ!_7)D#@5;Z%S/GO";VN;ND>O#M7O*DF0]*BTRM;O]6OG
MP7,>/1TZF.<'5S2%L3CLNSOG7'216#]"(8]57S!O+=A-2\L# ^2$#B:;DJ$=
M0%@><CWI:R&=!G)).;>%;Z#!F@V/YGPWS@GN;[X4Z595!B-"NCA ,>/(&#OK
MW#0'P4#H)8'0BC,V-S;DLNP!^[QC+N+.=#?B['?F-I7:2*%SGXC'U69'F^SM
M8(NP#]FU,N).AW[MFE<G!SP M/PL>7KR<! A@R#M3B#\V1P1:<[O!Z,* H5[
MJ%3TT:/CVM_4/TD?E:Y9[P-Q73V'M]?MH%.@FA+6<2=N%O8D+:U$@Y2=G[55
MF3QAK4KX[L;]<IN3VW'S]T?/;ZY)RK@FXN\/CI]M;0/95_/=B^W=LQ>='3M^
M=,1[P7X,;VJ[[IT#=_N$HT9I&&IFBS.7(_$=#TR5:#BV02.J7F:"V(UJWT\S
M[3<#(9M)+ /9%-Y9I>*!_=;"PID/,!-@X?2--'Y?TO#>$$T(A1QTSBZ1[)42
MAPW').+9*P^?PNZ^'=MG'5N>C:WS9;O ;89D4^]A$BU;:KU]&&QAZF1>DEVR
M3+094?=N_R[+?(HIWV&=*UZ?IIS__<'C(^P2*6[LA%;/#=*9)%_QCT)<V80$
ML*^B_AW:W'% /7A"C*M+)+'/[0&1Y 4W_*#K)($H)Y,+A@V9 CH29[F$X:+:
M_#C4*3@#4G+/50WHL4?C^A^I:L@FC[*ECI^2.\YHC@K'T2NKN&^DY"U=@0E^
MR3%N#G($=2.Q]&_.V1%5Q*:AZ5IJZU&5#>DCA(+G83(#SH+AM+G<>O\O/R._
M="$/AW^SM_K?#[P72/XB=9AL+.P]$A4%HX];P07%KP!:VU6&G"KM%D1;M.SZ
M@:/^=ZPVTH&8B8CV9W<5[=_MO(PX,(>[(A\>'SW%-OSJ*RXF$^!V0&AWE'.]
M9F)E!=S#T(=2*/M -$4.R@?Q<D@$@4=&\"K(PV =XKNXH)FY]"*^>2=R\P0^
MQ%UC;YMQ(B_:T"M]<1BV0UB?=)OVAG2&.T0Z#T\ZM!/T!DT B5K:)P=L$2-C
M^4'X%V<P.<4"&3</0E<\(1K)(>" [X(3>.%N:05[L\?E4=8#EZ\8VDY)&?3!
M:*+<0R'J7:[YO9](9L/:-1751FT2Y=#ZJT[)%5P@FJ+A@QWL!ZMX&^]1Y12N
MZFW(5;>Y6F3.K%- HJN]&?+X2Q_,W>53^W+%-0LDJ>VP=O!55-?<U./5N:SB
M9ME9:"D-FE^PMBS9UW!ZB#^R%O=T<G)T_-CQHQZNZ\U*SXYO#^E]8YLUBC85
M):NN%+IDVKB\EX+;V]%U/^EF0 H7RK7EJ^-$TF-RXT,:J!!@HLQ[B[^E';AS
M?/3P6]K!E]Q/L'2$LR(:)-.X46[00:%C"7@WHE8R'N'.6%:8G"_V'H-P&@)I
M_5EJM!W\E:U0FL(>7$0,D993T?W8 X-U<XB+$1A(D: YU=O'>O(*;R=/D$Z-
M;2B-OIXQL4#.N!] KN@Z. AOB5<Z+%)?>I B;S,;MEQ;Y)+-NN7Q55R-#FA1
MI&^.._EH7IDG [\J<U'7HDWL8#M]'5I9UES3'_?P9._Z<C\QYWQ[%M$&N'*-
M67'PX2>SV!TX#:Z\[50& JV"2R2UOJF?=<0!5=%&U(6*_EY%ZJM&YBW=NQ%<
MK@Q&PZX0NL^"S1%(%.EKI(B)C\77$(;F 46G*-/5G2 ;#')(4-:#<GIP?,C&
M("?Q6':]E.R8;3G3U,L4*7/T[39B,&*C)1W?/3DQ3O.E^9)P>EE*2/]M8"B#
MY.#DT(DWOV+/V!02)+ \3JOUOS-7)LN9^='>1'O"B2('CPZC,C)&SQ&#51Q+
MX' #Z)]5>:49Y^T<15*UR$;LF4Q;43E0(^LR K@2H%,V%E;Y@T^&^EE06]_K
MN!C@- SPP^LW/Y\>'JZRU&_9(3X[!*DYD<]8@;&1:NENDSI Q,7 ?L,^*;AQ
M5OT4KM(9L+_"'&U( )'#[*>!=#.SV5T2?B@3D"K\J"* ;Y<KU%;%4.NT$U>:
MX/+64)W!,W/8=:9IS.@B,H!B["Z?:[6ZD*/D>_&6O??R7RHX%M;D6"+-UQ5P
M"/5*ZIJ'*P@Q%4UDU;8Y\Z-9<D";6XH#^="YBL6K@_J0#O1-O"^G, ^B"469
M(N'E?3X98!VZ:5K1.M0U9B6W0.HY%/"=PT-@R2XFXQ>3%1N.[TN I>^Z/G"3
M^O.A):ZU_+.L]$^F^>R:WO,+*S @&6G,M0C\EJ/",#\;+=]F(^:.97.XGD*(
M1Z);K0,$T]*4?"F([ %DWM2I^4_R8UX.B;6\Y^(C%<91+5P_QXA8A[QQ$,V%
MY/L4MO1R-BQS5X7W[OS'MUJ%Y]6]_OQ4I>$JMH &+X%F=LI_%:;4+]/*H#IA
MA_T)WVIW=ZEV]VP%K8\31/3#<>5P>Q(%H/[,[BM]O; <<O\'DQ QV*(6J SY
M,$H]AD6W4AKL:TU6NARY2W#PYOM?[M&\;??OPI\MW*/P.VHF.KG R;*C<LX2
M(@(S$"VW\L@: <N)4Z>66EVJ1K.'S.I:UPH+Q</&6$KTS6B*0M<@BC1#"AD2
M-T_@'@#L>RU;"H8L^2?-/2UG.TQWO^>M^OKB5<??XE5?MHT60R;!^P.2\\+K
MM<ON$AT!SCBPI5]#7& ''*XA/N\A_N'%F[M(= #3Z:, [G7L_?4X5%-6W5#-
M6#.U^%#AU$A;=HZ2;"@T!ND]7.SF4=\S^U6U81ZI.A8.RN</#WW#O)Y_Y9>C
M?Q[Q\.Q?Z627VRO,:R*%GXS"IP[F:%(!/;W4.*5XITEQR\K4.;_$2?/>)5*<
MG!P<'QZ,#CMSB,CWX,Q4T-*$=[XC20K.>9B<DD@^>?CP45*.V&!,NX@JM#^O
M#$",8E25+F!]6VB](<_(KT(R&#KR/"_AFUSX^*P':0\PEG8\5BEN_,ZZ22@\
M:< ;D\1E#*I:">\V"E7K)O$98;9XX% :RC$9)_ ]5XIZ]@\ZX)_-)?T^!/K.
M<48MMN#1LQ?)R[8F*J]]$\Y__'S^,NP&^A ZA+VX,0#H2F+/1(IPP0^\*1RY
M/KLH_K") 8X%F,:LZ14-T9J8'3O?NVX-FK;""3BVE>KH,4T</?6Y-0'?<Y<U
M[%MZES2X@@P\Y]R\,#,8\700-P(R'@D6NVP_VE'+),7''_HE^(Z Z[O@NFT\
M?G0PC:[5^Z,D<C?A5+U5=BH9^L?/'ST6+$)I9' 8UV +RJ,E52$+71B8AKV)
MM)%"@,'N>V^N8QATNJ^+B,_XU,&[[(H/S86!E?V%^\USY&X0F0?R<]?S'KR!
MMZ+#&AQ4J8;I?=V[2R7CXGG_/*9:&/^YD\6C2!:'&_OF]<O:]\UUYHM>2V4I
M(5FSV_0BE#@+4J&?@'R9S89M53M:W'QL,4)-@+@E)H:I,:\H%00Q6J[NR)_)
M(OYD[]!J$[U.2OKQ\^VEI/^/)$DZ__]) 9*OSU Y^31#!4O)TO_U7]G)^.G3
M].3Y<?KXR9/'P_'(/'SV]-&3YT^/S</T>3I\\O\]_J_?R;BY;2OO8O;\\<>P
M_D:^.SL_?_WCV^3EVY_?G;[Y+7GWT\N--+HK<SX_>__A_/7+#V>ODO<?WK[\
M9_++F]<?DM-?3\]?):<_GI^=_7SVYL,G<I>M+NR 3N.'M^<_G[YY>?;@^]/W
M9Z\.=WL9&XIT?@FQ*E)+LTGI1>,\'Y&Q<?P\^:DD(057#DP4I$=?*3[%+O4L
MV^ *?<O6\5__<OS=PWO\[PWN@/'X=Y[R.X=60*]^0TKI[F_R^=F7WN3?><HW
MN6*A]DBFV[EVSB9M6#I\PTOK<LOHLG"8B2[$@^]1*7C_VZ_Z$"KYMA8HR-AK
MTFEY)W;(.F80^QIV\_!TMMOTYGGC!<U7'."[H+TK[;2?SG'WX @PS5W8_U7O
MU#:9^H_<U0"&]U9#TKM//F&C=H&(.&'')R)SLYE:(!+F$?^7!D15$!>"NMV2
MN*@UY:?Q@;"HB8A#6LC\'>>\P'Z[G\K.3,8\PSU@?$9T#\27O<U((5WWNL[
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MWY)?SU]_^'#VAD;Z\+8W^I:OP'OI:NP)V+EGRHPAUMK"HF'SR#()D*[J"RM
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M/-M-(I4^D?-V2#*FD\F/2 ,WKU-1_O[L97+ _B48S_H<IW;2:@Y#@J@C6 >
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M)V<X,9TF7W+9L.V6E.[LYF/5/@7*-QKR37>7-;7R31:)1FD;8Y2<$ >(@6Z
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MQ. -:@^-LQB%L6,9N<[K6COA !\"8FP(T!W^M3?Y+4.[4E&Y4?\H]R$1M4:
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MQP4*%<1FW,L.[,$@M@JYLNWQ<6KK*;K99Q,ZBI%-I=<Y?;$O[P_Z5L*]SW)
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MPTT(,3>Q\]&E30'#NH<IUAJH_']18<1!J0UBC0!)#7!Q[MP&,:Q^Z+E,RY#
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M;3,#.UZ6VCU)*AZK;((]^5 .$[IQK(<=9FG'"V:HX4</$SIB&GZC2L8F=0Q
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M7&/(4L.Q9:;R&GE614OR::4T,-8 </\1XT#XC8_$ARK3*W&9@IZC^R%7-,I
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MT\Z!2(HJ>5<.XN^WJ*]8U.V748V<%V6P!H]E:4LSY[:[8$2]DO/5QXB:J2_
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M'V1GY-GH+C02;(GWWM_Q+J[Z_)I7?V:EP) ]0$ .@CM( ?>"TV[O7.)S#WY
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MY&KT(5."+6=S$M][,Y)"IAIE)(V0=5NW!8GJ*>DO\Z_(:OU-6'2+%[3V,-_
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M!D T%GO]@$>]T2H2Y(I4>$OAO]B<&:3C=L<HUR\@HJ=)2J4Q'^W<X%_+2Y3
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MKU043A*L<]C:C:UM\W6QO[[_/X=2:A)TQ$WZ65CD:B45JF5V*B\:6_3I1SM
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M\L6TTA0H91D94J7X0.<S^((E<1MZ35+8OINF9.3"29\:[GIO'# S_$BT?.Q
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M@5]#;Q;.5X^5$.!DVIBPQ>NS@)JEH'9##BR[ZUZ]CT4\//@SQU+*RKBX<U8
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M9#;$&BB0R]Q0PQ%ZTZ+KLZ&A7E(E2USKIJH4QQZ:DA^- (7!?(89$W$_)'O
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ML-QHWN&B&!6?#746:Y^E/7 1:CUP'A6VJ-#1?T1)/.?*352M]@GEM8HS((=
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M:<A)IP>$BAY"Q79A6$P2PY<M O@X=+IQ@RE'KL+#101W!0=.-$%1.B.J"BS
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M7E\4['-6@P>V01SXJ7)\&5^5(8O9K\WHEAUS#,-?* ,0\(*@W)UWE^UO5S]
MV]LC6W=OR_W0>L CLS!S<=/$R47@E82 6JY$;?5#QM$/$L)Z[\P]:4]8F#C'
M)])X;7>"2*]4_#F4!Y_HT/I?)2R9CV?1'DUN*5'=?1N_E5 +FA\Z>#3AO)SA
M! L&%)1O^)?W]:1'P^A6MP7?H?$J(PE_:5903';.V4 EVT2)^YBLV+!\7P+/
M?.@6VTT&ZH>6M-;R>_G2W]E*MDN63[U=T^=7MF$@-<**M/ JE[.U"#@TVI[,
M;NLMV\*P0T46QV)>K0/JTM:+?"GHUAX*/J[3^-_1W_)R0MKE/3?7Z'D<]'KU
M:W](>\@;1\%8Z(B_1/1D.9N4N>TR>_ON;[]HEYFS^/KC4ZN&N[0\LK8D@#E8
M?B\"S[]>5C'Z.@8<07KH31U2;^JK%10]+MS07TXKBW@4*:[R'^1(Z9N&Y82Q
M]..(A,$4M4!!R"^#DF X=2NMKZY+9X5BQFZ"O3<__'H'YJSA[X7O+0VC\#+J
M*=IS@8M8DW+.)T30K"^&;N60(SP*%I<T+;5[4OUF!S;6=; 54(L?&Z)0T5^2
M2S1R^J-(*Y=0N7#S .X)KOBO!4-R_(/&GI:S <O=O=A5FZB4&' &X05\D%.-
MKVU-CYQ B/9 Z/_E\PP#B.CYK*R#>T>8:&[SCQZ*I(_.M],9U]=3W^58=5,_
M4ZW/X46%UYRV''TCS5-H3M.%4#B.H,%-#MPI:1H=I 81L.<'^XXTK>? _SK^
MQY@?SPY\IZ;87&%<Y]*0R1AF&L$,!N4QLTO->TKXD\R"K$QM=$6B .]M^OSH
M:.]P?R_9[XPA$-^]5W$%&T!VYEO2T]B7^Z#7CHX.#HZC,F%W).WB4=#\O(P!
M 1-B4G1ARMM"^P!Y1.XK)&_=.2WR$L&OA<OW.FAN#R]IIE,](V(WLW80"AOJ
MT9JD7!4/U3./9QL-I'43N3H@4SRR/>[EE$Q?!#<KQ8SZ.RWPS_%'NMXG#M]A
MC5K#M.BGT8NV)BFO';_>WW]^]\+/!KCH+#Y9" </N9)<-HDB8KPCYV@%L;4N
M=CL\+D + >0N:WJM(O1-G$*QP5V=&O Q(LHT-95:@*%,C)^ZB@J/N_D YN@S
M7$>[G>$:FN8EWQ)*DH'5;*07;@9CQ8Y"?IO88>AB'YA/)FEYT_,&]3P&CK=O
M/06I%?3#X[W+0/&]'T?O YP1VG?.*SN3ROG#Y\<G@K4G! /[8?>ZH!@:$L_,
MLR.PEG$NTL8]#&QTQY"Y3J73_GM=!">!*^F[S:RX[)Q_L!Y07@/S&)FE(7-
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M3N0#&,T274K##BQ[XS EN_)5RT&N^?1K):LXO8LZ*%?%%7HH)N7 6ET+0M$
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MK$\H3=)UV5[IFY(:SA>Y^<R'L 2Y1(Q) H22(T Q(1F*K'>R]],]Q06HL&B
M732[7;2VK:?_G'9'DXV4KLYIV5E_<8C#8YR]P[RVASCCH<+E:]UJ%\?3?G<*
M1O^T/LME/1^SFS\=TL_GU^"/%Q>X.'+QO5[AL^B*$(TMJ(, #4I2X,S#N CH
M19(ZZG.[9'1;*YAO:*-7@?ZJC7XL>CL;O>0$G?Z9$-W1@,%TCS=?[MR:$9@#
MU($!*@<',:DHBLRH,Z(MQ>2X^+NX+H*]SW!7W>"4LRB*JH-=A0XR!%E7NM.F
ME.B;T#X^=V#FKW^ TPYVJU[6P:64=+!)9R)G;<BIP*># Z72=X[BG:H/J5IZ
M)O46HI?:@66O!!02HG*J>+24LQ7YO/=/7M:;;"K[.S0:]VCTC.OI'9YM]0N[
MBZ>#8=T9_$6//Z_W\[/!(._66K]V],[CF;P%ZG(VUN)D%EDQ"E(0<!+OHR_6
M8\I!130DSS6G%@LK1J8;MW_L\$7&,-'N(5%%<CWG[K1'=Z,[2KU!C<RC7\[X
MR\E@A+UGP\'IR8@OT3O-W?Y!+<.UT^V?4M[F6IQT!E_M,U[/;_D>,QU1<O$>
MUQ[I20]'(ZZ8A!_)>Z7@9QYR>CK_4GXYV\6[F#!^76.SP_Y&C7T]YRF.'8PR
M!JCV8-:>$] J%A-U2NR/SKTU\Z^U(N**B)^-E5>I^)4LX&K1[YF  ,%0XDR=
MHF.I"#'75FPCG",-'G'QO>;"@WPGWJ8N$ULDIUB!W8RT)2:B2$8&;[S,,C3(
MV]PO@(OI!)_S+_WSM2XO--\RNAM-B3/0Q'I, *0ZBTZ((KRQ1<N4["5M%;0N
M/BPJ;>^5'[L)A^NL\7^@60JZI>#&Y/Q8]#O(6:BNDPF)95P!Y\'KX"W($DH=
MCQ:G&8043MA%Y>3*E0X>[_Q[VB*4Z'1<>UKNP(]>B>B<O+J6L#.(Z#:!8,HE
M4(B@0PA%9\$9K<R)LPH]'3TW85]K1<,5#3_UF)\0\:\\YB=%OVL<=BR.1$Q!
M!"C9HL9DG 5M1!0&H 'M_E=(\'SP.8Z^&$Y6AMI\?\+GTHB9,IT:<SH<\JW6
M1R.ZB[57[J1;(%#4G-,96YN/A8I1Q*BL=N3K?KB0I\G>?;0C+S%<G[1C?P=<
M10J=72P6#$%4@,F#,G609Y$J:KT,UC4!IS/HIP::DR[9N5""C-8!)?*0#'M$
M+;S3&N52F-/]XS-#^S%69971 .MY5"'4]1&<C0J]C8YR@WI!/Y$NU['Z.*#O
MW.M-2W=HO(R]HBZ14%@L.T-6S)ZQ9/<80;NB4*K0I U1%A/5N8P8*RXA.)>$
MSQ[0*PR9G(HJ&06)X^#BQKHZQ*\VE0QZW3R!;XO1''WB1:<90O_@HIEEGNTX
M=[>ESIU$6:$ "HE2G ,0,015QYN%4L<;90QQ<:/LBAEW&]^M$HF*R\D("3X[
M5/Q'!AV<S!I<65R?L5"+0,R:HHOB.#P67[1R7J4$I8@('%:TCYA,=$HOL.-8
MT>,>O$?M?E)69!5M!,H89=162LG.0R929G&]QTU0:3-SAEWL[1"_=.KV&)])
MJ8;8+DV6O3<Y!U% *8@^J9 <%2T+*32+:[L+"\X,+:=HBA9+*  0-7FMK%+6
M&*-]"%XL+C@_D#B*"C0'/_""0?(Z1Z\3>M)")B=#PL5U;PL/TNS<G&5#4EDJ
M;PI",#H(A][*9 F#E3$MIR7=\4"".S&GS%;#<M* L!J*9'P"Z8!!)6\1:8'5
M0C.0FJ%TB(FD\R6#DU!,"2K&4"(E@P":%K@EZ6.S8*;2[7?']+S[EC*#@/V#
M;NS1M/7]E[,V'@V&DW[U*]CM#3'3,0[?C":?.GA,=8>(7X;\5U/\H13"2=2I
M;G -DI'30I&SQK&]0?(-\(=-PVYV'E)PH@U6^F*-!5-L<%HB^T9IK$^4EM'N
M/I[X8CA([%)W:$0X3(?K_;Q!;ZDW.*F/T!3C*XDQBR8@BQ$-(D)FL_,^JU*\
M/ =PN8QO$0"<87]G\L'YI+4T 5C[HRFQKGH9R#@.?@UH#WWZ+> ][Z9ZG?[!
M^L&0[FHOI+NQ.+*>R FM4P+$'-E56A(U*_"9T^G%M[A& #;#+, 8=-YS;/,.
MDHJ8B@H6<[*<$8CHEM3"SETAY3U*A_U!;W!PMM,].&R.G6GM)M-_/7H LA@M
MVE1,9,R(; -Z AH$V^RLS2!I$YT&'24DZU 3:2=C,4F"#;2DUO;D=#0><!*^
M0[WIJ.+#[DE3+ V"))(Y>U 2R*4HC600$^=Q68@F)' -@6QV5L9>4>@43%T/
M'Z3+,2:=R(#0Q*"5M*16]C'E9JW_,>MNB)WYF$PQ&B;-D4;D:+6516?C7 K*
MNR6ULWF -L/\C',P:X,M: 1(86*(J7K';&H?9VQ &_(W@59'#P^.3VA,C4O0
MR =/GG*I@_!MK O)%.GKANPELZVI)36S>T=L=C:&VA=&+& HHEJ;-T%DG;+!
M(B.A:H"-87?X._9.Z9>SRX__XBO69JFSYU727P?KLM!6_^1T/)J4D+,:17CE
M8=K3Q>#JVSP=TG].J9_.OO D5XJ.=JA.';B3'0_N9E*'8MTC"M2Q09 "<ZED
M(G06$!*[[$81Z(XQNU=.JX80B-GCG=<Q8%T ''6(/H+S+-$XXA?5A*QU.0FD
M&T*@3*$P6925+@'+^BA)@M2(V4*)*!L@.E8A;*[C\V22UA8.8IA .!D-&(F9
M.1-E\J8)S9W+Z8'N-H3-L"L?G#(E*@4^ ;%LYLP'618YPLR"N@$36Y>40'<;
MPF;H@50*&JU!R!$$::],D-+'XEW"8$2C--"/%,)N_$@;3(:W6+?/WF*:#$_K
M77:ZHS>?/,M@2-V#_N;[=(C] ^*O[W"8&Z+#B'U?0>-"T!(<I5BTDIXD*<R&
MSJ?W-X7$/P!OEBB4SX[$!C($481*I8 -=>5PD2$*6]@_)]F :0 K$C=43LQP
M_$:=Q>),2?P_8"&!M3N96(DZ73>)767$*SFQ^)HX*"4P9BQD),0L8Q(Z&N4(
M2(,IU"@2_P"\62(Y,4,2LQA.#H5"BY <H97!0-(91+3.-&'<P8K$S903LYS+
MEZ4(%@CX3S*(KAB+WNN("#(V8-7*E9R8A45-9C?2:+R#8]I]AR<-4<-!$7C#
M5W16@B*#"8K2)M>A*75ER$;1=U$8<Q]!?$7?Z0;+F6RN=+4$3-O@D@3-\B$3
M&9>:,$MI\>A[)XQ9(O$PP[8(KT"Z)!QK7% BA6B<T'6NG9!$I0&S)%?BH7'>
M=Y9=N^@U%*'KZ"0K?- 20W0F.  536@4?1>%,2OQ<%_T-8:4SL("I@ L%T*V
M)@J)T9MDC,,5?1>%,4LD'F9'7T\R<:IFG*YKT02'K(5#<EA,K"NH-6&NU4H\
MS,"6IKM1I+,&I6U&( A1O"#-^@&3EP5(%"-%SLKF9C6:+0I;&B@<&DA=<B$J
M:S4FH2&H@@ZBHQ2,]MH%;U?4702V+)%@F!UU'65/&H43P4#.(>2$":QQ&0C\
M^1+G3=&[*\&P^%YWAEJ7%4, 'ZS*G*Y9@[D4GTVP  F-]XVB[J*P9248[H.Z
M"DHB*[R&1% <(%.XY!@C>8BQK*B[$&Q9(L$PPV6_4_ YL3X(@06"#%C 0*1D
M?0R@5RT,MR9M''^DZY456U^<1C[UET$_UX5:7TRH32]ZF";6<[=ZY1<<=3]=
M@ B'PS,VUATZ&0S'E->/!Z=L[Q>G?]S1MB&Z=S(VA[5NCEJ#]QG1@O3&R) E
M)M. +096-&XLC6?GC7503D<=H@@:($ITN6ACHN:[E" ;L%[DXC#GSJQH47Q>
M+-%JCMU!1I:<H-%+BU+&D(M#+1HP;7M%EGOS+$*S^Q"0G8,"4!LX8[;*\T^.
MA=[YDJ:2W8Y87+)\PZCG[9.ZO.*=8B1;(K2T^#:,3OO=*4#Y\NTNZ_]X&OJF
M%O'Q^,65+@Y??*^7^GS#2O420D*ANJAWMH&,3!C)4K8V4EE\Z/]%^8"C_ :-
M&-K/;#K=84=Q?HQF-L)]*?EVO;%8Z*Q"*:[ND)J\"%30>ZE5!*%UF?9S* &+
M2XQ%Q6BRS_%,,"*GL\8B#7%F#G4[2I\RUR35/BD6B>>[5\/E[M4KL&X$UJ<[
M6,-M=K#^B.SW[&!M@I":,@HB2*$N 1858EVZ220 VZ!]R5?^>?X;HMN0.;Y+
MI[)-4(>V)2<]:? Q1VLN9MHUWS_<\T#$6?EQ5E]61$=1DX%8:A.K I>LR6 P
MB]P$>+Z0K'7HW1X-CY\/L/_+4ZS;DX[/[M+(1\^PVW\^&(U^.3MW/%>74?^T
M@6AT^+0W>'=><*%'0"X*57UFR5&B5$Y)4!:#STZER?9.QHKLFT#5A6)-W>)W
MIT:?Z5WJUS:^[QZ?'B\T'[]Z]XGU?^[63P9O^4;YZOU>3/AWQ6O\>MHG68FT
M=S@<G!X<KI\,N[WZ0VB(F<1@O /*7K,M&)V\MT*0RRS7I<X25F8R S/I]E=F
MTFPSR40Y%&V\E!IDM,$[H=EL^/]%:0PK,VD4F6^C!M=OJ ;G2-7+]M=8MT[]
M?-/KY-"M6UV-"S&1=SD8 =ZG '7)$RRH?*8 YSL;";O(77D+Q?N5BKI->'!W
M;7-V-IV82LM28H!BA(1D;(P!(Q2IO X0@UJ9R4I%K<RD6YO\K706A':00D$)
MP:0BE/0>@Y3+KZ(ZQ'KC+0-<3VR"E%H4 1YML5Y&B#Y[L%IA2,G)$CS)&'4^
M[^630ID5=9:$.E*TE)E%YR,Z:9DWD2\*4<F8D!%.*LMLE$6]HLY,(UG-FZX$
MK>TT'O"IREP)7!N4)M>3]4=8D?@F)&:O)SGY,D$:T*A"Q!*CU5XSB3W%Q27Q
M]Q"E70>Q37ZQB](7LW+#W[R(B?+@O2\I:\"@(];)<<F"SB4+3\O)X(EFYQ^T
M6!&XX01V223#*;T!$B"#K.PEZ3"SO+ :8A.&M<]OR=V:PE],<YO>+YU_>_SL
MEQ=W!/X,IZ0K$HG#K4,+@(F"%=Z0E,63=8X:L#G4#P?^#-??RCID:WW0=?1B
M*@%$S""4*.0%GN_$L++\VX._^7)GX2U?I1R"S%G:)!C\A %34"G)NJ2KH@9,
MB_[AP)_AQ&*97;#*NCK@C=CRR2<;(1:E@W=-V+Q^0<'?W?R?Q;=\7U34R7FV
M=+"0@M3>VFQD74Y4A@8L0_/#@3_#[1(DZ"(UL+I/$#5AU)!D$40>2\:5VO]6
M\%_N;BR\Y1=73*SK5;HB(6L991TCIVU=AY6":\!ZP3\<^#-4^PK!DHI1*P.L
M\B)J[0/' BVT<66!IZ__1<4_Z>S?5_-.L[<_M<DJ&4&Y(H \BS\?0I&<_><Z
MBVF!]RO[8<&?Y19)7MH2E5%%@8K!FQ1L<%9$[>KZ\8MK^0ON]C?^9_'5OBLV
M.^VD+LZ#L]$3HP-9H?3!Q(NACHMH^3\L^#-<^P[1*P ,=8Q) +;VE"0G?DJ7
M$K5?X)B_X. _65]\M1] ZJ#K3DS@H>CDDRTJ:%*B>-)RU<*W>.#/SO*3SBIB
ML*JD")SN!1<%QWQC-*?YWJPL_UO!;_^[L_"6+T%F8]C6<]2@J^#SVIBB718U
M![0KRU\X\&=H^06RE8:E/16P!6**P20I8K!.&&K  OD+"OZ_7CY=>,M/X&/(
M0IL*?DDA<K:/N<@"QD19Y,KR%P[\&>;Y8)Q 0<X; B$P.! 0.1)X;U04N++\
M;P3_Q?/%C_FQ<$YG(5!D\#7Z4")P>I]$3E$:LXKYBP?^+->XQUAD0J') ^6(
M$&T66?H42LIV9?G?"GYG>_%;^(1*FK&742IDZ2>\+/PA8$1)UJWR_ 4$?W:6
M3X4*1I5$<8F]/6)*063OM.=4WZF\N);_%Q7_[W__>XD[=F;8MB^U31%TL)CK
MKCRU93_6 ;Q>Y5B26US+_V'!GV%_OJ=0?" P(H+S(;+:5TX$04:YDM7B6O["
M@S3#?G=%RMLDA#.24S'/:3E[Y@!$NCAK&K$,_(*"-#M+"NC &F&\0P'680P%
M+.1L9,3LXW2Q5WVQV.O*I&Z,UK6%5_7-%U[]Q/Z^8^%5 S[KY*7W'D')[$%X
M=I4)4),4UO_03O+&S_"U)80W+M</7A^=E_WXL+-ZB%^PA_U$NX=$X^>#])G'
M>#&D$^SFS?<G?"Z-UOMY>WQ(PZG.&*^/1C0>-21NB,0)O$(I(0$4[Z)P9*5@
M@9\%>(D_=-Q8\79A0ZE0QB3/"8ECIPJ24U-+(N08)98(J@&B="$X,]_E QO
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M%8 SR]T^A? KK4KVFQ7X1X?>^[/!=T<#4-(]WGJ^>RLO?CK*7&E\UN45)\&
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M_>7VJ07OQ/BJU=Y/3K2>\Y!&H_-_GO,#R$9&RF].C/@>Z8\0G%;*^%: *%K
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M_&UJG,8=0CE&D1P)4!\.J%N3[$[8$!A6&.5.%H@3C9$%5H>H8Y0YIC7G[M&
MFJ*RZJKF3\:,DIH_JYI/)#SPS.> W"@/FB$ :QV+#0ADI)/2,Z.\RNNOYDO
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MD-?CI:G[;,_[)G5_(G6?H!_8$X$E1I8S%2T#B:+C!&&F;<Z]=YR:4MUU/K,
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M'-DB!.!]##M'I%)25NZ<1?/F7)E]D^9X"ABJYY1L;'[Z&TL5:R%H1'(#E(:
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M/'"P/K%GR%E%D#.>!":(-H)O; G!-O%JM^MOJSX/[']J<+/!S0=ES<W68GU
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M]1) *'J*-#,!6<>(%"(E3F,&(7K[/%%/-W;O+NRE6G/0UFA85D[CIW#6>)G
M"A4)P3Y"GWDNS69\BM%2II.PWNKECQHWD'FWD+GHN#&QR3!'-"(T!,0U]LCY
M))'Q(47/HR6. V0RLVE6%'!1H\BR)Z[ ' >A'%'6&<Y)Q)IA%RQ100?%,+4-
MYZF? L]Q'D,E5B CI'30P'ER!;+(.(HZY?2F(23O0('IZO+*-9SG\?O==MI'
MN9;)YUC\)]K.\+@YTGD%.1TG7DFE,8_P?\4=#E@JD6S4TK$H&^I3-^1\.T]]
M(L=,YAP-T<F<MX%X9+7$8#):*C05ACN9D9/?'CGKY[)ZX@JL<*"2&:E9,EPE
MXDB046LIG!76<=I0G_HI\!SU\=H0HIQ'"8>$. T6V6!%=O<H#?:,%SD(DA"]
M!N>O'RGU64-WSVO;'E>Z?=N)\11MM\.@<?Q<#1T.T7&C "T9XPICY[WSV#N3
M:XM%0AKV4S?P7%!1 <BJ9T)C1!@'NY%$BHPC#.DH*:/,&I^/(Q+,-D7M[<;&
M\;-D\@KJK3(6&"Y5/*E@M 3BJXQ,PB7A><-^ZJ? <^P'S$RNB1?(!>\0-R0B
MDQ/042(U6*42D\BR M,U\-P^4O:SAHZ?_=)VBA>VC(W'YZK')Q+!0_!8,\*]
M)IH28S,+XLDXH$$-YZD;9"X(4K)&1Z*21YHJ@;@3# Q&9U#D3&HKB.$X;&QI
MO@:I?1J'SY)[732GZ4J<2YLX$U9;;$S4D8',%>4-Y:FA_LY3'A=,\ +TES.*
MN&<<.:$B\EC))+'$.M*-+=6DYFK\/3<'D?$&UUGQ5SO%ZGV-M^<J<J9<$]UZ
MJDS@QEG#$QB/WCNAO;>$-LRG9LBY*/D4M=HQK!2BU!+$L0_($J:1%#)H*F@D
M.F=58;='SL;94S/]E2(I(Z)0S"E.F'%8&!624%8K^-1$-M=0?Q?D) U2:^^0
M\EJ!_B:*M,(!1<9%U$)X0O'&EE2WW^EJ?#U/QM?S]E.[U_AZYA$SA@#KH9'6
M6,4YI48::CG#@=$8F%(-XZD;8BZ([I'8!9VT04+KB+BR!AEC,?*1JB@YX5ZJ
MC2U!'^-YM">NOZ"3.0^NH1X$S<%HH9AIP04/(D;,?<-XZJ>_\]6RP3Y)%A0V
M&@OZZ[5%FN/\@Q#!O?6>P +.\>UWMQI?SY/Q];P'=>W]G\%M@IH?KZ$8DO9!
M,4]Q2#PZHHF.@HCDE3>,,=O0GIK!YM[!=H;,,?4Y^<1:!]OG'V,T!$>5D-<)
M+$5M S+6*R28C=;AB'5U'H2L051 X^E9<H\Z*)P"IX1SRY60+G+K*8^&1J6%
M;LYSU5*!SV84F&(!!HIC*!BK$<]'NPQE'%G%M$Z2!9+$QI9NCG,UGIX;@\@_
M[2$\JS=X5NS!=R6H^[-QB//H]+03<]6H0?'+QC][;S?FJI$^=5M26*.  07C
M$K>1@S&2)%4R<,Q#$J8A1;7#U-UY4J0339Y*C*CP HQ)29 )*0$I(M1@+4BP
M'(S)35Q[6[+Q!2VGO]HX%HS"!)9-'I6U@0FF@TDR&L&3:3A1'?5WEA-)XWRT
M.*&(%4<\.(&LL0218)C"-GD2<"X*HFJOOX^4$]TR#>JE;.:31Z!\_?.+7.#W
M%_\\/(YE<3E;Z@I>+3;U#[/3X^]EIR??3T]/O[&V<1&6QA[.V$^]2\0J@(R8
MDTLRFRL^<<=URN4U?&JX6^VP_]4"AY8R/H084234(>Z41XXDDPNS1H5#)$KB
MG-3M]CG=&H=6S108#*Z #? W(B+W+L=LQZ2)=8IK;E)S2K^6"CQ+WD( "4EC
M4:3 X$!&&%D'#$X8Q;C$G LG<HJQV[.WQJ.U<H]6;8LL'_2'^:3:]]+:W\#B
MO5UIT/5#5,4B3]X29SCFEAI'00=U%$")$N6B25Q4/T3=FZ=$% B1\LHBYS00
M(:T9<BPY)(C"QN @HC%@#LL50.JR>K)&WJXGI_N6$Q=UY?#D,($<K+R<TVB2
MCPI^:]A4'75_EDU%;JT$[HL8A1]<)HD<" F!K6L,&+D,8PNZ3_#*G-E- =P:
M><KN#5B 6;VZ3<&@NM0$:LK^K.%^]0_+_CSQ72V>) _2*!P%XX088(!*8!:P
M]<#]=',FLWY+^;MO-/[\\"O\_O4C#D'RI!6*&G/$(Z'(QD20ETDG6,<U=[Y*
M1U'_:A7-MO22H7H&M-))AC5)''BY"23S<<JH5HG(T'#Q.BKPV8P"2^&%QDR
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ML^NIZ;[W B=)P00RE#N7M.6*60&0H+V&);@A4W74_5DRQ8Q)47&"-,ED*M&
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M!%H,W[:=I_[I;YZPH]@_*NWI<=L7G8G1.UAAX(K<_&$F(/J]3$#?3P1$?GV
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M VVH6LV0OO5BGJH9[1P8Z08%"C^X!+YFA8E(4VL]H=;YG#69\DU>^P)B30'
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MNBT\I/EV"0J">X<9HUY2'J"V@9+DQ1MBK40C?JFX2\!LV^5S2KCP;I"(GL=
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MSY"23"*'U Q&]2 ZRO&["4XCW3Y)(>[=DU2+?&-4Y]WVZ&YK?:$_(:,(>\8
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MRF#2O[OA0RE[G_O^0REY8W&B24LUOM+;M51WO_R4/H*Q@P88PCR@,J7 46H
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M:V4V8VJC=Z\S@.=[T:F0NGXH4[EME*9[Y^1S.=D99>9!F?:D;>00-%I1 J!
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M,,KPC)K$=W6]\W3B/1KPVXJJ5C\KZPW*E9M+S37)NET+H&Y^F!(CX0IZJ R
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M(/V']Z[^.6[6_YS*Y.*%-,$)#[A'N.3SE YC((A37$"L;% ;[Y58/+7MN1J
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MIF_J & KL<C5GNP$Y"C%,Z#4 Q[ 6<_XS[KM"C+ #%M/@:TI=0 0"0FE3SX
M0X"2Z ,HSZ(/@+RR4'$8DEV!D%BII,4LLRLCLU,]@"RK%<CJA \0'*;"60<"
M$=%?]]8"XZ)+$ 2,HDH"HC;UED.+I^ME47V-HGJO$Y#%= $QG? $B,0\:&4!
M]U)'^]]1(&E*"H+">"J8HLA%,5VQVKHEG@24S157T24HNPJ5M.6G0WEXZ1."
MQ>@?WAZTS7M\D/%M'GR;4C6 O3#<< M<,#PUMI5 ,T,!EB*N8-S%R.ITT$DJ
MRW5<%V:7+.8O?^*0Q7L^\9[P,H@66GLG  XVFB\J<& ()$!IR#U6Q#FBB[3
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M6V'S5;'>5_(>;]4TJR0JDNE-;X[Z3\Z[QO<K.>TG<_F!XT>?GWT_!;^O\P$
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M9<90AFFHO0Q26D0H%D03+:013 LCL:(ERN 1RDS$@3/*+ =E)N*]#&')O#!
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M>G&S9@<T?!QH#-<,*^&1RSV&N,O5/"3U(#/.11E2DB85-ZN S'*"#">>2)G
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M0U5\J9GX4A\F\YX8$XDGY5$.WB'.@D,VT( P"U';8#DA;!DSEPOP%. 9[9;
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MH1P=1@8K[!QQ2BF_LD96R:2HN.$V&< 7.Q@Z,OW1YJIZX^W1T#-IC6$=7:T
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M7R>=."K0DDG/0:][LG]07:W;8EYE,;L,W3C;MAV?A3)'GV'\\D,-KW6OE8<
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M@@GZ3GZOF[!/_B"&DS;8K=I+^FZ\^C!DWW</K??_C&$?H' 3#%?OI.YT\FD
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M=2VKVH$P>Z;;F)@PADH>/#>$.FVM#<3@E-,4:3JS_Z N&K,X]\*7JUNVV;W
M]ZP5#.:2HJAP0CQ1BDR,%C'K/#$JX#"JE\UJ=V:-1M5S9TJO>!(A,"XH#UQK
M(XE@6JJ<1 TS_/ ME!J7%HE+S6MNSTVZ1SP3).* N!,&<2,2TH)KI"P6CC-%
M*%'3B^S5U:R>78)?'"3-@$@LL:1]\%%;P2FU5F/.8R)112MQ8HLF2/7!F?D
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MZ@2142%JE4$\V( LXP)Q:T54.&"L<*X7^/BJJT_M-[E3M3\L?&K1.:M7UK[
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M0'A(HK?6+"@&W1FG. &(LR"3TQKSH)T1PB?&! _*,&[\F +74SR?*=XDS0V
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M>:;&EFX++LG2 !;VX(:-]B;'Z[6'>4_W?!>[6QK.@X.< .3-Q7UE/T&<KYZ
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M$(FLY6!#21RT(-&*%.=6*JS6TE5,GUMKZ;F+V80[-0<*)6<"<C08Q"7UR,;
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MU:'4<3<SDY;7L-D8HE"Q!Y6W!<8&-BUO+C)%65@$)K"&F\JP53 :.;V-&5%
MFE_HKG&*_>$@966"" MYS.B-PZMT_S =AC*I#PL1^50VL7+LSDV]O9%V*5\
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MY01>],V;MZICBOY.,VH7C .<H_IT\QL;P$=IE+L\21,W82S-PB3RPB1F7 J
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MX6,[#WQUWUS07W<K&#KP<85D>$41L1W3,UH!RG4_W544<7&<QD&<)(ECQXX
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M#%X;-J#/1[5\;O[Q B L6/?3Y\607H@N>J'OKJ'7D@(7>I[Z6*.)P-EB?HR
M8ES!?YEYL,8:6X0UGHVSQ<]\;RMV_94?.UON-WWF;GDL^<8K5R_6B[>B('@D
MBX6=]7QVH]L^HU-3)P>T@53WOQO^1HLS,S3YGCN62^#9W.];OIHL?-4;7>*7
M%ZEXH:Z**.['@/<%G$/P^(A<6]L4RF^8\1LVK,.Z^B.[+_/Q\Q#("<TA_3N"
ME.:75YLQMDNE9U=ES'W'(;5?U9(#)0U\UZ(R",OL]B,XP9F6%3-'^!WO^QOL
MV]P4/\^[#?FG7)RI_D*V7J004N;Y52^._'"?K[V@Q.FU7QV^VKX)E5SW@O,4
M<MUU-R87QWJP>_??\QMW=R_]8M[N_OEO>XLTKM1CON]%+'888[&?I;$O>"P!
MQ8K(302_:2ZATD./(AOKFPV%3Q__JC\?E=,>/OMKSX6_+SX->L[GP;O@8 ?6
M,?CD[!^]@^_]??9I\,[[;*[Y]U^GZ2#K'WS9NP3CXFOOZP?X^X_BT]?W@\\[
M9ZSG_5U\_O+.W=]Y?_KYX_OB\\[GP;^_[HU[A7/YYFAWW/MRYN\?;7\]!N,Y
M!$/:M=U(@&&=I\Q._3BU4^YY,DWB)//8QLM@TPFBK6A%1M</8P3\])8,L99B
M:REV)U*,Y;Y,0YXG.4BQU)>Q[X6>%P9!X,=)$CLDQ3S7\]=2[-ZEV/ZK.2F6
M>-SU R>P19YPFT4RL;F3A78DW"1,G"R)_!REF.NS+?>Q2+%;H\Z<_O<H4.?>
M-Z'.N1=<:9=XM]NDI>+Y\4FL#.!5'N<!<T*?Y:[D22+]A">>B$/.Y8UK.-82
MZZXE5F\1=X6.&T5)D-HL3#),H\>9AA&S$R^*?)%SW_,BE%AQLCJ3_L82:[E@
M^*'0:LVJ5[%J"-C"RUPO#G+.DL!/G(C'H2M"8-K03<4:7/P\5ET$%UF$T\\\
M&RRBQ&:!"R92$# ;1&R>P\%Q+R=P$<?^@V+5:_"#B87 8N75W/WPOKE^M8>S
MX/6KW9V'F/@\6@B(/ S83M&AG^@MU@%:'[8I*R<8[C4ONM(4^]6],-^])8\;
M1MU5U?H:1MTUC#I9M'AR'KN>&P5 *AS,'L]C-@>H:W,6^S+P$@D&T<9+U]E,
M K:5W*V3YGOYY'$XHM<"<BT@9P4DS[GO\#!*H]AE;AJ#=1DGJ<A9$*6I[WIK
M._/G"<@%.]-)1.@G*8C%- QME@G7YB+-;)]E/D]3+X.3 @'I;F)9G?]K"$C"
MS<\H#^_J]/,FT>\&I1</+ET0^';+4;Q[VWQ!S]_RW6]+P;OJMJZS%<?QG6?V
M.5N!O_JAZ\6N%_L[+3:Y&=]^=S;J0AJ>EDV/,A/O"*>+XMS9\6EM[6*9Y?=D
MHBYLEAO</F>1;?G1P]RL^TWW_!7WSKM]NN>/2(M]N-NT+\<6P:U#0/?U0TPI
M?KA[=X"-Y:G@96](G:R?8(^$IP]Q$Q^H-M@;COGPA+H@D0UJ;0^PA.CK;&>=
M^TW]?[CTMN;5-:\^!E[]K>HIUEG$OW$6L9.&0L8NB\(H9($;)V',7)EG+ ^2
M-'+=6[>T?8\]MB;R=54.L/42+N%C,3Y]I>=&[%YBCQG8O&V:IR&S(W[YJWAF
MO=[..Q_^<_=W]KQ/'WM.[^,G#ZZ[W-\1EY\^_GWZZ>M^O_?G.]:;SGMF/UW
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MP!PS)*FK\ZL,L^S12 A*RVA(CAL>]?7(J]T];31K[7ZW>UIKPH?3=JO5:32
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M96KA!/<QB8:26]FZ(QFK:LDP=WWJ"Z/>9<@!(OR^L+'2C4S7J8U!W0!KK8;
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M.H3DF6I_N)K$H(G]!1LC757;K?7$D:0$LX)]N,VUZ8&6[DF(Z-VM#K"8@4N
MF1C@O8M'59"IQ$2 SEW"$+B5[!/1OFQWHJ)7!-7EL:VFR$\'Y<+8&"DK%M@8
M\,C,>8H>?!$.7>7O0Q+6C C>*XP6BQ2%2QZ)FRD%^<Y&Z#F\!C4)E1_\'12
M86B-9R*)=R+!&F0X">0IJ534YJB/W?7]X%:>.==/#B ,&]CG6"&/!%Z4^H@F
M(D#T,4RC13PE3K9E9DNR'$0"C)@66OE-812X(\R,%<L\F5CV3]31C&$0. A;
M %K,.D)Z49"NL%*;U*(K<C*G$=8^F*Z83*6ECTN!YT2Z@6HT3!+%0FZ#5*:
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M-"0"]T9),!4#V1Q=*,)!^YL,CDKWA(H&BK_MP ^8A(^=-"C_AQL2U/T%A<R
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MR[Y<^7JGMK^6P]5,6JU1F@_[H> UNVL;Y*7U4!+7:A.JK^^D+(V'%V7+K\*
M:%;-4FDL[0=D0*4E6>K811]P.;5R:H4:<#DU-;5WE"F9DYF9%!Q5:W-%1S/)
MEGTOL'_.I58&$YE2V6Q7FZ?FXKJE)U2MY Y@;-V?R"3.:LWL_/(!:ZCXBS9_
M,3_$HU4?OGQVG/+X:(5-DM.Z:*);34E>!J\]G]Z7ESY^2SW:EETYF\FTJ2*
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MK.HRSE;0C2G-MV)N3'U'UENY+X]RLG6#>*59O41#,>N$>5P\ ?T]B#'#.T=
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MI[%'^&EW%6Z:-ALL2@?9?"9,_9$,)P0.$E)'4&'9(\4?'PPK)*9YZV(_W;X
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MMI)V5:8F[-B:5F^>>C9RQ< XOQ?VE$[=U0 4181=Q@QG^BU-A9:_58 Y1(9
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MXFC.NW[@/,!_1O'8^_7_ U!+ P04    " "B:*E6 S('5MT8   >' $ $0
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MT<<CE\9!Q%8ZPE]%DGXP$?LBLY@QV'?,.I"G67_:N@L>)B:MIX_S/RK:1$%
M(T'/OTF^6RY),*7R"_B*R^QY*KCW>)HJ\-(^5*$=Q#_GB+F,^@I5<K1D%#1R
M1'"8W\,$@SG#TX\'?"?KI(KZ#Q]-#J$GZ2.E!HJKC_]\!"38O\E&DM+R!?#Q
M( 0 ?"SGQN:!+QDV'3B0A+!)"J#_WX_?1;[I^('$C?U_C^%[>&HZ?" A =EB
M])SZ 7YWB/?Q8$C! !^A&?2.?__M_KK6FA*M9L^G3%.V67\^=<7_>DXG,]D[
MCJ!T..DO1YL$&ZSB$'MWP2?Q]Z:4)\3)(PV$&^*A35><UTJRY,MT(ANG-_!P
M ,3P1TA]XO%SRQA&(^S;D$[O8(9%'T-M /0Y*B'J RYK6H%1PMS)<\\>"1TZ
M=;(&WH#,IGU(%S#".3Q#'O$U'&,7^DMJ"]9*:(^W@;;0DB.;:CO(GY'/#QCC
M.<;1BQ9ID9$2P!,] !.NCF3[!E9NCD<(K/)HCB,"'=X9<D6N2AA/MX'1^;G0
MRG^U'=:\-AS/86KFU/<P"R__BDFTVI6>K>"LA/?=-FHVW]!_.K*I-XB;@-C9
M4C9I1@G^^UV!_[;>&ZP?%,ZO?/JT,P,Y8Z@$^,-61A3P=T0#+8)Q'"\6B*U@
M49%90*8@Q4$T<(5KC@2S$4R5"V=A30@UF2GA.^,G4!*Z/@UCACF6DK%8AAEK
M)^/MI,Q;!-T]?L1!C.^Q2V>2J29,%80J2'K=34@2)DZ.2XOF?N""_@\%MQ %
MW@4<N\*(1# UNFNEB8,2C=XF&GEN#K!S\OQ:A N?%,HU0@STIBZ:&F(E&OU-
M-/*,VNEVN0Y .T24Z>\=>0KEC!]OSGB.NF6S'$;"@#&8Y91".<LG5;.<4+=H
MEF\P"K7%.'E8.;>GFW,K"5LTK5\H]9Z([\-N=0V#"&9DXN-!&.I[ZYHX* %X
MMPE RDULGQD_1S)L$3!7B+#?D!_CKR"2,#<F^J6:5@G&^TTP.!]','+RG%J$
MP@5FY!'ZP",'8<1$-(X;BK]B;P8'GH$+/Y%(?W_5YZ=$ZT/)WEGS=G+,Q4)*
MV#L9_Q9A>!UX>!)A+\"A_@:=(U$B43HHY\E;--&7B 4@9>$(,^&F \G;VMVL
MQTL%3;]T8$[Y.L!8.A/% FFY3WG@NO&"]P+(HSEF%3'3&ZJ]>G2Y*=&K.&"O
M.3N"=67,U?F9LV^3&_@><WWO1C$#V1[.>8*O+EB5I$ID2H?M ALGX=,B!*3D
M/:!G@Z-V1J&<[XJCMI!T0=ZB:1X*A\X,!P;^\"*-<JI+Y^T"?8OF>HQGW(*\
M#J:4+9"!9[N"4#GKI9-XPL3)<6G3W,>3$/\5PP N'PT.?B4RY;R7#N 9"T?R
M:-6LZT3.]A*.TP[+]4NG=/VPG/-S^E>;C",] ![0Q-\QI@E+):*ED[P)HK*1
M-N%9#IP:85=+KL2I=,ZOB+ZV$9#/<4BXJP/.8A,2H#28*ERV^9"H$4R&3%7@
M'9<\ 6D#3KX%X0P0;12#N2U$-1?,,P*N3*?$IG3.S_%HZ]0G$3[CJ2_2*:>^
M=)#/\6CCU,L H-&L%TB4$UXZR4OR-LYU0^30"  U'R4JI4-_<QRRC6A5!A6-
M<&KBH$2HY""H"4ZV$1KMJ*(17*9<E1"6? U&$<LV IL/)!I: B5")3PEQT*>
M21MG7RL&:02+"4<E7B6W@4%LLXUP:H8EC0 UXZF$M.1A, IXMA'4JO"EH3NH
MEH$*KI.*=/R**&@;8<D%-PWWK4TZ)0@5SH,L--K&N2^'W\Q\VW7D2B1*OH2*
M&%XK =&*%@Q\GS[Q6\PP5T.&/1)QI8[#"QPAXN\V,J%J2PEUR8MA$+* 72UM
MWH'V'=D!1_; ^3GI0YL$I!R2X.4-O=C'=)K\-EF-&/5@:S$3AVTX*\$O.4NJ
MXB @$DE+7";2)R8K)VGM#6C!=.!YXE_DYY3D2S%N9*J$M^1IJ88W:Z2HW]]@
M+:PRGCW$D!LE)2H,U?DVG)4 E_PPZO6;MI56VGC3T[7:] NF,X:6<^*F=0CW
MH++K&U&B7W+S&&GOK&$G;;F5HM!P<?@6,2:<FF:XFW!4@ESR#35>38;?UTV\
MH5F<>S!7>"%EM#,P-QDJL:QP"C5C"2TXHHE68EE]?WS+1:G)3(7A:<E35',Y
MO?4K,9?Y8894!:$2E>:\DY;.?I+\83[[&X3*V6]./6GA[,M,D'RYO-3$HE.9
M=P#*_H:@"?%%1-0,HFVY*W&LRVCI%,OR9?8B6)1)&@7?O')-MAAU\=_+YR6O
MC[4-KE7T2N1*CIPU<N(/)^'78E@&01 C_RKFIM57Q.,Z7$[I5/ZZ#5!Z')70
MU52NX-:A:,"1+3A9$WS9I;EF;W@VS?X?O=TC^D?O#=-7Q;2_!TS[;YCN"=/O
MF+]Y"GN#1S@9S;#X\@&SA3Q,AR*H=(^B[52P,7,ERB6/ZAKEM"TG:2S9645S
MR=E=-NB(%EL,N?AO6EUTZ*,P%$%$<2S>VB)2\%,"6W*6;EA(ZVJESD8+K02R
M(1$[_<D,20.&2BA++E%%BG?N@3<L"U.??09AQ[,MG#5;,E=B7'*5*C'.?9>U
MUTK *[/SKT@ )WC" \E9"GBT?M0,]9>TH(+^7<G#6G<_ 'Y)FRQFG4=YDC<)
M2.8K"SY>D6?L<2OEA@:S"/.72TX,TU%>TH)2 DK>W'H)R <W1:/"^G)XLQW>
MKL,;;J4,:%_ZV#:@LC5_)?[E L!&UTO:'GG11N:*,CC4!,/DM8WP\0DQ+\T0
M,;0$=MVJ4DI*WFI3*4DZXJ0]<9*NK'-DVFD^: -9%8'8D\PT-:44E))SW%10
M:J(?;\+1I/7Y*T)"6%[\QDM&M2^EHFI.*20E]Y[QGD.#3M:%'/F;%FE$[G(Z
MQ6Z4O8Z&/X#A\.CZL8<]$@SNAM=[$AJ3II4"],([L1U']J;PYAQ']LA)N^20
MP.&=>I.H)EB+#CPZ_8)(P.\D9$ / F]]@$G([[$<7S@GRWTIJ=UU3"F-)7>G
MJ306^\JEDO<VO9]8$%+H=/Z$EK(K=+R5$IN_=IV=C3]3QN@3O]Y[%T=A! C
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MO5EO3L_T,2WL]#<;.NO+! /CZP<EBK_5//GE" 84@A9?H$\__1]02P,$%
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MQ2N75397B&Z13)ZN)JXJDU4-$+/E*$E("^B\!D/9IX ER-Q;IS],U9C:$$:
MM<YB[%B&<7HZGUU1M4C159LBD%$(IOH$H<H(!IWU)6GTU?<_\KU&PYAZ%48
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M#_/%ZG)ZPM^178YU2^9OC![Z^WRV^K!\O7C%WL=$E2 H) DUM9&T)IK60$[
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M5$O-W?N#-A$R!IOU>$C920P#9'NO<O=_"!?K9M&)<9YQR@:U7638[H9BHF)
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M>#'JV?&[AS WG(UT.@*[!^C=>#IS%___\&IN,5"C/;4<'7EI) B;<!=AEB)
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M%W'ZP245@_ 2W]O*DVX)\?"K6D?=6#]9Z).2BA[IS>P?Q*%H'KS0W@!.M90
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M=OFFU=AG1/U>XJR=S[I!_]Y-QE^&T_7@VE=%SFB(A[E%-U_AT/9 ,VB6;IL
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M0OKP.:5RX';;L*G,Z6(\+?5B?OUV3WS3W2$KT^5E0)8V!0LA!()N'<[71.&
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M O=CX4L&2=1HQS&3)4=G2L5F)3CVAM#W?=%!=>6 ;)S*;=,C#L/=2<Z/6F5
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MCP5]GH#FM*'C0!HSO5F+EY?Y/JAD?>8@J4>_UY4&?M%ZL-9QD5C*V?:VH>W
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MI><V!8\E9#*4-!M>(.X'%];@DH[&<N<)7"3E!BT8>.L9!)L03'$FQ'Y4A[\
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M$))34;CFC<0?HSB7X&E/^0[06/PAHK5N=\$T4.!T&Y[G"9KVY6HO]3T$/4#
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M,,TC+:#4YD-,62/)*B"#P$OM&#<85=9.TE]V"V\?M.[I]\@7H7@/ ^;#,37
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MC Q@H-6*F T1W$[4[ !LH+O3G:">Y_ZT*863(>5_4@5QWBL19*[[L&4Z)V1
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M.K%"/-58YZ3Z<(BXA]>#]>$52LA26,X$-X9I*RT#4(X.+QTUP8-@.]E^Q^O
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MX'$0U-E/7G_NO4E_G4E..28Q@80( 5%&,TA9Q*#D62)%S+)817U/O#=2IK;
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MUC&]!W@=3^Y=D.H^Q+<::<3S?!?+]H_VG9[L0=Y[+X/UT1B=OWZ@BWM9S;)
MQ4&H/5^LG3:3)4\@0PS!D+$$9S*.&%;6K-TM:VITO540\$9#!QJY *L%'?L#
M:TSW;7NJ;@H!^X;-@7;]P3<2W_:'T8UE[8#II-<+0XS'JW:V[!&JY2,]F/3+
M;WGQ>ENN&2=,193&4 II<@2R !*5$)@%-&(HQ4HXG/;OCSTUIC3:N5;]/D#+
M@A#[8S P 6[,[Q, <H"# \/UQV,D1C,*UJ6]S:GVQG/\\_-]+@OO];Y/H]%)
M8P>/C$=;IW7=HZDS'^E!2^9>5&NF_WS_OM!LH/EO$Z>..!9491CR"!/-42&#
MA)$0AFF@:""S-$CMP]PZ!$V-L'94U?ON1M?JCPZKM@M4"RKS!-7 O+:+TEI-
MYW2)BW Y,)XGV$:BO[[PN?&>!2:=)-CU_'B,:&'%'CW:?+YG49CC"E+FJN[V
ML>YZ^:9\I'DQ$SB*B=[\0BR4:7T5($@R'$,52,Y8J @*(\=:)A9B7;[CXY0V
MV:F#]HND1NFF"%*CKV-"E17R=A<>OM$<F&C[PNA>_,0!%U^U4&Q$CEL:Q0&$
MHTHI+L_V<-;V2[#<T>>ZJMUG:<;50Y3JG99+Y_\EZ6(6<B5IABE,>)Q!A'$$
MJ4PX3)@,5*9B$5$U6YK"3A;.FX-@)V=N(WZXU6/>:0Z^B O$%J[<0, -S#B'
M]95NP%IS$R+;ZFX._!OM@5%_((P=_+^!L![)'_2*N9N3V .X3J?19;SQG,@>
M5NXYE7V>=^/X:K&<?=;?B4UW0(X(4Z&"5'\,HI2;>Y:$:0I/>)H0[4Q&5K4&
M#\:=VG;[BUE:U3(WW^K^?N(A>-WD? 4D0Q\7]D7#>LV?L;W+H]./['AS^J>M
M)W<XVB@+^HP)Z_5Z[L\>"X&NU_^;E30K_IV>_UF8$25QDFI'*^80Q0G6ZS4*
M89(2+DF2!JF\OC;H"<%36]#ZNY%Y*%IY"F++#=X P V]R3M3VO(&+$O I'8&
M<G%3O_2!T7S@BI<=6 U9!/.4V)>OB]D!AE6IS*[G^U;PV0LA?Z^=T^(^9_.F
M4U>U#27_J+]Q[=%($"N:1H&$F218DY-((,.(0)-/GU+&.4J<6O7UT&%J/+63
M2C&O4RGRC1'5'W\*?^]:\<=]4NSH;&"H!V:VHX25K?Z;TAR[F2O&B $.MZX
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M$9[1,$'2S9OJK\K4*,>]=<05T] _X.&_72L)MQJJ8S25N![6 6,IIMADXGK
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M=R;U?V. 34ZZK\FQ([!A(1^8S2Z4 C@%^R"QV/U!'+8Z0)<"4Z@28 &09;4
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M5A_-*VVP'FTE11OM6Q9;79HR"R<^LM-%]16M<EYO"F8J#5DJ!(.*<?T"XX&
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M::2@*0<J4RX3A+%-&3)+>4[L,D+M,?V-2EVZMUT&M)L^!H!I8/HXIHVUPC=
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MX@4,XS13-C,/ TBRF$,4!U&8)CA,,VQ<R,YV]*DM[O'/2OY_!EL-0*,"J'4
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MB1&UV0192S ULE.O46)GPMB#;F;># KEP&39R#X#6^E!+?YLVX+M>::#(Z@
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M5$L)]L2T\.><0=' R74]-@,3R!$L+M$'9_"Q<'I=C]-(GB\'O.S<7_U(]/K
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MYR+#(@PR'CC53!Y%^JG1\G4]SL>=>#.>GNQT#DSSVSK/>XK/P$YUL*][FXH
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MIDR9,NMIIHS)2$ <Y1$D(2>0"8EC%.(D"7*[+#C3H:=&T9WDX UO9?\)%$O
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MJ-QBHO1+.C&ZQXU!M/MP_?RK6#^47#=N7#5VUF[G(".D=O"1A"1/U8Y-!II
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M^I,][;29]F/N'KXY;L3^NM^'GGF_^BI\:MZU6PO!^[WYW1I9I<#N-L8X>&.
M/5O#O1KZFX= ;XX>%!STQ=(?P(?OG1XE=;RQLY?N9L>PN9.J:A<TU30HXG$>
MQ1%,><)LY^H<\EP3F/!4"YQDB.:T*6#B>'?7*M")(/;+EO1]BU=&<-3E2L";
M6:GM;QU"_RX@[7A_=SUZ0\8$[6JZJ9M5*WN^[:7_C9X3*J%N]MJ%#7O#YV3X
MT4V?VU-=4^GF]DCBVX-2ZT_+JBQ3&5F2R$Q(F4C((J$@SH@R?Y,1%%S$B29I
M)CCR2YX[+6AL/F>M)R@5!8VF7E$Z%[%U(X\0B/5,&]W ZI (UXY$L-2W,V(&
M3G9K-_8XO>W"Y[M6LK252<3ZN3",4^8RE#NK&^O)S&RSA7>SE3!;L^=";3-
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MQ] F9&PD4:L)1*VG/0$L%?4IC'H&3X?KB  H]4P(#4"-BN!+.(!\BL9>#]1
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M=J-V+]E.'$$KCF@TZ(\FJCP"F\]1%8WR3.+P0SV1&9,\(3!.M6WDJG)(\EC
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M.C?H<*VW+IBUUX7KTF>[)$O;0C)-].[+WQ9-A28EW_\2:K6J^F).,5,41;&
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M;H(T/G6'M$LW5(?17[U%JCL"+GU3/4;K\,;ZVX+-RWE6LFZC7>\>=4(HYY1
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MK,B<Y'F:QRDT+[/,%J7.("5I#!G1/.8*2\:S8+G4IW48&U\>9 %ODX!!HW_
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M53S&4Y$CDC-!H:!I9CS7'$&&;;Q+'F4J2PEGU*MYJY_XL2W/1F/(*I6K=J[
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M5)GB74FLTB"-0Y8E/L3DV._4J*F9.K:X<",X^%U+#AK1.T?FN0Z%&TT- /#
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MNW8\=IUH3T".5(WV;:%CY&>^_*9-H9</DI5?=!-U7@,B$A*:':= 19JJXC"
MC+$ 9HD(>(33.*%>GNSCW4S-7C-20B,F,'+> "-IQ[+S)W!U8Z3KT1J8?2Q0
M7WR!\H\%/8M#7P&AQSL9-RKTK*('H:'GK_8C@J:$R^S^Z],,J4@)%@D8I>:
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MXJ.MR&FJUX-W'_/5+Z!5 6QT\"RI[C] ;CPV+.@#DYJI0F,1;\0W>53>&0W
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MEIAO!*2B"TQ&!8+'&@*E!,Z0L;=<>%_[_HC\5#^V%B#:(6E8%JP3Q^\4)0S
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MRK)FQNX+=X3!U>1'@%BB!I6$!:<+A:S,2J&UTLFW+@%O0WG?!>)-7?L>E3J
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M "=EFP#Z1L!%E) \(@AM+5EW%<!YCY!+Y+69C NJ-3C;<M!WEJ1C$/>H[@&
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M]#LN;Q^ACE@HQ7"EP#C.:3,(!DZ3ST?FW(MB=%2L=?_!.P3TZU6?$S_'RWT
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MWNI'\(61(2P^.[F?[_'P]WN'P*E:F[458=\H^/UJ.5^EM3:T"XM*1JU ENR
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M&7(^>38@T9%-\)EN;A\#9!UX8+98F\<J;WV2N#YJ6R=&X/'JZM3:/M:5<_J
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M'--!T#AECND0/4V\)OYE;1? %8GX\GMU3:[=7&YS">2)H'"5_AP@UJE^JAH
MF8OR_*#'@B?6Q>_Z]K3C"GJVL$VT-3':WN/7JU7Z'-;XXM,*\;HGY4>6MF>5
M%Z^M]98.)Z];/A*K@_M)0AB<3IFEE \:\?D$! \F:)J[K8W.EV,KH->P,]HD
MA) !)#=TS*)#.F8H0=K -2<9.G/8RKBNPLX1]7A(D#E$J!TX6.-?Z:]O"Z^<
MTS8Y[8 QI\FS14WQ=_# A%6110K!4^N ]8SL33NAI6?3W#O6.CB&UYW8;\N
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M8FP];^$$<KORQT_!W[E4UJES_H_E,O\YO[@("V+YDOBM.[XWDEC?_-$)WOF
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M#X+'X':B1CH%E]BRPD,I144#W$GR)WRP$#@9"(F.F\(5BZQU;> ><CHQMI.
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M14-MNB,GI5;AQ:*3:-V&^S,5SRL1/8['=Z)NND/7O9'LRCH5=7"0#7.U-SD
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MO.QR"J[7^_#(@Z4KVJ#WU4VMHX5K 9AE3!19O&R^O.LQ6B9.,/;I2S517*<
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M:%=S!+QPB$A>9[&1!9)KR-@ZPW808=.&"*/#8T"U]'&ZZAR 3_?5:ZVY$=9
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M:(W9/ZR*>C1,>O)C4\_J;1\MM97OA'A9KRYGMQUV'Q(NPFJ^W.0L0V;!25%
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M+,[2FE5/ME.R$L8J3SZCE^0S)LF\)S]")L3"52PA=X/*ZVOU]Y2W/5(:<W8
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M!Y9Q&QSGAO:@6H^C>I:0P0'G$"&_#)T#.#X\V'QW"93DA92P9US(R+0*G,4
MR(R"DDU17,7FY;T[:.DYX'/B&^LPEO== _3[Q>7'V7*<<%;.Y[,;<K[RV2J/
MEV?Y;ZO%NETD^86K6J6^#5>=XQ0FR]N14N"+(%=3H$1R-5-<-V=G-O,(,J;
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M'U!+ 0(4 Q0    ( *)HJ58<' KEL @  , # 0 1              "  0
M  !C>3(S<3$Q,'%E>#(R+FAT;5!+ 0(4 Q0    ( *)HJ59^<E+/=@<  $8E
M   2              "  =\(  !C>3(S<3$Q,'%E>#,Q,2YH=&U02P$"% ,4
M    " "B:*E6V H63&D'   Q)0  $@              @ &%$   8WDR,W$Q
M,3!Q97@S,3(N:'1M4$L! A0#%     @ HFBI5B);86RF!0  B2,  !$
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MP@  97@Q,#,M,C R,W!S=7-R='-R9W)A;G1A9W(N:'1M4$L! A0#%     @
MHFBI5K^"/ZE>GP  /Z\# !X              ( !N& ! &5X,3 T+3(P,C-R
M<W5S9W)A;G1A9W)E96UE+FAT;5!+ 0(4 Q0    ( *)HJ5:J1(7_=K4! *!!
M"@ >              "  5(  @!E>#$P-2TR,#(S<'-U<V]I<'-U<G1S<F%N
M9"YH=&U02P$"% ,4    " "B:*E6LK8?NGZ3 @"F#1X $0
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M+3(P,C,P-# Q7VQA8BYX;6Q02P$"% ,4    " "B:*E6@(TL0"2Z   5/ @
M%0              @ &^-P@ <')G;RTR,#(S,#0P,5]P<F4N>&UL4$L%!@
0   /  \ ! 0  !7R"     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
